molecule_chembl_id,target_chembl_id,target_pref_name,standard_type,standard_relation,standard_value,standard_units,assay_chembl_id,assay_type,assay_description,document_chembl_id,readout,smiles
CHEMBL303519,CHEMBL217,Dopamine D2 receptor,IC50,=,9800.0,nM,CHEMBL671073,B,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,CHEMBL1130912,IC50,c1cnc(N2CCN(Cc3cccc4c3Cc3ccccc3-4)CC2)nc1
CHEMBL292943,CHEMBL217,Dopamine D2 receptor,IC50,=,50.0,nM,CHEMBL671073,B,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,CHEMBL1130912,IC50,COc1ccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)cc1
CHEMBL61682,CHEMBL217,Dopamine D2 receptor,IC50,=,25.0,nM,CHEMBL671073,B,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,CHEMBL1130912,IC50,Fc1ccc(-c2cncc(CN3CCN(c4ccccc4F)CC3)c2)cc1
CHEMBL64487,CHEMBL217,Dopamine D2 receptor,IC50,=,360.0,nM,CHEMBL671073,B,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,CHEMBL1130912,IC50,COc1ccccc1-c1cccc(CN2CCN(c3ncccn3)CC2)c1
CHEMBL64597,CHEMBL217,Dopamine D2 receptor,IC50,=,300.0,nM,CHEMBL671073,B,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,CHEMBL1130912,IC50,c1cnc(N2CCN(Cc3cccc(-c4ccsc4)c3)CC2)nc1
CHEMBL291824,CHEMBL217,Dopamine D2 receptor,IC50,=,70.0,nM,CHEMBL671073,B,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,CHEMBL1130912,IC50,Fc1ccc(-c2cncc(CN3CCN(c4ccc(F)cc4)CC3)c2)cc1
CHEMBL59942,CHEMBL217,Dopamine D2 receptor,IC50,=,49.0,nM,CHEMBL671073,B,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,CHEMBL1130912,IC50,Fc1ccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)cc1
CHEMBL61657,CHEMBL217,Dopamine D2 receptor,IC50,=,60.0,nM,CHEMBL671073,B,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,CHEMBL1130912,IC50,Fc1ccc(-c2cncc(CN3CCN(c4ccccn4)CC3)c2)cc1
CHEMBL302183,CHEMBL217,Dopamine D2 receptor,IC50,=,120.0,nM,CHEMBL671073,B,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,CHEMBL1130912,IC50,Fc1ccc(-c2cncc(CN3CCN(c4ncccn4)CC3)c2)cc1
CHEMBL304692,CHEMBL217,Dopamine D2 receptor,IC50,=,2300.0,nM,CHEMBL671073,B,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,CHEMBL1130912,IC50,c1cnc(N2CCN(Cc3cccc4c3-c3ccccc3C4)CC2)nc1
CHEMBL555670,CHEMBL217,Dopamine D2 receptor,IC50,=,360.0,nM,CHEMBL671073,B,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,CHEMBL1130912,IC50,Cl.Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL291380,CHEMBL217,Dopamine D2 receptor,IC50,=,250.0,nM,CHEMBL671073,B,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,CHEMBL1130912,IC50,Fc1ccccc1-c1cccc(CN2CCN(c3ncccn3)CC2)c1
CHEMBL64671,CHEMBL217,Dopamine D2 receptor,IC50,=,490.0,nM,CHEMBL671073,B,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,CHEMBL1130912,IC50,COc1cccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)c1
CHEMBL62829,CHEMBL217,Dopamine D2 receptor,IC50,=,81.0,nM,CHEMBL671073,B,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,CHEMBL1130912,IC50,Fc1cccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)c1
CHEMBL64119,CHEMBL217,Dopamine D2 receptor,IC50,=,620.0,nM,CHEMBL671073,B,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,CHEMBL1130912,IC50,CC(C)Oc1cccnc1N(C)C1CCN(Cc2ccccc2)CC1.O=C(O)/C=C\C(=O)O
CHEMBL302904,CHEMBL217,Dopamine D2 receptor,IC50,=,23.0,nM,CHEMBL671073,B,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,CHEMBL1130912,IC50,Fc1ccc(-c2cncc(CN3CCN(c4ccccc4)CC3)c2)cc1
CHEMBL60957,CHEMBL217,Dopamine D2 receptor,IC50,=,450.0,nM,CHEMBL671073,B,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,CHEMBL1130912,IC50,Fc1ccc(-c2cncc(CN3CCN(c4cnccn4)CC3)c2)cc1
CHEMBL1204116,CHEMBL217,Dopamine D2 receptor,IC50,=,65.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c(Cl)c1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,IC50,=,113.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL1203260,CHEMBL217,Dopamine D2 receptor,IC50,=,263.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Cl.c1ccc([C@H]2C[C@@H]2CN2CCN(c3ccccn3)CC2)cc1
CHEMBL1202222,CHEMBL217,Dopamine D2 receptor,IC50,=,202.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Fc1ccc([C@H]2C[C@@H]2CN2CCN(c3ccc(Cl)cc3)CC2)cc1
CHEMBL2092961,CHEMBL217,Dopamine D2 receptor,IC50,=,60.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Cc1ccc(N2CCN(CC3CC3c3ccccc3)CC2)c(C)c1
CHEMBL1202211,CHEMBL217,Dopamine D2 receptor,IC50,=,17.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.COc1cc(Cl)ccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1
CHEMBL1202213,CHEMBL217,Dopamine D2 receptor,IC50,=,2.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Clc1cccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c1Cl
CHEMBL125455,CHEMBL217,Dopamine D2 receptor,IC50,=,64.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Clc1ccc(N2CCN(C[C@@H]3C[C@H]3c3ccccc3)CC2)c(Cl)c1
CHEMBL1202216,CHEMBL217,Dopamine D2 receptor,IC50,=,5.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.COc1ccccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1
CHEMBL1202217,CHEMBL217,Dopamine D2 receptor,IC50,=,171.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.COc1cccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c1
CHEMBL1202202,CHEMBL217,Dopamine D2 receptor,IC50,=,12.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Oc1ccc([C@H]2C[C@@H]2CN2CCN(c3ccc(Cl)cc3Cl)CC2)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,IC50,=,4.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1202221,CHEMBL217,Dopamine D2 receptor,IC50,=,146.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Clc1cccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c1
CHEMBL1202220,CHEMBL217,Dopamine D2 receptor,IC50,=,246.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)cc1
CHEMBL1203257,CHEMBL217,Dopamine D2 receptor,IC50,=,766.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Cl.c1ccc([C@H]2C[C@@H]2CN2CCN(c3ncccn3)CC2)cc1
CHEMBL1202219,CHEMBL217,Dopamine D2 receptor,IC50,=,13.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Fc1ccc([C@H]2C[C@@H]2CN2CCN(c3ccccc3Cl)CC2)cc1
CHEMBL1202210,CHEMBL217,Dopamine D2 receptor,IC50,=,128.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Cc1cc(Cl)ccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1
CHEMBL341497,CHEMBL217,Dopamine D2 receptor,IC50,=,37.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,c1ccc([C@H]2C[C@@H]2CN2CCN(c3ccccc3)CC2)cc1
CHEMBL1202215,CHEMBL217,Dopamine D2 receptor,IC50,=,5.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Clc1ccccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1
CHEMBL1202212,CHEMBL217,Dopamine D2 receptor,IC50,=,208.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)cc1Cl
CHEMBL1202209,CHEMBL217,Dopamine D2 receptor,IC50,=,68.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Cc1cc(F)ccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1
CHEMBL1202204,CHEMBL217,Dopamine D2 receptor,IC50,=,228.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.COc1c(Cl)cc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)cc1Cl
CHEMBL1204116,CHEMBL217,Dopamine D2 receptor,IC50,=,93.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c(Cl)c1
CHEMBL1202206,CHEMBL217,Dopamine D2 receptor,IC50,=,7.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.COc1ccc([C@H]2C[C@@H]2CN2CCN(c3ccc(Cl)cc3Cl)CC2)cc1
CHEMBL1202208,CHEMBL217,Dopamine D2 receptor,IC50,=,73.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Cc1ccc(N2CCN(C[C@@H]3C[C@H]3c3ccccc3)CC2)c(C)c1
CHEMBL1204119,CHEMBL217,Dopamine D2 receptor,IC50,=,45.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Cc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c(C)c1
CHEMBL1202205,CHEMBL217,Dopamine D2 receptor,IC50,=,5.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.COc1ccc(Cl)cc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1
CHEMBL1202224,CHEMBL217,Dopamine D2 receptor,IC50,=,752.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.COc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)cc1
CHEMBL1202225,CHEMBL217,Dopamine D2 receptor,IC50,=,32.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Clc1cc(Cl)cc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c1
CHEMBL1202223,CHEMBL217,Dopamine D2 receptor,IC50,=,56.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Fc1ccc([C@H]2C[C@@H]2CN2CCN(c3cccc(Cl)c3)CC2)cc1
CHEMBL1202214,CHEMBL217,Dopamine D2 receptor,IC50,=,10.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,Br.Br.COc1cc(F)ccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1
CHEMBL22242,CHEMBL217,Dopamine D2 receptor,IC50,=,880.0,nM,CHEMBL671074,B,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL1133592,IC50,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC
CHEMBL831,CHEMBL217,Dopamine D2 receptor,IC50,=,54.0,nM,CHEMBL884444,B,Compound was tested in vitro for its binding affinity towards human Dopamine receptor D2,CHEMBL1132638,IC50,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
CHEMBL415300,CHEMBL217,Dopamine D2 receptor,IC50,=,34.0,nM,CHEMBL671075,B,Binding affinity towards human Dopamine receptor D2,CHEMBL1132638,IC50,CN1CCN(C2=Nc3ccccc3Nc3ccc(Cl)cc32)CC1
CHEMBL72292,CHEMBL217,Dopamine D2 receptor,IC50,=,140.0,nM,CHEMBL671075,B,Binding affinity towards human Dopamine receptor D2,CHEMBL1132638,IC50,CN1CCN(C2=Nc3ccccc3Nc3ccc(OS(=O)(=O)C(F)(F)F)cc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,IC50,=,260.0,nM,CHEMBL671075,B,Binding affinity towards human Dopamine receptor D2,CHEMBL1132638,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL81485,CHEMBL217,Dopamine D2 receptor,IC50,=,1698.24,nM,CHEMBL857158,B,Binding affinity for human cloned Dopamine receptor D2L,CHEMBL1135380,IC50,CNCC1CC2c3ccccc3Cc3ccccc3N2O1
CHEMBL70319,CHEMBL217,Dopamine D2 receptor,IC50,=,30.0,nM,CHEMBL671075,B,Binding affinity towards human Dopamine receptor D2,CHEMBL1132638,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccc(OS(=O)(=O)C(F)(F)F)cc32)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,IC50,=,4.9,nM,CHEMBL671075,B,Binding affinity towards human Dopamine receptor D2,CHEMBL1132638,IC50,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL73589,CHEMBL217,Dopamine D2 receptor,IC50,=,23.0,nM,CHEMBL671075,B,Binding affinity towards human Dopamine receptor D2,CHEMBL1132638,IC50,CN1CCN(C2=Nc3ccccc3Sc3ccc(OS(=O)(=O)C(F)(F)F)cc32)CC1
CHEMBL83658,CHEMBL217,Dopamine D2 receptor,IC50,=,870.96,nM,CHEMBL857158,B,Binding affinity for human cloned Dopamine receptor D2L,CHEMBL1135380,IC50,CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1
CHEMBL313189,CHEMBL217,Dopamine D2 receptor,IC50,=,9549.93,nM,CHEMBL857158,B,Binding affinity for human cloned Dopamine receptor D2L,CHEMBL1135380,IC50,CN(C)CCC1CC2c3ccccc3Cc3ccccc3N2O1
CHEMBL430798,CHEMBL217,Dopamine D2 receptor,IC50,=,52.0,nM,CHEMBL671075,B,Binding affinity towards human Dopamine receptor D2,CHEMBL1132638,IC50,CN1CCN(C2=Nc3ccccc3Oc3ccc(OS(=O)(=O)C(F)(F)F)cc32)CC1
CHEMBL6437,CHEMBL217,Dopamine D2 receptor,IC50,=,7079.46,nM,CHEMBL857158,B,Binding affinity for human cloned Dopamine receptor D2L,CHEMBL1135380,IC50,CN1CCN2c3ccccc3Cc3ccccc3C2C1
CHEMBL19331,CHEMBL217,Dopamine D2 receptor,IC50,=,1030.0,nM,CHEMBL671650,B,Inhibitory concentration against binding of [3H]spiperone to human D2 dopaminergic receptor,CHEMBL1129926,IC50,Oc1ccc2c(c1)CCN2
CHEMBL2303762,CHEMBL217,Dopamine D2 receptor,IC50,=,2420.0,nM,CHEMBL671650,B,Inhibitory concentration against binding of [3H]spiperone to human D2 dopaminergic receptor,CHEMBL1129926,IC50,OC[C@H]1O[C@H](Oc2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)[C@H](O)[C@H](O)[C@H]1O
CHEMBL349034,CHEMBL217,Dopamine D2 receptor,IC50,=,79.0,nM,CHEMBL670114,B,The in vitro intrinsic activity was measured at DA D2 receptor by measuring its ability to increase [3H]thymidine uptake in CHO-K1 cells transfected with the Dopamine receptor D2,CHEMBL1131565,IC50,Fc1ccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)cc1
CHEMBL164792,CHEMBL217,Dopamine D2 receptor,IC50,=,9.9,nM,CHEMBL670114,B,The in vitro intrinsic activity was measured at DA D2 receptor by measuring its ability to increase [3H]thymidine uptake in CHO-K1 cells transfected with the Dopamine receptor D2,CHEMBL1131565,IC50,COc1ccccc1N1CCN(CC[C@H]2CC[C@H](Nc3ncccn3)CC2)CC1
CHEMBL331077,CHEMBL217,Dopamine D2 receptor,IC50,=,1905.46,nM,CHEMBL672502,B,Binding affinity against Dopamine receptor D2L,CHEMBL1135009,IC50,CN(C)CC1CC2c3ccccc3Cc3ccncc3N2O1
CHEMBL83658,CHEMBL217,Dopamine D2 receptor,IC50,=,870.96,nM,CHEMBL672502,B,Binding affinity against Dopamine receptor D2L,CHEMBL1135009,IC50,CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1
CHEMBL315772,CHEMBL217,Dopamine D2 receptor,IC50,=,8.71,nM,CHEMBL672502,B,Binding affinity against Dopamine receptor D2L,CHEMBL1135009,IC50,CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1
CHEMBL553331,CHEMBL217,Dopamine D2 receptor,IC50,=,43.0,nM,CHEMBL671744,B,Compound is evaluated for in vitro receptor binding affinity against Dopamine receptor D2,CHEMBL1128457,IC50,Cl.Cl.Cn1c(=O)c2c(ncn2CCCN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)n(C)c1=O
CHEMBL305660,CHEMBL217,Dopamine D2 receptor,IC50,=,61.0,nM,CHEMBL671744,B,Compound is evaluated for in vitro receptor binding affinity against Dopamine receptor D2,CHEMBL1128457,IC50,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1
CHEMBL338611,CHEMBL217,Dopamine D2 receptor,IC50,=,41.0,nM,CHEMBL671744,B,Compound is evaluated for in vitro receptor binding affinity against Dopamine receptor D2,CHEMBL1128457,IC50,Cn1c(=O)c2c(ncn2CCCN2CCC(C(c3ccccc3)c3ccccc3)CC2)n(C)c1=O.O=C(O)/C=C/C(=O)O
CHEMBL14376,CHEMBL217,Dopamine D2 receptor,IC50,=,110.0,nM,CHEMBL671343,B,Binding affinity against Dopamine receptor D2 was determined using [ [3H]-spiperone radioligand,CHEMBL1128281,IC50,COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1
CHEMBL11425,CHEMBL217,Dopamine D2 receptor,IC50,=,67.61,nM,CHEMBL670073,B,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,CHEMBL1129704,IC50,O=C1CC2(CCCC2)CC(=O)N1CCCCNCC1COc2ccccc2C1
CHEMBL11265,CHEMBL217,Dopamine D2 receptor,IC50,=,1096.48,nM,CHEMBL670678,B,Compound was evaluated for the binding affinity towards Dopamine receptor D2 by displacement of [3H]SCH-23390.,CHEMBL1129704,IC50,COc1cccc2c1CC1(CCCN1CCCCN1C(=O)CC3(CCCC3)CC1=O)CO2
CHEMBL417608,CHEMBL217,Dopamine D2 receptor,IC50,=,1778.28,nM,CHEMBL670073,B,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,CHEMBL1129704,IC50,CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)CC1COc2cccc(OC)c2C1
CHEMBL416523,CHEMBL217,Dopamine D2 receptor,IC50,=,29.51,nM,CHEMBL670073,B,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,CHEMBL1129704,IC50,COc1cccc2c1CC(CNCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2
CHEMBL11262,CHEMBL217,Dopamine D2 receptor,IC50,=,2570.4,nM,CHEMBL670073,B,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,CHEMBL1129704,IC50,CCCN(CCC)CC1COc2cccc(OC)c2C1
CHEMBL11592,CHEMBL217,Dopamine D2 receptor,IC50,=,10.0,nM,CHEMBL670073,B,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,CHEMBL1129704,IC50,CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1
CHEMBL116463,CHEMBL217,Dopamine D2 receptor,IC50,=,551.0,nM,CHEMBL671072,B,Inhibition of human dopamine receptor D2,CHEMBL1134625,IC50,N#Cc1ccc(CCOC(=O)NC2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1
CHEMBL326263,CHEMBL217,Dopamine D2 receptor,IC50,=,2240.0,nM,CHEMBL671072,B,Inhibition of human dopamine receptor D2,CHEMBL1134625,IC50,N#Cc1ccc(CCOC(=O)N2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1
CHEMBL113956,CHEMBL217,Dopamine D2 receptor,IC50,=,2890.0,nM,CHEMBL671072,B,Inhibition of human dopamine receptor D2,CHEMBL1134625,IC50,CCOc1ccc(CCNC(=O)N2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1
CHEMBL115280,CHEMBL217,Dopamine D2 receptor,IC50,=,538.0,nM,CHEMBL671072,B,Inhibition of human dopamine receptor D2,CHEMBL1134625,IC50,O=C1NCN(c2ccccc2)C12CCN(Cc1cccc(Oc3ccccc3)c1)CC2
CHEMBL325750,CHEMBL217,Dopamine D2 receptor,IC50,=,123.0,nM,CHEMBL671072,B,Inhibition of human dopamine receptor D2,CHEMBL1134625,IC50,O=C1NCN(c2ccccc2)C12CCN(Cc1ccc3nsnc3c1)CC2
CHEMBL115222,CHEMBL217,Dopamine D2 receptor,IC50,=,2120.0,nM,CHEMBL671072,B,Inhibition of human dopamine receptor D2,CHEMBL1134625,IC50,CNC(=O)CN1CN(c2ccccc2)C2(CCN(Cc3cc4c(cc3Cl)OCO4)CC2)C1=O
CHEMBL325516,CHEMBL217,Dopamine D2 receptor,IC50,=,2620.0,nM,CHEMBL671072,B,Inhibition of human dopamine receptor D2,CHEMBL1134625,IC50,O=C(OCCc1ccc(F)cc1)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL114484,CHEMBL217,Dopamine D2 receptor,IC50,=,480.0,nM,CHEMBL671072,B,Inhibition of human dopamine receptor D2,CHEMBL1134625,IC50,Cc1ccc(CN2CCC(n3c(O)nc4ccccc43)CC2)c(Cl)c1
CHEMBL326962,CHEMBL217,Dopamine D2 receptor,IC50,=,557.0,nM,CHEMBL671072,B,Inhibition of human dopamine receptor D2,CHEMBL1134625,IC50,O=C1NCN(c2ccccc2)C12CCN(Cc1ccc3c(c1)OCO3)CC2
CHEMBL116233,CHEMBL217,Dopamine D2 receptor,IC50,=,4700.0,nM,CHEMBL667743,B,Displacement of [3H]-spiperone from dopamine D2 receptor,CHEMBL1127992,IC50,O=C(/C=C/c1ccccc1)NC1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O
CHEMBL111964,CHEMBL217,Dopamine D2 receptor,IC50,=,4900.0,nM,CHEMBL667743,B,Displacement of [3H]-spiperone from dopamine D2 receptor,CHEMBL1127992,IC50,CN(C(=O)C#Cc1ccccc1)C1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O
CHEMBL113282,CHEMBL217,Dopamine D2 receptor,IC50,=,890.0,nM,CHEMBL667743,B,Displacement of [3H]-spiperone from dopamine D2 receptor,CHEMBL1127992,IC50,C(#Cc1ccccc1)CN(c1ccccc1)C1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O
CHEMBL112170,CHEMBL217,Dopamine D2 receptor,IC50,=,1500.0,nM,CHEMBL667743,B,Displacement of [3H]-spiperone from dopamine D2 receptor,CHEMBL1127992,IC50,O=C(C#Cc1ccccc1)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O
CHEMBL325063,CHEMBL217,Dopamine D2 receptor,IC50,=,7100.0,nM,CHEMBL667743,B,Displacement of [3H]-spiperone from dopamine D2 receptor,CHEMBL1127992,IC50,CN(C(=O)/C=C/c1ccccc1)C1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O
CHEMBL112957,CHEMBL217,Dopamine D2 receptor,IC50,=,4100.0,nM,CHEMBL667743,B,Displacement of [3H]-spiperone from dopamine D2 receptor,CHEMBL1127992,IC50,CN(CC#Cc1ccccc1)C1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O
CHEMBL113449,CHEMBL217,Dopamine D2 receptor,IC50,=,2500.0,nM,CHEMBL667743,B,Displacement of [3H]-spiperone from dopamine D2 receptor,CHEMBL1127992,IC50,O=C(C#Cc1ccccc1)NC1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O
CHEMBL42,CHEMBL217,Dopamine D2 receptor,IC50,=,230.0,nM,CHEMBL670113,B,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,CHEMBL1131412,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL359002,CHEMBL217,Dopamine D2 receptor,IC50,=,761.0,nM,CHEMBL670113,B,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,CHEMBL1131412,IC50,COc1ccccc1N1CCN(CCC(=O)NC2CCc3c(cccc3OC)C2)CC1
CHEMBL356358,CHEMBL217,Dopamine D2 receptor,IC50,=,810.0,nM,CHEMBL670113,B,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,CHEMBL1131412,IC50,COc1ccccc1C(=O)NCCN1CCN(c2ccccc2OC)CC1
CHEMBL2373205,CHEMBL217,Dopamine D2 receptor,IC50,=,870.0,nM,CHEMBL670113,B,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,CHEMBL1131412,IC50,COc1cccc(-c2csc(CCN3CCN(c4ccccc4OC)CC3)n2)c1.Cl
CHEMBL144811,CHEMBL217,Dopamine D2 receptor,IC50,=,250.0,nM,CHEMBL670113,B,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,CHEMBL1131412,IC50,COc1ccc(OC)c(C(=O)NCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL26929,CHEMBL217,Dopamine D2 receptor,IC50,=,20.0,nM,CHEMBL670113,B,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,CHEMBL1131412,IC50,COc1ccccc1N1CCN(CCCC2CCCc3c(OC)cccc32)CC1
CHEMBL424125,CHEMBL217,Dopamine D2 receptor,IC50,=,150.0,nM,CHEMBL670113,B,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,CHEMBL1131412,IC50,COc1ccc2c(c1)C(CCCN1CCN(c3ccccc3OC)CC1)CCC2
CHEMBL2373210,CHEMBL217,Dopamine D2 receptor,IC50,=,650.0,nM,CHEMBL670113,B,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,CHEMBL1131412,IC50,COc1ccc2c(c1)CC(NC(=O)CCN1CCN(c3ccccc3OC)CC1)CC2.Cl.Cl
CHEMBL54,CHEMBL217,Dopamine D2 receptor,IC50,=,4.1,nM,CHEMBL670113,B,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,CHEMBL1131412,IC50,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL286725,CHEMBL217,Dopamine D2 receptor,IC50,=,700.0,nM,CHEMBL670113,B,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,CHEMBL1131412,IC50,COc1cccc(C(=O)NCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL26677,CHEMBL217,Dopamine D2 receptor,IC50,=,13.0,nM,CHEMBL670113,B,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,CHEMBL1131412,IC50,COc1cccc(C(=O)CCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL134423,CHEMBL217,Dopamine D2 receptor,IC50,=,100.0,nM,CHEMBL666192,B,Binding affinity towards dopamine D2 receptor,CHEMBL1127235,IC50,Fc1ccc([Si]2(c3ccc(F)cc3)CCC(N3CCN(c4ccccc4)CC3)C2)cc1
CHEMBL134423,CHEMBL217,Dopamine D2 receptor,IC50,=,140.0,nM,CHEMBL666192,B,Binding affinity towards dopamine D2 receptor,CHEMBL1127235,IC50,Fc1ccc([Si]2(c3ccc(F)cc3)CCC(N3CCN(c4ccccc4)CC3)C2)cc1
CHEMBL35226,CHEMBL217,Dopamine D2 receptor,IC50,=,3400.0,nM,CHEMBL670685,B,Ability to displace [3H]YM-0915 from Dopamine receptor D2,CHEMBL1145012,IC50,CCCN1CCC(COc2nc3ccccc3c3c2CCCN3)CC1
CHEMBL84931,CHEMBL217,Dopamine D2 receptor,IC50,=,36.31,nM,CHEMBL672501,B,Binding affinity for human cloned Dopamine receptor D2L,CHEMBL1135381,IC50,CN(C)CC1CC2c3ccccc3Cc3ccc(F)cc3N2O1
CHEMBL315772,CHEMBL217,Dopamine D2 receptor,IC50,=,8.71,nM,CHEMBL672501,B,Binding affinity for human cloned Dopamine receptor D2L,CHEMBL1135381,IC50,CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1
CHEMBL314107,CHEMBL217,Dopamine D2 receptor,IC50,=,446.68,nM,CHEMBL672501,B,Binding affinity for human cloned Dopamine receptor D2L,CHEMBL1135381,IC50,CN(C)CC1CC2c3cc(F)ccc3Cc3ccc(F)cc3N2O1
CHEMBL83658,CHEMBL217,Dopamine D2 receptor,IC50,=,870.96,nM,CHEMBL672501,B,Binding affinity for human cloned Dopamine receptor D2L,CHEMBL1135381,IC50,CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1
CHEMBL85735,CHEMBL217,Dopamine D2 receptor,IC50,=,54.95,nM,CHEMBL672501,B,Binding affinity for human cloned Dopamine receptor D2L,CHEMBL1135381,IC50,Cc1ccc2c(c1)N1OC(CN(C)C)CC1c1ccccc1C2
CHEMBL6437,CHEMBL217,Dopamine D2 receptor,IC50,=,7079.46,nM,CHEMBL672501,B,Binding affinity for human cloned Dopamine receptor D2L,CHEMBL1135381,IC50,CN1CCN2c3ccccc3Cc3ccccc3C2C1
CHEMBL611207,CHEMBL217,Dopamine D2 receptor,IC50,=,63.0,nM,CHEMBL833053,B,Concentration required to inhibit [3H]YM-09151-2 binding to human D2 dopamine receptor,CHEMBL1137093,IC50,CN1CCCC[C@@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21
CHEMBL611207,CHEMBL217,Dopamine D2 receptor,IC50,=,77.0,nM,CHEMBL833053,B,Concentration required to inhibit [3H]YM-09151-2 binding to human D2 dopamine receptor,CHEMBL1137093,IC50,CN1CCCC[C@@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21
CHEMBL608530,CHEMBL217,Dopamine D2 receptor,IC50,=,837.0,nM,CHEMBL833053,B,Concentration required to inhibit [3H]YM-09151-2 binding to human D2 dopamine receptor,CHEMBL1137093,IC50,CN1CCCC[C@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21
CHEMBL608530,CHEMBL217,Dopamine D2 receptor,IC50,=,1173.0,nM,CHEMBL833053,B,Concentration required to inhibit [3H]YM-09151-2 binding to human D2 dopamine receptor,CHEMBL1137093,IC50,CN1CCCC[C@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21
CHEMBL42,CHEMBL217,Dopamine D2 receptor,IC50,=,9.0,nM,CHEMBL872217,B,Inhibitory concentration against dopamine receptor D2,CHEMBL1140446,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL1255588,CHEMBL217,Dopamine D2 receptor,IC50,=,8.9,nM,CHEMBL881984,B,Percent inhibition against Dopamine receptor D2 at 1 uM,CHEMBL1140374,IC50,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1
CHEMBL54786,CHEMBL217,Dopamine D2 receptor,IC50,=,44.0,nM,CHEMBL872217,B,Inhibitory concentration against dopamine receptor D2,CHEMBL1140446,IC50,O=C1Cc2cc(CCN3CCN(c4cccc5ccccc45)CC3)ccc2N1
CHEMBL708,CHEMBL217,Dopamine D2 receptor,IC50,=,5.0,nM,CHEMBL872217,B,Inhibitory concentration against dopamine receptor D2,CHEMBL1140446,IC50,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL69584,CHEMBL217,Dopamine D2 receptor,IC50,=,690.0,nM,CHEMBL872217,B,Inhibitory concentration against dopamine receptor D2,CHEMBL1140446,IC50,O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2ccccc21
CHEMBL107742,CHEMBL217,Dopamine D2 receptor,IC50,=,188.0,nM,CHEMBL872217,B,Inhibitory concentration against dopamine receptor D2,CHEMBL1140446,IC50,Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4CC3C)CC2)cc1
CHEMBL320597,CHEMBL217,Dopamine D2 receptor,IC50,=,113.0,nM,CHEMBL872217,B,Inhibitory concentration against dopamine receptor D2,CHEMBL1140446,IC50,Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4C[C@H]3C)CC2)cc1
CHEMBL201019,CHEMBL217,Dopamine D2 receptor,IC50,=,5300.0,nM,CHEMBL858805,B,Binding affinity to dopamine receptor D2,CHEMBL1149398,IC50,CCOc1cc(N)c(Cl)cc1C(=O)NC[C@@H]1CCN2CCC[C@@H]12
CHEMBL37333,CHEMBL217,Dopamine D2 receptor,IC50,=,3900.0,nM,CHEMBL858805,B,Binding affinity to dopamine receptor D2,CHEMBL1149398,IC50,COc1cc(N)c(Cl)cc1C(=O)NC[C@H]1CCN2CCC[C@H]12
CHEMBL1729,CHEMBL217,Dopamine D2 receptor,IC50,=,227.0,nM,CHEMBL858805,B,Binding affinity to dopamine receptor D2,CHEMBL1149398,IC50,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC
CHEMBL250689,CHEMBL217,Dopamine D2 receptor,IC50,=,1000.0,nM,CHEMBL925073,B,Inhibition of dopamine D2 receptor,CHEMBL1140623,IC50,CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1
CHEMBL249854,CHEMBL217,Dopamine D2 receptor,IC50,=,640.0,nM,CHEMBL925073,B,Inhibition of dopamine D2 receptor,CHEMBL1140623,IC50,CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C
CHEMBL259415,CHEMBL217,Dopamine D2 receptor,IC50,=,6900.0,nM,CHEMBL920904,B,Binding affinity at dopamine D2 receptor,CHEMBL1144677,IC50,Cc1cccc(N2CCN(CCCC(=O)NCc3nc4ccccc4c(=O)n3-c3ccccc3)CC2)c1C
CHEMBL261102,CHEMBL217,Dopamine D2 receptor,IC50,=,1500.0,nM,CHEMBL920904,B,Binding affinity at dopamine D2 receptor,CHEMBL1144677,IC50,Cc1cccc(N2CCN(CCCC(=O)NCc3nc4cc(F)ccc4c(=O)n3-c3ccccc3)CC2)c1C
CHEMBL261019,CHEMBL217,Dopamine D2 receptor,IC50,=,6600.0,nM,CHEMBL920904,B,Binding affinity at dopamine D2 receptor,CHEMBL1144677,IC50,O=C(CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)NCc1nc2cc(F)ccc2c(=O)n1-c1ccccc1
CHEMBL261434,CHEMBL217,Dopamine D2 receptor,IC50,=,4000.0,nM,CHEMBL920904,B,Binding affinity at dopamine D2 receptor,CHEMBL1144677,IC50,Cc1cccc(N2CCN(CCCC(=O)NCc3nc4ccc(F)cc4c(=O)n3-c3ccccc3)CC2)c1C
CHEMBL259776,CHEMBL217,Dopamine D2 receptor,IC50,=,5300.0,nM,CHEMBL920904,B,Binding affinity at dopamine D2 receptor,CHEMBL1144677,IC50,COc1ccccc1N1CCN(CCCC(=O)NCc2nc3ccc(F)cc3c(=O)n2-c2ccccc2)CC1
CHEMBL260907,CHEMBL217,Dopamine D2 receptor,IC50,=,1000.0,nM,CHEMBL920904,B,Binding affinity at dopamine D2 receptor,CHEMBL1144677,IC50,CCOc1ccccc1N1CCN(CCCC(=O)NCc2nc3ccc(F)cc3c(=O)n2-c2ccccc2)CC1
CHEMBL259199,CHEMBL217,Dopamine D2 receptor,IC50,=,1500.0,nM,CHEMBL920904,B,Binding affinity at dopamine D2 receptor,CHEMBL1144677,IC50,CCOc1ccccc1N1CCN(CCCC(=O)NCc2nc3cc(F)ccc3c(=O)n2-c2ccc(OC)cc2)CC1
CHEMBL406221,CHEMBL217,Dopamine D2 receptor,IC50,=,140.0,nM,CHEMBL920904,B,Binding affinity at dopamine D2 receptor,CHEMBL1144677,IC50,CCOc1ccccc1N1CCN(CCCC(=O)NCc2nc3ccc(F)cc3c(=O)n2-c2ccc(OC)cc2)CC1
CHEMBL503468,CHEMBL217,Dopamine D2 receptor,IC50,=,700.0,nM,CHEMBL965249,B,Binding affinity to human dopamine D2 receptor,CHEMBL1150432,IC50,O=C(Nc1ccc2[nH]cc(C3CCN(CCCCCCCN4CCC(c5c[nH]c6ccc(NC(=O)c7ccc(F)cc7)cc56)CC4)CC3)c2c1)c1ccc(F)cc1
CHEMBL461571,CHEMBL217,Dopamine D2 receptor,IC50,=,3550.0,nM,CHEMBL980770,B,Displacement of radioligand from dopamine D2S receptor,CHEMBL1139415,IC50,Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1
CHEMBL1255588,CHEMBL217,Dopamine D2 receptor,IC50,=,8.7,nM,CHEMBL953137,B,Displacement of radiolabeled (+)butaclamol from human dopamine D2S receptor,CHEMBL1140203,IC50,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1
CHEMBL522460,CHEMBL217,Dopamine D2 receptor,IC50,=,2650.0,nM,CHEMBL983581,B,Inhibition of dopamine D2 receptor,CHEMBL1142444,IC50,Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1
CHEMBL478034,CHEMBL217,Dopamine D2 receptor,IC50,=,1130.0,nM,CHEMBL983581,B,Inhibition of dopamine D2 receptor,CHEMBL1142444,IC50,O=c1[nH]c2ccccc2n1C1CCN(C2CCN(Cc3ccccc3[N+](=O)[O-])CC2)CC1
CHEMBL477821,CHEMBL217,Dopamine D2 receptor,IC50,=,2060.0,nM,CHEMBL983581,B,Inhibition of dopamine D2 receptor,CHEMBL1142444,IC50,O=c1[nH]c2ccccc2n1C1CCN(C2CCN(Cc3ccccc3Cl)CC2)CC1
CHEMBL489576,CHEMBL217,Dopamine D2 receptor,IC50,=,2690.0,nM,CHEMBL983581,B,Inhibition of dopamine D2 receptor,CHEMBL1142444,IC50,O=c1[nH]c2cc(F)ccc2n1C1CCN(C2CCN(Cc3ccccc3C(F)(F)F)CC2)CC1
CHEMBL1255588,CHEMBL217,Dopamine D2 receptor,IC50,=,15.0,nM,CHEMBL982014,B,Inhibition of human dopamine D2 receptor,CHEMBL1155111,IC50,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1
CHEMBL584554,CHEMBL217,Dopamine D2 receptor,IC50,=,1590.0,nM,CHEMBL1046708,B,Inhibition of dopamine D2 receptor,CHEMBL1154177,IC50,CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C(=O)Nc2ccccc2)C1
CHEMBL1086626,CHEMBL217,Dopamine D2 receptor,IC50,=,1071.0,nM,CHEMBL1101348,B,Inhibition of dopamine D2 receptor,CHEMBL1154983,IC50,Cc1[nH]c(-c2ccccc2)cc1C(=O)NCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL1086754,CHEMBL217,Dopamine D2 receptor,IC50,=,2542.0,nM,CHEMBL1101348,B,Inhibition of dopamine D2 receptor,CHEMBL1154983,IC50,Cc1c(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc(-c2ccccc2)n1C
CHEMBL1086756,CHEMBL217,Dopamine D2 receptor,IC50,=,3736.0,nM,CHEMBL1101348,B,Inhibition of dopamine D2 receptor,CHEMBL1154983,IC50,CCCn1c(-c2ccccc2)cc(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1C
CHEMBL1642118,CHEMBL217,Dopamine D2 receptor,IC50,=,136.0,nM,CHEMBL1647768,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in cells,CHEMBL1641464,IC50,CC1CC(=O)c2ccc(N3CCN(C)CC3)cc2N1S(=O)(=O)c1ccc2ccccc2c1
CHEMBL1642128,CHEMBL217,Dopamine D2 receptor,IC50,=,1784.0,nM,CHEMBL1647768,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in cells,CHEMBL1641464,IC50,Cc1cc(N2CCN(C)CC2)c2c(c1)N(S(=O)(=O)c1ccc3ccccc3c1)C(C)CC2=O
CHEMBL1255588,CHEMBL217,Dopamine D2 receptor,IC50,=,12.0,nM,CHEMBL1663583,B,Inhibition of human dopamine D2 receptor,CHEMBL1649335,IC50,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1
CHEMBL1807825,CHEMBL217,Dopamine D2 receptor,IC50,=,3981.07,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,CCOc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1
CHEMBL1807824,CHEMBL217,Dopamine D2 receptor,IC50,=,2511.89,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,CCc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1
CHEMBL1807823,CHEMBL217,Dopamine D2 receptor,IC50,=,3981.07,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3)c2s1
CHEMBL1807821,CHEMBL217,Dopamine D2 receptor,IC50,=,794.33,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCOCCc3ccccc3)c2s1
CHEMBL1807820,CHEMBL217,Dopamine D2 receptor,IC50,=,199.53,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCOCCc3cccc4ccccc34)c2s1
CHEMBL1807819,CHEMBL217,Dopamine D2 receptor,IC50,=,630.96,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCCOCCc3ccccc3)c2s1
CHEMBL82663,CHEMBL217,Dopamine D2 receptor,IC50,=,100.0,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,O=S(=O)(CCCOCCc1ccccc1)CCNCCc1ccc(O)c2nc(O)sc12
CHEMBL1346,CHEMBL217,Dopamine D2 receptor,IC50,=,25118.86,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1
CHEMBL1807826,CHEMBL217,Dopamine D2 receptor,IC50,=,501.19,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(C(F)(F)F)c3)c2s1
CHEMBL1807828,CHEMBL217,Dopamine D2 receptor,IC50,=,1584.89,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3Cl)c2s1
CHEMBL1807829,CHEMBL217,Dopamine D2 receptor,IC50,=,398.11,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3Cl)c2s1
CHEMBL1807831,CHEMBL217,Dopamine D2 receptor,IC50,=,794.33,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCS(=O)(=O)CCCNCCc3cccc(Cl)c3)c2s1
CHEMBL1807832,CHEMBL217,Dopamine D2 receptor,IC50,=,3162.28,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOCCCNCCc3cccc(Cl)c3)c2s1
CHEMBL1807869,CHEMBL217,Dopamine D2 receptor,IC50,=,1584.89,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3)c2s1
CHEMBL1807870,CHEMBL217,Dopamine D2 receptor,IC50,=,1000.0,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3ccccc3Cl)c2s1
CHEMBL1807871,CHEMBL217,Dopamine D2 receptor,IC50,=,1000.0,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3Cl)c2s1
CHEMBL1807873,CHEMBL217,Dopamine D2 receptor,IC50,=,1995.26,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3Cl)c2s1
CHEMBL1807874,CHEMBL217,Dopamine D2 receptor,IC50,=,2511.89,nM,CHEMBL1810621,B,Binding affinity to dopamine 2 receptor,CHEMBL1806408,IC50,CN(CCOCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)CCc1ccccc1
CHEMBL3216758,CHEMBL217,Dopamine D2 receptor,IC50,=,908.0,nM,CHEMBL1827739,B,Inhibition of dopamine D2 receptor by competition binding assay,CHEMBL1821711,IC50,Cc1nc(C(=O)NCCN2CCN(c3cccc(Cl)c3Cl)CC2)c(C)n1-c1ccccc1.Cl.Cl.Cl.Cl
CHEMBL3216098,CHEMBL217,Dopamine D2 receptor,IC50,=,1369.0,nM,CHEMBL1827739,B,Inhibition of dopamine D2 receptor by competition binding assay,CHEMBL1821711,IC50,Cc1nc(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c(C)n1-c1ccccc1.Cl.Cl.Cl.Cl
CHEMBL49,CHEMBL217,Dopamine D2 receptor,IC50,=,323.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
CHEMBL493,CHEMBL217,Dopamine D2 receptor,IC50,=,1.582,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL508112,CHEMBL217,Dopamine D2 receptor,IC50,=,5866.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,c1ccc2sc(SSc3nc4ccccc4s3)nc2c1
CHEMBL296419,CHEMBL217,Dopamine D2 receptor,IC50,=,4521.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1
CHEMBL1113,CHEMBL217,Dopamine D2 receptor,IC50,=,200.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
CHEMBL633,CHEMBL217,Dopamine D2 receptor,IC50,=,19952.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1
CHEMBL1403281,CHEMBL217,Dopamine D2 receptor,IC50,=,1.95,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL629,CHEMBL217,Dopamine D2 receptor,IC50,=,1009.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CN(C)CCC=C1c2ccccc2CCc2ccccc21
CHEMBL305660,CHEMBL217,Dopamine D2 receptor,IC50,=,1149.1,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1
CHEMBL64894,CHEMBL217,Dopamine D2 receptor,IC50,=,3178.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]
CHEMBL808,CHEMBL217,Dopamine D2 receptor,IC50,=,12807.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1
CHEMBL1385840,CHEMBL217,Dopamine D2 receptor,IC50,=,5.032,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL30008,CHEMBL217,Dopamine D2 receptor,IC50,=,352.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1
CHEMBL119443,CHEMBL217,Dopamine D2 receptor,IC50,=,552.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL726,CHEMBL217,Dopamine D2 receptor,IC50,=,1.616,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
CHEMBL442,CHEMBL217,Dopamine D2 receptor,IC50,=,4.3,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL1108,CHEMBL217,Dopamine D2 receptor,IC50,=,2.407,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,IC50,=,6.592,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1626,CHEMBL217,Dopamine D2 receptor,IC50,=,136.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1
CHEMBL936,CHEMBL217,Dopamine D2 receptor,IC50,=,3290.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1
CHEMBL1729,CHEMBL217,Dopamine D2 receptor,IC50,=,473.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC
CHEMBL1255837,CHEMBL217,Dopamine D2 receptor,IC50,=,1.474,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O
CHEMBL964,CHEMBL217,Dopamine D2 receptor,IC50,=,23018.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CCN(CC)C(=S)SSC(=S)N(CC)CC
CHEMBL104,CHEMBL217,Dopamine D2 receptor,IC50,=,12186.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1
CHEMBL1732,CHEMBL217,Dopamine D2 receptor,IC50,=,8.88,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL411,CHEMBL217,Dopamine D2 receptor,IC50,=,13321.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1
CHEMBL43064,CHEMBL217,Dopamine D2 receptor,IC50,=,776.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,IC50,=,387.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL71,CHEMBL217,Dopamine D2 receptor,IC50,=,54.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL415,CHEMBL217,Dopamine D2 receptor,IC50,=,413.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21
CHEMBL516,CHEMBL217,Dopamine D2 receptor,IC50,=,164.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1
CHEMBL219916,CHEMBL217,Dopamine D2 receptor,IC50,=,2.647,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
CHEMBL723,CHEMBL217,Dopamine D2 receptor,IC50,=,146.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12
CHEMBL564,CHEMBL217,Dopamine D2 receptor,IC50,=,505.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CN(C)CCCN1c2ccccc2Sc2ccccc21
CHEMBL643,CHEMBL217,Dopamine D2 receptor,IC50,=,779.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CC(CN1c2ccccc2Sc2ccccc21)N(C)C
CHEMBL531,CHEMBL217,Dopamine D2 receptor,IC50,=,111.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL1909072,CHEMBL217,Dopamine D2 receptor,IC50,=,4.05,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,IC50,=,118.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL716,CHEMBL217,Dopamine D2 receptor,IC50,=,1329.9,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL728,CHEMBL217,Dopamine D2 receptor,IC50,=,11.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL1065,CHEMBL217,Dopamine D2 receptor,IC50,=,807.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1
CHEMBL21731,CHEMBL217,Dopamine D2 receptor,IC50,=,3463.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CNCCCC12CCC(c3ccccc31)c1ccccc12
CHEMBL86,CHEMBL217,Dopamine D2 receptor,IC50,=,127.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC
CHEMBL91,CHEMBL217,Dopamine D2 receptor,IC50,=,12504.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
CHEMBL19215,CHEMBL217,Dopamine D2 receptor,IC50,=,63.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21
CHEMBL1221512,CHEMBL217,Dopamine D2 receptor,IC50,=,157.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS
CHEMBL157138,CHEMBL217,Dopamine D2 receptor,IC50,=,2.86,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL1909065,CHEMBL217,Dopamine D2 receptor,IC50,=,702.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C
CHEMBL1201356,CHEMBL217,Dopamine D2 receptor,IC50,=,829.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL267044,CHEMBL217,Dopamine D2 receptor,IC50,=,128.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC
CHEMBL141343,CHEMBL217,Dopamine D2 receptor,IC50,=,16760.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,Cc1c(C)c2c(c(C)c1O)CCC(C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2
CHEMBL15245,CHEMBL217,Dopamine D2 receptor,IC50,=,2060.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL479,CHEMBL217,Dopamine D2 receptor,IC50,=,35.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2
CHEMBL83,CHEMBL217,Dopamine D2 receptor,IC50,=,13885.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
CHEMBL84158,CHEMBL217,Dopamine D2 receptor,IC50,=,1232.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC
CHEMBL85,CHEMBL217,Dopamine D2 receptor,IC50,=,20.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL26,CHEMBL217,Dopamine D2 receptor,IC50,=,205.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC
CHEMBL17157,CHEMBL217,Dopamine D2 receptor,IC50,=,6167.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1
CHEMBL81,CHEMBL217,Dopamine D2 receptor,IC50,=,1174.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,IC50,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12
CHEMBL1934127,CHEMBL217,Dopamine D2 receptor,IC50,=,500.0,nM,CHEMBL1936809,B,Inhibition of dopamine D2 receptor,CHEMBL1932960,IC50,CC(=O)N[C@@H]1CC2(CCN(Cc3ccc4[nH]c5ccc(Cl)cc5c4c3)CC2)c2ccccc21
CHEMBL1934130,CHEMBL217,Dopamine D2 receptor,IC50,=,1500.0,nM,CHEMBL1936809,B,Inhibition of dopamine D2 receptor,CHEMBL1932960,IC50,CC(=O)N[C@@H]1CC2(CCN(Cc3ccc4c(c3)c3ccccc3n4C(N)=O)CC2)c2ccccc21
CHEMBL1947157,CHEMBL217,Dopamine D2 receptor,IC50,=,251.19,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1
CHEMBL1944689,CHEMBL217,Dopamine D2 receptor,IC50,=,1000.0,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4c(Cl)cccc4Cl)cc3)c2s1
CHEMBL1944690,CHEMBL217,Dopamine D2 receptor,IC50,=,630.96,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4Cl)c3)c2s1
CHEMBL1944691,CHEMBL217,Dopamine D2 receptor,IC50,=,398.11,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4F)c3)c2s1
CHEMBL1944692,CHEMBL217,Dopamine D2 receptor,IC50,=,1995.26,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4F)cc3)c2s1
CHEMBL1944694,CHEMBL217,Dopamine D2 receptor,IC50,=,630.96,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,COc1ccccc1CCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1
CHEMBL1944695,CHEMBL217,Dopamine D2 receptor,IC50,=,1995.26,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4)cc3)c2s1
CHEMBL1945031,CHEMBL217,Dopamine D2 receptor,IC50,=,398.11,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,Cc1cccc2c(CCNCc3cccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)c3)c[nH]c12
CHEMBL1945033,CHEMBL217,Dopamine D2 receptor,IC50,=,1584.89,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)c2s1
CHEMBL1945034,CHEMBL217,Dopamine D2 receptor,IC50,=,2511.89,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccn4)cc3)c2s1
CHEMBL1945035,CHEMBL217,Dopamine D2 receptor,IC50,=,794.33,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccccc3CNCCc3ccccc3F)c2s1
CHEMBL1945036,CHEMBL217,Dopamine D2 receptor,IC50,=,2511.89,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,CC(CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1)c1ccccc1
CHEMBL1945037,CHEMBL217,Dopamine D2 receptor,IC50,=,316.23,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccc4)c3)c2s1
CHEMBL1945039,CHEMBL217,Dopamine D2 receptor,IC50,=,1000.0,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,COc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1
CHEMBL1945040,CHEMBL217,Dopamine D2 receptor,IC50,=,2511.89,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,COc1ccccc1CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1
CHEMBL1945041,CHEMBL217,Dopamine D2 receptor,IC50,=,251.19,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4Cl)c3)c2s1
CHEMBL1945042,CHEMBL217,Dopamine D2 receptor,IC50,=,630.96,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4F)c3)c2s1
CHEMBL1945043,CHEMBL217,Dopamine D2 receptor,IC50,=,5011.87,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccn4)c3)c2s1
CHEMBL1945044,CHEMBL217,Dopamine D2 receptor,IC50,=,794.33,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,COc1cccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)c1
CHEMBL1945289,CHEMBL217,Dopamine D2 receptor,IC50,=,794.33,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,COc1ccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)cc1
CHEMBL1945290,CHEMBL217,Dopamine D2 receptor,IC50,=,1258.93,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,CCOc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1
CHEMBL1945291,CHEMBL217,Dopamine D2 receptor,IC50,=,1000.0,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,COc1ccccc1CN(C)Cc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1
CHEMBL1945292,CHEMBL217,Dopamine D2 receptor,IC50,=,794.33,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,COCCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1
CHEMBL1945294,CHEMBL217,Dopamine D2 receptor,IC50,=,3162.28,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CN4CCCC4)c3)c2s1
CHEMBL1945296,CHEMBL217,Dopamine D2 receptor,IC50,=,79.43,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1
CHEMBL1945297,CHEMBL217,Dopamine D2 receptor,IC50,=,125.89,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,CC(Cc1cccc(CNCCc2c(Cl)cccc2Cl)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12
CHEMBL1945298,CHEMBL217,Dopamine D2 receptor,IC50,=,398.11,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOc3cccc(CNCCc4ccccc4F)c3)c2s1
CHEMBL1945299,CHEMBL217,Dopamine D2 receptor,IC50,=,1000.0,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,COc1ccccc1CNCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1
CHEMBL1945504,CHEMBL217,Dopamine D2 receptor,IC50,=,1995.26,nM,CHEMBL1947794,B,Displacement of radiolabeled spiperone from dopamine D2 receptor,CHEMBL1944599,IC50,COc1ccccc1CNCc1ccc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1
CHEMBL2016616,CHEMBL217,Dopamine D2 receptor,IC50,=,2440.0,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1
CHEMBL2016615,CHEMBL217,Dopamine D2 receptor,IC50,=,2078.0,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1
CHEMBL2016614,CHEMBL217,Dopamine D2 receptor,IC50,=,8939.0,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CCCCCCCCCC(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL2016608,CHEMBL217,Dopamine D2 receptor,IC50,=,2662.0,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCC(=O)N3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1
CHEMBL2016607,CHEMBL217,Dopamine D2 receptor,IC50,=,776.0,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CCCCCCCCCC(=O)N1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL42,CHEMBL217,Dopamine D2 receptor,IC50,=,206.0,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016631,CHEMBL217,Dopamine D2 receptor,IC50,=,7762.47,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,O=C(CCCCCCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016630,CHEMBL217,Dopamine D2 receptor,IC50,=,10715.19,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,O=C(CCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016629,CHEMBL217,Dopamine D2 receptor,IC50,=,1096.48,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,O=C(CCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016628,CHEMBL217,Dopamine D2 receptor,IC50,=,44.67,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,O=C(CCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016627,CHEMBL217,Dopamine D2 receptor,IC50,=,23.44,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,O=C(CCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016626,CHEMBL217,Dopamine D2 receptor,IC50,=,87.1,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,O=C(CCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016625,CHEMBL217,Dopamine D2 receptor,IC50,=,1445.44,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016624,CHEMBL217,Dopamine D2 receptor,IC50,=,2398.83,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCC(=O)OCCOC(=O)CCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1
CHEMBL2016623,CHEMBL217,Dopamine D2 receptor,IC50,=,2630.27,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCC(=O)N3CCN(C(=O)CCCC(=O)N4CCN(C(=O)CCCC(=O)NN5c6ccc(Cl)cc6N=C(N6CCN(C)CC6)c6ccccc65)CC4)CC3)c3ccccc32)CC1
CHEMBL2016622,CHEMBL217,Dopamine D2 receptor,IC50,=,1621.81,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCC(=O)N3CCN(C(=O)CCC(=O)NN4c5ccc(Cl)cc5N=C(N5CCN(C)CC5)c5ccccc54)CC3)c3ccccc32)CC1
CHEMBL2016616,CHEMBL217,Dopamine D2 receptor,IC50,=,2454.71,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1
CHEMBL2016615,CHEMBL217,Dopamine D2 receptor,IC50,=,2041.74,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1
CHEMBL2016614,CHEMBL217,Dopamine D2 receptor,IC50,=,8912.51,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CCCCCCCCCC(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL2016608,CHEMBL217,Dopamine D2 receptor,IC50,=,1778.28,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCC(=O)N3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1
CHEMBL2016607,CHEMBL217,Dopamine D2 receptor,IC50,=,776.25,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CCCCCCCCCC(=O)N1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL42,CHEMBL217,Dopamine D2 receptor,IC50,=,204.17,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016622,CHEMBL217,Dopamine D2 receptor,IC50,=,1617.0,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCC(=O)N3CCN(C(=O)CCC(=O)NN4c5ccc(Cl)cc5N=C(N5CCN(C)CC5)c5ccccc54)CC3)c3ccccc32)CC1
CHEMBL2016623,CHEMBL217,Dopamine D2 receptor,IC50,=,2633.0,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCC(=O)N3CCN(C(=O)CCCC(=O)N4CCN(C(=O)CCCC(=O)NN5c6ccc(Cl)cc6N=C(N6CCN(C)CC6)c6ccccc65)CC4)CC3)c3ccccc32)CC1
CHEMBL2016624,CHEMBL217,Dopamine D2 receptor,IC50,=,2412.0,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCC(=O)OCCOC(=O)CCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1
CHEMBL2016625,CHEMBL217,Dopamine D2 receptor,IC50,=,1455.0,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,CCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016626,CHEMBL217,Dopamine D2 receptor,IC50,=,87.0,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,O=C(CCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016627,CHEMBL217,Dopamine D2 receptor,IC50,=,23.0,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,O=C(CCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016628,CHEMBL217,Dopamine D2 receptor,IC50,=,44.0,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,O=C(CCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016629,CHEMBL217,Dopamine D2 receptor,IC50,=,1119.0,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,O=C(CCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016630,CHEMBL217,Dopamine D2 receptor,IC50,=,11000.0,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,O=C(CCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016631,CHEMBL217,Dopamine D2 receptor,IC50,=,7800.0,nM,CHEMBL2020816,B,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,CHEMBL2016514,IC50,O=C(CCCCCCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL267930,CHEMBL217,Dopamine D2 receptor,IC50,=,1.27,nM,CHEMBL2060922,B,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
CHEMBL487387,CHEMBL217,Dopamine D2 receptor,IC50,=,105.41,nM,CHEMBL2060922,B,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL2057457,CHEMBL217,Dopamine D2 receptor,IC50,=,456.13,nM,CHEMBL2060922,B,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL2057456,CHEMBL217,Dopamine D2 receptor,IC50,=,514.46,nM,CHEMBL2060922,B,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1cc2c(cc1O)[C@@H]1Cc3c(CO)c(OC)cc(OC)c3CN1CC2
CHEMBL2057453,CHEMBL217,Dopamine D2 receptor,IC50,=,873.14,nM,CHEMBL2060922,B,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1ccc2c(c1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2
CHEMBL2057451,CHEMBL217,Dopamine D2 receptor,IC50,=,1155.3,nM,CHEMBL2060922,B,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1cc2c(cc1OC)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL245621,CHEMBL217,Dopamine D2 receptor,IC50,=,7.0,nM,CHEMBL2330406,B,Inhibition of dopamine receptor D2 (unknown origin),CHEMBL2321744,IC50,O=C(NCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)c1ccc(F)cc1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,IC50,=,10.0,nM,CHEMBL2352923,B,Displacement of [3H]raclopride from D2 receptor in human corpus striatum after 30 mins by scintillation counting,CHEMBL2346662,IC50,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL567,CHEMBL217,Dopamine D2 receptor,IC50,=,0.3,nM,CHEMBL2390217,B,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 assessed as inhibition of agonist-induced response incubated for 60 mins in incubator followed by 15 mins at room temperature by FLIPR assay,CHEMBL2385071,IC50,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL2387229,CHEMBL217,Dopamine D2 receptor,IC50,=,26.3,nM,CHEMBL2390217,B,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 assessed as inhibition of agonist-induced response incubated for 60 mins in incubator followed by 15 mins at room temperature by FLIPR assay,CHEMBL2385071,IC50,Cc1cc(=O)oc2c(Cl)c(OCCCCN3CCC(c4noc5cc(F)ccc45)CC3)ccc12
CHEMBL2393246,CHEMBL217,Dopamine D2 receptor,IC50,=,162.8,nM,CHEMBL2396124,B,Displacement of [3H]-methylspiperone from dopamine D2L receptor (unknown origin) after 60 mins,CHEMBL2390866,IC50,COc1cccc(Nc2nc(Cc3ccccc3)nc3c2CCNCC3)c1.Cl
CHEMBL2393243,CHEMBL217,Dopamine D2 receptor,IC50,=,146.7,nM,CHEMBL2396124,B,Displacement of [3H]-methylspiperone from dopamine D2L receptor (unknown origin) after 60 mins,CHEMBL2390866,IC50,Cl.c1ccc(Cc2nc3c(c(Nc4ccccc4)n2)CCNCC3)cc1
CHEMBL2393245,CHEMBL217,Dopamine D2 receptor,IC50,=,85.8,nM,CHEMBL2396124,B,Displacement of [3H]-methylspiperone from dopamine D2L receptor (unknown origin) after 60 mins,CHEMBL2390866,IC50,Cl.Clc1cccc(Nc2nc(Cc3ccccc3)nc3c2CCNCC3)c1
CHEMBL2393244,CHEMBL217,Dopamine D2 receptor,IC50,=,63.3,nM,CHEMBL2396124,B,Displacement of [3H]-methylspiperone from dopamine D2L receptor (unknown origin) after 60 mins,CHEMBL2390866,IC50,Cl.Fc1cccc(Nc2nc(Cc3ccccc3)nc3c2CCNCC3)c1
CHEMBL1255588,CHEMBL217,Dopamine D2 receptor,IC50,=,1.4,nM,CHEMBL2395588,B,Binding affinity to human dopamine D2S receptor by radioligand displacement assay,CHEMBL2390917,IC50,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1
CHEMBL267930,CHEMBL217,Dopamine D2 receptor,IC50,=,0.25,nM,CHEMBL2395274,B,Displacement of [3H]Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells after 2 hrs,CHEMBL2390918,IC50,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
CHEMBL1255588,CHEMBL217,Dopamine D2 receptor,IC50,=,2.2,nM,CHEMBL2395699,B,Binding affinity to human dopamine D2S receptor by radioligand displacement assay,CHEMBL2390830,IC50,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1
CHEMBL2392349,CHEMBL217,Dopamine D2 receptor,IC50,=,3.5,nM,CHEMBL2395897,B,Inhibition of human recombinant dopamine D2S receptor expressed in HEK293 cells,CHEMBL2390830,IC50,COc1ccccc1N1CCN(CCCCCN2Cc3ccc4ccccc4c3C2=O)CC1
CHEMBL643,CHEMBL217,Dopamine D2 receptor,IC50,=,100.0,nM,CHEMBL3090831,B,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,CHEMBL3085767,IC50,CC(CN1c2ccccc2Sc2ccccc21)N(C)C
CHEMBL71,CHEMBL217,Dopamine D2 receptor,IC50,=,12.0,nM,CHEMBL3090831,B,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,CHEMBL3085767,IC50,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL11,CHEMBL217,Dopamine D2 receptor,IC50,=,410.0,nM,CHEMBL3090831,B,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,CHEMBL3085767,IC50,CN(C)CCCN1c2ccccc2CCc2ccccc21
CHEMBL1557,CHEMBL217,Dopamine D2 receptor,IC50,=,100000.0,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,IC50,Cl.NCCc1ccc(O)c(O)c1
CHEMBL1557,CHEMBL217,Dopamine D2 receptor,IC50,=,1000.0,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,IC50,Cl.NCCc1ccc(O)c(O)c1
CHEMBL3113644,CHEMBL217,Dopamine D2 receptor,IC50,=,16280.0,nM,CHEMBL3117964,B,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK cells co-expressing Gqi5 assessed as inhibition of dopamine-induced effect by FLIPR assay,CHEMBL3112537,IC50,Nc1ccc2oc(=O)c(CN3CCCC3)cc2c1
CHEMBL3134071,CHEMBL217,Dopamine D2 receptor,IC50,=,1550.0,nM,CHEMBL3136959,B,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,CHEMBL3132795,IC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCCCCCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3
CHEMBL3134070,CHEMBL217,Dopamine D2 receptor,IC50,=,2680.0,nM,CHEMBL3136959,B,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,CHEMBL3132795,IC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCCCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3
CHEMBL3134068,CHEMBL217,Dopamine D2 receptor,IC50,=,183.0,nM,CHEMBL3136959,B,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,CHEMBL3132795,IC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3
CHEMBL3134067,CHEMBL217,Dopamine D2 receptor,IC50,=,1350.0,nM,CHEMBL3136959,B,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,CHEMBL3132795,IC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3
CHEMBL3134066,CHEMBL217,Dopamine D2 receptor,IC50,=,3600.0,nM,CHEMBL3136959,B,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,CHEMBL3132795,IC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3
CHEMBL3134065,CHEMBL217,Dopamine D2 receptor,IC50,=,5320.0,nM,CHEMBL3136959,B,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,CHEMBL3132795,IC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3
CHEMBL3134064,CHEMBL217,Dopamine D2 receptor,IC50,=,4360.0,nM,CHEMBL3136959,B,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,CHEMBL3132795,IC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3
CHEMBL3134063,CHEMBL217,Dopamine D2 receptor,IC50,=,6540.0,nM,CHEMBL3136959,B,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,CHEMBL3132795,IC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCNC(=O)OC(C)(C)C)c(O)c1-3
CHEMBL53,CHEMBL217,Dopamine D2 receptor,IC50,=,117.0,nM,CHEMBL3136959,B,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,CHEMBL3132795,IC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,IC50,=,11.22,nM,CHEMBL3293231,B,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,CHEMBL3286313,IC50,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,IC50,=,1.66,nM,CHEMBL3293231,B,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,CHEMBL3286313,IC50,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL3287397,CHEMBL217,Dopamine D2 receptor,IC50,=,363.08,nM,CHEMBL3293231,B,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,CHEMBL3286313,IC50,O=Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL3287402,CHEMBL217,Dopamine D2 receptor,IC50,=,28.84,nM,CHEMBL3293231,B,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,CHEMBL3286313,IC50,O=Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1
CHEMBL3287403,CHEMBL217,Dopamine D2 receptor,IC50,=,3.802,nM,CHEMBL3293231,B,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,CHEMBL3286313,IC50,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL54,CHEMBL217,Dopamine D2 receptor,IC50,=,0.7079,nM,CHEMBL3293231,B,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,CHEMBL3286313,IC50,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,IC50,=,11.0,nM,CHEMBL3293231,B,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,CHEMBL3286313,IC50,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,IC50,=,1.7,nM,CHEMBL3293231,B,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,CHEMBL3286313,IC50,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL3287397,CHEMBL217,Dopamine D2 receptor,IC50,=,360.0,nM,CHEMBL3293231,B,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,CHEMBL3286313,IC50,O=Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL3287402,CHEMBL217,Dopamine D2 receptor,IC50,=,22.0,nM,CHEMBL3293231,B,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,CHEMBL3286313,IC50,O=Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1
CHEMBL3287403,CHEMBL217,Dopamine D2 receptor,IC50,=,3.8,nM,CHEMBL3293231,B,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,CHEMBL3286313,IC50,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL54,CHEMBL217,Dopamine D2 receptor,IC50,=,0.7,nM,CHEMBL3293231,B,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,CHEMBL3286313,IC50,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL3299093,CHEMBL217,Dopamine D2 receptor,IC50,=,93.3,nM,CHEMBL3300164,B,Antagonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of dopamine-induced ERK1/2 phosphorylation treated for 30 mins prior to dopamine stimulation for 5 mins by AlphaScreen assay,CHEMBL3297649,IC50,COc1ccccc1N1CCN(CCNC(=O)OC(C)(C)C)CC1
CHEMBL3299097,CHEMBL217,Dopamine D2 receptor,IC50,=,3.98,nM,CHEMBL3300164,B,Antagonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of dopamine-induced ERK1/2 phosphorylation treated for 30 mins prior to dopamine stimulation for 5 mins by AlphaScreen assay,CHEMBL3297649,IC50,COc1ccccc1N1CCN(CCCCCCNC(=O)OC(C)(C)C)CC1
CHEMBL3299093,CHEMBL217,Dopamine D2 receptor,IC50,=,93.33,nM,CHEMBL3300164,B,Antagonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of dopamine-induced ERK1/2 phosphorylation treated for 30 mins prior to dopamine stimulation for 5 mins by AlphaScreen assay,CHEMBL3297649,IC50,COc1ccccc1N1CCN(CCNC(=O)OC(C)(C)C)CC1
CHEMBL3299097,CHEMBL217,Dopamine D2 receptor,IC50,=,3.981,nM,CHEMBL3300164,B,Antagonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of dopamine-induced ERK1/2 phosphorylation treated for 30 mins prior to dopamine stimulation for 5 mins by AlphaScreen assay,CHEMBL3297649,IC50,COc1ccccc1N1CCN(CCCCCCNC(=O)OC(C)(C)C)CC1
CHEMBL3322993,CHEMBL217,Dopamine D2 receptor,IC50,=,26.0,nM,CHEMBL3379904,B,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,CHEMBL3351252,IC50,COc1ccccc1N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1
CHEMBL3322994,CHEMBL217,Dopamine D2 receptor,IC50,=,55.0,nM,CHEMBL3379904,B,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,CHEMBL3351252,IC50,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cn2ccccc2n1
CHEMBL3323011,CHEMBL217,Dopamine D2 receptor,IC50,=,2300.0,nM,CHEMBL3379904,B,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,CHEMBL3351252,IC50,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1
CHEMBL3323013,CHEMBL217,Dopamine D2 receptor,IC50,=,490.0,nM,CHEMBL3379904,B,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,CHEMBL3351252,IC50,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3nc4ccccc4[nH]3)CC2)cc(C(F)(F)F)n1
CHEMBL3323015,CHEMBL217,Dopamine D2 receptor,IC50,=,205.0,nM,CHEMBL3379904,B,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,CHEMBL3351252,IC50,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4cccnc4n3)CC2)cc(C(F)(F)F)n1
CHEMBL3323016,CHEMBL217,Dopamine D2 receptor,IC50,=,420.0,nM,CHEMBL3379904,B,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,CHEMBL3351252,IC50,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccncc4n3)CC2)cc(C(F)(F)F)n1
CHEMBL3323017,CHEMBL217,Dopamine D2 receptor,IC50,=,1160.0,nM,CHEMBL3379904,B,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,CHEMBL3351252,IC50,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4nc(Cl)ccc4n3)CC2)cc(C(F)(F)F)n1
CHEMBL3322993,CHEMBL217,Dopamine D2 receptor,IC50,=,6.6,nM,CHEMBL3372144,B,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,CHEMBL3351252,IC50,COc1ccccc1N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1
CHEMBL3322994,CHEMBL217,Dopamine D2 receptor,IC50,=,91.0,nM,CHEMBL3372144,B,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,CHEMBL3351252,IC50,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cn2ccccc2n1
CHEMBL3322995,CHEMBL217,Dopamine D2 receptor,IC50,=,60.0,nM,CHEMBL3372144,B,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,CHEMBL3351252,IC50,O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cn2ccccc2n1
CHEMBL3322998,CHEMBL217,Dopamine D2 receptor,IC50,=,161.0,nM,CHEMBL3372144,B,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,CHEMBL3351252,IC50,O=C(NCCCCN1CCN(c2ccnc3ccccc23)CC1)c1cn2ccccc2n1
CHEMBL3323003,CHEMBL217,Dopamine D2 receptor,IC50,=,248.0,nM,CHEMBL3372144,B,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,CHEMBL3351252,IC50,O=C(NCCCCN1CCN(c2ncnc3ccccc23)CC1)c1cn2ccccc2n1
CHEMBL3323011,CHEMBL217,Dopamine D2 receptor,IC50,=,261.0,nM,CHEMBL3372144,B,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,CHEMBL3351252,IC50,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1
CHEMBL3323012,CHEMBL217,Dopamine D2 receptor,IC50,=,418.0,nM,CHEMBL3372144,B,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,CHEMBL3351252,IC50,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cc4ccccc4[nH]3)CC2)cc(C(F)(F)F)n1
CHEMBL3323013,CHEMBL217,Dopamine D2 receptor,IC50,=,301.0,nM,CHEMBL3372144,B,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,CHEMBL3351252,IC50,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3nc4ccccc4[nH]3)CC2)cc(C(F)(F)F)n1
CHEMBL3323015,CHEMBL217,Dopamine D2 receptor,IC50,=,37.0,nM,CHEMBL3372144,B,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,CHEMBL3351252,IC50,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4cccnc4n3)CC2)cc(C(F)(F)F)n1
CHEMBL3323016,CHEMBL217,Dopamine D2 receptor,IC50,=,49.0,nM,CHEMBL3372144,B,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,CHEMBL3351252,IC50,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccncc4n3)CC2)cc(C(F)(F)F)n1
CHEMBL3323017,CHEMBL217,Dopamine D2 receptor,IC50,=,22.0,nM,CHEMBL3372144,B,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,CHEMBL3351252,IC50,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4nc(Cl)ccc4n3)CC2)cc(C(F)(F)F)n1
CHEMBL3323019,CHEMBL217,Dopamine D2 receptor,IC50,=,311.0,nM,CHEMBL3372144,B,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,CHEMBL3351252,IC50,CN(C)Cc1c(C(=O)NCCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)[nH]c2ccccc12
CHEMBL3323112,CHEMBL217,Dopamine D2 receptor,IC50,=,217.0,nM,CHEMBL3372144,B,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,CHEMBL3351252,IC50,CN(C)Cc1c(C(=O)NCCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)nc2ccccn12
CHEMBL3323114,CHEMBL217,Dopamine D2 receptor,IC50,=,281.0,nM,CHEMBL3372144,B,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,CHEMBL3351252,IC50,CN(C)Cc1cccc2nc(C(=O)NCCCCN3CCN(c4cc(C(F)(F)F)nc(C(C)(C)C)n4)CC3)cn12
CHEMBL54,CHEMBL217,Dopamine D2 receptor,IC50,=,0.16,nM,CHEMBL3372144,B,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,CHEMBL3351252,IC50,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL3335539,CHEMBL217,Dopamine D2 receptor,IC50,=,16500.0,nM,CHEMBL3383656,B,Inhibition of human dopamine D2L receptor,CHEMBL3352711,IC50,COc1ccc(CN2CCOC(CCc3ccccc3)C2)cc1
CHEMBL3335555,CHEMBL217,Dopamine D2 receptor,IC50,=,16500.0,nM,CHEMBL3383656,B,Inhibition of human dopamine D2L receptor,CHEMBL3352711,IC50,Oc1ccc(CN2CCO[C@H](CCc3ccccc3)C2)cc1
CHEMBL1627305,CHEMBL217,Dopamine D2 receptor,IC50,=,4400.0,nM,CHEMBL3599945,B,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,CHEMBL3596172,IC50,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL3597643,CHEMBL217,Dopamine D2 receptor,IC50,=,87.0,nM,CHEMBL3599945,B,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,CHEMBL3596172,IC50,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cc2ccccc2[nH]1
CHEMBL68740,CHEMBL217,Dopamine D2 receptor,IC50,=,564.4,nM,CHEMBL3599945,B,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,CHEMBL3596172,IC50,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(F)ccc2[nH]1
CHEMBL3597635,CHEMBL217,Dopamine D2 receptor,IC50,=,29.0,nM,CHEMBL3599945,B,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,CHEMBL3596172,IC50,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cnc2ccccc2c1
CHEMBL3597636,CHEMBL217,Dopamine D2 receptor,IC50,=,720.0,nM,CHEMBL3599945,B,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,CHEMBL3596172,IC50,O=C(NCCC(O)CN1CCN(c2cccc3ccccc23)CC1)c1cnc2ccccc2c1
CHEMBL3597637,CHEMBL217,Dopamine D2 receptor,IC50,=,63.0,nM,CHEMBL3599945,B,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,CHEMBL3596172,IC50,COc1c(Cl)cccc1N1CCN(CCCCNC(=O)c2cnc3ccccc3c2)CC1
CHEMBL3623290,CHEMBL217,Dopamine D2 receptor,IC50,=,797.0,nM,CHEMBL3624486,B,Inhibition of recombinant D2 receptor (unknown origin),CHEMBL3621142,IC50,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C
CHEMBL8514,CHEMBL217,Dopamine D2 receptor,IC50,=,1.1,nM,CHEMBL3779713,B,Displacement of [3H]methylspiperone from human recombinant Dopamine D2S receptor expressed in HEK293 cells,CHEMBL3774372,IC50,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1
CHEMBL3126735,CHEMBL217,Dopamine D2 receptor,IC50,=,2000.0,nM,CHEMBL3863997,B,Antagonist activity at DRD2 (unknown origin) expressed in HEK293T cells transfected with Galphai1-RLuc8 and gamma2-GFP10 assessed as inhibition of quinpirole-induced Gi1 activation pre-incubated with quinpirole for 10 mins before compound incubation for 10 mins by BRET assay,CHEMBL3862037,IC50,Fc1ccc(C(SCCNCCCc2ccccc2)c2ccc(F)cc2)cc1
CHEMBL1201192,CHEMBL217,Dopamine D2 receptor,IC50,=,2.1,nM,CHEMBL3863997,B,Antagonist activity at DRD2 (unknown origin) expressed in HEK293T cells transfected with Galphai1-RLuc8 and gamma2-GFP10 assessed as inhibition of quinpirole-induced Gi1 activation pre-incubated with quinpirole for 10 mins before compound incubation for 10 mins by BRET assay,CHEMBL3862037,IC50,NC(=O)C[S@@+]([O-])C(c1ccccc1)c1ccccc1
CHEMBL3885419,CHEMBL217,Dopamine D2 receptor,IC50,=,1.1,nM,CHEMBL3876354,B,Displacement of [3H]methyl-spiperone from human recombinant dopamine D2S receptor expressed in HEK293 cells measured after 60 mins by scintillation counting method,CHEMBL3875185,IC50,CC(C)(C)[C@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1
CHEMBL244562,CHEMBL217,Dopamine D2 receptor,IC50,=,41.0,nM,CHEMBL3705175,B,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",CHEMBL3638880,IC50,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc(=O)[nH]2)cc1
CHEMBL398175,CHEMBL217,Dopamine D2 receptor,IC50,=,1300.0,nM,CHEMBL3705175,B,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",CHEMBL3638880,IC50,Cc1cccc(-c2ccc(C(=O)NC/C=C/CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2)n1
CHEMBL244773,CHEMBL217,Dopamine D2 receptor,IC50,=,368.0,nM,CHEMBL3705175,B,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",CHEMBL3638880,IC50,Cc1cccnc1-c1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1
CHEMBL244774,CHEMBL217,Dopamine D2 receptor,IC50,=,22.9,nM,CHEMBL3705175,B,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",CHEMBL3638880,IC50,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc[n+]2[O-])cc1
CHEMBL394541,CHEMBL217,Dopamine D2 receptor,IC50,=,175.0,nM,CHEMBL3705175,B,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",CHEMBL3638880,IC50,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc(-c3ccccn3)cc2)CC1
CHEMBL244989,CHEMBL217,Dopamine D2 receptor,IC50,=,179.0,nM,CHEMBL3705175,B,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",CHEMBL3638880,IC50,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1
CHEMBL244990,CHEMBL217,Dopamine D2 receptor,IC50,=,15.8,nM,CHEMBL3705175,B,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",CHEMBL3638880,IC50,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL390253,CHEMBL217,Dopamine D2 receptor,IC50,=,88.3,nM,CHEMBL3705175,B,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",CHEMBL3638880,IC50,O=C(NCC(O)CCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL3982119,CHEMBL217,Dopamine D2 receptor,IC50,=,1727.6,nM,CHEMBL3888598,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(cc1OC)[C@@H]1Cc3c(OC)ccc(OC)c3CN1CC2
CHEMBL3903297,CHEMBL217,Dopamine D2 receptor,IC50,=,1239.4,nM,CHEMBL3888598,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,c1c2c(cc3c1OCO3)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL3897805,CHEMBL217,Dopamine D2 receptor,IC50,=,2508.05,nM,CHEMBL3888598,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1ccc(OC)c2c1C[C@H]1c3cc4c(cc3CCN1C2)OCO4
CHEMBL2057451,CHEMBL217,Dopamine D2 receptor,IC50,=,1155.3,nM,CHEMBL3888598,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(cc1OC)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL2334893,CHEMBL217,Dopamine D2 receptor,IC50,=,91.11,nM,CHEMBL3888598,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(cc1O)[C@@H]1Cc3cc4c(cc3CN1CC2)OCO4
CHEMBL2057457,CHEMBL217,Dopamine D2 receptor,IC50,=,456.13,nM,CHEMBL3888598,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL267930,CHEMBL217,Dopamine D2 receptor,IC50,=,2.56,nM,CHEMBL3888598,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
CHEMBL8514,CHEMBL217,Dopamine D2 receptor,IC50,=,0.81,nM,CHEMBL4001156,B,Displacement of [3H]methyl-spiperone from human recombinant D2S receptor in HEK293 cells after 60 mins by scintillation counting,CHEMBL4000185,IC50,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1
CHEMBL3797209,CHEMBL217,Dopamine D2 receptor,IC50,=,157.8,nM,CHEMBL4011220,B,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,CHEMBL4007493,IC50,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL4068455,CHEMBL217,Dopamine D2 receptor,IC50,=,712.9,nM,CHEMBL4011220,B,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,CHEMBL4007493,IC50,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL3797209,CHEMBL217,Dopamine D2 receptor,IC50,=,931.1,nM,CHEMBL4011224,B,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,CHEMBL4007493,IC50,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL4076129,CHEMBL217,Dopamine D2 receptor,IC50,=,4487.5,nM,CHEMBL4011224,B,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,CHEMBL4007493,IC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCOCCCCc2ccccc2)C1
CHEMBL4077430,CHEMBL217,Dopamine D2 receptor,IC50,=,4102.0,nM,CHEMBL4011224,B,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,CHEMBL4007493,IC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOc2ccc3c(c2)NC(=O)CC3)C1
CHEMBL4068455,CHEMBL217,Dopamine D2 receptor,IC50,=,3647.5,nM,CHEMBL4011224,B,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,CHEMBL4007493,IC50,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL4093477,CHEMBL217,Dopamine D2 receptor,IC50,=,2971.7,nM,CHEMBL4011224,B,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,CHEMBL4007493,IC50,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL3797209,CHEMBL217,Dopamine D2 receptor,IC50,=,98.9,nM,CHEMBL4011228,B,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,CHEMBL4007493,IC50,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL4076129,CHEMBL217,Dopamine D2 receptor,IC50,=,801.7,nM,CHEMBL4011228,B,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,CHEMBL4007493,IC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCOCCCCc2ccccc2)C1
CHEMBL4068455,CHEMBL217,Dopamine D2 receptor,IC50,=,2013.7,nM,CHEMBL4011228,B,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,CHEMBL4007493,IC50,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL4093477,CHEMBL217,Dopamine D2 receptor,IC50,=,4529.0,nM,CHEMBL4011228,B,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,CHEMBL4007493,IC50,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL4128926,CHEMBL217,Dopamine D2 receptor,IC50,=,1.8,nM,CHEMBL4121476,B,Displacement of [3H]7-OH-DPAT from human recombinant dopamine D2S receptor after 60 mins by scintillation counting analysis,CHEMBL4118122,IC50,CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12
CHEMBL4515776,CHEMBL217,Dopamine D2 receptor,IC50,=,15.0,nM,CHEMBL4310164,B,Antagonist activity at human dopamine D2 receptor expressed in CHO cells co-expressing A2A receptor assessed as reduction in sumanirole-induced response after 90 mins by DMR analysis,CHEMBL4308850,IC50,COC(=O)CN(CC(=O)NCCOCCOCCNC(=O)CCC(=O)Nc1ccc(CCN2CN(c3ccccc3)C3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)C2=O)cc1)CC(=O)NCCOCCOCCNC(=O)CCC(=O)Nc1ccc(CCN2CN(c3ccccc3)C3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)C2=O)cc1
CHEMBL4542935,CHEMBL217,Dopamine D2 receptor,IC50,=,280.0,nM,CHEMBL4310164,B,Antagonist activity at human dopamine D2 receptor expressed in CHO cells co-expressing A2A receptor assessed as reduction in sumanirole-induced response after 90 mins by DMR analysis,CHEMBL4308850,IC50,COC(=O)CN(CC(=O)NCCOCCOCCNC(C)=O)CC(=O)NCCOCCOCCNC(=O)CCC(=O)Nc1ccc(CCN2CN(c3ccccc3)C3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)C2=O)cc1
CHEMBL4467483,CHEMBL217,Dopamine D2 receptor,IC50,=,30.2,nM,CHEMBL4345338,B,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@@H](C2)N(C)CC3
CHEMBL4564103,CHEMBL217,Dopamine D2 receptor,IC50,=,316.23,nM,CHEMBL4345338,B,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@H](C2)N(C)CC3
CHEMBL4579687,CHEMBL217,Dopamine D2 receptor,IC50,=,44.67,nM,CHEMBL4345338,B,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@@H](C2)N(C)CC3
CHEMBL4513262,CHEMBL217,Dopamine D2 receptor,IC50,=,1949.84,nM,CHEMBL4345338,B,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@H](C2)N(C)CC3
CHEMBL4439029,CHEMBL217,Dopamine D2 receptor,IC50,=,28.18,nM,CHEMBL4345338,B,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,CCc1ccc2c3c1CCN(C)[C@@H]3Cc1ccc(OC)c(OC)c1-2
CHEMBL4442011,CHEMBL217,Dopamine D2 receptor,IC50,=,40.74,nM,CHEMBL4345338,B,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,CCc1ccc2c3c1CCN(C)[C@H]3Cc1ccc(OC)c(OC)c1-2
CHEMBL4589737,CHEMBL217,Dopamine D2 receptor,IC50,=,3630.78,nM,CHEMBL4345338,B,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1ccc(C)c3c1[C@@H](C2)N(C)CC3
CHEMBL8809,CHEMBL217,Dopamine D2 receptor,IC50,=,1.82,nM,CHEMBL4345338,B,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC
CHEMBL4467483,CHEMBL217,Dopamine D2 receptor,IC50,=,30.35,nM,CHEMBL4345338,B,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@@H](C2)N(C)CC3
CHEMBL4564103,CHEMBL217,Dopamine D2 receptor,IC50,=,337.5,nM,CHEMBL4345338,B,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@H](C2)N(C)CC3
CHEMBL4579687,CHEMBL217,Dopamine D2 receptor,IC50,=,45.07,nM,CHEMBL4345338,B,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@@H](C2)N(C)CC3
CHEMBL4513262,CHEMBL217,Dopamine D2 receptor,IC50,=,1957.0,nM,CHEMBL4345338,B,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@H](C2)N(C)CC3
CHEMBL4439029,CHEMBL217,Dopamine D2 receptor,IC50,=,28.2,nM,CHEMBL4345338,B,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,CCc1ccc2c3c1CCN(C)[C@@H]3Cc1ccc(OC)c(OC)c1-2
CHEMBL4442011,CHEMBL217,Dopamine D2 receptor,IC50,=,40.77,nM,CHEMBL4345338,B,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,CCc1ccc2c3c1CCN(C)[C@H]3Cc1ccc(OC)c(OC)c1-2
CHEMBL4589737,CHEMBL217,Dopamine D2 receptor,IC50,=,3629.0,nM,CHEMBL4345338,B,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1ccc(C)c3c1[C@@H](C2)N(C)CC3
CHEMBL8809,CHEMBL217,Dopamine D2 receptor,IC50,=,1.83,nM,CHEMBL4345338,B,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC
CHEMBL4451797,CHEMBL217,Dopamine D2 receptor,IC50,=,71.0,nM,CHEMBL4394479,B,Antagonist activity at D2L receptor (unknown origin) expressed in human HTLA cells assessed as inhibition of dopamine-stimulated beta-arrestin2 recruitment measured after 20 to 22 hrs by brightglo-luciferase reporter gene assay,CHEMBL4393669,IC50,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3cccc(Cl)c3C2)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,IC50,=,140.0,nM,CHEMBL4394479,B,Antagonist activity at D2L receptor (unknown origin) expressed in human HTLA cells assessed as inhibition of dopamine-stimulated beta-arrestin2 recruitment measured after 20 to 22 hrs by brightglo-luciferase reporter gene assay,CHEMBL4393669,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL3306803,CHEMBL217,Dopamine D2 receptor,IC50,=,4.1,nM,CHEMBL4710573,B,Partial agonist activity at presynaptic D2 receptor (unknown origin),CHEMBL4706566,IC50,CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12
CHEMBL3306803,CHEMBL217,Dopamine D2 receptor,IC50,=,3.2,nM,CHEMBL4710574,B,Antagonist activity at postsynaptic D2 receptor (unknown origin),CHEMBL4706566,IC50,CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12
CHEMBL3091687,CHEMBL217,Dopamine D2 receptor,IC50,=,5700.0,nM,CHEMBL5048805,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL5046278,IC50,NCCCCN(C[C@H]1Cc2ccccc2CN1)[C@H]1CCCc2cccnc21
CHEMBL5070958,CHEMBL217,Dopamine D2 receptor,IC50,=,9400.0,nM,CHEMBL5048805,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL5046278,IC50,NCCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21
CHEMBL5076569,CHEMBL217,Dopamine D2 receptor,IC50,=,10000.0,nM,CHEMBL5048805,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL5046278,IC50,NCCCCN(C[C@H]1Cc2cccnc2CN1)[C@H]1CCCc2cccnc21
CHEMBL5081505,CHEMBL217,Dopamine D2 receptor,IC50,=,9800.0,nM,CHEMBL5048805,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL5046278,IC50,c1cnc2c(c1)CN[C@@H](CN(CCCC1CCNCC1)[C@H]1CCCc3cccnc31)C2
CHEMBL518924,CHEMBL217,Dopamine D2 receptor,IC50,=,4100.0,nM,CHEMBL5048805,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL5046278,IC50,NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21
CHEMBL5177023,CHEMBL217,Dopamine D2 receptor,IC50,=,1000.0,nM,CHEMBL5120437,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL5113538,IC50,Cc1c(C#Cc2ccc(CN3CCC(CO)CC3)cc2)cc(C(F)F)c2cn(C(C(=O)Nc3nccs3)c3ncn4c3CCC43CC3)nc12
CHEMBL4650337,CHEMBL217,Dopamine D2 receptor,IC50,=,24000.0,nM,CHEMBL5233300,B,Agonist activity at D2 (unknown origin) by beta-arrestin recruitment assay,CHEMBL5233201,IC50,CNC[C@@H]1OCCc2ccsc21
CHEMBL5278239,CHEMBL217,Dopamine D2 receptor,IC50,=,4.571,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,CN(CC(=O)NCc1ccccc1)C(=O)CCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL5268231,CHEMBL217,Dopamine D2 receptor,IC50,=,2.884,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,CN(CC(=O)NC1CCCCC1)C(=O)CCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL5274482,CHEMBL217,Dopamine D2 receptor,IC50,=,1548.82,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,CN(CC(=O)NC(C)(C)C)C(=O)CCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL5281830,CHEMBL217,Dopamine D2 receptor,IC50,=,5.012,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc(-c2ccccc2)c1C(=O)NCc1ccccc1
CHEMBL5281787,CHEMBL217,Dopamine D2 receptor,IC50,=,1737.8,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc(-c2ccccc2)c1C(=O)NC1CCCCC1
CHEMBL5274672,CHEMBL217,Dopamine D2 receptor,IC50,=,162.18,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc(-c2ccccc2)c1C(=O)NC(C)(C)C
CHEMBL5288557,CHEMBL217,Dopamine D2 receptor,IC50,=,13489.63,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,O=C(Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc2ccccc21)NCc1ccccc1
CHEMBL5280979,CHEMBL217,Dopamine D2 receptor,IC50,=,9120.11,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,O=C(Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc2ccccc21)NC1CCCCC1
CHEMBL5273880,CHEMBL217,Dopamine D2 receptor,IC50,=,371.54,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,CC(C)(C)NC(=O)Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc2ccccc21
CHEMBL5278601,CHEMBL217,Dopamine D2 receptor,IC50,=,2.188,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,O=C(Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc2cc(Br)c(Br)cc21)NCc1ccccc1
CHEMBL5275349,CHEMBL217,Dopamine D2 receptor,IC50,=,3801.89,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,O=C(Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc2cc(Br)c(Br)cc21)NC1CCCCC1
CHEMBL5282604,CHEMBL217,Dopamine D2 receptor,IC50,=,446.68,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,CC(C)(C)NC(=O)Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc2cc(Br)c(Br)cc21
CHEMBL5266395,CHEMBL217,Dopamine D2 receptor,IC50,=,1380.38,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)N1C=CN(Cc2ccccc2)C(=O)C1
CHEMBL5280677,CHEMBL217,Dopamine D2 receptor,IC50,=,109.65,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)N1C=CN(C2CCCCC2)C(=O)C1
CHEMBL5290330,CHEMBL217,Dopamine D2 receptor,IC50,=,1737.8,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,CC(C)(C)N1C=CN(C(=O)CCCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1=O
CHEMBL5273430,CHEMBL217,Dopamine D2 receptor,IC50,=,1.096,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,CN1CCN(C(=O)CCCN2CCN(c3cccc(Cl)c3Cl)CC2)C(C(=O)NCc2ccccc2)C1
CHEMBL5270832,CHEMBL217,Dopamine D2 receptor,IC50,=,1.66,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,CN1CCN(C(=O)CCCN2CCN(c3cccc(Cl)c3Cl)CC2)C(C(=O)NC2CCCCC2)C1
CHEMBL5278254,CHEMBL217,Dopamine D2 receptor,IC50,=,1479.11,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,CN1CCN(C(=O)CCCN2CCN(c3cccc(Cl)c3Cl)CC2)C(C(=O)NC(C)(C)C)C1
CHEMBL5283891,CHEMBL217,Dopamine D2 receptor,IC50,=,1.148,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,O=C1NCCN(C(=O)CCCN2CCN(c3cccc(Cl)c3Cl)CC2)C1C(=O)NCc1ccccc1
CHEMBL5269858,CHEMBL217,Dopamine D2 receptor,IC50,=,3311.31,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,O=C1NCCN(C(=O)CCCN2CCN(c3cccc(Cl)c3Cl)CC2)C1C(=O)NC1CCCCC1
CHEMBL5266508,CHEMBL217,Dopamine D2 receptor,IC50,=,3.802,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,CC(C)(C)NC(=O)C1C(=O)NCCN1C(=O)CCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,IC50,=,2.63,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,IC50,=,38.02,nM,CHEMBL5236927,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,CHEMBL5236546,IC50,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,IC50,=,1.0,nM,CHEMBL5236933,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as beta-arrestin recruitment preincubated for 10 mins with coelenterazine followed by compound addition and measured after 10 mins by BRET assay,CHEMBL5236546,IC50,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4639128,CHEMBL217,Dopamine D2 receptor,IC50,=,3162.28,nM,CHEMBL5303889,B,Cross screening panel,CHEMBL4630907,IC50,COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1
CHEMBL5410211,CHEMBL217,Dopamine D2 receptor,IC50,=,1400.0,nM,CHEMBL5464398,B,Bayer Inhouse kinase panel (DRD2),CHEMBL5463728,IC50,CNc1cc[n+](CCNC(=O)c2ccn3c(-c4c(C)noc4C)cnc3c2)cc1.[Cl-]
CHEMBL3903492,CHEMBL217,Dopamine D2 receptor,IC50,=,8500.0,nM,CHEMBL5481013,B,"Selectivity interaction (CEREP panel (binding assay, receptors and ion channels)) EUB0001623a DRD2",CHEMBL5465560,IC50,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12
CHEMBL156651,CHEMBL217,Dopamine D2 receptor,Ki,=,0.067,nM,CHEMBL670962,B,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p,CHEMBL1132286,KI,NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12
CHEMBL156651,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL666181,B,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p,CHEMBL1132286,KI,NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12
CHEMBL156651,CHEMBL217,Dopamine D2 receptor,Ki,=,0.196,nM,CHEMBL665377,B,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,CHEMBL1132286,KI,NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12
CHEMBL156651,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL666183,B,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,CHEMBL1132286,KI,NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12
CHEMBL156651,CHEMBL217,Dopamine D2 receptor,Ki,=,0.05,nM,CHEMBL665376,B,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p (pretreatment with 100 nM of compound),CHEMBL1132286,KI,NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12
CHEMBL156651,CHEMBL217,Dopamine D2 receptor,Ki,=,188.0,nM,CHEMBL666182,B,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p (pretreatment with 100 nM of compound),CHEMBL1132286,KI,NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12
CHEMBL156651,CHEMBL217,Dopamine D2 receptor,Ki,=,0.09,nM,CHEMBL666180,B,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p (pretreatment with 100 nM of compound),CHEMBL1132286,KI,NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12
CHEMBL156651,CHEMBL217,Dopamine D2 receptor,Ki,=,211.0,nM,CHEMBL666183,B,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,CHEMBL1132286,KI,NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12
CHEMBL349833,CHEMBL217,Dopamine D2 receptor,Ki,=,139.0,nM,CHEMBL672162,B,Displacement of [3H]-YM 09151 from D2 receptor,CHEMBL1136593,KI,CC1Cc2cccc3c2N1C(=O)C(N1CCN(Cc2ccc(Cl)cc2)CC1)CC3
CHEMBL439646,CHEMBL217,Dopamine D2 receptor,Ki,=,201.0,nM,CHEMBL672162,B,Displacement of [3H]-YM 09151 from D2 receptor,CHEMBL1136593,KI,CC1(C)Cc2cccc3c2N1C(=O)C(N1CCN(Cc2ccc(Cl)cc2)CC1)CC3
CHEMBL87187,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL671377,B,Binding ability of compound to human Dopamine receptor D2,CHEMBL1131962,KI,Nc1cccc(-c2ccc(CCN3CCN(c4cccc5cccnc45)CC3)cc2)n1
CHEMBL351963,CHEMBL217,Dopamine D2 receptor,Ki,=,209.0,nM,CHEMBL672162,B,Displacement of [3H]-YM 09151 from D2 receptor,CHEMBL1136593,KI,Cc1ccc(CN2CCN(C3CCc4cccc5c4N(CC5)C3=O)CC2)cc1
CHEMBL309118,CHEMBL217,Dopamine D2 receptor,Ki,=,512.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,O=C(NCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2=O
CHEMBL315864,CHEMBL217,Dopamine D2 receptor,Ki,=,87.3,nM,CHEMBL884862,B,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,CHEMBL1130595,KI,Oc1nc2c(N3CCN(Cc4ccccc4)CC3)cccc2[nH]1
CHEMBL322179,CHEMBL217,Dopamine D2 receptor,Ki,=,777.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cccc2c1-c1ccccc1C2=O
CHEMBL419505,CHEMBL217,Dopamine D2 receptor,Ki,=,262.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)-c1ccccc1-2
CHEMBL108527,CHEMBL217,Dopamine D2 receptor,Ki,=,1680.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,O=C(NCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1Cc1ccccc1-2
CHEMBL110411,CHEMBL217,Dopamine D2 receptor,Ki,=,217.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)-c1ccccc1C2
CHEMBL330108,CHEMBL217,Dopamine D2 receptor,Ki,=,540.0,nM,CHEMBL884862,B,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,CHEMBL1130595,KI,O=C1Cc2c(ccc(Cl)c2N2CCN(Cc3ccccc3)CC2)N1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,113.0,nM,CHEMBL672162,B,Displacement of [3H]-YM 09151 from D2 receptor,CHEMBL1136593,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL267562,CHEMBL217,Dopamine D2 receptor,Ki,=,625.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,Fc1ccc(C(OC2CC3CCC(C2)N3Cc2ccc(Cl)c(Cl)c2)c2ccc(F)cc2)cc1
CHEMBL156164,CHEMBL217,Dopamine D2 receptor,Ki,=,0.071,nM,CHEMBL670962,B,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p,CHEMBL1132286,KI,NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12
CHEMBL156164,CHEMBL217,Dopamine D2 receptor,Ki,=,196.0,nM,CHEMBL666181,B,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p,CHEMBL1132286,KI,NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12
CHEMBL156164,CHEMBL217,Dopamine D2 receptor,Ki,=,0.122,nM,CHEMBL665377,B,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,CHEMBL1132286,KI,NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12
CHEMBL156164,CHEMBL217,Dopamine D2 receptor,Ki,=,246.0,nM,CHEMBL666183,B,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,CHEMBL1132286,KI,NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12
CHEMBL156164,CHEMBL217,Dopamine D2 receptor,Ki,=,0.031,nM,CHEMBL665376,B,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p (pretreatment with 100 nM of compound),CHEMBL1132286,KI,NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12
CHEMBL156164,CHEMBL217,Dopamine D2 receptor,Ki,=,168.0,nM,CHEMBL666182,B,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p (pretreatment with 100 nM of compound),CHEMBL1132286,KI,NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12
CHEMBL156164,CHEMBL217,Dopamine D2 receptor,Ki,=,0.064,nM,CHEMBL666180,B,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p (pretreatment with 100 nM of compound),CHEMBL1132286,KI,NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12
CHEMBL156164,CHEMBL217,Dopamine D2 receptor,Ki,=,202.0,nM,CHEMBL666183,B,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,CHEMBL1132286,KI,NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12
CHEMBL292759,CHEMBL217,Dopamine D2 receptor,Ki,=,3981.07,nM,CHEMBL674350,B,Compound was tested for its binding affinity against Dopamine receptor D2 in human cloned receptors in CHO cells using [125 I]iodosulpride,CHEMBL1132410,KI,COc1ccc(NS(=O)(=O)c2ccc(Br)cc2)cc1N1CCN(C)CC1
CHEMBL301242,CHEMBL217,Dopamine D2 receptor,Ki,=,89.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2=O
CHEMBL29846,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL674350,B,Compound was tested for its binding affinity against Dopamine receptor D2 in human cloned receptors in CHO cells using [125 I]iodosulpride,CHEMBL1132410,KI,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCN(C)CC1
CHEMBL352207,CHEMBL217,Dopamine D2 receptor,Ki,=,116.0,nM,CHEMBL672162,B,Displacement of [3H]-YM 09151 from D2 receptor,CHEMBL1136593,KI,O=C1C(N2CCN(Cc3ccc(Cl)cc3)CC2)CCc2cccc3c2N1CC3
CHEMBL310310,CHEMBL217,Dopamine D2 receptor,Ki,=,1740.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,CN1C2CCC1CC(OC(c1ccccc1)c1ccc(Cl)cc1)C2
CHEMBL108637,CHEMBL217,Dopamine D2 receptor,Ki,=,825.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL67750,CHEMBL217,Dopamine D2 receptor,Ki,=,2570.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,O=C(NCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL314952,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL884862,B,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,CHEMBL1130595,KI,O=C1Cc2c(cccc2N2CCN(Cc3ccccc3)CC2)N1
CHEMBL351989,CHEMBL217,Dopamine D2 receptor,Ki,=,165.0,nM,CHEMBL672162,B,Displacement of [3H]-YM 09151 from D2 receptor,CHEMBL1136593,KI,Cc1ccc(CN2CCN(C3CCc4cccc5c4N(C3=O)C(C)(C)C5)CC2)cc1
CHEMBL110120,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,OC1CCc2c(c3ccccc3n2CCCN2CCN(c3ccccc3)CC2)C1
CHEMBL40650,CHEMBL217,Dopamine D2 receptor,Ki,=,19.7,nM,CHEMBL670782,B,Binding affinity against Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1130166,KI,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21
CHEMBL159742,CHEMBL217,Dopamine D2 receptor,Ki,=,952.0,nM,CHEMBL672162,B,Displacement of [3H]-YM 09151 from D2 receptor,CHEMBL1136593,KI,COc1cc(C)ccc1CN1CCN(C2CCc3cccc4c3N(C2=O)C(C)(C)C4)CC1
CHEMBL88837,CHEMBL217,Dopamine D2 receptor,Ki,=,257.5,nM,CHEMBL884862,B,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,CHEMBL1130595,KI,c1ccc(CN2CCN(c3cccc4[nH]cnc34)CC2)cc1
CHEMBL354699,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL672162,B,Displacement of [3H]-YM 09151 from D2 receptor,CHEMBL1136593,KI,COc1ccc(Cl)cc1CN1CCN(C2CCc3cccc4c3N(C2=O)C(C)(C)C4)CC1
CHEMBL323997,CHEMBL217,Dopamine D2 receptor,Ki,=,927.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,Fc1ccc(C(OCCN2C3CCC2CC(OC(c2ccc(F)cc2)c2ccc(F)cc2)C3)c2ccc(F)cc2)cc1
CHEMBL68191,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL672162,B,Displacement of [3H]-YM 09151 from D2 receptor,CHEMBL1136593,KI,CCN1C(=O)C(N2CCN(Cc3ccc(Cl)cc3)CC2)Cc2ccccc21
CHEMBL69584,CHEMBL217,Dopamine D2 receptor,Ki,=,690.0,nM,CHEMBL672162,B,Displacement of [3H]-YM 09151 from D2 receptor,CHEMBL1136593,KI,O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2ccccc21
CHEMBL307800,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)C1c2ccccc2-c2ccccc21
CHEMBL306672,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,O=C1c2ccccc2C(=O)N1CCCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL345438,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL672162,B,Displacement of [3H]-YM 09151 from D2 receptor,CHEMBL1136593,KI,Cc1ccc(CN2CCN(C3CCc4cccc5c4N(C3=O)C(C)C5)CC2)cc1
CHEMBL110435,CHEMBL217,Dopamine D2 receptor,Ki,=,1120.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,Fc1ccc(C(OCCOC2CC3CCC(C2)N3)c2ccc(F)cc2)cc1
CHEMBL69717,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,O=C1c2ccccc2C(=O)N1CCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL302796,CHEMBL217,Dopamine D2 receptor,Ki,=,606.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,O=C(NCCCN1CCN(c2ccccc2)CC1)C1c2ccccc2-c2ccccc21
CHEMBL88365,CHEMBL217,Dopamine D2 receptor,Ki,=,246.0,nM,CHEMBL884862,B,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,CHEMBL1130595,KI,Oc1cccc(N2CCN(Cc3ccccc3)CC2)c1
CHEMBL328051,CHEMBL217,Dopamine D2 receptor,Ki,=,53.0,nM,CHEMBL884862,B,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,CHEMBL1130595,KI,c1ccc(CN2CCN(c3cccc4[nH]ccc34)CC2)cc1
CHEMBL320114,CHEMBL217,Dopamine D2 receptor,Ki,=,672.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,CN1C2CCC1CC(OC1c3ccccc3Cc3ccccc31)C2
CHEMBL542139,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL674350,B,Compound was tested for its binding affinity against Dopamine receptor D2 in human cloned receptors in CHO cells using [125 I]iodosulpride,CHEMBL1132410,KI,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1.Cl
CHEMBL2308105,CHEMBL217,Dopamine D2 receptor,Ki,=,81.3,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,Fc1ccc(C(O[C@H]2C[C@H]3CC[C@@H](C2)N3CCCCc2ccccc2)c2ccc(F)cc2)cc1
CHEMBL68860,CHEMBL217,Dopamine D2 receptor,Ki,=,414.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,O=C(NCCCN1CCN(c2cccc(Cl)c2Cl)CC1)C1c2ccccc2-c2ccccc21
CHEMBL90476,CHEMBL217,Dopamine D2 receptor,Ki,=,47.0,nM,CHEMBL884862,B,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,CHEMBL1130595,KI,Brc1ccc(N2CCN(Cc3ccccc3)CC2)c2cc[nH]c12
CHEMBL88289,CHEMBL217,Dopamine D2 receptor,Ki,=,4.1,nM,CHEMBL884862,B,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,CHEMBL1130595,KI,FC(F)(F)c1nc2c(N3CCN(Cc4ccccc4)CC3)cccc2[nH]1
CHEMBL106660,CHEMBL217,Dopamine D2 receptor,Ki,=,59.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,Clc1cccc(C(OC2CC3CCC(C2)N3CCCc2ccccc2)c2ccccc2)c1
CHEMBL351612,CHEMBL217,Dopamine D2 receptor,Ki,=,313.0,nM,CHEMBL672162,B,Displacement of [3H]-YM 09151 from D2 receptor,CHEMBL1136593,KI,COc1ccc(C)cc1CN1CCN(C2CCc3cccc4c3N(C2=O)C(C)(C)C4)CC1
CHEMBL68720,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,O=C(NCCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2=O
CHEMBL311539,CHEMBL217,Dopamine D2 receptor,Ki,=,81.3,nM,CHEMBL884862,B,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,CHEMBL1130595,KI,Clc1ccc2[nH]ccc2c1N1CCN(Cc2ccccc2)CC1
CHEMBL110349,CHEMBL217,Dopamine D2 receptor,Ki,=,473.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cccc2c1Cc1ccccc1-2
CHEMBL12004,CHEMBL217,Dopamine D2 receptor,Ki,=,379.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,Fc1ccc(C(OC2CC3CCC(C2)N3Cc2cccc3ccccc23)c2ccc(F)cc2)cc1
CHEMBL109299,CHEMBL217,Dopamine D2 receptor,Ki,=,218.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,Fc1ccc(C(OC2CC3CCC(C2)N3Cc2cc3ccccc3[nH]2)c2ccc(F)cc2)cc1
CHEMBL12375,CHEMBL217,Dopamine D2 receptor,Ki,=,132.0,nM,CHEMBL671385,B,Binding affinity at human dopamine receptor D2,CHEMBL1134599,KI,Fc1ccc(C(OC2CC3CCC(C2)N3Cc2ccccc2)c2ccc(F)cc2)cc1
CHEMBL317488,CHEMBL217,Dopamine D2 receptor,Ki,=,0.09,nM,CHEMBL670962,B,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p,CHEMBL1132286,KI,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O
CHEMBL317488,CHEMBL217,Dopamine D2 receptor,Ki,=,73.2,nM,CHEMBL666181,B,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p,CHEMBL1132286,KI,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O
CHEMBL317488,CHEMBL217,Dopamine D2 receptor,Ki,=,0.13,nM,CHEMBL665377,B,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,CHEMBL1132286,KI,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O
CHEMBL317488,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL666183,B,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,CHEMBL1132286,KI,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O
CHEMBL317488,CHEMBL217,Dopamine D2 receptor,Ki,=,0.04,nM,CHEMBL665376,B,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p (pretreatment with 100 nM of compound),CHEMBL1132286,KI,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O
CHEMBL317488,CHEMBL217,Dopamine D2 receptor,Ki,=,60.1,nM,CHEMBL666182,B,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p (pretreatment with 100 nM of compound),CHEMBL1132286,KI,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O
CHEMBL317488,CHEMBL217,Dopamine D2 receptor,Ki,=,0.06,nM,CHEMBL666180,B,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p (pretreatment with 100 nM of compound),CHEMBL1132286,KI,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O
CHEMBL317488,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL666183,B,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,CHEMBL1132286,KI,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O
CHEMBL7549,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL678343,B,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",CHEMBL1127438,KI,CCCN1CCC[C@@H](c2cccc(O)c2)C1
CHEMBL7549,CHEMBL217,Dopamine D2 receptor,Ki,=,8.5,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,CCCN1CCC[C@@H](c2cccc(O)c2)C1
CHEMBL311730,CHEMBL217,Dopamine D2 receptor,Ki,=,447.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,CCCN1CCC[C@@H](c2cccc(S(C)(=O)=O)c2)C1
CHEMBL327245,CHEMBL217,Dopamine D2 receptor,Ki,=,2550.0,nM,CHEMBL673083,B,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,CHEMBL1133667,KI,COc1cccc(C(=O)CCCN2CCN(c3ccc(Cl)cc3)CC2)c1
CHEMBL96462,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL673083,B,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,CHEMBL1133667,KI,COc1cccc(CNCCN2CCN(c3ccc(Cl)cc3)CC2)c1
CHEMBL24222,CHEMBL217,Dopamine D2 receptor,Ki,=,50.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,C=CCN1CC[C@@H]2c3cccc(OC)c3CC[C@H]21
CHEMBL49231,CHEMBL217,Dopamine D2 receptor,Ki,=,349.0,nM,CHEMBL671981,B,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,CHEMBL1130052,KI,COc1ccccc1N1CCN(CNC(=O)c2ccc(Cl)cc2)CC1
CHEMBL328894,CHEMBL217,Dopamine D2 receptor,Ki,=,519.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,N#Cc1cccc([C@@H]2CCCN(CC3CC3)C2)c1
CHEMBL27251,CHEMBL217,Dopamine D2 receptor,Ki,=,2250.0,nM,CHEMBL672309,B,Binding affinity towards Dopamine receptor D2,CHEMBL1145819,KI,CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N
CHEMBL298763,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL671981,B,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,CHEMBL1130052,KI,O=C(NCN1CCN(c2ccccc2Cl)CC1)c1ccccc1
CHEMBL92817,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL678343,B,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",CHEMBL1127438,KI,CCCN1CCC[C@@H](c2cccc(Br)c2)C1
CHEMBL315879,CHEMBL217,Dopamine D2 receptor,Ki,=,2350.0,nM,CHEMBL673083,B,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,CHEMBL1133667,KI,COc1cccc(C(=O)NCCCCN2CCN(c3ccc(Cl)cc3)CC2)c1
CHEMBL93917,CHEMBL217,Dopamine D2 receptor,Ki,=,69.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,CCCN1CCC[C@@H](c2cccc(CC#N)c2)C1
CHEMBL90798,CHEMBL217,Dopamine D2 receptor,Ki,=,235.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,CCN1CCC[C@@H](c2cccc(C#N)c2)C1
CHEMBL328119,CHEMBL217,Dopamine D2 receptor,Ki,=,73.0,nM,CHEMBL678343,B,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",CHEMBL1127438,KI,O=S(=O)(Oc1cccc([C@@H]2CCCN(CCc3ccccc3)C2)c1)C(F)(F)F
CHEMBL93570,CHEMBL217,Dopamine D2 receptor,Ki,=,134.0,nM,CHEMBL678343,B,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",CHEMBL1127438,KI,CCc1sccc1N1CCC[C@@H](c2cccc(C#N)c2)C1
CHEMBL93570,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,CCc1sccc1N1CCC[C@@H](c2cccc(C#N)c2)C1
CHEMBL92713,CHEMBL217,Dopamine D2 receptor,Ki,=,3950.0,nM,CHEMBL673083,B,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,CHEMBL1133667,KI,COc1cccc(C(=O)NCCCN2CCN(c3ccc(Cl)cc3)CC2)c1
CHEMBL328283,CHEMBL217,Dopamine D2 receptor,Ki,=,262.0,nM,CHEMBL673083,B,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,CHEMBL1133667,KI,COc1ccc2c(c1)C(NCCN1CCN(c3ccc(Cl)cc3)CC1)CCC2
CHEMBL300956,CHEMBL217,Dopamine D2 receptor,Ki,=,1150.0,nM,CHEMBL671981,B,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,CHEMBL1130052,KI,Cc1ccc(C(=O)NCN2CCN(c3ccccc3C#N)CC2)cc1
CHEMBL49876,CHEMBL217,Dopamine D2 receptor,Ki,=,929.0,nM,CHEMBL671981,B,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,CHEMBL1130052,KI,N#Cc1ccccc1N1CCN(CNC(=O)c2ccc(Cl)cc2)CC1
CHEMBL45244,CHEMBL217,Dopamine D2 receptor,Ki,=,3740.0,nM,CHEMBL671981,B,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,CHEMBL1130052,KI,Cc1cccc(C(=O)NCN2CCN(c3ccccc3C#N)CC2)c1
CHEMBL329443,CHEMBL217,Dopamine D2 receptor,Ki,=,91.0,nM,CHEMBL678343,B,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",CHEMBL1127438,KI,CCCN1CCC[C@@H](c2cccc(S(=O)(=O)N(C)C)c2)C1
CHEMBL329443,CHEMBL217,Dopamine D2 receptor,Ki,=,227.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,CCCN1CCC[C@@H](c2cccc(S(=O)(=O)N(C)C)c2)C1
CHEMBL281924,CHEMBL217,Dopamine D2 receptor,Ki,=,7.1,nM,CHEMBL672309,B,Binding affinity towards Dopamine receptor D2,CHEMBL1145819,KI,CO[C@]1(C)c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1
CHEMBL281923,CHEMBL217,Dopamine D2 receptor,Ki,=,71.0,nM,CHEMBL672309,B,Binding affinity towards Dopamine receptor D2,CHEMBL1145819,KI,CO[C@@]1(C)c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1
CHEMBL298166,CHEMBL217,Dopamine D2 receptor,Ki,=,1330.0,nM,CHEMBL671981,B,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,CHEMBL1130052,KI,Cc1cccc(C(=O)NCN2CCN(c3ccccc3Cl)CC2)c1
CHEMBL93383,CHEMBL217,Dopamine D2 receptor,Ki,=,106.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,CC(C)N1CCC[C@@H](c2cccc(C#N)c2)C1
CHEMBL335545,CHEMBL217,Dopamine D2 receptor,Ki,=,25.5,nM,CHEMBL672911,B,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]spiperone,CHEMBL1128721,KI,C1=C(c2ccccc2)CCN(C[C@@H]2CCC=C(c3ccccc3)C2)C1
CHEMBL335545,CHEMBL217,Dopamine D2 receptor,Ki,=,8.4,nM,CHEMBL672910,B,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]N-0437,CHEMBL1128721,KI,C1=C(c2ccccc2)CCN(C[C@@H]2CCC=C(c3ccccc3)C2)C1
CHEMBL92183,CHEMBL217,Dopamine D2 receptor,Ki,=,265.0,nM,CHEMBL678343,B,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",CHEMBL1127438,KI,CCCN1CCC[C@@H](c2cccc(C#N)c2)C1
CHEMBL92183,CHEMBL217,Dopamine D2 receptor,Ki,=,119.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,CCCN1CCC[C@@H](c2cccc(C#N)c2)C1
CHEMBL314536,CHEMBL217,Dopamine D2 receptor,Ki,=,134.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,CCCN1CCC[C@@H](c2cccc(-c3ccsc3)c2)C1
CHEMBL91228,CHEMBL217,Dopamine D2 receptor,Ki,=,1178.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,C#CCN1CCC[C@@H](c2cccc(C#N)c2)C1
CHEMBL329228,CHEMBL217,Dopamine D2 receptor,Ki,=,282.0,nM,CHEMBL673083,B,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,CHEMBL1133667,KI,COc1cccc(NC(=O)CCN2CCN(c3ccc(Cl)cc3)CC2)c1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,5.6,nM,CHEMBL673082,B,"In vitro binding affinity towards Dopamine receptor D2L, using [3H]spiroperidol radioligand in Sf9 baculovirus expression.",CHEMBL1133667,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL330470,CHEMBL217,Dopamine D2 receptor,Ki,=,3960.0,nM,CHEMBL673083,B,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,CHEMBL1133667,KI,COc1ccc2c(c1)C(=O)N(CCN1CCN(c3ccc(Cl)cc3)CC1)CC2
CHEMBL94811,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL678343,B,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",CHEMBL1127438,KI,N#Cc1cccc([C@@H]2CCCN(CCCc3ccccc3)C2)c1
CHEMBL94811,CHEMBL217,Dopamine D2 receptor,Ki,=,29.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,N#Cc1cccc([C@@H]2CCCN(CCCc3ccccc3)C2)c1
CHEMBL147159,CHEMBL217,Dopamine D2 receptor,Ki,=,10.3,nM,CHEMBL672911,B,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]spiperone,CHEMBL1128721,KI,Oc1ccc(C2=CCN(C[C@@H]3CCC=C(c4ccc(O)cc4)C3)CC2)cc1
CHEMBL147159,CHEMBL217,Dopamine D2 receptor,Ki,=,2.2,nM,CHEMBL672910,B,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]N-0437,CHEMBL1128721,KI,Oc1ccc(C2=CCN(C[C@@H]3CCC=C(c4ccc(O)cc4)C3)CC2)cc1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,876.0,nM,CHEMBL673082,B,"In vitro binding affinity towards Dopamine receptor D2L, using [3H]spiroperidol radioligand in Sf9 baculovirus expression.",CHEMBL1133667,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL96799,CHEMBL217,Dopamine D2 receptor,Ki,=,3170.0,nM,CHEMBL673084,B,"In vitro binding affinity towards human Dopamine receptor D2L, using [3H]spiroperidol radioligand in Sf9 baculovirus expression.",CHEMBL1133667,KI,COc1cccc2c1CCN(CCN1CCN(c3ccc(Cl)cc3)CC1)C2=O
CHEMBL423659,CHEMBL217,Dopamine D2 receptor,Ki,=,4180.0,nM,CHEMBL671981,B,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,CHEMBL1130052,KI,N#Cc1ccccc1N1CCN(CNC(=O)c2ccccc2)CC1
CHEMBL93101,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,CCCN1CCC[C@@H](c2cccc(CO)c2)C1
CHEMBL92939,CHEMBL217,Dopamine D2 receptor,Ki,=,984.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,C=CCN1CCC2c3cccc(C#N)c3CCC21
CHEMBL93582,CHEMBL217,Dopamine D2 receptor,Ki,=,602.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,CCCN1CCC[C@@H](c2cccc(OC)c2)C1
CHEMBL93682,CHEMBL217,Dopamine D2 receptor,Ki,=,314.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,N#Cc1cccc([C@@H]2CCCNC2)c1
CHEMBL318747,CHEMBL217,Dopamine D2 receptor,Ki,=,2740.0,nM,CHEMBL673083,B,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,CHEMBL1133667,KI,COc1cccc(CCCCN2CCN(c3ccc(Cl)cc3)CC2)c1
CHEMBL51536,CHEMBL217,Dopamine D2 receptor,Ki,=,466.0,nM,CHEMBL671981,B,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,CHEMBL1130052,KI,Cc1ccc(C(=O)NCN2CCN(c3ccccc3Cl)CC2)cc1
CHEMBL93212,CHEMBL217,Dopamine D2 receptor,Ki,=,254.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,C=CCN1CCC[C@@H](c2cccc(C#N)c2)C1
CHEMBL90662,CHEMBL217,Dopamine D2 receptor,Ki,=,1040.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,CN1CCC[C@@H](c2cccc(C#N)c2)C1
CHEMBL51023,CHEMBL217,Dopamine D2 receptor,Ki,=,291.0,nM,CHEMBL671981,B,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,CHEMBL1130052,KI,COc1ccccc1N1CCN(CNC(=O)c2ccc(C)cc2)CC1
CHEMBL280955,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,C=CCN1CC[C@H]2c3cccc(OC)c3CC[C@H]21
CHEMBL93594,CHEMBL217,Dopamine D2 receptor,Ki,=,192.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,CCCN1CCC[C@@H](c2cccc(OS(C)(=O)=O)c2)C1
CHEMBL93646,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,N#Cc1cccc([C@@H]2CCCN(CCc3ccccc3)C2)c1
CHEMBL321557,CHEMBL217,Dopamine D2 receptor,Ki,=,3400.0,nM,CHEMBL673083,B,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,CHEMBL1133667,KI,COc1cccc2c1CCCC2CCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL90359,CHEMBL217,Dopamine D2 receptor,Ki,=,48.0,nM,CHEMBL678343,B,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",CHEMBL1127438,KI,CCCN1CCC[C@@H](c2cccc(OS(=O)(=O)C(F)(F)F)c2)C1
CHEMBL93946,CHEMBL217,Dopamine D2 receptor,Ki,=,820.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,CCCN1CCC[C@@H](c2cccc(OCC(F)(F)F)c2)C1
CHEMBL356269,CHEMBL217,Dopamine D2 receptor,Ki,=,94.0,nM,CHEMBL672911,B,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]spiperone,CHEMBL1128721,KI,Oc1ccc(C2=CCN(C[C@@H]3CCC=C(c4ccccc4)C3)CC2)cc1
CHEMBL356269,CHEMBL217,Dopamine D2 receptor,Ki,=,5.7,nM,CHEMBL672910,B,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]N-0437,CHEMBL1128721,KI,Oc1ccc(C2=CCN(C[C@@H]3CCC=C(c4ccccc4)C3)CC2)cc1
CHEMBL93403,CHEMBL217,Dopamine D2 receptor,Ki,=,1900.0,nM,CHEMBL673083,B,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,CHEMBL1133667,KI,COc1cccc(C(=O)NCCN2CCN(c3ccc(Cl)cc3)CC2)c1
CHEMBL2112375,CHEMBL217,Dopamine D2 receptor,Ki,=,3180.0,nM,CHEMBL673083,B,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,CHEMBL1133667,KI,COc1cccc2c1CCCC2NCCN1CCN(c2ccc(Cl)cc2)CC1.Cl.Cl
CHEMBL296506,CHEMBL217,Dopamine D2 receptor,Ki,=,835.0,nM,CHEMBL671981,B,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,CHEMBL1130052,KI,COc1ccccc1N1CCN(CNC(=O)c2cccc(C)c2)CC1
CHEMBL49502,CHEMBL217,Dopamine D2 receptor,Ki,=,897.0,nM,CHEMBL671981,B,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,CHEMBL1130052,KI,N#Cc1ccccc1N1CCN(CNC(=O)c2cccc(Cl)c2)CC1
CHEMBL296953,CHEMBL217,Dopamine D2 receptor,Ki,=,495.0,nM,CHEMBL671981,B,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,CHEMBL1130052,KI,O=C(NCN1CCN(c2ccccc2Cl)CC1)c1ccc(Cl)cc1
CHEMBL413483,CHEMBL217,Dopamine D2 receptor,Ki,=,98.0,nM,CHEMBL678343,B,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",CHEMBL1127438,KI,CCC(C)N1CCC[C@@H](c2cccc(C#N)c2)C1
CHEMBL413483,CHEMBL217,Dopamine D2 receptor,Ki,=,187.0,nM,CHEMBL679938,B,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",CHEMBL1127438,KI,CCC(C)N1CCC[C@@H](c2cccc(C#N)c2)C1
CHEMBL281048,CHEMBL217,Dopamine D2 receptor,Ki,=,261.0,nM,CHEMBL672309,B,Binding affinity towards Dopamine receptor D2,CHEMBL1145819,KI,CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@H]3N
CHEMBL48819,CHEMBL217,Dopamine D2 receptor,Ki,=,451.0,nM,CHEMBL671981,B,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,CHEMBL1130052,KI,COc1ccccc1N1CCN(CNC(=O)c2cccc(Cl)c2)CC1
CHEMBL295094,CHEMBL217,Dopamine D2 receptor,Ki,=,2420.0,nM,CHEMBL671981,B,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,CHEMBL1130052,KI,O=C(NCN1CCN(c2ccccc2Cl)CC1)c1cccc(Cl)c1
CHEMBL357416,CHEMBL217,Dopamine D2 receptor,Ki,=,3.5,nM,CHEMBL672911,B,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]spiperone,CHEMBL1128721,KI,Oc1ccc(C2=CCC[C@@H](CN3CC=C(c4ccccc4)CC3)C2)cc1
CHEMBL357416,CHEMBL217,Dopamine D2 receptor,Ki,=,0.2,nM,CHEMBL672910,B,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]N-0437,CHEMBL1128721,KI,Oc1ccc(C2=CCC[C@@H](CN3CC=C(c4ccccc4)CC3)C2)cc1
CHEMBL92578,CHEMBL217,Dopamine D2 receptor,Ki,=,145.0,nM,CHEMBL678343,B,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",CHEMBL1127438,KI,CCCN1CCC[C@@H](c2cccc(C=O)c2)C1
CHEMBL420067,CHEMBL217,Dopamine D2 receptor,Ki,=,980.0,nM,CHEMBL673083,B,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,CHEMBL1133667,KI,COc1ccc2c(c1)C(CCCN1CCN(c3ccc(Cl)cc3)CC1)CCC2
CHEMBL48807,CHEMBL217,Dopamine D2 receptor,Ki,=,1880.0,nM,CHEMBL671981,B,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,CHEMBL1130052,KI,COc1ccccc1N1CCN(CNC(=O)c2ccccc2)CC1
CHEMBL90374,CHEMBL217,Dopamine D2 receptor,Ki,=,16000.0,nM,CHEMBL672382,B,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,CHEMBL1134560,KI,Clc1ccc(N2CCN(Cc3cccn4nccc34)CC2)cc1
CHEMBL90374,CHEMBL217,Dopamine D2 receptor,Ki,=,21000.0,nM,CHEMBL672572,B,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,CHEMBL1134560,KI,Clc1ccc(N2CCN(Cc3cccn4nccc34)CC2)cc1
CHEMBL7927,CHEMBL217,Dopamine D2 receptor,Ki,=,3200.0,nM,CHEMBL672382,B,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,CHEMBL1134560,KI,Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL7927,CHEMBL217,Dopamine D2 receptor,Ki,=,4300.0,nM,CHEMBL672572,B,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,CHEMBL1134560,KI,Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL38580,CHEMBL217,Dopamine D2 receptor,Ki,=,47.5,nM,CHEMBL669149,B,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,CHEMBL1132392,KI,CCCN(CCC)C1COc2c(cccc2-c2ccoc2)C1
CHEMBL100454,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL671419,B,In vitro binding affinity of compound against neuronal Dopamine receptor D2,CHEMBL1150510,KI,CN1CCN(C2=Nc3ccccc3Nc3sc(CO)cc32)CC1
CHEMBL88937,CHEMBL217,Dopamine D2 receptor,Ki,=,31000.0,nM,CHEMBL672382,B,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,CHEMBL1134560,KI,Clc1ccc(N2CCN(Cc3cccc4ccnn34)CC2)cc1
CHEMBL88937,CHEMBL217,Dopamine D2 receptor,Ki,=,67000.0,nM,CHEMBL672572,B,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,CHEMBL1134560,KI,Clc1ccc(N2CCN(Cc3cccc4ccnn34)CC2)cc1
CHEMBL300647,CHEMBL217,Dopamine D2 receptor,Ki,=,0.66,nM,CHEMBL670964,B,The compound was tested for binding affinity against dopamine receptor D2 using raclopride as radioligand,CHEMBL1125700,KI,CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12
CHEMBL39847,CHEMBL217,Dopamine D2 receptor,Ki,=,398.0,nM,CHEMBL669149,B,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,CHEMBL1132392,KI,CCCN(CCC)C1COc2c(cccc2-c2ccsc2)C1
CHEMBL310843,CHEMBL217,Dopamine D2 receptor,Ki,=,3400.0,nM,CHEMBL672382,B,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,CHEMBL1134560,KI,Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1
CHEMBL310843,CHEMBL217,Dopamine D2 receptor,Ki,=,6300.0,nM,CHEMBL672572,B,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,CHEMBL1134560,KI,Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1
CHEMBL41200,CHEMBL217,Dopamine D2 receptor,Ki,=,1090.0,nM,CHEMBL669149,B,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,CHEMBL1132392,KI,CCCN(CCC)C1COc2c(cccc2-c2ccc(OC)cc2)C1
CHEMBL432059,CHEMBL217,Dopamine D2 receptor,Ki,=,13000.0,nM,CHEMBL672382,B,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,CHEMBL1134560,KI,Clc1ccc(N2CCN(Cc3ccc4ccnn4c3)CC2)cc1
CHEMBL432059,CHEMBL217,Dopamine D2 receptor,Ki,=,15000.0,nM,CHEMBL672572,B,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,CHEMBL1134560,KI,Clc1ccc(N2CCN(Cc3ccc4ccnn4c3)CC2)cc1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL671419,B,In vitro binding affinity of compound against neuronal Dopamine receptor D2,CHEMBL1150510,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL348285,CHEMBL217,Dopamine D2 receptor,Ki,=,355.0,nM,CHEMBL672313,B,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,CHEMBL1130416,KI,CN[C@@H]1Cc2cccc3ncn(c23)C1
CHEMBL531,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL672313,B,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,CHEMBL1130416,KI,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL157138,CHEMBL217,Dopamine D2 receptor,Ki,=,0.5,nM,CHEMBL672313,B,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,CHEMBL1130416,KI,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL419792,CHEMBL217,Dopamine D2 receptor,Ki,=,9.0,nM,CHEMBL672313,B,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,CHEMBL1130416,KI,CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL91362,CHEMBL217,Dopamine D2 receptor,Ki,=,37000.0,nM,CHEMBL672382,B,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,CHEMBL1134560,KI,CCOC(=O)c1cnn2cccc(CN3CCN(c4ccc(Cl)cc4)CC3)c12
CHEMBL91362,CHEMBL217,Dopamine D2 receptor,Ki,=,45000.0,nM,CHEMBL672572,B,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,CHEMBL1134560,KI,CCOC(=O)c1cnn2cccc(CN3CCN(c4ccc(Cl)cc4)CC3)c12
CHEMBL300647,CHEMBL217,Dopamine D2 receptor,Ki,=,6.5,nM,CHEMBL670963,B,The compound was tested for binding affinity against Dopamine receptor D2 using raclopride as radioligand,CHEMBL1125700,KI,CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12
CHEMBL345458,CHEMBL217,Dopamine D2 receptor,Ki,=,1281.0,nM,CHEMBL672313,B,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,CHEMBL1130416,KI,CN(C)[C@@H]1Cc2cccc3ncn(c23)C1
CHEMBL493,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL672313,B,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,CHEMBL1130416,KI,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL1125,CHEMBL217,Dopamine D2 receptor,Ki,=,9.0,nM,CHEMBL671419,B,In vitro binding affinity of compound against neuronal Dopamine receptor D2,CHEMBL1150510,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCNCC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL672382,B,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,CHEMBL1134560,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL672572,B,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,CHEMBL1134560,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL38428,CHEMBL217,Dopamine D2 receptor,Ki,=,128.0,nM,CHEMBL669149,B,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,CHEMBL1132392,KI,CCCN(CCC)C1COc2c(O)cccc2C1
CHEMBL43073,CHEMBL217,Dopamine D2 receptor,Ki,=,763.0,nM,CHEMBL669149,B,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,CHEMBL1132392,KI,CCCN(CCC)C1COc2c(cccc2-c2ccc(C(F)(F)F)cc2)C1
CHEMBL589,CHEMBL217,Dopamine D2 receptor,Ki,=,7.2,nM,CHEMBL672313,B,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,CHEMBL1130416,KI,CCCN(CCC)CCc1cccc2c1CC(=O)N2
CHEMBL422344,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL672313,B,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,CHEMBL1130416,KI,CN(C)[C@@H]1Cc2cccc3nc(O)n(c23)C1
CHEMBL38656,CHEMBL217,Dopamine D2 receptor,Ki,=,1360.0,nM,CHEMBL669149,B,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,CHEMBL1132392,KI,CCCN(CCC)C1COc2c(cccc2C(=O)c2ccoc2)C1
CHEMBL440512,CHEMBL217,Dopamine D2 receptor,Ki,=,119.0,nM,CHEMBL671419,B,In vitro binding affinity of compound against neuronal Dopamine receptor D2,CHEMBL1150510,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CC[N+](C)([O-])CC1
CHEMBL45491,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL670964,B,The compound was tested for binding affinity against dopamine receptor D2 using raclopride as radioligand,CHEMBL1125700,KI,CN(C)C1C=CC2(CC1)c1ccccc1CCc1ccc(Cl)cc12
CHEMBL328925,CHEMBL217,Dopamine D2 receptor,Ki,=,39000.0,nM,CHEMBL672382,B,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,CHEMBL1134560,KI,OCc1cnn2cccc(CN3CCN(c4ccc(Cl)cc4)CC3)c12
CHEMBL328925,CHEMBL217,Dopamine D2 receptor,Ki,=,53000.0,nM,CHEMBL672572,B,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,CHEMBL1134560,KI,OCc1cnn2cccc(CN3CCN(c4ccc(Cl)cc4)CC3)c12
CHEMBL45491,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL670964,B,The compound was tested for binding affinity against dopamine receptor D2 using raclopride as radioligand,CHEMBL1125700,KI,CN(C)C1C=CC2(CC1)c1ccccc1CCc1ccc(Cl)cc12
CHEMBL434665,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL672313,B,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,CHEMBL1130416,KI,CCCN[C@@H]1Cc2cccc3nc(O)n(c23)C1
CHEMBL41134,CHEMBL217,Dopamine D2 receptor,Ki,=,590.0,nM,CHEMBL669149,B,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,CHEMBL1132392,KI,CCCN(CCC)C1COc2c(cccc2-c2ccccc2)C1
CHEMBL56,CHEMBL217,Dopamine D2 receptor,Ki,=,3243.0,nM,CHEMBL673097,B,Inhibitory activity against [125I]- NCQ298 binding to dopamine receptor D2 in Sf 9 cells,CHEMBL1126858,KI,CCCN(CCC)C1CCc2cccc(O)c2C1
CHEMBL122533,CHEMBL217,Dopamine D2 receptor,Ki,=,0.2512,nM,CHEMBL670399,B,Binding affinity towards dopamine D2 receptor,CHEMBL1128138,KI,COc1cc(N)c(Cl)cc1C(=O)NC1CC2CCCC(C1)N2Cc1ccccc1
CHEMBL1744089,CHEMBL217,Dopamine D2 receptor,Ki,=,857.0,nM,CHEMBL670667,B,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,CHEMBL1126741,KI,CCCN[C@@H]1CCc2ccc3[nH]c(C(N)=O)cc3c2C1
CHEMBL148694,CHEMBL217,Dopamine D2 receptor,Ki,=,149.0,nM,CHEMBL673081,B,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,CHEMBL1135647,KI,Cc1ccc2c(c1)C(NC1CC3CCC(C1)N3Cc1ccccc1)=Nc1cccnc1N2
CHEMBL1788192,CHEMBL217,Dopamine D2 receptor,Ki,=,389.0,nM,CHEMBL670667,B,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,CHEMBL1126741,KI,CCCN(CC1CC1)[C@@H]1CCc2ccc3[nH]c(C(N)=O)cc3c2C1
CHEMBL358657,CHEMBL217,Dopamine D2 receptor,Ki,=,183.0,nM,CHEMBL673081,B,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,CHEMBL1135647,KI,Cc1ccc2c(c1)C(NC1CCN(Cc3ccccc3)CC1)=Nc1cccnc1N2
CHEMBL146856,CHEMBL217,Dopamine D2 receptor,Ki,=,9943.0,nM,CHEMBL673081,B,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,CHEMBL1135647,KI,Clc1ccc2c(c1)C(N1CCN(Cc3ccccc3)CC1)=Nc1cccnc1N2
CHEMBL148042,CHEMBL217,Dopamine D2 receptor,Ki,=,19117.0,nM,CHEMBL673081,B,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,CHEMBL1135647,KI,CN1CCCN(C2=Nc3cccnc3Nc3ccc(Cl)cc32)CC1
CHEMBL285755,CHEMBL217,Dopamine D2 receptor,Ki,=,142.0,nM,CHEMBL673097,B,Inhibitory activity against [125I]- NCQ298 binding to dopamine receptor D2 in Sf 9 cells,CHEMBL1126858,KI,CCCN(CCC)C1CCc2ccc(O)cc2C1
CHEMBL422310,CHEMBL217,Dopamine D2 receptor,Ki,=,635.0,nM,CHEMBL673081,B,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,CHEMBL1135647,KI,Cc1ccc2c(c1)C(N1CCN(CCc3ccccc3)CC1)=Nc1cccnc1N2
CHEMBL26998,CHEMBL217,Dopamine D2 receptor,Ki,=,93.0,nM,CHEMBL670667,B,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,CHEMBL1126741,KI,CCCN(CCC)[C@@H]1CCc2cccc(O)c2C1
CHEMBL347959,CHEMBL217,Dopamine D2 receptor,Ki,=,2596.0,nM,CHEMBL673081,B,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,CHEMBL1135647,KI,Cc1ccc2c(c1)C(NC1CCN(C)CC1)=Nc1cccnc1N2
CHEMBL49,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL670667,B,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,CHEMBL1126741,KI,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
CHEMBL436274,CHEMBL217,Dopamine D2 receptor,Ki,=,892.0,nM,CHEMBL673081,B,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,CHEMBL1135647,KI,Clc1ccc2c(c1)C(N1CCN(CCc3ccccc3)CC1)=Nc1cccnc1N2
CHEMBL63329,CHEMBL217,Dopamine D2 receptor,Ki,=,5940.0,nM,CHEMBL673081,B,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,CHEMBL1135647,KI,Cc1ccc2c(c1)C(N1CCN(C)CC1)=Nc1cccnc1N2
CHEMBL284716,CHEMBL217,Dopamine D2 receptor,Ki,=,1072.0,nM,CHEMBL673097,B,Inhibitory activity against [125I]- NCQ298 binding to dopamine receptor D2 in Sf 9 cells,CHEMBL1126858,KI,CCCN(C/C=C/I)C1CCc2cccc(O)c2C1
CHEMBL148559,CHEMBL217,Dopamine D2 receptor,Ki,=,571.0,nM,CHEMBL673081,B,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,CHEMBL1135647,KI,Clc1ccc2c(c1)C(N1CCN(C3CCCCC3)CC1)=Nc1cccnc1N2
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,372.0,nM,CHEMBL673081,B,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,CHEMBL1135647,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL1744088,CHEMBL217,Dopamine D2 receptor,Ki,=,44.0,nM,CHEMBL670667,B,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,CHEMBL1126741,KI,CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)[C@@H]1CCc2ccc3[nH]c(C#N)cc3c2C1
CHEMBL356149,CHEMBL217,Dopamine D2 receptor,Ki,=,1099.0,nM,CHEMBL673081,B,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,CHEMBL1135647,KI,CN1CCC(NC2=Nc3cccnc3Nc3ccc(Cl)cc32)CC1
CHEMBL148353,CHEMBL217,Dopamine D2 receptor,Ki,=,136.0,nM,CHEMBL673081,B,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,CHEMBL1135647,KI,Clc1ccc2c(c1)C(NC1CC3CCC(C1)N3Cc1ccccc1)=Nc1cccnc1N2
CHEMBL1744037,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL670667,B,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,CHEMBL1126741,KI,CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)[C@@H]1CCc2ccc3[nH]c(C(N)=O)cc3c2C1
CHEMBL71920,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL670667,B,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,CHEMBL1126741,KI,CCCN(CCC)[C@@H]1CCc2ccc3[nH]c(C#N)cc3c2C1
CHEMBL342536,CHEMBL217,Dopamine D2 receptor,Ki,=,183.0,nM,CHEMBL673081,B,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,CHEMBL1135647,KI,Clc1ccc2c(c1)C(NC1CCN(Cc3ccccc3)CC1)=Nc1cccnc1N2
CHEMBL63576,CHEMBL217,Dopamine D2 receptor,Ki,=,2235.0,nM,CHEMBL673081,B,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,CHEMBL1135647,KI,CN1CCN(C2=Nc3cccnc3Nc3ccc(Cl)cc32)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,8.5,nM,CHEMBL673081,B,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,CHEMBL1135647,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1744035,CHEMBL217,Dopamine D2 receptor,Ki,=,896.0,nM,CHEMBL670667,B,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,CHEMBL1126741,KI,CCCN(CCC)[C@H]1CCc2ccc3[nH]c(C#N)cc3c2C1
CHEMBL131926,CHEMBL217,Dopamine D2 receptor,Ki,=,1.259,nM,CHEMBL670399,B,Binding affinity towards dopamine D2 receptor,CHEMBL1128138,KI,COc1nc(N)c(Cl)cc1C(=O)NC1CC2CCCC(C1)N2Cc1ccccc1
CHEMBL1744036,CHEMBL217,Dopamine D2 receptor,Ki,=,215.0,nM,CHEMBL670667,B,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,CHEMBL1126741,KI,CCCN(CCC)[C@@H]1CCc2ccc3[nH]c(C(N)=O)cc3c2C1
CHEMBL1788191,CHEMBL217,Dopamine D2 receptor,Ki,=,914.0,nM,CHEMBL670667,B,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,CHEMBL1126741,KI,CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)[C@H]1CCc2ccc3[nH]c(C(N)=O)cc3c2C1
CHEMBL280955,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL672485,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1127015,KI,C=CCN1CC[C@H]2c3cccc(OC)c3CC[C@H]21
CHEMBL131484,CHEMBL217,Dopamine D2 receptor,Ki,=,1320.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Cc1ccc(OCCCNCCOc2ccc(Cl)cc2)cc1
CHEMBL131997,CHEMBL217,Dopamine D2 receptor,Ki,=,299.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Cc1ccc(OCCNCCCOc2ccccc2)cc1Cl
CHEMBL29336,CHEMBL217,Dopamine D2 receptor,Ki,=,5692.0,nM,CHEMBL672800,B,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,CHEMBL1129096,KI,COc1ccc(N2CCN(CCNC(=O)c3cc(Br)c4ccccc4c3OC)CC2)cc1
CHEMBL128276,CHEMBL217,Dopamine D2 receptor,Ki,=,1950.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,COc1ccc(OCCNCCCOc2ccccc2)cc1
CHEMBL285873,CHEMBL217,Dopamine D2 receptor,Ki,=,75.0,nM,CHEMBL672485,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1127015,KI,C=CCN1CC[C@H]2c3cccc(O)c3CC[C@H]21
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL283528,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL672310,B,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,CHEMBL1133417,KI,CCCCN1CCC[C@H]1CNC(=O)c1cc(Cl)cc2c1OCCN2C
CHEMBL416939,CHEMBL217,Dopamine D2 receptor,Ki,=,2529.0,nM,CHEMBL672800,B,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,CHEMBL1129096,KI,COc1c(C(=O)NCCN2CCN(c3ccccc3)CC2)cc(Cl)c2ccccc12
CHEMBL356945,CHEMBL217,Dopamine D2 receptor,Ki,=,460.0,nM,CHEMBL672310,B,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,CHEMBL1133417,KI,COc1ccc(SC)cc1C(=O)NC[C@@H]1CCCN1CCc1ccccc1
CHEMBL283034,CHEMBL217,Dopamine D2 receptor,Ki,=,1207.0,nM,CHEMBL672800,B,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,CHEMBL1129096,KI,COc1c(C(=O)NCCN2CCN(c3cccc(C)c3)CC2)cc(Br)c2ccccc12
CHEMBL282083,CHEMBL217,Dopamine D2 receptor,Ki,=,71.0,nM,CHEMBL672800,B,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,CHEMBL1129096,KI,COc1c(C(=O)NCCN2CCN(c3ccccc3)CC2)cc(C#N)c2ccccc12
CHEMBL442535,CHEMBL217,Dopamine D2 receptor,Ki,=,703.0,nM,CHEMBL672800,B,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,CHEMBL1129096,KI,COc1c(C(=O)NCCN2CCN(c3cccc(Cl)c3)CC2)cc(Br)c2ccccc12
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.5,nM,CHEMBL672310,B,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,CHEMBL1133417,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL129931,CHEMBL217,Dopamine D2 receptor,Ki,=,519.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,c1ccc(CCCNCCCOc2ccccc2)cc1
CHEMBL284896,CHEMBL217,Dopamine D2 receptor,Ki,=,7000.0,nM,CHEMBL672800,B,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,CHEMBL1129096,KI,COc1c(C(=O)NCCN2CCN(c3ccccc3)CC2)ccc2ccccc12
CHEMBL275543,CHEMBL217,Dopamine D2 receptor,Ki,=,59.0,nM,CHEMBL672485,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1127015,KI,C=CCN1CCC2c3cccc(O)c3CC[C@@H]21
CHEMBL24588,CHEMBL217,Dopamine D2 receptor,Ki,=,93.0,nM,CHEMBL672485,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1127015,KI,CCCN1CC[C@@H]2c3cccc(O)c3CC[C@H]21
CHEMBL281363,CHEMBL217,Dopamine D2 receptor,Ki,=,800.0,nM,CHEMBL672310,B,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,CHEMBL1133417,KI,CN1CCOc2c(C(=O)NC[C@@H]3CCCN3CCc3ccccc3)cc(Cl)cc21
CHEMBL128313,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Cc1ccccc1OCCNCCCOc1ccccc1
CHEMBL128647,CHEMBL217,Dopamine D2 receptor,Ki,=,268.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Cc1ccc(OCCNCCCOc2ccccc2)cc1
CHEMBL30208,CHEMBL217,Dopamine D2 receptor,Ki,=,1892.0,nM,CHEMBL672800,B,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,CHEMBL1129096,KI,COc1c(C(=O)NCCN2CCN(c3ccccc3)CC2)cc(Br)c2ccccc12
CHEMBL279937,CHEMBL217,Dopamine D2 receptor,Ki,=,57.0,nM,CHEMBL672310,B,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,CHEMBL1133417,KI,CN1CCOc2c(C(=O)NC[C@H]3CCCN3CCc3ccccc3)cc(Cl)cc21
CHEMBL10570,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL672485,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1127015,KI,C=CCN1CCC2c3cccc(OC)c3CC[C@H]21
CHEMBL129757,CHEMBL217,Dopamine D2 receptor,Ki,=,245.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Fc1ccc(OCCCNCCOc2ccc(Cl)cc2)cc1
CHEMBL341225,CHEMBL217,Dopamine D2 receptor,Ki,=,5730.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Cc1ccc(OCCNCCCOc2ccc(Br)cc2)cc1
CHEMBL128281,CHEMBL217,Dopamine D2 receptor,Ki,=,222.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Cc1ccc(SCCNCCCOc2ccccc2)cc1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,91.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL418705,CHEMBL217,Dopamine D2 receptor,Ki,=,77.0,nM,CHEMBL672485,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1127015,KI,C=CCN1CCC2c3c(cccc3OC)CC[C@@H]21
CHEMBL131357,CHEMBL217,Dopamine D2 receptor,Ki,=,391.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Cc1ccc(OCCNCCCOc2ccc(F)cc2)cc1
CHEMBL51,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL672310,B,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,CHEMBL1133417,KI,O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
CHEMBL132884,CHEMBL217,Dopamine D2 receptor,Ki,=,228.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Clc1ccc(OCCNCCCOc2ccccc2)cc1
CHEMBL24222,CHEMBL217,Dopamine D2 receptor,Ki,=,50.0,nM,CHEMBL672488,B,"Compound was evaluated for the binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in rat striatum",CHEMBL1127015,KI,C=CCN1CC[C@@H]2c3cccc(OC)c3CC[C@H]21
CHEMBL131299,CHEMBL217,Dopamine D2 receptor,Ki,=,64.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Cc1ccc(OCCCNCCOc2ccccc2)cc1
CHEMBL148352,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL672310,B,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,CHEMBL1133417,KI,COc1cc2c(c(C(=O)NC[C@@H]3CCCN3CCc3ccccc3)c1)OCC2
CHEMBL28964,CHEMBL217,Dopamine D2 receptor,Ki,=,484.0,nM,CHEMBL672800,B,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,CHEMBL1129096,KI,COc1c(C(=O)NCCN2CCN(c3ccccc3C)CC2)cc(Br)c2ccccc12
CHEMBL29610,CHEMBL217,Dopamine D2 receptor,Ki,=,996.0,nM,CHEMBL672800,B,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,CHEMBL1129096,KI,COc1c(C(=O)NCCN2CCN(c3ccc(C)cc3)CC2)cc(Br)c2ccccc12
CHEMBL30146,CHEMBL217,Dopamine D2 receptor,Ki,=,303.0,nM,CHEMBL672800,B,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,CHEMBL1129096,KI,COc1ccccc1N1CCN(CCNC(=O)c2cc(Br)c3ccccc3c2OC)CC1
CHEMBL279729,CHEMBL217,Dopamine D2 receptor,Ki,=,630.0,nM,CHEMBL672310,B,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,CHEMBL1133417,KI,CCCCN1CCC[C@@H]1CNC(=O)c1cc(Cl)cc2c1OCCN2C
CHEMBL56,CHEMBL217,Dopamine D2 receptor,Ki,=,86.0,nM,CHEMBL672485,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1127015,KI,CCCN(CCC)C1CCc2cccc(O)c2C1
CHEMBL129534,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Clc1cccc(OCCNCCCOc2ccccc2)c1
CHEMBL130370,CHEMBL217,Dopamine D2 receptor,Ki,=,277.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Cc1ccc(OCCCNCCOc2ccc(C)cc2)cc1
CHEMBL283738,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL672485,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1127015,KI,C=CCN1CC[C@@H]2c3c(O)cccc3CC[C@H]21
CHEMBL130347,CHEMBL217,Dopamine D2 receptor,Ki,=,352.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Clc1ccc(SCCNCCCOc2ccccc2)cc1
CHEMBL10408,CHEMBL217,Dopamine D2 receptor,Ki,=,108.0,nM,CHEMBL672485,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1127015,KI,C=CCN1CCC2c3cccc(O)c3CC[C@H]21
CHEMBL129927,CHEMBL217,Dopamine D2 receptor,Ki,=,143.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Cc1ccc(OCCNCCCOc2ccccc2)cc1C
CHEMBL29182,CHEMBL217,Dopamine D2 receptor,Ki,=,1173.0,nM,CHEMBL672800,B,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,CHEMBL1129096,KI,COc1c(C(=O)NCCN2CCN(c3cccc(C)c3C)CC2)cc(Br)c2ccccc12
CHEMBL149723,CHEMBL217,Dopamine D2 receptor,Ki,=,6.7,nM,CHEMBL672310,B,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,CHEMBL1133417,KI,CSc1cc2c(c(C(=O)NC[C@H]3CCCN3CCc3ccccc3)c1)OCC2
CHEMBL10270,CHEMBL217,Dopamine D2 receptor,Ki,=,6.7,nM,CHEMBL672485,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1127015,KI,C=CCN1CCC2c3c(cccc3OC)CC[C@H]21
CHEMBL63321,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL672307,B,Ability to partially antagonise [3H]-SCH- 23388 binding to the Dopamine receptor D2,CHEMBL1123996,KI,CN1CCc2cc(Cl)c(O)cc2[C@H](c2ccccc2)C1
CHEMBL128232,CHEMBL217,Dopamine D2 receptor,Ki,=,61.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Cc1cccc(OCCNCCCOc2ccccc2)c1
CHEMBL334545,CHEMBL217,Dopamine D2 receptor,Ki,=,296.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Cc1ccc(OCCNCCCOc2ccccc2C)cc1
CHEMBL132455,CHEMBL217,Dopamine D2 receptor,Ki,=,1400.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,O=[N+]([O-])c1ccc(OCCNCCCOc2ccccc2)cc1
CHEMBL29435,CHEMBL217,Dopamine D2 receptor,Ki,=,1288.0,nM,CHEMBL672800,B,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,CHEMBL1129096,KI,COc1c(C(=O)NCCN2CCN(c3cccc([N+](=O)[O-])c3)CC2)cc(Br)c2ccccc12
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL670741,B,"Compound was evaluated for the binding affinity against [3H]U-86,170-labeled D2 sites in cloned CHO cells",CHEMBL1127015,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL435598,CHEMBL217,Dopamine D2 receptor,Ki,=,292.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Cc1ccc(OCCNCCCOc2cccc(C)c2)cc1
CHEMBL29849,CHEMBL217,Dopamine D2 receptor,Ki,=,1288.0,nM,CHEMBL672800,B,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,CHEMBL1129096,KI,COc1cccc(N2CCN(CCNC(=O)c3cc(Br)c4ccccc4c3OC)CC2)c1
CHEMBL29436,CHEMBL217,Dopamine D2 receptor,Ki,=,151.0,nM,CHEMBL672800,B,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,CHEMBL1129096,KI,COc1c(C(=O)NCCN2CCN(c3ccccc3[N+](=O)[O-])CC2)cc(Br)c2ccccc12
CHEMBL287443,CHEMBL217,Dopamine D2 receptor,Ki,=,5692.0,nM,CHEMBL672800,B,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,CHEMBL1129096,KI,COc1c(C(=O)NCCN2CCN(c3ccc([N+](=O)[O-])cc3)CC2)cc(Br)c2ccccc12
CHEMBL22892,CHEMBL217,Dopamine D2 receptor,Ki,=,556.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Oc1ccc(OCCNCCCOc2ccccc2)cc1
CHEMBL334989,CHEMBL217,Dopamine D2 receptor,Ki,=,364.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Cc1ccc(CCCNCCCOc2ccccc2)cc1
CHEMBL25483,CHEMBL217,Dopamine D2 receptor,Ki,=,4.1,nM,CHEMBL672485,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1127015,KI,C=CCN1CC[C@@H]2c3cccc(O)c3CC[C@H]21
CHEMBL131396,CHEMBL217,Dopamine D2 receptor,Ki,=,112.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Clc1ccccc1OCCNCCCOc1ccccc1
CHEMBL337627,CHEMBL217,Dopamine D2 receptor,Ki,=,227.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Clc1ccc(OCCNCCCSc2ccccc2)cc1
CHEMBL286205,CHEMBL217,Dopamine D2 receptor,Ki,=,8.5,nM,CHEMBL672485,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1127015,KI,C=CCN1CC[C@@H]2c3c(cccc3OC)CC[C@H]21
CHEMBL128524,CHEMBL217,Dopamine D2 receptor,Ki,=,251.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,c1ccc(OCCCNCCOc2ccccc2)cc1
CHEMBL30206,CHEMBL217,Dopamine D2 receptor,Ki,=,517.0,nM,CHEMBL672800,B,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,CHEMBL1129096,KI,COc1c(C(=O)NCCN2CCN(c3ccccc3Cl)CC2)cc(Br)c2ccccc12
CHEMBL130402,CHEMBL217,Dopamine D2 receptor,Ki,=,118.0,nM,CHEMBL671378,B,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,CHEMBL1130257,KI,Cc1ccc(OCCNCCCSc2ccccc2)cc1
CHEMBL26560,CHEMBL217,Dopamine D2 receptor,Ki,=,218.0,nM,CHEMBL672485,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1127015,KI,CCCN1CC[C@H]2c3cccc(O)c3CC[C@H]21
CHEMBL264394,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,Cc1noc(-c2ccc(CSc3nc4ccccc4n3Cc3ccc(Cl)cc3)cc2)n1
CHEMBL2368625,CHEMBL217,Dopamine D2 receptor,Ki,=,79.43,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,CS(=O)(=O)Oc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccccc3F)CC1)CC2.Cl
CHEMBL2368626,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccccc3F)CC1)CC2.Cl
CHEMBL108242,CHEMBL217,Dopamine D2 receptor,Ki,=,550.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,COC(=O)c1ccc(C[S+]([O-])c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL108242,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL671381,B,Binding affinity against human recombinant dopamine receptor D2 in presence of 0.5% human serum albumin,CHEMBL1146646,KI,COC(=O)c1ccc(C[S+]([O-])c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL2113364,CHEMBL217,Dopamine D2 receptor,Ki,=,63.1,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,CS(=O)(=O)Oc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccc(F)cc3)CC1)CC2.Cl
CHEMBL2113357,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,Cc1cnc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)c2)o1.Cl
CHEMBL107974,CHEMBL217,Dopamine D2 receptor,Ki,=,550.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,CSc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL108616,CHEMBL217,Dopamine D2 receptor,Ki,=,270.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,CC(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL29433,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL670660,B,"The compound was tested for the binding affinity towards human cloned Dopamine receptor D2 in CHO cells, using [125I]iodosulpride as radioligand",CHEMBL1135108,KI,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCN2CCC[C@H]2C1
CHEMBL282971,CHEMBL217,Dopamine D2 receptor,Ki,=,1995.26,nM,CHEMBL670660,B,"The compound was tested for the binding affinity towards human cloned Dopamine receptor D2 in CHO cells, using [125I]iodosulpride as radioligand",CHEMBL1135108,KI,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCN2CCC[C@@H]2C1
CHEMBL2368617,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccc(C#N)cc3)CC1)CC2.Cl
CHEMBL3084605,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,Cl.Cn1nccc1-c1cccc(C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(S(C)(=O)=O)cc4CC3)CC2)c1
CHEMBL108289,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,COC(=O)c1ccc(CCc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL108289,CHEMBL217,Dopamine D2 receptor,Ki,=,137.0,nM,CHEMBL671381,B,Binding affinity against human recombinant dopamine receptor D2 in presence of 0.5% human serum albumin,CHEMBL1146646,KI,COC(=O)c1ccc(CCc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL110774,CHEMBL217,Dopamine D2 receptor,Ki,=,6700.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,Clc1ccc(Cn2c(SCc3ccccc3)nc3ccccc32)cc1
CHEMBL3084612,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,Cc1coc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(OS(C)(=O)=O)cc5CC4)CC3)c2)n1.Cl
CHEMBL3084626,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,Cc1cc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(OS(C)(=O)=O)cc5CC4)CC3)c2)on1.Cl
CHEMBL109189,CHEMBL217,Dopamine D2 receptor,Ki,=,800.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,CN(C)C(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL108979,CHEMBL217,Dopamine D2 receptor,Ki,=,330.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,COC(=O)Cc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL320734,CHEMBL217,Dopamine D2 receptor,Ki,=,6200.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,COC(=O)c1ccc(Cc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL2113358,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,Cc1cc(C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(OS(C)(=O)=O)cc4CC3)CC2)c2ccccc2n1.Cl
CHEMBL2368622,CHEMBL217,Dopamine D2 receptor,Ki,=,79.43,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,CS(=O)(=O)Oc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3cccc(F)c3)CC1)CC2.Cl
CHEMBL2368633,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,COc1ccccc1/C=C/C(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(OS(C)(=O)=O)cc3CC2)CC1.Cl
CHEMBL3084613,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,Cc1nc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(OS(C)(=O)=O)cc5CC4)CC3)c2)no1.Cl
CHEMBL3084620,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cccc4ccccc34)CC1)CC2.Cl
CHEMBL108243,CHEMBL217,Dopamine D2 receptor,Ki,=,8000.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,COC(=O)c1ccc(-c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL108243,CHEMBL217,Dopamine D2 receptor,Ki,=,800.0,nM,CHEMBL671381,B,Binding affinity against human recombinant dopamine receptor D2 in presence of 0.5% human serum albumin,CHEMBL1146646,KI,COC(=O)c1ccc(-c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL2368620,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccccc3C#N)CC1)CC2.Cl
CHEMBL108297,CHEMBL217,Dopamine D2 receptor,Ki,=,1200.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,NS(=O)(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL29410,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL670660,B,"The compound was tested for the binding affinity towards human cloned Dopamine receptor D2 in CHO cells, using [125I]iodosulpride as radioligand",CHEMBL1135108,KI,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCN2CCCCC2C1
CHEMBL321405,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,CS(=O)(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL3084624,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,CS(=O)(=O)Oc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cccc4ccccc34)CC1)CC2.Cl
CHEMBL3084597,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,Cc1ncc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(OS(C)(=O)=O)cc5CC4)CC3)c2)o1.Cl
CHEMBL107988,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,COC(=O)c1cccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)c1
CHEMBL3084598,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,Cc1ccc2c(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(OS(C)(=O)=O)cc5CC4)CC3)cccc2n1.Cl
CHEMBL3084629,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,Cc1cnc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(OS(C)(=O)=O)cc5CC4)CC3)c2)o1.Cl
CHEMBL3084625,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,CS(=O)(=O)Oc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cccc4ncccc34)CC1)CC2.Cl
CHEMBL3084599,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,Cc1ccc2c(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)cccc2n1.Cl
CHEMBL2113356,CHEMBL217,Dopamine D2 receptor,Ki,=,31.62,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,COc1ccc(/C=C/C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(OS(C)(=O)=O)cc4CC3)CC2)cc1.Cl
CHEMBL108564,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,COC(=O)c1ccc(CNc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL111006,CHEMBL217,Dopamine D2 receptor,Ki,=,4200.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,N#Cc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL29846,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL670660,B,"The compound was tested for the binding affinity towards human cloned Dopamine receptor D2 in CHO cells, using [125I]iodosulpride as radioligand",CHEMBL1135108,KI,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCN(C)CC1
CHEMBL431298,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL670660,B,"The compound was tested for the binding affinity towards human cloned Dopamine receptor D2 in CHO cells, using [125I]iodosulpride as radioligand",CHEMBL1135108,KI,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1
CHEMBL3084596,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,CS(=O)(=O)Oc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cccc(-n4cccc4)c3)CC1)CC2.Cl
CHEMBL3084602,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,Cc1ncc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)c2)o1.Cl
CHEMBL108698,CHEMBL217,Dopamine D2 receptor,Ki,=,300.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,CC(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL108856,CHEMBL217,Dopamine D2 receptor,Ki,=,96.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,Cc1nc(-c2ccc(CSc3nc4ccccc4n3Cc3ccc(Cl)cc3)cc2)no1
CHEMBL79834,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL673098,B,Tested for binding affinity against dopamine receptor D2,CHEMBL1126779,KI,O=C1NCN(c2ccccc2)C12CCN(CCCOc1ccc(F)cc1)CC2
CHEMBL2368618,CHEMBL217,Dopamine D2 receptor,Ki,=,63.1,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,COc1cccc(/C=C/C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(OS(C)(=O)=O)cc4CC3)CC2)c1.Cl
CHEMBL2368623,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3cccc(F)c3)CC1)CC2.Cl
CHEMBL2368619,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3c(F)cccc3F)CC1)CC2.Cl
CHEMBL3084615,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,Cc1cc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)c2)on1.Cl
CHEMBL324619,CHEMBL217,Dopamine D2 receptor,Ki,=,73.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,COC(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL324619,CHEMBL217,Dopamine D2 receptor,Ki,=,297.0,nM,CHEMBL671381,B,Binding affinity against human recombinant dopamine receptor D2 in presence of 0.5% human serum albumin,CHEMBL1146646,KI,COC(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL110431,CHEMBL217,Dopamine D2 receptor,Ki,=,2600.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,FC(F)(F)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL2368624,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3cccc(C#N)c3)CC1)CC2.Cl
CHEMBL108146,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,CC(C)(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL2368629,CHEMBL217,Dopamine D2 receptor,Ki,=,79.43,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccc(F)cc3)CC1)CC2.Cl
CHEMBL110063,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,COC(=O)c1ccc(Nc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL110063,CHEMBL217,Dopamine D2 receptor,Ki,=,5400.0,nM,CHEMBL671381,B,Binding affinity against human recombinant dopamine receptor D2 in presence of 0.5% human serum albumin,CHEMBL1146646,KI,COC(=O)c1ccc(Nc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL111054,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,COC(=O)c1ccc(/C=C/c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL111054,CHEMBL217,Dopamine D2 receptor,Ki,=,67.0,nM,CHEMBL671381,B,Binding affinity against human recombinant dopamine receptor D2 in presence of 0.5% human serum albumin,CHEMBL1146646,KI,COC(=O)c1ccc(/C=C/c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL3084601,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,CS(=O)(=O)Oc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cccc(-c4ncccn4)c3)CC1)CC2.Cl
CHEMBL2368627,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3cc(F)cc(F)c3)CC1)CC2.Cl
CHEMBL2113363,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,Cc1ccc2c(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)ccc(F)c2n1.Cl
CHEMBL267930,CHEMBL217,Dopamine D2 receptor,Ki,=,0.2,nM,CHEMBL673098,B,Tested for binding affinity against dopamine receptor D2,CHEMBL1126779,KI,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
CHEMBL3084616,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL674348,B,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,CHEMBL1145891,KI,Cc1nc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)c2)no1.Cl
CHEMBL109179,CHEMBL217,Dopamine D2 receptor,Ki,=,3500.0,nM,CHEMBL671383,B,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,CHEMBL1146646,KI,O=C(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1
CHEMBL160998,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL672225,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1134827,KI,N#Cc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)c3cc4ccccc4[nH]3)CC1)C2
CHEMBL344602,CHEMBL217,Dopamine D2 receptor,Ki,=,2000.0,nM,CHEMBL672383,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2cc(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)[nH]c2c1
CHEMBL344602,CHEMBL217,Dopamine D2 receptor,Ki,=,1400.0,nM,CHEMBL672577,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2cc(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)[nH]c2c1
CHEMBL308980,CHEMBL217,Dopamine D2 receptor,Ki,=,948.0,nM,CHEMBL878132,B,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,CHEMBL1127981,KI,C(=C/c1ccccc1)\COCC1CCN(CCCc2ccccc2)CC1
CHEMBL80656,CHEMBL217,Dopamine D2 receptor,Ki,=,554.0,nM,CHEMBL878132,B,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,CHEMBL1127981,KI,c1ccc(CCCOCC2CCN(Cc3ccccc3)CC2)cc1
CHEMBL97856,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,O=C(NCCCCN1CC[C@H]2c3ccc(O)cc3CC[C@@H]21)c1ccc(-c2ccccc2)cc1
CHEMBL140258,CHEMBL217,Dopamine D2 receptor,Ki,=,500.0,nM,CHEMBL672383,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2cc(CN3CCN(c4ccccc4Cl)CC3)[nH]c2c1
CHEMBL140258,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL672577,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2cc(CN3CCN(c4ccccc4Cl)CC3)[nH]c2c1
CHEMBL293828,CHEMBL217,Dopamine D2 receptor,Ki,=,1905.46,nM,CHEMBL670683,B,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,CHEMBL1124647,KI,CCCN1CCc2cc(Cl)c(O)cc2[C@@H]1c1ccccc1
CHEMBL308098,CHEMBL217,Dopamine D2 receptor,Ki,=,1062.0,nM,CHEMBL878132,B,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,CHEMBL1127981,KI,Fc1ccc(C#CCOCCC2CCN(CCc3ccccc3)CC2)cc1
CHEMBL303993,CHEMBL217,Dopamine D2 receptor,Ki,=,1862.09,nM,CHEMBL670683,B,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,CHEMBL1124647,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H]1c1ccccc1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,31.62,nM,CHEMBL670684,B,In vitro binding affinity for Dopamine receptor D2,CHEMBL1134798,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL344270,CHEMBL217,Dopamine D2 receptor,Ki,=,790.0,nM,CHEMBL672383,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]cc(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)c2c1
CHEMBL344270,CHEMBL217,Dopamine D2 receptor,Ki,=,480.0,nM,CHEMBL672577,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]cc(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)c2c1
CHEMBL97840,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL670662,B,Displacement of [125I]iodosulpiride from Dopamine receptor D2 expressed in CHO cells,CHEMBL1130629,KI,O=C(NCCCCN1CCC[C@@H]2c3ccccc3CC[C@@H]21)c1ccc(-c2ccccc2)cc1
CHEMBL143355,CHEMBL217,Dopamine D2 receptor,Ki,=,1400.0,nM,CHEMBL672383,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]cc(CN3CCN(c4ccccc4Cl)CC3)c2c1
CHEMBL143355,CHEMBL217,Dopamine D2 receptor,Ki,=,540.0,nM,CHEMBL672577,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]cc(CN3CCN(c4ccccc4Cl)CC3)c2c1
CHEMBL140165,CHEMBL217,Dopamine D2 receptor,Ki,=,2400.0,nM,CHEMBL672383,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]cc(CN3CCN(c4ccc(F)cc4)CC3)c2c1
CHEMBL140165,CHEMBL217,Dopamine D2 receptor,Ki,=,1800.0,nM,CHEMBL672577,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]cc(CN3CCN(c4ccc(F)cc4)CC3)c2c1
CHEMBL65397,CHEMBL217,Dopamine D2 receptor,Ki,=,3715.35,nM,CHEMBL670683,B,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,CHEMBL1124647,KI,Oc1cc2c(cc1Cl)CCN[C@H]2c1ccccc1
CHEMBL97118,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,COc1cccc2c1CC[C@H]1[C@H]2CCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1
CHEMBL161916,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL672225,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1134827,KI,COc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccc(F)cc3)CC1)C2
CHEMBL85606,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL672225,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1134827,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2
CHEMBL99876,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,CS(=O)(=O)Oc1cccc2c1CC[C@H]1[C@H]2CCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1
CHEMBL161853,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL672225,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1134827,KI,COc1cccc(/C=C/C(=O)N[C@H]2CC[C@H](CCN3Cc4ccc(C#N)cc4C3)CC2)c1
CHEMBL142217,CHEMBL217,Dopamine D2 receptor,Ki,=,34000.0,nM,CHEMBL672383,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]cc(CN3CCN(c4ccccc4)CC3)c2c1
CHEMBL142217,CHEMBL217,Dopamine D2 receptor,Ki,=,3500.0,nM,CHEMBL672577,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]cc(CN3CCN(c4ccccc4)CC3)c2c1
CHEMBL293158,CHEMBL217,Dopamine D2 receptor,Ki,=,19054.61,nM,CHEMBL670683,B,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,CHEMBL1124647,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]1c1ccccc1
CHEMBL318925,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,CS(=O)(=O)Oc1cccc2c1CC[C@H]1[C@H]2CCCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1
CHEMBL97107,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,O=C(NCCCCN1CC[C@@H]2c3ccccc3CC[C@@H]21)c1ccc(-c2ccccc2)cc1
CHEMBL329702,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,CS(=O)(=O)Oc1ccc2c(c1)CC[C@H]1[C@H]2CCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1
CHEMBL299879,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL672346,B,Binding affinity against cloned human Dopamine receptor D2 was evaluated,CHEMBL1135171,KI,O=[N+]([O-])c1ccccc1S(=O)(=O)NC[C@H]1CC[C@H](CNCC2CCc3ccccc3C2)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.7943,nM,CHEMBL670684,B,In vitro binding affinity for Dopamine receptor D2,CHEMBL1134798,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL97149,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,COc1cccc2c1CC[C@@H]1[C@@H]2CCCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1
CHEMBL342001,CHEMBL217,Dopamine D2 receptor,Ki,=,4300.0,nM,CHEMBL672383,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]cc(CN3CCN(c4ccc(Cl)cc4)CC3)c2c1
CHEMBL342001,CHEMBL217,Dopamine D2 receptor,Ki,=,2600.0,nM,CHEMBL672577,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]cc(CN3CCN(c4ccc(Cl)cc4)CC3)c2c1
CHEMBL143761,CHEMBL217,Dopamine D2 receptor,Ki,=,28000.0,nM,CHEMBL672383,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]c(CN3CCN(c4ccc(F)cc4)CC3)cc2c1
CHEMBL143761,CHEMBL217,Dopamine D2 receptor,Ki,=,19000.0,nM,CHEMBL672577,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]c(CN3CCN(c4ccc(F)cc4)CC3)cc2c1
CHEMBL80968,CHEMBL217,Dopamine D2 receptor,Ki,=,2183.0,nM,CHEMBL878132,B,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,CHEMBL1127981,KI,Fc1ccc(/C=C/COCC2CCN(Cc3ccccc3)CC2)cc1
CHEMBL419706,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,O=C(NCCCCN1CCC[C@@H]2c3cccc(O)c3CC[C@H]21)c1ccc(-c2ccccc2)cc1
CHEMBL59603,CHEMBL217,Dopamine D2 receptor,Ki,=,1819.7,nM,CHEMBL670682,B,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,CHEMBL1124647,KI,Oc1cc2c(cc1Cl)CNC[C@H]2c1ccccc1
CHEMBL77206,CHEMBL217,Dopamine D2 receptor,Ki,=,241.0,nM,CHEMBL878132,B,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,CHEMBL1127981,KI,C(=C/c1ccccc1)\COCC1CCN(CCc2ccccc2)CC1
CHEMBL302393,CHEMBL217,Dopamine D2 receptor,Ki,=,263.03,nM,CHEMBL670683,B,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,CHEMBL1124647,KI,CN1Cc2cc(Cl)c(O)cc2[C@H](c2ccccc2)C1
CHEMBL282927,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL670684,B,In vitro binding affinity for Dopamine receptor D2,CHEMBL1134798,KI,NC(=O)C1CCC(CN2CCC(=C(c3ccccc3)c3ccc(F)cc3)CC2)O1
CHEMBL95759,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,O=C(NCCCCN1CCC[C@H]2c3ccc(O)cc3CC[C@@H]21)c1ccc(-c2ccccc2)cc1
CHEMBL99198,CHEMBL217,Dopamine D2 receptor,Ki,=,25.12,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,O=C(NCCCCN1CCC[C@H]2c3cccc(O)c3CC[C@@H]21)c1ccc(-c2ccccc2)cc1
CHEMBL430444,CHEMBL217,Dopamine D2 receptor,Ki,=,4324.0,nM,CHEMBL878132,B,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,CHEMBL1127981,KI,FC(F)(F)c1ccc(/C=C/COCC2CCN(Cc3ccccc3)CC2)cc1
CHEMBL76927,CHEMBL217,Dopamine D2 receptor,Ki,=,1837.0,nM,CHEMBL878132,B,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,CHEMBL1127981,KI,Fc1ccc(CCN2CCC(CCOCC#Cc3ccccc3)CC2)cc1
CHEMBL317996,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,CS(=O)(=O)Oc1cccc2c1CC[C@H]1[C@@H]2CCCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1
CHEMBL716,CHEMBL217,Dopamine D2 receptor,Ki,=,63.1,nM,CHEMBL670684,B,In vitro binding affinity for Dopamine receptor D2,CHEMBL1134798,KI,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL141035,CHEMBL217,Dopamine D2 receptor,Ki,=,2300.0,nM,CHEMBL672383,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]c(CN3CCN(c4ccccc4Cl)CC3)cc2c1
CHEMBL141035,CHEMBL217,Dopamine D2 receptor,Ki,=,950.0,nM,CHEMBL672577,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]c(CN3CCN(c4ccccc4Cl)CC3)cc2c1
CHEMBL2111591,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,COc1cccc2c1CC[C@H]1[C@H]2CCCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1
CHEMBL161126,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL672225,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1134827,KI,O=C(/C=C/c1ccc(F)cc1)N[C@H]1CC[C@H](CCN2Cc3ccc(C(F)(F)F)cc3C2)CC1
CHEMBL343880,CHEMBL217,Dopamine D2 receptor,Ki,=,5600.0,nM,CHEMBL672383,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2cc(CN3CCN(c4ccccc4)CC3)[nH]c2c1
CHEMBL343880,CHEMBL217,Dopamine D2 receptor,Ki,=,2500.0,nM,CHEMBL672577,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2cc(CN3CCN(c4ccccc4)CC3)[nH]c2c1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL672383,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1133533,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL672578,B,Competitive binding affinity against human Dopamine receptor D2S by displacing [3H]spiperone from CHO cells,CHEMBL1133533,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL140006,CHEMBL217,Dopamine D2 receptor,Ki,=,43000.0,nM,CHEMBL672383,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]c(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)cc2c1
CHEMBL140006,CHEMBL217,Dopamine D2 receptor,Ki,=,36000.0,nM,CHEMBL672577,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]c(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)cc2c1
CHEMBL64117,CHEMBL217,Dopamine D2 receptor,Ki,=,144.54,nM,CHEMBL670683,B,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,CHEMBL1124647,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H]1Cc1ccccc1
CHEMBL62,CHEMBL217,Dopamine D2 receptor,Ki,=,891.25,nM,CHEMBL670683,B,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,CHEMBL1124647,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL311508,CHEMBL217,Dopamine D2 receptor,Ki,=,1356.0,nM,CHEMBL878132,B,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,CHEMBL1127981,KI,C(#Cc1ccccc1)COC1CCN(CCc2ccccc2)CC1
CHEMBL140099,CHEMBL217,Dopamine D2 receptor,Ki,=,3100.0,nM,CHEMBL672383,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]c(CN3CCN(c4ccccc4)CC3)cc2c1
CHEMBL140099,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL672577,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]c(CN3CCN(c4ccccc4)CC3)cc2c1
CHEMBL162193,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL672225,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1134827,KI,N#Cc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccc(F)cc3)CC1)C2
CHEMBL78067,CHEMBL217,Dopamine D2 receptor,Ki,=,131.0,nM,CHEMBL878132,B,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,CHEMBL1127981,KI,C(#Cc1ccccc1)COCCC1CCN(CCc2ccccc2)CC1
CHEMBL95743,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,O=C(NCCCCN1CCC[C@@H]2c3ccccc3CC[C@H]21)c1ccc(-c2ccccc2)cc1
CHEMBL45244,CHEMBL217,Dopamine D2 receptor,Ki,=,3740.0,nM,CHEMBL672163,B,Binding affinity towards cloned human Dopamine receptor D2,CHEMBL1133786,KI,Cc1cccc(C(=O)NCN2CCN(c3ccccc3C#N)CC2)c1
CHEMBL319116,CHEMBL217,Dopamine D2 receptor,Ki,=,63.1,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,O=C(NCCCCN1CC[C@H]2c3cccc(O)c3CC[C@@H]21)c1ccc(-c2ccccc2)cc1
CHEMBL140594,CHEMBL217,Dopamine D2 receptor,Ki,=,7900.0,nM,CHEMBL672383,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]c(CN3CCN(c4ccc(Cl)cc4)CC3)cc2c1
CHEMBL140594,CHEMBL217,Dopamine D2 receptor,Ki,=,7600.0,nM,CHEMBL672577,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1133533,KI,N#Cc1ccc2[nH]c(CN3CCN(c4ccc(Cl)cc4)CC3)cc2c1
CHEMBL2111592,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,CS(=O)(=O)Oc1cccc2c1CCC1C2CCCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1
CHEMBL319355,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,CS(=O)(=O)Oc1cccc2c1CC[C@@H]1[C@@H]2CCCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1
CHEMBL97440,CHEMBL217,Dopamine D2 receptor,Ki,=,1995.26,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,CS(=O)(=O)Oc1ccc2c(c1)CC[C@H]1[C@H]2CCCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1
CHEMBL351722,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL672225,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1134827,KI,N#Cc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2
CHEMBL158627,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL672225,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1134827,KI,CS(=O)(=O)Oc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccc(F)cc3)CC1)C2
CHEMBL98452,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL674943,B,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1130629,KI,O=C(NCCCCN1CC[C@H]2c3ccccc3CC[C@@H]21)c1ccc(-c2ccccc2)cc1
CHEMBL351300,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL672225,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1134827,KI,O=C(/C=C/c1ccc(F)cc1)N[C@H]1CC[C@H](CCN2Cc3ccc(Br)cc3C2)CC1
CHEMBL75860,CHEMBL217,Dopamine D2 receptor,Ki,=,620.0,nM,CHEMBL878132,B,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,CHEMBL1127981,KI,C(COCC1CCN(Cc2ccccc2)CC1)=C(c1ccccc1)c1ccccc1
CHEMBL89420,CHEMBL217,Dopamine D2 receptor,Ki,=,85.6,nM,CHEMBL672205,B,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,CHEMBL1132669,KI,c1ccc(CNCCOc2cccc3[nH]cnc23)cc1
CHEMBL278751,CHEMBL217,Dopamine D2 receptor,Ki,=,63.1,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)[C@@H]1CCc2c(OC)cccc2[C@@H]1C
CHEMBL37604,CHEMBL217,Dopamine D2 receptor,Ki,=,1209.0,nM,CHEMBL672174,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1131363,KI,Cc1ccc(C2CCN(CCC3NC(=O)c4ccccc43)CC2)cc1C
CHEMBL86504,CHEMBL217,Dopamine D2 receptor,Ki,=,32.4,nM,CHEMBL672205,B,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,CHEMBL1132669,KI,FC(F)(F)c1nc2c(OCCNCc3ccccc3)cc(Cl)cc2[nH]1
CHEMBL87137,CHEMBL217,Dopamine D2 receptor,Ki,=,79.8,nM,CHEMBL672205,B,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,CHEMBL1132669,KI,c1ccc(CNCCOc2cccc3[nH]ncc23)cc1
CHEMBL71275,CHEMBL217,Dopamine D2 receptor,Ki,=,82.3,nM,CHEMBL669147,B,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN[C@@H]1CCc2c(cccc2OC)C1
CHEMBL71275,CHEMBL217,Dopamine D2 receptor,Ki,=,114.0,nM,CHEMBL669148,B,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN[C@@H]1CCc2c(cccc2OC)C1
CHEMBL433121,CHEMBL217,Dopamine D2 receptor,Ki,=,215.0,nM,CHEMBL669147,B,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN(Cc1ccc([N+](=O)[O-])cc1)[C@@H]1CCc2c(cccc2OC)C1
CHEMBL433121,CHEMBL217,Dopamine D2 receptor,Ki,=,59.2,nM,CHEMBL669148,B,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN(Cc1ccc([N+](=O)[O-])cc1)[C@@H]1CCc2c(cccc2OC)C1
CHEMBL157293,CHEMBL217,Dopamine D2 receptor,Ki,=,68.4,nM,CHEMBL670524,B,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,CHEMBL1135449,KI,C#CCN(CCCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1
CHEMBL35093,CHEMBL217,Dopamine D2 receptor,Ki,=,2748.0,nM,CHEMBL672174,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1131363,KI,Cc1ccc(N2CCN(CC[C@H]3NC(=O)c4ccccc43)CC2)cc1C
CHEMBL129997,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)[C@@H]1CCc2c(ccc(C(O)Cc3ccc(Cl)cc3)c2OC)C1
CHEMBL424458,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)[C@@H]1CCc2c(ccc(CCc3ccc(C(F)(F)F)cc3)c2OC)C1
CHEMBL338938,CHEMBL217,Dopamine D2 receptor,Ki,=,6309.57,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)C1CCc2cc(CN(C(N)=O)c3ccc(OC)cc3)ccc2C1
CHEMBL422883,CHEMBL217,Dopamine D2 receptor,Ki,=,354.0,nM,CHEMBL670524,B,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,CHEMBL1135449,KI,O=C(NCCN(CCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1)c1ccccc1
CHEMBL314174,CHEMBL217,Dopamine D2 receptor,Ki,=,3.9,nM,CHEMBL672205,B,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,CHEMBL1132669,KI,Oc1nc2c(OCCNCc3ccccc3)cccc2[nH]1
CHEMBL130843,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)C1CCc2cc(CSc3ccc(OC)cc3)ccc2C1
CHEMBL69706,CHEMBL217,Dopamine D2 receptor,Ki,=,339.0,nM,CHEMBL669147,B,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN(Cc1cccs1)[C@@H]1CCc2c(cccc2OC)C1
CHEMBL69706,CHEMBL217,Dopamine D2 receptor,Ki,=,152.0,nM,CHEMBL669148,B,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN(Cc1cccs1)[C@@H]1CCc2c(cccc2OC)C1
CHEMBL334529,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)C1CCc2cc(CS(=O)(=O)c3ccc(OC)cc3)ccc2C1
CHEMBL64283,CHEMBL217,Dopamine D2 receptor,Ki,=,81.8,nM,CHEMBL672205,B,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,CHEMBL1132669,KI,c1ccc(CNCCOc2cccc3[nH]ccc23)cc1
CHEMBL336971,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)[C@@H]1CCc2cc(CCc3ccc(/C(C)=N\O)cc3)ccc2C1
CHEMBL338496,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)C1CCc2cc(CN(C(C)=O)c3ccc(OC)cc3)ccc2C1
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,908.0,nM,CHEMBL672174,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1131363,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL158013,CHEMBL217,Dopamine D2 receptor,Ki,=,245.0,nM,CHEMBL670524,B,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,CHEMBL1135449,KI,C#CCN(CCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1
CHEMBL87192,CHEMBL217,Dopamine D2 receptor,Ki,=,1.75,nM,CHEMBL672205,B,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,CHEMBL1132669,KI,FC(F)(F)c1nc2c(OCCNCc3ccccc3)cccc2[nH]1
CHEMBL133800,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)C1CCc2cc(CCc3ccc(C(C)=O)cc3)ccc2C1
CHEMBL130678,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)[C@@H]1CCc2cc(CS(=O)(=O)c3ccc(I)cc3)ccc2C1
CHEMBL132574,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)[C@@H]1CCc2c(ccc(C(O)Cc3ccc(Cl)cc3)c2OC)[C@@H]1C
CHEMBL130101,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)C1CCc2cc(CCc3ccc(C(=O)OCC)cc3)ccc2C1
CHEMBL130423,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)[C@@H]1CCc2c(ccc(C(O)Cc3ccccc3)c2OC)C1
CHEMBL67923,CHEMBL217,Dopamine D2 receptor,Ki,=,64.1,nM,CHEMBL669147,B,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN(Cc1ccc(OC)cc1)[C@@H]1CCc2c(cccc2OC)C1
CHEMBL67923,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL669148,B,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN(Cc1ccc(OC)cc1)[C@@H]1CCc2c(cccc2OC)C1
CHEMBL129997,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)[C@@H]1CCc2c(ccc(C(O)Cc3ccc(Cl)cc3)c2OC)C1
CHEMBL68573,CHEMBL217,Dopamine D2 receptor,Ki,=,6.35,nM,CHEMBL669147,B,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN(CCC)[C@@H]1CCc2c(cccc2OC)C1
CHEMBL68573,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL669148,B,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN(CCC)[C@@H]1CCc2c(cccc2OC)C1
CHEMBL327782,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL672205,B,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,CHEMBL1132669,KI,Sc1nc2c(OCCNCc3ccccc3)cccc2[nH]1
CHEMBL89037,CHEMBL217,Dopamine D2 receptor,Ki,=,6.5,nM,CHEMBL672205,B,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,CHEMBL1132669,KI,Sc1nc2c(OCCNCc3ccccc3)cc(Cl)cc2[nH]1
CHEMBL132789,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)[C@@H]1CCc2cc(CCc3ccc(Cl)cc3)ccc2C1
CHEMBL37170,CHEMBL217,Dopamine D2 receptor,Ki,=,5882.0,nM,CHEMBL672174,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1131363,KI,Cc1ccc(N2CCN(CC[C@@H]3NC(=O)c4ccccc43)CC2)cc1C
CHEMBL303502,CHEMBL217,Dopamine D2 receptor,Ki,=,118.0,nM,CHEMBL669147,B,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN(Cc1ccco1)[C@@H]1CCc2c(cccc2OC)C1
CHEMBL303502,CHEMBL217,Dopamine D2 receptor,Ki,=,125.0,nM,CHEMBL669148,B,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN(Cc1ccco1)[C@@H]1CCc2c(cccc2OC)C1
CHEMBL346512,CHEMBL217,Dopamine D2 receptor,Ki,=,622.0,nM,CHEMBL670524,B,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,CHEMBL1135449,KI,N#CCCCN(CCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1
CHEMBL441089,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)C1CCc2cc(CCc3ccc(OC)cc3)ccc2C1
CHEMBL130304,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)C1CCc2cc(CCc3ccc(O)cc3)ccc2C1
CHEMBL38262,CHEMBL217,Dopamine D2 receptor,Ki,=,1842.0,nM,CHEMBL672174,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1131363,KI,Cc1ccc(N2CCN(CCC3NC(=O)c4ccccc43)CC2)cc1C
CHEMBL155826,CHEMBL217,Dopamine D2 receptor,Ki,=,114.0,nM,CHEMBL670524,B,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,CHEMBL1135449,KI,CCCN(CCCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1
CHEMBL156816,CHEMBL217,Dopamine D2 receptor,Ki,=,782.0,nM,CHEMBL670524,B,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,CHEMBL1135449,KI,O=C(NCCCCN(CCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1)c1ccccc1
CHEMBL157035,CHEMBL217,Dopamine D2 receptor,Ki,=,7.37,nM,CHEMBL670524,B,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,CHEMBL1135449,KI,C#CCN(CCCCN1CCN(c2cccc(Cl)c2Cl)CC1)C1CCc2ccc(O)cc2C1
CHEMBL329398,CHEMBL217,Dopamine D2 receptor,Ki,=,2.6,nM,CHEMBL672205,B,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,CHEMBL1132669,KI,Oc1nc2c(OCCNCc3ccccc3)cc(Cl)cc2[nH]1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,1.89,nM,CHEMBL669147,B,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,NCCc1ccc(O)c(O)c1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,759.0,nM,CHEMBL669148,B,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,NCCc1ccc(O)c(O)c1
CHEMBL87067,CHEMBL217,Dopamine D2 receptor,Ki,=,15.2,nM,CHEMBL672205,B,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,CHEMBL1132669,KI,Cc1nc2c(OCCNCc3ccccc3)cccc2[nH]1
CHEMBL133519,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)[C@@H]1CCc2cc(CCc3ccc(C(C)=O)cc3)ccc2C1
CHEMBL131556,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)[C@@H]1CCc2cc(CS(=O)(=O)c3ccc(OC)cc3)ccc2C1
CHEMBL156639,CHEMBL217,Dopamine D2 receptor,Ki,=,213.0,nM,CHEMBL670524,B,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,CHEMBL1135449,KI,CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1
CHEMBL64508,CHEMBL217,Dopamine D2 receptor,Ki,=,75.8,nM,CHEMBL672205,B,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,CHEMBL1132669,KI,Oc1cccc(OCCNCc2ccccc2)c1
CHEMBL68545,CHEMBL217,Dopamine D2 receptor,Ki,=,75.0,nM,CHEMBL669147,B,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN(Cc1ccccc1)[C@@H]1CCc2c(cccc2OC)C1
CHEMBL68545,CHEMBL217,Dopamine D2 receptor,Ki,=,65.6,nM,CHEMBL669148,B,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN(Cc1ccccc1)[C@@H]1CCc2c(cccc2OC)C1
CHEMBL156689,CHEMBL217,Dopamine D2 receptor,Ki,=,27.4,nM,CHEMBL670524,B,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,CHEMBL1135449,KI,CCCN(CCN1CCN(c2cccc(Cl)c2Cl)CC1)C1CCc2ccc(O)cc2C1
CHEMBL71599,CHEMBL217,Dopamine D2 receptor,Ki,=,69.7,nM,CHEMBL669147,B,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN(Cc1ccc(F)cc1)[C@@H]1CCc2c(cccc2OC)C1
CHEMBL71599,CHEMBL217,Dopamine D2 receptor,Ki,=,43.8,nM,CHEMBL669148,B,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN(Cc1ccc(F)cc1)[C@@H]1CCc2c(cccc2OC)C1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.16,nM,CHEMBL669147,B,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.44,nM,CHEMBL669148,B,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL132769,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)[C@@H]1CCc2c(ccc(CCc3ccc(Cl)cc3)c2OC)C1
CHEMBL132724,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)[C@H]1CCc2cc(CCc3ccc(Cl)cc3)ccc2C1
CHEMBL130665,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)C1CCc2cc(CCc3ccccc3)ccc2C1
CHEMBL69985,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL669147,B,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN(CCC)[C@@H]1CCc2c(F)cccc2C1
CHEMBL69985,CHEMBL217,Dopamine D2 receptor,Ki,=,201.0,nM,CHEMBL669148,B,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,CCCN(CCC)[C@@H]1CCc2c(F)cccc2C1
CHEMBL157036,CHEMBL217,Dopamine D2 receptor,Ki,=,8.78,nM,CHEMBL670524,B,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,CHEMBL1135449,KI,CCCN(CCCCN1CCN(c2cccc(Cl)c2Cl)CC1)C1CCc2ccc(O)cc2C1
CHEMBL59752,CHEMBL217,Dopamine D2 receptor,Ki,=,4.25,nM,CHEMBL672205,B,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,CHEMBL1132669,KI,O=C1Cc2c(cccc2OCCNCc2ccccc2)N1
CHEMBL69733,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL665381,B,Compound was evaluated for binding affinity against Dopamine D2 receptor using radioligand binding assay,CHEMBL1153669,KI,COc1ccc(CCCN2CCC(CCC(=O)c3cc(Cl)c(N)c4c3OCCO4)CC2)cc1OC
CHEMBL65896,CHEMBL217,Dopamine D2 receptor,Ki,=,1310.0,nM,CHEMBL669147,B,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,COc1cccc2c1CC[C@@H](NCc1ccccc1)C2
CHEMBL65896,CHEMBL217,Dopamine D2 receptor,Ki,=,1010.0,nM,CHEMBL669148,B,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,CHEMBL1131815,KI,COc1cccc2c1CC[C@@H](NCc1ccccc1)C2
CHEMBL65847,CHEMBL217,Dopamine D2 receptor,Ki,=,179.0,nM,CHEMBL669145,B,Inhibition of [3H]quinpirole binding to human dopamine D2A receptor expressed in LtK cells,CHEMBL1131815,KI,CCCN(Cc1ccccc1)[C@@H]1CCc2c(F)cccc2C1
CHEMBL65847,CHEMBL217,Dopamine D2 receptor,Ki,=,415.0,nM,CHEMBL669146,B,Inhibition of [3H]raclopride binding to human dopamine D2A receptor expressed in LtK cells,CHEMBL1131815,KI,CCCN(Cc1ccccc1)[C@@H]1CCc2c(F)cccc2C1
CHEMBL130282,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)C1CCc2cc(CCc3ccc(/C(C)=N\O)cc3)ccc2C1
CHEMBL133166,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL674345,B,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,CHEMBL1129777,KI,CCCN(CCC)C1CCc2cc(CN(C(=O)OC)c3ccc(OC)cc3)ccc2C1
CHEMBL444342,CHEMBL217,Dopamine D2 receptor,Ki,=,5.9,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1ccccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCCS3
CHEMBL558036,CHEMBL217,Dopamine D2 receptor,Ki,=,6512.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,Cc1ccccc1N1CCN(CCCCc2cc(-c3ccccc3)no2)CC1.Cl
CHEMBL554016,CHEMBL217,Dopamine D2 receptor,Ki,=,585.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,Cl.Fc1ccccc1N1CCN(CCCCc2cc(/C=C/c3ccccc3)no2)CC1
CHEMBL544925,CHEMBL217,Dopamine D2 receptor,Ki,=,3828.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,COc1ccc(-c2cc(CCCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)on2)c(OC)c1.Cl
CHEMBL407641,CHEMBL217,Dopamine D2 receptor,Ki,=,5.4,nM,CHEMBL672311,B,Binding affinity to Dopamine receptor D2 was determined,CHEMBL1134832,KI,CNc1nc(Cl)c(SC)c(N2CCN(C)CC2)n1
CHEMBL80711,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL670396,B,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,CHEMBL1130531,KI,COc1ccccc1N1CCN(CCCNC2=Nc3ccccc3OC2)CC1.O=C(O)/C=C/C(=O)O
CHEMBL15242,CHEMBL217,Dopamine D2 receptor,Ki,=,31.0,nM,CHEMBL672311,B,Binding affinity to Dopamine receptor D2 was determined,CHEMBL1134832,KI,CN1CCN(c2nc3ccccc3c(Cl)c2Sc2ccccc2)CC1
CHEMBL15270,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL672311,B,Binding affinity to Dopamine receptor D2 was determined,CHEMBL1134832,KI,Cc1nc(Cl)c(Sc2ccc(Cl)cc2)c(NC2CCN(Cc3ccccc3)CC2)n1
CHEMBL80645,CHEMBL217,Dopamine D2 receptor,Ki,=,2540.0,nM,CHEMBL670396,B,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,CHEMBL1130531,KI,O=C(O)/C=C/C(=O)O.c1cnc(N2CCN(CCCCCNC3=Nc4ccccc4OC3)CC2)nc1
CHEMBL166310,CHEMBL217,Dopamine D2 receptor,Ki,=,4.1,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3
CHEMBL166366,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1ccccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCO3
CHEMBL349057,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1cc(F)ccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCO3
CHEMBL165723,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1ccc(F)cc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3
CHEMBL163261,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1ccccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCCC3
CHEMBL543277,CHEMBL217,Dopamine D2 receptor,Ki,=,9724.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,C(=C/c1cc(CCCCN2CCN(c3ccccc3)CC2)on1)\c1ccccc1.Cl
CHEMBL164744,CHEMBL217,Dopamine D2 receptor,Ki,=,7.7,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,O=CNc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3
CHEMBL543278,CHEMBL217,Dopamine D2 receptor,Ki,=,440.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,COc1ccc(-c2cc(CCCCN3CCN(c4ccccc4OC)CC3)on2)c(OC)c1.Cl
CHEMBL541025,CHEMBL217,Dopamine D2 receptor,Ki,=,418.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,COc1ccc(-c2cc(CCCCN3CCN(c4ccccc4OC)CC3)on2)cc1OC.Cl
CHEMBL412665,CHEMBL217,Dopamine D2 receptor,Ki,=,2011.0,nM,CHEMBL670396,B,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,CHEMBL1130531,KI,O=C(O)/C=C/C(=O)O.c1ccc(N2CCN(CCCNC3=Nc4ccccc4OC3)CC2)cc1
CHEMBL348977,CHEMBL217,Dopamine D2 receptor,Ki,=,68.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1ccccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCC3
CHEMBL352686,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1ccccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCC3
CHEMBL160817,CHEMBL217,Dopamine D2 receptor,Ki,=,246.0,nM,CHEMBL672386,B,Binding affinity of compound was tested for Dopamine receptor D2L,CHEMBL1145970,KI,O=C(CCCCCN1CCN(c2noc3ccccc23)CC1)c1ccccc1O
CHEMBL165126,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1c(F)cccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3
CHEMBL544689,CHEMBL217,Dopamine D2 receptor,Ki,=,1727.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,COc1ccccc1N1CCN(CCCCc2cc(-c3ccccc3)no2)CC1.Cl
CHEMBL352648,CHEMBL217,Dopamine D2 receptor,Ki,=,8.8,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,O=C(CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3)c1ccc(F)cc1
CHEMBL162102,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,CS(=O)(=O)Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3
CHEMBL354005,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCS3
CHEMBL349683,CHEMBL217,Dopamine D2 receptor,Ki,=,3.5,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCC3
CHEMBL541270,CHEMBL217,Dopamine D2 receptor,Ki,=,295.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,COc1ccccc1N1CCN(CCCCc2cc(-c3cccc([N+](=O)[O-])c3)no2)CC1.Cl
CHEMBL541524,CHEMBL217,Dopamine D2 receptor,Ki,=,486.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,Cl.c1ccc(-c2cc(CCCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)on2)cc1
CHEMBL165780,CHEMBL217,Dopamine D2 receptor,Ki,=,2.3,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCO3
CHEMBL538977,CHEMBL217,Dopamine D2 receptor,Ki,=,1470.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,Cl.O=[N+]([O-])c1cccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)c1
CHEMBL539744,CHEMBL217,Dopamine D2 receptor,Ki,=,964.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,COc1ccccc1N1CCN(CCCCc2cc(/C=C/c3ccccc3)no2)CC1.Cl
CHEMBL159022,CHEMBL217,Dopamine D2 receptor,Ki,=,78.1,nM,CHEMBL672386,B,Binding affinity of compound was tested for Dopamine receptor D2L,CHEMBL1145970,KI,COc1ccccc1C(=O)CCCCCN1CCN(c2noc3ccccc23)CC1
CHEMBL309858,CHEMBL217,Dopamine D2 receptor,Ki,=,2745.0,nM,CHEMBL670396,B,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,CHEMBL1130531,KI,O=C(O)/C=C/C(=O)O.c1ccc(N2CCN(CCCCNC3=Nc4ccccc4OC3)CC2)cc1
CHEMBL424384,CHEMBL217,Dopamine D2 receptor,Ki,=,2.3,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1cc(Cl)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3
CHEMBL166310,CHEMBL217,Dopamine D2 receptor,Ki,=,2.7,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3
CHEMBL554897,CHEMBL217,Dopamine D2 receptor,Ki,=,5148.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,COc1ccc(-c2cc(CCCCN3CCN(c4ccccc4F)CC3)on2)cc1OC.Cl
CHEMBL349151,CHEMBL217,Dopamine D2 receptor,Ki,=,4.7,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1cc(F)ccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCCS3
CHEMBL538474,CHEMBL217,Dopamine D2 receptor,Ki,=,3366.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,Cl.c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1
CHEMBL542809,CHEMBL217,Dopamine D2 receptor,Ki,=,341.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,CCOc1ccccc1N1CCN(CCCCc2cc(-c3ccccc3)no2)CC1.Cl
CHEMBL350567,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,O=C(CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3)c1ccccc1
CHEMBL543040,CHEMBL217,Dopamine D2 receptor,Ki,=,620.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,Cl.c1ccc(C(c2ccccc2)N2CCN(CCCCc3cc(-c4cccs4)no3)CC2)cc1
CHEMBL274047,CHEMBL217,Dopamine D2 receptor,Ki,=,460.0,nM,CHEMBL672311,B,Binding affinity to Dopamine receptor D2 was determined,CHEMBL1134832,KI,O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN1CCN(c2ncccn2)CC1
CHEMBL352194,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1ccccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCC3
CHEMBL14998,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL672311,B,Binding affinity to Dopamine receptor D2 was determined,CHEMBL1134832,KI,Cc1nc(Cl)c(Sc2ccc(Cl)cc2)c(N2CCN(C)CC2)n1
CHEMBL163742,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1ccccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCS3
CHEMBL351459,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1ccccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCS3
CHEMBL163904,CHEMBL217,Dopamine D2 receptor,Ki,=,29.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1cc(F)ccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCC3
CHEMBL553810,CHEMBL217,Dopamine D2 receptor,Ki,=,1522.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,Cl.O=[N+]([O-])c1cccc(-c2cc(CCCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)on2)c1
CHEMBL538723,CHEMBL217,Dopamine D2 receptor,Ki,=,119.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,CCOc1ccccc1N1CCN(CCCCc2cc(-c3ccc(OC)c(OC)c3)no2)CC1.Cl
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,448.0,nM,CHEMBL672347,B,Binding affinity against human Dopamine receptor D2 using [3H]spiperone as radioligand,CHEMBL1149162,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL351247,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1cc(F)ccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCS3
CHEMBL164338,CHEMBL217,Dopamine D2 receptor,Ki,=,15.1,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,CCOC(=O)Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3
CHEMBL542324,CHEMBL217,Dopamine D2 receptor,Ki,=,4136.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,Cl.c1ccc(N2CCN(CCCCc3cc(-c4cccs4)no3)CC2)cc1
CHEMBL544220,CHEMBL217,Dopamine D2 receptor,Ki,=,321.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,COc1ccccc1N1CCN(CCCCc2cc(-c3ccc(F)cc3)no2)CC1.Cl
CHEMBL541826,CHEMBL217,Dopamine D2 receptor,Ki,=,94.0,nM,CHEMBL670396,B,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,CHEMBL1130531,KI,Br.c1ccc(N2CCN(CCCCCNC3=Nc4ccccc4OC3)CC2)cc1
CHEMBL163895,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,CCNC(=O)Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3
CHEMBL351708,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1ccccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCO3
CHEMBL544451,CHEMBL217,Dopamine D2 receptor,Ki,=,2108.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,Cc1ccccc1N1CCN(CCCCc2cc(-c3cccs3)no2)CC1.Cl
CHEMBL543041,CHEMBL217,Dopamine D2 receptor,Ki,=,491.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,C(=C/c1cc(CCCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)on1)\c1ccccc1.Cl
CHEMBL539235,CHEMBL217,Dopamine D2 receptor,Ki,=,2530.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,Cl.Fc1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1
CHEMBL80627,CHEMBL217,Dopamine D2 receptor,Ki,=,543.0,nM,CHEMBL670396,B,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,CHEMBL1130531,KI,O=C(O)/C=C/C(=O)O.c1ccc(N2CCN(CCCCCNC3=Nc4ccccc4OC3)CC2)nc1
CHEMBL542573,CHEMBL217,Dopamine D2 receptor,Ki,=,2196.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,COc1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)c(OC)c1.Cl
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL165897,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1cc(F)ccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCCC3
CHEMBL557829,CHEMBL217,Dopamine D2 receptor,Ki,=,194.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,CCOc1ccccc1N1CCN(CCCCc2cc(-c3cccs3)no2)CC1.Cl
CHEMBL352182,CHEMBL217,Dopamine D2 receptor,Ki,=,4.7,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1cc(Br)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3
CHEMBL168051,CHEMBL217,Dopamine D2 receptor,Ki,=,31.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,CNc1ccccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3
CHEMBL351592,CHEMBL217,Dopamine D2 receptor,Ki,=,5.2,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCC3
CHEMBL542325,CHEMBL217,Dopamine D2 receptor,Ki,=,726.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,COc1ccccc1N1CCN(CCCCc2cc(-c3cccs3)no2)CC1.Cl
CHEMBL537975,CHEMBL217,Dopamine D2 receptor,Ki,=,95.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,CCOc1ccccc1N1CCN(CCCCc2cc(-c3cccc([N+](=O)[O-])c3)no2)CC1.Cl
CHEMBL164909,CHEMBL217,Dopamine D2 receptor,Ki,=,50.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1cc(O)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3
CHEMBL557409,CHEMBL217,Dopamine D2 receptor,Ki,=,3388.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,COc1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1OC.Cl
CHEMBL541791,CHEMBL217,Dopamine D2 receptor,Ki,=,1401.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,COc1ccc(-c2cc(CCCCN3CCN(c4ccccc4C)CC3)on2)cc1OC.Cl
CHEMBL539999,CHEMBL217,Dopamine D2 receptor,Ki,=,1461.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,Cl.Fc1ccc(-c2cc(CCCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)on2)cc1
CHEMBL14899,CHEMBL217,Dopamine D2 receptor,Ki,=,188.0,nM,CHEMBL672311,B,Binding affinity to Dopamine receptor D2 was determined,CHEMBL1134832,KI,CNc1nc(Cl)c(Sc2ccccc2)c(N2CCN(C)CC2)n1
CHEMBL164185,CHEMBL217,Dopamine D2 receptor,Ki,=,6.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1ccccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3
CHEMBL162768,CHEMBL217,Dopamine D2 receptor,Ki,=,3.4,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,CC(=O)Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3
CHEMBL164185,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL672312,B,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,CHEMBL1144968,KI,Nc1ccccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3
CHEMBL542571,CHEMBL217,Dopamine D2 receptor,Ki,=,2618.0,nM,CHEMBL672182,B,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,CHEMBL1135103,KI,COc1ccc(-c2cc(CCCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)on2)cc1OC.Cl
CHEMBL310843,CHEMBL217,Dopamine D2 receptor,Ki,=,1310.0,nM,CHEMBL672347,B,Binding affinity against human Dopamine receptor D2 using [3H]spiperone as radioligand,CHEMBL1149162,KI,Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1
CHEMBL325104,CHEMBL217,Dopamine D2 receptor,Ki,=,6600.0,nM,CHEMBL673074,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1131871,KI,C#Cc1cccn1C1CCN(Cc2ccccc2)CC1
CHEMBL325104,CHEMBL217,Dopamine D2 receptor,Ki,=,6300.0,nM,CHEMBL672580,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1131871,KI,C#Cc1cccn1C1CCN(Cc2ccccc2)CC1
CHEMBL64566,CHEMBL217,Dopamine D2 receptor,Ki,=,6250.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNC[C@@H]2CCN(Cc3ccccc3)C2)c[nH]1
CHEMBL64566,CHEMBL217,Dopamine D2 receptor,Ki,=,2750.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNC[C@@H]2CCN(Cc3ccccc3)C2)c[nH]1
CHEMBL119455,CHEMBL217,Dopamine D2 receptor,Ki,=,58.5,nM,CHEMBL670676,B,Ability to displace [3H]raclopride binding to cloned human Dopamine receptor D2A,CHEMBL1128704,KI,CN1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3
CHEMBL53510,CHEMBL217,Dopamine D2 receptor,Ki,=,1070.0,nM,CHEMBL670676,B,Ability to displace [3H]raclopride binding to cloned human Dopamine receptor D2A,CHEMBL1128704,KI,Cc1ccc2c(c1O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL107529,CHEMBL217,Dopamine D2 receptor,Ki,=,3400.0,nM,CHEMBL673074,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1131871,KI,c1ccc(CN2CCC(n3ccc(-c4cnco4)c3)CC2)cc1
CHEMBL107529,CHEMBL217,Dopamine D2 receptor,Ki,=,3200.0,nM,CHEMBL672580,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1131871,KI,c1ccc(CN2CCC(n3ccc(-c4cnco4)c3)CC2)cc1
CHEMBL84819,CHEMBL217,Dopamine D2 receptor,Ki,=,1403.0,nM,CHEMBL670391,B,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,CHEMBL1149936,KI,Clc1cccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)c1
CHEMBL313620,CHEMBL217,Dopamine D2 receptor,Ki,=,8.8,nM,CHEMBL670391,B,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,CHEMBL1149936,KI,COc1ccccc1N1CCN(CCCOc2ccc(-c3nc4ccccc4[nH]3)cc2)CC1
CHEMBL64376,CHEMBL217,Dopamine D2 receptor,Ki,=,2300.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)cs2)cc1
CHEMBL64376,CHEMBL217,Dopamine D2 receptor,Ki,=,1060.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)cs2)cc1
CHEMBL64043,CHEMBL217,Dopamine D2 receptor,Ki,=,28000.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,c1ccc(CN2CCN(Cc3csc(-c4ccccc4)n3)CC2)cc1
CHEMBL64043,CHEMBL217,Dopamine D2 receptor,Ki,=,19500.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,c1ccc(CN2CCN(Cc3csc(-c4ccccc4)n3)CC2)cc1
CHEMBL267044,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC
CHEMBL267044,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC
CHEMBL302186,CHEMBL217,Dopamine D2 receptor,Ki,=,23000.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,c1ccc(CN2CCC(NCc3csc(-c4ccccc4)n3)CC2)cc1
CHEMBL302186,CHEMBL217,Dopamine D2 receptor,Ki,=,13500.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,c1ccc(CN2CCC(NCc3csc(-c4ccccc4)n3)CC2)cc1
CHEMBL104092,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL673074,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1131871,KI,C(#Cc1cccn1C1CCN(Cc2ccccc2)CC1)c1ccccc1
CHEMBL104092,CHEMBL217,Dopamine D2 receptor,Ki,=,8300.0,nM,CHEMBL672580,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1131871,KI,C(#Cc1cccn1C1CCN(Cc2ccccc2)CC1)c1ccccc1
CHEMBL2111525,CHEMBL217,Dopamine D2 receptor,Ki,=,510.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNCC2CCN(Cc3ccccc3)C2)co1
CHEMBL2111525,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNCC2CCN(Cc3ccccc3)C2)co1
CHEMBL312877,CHEMBL217,Dopamine D2 receptor,Ki,=,293.0,nM,CHEMBL670391,B,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,CHEMBL1149936,KI,COc1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1
CHEMBL294780,CHEMBL217,Dopamine D2 receptor,Ki,=,3000.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)co2)cc1
CHEMBL294780,CHEMBL217,Dopamine D2 receptor,Ki,=,1750.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)co2)cc1
CHEMBL293225,CHEMBL217,Dopamine D2 receptor,Ki,=,940.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNC2CCN(Cc3ccccc3)CC2)co1
CHEMBL293225,CHEMBL217,Dopamine D2 receptor,Ki,=,630.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNC2CCN(Cc3ccccc3)CC2)co1
CHEMBL62602,CHEMBL217,Dopamine D2 receptor,Ki,=,320.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNC[C@@H]2CCN(Cc3ccccc3)C2)co1
CHEMBL62602,CHEMBL217,Dopamine D2 receptor,Ki,=,245.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNC[C@@H]2CCN(Cc3ccccc3)C2)co1
CHEMBL104453,CHEMBL217,Dopamine D2 receptor,Ki,=,610.0,nM,CHEMBL673074,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1131871,KI,c1ccc(CN2CCC(n3cccc3-c3cnco3)CC2)cc1
CHEMBL104453,CHEMBL217,Dopamine D2 receptor,Ki,=,320.0,nM,CHEMBL672580,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1131871,KI,c1ccc(CN2CCC(n3cccc3-c3cnco3)CC2)cc1
CHEMBL87260,CHEMBL217,Dopamine D2 receptor,Ki,=,865.0,nM,CHEMBL670391,B,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,CHEMBL1149936,KI,Clc1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1
CHEMBL87478,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL670391,B,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,CHEMBL1149936,KI,CCCSc1ccccc1N1CCN(CCCOc2ccc(-c3nc4ccccc4[nH]3)cc2)CC1
CHEMBL2111528,CHEMBL217,Dopamine D2 receptor,Ki,=,185.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNCC2CCN(Cc3ccccc3)C2)cs1
CHEMBL2111528,CHEMBL217,Dopamine D2 receptor,Ki,=,92.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNCC2CCN(Cc3ccccc3)C2)cs1
CHEMBL141537,CHEMBL217,Dopamine D2 receptor,Ki,=,779.0,nM,CHEMBL672183,B,Displacement of [3H]quinpirole from Dopamine receptor D2,CHEMBL1129381,KI,Fc1cccc2c1CC[C@@H](NCc1ccccc1)C2
CHEMBL141537,CHEMBL217,Dopamine D2 receptor,Ki,=,2830.0,nM,CHEMBL672184,B,Inhibition of [3H]raclopride binding to Dopamine receptor D2,CHEMBL1129381,KI,Fc1cccc2c1CC[C@@H](NCc1ccccc1)C2
CHEMBL85441,CHEMBL217,Dopamine D2 receptor,Ki,=,406.0,nM,CHEMBL670391,B,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,CHEMBL1149936,KI,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL673074,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1131871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL672580,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1131871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL64668,CHEMBL217,Dopamine D2 receptor,Ki,=,3800.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CN(C)C[C@@H]2CCN(Cc3ccccc3)C2)co1
CHEMBL64668,CHEMBL217,Dopamine D2 receptor,Ki,=,3250.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CN(C)C[C@@H]2CCN(Cc3ccccc3)C2)co1
CHEMBL422959,CHEMBL217,Dopamine D2 receptor,Ki,=,49000.0,nM,CHEMBL673074,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1131871,KI,O=Cc1ccn(C2CCN(Cc3ccccc3)CC2)c1
CHEMBL422959,CHEMBL217,Dopamine D2 receptor,Ki,=,65000.0,nM,CHEMBL672580,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1131871,KI,O=Cc1ccn(C2CCN(Cc3ccccc3)CC2)c1
CHEMBL85972,CHEMBL217,Dopamine D2 receptor,Ki,=,269.0,nM,CHEMBL670391,B,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,CHEMBL1149936,KI,c1cnc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)nc1
CHEMBL64288,CHEMBL217,Dopamine D2 receptor,Ki,=,690.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CN2CCN(c3ccccc3)CC2)co1
CHEMBL64288,CHEMBL217,Dopamine D2 receptor,Ki,=,330.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CN2CCN(c3ccccc3)CC2)co1
CHEMBL69985,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL672183,B,Displacement of [3H]quinpirole from Dopamine receptor D2,CHEMBL1129381,KI,CCCN(CCC)[C@@H]1CCc2c(F)cccc2C1
CHEMBL69985,CHEMBL217,Dopamine D2 receptor,Ki,=,201.0,nM,CHEMBL672184,B,Inhibition of [3H]raclopride binding to Dopamine receptor D2,CHEMBL1129381,KI,CCCN(CCC)[C@@H]1CCc2c(F)cccc2C1
CHEMBL139345,CHEMBL217,Dopamine D2 receptor,Ki,=,167.0,nM,CHEMBL672183,B,Displacement of [3H]quinpirole from Dopamine receptor D2,CHEMBL1129381,KI,CCCN[C@@H]1CCc2c(F)cccc2C1
CHEMBL139345,CHEMBL217,Dopamine D2 receptor,Ki,=,582.0,nM,CHEMBL672184,B,Inhibition of [3H]raclopride binding to Dopamine receptor D2,CHEMBL1129381,KI,CCCN[C@@H]1CCc2c(F)cccc2C1
CHEMBL139089,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL672183,B,Displacement of [3H]quinpirole from Dopamine receptor D2,CHEMBL1129381,KI,O=C1CC2(CCCC2)CC(=O)N1CCCCN[C@@H]1CCc2c(F)cccc2C1
CHEMBL139089,CHEMBL217,Dopamine D2 receptor,Ki,=,68.2,nM,CHEMBL672794,B,Inhibition of [3H]raclopride binding to Dopamine receptor D2,CHEMBL1129381,KI,O=C1CC2(CCCC2)CC(=O)N1CCCCN[C@@H]1CCc2c(F)cccc2C1
CHEMBL326877,CHEMBL217,Dopamine D2 receptor,Ki,=,8500.0,nM,CHEMBL673074,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1131871,KI,c1ccc(CN2CCC(n3cccc3)CC2)cc1
CHEMBL326877,CHEMBL217,Dopamine D2 receptor,Ki,=,9800.0,nM,CHEMBL672580,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1131871,KI,c1ccc(CN2CCC(n3cccc3)CC2)cc1
CHEMBL64696,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CN2CCN(Cc3ccccc3)CC2)co1
CHEMBL64696,CHEMBL217,Dopamine D2 receptor,Ki,=,790.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CN2CCN(Cc3ccccc3)CC2)co1
CHEMBL65641,CHEMBL217,Dopamine D2 receptor,Ki,=,1070.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNCC[C@@H]2CCN(Cc3ccccc3)C2)co1
CHEMBL65641,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNCC[C@@H]2CCN(Cc3ccccc3)C2)co1
CHEMBL138998,CHEMBL217,Dopamine D2 receptor,Ki,=,4.94,nM,CHEMBL672183,B,Displacement of [3H]quinpirole from Dopamine receptor D2,CHEMBL1129381,KI,CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)[C@@H]1CCc2c(F)cccc2C1
CHEMBL138998,CHEMBL217,Dopamine D2 receptor,Ki,=,16.9,nM,CHEMBL672794,B,Inhibition of [3H]raclopride binding to Dopamine receptor D2,CHEMBL1129381,KI,CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)[C@@H]1CCc2c(F)cccc2C1
CHEMBL516,CHEMBL217,Dopamine D2 receptor,Ki,=,112.0,nM,CHEMBL672315,B,Binding affinity towards dopamine receptor D2 using [3H]spiperone as radioligand,CHEMBL1148436,KI,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1
CHEMBL62996,CHEMBL217,Dopamine D2 receptor,Ki,=,6650.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,Oc1ccc(Br)cc1-c1nc(CN2CCN(c3ccccc3)CC2)co1
CHEMBL62996,CHEMBL217,Dopamine D2 receptor,Ki,=,4400.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,Oc1ccc(Br)cc1-c1nc(CN2CCN(c3ccccc3)CC2)co1
CHEMBL64752,CHEMBL217,Dopamine D2 receptor,Ki,=,2450.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CN[C@@H]2CCN(Cc3ccccc3)C2)co1
CHEMBL64752,CHEMBL217,Dopamine D2 receptor,Ki,=,2000.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CN[C@@H]2CCN(Cc3ccccc3)C2)co1
CHEMBL109173,CHEMBL217,Dopamine D2 receptor,Ki,=,1400.0,nM,CHEMBL673074,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1131871,KI,O=Cc1cccn1C1CCN(Cc2ccccc2)CC1
CHEMBL109173,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL672580,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1131871,KI,O=Cc1cccn1C1CCN(Cc2ccccc2)CC1
CHEMBL108160,CHEMBL217,Dopamine D2 receptor,Ki,=,6200.0,nM,CHEMBL673074,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1131871,KI,C[Si](C)(C)C#Cc1cccn1C1CCN(Cc2ccccc2)CC1
CHEMBL108160,CHEMBL217,Dopamine D2 receptor,Ki,=,4900.0,nM,CHEMBL672580,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1131871,KI,C[Si](C)(C)C#Cc1cccn1C1CCN(Cc2ccccc2)CC1
CHEMBL345087,CHEMBL217,Dopamine D2 receptor,Ki,=,1530.0,nM,CHEMBL672183,B,Displacement of [3H]quinpirole from Dopamine receptor D2,CHEMBL1129381,KI,CCCN(C(C)C)[C@@H]1CCc2c(F)cccc2C1
CHEMBL345087,CHEMBL217,Dopamine D2 receptor,Ki,=,4720.0,nM,CHEMBL672184,B,Inhibition of [3H]raclopride binding to Dopamine receptor D2,CHEMBL1129381,KI,CCCN(C(C)C)[C@@H]1CCc2c(F)cccc2C1
CHEMBL62624,CHEMBL217,Dopamine D2 receptor,Ki,=,195.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNC2CCN(Cc3ccccc3)CC2)cs1
CHEMBL62624,CHEMBL217,Dopamine D2 receptor,Ki,=,105.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNC2CCN(Cc3ccccc3)CC2)cs1
CHEMBL138792,CHEMBL217,Dopamine D2 receptor,Ki,=,585.0,nM,CHEMBL672183,B,Displacement of [3H]quinpirole from Dopamine receptor D2,CHEMBL1129381,KI,N[C@@H]1CCc2c(F)cccc2C1
CHEMBL138792,CHEMBL217,Dopamine D2 receptor,Ki,=,864.0,nM,CHEMBL672184,B,Inhibition of [3H]raclopride binding to Dopamine receptor D2,CHEMBL1129381,KI,N[C@@H]1CCc2c(F)cccc2C1
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,41.9,nM,CHEMBL670676,B,Ability to displace [3H]raclopride binding to cloned human Dopamine receptor D2A,CHEMBL1128704,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL11,CHEMBL217,Dopamine D2 receptor,Ki,=,726.0,nM,CHEMBL672315,B,Binding affinity towards dopamine receptor D2 using [3H]spiperone as radioligand,CHEMBL1148436,KI,CN(C)CCCN1c2ccccc2CCc2ccccc21
CHEMBL326864,CHEMBL217,Dopamine D2 receptor,Ki,=,11000.0,nM,CHEMBL673074,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1131871,KI,N#CC(C#N)=Cc1cccn1C1CCN(Cc2ccccc2)CC1
CHEMBL326864,CHEMBL217,Dopamine D2 receptor,Ki,=,7800.0,nM,CHEMBL672580,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1131871,KI,N#CC(C#N)=Cc1cccn1C1CCN(Cc2ccccc2)CC1
CHEMBL65847,CHEMBL217,Dopamine D2 receptor,Ki,=,179.0,nM,CHEMBL672183,B,Displacement of [3H]quinpirole from Dopamine receptor D2,CHEMBL1129381,KI,CCCN(Cc1ccccc1)[C@@H]1CCc2c(F)cccc2C1
CHEMBL65847,CHEMBL217,Dopamine D2 receptor,Ki,=,415.0,nM,CHEMBL672184,B,Inhibition of [3H]raclopride binding to Dopamine receptor D2,CHEMBL1129381,KI,CCCN(Cc1ccccc1)[C@@H]1CCc2c(F)cccc2C1
CHEMBL342630,CHEMBL217,Dopamine D2 receptor,Ki,=,2450.0,nM,CHEMBL672183,B,Displacement of [3H]quinpirole from Dopamine receptor D2,CHEMBL1129381,KI,CC(C)N[C@@H]1CCc2c(F)cccc2C1
CHEMBL342630,CHEMBL217,Dopamine D2 receptor,Ki,=,5940.0,nM,CHEMBL672184,B,Inhibition of [3H]raclopride binding to Dopamine receptor D2,CHEMBL1129381,KI,CC(C)N[C@@H]1CCc2c(F)cccc2C1
CHEMBL2112936,CHEMBL217,Dopamine D2 receptor,Ki,=,3200.0,nM,CHEMBL671655,B,Binding affinity against dopamine D2 receptor,CHEMBL1132065,KI,N[C@H]1CCCC[C@@H]1NC(=O)c1c2c(c3c4c(ncnc14)-c1ccccc1C3=O)N[C@@H]1CCCC[C@H]1N2
CHEMBL62601,CHEMBL217,Dopamine D2 receptor,Ki,=,45500.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,COc1c(-c2nc(CNC[C@@H]3CCN(Cc4ccccc4)C3)co2)cc(Br)c2ccccc12
CHEMBL62601,CHEMBL217,Dopamine D2 receptor,Ki,=,17500.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,COc1c(-c2nc(CNC[C@@H]3CCN(Cc4ccccc4)C3)co2)cc(Br)c2ccccc12
CHEMBL307956,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL672315,B,Binding affinity towards dopamine receptor D2 using [3H]spiperone as radioligand,CHEMBL1148436,KI,c1ccc2c(c1)Cc1ccccc1C21CCNC1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,1.89,nM,CHEMBL672183,B,Displacement of [3H]quinpirole from Dopamine receptor D2,CHEMBL1129381,KI,NCCc1ccc(O)c(O)c1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,572.0,nM,CHEMBL672184,B,Inhibition of [3H]raclopride binding to Dopamine receptor D2,CHEMBL1129381,KI,NCCc1ccc(O)c(O)c1
CHEMBL106635,CHEMBL217,Dopamine D2 receptor,Ki,=,8500.0,nM,CHEMBL673074,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1131871,KI,Ic1cccn1C1CCN(Cc2ccccc2)CC1
CHEMBL106635,CHEMBL217,Dopamine D2 receptor,Ki,=,5300.0,nM,CHEMBL672580,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1131871,KI,Ic1cccn1C1CCN(Cc2ccccc2)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.16,nM,CHEMBL672183,B,Displacement of [3H]quinpirole from Dopamine receptor D2,CHEMBL1129381,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.66,nM,CHEMBL672184,B,Inhibition of [3H]raclopride binding to Dopamine receptor D2,CHEMBL1129381,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL64325,CHEMBL217,Dopamine D2 receptor,Ki,=,610.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CN2CCN(c3ccccc3)CC2)cs1
CHEMBL64325,CHEMBL217,Dopamine D2 receptor,Ki,=,440.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CN2CCN(c3ccccc3)CC2)cs1
CHEMBL141510,CHEMBL217,Dopamine D2 receptor,Ki,=,45.6,nM,CHEMBL672183,B,Displacement of [3H]quinpirole from Dopamine receptor D2,CHEMBL1129381,KI,CCCCN(CCC)[C@@H]1CCc2c(F)cccc2C1
CHEMBL141510,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL672184,B,Inhibition of [3H]raclopride binding to Dopamine receptor D2,CHEMBL1129381,KI,CCCCN(CCC)[C@@H]1CCc2c(F)cccc2C1
CHEMBL59702,CHEMBL217,Dopamine D2 receptor,Ki,=,14000.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,c1ccc(CN2CCC(NCc3coc(-c4ccccc4)n3)CC2)cc1
CHEMBL59702,CHEMBL217,Dopamine D2 receptor,Ki,=,8650.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,c1ccc(CN2CCC(NCc3coc(-c4ccccc4)n3)CC2)cc1
CHEMBL2111527,CHEMBL217,Dopamine D2 receptor,Ki,=,510.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNCCC2CCN(Cc3ccccc3)C2)co1
CHEMBL2111527,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNCCC2CCN(Cc3ccccc3)C2)co1
CHEMBL141511,CHEMBL217,Dopamine D2 receptor,Ki,=,254.0,nM,CHEMBL672183,B,Displacement of [3H]quinpirole from Dopamine receptor D2,CHEMBL1129381,KI,CCCCN[C@@H]1CCc2c(F)cccc2C1
CHEMBL141511,CHEMBL217,Dopamine D2 receptor,Ki,=,790.0,nM,CHEMBL672184,B,Inhibition of [3H]raclopride binding to Dopamine receptor D2,CHEMBL1129381,KI,CCCCN[C@@H]1CCc2c(F)cccc2C1
CHEMBL314983,CHEMBL217,Dopamine D2 receptor,Ki,=,70.0,nM,CHEMBL670391,B,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,CHEMBL1149936,KI,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)nc1
CHEMBL64139,CHEMBL217,Dopamine D2 receptor,Ki,=,420.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNC[C@@H]2CCN(Cc3ccccc3)C2)cs1
CHEMBL64139,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNC[C@@H]2CCN(Cc3ccccc3)C2)cs1
CHEMBL104201,CHEMBL217,Dopamine D2 receptor,Ki,=,13000.0,nM,CHEMBL673074,B,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,CHEMBL1131871,KI,N#CC(C#N)=Cc1ccn(C2CCN(Cc3ccccc3)CC2)c1
CHEMBL104201,CHEMBL217,Dopamine D2 receptor,Ki,=,18000.0,nM,CHEMBL672580,B,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,CHEMBL1131871,KI,N#CC(C#N)=Cc1ccn(C2CCN(Cc3ccccc3)CC2)c1
CHEMBL88058,CHEMBL217,Dopamine D2 receptor,Ki,=,126.0,nM,CHEMBL670391,B,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,CHEMBL1149936,KI,Clc1ccccc1N1CCN(CCCOc2ccc(-c3nc4ccccc4[nH]3)cc2)CC1
CHEMBL62703,CHEMBL217,Dopamine D2 receptor,Ki,=,27500.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,c1ccc(CN2CCN(Cc3coc(-c4ccccc4)n3)CC2)cc1
CHEMBL62703,CHEMBL217,Dopamine D2 receptor,Ki,=,21500.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,c1ccc(CN2CCN(Cc3coc(-c4ccccc4)n3)CC2)cc1
CHEMBL293645,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CN2CCN(Cc3ccccc3)CC2)cs1
CHEMBL293645,CHEMBL217,Dopamine D2 receptor,Ki,=,85.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CN2CCN(Cc3ccccc3)CC2)cs1
CHEMBL59749,CHEMBL217,Dopamine D2 receptor,Ki,=,7900.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,c1ccc(CN2CC[C@@H](CNCc3csc(-c4ccccc4)n3)C2)cc1
CHEMBL59749,CHEMBL217,Dopamine D2 receptor,Ki,=,5050.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,c1ccc(CN2CC[C@@H](CNCc3csc(-c4ccccc4)n3)C2)cc1
CHEMBL2111526,CHEMBL217,Dopamine D2 receptor,Ki,=,8250.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNC2CCN(Cc3ccccc3)C2)co1
CHEMBL2111526,CHEMBL217,Dopamine D2 receptor,Ki,=,6600.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,COc1ccc(Br)cc1-c1nc(CNC2CCN(Cc3ccccc3)C2)co1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL59749,CHEMBL217,Dopamine D2 receptor,Ki,=,7950.0,nM,CHEMBL673073,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,CHEMBL1133305,KI,c1ccc(CN2CC[C@@H](CNCc3csc(-c4ccccc4)n3)C2)cc1
CHEMBL59749,CHEMBL217,Dopamine D2 receptor,Ki,=,6400.0,nM,CHEMBL672579,B,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL1133305,KI,c1ccc(CN2CC[C@@H](CNCc3csc(-c4ccccc4)n3)C2)cc1
CHEMBL98946,CHEMBL217,Dopamine D2 receptor,Ki,=,416.0,nM,CHEMBL672165,B,Binding affinity towards cloned human Dopamine receptor D2 was determined,CHEMBL1136188,KI,Cn1ncc2c1-c1c(Cl)sc(Cl)c1CCC2
CHEMBL74355,CHEMBL217,Dopamine D2 receptor,Ki,=,1300.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC
CHEMBL150210,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,Fc1ccc(CCN2CCC3(CCc4ccccc4C3)CC2)c(F)c1
CHEMBL149423,CHEMBL217,Dopamine D2 receptor,Ki,=,840.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,Fc1ccc(CCN2CCC3(CCc4cccc(F)c4O3)CC2)c(F)c1
CHEMBL423206,CHEMBL217,Dopamine D2 receptor,Ki,=,1800.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,Fc1ccc2c(c1)CCC1(CCN(C3CCc4ccccc4C3)CC1)O2
CHEMBL98945,CHEMBL217,Dopamine D2 receptor,Ki,=,489.0,nM,CHEMBL672165,B,Binding affinity towards cloned human Dopamine receptor D2 was determined,CHEMBL1136188,KI,CCn1ncc2c1-c1c(Cl)sc(Cl)c1CCC2
CHEMBL708,CHEMBL217,Dopamine D2 receptor,Ki,=,9.7,nM,CHEMBL672169,B,Binding affinity towards human Dopamine receptor D2,CHEMBL1149193,KI,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL611801,CHEMBL217,Dopamine D2 receptor,Ki,=,340.0,nM,CHEMBL672210,B,Affinity towards Dopamine receptor D2,CHEMBL1131163,KI,CN(C)C1CCc2cc(O)c(O)cc2C1
CHEMBL34095,CHEMBL217,Dopamine D2 receptor,Ki,=,350.0,nM,CHEMBL672210,B,Affinity towards Dopamine receptor D2,CHEMBL1131163,KI,C=CCN1CCc2c(cc(O)c(O)c2Br)[C@@H](c2ccccc2)C1
CHEMBL98830,CHEMBL217,Dopamine D2 receptor,Ki,=,462.0,nM,CHEMBL672165,B,Binding affinity towards cloned human Dopamine receptor D2 was determined,CHEMBL1136188,KI,Cc1sc(C)c2c1CCc1cnn(C)c1-2
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL672169,B,Binding affinity towards human Dopamine receptor D2,CHEMBL1149193,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL612083,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL672210,B,Affinity towards Dopamine receptor D2,CHEMBL1131163,KI,CCCN(CCc1ccccc1)[C@H]1CCc2c(O)cccc2C1
CHEMBL316727,CHEMBL217,Dopamine D2 receptor,Ki,=,176.0,nM,CHEMBL672165,B,Binding affinity towards cloned human Dopamine receptor D2 was determined,CHEMBL1136188,KI,Cc1sc(C)c2c1CCCc1cnn(C)c1-2
CHEMBL145939,CHEMBL217,Dopamine D2 receptor,Ki,=,1400.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,O=S(=O)(c1ccccc1)C1CCN(CCc2ccc(F)cc2F)CC1
CHEMBL716,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL672169,B,Binding affinity towards human Dopamine receptor D2,CHEMBL1149193,KI,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL416732,CHEMBL217,Dopamine D2 receptor,Ki,=,5400.0,nM,CHEMBL670395,B,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,CHEMBL1129926,KI,CC1NCCc2cc(O)c(O)cc21
CHEMBL19844,CHEMBL217,Dopamine D2 receptor,Ki,=,1900.0,nM,CHEMBL670395,B,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,CHEMBL1129926,KI,CN1CCc2cc(O)c(O)cc2C1Cc1ccc(O)c(O)c1
CHEMBL148058,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,NC(=O)c1ccc(S(=O)(=O)C2CCN(CCc3ccc(F)cc3F)CC2)cc1
CHEMBL432579,CHEMBL217,Dopamine D2 receptor,Ki,=,2066.0,nM,CHEMBL672165,B,Binding affinity towards cloned human Dopamine receptor D2 was determined,CHEMBL1136188,KI,Cc1sc(C)c2c1CCCc1c[nH]nc1-2
CHEMBL25856,CHEMBL217,Dopamine D2 receptor,Ki,=,1700.0,nM,CHEMBL672210,B,Affinity towards Dopamine receptor D2,CHEMBL1131163,KI,Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2
CHEMBL531,CHEMBL217,Dopamine D2 receptor,Ki,=,50.0,nM,CHEMBL672210,B,Affinity towards Dopamine receptor D2,CHEMBL1131163,KI,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL100203,CHEMBL217,Dopamine D2 receptor,Ki,=,111.0,nM,CHEMBL672165,B,Binding affinity towards cloned human Dopamine receptor D2 was determined,CHEMBL1136188,KI,Cc1sc(C)c2c1SCc1cnn(C)c1-2
CHEMBL343411,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,O=C(CCCN1CCC(S(=O)(=O)c2ccccc2)CC1)c1ccc(F)cc1
CHEMBL433376,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL672165,B,Binding affinity towards cloned human Dopamine receptor D2 was determined,CHEMBL1136188,KI,Cc1oc(C)c2c1CCCc1cnn(C)c1-2
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,7940.0,nM,CHEMBL672210,B,Affinity towards Dopamine receptor D2,CHEMBL1131163,KI,NCCc1ccc(O)c(O)c1
CHEMBL225230,CHEMBL217,Dopamine D2 receptor,Ki,=,50.0,nM,CHEMBL672210,B,Affinity towards Dopamine receptor D2,CHEMBL1131163,KI,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL146144,CHEMBL217,Dopamine D2 receptor,Ki,=,1700.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,OC1c2ccccc2CCC12CCN(CCc1ccccc1)CC2
CHEMBL609151,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL672210,B,Affinity towards Dopamine receptor D2,CHEMBL1131163,KI,CN1C[C@H](C(N)=O)C=C2c3cccc4[nH]c(Br)c(c34)C[C@H]21
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL672169,B,Binding affinity towards human Dopamine receptor D2,CHEMBL1149193,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL99649,CHEMBL217,Dopamine D2 receptor,Ki,=,555.0,nM,CHEMBL672165,B,Binding affinity towards cloned human Dopamine receptor D2 was determined,CHEMBL1136188,KI,Cc1sc(C)c2c1CCCc1cnn(C(C)C)c1-2
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,3.3,nM,CHEMBL672169,B,Binding affinity towards human Dopamine receptor D2,CHEMBL1149193,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL24077,CHEMBL217,Dopamine D2 receptor,Ki,=,9550.0,nM,CHEMBL672210,B,Affinity towards Dopamine receptor D2,CHEMBL1131163,KI,Oc1cc2c(cc1O)[C@@H](c1ccccc1)CNCC2
CHEMBL83894,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccc(F)cc2)CC1
CHEMBL122761,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,O=C1c2ccc(Cl)cc2CCC12CCN(CCc1ccccc1)CC2
CHEMBL145584,CHEMBL217,Dopamine D2 receptor,Ki,=,20000.0,nM,CHEMBL672210,B,Affinity towards Dopamine receptor D2,CHEMBL1131163,KI,NCCc1cccc(O)c1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.4,nM,CHEMBL672169,B,Binding affinity towards human Dopamine receptor D2,CHEMBL1149193,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL285802,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL672169,B,Binding affinity towards human Dopamine receptor D2,CHEMBL1149193,KI,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21
CHEMBL317741,CHEMBL217,Dopamine D2 receptor,Ki,=,510.0,nM,CHEMBL672210,B,Affinity towards Dopamine receptor D2,CHEMBL1131163,KI,C=CCN1CCc2c(cc(O)c(O)c2Cl)[C@@H](c2ccccc2)C1
CHEMBL11608,CHEMBL217,Dopamine D2 receptor,Ki,=,160000.0,nM,CHEMBL672210,B,Affinity towards Dopamine receptor D2,CHEMBL1131163,KI,NCCc1ccc(O)cc1
CHEMBL329276,CHEMBL217,Dopamine D2 receptor,Ki,=,4166.0,nM,CHEMBL672165,B,Binding affinity towards cloned human Dopamine receptor D2 was determined,CHEMBL1136188,KI,Cc1sc(C)c2c1CCc1c[nH]nc1-2
CHEMBL146595,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,O=S1(=O)c2ccccc2CCC12CCN(CCc1ccc(F)cc1F)CC2
CHEMBL1160787,CHEMBL217,Dopamine D2 receptor,Ki,=,8000.0,nM,CHEMBL672210,B,Affinity towards Dopamine receptor D2,CHEMBL1131163,KI,Oc1cc2c(c(Cl)c1O)CCNC[C@@H]2c1ccccc1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,250.0,nM,CHEMBL670395,B,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,CHEMBL1129926,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL148348,CHEMBL217,Dopamine D2 receptor,Ki,=,490.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,Fc1ccc(CCN2CCC3(CCc4ccc(F)cc4O3)CC2)c(F)c1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,2570.0,nM,CHEMBL672210,B,Affinity towards Dopamine receptor D2,CHEMBL1131163,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL1255588,CHEMBL217,Dopamine D2 receptor,Ki,=,0.6,nM,CHEMBL670395,B,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,CHEMBL1129926,KI,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1
CHEMBL149510,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,OC(CCc1ccccc1)CN1CCC2(CCc3cc(F)ccc3O2)CC1
CHEMBL19344,CHEMBL217,Dopamine D2 receptor,Ki,=,3900.0,nM,CHEMBL670395,B,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,CHEMBL1129926,KI,Oc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1
CHEMBL19068,CHEMBL217,Dopamine D2 receptor,Ki,=,3400.0,nM,CHEMBL670395,B,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,CHEMBL1129926,KI,Oc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1O
CHEMBL19331,CHEMBL217,Dopamine D2 receptor,Ki,=,9400.0,nM,CHEMBL670395,B,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,CHEMBL1129926,KI,Oc1ccc2c(c1)CCN2
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,3.6,nM,CHEMBL670395,B,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,CHEMBL1129926,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL147431,CHEMBL217,Dopamine D2 receptor,Ki,=,750.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,Fc1ccc(CCN2CCC3(CCc4ccccc4O3)CC2)c(F)c1
CHEMBL357807,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,COc1ccc2c(c1)CCC1(CCN(CCCC(=O)c3ccc(F)cc3)CC1)O2
CHEMBL12713,CHEMBL217,Dopamine D2 receptor,Ki,=,7.4,nM,CHEMBL672169,B,Binding affinity towards human Dopamine receptor D2,CHEMBL1149193,KI,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1
CHEMBL99208,CHEMBL217,Dopamine D2 receptor,Ki,=,402.0,nM,CHEMBL672165,B,Binding affinity towards cloned human Dopamine receptor D2 was determined,CHEMBL1136188,KI,CCn1ncc2c1-c1c(C)sc(C)c1CCC2
CHEMBL317770,CHEMBL217,Dopamine D2 receptor,Ki,=,534.0,nM,CHEMBL672165,B,Binding affinity towards cloned human Dopamine receptor D2 was determined,CHEMBL1136188,KI,Clc1sc(Cl)c2c1CCCc1c[nH]nc1-2
CHEMBL148418,CHEMBL217,Dopamine D2 receptor,Ki,=,530.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,c1ccc(CCN2CCC3(CCc4ccccc4O3)CC2)cc1
CHEMBL146485,CHEMBL217,Dopamine D2 receptor,Ki,=,650.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,NC(=O)c1cccc(S(=O)(=O)C2CCN(CCc3ccc(F)cc3F)CC2)c1
CHEMBL318949,CHEMBL217,Dopamine D2 receptor,Ki,=,885.0,nM,CHEMBL672165,B,Binding affinity towards cloned human Dopamine receptor D2 was determined,CHEMBL1136188,KI,CCCn1ncc2c1-c1c(C)sc(C)c1CCC2
CHEMBL149429,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,O=S(=O)(c1ccc(Cl)cc1)C1CCN(CCc2ccc(F)cc2F)CC1
CHEMBL147164,CHEMBL217,Dopamine D2 receptor,Ki,=,710.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,Fc1ccc(CCN2CCC3(CCc4c(F)cccc4O3)CC2)c(F)c1
CHEMBL157138,CHEMBL217,Dopamine D2 receptor,Ki,=,0.8,nM,CHEMBL672210,B,Affinity towards Dopamine receptor D2,CHEMBL1131163,KI,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL317078,CHEMBL217,Dopamine D2 receptor,Ki,=,641.0,nM,CHEMBL672165,B,Binding affinity towards cloned human Dopamine receptor D2 was determined,CHEMBL1136188,KI,Cc1sc(C)c2c1CCCc1cn(C)nc1-2
CHEMBL2303762,CHEMBL217,Dopamine D2 receptor,Ki,=,11400.0,nM,CHEMBL670395,B,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,CHEMBL1129926,KI,OC[C@H]1O[C@H](Oc2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)[C@H](O)[C@H](O)[C@H]1O
CHEMBL146233,CHEMBL217,Dopamine D2 receptor,Ki,=,570.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,COc1ccc2c(c1)CCC1(CCN(CCc3ccc(F)cc3F)CC1)O2
CHEMBL146998,CHEMBL217,Dopamine D2 receptor,Ki,=,680.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,N#Cc1ccccc1S(=O)(=O)C1CCN(CCc2ccc(F)cc2F)CC1
CHEMBL359270,CHEMBL217,Dopamine D2 receptor,Ki,=,650.0,nM,CHEMBL697295,B,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,CHEMBL1135811,KI,Fc1ccc(CCN2CCC3(C=Cc4cc(F)ccc4O3)CC2)c(F)c1
CHEMBL588,CHEMBL217,Dopamine D2 receptor,Ki,=,810.0,nM,CHEMBL672210,B,Affinity towards Dopamine receptor D2,CHEMBL1131163,KI,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1
CHEMBL70267,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL670393,B,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,CHEMBL1130515,KI,C1=C(c2nc3ccccc3o2)CCN(Cc2ccccc2)C1
CHEMBL80919,CHEMBL217,Dopamine D2 receptor,Ki,=,0.6,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)c1cccs1
CHEMBL78791,CHEMBL217,Dopamine D2 receptor,Ki,=,3.4,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1
CHEMBL309979,CHEMBL217,Dopamine D2 receptor,Ki,=,7.4,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)C1CCCCC1
CHEMBL311575,CHEMBL217,Dopamine D2 receptor,Ki,=,16.5,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,Cc1ccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)c4cccs4)CC3)CC2)cc1
CHEMBL349034,CHEMBL217,Dopamine D2 receptor,Ki,=,8.5,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,Fc1ccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)cc1
CHEMBL309459,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccc(Cl)cc3)CC2)CC1)c1cccs1
CHEMBL321042,CHEMBL217,Dopamine D2 receptor,Ki,=,1600.0,nM,CHEMBL671034,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CN1CCc2cc(Br)c(O)cc2C(c2ccc(N)cc2)C1
CHEMBL430439,CHEMBL217,Dopamine D2 receptor,Ki,=,4.5,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)c1ccccc1
CHEMBL322760,CHEMBL217,Dopamine D2 receptor,Ki,=,710.0,nM,CHEMBL671034,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CN1CCc2cc(Br)c(O)cc2C(c2ccc(Nc3ccc([N+](=O)[O-])c4nonc34)cc2)C1
CHEMBL113196,CHEMBL217,Dopamine D2 receptor,Ki,=,0.3,nM,CHEMBL671034,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(Nc2ccc([N+](=O)[O-])c3nonc23)cc1)[C@H]1CCc2c(O)cccc2C1
CHEMBL309336,CHEMBL217,Dopamine D2 receptor,Ki,=,11.4,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,Cc1ccsc1C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL310401,CHEMBL217,Dopamine D2 receptor,Ki,=,37.5,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3)CC2)CC1)C1CCCCC1
CHEMBL78860,CHEMBL217,Dopamine D2 receptor,Ki,=,182.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,CCCN(C(=O)C1CCCCC1)[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL113527,CHEMBL217,Dopamine D2 receptor,Ki,=,3.2,nM,CHEMBL671034,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(Nc2ccc([N+](=O)[O-])c3nonc23)cc1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL164723,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,c1cnc(N[C@H]2CC[C@H](CCN3CCN(c4cccnc4)CC3)CC2)nc1
CHEMBL71173,CHEMBL217,Dopamine D2 receptor,Ki,=,1400.0,nM,CHEMBL670393,B,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,CHEMBL1130515,KI,C1=C(c2nc3ccccc3[nH]2)CCN(Cc2ccccc2)C1
CHEMBL305481,CHEMBL217,Dopamine D2 receptor,Ki,=,670.0,nM,CHEMBL670393,B,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,CHEMBL1130515,KI,Clc1ccc(CN2CC=C(c3nc4ccccc4[nH]3)CC2)cc1
CHEMBL78655,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(NC1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)c1cccs1
CHEMBL309623,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccccc3)CC2)CC1)C1CCCCC1
CHEMBL311772,CHEMBL217,Dopamine D2 receptor,Ki,=,40.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1
CHEMBL2113347,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL673026,B,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132939,KI,Cl.N#Cc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)c3cc4ccccc4[nH]3)CC1)CC2
CHEMBL165664,CHEMBL217,Dopamine D2 receptor,Ki,=,5.7,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,c1ccc(N2CCN(C[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)cc1
CHEMBL76908,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc(Cl)c4Cl)CC3)CC2)s1
CHEMBL320779,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL670746,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(N/C(S)=N/c2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)cc1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL310680,CHEMBL217,Dopamine D2 receptor,Ki,=,81.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccc(Cl)cc3)CC2)CC1)C1CCCCC1
CHEMBL1159663,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL671033,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(C)cc1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL164979,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,CN(CCc1ccccc1)CC[C@H]1CC[C@H](Nc2ncccn2)CC1
CHEMBL355371,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,c1ccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)nc1
CHEMBL2113349,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL673026,B,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132939,KI,Cl.N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cc4ccccc4[nH]3)CC1)C2
CHEMBL2368612,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL673026,B,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132939,KI,Cl.N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccccc3)CC1)C2
CHEMBL2110308,CHEMBL217,Dopamine D2 receptor,Ki,=,320.0,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,c1ccc(N2CCN(C3CCC(Nc4ncccn4)CC3)CC2)cc1
CHEMBL24077,CHEMBL217,Dopamine D2 receptor,Ki,=,6500.0,nM,CHEMBL671033,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,Oc1cc2c(cc1O)[C@@H](c1ccccc1)CNCC2
CHEMBL2092940,CHEMBL217,Dopamine D2 receptor,Ki,=,6.7,nM,CHEMBL671033,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(C)cc1)[C@H]1CCc2c(O)cccc2C1
CHEMBL553591,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL673026,B,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132939,KI,Cl.N#Cc1ccc2c(c1)CN(CCCCNC(=O)/C=C/c1c[nH]c3ccccc13)CC2
CHEMBL2368611,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL673026,B,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132939,KI,Cl.N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccc(F)cc3)CC1)C2
CHEMBL165440,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,c1cnc(N[C@H]2CC[C@H](CCN3CCc4ccccc4C3)CC2)nc1
CHEMBL70215,CHEMBL217,Dopamine D2 receptor,Ki,=,2000.0,nM,CHEMBL670393,B,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,CHEMBL1130515,KI,Clc1ccc(CN2CC=C(c3nc4cc(Cl)ccc4s3)CC2)cc1
CHEMBL2113350,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL673026,B,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132939,KI,Cl.N#Cc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccccc3)CC1)CC2
CHEMBL2113352,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL673026,B,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132939,KI,CS(=O)(=O)c1cccc(/C=C/C(=O)N[C@H]2CC[C@H](CCN3CCc4cc(C#N)ccc4C3)CC2)c1.Cl
CHEMBL165679,CHEMBL217,Dopamine D2 receptor,Ki,=,5.2,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,c1ccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)cc1
CHEMBL164792,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,COc1ccccc1N1CCN(CC[C@H]2CC[C@H](Nc3ncccn3)CC2)CC1
CHEMBL351617,CHEMBL217,Dopamine D2 receptor,Ki,=,6.0,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,COc1ccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)cc1
CHEMBL349980,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,c1cnc(N[C@H]2CC[C@H](CCN3CCN(c4ncccn4)CC3)CC2)nc1
CHEMBL350352,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,Clc1cccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)c1Cl
CHEMBL309727,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)c1ccsc1
CHEMBL80875,CHEMBL217,Dopamine D2 receptor,Ki,=,6.3,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,Cc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)c4cccs4)CC3)CC2)c1
CHEMBL80615,CHEMBL217,Dopamine D2 receptor,Ki,=,5.6,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,Cc1ccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)C4CCCCC4)CC3)CC2)cc1C
CHEMBL80315,CHEMBL217,Dopamine D2 receptor,Ki,=,16.5,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,CN(C(=O)c1cccs1)[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL301559,CHEMBL217,Dopamine D2 receptor,Ki,=,0.5,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1
CHEMBL2113348,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL673026,B,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132939,KI,Cl.N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccc4ccccc4c3)CC1)C2
CHEMBL606939,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL671033,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccccc1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL612083,CHEMBL217,Dopamine D2 receptor,Ki,=,2.1,nM,CHEMBL671033,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccccc1)[C@H]1CCc2c(O)cccc2C1
CHEMBL71216,CHEMBL217,Dopamine D2 receptor,Ki,=,330.0,nM,CHEMBL670393,B,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,CHEMBL1130515,KI,Clc1ccc(CN2CC=C(c3nc4cc(Cl)ccc4[nH]3)CC2)cc1
CHEMBL312752,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,Cc1csc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc(Cl)c4Cl)CC3)CC2)c1
CHEMBL267930,CHEMBL217,Dopamine D2 receptor,Ki,=,0.06,nM,CHEMBL671033,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
CHEMBL307869,CHEMBL217,Dopamine D2 receptor,Ki,=,340.0,nM,CHEMBL670393,B,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,CHEMBL1130515,KI,Clc1cccc(CN2CC=C(c3nc4ccccc4s3)CC2)c1
CHEMBL309623,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccccc3)CC2)CC1)C1CCCCC1
CHEMBL2112078,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL673026,B,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132939,KI,Cl.N#Cc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3c[nH]c4ccccc34)CC1)CC2
CHEMBL166151,CHEMBL217,Dopamine D2 receptor,Ki,=,4800.0,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,c1cnc(N[C@H]2CC[C@H](CCN3CCN(c4ccncc4)CC3)CC2)nc1
CHEMBL310204,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccccc3Cl)CC2)CC1)C1CCCCC1
CHEMBL552599,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL673026,B,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132939,KI,Cl.O=C(/C=C/c1c[nH]c2ccccc12)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1
CHEMBL324017,CHEMBL217,Dopamine D2 receptor,Ki,=,1360.0,nM,CHEMBL671033,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CN1CCc2cc(Br)c(O)cc2C(c2ccccc2)C1
CHEMBL165056,CHEMBL217,Dopamine D2 receptor,Ki,=,6.0,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,FC(F)(F)c1cccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)c1
CHEMBL78916,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3ccccc3)CC2)CC1
CHEMBL2110366,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL673026,B,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132939,KI,Cl.N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2
CHEMBL111532,CHEMBL217,Dopamine D2 receptor,Ki,=,6.8,nM,CHEMBL671033,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(N)cc1)C1CCc2c(O)cccc2C1
CHEMBL164604,CHEMBL217,Dopamine D2 receptor,Ki,=,4.7,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,C1=C(c2ccccc2)CCN(CC[C@H]2CC[C@H](Nc3ncccn3)CC2)C1
CHEMBL166252,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,c1cnc(N[C@H]2CC[C@H](CCN3CCN(c4nccs4)CC3)CC2)nc1
CHEMBL80571,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)C1CCCCC1
CHEMBL78406,CHEMBL217,Dopamine D2 receptor,Ki,=,71.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccccn3)CC2)CC1)c1cccs1
CHEMBL312430,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)c1ccco1
CHEMBL109897,CHEMBL217,Dopamine D2 receptor,Ki,=,4.8,nM,CHEMBL671034,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(N/C(S)=N/c2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)cc1)[C@H]1CCc2c(O)cccc2C1
CHEMBL78791,CHEMBL217,Dopamine D2 receptor,Ki,=,3.4,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1
CHEMBL349426,CHEMBL217,Dopamine D2 receptor,Ki,=,3.2,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,c1ccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncnc5ccccc45)CC3)CC2)cc1
CHEMBL3084971,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,c1ccc(N2CCN(CC[C@H]3CC[C@@H](Nc4ncccn4)CC3)CC2)cc1
CHEMBL71324,CHEMBL217,Dopamine D2 receptor,Ki,=,590.0,nM,CHEMBL670393,B,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,CHEMBL1130515,KI,Clc1ccc2[nH]c(C3=CCN(Cc4ccccc4)CC3)nc2c1
CHEMBL310158,CHEMBL217,Dopamine D2 receptor,Ki,=,41.5,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(NC1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)c1ccccc1
CHEMBL310577,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,COc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)c4cccs4)CC3)CC2)c1
CHEMBL78800,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccccc3Cl)CC2)CC1)c1cccs1
CHEMBL78617,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)C1CCCC1
CHEMBL78195,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)C1CCCCCC1
CHEMBL165689,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,c1cnc(N[C@H]2CC[C@H](CCN3CCN(c4cnccn4)CC3)CC2)nc1
CHEMBL69355,CHEMBL217,Dopamine D2 receptor,Ki,=,600.0,nM,CHEMBL670393,B,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,CHEMBL1130515,KI,C1=C(c2nc3ccccc3s2)CCN(Cc2ccccc2)C1
CHEMBL312803,CHEMBL217,Dopamine D2 receptor,Ki,=,177.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,COc1ccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)c4cccs4)CC3)CC2)cc1
CHEMBL2113351,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL673026,B,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132939,KI,Cl.N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cccc4ccccc34)CC1)C2
CHEMBL109684,CHEMBL217,Dopamine D2 receptor,Ki,=,13.3,nM,CHEMBL671033,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccccc1)C1CCc2c(O)cccc2C1
CHEMBL165140,CHEMBL217,Dopamine D2 receptor,Ki,=,7.4,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,c1ccc(N2CCN(CCC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)cc1
CHEMBL309501,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,Cc1ccccc1N1CCN(CC[C@H]2CC[C@H](NC(=O)c3cccs3)CC2)CC1
CHEMBL165047,CHEMBL217,Dopamine D2 receptor,Ki,=,4.8,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,CN(c1ncccn1)[C@H]1CC[C@H](CCN2CCN(c3ccccc3)CC2)CC1
CHEMBL77411,CHEMBL217,Dopamine D2 receptor,Ki,=,339.0,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)C12CC3CC(CC(C3)C1)C2
CHEMBL78950,CHEMBL217,Dopamine D2 receptor,Ki,=,1.4,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,COc1ccccc1N1CCN(CC[C@H]2CC[C@H](NC(=O)c3cccs3)CC2)CC1
CHEMBL78368,CHEMBL217,Dopamine D2 receptor,Ki,=,6.5,nM,CHEMBL671651,B,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,CHEMBL1151542,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3)CC2)CC1)c1cccs1
CHEMBL109787,CHEMBL217,Dopamine D2 receptor,Ki,=,0.45,nM,CHEMBL671034,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(Nc2ccc([N+](=O)[O-])c3nonc23)cc1)C1CCc2c(O)cccc2C1
CHEMBL92649,CHEMBL217,Dopamine D2 receptor,Ki,=,0.66,nM,CHEMBL671034,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,O=C(CCCN1CCC2(CC1)C(=O)N(CCc1ccc(Nc3ccc([N+](=O)[O-])c4nonc34)cc1)CN2c1ccccc1)c1ccc(F)cc1
CHEMBL165381,CHEMBL217,Dopamine D2 receptor,Ki,=,2400.0,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,CCCN(CCC)CC[C@H]1CC[C@H](Nc2ncccn2)CC1
CHEMBL320526,CHEMBL217,Dopamine D2 receptor,Ki,=,7.0,nM,CHEMBL671034,B,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(N/C(S)=N/c2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)cc1)C1CCc2c(O)cccc2C1
CHEMBL2110308,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL672206,B,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,CHEMBL1131565,KI,c1ccc(N2CCN(C3CCC(Nc4ncccn4)CC3)CC2)cc1
CHEMBL284346,CHEMBL217,Dopamine D2 receptor,Ki,=,1600.0,nM,CHEMBL671371,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132043,KI,Cc1c(-c2ccccc2)nnn1C1CCN(Cc2ccccc2)CC1
CHEMBL139600,CHEMBL217,Dopamine D2 receptor,Ki,=,30.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL139600,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL496687,CHEMBL217,Dopamine D2 receptor,Ki,=,1400.0,nM,CHEMBL671367,B,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,CHEMBL1134475,KI,Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(-c3cccc4ccccc34)[nH]c2c1
CHEMBL279247,CHEMBL217,Dopamine D2 receptor,Ki,=,6.1,nM,CHEMBL671371,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132043,KI,Cc1nn(C2CCN(Cc3ccccc3)CC2)cc1-c1ccccc1
CHEMBL40284,CHEMBL217,Dopamine D2 receptor,Ki,=,1600.0,nM,CHEMBL671367,B,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,CHEMBL1134475,KI,c1ccc(-c2[nH]c3ccccc3c2C2CNCCO2)cc1
CHEMBL59725,CHEMBL217,Dopamine D2 receptor,Ki,=,3600.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL59725,CHEMBL217,Dopamine D2 receptor,Ki,=,2600.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,74.0,nM,CHEMBL671371,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132043,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL25236,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL25236,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL143352,CHEMBL217,Dopamine D2 receptor,Ki,=,270.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccn3nccc23)CC1
CHEMBL143352,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccn3nccc23)CC1
CHEMBL139926,CHEMBL217,Dopamine D2 receptor,Ki,=,320.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL139926,CHEMBL217,Dopamine D2 receptor,Ki,=,80.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL25938,CHEMBL217,Dopamine D2 receptor,Ki,=,66.0,nM,CHEMBL671371,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132043,KI,c1ccc(CN2CCC(c3cc(-c4ccccc4)[nH]n3)CC2)cc1
CHEMBL25772,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL671371,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132043,KI,Cc1c(-c2ccccc2)cnn1C1CCN(Cc2ccccc2)CC1
CHEMBL140968,CHEMBL217,Dopamine D2 receptor,Ki,=,71.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL140968,CHEMBL217,Dopamine D2 receptor,Ki,=,76.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL141419,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[te]2)CC1
CHEMBL141419,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[te]2)CC1
CHEMBL24809,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL671371,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132043,KI,Cc1cc(-c2ccccc2)n(C2CCN(Cc3ccccc3)CC2)n1
CHEMBL342060,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccn3nccc3c2)CC1
CHEMBL342060,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccn3nccc3c2)CC1
CHEMBL337531,CHEMBL217,Dopamine D2 receptor,Ki,=,91.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[te]1
CHEMBL337531,CHEMBL217,Dopamine D2 receptor,Ki,=,48.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[te]1
CHEMBL25887,CHEMBL217,Dopamine D2 receptor,Ki,=,1200.0,nM,CHEMBL671371,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132043,KI,Cc1nnn(C2CCN(Cc3ccccc3)CC2)c1-c1ccccc1
CHEMBL281195,CHEMBL217,Dopamine D2 receptor,Ki,=,90.0,nM,CHEMBL671371,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132043,KI,Cc1c(C2CCN(Cc3ccccc3)CC2)n[nH]c1-c1ccccc1
CHEMBL357684,CHEMBL217,Dopamine D2 receptor,Ki,=,830.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL357684,CHEMBL217,Dopamine D2 receptor,Ki,=,970.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL336930,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccnn3c2)CC1
CHEMBL336930,CHEMBL217,Dopamine D2 receptor,Ki,=,84.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccnn3c2)CC1
CHEMBL23537,CHEMBL217,Dopamine D2 receptor,Ki,=,510.0,nM,CHEMBL671371,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132043,KI,c1ccc(CN2CCC(n3nccc3-c3ccccc3)CC2)cc1
CHEMBL24051,CHEMBL217,Dopamine D2 receptor,Ki,=,370.0,nM,CHEMBL671371,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132043,KI,Cc1c(-c2ccccc2)cnn1C1CCN(Cc2cccc(Cl)c2)CC1
CHEMBL497054,CHEMBL217,Dopamine D2 receptor,Ki,=,1600.0,nM,CHEMBL671367,B,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,CHEMBL1134475,KI,Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(-c3ccsc3)[nH]c2c1
CHEMBL296512,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL671367,B,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,CHEMBL1134475,KI,Fc1ccc(-c2[nH]c3cc(F)ccc3c2C2CCCNC2)cc1
CHEMBL24170,CHEMBL217,Dopamine D2 receptor,Ki,=,460.0,nM,CHEMBL671371,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132043,KI,c1ccc(CN2CCC(n3cc(-c4ccccc4)nn3)CC2)cc1
CHEMBL24539,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL671371,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132043,KI,c1ccc(CN2CCC(n3nnc(-c4ccccc4)n3)CC2)cc1
CHEMBL496860,CHEMBL217,Dopamine D2 receptor,Ki,=,500.0,nM,CHEMBL671367,B,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,CHEMBL1134475,KI,Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(-c3ccc4ccccc4c3)[nH]c2c1
CHEMBL140612,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL140612,CHEMBL217,Dopamine D2 receptor,Ki,=,3.9,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL44310,CHEMBL217,Dopamine D2 receptor,Ki,=,500.0,nM,CHEMBL671367,B,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,CHEMBL1134475,KI,c1ccc(CCN2CCCC(c3c(-c4ccccc4)[nH]c4ccccc34)C2)cc1
CHEMBL287412,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL671371,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132043,KI,Cc1nn(C2CCN(Cc3cccc(Cl)c3)CC2)cc1-c1ccccc1
CHEMBL523245,CHEMBL217,Dopamine D2 receptor,Ki,=,900.0,nM,CHEMBL671367,B,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,CHEMBL1134475,KI,Fc1ccc(-c2[nH]c3cc(F)ccc3c2[C@@H]2CNCC[C@H]2F)cc1
CHEMBL287217,CHEMBL217,Dopamine D2 receptor,Ki,=,450.0,nM,CHEMBL671371,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132043,KI,c1ccc(CN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1
CHEMBL423735,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL423735,CHEMBL217,Dopamine D2 receptor,Ki,=,65.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL424294,CHEMBL217,Dopamine D2 receptor,Ki,=,87.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL424294,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL2113667,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL671367,B,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,CHEMBL1134475,KI,c1ccc(CCN2[C@@H]3CC[C@H]2CC(c2c(-c4ccccc4)[nH]c4ccccc24)C3)cc1
CHEMBL344677,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccc3ccnn23)CC1
CHEMBL344677,CHEMBL217,Dopamine D2 receptor,Ki,=,98.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccc3ccnn23)CC1
CHEMBL26120,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL671371,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132043,KI,Cc1nn(C2CCN(Cc3cccc(C#N)c3)CC2)cc1-c1ccccc1
CHEMBL40584,CHEMBL217,Dopamine D2 receptor,Ki,=,350.0,nM,CHEMBL671367,B,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,CHEMBL1134475,KI,c1ccc(CCN2CCC(c3c(-c4ccccc4)[nH]c4ccccc34)CC2)cc1
CHEMBL43819,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL671367,B,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,CHEMBL1134475,KI,CN1CCCC(c2c(-c3ccccc3)[nH]c3ccccc23)C1
CHEMBL139722,CHEMBL217,Dopamine D2 receptor,Ki,=,520.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL139722,CHEMBL217,Dopamine D2 receptor,Ki,=,480.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL46523,CHEMBL217,Dopamine D2 receptor,Ki,=,1600.0,nM,CHEMBL671367,B,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,CHEMBL1134475,KI,c1ccc(CN2CCCC(c3c(-c4ccccc4)[nH]c4ccccc34)C2)cc1
CHEMBL141845,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCNC(=O)c2cnn3ccccc23)CC1
CHEMBL141845,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCNC(=O)c2cnn3ccccc23)CC1
CHEMBL142020,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL142020,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL124444,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL672384,B,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1
CHEMBL124444,CHEMBL217,Dopamine D2 receptor,Ki,=,84.0,nM,CHEMBL672573,B,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1
CHEMBL305392,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,N#Cc1ccc2c(c1)C1CN(Cc3ccccc3)CC1CC2
CHEMBL413275,CHEMBL217,Dopamine D2 receptor,Ki,=,31.62,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,CC(=O)Nc1ccc(CN2C[C@H]3COc4ccc(C#N)cc4[C@@H]3C2)cc1
CHEMBL27247,CHEMBL217,Dopamine D2 receptor,Ki,=,7980.0,nM,CHEMBL670677,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1132996,KI,CC(=O)N[C@H]1c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1
CHEMBL126474,CHEMBL217,Dopamine D2 receptor,Ki,=,17.5,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(C(C)=O)cc2)CC1
CHEMBL126948,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(C(=O)c3ccccc3)cc2)CC1.O=C(O)C(=O)O
CHEMBL127114,CHEMBL217,Dopamine D2 receptor,Ki,=,81.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)C2CC2c2ccccc2)CC1.O=C(O)C(=O)O
CHEMBL127311,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccc(/C=C/C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL292485,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,N#Cc1ccc2c(c1)OCC1CN(Cc3ccccc3)CC21
CHEMBL417473,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL670677,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1132996,KI,CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@]3(C)O
CHEMBL263058,CHEMBL217,Dopamine D2 receptor,Ki,=,126.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCNC(=O)c2ccccc2I)CC1.O=C(O)C(=O)O
CHEMBL125525,CHEMBL217,Dopamine D2 receptor,Ki,=,47.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2coc3ccccc3c2=O)CC1.O=C(O)C(=O)O
CHEMBL127020,CHEMBL217,Dopamine D2 receptor,Ki,=,729.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,41.6,nM,CHEMBL664743,B,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,CHEMBL1132996,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL22778,CHEMBL217,Dopamine D2 receptor,Ki,=,3760.0,nM,CHEMBL664743,B,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,CHEMBL1132996,KI,CCCN(CCC)[C@H]1CCc2c(F)ccc(O)c2C1
CHEMBL340173,CHEMBL217,Dopamine D2 receptor,Ki,=,48.7,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)CCc2ccccc2)CC1.O=C(O)C(=O)O
CHEMBL126128,CHEMBL217,Dopamine D2 receptor,Ki,=,13.54,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccccc2)CC1.O=C(O)C(=O)O
CHEMBL304856,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,c1ccc(CN2CC3COc4ccccc4C3C2)cc1
CHEMBL64721,CHEMBL217,Dopamine D2 receptor,Ki,=,79.43,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,N#Cc1ccc2c(c1)C1CN(Cc3ccc(F)cc3)CC1CO2
CHEMBL66080,CHEMBL217,Dopamine D2 receptor,Ki,=,50.12,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,N#Cc1ccc2c(c1)[C@@H]1CN(CCCCNC(=O)c3ccc(-c4ccccc4)cc3)C[C@H]1CO2
CHEMBL127807,CHEMBL217,Dopamine D2 receptor,Ki,=,45.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(Cc2cccc(CNC(=O)c3ccc4ccccc4c3)c2)CC1.O=C(O)C(=O)O
CHEMBL285352,CHEMBL217,Dopamine D2 receptor,Ki,=,215.0,nM,CHEMBL670677,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1132996,KI,CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3O
CHEMBL126277,CHEMBL217,Dopamine D2 receptor,Ki,=,630.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(C2CC3CC(N4CCN(c5ccccc5OC)CC4)CC3C2)CC1.O=C(O)C(=O)O
CHEMBL129483,CHEMBL217,Dopamine D2 receptor,Ki,=,75.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1.O=C(O)C(=O)O
CHEMBL127230,CHEMBL217,Dopamine D2 receptor,Ki,=,65.2,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(Oc3ccccc3)cc2)CC1
CHEMBL27132,CHEMBL217,Dopamine D2 receptor,Ki,=,39.2,nM,CHEMBL664743,B,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,CHEMBL1132996,KI,C[C@H]1c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1
CHEMBL27251,CHEMBL217,Dopamine D2 receptor,Ki,=,2250.0,nM,CHEMBL670677,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1132996,KI,CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N
CHEMBL338841,CHEMBL217,Dopamine D2 receptor,Ki,=,161.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2cccc(I)c2)CC1
CHEMBL338063,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(Cl)cc2Cl)CC1.O=C(O)C(=O)O
CHEMBL65071,CHEMBL217,Dopamine D2 receptor,Ki,=,25.12,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,CC(=O)Nc1ccc(CN2CC3COc4ccc(C#N)cc4C3C2)cc1
CHEMBL99198,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,O=C(NCCCCN1CCC[C@H]2c3cccc(O)c3CC[C@@H]21)c1ccc(-c2ccccc2)cc1
CHEMBL164736,CHEMBL217,Dopamine D2 receptor,Ki,=,11000.0,nM,CHEMBL672527,B,Binding affinity on High Affinity Site of Dopamine receptor D2L,CHEMBL1133710,KI,CCCN(CCC)C1CCC(=C(C#C[Si](C)(C)C)C#C[Si](C)(C)C)CC1
CHEMBL164736,CHEMBL217,Dopamine D2 receptor,Ki,=,13000.0,nM,CHEMBL670558,B,Binding Affinity on High Affinity Site of Dopamine receptor D2S,CHEMBL1133710,KI,CCCN(CCC)C1CCC(=C(C#C[Si](C)(C)C)C#C[Si](C)(C)C)CC1
CHEMBL165171,CHEMBL217,Dopamine D2 receptor,Ki,=,5200.0,nM,CHEMBL672527,B,Binding affinity on High Affinity Site of Dopamine receptor D2L,CHEMBL1133710,KI,CCCN(CCC)C1CCC(=C(C#Cc2ccccc2)C#Cc2ccccc2)CC1
CHEMBL165171,CHEMBL217,Dopamine D2 receptor,Ki,=,7300.0,nM,CHEMBL670558,B,Binding Affinity on High Affinity Site of Dopamine receptor D2S,CHEMBL1133710,KI,CCCN(CCC)C1CCC(=C(C#Cc2ccccc2)C#Cc2ccccc2)CC1
CHEMBL282375,CHEMBL217,Dopamine D2 receptor,Ki,=,3650.0,nM,CHEMBL670677,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1132996,KI,CC(=O)N[C@@H]1c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1
CHEMBL341481,CHEMBL217,Dopamine D2 receptor,Ki,=,103.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(C2CC3CC(NC4CC5CC(N6CCN(c7ccccc7OC)CC6)CC5C4)CC3C2)CC1.O=C(O)C(=O)O
CHEMBL127080,CHEMBL217,Dopamine D2 receptor,Ki,=,56.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)C2(c3ccc(Cl)cc3)CCCC2)CC1.O=C(O)C(=O)O
CHEMBL273921,CHEMBL217,Dopamine D2 receptor,Ki,=,234.42,nM,CHEMBL672229,B,Binding affinity towards cloned human dopamine D2 receptor was determined,CHEMBL1136643,KI,O=C1c2ccccc2CCCN1CCN1CCC(n2c(O)nc3cc(F)ccc32)CC1
CHEMBL126136,CHEMBL217,Dopamine D2 receptor,Ki,=,15.2,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccccc2I)CC1
CHEMBL126780,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3oc2=O)CC1
CHEMBL126331,CHEMBL217,Dopamine D2 receptor,Ki,=,94.6,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccc2cc([C@H](C)C(=O)NCCCN3CCN(c4ccccc4OC)CC3)ccc2c1.O=C(O)C(=O)O
CHEMBL340712,CHEMBL217,Dopamine D2 receptor,Ki,=,76.4,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(I)cc2)CC1
CHEMBL127979,CHEMBL217,Dopamine D2 receptor,Ki,=,300.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCN2C(=O)c3ccccc3C2=O)CC1.O=C(O)C(=O)O
CHEMBL129606,CHEMBL217,Dopamine D2 receptor,Ki,=,235.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cccc(I)c2)CC1.O=C(O)C(=O)O
CHEMBL126439,CHEMBL217,Dopamine D2 receptor,Ki,=,53.2,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3n2)CC1.O=C(O)C(=O)O
CHEMBL129429,CHEMBL217,Dopamine D2 receptor,Ki,=,36.79,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(C(F)(F)F)cc2)CC1
CHEMBL126342,CHEMBL217,Dopamine D2 receptor,Ki,=,114.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2cccc(Oc3ccccc3)c2)CC1.O=C(O)C(=O)O
CHEMBL126892,CHEMBL217,Dopamine D2 receptor,Ki,=,20.9,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2nccc3ccccc23)CC1.O=C(O)C(=O)O
CHEMBL126656,CHEMBL217,Dopamine D2 receptor,Ki,=,44.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCNC(=O)Cc2cccc3ccccc23)CC1.O=C(O)C(=O)O
CHEMBL126441,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1/C=C/C(=O)NCCCCN1CCN(c2ccccc2OC)CC1
CHEMBL421085,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(Cl)c(Cl)c2)CC1.O=C(O)C(=O)O
CHEMBL126632,CHEMBL217,Dopamine D2 receptor,Ki,=,50.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1.O=C(O)C(=O)O
CHEMBL418321,CHEMBL217,Dopamine D2 receptor,Ki,=,50.12,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,Brc1ccc2c(c1)C1CN(Cc3ccccc3)CC1CO2
CHEMBL281924,CHEMBL217,Dopamine D2 receptor,Ki,=,7.1,nM,CHEMBL670677,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1132996,KI,CO[C@]1(C)c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1
CHEMBL280804,CHEMBL217,Dopamine D2 receptor,Ki,=,24.5,nM,CHEMBL670677,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1132996,KI,CCO[C@@]1(CC)c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1
CHEMBL127029,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccc(Cl)cc3)o2)CC1.O=C(O)C(=O)O
CHEMBL65122,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,N#Cc1ccc2c(c1)[C@@H]1CN(Cc3ccc(F)cc3)C[C@H]1CO2
CHEMBL284586,CHEMBL217,Dopamine D2 receptor,Ki,=,83.2,nM,CHEMBL664743,B,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,CHEMBL1132996,KI,CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)C3
CHEMBL26998,CHEMBL217,Dopamine D2 receptor,Ki,=,819.0,nM,CHEMBL664743,B,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,CHEMBL1132996,KI,CCCN(CCC)[C@@H]1CCc2cccc(O)c2C1
CHEMBL303979,CHEMBL217,Dopamine D2 receptor,Ki,=,25.12,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,Fc1ccc2c(c1)C1CN(Cc3ccccc3)CC1CO2
CHEMBL443006,CHEMBL217,Dopamine D2 receptor,Ki,=,25.12,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,CS(=O)(=O)Nc1ccc(CCN2CC3COc4ccc(C#N)cc4C3C2)cc1
CHEMBL2112210,CHEMBL217,Dopamine D2 receptor,Ki,=,19.95,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,N#Cc1ccc2c(c1)[C@H]1CN(CCCCNC(=O)c3ccc(-c4ccc(N)cc4)cc3)C[C@@H]1CO2
CHEMBL27309,CHEMBL217,Dopamine D2 receptor,Ki,=,182.0,nM,CHEMBL670677,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1132996,KI,CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@]3(C)O
CHEMBL129502,CHEMBL217,Dopamine D2 receptor,Ki,=,330.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCN2C(=O)C=C(c3ccccc3)C2=O)CC1.O=C(O)C(=O)O
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL672527,B,Binding affinity on High Affinity Site of Dopamine receptor D2L,CHEMBL1133710,KI,NCCc1ccc(O)c(O)c1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL670558,B,Binding Affinity on High Affinity Site of Dopamine receptor D2S,CHEMBL1133710,KI,NCCc1ccc(O)c(O)c1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,1900.0,nM,CHEMBL672528,B,Binding Affinity was tested on low Affinity Site of Dopamine receptor D2L,CHEMBL1133710,KI,NCCc1ccc(O)c(O)c1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL670556,B,Binding Affinity of Compound of Dopamine receptor D2S,CHEMBL1133710,KI,NCCc1ccc(O)c(O)c1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL671447,B,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2L,CHEMBL1133710,KI,NCCc1ccc(O)c(O)c1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL872880,B,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2S,CHEMBL1133710,KI,NCCc1ccc(O)c(O)c1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,15000.0,nM,CHEMBL672526,B,Binding Affinity was determined in the presence of 100 micro M Gpp(NH)p for decoupling of the ternary complex of Compound to Dopamine receptor D2L,CHEMBL1133710,KI,NCCc1ccc(O)c(O)c1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,15000.0,nM,CHEMBL670557,B,Binding Affinity was determined in the presence of 100 micro M Gpp(NH)p for decoupling of the ternary complex of Compound to Dopamine receptor D2S,CHEMBL1133710,KI,NCCc1ccc(O)c(O)c1
CHEMBL281357,CHEMBL217,Dopamine D2 receptor,Ki,=,527.0,nM,CHEMBL664743,B,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,CHEMBL1132996,KI,CN1CCc2cccc3c2[C@H]1Cc1ccccc1-3
CHEMBL26751,CHEMBL217,Dopamine D2 receptor,Ki,=,23.8,nM,CHEMBL670677,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1132996,KI,CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@H]3O
CHEMBL281048,CHEMBL217,Dopamine D2 receptor,Ki,=,261.0,nM,CHEMBL670677,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1132996,KI,CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@H]3N
CHEMBL126502,CHEMBL217,Dopamine D2 receptor,Ki,=,68.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(I)c2)CC1.O=C(O)C(=O)O
CHEMBL126746,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(-c3ccccc3)cc2)CC1
CHEMBL125459,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2cccc3c2OCO3)CC1
CHEMBL341299,CHEMBL217,Dopamine D2 receptor,Ki,=,11.1,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccco2)CC1.O=C(O)C(=O)O
CHEMBL293159,CHEMBL217,Dopamine D2 receptor,Ki,=,19.95,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,N#Cc1ccc2c(c1)[C@H]1CN(Cc3ccccc3)C[C@@H]1CO2
CHEMBL436157,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,CCCN1CC2COc3ccc(C#N)cc3C2C1
CHEMBL163087,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL672527,B,Binding affinity on High Affinity Site of Dopamine receptor D2L,CHEMBL1133710,KI,CCCN(CCC)C1CC=C(C#C[Si](C)(C)C)CC1
CHEMBL163087,CHEMBL217,Dopamine D2 receptor,Ki,=,970.0,nM,CHEMBL670558,B,Binding Affinity on High Affinity Site of Dopamine receptor D2S,CHEMBL1133710,KI,CCCN(CCC)C1CC=C(C#C[Si](C)(C)C)CC1
CHEMBL163087,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL672529,B,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2L,CHEMBL1133710,KI,CCCN(CCC)C1CC=C(C#C[Si](C)(C)C)CC1
CHEMBL163087,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL872880,B,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2S,CHEMBL1133710,KI,CCCN(CCC)C1CC=C(C#C[Si](C)(C)C)CC1
CHEMBL163087,CHEMBL217,Dopamine D2 receptor,Ki,=,-0.46,nM,CHEMBL673077,B,Dissociation constant on two binding sites of Dopamine receptor D2L,CHEMBL1133710,KI,CCCN(CCC)C1CC=C(C#C[Si](C)(C)C)CC1
CHEMBL163087,CHEMBL217,Dopamine D2 receptor,Ki,=,-0.63,nM,CHEMBL675127,B,Dissociation constant on two binding sites of Dopamine receptor D2S,CHEMBL1133710,KI,CCCN(CCC)C1CC=C(C#C[Si](C)(C)C)CC1
CHEMBL27940,CHEMBL217,Dopamine D2 receptor,Ki,=,201.0,nM,CHEMBL664743,B,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,CHEMBL1132996,KI,Cc1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL126313,CHEMBL217,Dopamine D2 receptor,Ki,=,71.9,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2sc3ccccc3c2Cl)CC1
CHEMBL339103,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)Cc2ccc3ccccc3c2)CC1.O=C(O)C(=O)O
CHEMBL291417,CHEMBL217,Dopamine D2 receptor,Ki,=,31.62,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,Clc1ccc2c(c1)C1CN(Cc3ccccc3)CC1CO2
CHEMBL59662,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,COc1ccc2c(c1)OCC1CN(Cc3ccccc3)CC21
CHEMBL64157,CHEMBL217,Dopamine D2 receptor,Ki,=,25.12,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,N#Cc1ccc2c(c1)[C@H]1CN(Cc3ccc(F)cc3)C[C@@H]1CO2
CHEMBL277790,CHEMBL217,Dopamine D2 receptor,Ki,=,79.43,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,N#Cc1ccc2c(c1)C1CN(CCCCNC(=O)c3ccc(-c4ccccc4)cc3)CC1CO2
CHEMBL338606,CHEMBL217,Dopamine D2 receptor,Ki,=,20.7,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(F)cc2)CC1
CHEMBL127038,CHEMBL217,Dopamine D2 receptor,Ki,=,10.3,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc3c(c2)OCO3)CC1
CHEMBL418671,CHEMBL217,Dopamine D2 receptor,Ki,=,31.62,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,CC(=O)Nc1ccc(CCN2C[C@@H]3COc4ccc(C#N)cc4[C@H]3C2)cc1
CHEMBL162762,CHEMBL217,Dopamine D2 receptor,Ki,=,270.0,nM,CHEMBL672527,B,Binding affinity on High Affinity Site of Dopamine receptor D2L,CHEMBL1133710,KI,C#CC1=CCC(N(CCC)CCC)CC1
CHEMBL162762,CHEMBL217,Dopamine D2 receptor,Ki,=,250.0,nM,CHEMBL670558,B,Binding Affinity on High Affinity Site of Dopamine receptor D2S,CHEMBL1133710,KI,C#CC1=CCC(N(CCC)CCC)CC1
CHEMBL162762,CHEMBL217,Dopamine D2 receptor,Ki,=,14000.0,nM,CHEMBL672528,B,Binding Affinity was tested on low Affinity Site of Dopamine receptor D2L,CHEMBL1133710,KI,C#CC1=CCC(N(CCC)CCC)CC1
CHEMBL162762,CHEMBL217,Dopamine D2 receptor,Ki,=,12000.0,nM,CHEMBL670556,B,Binding Affinity of Compound of Dopamine receptor D2S,CHEMBL1133710,KI,C#CC1=CCC(N(CCC)CCC)CC1
CHEMBL162762,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL672529,B,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2L,CHEMBL1133710,KI,C#CC1=CCC(N(CCC)CCC)CC1
CHEMBL162762,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL872880,B,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2S,CHEMBL1133710,KI,C#CC1=CCC(N(CCC)CCC)CC1
CHEMBL162762,CHEMBL217,Dopamine D2 receptor,Ki,=,19000.0,nM,CHEMBL672526,B,Binding Affinity was determined in the presence of 100 micro M Gpp(NH)p for decoupling of the ternary complex of Compound to Dopamine receptor D2L,CHEMBL1133710,KI,C#CC1=CCC(N(CCC)CCC)CC1
CHEMBL162762,CHEMBL217,Dopamine D2 receptor,Ki,=,17000.0,nM,CHEMBL670557,B,Binding Affinity was determined in the presence of 100 micro M Gpp(NH)p for decoupling of the ternary complex of Compound to Dopamine receptor D2S,CHEMBL1133710,KI,C#CC1=CCC(N(CCC)CCC)CC1
CHEMBL162762,CHEMBL217,Dopamine D2 receptor,Ki,=,2800.0,nM,CHEMBL673075,B,Dissociation constant of compound on one-site model Dopamine receptor D2L,CHEMBL1133710,KI,C#CC1=CCC(N(CCC)CCC)CC1
CHEMBL162762,CHEMBL217,Dopamine D2 receptor,Ki,=,2900.0,nM,CHEMBL672581,B,Dissociation constant of compound on one-site model Dopamine receptor D2S,CHEMBL1133710,KI,C#CC1=CCC(N(CCC)CCC)CC1
CHEMBL162762,CHEMBL217,Dopamine D2 receptor,Ki,=,-0.51,nM,CHEMBL673076,B,Dissociation constant of compound on two binding sites of Dopamine receptor D2L,CHEMBL1133710,KI,C#CC1=CCC(N(CCC)CCC)CC1
CHEMBL162762,CHEMBL217,Dopamine D2 receptor,Ki,=,-0.55,nM,CHEMBL675126,B,Dissociation constant of compound on two binding sites of Dopamine receptor D2S,CHEMBL1133710,KI,C#CC1=CCC(N(CCC)CCC)CC1
CHEMBL128133,CHEMBL217,Dopamine D2 receptor,Ki,=,56.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCNC(=O)Cc2ccc3ccccc3c2)CC1.O=C(O)C(=O)O
CHEMBL129465,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc([N+](=O)[O-])cc2)CC1.O=C(O)C(=O)O
CHEMBL339062,CHEMBL217,Dopamine D2 receptor,Ki,=,11.5,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(C=O)cc2)CC1.O=C(O)C(=O)O
CHEMBL127912,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2cccc(Cl)c2)CC1.O=C(O)C(=O)O
CHEMBL338552,CHEMBL217,Dopamine D2 receptor,Ki,=,9.5,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2cccs2)CC1.O=C(O)C(=O)O
CHEMBL125580,CHEMBL217,Dopamine D2 receptor,Ki,=,145.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCN2C(=O)c3cc4ccccc4cc3C2=O)CC1
CHEMBL279247,CHEMBL217,Dopamine D2 receptor,Ki,=,6.1,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,Cc1nn(C2CCN(Cc3ccccc3)CC2)cc1-c1ccccc1
CHEMBL294275,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,COc1ccc2c(c1)C1CN(Cc3ccccc3)CC1CO2
CHEMBL62823,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,CC(=O)Nc1ccc(CCN2C[C@H]3COc4ccc(C#N)cc4[C@@H]3C2)cc1
CHEMBL27254,CHEMBL217,Dopamine D2 receptor,Ki,=,146.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(I)cc2)CC1
CHEMBL125676,CHEMBL217,Dopamine D2 receptor,Ki,=,128.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(C(C)(C)C)cc2)CC1.O=C(O)C(=O)O
CHEMBL126280,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccsc2)CC1
CHEMBL294515,CHEMBL217,Dopamine D2 receptor,Ki,=,31.62,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,N#Cc1ccc2c(c1)[C@@H]1CN(Cc3ccccc3)C[C@H]1CO2
CHEMBL418321,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,Brc1ccc2c(c1)C1CN(Cc3ccccc3)CC1CO2
CHEMBL62416,CHEMBL217,Dopamine D2 receptor,Ki,=,12.59,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,CC(=O)Nc1ccc(CN2C[C@@H]3COc4ccc(C#N)cc4[C@H]3C2)cc1
CHEMBL164950,CHEMBL217,Dopamine D2 receptor,Ki,=,15000.0,nM,CHEMBL670558,B,Binding Affinity on High Affinity Site of Dopamine receptor D2S,CHEMBL1133710,KI,CCCN(CCC)C1CCC(=C(C#N)C#N)CC1
CHEMBL302416,CHEMBL217,Dopamine D2 receptor,Ki,=,25.12,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,N#Cc1ccc2c(c1)C1CN(Cc3ccccc3)CC1CO2
CHEMBL341134,CHEMBL217,Dopamine D2 receptor,Ki,=,23.7,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(Br)cc2)CC1.O=C(O)C(=O)O
CHEMBL340851,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(OCc3ccccc3)cc2)CC1
CHEMBL415520,CHEMBL217,Dopamine D2 receptor,Ki,=,50.2,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2cccc(C(F)(F)F)c2)CC1.O=C(O)C(=O)O
CHEMBL61565,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,CC(=O)Nc1ccc(CCN2CC3COc4ccc(C#N)cc4C3C2)cc1
CHEMBL26471,CHEMBL217,Dopamine D2 receptor,Ki,=,317.0,nM,CHEMBL670677,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1132996,KI,CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)C3=O
CHEMBL129035,CHEMBL217,Dopamine D2 receptor,Ki,=,7.2,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(/C=C/C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)cc2)CC1
CHEMBL126258,CHEMBL217,Dopamine D2 receptor,Ki,=,19.5,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(Cl)cc2)CC1.O=C(O)C(=O)O
CHEMBL129022,CHEMBL217,Dopamine D2 receptor,Ki,=,27.5,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1.O=C(O)C(=O)O
CHEMBL341241,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(C#N)cc2)CC1.O=C(O)C(=O)O
CHEMBL341542,CHEMBL217,Dopamine D2 receptor,Ki,=,14.5,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2cccnc2)CC1.O=C(O)C(=O)O
CHEMBL129767,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/C=C/c2ccccc2)CC1
CHEMBL126285,CHEMBL217,Dopamine D2 receptor,Ki,=,40.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCN2C(=O)c3cccc4cccc(c34)C2=O)CC1
CHEMBL302416,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,N#Cc1ccc2c(c1)C1CN(Cc3ccccc3)CC1CO2
CHEMBL281554,CHEMBL217,Dopamine D2 receptor,Ki,=,70.8,nM,CHEMBL670677,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1132996,KI,CCO[C@]1(CC)c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1
CHEMBL127288,CHEMBL217,Dopamine D2 receptor,Ki,=,26.5,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(C(C)(C)C)cc2)CC1
CHEMBL340608,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccccc2I)CC1
CHEMBL127923,CHEMBL217,Dopamine D2 receptor,Ki,=,38.5,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2cc(I)c(OC)c(OC)c2)CC1.O=C(O)C(=O)O
CHEMBL126749,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc3ccccc3c2)CC1
CHEMBL434403,CHEMBL217,Dopamine D2 receptor,Ki,=,19.95,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,CC(=O)c1ccc(C(=O)Nc2ccc(CCN3CC4COc5ccc(C#N)cc5C4C3)cc2)cc1
CHEMBL166325,CHEMBL217,Dopamine D2 receptor,Ki,=,15000.0,nM,CHEMBL672381,B,Binding Affinity was tested on High Affinity Site of Dopamine receptor D2L,CHEMBL1133710,KI,CCCN(CCC)C1CC=C(C#Cc2ccccc2)CC1
CHEMBL166325,CHEMBL217,Dopamine D2 receptor,Ki,=,15000.0,nM,CHEMBL672954,B,Binding Affinity was tested on High Affinity Site of Dopamine receptor D2S,CHEMBL1133710,KI,CCCN(CCC)C1CC=C(C#Cc2ccccc2)CC1
CHEMBL126312,CHEMBL217,Dopamine D2 receptor,Ki,=,28.4,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(Cc2ccccc2CNC(=O)c2ccc3ccccc3c2)CC1.O=C(O)C(=O)O
CHEMBL340313,CHEMBL217,Dopamine D2 receptor,Ki,=,178.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(C2CC3CC(NC(=O)c4ccc5ccccc5c4)CC3C2)CC1.O=C(O)C(=O)O
CHEMBL127654,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccccc2Cl)CC1.O=C(O)C(=O)O
CHEMBL65280,CHEMBL217,Dopamine D2 receptor,Ki,=,31.62,nM,CHEMBL670398,B,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,CHEMBL1131803,KI,N#Cc1ccc2c(c1)[C@H]1CN(CCCCNC(=O)c3ccc(-c4ccccc4)cc3)C[C@@H]1CO2
CHEMBL282863,CHEMBL217,Dopamine D2 receptor,Ki,=,19.4,nM,CHEMBL664743,B,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,CHEMBL1132996,KI,C[C@@H]1c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1
CHEMBL127234,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(Cc2ccccc2CNC(=O)/C=C/c2ccccc2)CC1
CHEMBL25236,CHEMBL217,Dopamine D2 receptor,Ki,=,61.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL165022,CHEMBL217,Dopamine D2 receptor,Ki,=,12000.0,nM,CHEMBL672527,B,Binding affinity on High Affinity Site of Dopamine receptor D2L,CHEMBL1133710,KI,C#CC(C#C)=C1CCC(N(CCC)CCC)CC1
CHEMBL421667,CHEMBL217,Dopamine D2 receptor,Ki,=,117.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCNC(=O)c2ccc(I)cc2)CC1
CHEMBL126834,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccc3c2-c2ccccc2C3=O)CC1
CHEMBL281923,CHEMBL217,Dopamine D2 receptor,Ki,=,71.0,nM,CHEMBL670677,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1132996,KI,CO[C@@]1(C)c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1
CHEMBL339620,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(Cc2ccc(CNC(=O)c3ccc4ccccc4c3)cc2)CC1.O=C(O)C(=O)O
CHEMBL126725,CHEMBL217,Dopamine D2 receptor,Ki,=,22.6,nM,CHEMBL671730,B,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,CHEMBL1144878,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(Cl)cc2)CC1.O=C(O)C(=O)O
CHEMBL3085215,CHEMBL217,Dopamine D2 receptor,Ki,=,30100.0,nM,CHEMBL670887,B,In vitro binding affinity at human cloned Dopamine receptor D2A by measuring its ability to displace [3H]raclopride from D2A receptor expressed in mouse fibroblast (LtK-) cells,CHEMBL1133455,KI,CCCN(C(C)C)[C@@H]1COc2cccc(C(C)=O)c2C1
CHEMBL419760,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCc4ccccc4C3)[nH]2)c1
CHEMBL113606,CHEMBL217,Dopamine D2 receptor,Ki,=,19.95,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN(Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1)Cc1ccccc1Cl
CHEMBL138989,CHEMBL217,Dopamine D2 receptor,Ki,=,330.0,nM,CHEMBL670786,B,Binding affinity towards Dopamine receptor D2,CHEMBL1135791,KI,C[C@@H]1C[C@@H](C)N1C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1
CHEMBL112219,CHEMBL217,Dopamine D2 receptor,Ki,=,25.12,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3c3ccc(C)cc3)[nH]2)c1
CHEMBL325859,CHEMBL217,Dopamine D2 receptor,Ki,=,25.12,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3c3ccc(OC)cc3)[nH]2)c1
CHEMBL111884,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN1[C@H](c2ccccc2)CC[C@H]1c1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1
CHEMBL21967,CHEMBL217,Dopamine D2 receptor,Ki,=,0.7943,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN(Cc1ccccc1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1
CHEMBL109532,CHEMBL217,Dopamine D2 receptor,Ki,=,7.943,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN(Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1)[C@H](C)c1ccccc1
CHEMBL325060,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3c3ccccc3C)[nH]2)c1
CHEMBL113229,CHEMBL217,Dopamine D2 receptor,Ki,=,3.162,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN(Cc1ccc2c(c1)OCO2)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1
CHEMBL322070,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN(Cc1ccc(Cl)cc1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1
CHEMBL74355,CHEMBL217,Dopamine D2 receptor,Ki,=,1300.0,nM,CHEMBL671362,B,Ability to displace [3H]-spiperone from CHO cells expressing human Dopamine receptor D2 was determined,CHEMBL1132835,KI,COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC
CHEMBL325658,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3c3cccc(OC)c3)[nH]2)c1
CHEMBL332270,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN(Cc1cccc(Cl)c1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1
CHEMBL112735,CHEMBL217,Dopamine D2 receptor,Ki,=,1.995,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN(Cc1ccc(OC)cc1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1
CHEMBL324044,CHEMBL217,Dopamine D2 receptor,Ki,=,31.62,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN(Cc1ccc(OC)c(OC)c1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1
CHEMBL321244,CHEMBL217,Dopamine D2 receptor,Ki,=,25.12,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN(Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1)[C@@H](C)c1ccccc1
CHEMBL112505,CHEMBL217,Dopamine D2 receptor,Ki,=,79.43,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN(Cc1cccc(OC)c1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1
CHEMBL263881,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL670786,B,Binding affinity towards Dopamine receptor D2,CHEMBL1135791,KI,CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL112705,CHEMBL217,Dopamine D2 receptor,Ki,=,0.3981,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN(Cc1ccc(C)cc1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1
CHEMBL91205,CHEMBL217,Dopamine D2 receptor,Ki,=,900.0,nM,CHEMBL671362,B,Ability to displace [3H]-spiperone from CHO cells expressing human Dopamine receptor D2 was determined,CHEMBL1132835,KI,c1ccc(-c2[nH]c3ccccc3c2CCN2CCCCC2)cc1
CHEMBL326662,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(C3CCCN3Cc3ccccc3)[nH]2)c1
CHEMBL2367896,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN1[C@@H](c2ccc(-c3cc(S(=O)(=O)CC)ccc3OC)[nH]2)CC[C@H]1c1ccccc1
CHEMBL113524,CHEMBL217,Dopamine D2 receptor,Ki,=,12.59,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN(Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1)C1CCCc2ccccc21
CHEMBL343755,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL670786,B,Binding affinity towards Dopamine receptor D2,CHEMBL1135791,KI,C[C@H]1C[C@H](C)N1C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1
CHEMBL323817,CHEMBL217,Dopamine D2 receptor,Ki,=,0.7943,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN(Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1)C1CCc2ccccc21
CHEMBL110793,CHEMBL217,Dopamine D2 receptor,Ki,=,15.85,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN(Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1)Cc1ccccc1OC
CHEMBL112268,CHEMBL217,Dopamine D2 receptor,Ki,=,7.943,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN(Cc1cccc(C)c1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1
CHEMBL137781,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL670784,B,Binding affinity against Dopamine receptor D2,CHEMBL1135791,KI,C[C@@H]1C[C@H](C)N1C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1
CHEMBL22156,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1
CHEMBL113523,CHEMBL217,Dopamine D2 receptor,Ki,=,6.31,nM,CHEMBL674353,B,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",CHEMBL1129831,KI,CCN(Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1)Cc1ccccc1C
CHEMBL2113718,CHEMBL217,Dopamine D2 receptor,Ki,=,2400.0,nM,CHEMBL671363,B,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,CHEMBL1135184,KI,N#Cc1cc(CN2CCN(c3ccccc3)CC2)c[nH]1
CHEMBL2113718,CHEMBL217,Dopamine D2 receptor,Ki,=,3400.0,nM,CHEMBL671365,B,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,CHEMBL1135184,KI,N#Cc1cc(CN2CCN(c3ccccc3)CC2)c[nH]1
CHEMBL319043,CHEMBL217,Dopamine D2 receptor,Ki,=,59.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,COc1ccc(OC)c(CN2CCN(CC(=O)N3c4ccccc4C[C@H]3C)CC2)c1
CHEMBL322222,CHEMBL217,Dopamine D2 receptor,Ki,=,1434.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc3c(c2)OCO3)CC1
CHEMBL107631,CHEMBL217,Dopamine D2 receptor,Ki,=,1178.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,COC(=O)[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL108282,CHEMBL217,Dopamine D2 receptor,Ki,=,191.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL25856,CHEMBL217,Dopamine D2 receptor,Ki,=,1520.0,nM,CHEMBL671379,B,Binding affinity against cloned human Dopamine receptor D2 using [3H]spiperone as radioligand transfected in HEK cells,CHEMBL1128531,KI,Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2
CHEMBL92189,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cc1c(-c2ccc(F)cc2)nc(O)n1C1CCN(Cc2ccccc2)CC1
CHEMBL103912,CHEMBL217,Dopamine D2 receptor,Ki,=,3107.0,nM,CHEMBL671417,B,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,CHEMBL1135499,KI,CCCN(CCC)CC1CCc2ccsc2C1
CHEMBL91621,CHEMBL217,Dopamine D2 receptor,Ki,=,86.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,O=C(Nc1ccccc1)NC1CCN(Cc2ccccc2)CC1
CHEMBL103441,CHEMBL217,Dopamine D2 receptor,Ki,=,1080.0,nM,CHEMBL671417,B,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,CHEMBL1135499,KI,CCCN(CCc1ccsc1)CCc1cccs1
CHEMBL58662,CHEMBL217,Dopamine D2 receptor,Ki,=,760.0,nM,CHEMBL671363,B,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,CHEMBL1135184,KI,C(#Cc1c[nH]c(CN2CCN(c3ccccc3)CC2)c1)c1ccccc1
CHEMBL58662,CHEMBL217,Dopamine D2 receptor,Ki,=,550.0,nM,CHEMBL671365,B,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,CHEMBL1135184,KI,C(#Cc1c[nH]c(CN2CCN(c3ccccc3)CC2)c1)c1ccccc1
CHEMBL431640,CHEMBL217,Dopamine D2 receptor,Ki,=,271.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,C=C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL321121,CHEMBL217,Dopamine D2 receptor,Ki,=,96.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,CC[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(C)cc2)CC1
CHEMBL91272,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,O=C(Nc1ccccn1)NC1CCN(Cc2ccccc2)CC1
CHEMBL93832,CHEMBL217,Dopamine D2 receptor,Ki,=,1300.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cc1c(-c2ccccc2)nc(O)n1C1CCN(Cc2cccc(Cl)c2)CC1
CHEMBL294394,CHEMBL217,Dopamine D2 receptor,Ki,=,3100.0,nM,CHEMBL671363,B,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,CHEMBL1135184,KI,c1ccc(N2CCN(Cc3ccc[nH]3)CC2)cc1
CHEMBL294394,CHEMBL217,Dopamine D2 receptor,Ki,=,3000.0,nM,CHEMBL671365,B,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,CHEMBL1135184,KI,c1ccc(N2CCN(Cc3ccc[nH]3)CC2)cc1
CHEMBL108011,CHEMBL217,Dopamine D2 receptor,Ki,=,218.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,CC(C)c1ccc(Cl)cc1CN1CCN(CC(=O)N2c3ccccc3C[C@H]2C)CC1
CHEMBL291143,CHEMBL217,Dopamine D2 receptor,Ki,=,1550.0,nM,CHEMBL671379,B,Binding affinity against cloned human Dopamine receptor D2 using [3H]spiperone as radioligand transfected in HEK cells,CHEMBL1128531,KI,NC[C@@H]1O[C@H](C23CC4CC(CC(C4)C2)C3)Cc2c1ccc(O)c2O
CHEMBL105623,CHEMBL217,Dopamine D2 receptor,Ki,=,439.0,nM,CHEMBL671417,B,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,CHEMBL1135499,KI,CCCN(CCc1ccsc1)CCc1ccsc1
CHEMBL320721,CHEMBL217,Dopamine D2 receptor,Ki,=,1096.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1c2ccccc2C[C@H]1CF
CHEMBL24077,CHEMBL217,Dopamine D2 receptor,Ki,=,4670.0,nM,CHEMBL671379,B,Binding affinity against cloned human Dopamine receptor D2 using [3H]spiperone as radioligand transfected in HEK cells,CHEMBL1128531,KI,Oc1cc2c(cc1O)[C@@H](c1ccccc1)CNCC2
CHEMBL91229,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cc1c(-c2ccccc2)nc(O)n1C1CCN(CCc2ccccc2)CC1
CHEMBL322638,CHEMBL217,Dopamine D2 receptor,Ki,=,375.0,nM,CHEMBL671417,B,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,CHEMBL1135499,KI,CCCN1CC(c2ccccc2)OC2c3cc(O)ccc3CCC21
CHEMBL57176,CHEMBL217,Dopamine D2 receptor,Ki,=,770.0,nM,CHEMBL671363,B,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,CHEMBL1135184,KI,C#Cc1c[nH]c(CN2CCN(c3ccccc3)CC2)c1
CHEMBL57176,CHEMBL217,Dopamine D2 receptor,Ki,=,580.0,nM,CHEMBL671365,B,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,CHEMBL1135184,KI,C#Cc1c[nH]c(CN2CCN(c3ccccc3)CC2)c1
CHEMBL91669,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cn1c(-c2ccccc2)cn(C2CCN(Cc3ccccc3)CC2)c1=O
CHEMBL94283,CHEMBL217,Dopamine D2 receptor,Ki,=,73.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cc1c(-c2cccc(Cl)c2)nc(O)n1C1CCN(Cc2ccccc2)CC1
CHEMBL102582,CHEMBL217,Dopamine D2 receptor,Ki,=,6.24,nM,CHEMBL671417,B,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,CHEMBL1135499,KI,CCCN1CCOC2c3cc(O)ccc3CCC21
CHEMBL107151,CHEMBL217,Dopamine D2 receptor,Ki,=,3027.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1c2ccccc2C[C@H]1CO
CHEMBL328739,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cc1c(-c2ccccc2)n(C)c(=O)n1C1CCN(Cc2ccccc2)CC1
CHEMBL60815,CHEMBL217,Dopamine D2 receptor,Ki,=,230.0,nM,CHEMBL671363,B,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,CHEMBL1135184,KI,c1ccc(-c2c[nH]c(CN3CCN(c4ccccc4)CC3)c2)cc1
CHEMBL60815,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL671365,B,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,CHEMBL1135184,KI,c1ccc(-c2c[nH]c(CN3CCN(c4ccccc4)CC3)c2)cc1
CHEMBL106169,CHEMBL217,Dopamine D2 receptor,Ki,=,758.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,CCc1ccc(CN2CCN(CC(=O)N3c4ccccc4C[C@H]3C)CC2)cc1
CHEMBL28338,CHEMBL217,Dopamine D2 receptor,Ki,=,710.0,nM,CHEMBL671379,B,Binding affinity against cloned human Dopamine receptor D2 using [3H]spiperone as radioligand transfected in HEK cells,CHEMBL1128531,KI,CCCc1cc2c(s1)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21
CHEMBL544814,CHEMBL217,Dopamine D2 receptor,Ki,=,4020.0,nM,CHEMBL671379,B,Binding affinity against cloned human Dopamine receptor D2 using [3H]spiperone as radioligand transfected in HEK cells,CHEMBL1128531,KI,CCCc1cc2c(s1)CN[C@H]1CCc3cc(O)c(O)cc3[C@H]21.Cl
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,74.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL91553,CHEMBL217,Dopamine D2 receptor,Ki,=,270.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cc1c(-c2ccccn2)nc(O)n1C1CCN(Cc2ccccc2)CC1
CHEMBL92859,CHEMBL217,Dopamine D2 receptor,Ki,=,95.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cc1cccc(CN2CCC(n3c(O)nc(-c4ccccc4)c3C)CC2)c1
CHEMBL91155,CHEMBL217,Dopamine D2 receptor,Ki,=,900.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,COc1cccc(CN2CCC(n3c(O)nc(-c4ccccc4)c3C)CC2)c1
CHEMBL1303,CHEMBL217,Dopamine D2 receptor,Ki,=,0.06,nM,CHEMBL671417,B,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,CHEMBL1135499,KI,CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1
CHEMBL320597,CHEMBL217,Dopamine D2 receptor,Ki,=,113.0,nM,CHEMBL672178,B,Binding affinity towards Dopamine receptor D2 was determined via standard competitive displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4C[C@H]3C)CC2)cc1
CHEMBL91821,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cc1nc(O)n(C2CCN(Cc3ccccc3)CC2)c1-c1ccccc1
CHEMBL91498,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,CCc1c(-c2ccccc2)nc(O)n1C1CCN(Cc2ccccc2)CC1
CHEMBL103622,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL671417,B,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,CHEMBL1135499,KI,CCCN(CCC)C1CCc2sccc2C1
CHEMBL106862,CHEMBL217,Dopamine D2 receptor,Ki,=,273.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,COc1cc(Cl)ccc1CN1CCN(CC(=O)N2c3ccccc3C[C@H]2C)CC1
CHEMBL90005,CHEMBL217,Dopamine D2 receptor,Ki,=,7.8,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cc1c(-c2cccs2)nc(O)n1C1CCN(Cc2ccccc2)CC1
CHEMBL316125,CHEMBL217,Dopamine D2 receptor,Ki,=,83.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cc1c(-c2ccccc2)nc(O)n1C1CCN(CC2CCCCC2)CC1
CHEMBL104678,CHEMBL217,Dopamine D2 receptor,Ki,=,43.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)c(Cl)c2)CC1
CHEMBL104323,CHEMBL217,Dopamine D2 receptor,Ki,=,2583.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2cc(F)c(Cl)cc2F)CC1
CHEMBL319923,CHEMBL217,Dopamine D2 receptor,Ki,=,219.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,CC[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL94023,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cc1c(-c2ccc(Cl)cc2)nc(O)n1C1CCN(Cc2ccccc2)CC1
CHEMBL105317,CHEMBL217,Dopamine D2 receptor,Ki,=,673.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,COc1ccc(CN2CCN(CC(=O)N3c4ccccc4C[C@H]3C)CC2)cc1
CHEMBL301559,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL671417,B,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,CHEMBL1135499,KI,CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1
CHEMBL104751,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,COc1ccc(Cl)cc1CN1CCN(CC(=O)N2c3ccccc3C[C@H]2C)CC1
CHEMBL450021,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,COc1ccc(-c2nc(O)n(C3CCN(Cc4ccccc4)CC3)c2C)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL326010,CHEMBL217,Dopamine D2 receptor,Ki,=,271.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2cc(Cl)cc(Cl)c2)CC1
CHEMBL320515,CHEMBL217,Dopamine D2 receptor,Ki,=,199.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(F)c(F)c2Cl)CC1
CHEMBL328667,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,O=C(Nc1nccc2ccccc12)NC1CCN(Cc2ccccc2)CC1
CHEMBL106119,CHEMBL217,Dopamine D2 receptor,Ki,=,9395.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,C[C@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL104058,CHEMBL217,Dopamine D2 receptor,Ki,=,286.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(F)cc2)CC1
CHEMBL105745,CHEMBL217,Dopamine D2 receptor,Ki,=,491.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,COC(=O)[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(C)cc2)CC1
CHEMBL91162,CHEMBL217,Dopamine D2 receptor,Ki,=,56.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cc1c(-c2ccccc2)nc(O)n1C1CCN(Cc2ccccc2)CC1
CHEMBL105172,CHEMBL217,Dopamine D2 receptor,Ki,=,95.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2cc(Cl)ccc2Cl)CC1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL671379,B,Binding affinity against cloned human Dopamine receptor D2 using [3H]spiperone as radioligand transfected in HEK cells,CHEMBL1128531,KI,NCCc1ccc(O)c(O)c1
CHEMBL103857,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL671417,B,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,CHEMBL1135499,KI,CCCN(CCC)C1CCc2ccsc2C1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,138.0,nM,CHEMBL672178,B,Binding affinity towards Dopamine receptor D2 was determined via standard competitive displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL105354,CHEMBL217,Dopamine D2 receptor,Ki,=,2364.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4C[C@@H]3C)CC2)cc1
CHEMBL321201,CHEMBL217,Dopamine D2 receptor,Ki,=,1149.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccccc2Cl)CC1
CHEMBL102632,CHEMBL217,Dopamine D2 receptor,Ki,=,630.0,nM,CHEMBL671417,B,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,CHEMBL1135499,KI,CCCN1CCOC2c3ccsc3CCC21
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL671363,B,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,CHEMBL1135184,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL671365,B,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,CHEMBL1135184,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL7927,CHEMBL217,Dopamine D2 receptor,Ki,=,3200.0,nM,CHEMBL671363,B,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,CHEMBL1135184,KI,Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL7927,CHEMBL217,Dopamine D2 receptor,Ki,=,4300.0,nM,CHEMBL671365,B,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,CHEMBL1135184,KI,Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL105601,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2cccc(F)c2)CC1
CHEMBL93432,CHEMBL217,Dopamine D2 receptor,Ki,=,8.8,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cc1c(-c2ccccc2)n(-c2ccccc2)c(=O)n1C1CCN(Cc2ccccc2)CC1
CHEMBL327176,CHEMBL217,Dopamine D2 receptor,Ki,=,330.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cc1c(-c2ccccc2)nc(O)n1C1CCN(CCCc2ccccc2)CC1
CHEMBL102414,CHEMBL217,Dopamine D2 receptor,Ki,=,3676.0,nM,CHEMBL671417,B,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,CHEMBL1135499,KI,Oc1ccc2c(c1)C1OCCN(CCc3cccs3)C1CC2
CHEMBL93958,CHEMBL217,Dopamine D2 receptor,Ki,=,82.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Oc1nc(-c2ccccc2)cn1C1CCN(Cc2ccccc2)CC1
CHEMBL89971,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cc1c(-c2ccccc2Cl)nc(O)n1C1CCN(Cc2ccccc2)CC1
CHEMBL104135,CHEMBL217,Dopamine D2 receptor,Ki,=,2037.0,nM,CHEMBL671417,B,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,CHEMBL1135499,KI,CCCN(CCC)CC1CCc2sccc2C1
CHEMBL15136,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL671417,B,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,CHEMBL1135499,KI,CCCN(CCC)[C@@H]1Cc2cccc(O)c2C[C@H]1C
CHEMBL56118,CHEMBL217,Dopamine D2 receptor,Ki,=,3700.0,nM,CHEMBL671363,B,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,CHEMBL1135184,KI,N#Cc1c[nH]c(CN2CCN(c3ccccc3)CC2)c1
CHEMBL56118,CHEMBL217,Dopamine D2 receptor,Ki,=,8000.0,nM,CHEMBL671365,B,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,CHEMBL1135184,KI,N#Cc1c[nH]c(CN2CCN(c3ccccc3)CC2)c1
CHEMBL321698,CHEMBL217,Dopamine D2 receptor,Ki,=,747.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2cccc(Cl)c2)CC1
CHEMBL263162,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cc1ccc(-c2nc(O)n(C3CCN(Cc4ccccc4)CC3)c2C)cc1
CHEMBL93969,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL671375,B,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,CHEMBL1132306,KI,Cc1c(-c2ccccc2)nc(O)n1C1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL105454,CHEMBL217,Dopamine D2 receptor,Ki,=,5940.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(C(F)(F)F)cc2)CC1
CHEMBL326863,CHEMBL217,Dopamine D2 receptor,Ki,=,134.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,CCOc1ccc(Cl)cc1CN1CCN(CC(=O)N2c3ccccc3C[C@H]2C)CC1
CHEMBL317670,CHEMBL217,Dopamine D2 receptor,Ki,=,713.0,nM,CHEMBL675680,B,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,CHEMBL1134937,KI,Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4C[C@H]3C)CC2)cc1F
CHEMBL269396,CHEMBL217,Dopamine D2 receptor,Ki,=,1400.0,nM,CHEMBL671374,B,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,CHEMBL1127435,KI,CC1CCN(C2=Cc3cc(Cl)ccc3Cc3ccccc32)CC1
CHEMBL90654,CHEMBL217,Dopamine D2 receptor,Ki,=,640.0,nM,CHEMBL671374,B,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,CHEMBL1127435,KI,C[C@@H]1c2ccccc2C=C(C2=CCN(C)CC2)c2ccccc21
CHEMBL91350,CHEMBL217,Dopamine D2 receptor,Ki,=,680.0,nM,CHEMBL671374,B,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,CHEMBL1127435,KI,CC1c2ccccc2C=C(C2=CCN(C)CC2)c2ccccc21
CHEMBL716,CHEMBL217,Dopamine D2 receptor,Ki,=,69.0,nM,CHEMBL672179,B,Binding affinity towards human D2 dopamine receptor.,CHEMBL1134342,KI,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL543473,CHEMBL217,Dopamine D2 receptor,Ki,=,629.0,nM,CHEMBL672777,B,In vitro ability to inhibit [3H]spiperone binding to Dopamine receptor D2,CHEMBL1126025,KI,C=CCN1CCc2cc(Br)c(O)cc2C(c2ccccc2)C1.Cl
CHEMBL831,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL675960,B,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,CHEMBL1127435,KI,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
CHEMBL90882,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL675960,B,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,CHEMBL1127435,KI,CN1CCN(C2=Cc3ccccc3Oc3ccc(Cl)cc32)CC1
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL673248,B,Tested for binding affinity towards human D2L receptor using [3H]spiperone as radioligand,CHEMBL1127372,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL2112882,CHEMBL217,Dopamine D2 receptor,Ki,=,3.162,nM,CHEMBL672230,B,Binding affinity against human Dopamine receptor D2 in CHO cells using [125I]iodosulpiride,CHEMBL1145901,KI,CC(C)C[C@H]1C(=O)N[C@@H](Cc2ccccc2)[C@]2(O)O[C@@](C)(NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)C(=O)N12
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,0.44,nM,CHEMBL672179,B,Binding affinity towards human D2 dopamine receptor.,CHEMBL1134342,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL418854,CHEMBL217,Dopamine D2 receptor,Ki,=,13.2,nM,CHEMBL669156,B,The compound was tested for binding affinity against human Dopamine receptor D2L,CHEMBL1132360,KI,COc1ccccc1N1CCC(CNCC2COc3ccc(Cl)cc3O2)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL671374,B,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,CHEMBL1127435,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL91310,CHEMBL217,Dopamine D2 receptor,Ki,=,57.0,nM,CHEMBL675960,B,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,CHEMBL1127435,KI,C=C1c2ccccc2C=C(N2CCN(C)CC2)c2ccccc21
CHEMBL282199,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL672232,B,Binding affinity towards Dopamine receptor D2 (human cloned receptor) in CHO cells using [125I]iodosulpiride radioligand.,CHEMBL1133573,KI,CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1
CHEMBL285802,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL672179,B,Binding affinity towards human D2 dopamine receptor.,CHEMBL1134342,KI,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21
CHEMBL7828,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL675960,B,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,CHEMBL1127435,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Oc3ccccc32)CC1
CHEMBL94067,CHEMBL217,Dopamine D2 receptor,Ki,=,520.0,nM,CHEMBL671374,B,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,CHEMBL1127435,KI,CC(C)=C1c2ccccc2C=C(C2=CCN(C)CC2)c2ccccc21
CHEMBL432762,CHEMBL217,Dopamine D2 receptor,Ki,=,94.0,nM,CHEMBL675960,B,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,CHEMBL1127435,KI,CC1c2ccccc2C=C(N2CCN(C)CC2)c2ccccc21
CHEMBL263881,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL672230,B,Binding affinity against human Dopamine receptor D2 in CHO cells using [125I]iodosulpiride,CHEMBL1145901,KI,CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,2.1,nM,CHEMBL672179,B,Binding affinity towards human D2 dopamine receptor.,CHEMBL1134342,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL94984,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL672232,B,Binding affinity towards Dopamine receptor D2 (human cloned receptor) in CHO cells using [125I]iodosulpiride radioligand.,CHEMBL1133573,KI,CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc3ccccc23)CC1
CHEMBL89719,CHEMBL217,Dopamine D2 receptor,Ki,=,730.0,nM,CHEMBL671374,B,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,CHEMBL1127435,KI,C[C@H]1c2ccccc2C=C(C2=CCN(C)CC2)c2ccccc21
CHEMBL335545,CHEMBL217,Dopamine D2 receptor,Ki,=,25.5,nM,CHEMBL673248,B,Tested for binding affinity towards human D2L receptor using [3H]spiperone as radioligand,CHEMBL1127372,KI,C1=C(c2ccccc2)CCN(C[C@@H]2CCC=C(c3ccccc3)C2)C1
CHEMBL836,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL672912,B,Binding affinity towards recombinant human Dopamine receptor D2L was determined using [3H]spiperone as radioligand,CHEMBL1133729,KI,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
CHEMBL836,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL672575,B,Binding affinity towards recombinant human Dopamine receptor D2S was determined using [3H]spiperone as radioligand,CHEMBL1133729,KI,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
CHEMBL7430,CHEMBL217,Dopamine D2 receptor,Ki,=,560.0,nM,CHEMBL671374,B,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,CHEMBL1127435,KI,CN1CCC(C2=Cc3cc(Cl)ccc3Cc3ccccc32)CC1
CHEMBL88464,CHEMBL217,Dopamine D2 receptor,Ki,=,8.7,nM,CHEMBL675960,B,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,CHEMBL1127435,KI,CN1CCN(C2=Cc3cc(Cl)ccc3Oc3ccccc32)CC1
CHEMBL12624,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL674938,B,Binding affinity towards Dopamine receptor D2. (human cloned receptor) in CHO cells using [125I]iodosulpiride radioligand.,CHEMBL1133573,KI,Cc1cccc(S(=O)(=O)N2CCC[C@@H]2CCN2CCC(C)CC2)c1
CHEMBL328246,CHEMBL217,Dopamine D2 receptor,Ki,=,690.0,nM,CHEMBL675960,B,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,CHEMBL1127435,KI,CC(C)=C1c2ccc(Cl)cc2C=C(N2CCN(C)CC2)c2ccccc21
CHEMBL708,CHEMBL217,Dopamine D2 receptor,Ki,=,2.8,nM,CHEMBL672179,B,Binding affinity towards human D2 dopamine receptor.,CHEMBL1134342,KI,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL73538,CHEMBL217,Dopamine D2 receptor,Ki,=,2500.0,nM,CHEMBL671374,B,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,CHEMBL1127435,KI,CN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1
CHEMBL94067,CHEMBL217,Dopamine D2 receptor,Ki,=,790.0,nM,CHEMBL671374,B,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,CHEMBL1127435,KI,CC(C)=C1c2ccccc2C=C(C2=CCN(C)CC2)c2ccccc21
CHEMBL275696,CHEMBL217,Dopamine D2 receptor,Ki,=,520.0,nM,CHEMBL675960,B,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,CHEMBL1127435,KI,CN1CCN(C2=Cc3cc(Cl)ccc3Cc3ccccc32)CC1
CHEMBL88870,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL675960,B,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,CHEMBL1127435,KI,CC(C)=C1c2ccccc2C=C(N2CCN(C)CC2)c2ccccc21
CHEMBL1788231,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL672232,B,Binding affinity towards Dopamine receptor D2 (human cloned receptor) in CHO cells using [125I]iodosulpiride radioligand.,CHEMBL1133573,KI,CC1CCN(CC[C@H]2CCCCN2S(=O)(=O)c2cccc3ccccc23)CC1
CHEMBL543472,CHEMBL217,Dopamine D2 receptor,Ki,=,4408.0,nM,CHEMBL672777,B,In vitro ability to inhibit [3H]spiperone binding to Dopamine receptor D2,CHEMBL1126025,KI,Cl.Oc1ccc2c(c1)C(c1ccccc1)CNCC2
CHEMBL327713,CHEMBL217,Dopamine D2 receptor,Ki,=,250.0,nM,CHEMBL671374,B,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,CHEMBL1127435,KI,C=C1c2ccccc2C=C(C2=CCN(C)CC2)c2ccccc21
CHEMBL7617,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL675960,B,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,CHEMBL1127435,KI,CN1CCN(C2=Cc3ccccc3Cc3ccc(Cl)cc32)CC1
CHEMBL540857,CHEMBL217,Dopamine D2 receptor,Ki,=,1374.0,nM,CHEMBL672778,B,In vitro ability to inhibit [3H]spiperone binding to Dopamine receptor D2 from pig anterior pituitary tissue,CHEMBL1126025,KI,Br.Oc1cc2c(cc1Cl)CCNCC2c1ccccc1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL672179,B,Binding affinity towards human D2 dopamine receptor.,CHEMBL1134342,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL557799,CHEMBL217,Dopamine D2 receptor,Ki,=,5760.0,nM,CHEMBL672777,B,In vitro ability to inhibit [3H]spiperone binding to Dopamine receptor D2,CHEMBL1126025,KI,Br.Oc1cc2c(cc1Br)CCNCC2c1ccccc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.5,nM,CHEMBL673248,B,Tested for binding affinity towards human D2L receptor using [3H]spiperone as radioligand,CHEMBL1127372,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL89970,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL675960,B,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,CHEMBL1127435,KI,CN1CCN(C2=Cc3ccccc3Oc3ccccc32)CC1
CHEMBL309106,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL672912,B,Binding affinity towards recombinant human Dopamine receptor D2L was determined using [3H]spiperone as radioligand,CHEMBL1133729,KI,CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1
CHEMBL309106,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL672575,B,Binding affinity towards recombinant human Dopamine receptor D2S was determined using [3H]spiperone as radioligand,CHEMBL1133729,KI,CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1
CHEMBL333784,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL672232,B,Binding affinity towards Dopamine receptor D2 (human cloned receptor) in CHO cells using [125I]iodosulpiride radioligand.,CHEMBL1133573,KI,CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2ccc(Cl)c(Cl)c2)CC1
CHEMBL94067,CHEMBL217,Dopamine D2 receptor,Ki,=,570.0,nM,CHEMBL671374,B,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,CHEMBL1127435,KI,CC(C)=C1c2ccccc2C=C(C2=CCN(C)CC2)c2ccccc21
CHEMBL90977,CHEMBL217,Dopamine D2 receptor,Ki,=,730.0,nM,CHEMBL675960,B,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,CHEMBL1127435,KI,C/C=C1/c2ccccc2C=C(N2CCN(C)CC2)c2ccccc21
CHEMBL266723,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL671374,B,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,CHEMBL1127435,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(C)c3ccccc32)CC1
CHEMBL116448,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL672232,B,Binding affinity towards Dopamine receptor D2 (human cloned receptor) in CHO cells using [125I]iodosulpiride radioligand.,CHEMBL1133573,KI,CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(Br)c2)CC1
CHEMBL415300,CHEMBL217,Dopamine D2 receptor,Ki,=,47.0,nM,CHEMBL671374,B,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,CHEMBL1127435,KI,CN1CCN(C2=Nc3ccccc3Nc3ccc(Cl)cc32)CC1
CHEMBL367129,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,CC(=O)c1ccc(-c2ccc(C(=O)NCCCCN3CCc4ccc(OS(=O)(=O)C(F)(F)F)cc4C3)cc2)cc1
CHEMBL291545,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,O=C(/C=C/c1ccc2[nH]ccc2c1)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1
CHEMBL432713,CHEMBL217,Dopamine D2 receptor,Ki,=,15.85,nM,CHEMBL670679,B,Binding affinity for Dopamine receptor D2 was determined,CHEMBL1133914,KI,O=C(/C=C/c1ccc(Cl)c(Cl)c1)NCCCCCN1CCC(c2c[nH]c3ccc(O)cc23)CC1
CHEMBL330865,CHEMBL217,Dopamine D2 receptor,Ki,=,219.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,COc1ccc2c(c1)CCC(C1CCN(CCc3ccccc3)CC1)C2=O
CHEMBL543176,CHEMBL217,Dopamine D2 receptor,Ki,=,1079.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,Br.O=C1c2ccccc2CCC1C1CCN(CC2CC2)CC1
CHEMBL73665,CHEMBL217,Dopamine D2 receptor,Ki,=,19.95,nM,CHEMBL670400,B,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,CHEMBL1128113,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccc(N)cc3)cc2)CC1
CHEMBL52987,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,COc1ccc(/C=C/C(=O)NCCCCN2CCc3ccc(OS(=O)(=O)C(F)(F)F)cc3C2)cc1
CHEMBL55840,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,O=C(/C=C/c1ccc2ccccc2c1)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1
CHEMBL52901,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,O=C(/C=C/c1cnc2ccccc2c1)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1
CHEMBL413343,CHEMBL217,Dopamine D2 receptor,Ki,=,330.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CNc1cc(OC)c(C(=O)NC[C@H]2CN(Cc3ccccc3)C[C@@H]2C)cc1Cl
CHEMBL413343,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CNc1cc(OC)c(C(=O)NC[C@H]2CN(Cc3ccccc3)C[C@@H]2C)cc1Cl
CHEMBL53833,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,O=C(NCCCCN1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1
CHEMBL52770,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,O=C(NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1)c1cccc(-c2ccccc2)c1
CHEMBL423440,CHEMBL217,Dopamine D2 receptor,Ki,=,2000.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,COc1ccc(Br)cc1C(=O)NC[C@H]1CCN(Cc2ccccc2)C1
CHEMBL423440,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,COc1ccc(Br)cc1C(=O)NC[C@H]1CCN(Cc2ccccc2)C1
CHEMBL54715,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,Cc1ccccc1-c1ccc(C(=O)NCCCCN2CCc3ccc(OS(=O)(=O)C(F)(F)F)cc3C2)cc1
CHEMBL57219,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(cccc2OS(=O)(=O)C(F)(F)F)C1
CHEMBL11066,CHEMBL217,Dopamine D2 receptor,Ki,=,2.4,nM,CHEMBL672486,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1126639,KI,CCCN1CC[C@@H]2Cc3c(O)cccc3C[C@H]21
CHEMBL11363,CHEMBL217,Dopamine D2 receptor,Ki,=,235.0,nM,CHEMBL672486,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1126639,KI,C=CCN1CC[C@@H]2Cc3c(O)cccc3C[C@H]21
CHEMBL70866,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL670400,B,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,CHEMBL1128113,KI,COc1ccc(OC)c(N2CCN(CCCCNC(=O)c3ccc(Br)cc3)CC2)c1
CHEMBL168566,CHEMBL217,Dopamine D2 receptor,Ki,=,820.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,COc1cc(N)c(Cl)cc1C(=O)NC[C@H]1CCN(Cc2ccccc2)C1
CHEMBL168566,CHEMBL217,Dopamine D2 receptor,Ki,=,540.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,COc1cc(N)c(Cl)cc1C(=O)NC[C@H]1CCN(Cc2ccccc2)C1
CHEMBL167414,CHEMBL217,Dopamine D2 receptor,Ki,=,1400.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,COc1cc(N)c(Cl)cc1C(=O)NC[C@@H]1CCN(Cc2ccccc2)C1
CHEMBL167414,CHEMBL217,Dopamine D2 receptor,Ki,=,640.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,COc1cc(N)c(Cl)cc1C(=O)NC[C@@H]1CCN(Cc2ccccc2)C1
CHEMBL169222,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CNc1cc(OC)c(C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2)cc1Cl
CHEMBL169222,CHEMBL217,Dopamine D2 receptor,Ki,=,58.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CNc1cc(OC)c(C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2)cc1Cl
CHEMBL101285,CHEMBL217,Dopamine D2 receptor,Ki,=,456.0,nM,CHEMBL671654,B,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,CHEMBL1131356,KI,Oc1ccccc1OCCNCc1ccccc1
CHEMBL99849,CHEMBL217,Dopamine D2 receptor,Ki,=,37.6,nM,CHEMBL671654,B,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,CHEMBL1131356,KI,CS(=O)(=O)Nc1cccc(OCCNCc2ccccc2)c1
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL670742,B,"Compound was evaluated for the binding affinity against [3H]U-86,170-labeled D2 sites in cloned CHO cells",CHEMBL1126639,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL11065,CHEMBL217,Dopamine D2 receptor,Ki,=,917.0,nM,CHEMBL672486,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1126639,KI,CCCN1CC[C@H]2Cc3c(O)cccc3C[C@@H]21
CHEMBL53351,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,CN(C)c1ccc(/C=C/C(=O)NCCCCN2CCc3ccc(OS(=O)(=O)C(F)(F)F)cc3C2)cc1
CHEMBL355566,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CNc1cc(OC)c(C(=O)NC[C@@H]2CN(Cc3ccccc3)C[C@@H]2C)cc1Cl
CHEMBL355566,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CNc1cc(OC)c(C(=O)NC[C@@H]2CN(Cc3ccccc3)C[C@@H]2C)cc1Cl
CHEMBL331470,CHEMBL217,Dopamine D2 receptor,Ki,=,344.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,O=C1c2ccc(F)cc2CCC1C1CCN(CCc2ccccc2)CC1
CHEMBL56,CHEMBL217,Dopamine D2 receptor,Ki,=,84.0,nM,CHEMBL670781,B,Binding affinity against Dopamine receptor D2,CHEMBL1129976,KI,CCCN(CCC)C1CCc2cccc(O)c2C1
CHEMBL354180,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CNc1cc(OC)c(C(=O)NC[C@@H]2CN(Cc3ccccc3)C[C@H]2C)cc1Cl
CHEMBL354180,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CNc1cc(OC)c(C(=O)NC[C@@H]2CN(Cc3ccccc3)C[C@H]2C)cc1Cl
CHEMBL168274,CHEMBL217,Dopamine D2 receptor,Ki,=,980.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CCC[C@H]1CN(Cc2ccccc2)C[C@@H]1CNC(=O)c1cc(Cl)c(NC)cc1OC
CHEMBL168274,CHEMBL217,Dopamine D2 receptor,Ki,=,540.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CCC[C@H]1CN(Cc2ccccc2)C[C@@H]1CNC(=O)c1cc(Cl)c(NC)cc1OC
CHEMBL543412,CHEMBL217,Dopamine D2 receptor,Ki,=,1630.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,Br.O=C(CC1CCN(CC2CC2)CC1)c1ccc(F)cc1
CHEMBL71960,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL670400,B,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,CHEMBL1128113,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(Br)cc2)CC1
CHEMBL279925,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,Cc1nnc(-c2ccc(-c3ccc(C(=O)NCCCCN4CCc5ccc(OS(=O)(=O)C(F)(F)F)cc5C4)cc3)cc2)o1
CHEMBL55276,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,O=C(/C=C/c1ccccc1)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1
CHEMBL55090,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,O=C(/C=C/c1ccc2ccccc2n1)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1
CHEMBL52468,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,O=C(/C=C/c1ccc2ncccc2c1)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1
CHEMBL544594,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,Cl.O=C1c2ccccc2CCC1C1CCN(Cc2ccccc2)CC1
CHEMBL553311,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,Cl.O=C(CCCN1CCC2(CCc3ccccc3C2=O)CC1)c1ccc(F)cc1
CHEMBL293347,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,CC(=O)c1ccc(/C=C/C(=O)NCCCCN2CCc3ccc(OS(=O)(=O)C(F)(F)F)cc3C2)cc1
CHEMBL52135,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,CC(=O)c1cccc(/C=C/C(=O)NCCCCN2CCc3ccc(OS(=O)(=O)C(F)(F)F)cc3C2)c1
CHEMBL54777,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,CNC(=O)c1ccc(-c2ccc(C(=O)NCCCCN3CCc4ccc(OS(=O)(=O)C(F)(F)F)cc4C3)cc2)cc1
CHEMBL168611,CHEMBL217,Dopamine D2 receptor,Ki,=,45.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CCC[C@H]1CN(Cc2ccccc2)C[C@H]1CNC(=O)c1cc(Cl)c(NC)cc1OC
CHEMBL168611,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CCC[C@H]1CN(Cc2ccccc2)C[C@H]1CNC(=O)c1cc(Cl)c(NC)cc1OC
CHEMBL297960,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,O=C(NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1)c1ccc(-c2ccc(N3CCCC3=O)cc2)cc1
CHEMBL300571,CHEMBL217,Dopamine D2 receptor,Ki,=,7.2,nM,CHEMBL671654,B,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,CHEMBL1131356,KI,Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CO2
CHEMBL11363,CHEMBL217,Dopamine D2 receptor,Ki,=,0.3,nM,CHEMBL672486,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1126639,KI,C=CCN1CC[C@@H]2Cc3c(O)cccc3C[C@H]21
CHEMBL71894,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL670400,B,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,CHEMBL1128113,KI,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(Br)cc1
CHEMBL52724,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,CNC(=O)c1cccc(-c2ccc(C(=O)NCCCCN3CCc4ccc(OS(=O)(=O)C(F)(F)F)cc4C3)cc2)c1
CHEMBL353090,CHEMBL217,Dopamine D2 receptor,Ki,=,3100.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,COc1ccc(Br)cc1C(=O)NC[C@@H]1CCN(Cc2ccccc2)C1
CHEMBL353090,CHEMBL217,Dopamine D2 receptor,Ki,=,1600.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,COc1ccc(Br)cc1C(=O)NC[C@@H]1CCN(Cc2ccccc2)C1
CHEMBL424575,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CCC[C@@H]1CN(Cc2ccccc2)C[C@@H]1CNC(=O)c1cc(Cl)c(NC)cc1OC
CHEMBL424575,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CCC[C@@H]1CN(Cc2ccccc2)C[C@@H]1CNC(=O)c1cc(Cl)c(NC)cc1OC
CHEMBL123014,CHEMBL217,Dopamine D2 receptor,Ki,=,540.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,COc1ccc2c(c1)CCC(C1CCN(Cc3ccccc3)CC1)C2=O
CHEMBL353087,CHEMBL217,Dopamine D2 receptor,Ki,=,19000.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,COc1cc(NC(C)=O)c(Cl)cc1C(=O)NC[C@@H]1CCN(Cc2ccccc2)C1
CHEMBL353087,CHEMBL217,Dopamine D2 receptor,Ki,=,21000.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,COc1cc(NC(C)=O)c(Cl)cc1C(=O)NC[C@@H]1CCN(Cc2ccccc2)C1
CHEMBL64508,CHEMBL217,Dopamine D2 receptor,Ki,=,75.8,nM,CHEMBL671654,B,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,CHEMBL1131356,KI,Oc1cccc(OCCNCc2ccccc2)c1
CHEMBL56,CHEMBL217,Dopamine D2 receptor,Ki,=,86.0,nM,CHEMBL672486,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1126639,KI,CCCN(CCC)C1CCc2cccc(O)c2C1
CHEMBL267044,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC
CHEMBL267044,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC
CHEMBL1713,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL670742,B,"Compound was evaluated for the binding affinity against [3H]U-86,170-labeled D2 sites in cloned CHO cells",CHEMBL1126639,KI,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21.Cl
CHEMBL123488,CHEMBL217,Dopamine D2 receptor,Ki,=,2192.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,O=C(O)CC(O)C(=O)O.O=C1c2ccccc2CCC12CCN(Cc1ccc(C(F)(F)F)cc1)CC2
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL670400,B,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,CHEMBL1128113,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL11388,CHEMBL217,Dopamine D2 receptor,Ki,=,75.0,nM,CHEMBL672486,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1126639,KI,CCCN1CC[C@@H]2Cc3c(cccc3OC)C[C@H]21
CHEMBL11066,CHEMBL217,Dopamine D2 receptor,Ki,=,0.5,nM,CHEMBL672486,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1126639,KI,CCCN1CC[C@@H]2Cc3c(O)cccc3C[C@H]21
CHEMBL88365,CHEMBL217,Dopamine D2 receptor,Ki,=,246.0,nM,CHEMBL671654,B,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,CHEMBL1131356,KI,Oc1cccc(N2CCN(Cc3ccccc3)CC2)c1
CHEMBL303336,CHEMBL217,Dopamine D2 receptor,Ki,=,640.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,c1ccc(CN2CCC3(CCCc4ccccc43)CC2)cc1
CHEMBL545058,CHEMBL217,Dopamine D2 receptor,Ki,=,125.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,Cl.O=C1c2ccc(Cl)cc2CCC1C1CCN(CCc2ccccc2)CC1
CHEMBL55524,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,O=C(/C=C\c1ccccc1)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1
CHEMBL64553,CHEMBL217,Dopamine D2 receptor,Ki,=,10.4,nM,CHEMBL671654,B,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,CHEMBL1131356,KI,Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2
CHEMBL11386,CHEMBL217,Dopamine D2 receptor,Ki,=,464.0,nM,CHEMBL672486,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1126639,KI,CCCN1[C@@H](C)C[C@@H]2Cc3cccc(OC)c3C[C@@H]21
CHEMBL545285,CHEMBL217,Dopamine D2 receptor,Ki,=,1137.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,Cl.O=C1c2ccccc2CCC12CCN(Cc1ccc(F)cc1)CC2
CHEMBL166587,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CNc1cc(OC)c(C(=O)NC[C@H]2CCN(Cc3ccccc3)C2)cc1Cl
CHEMBL166587,CHEMBL217,Dopamine D2 receptor,Ki,=,86.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CNc1cc(OC)c(C(=O)NC[C@H]2CCN(Cc3ccccc3)C2)cc1Cl
CHEMBL169193,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CNc1cc(OC)c(C(=O)NC[C@H]2CN(Cc3ccccc3)C[C@H]2C)cc1Cl
CHEMBL169193,CHEMBL217,Dopamine D2 receptor,Ki,=,79.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CNc1cc(OC)c(C(=O)NC[C@H]2CN(Cc3ccccc3)C[C@H]2C)cc1Cl
CHEMBL102490,CHEMBL217,Dopamine D2 receptor,Ki,=,9.0,nM,CHEMBL671654,B,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,CHEMBL1131356,KI,CS(=O)(=O)Nc1cc(OCCNCc2cccs2)ccc1Cl
CHEMBL267557,CHEMBL217,Dopamine D2 receptor,Ki,=,235.0,nM,CHEMBL672486,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1126639,KI,C=CCN1CC[C@H]2Cc3c(O)cccc3C[C@@H]21
CHEMBL542217,CHEMBL217,Dopamine D2 receptor,Ki,=,776.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,Br.CC(C1CC1)N1CCC(C2CCc3ccccc3C2=O)CC1
CHEMBL545287,CHEMBL217,Dopamine D2 receptor,Ki,=,61.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,Cl.O=C1c2ccccc2CCC1C1CCN(Cc2ccc(F)cc2)CC1
CHEMBL554437,CHEMBL217,Dopamine D2 receptor,Ki,=,1168.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,Cl.O=C1c2ccccc2CCC12CCN(CC1CCCCC1)CC2
CHEMBL11388,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL672486,B,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",CHEMBL1126639,KI,CCCN1CC[C@@H]2Cc3c(cccc3OC)C[C@H]21
CHEMBL552572,CHEMBL217,Dopamine D2 receptor,Ki,=,577.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,Cl.O=C1c2ccccc2CCC1C1CCN(Cc2ccc(C(F)(F)F)cc2)CC1
CHEMBL122538,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,O=C1c2ccc(F)cc2CCC1C1CCN(Cc2ccccc2)CC1
CHEMBL54948,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,Cc1cc(C(=O)NCCCCN2CCc3ccc(OS(=O)(=O)C(F)(F)F)cc3C2)ccc1-c1ccccc1
CHEMBL299038,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,O=C(NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1)c1ccc(-c2ccccc2)cc1
CHEMBL71707,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL670089,B,Binding affinity relative to indolopiperidine (compound 1) for Dopamine receptor D2 was determined,CHEMBL1133914,KI,O=C(/C=C/c1ccc(Cl)c(Cl)c1)N[C@H]1CC[C@@H](CN2[C@@H]3CC[C@H]2C[C@H](c2c[nH]c4ccc(O)cc24)C3)CC1
CHEMBL122165,CHEMBL217,Dopamine D2 receptor,Ki,=,515.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,O=C(O)/C=C/C(=O)O.O=C1c2c(F)cc(F)cc2CCC12CCN(CCc1ccccc1)CC2
CHEMBL52466,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,O=C(/C=C/c1ccc2nc(O)ccc2c1)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1
CHEMBL542709,CHEMBL217,Dopamine D2 receptor,Ki,=,1417.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,COc1ccc(CN2CCC3(CCc4ccccc4C3=O)CC2)cc1.Cl
CHEMBL167032,CHEMBL217,Dopamine D2 receptor,Ki,=,27000.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,COc1cc(NC(C)=O)c(Cl)cc1C(=O)NC[C@H]1CCN(Cc2ccccc2)C1
CHEMBL167032,CHEMBL217,Dopamine D2 receptor,Ki,=,25000.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,COc1cc(NC(C)=O)c(Cl)cc1C(=O)NC[C@H]1CCN(Cc2ccccc2)C1
CHEMBL124234,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,Cc1ccc(CN2CCC(C3CCc4ccccc4C3=O)CC2)cc1.O
CHEMBL169631,CHEMBL217,Dopamine D2 receptor,Ki,=,38000.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,COc1cc(N(C)C(C)=O)c(Cl)cc1C(=O)NC[C@H]1CCN(Cc2ccccc2)C1
CHEMBL169631,CHEMBL217,Dopamine D2 receptor,Ki,=,28000.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,COc1cc(N(C)C(C)=O)c(Cl)cc1C(=O)NC[C@H]1CCN(Cc2ccccc2)C1
CHEMBL168372,CHEMBL217,Dopamine D2 receptor,Ki,=,30000.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,COc1cc(N(C)C(C)=O)c(Cl)cc1C(=O)NC[C@@H]1CCN(Cc2ccccc2)C1
CHEMBL168372,CHEMBL217,Dopamine D2 receptor,Ki,=,19000.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,COc1cc(N(C)C(C)=O)c(Cl)cc1C(=O)NC[C@@H]1CCN(Cc2ccccc2)C1
CHEMBL99913,CHEMBL217,Dopamine D2 receptor,Ki,=,75.8,nM,CHEMBL671654,B,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,CHEMBL1131356,KI,CS(=O)(=O)Nc1cc(OCCNCc2ccccc2)ccc1Cl
CHEMBL539288,CHEMBL217,Dopamine D2 receptor,Ki,=,600.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,Br.O=C1c2ccccc2CCC1C1CCN(CCc2ccccc2)CC1
CHEMBL544123,CHEMBL217,Dopamine D2 receptor,Ki,=,1969.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,Cl.O=C1c2ccccc2CCC12CCN(Cc1ccc([N+](=O)[O-])cc1)CC2
CHEMBL294747,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL670400,B,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,CHEMBL1128113,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccc(C(C)=O)cc3)cc2)CC1
CHEMBL168544,CHEMBL217,Dopamine D2 receptor,Ki,=,54.0,nM,CHEMBL672913,B,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CCC[C@@H]1CN(Cc2ccccc2)C[C@H]1CNC(=O)c1cc(Cl)c(NC)cc1OC
CHEMBL168544,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL672576,B,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,CHEMBL1132075,KI,CCC[C@@H]1CN(Cc2ccccc2)C[C@H]1CNC(=O)c1cc(Cl)c(NC)cc1OC
CHEMBL51977,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(Cl)cccc2C1
CHEMBL416842,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,COc1cccc(/C=C/C(=O)NCCCCN2CCc3ccc(OS(=O)(=O)C(F)(F)F)cc3C2)c1
CHEMBL301475,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,O=C(/C=C/c1c[nH]c2ccccc12)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1
CHEMBL124411,CHEMBL217,Dopamine D2 receptor,Ki,=,410.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,CC(C)(C)c1ccc(CN2CCC(C3CCc4ccccc4C3=O)CC2)cc1
CHEMBL554874,CHEMBL217,Dopamine D2 receptor,Ki,=,3506.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,Cl.O=C1c2ccccc2CCC12CCN(Cc1ccccc1)CC2
CHEMBL423671,CHEMBL217,Dopamine D2 receptor,Ki,=,25.12,nM,CHEMBL670400,B,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,CHEMBL1128113,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccc(S(C)(=O)=O)cc3)cc2)CC1
CHEMBL542462,CHEMBL217,Dopamine D2 receptor,Ki,=,389.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,CC(C)(C)c1ccc(CN2CCC3(CCc4ccccc4C3=O)CC2)cc1.Cl
CHEMBL49,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL670781,B,Binding affinity against Dopamine receptor D2,CHEMBL1129976,KI,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
CHEMBL292577,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL672227,B,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1132014,KI,Cn1c(=O)ccc2cc(/C=C/C(=O)NCCCCN3CCc4ccc(OS(=O)(=O)C(F)(F)F)cc4C3)ccc21
CHEMBL543889,CHEMBL217,Dopamine D2 receptor,Ki,=,202.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,Cl.O=C1c2cccc(F)c2CCC1C1CCN(CCc2ccccc2)CC1
CHEMBL554873,CHEMBL217,Dopamine D2 receptor,Ki,=,2189.0,nM,CHEMBL673013,B,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,CHEMBL1127316,KI,Cl.O=C1c2ccccc2CCC12CCN(CCc1ccccc1)CC2
CHEMBL155124,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,O=C1CC(CN2CCN(c3ccccn3)CC2)Cc2ccccc21
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.6026,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL155388,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,COc1cc2c(cc1OC)C(=O)CC(CN1CCC(C(=O)c3ccc(F)cc3)CC1)C2
CHEMBL268799,CHEMBL217,Dopamine D2 receptor,Ki,=,71.0,nM,CHEMBL672164,B,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,CHEMBL1129306,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1
CHEMBL338270,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,O=C1c2ccccc2C(=O)N1CCCCCCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1
CHEMBL7549,CHEMBL217,Dopamine D2 receptor,Ki,=,9.0,nM,CHEMBL671177,B,Binding affinity of compound measured using [3H]spiperone for the cloned human dopamine receptor D2 long (high/low affinity is given as 9.0/1800),CHEMBL1134894,KI,CCCN1CCC[C@@H](c2cccc(O)c2)C1
CHEMBL7549,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL665383,B,Binding affinity of compound measured using [3H]spiperone for the cloned human dopamine receptor D2 short (high/low affinity is given as 27/1800),CHEMBL1134894,KI,CCCN1CCC[C@@H](c2cccc(O)c2)C1
CHEMBL541559,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL669942,B,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at high affinity state.,CHEMBL1125221,KI,Br.Oc1cc2c(c(Br)c1O)CCNCC2c1ccccc1
CHEMBL541559,CHEMBL217,Dopamine D2 receptor,Ki,=,2000.0,nM,CHEMBL669944,B,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at low affinity state.,CHEMBL1125221,KI,Br.Oc1cc2c(c(Br)c1O)CCNCC2c1ccccc1
CHEMBL155426,CHEMBL217,Dopamine D2 receptor,Ki,=,223.87,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,COc1ccc2c(c1)CC(CN1CCN(c3ccccc3OC)CC1)CC2=O
CHEMBL308480,CHEMBL217,Dopamine D2 receptor,Ki,=,223.87,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,O=C1CC(CN2CCC(C(=O)c3ccc(F)cc3)CC2)Cc2ccccc21
CHEMBL155257,CHEMBL217,Dopamine D2 receptor,Ki,=,151.36,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,COc1cc2c(cc1OC)C(=O)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)C2
CHEMBL445102,CHEMBL217,Dopamine D2 receptor,Ki,=,2.4,nM,CHEMBL672164,B,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,CHEMBL1129306,KI,OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.4,nM,CHEMBL672164,B,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,CHEMBL1129306,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL158402,CHEMBL217,Dopamine D2 receptor,Ki,=,1300.0,nM,CHEMBL672171,B,Binding affinity towards human dopamine receptor D2 by the displacement of [3H]spiperone radioligand from the cloned receptor expressed in CHO cells,CHEMBL1147426,KI,CN(C)CCSc1cccc(C2CCCCC2)n1
CHEMBL158973,CHEMBL217,Dopamine D2 receptor,Ki,=,330.0,nM,CHEMBL672171,B,Binding affinity towards human dopamine receptor D2 by the displacement of [3H]spiperone radioligand from the cloned receptor expressed in CHO cells,CHEMBL1147426,KI,CN(C)CCSC(C)(C)C
CHEMBL131495,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,O=C1c2ccccc2C(=O)N1CCCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1
CHEMBL308480,CHEMBL217,Dopamine D2 receptor,Ki,=,104.71,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,O=C1CC(CN2CCC(C(=O)c3ccc(F)cc3)CC2)Cc2ccccc21
CHEMBL423706,CHEMBL217,Dopamine D2 receptor,Ki,=,40.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,O=C(CCCN1CCC(CCc2c[nH]c3ccccc23)CC1)c1ccc(F)cc1
CHEMBL421902,CHEMBL217,Dopamine D2 receptor,Ki,=,40.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,O=C1c2ccc(F)cc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1
CHEMBL155257,CHEMBL217,Dopamine D2 receptor,Ki,=,162.18,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,COc1cc2c(cc1OC)C(=O)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)C2
CHEMBL308480,CHEMBL217,Dopamine D2 receptor,Ki,=,338.84,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,O=C1CC(CN2CCC(C(=O)c3ccc(F)cc3)CC2)Cc2ccccc21
CHEMBL421801,CHEMBL217,Dopamine D2 receptor,Ki,=,436.52,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,COc1ccc2c(c1)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)CC2=O
CHEMBL336771,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,O=C1c2ccc(F)cc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL672100,B,In vitro binding affinity towards Dopamine receptor D2 in human using [3H]-spiperone as radioligand,CHEMBL1139457,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,74.0,nM,CHEMBL672164,B,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,CHEMBL1129306,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL310153,CHEMBL217,Dopamine D2 receptor,Ki,=,204.17,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,COc1ccccc1N1CCN(CC2CC(=O)c3ccccc3C2)CC1
CHEMBL421801,CHEMBL217,Dopamine D2 receptor,Ki,=,457.09,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,COc1ccc2c(c1)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)CC2=O
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL133524,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1
CHEMBL544118,CHEMBL217,Dopamine D2 receptor,Ki,=,810000.0,nM,CHEMBL669942,B,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at high affinity state.,CHEMBL1125221,KI,CN1CCc2c(Cl)c(O)c(O)c(Cl)c2C(c2ccccc2)C1.Cl
CHEMBL414433,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1
CHEMBL340211,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL651364,B,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,CHEMBL1126960,KI,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1
CHEMBL339033,CHEMBL217,Dopamine D2 receptor,Ki,=,403.0,nM,CHEMBL651364,B,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,CHEMBL1126960,KI,O[C@H](CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL671176,B,Binding affinity of compound measured using [3H]-spiperone for the cloned human dopamine receptor D2 long (high/low affinity is given as 27/5400),CHEMBL1134894,KI,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,Ki,=,40.0,nM,CHEMBL665384,B,Binding affinity of compound measured using [3H]spiperone for the cloned human dopamine receptor D2 short (high/low affinity is given as 40/3600),CHEMBL1134894,KI,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL367045,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL672100,B,In vitro binding affinity towards Dopamine receptor D2 in human using [3H]-spiperone as radioligand,CHEMBL1139457,KI,CN1CCN(C2=Cn3cccc3Sc3ccccc32)CC1
CHEMBL155486,CHEMBL217,Dopamine D2 receptor,Ki,=,213.8,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2ccccc21
CHEMBL350166,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL672171,B,Binding affinity towards human dopamine receptor D2 by the displacement of [3H]spiperone radioligand from the cloned receptor expressed in CHO cells,CHEMBL1147426,KI,CN(C)CCSc1nc(-c2ccncc2)cs1
CHEMBL161765,CHEMBL217,Dopamine D2 receptor,Ki,=,450.0,nM,CHEMBL672171,B,Binding affinity towards human dopamine receptor D2 by the displacement of [3H]spiperone radioligand from the cloned receptor expressed in CHO cells,CHEMBL1147426,KI,CN(C)CCSc1cccc(-c2ccccc2)n1
CHEMBL158285,CHEMBL217,Dopamine D2 receptor,Ki,=,870.0,nM,CHEMBL672171,B,Binding affinity towards human dopamine receptor D2 by the displacement of [3H]spiperone radioligand from the cloned receptor expressed in CHO cells,CHEMBL1147426,KI,CN(C)CCSc1cccc(Br)n1
CHEMBL334956,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,O=C1c2ccccc2C(=O)N1CCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1
CHEMBL155486,CHEMBL217,Dopamine D2 receptor,Ki,=,64.57,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2ccccc21
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,3.7,nM,CHEMBL672100,B,In vitro binding affinity towards Dopamine receptor D2 in human using [3H]-spiperone as radioligand,CHEMBL1139457,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL340220,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,Cc1ccc2c(c1)C(=O)N(CCCCCN1CC=C(c3c[nH]c4ccc(F)cc34)CC1)C2=O
CHEMBL80845,CHEMBL217,Dopamine D2 receptor,Ki,=,230.0,nM,CHEMBL671175,B,Binding affinity of compound measured using [3H]spiperone for the cloned human dopamine receptor D2 long (high/low affinity is given as 230/53000),CHEMBL1134894,KI,CCCN1CCc2nn3ccccc3c2C1
CHEMBL80845,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL665382,B,Binding affinity of compound measured using [3H]spiperone for the cloned human dopamine receptor D2 short (high/low affinity is given as 130/50000),CHEMBL1134894,KI,CCCN1CCc2nn3ccccc3c2C1
CHEMBL59103,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL672164,B,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,CHEMBL1129306,KI,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1
CHEMBL59324,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL672164,B,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,CHEMBL1129306,KI,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1
CHEMBL545000,CHEMBL217,Dopamine D2 receptor,Ki,=,1900.0,nM,CHEMBL872494,B,The compound was evaluated for the binding affinity towards dopamine receptor D2 at high affinity state.,CHEMBL1125221,KI,CN1CCc2cc(O)c(O)cc2C(c2ccccc2)C1.Cl
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.44,nM,CHEMBL651364,B,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,CHEMBL1126960,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL130261,CHEMBL217,Dopamine D2 receptor,Ki,=,40.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,Cc1ccc2c(c1)C(=O)N(CCCCCN1CC=C(c3c[nH]c4ccccc34)CC1)C2=O
CHEMBL553503,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL669945,B,The compound was evaluated for the binding affinity towards dopamine receptor D2 at high affinity state.,CHEMBL1125221,KI,Br.Oc1cc2c(c(Cl)c1O)CCNCC2c1ccccc1
CHEMBL553503,CHEMBL217,Dopamine D2 receptor,Ki,=,8000.0,nM,CHEMBL669946,B,The compound was evaluated for the binding affinity towards dopamine receptor D2 at low affinity state.,CHEMBL1125221,KI,Br.Oc1cc2c(c(Cl)c1O)CCNCC2c1ccccc1
CHEMBL155388,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,COc1cc2c(cc1OC)C(=O)CC(CN1CCC(C(=O)c3ccc(F)cc3)CC1)C2
CHEMBL310867,CHEMBL217,Dopamine D2 receptor,Ki,=,85.0,nM,CHEMBL672385,B,Binding affinity of compound measured using [3H]spiperone for the cloned human Dopamine receptor D2L (high/low affinity is given as 85/6400),CHEMBL1134894,KI,CCCN(CCC)[C@H]1CCc2nn3ccccc3c2C1
CHEMBL310867,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL672574,B,Binding affinity of compound measured using [3H]spiperone for the cloned human dopamine receptor D2 short (high/low affinity is given as 35/3700),CHEMBL1134894,KI,CCCN(CCC)[C@H]1CCc2nn3ccccc3c2C1
CHEMBL554009,CHEMBL217,Dopamine D2 receptor,Ki,=,490.0,nM,CHEMBL669945,B,The compound was evaluated for the binding affinity towards dopamine receptor D2 at high affinity state.,CHEMBL1125221,KI,Br.CN1CCc2c(cc(O)c(O)c2Br)C(c2ccccc2)C1
CHEMBL554009,CHEMBL217,Dopamine D2 receptor,Ki,=,4000.0,nM,CHEMBL669946,B,The compound was evaluated for the binding affinity towards dopamine receptor D2 at low affinity state.,CHEMBL1125221,KI,Br.CN1CCc2c(cc(O)c(O)c2Br)C(c2ccccc2)C1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,223.87,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL27811,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,C1=C(c2c[nH]c3ccccc23)CCNC1
CHEMBL129852,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,Cc1cccc2c1C(=O)N(CCCCCN1CC=C(c3c[nH]c4ccccc34)CC1)C2=O
CHEMBL335259,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,Cc1cccc2c1C(=O)N(CCCCCN1CC=C(c3c[nH]c4ccc(F)cc34)CC1)C2=O
CHEMBL129159,CHEMBL217,Dopamine D2 receptor,Ki,=,279.0,nM,CHEMBL651364,B,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,CHEMBL1126960,KI,O[C@H](CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL339963,CHEMBL217,Dopamine D2 receptor,Ki,=,101.0,nM,CHEMBL651364,B,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,CHEMBL1126960,KI,O[C@@H](CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1
CHEMBL155388,CHEMBL217,Dopamine D2 receptor,Ki,=,275.42,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,COc1cc2c(cc1OC)C(=O)CC(CN1CCC(C(=O)c3ccc(F)cc3)CC1)C2
CHEMBL155486,CHEMBL217,Dopamine D2 receptor,Ki,=,57.54,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2ccccc21
CHEMBL129237,CHEMBL217,Dopamine D2 receptor,Ki,=,73.0,nM,CHEMBL651364,B,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,CHEMBL1126960,KI,O[C@@H](CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL157046,CHEMBL217,Dopamine D2 receptor,Ki,=,831.76,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,COc1cc2c(cc1OC)C(=O)CC(CN1CCN(c3ccccc3OC)CC1)C2
CHEMBL339098,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,O=C1c2cccc(F)c2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1
CHEMBL60859,CHEMBL217,Dopamine D2 receptor,Ki,=,3346.0,nM,CHEMBL651364,B,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,CHEMBL1126960,KI,OC(CCCN1CCN(c2ncc(F)cn2)CC1)c1ccc(F)cc1
CHEMBL544114,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL669945,B,The compound was evaluated for the binding affinity towards dopamine receptor D2 at high affinity state.,CHEMBL1125221,KI,Br.C=CCN1CCc2c(cc(O)c(O)c2Br)C(c2ccccc2)C1
CHEMBL544114,CHEMBL217,Dopamine D2 receptor,Ki,=,21000.0,nM,CHEMBL669946,B,The compound was evaluated for the binding affinity towards dopamine receptor D2 at low affinity state.,CHEMBL1125221,KI,Br.C=CCN1CCc2c(cc(O)c(O)c2Br)C(c2ccccc2)C1
CHEMBL129979,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1
CHEMBL153956,CHEMBL217,Dopamine D2 receptor,Ki,=,537.03,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,COc1ccc2c(c1)CC(CN1CCC(C(=O)c3ccc(F)cc3)CC1)CC2=O
CHEMBL57478,CHEMBL217,Dopamine D2 receptor,Ki,=,5500.0,nM,CHEMBL672164,B,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,CHEMBL1129306,KI,CC1CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL335844,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,O=C1c2cccc(F)c2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1
CHEMBL544115,CHEMBL217,Dopamine D2 receptor,Ki,=,55.0,nM,CHEMBL669942,B,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at high affinity state.,CHEMBL1125221,KI,Br.C=CCN1CCc2c(cc(O)c(O)c2Cl)C(c2ccccc2)C1
CHEMBL544115,CHEMBL217,Dopamine D2 receptor,Ki,=,1300.0,nM,CHEMBL669943,B,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at low affinity state,CHEMBL1125221,KI,Br.C=CCN1CCc2c(cc(O)c(O)c2Cl)C(c2ccccc2)C1
CHEMBL421801,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,COc1ccc2c(c1)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)CC2=O
CHEMBL542700,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL669941,B,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at high affinity state,CHEMBL1125221,KI,Cl.Oc1cc2c(cc1O)C(c1ccccc1)CNCC2
CHEMBL542700,CHEMBL217,Dopamine D2 receptor,Ki,=,8800.0,nM,CHEMBL669943,B,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at low affinity state,CHEMBL1125221,KI,Cl.Oc1cc2c(cc1O)C(c1ccccc1)CNCC2
CHEMBL153956,CHEMBL217,Dopamine D2 receptor,Ki,=,194.98,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,COc1ccc2c(c1)CC(CN1CCC(C(=O)c3ccc(F)cc3)CC1)CC2=O
CHEMBL153956,CHEMBL217,Dopamine D2 receptor,Ki,=,380.19,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,COc1ccc2c(c1)CC(CN1CCC(C(=O)c3ccc(F)cc3)CC1)CC2=O
CHEMBL155257,CHEMBL217,Dopamine D2 receptor,Ki,=,107.15,nM,CHEMBL670681,B,Binding affinity towards dopamine receptor D2,CHEMBL1149215,KI,COc1cc2c(cc1OC)C(=O)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)C2
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,960.0,nM,CHEMBL672164,B,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,CHEMBL1129306,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL543398,CHEMBL217,Dopamine D2 receptor,Ki,=,77.0,nM,CHEMBL669945,B,The compound was evaluated for the binding affinity towards dopamine receptor D2 at high affinity state.,CHEMBL1125221,KI,Br.CN1CCc2c(cc(O)c(O)c2Cl)C(c2ccccc2)C1
CHEMBL543398,CHEMBL217,Dopamine D2 receptor,Ki,=,2700.0,nM,CHEMBL669946,B,The compound was evaluated for the binding affinity towards dopamine receptor D2 at low affinity state.,CHEMBL1125221,KI,Br.CN1CCc2c(cc(O)c(O)c2Cl)C(c2ccccc2)C1
CHEMBL422618,CHEMBL217,Dopamine D2 receptor,Ki,=,40.0,nM,CHEMBL671418,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1136546,KI,Cc1cccc2c(C3=CCN(CCCCCN4C(=O)c5ccccc5C4=O)CC3)c[nH]c12
CHEMBL22156,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL674347,B,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1152020,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1
CHEMBL111749,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@@H]2C)cc1Cl
CHEMBL111749,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@@H]2C)cc1Cl
CHEMBL58296,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL671370,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1129307,KI,Clc1ccc(CN2CCC(c3cc(-c4ccc(Cl)cc4)on3)CC2)cc1
CHEMBL326454,CHEMBL217,Dopamine D2 receptor,Ki,=,2.3,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@H]2C)cc1Cl
CHEMBL326454,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@H]2C)cc1Cl
CHEMBL333836,CHEMBL217,Dopamine D2 receptor,Ki,=,195.0,nM,CHEMBL670880,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1129625,KI,CN1CCc2cccc3c2[C@H]1Cc1cccc(OS(=O)(=O)C(F)(F)F)c1-3
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,41.9,nM,CHEMBL670880,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1129625,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL113471,CHEMBL217,Dopamine D2 receptor,Ki,=,2500.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1c(C(=O)NCC[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12
CHEMBL113471,CHEMBL217,Dopamine D2 receptor,Ki,=,2800.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1c(C(=O)NCC[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12
CHEMBL112831,CHEMBL217,Dopamine D2 receptor,Ki,=,1600.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCCN(Cc2ccccc2)C1
CHEMBL112831,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCCN(Cc2ccccc2)C1
CHEMBL63209,CHEMBL217,Dopamine D2 receptor,Ki,=,7367.0,nM,CHEMBL672795,B,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,CHEMBL1132730,KI,CN1C(=O)C(N2CCN(Cc3ccc(Cl)cc3)CC2)CCc2ccccc21
CHEMBL280177,CHEMBL217,Dopamine D2 receptor,Ki,=,7.943,nM,CHEMBL674347,B,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1152020,KI,CCN1CCCCCC1c1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1
CHEMBL447476,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)N[C@H]2CCCN(Cc3ccccc3)C2)cc1Cl
CHEMBL447476,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)N[C@H]2CCCN(Cc3ccccc3)C2)cc1Cl
CHEMBL305276,CHEMBL217,Dopamine D2 receptor,Ki,=,133.0,nM,CHEMBL672795,B,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,CHEMBL1132730,KI,CN1C(=O)C(N2CCN(Cc3ccc(Cl)cc3)CC2)Cc2ccccc21
CHEMBL98305,CHEMBL217,Dopamine D2 receptor,Ki,=,1.14,nM,CHEMBL673086,B,Tested for agonist binding affinity by measuring displacement of [3H]NPA from Human Dopamine receptor D2L expressed in CHO K-1 cells,CHEMBL1133458,KI,CCCN1CCO[C@@H]2c3cc(O)ccc3SC[C@H]21
CHEMBL277945,CHEMBL217,Dopamine D2 receptor,Ki,=,6.31,nM,CHEMBL674347,B,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1152020,KI,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC
CHEMBL21118,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL674347,B,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1152020,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCC3)[nH]2)c1
CHEMBL281357,CHEMBL217,Dopamine D2 receptor,Ki,=,527.0,nM,CHEMBL670880,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1129625,KI,CN1CCc2cccc3c2[C@H]1Cc1ccccc1-3
CHEMBL333134,CHEMBL217,Dopamine D2 receptor,Ki,=,311.0,nM,CHEMBL670881,B,Displacement of [3H]-raclopride fromd human Dopamine receptor D2A expressed in LtK- cells,CHEMBL1129625,KI,CC(=O)c1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL118254,CHEMBL217,Dopamine D2 receptor,Ki,=,79.2,nM,CHEMBL670880,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1129625,KI,CCc1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL333725,CHEMBL217,Dopamine D2 receptor,Ki,=,1010.0,nM,CHEMBL670881,B,Displacement of [3H]-raclopride fromd human Dopamine receptor D2A expressed in LtK- cells,CHEMBL1129625,KI,CC(C)N1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3
CHEMBL109912,CHEMBL217,Dopamine D2 receptor,Ki,=,54.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)N[C@H]2CCN(Cc3ccccc3)C[C@@H]2C)cc1Cl
CHEMBL109912,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)N[C@H]2CCN(Cc3ccccc3)C[C@@H]2C)cc1Cl
CHEMBL113471,CHEMBL217,Dopamine D2 receptor,Ki,=,2000.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1c(C(=O)NCC[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12
CHEMBL113471,CHEMBL217,Dopamine D2 receptor,Ki,=,1900.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1c(C(=O)NCC[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12
CHEMBL61080,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL671370,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1129307,KI,Clc1ccc(CN2CCC(c3cc(-c4ccc(Cl)cc4)[nH]n3)CC2)cc1
CHEMBL21280,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL674347,B,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1152020,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCC3)[nH]2)c1
CHEMBL20763,CHEMBL217,Dopamine D2 receptor,Ki,=,7.943,nM,CHEMBL674347,B,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1152020,KI,CCN1CCCCC1c1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1
CHEMBL111749,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@@H]2C)cc1Cl
CHEMBL111749,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@@H]2C)cc1Cl
CHEMBL298875,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12
CHEMBL298875,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL670554,B,Ability to displace [3H]spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human cloned dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12
CHEMBL325772,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(I)c2ccccc12
CHEMBL325772,CHEMBL217,Dopamine D2 receptor,Ki,=,70.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(I)c2ccccc12
CHEMBL70565,CHEMBL217,Dopamine D2 receptor,Ki,=,1180.0,nM,CHEMBL673090,B,Tested for antagonist binding affinity by measuring displacement of [3H]spiperone from Human Dopamine receptor D2L expressed in CHO K-1 cells,CHEMBL1133458,KI,CCCN1CCO[C@@H]2c3cc(O)ccc3OC[C@H]21
CHEMBL21967,CHEMBL217,Dopamine D2 receptor,Ki,=,0.7943,nM,CHEMBL674347,B,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1152020,KI,CCN(Cc1ccccc1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1
CHEMBL280961,CHEMBL217,Dopamine D2 receptor,Ki,=,15.85,nM,CHEMBL674347,B,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1152020,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCC3c3ccccc3)[nH]2)c1
CHEMBL281177,CHEMBL217,Dopamine D2 receptor,Ki,=,12.59,nM,CHEMBL674347,B,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1152020,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCC3c3ccccc3)[nH]2)c1
CHEMBL119656,CHEMBL217,Dopamine D2 receptor,Ki,=,177.0,nM,CHEMBL670880,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1129625,KI,C=Cc1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL98836,CHEMBL217,Dopamine D2 receptor,Ki,=,74.0,nM,CHEMBL673086,B,Tested for agonist binding affinity by measuring displacement of [3H]NPA from Human Dopamine receptor D2L expressed in CHO K-1 cells,CHEMBL1133458,KI,CCCN1CCO[C@@H]2c3cc(O)ccc3SC[C@@H]21
CHEMBL77395,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL672168,B,Binding affinity towards human Dopamine receptor D2,CHEMBL1148372,KI,Fc1ccc2[nH]c(CN3CCN(c4ccccn4)CC3)cc2c1
CHEMBL325818,CHEMBL217,Dopamine D2 receptor,Ki,=,1300.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1c(C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12
CHEMBL325818,CHEMBL217,Dopamine D2 receptor,Ki,=,870.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1c(C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12
CHEMBL119154,CHEMBL217,Dopamine D2 receptor,Ki,=,826.0,nM,CHEMBL670881,B,Displacement of [3H]-raclopride fromd human Dopamine receptor D2A expressed in LtK- cells,CHEMBL1129625,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC)c1-3
CHEMBL325772,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(I)c2ccccc12
CHEMBL325772,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(I)c2ccccc12
CHEMBL112833,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,C#Cc1cc(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)c(OC)c2ccccc12
CHEMBL112833,CHEMBL217,Dopamine D2 receptor,Ki,=,82.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,C#Cc1cc(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)c(OC)c2ccccc12
CHEMBL447476,CHEMBL217,Dopamine D2 receptor,Ki,=,250.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)N[C@H]2CCCN(Cc3ccccc3)C2)cc1Cl
CHEMBL447476,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)N[C@H]2CCCN(Cc3ccccc3)C2)cc1Cl
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.4,nM,CHEMBL671370,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1129307,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL6416,CHEMBL217,Dopamine D2 receptor,Ki,=,520.0,nM,CHEMBL671370,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1129307,KI,Clc1ccc(-c2cc(C3CCN(CCc4ccccc4)CC3)[nH]n2)cc1
CHEMBL326454,CHEMBL217,Dopamine D2 receptor,Ki,=,3.7,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@H]2C)cc1Cl
CHEMBL326454,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@H]2C)cc1Cl
CHEMBL112831,CHEMBL217,Dopamine D2 receptor,Ki,=,7900.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCCN(Cc2ccccc2)C1
CHEMBL112831,CHEMBL217,Dopamine D2 receptor,Ki,=,4200.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCCN(Cc2ccccc2)C1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,113.0,nM,CHEMBL672795,B,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,CHEMBL1132730,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL67222,CHEMBL217,Dopamine D2 receptor,Ki,=,1373.0,nM,CHEMBL672795,B,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,CHEMBL1132730,KI,O=C1Nc2ccccc2CC1N1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL115969,CHEMBL217,Dopamine D2 receptor,Ki,=,183.0,nM,CHEMBL670880,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1129625,KI,CN1CCc2cccc3c2[C@H]1Cc1cccc(C#N)c1-3
CHEMBL333085,CHEMBL217,Dopamine D2 receptor,Ki,=,1330.0,nM,CHEMBL670881,B,Displacement of [3H]-raclopride fromd human Dopamine receptor D2A expressed in LtK- cells,CHEMBL1129625,KI,COc1ccccc1-c1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL322802,CHEMBL217,Dopamine D2 receptor,Ki,=,8.6,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(Cc2ccccc2)C[C@@H]1C
CHEMBL322802,CHEMBL217,Dopamine D2 receptor,Ki,=,7.4,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(Cc2ccccc2)C[C@@H]1C
CHEMBL325109,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1
CHEMBL325109,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1
CHEMBL119455,CHEMBL217,Dopamine D2 receptor,Ki,=,58.5,nM,CHEMBL670880,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1129625,KI,CN1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3
CHEMBL115402,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL670880,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1129625,KI,COc1cccc2c1-c1cccc3c1[C@@H](C2)N(C(C)C)CC3
CHEMBL20395,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL674347,B,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1152020,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCCC3c3ccccc3)[nH]2)c1
CHEMBL109472,CHEMBL217,Dopamine D2 receptor,Ki,=,6400.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(C#Cc2ccccc2)c2ccccc12
CHEMBL109472,CHEMBL217,Dopamine D2 receptor,Ki,=,4000.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(C#Cc2ccccc2)c2ccccc12
CHEMBL20407,CHEMBL217,Dopamine D2 receptor,Ki,=,3162.28,nM,CHEMBL674347,B,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1152020,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCOCC3)[nH]2)c1
CHEMBL22022,CHEMBL217,Dopamine D2 receptor,Ki,=,79.43,nM,CHEMBL674347,B,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1152020,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(C(C)N3CCCCCC3)[nH]2)c1
CHEMBL112395,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)NC2CCN(Cc3ccccc3)CC2)cc1Cl
CHEMBL112395,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)NC2CCN(Cc3ccccc3)CC2)cc1Cl
CHEMBL69584,CHEMBL217,Dopamine D2 receptor,Ki,=,690.0,nM,CHEMBL672795,B,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,CHEMBL1132730,KI,O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2ccccc21
CHEMBL27940,CHEMBL217,Dopamine D2 receptor,Ki,=,201.0,nM,CHEMBL670880,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1129625,KI,Cc1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL25924,CHEMBL217,Dopamine D2 receptor,Ki,=,233.0,nM,CHEMBL670880,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1129625,KI,CN1CCc2cccc3c2[C@H]1Cc1cccc(-c2ccccc2)c1-3
CHEMBL277631,CHEMBL217,Dopamine D2 receptor,Ki,=,25.12,nM,CHEMBL674347,B,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1152020,KI,CCN1CCCC1c1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1
CHEMBL282287,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL674347,B,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1152020,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(C(C)N3CCCC3)[nH]2)c1
CHEMBL20785,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL674347,B,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1152020,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(C(C)N3CCCCC3)[nH]2)c1
CHEMBL322802,CHEMBL217,Dopamine D2 receptor,Ki,=,470.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(Cc2ccccc2)C[C@@H]1C
CHEMBL322802,CHEMBL217,Dopamine D2 receptor,Ki,=,340.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(Cc2ccccc2)C[C@@H]1C
CHEMBL321492,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@H]2C)cc(Br)c2ccccc12
CHEMBL321492,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL670554,B,Ability to displace [3H]spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human cloned dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@H]2C)cc(Br)c2ccccc12
CHEMBL68191,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL672795,B,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,CHEMBL1132730,KI,CCN1C(=O)C(N2CCN(Cc3ccc(Cl)cc3)CC2)Cc2ccccc21
CHEMBL325818,CHEMBL217,Dopamine D2 receptor,Ki,=,640.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1c(C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12
CHEMBL325818,CHEMBL217,Dopamine D2 receptor,Ki,=,420.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1c(C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12
CHEMBL440687,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL672095,B,In vitro binding affinity tested on human Dopamine receptor D2 using [3H]spiperon as a radioligand,CHEMBL1148372,KI,c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1
CHEMBL440687,CHEMBL217,Dopamine D2 receptor,Ki,=,51000.0,nM,CHEMBL672097,B,In vitro binding affinity tested on human Dopamine receptor D2 (short) using [3H]spiperone as a radioligand,CHEMBL1148372,KI,c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1
CHEMBL440687,CHEMBL217,Dopamine D2 receptor,Ki,=,15000.0,nM,CHEMBL672096,B,In vitro binding affinity tested on human Dopamine receptor D2 (long) using [3H]spiperon as a radioligand,CHEMBL1148372,KI,c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1
CHEMBL277684,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL674347,B,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1152020,KI,CCN(CC)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1
CHEMBL298875,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12
CHEMBL298875,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12
CHEMBL99355,CHEMBL217,Dopamine D2 receptor,Ki,=,197.0,nM,CHEMBL673086,B,Tested for agonist binding affinity by measuring displacement of [3H]NPA from Human Dopamine receptor D2L expressed in CHO K-1 cells,CHEMBL1133458,KI,CCCN1CCOC2c3cc(O)ccc3[S+]([O-])CC21
CHEMBL430522,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@@H]2C)cc(Br)c2ccccc12
CHEMBL430522,CHEMBL217,Dopamine D2 receptor,Ki,=,700.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@@H]2C)cc(Br)c2ccccc12
CHEMBL27559,CHEMBL217,Dopamine D2 receptor,Ki,=,12.7,nM,CHEMBL670880,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1129625,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3
CHEMBL279039,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL674347,B,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,CHEMBL1152020,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3)[nH]2)c1
CHEMBL61079,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL671370,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1129307,KI,Cc1c(C2CCN(CCc3ccccc3)CC2)n[nH]c1-c1ccc(Cl)cc1
CHEMBL98197,CHEMBL217,Dopamine D2 receptor,Ki,=,854.0,nM,CHEMBL673086,B,Tested for agonist binding affinity by measuring displacement of [3H]NPA from Human Dopamine receptor D2L expressed in CHO K-1 cells,CHEMBL1133458,KI,CCCN1CCO[C@H]2c3cc(O)ccc3SC[C@@H]21
CHEMBL430522,CHEMBL217,Dopamine D2 receptor,Ki,=,490.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@@H]2C)cc(Br)c2ccccc12
CHEMBL430522,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@@H]2C)cc(Br)c2ccccc12
CHEMBL112833,CHEMBL217,Dopamine D2 receptor,Ki,=,500.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,C#Cc1cc(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)c(OC)c2ccccc12
CHEMBL112833,CHEMBL217,Dopamine D2 receptor,Ki,=,250.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,C#Cc1cc(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)c(OC)c2ccccc12
CHEMBL302075,CHEMBL217,Dopamine D2 receptor,Ki,=,93.0,nM,CHEMBL672795,B,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,CHEMBL1132730,KI,Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c(Cl)c1
CHEMBL109472,CHEMBL217,Dopamine D2 receptor,Ki,=,7700.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(C#Cc2ccccc2)c2ccccc12
CHEMBL109472,CHEMBL217,Dopamine D2 receptor,Ki,=,5500.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(C#Cc2ccccc2)c2ccccc12
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,74.0,nM,CHEMBL671370,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1129307,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL117841,CHEMBL217,Dopamine D2 receptor,Ki,=,551.0,nM,CHEMBL670880,B,Displacement of [3H]raclopride from human Dopamine receptor D2A,CHEMBL1129625,KI,COc1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL330216,CHEMBL217,Dopamine D2 receptor,Ki,=,533.0,nM,CHEMBL673090,B,Tested for antagonist binding affinity by measuring displacement of [3H]spiperone from Human Dopamine receptor D2L expressed in CHO K-1 cells,CHEMBL1133458,KI,CCCN1CCOC2c3cc(O)ccc3SCC21
CHEMBL109912,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)N[C@H]2CCN(Cc3ccccc3)C[C@@H]2C)cc1Cl
CHEMBL109912,CHEMBL217,Dopamine D2 receptor,Ki,=,6.4,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,CNc1cc(OC)c(C(=O)N[C@H]2CCN(Cc3ccccc3)C[C@@H]2C)cc1Cl
CHEMBL321492,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL671368,B,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,CHEMBL1136241,KI,COc1c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@H]2C)cc(Br)c2ccccc12
CHEMBL321492,CHEMBL217,Dopamine D2 receptor,Ki,=,135.0,nM,CHEMBL872881,B,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL1136241,KI,COc1c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@H]2C)cc(Br)c2ccccc12
CHEMBL61195,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL671370,B,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1129307,KI,Clc1ccc(CN2CCC(c3cc(-c4ccc(Cl)cc4)no3)CC2)cc1
CHEMBL87625,CHEMBL217,Dopamine D2 receptor,Ki,=,4985.0,nM,CHEMBL670392,B,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1128063,KI,CN(C)CCCOc1ccc(-c2nc3ccccc3n2C/C=C/Cn2c(-c3ccc(OCCCN(C)C)cc3)nc3ccccc32)cc1
CHEMBL83722,CHEMBL217,Dopamine D2 receptor,Ki,=,3945.0,nM,CHEMBL670392,B,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1128063,KI,C(=C/Cn1c(-c2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2)nc2ccccc21)\Cn1c(-c2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2)nc2ccccc21
CHEMBL135152,CHEMBL217,Dopamine D2 receptor,Ki,=,380.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCNC1CCc2c(cccc2OC)C1
CHEMBL11615,CHEMBL217,Dopamine D2 receptor,Ki,=,416.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN(CCC)C1CCc2c(cccc2OC)C1
CHEMBL315564,CHEMBL217,Dopamine D2 receptor,Ki,=,3700.0,nM,CHEMBL671178,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,CHEMBL1134812,KI,COc1ccc(Br)cc1C1=N[C@@H](CN2CCN(c3ccccc3)CC2)[C@@H](C)O1
CHEMBL315564,CHEMBL217,Dopamine D2 receptor,Ki,=,2400.0,nM,CHEMBL665385,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,CHEMBL1134812,KI,COc1ccc(Br)cc1C1=N[C@@H](CN2CCN(c3ccccc3)CC2)[C@@H](C)O1
CHEMBL83306,CHEMBL217,Dopamine D2 receptor,Ki,=,820.0,nM,CHEMBL671178,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,CHEMBL1134812,KI,C[C@@H]1OC(c2ccccc2)=N[C@H]1CN1CCN(c2ccccc2)CC1
CHEMBL83306,CHEMBL217,Dopamine D2 receptor,Ki,=,320.0,nM,CHEMBL665385,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,CHEMBL1134812,KI,C[C@@H]1OC(c2ccccc2)=N[C@H]1CN1CCN(c2ccccc2)CC1
CHEMBL336295,CHEMBL217,Dopamine D2 receptor,Ki,=,550.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN(CCc1cccs1)[C@@H]1CCc2ccc(OC)cc2C1
CHEMBL132261,CHEMBL217,Dopamine D2 receptor,Ki,=,1046.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN(CCc1cccs1)C1CCc2c(cccc2OC2CCCC2)C1
CHEMBL316222,CHEMBL217,Dopamine D2 receptor,Ki,=,2345.0,nM,CHEMBL670392,B,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1128063,KI,CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2C/C=C/Cn2c(-c3ccc(OCCCN(CC)CC)cc3)nc3ccccc32)cc1
CHEMBL106737,CHEMBL217,Dopamine D2 receptor,Ki,=,158.0,nM,CHEMBL671485,B,Compound is evaluated for binding affinity towards Dopamine receptor D2 using [3H]spiperone in CHO cells,CHEMBL1131058,KI,COc1ccccc1N1CCN(CC2CN=C3c4ccccc4NC(=O)N32)CC1
CHEMBL106737,CHEMBL217,Dopamine D2 receptor,Ki,=,239.0,nM,CHEMBL672180,B,Compound is evaluated for binding affinity towards recombinant human Dopamine receptor D2 using [3H]spiperone in CHO cells,CHEMBL1131058,KI,COc1ccccc1N1CCN(CC2CN=C3c4ccccc4NC(=O)N32)CC1
CHEMBL310045,CHEMBL217,Dopamine D2 receptor,Ki,=,1.3,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,Oc1nc2cccc(N3CCN(Cc4cccc(-c5ccsc5)c4)CC3)c2o1
CHEMBL80230,CHEMBL217,Dopamine D2 receptor,Ki,=,0.41,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,Oc1nc2cccc(N3CCN(Cc4ccc(O)c(-c5ccccc5)c4)CC3)c2o1
CHEMBL134747,CHEMBL217,Dopamine D2 receptor,Ki,=,524.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN(CCc1ccccc1)C1CCc2ccc(O)cc2C1
CHEMBL134759,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCNC1CCc2c(cccc2OC)C1
CHEMBL441092,CHEMBL217,Dopamine D2 receptor,Ki,=,1492.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,NC1CCc2c(O)cccc2C1
CHEMBL76990,CHEMBL217,Dopamine D2 receptor,Ki,=,1.8,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,Oc1nc2cccc(N3CCN(Cc4cncc(-c5ccccc5)c4)CC3)c2o1
CHEMBL540039,CHEMBL217,Dopamine D2 receptor,Ki,=,14000.0,nM,CHEMBL671178,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,CHEMBL1134812,KI,Cl.c1ccc(C2=NC[C@H](CN3CCN(c4ccccc4)CC3)N2)cc1
CHEMBL540039,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL665385,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,CHEMBL1134812,KI,Cl.c1ccc(C2=NC[C@H](CN3CCN(c4ccccc4)CC3)N2)cc1
CHEMBL7806,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN(CCc1ccsc1)C1CCc2c(O)cccc2C1
CHEMBL7806,CHEMBL217,Dopamine D2 receptor,Ki,=,0.14,nM,CHEMBL670173,B,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,CHEMBL1129692,KI,CCCN(CCc1ccsc1)C1CCc2c(O)cccc2C1
CHEMBL133830,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,NC1CCc2ccc(O)cc2C1
CHEMBL133830,CHEMBL217,Dopamine D2 receptor,Ki,=,3.3,nM,CHEMBL670173,B,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,CHEMBL1129692,KI,NC1CCc2ccc(O)cc2C1
CHEMBL313257,CHEMBL217,Dopamine D2 receptor,Ki,=,1750.0,nM,CHEMBL670392,B,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1128063,KI,CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2CCCCCCn2c(-c3ccc(OCCCN(CC)CC)cc3)nc3ccccc32)cc1
CHEMBL315560,CHEMBL217,Dopamine D2 receptor,Ki,=,1414.0,nM,CHEMBL670392,B,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1128063,KI,CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2C/C=C/Cn2c(-c3ccc(OC)cc3)nc3ccccc32)cc1
CHEMBL135944,CHEMBL217,Dopamine D2 receptor,Ki,=,3351.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN(CCC)[C@H]1CCc2ccc(OC)cc2C1
CHEMBL305834,CHEMBL217,Dopamine D2 receptor,Ki,=,9.3,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,Cc1cccc(-c2cccc(CN3CCN(c4cccc5nc(O)oc45)CC3)c2)c1
CHEMBL313320,CHEMBL217,Dopamine D2 receptor,Ki,=,2200.0,nM,CHEMBL671178,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,CHEMBL1134812,KI,COc1ccc(Br)cc1C1=N[C@@H](CN2CCN(c3ccccc3)CC2)CO1
CHEMBL313320,CHEMBL217,Dopamine D2 receptor,Ki,=,900.0,nM,CHEMBL665385,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,CHEMBL1134812,KI,COc1ccc(Br)cc1C1=N[C@@H](CN2CCN(c3ccccc3)CC2)CO1
CHEMBL308345,CHEMBL217,Dopamine D2 receptor,Ki,=,0.47,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,Oc1nc2cccc(N3CCN(Cc4cc(-c5ccc(F)cc5)ccn4)CC3)c2o1
CHEMBL82527,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL671178,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,CHEMBL1134812,KI,c1ccc(C2=N[C@@H](CN3CCN(c4ccccc4)CC3)CS2)cc1
CHEMBL82527,CHEMBL217,Dopamine D2 receptor,Ki,=,720.0,nM,CHEMBL665385,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,CHEMBL1134812,KI,c1ccc(C2=N[C@@H](CN3CCN(c4ccccc4)CC3)CS2)cc1
CHEMBL86249,CHEMBL217,Dopamine D2 receptor,Ki,=,803.0,nM,CHEMBL670392,B,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1128063,KI,CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2C/C=C/Cn2c(-c3ccc(OCCCN4CCN(c5ccccc5)CC4)cc3)nc3ccccc32)cc1
CHEMBL83306,CHEMBL217,Dopamine D2 receptor,Ki,=,3200.0,nM,CHEMBL671178,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,CHEMBL1134812,KI,C[C@@H]1OC(c2ccccc2)=N[C@H]1CN1CCN(c2ccccc2)CC1
CHEMBL83306,CHEMBL217,Dopamine D2 receptor,Ki,=,1900.0,nM,CHEMBL665385,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,CHEMBL1134812,KI,C[C@@H]1OC(c2ccccc2)=N[C@H]1CN1CCN(c2ccccc2)CC1
CHEMBL305706,CHEMBL217,Dopamine D2 receptor,Ki,=,4777.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN(CCC)[C@H]1CCc2ccc(O)cc2C1
CHEMBL305706,CHEMBL217,Dopamine D2 receptor,Ki,=,275.0,nM,CHEMBL670173,B,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,CHEMBL1129692,KI,CCCN(CCC)[C@H]1CCc2ccc(O)cc2C1
CHEMBL77934,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,Oc1nc2cccc(N3CCN(Cc4cccc(-c5cccc(Cl)c5)c4)CC3)c2o1
CHEMBL86060,CHEMBL217,Dopamine D2 receptor,Ki,=,690.0,nM,CHEMBL671178,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,CHEMBL1134812,KI,c1ccc(C2=N[C@@H](CN3CCN(c4ccccc4)CC3)CO2)cc1
CHEMBL86060,CHEMBL217,Dopamine D2 receptor,Ki,=,330.0,nM,CHEMBL665385,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,CHEMBL1134812,KI,c1ccc(C2=N[C@@H](CN3CCN(c4ccccc4)CC3)CO2)cc1
CHEMBL315564,CHEMBL217,Dopamine D2 receptor,Ki,=,21000.0,nM,CHEMBL671178,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,CHEMBL1134812,KI,COc1ccc(Br)cc1C1=N[C@@H](CN2CCN(c3ccccc3)CC2)[C@@H](C)O1
CHEMBL315564,CHEMBL217,Dopamine D2 receptor,Ki,=,18000.0,nM,CHEMBL665385,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,CHEMBL1134812,KI,COc1ccc(Br)cc1C1=N[C@@H](CN2CCN(c3ccccc3)CC2)[C@@H](C)O1
CHEMBL335971,CHEMBL217,Dopamine D2 receptor,Ki,=,58882.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN[C@@H]1CCc2ccc(OC)cc2C1
CHEMBL335392,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN(C)C1CCc2ccc(O)cc2C1
CHEMBL335392,CHEMBL217,Dopamine D2 receptor,Ki,=,0.67,nM,CHEMBL670173,B,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,CHEMBL1129692,KI,CCCN(C)C1CCc2ccc(O)cc2C1
CHEMBL313692,CHEMBL217,Dopamine D2 receptor,Ki,=,3438.0,nM,CHEMBL670392,B,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1128063,KI,CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2Cc2ccc(Cn3c(-c4ccc(OCCCN(CC)CC)cc4)nc4ccccc43)cc2)cc1
CHEMBL430242,CHEMBL217,Dopamine D2 receptor,Ki,=,6530.0,nM,CHEMBL670392,B,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1128063,KI,CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2C/C=C/Cn2c(-c3ccccc3)nc3ccccc32)cc1
CHEMBL305920,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,O=C1COc2c(cccc2N2CCN(Cc3cccc(-c4ccccc4)c3)CC2)N1
CHEMBL135954,CHEMBL217,Dopamine D2 receptor,Ki,=,59.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN(CCc1cccs1)C1CCc2ccc(O)cc2C1
CHEMBL135954,CHEMBL217,Dopamine D2 receptor,Ki,=,0.76,nM,CHEMBL670173,B,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,CHEMBL1129692,KI,CCCN(CCc1cccs1)C1CCc2ccc(O)cc2C1
CHEMBL87716,CHEMBL217,Dopamine D2 receptor,Ki,=,472.0,nM,CHEMBL670392,B,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1128063,KI,CCCCN(CCCC)CCCOc1ccc(-c2nc3ccccc3n2C/C=C/Cn2c(-c3ccc(OCCCN(CCCC)CCCC)cc3)nc3ccccc32)cc1
CHEMBL306634,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,Cn1c(=O)oc2c(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)cccc21
CHEMBL80156,CHEMBL217,Dopamine D2 receptor,Ki,=,6.0,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,N#Cc1cccc(-c2cccc(CN3CCN(c4cccc5nc(O)oc45)CC3)c2)c1
CHEMBL86060,CHEMBL217,Dopamine D2 receptor,Ki,=,1700.0,nM,CHEMBL671178,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,CHEMBL1134812,KI,c1ccc(C2=N[C@@H](CN3CCN(c4ccccc4)CC3)CO2)cc1
CHEMBL86060,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL665385,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,CHEMBL1134812,KI,c1ccc(C2=N[C@@H](CN3CCN(c4ccccc4)CC3)CO2)cc1
CHEMBL134326,CHEMBL217,Dopamine D2 receptor,Ki,=,5882.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN(CCC)[C@@H]1CCc2ccc(OC)cc2C1
CHEMBL334472,CHEMBL217,Dopamine D2 receptor,Ki,=,285.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCNC1CCc2c(O)cccc2C1
CHEMBL334472,CHEMBL217,Dopamine D2 receptor,Ki,=,0.5,nM,CHEMBL670173,B,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,CHEMBL1129692,KI,CCCNC1CCc2c(O)cccc2C1
CHEMBL75621,CHEMBL217,Dopamine D2 receptor,Ki,=,2.2,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,Oc1nc2cccc(N3CCN(Cc4cccc(-c5cccs5)c4)CC3)c2o1
CHEMBL109684,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN(CCc1ccccc1)C1CCc2c(O)cccc2C1
CHEMBL109684,CHEMBL217,Dopamine D2 receptor,Ki,=,0.5,nM,CHEMBL670173,B,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,CHEMBL1129692,KI,CCCN(CCc1ccccc1)C1CCc2c(O)cccc2C1
CHEMBL301559,CHEMBL217,Dopamine D2 receptor,Ki,=,56.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1
CHEMBL301559,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL670173,B,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,CHEMBL1129692,KI,CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1
CHEMBL58377,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,COc1ccccc1N1CCN(CCNC(=O)c2ccc(F)cc2)CC1
CHEMBL540039,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL673085,B,In vitro for its ability to displace [3H]- spiperone from cloned human Dopamine receptor D2L expressed in CHO cells,CHEMBL1134812,KI,Cl.c1ccc(C2=NC[C@H](CN3CCN(c4ccccc4)CC3)N2)cc1
CHEMBL540039,CHEMBL217,Dopamine D2 receptor,Ki,=,11000.0,nM,CHEMBL675128,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,CHEMBL1134812,KI,Cl.c1ccc(C2=NC[C@H](CN3CCN(c4ccccc4)CC3)N2)cc1
CHEMBL82527,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL671178,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,CHEMBL1134812,KI,c1ccc(C2=N[C@@H](CN3CCN(c4ccccc4)CC3)CS2)cc1
CHEMBL82527,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL665385,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,CHEMBL1134812,KI,c1ccc(C2=N[C@@H](CN3CCN(c4ccccc4)CC3)CS2)cc1
CHEMBL336652,CHEMBL217,Dopamine D2 receptor,Ki,=,836.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCNC1CCc2ccc(O)cc2C1
CHEMBL336652,CHEMBL217,Dopamine D2 receptor,Ki,=,3.8,nM,CHEMBL670173,B,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,CHEMBL1129692,KI,CCCNC1CCc2ccc(O)cc2C1
CHEMBL77472,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,c1ccc(-c2cccc(CN3CCN(c4cccc5c4OCCO5)CC3)c2)cc1
CHEMBL313320,CHEMBL217,Dopamine D2 receptor,Ki,=,400.0,nM,CHEMBL671178,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,CHEMBL1134812,KI,COc1ccc(Br)cc1C1=N[C@@H](CN2CCN(c3ccccc3)CC2)CO1
CHEMBL313320,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL665385,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,CHEMBL1134812,KI,COc1ccc(Br)cc1C1=N[C@@H](CN2CCN(c3ccccc3)CC2)CO1
CHEMBL30560,CHEMBL217,Dopamine D2 receptor,Ki,=,334.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,COc1cccc2c1CCC(N)C2
CHEMBL314663,CHEMBL217,Dopamine D2 receptor,Ki,=,56.0,nM,CHEMBL670392,B,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1128063,KI,C(=C/Cn1c(-c2ccc(OCCCN3CCCC3)cc2)nc2ccccc21)\Cn1c(-c2ccc(OCCCN3CCCC3)cc2)nc2ccccc21
CHEMBL309215,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,COc1cccc(-c2cccc(CN3CCN(c4cccc5nc(O)oc45)CC3)c2)c1
CHEMBL133938,CHEMBL217,Dopamine D2 receptor,Ki,=,1241.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN(CCc1cccs1)[C@H]1CCc2ccc(OC)cc2C1
CHEMBL133938,CHEMBL217,Dopamine D2 receptor,Ki,=,250.0,nM,CHEMBL670173,B,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,CHEMBL1129692,KI,CCCN(CCc1cccs1)[C@H]1CCc2ccc(OC)cc2C1
CHEMBL78058,CHEMBL217,Dopamine D2 receptor,Ki,=,4.6,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,O=C(NCCN1CCN(c2cccc3nc(O)oc23)CC1)c1ccc(F)cc1
CHEMBL218166,CHEMBL217,Dopamine D2 receptor,Ki,=,2.2,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1
CHEMBL310048,CHEMBL217,Dopamine D2 receptor,Ki,=,0.93,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,c1ccc(-c2cccc(CN3CCN(c4cccc5c4OCCN5)CC3)c2)cc1
CHEMBL134866,CHEMBL217,Dopamine D2 receptor,Ki,=,181.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,COc1cccc2c1CCC(N(C)C)C2
CHEMBL313147,CHEMBL217,Dopamine D2 receptor,Ki,=,1495.0,nM,CHEMBL670392,B,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1128063,KI,CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2CCCCn2c(-c3ccc(OCCCN(CC)CC)cc3)nc3ccccc32)cc1
CHEMBL419275,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,Oc1nc2cccc(N3CCN(Cc4cccc(-c5ccc(F)cc5)n4)CC3)c2o1
CHEMBL135932,CHEMBL217,Dopamine D2 receptor,Ki,=,55.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CN(C)C1CCc2ccc(O)cc2C1
CHEMBL135932,CHEMBL217,Dopamine D2 receptor,Ki,=,5.4,nM,CHEMBL670173,B,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,CHEMBL1129692,KI,CN(C)C1CCc2ccc(O)cc2C1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.4,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL86129,CHEMBL217,Dopamine D2 receptor,Ki,=,517.0,nM,CHEMBL670392,B,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1128063,KI,C(=C/Cn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc21)\Cn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc21
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,64.0,nM,CHEMBL671647,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells; high binding affinity,CHEMBL1134812,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,31000.0,nM,CHEMBL671646,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells; Low binding affinity,CHEMBL1134812,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL665386,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells; high binding affinity,CHEMBL1134812,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,4000.0,nM,CHEMBL875028,B,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells; Low binding affinity,CHEMBL1134812,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL336962,CHEMBL217,Dopamine D2 receptor,Ki,=,3206.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN[C@H]1CCc2ccc(OC)cc2C1
CHEMBL134571,CHEMBL217,Dopamine D2 receptor,Ki,=,173.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCN(C)C1CCc2ccc(O)cc2C1
CHEMBL134571,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL670173,B,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,CHEMBL1129692,KI,CCN(C)C1CCc2ccc(O)cc2C1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,69.0,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL308875,CHEMBL217,Dopamine D2 receptor,Ki,=,8.1,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,c1ccc(-c2cccc(CN3CCN(c4cccc5ccoc45)CC3)c2)cc1
CHEMBL422274,CHEMBL217,Dopamine D2 receptor,Ki,=,5825.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,COc1ccc2c(c1)CC(N)CC2
CHEMBL1744044,CHEMBL217,Dopamine D2 receptor,Ki,=,449.0,nM,CHEMBL671485,B,Compound is evaluated for binding affinity towards Dopamine receptor D2 using [3H]spiperone in CHO cells,CHEMBL1131058,KI,COc1ccccc1N1CCN(CC2CN=C3c4ccccc4N=C(SC)N32)CC1
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,3.1,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL134701,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCN(CC)C1CCc2c(cccc2OC)C1
CHEMBL315137,CHEMBL217,Dopamine D2 receptor,Ki,=,343.0,nM,CHEMBL670392,B,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1128063,KI,CCCN(CCC)CCCOc1ccc(-c2nc3ccccc3n2C/C=C/Cn2c(-c3ccc(OCCCN(CCC)CCC)cc3)nc3ccccc32)cc1
CHEMBL308476,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,c1ccc(-c2cccc(CN3CCN(c4cccc5c4CCCN5)CC3)c2)cc1
CHEMBL306830,CHEMBL217,Dopamine D2 receptor,Ki,=,8.1,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,Oc1nc2cccc(N3CCN(Cc4cccc(-c5ccc(F)cc5)c4)CC3)c2o1
CHEMBL77334,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,Oc1nc2cccc(N3CCN(Cc4cc(-c5ccccc5)ccc4F)CC3)c2o1
CHEMBL15146,CHEMBL217,Dopamine D2 receptor,Ki,=,90.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN(CCC)[C@@H]1CCc2c(O)cccc2C1
CHEMBL15146,CHEMBL217,Dopamine D2 receptor,Ki,=,55.1,nM,CHEMBL670173,B,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,CHEMBL1129692,KI,CCCN(CCC)[C@@H]1CCc2c(O)cccc2C1
CHEMBL269004,CHEMBL217,Dopamine D2 receptor,Ki,=,6.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN(CCC)[C@H]1CCc2c(O)cccc2C1
CHEMBL269004,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL670173,B,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,CHEMBL1129692,KI,CCCN(CCC)[C@H]1CCc2c(O)cccc2C1
CHEMBL292187,CHEMBL217,Dopamine D2 receptor,Ki,=,0.42,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,Fc1ccc(-c2ccc(CN3CCN(c4cccc5ccoc45)CC3)[nH]2)cc1
CHEMBL314937,CHEMBL217,Dopamine D2 receptor,Ki,=,1518.0,nM,CHEMBL670392,B,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1128063,KI,CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2C/C=C\Cn2c(-c3ccc(OCCCN(CC)CC)cc3)nc3ccccc32)cc1
CHEMBL316014,CHEMBL217,Dopamine D2 receptor,Ki,=,1027.0,nM,CHEMBL670392,B,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1128063,KI,CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2C/C=C/Cn2c(-c3ccc(OCCCC4CCCCC4)cc3)nc3ccccc32)cc1
CHEMBL78241,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,c1ccc(-c2cccc(CN3CCN(c4cccc5c4OCO5)CC3)c2)cc1
CHEMBL420016,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,N#Cc1ccccc1-c1cccc(CN2CCN(c3cccc4nc(O)oc34)CC2)c1
CHEMBL1303,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1
CHEMBL1303,CHEMBL217,Dopamine D2 receptor,Ki,=,0.06,nM,CHEMBL670173,B,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,CHEMBL1129692,KI,CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1
CHEMBL135048,CHEMBL217,Dopamine D2 receptor,Ki,=,131.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CNC1CCc2c(cccc2OC)C1
CHEMBL51433,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL672484,B,Compound is evaluated for binding affinity towards Dopamine receptor D2 using [3H]spiperone in CHO cells at 10 uM,CHEMBL1131058,KI,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
CHEMBL51433,CHEMBL217,Dopamine D2 receptor,Ki,=,132.0,nM,CHEMBL672180,B,Compound is evaluated for binding affinity towards recombinant human Dopamine receptor D2 using [3H]spiperone in CHO cells,CHEMBL1131058,KI,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
CHEMBL74805,CHEMBL217,Dopamine D2 receptor,Ki,=,2.9,nM,CHEMBL672308,B,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,CHEMBL1133937,KI,Oc1nc2cccc(N3CCN(Cc4ccnc(-c5ccc(F)cc5)c4)CC3)c2o1
CHEMBL94015,CHEMBL217,Dopamine D2 receptor,Ki,=,1183.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCN1COC[C@@H]2c3cc(O)ccc3OC[C@H]21
CHEMBL94015,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL670173,B,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,CHEMBL1129692,KI,CCCN1COC[C@@H]2c3cc(O)ccc3OC[C@H]21
CHEMBL131851,CHEMBL217,Dopamine D2 receptor,Ki,=,694.0,nM,CHEMBL670536,B,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,CHEMBL1129692,KI,CCCCNC1CCc2c(cccc2OC)C1
CHEMBL278751,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL665374,B,Binding affinity was measured at cloned mammalian dopamine D2 receptor expressed in CHO-K1 cells (using [3H]U-86170),CHEMBL1150496,KI,CCCN(CCC)[C@@H]1CCc2c(OC)cccc2[C@@H]1C
CHEMBL161811,CHEMBL217,Dopamine D2 receptor,Ki,=,546.0,nM,CHEMBL665374,B,Binding affinity was measured at cloned mammalian dopamine D2 receptor expressed in CHO-K1 cells (using [3H]U-86170),CHEMBL1150496,KI,CCCN(CCC)[C@@H]1CCc2c(OS(=O)(=O)C(F)(F)F)cccc2[C@@H]1C
CHEMBL160932,CHEMBL217,Dopamine D2 receptor,Ki,=,59000.0,nM,CHEMBL672909,B,Binding affinity of compound was tested in vitro for its ability to compete with [3H]spiperone radioligand at cloned human Dopamine receptor D2L stably expressed in CHO cells,CHEMBL1135071,KI,Cc1nn2c(C#N)cccc2c1CN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL160932,CHEMBL217,Dopamine D2 receptor,Ki,=,58000.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,Cc1nn2c(C#N)cccc2c1CN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL91122,CHEMBL217,Dopamine D2 receptor,Ki,=,3000.0,nM,CHEMBL671361,B,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,CHEMBL1132836,KI,COC[C@H]1CCCN1CCc1c(-c2ccccc2)[nH]c2ccccc12
CHEMBL330303,CHEMBL217,Dopamine D2 receptor,Ki,=,187.0,nM,CHEMBL671361,B,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,CHEMBL1132836,KI,CCN(C)CCc1c(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[nH]c2ccccc12
CHEMBL135044,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL671384,B,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,CHEMBL1130268,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CN1CCc3ccccc3C1)CC2
CHEMBL92416,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL671361,B,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,CHEMBL1132836,KI,CCN(C)CCc1c(-c2cccs2)[nH]c2ccccc12
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL671369,B,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,CHEMBL1130121,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL160749,CHEMBL217,Dopamine D2 receptor,Ki,=,14000.0,nM,CHEMBL671731,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,CHEMBL1135071,KI,Cc1nn2c(-c3ccc(F)cc3)cccc2c1CN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL160749,CHEMBL217,Dopamine D2 receptor,Ki,=,16000.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,Cc1nn2c(-c3ccc(F)cc3)cccc2c1CN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL336851,CHEMBL217,Dopamine D2 receptor,Ki,=,9.7,nM,CHEMBL675959,B,Tested for the inhibitory activity against D2H (high-affinity states) receptor in infected HEK 293 cells.,CHEMBL1127788,KI,CCCN(C/C=C/I)C1CCc2cc(O)ccc2C1
CHEMBL336851,CHEMBL217,Dopamine D2 receptor,Ki,=,547.0,nM,CHEMBL670083,B,Tested for the inhibitory activity against Dopamine D2 receptor in infected Sf9 cells,CHEMBL1127788,KI,CCCN(C/C=C/I)C1CCc2cc(O)ccc2C1
CHEMBL92489,CHEMBL217,Dopamine D2 receptor,Ki,=,774.0,nM,CHEMBL671369,B,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,CHEMBL1130121,KI,Cc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccccc1)CC3
CHEMBL91197,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL671361,B,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,CHEMBL1132836,KI,CCN(C)CCc1c(-c2ccccc2F)[nH]c2ccccc12
CHEMBL90911,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL671361,B,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,CHEMBL1132836,KI,CCN(C)CCc1c(-c2cccc(C(F)(F)F)c2)[nH]c2ccccc12
CHEMBL80833,CHEMBL217,Dopamine D2 receptor,Ki,=,960.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,Clc1ccc(-c2cc(C3CCCN(Cc4ccccc4)C3)[nH]n2)cc1
CHEMBL80207,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,CC1(c2cc(-c3ccc(Cl)cc3)[nH]n2)CCN(Cc2ccccc2)CC1
CHEMBL309901,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,Cc1c(C2CCN(Cc3ccccc3)CC2)n[nH]c1-c1ccc(Cl)cc1
CHEMBL2112285,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,O=C(/C=C(\O)c1ccc(Cl)cc1)C1CCN(Cc2ccccc2)CC1
CHEMBL61079,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,Cc1c(C2CCN(CCc3ccccc3)CC2)n[nH]c1-c1ccc(Cl)cc1
CHEMBL135357,CHEMBL217,Dopamine D2 receptor,Ki,=,7.0,nM,CHEMBL671384,B,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,CHEMBL1130268,KI,O=C(O)C(=O)O.Oc1cc2c(cc1Cl)CC[C@H](CNCc1ccccc1)O2
CHEMBL80318,CHEMBL217,Dopamine D2 receptor,Ki,=,90.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,Cc1c(-c2ccccc2)n[nH]c1C1=CCN(CCc2ccccc2)CC1
CHEMBL78923,CHEMBL217,Dopamine D2 receptor,Ki,=,8.6,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,Nc1nc(-c2ccc(Cl)cc2)cc(C2CCN(Cc3ccccc3)CC2)n1
CHEMBL314095,CHEMBL217,Dopamine D2 receptor,Ki,=,2780.0,nM,CHEMBL671369,B,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,CHEMBL1130121,KI,O=c1oc2cc(O)ccc2c2c1CN(Cc1ccc(Cl)cc1)CC2
CHEMBL134343,CHEMBL217,Dopamine D2 receptor,Ki,=,77.0,nM,CHEMBL671384,B,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,CHEMBL1130268,KI,O=C(O)C(=O)O.Oc1cc2c(cc1Cl)CC[C@@H](CNCc1ccccc1)O2
CHEMBL91549,CHEMBL217,Dopamine D2 receptor,Ki,=,85.0,nM,CHEMBL671361,B,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,CHEMBL1132836,KI,CCN(C)CCc1c(-c2ccccc2)[nH]c2ccccc12
CHEMBL328459,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL671361,B,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,CHEMBL1132836,KI,CCN(C)CCc1c(-c2ccc(F)cc2)[nH]c2ccccc12
CHEMBL90837,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL671361,B,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,CHEMBL1132836,KI,CCN(C)CCc1c(-c2cccc([N+](=O)[O-])c2)[nH]c2ccccc12
CHEMBL133085,CHEMBL217,Dopamine D2 receptor,Ki,=,10.8,nM,CHEMBL675959,B,Tested for the inhibitory activity against D2H (high-affinity states) receptor in infected HEK 293 cells.,CHEMBL1127788,KI,CCCN(C/C=C/I)C1COc2c(O)cccc2C1
CHEMBL133085,CHEMBL217,Dopamine D2 receptor,Ki,=,784.0,nM,CHEMBL670083,B,Tested for the inhibitory activity against Dopamine D2 receptor in infected Sf9 cells,CHEMBL1127788,KI,CCCN(C/C=C/I)C1COc2c(O)cccc2C1
CHEMBL160266,CHEMBL217,Dopamine D2 receptor,Ki,=,640.0,nM,CHEMBL671731,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,CHEMBL1135071,KI,Clc1ccc(N2CCN(Cc3cnn4c(N5CCN(Cc6ccccc6)CC5)cccc34)CC2)cc1
CHEMBL160266,CHEMBL217,Dopamine D2 receptor,Ki,=,400.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,Clc1ccc(N2CCN(Cc3cnn4c(N5CCN(Cc6ccccc6)CC5)cccc34)CC2)cc1
CHEMBL418802,CHEMBL217,Dopamine D2 receptor,Ki,=,6.7,nM,CHEMBL672490,B,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",CHEMBL1125523,KI,COC(=O)c1cc2c3c(ccc2[nH]1)OCC(CN1CCC(n2c(O)nc4ccccc42)CC1)O3
CHEMBL329126,CHEMBL217,Dopamine D2 receptor,Ki,=,1170.0,nM,CHEMBL671369,B,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,CHEMBL1130121,KI,COc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccc(C)cc1)CC3
CHEMBL79098,CHEMBL217,Dopamine D2 receptor,Ki,=,1300.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,c1ccc(CCN2CCC(c3cc(-c4ccncc4)[nH]n3)CC2)cc1
CHEMBL61195,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,Clc1ccc(CN2CCC(c3cc(-c4ccc(Cl)cc4)no3)CC2)cc1
CHEMBL78933,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,CCc1c(C2CCN(Cc3ccccc3)CC2)n[nH]c1-c1ccc(Cl)cc1
CHEMBL135395,CHEMBL217,Dopamine D2 receptor,Ki,=,9.7,nM,CHEMBL671384,B,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,CHEMBL1130268,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)OC(CNCc1ccccc1)CC2
CHEMBL320880,CHEMBL217,Dopamine D2 receptor,Ki,=,1.8,nM,CHEMBL672490,B,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",CHEMBL1125523,KI,NC(=O)c1cc2c3c(ccc2[nH]1)OCC(CN1CCC2(CC1)C(=O)NCN2c1ccccc1)O3
CHEMBL61080,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,Clc1ccc(CN2CCC(c3cc(-c4ccc(Cl)cc4)[nH]n3)CC2)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.4,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL349843,CHEMBL217,Dopamine D2 receptor,Ki,=,2557.0,nM,CHEMBL665374,B,Binding affinity was measured at cloned mammalian dopamine D2 receptor expressed in CHO-K1 cells (using [3H]U-86170),CHEMBL1150496,KI,CCCN[C@@H]1CCc2c(OS(=O)(=O)C(F)(F)F)cccc2[C@@H]1C
CHEMBL420954,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,Clc1ccc(-c2cc(C3CCN(CC4CCCCC4)CC3)[nH]n2)cc1
CHEMBL311832,CHEMBL217,Dopamine D2 receptor,Ki,=,690.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,c1ccc(CCN2CCC3(CCc4c3n[nH]c4-c3ccccc3)CC2)cc1
CHEMBL134807,CHEMBL217,Dopamine D2 receptor,Ki,=,10.4,nM,CHEMBL671384,B,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,CHEMBL1130268,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2
CHEMBL160626,CHEMBL217,Dopamine D2 receptor,Ki,=,44000.0,nM,CHEMBL672909,B,Binding affinity of compound was tested in vitro for its ability to compete with [3H]spiperone radioligand at cloned human Dopamine receptor D2L stably expressed in CHO cells,CHEMBL1135071,KI,N#Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12
CHEMBL160626,CHEMBL217,Dopamine D2 receptor,Ki,=,45000.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,N#Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12
CHEMBL7927,CHEMBL217,Dopamine D2 receptor,Ki,=,3200.0,nM,CHEMBL671731,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,CHEMBL1135071,KI,Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL7927,CHEMBL217,Dopamine D2 receptor,Ki,=,4300.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL58296,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,Clc1ccc(CN2CCC(c3cc(-c4ccc(Cl)cc4)on3)CC2)cc1
CHEMBL91542,CHEMBL217,Dopamine D2 receptor,Ki,=,0.42,nM,CHEMBL671361,B,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,CHEMBL1132836,KI,CCN(C)CCc1c(-c2ccc(C#N)cc2)[nH]c2ccccc12
CHEMBL110239,CHEMBL217,Dopamine D2 receptor,Ki,=,6.6,nM,CHEMBL675959,B,Tested for the inhibitory activity against D2H (high-affinity states) receptor in infected HEK 293 cells.,CHEMBL1127788,KI,CCCN(C/C=C/I)C1CCc2ccc(O)cc2C1
CHEMBL110239,CHEMBL217,Dopamine D2 receptor,Ki,=,265.0,nM,CHEMBL670083,B,Tested for the inhibitory activity against Dopamine D2 receptor in infected Sf9 cells,CHEMBL1127788,KI,CCCN(C/C=C/I)C1CCc2ccc(O)cc2C1
CHEMBL12264,CHEMBL217,Dopamine D2 receptor,Ki,=,3981.07,nM,CHEMBL670659,B,The compound was tested for its binding affinity towards cloned human Dopamine receptor D2 in CHO cells using [125I]iodosulpiride.,CHEMBL1131479,KI,Cc1cccc(S(=O)(=O)N(C)[C@H](C)CCN2CCC(C)CC2)c1
CHEMBL76090,CHEMBL217,Dopamine D2 receptor,Ki,=,125.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,Clc1ccc(-c2cc(C3CCN(Cc4ccccc4)CC3)[nH]n2)cc1
CHEMBL160396,CHEMBL217,Dopamine D2 receptor,Ki,=,56000.0,nM,CHEMBL671731,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,CHEMBL1135071,KI,OCc1cccn2ncc(CN3CCN(c4ccc(Cl)cc4)CC3)c12
CHEMBL160396,CHEMBL217,Dopamine D2 receptor,Ki,=,79000.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,OCc1cccn2ncc(CN3CCN(c4ccc(Cl)cc4)CC3)c12
CHEMBL345357,CHEMBL217,Dopamine D2 receptor,Ki,=,28000.0,nM,CHEMBL671731,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,CHEMBL1135071,KI,OCc1ccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn2c1
CHEMBL345357,CHEMBL217,Dopamine D2 receptor,Ki,=,22000.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,OCc1ccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn2c1
CHEMBL102175,CHEMBL217,Dopamine D2 receptor,Ki,=,5.7,nM,CHEMBL672490,B,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",CHEMBL1125523,KI,CCCCOC(=O)c1cc2c3c(ccc2[nH]1)OCC(CN1CCC2(CC1)C(=O)NCN2c1ccccc1)O3
CHEMBL101535,CHEMBL217,Dopamine D2 receptor,Ki,=,1.5,nM,CHEMBL672490,B,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",CHEMBL1125523,KI,N#Cc1cc2c3c(ccc2[nH]1)OCC(CN1CCC2(CC1)C(=O)NCN2c1ccccc1)O3
CHEMBL317433,CHEMBL217,Dopamine D2 receptor,Ki,=,0.2,nM,CHEMBL670743,B,"Compound was evaluated for the binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",CHEMBL1125523,KI,O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccc4[nH]ccc4c3O1)CC2
CHEMBL89921,CHEMBL217,Dopamine D2 receptor,Ki,=,1170.0,nM,CHEMBL671369,B,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,CHEMBL1130121,KI,Cc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccc(Cl)cc1)CC3
CHEMBL90569,CHEMBL217,Dopamine D2 receptor,Ki,=,5500.0,nM,CHEMBL671369,B,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,CHEMBL1130121,KI,COc1ccc2c3c(c(=O)oc2c1)CN(Cc1cccc(Cl)c1)CC3
CHEMBL160952,CHEMBL217,Dopamine D2 receptor,Ki,=,3700.0,nM,CHEMBL671731,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,CHEMBL1135071,KI,C#Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12
CHEMBL160952,CHEMBL217,Dopamine D2 receptor,Ki,=,6200.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,C#Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12
CHEMBL423247,CHEMBL217,Dopamine D2 receptor,Ki,=,4900.0,nM,CHEMBL671731,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,CHEMBL1135071,KI,Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12
CHEMBL423247,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12
CHEMBL91205,CHEMBL217,Dopamine D2 receptor,Ki,=,896.0,nM,CHEMBL671361,B,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,CHEMBL1132836,KI,c1ccc(-c2[nH]c3ccccc3c2CCN2CCCCC2)cc1
CHEMBL91446,CHEMBL217,Dopamine D2 receptor,Ki,=,92.0,nM,CHEMBL671361,B,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,CHEMBL1132836,KI,COC[C@@H]1CCCN1CCc1c(-c2ccccc2)[nH]c2ccccc12
CHEMBL27441,CHEMBL217,Dopamine D2 receptor,Ki,=,145.0,nM,CHEMBL665374,B,Binding affinity was measured at cloned mammalian dopamine D2 receptor expressed in CHO-K1 cells (using [3H]U-86170),CHEMBL1150496,KI,CCCN[C@@H]1CCc2c(OC)cccc2[C@@H]1C
CHEMBL156851,CHEMBL217,Dopamine D2 receptor,Ki,=,21000.0,nM,CHEMBL671731,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,CHEMBL1135071,KI,C#Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)c(C)nn12
CHEMBL156851,CHEMBL217,Dopamine D2 receptor,Ki,=,25000.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,C#Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)c(C)nn12
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,54000.0,nM,CHEMBL671731,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,CHEMBL1135071,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,38000.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL90739,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL671361,B,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,CHEMBL1132836,KI,C[C@H]1CCCCN1CCc1c(-c2ccccc2)[nH]c2ccccc12
CHEMBL285755,CHEMBL217,Dopamine D2 receptor,Ki,=,142.0,nM,CHEMBL675959,B,Tested for the inhibitory activity against D2H (high-affinity states) receptor in infected HEK 293 cells.,CHEMBL1127788,KI,CCCN(CCC)C1CCc2ccc(O)cc2C1
CHEMBL77015,CHEMBL217,Dopamine D2 receptor,Ki,=,650.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,Cc1cc(C2CCN(Cc3ccccc3)CC2)[nH]n1
CHEMBL310819,CHEMBL217,Dopamine D2 receptor,Ki,=,860.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,c1ccc(CCN2CCC(c3cc(-c4ccccn4)[nH]n3)CC2)cc1
CHEMBL2112284,CHEMBL217,Dopamine D2 receptor,Ki,=,410.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,CC1(C(=O)/C=C(\O)c2ccc(Cl)cc2)CCN(Cc2ccccc2)CC1
CHEMBL138016,CHEMBL217,Dopamine D2 receptor,Ki,=,228.0,nM,CHEMBL671384,B,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,CHEMBL1130268,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@H](CNCc1ccccc1)CC2
CHEMBL318166,CHEMBL217,Dopamine D2 receptor,Ki,=,5.8,nM,CHEMBL672490,B,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",CHEMBL1125523,KI,O=C(OCc1ccccc1)c1cc2c3c(ccc2[nH]1)OCC(CN1CCC2(CC1)C(=O)NCN2c1ccccc1)O3
CHEMBL77017,CHEMBL217,Dopamine D2 receptor,Ki,=,560.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,Clc1ccc(-c2cc(C3CCN(CCCc4ccccc4)CC3)[nH]n2)cc1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,74.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL160536,CHEMBL217,Dopamine D2 receptor,Ki,=,300.0,nM,CHEMBL671731,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,CHEMBL1135071,KI,Cc1nn2c(N3CCN(Cc4ccccc4)CC3)cccc2c1CN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL160536,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,Cc1nn2c(N3CCN(Cc4ccccc4)CC3)cccc2c1CN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL91463,CHEMBL217,Dopamine D2 receptor,Ki,=,250.0,nM,CHEMBL671361,B,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,CHEMBL1132836,KI,CCN(C)CCc1c(-c2ccc(Cl)cc2)[nH]c2ccccc12
CHEMBL103983,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL672490,B,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",CHEMBL1125523,KI,O=C(NCCCc1ccccc1)c1cc2c3c(ccc2[nH]1)OCC(CNCCCc1ccccc1)O3
CHEMBL80863,CHEMBL217,Dopamine D2 receptor,Ki,=,3400.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,Clc1ccc(-c2cc(C3CCCCN3Cc3ccccc3)[nH]n2)cc1
CHEMBL76355,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,Clc1ccc(-c2cc(C3CCN(Cc4ccccc4)C3)[nH]n2)cc1
CHEMBL337228,CHEMBL217,Dopamine D2 receptor,Ki,=,5.2,nM,CHEMBL671729,B,Binding affinity in humans to Dopamine receptor D2 expressed in CHO cells was determined using the agonist [3H]-spiperone.,CHEMBL1130268,KI,O=C(O)C(=O)O.Oc1cc2c(cc1Cl)CCC(CNCc1ccccc1)O2
CHEMBL134808,CHEMBL217,Dopamine D2 receptor,Ki,=,4.3,nM,CHEMBL672799,B,"Compound was tested to inhibit Dopa accumulation in to Dopamine receptor D2 at 10 mg/kg, sc",CHEMBL1130268,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)OC(CN1CCc3ccccc3C1)CC2
CHEMBL320173,CHEMBL217,Dopamine D2 receptor,Ki,=,3.1,nM,CHEMBL672489,B,Compound was evaluated for the binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using [3H]U-86170 as radioligand,CHEMBL1125523,KI,COC(=O)c1cc2c3c(ccc2[nH]1)OCC(CN1CCC2(CC1)C(=O)NCN2c1ccccc1)O3
CHEMBL78287,CHEMBL217,Dopamine D2 receptor,Ki,=,570.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,Clc1ccc(-c2cc(C3CCN(Cc4cccc(Cl)c4)CC3)[nH]n2)cc1
CHEMBL77744,CHEMBL217,Dopamine D2 receptor,Ki,=,61.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,c1ccc(CCN2CCC(c3cc(C4CCCCC4)n[nH]3)CC2)cc1
CHEMBL77743,CHEMBL217,Dopamine D2 receptor,Ki,=,65.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,c1ccc(CCN2CCC(c3cc(-c4cccs4)[nH]n3)CC2)cc1
CHEMBL330100,CHEMBL217,Dopamine D2 receptor,Ki,=,659.0,nM,CHEMBL671369,B,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,CHEMBL1130121,KI,COc1ccc2c3c(c(=O)oc2c1OC)CN(Cc1ccccc1)CC3
CHEMBL155913,CHEMBL217,Dopamine D2 receptor,Ki,=,5400.0,nM,CHEMBL671731,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,CHEMBL1135071,KI,Clc1ccc(N2CCN(Cc3cnn4c(-c5ccccc5)cccc34)CC2)cc1
CHEMBL155913,CHEMBL217,Dopamine D2 receptor,Ki,=,2800.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,Clc1ccc(N2CCN(Cc3cnn4c(-c5ccccc5)cccc34)CC2)cc1
CHEMBL160454,CHEMBL217,Dopamine D2 receptor,Ki,=,3100.0,nM,CHEMBL671731,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,CHEMBL1135071,KI,C[Si](C)(C)c1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12
CHEMBL160454,CHEMBL217,Dopamine D2 receptor,Ki,=,2800.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,C[Si](C)(C)c1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12
CHEMBL351550,CHEMBL217,Dopamine D2 receptor,Ki,=,28000.0,nM,CHEMBL671731,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,CHEMBL1135071,KI,Cc1nn2c(-c3ccccc3)cccc2c1CN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL351550,CHEMBL217,Dopamine D2 receptor,Ki,=,24000.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,Cc1nn2c(-c3ccccc3)cccc2c1CN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL671731,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,CHEMBL1135071,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL161507,CHEMBL217,Dopamine D2 receptor,Ki,=,2328.0,nM,CHEMBL665374,B,Binding affinity was measured at cloned mammalian dopamine D2 receptor expressed in CHO-K1 cells (using [3H]U-86170),CHEMBL1150496,KI,CCCN[C@@H]1CCc2c(C(=O)OC)cccc2[C@@H]1C
CHEMBL346805,CHEMBL217,Dopamine D2 receptor,Ki,=,9500.0,nM,CHEMBL671731,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,CHEMBL1135071,KI,O=Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12
CHEMBL346805,CHEMBL217,Dopamine D2 receptor,Ki,=,9200.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,O=Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12
CHEMBL328595,CHEMBL217,Dopamine D2 receptor,Ki,=,68.0,nM,CHEMBL671361,B,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,CHEMBL1132836,KI,CCN(C)CCc1c(-c2cccc(F)c2)[nH]c2ccccc12
CHEMBL323088,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL672490,B,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",CHEMBL1125523,KI,O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccc4[nH]c(CO)cc4c3O1)CC2
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,91.0,nM,CHEMBL671369,B,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,CHEMBL1130121,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL25938,CHEMBL217,Dopamine D2 receptor,Ki,=,66.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,c1ccc(CN2CCC(c3cc(-c4ccccc4)[nH]n3)CC2)cc1
CHEMBL77148,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,c1ccc(Cc2cc(C3CCN(Cc4ccccc4)CC3)[nH]n2)cc1
CHEMBL328054,CHEMBL217,Dopamine D2 receptor,Ki,=,436.0,nM,CHEMBL671369,B,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,CHEMBL1130121,KI,COc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccccc1)CC3
CHEMBL135725,CHEMBL217,Dopamine D2 receptor,Ki,=,73.9,nM,CHEMBL671384,B,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,CHEMBL1130268,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@H](CN1CCc3ccccc3C1)CC2
CHEMBL263282,CHEMBL217,Dopamine D2 receptor,Ki,=,3.6,nM,CHEMBL675959,B,Tested for the inhibitory activity against D2H (high-affinity states) receptor in infected HEK 293 cells.,CHEMBL1127788,KI,CCCN(C/C=C/I)C1CCc2c(O)cccc2C1
CHEMBL263282,CHEMBL217,Dopamine D2 receptor,Ki,=,324.0,nM,CHEMBL670083,B,Tested for the inhibitory activity against Dopamine D2 receptor in infected Sf9 cells,CHEMBL1127788,KI,CCCN(C/C=C/I)C1CCc2c(O)cccc2C1
CHEMBL6416,CHEMBL217,Dopamine D2 receptor,Ki,=,520.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,Clc1ccc(-c2cc(C3CCN(CCc4ccccc4)CC3)[nH]n2)cc1
CHEMBL309460,CHEMBL217,Dopamine D2 receptor,Ki,=,900.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,c1ccc(CCN2CCC(c3cc(-c4cccnc4)[nH]n3)CC2)cc1
CHEMBL91938,CHEMBL217,Dopamine D2 receptor,Ki,=,3700.0,nM,CHEMBL671369,B,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,CHEMBL1130121,KI,COc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccc(C(F)(F)F)cc1)CC3
CHEMBL156369,CHEMBL217,Dopamine D2 receptor,Ki,=,13000.0,nM,CHEMBL671731,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,CHEMBL1135071,KI,Cc1cccn2ncc(CN3CCN(c4ccc(Cl)cc4)CC3)c12
CHEMBL156369,CHEMBL217,Dopamine D2 receptor,Ki,=,12000.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,Cc1cccn2ncc(CN3CCN(c4ccc(Cl)cc4)CC3)c12
CHEMBL90263,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL671361,B,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,CHEMBL1132836,KI,C[C@@H]1CCCCN1CCc1c(-c2ccccc2)[nH]c2ccccc12
CHEMBL319023,CHEMBL217,Dopamine D2 receptor,Ki,=,255.0,nM,CHEMBL672490,B,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",CHEMBL1125523,KI,CCOC(=O)C1CCN(CC2COc3ccc4[nH]c(C(=O)OC)cc4c3O2)CC1
CHEMBL318374,CHEMBL217,Dopamine D2 receptor,Ki,=,15.9,nM,CHEMBL672490,B,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",CHEMBL1125523,KI,COC(=O)c1cc2c3c(ccc2[nH]1)OCC(CNCCCc1ccccc1)O3
CHEMBL312255,CHEMBL217,Dopamine D2 receptor,Ki,=,700.0,nM,CHEMBL672209,B,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,CHEMBL1130098,KI,Clc1ccc(-c2cc(C3CCN(Cc4ccccc4Cl)CC3)[nH]n2)cc1
CHEMBL156198,CHEMBL217,Dopamine D2 receptor,Ki,=,15000.0,nM,CHEMBL671731,B,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,CHEMBL1135071,KI,Fc1ccc(-c2cccc3c(CN4CCN(c5ccc(Cl)cc5)CC4)cnn23)cc1
CHEMBL156198,CHEMBL217,Dopamine D2 receptor,Ki,=,15000.0,nM,CHEMBL671732,B,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,CHEMBL1135071,KI,Fc1ccc(-c2cccc3c(CN4CCN(c5ccc(Cl)cc5)CC4)cnn23)cc1
CHEMBL106283,CHEMBL217,Dopamine D2 receptor,Ki,=,58.0,nM,CHEMBL672490,B,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",CHEMBL1125523,KI,O=C(O)c1cc2c3c(ccc2[nH]1)OCC(CN1CCC2(CC1)C(=O)NCN2c1ccccc1)O3
CHEMBL423890,CHEMBL217,Dopamine D2 receptor,Ki,=,7.2,nM,CHEMBL671384,B,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,CHEMBL1130268,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CO2
CHEMBL32402,CHEMBL217,Dopamine D2 receptor,Ki,=,911.0,nM,CHEMBL671653,B,Binding affinity against cloned human D2 receptor transfected in CHO-K1 cells using [3H]- spiperone as radioligand.,CHEMBL1130437,KI,OC(COc1ccccc1)CN1CCC(Oc2ccccc2)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,254.0,nM,CHEMBL672173,B,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,CHEMBL1130009,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL357448,CHEMBL217,Dopamine D2 receptor,Ki,=,2990.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1cccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL152587,CHEMBL217,Dopamine D2 receptor,Ki,=,770.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1cccc(C(=O)NCCCCN2CCN(c3nccc4ccccc34)CC2)c1
CHEMBL105977,CHEMBL217,Dopamine D2 receptor,Ki,=,272.0,nM,CHEMBL671421,B,In vitro binding affinity is the ability to displace [3H]spiperone from human Dopamine receptor D2 expressed in CHO-K1 cells,CHEMBL1128506,KI,CCCN(CCC)C1CCc2ncccc2C1
CHEMBL105977,CHEMBL217,Dopamine D2 receptor,Ki,=,466.0,nM,CHEMBL671420,B,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,CHEMBL1128506,KI,CCCN(CCC)C1CCc2ncccc2C1
CHEMBL152159,CHEMBL217,Dopamine D2 receptor,Ki,=,680.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1cccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL152756,CHEMBL217,Dopamine D2 receptor,Ki,=,930.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1cccc(C(=O)NCCCCN2CCN(c3cccc4ccccc34)CC2)c1
CHEMBL152304,CHEMBL217,Dopamine D2 receptor,Ki,=,430.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccnc2ccccc12
CHEMBL321513,CHEMBL217,Dopamine D2 receptor,Ki,=,296.0,nM,CHEMBL672173,B,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,CHEMBL1130009,KI,c1ccc(-c2nc(CN3CCN(c4cccnc4)CC3)c[nH]2)cc1
CHEMBL105512,CHEMBL217,Dopamine D2 receptor,Ki,=,462.0,nM,CHEMBL671421,B,In vitro binding affinity is the ability to displace [3H]spiperone from human Dopamine receptor D2 expressed in CHO-K1 cells,CHEMBL1128506,KI,CCCN(CCC)C1CCc2nc(N)sc2C1
CHEMBL105512,CHEMBL217,Dopamine D2 receptor,Ki,=,57.0,nM,CHEMBL671420,B,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,CHEMBL1128506,KI,CCCN(CCC)C1CCc2nc(N)sc2C1
CHEMBL152391,CHEMBL217,Dopamine D2 receptor,Ki,=,1410.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1cccc(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1
CHEMBL92713,CHEMBL217,Dopamine D2 receptor,Ki,=,3960.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1cccc(C(=O)NCCCN2CCN(c3ccc(Cl)cc3)CC2)c1
CHEMBL156845,CHEMBL217,Dopamine D2 receptor,Ki,=,7460.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1cccc(C(=O)NCCN2CCN(c3ccc(C)cc3)CC2)c1
CHEMBL347290,CHEMBL217,Dopamine D2 receptor,Ki,=,1560.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1cccc(C(=O)NCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1
CHEMBL2112911,CHEMBL217,Dopamine D2 receptor,Ki,=,5740.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,Cl.O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL103772,CHEMBL217,Dopamine D2 receptor,Ki,=,2250.0,nM,CHEMBL672173,B,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,CHEMBL1130009,KI,c1ccc(-c2nc(CN3CCN(c4ncccn4)CC3)c[nH]2)cc1
CHEMBL315879,CHEMBL217,Dopamine D2 receptor,Ki,=,2350.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1cccc(C(=O)NCCCCN2CCN(c3ccc(Cl)cc3)CC2)c1
CHEMBL106047,CHEMBL217,Dopamine D2 receptor,Ki,=,3940.0,nM,CHEMBL671420,B,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,CHEMBL1128506,KI,CCCN(CCC)C1CCc2cc(OC)ccc2C1
CHEMBL99967,CHEMBL217,Dopamine D2 receptor,Ki,=,2190.0,nM,CHEMBL672173,B,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,CHEMBL1130009,KI,c1ccc(-c2nc(CN3CCN(c4ccccn4)CC3)c[nH]2)cc1
CHEMBL152869,CHEMBL217,Dopamine D2 receptor,Ki,=,253.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1cccc(C(=O)NCCCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL31991,CHEMBL217,Dopamine D2 receptor,Ki,=,244.0,nM,CHEMBL671653,B,Binding affinity against cloned human D2 receptor transfected in CHO-K1 cells using [3H]- spiperone as radioligand.,CHEMBL1130437,KI,O[C@@H](COc1ccccc1)CN1CCC(Oc2ccccc2)CC1
CHEMBL282323,CHEMBL217,Dopamine D2 receptor,Ki,=,709.0,nM,CHEMBL671653,B,Binding affinity against cloned human D2 receptor transfected in CHO-K1 cells using [3H]- spiperone as radioligand.,CHEMBL1130437,KI,O[C@H](COc1ccccc1)CN1CCC(Oc2ccccc2)CC1
CHEMBL418758,CHEMBL217,Dopamine D2 receptor,Ki,=,1438.0,nM,CHEMBL671653,B,Binding affinity against cloned human D2 receptor transfected in CHO-K1 cells using [3H]- spiperone as radioligand.,CHEMBL1130437,KI,OC(COc1cccc2ccccc12)CN1CCC(Cc2ccccc2)CC1
CHEMBL1423,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL671484,B,Binding affinity towards Dopamine receptor D2,CHEMBL1145042,KI,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL152010,CHEMBL217,Dopamine D2 receptor,Ki,=,107.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1[nH]nc2ccccc12
CHEMBL154508,CHEMBL217,Dopamine D2 receptor,Ki,=,5200.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2ccccc2c1
CHEMBL61789,CHEMBL217,Dopamine D2 receptor,Ki,=,3800.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc(Br)c2ccccc12
CHEMBL286177,CHEMBL217,Dopamine D2 receptor,Ki,=,2336.0,nM,CHEMBL671653,B,Binding affinity against cloned human D2 receptor transfected in CHO-K1 cells using [3H]- spiperone as radioligand.,CHEMBL1130437,KI,OC(COc1cccc2ccccc12)CN1CCC(Oc2ccccc2)CC1
CHEMBL105509,CHEMBL217,Dopamine D2 receptor,Ki,=,1202.0,nM,CHEMBL671420,B,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,CHEMBL1128506,KI,CCCN(CCC)C1CCc2nc(OC)ccc2C1
CHEMBL345820,CHEMBL217,Dopamine D2 receptor,Ki,=,830.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc2ccccc12
CHEMBL286725,CHEMBL217,Dopamine D2 receptor,Ki,=,467.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1cccc(C(=O)NCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL93403,CHEMBL217,Dopamine D2 receptor,Ki,=,1900.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1cccc(C(=O)NCCN2CCN(c3ccc(Cl)cc3)CC2)c1
CHEMBL415014,CHEMBL217,Dopamine D2 receptor,Ki,=,1440.0,nM,CHEMBL672173,B,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,CHEMBL1130009,KI,Cc1[nH]c(-c2ccccc2)nc1CN1CCN(c2ncccn2)CC1
CHEMBL433741,CHEMBL217,Dopamine D2 receptor,Ki,=,77.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1cccc(C(=O)NCCCCN2CCN(c3cccc(C)c3C)CC2)c1
CHEMBL423040,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1cccc(C(=O)NCCCCN2CCN(c3noc4ccccc34)CC2)c1
CHEMBL110888,CHEMBL217,Dopamine D2 receptor,Ki,=,17.1,nM,CHEMBL671421,B,In vitro binding affinity is the ability to displace [3H]spiperone from human Dopamine receptor D2 expressed in CHO-K1 cells,CHEMBL1128506,KI,CCCN(CCC)C1CCc2nc(N)ccc2C1
CHEMBL110888,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL671420,B,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,CHEMBL1128506,KI,CCCN(CCC)C1CCc2nc(N)ccc2C1
CHEMBL273273,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL671421,B,In vitro binding affinity is the ability to displace [3H]spiperone from human Dopamine receptor D2 expressed in CHO-K1 cells,CHEMBL1128506,KI,CCCN(CCC)C1CCc2c(O)cccc2C1
CHEMBL273273,CHEMBL217,Dopamine D2 receptor,Ki,=,6.0,nM,CHEMBL671420,B,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,CHEMBL1128506,KI,CCCN(CCC)C1CCc2c(O)cccc2C1
CHEMBL152262,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1c[nH]c2ccccc12
CHEMBL318740,CHEMBL217,Dopamine D2 receptor,Ki,=,523.0,nM,CHEMBL671420,B,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,CHEMBL1128506,KI,CCCN(CCC)C1CCc2n[nH]cc2C1
CHEMBL2112910,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,Cl.O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL103871,CHEMBL217,Dopamine D2 receptor,Ki,=,254.0,nM,CHEMBL672173,B,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,CHEMBL1130009,KI,c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)c[nH]2)cc1
CHEMBL152576,CHEMBL217,Dopamine D2 receptor,Ki,=,1130.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1cccc(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1
CHEMBL196476,CHEMBL217,Dopamine D2 receptor,Ki,=,373.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1cccc2cc(C(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)oc12
CHEMBL156599,CHEMBL217,Dopamine D2 receptor,Ki,=,3680.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,COc1cccc(C(=O)NCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1
CHEMBL479,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL671484,B,Binding affinity towards Dopamine receptor D2,CHEMBL1145042,KI,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,4.8,nM,CHEMBL672173,B,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,CHEMBL1130009,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL346692,CHEMBL217,Dopamine D2 receptor,Ki,=,135.0,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.12,nM,CHEMBL672170,B,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,CHEMBL1136013,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL57219,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL672226,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1153677,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(cccc2OS(=O)(=O)C(F)(F)F)C1
CHEMBL294458,CHEMBL217,Dopamine D2 receptor,Ki,=,7350.0,nM,CHEMBL872499,B,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,CHEMBL1131791,KI,N#CC(C#N)=Cc1cc(CN2CCN(c3ccc(Cl)cc3)CC2)c[nH]1
CHEMBL294458,CHEMBL217,Dopamine D2 receptor,Ki,=,10300.0,nM,CHEMBL670553,B,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,CHEMBL1131791,KI,N#CC(C#N)=Cc1cc(CN2CCN(c3ccc(Cl)cc3)CC2)c[nH]1
CHEMBL71838,CHEMBL217,Dopamine D2 receptor,Ki,=,241.0,nM,CHEMBL672208,B,The compound was tested for CNS binding affinity towards Dopamine receptor D2 from cloned Human membranes.,CHEMBL1131250,KI,CNC(=O)c1ccc2c(c1)CCO[C@H]2CCN1CCN(c2ccc(OC)cc2)CC1
CHEMBL283247,CHEMBL217,Dopamine D2 receptor,Ki,=,1900.0,nM,CHEMBL672175,B,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,CHEMBL1131704,KI,CCCCc1cnc2c(c1)[C@@H]1c3cc(O)c(O)cc3CC[C@H]1NC2
CHEMBL287513,CHEMBL217,Dopamine D2 receptor,Ki,=,3600.0,nM,CHEMBL672175,B,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,CHEMBL1131704,KI,Oc1cc2c(cc1O)[C@H]1c3cc4c(nc3CN[C@@H]1CC2)CCCC4
CHEMBL28054,CHEMBL217,Dopamine D2 receptor,Ki,=,1300.0,nM,CHEMBL672175,B,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,CHEMBL1131704,KI,Oc1cc2c(cc1O)[C@H]1c3cnccc3CN[C@@H]1CC2
CHEMBL26365,CHEMBL217,Dopamine D2 receptor,Ki,=,890.0,nM,CHEMBL672175,B,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,CHEMBL1131704,KI,Oc1cc2c(cc1O)[C@H]1c3cncc(F)c3CN[C@@H]1CC2
CHEMBL281932,CHEMBL217,Dopamine D2 receptor,Ki,=,2500.0,nM,CHEMBL672175,B,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,CHEMBL1131704,KI,Oc1cc2c(cc1O)[C@H]1c3cccnc3CN[C@@H]1CC2
CHEMBL26965,CHEMBL217,Dopamine D2 receptor,Ki,=,450.0,nM,CHEMBL672175,B,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,CHEMBL1131704,KI,CCCc1ccc2c(n1)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21
CHEMBL353220,CHEMBL217,Dopamine D2 receptor,Ki,=,16000.0,nM,CHEMBL672098,B,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,CHEMBL1136617,KI,COc1ccc(Br)cc1C1=NCC[C@@H](CN2CCN(c3ccccc3)CC2)N1
CHEMBL353220,CHEMBL217,Dopamine D2 receptor,Ki,=,14000.0,nM,CHEMBL672099,B,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,CHEMBL1136617,KI,COc1ccc(Br)cc1C1=NCC[C@@H](CN2CCN(c3ccccc3)CC2)N1
CHEMBL294459,CHEMBL217,Dopamine D2 receptor,Ki,=,1850.0,nM,CHEMBL872499,B,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,CHEMBL1131791,KI,N#CC(C#N)=Cc1cc(CN2CCN(c3ccccc3)CC2)c[nH]1
CHEMBL294459,CHEMBL217,Dopamine D2 receptor,Ki,=,975.0,nM,CHEMBL670553,B,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,CHEMBL1131791,KI,N#CC(C#N)=Cc1cc(CN2CCN(c3ccccc3)CC2)c[nH]1
CHEMBL291801,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL672226,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1153677,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(cccc2OS(C)(=O)=O)C1
CHEMBL51977,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL672226,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1153677,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(Cl)cccc2C1
CHEMBL25856,CHEMBL217,Dopamine D2 receptor,Ki,=,1520.0,nM,CHEMBL672175,B,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,CHEMBL1131704,KI,Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2
CHEMBL420986,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL670555,B,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,CHEMBL1135019,KI,Oc1nc2c3c(ccc2[nH]1)CC[C@H](CNCc1ccccc1)O3
CHEMBL71798,CHEMBL217,Dopamine D2 receptor,Ki,=,158.0,nM,CHEMBL672208,B,The compound was tested for CNS binding affinity towards Dopamine receptor D2 from cloned Human membranes.,CHEMBL1131250,KI,CNC(=O)c1ccc2c(c1)CCO[C@@H]2CCN1CCN(c2ccc(OC)cc2)CC1
CHEMBL58669,CHEMBL217,Dopamine D2 receptor,Ki,=,25.12,nM,CHEMBL672226,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1153677,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(O)cccc2C1
CHEMBL303538,CHEMBL217,Dopamine D2 receptor,Ki,=,48500.0,nM,CHEMBL872499,B,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,CHEMBL1131791,KI,N#CC(C#N)=Cc1ccc(CN2CCN(c3ccc(Cl)cc3)CC2)[nH]1
CHEMBL303538,CHEMBL217,Dopamine D2 receptor,Ki,=,59000.0,nM,CHEMBL670553,B,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,CHEMBL1131791,KI,N#CC(C#N)=Cc1ccc(CN2CCN(c3ccc(Cl)cc3)CC2)[nH]1
CHEMBL169459,CHEMBL217,Dopamine D2 receptor,Ki,=,29000.0,nM,CHEMBL672102,B,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,CHEMBL1136617,KI,c1ccc(C2=NCC[C@@H](CN3CCN(c4ccccc4)CC3)N2)cc1
CHEMBL169459,CHEMBL217,Dopamine D2 receptor,Ki,=,30000.0,nM,CHEMBL672103,B,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 short in CHO cells,CHEMBL1136617,KI,c1ccc(C2=NCC[C@@H](CN3CCN(c4ccccc4)CC3)N2)cc1
CHEMBL28338,CHEMBL217,Dopamine D2 receptor,Ki,=,710.0,nM,CHEMBL672175,B,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,CHEMBL1131704,KI,CCCc1cc2c(s1)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21
CHEMBL416508,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL672226,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1153677,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(C#N)cccc2C1
CHEMBL440120,CHEMBL217,Dopamine D2 receptor,Ki,=,4000.0,nM,CHEMBL872499,B,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,CHEMBL1131791,KI,N#CC(C#N)=Cc1[nH]ccc1CN1CCN(c2ccccc2)CC1
CHEMBL440120,CHEMBL217,Dopamine D2 receptor,Ki,=,12750.0,nM,CHEMBL670553,B,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,CHEMBL1131791,KI,N#CC(C#N)=Cc1[nH]ccc1CN1CCN(c2ccccc2)CC1
CHEMBL64553,CHEMBL217,Dopamine D2 receptor,Ki,=,10.4,nM,CHEMBL670555,B,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,CHEMBL1135019,KI,Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2
CHEMBL60185,CHEMBL217,Dopamine D2 receptor,Ki,=,107.0,nM,CHEMBL670555,B,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,CHEMBL1135019,KI,c1ccc(CNC[C@H]2CCc3ccc4[nH]ccc4c3O2)cc1
CHEMBL313851,CHEMBL217,Dopamine D2 receptor,Ki,=,132.0,nM,CHEMBL670555,B,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,CHEMBL1135019,KI,FC(F)(F)c1nc2c3c(ccc2[nH]1)CCC(CNCc1ccccc1)O3
CHEMBL59642,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL672226,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1153677,KI,CN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(O)cccc2C1
CHEMBL61444,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL672226,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1153677,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(cccc2OCC2CC2)C1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL872499,B,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,CHEMBL1131791,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL670553,B,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,CHEMBL1131791,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL294747,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL672226,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1153677,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccc(C(C)=O)cc3)cc2)CC1
CHEMBL168571,CHEMBL217,Dopamine D2 receptor,Ki,=,7300.0,nM,CHEMBL672098,B,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,CHEMBL1136617,KI,O=C1C[C@H](CN2CCN(c3ccccc3)CC2)N=C(c2ccccc2)N1
CHEMBL168571,CHEMBL217,Dopamine D2 receptor,Ki,=,2800.0,nM,CHEMBL672099,B,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,CHEMBL1136617,KI,O=C1C[C@H](CN2CCN(c3ccccc3)CC2)N=C(c2ccccc2)N1
CHEMBL93753,CHEMBL217,Dopamine D2 receptor,Ki,=,67.0,nM,CHEMBL670555,B,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,CHEMBL1135019,KI,Oc1nc2c3c(ccc2[nH]1)CC[C@@H](CNCc1ccccc1)O3
CHEMBL71635,CHEMBL217,Dopamine D2 receptor,Ki,=,325.0,nM,CHEMBL672208,B,The compound was tested for CNS binding affinity towards Dopamine receptor D2 from cloned Human membranes.,CHEMBL1131250,KI,COc1ccc(N2CCN(CC[C@@H]3OCCc4cc(C(N)=O)ccc43)CC2)cc1
CHEMBL93779,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL670555,B,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,CHEMBL1135019,KI,Oc1nc2c3c(ccc2[nH]1)CCC(CNCc1ccccc1)O3
CHEMBL63449,CHEMBL217,Dopamine D2 receptor,Ki,=,423.0,nM,CHEMBL673017,B,In vitro binding affinity against dopamine receptor D2 using [3H]raclopride as radioligand in CHO cells (sc),CHEMBL1126740,KI,CCCN(CCC)[C@H]1CCc2ccc3[nH]cc(C(C)=O)c3c2C1
CHEMBL303556,CHEMBL217,Dopamine D2 receptor,Ki,=,9.3,nM,CHEMBL670555,B,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,CHEMBL1135019,KI,O=C1Cc2c(ccc3c2O[C@@H](CNCc2ccccc2)CC3)N1
CHEMBL300553,CHEMBL217,Dopamine D2 receptor,Ki,=,8950.0,nM,CHEMBL872499,B,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,CHEMBL1131791,KI,N#CC(C#N)=Cc1[nH]ccc1CN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL300553,CHEMBL217,Dopamine D2 receptor,Ki,=,15000.0,nM,CHEMBL670553,B,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,CHEMBL1131791,KI,N#CC(C#N)=Cc1[nH]ccc1CN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL71907,CHEMBL217,Dopamine D2 receptor,Ki,=,386.0,nM,CHEMBL672208,B,The compound was tested for CNS binding affinity towards Dopamine receptor D2 from cloned Human membranes.,CHEMBL1131250,KI,COc1ccc(N2CCN(CC[C@H]3OCCc4cc(C(N)=O)ccc43)CC2)cc1
CHEMBL27117,CHEMBL217,Dopamine D2 receptor,Ki,=,1400.0,nM,CHEMBL672175,B,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,CHEMBL1131704,KI,Cc1ccc2c(n1)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21
CHEMBL61717,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL672226,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1153677,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(cccc2OC)C1
CHEMBL169562,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL672098,B,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,CHEMBL1136617,KI,c1ccc(C2=NC[C@H](N3CCN(c4ccccc4)CC3)CCN2)cc1
CHEMBL169562,CHEMBL217,Dopamine D2 receptor,Ki,=,4200.0,nM,CHEMBL672099,B,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,CHEMBL1136617,KI,c1ccc(C2=NC[C@H](N3CCN(c4ccccc4)CC3)CCN2)cc1
CHEMBL59554,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL672226,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1153677,KI,COc1cccc2c1CCC(N(C)CCCCNC(=O)c1ccc(-c3ccccc3)cc1)C2
CHEMBL69385,CHEMBL217,Dopamine D2 receptor,Ki,=,348.0,nM,CHEMBL672207,B,The compound was tested for CNS binding affinity towards Dopamine receptor D2 from cloned Human membranes,CHEMBL1131250,KI,COc1ccc(N2CCN(CCC3OCCc4cc(C(N)=O)ccc43)CC2)cc1
CHEMBL282136,CHEMBL217,Dopamine D2 receptor,Ki,=,400.0,nM,CHEMBL672175,B,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,CHEMBL1131704,KI,Cc1cncc2c1CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21
CHEMBL59960,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL672226,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1153677,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(cccc2C(N)=O)C1
CHEMBL168541,CHEMBL217,Dopamine D2 receptor,Ki,=,18000.0,nM,CHEMBL672098,B,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,CHEMBL1136617,KI,O=C1C[C@@H](CN2CCN(c3ccccc3)CC2)N=C(c2ccccc2)N1
CHEMBL168541,CHEMBL217,Dopamine D2 receptor,Ki,=,6400.0,nM,CHEMBL672099,B,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,CHEMBL1136617,KI,O=C1C[C@@H](CN2CCN(c3ccccc3)CC2)N=C(c2ccccc2)N1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,64.0,nM,CHEMBL672098,B,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,CHEMBL1136617,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL672099,B,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,CHEMBL1136617,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL27101,CHEMBL217,Dopamine D2 receptor,Ki,=,2200.0,nM,CHEMBL672175,B,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,CHEMBL1131704,KI,Oc1cc2c(cc1O)[C@H]1c3ccc(F)nc3CN[C@@H]1CC2
CHEMBL285924,CHEMBL217,Dopamine D2 receptor,Ki,=,520.0,nM,CHEMBL672175,B,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,CHEMBL1131704,KI,COc1ccc2c(n1)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21
CHEMBL275379,CHEMBL217,Dopamine D2 receptor,Ki,=,12000.0,nM,CHEMBL672175,B,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,CHEMBL1131704,KI,Cc1cnc2c(c1)[C@@H]1c3cc(O)c(O)cc3CC[C@H]1NC2
CHEMBL71724,CHEMBL217,Dopamine D2 receptor,Ki,=,1431.0,nM,CHEMBL672208,B,The compound was tested for CNS binding affinity towards Dopamine receptor D2 from cloned Human membranes.,CHEMBL1131250,KI,COc1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1
CHEMBL284644,CHEMBL217,Dopamine D2 receptor,Ki,=,4400.0,nM,CHEMBL672175,B,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,CHEMBL1131704,KI,Oc1cc2c(cc1O)[C@H]1c3ccncc3CN[C@@H]1CC2
CHEMBL354748,CHEMBL217,Dopamine D2 receptor,Ki,=,19000.0,nM,CHEMBL672098,B,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,CHEMBL1136617,KI,c1ccc(C2=NC[C@@H](N3CCN(c4ccccc4)CC3)CCN2)cc1
CHEMBL354748,CHEMBL217,Dopamine D2 receptor,Ki,=,14000.0,nM,CHEMBL672099,B,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,CHEMBL1136617,KI,c1ccc(C2=NC[C@@H](N3CCN(c4ccccc4)CC3)CCN2)cc1
CHEMBL65274,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL673017,B,In vitro binding affinity against dopamine receptor D2 using [3H]raclopride as radioligand in CHO cells (sc),CHEMBL1126740,KI,CCCN(CCC)[C@@H]1CCc2ccc3[nH]cc(C(C)=O)c3c2C1
CHEMBL169889,CHEMBL217,Dopamine D2 receptor,Ki,=,44000.0,nM,CHEMBL672098,B,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,CHEMBL1136617,KI,COc1ccc(Br)cc1C1=NCC[C@H](CN2CCN(c3ccccc3)CC2)N1
CHEMBL169889,CHEMBL217,Dopamine D2 receptor,Ki,=,43000.0,nM,CHEMBL672099,B,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,CHEMBL1136617,KI,COc1ccc(Br)cc1C1=NCC[C@H](CN2CCN(c3ccccc3)CC2)N1
CHEMBL284959,CHEMBL217,Dopamine D2 receptor,Ki,=,9100.0,nM,CHEMBL672175,B,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,CHEMBL1131704,KI,Cc1cc2c(nc1C)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21
CHEMBL60038,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL672226,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1153677,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(Br)cccc2C1
CHEMBL60713,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL672226,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1153677,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2ccccc2C1
CHEMBL352925,CHEMBL217,Dopamine D2 receptor,Ki,=,25000.0,nM,CHEMBL672801,B,In vitro ability to displace [3H]spiperone from the cloned human dopamine D2 long receptor expressed in CHO cells,CHEMBL1136617,KI,c1ccc(C2=NCC[C@H](CN3CCN(c4ccccc4)CC3)N2)cc1
CHEMBL352925,CHEMBL217,Dopamine D2 receptor,Ki,=,32000.0,nM,CHEMBL671415,B,In vitro ability to displace [3H]spiperone from the cloned human dopamine D2 short receptor expressed in CHO cells,CHEMBL1136617,KI,c1ccc(C2=NCC[C@H](CN3CCN(c4ccccc4)CC3)N2)cc1
CHEMBL82864,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL674940,B,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,CHEMBL1133070,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cc4ccccc4[nH]3)CC1)CC2
CHEMBL326159,CHEMBL217,Dopamine D2 receptor,Ki,=,2760.0,nM,CHEMBL670885,B,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,CHEMBL1129624,KI,CC(=O)c1ccc2c(c1O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL324372,CHEMBL217,Dopamine D2 receptor,Ki,=,2980.0,nM,CHEMBL670886,B,In vitro affinity at human cloned Dopamine receptor D2A by [3H]raclopride displacement.,CHEMBL1129624,KI,COc1c(C(C)=O)ccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL118636,CHEMBL217,Dopamine D2 receptor,Ki,=,500.0,nM,CHEMBL671517,B,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]NPA as radioligand.,CHEMBL1133651,KI,CCCN(CCC)C1Cc2ccc3nc(N)sc3c2C1
CHEMBL119150,CHEMBL217,Dopamine D2 receptor,Ki,=,582.0,nM,CHEMBL670886,B,In vitro affinity at human cloned Dopamine receptor D2A by [3H]raclopride displacement.,CHEMBL1129624,KI,COc1c(-c2ccco2)ccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL334116,CHEMBL217,Dopamine D2 receptor,Ki,=,1040.0,nM,CHEMBL670885,B,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,CHEMBL1129624,KI,COc1c(OS(=O)(=O)C(F)(F)F)ccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,Ki,=,139.0,nM,CHEMBL671518,B,in vitro low binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]-spiperone as radioligand.,CHEMBL1133651,KI,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL92139,CHEMBL217,Dopamine D2 receptor,Ki,=,1600.0,nM,CHEMBL671380,B,Binding affinity against dopamine receptor D2 using [3H]spiperone radioligand in CHO cells,CHEMBL1134783,KI,CN(C)CCc1cccc2c1ccn2S(=O)(=O)c1ccccc1
CHEMBL86127,CHEMBL217,Dopamine D2 receptor,Ki,=,1995.26,nM,CHEMBL674940,B,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,CHEMBL1133070,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cccc4ncccc34)CC1)CC2
CHEMBL86183,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL674940,B,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,CHEMBL1133070,KI,CC(=O)Nc1cccc(/C=C/C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(C#N)cc4CC3)CC2)c1F
CHEMBL331100,CHEMBL217,Dopamine D2 receptor,Ki,=,1750.0,nM,CHEMBL670886,B,In vitro affinity at human cloned Dopamine receptor D2A by [3H]raclopride displacement.,CHEMBL1129624,KI,C=Cc1ccc2c(c1OC)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL314050,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL674940,B,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,CHEMBL1133070,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccc(F)cc3)CC1)CC2
CHEMBL76237,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL671380,B,Binding affinity against dopamine receptor D2 using [3H]spiperone radioligand in CHO cells,CHEMBL1134783,KI,COc1ccc2c(c1)c(CCN(C)C)cn2S(=O)(=O)c1ccccc1
CHEMBL86032,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL674940,B,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,CHEMBL1133070,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccc4c(c3)NC(=O)CO4)CC1)CC2
CHEMBL420789,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL674940,B,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,CHEMBL1133070,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3cccc(F)c3)CC1)CC2
CHEMBL119900,CHEMBL217,Dopamine D2 receptor,Ki,=,403.0,nM,CHEMBL670885,B,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,CHEMBL1129624,KI,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(OS(=O)(=O)C(F)(F)F)c(OC)c1-3
CHEMBL315209,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL674940,B,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,CHEMBL1133070,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccccc3F)CC1)CC2
CHEMBL119593,CHEMBL217,Dopamine D2 receptor,Ki,=,249.0,nM,CHEMBL670885,B,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,CHEMBL1129624,KI,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(C)c(O)c1-3
CHEMBL117730,CHEMBL217,Dopamine D2 receptor,Ki,=,4710.0,nM,CHEMBL670886,B,In vitro affinity at human cloned Dopamine receptor D2A by [3H]raclopride displacement.,CHEMBL1129624,KI,COc1c(C)ccc2c1-c1cccc3c1[C@@H](C2)NCC3
CHEMBL118637,CHEMBL217,Dopamine D2 receptor,Ki,=,1350.0,nM,CHEMBL671517,B,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]NPA as radioligand.,CHEMBL1133651,KI,CCCNC1Cc2cc3nc(N)sc3cc2C1
CHEMBL419505,CHEMBL217,Dopamine D2 receptor,Ki,=,262.0,nM,CHEMBL872490,B,Compound was evaluated for binding affinity against Dopamine receptor D2 subtype from primate,CHEMBL1130602,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)-c1ccccc1-2
CHEMBL85606,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL674940,B,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,CHEMBL1133070,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2
CHEMBL445111,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL674940,B,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,CHEMBL1133070,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)CC2
CHEMBL332178,CHEMBL217,Dopamine D2 receptor,Ki,=,248.0,nM,CHEMBL670885,B,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,CHEMBL1129624,KI,COc1c(C)ccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL419487,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL674940,B,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,CHEMBL1133070,KI,CC(=O)c1cccc(/C=C/C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(C#N)cc4CC3)CC2)c1
CHEMBL115524,CHEMBL217,Dopamine D2 receptor,Ki,=,2050.0,nM,CHEMBL670885,B,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,CHEMBL1129624,KI,CCc1ccc2c(c1O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL118771,CHEMBL217,Dopamine D2 receptor,Ki,=,238.0,nM,CHEMBL670885,B,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,CHEMBL1129624,KI,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(C)c(OC)c1-3
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,41.9,nM,CHEMBL670885,B,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,CHEMBL1129624,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL126340,CHEMBL217,Dopamine D2 receptor,Ki,=,750.0,nM,CHEMBL671380,B,Binding affinity against dopamine receptor D2 using [3H]spiperone radioligand in CHO cells,CHEMBL1134783,KI,CN(C)CCc1cccc2c1cc(C(=O)c1ccccc1)n2S(=O)(=O)c1ccccc1
CHEMBL325710,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL671517,B,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]NPA as radioligand.,CHEMBL1133651,KI,CCCN(CCC)C1Cc2cc3nc(N)sc3cc2C1
CHEMBL317535,CHEMBL217,Dopamine D2 receptor,Ki,=,59.0,nM,CHEMBL671380,B,Binding affinity against dopamine receptor D2 using [3H]spiperone radioligand in CHO cells,CHEMBL1134783,KI,CCOC(=O)c1[nH]c2ccccc2c1CCN(C)C
CHEMBL119455,CHEMBL217,Dopamine D2 receptor,Ki,=,58.5,nM,CHEMBL670885,B,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,CHEMBL1129624,KI,CN1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3
CHEMBL86402,CHEMBL217,Dopamine D2 receptor,Ki,=,3162.28,nM,CHEMBL674940,B,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,CHEMBL1133070,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccc4ccccc4c3)CC1)CC2
CHEMBL331005,CHEMBL217,Dopamine D2 receptor,Ki,=,411.0,nM,CHEMBL670885,B,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,CHEMBL1129624,KI,CCc1ccc2c(c1OC)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL53510,CHEMBL217,Dopamine D2 receptor,Ki,=,1070.0,nM,CHEMBL670885,B,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,CHEMBL1129624,KI,Cc1ccc2c(c1O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL116372,CHEMBL217,Dopamine D2 receptor,Ki,=,47.0,nM,CHEMBL671516,B,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]-0437 as radioligand.,CHEMBL1133651,KI,CCCN(CCC)C1COc2ccc3nc(N)sc3c2C1
CHEMBL116372,CHEMBL217,Dopamine D2 receptor,Ki,=,5920.0,nM,CHEMBL872883,B,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]spiperone as radioligand.,CHEMBL1133651,KI,CCCN(CCC)C1COc2ccc3nc(N)sc3c2C1
CHEMBL87600,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL674940,B,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,CHEMBL1133070,KI,COc1cccc(/C=C/C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(C#N)cc4CC3)CC2)c1
CHEMBL93868,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL671380,B,Binding affinity against dopamine receptor D2 using [3H]spiperone radioligand in CHO cells,CHEMBL1134783,KI,CN(C)CCc1cn(S(=O)(=O)c2ccccc2)c2ccccc12
CHEMBL300780,CHEMBL217,Dopamine D2 receptor,Ki,=,217.0,nM,CHEMBL872490,B,Compound was evaluated for binding affinity against Dopamine receptor D2 subtype from primate,CHEMBL1130602,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL332677,CHEMBL217,Dopamine D2 receptor,Ki,=,536.0,nM,CHEMBL671516,B,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]-0437 as radioligand.,CHEMBL1133651,KI,CCCN(CCC)C1COc2c(ccc3sc(N)nc23)C1
CHEMBL332677,CHEMBL217,Dopamine D2 receptor,Ki,=,3510.0,nM,CHEMBL872883,B,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]spiperone as radioligand.,CHEMBL1133651,KI,CCCN(CCC)C1COc2c(ccc3sc(N)nc23)C1
CHEMBL85711,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL674940,B,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,CHEMBL1133070,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cccc4ccccc34)CC1)CC2
CHEMBL313255,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL674940,B,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,CHEMBL1133070,KI,CC(=O)Nc1cccc(/C=C/C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(C#N)cc4CC3)CC2)c1
CHEMBL87753,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL674940,B,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,CHEMBL1133070,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccc4ccc(O)nc4c3)CC1)CC2
CHEMBL28321,CHEMBL217,Dopamine D2 receptor,Ki,=,1.3,nM,CHEMBL672101,B,In vitro binding affinity was measured at the cloned human Dopamine receptor D2 using [3H]spiroperidol as radioligand.,CHEMBL1131412,KI,COc1ccccc1N1CCN(Cc2ccn(-c3ccccc3)c2)CC1
CHEMBL544533,CHEMBL217,Dopamine D2 receptor,Ki,=,1460.0,nM,CHEMBL672709,B,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,CHEMBL1127001,KI,Cl.O=C1CC2(CCN(Cc3ccccc3)CC2)OC=C1c1ccccc1
CHEMBL148024,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL672101,B,In vitro binding affinity was measured at the cloned human Dopamine receptor D2 using [3H]spiroperidol as radioligand.,CHEMBL1131412,KI,COc1ccccc1N1CCN(CCNC2=Nc3ccccc3OC2)CC1
CHEMBL542400,CHEMBL217,Dopamine D2 receptor,Ki,=,2330.0,nM,CHEMBL672710,B,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,CHEMBL1127001,KI,Cl.O=C1CC2(CCN(CCc3ccccc3)CC2)OC=C1c1ccccc1F
CHEMBL538755,CHEMBL217,Dopamine D2 receptor,Ki,=,2030.0,nM,CHEMBL672710,B,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,CHEMBL1127001,KI,Cl.O=C1CC2(CCN(CCc3ccccc3)CC2)OC=C1c1ccccc1
CHEMBL553864,CHEMBL217,Dopamine D2 receptor,Ki,=,8780.0,nM,CHEMBL672710,B,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,CHEMBL1127001,KI,Cl.O=C1CC2(CCCN(Cc3ccccc3)C2)OC=C1c1ccc(F)cc1
CHEMBL542647,CHEMBL217,Dopamine D2 receptor,Ki,=,7600.0,nM,CHEMBL672709,B,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,CHEMBL1127001,KI,Cl.O=C1C=C(c2ccco2)OC2(CCN(CCc3ccccc3)CC2)C1
CHEMBL545697,CHEMBL217,Dopamine D2 receptor,Ki,=,1496.0,nM,CHEMBL672709,B,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,CHEMBL1127001,KI,COc1ccc(C2=COC3(CCN(CCc4ccccc4)CC3)CC2=O)cc1.Cl
CHEMBL552858,CHEMBL217,Dopamine D2 receptor,Ki,=,4100.0,nM,CHEMBL672709,B,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,CHEMBL1127001,KI,CN(C)CC1(C)CC(=O)C(c2ccccc2)=CO1.Cl
CHEMBL283353,CHEMBL217,Dopamine D2 receptor,Ki,=,2519.0,nM,CHEMBL672101,B,In vitro binding affinity was measured at the cloned human Dopamine receptor D2 using [3H]spiroperidol as radioligand.,CHEMBL1131412,KI,CCC(C)(C)C(=O)NCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL543344,CHEMBL217,Dopamine D2 receptor,Ki,=,47.0,nM,CHEMBL672710,B,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,CHEMBL1127001,KI,Cl.O=C1C(c2ccc(F)cc2)COC12CCN(Cc1ccccc1)CC2
CHEMBL539526,CHEMBL217,Dopamine D2 receptor,Ki,=,4200.0,nM,CHEMBL672709,B,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,CHEMBL1127001,KI,Cl.O=C1C=C(c2ccccc2)OC2(CCN(CCc3ccccc3)CC2)C1
CHEMBL539007,CHEMBL217,Dopamine D2 receptor,Ki,=,1530.0,nM,CHEMBL672710,B,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,CHEMBL1127001,KI,Cl.O=C1CC2(CCN(CCc3ccccc3)CC2)OCC1c1ccc(F)cc1
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,920.0,nM,CHEMBL672101,B,In vitro binding affinity was measured at the cloned human Dopamine receptor D2 using [3H]spiroperidol as radioligand.,CHEMBL1131412,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL543823,CHEMBL217,Dopamine D2 receptor,Ki,=,1080.0,nM,CHEMBL672709,B,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,CHEMBL1127001,KI,Cl.O=C1CC2(CCN(CCc3ccccc3)CC2)OC=C1c1cccs1
CHEMBL543822,CHEMBL217,Dopamine D2 receptor,Ki,=,2900.0,nM,CHEMBL672710,B,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,CHEMBL1127001,KI,Cl.O=C1CC2(CCN(CCc3ccccc3)CC2)OC=C1c1ccc(F)cc1
CHEMBL165504,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,c1ccc(OC[C@H]2CC[C@H]3CN(c4ncccn4)CCN3C2)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.84,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL253318,CHEMBL217,Dopamine D2 receptor,Ki,=,6110.0,nM,CHEMBL670883,B,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,CHEMBL1134169,KI,CN1CCc2ccc3[nH]c(=O)c4cccc5c4c3c2[C@H]1C5
CHEMBL120927,CHEMBL217,Dopamine D2 receptor,Ki,=,1330.0,nM,CHEMBL670883,B,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,CHEMBL1134169,KI,CN1CCc2ccc3cnc4cccc5c4c3c2[C@H]1C5
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,155.0,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL163009,CHEMBL217,Dopamine D2 receptor,Ki,=,68.0,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,Fc1ccc(OC[C@H]2CC[C@H]3CN(c4ncc(F)cn4)CCN3C2)cc1
CHEMBL349699,CHEMBL217,Dopamine D2 receptor,Ki,=,980.0,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,Fc1ccc(OC[C@@H]2CC[C@@H]3CN(c4ncc(F)cn4)CCN3C2)cc1
CHEMBL351611,CHEMBL217,Dopamine D2 receptor,Ki,=,44.0,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,c1ccc(OC[C@@H]2CC[C@H]3CN(c4ccccc4)CCN3C2)cc1
CHEMBL349904,CHEMBL217,Dopamine D2 receptor,Ki,=,1720.0,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,CC(C)(C)c1ccc(OC[C@@H]2CC[C@H]3CN(c4ncccn4)CCN3C2)cc1
CHEMBL122485,CHEMBL217,Dopamine D2 receptor,Ki,=,541.0,nM,CHEMBL670883,B,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,CHEMBL1134169,KI,CN1CCc2ccc3c(=O)oc4cccc5c4c3c2[C@H]1C5
CHEMBL161899,CHEMBL217,Dopamine D2 receptor,Ki,=,948.0,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,CC(=O)Nc1ccc(OC[C@@H]2CC[C@H]3CN(c4ncccn4)CCN3C2)cc1
CHEMBL350160,CHEMBL217,Dopamine D2 receptor,Ki,=,187.0,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,c1ccc(OC[C@@H]2CC[C@H]3CN(c4ccccn4)CCN3C2)cc1
CHEMBL166269,CHEMBL217,Dopamine D2 receptor,Ki,=,1140.0,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,c1ccc(OC[C@@H]2CC[C@H]3CN(c4ncccn4)CCN3C2)cc1
CHEMBL159903,CHEMBL217,Dopamine D2 receptor,Ki,=,1196.0,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,Fc1ccc(OC[C@@H]2CC[C@H]3CN(c4ncccn4)CCN3C2)cc1
CHEMBL162873,CHEMBL217,Dopamine D2 receptor,Ki,=,195.0,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,Fc1ccc(OC[C@H]2CC[C@@H]3CN(c4ncc(F)cn4)CCN3C2)cc1
CHEMBL414628,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL674343,B,Compound was evaluated for binding affinity against Dopamine receptor D2 in CHO cells using [125I]iodosulpiride as the radioligand,CHEMBL1134050,KI,COc1ccc(S(=O)(=O)N2CCc3ccc(I)cc32)cc1N1CCNCC1
CHEMBL165113,CHEMBL217,Dopamine D2 receptor,Ki,=,254.0,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,COC(=O)c1ccc(OC[C@@H]2CC[C@H]3CN(c4ncccn4)CCN3C2)cc1
CHEMBL253319,CHEMBL217,Dopamine D2 receptor,Ki,=,54.6,nM,CHEMBL670883,B,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,CHEMBL1134169,KI,CN1CCc2ccc3c(=O)[nH]c4cccc5c4c3c2[C@H]1C5
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,41.6,nM,CHEMBL670883,B,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,CHEMBL1134169,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL162265,CHEMBL217,Dopamine D2 receptor,Ki,=,185.0,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,c1ccc(OCC2CCC3CN(c4ncccn4)CCN3C2)cc1
CHEMBL122453,CHEMBL217,Dopamine D2 receptor,Ki,=,327.0,nM,CHEMBL670883,B,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,CHEMBL1134169,KI,CN1CCc2ccc3ncc4cccc5c4c3c2[C@H]1C5
CHEMBL161982,CHEMBL217,Dopamine D2 receptor,Ki,=,1880.0,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,Fc1ccc(OC[C@@H]2CC[C@H]3CN(c4ccc(Cl)cn4)CCN3C2)cc1
CHEMBL284586,CHEMBL217,Dopamine D2 receptor,Ki,=,83.2,nM,CHEMBL670883,B,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,CHEMBL1134169,KI,CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)C3
CHEMBL124419,CHEMBL217,Dopamine D2 receptor,Ki,=,265.0,nM,CHEMBL670883,B,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,CHEMBL1134169,KI,CN1CCc2ccc3oc(=O)c4cccc5c4c3c2[C@H]1C5
CHEMBL166321,CHEMBL217,Dopamine D2 receptor,Ki,=,206.0,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,Fc1ccc(OC[C@@H]2CC[C@H]3CN(c4ccc(F)cc4)CCN3C2)cc1
CHEMBL351098,CHEMBL217,Dopamine D2 receptor,Ki,=,918.0,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,COc1ccc(OC[C@@H]2CC[C@H]3CN(c4ncccn4)CCN3C2)cc1
CHEMBL165504,CHEMBL217,Dopamine D2 receptor,Ki,=,66.0,nM,CHEMBL670394,B,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,CHEMBL1131659,KI,c1ccc(OC[C@H]2CC[C@H]3CN(c4ncccn4)CCN3C2)cc1
CHEMBL91460,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL670658,B,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",CHEMBL1131981,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2nc(N)ncc2C1
CHEMBL20854,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CC1CN(CCCCNC(=O)C(C)(C)C)CCN1c1ccc(Cl)cc1
CHEMBL91510,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL670658,B,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",CHEMBL1131981,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2nc(NC)ncc2C1
CHEMBL21035,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CC(C)(C)C(=O)NCCCCN1CCN(c2ccccc2)CC1
CHEMBL93336,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL670658,B,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",CHEMBL1131981,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2nc(C)ncc2C1
CHEMBL93794,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL670658,B,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",CHEMBL1131981,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2ncnc(OC)c2C1
CHEMBL20367,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CC1(C(=O)NCCCCN2CCN(c3ccc(Cl)cc3)CC2)CCCCC1
CHEMBL328002,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL670658,B,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",CHEMBL1131981,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2nc(SC)ncc2C1
CHEMBL283353,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CCC(C)(C)C(=O)NCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL20996,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CCCCC(C)(C)C(=O)NCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL277937,CHEMBL217,Dopamine D2 receptor,Ki,=,1995.26,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CC(C)(C)C(=O)NCCCCN1CCN(c2ccc(F)cc2)CC1
CHEMBL20444,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CCCC(C)(C)C(=O)NCCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL20655,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CC1(C(=O)NCCN2CCN(c3ccc(Cl)cc3)CC2)CCCCC1
CHEMBL90897,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL670658,B,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",CHEMBL1131981,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2nc(N(C)C)ncc2C1
CHEMBL283142,CHEMBL217,Dopamine D2 receptor,Ki,=,63.1,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CC(C)(C)C(=O)NCCCCN1CCN(c2ccccc2Cl)CC1
CHEMBL423632,CHEMBL217,Dopamine D2 receptor,Ki,=,374.0,nM,CHEMBL670744,B,Compound was measured in vivo for its binding affinity at Dopamine receptor D2 using [3H]spiperone as radioligand.,CHEMBL1129884,KI,O=C(c1cccc(CN2CCc3c([nH]c4ccccc34)C2)c1)N1CCCCC1
CHEMBL90433,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL670658,B,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",CHEMBL1131981,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2nc(N)sc2C1
CHEMBL282008,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CC(C)(C)C(=O)NCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL92439,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL670658,B,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",CHEMBL1131981,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2nc(C(C)(C)C)ncc2C1
CHEMBL91156,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL670658,B,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",CHEMBL1131981,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2n[nH]cc2C1
CHEMBL20251,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,COc1cc(Cl)ccc1N1CCN(CCCCNC(=O)C(C)(C)C)CC1
CHEMBL10085,CHEMBL217,Dopamine D2 receptor,Ki,=,2.2,nM,CHEMBL670744,B,Compound was measured in vivo for its binding affinity at Dopamine receptor D2 using [3H]spiperone as radioligand.,CHEMBL1129884,KI,CC(C)Oc1ccccc1N1CCN(Cc2cccc(C(=O)N3CCCCC3)c2)CC1
CHEMBL20114,CHEMBL217,Dopamine D2 receptor,Ki,=,1995.26,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CC(C)C(=O)NCCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL277669,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CC(C)(C)C(=O)NCCCCN1CCN(c2ccc(Br)cc2)CC1
CHEMBL21011,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CCC(C)(C)C(=O)NCCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL20725,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CCCC(C)(C)C(=O)NCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL21168,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,O=C(NCCN1CCN(c2ccc(Cl)cc2)CC1)C12CC3CC(CC(C3)C1)C2
CHEMBL92438,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL670658,B,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",CHEMBL1131981,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2ncncc2C1
CHEMBL21252,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CC(=O)NCCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL21119,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,O=C(NCCCCN1CCN(c2ccc(Cl)cc2)CC1)C12CC3CC(CC(C3)C1)C2
CHEMBL93703,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL670658,B,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",CHEMBL1131981,KI,CN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2nc(N)ncc2C1
CHEMBL20204,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CC(C)(C)C(=O)NCCCCN1CCN2c3ccc(Cl)cc3CCC2C1
CHEMBL94015,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL670657,B,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,CHEMBL1131981,KI,CCCN1COC[C@@H]2c3cc(O)ccc3OC[C@H]21
CHEMBL21059,CHEMBL217,Dopamine D2 receptor,Ki,=,3981.07,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CC(C)(C)C(=O)NCCCCN1CCN(c2ccc(C(F)(F)F)cc2)CC1
CHEMBL21205,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,O=C(NCCCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccccc1
CHEMBL278288,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CC(C)(C)C(=O)NCCCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL20729,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CC(C)(C)C(=O)NCCCCN1CCN(c2cccc(Cl)c2)CC1
CHEMBL21008,CHEMBL217,Dopamine D2 receptor,Ki,=,19.95,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,COc1ccccc1N1CCN(CCCCNC(=O)C(C)(C)C)CC1
CHEMBL20493,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL670172,B,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",CHEMBL1129089,KI,CC(C)(C)C(=O)NCCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL28056,CHEMBL217,Dopamine D2 receptor,Ki,=,2470.0,nM,CHEMBL673593,B,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,CHEMBL1134402,KI,Cc1cccc(C#N)c1-c1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL282199,CHEMBL217,Dopamine D2 receptor,Ki,=,316.0,nM,CHEMBL673593,B,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,CHEMBL1134402,KI,CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1
CHEMBL27251,CHEMBL217,Dopamine D2 receptor,Ki,=,2250.0,nM,CHEMBL673593,B,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,CHEMBL1134402,KI,CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N
CHEMBL169323,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL674942,B,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,CHEMBL1129892,KI,CCCN1CCO[C@@H]2c3cc4c(cc3CC[C@H]21)CCO4
CHEMBL170976,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL674942,B,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,CHEMBL1129892,KI,CCCN1CCC[C@@H]2c3cc4c(cc3CC[C@H]21)CCO4
CHEMBL1204203,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL664619,B,In vitro binding affinity towards D2 receptor was determined,CHEMBL1134606,KI,CCS(=O)(=O)Nc1cccc(N2CCN(CCCCN3C(=O)C4CCCN4C3=O)CC2)c1.Cl
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,41.9,nM,CHEMBL673593,B,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,CHEMBL1134402,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL2021524,CHEMBL217,Dopamine D2 receptor,Ki,=,225.0,nM,CHEMBL673095,B,In vitro binding affinity towards Dopamine receptor D2 by using [3H]U-86170 as radioligand,CHEMBL1128298,KI,CCCN[C@H]1CCc2cccc(CS(=O)(=O)C(F)(F)F)c2C1.Cl
CHEMBL26907,CHEMBL217,Dopamine D2 receptor,Ki,=,3380.0,nM,CHEMBL673593,B,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,CHEMBL1134402,KI,Cc1cccc(O)c1-c1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL156896,CHEMBL217,Dopamine D2 receptor,Ki,=,600.0,nM,CHEMBL671652,B,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,CHEMBL1132519,KI,c1c[nH]c2nc(CN3CCc4ccccc4C3)cc-2c1
CHEMBL171825,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL674942,B,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,CHEMBL1129892,KI,c1c2c(cc3c1CC[C@H]1NCCO[C@H]31)OCC2
CHEMBL281357,CHEMBL217,Dopamine D2 receptor,Ki,=,527.0,nM,CHEMBL673593,B,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,CHEMBL1134402,KI,CN1CCc2cccc3c2[C@H]1Cc1ccccc1-3
CHEMBL169322,CHEMBL217,Dopamine D2 receptor,Ki,=,5011.87,nM,CHEMBL674942,B,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,CHEMBL1129892,KI,CC(C)CN1CCO[C@@H]2c3cc4c(cc3CC[C@H]21)CCO4
CHEMBL156732,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL671652,B,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,CHEMBL1132519,KI,c1ccc(CCC2CCN(Cc3cc4ccc[nH]c-4n3)CC2)cc1
CHEMBL25924,CHEMBL217,Dopamine D2 receptor,Ki,=,233.0,nM,CHEMBL673593,B,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,CHEMBL1134402,KI,CN1CCc2cccc3c2[C@H]1Cc1cccc(-c2ccccc2)c1-3
CHEMBL282413,CHEMBL217,Dopamine D2 receptor,Ki,=,2260.0,nM,CHEMBL673593,B,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,CHEMBL1134402,KI,CN1CCc2cccc3c2[C@H]1Cc1cccc(-c2c(OS(=O)(=O)C(F)(F)F)cccc2OS(=O)(=O)C(F)(F)F)c1-3
CHEMBL347291,CHEMBL217,Dopamine D2 receptor,Ki,=,900.0,nM,CHEMBL671652,B,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,CHEMBL1132519,KI,COc1ccc(N2CCN(CCc3c[nH]c4ncccc34)CC2)cc1
CHEMBL2112913,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL671652,B,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,CHEMBL1132519,KI,C1=C(/C=C/c2ccccc2)CCN(CCc2c[nH]c3ncccc23)C1
CHEMBL347155,CHEMBL217,Dopamine D2 receptor,Ki,=,800.0,nM,CHEMBL671652,B,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,CHEMBL1132519,KI,Clc1ccc(N2CCN(CCc3cc4ccc[nH]c-4n3)CC2)cc1
CHEMBL2021538,CHEMBL217,Dopamine D2 receptor,Ki,=,115.0,nM,CHEMBL872497,B,In vitro binding affinity towards Dopamine receptor D2 by using [3H]spiperone as radioligand,CHEMBL1128298,KI,CCCN[C@H]1CCc2c(cccc2CS(=O)(=O)C(F)(F)F)C1.Cl
CHEMBL2021538,CHEMBL217,Dopamine D2 receptor,Ki,=,8.7,nM,CHEMBL673095,B,In vitro binding affinity towards Dopamine receptor D2 by using [3H]U-86170 as radioligand,CHEMBL1128298,KI,CCCN[C@H]1CCc2c(cccc2CS(=O)(=O)C(F)(F)F)C1.Cl
CHEMBL171826,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL674942,B,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,CHEMBL1129892,KI,CN1CCO[C@@H]2c3cc4c(cc3CC[C@H]21)CCO4
CHEMBL1628275,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL663159,B,Binding affinity for DA2 receptor,CHEMBL1126894,KI,Cl.O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN1CCN(c2ncccn2)CC1
CHEMBL26998,CHEMBL217,Dopamine D2 receptor,Ki,=,90.0,nM,CHEMBL673095,B,In vitro binding affinity towards Dopamine receptor D2 by using [3H]U-86170 as radioligand,CHEMBL1128298,KI,CCCN(CCC)[C@@H]1CCc2cccc(O)c2C1
CHEMBL28437,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL673095,B,In vitro binding affinity towards Dopamine receptor D2 by using [3H]U-86170 as radioligand,CHEMBL1128298,KI,CCCN(CCC)C1CCc2cccc(OS(=O)(=O)C(F)(F)F)c2C1
CHEMBL28313,CHEMBL217,Dopamine D2 receptor,Ki,=,108.0,nM,CHEMBL673095,B,In vitro binding affinity towards Dopamine receptor D2 by using [3H]U-86170 as radioligand,CHEMBL1128298,KI,CCCNC1CCc2cccc(OS(=O)(=O)C(F)(F)F)c2C1
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,960.0,nM,CHEMBL671652,B,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,CHEMBL1132519,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL154286,CHEMBL217,Dopamine D2 receptor,Ki,=,640.0,nM,CHEMBL671652,B,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,CHEMBL1132519,KI,c1ccc2c(c1)CCN(Cc1c[nH]c3ncccc13)C2
CHEMBL170923,CHEMBL217,Dopamine D2 receptor,Ki,=,12589.25,nM,CHEMBL674942,B,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,CHEMBL1129892,KI,CCCN1CCO[C@@H]2c3cc4c(cc3OC[C@H]21)CCO4
CHEMBL154482,CHEMBL217,Dopamine D2 receptor,Ki,=,1300.0,nM,CHEMBL671652,B,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,CHEMBL1132519,KI,C1=C(/C=C/c2ccccc2)CCN(CCc2cc3ccc[nH]c-3n2)C1
CHEMBL12264,CHEMBL217,Dopamine D2 receptor,Ki,=,3981.0,nM,CHEMBL673593,B,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,CHEMBL1134402,KI,Cc1cccc(S(=O)(=O)N(C)[C@H](C)CCN2CCC(C)CC2)c1
CHEMBL171672,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL674942,B,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,CHEMBL1129892,KI,c1c2c(cc3c1CC[C@@H]1[C@@H]3OCCN1CC1CC1)OCC2
CHEMBL2112912,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL671652,B,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,CHEMBL1132519,KI,C1=C(c2ccccc2)CCN(CCc2c[nH]c3ncccc23)C1
CHEMBL283065,CHEMBL217,Dopamine D2 receptor,Ki,=,2030.0,nM,CHEMBL673593,B,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,CHEMBL1134402,KI,COc1cccc(OC)c1-c1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL25815,CHEMBL217,Dopamine D2 receptor,Ki,=,105.0,nM,CHEMBL673593,B,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,CHEMBL1134402,KI,O=C1Nc2cccc3c2[C@]1(CCCCN1CC=C(c2ccccc2)CC1)CCC3
CHEMBL2021539,CHEMBL217,Dopamine D2 receptor,Ki,=,311.0,nM,CHEMBL872497,B,In vitro binding affinity towards Dopamine receptor D2 by using [3H]spiperone as radioligand,CHEMBL1128298,KI,CCCN[C@@H]1CCc2cccc(CS(=O)(=O)C(F)(F)F)c2C1.Cl
CHEMBL2021539,CHEMBL217,Dopamine D2 receptor,Ki,=,69.0,nM,CHEMBL673095,B,In vitro binding affinity towards Dopamine receptor D2 by using [3H]U-86170 as radioligand,CHEMBL1128298,KI,CCCN[C@@H]1CCc2cccc(CS(=O)(=O)C(F)(F)F)c2C1.Cl
CHEMBL28056,CHEMBL217,Dopamine D2 receptor,Ki,=,498.0,nM,CHEMBL673593,B,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,CHEMBL1134402,KI,Cc1cccc(C#N)c1-c1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL140184,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL674942,B,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,CHEMBL1129892,KI,CCCN(CCC)C1CCc2cc3c(cc2C1)OCC3
CHEMBL49,CHEMBL217,Dopamine D2 receptor,Ki,=,90.0,nM,CHEMBL663159,B,Binding affinity for DA2 receptor,CHEMBL1126894,KI,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
CHEMBL155207,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL671652,B,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,CHEMBL1132519,KI,c1ccc(CCC2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL26907,CHEMBL217,Dopamine D2 receptor,Ki,=,2500.0,nM,CHEMBL673593,B,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,CHEMBL1134402,KI,Cc1cccc(O)c1-c1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL554220,CHEMBL217,Dopamine D2 receptor,Ki,=,50.0,nM,CHEMBL673096,B,In vitro binding affinity towards dopamine D2 receptor by using [3H]U-86170 as radioligand,CHEMBL1128298,KI,CCCN[C@@H]1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1.Cl
CHEMBL555900,CHEMBL217,Dopamine D2 receptor,Ki,=,2600.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,CN1CCC2(CC1)OC=C(c1ccc(F)cc1)C2=O.Cl
CHEMBL556831,CHEMBL217,Dopamine D2 receptor,Ki,=,153.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C1C(c2ccccc2)=COC12CCN(CCc1ccsc1)CC2
CHEMBL210578,CHEMBL217,Dopamine D2 receptor,Ki,=,0.31,nM,CHEMBL671416,B,In vitro ability to inhibit the binding of [3H]spiperone to cloned human Dopamine receptor D2 using apomorphine induced climbing test in male Swiss mice,CHEMBL1136328,KI,O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1
CHEMBL210578,CHEMBL217,Dopamine D2 receptor,Ki,=,0.309,nM,CHEMBL674342,B,Cataleptogenic effect against cloned human Dopamine receptor D2 in male Sprague-Dawley rats in a bar test,CHEMBL1136328,KI,O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1
CHEMBL542395,CHEMBL217,Dopamine D2 receptor,Ki,=,2420.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C1C(c2ccccc2)=COC12CCN(Cc1ccc(F)cc1)CC2
CHEMBL543343,CHEMBL217,Dopamine D2 receptor,Ki,=,3130.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C1C(c2ccc3ccccc3c2)=COC12CCN(CCc1ccccc1)CC2
CHEMBL542877,CHEMBL217,Dopamine D2 receptor,Ki,=,20000.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C1C(c2ccccc2)=COC12CCN(Cc1ccccc1)C2
CHEMBL545693,CHEMBL217,Dopamine D2 receptor,Ki,=,217.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C1C(c2ccc(F)cc2)=COC12CCN(CCc1ccccc1)CC2
CHEMBL288721,CHEMBL217,Dopamine D2 receptor,Ki,=,614.0,nM,CHEMBL670884,B,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,CHEMBL1128333,KI,CCCN(C(C)C)[C@@H]1CCc2cccc(O)c2[C@@H]1C
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL671416,B,In vitro ability to inhibit the binding of [3H]spiperone to cloned human Dopamine receptor D2 using apomorphine induced climbing test in male Swiss mice,CHEMBL1136328,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,134.9,nM,CHEMBL674342,B,Cataleptogenic effect against cloned human Dopamine receptor D2 in male Sprague-Dawley rats in a bar test,CHEMBL1136328,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL553784,CHEMBL217,Dopamine D2 receptor,Ki,=,5320.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C1C=C(c2ccc(F)cc2)OC12CCN(CCc1ccccc1)CC2
CHEMBL545454,CHEMBL217,Dopamine D2 receptor,Ki,=,2690.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,CN(C)CCC1(c2ccccc2)OC=C(c2ccccc2)C1=O.Cl
CHEMBL553372,CHEMBL217,Dopamine D2 receptor,Ki,=,550.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C1C(c2ccccc2)=COC12CCN(CCc1ccccc1)CC2
CHEMBL543344,CHEMBL217,Dopamine D2 receptor,Ki,=,47.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C1C(c2ccc(F)cc2)COC12CCN(Cc1ccccc1)CC2
CHEMBL41802,CHEMBL217,Dopamine D2 receptor,Ki,=,87.0,nM,CHEMBL670884,B,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,CHEMBL1128333,KI,CCCN(CCC)[C@@H]1CCc2ccccc2[C@@H]1C
CHEMBL542398,CHEMBL217,Dopamine D2 receptor,Ki,=,962.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C1C(c2ccc(F)cc2)=COC12CCN(CC1CCCCC1)CC2
CHEMBL556035,CHEMBL217,Dopamine D2 receptor,Ki,=,2070.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,COc1ccc(C2=COC3(CCN(CCc4ccccc4)CC3)C2=O)cc1.Cl
CHEMBL554415,CHEMBL217,Dopamine D2 receptor,Ki,=,1420.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C1C(c2ccc(F)cc2)=COC12CCN(Cc1ccccc1)CC2
CHEMBL43475,CHEMBL217,Dopamine D2 receptor,Ki,=,30.0,nM,CHEMBL670884,B,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,CHEMBL1128333,KI,CCCN(CCC)[C@@H]1CCc2cccc(O)c2[C@@H]1C
CHEMBL553666,CHEMBL217,Dopamine D2 receptor,Ki,=,24000.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,C#CCN1CCC2(CC1)OC=C(c1ccccc1)C2=O.Cl
CHEMBL545695,CHEMBL217,Dopamine D2 receptor,Ki,=,1656.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C1C(c2ccc(F)cc2)=COC12CCN(Cc1ccc(F)cc1)CC2
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.89,nM,CHEMBL671416,B,In vitro ability to inhibit the binding of [3H]spiperone to cloned human Dopamine receptor D2 using apomorphine induced climbing test in male Swiss mice,CHEMBL1136328,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.8913,nM,CHEMBL674342,B,Cataleptogenic effect against cloned human Dopamine receptor D2 in male Sprague-Dawley rats in a bar test,CHEMBL1136328,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL90746,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL670091,B,The compound's binding affinity against Dopamine receptor D2,CHEMBL1130120,KI,CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2-c2ccccc2)CC1
CHEMBL539521,CHEMBL217,Dopamine D2 receptor,Ki,=,152.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C(CCCN1CCCC2(C1)OC(c1ccccc1)=CC2=O)c1ccc(F)cc1
CHEMBL540033,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,CN(C)CCC1(c2ccccc2)OC=CC1=O.Cl
CHEMBL552687,CHEMBL217,Dopamine D2 receptor,Ki,=,2370.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C1C(c2ccccc2)=COC12CCN(Cc1ccccc1)CC2
CHEMBL543591,CHEMBL217,Dopamine D2 receptor,Ki,=,8400.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,COc1ccc(C2=CC(=O)C3(CCN(CCc4ccccc4)CC3)O2)cc1.Cl
CHEMBL69259,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,CN1CCC2(CC1)OC(C)(c1ccccc1)CC2=O.O=C(O)/C=C/C(=O)O
CHEMBL287770,CHEMBL217,Dopamine D2 receptor,Ki,=,1050.0,nM,CHEMBL670884,B,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,CHEMBL1128333,KI,CCCN(CCC)[C@H]1CCc2cccc(OC)c2[C@H]1C
CHEMBL556133,CHEMBL217,Dopamine D2 receptor,Ki,=,2900.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,CN1CCC2(CC1)OC(c1ccccc1)=CC2=O.Cl
CHEMBL540799,CHEMBL217,Dopamine D2 receptor,Ki,=,70.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C(CCCN1CCC2(CC1)OC=C(c1ccccc1)C2=O)c1ccc(F)cc1
CHEMBL538248,CHEMBL217,Dopamine D2 receptor,Ki,=,2110.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C1C(c2ccccc2)=COC12CCN(Cc1cccc(Cl)c1)CC2
CHEMBL290091,CHEMBL217,Dopamine D2 receptor,Ki,=,40.0,nM,CHEMBL670884,B,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,CHEMBL1128333,KI,CCCN(CCC)[C@@H]1CCc2cccc(C(C)=O)c2[C@@H]1C
CHEMBL40634,CHEMBL217,Dopamine D2 receptor,Ki,=,58.8,nM,CHEMBL670884,B,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,CHEMBL1128333,KI,CCCN(CCC)[C@@H]1CCc2cccc(C(=O)OC)c2[C@@H]1C
CHEMBL559021,CHEMBL217,Dopamine D2 receptor,Ki,=,7630.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C1C(c2ccccc2)=COC12CCN(Cc1ccco1)CC2
CHEMBL541055,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,CN1C2CCC1CC1(C2)OC=C(c2ccccc2)C1=O.Cl
CHEMBL290446,CHEMBL217,Dopamine D2 receptor,Ki,=,33.9,nM,CHEMBL670884,B,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,CHEMBL1128333,KI,CCCN(CCC)[C@@H]1CCc2cccc(OC)c2[C@@H]1C
CHEMBL540538,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,CCN(CC)CCC1(C)OC=C(c2ccccc2)C1=O.Cl
CHEMBL553082,CHEMBL217,Dopamine D2 receptor,Ki,=,32000.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cc1cc(CN2CCC3(CC2)OC=C(c2ccccc2)C3=O)on1.Cl
CHEMBL544996,CHEMBL217,Dopamine D2 receptor,Ki,=,642.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C1C(c2ccccc2)=COC12CCN(CC1CCCCC1)CC2
CHEMBL290546,CHEMBL217,Dopamine D2 receptor,Ki,=,124.0,nM,CHEMBL670884,B,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,CHEMBL1128333,KI,CCCN(CCC)[C@@H]1CCc2cccc(OS(=O)(=O)C(F)(F)F)c2[C@@H]1C
CHEMBL541817,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C1C(c2ccccc2)=COC12CCNCC2
CHEMBL555614,CHEMBL217,Dopamine D2 receptor,Ki,=,4870.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,C=CCN1CCC2(CC1)OC=C(c1ccccc1)C2=O.Cl
CHEMBL545222,CHEMBL217,Dopamine D2 receptor,Ki,=,7180.0,nM,CHEMBL671745,B,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,CHEMBL1127181,KI,Cl.O=C1C=C(c2ccccc2)OC12CCN(CCc1ccccc1)CC2
CHEMBL292186,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL672215,B,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,CHEMBL1129308,KI,COc1cc2ccccc2cc1C(=O)CCC1CCN(Cc2ccccc2)CC1
CHEMBL52096,CHEMBL217,Dopamine D2 receptor,Ki,=,13.7,nM,CHEMBL670879,B,Compound was measured for the binding affinity in homogenated mouse fibroblast (LTK) cells transfected with human Dopamine receptor D2A using [3H]raclopride as radioligand.,CHEMBL1130712,KI,Cc1cc(=O)oc2cc(OCCCN3CCN(c4ccccc4)CC3)ccc12
CHEMBL2093001,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL674346,B,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",CHEMBL1129847,KI,COc1ccc(S(=O)(=O)N(C)c2ccccc2)cc1-c1ccc(CN2CCCCC[C@H]2c2ccccc2)[nH]1
CHEMBL144600,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL674346,B,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",CHEMBL1129847,KI,COc1ccc(S(N)(=O)=O)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1
CHEMBL22156,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL674346,B,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",CHEMBL1129847,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1
CHEMBL433552,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL674346,B,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",CHEMBL1129847,KI,COc1ccc(S(=O)(=O)Oc2ccccc2)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1
CHEMBL145545,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL674346,B,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",CHEMBL1129847,KI,COc1ccc(S(=O)(=O)N(C)c2ccccc2)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1
CHEMBL423198,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL674346,B,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",CHEMBL1129847,KI,COc1ccc(S(=O)(=O)N2CCOCC2)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1
CHEMBL299479,CHEMBL217,Dopamine D2 receptor,Ki,=,1995.26,nM,CHEMBL672215,B,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,CHEMBL1129308,KI,O=C(OCC1CCN(Cc2ccccc2)CC1)c1ccc(Cl)cc1
CHEMBL422788,CHEMBL217,Dopamine D2 receptor,Ki,=,10.8,nM,CHEMBL670879,B,Compound was measured for the binding affinity in homogenated mouse fibroblast (LTK) cells transfected with human Dopamine receptor D2A using [3H]raclopride as radioligand.,CHEMBL1130712,KI,Cc1cc2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2oc1=O
CHEMBL120661,CHEMBL217,Dopamine D2 receptor,Ki,=,5.92,nM,CHEMBL670879,B,Compound was measured for the binding affinity in homogenated mouse fibroblast (LTK) cells transfected with human Dopamine receptor D2A using [3H]raclopride as radioligand.,CHEMBL1130712,KI,Cc1c(C)c2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2oc1=O
CHEMBL57407,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL672215,B,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,CHEMBL1129308,KI,COc1cc2ccccc2cc1COCC1CCN(Cc2ccccc2)CC1
CHEMBL144055,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL674346,B,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",CHEMBL1129847,KI,CCN(Cc1ccccc1)S(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1
CHEMBL61248,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL672215,B,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,CHEMBL1129308,KI,COc1cc2ccccc2cc1C(=O)NCC1CCN(Cc2ccccc2)CC1
CHEMBL144141,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL674346,B,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",CHEMBL1129847,KI,COc1ccc(S(=O)(=O)Nc2ccccc2)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1
CHEMBL59075,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL672215,B,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,CHEMBL1129308,KI,COc1cc2ccccc2cc1OCCC1CCN(Cc2ccccc2)CC1
CHEMBL59326,CHEMBL217,Dopamine D2 receptor,Ki,=,3162.28,nM,CHEMBL672215,B,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,CHEMBL1129308,KI,COc1cc2ccccc2cc1C(=O)OCC1CCN(Cc2ccccc2)CC1
CHEMBL145408,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL674346,B,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",CHEMBL1129847,KI,COc1ccc(S(=O)(=O)N2CCCc3ccccc32)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1
CHEMBL61090,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL672215,B,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,CHEMBL1129308,KI,COc1cc2ccccc2cc1CC(=O)CC1CCN(Cc2ccccc2)CC1
CHEMBL145141,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL674346,B,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",CHEMBL1129847,KI,COc1ccc(S(=O)(=O)Cc2ccccc2)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1
CHEMBL2093000,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL674346,B,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",CHEMBL1129847,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCC[C@H]3c3ccccc3)[nH]2)c1
CHEMBL433255,CHEMBL217,Dopamine D2 receptor,Ki,=,7943.28,nM,CHEMBL672215,B,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,CHEMBL1129308,KI,COc1cc2ccccc2cc1OC(=O)CC1CCN(Cc2ccccc2)CC1
CHEMBL120590,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL670879,B,Compound was measured for the binding affinity in homogenated mouse fibroblast (LTK) cells transfected with human Dopamine receptor D2A using [3H]raclopride as radioligand.,CHEMBL1130712,KI,O=c1ccc2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2o1
CHEMBL1788252,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL674346,B,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",CHEMBL1129847,KI,COc1ccc(S(=O)(=O)N(C)c2ccccc2)cc1-c1ccc(CN2CCCCC[C@@H]2c2ccccc2)[nH]1
CHEMBL60708,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL672215,B,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,CHEMBL1129308,KI,COc1cc2ccccc2cc1C(=O)NC1CCN(Cc2ccccc2)C1
CHEMBL1788258,CHEMBL217,Dopamine D2 receptor,Ki,=,25.12,nM,CHEMBL674346,B,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",CHEMBL1129847,KI,CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCC[C@@H]3c3ccccc3)[nH]2)c1
CHEMBL344531,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL674346,B,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",CHEMBL1129847,KI,COc1ccc(S(=O)(=O)C(C)C)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1
CHEMBL57019,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL672215,B,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,CHEMBL1129308,KI,COc1cc2ccccc2cc1C(=O)OCC1CCN(Cc2ccccc2)C1
CHEMBL280490,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL674346,B,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",CHEMBL1129847,KI,COc1ccc(S(=O)(=O)N(C)C)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1
CHEMBL356526,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL674346,B,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",CHEMBL1129847,KI,COc1ccc(S(=O)(=O)N2CCc3ccccc3C2)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1
CHEMBL106598,CHEMBL217,Dopamine D2 receptor,Ki,=,2145.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2c(Cl)cccc21
CHEMBL107742,CHEMBL217,Dopamine D2 receptor,Ki,=,188.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4CC3C)CC2)cc1
CHEMBL419908,CHEMBL217,Dopamine D2 receptor,Ki,=,620.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2cccc(OC(F)(F)F)c2)CC1
CHEMBL89970,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL672525,B,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,CHEMBL1128570,KI,CN1CCN(C2=Cc3ccccc3Oc3ccccc32)CC1
CHEMBL163239,CHEMBL217,Dopamine D2 receptor,Ki,=,440.0,nM,CHEMBL672525,B,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,CHEMBL1128570,KI,CC(C)=C1c2ccccc2C=C(C2=CCN(C)CC2)c2cc(Cl)ccc21
CHEMBL104614,CHEMBL217,Dopamine D2 receptor,Ki,=,887.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(F)cc2)CC1
CHEMBL107020,CHEMBL217,Dopamine D2 receptor,Ki,=,214.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2cc(Cl)cc(Cl)c2)CC1
CHEMBL104719,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CC1Cc2ccccc2N1C(=O)CC1CCN(Cc2cccc(F)c2)CC1
CHEMBL319650,CHEMBL217,Dopamine D2 receptor,Ki,=,487.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,COc1cccc2c1CCN2C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL150181,CHEMBL217,Dopamine D2 receptor,Ki,=,2340.0,nM,CHEMBL671372,B,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,CHEMBL1132537,KI,Cc1ccc(N2CCN(Cc3ccc4c(c3)NC(=O)CO4)CC2)cc1C
CHEMBL149497,CHEMBL217,Dopamine D2 receptor,Ki,=,1130.0,nM,CHEMBL671372,B,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,CHEMBL1132537,KI,COc1ccc(C2CCN(Cc3ccc4c(c3)OCC(=O)N4)CC2)cc1
CHEMBL106897,CHEMBL217,Dopamine D2 receptor,Ki,=,4126.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,CC1CCc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL104138,CHEMBL217,Dopamine D2 receptor,Ki,=,4742.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,C[C@@H]1CN(Cc2ccc(Cl)cc2)CC[N@@+]1(C)CC(=O)N1CCc2ccccc21
CHEMBL104716,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,Cc1ccc(CN2CCC(CC(=O)N3c4ccccc4CC3C)CC2)cc1
CHEMBL544418,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL672525,B,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,CHEMBL1128570,KI,C=CCN1CC=C(C2=Cc3ccccc3Oc3ccccc32)CC1.Cl
CHEMBL149596,CHEMBL217,Dopamine D2 receptor,Ki,=,572.0,nM,CHEMBL671372,B,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,CHEMBL1132537,KI,Cc1ccc(C2CCN(Cc3ccc4c(c3)NC(=O)CO4)CC2)cc1C
CHEMBL104196,CHEMBL217,Dopamine D2 receptor,Ki,=,2610.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCOc2ccccc21
CHEMBL326202,CHEMBL217,Dopamine D2 receptor,Ki,=,518.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CC1Cc2ccccc2N1C(=O)CC1CCN(Cc2ccc(F)cc2Cl)CC1
CHEMBL322326,CHEMBL217,Dopamine D2 receptor,Ki,=,1642.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,O=C1Cc2ccccc2N1CCN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL147130,CHEMBL217,Dopamine D2 receptor,Ki,=,2200.0,nM,CHEMBL671372,B,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,CHEMBL1132537,KI,O=C1COc2ccc(CN3CCN(c4ccccc4)CC3)cc2N1
CHEMBL104788,CHEMBL217,Dopamine D2 receptor,Ki,=,92.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CC1Cc2ccccc2N1C(=O)CC1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL104756,CHEMBL217,Dopamine D2 receptor,Ki,=,8620.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,C[C@@H]1CN(CC(=O)N2CCc3ccccc32)C[C@H](C)N1Cc1ccc(Cl)cc1
CHEMBL151286,CHEMBL217,Dopamine D2 receptor,Ki,=,287.0,nM,CHEMBL671372,B,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,CHEMBL1132537,KI,Cc1ccc(C2CCN(Cc3ccc4c(c3)OCC(=O)N4)CC2)cc1
CHEMBL104713,CHEMBL217,Dopamine D2 receptor,Ki,=,341.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,CC(C)CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL104256,CHEMBL217,Dopamine D2 receptor,Ki,=,1530.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,Cc1ccccc1CN1CCN(CC(=O)N2c3ccccc3CC2C)CC1
CHEMBL104155,CHEMBL217,Dopamine D2 receptor,Ki,=,1414.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CC1Cc2ccccc2N1C(=O)CC1CCN(Cc2ccccc2F)CC1
CHEMBL106998,CHEMBL217,Dopamine D2 receptor,Ki,=,1692.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,Cc1ccc2c(c1)CCN2C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL323537,CHEMBL217,Dopamine D2 receptor,Ki,=,2629.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCCc2ccccc21
CHEMBL106914,CHEMBL217,Dopamine D2 receptor,Ki,=,834.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CC1Cc2ccccc2N1C(=O)CC1CCN(Cc2ccccc2Cl)CC1
CHEMBL107351,CHEMBL217,Dopamine D2 receptor,Ki,=,6740.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,C[C@@H]1CN(CC(=O)N2CCc3ccccc32)[C@@H](C)CN1Cc1ccc(Cl)cc1
CHEMBL105304,CHEMBL217,Dopamine D2 receptor,Ki,=,119.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,Cc1ccc(C)c(CN2CCN(CC(=O)N3c4ccccc4CC3C)CC2)c1
CHEMBL556969,CHEMBL217,Dopamine D2 receptor,Ki,=,61.0,nM,CHEMBL672525,B,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,CHEMBL1128570,KI,CCN1CC=C(C2=Cc3ccccc3Oc3ccccc32)CC1.Cl
CHEMBL321058,CHEMBL217,Dopamine D2 receptor,Ki,=,3431.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,Cc1cccc2c1CCN2C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL105595,CHEMBL217,Dopamine D2 receptor,Ki,=,6357.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,Cc1ccc2c(c1)N(C(=O)CN1CCN(Cc3ccc(Cl)cc3)CC1)CC2
CHEMBL323213,CHEMBL217,Dopamine D2 receptor,Ki,=,377.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1c2ccccc2[C@H]2CCCC[C@H]21
CHEMBL104579,CHEMBL217,Dopamine D2 receptor,Ki,=,158.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,COc1ccc(CN2CCC(CC(=O)N3c4ccccc4CC3C)CC2)cc1
CHEMBL104063,CHEMBL217,Dopamine D2 receptor,Ki,=,8053.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,O=c1oc2ccccc2n1CCN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL419916,CHEMBL217,Dopamine D2 receptor,Ki,=,1918.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(C(C)(C)C)cc2)CC1
CHEMBL104321,CHEMBL217,Dopamine D2 receptor,Ki,=,5287.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(C(F)(F)F)cc2)CC1
CHEMBL321734,CHEMBL217,Dopamine D2 receptor,Ki,=,225.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,COc1ccccc1CN1CCN(CC(=O)N2c3ccccc3CC2C)CC1
CHEMBL105011,CHEMBL217,Dopamine D2 receptor,Ki,=,166.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,Cc1cccc(CN2CCC(CC(=O)N3c4ccccc4CC3C)CC2)c1
CHEMBL320440,CHEMBL217,Dopamine D2 receptor,Ki,=,1784.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CC(C)c1ccc(CN2CCN(CC(=O)N3c4ccccc4CC3C)CC2)cc1
CHEMBL147059,CHEMBL217,Dopamine D2 receptor,Ki,=,610.0,nM,CHEMBL671372,B,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,CHEMBL1132537,KI,Cc1ccc(C2CCN(Cc3ccc4c(c3)OCC(=O)N4)CC2)cc1C
CHEMBL317879,CHEMBL217,Dopamine D2 receptor,Ki,=,117.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,CC1(C)Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL104273,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,Cc1ccc(CN2CCC(CC(=O)N3c4ccccc4CC3C)CC2)cc1F
CHEMBL320067,CHEMBL217,Dopamine D2 receptor,Ki,=,4375.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,CC1CN(C(=O)CN2CCN(Cc3ccc(Cl)cc3)CC2)c2ccccc21
CHEMBL107793,CHEMBL217,Dopamine D2 receptor,Ki,=,509.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,CCC1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL323022,CHEMBL217,Dopamine D2 receptor,Ki,=,5247.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CC1Cc2ccccc2N1C(=O)CN1CCN(CCc2ccc(Cl)cc2)CC1
CHEMBL107804,CHEMBL217,Dopamine D2 receptor,Ki,=,3011.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2cc(F)cc(F)c2)CC1
CHEMBL432762,CHEMBL217,Dopamine D2 receptor,Ki,=,94.0,nM,CHEMBL672524,B,Ability to inhibit the binding of [3H]spiperone to the D2L dopamine receptor in COS7 cells,CHEMBL1128570,KI,CC1c2ccccc2C=C(N2CCN(C)CC2)c2ccccc21
CHEMBL346398,CHEMBL217,Dopamine D2 receptor,Ki,=,52.5,nM,CHEMBL671372,B,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,CHEMBL1132537,KI,Cc1ccc(C2CCN(Cc3ccc4c(c3)NC(=O)CO4)CC2)cc1
CHEMBL104832,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CC1Cc2ccccc2N1C(=O)CC1CCN(Cc2cccc(Cl)c2)CC1
CHEMBL94067,CHEMBL217,Dopamine D2 receptor,Ki,=,570.0,nM,CHEMBL672525,B,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,CHEMBL1128570,KI,CC(C)=C1c2ccccc2C=C(C2=CCN(C)CC2)c2ccccc21
CHEMBL542029,CHEMBL217,Dopamine D2 receptor,Ki,=,44.0,nM,CHEMBL672525,B,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,CHEMBL1128570,KI,CCN1CC=C(C2=Cc3ccccc3Cc3ccccc32)CC1.Cl
CHEMBL163863,CHEMBL217,Dopamine D2 receptor,Ki,=,230.0,nM,CHEMBL672525,B,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,CHEMBL1128570,KI,CN1CC=C(C2=Cc3ccccc3Oc3ccccc32)CC1
CHEMBL348435,CHEMBL217,Dopamine D2 receptor,Ki,=,5590.0,nM,CHEMBL671372,B,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,CHEMBL1132537,KI,COc1ccc(N2CCN(Cc3ccc4c(c3)NC(=O)CO4)CC2)cc1
CHEMBL318739,CHEMBL217,Dopamine D2 receptor,Ki,=,607.0,nM,CHEMBL672176,B,Binding affinity toward Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as the competitive ligand,CHEMBL1134936,KI,O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2ccc(Cl)cc21
CHEMBL318760,CHEMBL217,Dopamine D2 receptor,Ki,=,3780.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,CSc1ccc2c(c1)CCN2C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL108157,CHEMBL217,Dopamine D2 receptor,Ki,=,1207.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,O=c1sc2ccccc2n1CCN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL106751,CHEMBL217,Dopamine D2 receptor,Ki,=,1252.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CC(c1ccc(Cl)cc1)N1CCN(CC(=O)N2c3ccccc3CC2C)CC1
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,1.4,nM,CHEMBL672525,B,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,CHEMBL1128570,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL106917,CHEMBL217,Dopamine D2 receptor,Ki,=,3780.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,CN(C)S(=O)(=O)c1ccc2c(c1)CCN2C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL149233,CHEMBL217,Dopamine D2 receptor,Ki,=,129.0,nM,CHEMBL671372,B,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,CHEMBL1132537,KI,O=C1COc2cc(CN3CCN(c4ccccc4)CC3)ccc2N1
CHEMBL151533,CHEMBL217,Dopamine D2 receptor,Ki,=,346.0,nM,CHEMBL671372,B,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,CHEMBL1132537,KI,Cc1ccc(N2CCN(Cc3ccc4c(c3)OCC(=O)N4)CC2)cc1C
CHEMBL321538,CHEMBL217,Dopamine D2 receptor,Ki,=,753.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CCc1ccc(CN2CCN(CC(=O)N3c4ccccc4CC3C)CC2)cc1
CHEMBL104498,CHEMBL217,Dopamine D2 receptor,Ki,=,5847.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,O=C(CCN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2ccccc21
CHEMBL544184,CHEMBL217,Dopamine D2 receptor,Ki,=,680.0,nM,CHEMBL672525,B,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,CHEMBL1128570,KI,CC1c2ccccc2C=C(C2=CCN(C)CC2)c2ccccc21.Cl
CHEMBL146757,CHEMBL217,Dopamine D2 receptor,Ki,=,698.0,nM,CHEMBL671372,B,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,CHEMBL1132537,KI,COc1ccc(C2CCN(Cc3ccc4c(c3)NC(=O)CO4)CC2)cc1
CHEMBL345552,CHEMBL217,Dopamine D2 receptor,Ki,=,493.0,nM,CHEMBL671372,B,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,CHEMBL1132537,KI,Cc1ccc(N2CCN(Cc3ccc4c(c3)NC(=O)CO4)CC2)cc1
CHEMBL107229,CHEMBL217,Dopamine D2 receptor,Ki,=,4623.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,Cc1cccc2c1N(C(=O)CN1CCN(Cc3ccc(Cl)cc3)CC1)CC2
CHEMBL107962,CHEMBL217,Dopamine D2 receptor,Ki,=,3325.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1c2ccccc2CC12CCCCC2
CHEMBL107391,CHEMBL217,Dopamine D2 receptor,Ki,=,2220.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,CC1CCc2cc(F)ccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL419356,CHEMBL217,Dopamine D2 receptor,Ki,=,71.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CC1Cc2ccccc2N1C(=O)CC1CCN(Cc2ccc(F)cc2)CC1
CHEMBL539057,CHEMBL217,Dopamine D2 receptor,Ki,=,82.0,nM,CHEMBL672525,B,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,CHEMBL1128570,KI,CN1CCC(C2=Cc3ccccc3Oc3ccccc32)CC1.Cl
CHEMBL323525,CHEMBL217,Dopamine D2 receptor,Ki,=,2094.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,COc1ccc(CN2CCN(CC(=O)N3c4ccccc4CC3C)CC2)cc1
CHEMBL554670,CHEMBL217,Dopamine D2 receptor,Ki,=,89.0,nM,CHEMBL672525,B,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,CHEMBL1128570,KI,CN1CC=C(C2=Cc3ccccc3Cc3ccccc32)CC1.Cl
CHEMBL90882,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL672525,B,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,CHEMBL1128570,KI,CN1CCN(C2=Cc3ccccc3Oc3ccc(Cl)cc32)CC1
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,908.0,nM,CHEMBL671372,B,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,CHEMBL1132537,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL150173,CHEMBL217,Dopamine D2 receptor,Ki,=,2980.0,nM,CHEMBL671372,B,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,CHEMBL1132537,KI,Cc1ccc(N2CCN(Cc3ccc4c(c3)OCC(=O)N4)CC2)cc1
CHEMBL831,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL672525,B,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,CHEMBL1128570,KI,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
CHEMBL105625,CHEMBL217,Dopamine D2 receptor,Ki,=,450.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2ccc([N+](=O)[O-])cc21
CHEMBL106916,CHEMBL217,Dopamine D2 receptor,Ki,=,209.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL321871,CHEMBL217,Dopamine D2 receptor,Ki,=,2524.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,CC(C)C1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL104160,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,CC1CC(C)(C)N(C(=O)CN2CCN(Cc3ccc(Cl)cc3)CC2)c2ccccc21
CHEMBL106742,CHEMBL217,Dopamine D2 receptor,Ki,=,306.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,Cc1ccc(CN2CCC(CC(=O)N3c4ccccc4CC3C)CC2)cc1C
CHEMBL106208,CHEMBL217,Dopamine D2 receptor,Ki,=,3823.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(OC(F)(F)F)cc2)CC1
CHEMBL322567,CHEMBL217,Dopamine D2 receptor,Ki,=,1225.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,O=C1C(=O)N(CCN2CCN(Cc3ccc(Cl)cc3)CC2)c2ccccc21
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL672525,B,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,CHEMBL1128570,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL319927,CHEMBL217,Dopamine D2 receptor,Ki,=,183.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,C[C@@H]1[C@@H](C)c2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL107338,CHEMBL217,Dopamine D2 receptor,Ki,=,1926.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,Cc1ccc2c(c1)N(C(=O)CN1CCN(Cc3ccc(Cl)cc3)CC1)C(C)(C)CC2C
CHEMBL104399,CHEMBL217,Dopamine D2 receptor,Ki,=,5839.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,C[C@@H]1CN(Cc2ccc(Cl)cc2)CCN1CC(=O)N1CCc2ccccc21
CHEMBL326670,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,C[C@@H]1c2ccccc2N(C(=O)CN2CCN(Cc3ccc(Cl)cc3)CC2)[C@@H]1C
CHEMBL441274,CHEMBL217,Dopamine D2 receptor,Ki,=,187.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1c2ccccc2CC12CCCC2
CHEMBL107384,CHEMBL217,Dopamine D2 receptor,Ki,=,883.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,CC1N(C(=O)CN2CCN(Cc3ccc(Cl)cc3)CC2)c2ccccc2C1(C)C
CHEMBL104380,CHEMBL217,Dopamine D2 receptor,Ki,=,979.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,O=S1(=O)Cc2ccccc2N1CCCN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL346389,CHEMBL217,Dopamine D2 receptor,Ki,=,413.0,nM,CHEMBL671372,B,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,CHEMBL1132537,KI,O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1
CHEMBL326250,CHEMBL217,Dopamine D2 receptor,Ki,=,129.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,CCC1(CC)Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,138.0,nM,CHEMBL872891,B,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",CHEMBL1134936,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL69584,CHEMBL217,Dopamine D2 receptor,Ki,=,690.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2ccccc21
CHEMBL317266,CHEMBL217,Dopamine D2 receptor,Ki,=,2552.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2ccc(F)cc21
CHEMBL107755,CHEMBL217,Dopamine D2 receptor,Ki,=,5847.0,nM,CHEMBL872882,B,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,CHEMBL1134936,KI,O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCCC2CCCCC21
CHEMBL555362,CHEMBL217,Dopamine D2 receptor,Ki,=,83.0,nM,CHEMBL672525,B,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,CHEMBL1128570,KI,C=CCN1CC=C(C2=Cc3ccccc3Cc3ccccc32)CC1.Cl
CHEMBL91157,CHEMBL217,Dopamine D2 receptor,Ki,=,230.0,nM,CHEMBL840034,B,Inhibition of [3H]spiperone binding to Dopamine receptor D2,CHEMBL1142735,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2
CHEMBL328114,CHEMBL217,Dopamine D2 receptor,Ki,=,959.0,nM,CHEMBL840034,B,Inhibition of [3H]spiperone binding to Dopamine receptor D2,CHEMBL1142735,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2
CHEMBL175832,CHEMBL217,Dopamine D2 receptor,Ki,=,313.0,nM,CHEMBL830303,B,Binding affinity against human Dopamine receptor D2,CHEMBL1142766,KI,O=S(=O)(c1ccc(F)cc1)C1(F)CCN(CCc2ccc(F)cc2F)CC1
CHEMBL368816,CHEMBL217,Dopamine D2 receptor,Ki,=,863.0,nM,CHEMBL830303,B,Binding affinity against human Dopamine receptor D2,CHEMBL1142766,KI,N#Cc1ccc(S(=O)(=O)C2(F)CCN(CCc3ccc(F)cc3F)CC2)cc1
CHEMBL177401,CHEMBL217,Dopamine D2 receptor,Ki,=,791.0,nM,CHEMBL830303,B,Binding affinity against human Dopamine receptor D2,CHEMBL1142766,KI,O=S(=O)(c1cccc(F)c1)C1(F)CCN(CCc2ccc(F)cc2F)CC1
CHEMBL177416,CHEMBL217,Dopamine D2 receptor,Ki,=,266.0,nM,CHEMBL830303,B,Binding affinity against human Dopamine receptor D2,CHEMBL1142766,KI,O=S(=O)(c1ccccc1F)C1(F)CCN(CCc2ccc(F)cc2F)CC1
CHEMBL176109,CHEMBL217,Dopamine D2 receptor,Ki,=,2000.0,nM,CHEMBL830303,B,Binding affinity against human Dopamine receptor D2,CHEMBL1142766,KI,O=S(=O)(c1ccc(N2CCC2)cc1)C1(F)CCN(CCc2ccc(F)cc2F)CC1
CHEMBL267930,CHEMBL217,Dopamine D2 receptor,Ki,=,0.12,nM,CHEMBL839477,B,Binding affinity for human dopamine receptor D2 long,CHEMBL1141881,KI,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
CHEMBL7927,CHEMBL217,Dopamine D2 receptor,Ki,=,3200.0,nM,CHEMBL839477,B,Binding affinity for human dopamine receptor D2 long,CHEMBL1141881,KI,Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL310843,CHEMBL217,Dopamine D2 receptor,Ki,=,3400.0,nM,CHEMBL839477,B,Binding affinity for human dopamine receptor D2 long,CHEMBL1141881,KI,Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1
CHEMBL59725,CHEMBL217,Dopamine D2 receptor,Ki,=,3600.0,nM,CHEMBL839477,B,Binding affinity for human dopamine receptor D2 long,CHEMBL1141881,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL88937,CHEMBL217,Dopamine D2 receptor,Ki,=,31000.0,nM,CHEMBL839477,B,Binding affinity for human dopamine receptor D2 long,CHEMBL1141881,KI,Clc1ccc(N2CCN(Cc3cccc4ccnn34)CC2)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.3,nM,CHEMBL839477,B,Binding affinity for human dopamine receptor D2 long,CHEMBL1141881,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL124444,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL839477,B,Binding affinity for human dopamine receptor D2 long,CHEMBL1141881,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1
CHEMBL141845,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL839477,B,Binding affinity for human dopamine receptor D2 long,CHEMBL1141881,KI,COc1ccccc1N1CCN(CCNC(=O)c2cnn3ccccc23)CC1
CHEMBL26,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL839477,B,Binding affinity for human dopamine receptor D2 long,CHEMBL1141881,KI,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC
CHEMBL175838,CHEMBL217,Dopamine D2 receptor,Ki,=,19.6,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccnc1
CHEMBL367720,CHEMBL217,Dopamine D2 receptor,Ki,=,31.2,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccncc1
CHEMBL180010,CHEMBL217,Dopamine D2 receptor,Ki,=,93.3,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL414838,CHEMBL217,Dopamine D2 receptor,Ki,=,54.5,nM,CHEMBL827140,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccnc2)cc1
CHEMBL425143,CHEMBL217,Dopamine D2 receptor,Ki,=,43.7,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccncc2)cc1
CHEMBL368961,CHEMBL217,Dopamine D2 receptor,Ki,=,45.7,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ncccn2)cc1
CHEMBL179351,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ncc[nH]2)cc1
CHEMBL175462,CHEMBL217,Dopamine D2 receptor,Ki,=,65.5,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2n1
CHEMBL175734,CHEMBL217,Dopamine D2 receptor,Ki,=,149.0,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL366904,CHEMBL217,Dopamine D2 receptor,Ki,=,76.5,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL304605,CHEMBL217,Dopamine D2 receptor,Ki,=,168.0,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL300780,CHEMBL217,Dopamine D2 receptor,Ki,=,112.0,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL302374,CHEMBL217,Dopamine D2 receptor,Ki,=,39.3,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1
CHEMBL262724,CHEMBL217,Dopamine D2 receptor,Ki,=,29.6,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2n1
CHEMBL69451,CHEMBL217,Dopamine D2 receptor,Ki,=,24.8,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL179960,CHEMBL217,Dopamine D2 receptor,Ki,=,18.2,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccnc2)cc1
CHEMBL59725,CHEMBL217,Dopamine D2 receptor,Ki,=,64.7,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL139926,CHEMBL217,Dopamine D2 receptor,Ki,=,44.8,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL177398,CHEMBL217,Dopamine D2 receptor,Ki,=,10.1,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1F
CHEMBL175677,CHEMBL217,Dopamine D2 receptor,Ki,=,8.8,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(F)c1
CHEMBL366900,CHEMBL217,Dopamine D2 receptor,Ki,=,6.1,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(F)cc1
CHEMBL179003,CHEMBL217,Dopamine D2 receptor,Ki,=,10.2,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1Cl
CHEMBL176884,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(Cl)c1
CHEMBL175466,CHEMBL217,Dopamine D2 receptor,Ki,=,17.5,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(Cl)cc1
CHEMBL176212,CHEMBL217,Dopamine D2 receptor,Ki,=,10.6,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1I
CHEMBL179053,CHEMBL217,Dopamine D2 receptor,Ki,=,28.1,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(I)c1
CHEMBL180060,CHEMBL217,Dopamine D2 receptor,Ki,=,35.4,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1
CHEMBL414839,CHEMBL217,Dopamine D2 receptor,Ki,=,3.7,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,COc1ccccc1C(=O)NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL175875,CHEMBL217,Dopamine D2 receptor,Ki,=,39.1,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,COc1cccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)c1
CHEMBL71327,CHEMBL217,Dopamine D2 receptor,Ki,=,2.9,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1
CHEMBL179025,CHEMBL217,Dopamine D2 receptor,Ki,=,16.9,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccn1
CHEMBL362285,CHEMBL217,Dopamine D2 receptor,Ki,=,21.2,nM,CHEMBL840158,B,In vitro binding affinity against recombinant human dopamine receptor D2L in human liver microsomes,CHEMBL1141892,KI,CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CCC[C@H](O)CC3)CC1
CHEMBL181469,CHEMBL217,Dopamine D2 receptor,Ki,=,6.2,nM,CHEMBL840158,B,In vitro binding affinity against recombinant human dopamine receptor D2L in human liver microsomes,CHEMBL1141892,KI,CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CCC[C@@H](O)CC3)CC1
CHEMBL179649,CHEMBL217,Dopamine D2 receptor,Ki,=,11.9,nM,CHEMBL840158,B,In vitro binding affinity against recombinant human dopamine receptor D2L in human liver microsomes,CHEMBL1141892,KI,CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CC[C@@H](O)CCC3)CC1
CHEMBL360457,CHEMBL217,Dopamine D2 receptor,Ki,=,3.6,nM,CHEMBL840158,B,In vitro binding affinity against recombinant human dopamine receptor D2L in human liver microsomes,CHEMBL1141892,KI,CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CC[C@H](O)CCC3)CC1
CHEMBL178803,CHEMBL217,Dopamine D2 receptor,Ki,=,0.14,nM,CHEMBL840158,B,In vitro binding affinity against recombinant human dopamine receptor D2L in human liver microsomes,CHEMBL1141892,KI,CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CCCCCC3)CC1
CHEMBL74355,CHEMBL217,Dopamine D2 receptor,Ki,=,1300.0,nM,CHEMBL830303,B,Binding affinity against human Dopamine receptor D2,CHEMBL1142766,KI,COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC
CHEMBL182379,CHEMBL217,Dopamine D2 receptor,Ki,=,59.0,nM,CHEMBL828883,B,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,CHEMBL1137095,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(I)ccc3o2)CC1
CHEMBL182379,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL828760,B,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,CHEMBL1137095,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(I)ccc3o2)CC1
CHEMBL184383,CHEMBL217,Dopamine D2 receptor,Ki,=,3200.0,nM,CHEMBL828883,B,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,CHEMBL1137095,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(I)ccc2o1
CHEMBL184383,CHEMBL217,Dopamine D2 receptor,Ki,=,430.0,nM,CHEMBL828760,B,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,CHEMBL1137095,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(I)ccc2o1
CHEMBL184993,CHEMBL217,Dopamine D2 receptor,Ki,=,48.0,nM,CHEMBL828883,B,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,CHEMBL1137095,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(I)ccc3s2)CC1
CHEMBL184993,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL828760,B,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,CHEMBL1137095,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(I)ccc3s2)CC1
CHEMBL183871,CHEMBL217,Dopamine D2 receptor,Ki,=,450.0,nM,CHEMBL828883,B,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,CHEMBL1137095,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(I)ccc2s1
CHEMBL183871,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL828760,B,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,CHEMBL1137095,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(I)ccc2s1
CHEMBL182652,CHEMBL217,Dopamine D2 receptor,Ki,=,75.0,nM,CHEMBL828883,B,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,CHEMBL1137095,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(I)s2)CC1
CHEMBL182652,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL828760,B,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,CHEMBL1137095,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(I)s2)CC1
CHEMBL362101,CHEMBL217,Dopamine D2 receptor,Ki,=,89.0,nM,CHEMBL828883,B,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,CHEMBL1137095,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)s1
CHEMBL362101,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL828760,B,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,CHEMBL1137095,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)s1
CHEMBL59725,CHEMBL217,Dopamine D2 receptor,Ki,=,3600.0,nM,CHEMBL828883,B,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,CHEMBL1137095,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL59725,CHEMBL217,Dopamine D2 receptor,Ki,=,2600.0,nM,CHEMBL828760,B,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,CHEMBL1137095,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL611207,CHEMBL217,Dopamine D2 receptor,Ki,=,1.2,nM,CHEMBL827195,B,High binding affinity towards human D2 dopamine receptor was determined by using [3H]YM-09151-2 as radioligand,CHEMBL1137093,KI,CN1CCCC[C@@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21
CHEMBL611207,CHEMBL217,Dopamine D2 receptor,Ki,=,1841.0,nM,CHEMBL827187,B,Low binding affinity towards human D2 dopamine receptor was determined by using [3H]YM-09151-2 as radioligand,CHEMBL1137093,KI,CN1CCCC[C@@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21
CHEMBL182721,CHEMBL217,Dopamine D2 receptor,Ki,=,1.66,nM,CHEMBL838638,B,Binding affinity against Dopamine receptor D2,CHEMBL1137161,KI,c1ccc2c(N3CCN(CCc4ccc5c(c4)NCN5)CC3)cccc2c1
CHEMBL184770,CHEMBL217,Dopamine D2 receptor,Ki,=,51.29,nM,CHEMBL838638,B,Binding affinity against Dopamine receptor D2,CHEMBL1137161,KI,Cc1cccc(N2CCN(CCc3ccc4[nH]nnc4c3)CC2)c1C
CHEMBL363124,CHEMBL217,Dopamine D2 receptor,Ki,=,23.99,nM,CHEMBL838638,B,Binding affinity against Dopamine receptor D2,CHEMBL1137161,KI,c1ccc2c(N3CCN(CCc4ccc5[nH]nnc5c4)CC3)cccc2c1
CHEMBL183776,CHEMBL217,Dopamine D2 receptor,Ki,=,5.37,nM,CHEMBL838638,B,Binding affinity against Dopamine receptor D2,CHEMBL1137161,KI,COc1ccccc1N1CCN(CCc2ccc3[nH]nnc3c2)CC1
CHEMBL181898,CHEMBL217,Dopamine D2 receptor,Ki,=,28.18,nM,CHEMBL838638,B,Binding affinity against Dopamine receptor D2,CHEMBL1137161,KI,Oc1nc2cc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc2[nH]1
CHEMBL185436,CHEMBL217,Dopamine D2 receptor,Ki,=,31.62,nM,CHEMBL838638,B,Binding affinity against Dopamine receptor D2,CHEMBL1137161,KI,c1ccc(-c2nc3cc(CCN4CCN(c5ccccc5)CC4)ccc3[nH]2)cc1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,77.62,nM,CHEMBL838638,B,Binding affinity against Dopamine receptor D2,CHEMBL1137161,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL611207,CHEMBL217,Dopamine D2 receptor,Ki,=,2.2,nM,CHEMBL827195,B,High binding affinity towards human D2 dopamine receptor was determined by using [3H]YM-09151-2 as radioligand,CHEMBL1137093,KI,CN1CCCC[C@@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21
CHEMBL611207,CHEMBL217,Dopamine D2 receptor,Ki,=,1545.0,nM,CHEMBL827187,B,Low binding affinity towards human D2 dopamine receptor was determined by using [3H]YM-09151-2 as radioligand,CHEMBL1137093,KI,CN1CCCC[C@@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21
CHEMBL363452,CHEMBL217,Dopamine D2 receptor,Ki,=,370.0,nM,CHEMBL875190,B,Binding affinity against D2L receptor,CHEMBL1138823,KI,C[C@H](Nc1ccnc(NCCOc2ccc(F)cc2)c1)c1ccccc1
CHEMBL608530,CHEMBL217,Dopamine D2 receptor,Ki,=,304.0,nM,CHEMBL840079,B,Binding affinity towards human D2 dopamine receptor was determined by using [3H]YM-09151-2 as radioligand,CHEMBL1137093,KI,CN1CCCC[C@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21
CHEMBL608530,CHEMBL217,Dopamine D2 receptor,Ki,=,426.0,nM,CHEMBL840079,B,Binding affinity towards human D2 dopamine receptor was determined by using [3H]YM-09151-2 as radioligand,CHEMBL1137093,KI,CN1CCCC[C@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21
CHEMBL187804,CHEMBL217,Dopamine D2 receptor,Ki,=,8000.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1
CHEMBL424808,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,Nc1cccc(-c2ccc(C(=O)NC3CCN(Cc4ccccc4)C3)cc2)c1
CHEMBL182075,CHEMBL217,Dopamine D2 receptor,Ki,=,4000.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,CSc1ccc(-c2ccc(C(=O)NC3CCN(Cc4ccccc4)C3)cc2)cc1
CHEMBL185156,CHEMBL217,Dopamine D2 receptor,Ki,=,600.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccccc2)cc1
CHEMBL360394,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,O=C(NC1CCN(Cc2ccccc2)C1)c1cccc(-c2ccccc2)c1
CHEMBL184388,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccc(F)cc2)cc1
CHEMBL183160,CHEMBL217,Dopamine D2 receptor,Ki,=,4000.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2cccc(F)c2)cc1
CHEMBL366043,CHEMBL217,Dopamine D2 receptor,Ki,=,2600.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccc(Cl)cc2)cc1
CHEMBL184551,CHEMBL217,Dopamine D2 receptor,Ki,=,3100.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,O=Cc1ccccc1-c1ccc(C(=O)NC2CCN(Cc3ccccc3)C2)cc1
CHEMBL427522,CHEMBL217,Dopamine D2 receptor,Ki,=,3700.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,O=Cc1ccc(-c2ccc(C(=O)NC3CCN(Cc4ccccc4)C3)cc2)cc1
CHEMBL187236,CHEMBL217,Dopamine D2 receptor,Ki,=,840.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2cccs2)cc1
CHEMBL187122,CHEMBL217,Dopamine D2 receptor,Ki,=,1200.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccsc2)cc1
CHEMBL186558,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,O=C(N[C@@H]1CCN(Cc2ccccc2)C1)c1ccc(-c2cccs2)cc1
CHEMBL360424,CHEMBL217,Dopamine D2 receptor,Ki,=,980.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,O=C(N[C@H]1CCN(Cc2ccccc2)C1)c1ccc(-c2cccs2)cc1
CHEMBL366304,CHEMBL217,Dopamine D2 receptor,Ki,=,900.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,O=C(N[C@@H]1CCN(Cc2ccccc2)C1)c1ccc(-c2ccsc2)cc1
CHEMBL364782,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,O=C(N[C@H]1CCN(Cc2ccccc2)C1)c1ccc(-c2ccsc2)cc1
CHEMBL187113,CHEMBL217,Dopamine D2 receptor,Ki,=,94.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,O=C(N[C@@H]1CCN(Cc2ccccc2)C1)c1cccc(-c2ccsc2)c1
CHEMBL426062,CHEMBL217,Dopamine D2 receptor,Ki,=,70.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,O=C(N[C@H]1CCN(Cc2ccccc2)C1)c1cccc(-c2ccsc2)c1
CHEMBL361035,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL839650,B,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,CHEMBL1137866,KI,O=C(N[C@H]1CCN(Cc2ccccc2)C1)c1cccc(-c2cccs2)c1
CHEMBL537182,CHEMBL217,Dopamine D2 receptor,Ki,=,189.8,nM,CHEMBL838814,B,Binding affinity for dopamine D2 receptor,CHEMBL1138643,KI,Cl.O=C(CCCN1C2CCC1CC(c1ccc(Cl)cc1)C2)c1ccc(F)cc1
CHEMBL553417,CHEMBL217,Dopamine D2 receptor,Ki,=,124.4,nM,CHEMBL838814,B,Binding affinity for dopamine D2 receptor,CHEMBL1138643,KI,Cl.O=C(CCCN1C2CCC1CC(c1ccccc1)C2)c1ccc(F)cc1
CHEMBL553327,CHEMBL217,Dopamine D2 receptor,Ki,=,2.3,nM,CHEMBL838814,B,Binding affinity for dopamine D2 receptor,CHEMBL1138643,KI,Cl.O=C(CCCN1C2CCC1CC(O)(c1ccccc1)C2)c1ccc(F)cc1
CHEMBL558392,CHEMBL217,Dopamine D2 receptor,Ki,=,253.5,nM,CHEMBL838814,B,Binding affinity for dopamine D2 receptor,CHEMBL1138643,KI,Cl.O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL556361,CHEMBL217,Dopamine D2 receptor,Ki,=,1231.0,nM,CHEMBL838814,B,Binding affinity for dopamine D2 receptor,CHEMBL1138643,KI,Cl.O=C(CN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1
CHEMBL537183,CHEMBL217,Dopamine D2 receptor,Ki,=,1050.0,nM,CHEMBL838814,B,Binding affinity for dopamine D2 receptor,CHEMBL1138643,KI,Cl.OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2Cc1ccc(F)cc1
CHEMBL555670,CHEMBL217,Dopamine D2 receptor,Ki,=,960.0,nM,CHEMBL838814,B,Binding affinity for dopamine D2 receptor,CHEMBL1138643,KI,Cl.Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL361875,CHEMBL217,Dopamine D2 receptor,Ki,=,1210.0,nM,CHEMBL830366,B,Inhibition of [3H]raclopride binding to human dopamine D2A receptor expressed in Ltk cells,CHEMBL1138658,KI,CCCN(CCC)[C@H]1CCc2c(cccc2-c2c(OC)cccc2OC)C1
CHEMBL363466,CHEMBL217,Dopamine D2 receptor,Ki,=,241.0,nM,CHEMBL830366,B,Inhibition of [3H]raclopride binding to human dopamine D2A receptor expressed in Ltk cells,CHEMBL1138658,KI,COc1cccc(OC)c1-c1cccc2c1CC[C@H](N(C)C)C2
CHEMBL184049,CHEMBL217,Dopamine D2 receptor,Ki,=,158.0,nM,CHEMBL838569,B,Binding affinity for human recombinant dopamine receptor D2L,CHEMBL1138672,KI,COc1ccc2c(c1)OCCN(C)CCc1ccccc1C2
CHEMBL184050,CHEMBL217,Dopamine D2 receptor,Ki,=,274.0,nM,CHEMBL838569,B,Binding affinity for human recombinant dopamine receptor D2L,CHEMBL1138672,KI,CN1CCOc2cc(O)ccc2Cc2ccccc2CC1
CHEMBL364586,CHEMBL217,Dopamine D2 receptor,Ki,=,5317.0,nM,CHEMBL838569,B,Binding affinity for human recombinant dopamine receptor D2L,CHEMBL1138672,KI,O=C(c1ccccc1)c1ccccc1OCCN1CCCC1
CHEMBL185875,CHEMBL217,Dopamine D2 receptor,Ki,=,6280.0,nM,CHEMBL838569,B,Binding affinity for human recombinant dopamine receptor D2L,CHEMBL1138672,KI,OC(c1ccccc1)c1ccccc1OCCN1CCCC1
CHEMBL186720,CHEMBL217,Dopamine D2 receptor,Ki,=,2740.0,nM,CHEMBL838569,B,Binding affinity for human recombinant dopamine receptor D2L,CHEMBL1138672,KI,CN(C)CCOc1ccccc1Cc1ccccc1
CHEMBL366265,CHEMBL217,Dopamine D2 receptor,Ki,=,2024.0,nM,CHEMBL838569,B,Binding affinity for human recombinant dopamine receptor D2L,CHEMBL1138672,KI,CCN(CC)CCOc1ccccc1Cc1ccccc1
CHEMBL364565,CHEMBL217,Dopamine D2 receptor,Ki,=,1015.0,nM,CHEMBL838569,B,Binding affinity for human recombinant dopamine receptor D2L,CHEMBL1138672,KI,c1ccc(Cc2ccccc2OCCN2CCCCC2)cc1
CHEMBL184073,CHEMBL217,Dopamine D2 receptor,Ki,=,4188.0,nM,CHEMBL838569,B,Binding affinity for human recombinant dopamine receptor D2L,CHEMBL1138672,KI,c1ccc(Cc2ccccc2OCCN2CCN(c3ccccc3)CC2)cc1
CHEMBL187367,CHEMBL217,Dopamine D2 receptor,Ki,=,1006.0,nM,CHEMBL838569,B,Binding affinity for human recombinant dopamine receptor D2L,CHEMBL1138672,KI,c1ccc(Cc2ccccc2OCCCN2CCCC2)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,2.2,nM,CHEMBL839543,B,Binding affinity for human recombinant dopamine D2 receptor,CHEMBL1138672,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL187928,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL840226,B,Binding affinity towards human dopamine receptor D2 expressed in CHO cells using the radioligand [125I]iodosulpiride,CHEMBL1142810,KI,O=C(/C=C/c1ccccc1)N(Cc1ccc(-c2ccc(CNCCc3ccccc3)cc2)cc1)Cc1cccnc1.O=C(O)C(F)(F)F
CHEMBL191460,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL840226,B,Binding affinity towards human dopamine receptor D2 expressed in CHO cells using the radioligand [125I]iodosulpiride,CHEMBL1142810,KI,CN(C)CCN(Cc1ccc(-c2ccc(CNCCc3ccccc3)cc2)cc1)C(=O)CCC1CCCC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL188486,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL840226,B,Binding affinity towards human dopamine receptor D2 expressed in CHO cells using the radioligand [125I]iodosulpiride,CHEMBL1142810,KI,CN(C)CCN(Cc1ccc(-c2ccc(CNCCc3ccccc3)cc2)cc1)C(=O)/C=C/c1ccccc1.O=C(O)C(F)(F)F
CHEMBL316983,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL829839,B,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,CHEMBL1143571,KI,CCCN(CCC)[C@H]1CCn2c(C=O)ccc2C1
CHEMBL316983,CHEMBL217,Dopamine D2 receptor,Ki,=,6900.0,nM,CHEMBL829826,B,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,CHEMBL1143571,KI,CCCN(CCC)[C@H]1CCn2c(C=O)ccc2C1
CHEMBL316983,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL829840,B,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,CHEMBL1143571,KI,CCCN(CCC)[C@H]1CCn2c(C=O)ccc2C1
CHEMBL316983,CHEMBL217,Dopamine D2 receptor,Ki,=,3000.0,nM,CHEMBL829827,B,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,CHEMBL1143571,KI,CCCN(CCC)[C@H]1CCn2c(C=O)ccc2C1
CHEMBL372020,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL829839,B,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,CHEMBL1143571,KI,CCCN(CCC)[C@H]1CCn2c(C#N)ccc2C1
CHEMBL372020,CHEMBL217,Dopamine D2 receptor,Ki,=,6500.0,nM,CHEMBL829826,B,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,CHEMBL1143571,KI,CCCN(CCC)[C@H]1CCn2c(C#N)ccc2C1
CHEMBL372020,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL829840,B,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,CHEMBL1143571,KI,CCCN(CCC)[C@H]1CCn2c(C#N)ccc2C1
CHEMBL372020,CHEMBL217,Dopamine D2 receptor,Ki,=,5100.0,nM,CHEMBL829827,B,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,CHEMBL1143571,KI,CCCN(CCC)[C@H]1CCn2c(C#N)ccc2C1
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL829839,B,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,CHEMBL1143571,KI,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,Ki,=,6300.0,nM,CHEMBL829826,B,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,CHEMBL1143571,KI,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL829840,B,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,CHEMBL1143571,KI,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,Ki,=,1900.0,nM,CHEMBL829827,B,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,CHEMBL1143571,KI,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL829839,B,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,CHEMBL1143571,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,3100.0,nM,CHEMBL829826,B,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,CHEMBL1143571,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL829840,B,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,CHEMBL1143571,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,3000.0,nM,CHEMBL829827,B,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,CHEMBL1143571,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL13647,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL826339,B,Binding affinity for human Dopamine receptor D2,CHEMBL1143615,KI,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
CHEMBL299691,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL826339,B,Binding affinity for human Dopamine receptor D2,CHEMBL1143615,KI,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2F)CC1
CHEMBL57546,CHEMBL217,Dopamine D2 receptor,Ki,=,2200.0,nM,CHEMBL826339,B,Binding affinity for human Dopamine receptor D2,CHEMBL1143615,KI,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)cc2)CC1
CHEMBL192099,CHEMBL217,Dopamine D2 receptor,Ki,=,2200.0,nM,CHEMBL826339,B,Binding affinity for human Dopamine receptor D2,CHEMBL1143615,KI,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)c(F)c2)CC1
CHEMBL556313,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL826339,B,Binding affinity for human Dopamine receptor D2,CHEMBL1143615,KI,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2F)CC1
CHEMBL193620,CHEMBL217,Dopamine D2 receptor,Ki,=,700.0,nM,CHEMBL826339,B,Binding affinity for human Dopamine receptor D2,CHEMBL1143615,KI,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)c(F)cc2F)CC1
CHEMBL98241,CHEMBL217,Dopamine D2 receptor,Ki,=,580.0,nM,CHEMBL826339,B,Binding affinity for human Dopamine receptor D2,CHEMBL1143615,KI,C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O
CHEMBL425190,CHEMBL217,Dopamine D2 receptor,Ki,=,3162.28,nM,CHEMBL838639,B,Binding affinity for human dopamine receptor D2,CHEMBL1139504,KI,Cc1ccc2c(OCCN3CCN(Cc4cccc5cccnc45)CC3)cccc2n1
CHEMBL301242,CHEMBL217,Dopamine D2 receptor,Ki,=,19.4,nM,CHEMBL828890,B,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,CHEMBL1139520,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2=O
CHEMBL301242,CHEMBL217,Dopamine D2 receptor,Ki,=,70.1,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2=O
CHEMBL59725,CHEMBL217,Dopamine D2 receptor,Ki,=,42.5,nM,CHEMBL828890,B,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,CHEMBL1139520,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL59725,CHEMBL217,Dopamine D2 receptor,Ki,=,64.7,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL139926,CHEMBL217,Dopamine D2 receptor,Ki,=,119.0,nM,CHEMBL828890,B,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,CHEMBL1139520,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL139926,CHEMBL217,Dopamine D2 receptor,Ki,=,44.8,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL244083,CHEMBL217,Dopamine D2 receptor,Ki,=,398.0,nM,CHEMBL829065,B,Inhibition of [125I]iodosulpiride binding to human Dopamine D2 receptor expressed in CHO cells,CHEMBL1139520,KI,Cc1nc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)c2)no1
CHEMBL302374,CHEMBL217,Dopamine D2 receptor,Ki,=,39.3,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1
CHEMBL302374,CHEMBL217,Dopamine D2 receptor,Ki,=,51.4,nM,CHEMBL828890,B,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,CHEMBL1139520,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1
CHEMBL262724,CHEMBL217,Dopamine D2 receptor,Ki,=,29.6,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2n1
CHEMBL262724,CHEMBL217,Dopamine D2 receptor,Ki,=,58.3,nM,CHEMBL828890,B,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,CHEMBL1139520,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2n1
CHEMBL69451,CHEMBL217,Dopamine D2 receptor,Ki,=,24.8,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL69451,CHEMBL217,Dopamine D2 receptor,Ki,=,61.2,nM,CHEMBL828890,B,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,CHEMBL1139520,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL71327,CHEMBL217,Dopamine D2 receptor,Ki,=,23.4,nM,CHEMBL828890,B,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,CHEMBL1139520,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1
CHEMBL71327,CHEMBL217,Dopamine D2 receptor,Ki,=,2.9,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1
CHEMBL69571,CHEMBL217,Dopamine D2 receptor,Ki,=,62.9,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2
CHEMBL304605,CHEMBL217,Dopamine D2 receptor,Ki,=,168.0,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL71865,CHEMBL217,Dopamine D2 receptor,Ki,=,15.2,nM,CHEMBL828890,B,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,CHEMBL1139520,KI,O=C(NC/C=C\CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1
CHEMBL71865,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,O=C(NC/C=C\CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1
CHEMBL180060,CHEMBL217,Dopamine D2 receptor,Ki,=,35.4,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1
CHEMBL180060,CHEMBL217,Dopamine D2 receptor,Ki,=,192.0,nM,CHEMBL828890,B,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,CHEMBL1139520,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1
CHEMBL370713,CHEMBL217,Dopamine D2 receptor,Ki,=,30.4,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,COc1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1
CHEMBL370713,CHEMBL217,Dopamine D2 receptor,Ki,=,96.5,nM,CHEMBL828890,B,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,CHEMBL1139520,KI,COc1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1
CHEMBL194493,CHEMBL217,Dopamine D2 receptor,Ki,=,19.7,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc([N+](=O)[O-])cc1
CHEMBL194493,CHEMBL217,Dopamine D2 receptor,Ki,=,31.0,nM,CHEMBL828890,B,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,CHEMBL1139520,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc([N+](=O)[O-])cc1
CHEMBL195057,CHEMBL217,Dopamine D2 receptor,Ki,=,13.7,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(O)cc1
CHEMBL195057,CHEMBL217,Dopamine D2 receptor,Ki,=,65.8,nM,CHEMBL828890,B,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,CHEMBL1139520,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(O)cc1
CHEMBL366904,CHEMBL217,Dopamine D2 receptor,Ki,=,76.5,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL366904,CHEMBL217,Dopamine D2 receptor,Ki,=,131.0,nM,CHEMBL828890,B,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,CHEMBL1139520,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL175734,CHEMBL217,Dopamine D2 receptor,Ki,=,149.0,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL175734,CHEMBL217,Dopamine D2 receptor,Ki,=,245.0,nM,CHEMBL828890,B,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,CHEMBL1139520,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL180010,CHEMBL217,Dopamine D2 receptor,Ki,=,93.3,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL180010,CHEMBL217,Dopamine D2 receptor,Ki,=,106.0,nM,CHEMBL828890,B,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,CHEMBL1139520,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL364516,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL829061,B,Inhibition of [3H]spiperone binding to human dopamine receptor D2 long expressed in Chinese hamster ovary cells,CHEMBL1139523,KI,
CHEMBL364516,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL829637,B,Inhibition of [3H]spiperone binding to human dopamine receptor D2 short expressed in Chinese hamster ovary cells,CHEMBL1139523,KI,
CHEMBL194555,CHEMBL217,Dopamine D2 receptor,Ki,=,31.0,nM,CHEMBL829061,B,Inhibition of [3H]spiperone binding to human dopamine receptor D2 long expressed in Chinese hamster ovary cells,CHEMBL1139523,KI,
CHEMBL194555,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL829637,B,Inhibition of [3H]spiperone binding to human dopamine receptor D2 short expressed in Chinese hamster ovary cells,CHEMBL1139523,KI,
CHEMBL191962,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL829061,B,Inhibition of [3H]spiperone binding to human dopamine receptor D2 long expressed in Chinese hamster ovary cells,CHEMBL1139523,KI,
CHEMBL191962,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL829637,B,Inhibition of [3H]spiperone binding to human dopamine receptor D2 short expressed in Chinese hamster ovary cells,CHEMBL1139523,KI,
CHEMBL370297,CHEMBL217,Dopamine D2 receptor,Ki,=,43.0,nM,CHEMBL829061,B,Inhibition of [3H]spiperone binding to human dopamine receptor D2 long expressed in Chinese hamster ovary cells,CHEMBL1139523,KI,
CHEMBL370297,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL829637,B,Inhibition of [3H]spiperone binding to human dopamine receptor D2 short expressed in Chinese hamster ovary cells,CHEMBL1139523,KI,
CHEMBL195083,CHEMBL217,Dopamine D2 receptor,Ki,=,99.0,nM,CHEMBL829061,B,Inhibition of [3H]spiperone binding to human dopamine receptor D2 long expressed in Chinese hamster ovary cells,CHEMBL1139523,KI,
CHEMBL195083,CHEMBL217,Dopamine D2 receptor,Ki,=,72.0,nM,CHEMBL829637,B,Inhibition of [3H]spiperone binding to human dopamine receptor D2 short expressed in Chinese hamster ovary cells,CHEMBL1139523,KI,
CHEMBL425731,CHEMBL217,Dopamine D2 receptor,Ki,=,66.0,nM,CHEMBL829061,B,Inhibition of [3H]spiperone binding to human dopamine receptor D2 long expressed in Chinese hamster ovary cells,CHEMBL1139523,KI,
CHEMBL425731,CHEMBL217,Dopamine D2 receptor,Ki,=,45.0,nM,CHEMBL829637,B,Inhibition of [3H]spiperone binding to human dopamine receptor D2 short expressed in Chinese hamster ovary cells,CHEMBL1139523,KI,
CHEMBL371165,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL829061,B,Inhibition of [3H]spiperone binding to human dopamine receptor D2 long expressed in Chinese hamster ovary cells,CHEMBL1139523,KI,
CHEMBL371165,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL829637,B,Inhibition of [3H]spiperone binding to human dopamine receptor D2 short expressed in Chinese hamster ovary cells,CHEMBL1139523,KI,
CHEMBL540612,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL829061,B,Inhibition of [3H]spiperone binding to human dopamine receptor D2 long expressed in Chinese hamster ovary cells,CHEMBL1139523,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1.Cl
CHEMBL540612,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL830376,B,Inhibition of [3H]spiperone binding to human dopamine receptor D2 short,CHEMBL1139523,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1.Cl
CHEMBL25236,CHEMBL217,Dopamine D2 receptor,Ki,=,61.0,nM,CHEMBL876373,B,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2 receptor expressed in CHO cells,CHEMBL1139520,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL85606,CHEMBL217,Dopamine D2 receptor,Ki,=,1050.0,nM,CHEMBL876379,B,Inhibition of [125I]iodosulpiride binding to human Dopamine D2L receptor expressed in CHO cells,CHEMBL1139520,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2
CHEMBL300780,CHEMBL217,Dopamine D2 receptor,Ki,=,698.0,nM,CHEMBL828890,B,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,CHEMBL1139520,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL300780,CHEMBL217,Dopamine D2 receptor,Ki,=,112.0,nM,CHEMBL828891,B,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,CHEMBL1139520,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL370713,CHEMBL217,Dopamine D2 receptor,Ki,=,30.4,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,COc1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1
CHEMBL372022,CHEMBL217,Dopamine D2 receptor,Ki,=,6.6,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1O
CHEMBL195057,CHEMBL217,Dopamine D2 receptor,Ki,=,13.7,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(O)cc1
CHEMBL191795,CHEMBL217,Dopamine D2 receptor,Ki,=,7.4,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1[N+](=O)[O-]
CHEMBL364759,CHEMBL217,Dopamine D2 receptor,Ki,=,21.9,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc([N+](=O)[O-])c1
CHEMBL194493,CHEMBL217,Dopamine D2 receptor,Ki,=,19.7,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc([N+](=O)[O-])cc1
CHEMBL426994,CHEMBL217,Dopamine D2 receptor,Ki,=,18.2,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,Nc1ccccc1C(=O)NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL191855,CHEMBL217,Dopamine D2 receptor,Ki,=,29.0,nM,CHEMBL838683,B,Binding affinity for human dopamine D2 receptor,CHEMBL1145183,KI,Nc1cccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)c1
CHEMBL128524,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,c1ccc(OCCCNCCOc2ccccc2)cc1
CHEMBL131396,CHEMBL217,Dopamine D2 receptor,Ki,=,112.2,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,Clc1ccccc1OCCNCCCOc1ccccc1
CHEMBL128313,CHEMBL217,Dopamine D2 receptor,Ki,=,19.95,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,Cc1ccccc1OCCNCCCOc1ccccc1
CHEMBL129534,CHEMBL217,Dopamine D2 receptor,Ki,=,21.88,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,Clc1cccc(OCCNCCCOc2ccccc2)c1
CHEMBL128232,CHEMBL217,Dopamine D2 receptor,Ki,=,61.66,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,Cc1cccc(OCCNCCCOc2ccccc2)c1
CHEMBL128647,CHEMBL217,Dopamine D2 receptor,Ki,=,269.15,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,Cc1ccc(OCCNCCCOc2ccccc2)cc1
CHEMBL128276,CHEMBL217,Dopamine D2 receptor,Ki,=,1949.84,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,COc1ccc(OCCNCCCOc2ccccc2)cc1
CHEMBL22892,CHEMBL217,Dopamine D2 receptor,Ki,=,562.34,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,Oc1ccc(OCCNCCCOc2ccccc2)cc1
CHEMBL132884,CHEMBL217,Dopamine D2 receptor,Ki,=,229.09,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,Clc1ccc(OCCNCCCOc2ccccc2)cc1
CHEMBL132455,CHEMBL217,Dopamine D2 receptor,Ki,=,1412.54,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,O=[N+]([O-])c1ccc(OCCNCCCOc2ccccc2)cc1
CHEMBL131997,CHEMBL217,Dopamine D2 receptor,Ki,=,302.0,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,Cc1ccc(OCCNCCCOc2ccccc2)cc1Cl
CHEMBL129927,CHEMBL217,Dopamine D2 receptor,Ki,=,144.54,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,Cc1ccc(OCCNCCCOc2ccccc2)cc1C
CHEMBL131484,CHEMBL217,Dopamine D2 receptor,Ki,=,1318.26,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,Cc1ccc(OCCCNCCOc2ccc(Cl)cc2)cc1
CHEMBL129757,CHEMBL217,Dopamine D2 receptor,Ki,=,245.47,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,Fc1ccc(OCCCNCCOc2ccc(Cl)cc2)cc1
CHEMBL131299,CHEMBL217,Dopamine D2 receptor,Ki,=,64.57,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,Cc1ccc(OCCCNCCOc2ccccc2)cc1
CHEMBL334545,CHEMBL217,Dopamine D2 receptor,Ki,=,295.12,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,Cc1ccc(OCCNCCCOc2ccccc2C)cc1
CHEMBL435598,CHEMBL217,Dopamine D2 receptor,Ki,=,295.12,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,Cc1ccc(OCCNCCCOc2cccc(C)c2)cc1
CHEMBL130370,CHEMBL217,Dopamine D2 receptor,Ki,=,275.42,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,Cc1ccc(OCCCNCCOc2ccc(C)cc2)cc1
CHEMBL341225,CHEMBL217,Dopamine D2 receptor,Ki,=,5754.4,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,Cc1ccc(OCCNCCCOc2ccc(Br)cc2)cc1
CHEMBL131357,CHEMBL217,Dopamine D2 receptor,Ki,=,389.05,nM,CHEMBL835389,B,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,CHEMBL1143544,KI,Cc1ccc(OCCNCCCOc2ccc(F)cc2)cc1
CHEMBL366164,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL829120,B,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,CHEMBL1142715,KI,CN(C)C[C@H]1C[C@@H]2c3ccccc3Sc3ccc(F)cc3[C@H]2O1
CHEMBL329566,CHEMBL217,Dopamine D2 receptor,Ki,=,61.0,nM,CHEMBL829120,B,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,CHEMBL1142715,KI,CN(C)C[C@H]1C[C@@H]2c3ccccc3Cc3ccccc3[C@H]2O1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL829120,B,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,CHEMBL1142715,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,144.0,nM,CHEMBL829120,B,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,CHEMBL1142715,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL829120,B,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,CHEMBL1142715,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,6.4,nM,CHEMBL829120,B,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,CHEMBL1142715,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL6437,CHEMBL217,Dopamine D2 receptor,Ki,=,2197.0,nM,CHEMBL829120,B,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,CHEMBL1142715,KI,CN1CCN2c3ccccc3Cc3ccccc3C2C1
CHEMBL195706,CHEMBL217,Dopamine D2 receptor,Ki,=,191.0,nM,CHEMBL829120,B,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,CHEMBL1142715,KI,CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(F)cc3[C@H]2O1
CHEMBL194659,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL829120,B,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,CHEMBL1142715,KI,CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(F)cc3[C@H]2O1
CHEMBL364270,CHEMBL217,Dopamine D2 receptor,Ki,=,68.0,nM,CHEMBL829120,B,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,CHEMBL1142715,KI,CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1
CHEMBL435301,CHEMBL217,Dopamine D2 receptor,Ki,=,5.9,nM,CHEMBL829120,B,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,CHEMBL1142715,KI,CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1
CHEMBL195856,CHEMBL217,Dopamine D2 receptor,Ki,=,369.0,nM,CHEMBL829120,B,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,CHEMBL1142715,KI,CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(Br)cc3[C@H]2O1
CHEMBL193435,CHEMBL217,Dopamine D2 receptor,Ki,=,66.0,nM,CHEMBL829120,B,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,CHEMBL1142715,KI,CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Br)cc3[C@H]2O1
CHEMBL363581,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL829120,B,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,CHEMBL1142715,KI,CN(C)C[C@@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1
CHEMBL193639,CHEMBL217,Dopamine D2 receptor,Ki,=,2.3,nM,CHEMBL829120,B,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,CHEMBL1142715,KI,CN(C)C[C@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1
CHEMBL193639,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL829120,B,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,CHEMBL1142715,KI,CN(C)C[C@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1
CHEMBL48807,CHEMBL217,Dopamine D2 receptor,Ki,=,2454.71,nM,CHEMBL835392,B,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,CHEMBL1143544,KI,COc1ccccc1N1CCN(CNC(=O)c2ccccc2)CC1
CHEMBL298763,CHEMBL217,Dopamine D2 receptor,Ki,=,177.83,nM,CHEMBL835392,B,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,CHEMBL1143544,KI,O=C(NCN1CCN(c2ccccc2Cl)CC1)c1ccccc1
CHEMBL423659,CHEMBL217,Dopamine D2 receptor,Ki,=,3019.95,nM,CHEMBL835392,B,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,CHEMBL1143544,KI,N#Cc1ccccc1N1CCN(CNC(=O)c2ccccc2)CC1
CHEMBL296506,CHEMBL217,Dopamine D2 receptor,Ki,=,2454.71,nM,CHEMBL835392,B,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,CHEMBL1143544,KI,COc1ccccc1N1CCN(CNC(=O)c2cccc(C)c2)CC1
CHEMBL298166,CHEMBL217,Dopamine D2 receptor,Ki,=,467.74,nM,CHEMBL835392,B,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,CHEMBL1143544,KI,Cc1cccc(C(=O)NCN2CCN(c3ccccc3Cl)CC2)c1
CHEMBL45244,CHEMBL217,Dopamine D2 receptor,Ki,=,2818.38,nM,CHEMBL835392,B,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,CHEMBL1143544,KI,Cc1cccc(C(=O)NCN2CCN(c3ccccc3C#N)CC2)c1
CHEMBL51023,CHEMBL217,Dopamine D2 receptor,Ki,=,173.78,nM,CHEMBL835392,B,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,CHEMBL1143544,KI,COc1ccccc1N1CCN(CNC(=O)c2ccc(C)cc2)CC1
CHEMBL51536,CHEMBL217,Dopamine D2 receptor,Ki,=,48.98,nM,CHEMBL835392,B,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,CHEMBL1143544,KI,Cc1ccc(C(=O)NCN2CCN(c3ccccc3Cl)CC2)cc1
CHEMBL300956,CHEMBL217,Dopamine D2 receptor,Ki,=,380.19,nM,CHEMBL835392,B,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,CHEMBL1143544,KI,Cc1ccc(C(=O)NCN2CCN(c3ccccc3C#N)CC2)cc1
CHEMBL48819,CHEMBL217,Dopamine D2 receptor,Ki,=,1445.44,nM,CHEMBL835392,B,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,CHEMBL1143544,KI,COc1ccccc1N1CCN(CNC(=O)c2cccc(Cl)c2)CC1
CHEMBL295094,CHEMBL217,Dopamine D2 receptor,Ki,=,363.08,nM,CHEMBL835392,B,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,CHEMBL1143544,KI,O=C(NCN1CCN(c2ccccc2Cl)CC1)c1cccc(Cl)c1
CHEMBL49502,CHEMBL217,Dopamine D2 receptor,Ki,=,2290.87,nM,CHEMBL835392,B,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,CHEMBL1143544,KI,N#Cc1ccccc1N1CCN(CNC(=O)c2cccc(Cl)c2)CC1
CHEMBL49231,CHEMBL217,Dopamine D2 receptor,Ki,=,269.15,nM,CHEMBL835392,B,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,CHEMBL1143544,KI,COc1ccccc1N1CCN(CNC(=O)c2ccc(Cl)cc2)CC1
CHEMBL296953,CHEMBL217,Dopamine D2 receptor,Ki,=,66.07,nM,CHEMBL835392,B,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,CHEMBL1143544,KI,O=C(NCN1CCN(c2ccccc2Cl)CC1)c1ccc(Cl)cc1
CHEMBL49876,CHEMBL217,Dopamine D2 receptor,Ki,=,602.56,nM,CHEMBL835392,B,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,CHEMBL1143544,KI,N#Cc1ccccc1N1CCN(CNC(=O)c2ccc(Cl)cc2)CC1
CHEMBL194727,CHEMBL217,Dopamine D2 receptor,Ki,=,98.0,nM,CHEMBL884780,B,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(F)cc2)CC1
CHEMBL194727,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL884781,B,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(F)cc2)CC1
CHEMBL196744,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL884780,B,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(F)cc1
CHEMBL196744,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL884781,B,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(F)cc1
CHEMBL198993,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL884780,B,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(F)nc2)CC1
CHEMBL198993,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL884781,B,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(F)nc2)CC1
CHEMBL197162,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL884780,B,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(F)nc1
CHEMBL197162,CHEMBL217,Dopamine D2 receptor,Ki,=,29.0,nM,CHEMBL884781,B,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(F)nc1
CHEMBL197214,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL884780,B,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(F)n2)CC1
CHEMBL197214,CHEMBL217,Dopamine D2 receptor,Ki,=,400.0,nM,CHEMBL884781,B,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(F)n2)CC1
CHEMBL197195,CHEMBL217,Dopamine D2 receptor,Ki,=,44.0,nM,CHEMBL884780,B,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(F)n1
CHEMBL197195,CHEMBL217,Dopamine D2 receptor,Ki,=,57.0,nM,CHEMBL884781,B,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(F)n1
CHEMBL194755,CHEMBL217,Dopamine D2 receptor,Ki,=,72.0,nM,CHEMBL884780,B,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc(F)cc2)CC1
CHEMBL194755,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL884781,B,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc(F)cc2)CC1
CHEMBL195247,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL884780,B,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,O=S(=O)(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(F)cc1
CHEMBL195247,CHEMBL217,Dopamine D2 receptor,Ki,=,49.0,nM,CHEMBL884781,B,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,O=S(=O)(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(F)cc1
CHEMBL59725,CHEMBL217,Dopamine D2 receptor,Ki,=,3600.0,nM,CHEMBL884780,B,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL59725,CHEMBL217,Dopamine D2 receptor,Ki,=,2600.0,nM,CHEMBL884781,B,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,CHEMBL1143473,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL196928,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL872139,B,High binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN(CCC)C1CCn2nccc2C1
CHEMBL196928,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL872142,B,High binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN(CCC)C1CCn2nccc2C1
CHEMBL196928,CHEMBL217,Dopamine D2 receptor,Ki,=,18000.0,nM,CHEMBL872138,B,Low binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN(CCC)C1CCn2nccc2C1
CHEMBL196928,CHEMBL217,Dopamine D2 receptor,Ki,=,8500.0,nM,CHEMBL872141,B,Low binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN(CCC)C1CCn2nccc2C1
CHEMBL193337,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL872139,B,High binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN(CCC)[C@H]1CCn2nccc2C1
CHEMBL193337,CHEMBL217,Dopamine D2 receptor,Ki,=,250.0,nM,CHEMBL872142,B,High binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN(CCC)[C@H]1CCn2nccc2C1
CHEMBL193337,CHEMBL217,Dopamine D2 receptor,Ki,=,15000.0,nM,CHEMBL872138,B,Low binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN(CCC)[C@H]1CCn2nccc2C1
CHEMBL193337,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL872141,B,Low binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN(CCC)[C@H]1CCn2nccc2C1
CHEMBL194099,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL872139,B,High binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN(CCC)C1CCn2ncc(Cl)c2C1
CHEMBL194099,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL872142,B,High binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN(CCC)C1CCn2ncc(Cl)c2C1
CHEMBL194099,CHEMBL217,Dopamine D2 receptor,Ki,=,12000.0,nM,CHEMBL872141,B,Low binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN(CCC)C1CCn2ncc(Cl)c2C1
CHEMBL198174,CHEMBL217,Dopamine D2 receptor,Ki,=,5900.0,nM,CHEMBL872127,B,Binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN(CCC)C1CCn2ncc(C=O)c2C1
CHEMBL198174,CHEMBL217,Dopamine D2 receptor,Ki,=,4000.0,nM,CHEMBL872131,B,Binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN(CCC)C1CCn2ncc(C=O)c2C1
CHEMBL316983,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL872139,B,High binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN(CCC)[C@H]1CCn2c(C=O)ccc2C1
CHEMBL316983,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL872142,B,High binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN(CCC)[C@H]1CCn2c(C=O)ccc2C1
CHEMBL316983,CHEMBL217,Dopamine D2 receptor,Ki,=,6900.0,nM,CHEMBL885374,B,"Binding affinity (low) towards human dopamine receptor 2 long against radioligand [3H]spiperone, expressed in Chinese hamster ovary cells",CHEMBL1141074,KI,CCCN(CCC)[C@H]1CCn2c(C=O)ccc2C1
CHEMBL316983,CHEMBL217,Dopamine D2 receptor,Ki,=,3000.0,nM,CHEMBL885377,B,"Binding affinity (low) towards human dopamine receptor 2 short against radioligand [3H]spiperone, expressed in Chinese hamster ovary cells",CHEMBL1141074,KI,CCCN(CCC)[C@H]1CCn2c(C=O)ccc2C1
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL872139,B,High binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL872142,B,High binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,Ki,=,6300.0,nM,CHEMBL872138,B,Low binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,Ki,=,1900.0,nM,CHEMBL872141,B,Low binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL872142,B,High binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,CHEMBL1141074,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,3100.0,nM,CHEMBL885379,B,"Binding affinity (low) towards human dopamine receptor 2 (long) against radioligand [3H]spiperone, expressed in Chinese hamster ovary cells",CHEMBL1141074,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,3000.0,nM,CHEMBL885377,B,"Binding affinity (low) towards human dopamine receptor 2 short against radioligand [3H]spiperone, expressed in Chinese hamster ovary cells",CHEMBL1141074,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL195015,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,c1cc2c(c(N3CCN(Cc4c[nH]c5ccccc45)CC3)c1)OCCO2
CHEMBL196505,CHEMBL217,Dopamine D2 receptor,Ki,=,45.0,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,c1cc2c(c(N3CCN(CCc4c[nH]c5ccccc45)CC3)c1)OCCO2
CHEMBL196171,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)OCCO2
CHEMBL194844,CHEMBL217,Dopamine D2 receptor,Ki,=,5.1,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,c1cc2c(c(N3CCN(CCCCc4c[nH]c5ccccc45)CC3)c1)OCCO2
CHEMBL263329,CHEMBL217,Dopamine D2 receptor,Ki,=,9.1,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,c1cc2c(c(N3CCN(CCCCCc4c[nH]c5ccccc45)CC3)c1)OCCO2
CHEMBL193854,CHEMBL217,Dopamine D2 receptor,Ki,=,8.1,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,Fc1cccc2[nH]cc(CCCN3CCN(c4cccc5c4OCCO5)CC3)c12
CHEMBL193501,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,Fc1ccc2[nH]cc(CCCN3CCN(c4cccc5c4OCCO5)CC3)c2c1
CHEMBL369984,CHEMBL217,Dopamine D2 receptor,Ki,=,14.6,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,Fc1ccc2c(CCCN3CCN(c4cccc5c4OCCO5)CC3)c[nH]c2c1
CHEMBL196893,CHEMBL217,Dopamine D2 receptor,Ki,=,10.6,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,Fc1cccc2c(CCCN3CCN(c4cccc5c4OCCO5)CC3)c[nH]c12
CHEMBL196132,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,COc1ccc2[nH]cc(CCCN3CCN(c4cccc5c4OCCO5)CC3)c2c1
CHEMBL365605,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,Clc1cccc2[nH]cc(CCCN3CCN(c4cccc5c4OCCO5)CC3)c12
CHEMBL370359,CHEMBL217,Dopamine D2 receptor,Ki,=,31.6,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,Clc1ccc2[nH]cc(CCCN3CCN(c4cccc5c4OCCO5)CC3)c2c1
CHEMBL194240,CHEMBL217,Dopamine D2 receptor,Ki,=,2.1,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,Clc1ccc2c(CCCN3CCN(c4cccc5c4OCCO5)CC3)c[nH]c2c1
CHEMBL194510,CHEMBL217,Dopamine D2 receptor,Ki,=,15.5,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,Clc1cccc2c(CCCN3CCN(c4cccc5c4OCCO5)CC3)c[nH]c12
CHEMBL198107,CHEMBL217,Dopamine D2 receptor,Ki,=,10.7,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,Cc1ccc2[nH]cc(CCCN3CCN(c4cccc5c4OCCO5)CC3)c2c1
CHEMBL372735,CHEMBL217,Dopamine D2 receptor,Ki,=,15.9,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,Cc1cccc2c(CCCN3CCN(c4cccc5c4OCCO5)CC3)c[nH]c12
CHEMBL198812,CHEMBL217,Dopamine D2 receptor,Ki,=,20.3,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)CCCO2
CHEMBL198040,CHEMBL217,Dopamine D2 receptor,Ki,=,11.3,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)CCCN2
CHEMBL198041,CHEMBL217,Dopamine D2 receptor,Ki,=,90.0,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,CN1CCCc2c1cccc2N1CCN(CCCc2c[nH]c3ccccc23)CC1
CHEMBL197839,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,CC1CNc2cccc(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c2C1
CHEMBL383396,CHEMBL217,Dopamine D2 receptor,Ki,=,11.4,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,O=C1CCc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)N1
CHEMBL198069,CHEMBL217,Dopamine D2 receptor,Ki,=,4.3,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,O=C1COc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)N1
CHEMBL198070,CHEMBL217,Dopamine D2 receptor,Ki,=,4.5,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,CC1Oc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)NC1=O
CHEMBL199045,CHEMBL217,Dopamine D2 receptor,Ki,=,7.4,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,CC1(C)Oc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)NC1=O
CHEMBL197943,CHEMBL217,Dopamine D2 receptor,Ki,=,35.7,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,CC1Oc2c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)cccc2N(C)C1=O
CHEMBL197665,CHEMBL217,Dopamine D2 receptor,Ki,=,17.9,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)OCCN2
CHEMBL198216,CHEMBL217,Dopamine D2 receptor,Ki,=,8.7,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,C[C@H]1Oc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)NC1=O
CHEMBL198224,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,C[C@@H]1Oc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)NC1=O
CHEMBL196514,CHEMBL217,Dopamine D2 receptor,Ki,=,6.9,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,C[C@H]1Oc2c(cccc2N2CCN(CCCc3c[nH]c4ccc(F)cc34)CC2)NC1=O
CHEMBL370457,CHEMBL217,Dopamine D2 receptor,Ki,=,4.7,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,C[C@@H]1Oc2c(cccc2N2CCN(CCCc3c[nH]c4ccc(F)cc34)CC2)NC1=O
CHEMBL196172,CHEMBL217,Dopamine D2 receptor,Ki,=,5.3,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,C[C@H]1Oc2c(cccc2N2CCN(CCCc3c[nH]c4c(F)cccc34)CC2)NC1=O
CHEMBL198357,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,C[C@@H]1Oc2c(cccc2N2CCN(CCCc3c[nH]c4c(F)cccc34)CC2)NC1=O
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL872394,B,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,CHEMBL1140372,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL371289,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,CC1CC(=O)Nc2c(CCN3CCN(c4nsc5ccccc45)CC3)cccc21
CHEMBL197870,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,CC1CC(=O)Nc2c(CCN3CCN(c4nsc5ccccc45)CC3)cc(F)cc21
CHEMBL197614,CHEMBL217,Dopamine D2 receptor,Ki,=,73.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,CC1Cc2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c2NC1=O
CHEMBL372541,CHEMBL217,Dopamine D2 receptor,Ki,=,81.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,CC1CC(=O)N(C)c2c(CCN3CCN(c4nsc5ccccc45)CC3)cccc21
CHEMBL438980,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,O=C1CC(c2ccccc2)c2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c2N1
CHEMBL440389,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,Cc1ccc(CCN2CCN(c3nsc4ccccc34)CC2)c2c1C(C)CC(=O)N2
CHEMBL425208,CHEMBL217,Dopamine D2 receptor,Ki,=,92.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,CC1CC(=O)Nc2c(CCN3CCN(c4n[s+]([O-])c5ccccc45)CC3)cc(F)cc21
CHEMBL198599,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,Cc1cc(CCN2CCN(c3noc4ccccc34)CC2)c2c(c1)C(C)CC(=O)N2
CHEMBL194312,CHEMBL217,Dopamine D2 receptor,Ki,=,59.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,CC1(C)CCNc2c(CCN3CCN(c4nsc5ccccc45)CC3)cccc21
CHEMBL363829,CHEMBL217,Dopamine D2 receptor,Ki,=,55.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,CC1(C)CCNc2c(CCN3CCN(c4nsc5ccccc45)CC3)cc(F)cc21
CHEMBL194953,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,CC1CCN(C(=O)c2ccccc2)c2c(CCN3CCN(c4nsc5ccccc45)CC3)cccc21
CHEMBL369913,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,CC(=O)N1CCC(C)c2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c21
CHEMBL262469,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,COc1cccc(OC)c1CC(=O)N1CCC(C)c2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c21
CHEMBL199161,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,COc1cccc(CC(=O)N2CCC(C)c3cccc(CCN4CCN(c5nsc6ccccc56)CC4)c32)c1
CHEMBL197677,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,CC1CCN(C(=O)C2CCCCC2)c2c(CCN3CCN(c4nsc5ccccc45)CC3)cccc21
CHEMBL372811,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,CC(=O)N1CCC(C)c2cc(F)cc(CCN3CCN(c4nsc5ccccc45)CC3)c21
CHEMBL197663,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,CC(=O)N1CCC(C)c2c(C)ccc(CCN3CCN(c4noc5ccccc45)CC3)c21
CHEMBL370659,CHEMBL217,Dopamine D2 receptor,Ki,=,29.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,CC(=O)N1CCC(C)c2cc(F)cc(CCN3CCN(c4noc5ccccc45)CC3)c21
CHEMBL439680,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,CC(=O)N1CCC(c2ccccc2)c2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c21
CHEMBL197990,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL872392,B,Binding affinity against Dopamine receptor D2 expressed in CHO cells,CHEMBL1140391,KI,CC(=O)N1CCC(C)c2c(C)ccc(CCN3CCN(c4nsc5ccccc45)CC3)c21
CHEMBL83617,CHEMBL217,Dopamine D2 receptor,Ki,=,4.7,nM,CHEMBL881219,B,Inhibition constant against dopamine receptor D2,CHEMBL1140446,KI,NC(=O)c1ccc2c(c1)CCOC2CCN1CC=C(c2c[nH]c3cc(F)ccc23)CC1
CHEMBL197982,CHEMBL217,Dopamine D2 receptor,Ki,=,291.0,nM,CHEMBL881219,B,Inhibition constant against dopamine receptor D2,CHEMBL1140446,KI,C[C@@H]1CN(c2cccc3cc(F)ccc23)CCN1CCC1OCCc2c1sc(C(N)=O)c2Cl
CHEMBL361035,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL860444,B,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,CHEMBL1141940,KI,O=C(N[C@H]1CCN(Cc2ccccc2)C1)c1cccc(-c2cccs2)c1
CHEMBL360424,CHEMBL217,Dopamine D2 receptor,Ki,=,980.0,nM,CHEMBL860444,B,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,CHEMBL1141940,KI,O=C(N[C@H]1CCN(Cc2ccccc2)C1)c1ccc(-c2cccs2)cc1
CHEMBL370652,CHEMBL217,Dopamine D2 receptor,Ki,=,1300.0,nM,CHEMBL860444,B,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,CHEMBL1141940,KI,O=C(N[C@H]1CCN(Cc2ccc(C(F)(F)F)cc2)C1)c1cccc(-c2cccs2)c1
CHEMBL373032,CHEMBL217,Dopamine D2 receptor,Ki,=,500.0,nM,CHEMBL860444,B,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,CHEMBL1141940,KI,O=C(N[C@H]1CCN(Cc2ccc(OC(F)(F)F)cc2)C1)c1cccc(-c2cccs2)c1
CHEMBL381019,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL860444,B,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,CHEMBL1141940,KI,Cc1ccc(CN2CC[C@H](NC(=O)c3cccc(-c4cccs4)c3)C2)cc1
CHEMBL197381,CHEMBL217,Dopamine D2 receptor,Ki,=,230.0,nM,CHEMBL860444,B,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,CHEMBL1141940,KI,O=C(N[C@H]1CCN(Cc2ccc(Cl)cc2)C1)c1cccc(-c2cccs2)c1
CHEMBL427555,CHEMBL217,Dopamine D2 receptor,Ki,=,4460.0,nM,CHEMBL860444,B,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,CHEMBL1141940,KI,COc1cccc(CN2CC[C@H](NC(=O)c3ccc(-c4cccs4)cc3)C2)c1
CHEMBL197225,CHEMBL217,Dopamine D2 receptor,Ki,=,1800.0,nM,CHEMBL860444,B,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,CHEMBL1141940,KI,O=C(N[C@H]1CCN(Cc2ccc3c(c2)OCO3)C1)c1ccc(-c2cccs2)cc1
CHEMBL370823,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL860444,B,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,CHEMBL1141940,KI,O=C(N[C@H]1CCN(Cc2ccc(F)cc2)C1)c1ccc(-c2cccs2)cc1
CHEMBL196866,CHEMBL217,Dopamine D2 receptor,Ki,=,38000.0,nM,CHEMBL860444,B,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,CHEMBL1141940,KI,O=C(N[C@H]1CCN(Cc2ccccc2F)C1)c1ccc(-c2cccs2)cc1
CHEMBL198580,CHEMBL217,Dopamine D2 receptor,Ki,=,18000.0,nM,CHEMBL860444,B,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,CHEMBL1141940,KI,O=C(N[C@H]1CCN(Cc2ccc(F)c(F)c2)C1)c1ccc(-c2cccs2)cc1
CHEMBL199186,CHEMBL217,Dopamine D2 receptor,Ki,=,29000.0,nM,CHEMBL860444,B,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,CHEMBL1141940,KI,O=C(N[C@H]1CCN(Cc2ccc(Cl)c(Cl)c2)C1)c1ccc(-c2cccs2)cc1
CHEMBL370110,CHEMBL217,Dopamine D2 receptor,Ki,=,1.2,nM,CHEMBL863370,B,Inhibitory activity against dopamine D2(long) receptor,CHEMBL1141234,KI,CN1CCc2c(sc3ncn(CCN4CCN(c5cncc6ccccc56)CC4)c(=O)c23)C1
CHEMBL198463,CHEMBL217,Dopamine D2 receptor,Ki,=,1.46,nM,CHEMBL863370,B,Inhibitory activity against dopamine D2(long) receptor,CHEMBL1141234,KI,CN1CCc2c(sc3ncn(CCN4CCN(c5ccnc6ccccc56)CC4)c(=O)c23)C1
CHEMBL199824,CHEMBL217,Dopamine D2 receptor,Ki,=,22.01,nM,CHEMBL868787,B,Binding affinity to dopamine D2 receptor,CHEMBL1148600,KI,Cn1c(=O)cnn(CCCCN2CCN(c3cccc4ccc(O[11CH3])cc34)CC2)c1=O
CHEMBL199876,CHEMBL217,Dopamine D2 receptor,Ki,=,2370.0,nM,CHEMBL864519,B,Binding affinity to dopamine D2 receptor,CHEMBL1148546,KI,O=c1[nH]c2[nH]c(-c3ccc(Cl)cc3)cc2c(=O)n1CCN1CCN(c2ccccc2Cl)CC1
CHEMBL370136,CHEMBL217,Dopamine D2 receptor,Ki,=,164.6,nM,CHEMBL864519,B,Binding affinity to dopamine D2 receptor,CHEMBL1148546,KI,COc1ccc(-c2cc3c(=O)n(CCN4CCN(c5ccccc5Cl)CC4)c(=O)[nH]c3[nH]2)cc1
CHEMBL370364,CHEMBL217,Dopamine D2 receptor,Ki,=,1720.0,nM,CHEMBL864519,B,Binding affinity to dopamine D2 receptor,CHEMBL1148546,KI,Cc1ccc(-c2cc3c(=O)n(CCN4CCN(c5ccccc5Cl)CC4)c(=O)[nH]c3[nH]2)cc1
CHEMBL443567,CHEMBL217,Dopamine D2 receptor,Ki,=,356.1,nM,CHEMBL864519,B,Binding affinity to dopamine D2 receptor,CHEMBL1148546,KI,O=c1[nH]c2[nH]c(-c3ccccc3Cl)cc2c(=O)n1CCN1CCN(c2ccccc2Cl)CC1
CHEMBL197656,CHEMBL217,Dopamine D2 receptor,Ki,=,363.2,nM,CHEMBL864519,B,Binding affinity to dopamine D2 receptor,CHEMBL1148546,KI,COc1ccccc1-c1cc2c(=O)n(CCN3CCN(c4ccccc4Cl)CC3)c(=O)[nH]c2[nH]1
CHEMBL200802,CHEMBL217,Dopamine D2 receptor,Ki,=,626.5,nM,CHEMBL864519,B,Binding affinity to dopamine D2 receptor,CHEMBL1148546,KI,Cc1ccccc1-c1cc2c(=O)n(CCN3CCN(c4ccccc4Cl)CC3)c(=O)[nH]c2[nH]1
CHEMBL203362,CHEMBL217,Dopamine D2 receptor,Ki,=,137.2,nM,CHEMBL864519,B,Binding affinity to dopamine D2 receptor,CHEMBL1148546,KI,O=c1[nH]c2[nH]c(-c3ccccc3)cc2c(=O)n1CCN1CCN(c2ccccc2Cl)CC1
CHEMBL196476,CHEMBL217,Dopamine D2 receptor,Ki,=,373.0,nM,CHEMBL861746,B,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,CHEMBL1148573,KI,COc1cccc2cc(C(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)oc12
CHEMBL199859,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL861746,B,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,CHEMBL1148573,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc(-c3ccco3)[nH]n2)CC1
CHEMBL201270,CHEMBL217,Dopamine D2 receptor,Ki,=,27.2,nM,CHEMBL861746,B,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,CHEMBL1148573,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-n3ccnc3)cc2)CC1
CHEMBL203302,CHEMBL217,Dopamine D2 receptor,Ki,=,141.0,nM,CHEMBL861746,B,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,CHEMBL1148573,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(N3CCOCC3)cc2)CC1
CHEMBL126780,CHEMBL217,Dopamine D2 receptor,Ki,=,146.0,nM,CHEMBL861746,B,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,CHEMBL1148573,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3oc2=O)CC1
CHEMBL201551,CHEMBL217,Dopamine D2 receptor,Ki,=,86.2,nM,CHEMBL861746,B,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,CHEMBL1148573,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3c(c2)OCO3)CC1
CHEMBL199498,CHEMBL217,Dopamine D2 receptor,Ki,=,179.0,nM,CHEMBL861746,B,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,CHEMBL1148573,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3nccnc3c2)CC1
CHEMBL201698,CHEMBL217,Dopamine D2 receptor,Ki,=,369.0,nM,CHEMBL861746,B,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,CHEMBL1148573,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cccc(OC)c3o2)CC1
CHEMBL201027,CHEMBL217,Dopamine D2 receptor,Ki,=,519.0,nM,CHEMBL861746,B,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,CHEMBL1148573,KI,COc1ccc2ccnc(N3CCN(CCCCNC(=O)c4cc5cccc(OC)c5o4)CC3)c2c1
CHEMBL201326,CHEMBL217,Dopamine D2 receptor,Ki,=,1246.0,nM,CHEMBL861746,B,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,CHEMBL1148573,KI,COc1cccc2cc(C(=O)NCCCCN3CCN(c4cccc5nccnc45)CC3)oc12
CHEMBL202713,CHEMBL217,Dopamine D2 receptor,Ki,=,56.6,nM,CHEMBL861746,B,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,CHEMBL1148573,KI,COc1cccc2cc(C(=O)NCCCCN3CCN(c4[nH]nc5ccccc45)CC3)oc12
CHEMBL382850,CHEMBL217,Dopamine D2 receptor,Ki,=,253.0,nM,CHEMBL859835,B,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by radioligand binding assay,CHEMBL1147728,KI,CCN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL1204122,CHEMBL217,Dopamine D2 receptor,Ki,=,17.5,nM,CHEMBL859835,B,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by radioligand binding assay,CHEMBL1147728,KI,Br.CN1CCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL201525,CHEMBL217,Dopamine D2 receptor,Ki,=,56.5,nM,CHEMBL859835,B,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by radioligand binding assay,CHEMBL1147728,KI,CN1CCc2ccccc2Cc2ccccc2CC1
CHEMBL201093,CHEMBL217,Dopamine D2 receptor,Ki,=,198.0,nM,CHEMBL859835,B,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by radioligand binding assay,CHEMBL1147728,KI,CN1CCc2ccccc2Cc2ccsc2CC1
CHEMBL201483,CHEMBL217,Dopamine D2 receptor,Ki,=,712.0,nM,CHEMBL859835,B,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by radioligand binding assay,CHEMBL1147728,KI,CN1CCc2ccccc2Cc2ccn(C)c2CC1
CHEMBL203200,CHEMBL217,Dopamine D2 receptor,Ki,=,447.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,CC(C)(C)c1nc(N2CCN(CCCCn3cccnc3=O)CC2)cc(C(F)(F)F)n1
CHEMBL426473,CHEMBL217,Dopamine D2 receptor,Ki,=,356.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,Cc1cn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c(=O)n(C)c1=O
CHEMBL200026,CHEMBL217,Dopamine D2 receptor,Ki,=,610.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,Cn1c(=O)ccn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c1=O
CHEMBL201509,CHEMBL217,Dopamine D2 receptor,Ki,=,473.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,CC(C)(C)c1nc(N2CCN(CCCCn3cc(C#N)c(=O)[nH]c3=O)CC2)cc(C(F)(F)F)n1
CHEMBL382568,CHEMBL217,Dopamine D2 receptor,Ki,=,646.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,CC(C)(C)c1nc(N2CCN(CCCCn3cc(C(F)(F)F)c(=O)[nH]c3=O)CC2)cc(C(F)(F)F)n1
CHEMBL201240,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,CC(C)(C)c1nc(N2CCN(CCCCn3cc(Cl)c(=O)[nH]c3=O)CC2)cc(C(F)(F)F)n1
CHEMBL202827,CHEMBL217,Dopamine D2 receptor,Ki,=,602.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,CC(C)(C)c1nc(N2CCN(CCCCn3cc(F)c(=O)[nH]c3=O)CC2)cc(C(F)(F)F)n1
CHEMBL202774,CHEMBL217,Dopamine D2 receptor,Ki,=,148.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,CCc1cn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c(=O)[nH]c1=O
CHEMBL201115,CHEMBL217,Dopamine D2 receptor,Ki,=,320.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,Cc1cn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c(=O)[nH]c1=O
CHEMBL439338,CHEMBL217,Dopamine D2 receptor,Ki,=,351.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,CC(C)(C)c1nc(N2CCN(CCCSc3nccc(O)n3)CC2)cc(C(F)(F)F)n1
CHEMBL201376,CHEMBL217,Dopamine D2 receptor,Ki,=,89.4,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,CC(C)(C)c1nc(N2CCN(CCCCn3ccc(N4CCCCC4)nc3=O)CC2)cc(C(F)(F)F)n1
CHEMBL199453,CHEMBL217,Dopamine D2 receptor,Ki,=,82.1,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,CC(C)(C)c1nc(N2CCN(CCCCn3ccc(N4CCC4)nc3=O)CC2)cc(C(F)(F)F)n1
CHEMBL200028,CHEMBL217,Dopamine D2 receptor,Ki,=,168.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,CC(C)(C)c1nc(N2CCN(CCCCn3ccc(-c4ccccc4)nc3=O)CC2)cc(C(F)(F)F)n1
CHEMBL199663,CHEMBL217,Dopamine D2 receptor,Ki,=,302.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,CC(C)(C)c1nc(N2CCN(CCCCn3ccc(C4CCCCC4)nc3=O)CC2)cc(C(F)(F)F)n1
CHEMBL202298,CHEMBL217,Dopamine D2 receptor,Ki,=,273.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,CC(C)(C)c1nc(N2CCN(CCCCn3ccc(C4CCC4)nc3=O)CC2)cc(C(F)(F)F)n1
CHEMBL202229,CHEMBL217,Dopamine D2 receptor,Ki,=,155.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,CC(C)(C)c1nc(N2CCN(CCCCn3ccc(C4CC4)nc3=O)CC2)cc(C(F)(F)F)n1
CHEMBL202175,CHEMBL217,Dopamine D2 receptor,Ki,=,216.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,CC(C)(C)c1ccn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c(=O)n1
CHEMBL202253,CHEMBL217,Dopamine D2 receptor,Ki,=,307.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,Cc1ccn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c(=O)n1
CHEMBL202072,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,CCOc1ccn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c(=O)n1
CHEMBL383188,CHEMBL217,Dopamine D2 receptor,Ki,=,196.0,nM,CHEMBL865866,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149389,KI,CC(C)(C)c1nc(N2CCN(CCCCn3ccc(=O)[nH]c3=O)CC2)cc(C(F)(F)F)n1
CHEMBL383205,CHEMBL217,Dopamine D2 receptor,Ki,=,126.0,nM,CHEMBL853595,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149426,KI,CC(C)(C)c1nc(N2CCN(CCCCN3C(=O)CCc4ccccc43)CC2)cc(C(F)(F)F)n1
CHEMBL201232,CHEMBL217,Dopamine D2 receptor,Ki,=,246.0,nM,CHEMBL853595,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149426,KI,CC(C)(C)c1nc(N2CCN(CCCCN3C(=O)CCC(=O)c4ccccc43)CC2)cc(C(F)(F)F)n1
CHEMBL201481,CHEMBL217,Dopamine D2 receptor,Ki,=,65.0,nM,CHEMBL853595,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149426,KI,CC(C)(C)c1nc(N2CCN(CCCCN3CCC(=O)CCC3=O)CC2)cc(C(F)(F)F)n1
CHEMBL203471,CHEMBL217,Dopamine D2 receptor,Ki,=,467.0,nM,CHEMBL853595,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149426,KI,COc1cc2c(cc1OC)N(CCCCN1CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC1)C(=O)CCC2=O
CHEMBL201318,CHEMBL217,Dopamine D2 receptor,Ki,=,93.0,nM,CHEMBL853595,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149426,KI,CC(C)(C)c1nc(N2CCN(CCCCN3C(=O)CCCc4c(O)cccc43)CC2)cc(C(F)(F)F)n1
CHEMBL202704,CHEMBL217,Dopamine D2 receptor,Ki,=,243.0,nM,CHEMBL853595,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149426,KI,COc1cccc2c1CCCC(=O)N2CCCCN1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1
CHEMBL370191,CHEMBL217,Dopamine D2 receptor,Ki,=,83.0,nM,CHEMBL853595,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149426,KI,CC(C)(C)c1nc(N2CCN(CCCCN3C(=O)CCSc4ccccc43)CC2)cc(C(F)(F)F)n1
CHEMBL380597,CHEMBL217,Dopamine D2 receptor,Ki,=,118.0,nM,CHEMBL853595,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149426,KI,CC(C)(C)c1nc(N2CCN(CCCCN3C(=O)CCCc4ccccc43)CC2)cc(C(F)(F)F)n1
CHEMBL201386,CHEMBL217,Dopamine D2 receptor,Ki,=,142.0,nM,CHEMBL853595,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149426,KI,CC(C)(C)c1nc(N2CCN(CCCCN3C(=O)CC(=O)c4ccccc43)CC2)cc(C(F)(F)F)n1
CHEMBL201743,CHEMBL217,Dopamine D2 receptor,Ki,=,151.0,nM,CHEMBL853595,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149426,KI,CC(C)(C)c1nc(N2CCN(CCCCn3c(=O)ccc4ccccc43)CC2)cc(C(F)(F)F)n1
CHEMBL382591,CHEMBL217,Dopamine D2 receptor,Ki,=,354.0,nM,CHEMBL853595,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149426,KI,CC(C)(C)c1nc(N2CCN(CCCCN3C(=O)COc4ccccc43)CC2)cc(C(F)(F)F)n1
CHEMBL203260,CHEMBL217,Dopamine D2 receptor,Ki,=,289.0,nM,CHEMBL853595,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149426,KI,C[C@@H](CCCN1C(=O)CCc2ccccc21)N1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1
CHEMBL426111,CHEMBL217,Dopamine D2 receptor,Ki,=,261.0,nM,CHEMBL853595,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149426,KI,C[C@H](CCN1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1)CN1C(=O)CCc2ccccc21
CHEMBL201400,CHEMBL217,Dopamine D2 receptor,Ki,=,669.0,nM,CHEMBL853595,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149426,KI,C/C(=C\CN1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1)CN1C(=O)CCc2ccccc21
CHEMBL201557,CHEMBL217,Dopamine D2 receptor,Ki,=,254.0,nM,CHEMBL853595,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1149426,KI,CC(C)(C)c1nc(N2CCN(C/C=C/CN3C(=O)CCc4ccccc43)CC2)cc(C(F)(F)F)n1
CHEMBL204065,CHEMBL217,Dopamine D2 receptor,Ki,=,6.5,nM,CHEMBL861435,B,Displacement of [3H]spiperone from D2L dopamine receptor,CHEMBL1138197,KI,COc1ccc2c(c1)CCN(C)CCc1cc(OC)ccc1C2
CHEMBL381936,CHEMBL217,Dopamine D2 receptor,Ki,=,58.7,nM,CHEMBL861435,B,Displacement of [3H]spiperone from D2L dopamine receptor,CHEMBL1138197,KI,CN1CCc2cc(O)ccc2Cc2ccc(O)cc2CC1
CHEMBL379662,CHEMBL217,Dopamine D2 receptor,Ki,=,164.0,nM,CHEMBL861435,B,Displacement of [3H]spiperone from D2L dopamine receptor,CHEMBL1138197,KI,COc1cccc2c1Cc1ccccc1CCN(C)CC2
CHEMBL203689,CHEMBL217,Dopamine D2 receptor,Ki,=,84.0,nM,CHEMBL861435,B,Displacement of [3H]spiperone from D2L dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2c(O)cccc2CC1
CHEMBL203047,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL861435,B,Displacement of [3H]spiperone from D2L dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2cc(O)c(Cl)cc2CC1
CHEMBL380464,CHEMBL217,Dopamine D2 receptor,Ki,=,0.99,nM,CHEMBL861435,B,Displacement of [3H]spiperone from D2L dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2c(ccc(O)c2Cl)CC1
CHEMBL203734,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL861435,B,Displacement of [3H]spiperone from D2L dopamine receptor,CHEMBL1138197,KI,COc1c(Cl)cc2c(c1Cl)Cc1ccccc1CCN(C)CC2
CHEMBL381946,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL861435,B,Displacement of [3H]spiperone from D2L dopamine receptor,CHEMBL1138197,KI,COc1ccc2c(c1)Cc1ccccc1CCN(C)CC2
CHEMBL382010,CHEMBL217,Dopamine D2 receptor,Ki,=,36.9,nM,CHEMBL861435,B,Displacement of [3H]spiperone from D2L dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2cc(O)ccc2CC1
CHEMBL204098,CHEMBL217,Dopamine D2 receptor,Ki,=,37.3,nM,CHEMBL861435,B,Displacement of [3H]spiperone from D2L dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2cc(N)c(O)cc2CC1
CHEMBL383451,CHEMBL217,Dopamine D2 receptor,Ki,=,88.0,nM,CHEMBL861435,B,Displacement of [3H]spiperone from D2L dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2cc(Cl)c(O)c(Cl)c2CC1
CHEMBL203637,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL861435,B,Displacement of [3H]spiperone from D2L dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2ccc(O)c(Cl)c2CC1
CHEMBL380330,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL861435,B,Displacement of [3H]spiperone from D2L dopamine receptor,CHEMBL1138197,KI,COc1ccc2c(c1)CCN(C)CCc1ccccc1C2
CHEMBL201170,CHEMBL217,Dopamine D2 receptor,Ki,=,17.5,nM,CHEMBL861435,B,Displacement of [3H]spiperone from D2L dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL441618,CHEMBL217,Dopamine D2 receptor,Ki,=,44.7,nM,CHEMBL861435,B,Displacement of [3H]spiperone from D2L dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL202780,CHEMBL217,Dopamine D2 receptor,Ki,=,900.0,nM,CHEMBL865592,B,Displacement of [3H]spiperone from the cloned human D2 receptor expressed in CHO cells,CHEMBL1139656,KI,CC(C)(CCCN1CC[C@@H]2CCCC[C@H]2C1)S(=O)(=O)c1ccccc1
CHEMBL204269,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL865592,B,Displacement of [3H]spiperone from the cloned human D2 receptor expressed in CHO cells,CHEMBL1139656,KI,CC(C)(CCCN1CCCC(c2ccccc2)C1)S(=O)(=O)c1ccccc1
CHEMBL379238,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL865592,B,Displacement of [3H]spiperone from the cloned human D2 receptor expressed in CHO cells,CHEMBL1139656,KI,CC(C)(CCCN1CCCC(c2cnco2)C1)S(=O)(=O)c1ccccc1
CHEMBL203400,CHEMBL217,Dopamine D2 receptor,Ki,=,710.0,nM,CHEMBL865592,B,Displacement of [3H]spiperone from the cloned human D2 receptor expressed in CHO cells,CHEMBL1139656,KI,CCOC(=O)[C@@H]1CCCN(CCCC(C)(C)S(=O)(=O)c2ccccc2)C1
CHEMBL202253,CHEMBL217,Dopamine D2 receptor,Ki,=,307.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,Cc1ccn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c(=O)n1
CHEMBL207871,CHEMBL217,Dopamine D2 receptor,Ki,=,244.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)CCc3ccccc3)CC2)cc(C(F)(F)F)n1
CHEMBL424690,CHEMBL217,Dopamine D2 receptor,Ki,=,174.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CC(C)(C)c1nc(N2CCN(CCCCCC(=O)NCc3ccccc3)CC2)cc(C(F)(F)F)n1
CHEMBL208228,CHEMBL217,Dopamine D2 receptor,Ki,=,212.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CCN(Cc1ccccc1)C(=O)NCCCCN1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1
CHEMBL202858,CHEMBL217,Dopamine D2 receptor,Ki,=,17.3,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CCN(CC)C(=O)NCCCCN1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1
CHEMBL202857,CHEMBL217,Dopamine D2 receptor,Ki,=,159.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)NCC3CCCCC3)CC2)cc(C(F)(F)F)n1
CHEMBL377299,CHEMBL217,Dopamine D2 receptor,Ki,=,234.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)NCCc3ccccc3)CC2)cc(C(F)(F)F)n1
CHEMBL424678,CHEMBL217,Dopamine D2 receptor,Ki,=,137.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)NCc3ccccc3)CC2)cc(C(F)(F)F)n1
CHEMBL205497,CHEMBL217,Dopamine D2 receptor,Ki,=,59.1,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)Nc3ccccc3)CC2)cc(C(F)(F)F)n1
CHEMBL381514,CHEMBL217,Dopamine D2 receptor,Ki,=,91.3,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CC(C)(C)CNC(=O)NCCCCN1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1
CHEMBL205264,CHEMBL217,Dopamine D2 receptor,Ki,=,65.8,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CC(C)(C)NC(=O)NCCCCN1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1
CHEMBL203943,CHEMBL217,Dopamine D2 receptor,Ki,=,195.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,Cc1cccc(=O)n1CCCCN1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1
CHEMBL205238,CHEMBL217,Dopamine D2 receptor,Ki,=,128.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CC(C)(C)c1nc(N2CCN(CCCCn3cc(Cl)ccc3=O)CC2)cc(C(F)(F)F)n1
CHEMBL205498,CHEMBL217,Dopamine D2 receptor,Ki,=,399.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CC(C)(C)c1nc(N2CCN(CCCCn3cc(C(F)(F)F)ccc3=O)CC2)cc(C(F)(F)F)n1
CHEMBL206528,CHEMBL217,Dopamine D2 receptor,Ki,=,409.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CC(C)(C)c1nc(N2CCN(CCCCn3cccc(C(F)(F)F)c3=O)CC2)cc(C(F)(F)F)n1
CHEMBL203016,CHEMBL217,Dopamine D2 receptor,Ki,=,171.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,Cc1cccn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c1=O
CHEMBL380171,CHEMBL217,Dopamine D2 receptor,Ki,=,168.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,COc1cccn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c1=O
CHEMBL207880,CHEMBL217,Dopamine D2 receptor,Ki,=,527.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CC(C)(C)c1nc(N2CCN(CCCCn3ccc(-c4ccccc4)cc3=O)CC2)cc(C(F)(F)F)n1
CHEMBL200028,CHEMBL217,Dopamine D2 receptor,Ki,=,168.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CC(C)(C)c1nc(N2CCN(CCCCn3ccc(-c4ccccc4)nc3=O)CC2)cc(C(F)(F)F)n1
CHEMBL205733,CHEMBL217,Dopamine D2 receptor,Ki,=,231.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CC(C)(C)c1nc(N2CCN(CCCCn3ccc(C(F)(F)F)cc3=O)CC2)cc(C(F)(F)F)n1
CHEMBL205961,CHEMBL217,Dopamine D2 receptor,Ki,=,936.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CC(C)(C)c1nc(N2CCN(CCCCn3ccc(C(F)(F)F)nc3=O)CC2)cc(C(F)(F)F)n1
CHEMBL202670,CHEMBL217,Dopamine D2 receptor,Ki,=,25.5,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CC(C)(C)c1nc(N2CCN(CCCCn3ccc(O)cc3=O)CC2)cc(C(F)(F)F)n1
CHEMBL383188,CHEMBL217,Dopamine D2 receptor,Ki,=,196.0,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,CC(C)(C)c1nc(N2CCN(CCCCn3ccc(=O)[nH]c3=O)CC2)cc(C(F)(F)F)n1
CHEMBL382773,CHEMBL217,Dopamine D2 receptor,Ki,=,62.6,nM,CHEMBL862319,B,Binding affinity to cloned human dopamine D2 receptor,CHEMBL1146925,KI,Cc1ccn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c(=O)c1
CHEMBL426317,CHEMBL217,Dopamine D2 receptor,Ki,=,2575.0,nM,CHEMBL861210,B,Binding affinity to D2 dopamine receptor by radioligand binding assay,CHEMBL1146943,KI,COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1
CHEMBL49,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL870200,B,Binding affinity to D2 receptor by radioligand binding assay,CHEMBL1147799,KI,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
CHEMBL284092,CHEMBL217,Dopamine D2 receptor,Ki,=,58.0,nM,CHEMBL870200,B,Binding affinity to D2 receptor by radioligand binding assay,CHEMBL1147799,KI,CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1
CHEMBL8412,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL870200,B,Binding affinity to D2 receptor by radioligand binding assay,CHEMBL1147799,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ncccn2)CC1
CHEMBL25236,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL860507,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1148643,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL208847,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL860506,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1148643,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3c4ccc(c3o2)CCc2ccc(cc2)CC4)CC1
CHEMBL25236,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL860506,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1148643,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL426863,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL860506,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1148643,KI,O=C(NCCCCN1CCN(c2cccc(F)c2F)CC1)c1cc2ccc1CCc1ccc(cc1)CC2
CHEMBL209876,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL860506,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1148643,KI,COc1c(Cl)cccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1
CHEMBL210461,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL860506,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1148643,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccc1CCc1ccc(cc1)CC2
CHEMBL210567,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL860506,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1148643,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1
CHEMBL208847,CHEMBL217,Dopamine D2 receptor,Ki,=,84.0,nM,CHEMBL860507,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1148643,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3c4ccc(c3o2)CCc2ccc(cc2)CC4)CC1
CHEMBL210567,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL860507,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1148643,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1
CHEMBL210567,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL860506,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1148643,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1
CHEMBL210567,CHEMBL217,Dopamine D2 receptor,Ki,=,5.6,nM,CHEMBL860507,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1148643,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1
CHEMBL210461,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL860507,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1148643,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccc1CCc1ccc(cc1)CC2
CHEMBL209876,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL860507,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1148643,KI,COc1c(Cl)cccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1
CHEMBL426863,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL860507,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1148643,KI,O=C(NCCCCN1CCN(c2cccc(F)c2F)CC1)c1cc2ccc1CCc1ccc(cc1)CC2
CHEMBL425057,CHEMBL217,Dopamine D2 receptor,Ki,=,340.0,nM,CHEMBL871242,B,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,CHEMBL1147793,KI,c1ccc(N2CCN(Cc3cnn(-c4ccccn4)c3)CC2)cc1
CHEMBL60815,CHEMBL217,Dopamine D2 receptor,Ki,=,230.0,nM,CHEMBL871242,B,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,CHEMBL1147793,KI,c1ccc(-c2c[nH]c(CN3CCN(c4ccccc4)CC3)c2)cc1
CHEMBL379177,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL871242,B,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,CHEMBL1147793,KI,C1=C(c2ccccc2)CCN(Cc2cn(-c3ccccc3)nn2)C1
CHEMBL210318,CHEMBL217,Dopamine D2 receptor,Ki,=,3000.0,nM,CHEMBL871242,B,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,CHEMBL1147793,KI,c1ccc(N2CCN(Cc3ccc(-n4cccn4)cc3)CC2)cc1
CHEMBL378455,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL871242,B,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,CHEMBL1147793,KI,C1=C(c2ccccc2)CCN(Cc2cnn(-c3ccccc3)c2)C1
CHEMBL210232,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL871242,B,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,CHEMBL1147793,KI,COc1ccccc1N1CCN(Cc2cn(-c3ccccc3)nn2)CC1
CHEMBL211026,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL871242,B,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,CHEMBL1147793,KI,c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1
CHEMBL377200,CHEMBL217,Dopamine D2 receptor,Ki,=,630.0,nM,CHEMBL871242,B,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,CHEMBL1147793,KI,Cc1c(CN2CCN(c3ccccc3)CC2)cnn1-c1ccccc1
CHEMBL209832,CHEMBL217,Dopamine D2 receptor,Ki,=,6000.0,nM,CHEMBL871242,B,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,CHEMBL1147793,KI,c1ccc(-n2cc(CN3CCN(c4ncccn4)CC3)cn2)cc1
CHEMBL208018,CHEMBL217,Dopamine D2 receptor,Ki,=,71.0,nM,CHEMBL871242,B,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,CHEMBL1147793,KI,Cc1nn(-c2ccccc2)cc1CN1CCN(c2ccccc2)CC1
CHEMBL379602,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL871242,B,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,CHEMBL1147793,KI,COc1ccccc1N1CCN(Cc2cnn(-c3ccccc3)c2)CC1
CHEMBL210717,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL871242,B,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,CHEMBL1147793,KI,Fc1ccccc1N1CCN(Cc2cnn(-c3ccccc3)c2)CC1
CHEMBL437490,CHEMBL217,Dopamine D2 receptor,Ki,=,450.0,nM,CHEMBL871242,B,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,CHEMBL1147793,KI,Fc1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1
CHEMBL210955,CHEMBL217,Dopamine D2 receptor,Ki,=,2900.0,nM,CHEMBL871242,B,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,CHEMBL1147793,KI,Clc1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1
CHEMBL210405,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL871242,B,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,CHEMBL1147793,KI,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1
CHEMBL210404,CHEMBL217,Dopamine D2 receptor,Ki,=,40.0,nM,CHEMBL871242,B,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,CHEMBL1147793,KI,COc1ccccc1N1CCN(Cc2cnn(-c3ccccn3)c2)CC1
CHEMBL425057,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL871243,B,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,CHEMBL1147793,KI,c1ccc(N2CCN(Cc3cnn(-c4ccccn4)c3)CC2)cc1
CHEMBL60815,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL871243,B,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,CHEMBL1147793,KI,c1ccc(-c2c[nH]c(CN3CCN(c4ccccc4)CC3)c2)cc1
CHEMBL379177,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL871243,B,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,CHEMBL1147793,KI,C1=C(c2ccccc2)CCN(Cc2cn(-c3ccccc3)nn2)C1
CHEMBL210318,CHEMBL217,Dopamine D2 receptor,Ki,=,2400.0,nM,CHEMBL871243,B,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,CHEMBL1147793,KI,c1ccc(N2CCN(Cc3ccc(-n4cccn4)cc3)CC2)cc1
CHEMBL378455,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL871243,B,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,CHEMBL1147793,KI,C1=C(c2ccccc2)CCN(Cc2cnn(-c3ccccc3)c2)C1
CHEMBL210232,CHEMBL217,Dopamine D2 receptor,Ki,=,65.0,nM,CHEMBL871243,B,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,CHEMBL1147793,KI,COc1ccccc1N1CCN(Cc2cn(-c3ccccc3)nn2)CC1
CHEMBL211026,CHEMBL217,Dopamine D2 receptor,Ki,=,860.0,nM,CHEMBL871243,B,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,CHEMBL1147793,KI,c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1
CHEMBL377200,CHEMBL217,Dopamine D2 receptor,Ki,=,250.0,nM,CHEMBL871243,B,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,CHEMBL1147793,KI,Cc1c(CN2CCN(c3ccccc3)CC2)cnn1-c1ccccc1
CHEMBL209832,CHEMBL217,Dopamine D2 receptor,Ki,=,14000.0,nM,CHEMBL871243,B,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,CHEMBL1147793,KI,c1ccc(-n2cc(CN3CCN(c4ncccn4)CC3)cn2)cc1
CHEMBL208018,CHEMBL217,Dopamine D2 receptor,Ki,=,43.0,nM,CHEMBL871243,B,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,CHEMBL1147793,KI,Cc1nn(-c2ccccc2)cc1CN1CCN(c2ccccc2)CC1
CHEMBL379602,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL871243,B,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,CHEMBL1147793,KI,COc1ccccc1N1CCN(Cc2cnn(-c3ccccc3)c2)CC1
CHEMBL210717,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL871243,B,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,CHEMBL1147793,KI,Fc1ccccc1N1CCN(Cc2cnn(-c3ccccc3)c2)CC1
CHEMBL437490,CHEMBL217,Dopamine D2 receptor,Ki,=,400.0,nM,CHEMBL871243,B,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,CHEMBL1147793,KI,Fc1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1
CHEMBL210955,CHEMBL217,Dopamine D2 receptor,Ki,=,1900.0,nM,CHEMBL871243,B,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,CHEMBL1147793,KI,Clc1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1
CHEMBL210405,CHEMBL217,Dopamine D2 receptor,Ki,=,75.0,nM,CHEMBL871243,B,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,CHEMBL1147793,KI,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1
CHEMBL210404,CHEMBL217,Dopamine D2 receptor,Ki,=,31.0,nM,CHEMBL871243,B,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,CHEMBL1147793,KI,COc1ccccc1N1CCN(Cc2cnn(-c3ccccn3)c2)CC1
CHEMBL150161,CHEMBL217,Dopamine D2 receptor,Ki,=,51.1,nM,CHEMBL868244,B,Binding affinity to human cloned dopamine D2 receptor by radioligand binding assay,CHEMBL1148503,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1
CHEMBL210578,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL868244,B,Binding affinity to human cloned dopamine D2 receptor by radioligand binding assay,CHEMBL1148503,KI,O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1
CHEMBL150161,CHEMBL217,Dopamine D2 receptor,Ki,=,489.0,nM,CHEMBL868244,B,Binding affinity to human cloned dopamine D2 receptor by radioligand binding assay,CHEMBL1148503,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1
CHEMBL212631,CHEMBL217,Dopamine D2 receptor,Ki,=,400.0,nM,CHEMBL864790,B,Displacement of [3H]7-OH-DPAT from porcine dopamine receptor D2,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3ccccc3n2)CC1
CHEMBL212631,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL864789,B,Displacement of [3H]7-OH-DPAT from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3ccccc3n2)CC1
CHEMBL143761,CHEMBL217,Dopamine D2 receptor,Ki,=,19000.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,N#Cc1ccc2[nH]c(CN3CCN(c4ccc(F)cc4)CC3)cc2c1
CHEMBL143761,CHEMBL217,Dopamine D2 receptor,Ki,=,28000.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,N#Cc1ccc2[nH]c(CN3CCN(c4ccc(F)cc4)CC3)cc2c1
CHEMBL140099,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,N#Cc1ccc2[nH]c(CN3CCN(c4ccccc4)CC3)cc2c1
CHEMBL140099,CHEMBL217,Dopamine D2 receptor,Ki,=,3100.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,N#Cc1ccc2[nH]c(CN3CCN(c4ccccc4)CC3)cc2c1
CHEMBL7927,CHEMBL217,Dopamine D2 receptor,Ki,=,4300.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL7927,CHEMBL217,Dopamine D2 receptor,Ki,=,3200.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL208274,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3cc(C)cc(-c4ccccc4)c3n2)CC1
CHEMBL208274,CHEMBL217,Dopamine D2 receptor,Ki,=,49.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3cc(C)cc(-c4ccccc4)c3n2)CC1
CHEMBL212160,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3c(-n4cccn4)cccc3n2)CC1
CHEMBL212160,CHEMBL217,Dopamine D2 receptor,Ki,=,590.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3c(-n4cccn4)cccc3n2)CC1
CHEMBL210551,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3cc(C)cc(-n4cccn4)c3n2)CC1
CHEMBL210551,CHEMBL217,Dopamine D2 receptor,Ki,=,530.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3cc(C)cc(-n4cccn4)c3n2)CC1
CHEMBL211118,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3cc(C)cc(N4CCOCC4)c3n2)CC1
CHEMBL211118,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3cc(C)cc(N4CCOCC4)c3n2)CC1
CHEMBL210283,CHEMBL217,Dopamine D2 receptor,Ki,=,2700.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3cc(C)cc(C#N)c3n2)CC1
CHEMBL210283,CHEMBL217,Dopamine D2 receptor,Ki,=,4200.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3cc(C)cc(C#N)c3n2)CC1
CHEMBL210341,CHEMBL217,Dopamine D2 receptor,Ki,=,3700.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,Clc1ccc(N2CCN(Cc3cn4cc(Br)ccc4n3)CC2)cc1Cl
CHEMBL210341,CHEMBL217,Dopamine D2 receptor,Ki,=,3500.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,Clc1ccc(N2CCN(Cc3cn4cc(Br)ccc4n3)CC2)cc1Cl
CHEMBL211590,CHEMBL217,Dopamine D2 receptor,Ki,=,97.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3cc(C)cc(I)c3n2)CC1
CHEMBL211590,CHEMBL217,Dopamine D2 receptor,Ki,=,88.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3cc(C)cc(I)c3n2)CC1
CHEMBL211539,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3cc(C)cc(Br)c3n2)CC1
CHEMBL211539,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3cc(C)cc(Br)c3n2)CC1
CHEMBL379125,CHEMBL217,Dopamine D2 receptor,Ki,=,72.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3cc(I)ccc3n2)CC1
CHEMBL379125,CHEMBL217,Dopamine D2 receptor,Ki,=,73.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3cc(I)ccc3n2)CC1
CHEMBL211164,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3cc(Br)ccc3n2)CC1
CHEMBL211164,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3cc(Br)ccc3n2)CC1
CHEMBL380287,CHEMBL217,Dopamine D2 receptor,Ki,=,7800.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,CN1CCN(c2ccc3nc(CN4CCN(c5ccc(Cl)c(Cl)c5)CC4)cn3n2)CC1
CHEMBL380287,CHEMBL217,Dopamine D2 receptor,Ki,=,8000.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,CN1CCN(c2ccc3nc(CN4CCN(c5ccc(Cl)c(Cl)c5)CC4)cn3n2)CC1
CHEMBL207543,CHEMBL217,Dopamine D2 receptor,Ki,=,710.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,Clc1ccc(N2CCN(Cc3cn4nc(N5CCCCC5)ccc4n3)CC2)cc1Cl
CHEMBL207543,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,Clc1ccc(N2CCN(Cc3cn4nc(N5CCCCC5)ccc4n3)CC2)cc1Cl
CHEMBL425064,CHEMBL217,Dopamine D2 receptor,Ki,=,49000.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,Fc1ccc(N2CCN(Cc3cn4cccnc4n3)CC2)cc1
CHEMBL425064,CHEMBL217,Dopamine D2 receptor,Ki,=,55000.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,Fc1ccc(N2CCN(Cc3cn4cccnc4n3)CC2)cc1
CHEMBL377542,CHEMBL217,Dopamine D2 receptor,Ki,=,68000.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,Fc1ccc(N2CCN(Cc3cn4ccncc4n3)CC2)cc1
CHEMBL377542,CHEMBL217,Dopamine D2 receptor,Ki,=,64000.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,Fc1ccc(N2CCN(Cc3cn4ccncc4n3)CC2)cc1
CHEMBL211135,CHEMBL217,Dopamine D2 receptor,Ki,=,8200.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,Clc1ccc(N2CCN(Cc3cn4nc(Cl)ccc4n3)CC2)cc1
CHEMBL211135,CHEMBL217,Dopamine D2 receptor,Ki,=,12000.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,Clc1ccc(N2CCN(Cc3cn4nc(Cl)ccc4n3)CC2)cc1
CHEMBL378515,CHEMBL217,Dopamine D2 receptor,Ki,=,79.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3nc(Cl)ccc3n2)CC1
CHEMBL378515,CHEMBL217,Dopamine D2 receptor,Ki,=,96.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3nc(Cl)ccc3n2)CC1
CHEMBL209034,CHEMBL217,Dopamine D2 receptor,Ki,=,670.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,Clc1ccc2nc(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)cn2n1
CHEMBL209034,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,Clc1ccc2nc(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)cn2n1
CHEMBL207488,CHEMBL217,Dopamine D2 receptor,Ki,=,9900.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,Fc1ccc(N2CCN(Cc3cn4nc(Cl)ccc4n3)CC2)cc1
CHEMBL212370,CHEMBL217,Dopamine D2 receptor,Ki,=,15000.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,Clc1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1
CHEMBL212370,CHEMBL217,Dopamine D2 receptor,Ki,=,16000.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,Clc1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1
CHEMBL212631,CHEMBL217,Dopamine D2 receptor,Ki,=,930.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3ccccc3n2)CC1
CHEMBL378680,CHEMBL217,Dopamine D2 receptor,Ki,=,2700.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,Clc1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1Cl
CHEMBL378680,CHEMBL217,Dopamine D2 receptor,Ki,=,3200.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,Clc1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1Cl
CHEMBL380054,CHEMBL217,Dopamine D2 receptor,Ki,=,19000.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,Fc1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1
CHEMBL380054,CHEMBL217,Dopamine D2 receptor,Ki,=,21000.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,Fc1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1
CHEMBL212631,CHEMBL217,Dopamine D2 receptor,Ki,=,990.0,nM,CHEMBL866799,B,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,CHEMBL1138042,KI,COc1ccccc1N1CCN(Cc2cn3ccccc3n2)CC1
CHEMBL207488,CHEMBL217,Dopamine D2 receptor,Ki,=,12000.0,nM,CHEMBL866800,B,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,CHEMBL1138042,KI,Fc1ccc(N2CCN(Cc3cn4nc(Cl)ccc4n3)CC2)cc1
CHEMBL377050,CHEMBL217,Dopamine D2 receptor,Ki,=,172.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1
CHEMBL212782,CHEMBL217,Dopamine D2 receptor,Ki,=,128.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CCO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1
CHEMBL376955,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,N#CCO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1
CHEMBL377388,CHEMBL217,Dopamine D2 receptor,Ki,=,257.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CCO/N=C(\CCN1CCN(c2nccs2)CC1)c1ccccc1
CHEMBL437687,CHEMBL217,Dopamine D2 receptor,Ki,=,112.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1C
CHEMBL426510,CHEMBL217,Dopamine D2 receptor,Ki,=,101.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1cccc(F)c1
CHEMBL213164,CHEMBL217,Dopamine D2 receptor,Ki,=,46.6,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1cccc(F)c1
CHEMBL212784,CHEMBL217,Dopamine D2 receptor,Ki,=,98.7,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1cccc(Cl)c1
CHEMBL212861,CHEMBL217,Dopamine D2 receptor,Ki,=,68.4,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1cccc(C)c1
CHEMBL212903,CHEMBL217,Dopamine D2 receptor,Ki,=,68.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1cccc(C)c1
CHEMBL211836,CHEMBL217,Dopamine D2 receptor,Ki,=,125.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1cccc(C#N)c1
CHEMBL212969,CHEMBL217,Dopamine D2 receptor,Ki,=,168.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1
CHEMBL427048,CHEMBL217,Dopamine D2 receptor,Ki,=,221.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1
CHEMBL212235,CHEMBL217,Dopamine D2 receptor,Ki,=,63.8,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(Cl)cc1
CHEMBL211732,CHEMBL217,Dopamine D2 receptor,Ki,=,132.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1cc(F)cc(F)c1
CHEMBL215705,CHEMBL217,Dopamine D2 receptor,Ki,=,225.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1cc(F)cc(F)c1
CHEMBL378576,CHEMBL217,Dopamine D2 receptor,Ki,=,171.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(F)c(Cl)c1
CHEMBL378324,CHEMBL217,Dopamine D2 receptor,Ki,=,64.5,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(Cl)c(Cl)c1
CHEMBL215450,CHEMBL217,Dopamine D2 receptor,Ki,=,60.9,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccc(Cl)c(C)c1
CHEMBL212444,CHEMBL217,Dopamine D2 receptor,Ki,=,137.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(C)c(C)c1
CHEMBL212291,CHEMBL217,Dopamine D2 receptor,Ki,=,1820.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1cccnc1
CHEMBL212292,CHEMBL217,Dopamine D2 receptor,Ki,=,76.5,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(\CCN1CCN(c2ccccn2)CC1C)c1ccc(Cl)cc1
CHEMBL210101,CHEMBL217,Dopamine D2 receptor,Ki,=,25.3,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(\CCN1CCC(c2ccccn2)CC1)c1ccc(Cl)cc1
CHEMBL437532,CHEMBL217,Dopamine D2 receptor,Ki,=,19.4,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(/CCN1CCC(c2ccccn2)CC1)c1ccc(Cl)cc1
CHEMBL212891,CHEMBL217,Dopamine D2 receptor,Ki,=,2530.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(\CN1CCN(c2ccccn2)CC1)c1ccc(F)cc1
CHEMBL214247,CHEMBL217,Dopamine D2 receptor,Ki,=,995.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(\c1ccc(Cl)cc1)C(O)CN1CCN(c2ccccn2)CC1
CHEMBL441529,CHEMBL217,Dopamine D2 receptor,Ki,=,368.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(/c1ccc(Cl)cc1)C(O)CN1CCN(c2ccccn2)CC1
CHEMBL213004,CHEMBL217,Dopamine D2 receptor,Ki,=,146.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(/c1ccc(Cl)cc1)C(C)CN1CCN(c2ccccn2)CC1
CHEMBL212288,CHEMBL217,Dopamine D2 receptor,Ki,=,164.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,CO/N=C(/c1ccc(Cl)cc1)C(CNOC)CN1CCN(c2ccccn2)CC1
CHEMBL214314,CHEMBL217,Dopamine D2 receptor,Ki,=,257.0,nM,CHEMBL863653,B,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,CHEMBL1145336,KI,O/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,208.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL214407,CHEMBL217,Dopamine D2 receptor,Ki,=,431.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Oc3ccccc3)c3ccccc32)CC1
CHEMBL212844,CHEMBL217,Dopamine D2 receptor,Ki,=,3000.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3-n3ccnc3)c3ccccc32)CC1
CHEMBL210016,CHEMBL217,Dopamine D2 receptor,Ki,=,3772.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3N3CCN(C)CC3)c3ccccc32)CC1
CHEMBL212383,CHEMBL217,Dopamine D2 receptor,Ki,=,215.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3N3CCCCC3)c3ccccc32)CC1
CHEMBL212186,CHEMBL217,Dopamine D2 receptor,Ki,=,3818.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3NC3CCCCC3)c3ccccc32)CC1
CHEMBL213443,CHEMBL217,Dopamine D2 receptor,Ki,=,931.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc4ccccc4n3)c3ccccc32)CC1
CHEMBL213278,CHEMBL217,Dopamine D2 receptor,Ki,=,484.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3nccc4ccccc34)c3ccccc32)CC1
CHEMBL378512,CHEMBL217,Dopamine D2 receptor,Ki,=,274.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CCOc1ccc2ccccc2c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL213882,CHEMBL217,Dopamine D2 receptor,Ki,=,1314.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc4ccccc4c3)c3ccccc32)CC1
CHEMBL213834,CHEMBL217,Dopamine D2 receptor,Ki,=,458.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc4ccccc34)c3ccccc32)CC1
CHEMBL384500,CHEMBL217,Dopamine D2 receptor,Ki,=,630.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccnc3Cl)c3ccccc32)CC1
CHEMBL405751,CHEMBL217,Dopamine D2 receptor,Ki,=,2084.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cnn(-c4ccccc4)c3C(F)(F)F)c3ccccc32)CC1
CHEMBL213372,CHEMBL217,Dopamine D2 receptor,Ki,=,460.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccon3)c3ccccc32)CC1
CHEMBL378914,CHEMBL217,Dopamine D2 receptor,Ki,=,196.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CCOc1c(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)sc2ccccc12
CHEMBL384916,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3sccc3-c3ccccc3)c3ccccc32)CC1
CHEMBL437112,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CCOc1csc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)c1
CHEMBL212896,CHEMBL217,Dopamine D2 receptor,Ki,=,2997.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccsc3)c3ccccc32)CC1
CHEMBL379874,CHEMBL217,Dopamine D2 receptor,Ki,=,1474.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccs3)c3ccccc32)CC1
CHEMBL426868,CHEMBL217,Dopamine D2 receptor,Ki,=,837.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccco3)c3ccccc32)CC1
CHEMBL377756,CHEMBL217,Dopamine D2 receptor,Ki,=,92.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(N)cccc3C(F)(F)F)c3ccccc32)CC1
CHEMBL213424,CHEMBL217,Dopamine D2 receptor,Ki,=,1015.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,Cc1cccc(N)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL213336,CHEMBL217,Dopamine D2 receptor,Ki,=,287.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,Cc1cccc(C)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL378669,CHEMBL217,Dopamine D2 receptor,Ki,=,496.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(N)cccc3Cl)c3ccccc32)CC1
CHEMBL213492,CHEMBL217,Dopamine D2 receptor,Ki,=,383.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(F)cccc3C(F)(F)F)c3ccccc32)CC1
CHEMBL425069,CHEMBL217,Dopamine D2 receptor,Ki,=,340.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,COc1cccc(OC)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL427230,CHEMBL217,Dopamine D2 receptor,Ki,=,608.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cc(Cl)cc(Cl)c3)c3ccccc32)CC1
CHEMBL213881,CHEMBL217,Dopamine D2 receptor,Ki,=,390.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(Cl)cc(Cl)cc3Cl)c3ccccc32)CC1
CHEMBL386122,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(Cl)cccc3Cl)c3ccccc32)CC1
CHEMBL212077,CHEMBL217,Dopamine D2 receptor,Ki,=,6394.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc(Cl)c(Cl)c3)c3ccccc32)CC1
CHEMBL212912,CHEMBL217,Dopamine D2 receptor,Ki,=,181.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1
CHEMBL213477,CHEMBL217,Dopamine D2 receptor,Ki,=,374.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3F)c3ccccc32)CC1
CHEMBL377584,CHEMBL217,Dopamine D2 receptor,Ki,=,350.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(I)c3)c3ccccc32)CC1
CHEMBL213084,CHEMBL217,Dopamine D2 receptor,Ki,=,181.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(Cl)c3)c3ccccc32)CC1
CHEMBL213083,CHEMBL217,Dopamine D2 receptor,Ki,=,921.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(F)c3)c3ccccc32)CC1
CHEMBL214016,CHEMBL217,Dopamine D2 receptor,Ki,=,1126.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,COc1cccc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)c1
CHEMBL213793,CHEMBL217,Dopamine D2 receptor,Ki,=,517.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,Cc1cccc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)c1
CHEMBL215885,CHEMBL217,Dopamine D2 receptor,Ki,=,3000.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,COc1ccc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)cc1
CHEMBL213795,CHEMBL217,Dopamine D2 receptor,Ki,=,1521.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,Cc1ccc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)cc1
CHEMBL214142,CHEMBL217,Dopamine D2 receptor,Ki,=,9251.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc(Cl)cc3)c3ccccc32)CC1
CHEMBL213775,CHEMBL217,Dopamine D2 receptor,Ki,=,2386.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc(Br)cc3)c3ccccc32)CC1
CHEMBL212608,CHEMBL217,Dopamine D2 receptor,Ki,=,1150.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3)c3ccccc32)CC1
CHEMBL213388,CHEMBL217,Dopamine D2 receptor,Ki,=,1776.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)C3CCCCC3)c3ccccc32)CC1
CHEMBL386424,CHEMBL217,Dopamine D2 receptor,Ki,=,1600.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)/C=C/c3ccccc3)c3ccccc32)CC1
CHEMBL215950,CHEMBL217,Dopamine D2 receptor,Ki,=,582.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,COc1ccc(CCC(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)cc1Cl
CHEMBL215611,CHEMBL217,Dopamine D2 receptor,Ki,=,621.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCc3ccccc3)c3ccccc32)CC1
CHEMBL211461,CHEMBL217,Dopamine D2 receptor,Ki,=,1950.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCC3CCCC3)c3ccccc32)CC1
CHEMBL212597,CHEMBL217,Dopamine D2 receptor,Ki,=,400.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CCCC(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL212486,CHEMBL217,Dopamine D2 receptor,Ki,=,1900.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)C(F)(F)F)c3ccccc32)CC1
CHEMBL215140,CHEMBL217,Dopamine D2 receptor,Ki,=,647.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(N)c3ccccc32)CC1
CHEMBL212912,CHEMBL217,Dopamine D2 receptor,Ki,=,181.0,nM,CHEMBL870474,B,Binding affinity at dopamine D2 receptor,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1
CHEMBL213834,CHEMBL217,Dopamine D2 receptor,Ki,=,458.0,nM,CHEMBL870474,B,Binding affinity at dopamine D2 receptor,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc4ccccc34)c3ccccc32)CC1
CHEMBL213424,CHEMBL217,Dopamine D2 receptor,Ki,=,1015.0,nM,CHEMBL870474,B,Binding affinity at dopamine D2 receptor,CHEMBL1146871,KI,Cc1cccc(N)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL213336,CHEMBL217,Dopamine D2 receptor,Ki,=,287.0,nM,CHEMBL870474,B,Binding affinity at dopamine D2 receptor,CHEMBL1146871,KI,Cc1cccc(C)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL378669,CHEMBL217,Dopamine D2 receptor,Ki,=,496.0,nM,CHEMBL870474,B,Binding affinity at dopamine D2 receptor,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(N)cccc3Cl)c3ccccc32)CC1
CHEMBL213492,CHEMBL217,Dopamine D2 receptor,Ki,=,383.0,nM,CHEMBL870474,B,Binding affinity at dopamine D2 receptor,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(F)cccc3C(F)(F)F)c3ccccc32)CC1
CHEMBL425069,CHEMBL217,Dopamine D2 receptor,Ki,=,340.0,nM,CHEMBL870474,B,Binding affinity at dopamine D2 receptor,CHEMBL1146871,KI,COc1cccc(OC)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,208.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL212807,CHEMBL217,Dopamine D2 receptor,Ki,=,97.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1cccc(OC)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2cc(Cl)ccc21
CHEMBL212936,CHEMBL217,Dopamine D2 receptor,Ki,=,36.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3I)c3ccc(Cl)cc32)CC1
CHEMBL379942,CHEMBL217,Dopamine D2 receptor,Ki,=,175.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,Cc1ccccc1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2cc(Cl)ccc21
CHEMBL213110,CHEMBL217,Dopamine D2 receptor,Ki,=,267.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1cc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3cc(Cl)ccc32)cc(OC)c1OC
CHEMBL212700,CHEMBL217,Dopamine D2 receptor,Ki,=,286.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc4c(c3)OCO4)c3ccc(Cl)cc32)CC1
CHEMBL213466,CHEMBL217,Dopamine D2 receptor,Ki,=,270.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cc(F)c(F)c(F)c3F)c3ccc(Cl)cc32)CC1
CHEMBL378341,CHEMBL217,Dopamine D2 receptor,Ki,=,69.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cc(F)ccc3C(F)(F)F)c3ccc(Cl)cc32)CC1
CHEMBL384069,CHEMBL217,Dopamine D2 receptor,Ki,=,139.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1cccc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3cc(Cl)ccc32)c1
CHEMBL212402,CHEMBL217,Dopamine D2 receptor,Ki,=,175.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(C#N)c3)c3ccc(Cl)cc32)CC1
CHEMBL378648,CHEMBL217,Dopamine D2 receptor,Ki,=,194.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc(C#N)cc3)c3ccc(Cl)cc32)CC1
CHEMBL215414,CHEMBL217,Dopamine D2 receptor,Ki,=,197.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1cccc(OC)c1C(=O)NN1c2ccccc2N=C(N2CCN(C)CC2)c2cc(Cl)ccc21
CHEMBL214503,CHEMBL217,Dopamine D2 receptor,Ki,=,231.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3ccccc3N(NC(=O)c3ccccc3I)c3ccc(Cl)cc32)CC1
CHEMBL385295,CHEMBL217,Dopamine D2 receptor,Ki,=,1571.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,Cc1ccccc1C(=O)NN1c2ccccc2N=C(N2CCN(C)CC2)c2cc(Cl)ccc21
CHEMBL377420,CHEMBL217,Dopamine D2 receptor,Ki,=,3230.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1cc(C(=O)NN2c3ccccc3N=C(N3CCN(C)CC3)c3cc(Cl)ccc32)cc(OC)c1OC
CHEMBL213472,CHEMBL217,Dopamine D2 receptor,Ki,=,1261.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3ccccc3N(NC(=O)c3ccc4c(c3)OCO4)c3ccc(Cl)cc32)CC1
CHEMBL213145,CHEMBL217,Dopamine D2 receptor,Ki,=,759.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3ccccc3N(NC(=O)c3cc(F)c(F)c(F)c3F)c3ccc(Cl)cc32)CC1
CHEMBL213193,CHEMBL217,Dopamine D2 receptor,Ki,=,421.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3ccccc3N(NC(=O)c3cc(F)ccc3C(F)(F)F)c3ccc(Cl)cc32)CC1
CHEMBL213239,CHEMBL217,Dopamine D2 receptor,Ki,=,1379.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1cccc(C(=O)NN2c3ccccc3N=C(N3CCN(C)CC3)c3cc(Cl)ccc32)c1
CHEMBL213238,CHEMBL217,Dopamine D2 receptor,Ki,=,1186.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3ccccc3N(NC(=O)c3cccc(C#N)c3)c3ccc(Cl)cc32)CC1
CHEMBL213201,CHEMBL217,Dopamine D2 receptor,Ki,=,1969.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3ccccc3N(NC(=O)c3ccc(C#N)cc3)c3ccc(Cl)cc32)CC1
CHEMBL215669,CHEMBL217,Dopamine D2 receptor,Ki,=,3.4,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,FC(F)(F)Oc1cccc(CN2CCN(C3=Nc4cc(Cl)ccc4Nc4ccccc43)CC2)c1
CHEMBL384634,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,FC1(F)Oc2cccc(CN3CCN(C4=Nc5cc(Cl)ccc5Nc5ccccc54)CC3)c2O1
CHEMBL213577,CHEMBL217,Dopamine D2 receptor,Ki,=,29.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,Clc1ccc2c(c1)N=C(N1CCN(Cc3ccc4c(c3)OCCO4)CC1)c1ccccc1N2
CHEMBL378301,CHEMBL217,Dopamine D2 receptor,Ki,=,65.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,Cc1ccc(CN2CCN(C3=Nc4cc(Cl)ccc4Nc4ccccc43)CC2)c(C)c1
CHEMBL211915,CHEMBL217,Dopamine D2 receptor,Ki,=,80.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,Clc1ccc2c(c1)N=C(N1CCN(Cc3cccc4c3OCO4)CC1)c1ccccc1N2
CHEMBL213200,CHEMBL217,Dopamine D2 receptor,Ki,=,177.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,Fc1ccc(CN2CCN(C3=Nc4cc(Cl)ccc4Nc4ccccc43)CC2)c(F)c1
CHEMBL379593,CHEMBL217,Dopamine D2 receptor,Ki,=,998.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CC(C)N1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1
CHEMBL213335,CHEMBL217,Dopamine D2 receptor,Ki,=,409.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CCCN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1
CHEMBL215842,CHEMBL217,Dopamine D2 receptor,Ki,=,709.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CCN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1
CHEMBL384248,CHEMBL217,Dopamine D2 receptor,Ki,=,28425.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccncc3)c3ccccc32)CC1
CHEMBL215997,CHEMBL217,Dopamine D2 receptor,Ki,=,12710.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccnc3)c3ccccc32)CC1
CHEMBL425069,CHEMBL217,Dopamine D2 receptor,Ki,=,340.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1cccc(OC)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL213336,CHEMBL217,Dopamine D2 receptor,Ki,=,287.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,Cc1cccc(C)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL212438,CHEMBL217,Dopamine D2 receptor,Ki,=,1280.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cc(F)c(F)c(F)c3F)c3ccccc32)CC1
CHEMBL379875,CHEMBL217,Dopamine D2 receptor,Ki,=,5561.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1cc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)cc(OC)c1OC
CHEMBL437917,CHEMBL217,Dopamine D2 receptor,Ki,=,1616.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc(F)cc3C(F)(F)F)c3ccccc32)CC1
CHEMBL213668,CHEMBL217,Dopamine D2 receptor,Ki,=,828.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc4c(c3)OCO4)c3ccccc32)CC1
CHEMBL384269,CHEMBL217,Dopamine D2 receptor,Ki,=,533.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(F)c3F)c3ccccc32)CC1
CHEMBL212912,CHEMBL217,Dopamine D2 receptor,Ki,=,181.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1
CHEMBL377877,CHEMBL217,Dopamine D2 receptor,Ki,=,792.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Br)c3ccccc32)CC1
CHEMBL380236,CHEMBL217,Dopamine D2 receptor,Ki,=,1362.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(C(F)(F)F)c3)c3ccccc32)CC1
CHEMBL212905,CHEMBL217,Dopamine D2 receptor,Ki,=,3648.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(C#N)c3)c3ccccc32)CC1
CHEMBL212608,CHEMBL217,Dopamine D2 receptor,Ki,=,1150.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3)c3ccccc32)CC1
CHEMBL379560,CHEMBL217,Dopamine D2 receptor,Ki,=,1126.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1ccccc1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL211910,CHEMBL217,Dopamine D2 receptor,Ki,=,202.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1ccccc1CNN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL212384,CHEMBL217,Dopamine D2 receptor,Ki,=,3896.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)Nc3cc(Cl)cc(Cl)c3)c3ccccc32)CC1
CHEMBL377452,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,Cc1ccccc1S(=O)(=O)N1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL209805,CHEMBL217,Dopamine D2 receptor,Ki,=,338.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,Cc1ccc(S(=O)(=O)N2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)cc1
CHEMBL378543,CHEMBL217,Dopamine D2 receptor,Ki,=,4927.0,nM,CHEMBL911524,B,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,CHEMBL1146903,KI,Cc1ccccc1C(=O)N1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL215581,CHEMBL217,Dopamine D2 receptor,Ki,=,1850.0,nM,CHEMBL870468,B,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1146871,KI,CCCC(CCC)C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL215010,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL907725,B,Binding affinity to D2 receptor,CHEMBL1137322,KI,c1ccc(CCc2ccccc2OCc2ccccc2)cc1
CHEMBL217281,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL907725,B,Binding affinity to D2 receptor,CHEMBL1137322,KI,COc1cccc(CCc2ccccc2OCc2cccnc2)c1
CHEMBL217425,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL907725,B,Binding affinity to D2 receptor,CHEMBL1137322,KI,c1ccc(CCc2ccccc2OCc2cccnc2)cc1
CHEMBL387052,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL907725,B,Binding affinity to D2 receptor,CHEMBL1137322,KI,COc1cccc(CCc2ccccc2OCc2ccccn2)c1
CHEMBL216198,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL907725,B,Binding affinity to D2 receptor,CHEMBL1137322,KI,c1ccc(CCc2ccccc2OCc2ccccn2)cc1
CHEMBL217886,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL907725,B,Binding affinity to D2 receptor,CHEMBL1137322,KI,COc1cccc(CCc2ccccc2OCc2cccc(OC)c2)c1
CHEMBL214739,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL907725,B,Binding affinity to D2 receptor,CHEMBL1137322,KI,COc1cccc(CCc2ccccc2OCc2ccccc2)c1
CHEMBL441618,CHEMBL217,Dopamine D2 receptor,Ki,=,44.5,nM,CHEMBL908321,B,Displacement of [3H]spiperone from human D2L dopamine receptor expressed in CHO cells,CHEMBL1137400,KI,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL216258,CHEMBL217,Dopamine D2 receptor,Ki,=,14.5,nM,CHEMBL908321,B,Displacement of [3H]spiperone from human D2L dopamine receptor expressed in CHO cells,CHEMBL1137400,KI,CN1CCCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL216439,CHEMBL217,Dopamine D2 receptor,Ki,=,143.0,nM,CHEMBL908321,B,Displacement of [3H]spiperone from human D2L dopamine receptor expressed in CHO cells,CHEMBL1137400,KI,CN1CCCc2c([nH]c3ccccc23)Cc2ccccc2CC1
CHEMBL384538,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL907725,B,Binding affinity to D2 receptor,CHEMBL1137322,KI,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)C[C@@H]4OC(=O)C(=C)[C@H]4CCCC)CC[C@@H]23)C[C@@H](O)[C@H](C)[C@@H]1O
CHEMBL71,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL911249,B,Displacement of [3H]spiperone from dopamine D2-like receptor in porcine striata homogenate,CHEMBL1137342,KI,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL1203924,CHEMBL217,Dopamine D2 receptor,Ki,=,340.0,nM,CHEMBL911249,B,Displacement of [3H]spiperone from dopamine D2-like receptor in porcine striata homogenate,CHEMBL1137342,KI,CCCN1Cc2ccccc2C2c3cc(O)c(O)cc3OCC21.Cl
CHEMBL384046,CHEMBL217,Dopamine D2 receptor,Ki,=,6800.0,nM,CHEMBL911249,B,Displacement of [3H]spiperone from dopamine D2-like receptor in porcine striata homogenate,CHEMBL1137342,KI,Oc1cc2c(cc1O)[C@@H]1c3ccccc3CN[C@H]1CO2
CHEMBL387250,CHEMBL217,Dopamine D2 receptor,Ki,=,2500.0,nM,CHEMBL911249,B,Displacement of [3H]spiperone from dopamine D2-like receptor in porcine striata homogenate,CHEMBL1137342,KI,Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CO2
CHEMBL217299,CHEMBL217,Dopamine D2 receptor,Ki,=,3700.0,nM,CHEMBL911249,B,Displacement of [3H]spiperone from dopamine D2-like receptor in porcine striata homogenate,CHEMBL1137342,KI,Oc1cc2c(cc1O)C1c3ccccc3CNC1CO2
CHEMBL25856,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL911249,B,Displacement of [3H]spiperone from dopamine D2-like receptor in porcine striata homogenate,CHEMBL1137342,KI,Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2
CHEMBL217299,CHEMBL217,Dopamine D2 receptor,Ki,=,1910.0,nM,CHEMBL912418,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1137342,KI,Oc1cc2c(cc1O)C1c3ccccc3CNC1CO2
CHEMBL220189,CHEMBL217,Dopamine D2 receptor,Ki,=,235.0,nM,CHEMBL910434,B,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,CHEMBL1137302,KI,Cc1cccc(C(=O)NCN2CCC(c3ccccc3)CC2)c1
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,3.6,nM,CHEMBL910434,B,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,CHEMBL1137302,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL375596,CHEMBL217,Dopamine D2 receptor,Ki,=,2900.0,nM,CHEMBL910434,B,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,CHEMBL1137302,KI,Cc1cccc(NC(=O)CN2CCC(c3ccccn3)CC2)c1
CHEMBL216794,CHEMBL217,Dopamine D2 receptor,Ki,=,3500.0,nM,CHEMBL910434,B,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,CHEMBL1137302,KI,Cc1cccc(C(=O)NCN2CCC(c3ccccn3)CC2)c1
CHEMBL376092,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL910434,B,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,CHEMBL1137302,KI,COc1ccccc1C1CCN(CNC(=O)c2cccc(C)c2)CC1
CHEMBL221652,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL912013,B,Displacement of [3H]spiperone from human dopamine D2(long) expressed in CHO cell membrane,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3cccc([18F])n3)cc2)CC1
CHEMBL221652,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL912014,B,Displacement of [3H]spiperone from human dopamine D2(short) expressed in CHO cell membrane,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3cccc([18F])n3)cc2)CC1
CHEMBL221640,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL912013,B,Displacement of [3H]spiperone from human dopamine D2(long) expressed in CHO cell membrane,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccc([18F])nc3)cc2)CC1
CHEMBL221640,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL912014,B,Displacement of [3H]spiperone from human dopamine D2(short) expressed in CHO cell membrane,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccc([18F])nc3)cc2)CC1
CHEMBL25236,CHEMBL217,Dopamine D2 receptor,Ki,=,208.93,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL218150,CHEMBL217,Dopamine D2 receptor,Ki,=,2290.87,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(Br)ccc2[nH]1
CHEMBL218638,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccc(C#N)cc3[nH]2)CC1
CHEMBL218444,CHEMBL217,Dopamine D2 receptor,Ki,=,109.65,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(Br)ccc3[nH]2)CC1
CHEMBL220700,CHEMBL217,Dopamine D2 receptor,Ki,=,141.25,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(C#N)ccc3[nH]2)CC1
CHEMBL346692,CHEMBL217,Dopamine D2 receptor,Ki,=,3090.3,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL376020,CHEMBL217,Dopamine D2 receptor,Ki,=,128.82,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(C#N)ccc3o2)CC1
CHEMBL376445,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(Br)ccc2o1
CHEMBL221681,CHEMBL217,Dopamine D2 receptor,Ki,=,95.5,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(Br)ccc3o2)CC1
CHEMBL139926,CHEMBL217,Dopamine D2 receptor,Ki,=,323.59,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL124444,CHEMBL217,Dopamine D2 receptor,Ki,=,109.65,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1
CHEMBL218368,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,C#Cc1ccc2cc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)sc2c1
CHEMBL218318,CHEMBL217,Dopamine D2 receptor,Ki,=,67.61,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(C#N)ccc3s2)CC1
CHEMBL221397,CHEMBL217,Dopamine D2 receptor,Ki,=,407.38,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,C#Cc1ccc2sc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)cc2c1
CHEMBL59725,CHEMBL217,Dopamine D2 receptor,Ki,=,3630.78,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL424294,CHEMBL217,Dopamine D2 receptor,Ki,=,87.1,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL374749,CHEMBL217,Dopamine D2 receptor,Ki,=,128.82,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1ccc(-c2ccccc2)cc1
CHEMBL221549,CHEMBL217,Dopamine D2 receptor,Ki,=,281.84,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccc(C(=O)NCCCCN2CCN(c3ccccc3Cl)CC2)cc1OC
CHEMBL219274,CHEMBL217,Dopamine D2 receptor,Ki,=,467.74,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1ccc(Cl)cc1
CHEMBL218203,CHEMBL217,Dopamine D2 receptor,Ki,=,457.09,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1ccc2ccccc2c1
CHEMBL210955,CHEMBL217,Dopamine D2 receptor,Ki,=,2884.03,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,Clc1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1
CHEMBL210405,CHEMBL217,Dopamine D2 receptor,Ki,=,141.25,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1
CHEMBL210404,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(Cc2cnn(-c3ccccn3)c2)CC1
CHEMBL425057,CHEMBL217,Dopamine D2 receptor,Ki,=,338.84,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,c1ccc(N2CCN(Cc3cnn(-c4ccccn4)c3)CC2)cc1
CHEMBL310843,CHEMBL217,Dopamine D2 receptor,Ki,=,3388.44,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1
CHEMBL160952,CHEMBL217,Dopamine D2 receptor,Ki,=,3715.35,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,C#Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12
CHEMBL423247,CHEMBL217,Dopamine D2 receptor,Ki,=,4897.79,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12
CHEMBL218787,CHEMBL217,Dopamine D2 receptor,Ki,=,7585.78,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,Clc1ccc(N2CCN(Cc3cnn4c(I)cccc34)CC2)cc1
CHEMBL345357,CHEMBL217,Dopamine D2 receptor,Ki,=,27542.29,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,OCc1ccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn2c1
CHEMBL7927,CHEMBL217,Dopamine D2 receptor,Ki,=,2818.38,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL344677,CHEMBL217,Dopamine D2 receptor,Ki,=,151.36,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccc3ccnn23)CC1
CHEMBL342060,CHEMBL217,Dopamine D2 receptor,Ki,=,190.55,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccn3nccc3c2)CC1
CHEMBL143352,CHEMBL217,Dopamine D2 receptor,Ki,=,269.15,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccn3nccc23)CC1
CHEMBL139600,CHEMBL217,Dopamine D2 receptor,Ki,=,30.2,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL141845,CHEMBL217,Dopamine D2 receptor,Ki,=,288.4,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCNC(=O)c2cnn3ccccc23)CC1
CHEMBL140968,CHEMBL217,Dopamine D2 receptor,Ki,=,70.79,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL142020,CHEMBL217,Dopamine D2 receptor,Ki,=,309.03,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL357684,CHEMBL217,Dopamine D2 receptor,Ki,=,831.76,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL139722,CHEMBL217,Dopamine D2 receptor,Ki,=,524.81,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL218151,CHEMBL217,Dopamine D2 receptor,Ki,=,338.84,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,N#Cc1ccc2cc(C(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)[nH]c2c1
CHEMBL221129,CHEMBL217,Dopamine D2 receptor,Ki,=,5.248,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,CCCc1c(C(=O)NCCCCCN2CCN(c3ccccc3OC)CC2)nnn1Cc1ccccc1Br
CHEMBL386986,CHEMBL217,Dopamine D2 receptor,Ki,=,21.88,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,CCCc1c(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)nnn1Cc1ccccc1Br
CHEMBL217981,CHEMBL217,Dopamine D2 receptor,Ki,=,4.898,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2nnn(Cc3ccccc3Br)c2C)CC1
CHEMBL385289,CHEMBL217,Dopamine D2 receptor,Ki,=,61.66,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2nnn(Cc3ccccc3Br)c2C)CC1
CHEMBL218351,CHEMBL217,Dopamine D2 receptor,Ki,=,42.66,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,CCCc1c(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)nnn1Cc1ccc(OC)cc1
CHEMBL220754,CHEMBL217,Dopamine D2 receptor,Ki,=,16.98,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccc(Cn2nnc(C(=O)NCCCCCN3CCN(c4ccccc4OC)CC3)c2C)cc1
CHEMBL221866,CHEMBL217,Dopamine D2 receptor,Ki,=,9.12,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccc(Cn2nnc(C(=O)NCCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)c2C)cc1
CHEMBL437525,CHEMBL217,Dopamine D2 receptor,Ki,=,54.95,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccc(Cn2nnc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2C)cc1
CHEMBL218607,CHEMBL217,Dopamine D2 receptor,Ki,=,57.54,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,CCCc1c(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)nnn1Cc1ccccc1
CHEMBL425285,CHEMBL217,Dopamine D2 receptor,Ki,=,14.13,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,CCCc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nnn1Cc1ccccc1
CHEMBL221587,CHEMBL217,Dopamine D2 receptor,Ki,=,9.333,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2nnn(Cc3ccccc3)c2C)CC1
CHEMBL221897,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,Cc1c(C(=O)NCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nnn1Cc1ccccc1
CHEMBL221843,CHEMBL217,Dopamine D2 receptor,Ki,=,229.09,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2nnn(Cc3ccccc3)c2C)CC1
CHEMBL373873,CHEMBL217,Dopamine D2 receptor,Ki,=,38.9,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,Cc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nnn1Cc1ccccc1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,1.82,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.122,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,53703.18,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL221814,CHEMBL217,Dopamine D2 receptor,Ki,=,218.78,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,c1ccc(C2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1
CHEMBL221600,CHEMBL217,Dopamine D2 receptor,Ki,=,38.02,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,c1ccc(C2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1
CHEMBL377200,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,Cc1c(CN2CCN(c3ccccc3)CC2)cnn1-c1ccccc1
CHEMBL208018,CHEMBL217,Dopamine D2 receptor,Ki,=,70.79,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,Cc1nn(-c2ccccc2)cc1CN1CCN(c2ccccc2)CC1
CHEMBL210717,CHEMBL217,Dopamine D2 receptor,Ki,=,63.1,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,Fc1ccccc1N1CCN(Cc2cnn(-c3ccccc3)c2)CC1
CHEMBL437490,CHEMBL217,Dopamine D2 receptor,Ki,=,446.68,nM,CHEMBL913685,B,Binding affinity to dopamine D2,CHEMBL1141401,KI,Fc1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1
CHEMBL231326,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CNC3)cc1
CHEMBL231350,CHEMBL217,Dopamine D2 receptor,Ki,=,50.12,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,CC(C)Nc1cc2c(cc1NS(=O)(=O)c1ccc(-c3ccc(Cl)cc3)cc1)CCN(C)CC2
CHEMBL231349,CHEMBL217,Dopamine D2 receptor,Ki,=,6.31,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,CC(C)Oc1cc2c(cc1NS(=O)(=O)c1ccc(-c3ccc(Cl)cc3)cc1)CCN(C)CC2
CHEMBL231249,CHEMBL217,Dopamine D2 receptor,Ki,=,3.981,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,COc1cc2c(cc1NS(=O)(=O)c1ccc(-c3ccc(Cl)cc3)cc1)CCN(C)CC2
CHEMBL231648,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,CN1CCc2cc(Cl)c(NS(=O)(=O)c3ccc(-c4ccc(Cl)cc4)cc3)cc2CC1
CHEMBL231546,CHEMBL217,Dopamine D2 receptor,Ki,=,63.1,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,CN1CCc2cc(Br)c(NS(=O)(=O)c3ccc(-c4ccc(Cl)cc4)cc3)cc2CC1
CHEMBL397476,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,CC(C)c1cc2c(cc1NS(=O)(=O)c1ccc(-c3ccc(Cl)cc3)cc1)CCN(C)CC2
CHEMBL395525,CHEMBL217,Dopamine D2 receptor,Ki,=,15.85,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,Cc1cc2c(cc1NS(=O)(=O)c1ccc(-c3ccc(Cl)cc3)cc1)CCN(C)CC2
CHEMBL230930,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,Cc1noc(C)c1-c1ccc(S(=O)(=O)Nc2ccc3c(c2)CCN(C)CC3)cc1
CHEMBL230070,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,Cc1ccc(-c2ccc(S(=O)(=O)Nc3ccc4c(c3)CCN(C)CC4)cc2)s1
CHEMBL388674,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,CN1CCc2ccc(NS(=O)(=O)c3ccc(-c4ccc(Cl)cc4)s3)cc2CC1
CHEMBL230069,CHEMBL217,Dopamine D2 receptor,Ki,=,31.62,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,Cc1cc(S(=O)(=O)Nc2ccc3c(c2)CCN(C)CC3)ccc1-c1ccc(Cl)cc1
CHEMBL231640,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,CN1CCc2ccc(NS(=O)(=O)c3ccc(-c4ccc(C#N)cc4)cc3)cc2CC1
CHEMBL231431,CHEMBL217,Dopamine D2 receptor,Ki,=,50.12,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,CN1CCc2ccc(NS(=O)(=O)c3ccc(-c4ccc(F)c(Cl)c4)cc3)cc2CC1
CHEMBL231430,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,CN1CCc2ccc(NS(=O)(=O)c3ccc(-c4ccc(Cl)cc4)cc3)cc2CC1
CHEMBL231334,CHEMBL217,Dopamine D2 receptor,Ki,=,31.62,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCN(C)CC3)cc1
CHEMBL266018,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCNCC3)cc1
CHEMBL231333,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CN(C)CC3)cc1
CHEMBL388247,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CNCC3)cc1
CHEMBL395501,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CN(C)C3)cc1
CHEMBL388247,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL905981,B,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,CHEMBL1143778,KI,CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CNCC3)cc1
CHEMBL61248,CHEMBL217,Dopamine D2 receptor,Ki,=,126.0,nM,CHEMBL887349,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor,CHEMBL1144602,KI,COc1cc2ccccc2cc1C(=O)NCC1CCN(Cc2ccccc2)CC1
CHEMBL390129,CHEMBL217,Dopamine D2 receptor,Ki,=,144.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC
CHEMBL390473,CHEMBL217,Dopamine D2 receptor,Ki,=,94.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC
CHEMBL228659,CHEMBL217,Dopamine D2 receptor,Ki,=,178.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC
CHEMBL228658,CHEMBL217,Dopamine D2 receptor,Ki,=,104.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC
CHEMBL228608,CHEMBL217,Dopamine D2 receptor,Ki,=,106.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC
CHEMBL228607,CHEMBL217,Dopamine D2 receptor,Ki,=,88.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC
CHEMBL387833,CHEMBL217,Dopamine D2 receptor,Ki,=,276.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC
CHEMBL228606,CHEMBL217,Dopamine D2 receptor,Ki,=,284.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC
CHEMBL538397,CHEMBL217,Dopamine D2 receptor,Ki,=,201.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC
CHEMBL228554,CHEMBL217,Dopamine D2 receptor,Ki,=,104.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1
CHEMBL387832,CHEMBL217,Dopamine D2 receptor,Ki,=,154.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1
CHEMBL228553,CHEMBL217,Dopamine D2 receptor,Ki,=,129.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1
CHEMBL228496,CHEMBL217,Dopamine D2 receptor,Ki,=,85.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1
CHEMBL228494,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F
CHEMBL228445,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F
CHEMBL390192,CHEMBL217,Dopamine D2 receptor,Ki,=,82.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1
CHEMBL442059,CHEMBL217,Dopamine D2 receptor,Ki,=,69.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1
CHEMBL228390,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2
CHEMBL439197,CHEMBL217,Dopamine D2 receptor,Ki,=,57.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2
CHEMBL228389,CHEMBL217,Dopamine D2 receptor,Ki,=,83.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC
CHEMBL228334,CHEMBL217,Dopamine D2 receptor,Ki,=,111.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC
CHEMBL228333,CHEMBL217,Dopamine D2 receptor,Ki,=,71.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2
CHEMBL389104,CHEMBL217,Dopamine D2 receptor,Ki,=,66.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2
CHEMBL228332,CHEMBL217,Dopamine D2 receptor,Ki,=,159.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F
CHEMBL228280,CHEMBL217,Dopamine D2 receptor,Ki,=,187.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F
CHEMBL228279,CHEMBL217,Dopamine D2 receptor,Ki,=,154.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1
CHEMBL388897,CHEMBL217,Dopamine D2 receptor,Ki,=,129.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1
CHEMBL228278,CHEMBL217,Dopamine D2 receptor,Ki,=,133.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC
CHEMBL229085,CHEMBL217,Dopamine D2 receptor,Ki,=,144.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC
CHEMBL229084,CHEMBL217,Dopamine D2 receptor,Ki,=,79.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,CC(C)Oc1ccccc1C1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1
CHEMBL390184,CHEMBL217,Dopamine D2 receptor,Ki,=,79.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,CC(C)Oc1ccccc1C1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1
CHEMBL388361,CHEMBL217,Dopamine D2 receptor,Ki,=,55.0,nM,CHEMBL889238,B,Binding affinity for dopamine D2 receptor,CHEMBL1145372,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC
CHEMBL185271,CHEMBL217,Dopamine D2 receptor,Ki,=,2800.0,nM,CHEMBL894444,B,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,CHEMBL1148741,KI,COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(c3cccc(NC(C)=O)c3)CC2)C(=O)N1
CHEMBL244372,CHEMBL217,Dopamine D2 receptor,Ki,=,780.0,nM,CHEMBL894444,B,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,CHEMBL1148741,KI,O=C(Cc1ccccc1)Nc1cccc(C2CCN(CCCC(=O)c3ccc(Cl)cc3)CC2)c1
CHEMBL394569,CHEMBL217,Dopamine D2 receptor,Ki,=,610.0,nM,CHEMBL894444,B,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,CHEMBL1148741,KI,CC(C)C(=O)Nc1cccc(C2CCN(CCCC(=O)c3ccc(Cl)cc3)CC2)c1
CHEMBL244004,CHEMBL217,Dopamine D2 receptor,Ki,=,6100.0,nM,CHEMBL894444,B,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,CHEMBL1148741,KI,CC(=O)Nc1cccc(C2CCN(CCCC(=O)c3ccc(C)c(C)c3)CC2)c1
CHEMBL243794,CHEMBL217,Dopamine D2 receptor,Ki,=,1400.0,nM,CHEMBL894444,B,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,CHEMBL1148741,KI,CC(=O)Nc1cccc(C2CCN(CCCC(=O)c3ccc(Cl)cc3)CC2)c1
CHEMBL363548,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL894444,B,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,CHEMBL1148741,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(Cl)cc1
CHEMBL242004,CHEMBL217,Dopamine D2 receptor,Ki,=,7400.0,nM,CHEMBL894444,B,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,CHEMBL1148741,KI,Cc1ccc(NC(=O)C(C)C)cc1C1CCN(Cc2ccc(Oc3ccc(F)c(F)c3)cc2)CC1
CHEMBL242003,CHEMBL217,Dopamine D2 receptor,Ki,=,400.0,nM,CHEMBL894444,B,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,CHEMBL1148741,KI,Cc1ccc(C2CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC2)cc1NC(=O)C(C)C
CHEMBL245231,CHEMBL217,Dopamine D2 receptor,Ki,=,470.0,nM,CHEMBL894444,B,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,CHEMBL1148741,KI,CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC2)c1
CHEMBL389129,CHEMBL217,Dopamine D2 receptor,Ki,=,2900.0,nM,CHEMBL894444,B,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,CHEMBL1148741,KI,CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(Cl)c(Cl)c4)cc3)CC2)c1
CHEMBL245229,CHEMBL217,Dopamine D2 receptor,Ki,=,1400.0,nM,CHEMBL894444,B,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,CHEMBL1148741,KI,COc1ccc(Oc2ccc(CN3CCC(c4cccc(NC(=O)C(C)C)c4)CC3)cc2)cc1
CHEMBL245010,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL894444,B,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,CHEMBL1148741,KI,CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(Cl)cc4)cc3)CC2)c1
CHEMBL389128,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL894444,B,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,CHEMBL1148741,KI,CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)c1
CHEMBL390212,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL894444,B,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,CHEMBL1148741,KI,COc1ccc(Oc2cccc(CN3CCC(c4cccc(NC(=O)C(C)C)c4)CC3)c2)cc1
CHEMBL244374,CHEMBL217,Dopamine D2 receptor,Ki,=,1300.0,nM,CHEMBL894444,B,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,CHEMBL1148741,KI,Cc1ccc(Oc2cccc(CN3CCC(c4cccc(NC(=O)C(C)C)c4)CC3)c2)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL244577,CHEMBL217,Dopamine D2 receptor,Ki,=,292.0,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,O=C(CCCCCN1CCN(c2ccccc2F)CC1)NC1CCCc2ccccc21
CHEMBL244161,CHEMBL217,Dopamine D2 receptor,Ki,=,107.0,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,CNc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1
CHEMBL243955,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,CN(C)c1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1
CHEMBL243954,CHEMBL217,Dopamine D2 receptor,Ki,=,224.0,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NC1CCCc2ccccc21
CHEMBL243744,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,CC(C)c1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1
CHEMBL243743,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,CCCCc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1
CHEMBL243742,CHEMBL217,Dopamine D2 receptor,Ki,=,123.0,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,CCCc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1
CHEMBL243523,CHEMBL217,Dopamine D2 receptor,Ki,=,173.0,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,CCc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1
CHEMBL230872,CHEMBL217,Dopamine D2 receptor,Ki,=,49.0,nM,CHEMBL895394,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,CHEMBL1148812,KI,COc1ccccc1N1CCN(CCCOc2ccc(-c3cn4ccccc4n3)cc2)CC1
CHEMBL394863,CHEMBL217,Dopamine D2 receptor,Ki,=,1050.0,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,O=C(NC[C@H]1C[C@H]1CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL231156,CHEMBL217,Dopamine D2 receptor,Ki,=,53.7,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,O=C(NC[C@H]1C[C@@H]1CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL231055,CHEMBL217,Dopamine D2 receptor,Ki,=,68.4,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,COc1ccccc1N1CCN(CCC(O)CNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1
CHEMBL394862,CHEMBL217,Dopamine D2 receptor,Ki,=,84.0,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,O=C(NCC(O)CCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL390253,CHEMBL217,Dopamine D2 receptor,Ki,=,28.4,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,O=C(NCC(O)CCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL242434,CHEMBL217,Dopamine D2 receptor,Ki,=,134.0,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,CC(=O)OC(CCNC(=O)c1ccc(-c2ccccn2)cc1)CN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL242218,CHEMBL217,Dopamine D2 receptor,Ki,=,249.0,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,COc1ccccc1N1CCN(CC(O)CCNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1
CHEMBL242644,CHEMBL217,Dopamine D2 receptor,Ki,=,284.0,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,COc1ccccc1N1CCN(CC(O)CCNC(=O)c2ccc(-c3ccccn3)cc2)CC1
CHEMBL396024,CHEMBL217,Dopamine D2 receptor,Ki,=,319.0,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL244990,CHEMBL217,Dopamine D2 receptor,Ki,=,267.0,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL244989,CHEMBL217,Dopamine D2 receptor,Ki,=,48.4,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1
CHEMBL394541,CHEMBL217,Dopamine D2 receptor,Ki,=,69.0,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc(-c3ccccn3)cc2)CC1
CHEMBL244775,CHEMBL217,Dopamine D2 receptor,Ki,=,1160.0,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,O=C(NC/C=C/C[N+]1([O-])CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL244774,CHEMBL217,Dopamine D2 receptor,Ki,=,25.8,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc[n+]2[O-])cc1
CHEMBL244773,CHEMBL217,Dopamine D2 receptor,Ki,=,92.0,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,Cc1cccnc1-c1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1
CHEMBL398175,CHEMBL217,Dopamine D2 receptor,Ki,=,105.0,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,Cc1cccc(-c2ccc(C(=O)NC/C=C/CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2)n1
CHEMBL244562,CHEMBL217,Dopamine D2 receptor,Ki,=,23.6,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc(=O)[nH]2)cc1
CHEMBL241973,CHEMBL217,Dopamine D2 receptor,Ki,=,28.3,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccccn3)cc2)CC1
CHEMBL110365,CHEMBL217,Dopamine D2 receptor,Ki,=,55.4,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1
CHEMBL180010,CHEMBL217,Dopamine D2 receptor,Ki,=,93.3,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL304605,CHEMBL217,Dopamine D2 receptor,Ki,=,168.0,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL69451,CHEMBL217,Dopamine D2 receptor,Ki,=,24.8,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL300780,CHEMBL217,Dopamine D2 receptor,Ki,=,112.0,nM,CHEMBL895648,B,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1148745,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,2.6,nM,CHEMBL895394,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,CHEMBL1148812,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL230218,CHEMBL217,Dopamine D2 receptor,Ki,=,560.0,nM,CHEMBL895394,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,CHEMBL1148812,KI,Cc1cccn2cc(-c3ccc(OCCCCN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)nc12
CHEMBL231057,CHEMBL217,Dopamine D2 receptor,Ki,=,159.0,nM,CHEMBL895394,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,CHEMBL1148812,KI,COc1ccccc1N1CCN(CCCCOc2ccc(-c3cn4cccc(C)c4n3)cc2)CC1
CHEMBL231260,CHEMBL217,Dopamine D2 receptor,Ki,=,111.0,nM,CHEMBL895394,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,CHEMBL1148812,KI,Cc1ccn2cc(-c3ccc(OCCCCN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)nc2c1
CHEMBL231158,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL895394,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,CHEMBL1148812,KI,COc1ccccc1N1CCN(CCCCOc2ccc(-c3cn4ccc(C)cc4n3)cc2)CC1
CHEMBL231183,CHEMBL217,Dopamine D2 receptor,Ki,=,149.0,nM,CHEMBL895394,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,CHEMBL1148812,KI,Cc1ccc2nc(-c3ccc(OCCCCN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)cn2c1
CHEMBL231182,CHEMBL217,Dopamine D2 receptor,Ki,=,47.0,nM,CHEMBL895394,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,CHEMBL1148812,KI,COc1ccccc1N1CCN(CCCCOc2ccc(-c3cn4cc(C)ccc4n3)cc2)CC1
CHEMBL387784,CHEMBL217,Dopamine D2 receptor,Ki,=,68.0,nM,CHEMBL895394,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,CHEMBL1148812,KI,Clc1cccc(N2CCN(CCCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)c1Cl
CHEMBL231181,CHEMBL217,Dopamine D2 receptor,Ki,=,179.0,nM,CHEMBL895394,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,CHEMBL1148812,KI,COc1ccccc1N1CCN(CCCCOc2ccc(-c3cn4ccccc4n3)cc2)CC1
CHEMBL231080,CHEMBL217,Dopamine D2 receptor,Ki,=,125.0,nM,CHEMBL895394,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,CHEMBL1148812,KI,Cc1cccn2cc(-c3ccc(OCCCN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)nc12
CHEMBL387569,CHEMBL217,Dopamine D2 receptor,Ki,=,49.0,nM,CHEMBL895394,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,CHEMBL1148812,KI,COc1ccccc1N1CCN(CCCOc2ccc(-c3cn4cccc(C)c4n3)cc2)CC1
CHEMBL231079,CHEMBL217,Dopamine D2 receptor,Ki,=,83.0,nM,CHEMBL895394,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,CHEMBL1148812,KI,Cc1ccn2cc(-c3ccc(OCCCN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)nc2c1
CHEMBL231078,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL895394,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,CHEMBL1148812,KI,COc1ccccc1N1CCN(CCCOc2ccc(-c3cn4ccc(C)cc4n3)cc2)CC1
CHEMBL230972,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL895394,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,CHEMBL1148812,KI,COc1ccccc1N1CCN(CCCOc2ccc(-c3cn4cc(C)ccc4n3)cc2)CC1
CHEMBL230971,CHEMBL217,Dopamine D2 receptor,Ki,=,44.0,nM,CHEMBL895394,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,CHEMBL1148812,KI,Clc1cccc(N2CCN(CCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)c1Cl
CHEMBL389356,CHEMBL217,Dopamine D2 receptor,Ki,=,518.0,nM,CHEMBL895724,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1148752,KI,CN1CCCc2cc(O)ccc2Cc2ccccc2CC1
CHEMBL397207,CHEMBL217,Dopamine D2 receptor,Ki,=,1028.0,nM,CHEMBL895724,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1148752,KI,COc1cc2c(cc1OC)Cc1ccccc1CCCN(C)CC2
CHEMBL394779,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL895724,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1148752,KI,CN1CCCc2ccccc2Cc2cc(O)ccc2CC1
CHEMBL231374,CHEMBL217,Dopamine D2 receptor,Ki,=,1396.0,nM,CHEMBL895724,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1148752,KI,COc1ccc2c(c1)Cc1ccccc1CCCN(C)CC2
CHEMBL396950,CHEMBL217,Dopamine D2 receptor,Ki,=,857.0,nM,CHEMBL895724,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1148752,KI,Oc1ccc2c(c1)CCCNCCc1ccccc1C2
CHEMBL231171,CHEMBL217,Dopamine D2 receptor,Ki,=,172.0,nM,CHEMBL895724,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1148752,KI,COc1ccc2c(c1)CCCN(C)CCCc1ccccc1C2
CHEMBL389559,CHEMBL217,Dopamine D2 receptor,Ki,=,382.0,nM,CHEMBL895724,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1148752,KI,CN1CCCc2ccccc2Cc2ccc(O)cc2CCC1
CHEMBL276778,CHEMBL217,Dopamine D2 receptor,Ki,=,87.0,nM,CHEMBL895724,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1148752,KI,COc1ccc2c(c1)CCN(C)CCCc1ccccc1C2
CHEMBL231070,CHEMBL217,Dopamine D2 receptor,Ki,=,74.0,nM,CHEMBL895724,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1148752,KI,CN1CCCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL389357,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL895724,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1148752,KI,COc1ccc2c(c1)CCCN(C)CCc1ccccc1C2
CHEMBL222188,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21
CHEMBL222477,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,O=C(CCCCCN1CCN(c2ccccc2Cl)CC1)NC1CCCc2ccccc21
CHEMBL225571,CHEMBL217,Dopamine D2 receptor,Ki,=,681.0,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,O=C(CCCCCN1CCN(c2ccccc2[N+](=O)[O-])CC1)NC1CCCc2ccccc21
CHEMBL221513,CHEMBL217,Dopamine D2 receptor,Ki,=,265.0,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,N#Cc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1
CHEMBL225512,CHEMBL217,Dopamine D2 receptor,Ki,=,987.0,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,O=C(CCCCCN1CCN(c2ccccc2O)CC1)NC1CCCc2ccccc21
CHEMBL389718,CHEMBL217,Dopamine D2 receptor,Ki,=,68.0,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,CC(=O)c1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1
CHEMBL222755,CHEMBL217,Dopamine D2 receptor,Ki,=,143.0,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,Cc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1
CHEMBL224820,CHEMBL217,Dopamine D2 receptor,Ki,=,26.4,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,COc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1
CHEMBL225284,CHEMBL217,Dopamine D2 receptor,Ki,=,7.3,nM,CHEMBL894060,B,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,CHEMBL1148718,KI,CSc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1
CHEMBL131495,CHEMBL217,Dopamine D2 receptor,Ki,=,3.162,nM,CHEMBL895618,B,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,CHEMBL1148822,KI,O=C1c2ccccc2C(=O)N1CCCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1
CHEMBL243712,CHEMBL217,Dopamine D2 receptor,Ki,=,12.59,nM,CHEMBL895618,B,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,CHEMBL1148822,KI,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC
CHEMBL708,CHEMBL217,Dopamine D2 receptor,Ki,=,12.59,nM,CHEMBL895618,B,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,CHEMBL1148822,KI,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,6.31,nM,CHEMBL895618,B,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,CHEMBL1148822,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,5.012,nM,CHEMBL895618,B,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,CHEMBL1148822,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,19.95,nM,CHEMBL895618,B,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,CHEMBL1148822,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL895618,B,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,CHEMBL1148822,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,5.012,nM,CHEMBL895618,B,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,CHEMBL1148822,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL71,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL895618,B,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,CHEMBL1148822,KI,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL196514,CHEMBL217,Dopamine D2 receptor,Ki,=,0.7943,nM,CHEMBL895618,B,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,CHEMBL1148822,KI,C[C@H]1Oc2c(cccc2N2CCN(CCCc3c[nH]c4ccc(F)cc34)CC2)NC1=O
CHEMBL221692,CHEMBL217,Dopamine D2 receptor,Ki,=,3.981,nM,CHEMBL895618,B,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,CHEMBL1148822,KI,Fc1ccc(-c2cncc(CN3CCN(c4cccc5c4OCCO5)CC3)c2)cc1
CHEMBL243012,CHEMBL217,Dopamine D2 receptor,Ki,=,80.0,nM,CHEMBL892631,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cells,CHEMBL1147208,KI,COc1ccc(C2=NO[C@H](CCCN3CCN(C(c4ccc(F)cc4)c4ccc(F)cc4)CC3)C2)cc1OC
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,3.3,nM,CHEMBL892631,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cells,CHEMBL1147208,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL243225,CHEMBL217,Dopamine D2 receptor,Ki,=,70.0,nM,CHEMBL892631,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cells,CHEMBL1147208,KI,CCOc1ccccc1N1CCN(CCC[C@H]2CC(c3ccc(OC)c(OC)c3)=NO2)CC1
CHEMBL243224,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL892631,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cells,CHEMBL1147208,KI,CCOc1ccccc1N1CCN(CCC[C@@H]2CC(c3ccc(OC)c(OC)c3)=NO2)CC1
CHEMBL390181,CHEMBL217,Dopamine D2 receptor,Ki,=,400.0,nM,CHEMBL892631,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cells,CHEMBL1147208,KI,COc1ccc(C2=NO[C@@H](CCCN3CCN(C(c4ccc(F)cc4)c4ccc(F)cc4)CC3)C2)cc1OC
CHEMBL244946,CHEMBL217,Dopamine D2 receptor,Ki,=,9549.93,nM,CHEMBL895485,B,Binding affinity to human recombinant dopamine D2,CHEMBL1148818,KI,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1
CHEMBL391107,CHEMBL217,Dopamine D2 receptor,Ki,=,191.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3)CC2)CC1
CHEMBL233790,CHEMBL217,Dopamine D2 receptor,Ki,=,80.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1
CHEMBL232609,CHEMBL217,Dopamine D2 receptor,Ki,=,61.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1
CHEMBL391017,CHEMBL217,Dopamine D2 receptor,Ki,=,43.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccncc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL232607,CHEMBL217,Dopamine D2 receptor,Ki,=,92.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccncc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL391016,CHEMBL217,Dopamine D2 receptor,Ki,=,55.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccnc3)CC2)CC1
CHEMBL234854,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccnc3)CC2)CC1
CHEMBL234650,CHEMBL217,Dopamine D2 receptor,Ki,=,71.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)Cc3ccccc3)CC2)CC1
CHEMBL234649,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)Cc3ccccc3)CC2)CC1
CHEMBL234476,CHEMBL217,Dopamine D2 receptor,Ki,=,425.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,O=S(=O)(N[C@H]1CC[C@@H](N2CCN(c3ccccc3OCC3CC3)CC2)CC1)c1cc(Cl)ccc1F
CHEMBL234474,CHEMBL217,Dopamine D2 receptor,Ki,=,588.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OCC3CC3)CC2)CC1
CHEMBL233584,CHEMBL217,Dopamine D2 receptor,Ki,=,123.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OCC4CC4)CC3)CC2)cc1OC
CHEMBL394139,CHEMBL217,Dopamine D2 receptor,Ki,=,356.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cc(Cl)ccc3F)CC2)CC1
CHEMBL233816,CHEMBL217,Dopamine D2 receptor,Ki,=,259.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL391530,CHEMBL217,Dopamine D2 receptor,Ki,=,810.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC
CHEMBL233582,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1
CHEMBL233410,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1
CHEMBL393105,CHEMBL217,Dopamine D2 receptor,Ki,=,271.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1
CHEMBL233407,CHEMBL217,Dopamine D2 receptor,Ki,=,198.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1
CHEMBL393104,CHEMBL217,Dopamine D2 receptor,Ki,=,76.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1
CHEMBL391035,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1
CHEMBL234609,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,Cc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl
CHEMBL234423,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl
CHEMBL234422,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL429623,CHEMBL217,Dopamine D2 receptor,Ki,=,45.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL234232,CHEMBL217,Dopamine D2 receptor,Ki,=,1.9,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(C(F)(F)F)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL234231,CHEMBL217,Dopamine D2 receptor,Ki,=,194.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(C(F)(F)F)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL429076,CHEMBL217,Dopamine D2 receptor,Ki,=,36.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(Br)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL233849,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(Br)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL234607,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL233816,CHEMBL217,Dopamine D2 receptor,Ki,=,101.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL392066,CHEMBL217,Dopamine D2 receptor,Ki,=,139.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(F)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL233814,CHEMBL217,Dopamine D2 receptor,Ki,=,173.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(F)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL233623,CHEMBL217,Dopamine D2 receptor,Ki,=,50.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(C)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL393725,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(C)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL234194,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(OC)c(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1
CHEMBL236832,CHEMBL217,Dopamine D2 receptor,Ki,=,81.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(OC)c(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1
CHEMBL236621,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC
CHEMBL391530,CHEMBL217,Dopamine D2 receptor,Ki,=,94.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC
CHEMBL392377,CHEMBL217,Dopamine D2 receptor,Ki,=,58.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1
CHEMBL236830,CHEMBL217,Dopamine D2 receptor,Ki,=,430.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1
CHEMBL236618,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1
CHEMBL236617,CHEMBL217,Dopamine D2 receptor,Ki,=,122.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1
CHEMBL428197,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(F)cc3)CC2)CC1
CHEMBL234874,CHEMBL217,Dopamine D2 receptor,Ki,=,69.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(F)cc3)CC2)CC1
CHEMBL233416,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1
CHEMBL233592,CHEMBL217,Dopamine D2 receptor,Ki,=,118.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1
CHEMBL232780,CHEMBL217,Dopamine D2 receptor,Ki,=,64.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(F)c3)CC2)CC1
CHEMBL232779,CHEMBL217,Dopamine D2 receptor,Ki,=,74.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(F)c3)CC2)CC1
CHEMBL232593,CHEMBL217,Dopamine D2 receptor,Ki,=,86.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1
CHEMBL232592,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1
CHEMBL234681,CHEMBL217,Dopamine D2 receptor,Ki,=,31.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3F)CC2)CC1
CHEMBL399195,CHEMBL217,Dopamine D2 receptor,Ki,=,149.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3F)CC2)CC1
CHEMBL234680,CHEMBL217,Dopamine D2 receptor,Ki,=,2.4,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3C#N)CC2)CC1
CHEMBL234679,CHEMBL217,Dopamine D2 receptor,Ki,=,55.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3C#N)CC2)CC1
CHEMBL234669,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL894519,B,Binding affinity to human dopamine D2 receptor,CHEMBL1148021,KI,CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3)CC2)CC1
CHEMBL394110,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL898619,B,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,CHEMBL1149628,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1
CHEMBL393492,CHEMBL217,Dopamine D2 receptor,Ki,=,319.0,nM,CHEMBL898619,B,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,CHEMBL1149628,KI,COc1ccccc1N1CCN(CCCCN2Cc3ccccc3C2=O)CC1
CHEMBL240996,CHEMBL217,Dopamine D2 receptor,Ki,=,387.0,nM,CHEMBL898619,B,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,CHEMBL1149628,KI,O=C1c2ccccc2CN1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1
CHEMBL240995,CHEMBL217,Dopamine D2 receptor,Ki,=,760.0,nM,CHEMBL898619,B,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,CHEMBL1149628,KI,O=C1c2ccccc2CN1CCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL240774,CHEMBL217,Dopamine D2 receptor,Ki,=,189.0,nM,CHEMBL898619,B,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,CHEMBL1149628,KI,O=C1c2ccccc2CN1CCCCN1CCN(c2ccccc2)CC1
CHEMBL394080,CHEMBL217,Dopamine D2 receptor,Ki,=,405.0,nM,CHEMBL898619,B,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,CHEMBL1149628,KI,COc1ccccc1N1CCN(CCCCN2C(=O)Cc3ccccc32)CC1
CHEMBL268371,CHEMBL217,Dopamine D2 receptor,Ki,=,323.0,nM,CHEMBL898619,B,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,CHEMBL1149628,KI,O=C1Cc2ccccc2N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1
CHEMBL239917,CHEMBL217,Dopamine D2 receptor,Ki,=,1747.0,nM,CHEMBL898619,B,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,CHEMBL1149628,KI,O=C1Cc2ccccc2N1CCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL395933,CHEMBL217,Dopamine D2 receptor,Ki,=,162.0,nM,CHEMBL898619,B,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,CHEMBL1149628,KI,O=C1Cc2ccccc2N1CCCCN1CCN(c2ccccc2)CC1
CHEMBL239700,CHEMBL217,Dopamine D2 receptor,Ki,=,184.0,nM,CHEMBL898619,B,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,CHEMBL1149628,KI,COc1ccccc1N1CCN(CCCCn2cnc3ccccc3c2=O)CC1
CHEMBL398813,CHEMBL217,Dopamine D2 receptor,Ki,=,73.0,nM,CHEMBL898619,B,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,CHEMBL1149628,KI,O=c1c2ccccc2ncn1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1
CHEMBL238718,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL898619,B,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,CHEMBL1149628,KI,O=c1c2ccccc2ncn1CCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL238717,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL898619,B,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,CHEMBL1149628,KI,O=c1c2ccccc2ncn1CCCCN1CCN(c2ccccc2)CC1
CHEMBL238917,CHEMBL217,Dopamine D2 receptor,Ki,=,360.0,nM,CHEMBL898619,B,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,CHEMBL1149628,KI,COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1
CHEMBL238916,CHEMBL217,Dopamine D2 receptor,Ki,=,113.0,nM,CHEMBL898619,B,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,CHEMBL1149628,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1
CHEMBL238915,CHEMBL217,Dopamine D2 receptor,Ki,=,177.0,nM,CHEMBL898619,B,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,CHEMBL1149628,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL240377,CHEMBL217,Dopamine D2 receptor,Ki,=,598.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C1c2ccccc2C(=O)N1CCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1
CHEMBL240589,CHEMBL217,Dopamine D2 receptor,Ki,=,1272.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(/C=C/c1ccccc1)NCCCCN1CCc2ccccc2C1
CHEMBL25236,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL241225,CHEMBL217,Dopamine D2 receptor,Ki,=,163.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,COc1ccccc1NC1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL392791,CHEMBL217,Dopamine D2 receptor,Ki,=,2288.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,COc1ccccc1NC1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1
CHEMBL241018,CHEMBL217,Dopamine D2 receptor,Ki,=,4620.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,COc1ccccc1N(C(=O)c1ccccc1)C1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL238875,CHEMBL217,Dopamine D2 receptor,Ki,=,13350.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,COc1ccccc1N(C(C)=O)C1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL392579,CHEMBL217,Dopamine D2 receptor,Ki,=,1570.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCC(N(Cc2ccccc2)c2ccccc2)CC1)c1cc2ccccc2s1
CHEMBL239923,CHEMBL217,Dopamine D2 receptor,Ki,=,703.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCC(N(Cc2ccccc2)c2ccccc2)CC1)c1ccc2ccccc2c1
CHEMBL239708,CHEMBL217,Dopamine D2 receptor,Ki,=,128.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C1c2ccccc2C(=O)N1CCCCN1CCC(N(Cc2ccccc2)c2ccccc2)CC1
CHEMBL239706,CHEMBL217,Dopamine D2 receptor,Ki,=,849.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1)c1cc2ccccc2s1
CHEMBL239493,CHEMBL217,Dopamine D2 receptor,Ki,=,252.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1)c1ccc2ccccc2c1
CHEMBL393775,CHEMBL217,Dopamine D2 receptor,Ki,=,1149.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C1Cc2ccccc2C(=C2CCN(CCCCN3C(=O)c4ccccc4C3=O)CC2)c2ccsc21
CHEMBL239067,CHEMBL217,Dopamine D2 receptor,Ki,=,258.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCN2c3ccccc3Cc3ccccc3C2C1)C1CCCCC1
CHEMBL239066,CHEMBL217,Dopamine D2 receptor,Ki,=,497.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCN2c3ccccc3Cc3ccccc3C2C1)c1cccs1
CHEMBL393774,CHEMBL217,Dopamine D2 receptor,Ki,=,4925.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCN2c3ccccc3Cc3ccccc3C2C1)c1cc2ccccc2s1
CHEMBL239065,CHEMBL217,Dopamine D2 receptor,Ki,=,429.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(/C=C/c1ccccc1)NCCCCN1CCN2c3ccccc3Cc3ccccc3C2C1
CHEMBL238859,CHEMBL217,Dopamine D2 receptor,Ki,=,1324.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCN2c3ccccc3Cc3ccccc3C2C1)c1ccc2ccccc2c1
CHEMBL238858,CHEMBL217,Dopamine D2 receptor,Ki,=,808.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C1c2ccccc2C(=O)N1CCCCN1CCN2c3ccccc3Cc3ccccc3C2C1
CHEMBL391120,CHEMBL217,Dopamine D2 receptor,Ki,=,619.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,COc1ccccc1C(c1ccccc1OC)N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL240564,CHEMBL217,Dopamine D2 receptor,Ki,=,972.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,COc1ccccc1C(c1ccccc1OC)N1CCN(CCCCNC(=O)/C=C/c2ccccc2)CC1
CHEMBL391895,CHEMBL217,Dopamine D2 receptor,Ki,=,313.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,COc1ccccc1C(c1ccccc1OC)N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL240600,CHEMBL217,Dopamine D2 receptor,Ki,=,626.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,COc1ccccc1C(c1ccccc1)N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL436998,CHEMBL217,Dopamine D2 receptor,Ki,=,663.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCCN(C(c2ccccc2)c2ccccc2)CC1)c1cccs1
CHEMBL401224,CHEMBL217,Dopamine D2 receptor,Ki,=,633.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCCN(C(c2ccccc2)c2ccccc2)CC1)c1cc2ccccc2s1
CHEMBL401223,CHEMBL217,Dopamine D2 receptor,Ki,=,161.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(/C=C/c1ccccc1)NCCCCN1CCCN(C(c2ccccc2)c2ccccc2)CC1
CHEMBL394189,CHEMBL217,Dopamine D2 receptor,Ki,=,136.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCCN(C(c2ccccc2)c2ccccc2)CC1)c1ccc2ccccc2c1
CHEMBL239539,CHEMBL217,Dopamine D2 receptor,Ki,=,189.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1)C1CCCCC1
CHEMBL241660,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1)c1cccs1
CHEMBL241659,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1)c1cc2ccccc2s1
CHEMBL241455,CHEMBL217,Dopamine D2 receptor,Ki,=,963.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(/C=C/c1ccccc1)NCCCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1
CHEMBL394019,CHEMBL217,Dopamine D2 receptor,Ki,=,587.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1)c1ccc2ccccc2c1
CHEMBL429462,CHEMBL217,Dopamine D2 receptor,Ki,=,435.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)C1CCCCC1
CHEMBL241027,CHEMBL217,Dopamine D2 receptor,Ki,=,621.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1cccs1
CHEMBL391057,CHEMBL217,Dopamine D2 receptor,Ki,=,590.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1cc2ccccc2s1
CHEMBL241026,CHEMBL217,Dopamine D2 receptor,Ki,=,652.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(/C=C/c1ccccc1)NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1
CHEMBL240588,CHEMBL217,Dopamine D2 receptor,Ki,=,457.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1ccc2ccccc2c1
CHEMBL240587,CHEMBL217,Dopamine D2 receptor,Ki,=,226.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C1c2ccccc2C(=O)N1CCCCN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1
CHEMBL240379,CHEMBL217,Dopamine D2 receptor,Ki,=,1180.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C1c2ccccc2C(=O)N1CCCCN1CCCN(C(c2ccccc2)c2ccccc2)CC1
CHEMBL240378,CHEMBL217,Dopamine D2 receptor,Ki,=,559.0,nM,CHEMBL897619,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,CHEMBL1137479,KI,O=C1c2ccccc2C(=O)N1CCCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1
CHEMBL241631,CHEMBL217,Dopamine D2 receptor,Ki,=,69.0,nM,CHEMBL898785,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,CHEMBL1137491,KI,C#Cc1ccc(C(=O)NCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1
CHEMBL239733,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL898785,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,CHEMBL1137491,KI,C#Cc1cccc(C(=O)NCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1
CHEMBL393365,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL898785,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,CHEMBL1137491,KI,C#Cc1ccc(C(=O)NCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1
CHEMBL240584,CHEMBL217,Dopamine D2 receptor,Ki,=,31.0,nM,CHEMBL898785,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,CHEMBL1137491,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2cccc(C#Cc3ccccc3)c2)CC1
CHEMBL241436,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL898785,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,CHEMBL1137491,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(C#Cc2ccccc2)c1
CHEMBL392437,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL898785,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,CHEMBL1137491,KI,C#Cc1cccc(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1
CHEMBL241641,CHEMBL217,Dopamine D2 receptor,Ki,=,780.0,nM,CHEMBL898785,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,CHEMBL1137491,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(C#Cc2ccccc2)cc1
CHEMBL394292,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL898785,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,CHEMBL1137491,KI,C#Cc1ccc(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1
CHEMBL391257,CHEMBL217,Dopamine D2 receptor,Ki,=,1200.0,nM,CHEMBL898785,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,CHEMBL1137491,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(C#Cc3ccccc3)c2)CC1
CHEMBL391256,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL898785,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,CHEMBL1137491,KI,C#Cc1cccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL241424,CHEMBL217,Dopamine D2 receptor,Ki,=,1400.0,nM,CHEMBL898785,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,CHEMBL1137491,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(C#Cc3ccccc3)cc2)CC1
CHEMBL241212,CHEMBL217,Dopamine D2 receptor,Ki,=,250.0,nM,CHEMBL898785,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,CHEMBL1137491,KI,C#Cc1ccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL241211,CHEMBL217,Dopamine D2 receptor,Ki,=,1200.0,nM,CHEMBL898785,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,CHEMBL1137491,KI,O=C(NCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(C#Cc2ccccc2)c1
CHEMBL394473,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL898785,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,CHEMBL1137491,KI,C#Cc1cccc(C(=O)NCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1
CHEMBL241210,CHEMBL217,Dopamine D2 receptor,Ki,=,4700.0,nM,CHEMBL898785,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,CHEMBL1137491,KI,O=C(NCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(C#Cc2ccccc2)cc1
CHEMBL241631,CHEMBL217,Dopamine D2 receptor,Ki,=,48.0,nM,CHEMBL898786,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,CHEMBL1137491,KI,C#Cc1ccc(C(=O)NCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1
CHEMBL239733,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL898786,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,CHEMBL1137491,KI,C#Cc1cccc(C(=O)NCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1
CHEMBL393365,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL898786,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,CHEMBL1137491,KI,C#Cc1ccc(C(=O)NCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1
CHEMBL240584,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL898786,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,CHEMBL1137491,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2cccc(C#Cc3ccccc3)c2)CC1
CHEMBL241436,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL898786,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,CHEMBL1137491,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(C#Cc2ccccc2)c1
CHEMBL392437,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL898786,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,CHEMBL1137491,KI,C#Cc1cccc(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1
CHEMBL241641,CHEMBL217,Dopamine D2 receptor,Ki,=,840.0,nM,CHEMBL898786,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,CHEMBL1137491,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(C#Cc2ccccc2)cc1
CHEMBL394292,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL898786,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,CHEMBL1137491,KI,C#Cc1ccc(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1
CHEMBL391257,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL898786,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,CHEMBL1137491,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(C#Cc3ccccc3)c2)CC1
CHEMBL391256,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL898786,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,CHEMBL1137491,KI,C#Cc1cccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL241424,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL898786,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,CHEMBL1137491,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(C#Cc3ccccc3)cc2)CC1
CHEMBL241212,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL898786,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,CHEMBL1137491,KI,C#Cc1ccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL241211,CHEMBL217,Dopamine D2 receptor,Ki,=,1400.0,nM,CHEMBL898786,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,CHEMBL1137491,KI,O=C(NCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(C#Cc2ccccc2)c1
CHEMBL394473,CHEMBL217,Dopamine D2 receptor,Ki,=,83.0,nM,CHEMBL898786,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,CHEMBL1137491,KI,C#Cc1cccc(C(=O)NCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1
CHEMBL241210,CHEMBL217,Dopamine D2 receptor,Ki,=,9900.0,nM,CHEMBL898786,B,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,CHEMBL1137491,KI,O=C(NCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(C#Cc2ccccc2)cc1
CHEMBL391530,CHEMBL217,Dopamine D2 receptor,Ki,=,136.0,nM,CHEMBL900500,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1137555,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC
CHEMBL228389,CHEMBL217,Dopamine D2 receptor,Ki,=,83.0,nM,CHEMBL900500,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1137555,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC
CHEMBL228334,CHEMBL217,Dopamine D2 receptor,Ki,=,112.0,nM,CHEMBL900500,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1137555,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC
CHEMBL238402,CHEMBL217,Dopamine D2 receptor,Ki,=,114.0,nM,CHEMBL900500,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1137555,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC
CHEMBL438673,CHEMBL217,Dopamine D2 receptor,Ki,=,192.0,nM,CHEMBL900500,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1137555,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC
CHEMBL228607,CHEMBL217,Dopamine D2 receptor,Ki,=,88.0,nM,CHEMBL900500,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1137555,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC
CHEMBL387833,CHEMBL217,Dopamine D2 receptor,Ki,=,228.0,nM,CHEMBL900500,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1137555,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC
CHEMBL228606,CHEMBL217,Dopamine D2 receptor,Ki,=,284.0,nM,CHEMBL900500,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1137555,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC
CHEMBL538397,CHEMBL217,Dopamine D2 receptor,Ki,=,330.0,nM,CHEMBL900500,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1137555,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC
CHEMBL228278,CHEMBL217,Dopamine D2 receptor,Ki,=,133.0,nM,CHEMBL900500,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1137555,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC
CHEMBL229085,CHEMBL217,Dopamine D2 receptor,Ki,=,144.0,nM,CHEMBL900500,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1137555,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC
CHEMBL388361,CHEMBL217,Dopamine D2 receptor,Ki,=,55.0,nM,CHEMBL900500,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1137555,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC
CHEMBL390129,CHEMBL217,Dopamine D2 receptor,Ki,=,165.0,nM,CHEMBL900500,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1137555,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC
CHEMBL238401,CHEMBL217,Dopamine D2 receptor,Ki,=,2.7,nM,CHEMBL900500,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1137555,KI,CCN([C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1
CHEMBL429453,CHEMBL217,Dopamine D2 receptor,Ki,=,113.0,nM,CHEMBL900500,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1137555,KI,CCN([C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1
CHEMBL236621,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL900500,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1137555,KI,COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC
CHEMBL392822,CHEMBL217,Dopamine D2 receptor,Ki,=,382.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,OC1(c2ccccc2Cl)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL445102,CHEMBL217,Dopamine D2 receptor,Ki,=,11.2,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL247058,CHEMBL217,Dopamine D2 receptor,Ki,=,5.5,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,COc1ccc2[nH]cc(CN3CCC(O)(c4ccc(SC)cc4)CC3)c2c1
CHEMBL401031,CHEMBL217,Dopamine D2 receptor,Ki,=,23.9,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,CSc1ccc(C2(O)CCN(Cc3c[nH]c4ccccc34)CC2)cc1
CHEMBL246855,CHEMBL217,Dopamine D2 receptor,Ki,=,188.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,CCCCCCn1cc(CN2CCC(O)(c3ccc(Cl)cc3)CC2)c2ccccc21
CHEMBL400827,CHEMBL217,Dopamine D2 receptor,Ki,=,29.6,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,Cn1cc(CN2CCC(O)(c3ccc(Cl)cc3)CC2)c2ccccc21
CHEMBL246854,CHEMBL217,Dopamine D2 receptor,Ki,=,54.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,CSc1ccc(C2(O)CCN(Cc3coc4ccccc34)CC2)cc1
CHEMBL246644,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,OC1(c2ccc(Cl)cc2)CCN(Cc2coc3ccccc23)CC1
CHEMBL246643,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,OC1(c2ccc(Cl)c(Cl)c2)CCN(Cc2coc3ccccc23)CC1
CHEMBL394066,CHEMBL217,Dopamine D2 receptor,Ki,=,548.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,OC1(c2ccc(Cl)cc2)CCN(Cc2n[nH]c3ccccc23)CC1
CHEMBL246642,CHEMBL217,Dopamine D2 receptor,Ki,=,438.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,OC1(c2ccc(Cl)c(Cl)c2)CCN(Cc2n[nH]c3ccccc23)CC1
CHEMBL246439,CHEMBL217,Dopamine D2 receptor,Ki,=,15.4,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,Cc1[nH]c2ccccc2c1CN1CCC(O)(c2ccc(Cl)cc2)CC1
CHEMBL400826,CHEMBL217,Dopamine D2 receptor,Ki,=,165.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,C=CCOC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL246438,CHEMBL217,Dopamine D2 receptor,Ki,=,68.1,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,COC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL246437,CHEMBL217,Dopamine D2 receptor,Ki,=,2370.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,OCC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL399601,CHEMBL217,Dopamine D2 receptor,Ki,=,2000.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,CC(=O)NCC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL399396,CHEMBL217,Dopamine D2 receptor,Ki,=,58.8,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,CCOC(=O)C1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL246231,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,COC(=O)C1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL246230,CHEMBL217,Dopamine D2 receptor,Ki,=,199.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,N#CC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL394065,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,FC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL246021,CHEMBL217,Dopamine D2 receptor,Ki,=,83.1,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,CC(=O)NC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL430198,CHEMBL217,Dopamine D2 receptor,Ki,=,184.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,NC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL246020,CHEMBL217,Dopamine D2 receptor,Ki,=,992.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,CC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL245816,CHEMBL217,Dopamine D2 receptor,Ki,=,4265.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,OC1(c2ccc(Cl)cc2)CCCN(Cc2c[nH]c3ccccc23)C1
CHEMBL245815,CHEMBL217,Dopamine D2 receptor,Ki,=,2890.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,OC1(Cc2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL393027,CHEMBL217,Dopamine D2 receptor,Ki,=,201.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,OC1(c2ccc(Cl)cc2)CCCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL245615,CHEMBL217,Dopamine D2 receptor,Ki,=,98.4,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,OC1(c2ccc(-c3ccccc3)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL398368,CHEMBL217,Dopamine D2 receptor,Ki,=,159.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,CCCCCCOc1ccc(C2(O)CCN(Cc3c[nH]c4ccccc34)CC2)cc1
CHEMBL245614,CHEMBL217,Dopamine D2 receptor,Ki,=,177.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,COc1ccc(C2(O)CCN(Cc3c[nH]c4ccccc34)CC2)cc1
CHEMBL392823,CHEMBL217,Dopamine D2 receptor,Ki,=,5360.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,Oc1ccc(C2(O)CCN(Cc3c[nH]c4ccccc34)CC2)cc1
CHEMBL246849,CHEMBL217,Dopamine D2 receptor,Ki,=,127.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,OC1(c2ccc(F)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL246848,CHEMBL217,Dopamine D2 receptor,Ki,=,106.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,OC1(c2cccc(C(F)(F)F)c2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL246637,CHEMBL217,Dopamine D2 receptor,Ki,=,6.9,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,OC1(c2ccc(Cl)c(Cl)c2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL396092,CHEMBL217,Dopamine D2 receptor,Ki,=,129.0,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,OC1(c2cccc(Cl)c2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL397770,CHEMBL217,Dopamine D2 receptor,Ki,=,26.1,nM,CHEMBL902495,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1138415,KI,OC1(c2cccc(Cl)c2Cl)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL393539,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL885603,B,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,CHEMBL1139046,KI,Cc1ccc2c(OCCN3CCC(Cc4ccc5c(c4F)NC(=O)CO5)CC3)cc(F)cc2n1
CHEMBL238732,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL885603,B,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,CHEMBL1139046,KI,Cc1ccc2c(OCCN3CCC(Cc4cc(F)c5c(c4)NC(=O)CO5)CC3)cc(Cl)cc2n1
CHEMBL391661,CHEMBL217,Dopamine D2 receptor,Ki,=,3162.28,nM,CHEMBL885603,B,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,CHEMBL1139046,KI,Cc1ccc2c(OCCN3CCC(Cc4cc5c(cc4F)OCC(=O)N5)CC3)cc(Cl)cc2n1
CHEMBL238520,CHEMBL217,Dopamine D2 receptor,Ki,=,1995.26,nM,CHEMBL885603,B,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,CHEMBL1139046,KI,Cc1ccc2c(OCCN3CCC(Cc4cc5c(cc4F)OCC(=O)N5)CC3)cc(F)cc2n1
CHEMBL238519,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL885603,B,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,CHEMBL1139046,KI,Cc1ccc2c(OCCN3CCC(Cc4ccc5c(c4F)NC(=O)CO5)CC3)cc(Cl)cc2n1
CHEMBL183460,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL885603,B,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,CHEMBL1139046,KI,Cc1ccc2c(OCCN3CCC(Cc4ccc5c(c4)NC(=O)CO5)CC3)cccc2n1
CHEMBL441618,CHEMBL217,Dopamine D2 receptor,Ki,=,44.5,nM,CHEMBL885887,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1139077,KI,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL201525,CHEMBL217,Dopamine D2 receptor,Ki,=,56.5,nM,CHEMBL885887,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1139077,KI,CN1CCc2ccccc2Cc2ccccc2CC1
CHEMBL201170,CHEMBL217,Dopamine D2 receptor,Ki,=,17.5,nM,CHEMBL885887,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1139077,KI,CN1CCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL380330,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL885887,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1139077,KI,COc1ccc2c(c1)CCN(C)CCc1ccccc1C2
CHEMBL245764,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL885887,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1139077,KI,COc1ccc2c(c1)c1c(n2C)Cc2ccccc2CCN(C)CC1
CHEMBL245571,CHEMBL217,Dopamine D2 receptor,Ki,=,74.7,nM,CHEMBL885887,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1139077,KI,CN1CCc2cc(O)ccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL396561,CHEMBL217,Dopamine D2 receptor,Ki,=,22.8,nM,CHEMBL885887,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1139077,KI,COc1ccc2c(c1)CCN(C)CCc1c([nH]c3ccccc13)C2
CHEMBL245570,CHEMBL217,Dopamine D2 receptor,Ki,=,38.4,nM,CHEMBL885887,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1139077,KI,CN1CCc2ccccc2Cc2[nH]c3ccc(O)cc3c2CC1
CHEMBL396560,CHEMBL217,Dopamine D2 receptor,Ki,=,11.9,nM,CHEMBL885887,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1139077,KI,COc1ccc2[nH]c3c(c2c1)CCN(C)CCc1ccccc1C3
CHEMBL175832,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL886666,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1139157,KI,O=S(=O)(c1ccc(F)cc1)C1(F)CCN(CCc2ccc(F)cc2F)CC1
CHEMBL240888,CHEMBL217,Dopamine D2 receptor,Ki,=,31000.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,COc1cccc(C2=NCCc3c2[nH]c2ccccc32)c1
CHEMBL392888,CHEMBL217,Dopamine D2 receptor,Ki,=,59000.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,CN(/C=N/c1ccc2c(c1)C(O)CC2)Cc1ccccc1
CHEMBL240025,CHEMBL217,Dopamine D2 receptor,Ki,=,1600.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,CC(=O)OC1CCc2ccc(/N=C/N(C)Cc3ccccc3)cc21
CHEMBL392887,CHEMBL217,Dopamine D2 receptor,Ki,=,1700.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,COc1cc2c(cc1OC)CN(/C=N/c1ccc3c(c1)C(O)CCCC3)CC2
CHEMBL429644,CHEMBL217,Dopamine D2 receptor,Ki,=,3100.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,CCCCSC1CCc2ccc(/N=C/N3CCc4cc(OC)c(OC)cc4C3)cc21
CHEMBL241283,CHEMBL217,Dopamine D2 receptor,Ki,=,8200.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,CCCCSC1=CCc2ccc(/N=C/N3CCc4cc(OC)c(OC)cc4C3)cc21
CHEMBL241103,CHEMBL217,Dopamine D2 receptor,Ki,=,1700.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,CC(=O)OC1CCc2ccc(/N=C/N3CCc4ccccc4C3)cc21
CHEMBL241102,CHEMBL217,Dopamine D2 receptor,Ki,=,12000.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,COc1cc2c(cc1OC)CN(/C=N/c1ccc3c(c1)C(OC(C)=O)CC3)CC2
CHEMBL241101,CHEMBL217,Dopamine D2 receptor,Ki,=,14000.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,COC(=O)N1CCc2ccc(/N=C/N3CCc4cc(OC)c(OC)cc4C3)cc21
CHEMBL240023,CHEMBL217,Dopamine D2 receptor,Ki,=,42000.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,CCCOC1CCCc2ccc(/N=C/N3CCc4cc(OC)c(OC)cc4C3)cc21
CHEMBL392970,CHEMBL217,Dopamine D2 receptor,Ki,=,14000.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,COc1cc2c(cc1OC)CN(/C=N/c1ccc3c(c1)C(OC(C)=O)CCCC3)CC2
CHEMBL240022,CHEMBL217,Dopamine D2 receptor,Ki,=,11000.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,COc1cc2c(cc1OC)CN(/C=N/c1ccc3c(c1)C(OC(C)=O)CCC3)CC2
CHEMBL240021,CHEMBL217,Dopamine D2 receptor,Ki,=,54000.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,COc1cc2c(cc1OC)CN(/C=N/c1ccc3c(c1)N(C(=O)OC(C)(C)C)CC3)CC2
CHEMBL241281,CHEMBL217,Dopamine D2 receptor,Ki,=,2400.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,CC(=O)OC1CCCc2ccc(/N=C/N3CCc4ccccc4C3)cc21
CHEMBL391190,CHEMBL217,Dopamine D2 receptor,Ki,=,1900.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,COc1ccc2[nH]c3c(c2c1)CCNC3Cc1ccc2c(c1)OCO2
CHEMBL328476,CHEMBL217,Dopamine D2 receptor,Ki,=,4600.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,c1ccc2c3c([nH]c2c1)C(Cc1ccc2c(c1)OCO2)NCC3
CHEMBL393275,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,COc1cccc(CC2NCCc3c2[nH]c2ccc(OC)cc32)c1
CHEMBL319005,CHEMBL217,Dopamine D2 receptor,Ki,=,1600.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,COc1cccc(CC2NCCc3c2[nH]c2ccccc32)c1
CHEMBL241099,CHEMBL217,Dopamine D2 receptor,Ki,=,200000.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,COc1ccc2[nH]c3c(c2c1)CCN=C3c1cc([N+](=O)[O-])cn1C
CHEMBL241082,CHEMBL217,Dopamine D2 receptor,Ki,=,25000.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,COc1cccc(C2=NCCc3c2[nH]c2ccc(OC)cc32)c1
CHEMBL392401,CHEMBL217,Dopamine D2 receptor,Ki,=,88000.0,nM,CHEMBL886705,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1139165,KI,Oc1cccc(C2NCCc3c2[nH]c2ccccc32)c1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,223.87,nM,CHEMBL923071,B,Displacement of [3H]spiperone human cloned dopamine D2 receptor,CHEMBL1140677,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.6026,nM,CHEMBL923071,B,Displacement of [3H]spiperone human cloned dopamine D2 receptor,CHEMBL1140677,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL392158,CHEMBL217,Dopamine D2 receptor,Ki,=,2.1,nM,CHEMBL941849,B,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,CHEMBL1139804,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCF)cc(OC)c1OC
CHEMBL392158,CHEMBL217,Dopamine D2 receptor,Ki,=,2.2,nM,CHEMBL941850,B,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,CHEMBL1139804,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCF)cc(OC)c1OC
CHEMBL397592,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL941850,B,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,CHEMBL1139804,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(Br)ccc1OC
CHEMBL240106,CHEMBL217,Dopamine D2 receptor,Ki,=,0.85,nM,CHEMBL941850,B,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,CHEMBL1139804,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(Br)cc(OC)c1OC
CHEMBL397103,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL941850,B,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,CHEMBL1139804,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(I)ccc1OC
CHEMBL241169,CHEMBL217,Dopamine D2 receptor,Ki,=,0.68,nM,CHEMBL941850,B,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,CHEMBL1139804,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(I)cc(OC)c1OC
CHEMBL76402,CHEMBL217,Dopamine D2 receptor,Ki,=,0.65,nM,CHEMBL941850,B,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,CHEMBL1139804,KI,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Br)cc(OC)c1OC
CHEMBL8809,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL941850,B,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,CHEMBL1139804,KI,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC
CHEMBL267723,CHEMBL217,Dopamine D2 receptor,Ki,=,4.2,nM,CHEMBL941850,B,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,CHEMBL1139804,KI,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(I)c1O
CHEMBL428561,CHEMBL217,Dopamine D2 receptor,Ki,=,30.0,nM,CHEMBL941850,B,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,CHEMBL1139804,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCF)ccc1OC
CHEMBL397592,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL941849,B,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,CHEMBL1139804,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(Br)ccc1OC
CHEMBL240106,CHEMBL217,Dopamine D2 receptor,Ki,=,0.88,nM,CHEMBL941849,B,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,CHEMBL1139804,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(Br)cc(OC)c1OC
CHEMBL397103,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL941849,B,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,CHEMBL1139804,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(I)ccc1OC
CHEMBL241169,CHEMBL217,Dopamine D2 receptor,Ki,=,0.74,nM,CHEMBL941849,B,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,CHEMBL1139804,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(I)cc(OC)c1OC
CHEMBL76402,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL941849,B,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,CHEMBL1139804,KI,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Br)cc(OC)c1OC
CHEMBL8809,CHEMBL217,Dopamine D2 receptor,Ki,=,31.0,nM,CHEMBL941849,B,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,CHEMBL1139804,KI,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC
CHEMBL267723,CHEMBL217,Dopamine D2 receptor,Ki,=,4.2,nM,CHEMBL941849,B,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,CHEMBL1139804,KI,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(I)c1O
CHEMBL428561,CHEMBL217,Dopamine D2 receptor,Ki,=,30.0,nM,CHEMBL941849,B,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,CHEMBL1139804,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCF)ccc1OC
CHEMBL156639,CHEMBL217,Dopamine D2 receptor,Ki,=,142.0,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1
CHEMBL250552,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2c(O)cccc2C1
CHEMBL250552,CHEMBL217,Dopamine D2 receptor,Ki,=,238.0,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2c(O)cccc2C1
CHEMBL252539,CHEMBL217,Dopamine D2 receptor,Ki,=,14.6,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,CCCN(CCN1CCN(c2cccc(Cl)c2Cl)CC1)C1CCc2c(O)cccc2C1
CHEMBL399164,CHEMBL217,Dopamine D2 receptor,Ki,=,9.56,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,CCCN(CCN1CCN(c2ccccc2OC)CC1)C1CCc2c(O)cccc2C1
CHEMBL399164,CHEMBL217,Dopamine D2 receptor,Ki,=,35.8,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,CCCN(CCN1CCN(c2ccccc2OC)CC1)C1CCc2c(O)cccc2C1
CHEMBL399164,CHEMBL217,Dopamine D2 receptor,Ki,=,88.7,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,CCCN(CCN1CCN(c2ccccc2OC)CC1)C1CCc2c(O)cccc2C1
CHEMBL252343,CHEMBL217,Dopamine D2 receptor,Ki,=,90.6,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2ccc3c(c2C1)CC(=O)N3
CHEMBL252342,CHEMBL217,Dopamine D2 receptor,Ki,=,638.0,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2ccc(N)cc2C1
CHEMBL155826,CHEMBL217,Dopamine D2 receptor,Ki,=,19.3,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,CCCN(CCCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1
CHEMBL155826,CHEMBL217,Dopamine D2 receptor,Ki,=,19.4,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,CCCN(CCCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1
CHEMBL157293,CHEMBL217,Dopamine D2 receptor,Ki,=,32.9,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,C#CCN(CCCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1
CHEMBL157293,CHEMBL217,Dopamine D2 receptor,Ki,=,25.2,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,C#CCN(CCCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1
CHEMBL254203,CHEMBL217,Dopamine D2 receptor,Ki,=,21.7,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,CCCN(CCCCN1CCN(c2ccccc2)CC1)C1CCc2cc(O)c(O)cc2C1
CHEMBL254202,CHEMBL217,Dopamine D2 receptor,Ki,=,70.3,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2cc(O)c(O)cc2C1
CHEMBL254199,CHEMBL217,Dopamine D2 receptor,Ki,=,24.6,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,Oc1ccc2c(c1)CC(N(CCc1cccs1)CCN1CCN(c3ccccc3)CC1)CC2
CHEMBL254198,CHEMBL217,Dopamine D2 receptor,Ki,=,167.0,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,CCCN(CCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1
CHEMBL253992,CHEMBL217,Dopamine D2 receptor,Ki,=,649.0,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2cc(O)ccc2C1
CHEMBL250552,CHEMBL217,Dopamine D2 receptor,Ki,=,58.6,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2c(O)cccc2C1
CHEMBL301559,CHEMBL217,Dopamine D2 receptor,Ki,=,202.0,nM,CHEMBL926379,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140704,KI,CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1
CHEMBL431298,CHEMBL217,Dopamine D2 receptor,Ki,=,460.0,nM,CHEMBL927708,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1140794,KI,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1
CHEMBL708,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL252430,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1cccnc1
CHEMBL252429,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1ccc(F)cc1
CHEMBL252030,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,CC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21
CHEMBL398711,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)C(F)(F)F
CHEMBL251834,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccno1
CHEMBL398744,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccco1
CHEMBL252201,CHEMBL217,Dopamine D2 receptor,Ki,=,33.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,O=C(CCc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21
CHEMBL253878,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,O=C(Cc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21
CHEMBL398619,CHEMBL217,Dopamine D2 receptor,Ki,=,6.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1cccnc1
CHEMBL442290,CHEMBL217,Dopamine D2 receptor,Ki,=,6.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(F)cc1
CHEMBL253439,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(Cl)cc1
CHEMBL398618,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,Cc1ccc(C(=O)NC2CCc3ccc(CCN4CCN(c5nsc6ccccc56)CC4)cc32)cc1
CHEMBL253233,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccccc1
CHEMBL400236,CHEMBL217,Dopamine D2 receptor,Ki,=,67.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,CC(C)C(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21
CHEMBL253024,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C1CC1
CHEMBL400235,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,CCCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21
CHEMBL253022,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,CCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21
CHEMBL252818,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,CC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21
CHEMBL404000,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21
CHEMBL252816,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL945767,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL1140829,KI,O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C(F)(F)F
CHEMBL256041,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)NCc3cccc(F)c3)CC2)CC1
CHEMBL256041,CHEMBL217,Dopamine D2 receptor,Ki,=,183.0,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)NCc3cccc(F)c3)CC2)CC1
CHEMBL256040,CHEMBL217,Dopamine D2 receptor,Ki,=,6.5,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cc(Cl)cc3Cl)CC2)CC1
CHEMBL256040,CHEMBL217,Dopamine D2 receptor,Ki,=,103.0,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cc(Cl)cc3Cl)CC2)CC1
CHEMBL256597,CHEMBL217,Dopamine D2 receptor,Ki,=,4.7,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cccc3Cl)CC2)CC1
CHEMBL256597,CHEMBL217,Dopamine D2 receptor,Ki,=,55.0,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cccc3Cl)CC2)CC1
CHEMBL256804,CHEMBL217,Dopamine D2 receptor,Ki,=,54.0,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)c(F)c3)CC2)CC1
CHEMBL256804,CHEMBL217,Dopamine D2 receptor,Ki,=,127.0,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)c(F)c3)CC2)CC1
CHEMBL270589,CHEMBL217,Dopamine D2 receptor,Ki,=,2.4,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(F)cccc3F)CC2)CC1
CHEMBL270589,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(F)cccc3F)CC2)CC1
CHEMBL257097,CHEMBL217,Dopamine D2 receptor,Ki,=,0.46,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cc(F)ccc3F)CC2)CC1
CHEMBL257097,CHEMBL217,Dopamine D2 receptor,Ki,=,199.0,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cc(F)ccc3F)CC2)CC1
CHEMBL403280,CHEMBL217,Dopamine D2 receptor,Ki,=,0.69,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)cc3F)CC2)CC1
CHEMBL403280,CHEMBL217,Dopamine D2 receptor,Ki,=,35.5,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)cc3F)CC2)CC1
CHEMBL271913,CHEMBL217,Dopamine D2 receptor,Ki,=,1.2,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,COc1ccc(Cl)cc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL271913,CHEMBL217,Dopamine D2 receptor,Ki,=,99.0,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,COc1ccc(Cl)cc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL256853,CHEMBL217,Dopamine D2 receptor,Ki,=,892.0,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,COc1ccc(NC(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c(OC)c1
CHEMBL256853,CHEMBL217,Dopamine D2 receptor,Ki,=,288.0,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,COc1ccc(NC(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c(OC)c1
CHEMBL257077,CHEMBL217,Dopamine D2 receptor,Ki,=,84.0,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cccc(Cl)c3)CC2)CC1
CHEMBL257077,CHEMBL217,Dopamine D2 receptor,Ki,=,108.0,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cccc(Cl)c3)CC2)CC1
CHEMBL272340,CHEMBL217,Dopamine D2 receptor,Ki,=,921.0,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,COc1ccccc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL272340,CHEMBL217,Dopamine D2 receptor,Ki,=,390.0,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,COc1ccccc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
CHEMBL257098,CHEMBL217,Dopamine D2 receptor,Ki,=,33.0,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccccc3Cl)CC2)CC1
CHEMBL257098,CHEMBL217,Dopamine D2 receptor,Ki,=,878.0,nM,CHEMBL948052,B,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,CHEMBL1143857,KI,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccccc3Cl)CC2)CC1
CHEMBL256492,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL931954,B,Binding affinity to human dopamine D2 long receptor,CHEMBL1143133,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCF
CHEMBL310843,CHEMBL217,Dopamine D2 receptor,Ki,=,3400.0,nM,CHEMBL931954,B,Binding affinity to human dopamine D2 long receptor,CHEMBL1143133,KI,Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1
CHEMBL256637,CHEMBL217,Dopamine D2 receptor,Ki,=,760.0,nM,CHEMBL931954,B,Binding affinity to human dopamine D2 long receptor,CHEMBL1143133,KI,COc1cc(CN2CCN(c3ccc(Cl)cc3)CC2)c(OCCF)cc1OC
CHEMBL255163,CHEMBL217,Dopamine D2 receptor,Ki,=,590.0,nM,CHEMBL931954,B,Binding affinity to human dopamine D2 long receptor,CHEMBL1143133,KI,FCCOc1cccc(CN2CCN(c3ccc(Cl)cc3)CC2)c1
CHEMBL272073,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL931954,B,Binding affinity to human dopamine D2 long receptor,CHEMBL1143133,KI,FCCOc1ccc(CN2CCN(c3ccc(Cl)cc3)CC2)cc1
CHEMBL404888,CHEMBL217,Dopamine D2 receptor,Ki,=,21000.0,nM,CHEMBL931954,B,Binding affinity to human dopamine D2 long receptor,CHEMBL1143133,KI,COc1cc(CN2CCN(c3ccc(Cl)cc3)CC2)ccc1OCCF
CHEMBL270406,CHEMBL217,Dopamine D2 receptor,Ki,=,94.0,nM,CHEMBL931954,B,Binding affinity to human dopamine D2 long receptor,CHEMBL1143133,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)c(OCCF)cc1OC
CHEMBL270408,CHEMBL217,Dopamine D2 receptor,Ki,=,57.0,nM,CHEMBL931954,B,Binding affinity to human dopamine D2 long receptor,CHEMBL1143133,KI,COc1ccccc1N1CCN(Cc2cccc(OCCF)c2)CC1
CHEMBL271513,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL931954,B,Binding affinity to human dopamine D2 long receptor,CHEMBL1143133,KI,COc1ccccc1N1CCN(Cc2ccc(OCCF)cc2)CC1
CHEMBL270056,CHEMBL217,Dopamine D2 receptor,Ki,=,330.0,nM,CHEMBL934518,B,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,CHEMBL1143102,KI,Fc1cccc(N2CCN(Cc3cnn4ccccc34)CC2)n1
CHEMBL310843,CHEMBL217,Dopamine D2 receptor,Ki,=,3400.0,nM,CHEMBL934518,B,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,CHEMBL1143102,KI,Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1
CHEMBL7927,CHEMBL217,Dopamine D2 receptor,Ki,=,2900.0,nM,CHEMBL934518,B,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,CHEMBL1143102,KI,Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL407818,CHEMBL217,Dopamine D2 receptor,Ki,=,6100.0,nM,CHEMBL934518,B,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,CHEMBL1143102,KI,Oc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL272602,CHEMBL217,Dopamine D2 receptor,Ki,=,4500.0,nM,CHEMBL934518,B,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,CHEMBL1143102,KI,Oc1ccccc1N1CCN(Cc2cnn3ccccc23)CC1
CHEMBL272853,CHEMBL217,Dopamine D2 receptor,Ki,=,30000.0,nM,CHEMBL934518,B,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,CHEMBL1143102,KI,FCCOc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1
CHEMBL405260,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL934518,B,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,CHEMBL1143102,KI,FCCOc1ccccc1N1CCN(Cc2cc3ccccn3n2)CC1
CHEMBL272873,CHEMBL217,Dopamine D2 receptor,Ki,=,66000.0,nM,CHEMBL934518,B,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,CHEMBL1143102,KI,FCCOc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL411437,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL934518,B,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,CHEMBL1143102,KI,FCCOc1ccccc1N1CCN(Cc2cnn3ccccc23)CC1
CHEMBL272396,CHEMBL217,Dopamine D2 receptor,Ki,=,880.0,nM,CHEMBL934518,B,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,CHEMBL1143102,KI,Brc1cccc(N2CCN(Cc3cc4ccccn4n3)CC2)n1
CHEMBL405292,CHEMBL217,Dopamine D2 receptor,Ki,=,3400.0,nM,CHEMBL934518,B,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,CHEMBL1143102,KI,Fc1cccc(N2CCN(Cc3cc4ccccn4n3)CC2)n1
CHEMBL272395,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL934518,B,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,CHEMBL1143102,KI,Brc1cccc(N2CCN(Cc3cnn4ccccc34)CC2)n1
CHEMBL270056,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL934519,B,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,CHEMBL1143102,KI,Fc1cccc(N2CCN(Cc3cnn4ccccc34)CC2)n1
CHEMBL310843,CHEMBL217,Dopamine D2 receptor,Ki,=,6300.0,nM,CHEMBL934519,B,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,CHEMBL1143102,KI,Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1
CHEMBL7927,CHEMBL217,Dopamine D2 receptor,Ki,=,2200.0,nM,CHEMBL934519,B,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,CHEMBL1143102,KI,Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL407818,CHEMBL217,Dopamine D2 receptor,Ki,=,87000.0,nM,CHEMBL934519,B,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,CHEMBL1143102,KI,Oc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL272602,CHEMBL217,Dopamine D2 receptor,Ki,=,4700.0,nM,CHEMBL934519,B,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,CHEMBL1143102,KI,Oc1ccccc1N1CCN(Cc2cnn3ccccc23)CC1
CHEMBL272853,CHEMBL217,Dopamine D2 receptor,Ki,=,50000.0,nM,CHEMBL934519,B,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,CHEMBL1143102,KI,FCCOc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1
CHEMBL405260,CHEMBL217,Dopamine D2 receptor,Ki,=,79.0,nM,CHEMBL934519,B,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,CHEMBL1143102,KI,FCCOc1ccccc1N1CCN(Cc2cc3ccccn3n2)CC1
CHEMBL272873,CHEMBL217,Dopamine D2 receptor,Ki,=,79000.0,nM,CHEMBL934519,B,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,CHEMBL1143102,KI,FCCOc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL411437,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL934519,B,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,CHEMBL1143102,KI,FCCOc1ccccc1N1CCN(Cc2cnn3ccccc23)CC1
CHEMBL272396,CHEMBL217,Dopamine D2 receptor,Ki,=,550.0,nM,CHEMBL934519,B,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,CHEMBL1143102,KI,Brc1cccc(N2CCN(Cc3cc4ccccn4n3)CC2)n1
CHEMBL405292,CHEMBL217,Dopamine D2 receptor,Ki,=,1700.0,nM,CHEMBL934519,B,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,CHEMBL1143102,KI,Fc1cccc(N2CCN(Cc3cc4ccccn4n3)CC2)n1
CHEMBL272395,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL934519,B,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,CHEMBL1143102,KI,Brc1cccc(N2CCN(Cc3cnn4ccccc34)CC2)n1
CHEMBL409662,CHEMBL217,Dopamine D2 receptor,Ki,=,950.0,nM,CHEMBL927100,B,Inhibition of dopamine D2 receptor,CHEMBL1144747,KI,CCC1(CCCCN2CCN(c3ccc(Cl)cc3)CC2)C(=O)Nc2cc(F)ccc21
CHEMBL411663,CHEMBL217,Dopamine D2 receptor,Ki,=,330.0,nM,CHEMBL927100,B,Inhibition of dopamine D2 receptor,CHEMBL1144747,KI,O=C1Nc2ccc(F)cc2C1CCCCN1CCN(c2ccccc2)CC1
CHEMBL260994,CHEMBL217,Dopamine D2 receptor,Ki,=,960.0,nM,CHEMBL927100,B,Inhibition of dopamine D2 receptor,CHEMBL1144747,KI,O=C1Nc2ccccc2C1CCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL986942,B,Displacement of [3H]raclopride from human cloned dopamine D2 receptor expressed in CHO cell membrane,CHEMBL1149860,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL465054,CHEMBL217,Dopamine D2 receptor,Ki,=,88.0,nM,CHEMBL986942,B,Displacement of [3H]raclopride from human cloned dopamine D2 receptor expressed in CHO cell membrane,CHEMBL1149860,KI,CN1CCc2cc(-c3ccccc3)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL517028,CHEMBL217,Dopamine D2 receptor,Ki,=,3.8,nM,CHEMBL986942,B,Displacement of [3H]raclopride from human cloned dopamine D2 receptor expressed in CHO cell membrane,CHEMBL1149860,KI,CN1CCc2cc(-c3ccc(O)cc3)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL498565,CHEMBL217,Dopamine D2 receptor,Ki,=,516.0,nM,CHEMBL959090,B,Binding affinity at dopamine D2 receptor,CHEMBL1150346,KI,CN(CCc1ccccc1OC(F)(F)F)CCN1CCCC1
CHEMBL522708,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL954061,B,Displacement of radioligand from human cloned dopamine D2 receptor,CHEMBL1150291,KI,Cc1ccc2c(OCCN3CCC(Cc4cccc(N5CCCS5(=O)=O)c4)CC3)cccc2n1
CHEMBL497963,CHEMBL217,Dopamine D2 receptor,Ki,=,63.1,nM,CHEMBL954061,B,Displacement of radioligand from human cloned dopamine D2 receptor,CHEMBL1150291,KI,Cc1ccc2c(OCCN3CCC(Cc4cccc(NS(C)(=O)=O)c4)CC3)cccc2n1
CHEMBL498774,CHEMBL217,Dopamine D2 receptor,Ki,=,213.0,nM,CHEMBL959090,B,Binding affinity at dopamine D2 receptor,CHEMBL1150346,KI,CCN(CCc1ccccc1OC(F)(F)F)CCN1CCCCC1
CHEMBL497338,CHEMBL217,Dopamine D2 receptor,Ki,=,146.0,nM,CHEMBL959090,B,Binding affinity at dopamine D2 receptor,CHEMBL1150346,KI,CN(CCc1ccccc1OC(F)(F)F)CCN1CCCCC1
CHEMBL445977,CHEMBL217,Dopamine D2 receptor,Ki,=,266.0,nM,CHEMBL959090,B,Binding affinity at dopamine D2 receptor,CHEMBL1150346,KI,CCN(CCc1ccccc1OC(F)(F)F)CCN1CCCC1
CHEMBL3084502,CHEMBL217,Dopamine D2 receptor,Ki,=,33.4,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12
CHEMBL246637,CHEMBL217,Dopamine D2 receptor,Ki,=,6.9,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,OC1(c2ccc(Cl)c(Cl)c2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL445102,CHEMBL217,Dopamine D2 receptor,Ki,=,11.2,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL3084524,CHEMBL217,Dopamine D2 receptor,Ki,=,1.4,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@@]1(c2ccc(Cl)c(Cl)c2)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccc(F)cc12
CHEMBL3084523,CHEMBL217,Dopamine D2 receptor,Ki,=,5.6,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1coc2c1ccc1ccccc12
CHEMBL3084522,CHEMBL217,Dopamine D2 receptor,Ki,=,11.7,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccc3ccccc3c12
CHEMBL3084521,CHEMBL217,Dopamine D2 receptor,Ki,=,1.2,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccc(F)cc12
CHEMBL3084520,CHEMBL217,Dopamine D2 receptor,Ki,=,1.5,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,COc1ccc2occ(CN3[C@@H]4CC[C@H]3C[C@](O)(c3ccc(Cl)cc3)C4)c2c1
CHEMBL3084519,CHEMBL217,Dopamine D2 receptor,Ki,=,1.5,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@@]1(c2ccc(Br)cc2)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccccc12
CHEMBL3084518,CHEMBL217,Dopamine D2 receptor,Ki,=,4.9,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@@]1(c2ccc(F)cc2)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccccc12
CHEMBL3084517,CHEMBL217,Dopamine D2 receptor,Ki,=,40.1,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@@]1(c2cccc(Cl)c2Cl)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccccc12
CHEMBL3084516,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@]1(c2ccc(Cl)c(Cl)c2)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccccc12
CHEMBL3084515,CHEMBL217,Dopamine D2 receptor,Ki,=,1.06,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccccc12
CHEMBL3084514,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@@]1(c2cccc(Cl)c2Cl)C[C@H]2CC[C@@H](C1)N2Cc1csc2ccccc12
CHEMBL3084513,CHEMBL217,Dopamine D2 receptor,Ki,=,29.8,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@@]1(c2ccc(Cl)c(Cl)c2)C[C@H]2CC[C@@H](C1)N2Cc1csc2ccccc12
CHEMBL3084512,CHEMBL217,Dopamine D2 receptor,Ki,=,12.9,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1csc2ccccc12
CHEMBL3084511,CHEMBL217,Dopamine D2 receptor,Ki,=,554.0,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,COc1ccc2[nH]cc(CN3[C@@H]4CC[C@H]3C[C@](O)(c3ccc(SC)cc3)C4)c2c1
CHEMBL3084510,CHEMBL217,Dopamine D2 receptor,Ki,=,39.4,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,COc1ccc2[nH]cc(CN3[C@@H]4CC[C@H]3C[C@](O)(c3ccc(Cl)cc3)C4)c2c1
CHEMBL3084509,CHEMBL217,Dopamine D2 receptor,Ki,=,225.0,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1n[nH]c2ccccc12
CHEMBL3084508,CHEMBL217,Dopamine D2 receptor,Ki,=,565.0,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,CSc1ccc([C@]2(O)C[C@H]3CC[C@@H](C2)N3Cc2c[nH]c3ccccc23)cc1
CHEMBL3084507,CHEMBL217,Dopamine D2 receptor,Ki,=,2070.0,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,COc1ccccc1[C@]1(O)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12
CHEMBL3084506,CHEMBL217,Dopamine D2 receptor,Ki,=,196.0,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@@]1(c2ccc3ccccc3c2)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12
CHEMBL3084505,CHEMBL217,Dopamine D2 receptor,Ki,=,41.4,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@@]1(c2ccc(F)cc2)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12
CHEMBL3084504,CHEMBL217,Dopamine D2 receptor,Ki,=,545.0,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@@]1(c2cccc(Cl)c2Cl)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12
CHEMBL3084503,CHEMBL217,Dopamine D2 receptor,Ki,=,35.3,nM,CHEMBL1033058,B,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1140093,KI,O[C@@]1(c2ccc(Cl)c(Cl)c2)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12
CHEMBL143022,CHEMBL217,Dopamine D2 receptor,Ki,=,151.36,nM,CHEMBL1027240,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1140101,KI,O=C1CC(CN2CCC(C(=O)c3ccc(F)cc3)CC2)Cc2occc21
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,223.87,nM,CHEMBL1027240,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1140101,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.6026,nM,CHEMBL1027240,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1140101,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL459930,CHEMBL217,Dopamine D2 receptor,Ki,=,213.8,nM,CHEMBL1027240,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1140101,KI,CCOC(=O)c1oc2c(c1C)C(=O)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)C2
CHEMBL516809,CHEMBL217,Dopamine D2 receptor,Ki,=,12.02,nM,CHEMBL1027240,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1140101,KI,O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2oc(-c3ccccc3)cc21
CHEMBL461627,CHEMBL217,Dopamine D2 receptor,Ki,=,85.11,nM,CHEMBL1027240,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1140101,KI,COC(=O)c1coc2c1C(=O)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)C2
CHEMBL523680,CHEMBL217,Dopamine D2 receptor,Ki,=,15.85,nM,CHEMBL1027240,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1140101,KI,Cl.O=C1C[C@H](CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2occc21
CHEMBL492689,CHEMBL217,Dopamine D2 receptor,Ki,=,41.69,nM,CHEMBL1027240,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1140101,KI,Cl.O=C1C[C@@H](CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2occc21
CHEMBL164471,CHEMBL217,Dopamine D2 receptor,Ki,=,45.71,nM,CHEMBL1027240,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1140101,KI,O=C1c2ccoc2CCC1CCN1CCC(c2noc3cc(F)ccc23)CC1
CHEMBL159929,CHEMBL217,Dopamine D2 receptor,Ki,=,724.44,nM,CHEMBL1027240,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1140101,KI,O=C(c1ccc(F)cc1)C1CCN(CCC2CCc3occc3C2=O)CC1
CHEMBL143027,CHEMBL217,Dopamine D2 receptor,Ki,=,16.22,nM,CHEMBL1027240,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1140101,KI,O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2occc21
CHEMBL522194,CHEMBL217,Dopamine D2 receptor,Ki,=,91.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,COc1ccccc1N1CCN(CCCCCC(=O)NCc2ccc(OS(C)(=O)=O)cc2)CC1
CHEMBL494661,CHEMBL217,Dopamine D2 receptor,Ki,=,7.8,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,CC(C)c1ccccc1N1CCN(CCCCCC(=O)NCc2ccc(OS(C)(=O)=O)cc2)CC1
CHEMBL494458,CHEMBL217,Dopamine D2 receptor,Ki,=,723.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,CS(=O)(=O)Oc1ccc(CNC(=O)CCCCCN2CCN(c3ccccc3-c3ccccc3)CC2)cc1
CHEMBL521687,CHEMBL217,Dopamine D2 receptor,Ki,=,30.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,CSc1ccccc1N1CCN(CCCCCC(=O)NCc2ccc(OS(C)(=O)=O)cc2)CC1
CHEMBL494512,CHEMBL217,Dopamine D2 receptor,Ki,=,311.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,COc1ccccc1N1CCN(CCCCCC(=O)NCc2ccc(C#N)cc2)CC1
CHEMBL494312,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,CC(C)c1ccccc1N1CCN(CCCCCC(=O)NCc2ccc(C#N)cc2)CC1
CHEMBL522691,CHEMBL217,Dopamine D2 receptor,Ki,=,142.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,N#Cc1ccc(CNC(=O)CCCCCN2CCN(c3ccccc3-c3ccccc3)CC2)cc1
CHEMBL493909,CHEMBL217,Dopamine D2 receptor,Ki,=,5.3,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,CSc1ccccc1N1CCN(CCCCCC(=O)NCc2ccc(C#N)cc2)CC1
CHEMBL493709,CHEMBL217,Dopamine D2 receptor,Ki,=,501.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,COc1ccccc1N1CCN(CCCCCC(=O)NCc2ccncc2)CC1
CHEMBL522343,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,CC(C)c1ccccc1N1CCN(CCCCCC(=O)NCc2ccncc2)CC1
CHEMBL494709,CHEMBL217,Dopamine D2 receptor,Ki,=,185.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccncc1
CHEMBL495321,CHEMBL217,Dopamine D2 receptor,Ki,=,64.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,CSc1ccccc1N1CCN(CCCCCC(=O)NCc2ccncc2)CC1
CHEMBL495120,CHEMBL217,Dopamine D2 receptor,Ki,=,226.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,COc1ccccc1N1CCN(CCCCCC(=O)NCc2ccccc2)CC1
CHEMBL492872,CHEMBL217,Dopamine D2 receptor,Ki,=,9.2,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,CC(C)c1ccccc1N1CCN(CCCCCC(=O)NCc2ccccc2)CC1
CHEMBL492871,CHEMBL217,Dopamine D2 receptor,Ki,=,503.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1
CHEMBL492691,CHEMBL217,Dopamine D2 receptor,Ki,=,33.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,CSc1ccccc1N1CCN(CCCCCC(=O)NCc2ccccc2)CC1
CHEMBL492690,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,COc1ccccc1N1CCN(CCCCCC(=O)N2CCc3ccccc3C2)CC1
CHEMBL492282,CHEMBL217,Dopamine D2 receptor,Ki,=,1.3,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,CC(C)c1ccccc1N1CCN(CCCCCC(=O)N2CCc3ccccc3C2)CC1
CHEMBL492480,CHEMBL217,Dopamine D2 receptor,Ki,=,362.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)N1CCc2ccccc2C1
CHEMBL493305,CHEMBL217,Dopamine D2 receptor,Ki,=,40.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,CSc1ccccc1N1CCN(CCCCCC(=O)N2CCc3ccccc3C2)CC1
CHEMBL494316,CHEMBL217,Dopamine D2 receptor,Ki,=,730.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,COc1ccccc1N1CCN(CCCCCC(=O)N2Cc3ccccc3C2)CC1
CHEMBL494119,CHEMBL217,Dopamine D2 receptor,Ki,=,65.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,CC(C)c1ccccc1N1CCN(CCCCCC(=O)N2Cc3ccccc3C2)CC1
CHEMBL494118,CHEMBL217,Dopamine D2 receptor,Ki,=,93.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)N1Cc2ccccc2C1
CHEMBL523381,CHEMBL217,Dopamine D2 receptor,Ki,=,96.0,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,CSc1ccccc1N1CCN(CCCCCC(=O)N2Cc3ccccc3C2)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,4.2,nM,CHEMBL1034994,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,CHEMBL1140136,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1255588,CHEMBL217,Dopamine D2 receptor,Ki,=,2.9,nM,CHEMBL953137,B,Displacement of radiolabeled (+)butaclamol from human dopamine D2S receptor,CHEMBL1140203,KI,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1
CHEMBL458792,CHEMBL217,Dopamine D2 receptor,Ki,=,298000.0,nM,CHEMBL938581,B,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,CHEMBL1140844,KI,COc1cccc(CCc2ccccc2OCCCN2CCN(c3cccc(Cl)c3)CC2)c1
CHEMBL457899,CHEMBL217,Dopamine D2 receptor,Ki,=,1412000.0,nM,CHEMBL938581,B,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,CHEMBL1140844,KI,COc1cccc(CCc2ccccc2OCCCN2CCN(c3cccc(C(F)(F)F)c3)CC2)c1
CHEMBL514286,CHEMBL217,Dopamine D2 receptor,Ki,=,427000.0,nM,CHEMBL938581,B,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,CHEMBL1140844,KI,COc1cccc(CCc2ccccc2OCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL456647,CHEMBL217,Dopamine D2 receptor,Ki,=,6300.0,nM,CHEMBL938581,B,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,CHEMBL1140844,KI,COc1cccc(CCc2ccccc2OCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL516334,CHEMBL217,Dopamine D2 receptor,Ki,=,67000.0,nM,CHEMBL938581,B,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,CHEMBL1140844,KI,COc1cccc(CCc2ccccc2OCCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL457921,CHEMBL217,Dopamine D2 receptor,Ki,=,655000.0,nM,CHEMBL938581,B,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,CHEMBL1140844,KI,COc1cccc(CCc2ccccc2OCCCN2CCN(c3ccc(F)cc3)CC2)c1
CHEMBL456673,CHEMBL217,Dopamine D2 receptor,Ki,=,1324000.0,nM,CHEMBL938581,B,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,CHEMBL1140844,KI,COc1cccc(CCc2ccccc2OCCCCN2CCN(c3ccc(F)cc3)CC2)c1
CHEMBL514098,CHEMBL217,Dopamine D2 receptor,Ki,=,847000.0,nM,CHEMBL938581,B,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,CHEMBL1140844,KI,COc1cccc(CCc2ccccc2OCCCCCN2CCN(c3ccc(F)cc3)CC2)c1
CHEMBL456674,CHEMBL217,Dopamine D2 receptor,Ki,=,629000.0,nM,CHEMBL938581,B,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,CHEMBL1140844,KI,COc1cccc(CCc2ccccc2OCCN2CCN(c3ncccn3)CC2)c1
CHEMBL456675,CHEMBL217,Dopamine D2 receptor,Ki,=,20000.0,nM,CHEMBL938581,B,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,CHEMBL1140844,KI,COc1cccc(CCc2ccccc2OCCCN2CCN(c3ncccn3)CC2)c1
CHEMBL487760,CHEMBL217,Dopamine D2 receptor,Ki,=,854000.0,nM,CHEMBL938581,B,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,CHEMBL1140844,KI,COc1cccc(CCc2ccccc2OCCCCN2CCN(c3ncccn3)CC2)c1
CHEMBL487960,CHEMBL217,Dopamine D2 receptor,Ki,=,178000.0,nM,CHEMBL938581,B,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,CHEMBL1140844,KI,COc1cccc(CCc2ccccc2OCCN2CCN(C)CC2)c1
CHEMBL518931,CHEMBL217,Dopamine D2 receptor,Ki,=,565000.0,nM,CHEMBL938581,B,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,CHEMBL1140844,KI,COc1cccc(CCc2ccccc2OCCCN2CCN(C)CC2)c1
CHEMBL485720,CHEMBL217,Dopamine D2 receptor,Ki,=,114000.0,nM,CHEMBL938581,B,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,CHEMBL1140844,KI,COc1cccc(CCc2ccccc2OCCCN2CCc3ccccc3C2)c1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,6400.0,nM,CHEMBL938581,B,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,CHEMBL1140844,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL201270,CHEMBL217,Dopamine D2 receptor,Ki,=,51.7,nM,CHEMBL938625,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,CHEMBL1140855,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-n3ccnc3)cc2)CC1
CHEMBL424667,CHEMBL217,Dopamine D2 receptor,Ki,=,31.0,nM,CHEMBL938625,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,CHEMBL1140855,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3nonc3c2)CC1
CHEMBL465014,CHEMBL217,Dopamine D2 receptor,Ki,=,121.0,nM,CHEMBL938625,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,CHEMBL1140855,KI,COc1ccccc1N1CCN(CCCNC(=O)c2ccc(-n3ccnc3)cc2)CC1
CHEMBL456232,CHEMBL217,Dopamine D2 receptor,Ki,=,89.4,nM,CHEMBL938625,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,CHEMBL1140855,KI,COc1ccccc1N1CCN(CCCNC(=O)c2ccc3nonc3c2)CC1
CHEMBL514562,CHEMBL217,Dopamine D2 receptor,Ki,=,243.0,nM,CHEMBL938625,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,CHEMBL1140855,KI,COc1cccc(N2CCN(CCCCNC(=O)c3ccc(-n4ccnc4)cc3)CC2)c1
CHEMBL456233,CHEMBL217,Dopamine D2 receptor,Ki,=,5.92,nM,CHEMBL938625,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,CHEMBL1140855,KI,O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1ccc(-n2ccnc2)cc1
CHEMBL515535,CHEMBL217,Dopamine D2 receptor,Ki,=,17.8,nM,CHEMBL938625,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,CHEMBL1140855,KI,O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1ccc2nonc2c1
CHEMBL458758,CHEMBL217,Dopamine D2 receptor,Ki,=,196.0,nM,CHEMBL938625,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,CHEMBL1140855,KI,O=C(NCCCCN1CCN(c2cccc(OCCF)c2)CC1)c1ccc(-n2ccnc2)cc1
CHEMBL514908,CHEMBL217,Dopamine D2 receptor,Ki,=,133.0,nM,CHEMBL938625,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,CHEMBL1140855,KI,COc1cc(F)cc(N2CCN(CCCCNC(=O)c3ccc(-n4ccnc4)cc3)CC2)c1
CHEMBL458354,CHEMBL217,Dopamine D2 receptor,Ki,=,1341.0,nM,CHEMBL938625,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,CHEMBL1140855,KI,COc1cc(F)cc(N2CCN(CCCCNC(=O)c3ccc4nonc4c3)CC2)c1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,4.2,nM,CHEMBL938625,B,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,CHEMBL1140855,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL476641,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL993531,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL1153914,KI,COc1ccccc1N1CCN(CCCN2CCCc3ccccc3C2=O)CC1
CHEMBL477055,CHEMBL217,Dopamine D2 receptor,Ki,=,218.78,nM,CHEMBL993531,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL1153914,KI,O=C1c2ccccc2CCCN1CCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL477250,CHEMBL217,Dopamine D2 receptor,Ki,=,12.3,nM,CHEMBL993531,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL1153914,KI,COc1ccccc1N1CCN(CCCCN2CCc3ccccc3C2=O)CC1
CHEMBL477646,CHEMBL217,Dopamine D2 receptor,Ki,=,11.48,nM,CHEMBL993531,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL1153914,KI,O=C1c2ccccc2CCN1CCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL514382,CHEMBL217,Dopamine D2 receptor,Ki,=,35.48,nM,CHEMBL993531,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL1153914,KI,O=C1c2ccccc2CCN1CCCCN1CCN(c2ccccc2Cl)CC1
CHEMBL478688,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL993531,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL1153914,KI,COc1cccc(N2CCN(CCCCN3CCc4ccccc4C3=O)CC2)c1
CHEMBL477206,CHEMBL217,Dopamine D2 receptor,Ki,=,3.631,nM,CHEMBL993531,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL1153914,KI,COc1ccccc1N1CCN(CCCCN2CCCc3ccccc3C2=O)CC1
CHEMBL476185,CHEMBL217,Dopamine D2 receptor,Ki,=,229.09,nM,CHEMBL993531,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL1153914,KI,O=C1c2ccccc2CCCN1CCCCN1CCN(c2ccccn2)CC1
CHEMBL476393,CHEMBL217,Dopamine D2 receptor,Ki,=,151.36,nM,CHEMBL993531,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL1153914,KI,O=C1c2ccccc2CCCN1CCCCN1CCN(c2ncccn2)CC1
CHEMBL476394,CHEMBL217,Dopamine D2 receptor,Ki,=,36.31,nM,CHEMBL993531,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL1153914,KI,O=C1c2ccccc2CCCN1CCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL476808,CHEMBL217,Dopamine D2 receptor,Ki,=,20.42,nM,CHEMBL993531,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL1153914,KI,COc1ccccc1N1CCN(CCCCCN2CCc3ccccc3C2=O)CC1
CHEMBL515472,CHEMBL217,Dopamine D2 receptor,Ki,=,2686.0,nM,CHEMBL961026,B,Inhibition of human cloned dopamine D2 receptor by competitive binding experiment,CHEMBL1153452,KI,COc1c(OCCF)cccc1[C@H](O)C1CCN(CCc2ccc(F)cc2)CC1
CHEMBL516088,CHEMBL217,Dopamine D2 receptor,Ki,=,3828.0,nM,CHEMBL961026,B,Inhibition of human cloned dopamine D2 receptor by competitive binding experiment,CHEMBL1153452,KI,COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(F)cc2)CC1
CHEMBL62919,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL961033,B,Binding affinity to dopamine D2 receptor by competitive binding experiment,CHEMBL1153452,KI,O=C(c1ccc(F)cc1)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1
CHEMBL74355,CHEMBL217,Dopamine D2 receptor,Ki,=,2250.0,nM,CHEMBL961033,B,Binding affinity to dopamine D2 receptor by competitive binding experiment,CHEMBL1153452,KI,COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC
CHEMBL267930,CHEMBL217,Dopamine D2 receptor,Ki,=,0.1,nM,CHEMBL1013927,B,Displacement of [3H]sulpiride from dopamine D2 receptor,CHEMBL1147348,KI,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
CHEMBL441618,CHEMBL217,Dopamine D2 receptor,Ki,=,41.69,nM,CHEMBL982103,B,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,CHEMBL1157471,KI,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL459871,CHEMBL217,Dopamine D2 receptor,Ki,=,389.05,nM,CHEMBL982103,B,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,CHEMBL1157471,KI,Oc1ccc2c(c1)CCNCCc1ccccc1C2
CHEMBL389357,CHEMBL217,Dopamine D2 receptor,Ki,=,24.55,nM,CHEMBL982103,B,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,CHEMBL1157471,KI,COc1ccc2c(c1)CCCN(C)CCc1ccccc1C2
CHEMBL508399,CHEMBL217,Dopamine D2 receptor,Ki,=,77.62,nM,CHEMBL982103,B,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,CHEMBL1157471,KI,CCN1CCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL276778,CHEMBL217,Dopamine D2 receptor,Ki,=,86.7,nM,CHEMBL982103,B,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,CHEMBL1157471,KI,COc1ccc2c(c1)CCN(C)CCCc1ccccc1C2
CHEMBL231070,CHEMBL217,Dopamine D2 receptor,Ki,=,41.69,nM,CHEMBL982103,B,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,CHEMBL1157471,KI,CN1CCCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL380330,CHEMBL217,Dopamine D2 receptor,Ki,=,12.88,nM,CHEMBL982103,B,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,CHEMBL1157471,KI,COc1ccc2c(c1)CCN(C)CCc1ccccc1C2
CHEMBL201525,CHEMBL217,Dopamine D2 receptor,Ki,=,58.88,nM,CHEMBL982103,B,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,CHEMBL1157471,KI,CN1CCc2ccccc2Cc2ccccc2CC1
CHEMBL203637,CHEMBL217,Dopamine D2 receptor,Ki,=,3.548,nM,CHEMBL982103,B,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,CHEMBL1157471,KI,CN1CCc2ccccc2Cc2ccc(O)c(Cl)c2CC1
CHEMBL201170,CHEMBL217,Dopamine D2 receptor,Ki,=,17.38,nM,CHEMBL982103,B,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,CHEMBL1157471,KI,CN1CCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL245570,CHEMBL217,Dopamine D2 receptor,Ki,=,43.65,nM,CHEMBL982103,B,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,CHEMBL1157471,KI,CN1CCc2ccccc2Cc2[nH]c3ccc(O)cc3c2CC1
CHEMBL216439,CHEMBL217,Dopamine D2 receptor,Ki,=,114.82,nM,CHEMBL982103,B,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,CHEMBL1157471,KI,CN1CCCc2c([nH]c3ccccc23)Cc2ccccc2CC1
CHEMBL216258,CHEMBL217,Dopamine D2 receptor,Ki,=,13.49,nM,CHEMBL982103,B,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,CHEMBL1157471,KI,CN1CCCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL495075,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL1009492,B,Binding affinity to dopamine D2 receptor,CHEMBL1155072,KI,O=C(N[C@H]1CCN(Cc2ccc(OC3CCNCC3)c(Br)c2)C1)c1ccc(Cl)c(Cl)c1
CHEMBL267930,CHEMBL217,Dopamine D2 receptor,Ki,=,0.44,nM,CHEMBL937845,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1155028,KI,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,98.0,nM,CHEMBL937845,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1155028,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL520610,CHEMBL217,Dopamine D2 receptor,Ki,=,328.0,nM,CHEMBL937845,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1155028,KI,CN1CCc2c3c(cc4nc(N)sc24)-c2c(ccc(O)c2O)C[C@H]31
CHEMBL289330,CHEMBL217,Dopamine D2 receptor,Ki,=,0.003,nM,CHEMBL982124,B,Binding affinity to dopamine D2 receptor,CHEMBL1157474,KI,CCN1CCC[C@H]1CNC(=O)c1cc(Br)cc(OC)c1OC
CHEMBL338337,CHEMBL217,Dopamine D2 receptor,Ki,=,540.0,nM,CHEMBL983536,B,Displacement of [3H]YM-09151-2 from human dopamine D2S receptor in membrane suspensions by liquid scintillation counter,CHEMBL1144236,KI,Cc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c(C)c1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,5.09,nM,CHEMBL983536,B,Displacement of [3H]YM-09151-2 from human dopamine D2S receptor in membrane suspensions by liquid scintillation counter,CHEMBL1144236,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL492033,CHEMBL217,Dopamine D2 receptor,Ki,=,515.0,nM,CHEMBL983536,B,Displacement of [3H]YM-09151-2 from human dopamine D2S receptor in membrane suspensions by liquid scintillation counter,CHEMBL1144236,KI,Cc1ccc(N2CCN(C[C@@H]3C[C@@H]3c3ccccc3)CC2)c(C)c1
CHEMBL523993,CHEMBL217,Dopamine D2 receptor,Ki,=,935.0,nM,CHEMBL983536,B,Displacement of [3H]YM-09151-2 from human dopamine D2S receptor in membrane suspensions by liquid scintillation counter,CHEMBL1144236,KI,Cc1ccc(N2CCN(C[C@H]3C[C@H]3c3ccccc3)CC2)c(C)c1
CHEMBL490417,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL990622,B,Binding affinity at dopamine D2 receptor,CHEMBL1142481,KI,Cc1ccc2c(N3CCN(CCc4ccc5c(c4)NC(=O)CO5)CC3)cccc2n1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,450.0,nM,CHEMBL995087,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL1142495,KI,NCCc1ccc(O)c(O)c1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,360.0,nM,CHEMBL995088,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1142495,KI,NCCc1ccc(O)c(O)c1
CHEMBL483593,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL995087,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL1142495,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CC=C(C#C[Si](C)(C)C)CC1
CHEMBL483593,CHEMBL217,Dopamine D2 receptor,Ki,=,360.0,nM,CHEMBL995088,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1142495,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CC=C(C#C[Si](C)(C)C)CC1
CHEMBL484357,CHEMBL217,Dopamine D2 receptor,Ki,=,5500.0,nM,CHEMBL995087,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL1142495,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CC=C(C#Cc2ccccc2)CC1
CHEMBL484358,CHEMBL217,Dopamine D2 receptor,Ki,=,40.0,nM,CHEMBL995087,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL1142495,KI,C#CC1=CCC(N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL484358,CHEMBL217,Dopamine D2 receptor,Ki,=,43.0,nM,CHEMBL995088,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1142495,KI,C#CC1=CCC(N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL485384,CHEMBL217,Dopamine D2 receptor,Ki,=,690.0,nM,CHEMBL995087,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL1142495,KI,CCCN(CCCCn1cc(-c2ccc(-c3ccccc3)cc2)nn1)C1CC=C(C#C[Si](C)(C)C)CC1
CHEMBL485384,CHEMBL217,Dopamine D2 receptor,Ki,=,670.0,nM,CHEMBL995088,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1142495,KI,CCCN(CCCCn1cc(-c2ccc(-c3ccccc3)cc2)nn1)C1CC=C(C#C[Si](C)(C)C)CC1
CHEMBL491466,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL995087,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL1142495,KI,CCCN(CCCCn1cc(-c2ccc(-c3ccccc3)cc2)nn1)C1CC=C(C#Cc2ccccc2)CC1
CHEMBL491466,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL995088,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1142495,KI,CCCN(CCCCn1cc(-c2ccc(-c3ccccc3)cc2)nn1)C1CC=C(C#Cc2ccccc2)CC1
CHEMBL484202,CHEMBL217,Dopamine D2 receptor,Ki,=,610.0,nM,CHEMBL995087,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL1142495,KI,C#CC1=CCC(N(CCC)CCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)CC1
CHEMBL484202,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL995088,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1142495,KI,C#CC1=CCC(N(CCC)CCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)CC1
CHEMBL484203,CHEMBL217,Dopamine D2 receptor,Ki,=,4100.0,nM,CHEMBL995087,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL1142495,KI,CC#CC1=CCC(N(CCC)CCCCn2cc(C)nn2)CC1
CHEMBL484203,CHEMBL217,Dopamine D2 receptor,Ki,=,2100.0,nM,CHEMBL995088,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1142495,KI,CC#CC1=CCC(N(CCC)CCCCn2cc(C)nn2)CC1
CHEMBL444128,CHEMBL217,Dopamine D2 receptor,Ki,=,21000.0,nM,CHEMBL995087,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL1142495,KI,CCCNCCCCNC(=O)c1ccc(-c2ccccc2)cc1
CHEMBL484204,CHEMBL217,Dopamine D2 receptor,Ki,=,9700.0,nM,CHEMBL995087,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL1142495,KI,CCCN(CCC)CCCCNC(=O)c1ccc(-c2ccccc2)cc1
CHEMBL484204,CHEMBL217,Dopamine D2 receptor,Ki,=,8800.0,nM,CHEMBL995088,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1142495,KI,CCCN(CCC)CCCCNC(=O)c1ccc(-c2ccccc2)cc1
CHEMBL485227,CHEMBL217,Dopamine D2 receptor,Ki,=,4700.0,nM,CHEMBL995087,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL1142495,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCCCC1
CHEMBL485227,CHEMBL217,Dopamine D2 receptor,Ki,=,6300.0,nM,CHEMBL995088,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1142495,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCCCC1
CHEMBL484538,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL993385,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1142503,KI,Br.Cc1cccc(-c2c(O)c(O)cc3c2CCN(C)CC3c2cccc(C)c2)c1
CHEMBL520821,CHEMBL217,Dopamine D2 receptor,Ki,=,29.0,nM,CHEMBL993385,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1142503,KI,Br.Cc1cccc(C2CN(C)CCc3c2cc(O)c(O)c3-c2ccc3ccccc3c2)c1
CHEMBL484357,CHEMBL217,Dopamine D2 receptor,Ki,=,4700.0,nM,CHEMBL995088,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1142495,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CC=C(C#Cc2ccccc2)CC1
CHEMBL86760,CHEMBL217,Dopamine D2 receptor,Ki,=,6280.0,nM,CHEMBL994219,B,Displacement of [3H]spiperone from dopamine D2 receptor,CHEMBL1142528,KI,CCCCCCc1ccc2c(c1)Cc1ccccc1C2CN
CHEMBL458001,CHEMBL217,Dopamine D2 receptor,Ki,=,5248.07,nM,CHEMBL991395,B,Displacement of [125I]iodosulpiride from dopamine D2 receptor expressed in CHO cells,CHEMBL1143385,KI,O=C(Nc1cccc(Cn2ncc(N3CCNCC3)c(Cl)c2=O)c1)c1ccc(-c2ccccc2)cc1
CHEMBL458002,CHEMBL217,Dopamine D2 receptor,Ki,=,4897.79,nM,CHEMBL991395,B,Displacement of [125I]iodosulpiride from dopamine D2 receptor expressed in CHO cells,CHEMBL1143385,KI,Cc1ccc(Cn2ncc(N3CCNCC3)c(Cl)c2=O)cc1NC(=O)c1ccc(-c2ccccc2)cc1
CHEMBL458220,CHEMBL217,Dopamine D2 receptor,Ki,=,5128.61,nM,CHEMBL991395,B,Displacement of [125I]iodosulpiride from dopamine D2 receptor expressed in CHO cells,CHEMBL1143385,KI,Cc1c(Cn2ncc(N3CCNCC3)c(Cl)c2=O)cccc1NC(=O)c1ccc(-c2ccccc2)cc1
CHEMBL519688,CHEMBL217,Dopamine D2 receptor,Ki,=,4570.88,nM,CHEMBL981461,B,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1154395,KI,CCCCNC(=O)c1ccc2c(c1)[C@H]1OCCN(CCC)[C@@H]1CC2
CHEMBL482556,CHEMBL217,Dopamine D2 receptor,Ki,=,1202.26,nM,CHEMBL981461,B,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1154395,KI,CCCN1CCO[C@@H]2c3cc4c(=O)[nH]ccc4cc3CC[C@H]21
CHEMBL485325,CHEMBL217,Dopamine D2 receptor,Ki,=,1479.11,nM,CHEMBL981461,B,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1154395,KI,CCCN1CCO[C@@H]2c3cc4c(cc3CC[C@H]21)CCOC4=O
CHEMBL485029,CHEMBL217,Dopamine D2 receptor,Ki,=,1862.09,nM,CHEMBL981461,B,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1154395,KI,CCCN1CCO[C@@H]2c3cc(C(=O)N(C)C)ccc3CC[C@H]21
CHEMBL589,CHEMBL217,Dopamine D2 receptor,Ki,=,691.83,nM,CHEMBL981461,B,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1154395,KI,CCCN(CCC)CCc1cccc2c1CC(=O)N2
CHEMBL485027,CHEMBL217,Dopamine D2 receptor,Ki,=,3388.44,nM,CHEMBL981461,B,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1154395,KI,CCCN1CCO[C@@H]2c3cc(C(=O)NCc4ccc(OC)cc4)ccc3CC[C@H]21
CHEMBL485127,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL981461,B,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1154395,KI,CCCN1CCO[C@H]2c3cc4c(cc3CC[C@@H]21)CNC4=O
CHEMBL484170,CHEMBL217,Dopamine D2 receptor,Ki,=,7943.28,nM,CHEMBL981461,B,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1154395,KI,CCCN1CCO[C@@H]2c3cc(C(=O)NC)ccc3CC[C@H]21
CHEMBL484732,CHEMBL217,Dopamine D2 receptor,Ki,=,776.25,nM,CHEMBL981461,B,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1154395,KI,CCCN1CCO[C@@H]2c3cc4c(cc3CC[C@H]21)CCNC4=O
CHEMBL449250,CHEMBL217,Dopamine D2 receptor,Ki,=,758.58,nM,CHEMBL981461,B,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1154395,KI,CCCN1CCOC2c3cc(C(N)=O)ccc3CCC21
CHEMBL484599,CHEMBL217,Dopamine D2 receptor,Ki,=,1202.26,nM,CHEMBL981461,B,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1154395,KI,CCCN1CCO[C@@H]2c3cc(C(N)=O)ccc3CC[C@H]21
CHEMBL482978,CHEMBL217,Dopamine D2 receptor,Ki,=,3090.3,nM,CHEMBL981461,B,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1154395,KI,CCCN1CCO[C@@H]2c3cc(C(C)=O)ccc3CC[C@H]21
CHEMBL485352,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL981461,B,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1154395,KI,CCCN1CCO[C@@H]2c3cc(C#N)ccc3CC[C@H]21
CHEMBL484598,CHEMBL217,Dopamine D2 receptor,Ki,=,831.76,nM,CHEMBL981461,B,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1154395,KI,CCCN1CCO[C@@H]2c3cc4c(cc3CC[C@H]21)CNC4=O
CHEMBL485128,CHEMBL217,Dopamine D2 receptor,Ki,=,2041.74,nM,CHEMBL981461,B,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1154395,KI,CCCN1CCO[C@@H]2c3cc4c(cc3CC[C@H]21)COC4=O
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL992743,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1155799,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.4,nM,CHEMBL992743,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1155799,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL716,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL992743,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1155799,KI,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL992743,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1155799,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL708,CHEMBL217,Dopamine D2 receptor,Ki,=,3.1,nM,CHEMBL992743,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1155799,KI,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,2.2,nM,CHEMBL992743,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1155799,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL476109,CHEMBL217,Dopamine D2 receptor,Ki,=,178.4,nM,CHEMBL992743,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1155799,KI,O=C(CCCN1C2CCC1CN(c1ccc(Cl)cc1)CC2)c1ccc(F)cc1
CHEMBL476108,CHEMBL217,Dopamine D2 receptor,Ki,=,43.3,nM,CHEMBL992743,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1155799,KI,O=C(CCCN1CCCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL140872,CHEMBL217,Dopamine D2 receptor,Ki,=,98.0,nM,CHEMBL992743,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1155799,KI,O=C(CCCN1CCN(c2ncccn2)CC1)c1ccc(F)cc1
CHEMBL476934,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL992743,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1155799,KI,O=C(CCCN1CC2CC1CN2c1ccc(Cl)cc1)c1ccc(F)cc1
CHEMBL476933,CHEMBL217,Dopamine D2 receptor,Ki,=,155.0,nM,CHEMBL992743,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1155799,KI,O=C(CCCN1CC2CCC(C1)N2c1ccccc1)c1ccc(F)cc1
CHEMBL150161,CHEMBL217,Dopamine D2 receptor,Ki,=,489.4,nM,CHEMBL992743,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1155799,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1
CHEMBL150161,CHEMBL217,Dopamine D2 receptor,Ki,=,51.1,nM,CHEMBL992743,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1155799,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1
CHEMBL340816,CHEMBL217,Dopamine D2 receptor,Ki,=,124.4,nM,CHEMBL992743,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1155799,KI,O=C(CCCN1C2CCC1CC(c1ccccc1)C2)c1ccc(F)cc1
CHEMBL478617,CHEMBL217,Dopamine D2 receptor,Ki,=,2.3,nM,CHEMBL992743,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1155799,KI,O=C(CCCN1C2CCC1CC(O)(c1ccccc1)C2)c1ccc(F)cc1
CHEMBL210578,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL992743,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1155799,KI,O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1
CHEMBL476935,CHEMBL217,Dopamine D2 receptor,Ki,=,253.5,nM,CHEMBL992743,B,Binding affinity to human cloned dopamine D2 receptor,CHEMBL1155799,KI,O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL629,CHEMBL217,Dopamine D2 receptor,Ki,=,196.0,nM,CHEMBL1030600,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1149085,KI,CN(C)CCC=C1c2ccccc2CCc2ccccc21
CHEMBL457957,CHEMBL217,Dopamine D2 receptor,Ki,=,904.0,nM,CHEMBL1030600,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1149085,KI,CN(CCC=C1c2ccccc2CCc2ccccc21)C(=O)Cc1ccc(OCCCN2CCCCC2)cc1
CHEMBL459350,CHEMBL217,Dopamine D2 receptor,Ki,=,101.0,nM,CHEMBL1030600,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1149085,KI,CN(CCC=C1c2ccccc2CCc2ccccc21)Cc1ccc(OCCCN2CCCCC2)cc1
CHEMBL21731,CHEMBL217,Dopamine D2 receptor,Ki,=,665.0,nM,CHEMBL1030600,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1149085,KI,CNCCCC12CCC(c3ccccc31)c1ccccc12
CHEMBL517244,CHEMBL217,Dopamine D2 receptor,Ki,=,146.0,nM,CHEMBL1030600,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1149085,KI,CN(CCCC12CCC(c3ccccc31)c1ccccc12)Cc1ccc(OCCCN2CCCCC2)cc1
CHEMBL71,CHEMBL217,Dopamine D2 receptor,Ki,=,4.06,nM,CHEMBL1030600,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1149085,KI,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL459373,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL1030600,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1149085,KI,CN(CCCN1c2ccccc2Sc2ccc(Cl)cc21)Cc1ccc(OCCCN2CCCCC2)cc1
CHEMBL908,CHEMBL217,Dopamine D2 receptor,Ki,=,2.96,nM,CHEMBL1030600,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1149085,KI,CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21
CHEMBL517407,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL1030600,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1149085,KI,CN(CC/C=C1\c2ccccc2Sc2ccc(Cl)cc21)Cc1ccc(OCCCN2CCCCC2)cc1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,83.0,nM,CHEMBL1030600,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1149085,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL464811,CHEMBL217,Dopamine D2 receptor,Ki,=,285.0,nM,CHEMBL1030600,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1149085,KI,Clc1ccc2c(c1)N=C(N1CCN(Cc3ccc(OCCCN4CCCCC4)cc3)CC1)c1ccccc1N2
CHEMBL726,CHEMBL217,Dopamine D2 receptor,Ki,=,1.44,nM,CHEMBL1030600,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1149085,KI,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
CHEMBL455288,CHEMBL217,Dopamine D2 receptor,Ki,=,47.0,nM,CHEMBL1030600,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1149085,KI,O=C(OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1)c1ccc(OCCCN2CCCCC2)cc1
CHEMBL210578,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL1033197,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1152692,KI,O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1
CHEMBL456429,CHEMBL217,Dopamine D2 receptor,Ki,=,1231.0,nM,CHEMBL1033197,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1152692,KI,O=C(CN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1
CHEMBL456430,CHEMBL217,Dopamine D2 receptor,Ki,=,1050.0,nM,CHEMBL1033197,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1152692,KI,OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2Cc1ccc(F)cc1
CHEMBL514590,CHEMBL217,Dopamine D2 receptor,Ki,=,588.0,nM,CHEMBL1033197,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1152692,KI,OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2Cc1c[nH]c2ncccc12
CHEMBL3084502,CHEMBL217,Dopamine D2 receptor,Ki,=,160.3,nM,CHEMBL1033197,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1152692,KI,O[C@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12
CHEMBL460854,CHEMBL217,Dopamine D2 receptor,Ki,=,53.0,nM,CHEMBL1033197,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1152692,KI,OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2CCc1c[nH]c2ccccc12
CHEMBL460223,CHEMBL217,Dopamine D2 receptor,Ki,=,970.0,nM,CHEMBL1033197,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1152692,KI,Clc1ccc(N2CCCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL514591,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL1033197,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1152692,KI,O=C(CCCN1CC2CC1N(c1ccc(Cl)cc1)C2)c1ccc(F)cc1
CHEMBL514747,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL1033197,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1152692,KI,Clc1ccc(N2CC3CC2CN3Cc2c[nH]c3ncccc23)cc1
CHEMBL150161,CHEMBL217,Dopamine D2 receptor,Ki,=,33.0,nM,CHEMBL1033197,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1152692,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1
CHEMBL460644,CHEMBL217,Dopamine D2 receptor,Ki,=,1170.0,nM,CHEMBL1033197,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1152692,KI,c1cnc(N2CCN(Cc3c[nH]c4ncccc34)CC2)nc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.1,nM,CHEMBL1033197,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1152692,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL476935,CHEMBL217,Dopamine D2 receptor,Ki,=,254.0,nM,CHEMBL1033197,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1152692,KI,O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL445102,CHEMBL217,Dopamine D2 receptor,Ki,=,11.2,nM,CHEMBL1033197,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1152692,KI,OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,960.0,nM,CHEMBL1033197,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1152692,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL550222,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL1031094,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor E181V/I183S mutant expressed in HEK293 cells,CHEMBL1158482,KI,CSc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL142020,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL1031094,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor E181V/I183S mutant expressed in HEK293 cells,CHEMBL1158482,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL561763,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL1031094,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor E181V/I183S mutant expressed in HEK293 cells,CHEMBL1158482,KI,CSc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL140612,CHEMBL217,Dopamine D2 receptor,Ki,=,83.0,nM,CHEMBL1031094,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor E181V/I183S mutant expressed in HEK293 cells,CHEMBL1158482,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL562620,CHEMBL217,Dopamine D2 receptor,Ki,=,3600.0,nM,CHEMBL1031094,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor E181V/I183S mutant expressed in HEK293 cells,CHEMBL1158482,KI,COc1ccccc1N1CCN(Cc2cc3ccccn3n2)CC1
CHEMBL310843,CHEMBL217,Dopamine D2 receptor,Ki,=,47000.0,nM,CHEMBL1031094,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor E181V/I183S mutant expressed in HEK293 cells,CHEMBL1158482,KI,Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1
CHEMBL550222,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL1031088,B,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1158482,KI,CSc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL142020,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL1031088,B,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1158482,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL561763,CHEMBL217,Dopamine D2 receptor,Ki,=,2.2,nM,CHEMBL1031088,B,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1158482,KI,CSc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL140612,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL1031088,B,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1158482,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL562620,CHEMBL217,Dopamine D2 receptor,Ki,=,350.0,nM,CHEMBL1031088,B,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1158482,KI,COc1ccccc1N1CCN(Cc2cc3ccccn3n2)CC1
CHEMBL561622,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL1031088,B,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1158482,KI,Clc1ccc(N2CCN(CCCCCc3cc4ccccn4n3)CC2)cc1
CHEMBL310843,CHEMBL217,Dopamine D2 receptor,Ki,=,2300.0,nM,CHEMBL1031088,B,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,CHEMBL1158482,KI,Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1
CHEMBL550222,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL1031082,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1158482,KI,CSc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL142020,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL1031082,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1158482,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL561763,CHEMBL217,Dopamine D2 receptor,Ki,=,1.4,nM,CHEMBL1031082,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1158482,KI,CSc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL140612,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL1031082,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1158482,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL562620,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL1031082,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1158482,KI,COc1ccccc1N1CCN(Cc2cc3ccccn3n2)CC1
CHEMBL561622,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL1031082,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1158482,KI,Clc1ccc(N2CCN(CCCCCc3cc4ccccn4n3)CC2)cc1
CHEMBL310843,CHEMBL217,Dopamine D2 receptor,Ki,=,3400.0,nM,CHEMBL1031082,B,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,CHEMBL1158482,KI,Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1
CHEMBL551964,CHEMBL217,Dopamine D2 receptor,Ki,=,1306.0,nM,CHEMBL1062991,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL1151947,KI,Cc1ccc2c3c(ccc2n1)OC[C@H](CN1CCN(c2ccc4cc(C#N)ccc4n2)CC1)O3
CHEMBL552373,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL1057891,B,Binding affinity to human dopamine D2 receptor by filtration binding assay,CHEMBL1152393,KI,N#Cc1cccc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)c1
CHEMBL563614,CHEMBL217,Dopamine D2 receptor,Ki,=,2300.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,COc1ccccc1N1CCN(Cc2c(C)nc3cc(C)nc(C)n23)CC1
CHEMBL564709,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,COc1ccc(N2CCN(Cc3c(C)nc4cc(C)nc(C)n34)CC2)cc1
CHEMBL561262,CHEMBL217,Dopamine D2 receptor,Ki,=,40000.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,COc1ccccc1N1CCN(Cc2c(C)nc3cc(C)ncn23)CC1
CHEMBL550920,CHEMBL217,Dopamine D2 receptor,Ki,=,9100.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,COc1ccc(N2CCN(Cc3c(C)nc4cc(C)ncn34)CC2)cc1
CHEMBL552268,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,COc1ccccc1N1CCN(Cc2cc3c(=O)[nH]c(N(C)C)nc3[nH]2)CC1
CHEMBL559868,CHEMBL217,Dopamine D2 receptor,Ki,=,2600.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,Clc1nccc2c(CN3CCN(c4ccccc4)CC3)c[nH]c12
CHEMBL558838,CHEMBL217,Dopamine D2 receptor,Ki,=,2900.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,COc1ccccc1N1CCN(Cc2c(C)[nH]c3nc(N(C)C)ncc23)CC1
CHEMBL550392,CHEMBL217,Dopamine D2 receptor,Ki,=,8600.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,Cc1cc2nc(C)c(CN3CCN(c4ccccc4)CC3)n2c(C)n1
CHEMBL554692,CHEMBL217,Dopamine D2 receptor,Ki,=,26000.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,Cc1cc2nc(C)c(CN3CCN(c4ccc(Cl)cc4)CC3)n2c(C)n1
CHEMBL563078,CHEMBL217,Dopamine D2 receptor,Ki,=,3300.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,Cc1cc2nc(C)c(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)n2c(C)n1
CHEMBL562384,CHEMBL217,Dopamine D2 receptor,Ki,=,17000.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,Cc1cc2nc(C)c(CN3CCN(c4ccccn4)CC3)n2c(C)n1
CHEMBL549638,CHEMBL217,Dopamine D2 receptor,Ki,=,4700.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,Cc1cc2nc(C)c(CN3CCN(c4ccc(F)cc4)CC3)n2c(C)n1
CHEMBL563109,CHEMBL217,Dopamine D2 receptor,Ki,=,1300.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,COc1ccccc1N1CCN(Cc2cnc3cc(C)nc(C)n23)CC1
CHEMBL556288,CHEMBL217,Dopamine D2 receptor,Ki,=,390.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,Cn1c(N2CCCC2)nc2c(CN3CCN(c4ccccc4)CC3)c[nH]c2c1=O
CHEMBL564688,CHEMBL217,Dopamine D2 receptor,Ki,=,570.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,Cn1c(N2CCCC2)nc2c(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)c[nH]c2c1=O
CHEMBL551199,CHEMBL217,Dopamine D2 receptor,Ki,=,270.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,Cn1c(N2CCCC2)nc2c(CN3CCN(c4ccccn4)CC3)c[nH]c2c1=O
CHEMBL559399,CHEMBL217,Dopamine D2 receptor,Ki,=,840.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,Cn1c(N2CCCC2)nc2c(CN3CCN(c4ccc(F)cc4)CC3)c[nH]c2c1=O
CHEMBL561123,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,Cn1c(N2CCOCC2)nc2c(CN3CCN(c4ccccc4)CC3)c[nH]c2c1=O
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,54000.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL563614,CHEMBL217,Dopamine D2 receptor,Ki,=,2900.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,COc1ccccc1N1CCN(Cc2c(C)nc3cc(C)nc(C)n23)CC1
CHEMBL564709,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,COc1ccc(N2CCN(Cc3c(C)nc4cc(C)nc(C)n34)CC2)cc1
CHEMBL561262,CHEMBL217,Dopamine D2 receptor,Ki,=,53000.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,COc1ccccc1N1CCN(Cc2c(C)nc3cc(C)ncn23)CC1
CHEMBL550920,CHEMBL217,Dopamine D2 receptor,Ki,=,13000.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,COc1ccc(N2CCN(Cc3c(C)nc4cc(C)ncn34)CC2)cc1
CHEMBL552268,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,COc1ccccc1N1CCN(Cc2cc3c(=O)[nH]c(N(C)C)nc3[nH]2)CC1
CHEMBL559868,CHEMBL217,Dopamine D2 receptor,Ki,=,2900.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,Clc1nccc2c(CN3CCN(c4ccccc4)CC3)c[nH]c12
CHEMBL550392,CHEMBL217,Dopamine D2 receptor,Ki,=,11000.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,Cc1cc2nc(C)c(CN3CCN(c4ccccc4)CC3)n2c(C)n1
CHEMBL554692,CHEMBL217,Dopamine D2 receptor,Ki,=,57000.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,Cc1cc2nc(C)c(CN3CCN(c4ccc(Cl)cc4)CC3)n2c(C)n1
CHEMBL563078,CHEMBL217,Dopamine D2 receptor,Ki,=,5500.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,Cc1cc2nc(C)c(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)n2c(C)n1
CHEMBL562384,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,Cc1cc2nc(C)c(CN3CCN(c4ccccn4)CC3)n2c(C)n1
CHEMBL549638,CHEMBL217,Dopamine D2 receptor,Ki,=,3500.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,Cc1cc2nc(C)c(CN3CCN(c4ccc(F)cc4)CC3)n2c(C)n1
CHEMBL563109,CHEMBL217,Dopamine D2 receptor,Ki,=,570.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,COc1ccccc1N1CCN(Cc2cnc3cc(C)nc(C)n23)CC1
CHEMBL556288,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,Cn1c(N2CCCC2)nc2c(CN3CCN(c4ccccc4)CC3)c[nH]c2c1=O
CHEMBL564688,CHEMBL217,Dopamine D2 receptor,Ki,=,380.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,Cn1c(N2CCCC2)nc2c(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)c[nH]c2c1=O
CHEMBL551199,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,Cn1c(N2CCCC2)nc2c(CN3CCN(c4ccccn4)CC3)c[nH]c2c1=O
CHEMBL559399,CHEMBL217,Dopamine D2 receptor,Ki,=,400.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,Cn1c(N2CCCC2)nc2c(CN3CCN(c4ccc(F)cc4)CC3)c[nH]c2c1=O
CHEMBL561123,CHEMBL217,Dopamine D2 receptor,Ki,=,730.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,Cn1c(N2CCOCC2)nc2c(CN3CCN(c4ccccc4)CC3)c[nH]c2c1=O
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,38000.0,nM,CHEMBL1061433,B,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,CHEMBL1152959,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL558838,CHEMBL217,Dopamine D2 receptor,Ki,=,2600.0,nM,CHEMBL1061432,B,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,CHEMBL1152959,KI,COc1ccccc1N1CCN(Cc2c(C)[nH]c3nc(N(C)C)ncc23)CC1
CHEMBL574595,CHEMBL217,Dopamine D2 receptor,Ki,=,39.1,nM,CHEMBL1041331,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1154108,KI,COc1ccccc1N1CCN(CCCn2cc(CCCN3CCc4cc(O)c(O)cc4C(c4ccccc4C)C3)nn2)CC1
CHEMBL585740,CHEMBL217,Dopamine D2 receptor,Ki,=,115.0,nM,CHEMBL1041331,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1154108,KI,COc1ccccc1N1CCN(CCCn2cc(CCCN3CCc4cc(O)c(O)cc4C(c4cccc(C)c4)C3)nn2)CC1
CHEMBL585741,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL1041331,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1154108,KI,Cc1cccc(C2CN(CCCc3cn(CCCN4CCN(c5nsc6ccccc56)CC4)nn3)CCc3cc(O)c(O)cc32)c1
CHEMBL582945,CHEMBL217,Dopamine D2 receptor,Ki,=,80.0,nM,CHEMBL1041331,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1154108,KI,COc1ccccc1N1CCN(CCCn2cc(CCCCN3CCc4cc(O)c(O)cc4C(c4cccc(C)c4)C3)nn2)CC1
CHEMBL574700,CHEMBL217,Dopamine D2 receptor,Ki,=,19.1,nM,CHEMBL1041331,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1154108,KI,COc1ccccc1N1CCN(CCCc2cn(CCCN3CCc4cc(O)c(O)cc4C(c4ccccc4C)C3)nn2)CC1
CHEMBL286080,CHEMBL217,Dopamine D2 receptor,Ki,=,720000.0,nM,CHEMBL1041332,B,Binding affinity to dopamine D2 receptor,CHEMBL1154108,KI,Oc1cc2c(cc1O)C(c1ccccc1)CNCC2
CHEMBL573791,CHEMBL217,Dopamine D2 receptor,Ki,=,6.5,nM,CHEMBL1044860,B,Binding affinity to human cloned dopamine D2-long expressed in CHO cells,CHEMBL1154112,KI,COc1ccccc1N1CCN(CCNC(=O)c2cn(-c3ccc([N+](=O)[O-])cc3)nn2)CC1
CHEMBL573792,CHEMBL217,Dopamine D2 receptor,Ki,=,810.0,nM,CHEMBL1044860,B,Binding affinity to human cloned dopamine D2-long expressed in CHO cells,CHEMBL1154112,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cn(-c2ccc([N+](=O)[O-])cc2)nn1
CHEMBL574030,CHEMBL217,Dopamine D2 receptor,Ki,=,49.0,nM,CHEMBL1044860,B,Binding affinity to human cloned dopamine D2-long expressed in CHO cells,CHEMBL1154112,KI,COc1ccc(-n2cc(C(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nn2)cc1
CHEMBL572379,CHEMBL217,Dopamine D2 receptor,Ki,=,53.0,nM,CHEMBL1044860,B,Binding affinity to human cloned dopamine D2-long expressed in CHO cells,CHEMBL1154112,KI,O=C(CCCc1cn(-c2ccc([N+](=O)[O-])cc2)nn1)NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL572867,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL1044860,B,Binding affinity to human cloned dopamine D2-long expressed in CHO cells,CHEMBL1154112,KI,COc1ccc(-n2cc(CCCC(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nn2)cc1
CHEMBL573791,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL1044861,B,Binding affinity to human cloned dopamine D2-short expressed in CHO cells,CHEMBL1154112,KI,COc1ccccc1N1CCN(CCNC(=O)c2cn(-c3ccc([N+](=O)[O-])cc3)nn2)CC1
CHEMBL573792,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL1044861,B,Binding affinity to human cloned dopamine D2-short expressed in CHO cells,CHEMBL1154112,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cn(-c2ccc([N+](=O)[O-])cc2)nn1
CHEMBL574030,CHEMBL217,Dopamine D2 receptor,Ki,=,1700.0,nM,CHEMBL1044861,B,Binding affinity to human cloned dopamine D2-short expressed in CHO cells,CHEMBL1154112,KI,COc1ccc(-n2cc(C(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nn2)cc1
CHEMBL572379,CHEMBL217,Dopamine D2 receptor,Ki,=,44.0,nM,CHEMBL1044861,B,Binding affinity to human cloned dopamine D2-short expressed in CHO cells,CHEMBL1154112,KI,O=C(CCCc1cn(-c2ccc([N+](=O)[O-])cc2)nn1)NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL572867,CHEMBL217,Dopamine D2 receptor,Ki,=,68.0,nM,CHEMBL1044861,B,Binding affinity to human cloned dopamine D2-short expressed in CHO cells,CHEMBL1154112,KI,COc1ccc(-n2cc(CCCC(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nn2)cc1
CHEMBL575760,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL1059279,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1154195,KI,O=C1CC(CN2CCC(C(=O)c3ccc(F)cc3)CC2)Cc2ncncc21
CHEMBL572708,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL1059279,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1154195,KI,O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2ncncc21
CHEMBL566508,CHEMBL217,Dopamine D2 receptor,Ki,=,32.36,nM,CHEMBL1059279,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1154195,KI,CSc1ncc2c(n1)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)CC2=O
CHEMBL583772,CHEMBL217,Dopamine D2 receptor,Ki,=,234.42,nM,CHEMBL1059279,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1154195,KI,CNc1ncc2c(n1)CC(CN1CCC(C(=O)c3ccc(F)cc3)CC1)CC2=O
CHEMBL576756,CHEMBL217,Dopamine D2 receptor,Ki,=,48.98,nM,CHEMBL1059279,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1154195,KI,CNc1ncc2c(n1)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)CC2=O
CHEMBL575788,CHEMBL217,Dopamine D2 receptor,Ki,=,33.88,nM,CHEMBL1059279,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1154195,KI,O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2nc(-c3ccccc3)ncc21
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.6026,nM,CHEMBL1059279,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1154195,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,223.87,nM,CHEMBL1059279,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1154195,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,6.166,nM,CHEMBL1059279,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,CHEMBL1154195,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL574569,CHEMBL217,Dopamine D2 receptor,Ki,=,15000.0,nM,CHEMBL1059353,B,Displacement of [3H]spiperone from human cloned dopamine D2long receptor expressed in CHO cells,CHEMBL1154597,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(-c3cn(Cc4ccc(-c5ccc(Cn6cc(-c7cccc(C(=O)NCCCCN8CCN(c9ccccc9OC)CC8)c7)nn6)cc5)cc4)nn3)c2)CC1
CHEMBL574569,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL1059354,B,Displacement of [3H]spiperone from human cloned dopamine D2short receptor expressed in CHO cells,CHEMBL1154597,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(-c3cn(Cc4ccc(-c5ccc(Cn6cc(-c7cccc(C(=O)NCCCCN8CCN(c9ccccc9OC)CC8)c7)nn6)cc5)cc4)nn3)c2)CC1
CHEMBL574534,CHEMBL217,Dopamine D2 receptor,Ki,=,2000.0,nM,CHEMBL1059353,B,Displacement of [3H]spiperone from human cloned dopamine D2long receptor expressed in CHO cells,CHEMBL1154597,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3cn(Cc4ccc(-c5ccc(Cn6cc(-c7ccc(C(=O)NCCCCN8CCN(c9ccccc9OC)CC8)cc7)nn6)cc5)cc4)nn3)cc2)CC1
CHEMBL574534,CHEMBL217,Dopamine D2 receptor,Ki,=,770.0,nM,CHEMBL1059354,B,Displacement of [3H]spiperone from human cloned dopamine D2short receptor expressed in CHO cells,CHEMBL1154597,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3cn(Cc4ccc(-c5ccc(Cn6cc(-c7ccc(C(=O)NCCCCN8CCN(c9ccccc9OC)CC8)cc7)nn6)cc5)cc4)nn3)cc2)CC1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,950.0,nM,CHEMBL1059353,B,Displacement of [3H]spiperone from human cloned dopamine D2long receptor expressed in CHO cells,CHEMBL1154597,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,870.0,nM,CHEMBL1059354,B,Displacement of [3H]spiperone from human cloned dopamine D2short receptor expressed in CHO cells,CHEMBL1154597,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL514885,CHEMBL217,Dopamine D2 receptor,Ki,=,264.0,nM,CHEMBL1050539,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1156805,KI,CCCN(CCN1CCN(c2ccc(-c3ccccc3)cc2)CC1)[C@H]1CCc2nc(N)sc2C1
CHEMBL301559,CHEMBL217,Dopamine D2 receptor,Ki,=,202.0,nM,CHEMBL1050539,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1156805,KI,CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1
CHEMBL570188,CHEMBL217,Dopamine D2 receptor,Ki,=,270.0,nM,CHEMBL1050539,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1156805,KI,CCCN(CCN1CCN(c2ccc(-c3ccncc3)cc2)CC1)[C@H]1CCc2nc(N)sc2C1
CHEMBL571992,CHEMBL217,Dopamine D2 receptor,Ki,=,269.0,nM,CHEMBL1050539,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1156805,KI,CCCN(CCN1CCN(c2nccc3ccccc23)CC1)[C@H]1CCc2nc(N)sc2C1
CHEMBL577073,CHEMBL217,Dopamine D2 receptor,Ki,=,109.0,nM,CHEMBL1050539,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1156805,KI,CCCN(CCN1CCN(c2ccnc3ccccc23)CC1)[C@H]1CCc2nc(N)sc2C1
CHEMBL273273,CHEMBL217,Dopamine D2 receptor,Ki,=,58.8,nM,CHEMBL1050539,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1156805,KI,CCCN(CCC)C1CCc2c(O)cccc2C1
CHEMBL457025,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL1050539,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1156805,KI,CCCN(CCN1CCN(c2ccccc2)CC1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL569746,CHEMBL217,Dopamine D2 receptor,Ki,=,47.5,nM,CHEMBL1050539,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1156805,KI,CCCN(CCN1CCN(C(=O)c2cc3ccccc3[nH]2)CC1)[C@H]1CCc2c(O)cccc2C1
CHEMBL569322,CHEMBL217,Dopamine D2 receptor,Ki,=,21.7,nM,CHEMBL1050539,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1156805,KI,CCCN(CCN1CCN(c2nccc3ccccc23)CC1)C1CCc2ccc(O)cc2C1
CHEMBL456825,CHEMBL217,Dopamine D2 receptor,Ki,=,40.6,nM,CHEMBL1050539,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1156805,KI,CCCN(CCN1CCN(c2ccccc2)CC1)[C@@H]1CCc2ccc(O)cc2C1
CHEMBL569107,CHEMBL217,Dopamine D2 receptor,Ki,=,57.7,nM,CHEMBL1050539,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1156805,KI,CCCN(CCN1CCN(c2cccc3ncccc23)CC1)[C@H]1CCc2nc(N)sc2C1
CHEMBL569747,CHEMBL217,Dopamine D2 receptor,Ki,=,13.5,nM,CHEMBL1050539,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1156805,KI,CCCN(CCN1CCN(c2cccc3ccccc23)CC1)C1CCc2ccc(O)cc2C1
CHEMBL569003,CHEMBL217,Dopamine D2 receptor,Ki,=,8.85,nM,CHEMBL1050539,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1156805,KI,CCCN(CCN1CCN(c2ccc3ccccc3c2)CC1)C1CCc2ccc(O)cc2C1
CHEMBL568822,CHEMBL217,Dopamine D2 receptor,Ki,=,5.22,nM,CHEMBL1050539,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1156805,KI,CCCN(CCN1CCN(c2cccc3ncccc23)CC1)C1CCc2ccc(O)cc2C1
CHEMBL569977,CHEMBL217,Dopamine D2 receptor,Ki,=,3.74,nM,CHEMBL1050539,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1156805,KI,CCCN(CCN1CCN(c2ccnc3ccccc23)CC1)[C@H]1CCc2c(cccc2OC)C1
CHEMBL570187,CHEMBL217,Dopamine D2 receptor,Ki,=,7.08,nM,CHEMBL1050539,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1156805,KI,CCCN(CCN1CCN(c2ccnc3ccccc23)CC1)C1CCc2ccc(O)cc2C1
CHEMBL568801,CHEMBL217,Dopamine D2 receptor,Ki,=,4.89,nM,CHEMBL1050539,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL1156805,KI,CCCN(CCN1CCN(c2ccnc3ccccc23)CC1)C1CCc2c(cccc2OC)C1
CHEMBL565935,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=C1Cc2c(ccc3c2OC[C@H](CNCC2CCc4c([nH]c5ccc(F)cc45)C2)O3)N1
CHEMBL566155,CHEMBL217,Dopamine D2 receptor,Ki,=,36.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=C1Cc2c(ccc3c2OC[C@H](CNCCC2CCc4c([nH]c5ccc(F)cc45)C2)O3)N1
CHEMBL566379,CHEMBL217,Dopamine D2 receptor,Ki,=,50.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=C1Cc2c(ccc3c2OC[C@H](CNCCCC2CCc4c([nH]c5ccc(F)cc45)C2)O3)N1
CHEMBL566379,CHEMBL217,Dopamine D2 receptor,Ki,=,45.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=C1Cc2c(ccc3c2OC[C@H](CNCCCC2CCc4c([nH]c5ccc(F)cc45)C2)O3)N1
CHEMBL569251,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=C1Cc2c(ccc3c2OC[C@H](CNCC2CCc4[nH]c5ccc(F)cc5c4C2)O3)N1
CHEMBL569251,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=C1Cc2c(ccc3c2OC[C@H](CNCC2CCc4[nH]c5ccc(F)cc5c4C2)O3)N1
CHEMBL1237165,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,Cl.O=C1Cc2c(ccc3c2OC[C@H](CNCCC2CCc4[nH]c5ccc(F)cc5c4C2)O3)N1
CHEMBL568538,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=C1Cc2c(ccc3c2OC[C@H](CNCCC2CCc4[nH]c5ccc(F)cc5c4C2)O3)N1
CHEMBL566380,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=c1[nH]c2cccc(N3CCN(CC4CCc5c([nH]c6ccc(F)cc56)C4)CC3)c2o1
CHEMBL568103,CHEMBL217,Dopamine D2 receptor,Ki,=,50.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=c1[nH]c2cccc(N3CCN(CCCC4CCc5c([nH]c6ccc(F)cc56)C4)CC3)c2o1
CHEMBL569513,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=c1[nH]c2cccc(N3CCN(CC4CCc5[nH]c6ccc(F)cc6c5C4)CC3)c2o1
CHEMBL569513,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=c1[nH]c2cccc(N3CCN(CC4CCc5[nH]c6ccc(F)cc6c5C4)CC3)c2o1
CHEMBL567454,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=c1[nH]c2cccc(OC3CCN(CC4CCc5[nH]c6ccc(F)cc6c5C4)CC3)c2o1
CHEMBL565553,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=c1[nH]c2cccc(OC3CCN(CCC4CCc5[nH]c6ccc(F)cc6c5C4)CC3)c2o1
CHEMBL566396,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=c1[nH]c2cccc(OCC3CCN(CC4CCc5[nH]c6ccc(F)cc6c5C4)CC3)c2o1
CHEMBL569476,CHEMBL217,Dopamine D2 receptor,Ki,=,720.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=c1[nH]c2cccc(OCC3CCN(CCC4CCc5[nH]c6ccc(F)cc6c5C4)CC3)c2o1
CHEMBL566172,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=c1[nH]c2cccc(CN3CCN(CC4CCc5[nH]c6ccc(F)cc6c5C4)CC3)c2o1
CHEMBL571464,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=C1Cc2c(cccc2N2CCN(CC3CCc4[nH]c5ccc(F)cc5c4C3)CC2)N1
CHEMBL2094011,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=C1Cc2c(cccc2N2CCN(CCC3CCc4[nH]c5ccc(F)cc5c4C3)CC2)N1
CHEMBL566356,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=c1[nH]c2cccc(N3C[C@H]4C[C@@H]3CN4CC3CCc4[nH]c5ccc(F)cc5c4C3)c2o1
CHEMBL1237149,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,Br.O=c1[nH]c2cccc(N3C[C@H]4C[C@@H]3CN4CC3CCc4[nH]c5ccc(F)cc5c4C3)c2o1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL1040200,B,Displacement of [3H]spiperone from D2 receptor,CHEMBL1156031,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL552373,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL1043568,B,Antagonistic activity at human DRD2 receptor by filtration binding assay,CHEMBL1155321,KI,N#Cc1cccc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)c1
CHEMBL85606,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2
CHEMBL244946,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1
CHEMBL563635,CHEMBL217,Dopamine D2 receptor,Ki,=,25.12,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,CCN(CC)CCN1CCN(c2cccc(Cl)c2)C1=O
CHEMBL555744,CHEMBL217,Dopamine D2 receptor,Ki,=,79.43,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,COC[C@@H]1CCCN1N1CCN(c2cccc(Cl)c2)C1=O
CHEMBL563563,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,CC1(C)C[C@@H]2C[C@@](C)(CN2CCN2CCN(c3cccc(Cl)c3)C2=O)C1
CHEMBL563860,CHEMBL217,Dopamine D2 receptor,Ki,=,3.981,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,O=C1N(CCN2C[C@H]3CC[C@@H]2C3)CCN1c1cccc(Cl)c1
CHEMBL541435,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,COCC1[C@@H]2CC[C@H]1CN(CCN1CCN(c3cccc(Cl)c3)C1=O)C2
CHEMBL551927,CHEMBL217,Dopamine D2 receptor,Ki,=,15.85,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,C[C@@]12CC(c3ccccc3)C[C@@H](C1)N(CCN1CCN(c3cccc(Cl)c3)C1=O)C2
CHEMBL565075,CHEMBL217,Dopamine D2 receptor,Ki,=,25.12,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,O=C1N(CCN2C[C@H]3CC[C@H](CC3)C2)CCN1c1cccc(Cl)c1
CHEMBL564930,CHEMBL217,Dopamine D2 receptor,Ki,=,31.62,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,CC1(C)[C@H]2CC[C@]1(C)CN(CCN1CCN(c3cccc(Cl)c3)C1=O)C2
CHEMBL562464,CHEMBL217,Dopamine D2 receptor,Ki,=,25.12,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,O=C1N(CCN2C[C@@H]3CC[C@H]2Cc2ccccc2C3)CCN1c1cccc(Cl)c1
CHEMBL563580,CHEMBL217,Dopamine D2 receptor,Ki,=,5.012,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,O=C1N(CCN2[C@@H]3CCC[C@H]2CC3)CCN1c1cccc(Cl)c1
CHEMBL556496,CHEMBL217,Dopamine D2 receptor,Ki,=,25.12,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,COc1cccc(C2CCCN(CCN3CCN(c4cccc(Cl)c4)C3=O)C2)c1
CHEMBL557110,CHEMBL217,Dopamine D2 receptor,Ki,=,79.43,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,O=C1N(CCN2CCCC(OCc3ccccc3)C2)CCN1c1cccc(Cl)c1
CHEMBL561128,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,O=C1N(CCN2CCC(c3ccc(Cl)cc3)CC2)CCN1c1cccc(Cl)c1
CHEMBL563926,CHEMBL217,Dopamine D2 receptor,Ki,=,50.12,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,COc1cccc(CCN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)c1
CHEMBL554693,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,COc1ccc(CCN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)cc1OC
CHEMBL561326,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,O=C1N(CCN2CCC(c3nnc(-c4ccccc4)o3)CC2)CCN1c1cccc(Cl)c1
CHEMBL554738,CHEMBL217,Dopamine D2 receptor,Ki,=,50.12,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,CN(CCN1CCN(c2cccc(Cl)c2)C1=O)Cc1cc2ccccc2s1
CHEMBL549438,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,Cc1cc(CN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)on1
CHEMBL559873,CHEMBL217,Dopamine D2 receptor,Ki,=,3.162,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,O=C1N(CCN2CCCc3sccc3C2)CCN1c1cccc(Cl)c1
CHEMBL562833,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,CC1(C)[C@@H]2CC[C@]13CCN(CCN1CCN(c4cccc(Cl)c4)C1=O)C3C2
CHEMBL560177,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(Cl)c1
CHEMBL563274,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,CN(CCN1CCN(c2cccc(Cl)c2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C
CHEMBL558058,CHEMBL217,Dopamine D2 receptor,Ki,=,19.95,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,CN(CCN1CCN(c2cccc(C(F)(F)F)c2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C
CHEMBL564948,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,Cc1ccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)cc1
CHEMBL563435,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,COc1cccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)c1
CHEMBL560270,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,Cc1cccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)c1
CHEMBL562948,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,CN(CCN1CCN(c2ccccc2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C
CHEMBL562836,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,CN(CCN1CCN(c2ccc(F)cc2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C
CHEMBL567919,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL1044430,B,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,CHEMBL1155321,KI,CN(CCN1CCN(C2COOC2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C
CHEMBL380330,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL1038853,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,COc1ccc2c(c1)CCN(C)CCc1ccccc1C2
CHEMBL201170,CHEMBL217,Dopamine D2 receptor,Ki,=,17.5,nM,CHEMBL1038853,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,CN1CCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL487387,CHEMBL217,Dopamine D2 receptor,Ki,=,974.0,nM,CHEMBL1038853,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL596448,CHEMBL217,Dopamine D2 receptor,Ki,=,320.0,nM,CHEMBL1038853,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,COc1ccc2c(c1)CCN1Cc3ccccc3CC21
CHEMBL593897,CHEMBL217,Dopamine D2 receptor,Ki,=,486.0,nM,CHEMBL1038853,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,Oc1ccc2c(c1)CCN1Cc3ccccc3CC21
CHEMBL25856,CHEMBL217,Dopamine D2 receptor,Ki,=,2607.0,nM,CHEMBL1038853,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2
CHEMBL594798,CHEMBL217,Dopamine D2 receptor,Ki,=,2724.0,nM,CHEMBL1038853,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,Cc1ccccc1CC1c2ccc(O)cc2CCN1C
CHEMBL594127,CHEMBL217,Dopamine D2 receptor,Ki,=,7371.0,nM,CHEMBL1038853,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,COc1ccc2c(c1)CCN(C)C2Cc1ccccc1C
CHEMBL467094,CHEMBL217,Dopamine D2 receptor,Ki,=,858.0,nM,CHEMBL1066743,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor,CHEMBL1153197,KI,COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4
CHEMBL589390,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL1038007,B,Displacement of [3H]Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells,CHEMBL1153163,KI,Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1
CHEMBL592752,CHEMBL217,Dopamine D2 receptor,Ki,=,85.11,nM,CHEMBL1038007,B,Displacement of [3H]Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells,CHEMBL1153163,KI,Cc1ccc2c(c1)c1c(n2CCc2ccccc2)CCN(C)C1
CHEMBL605405,CHEMBL217,Dopamine D2 receptor,Ki,=,34.67,nM,CHEMBL1038007,B,Displacement of [3H]Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells,CHEMBL1153163,KI,Cc1ccc2c(c1)c1c(n2/C=C\c2ccccc2)CCN(C)C1
CHEMBL270426,CHEMBL217,Dopamine D2 receptor,Ki,=,235.0,nM,CHEMBL1065707,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1159064,KI,COc1cc2c3c(c1)-c1c(O)cccc1C[C@H]3N(C)CC2
CHEMBL119455,CHEMBL217,Dopamine D2 receptor,Ki,=,208.0,nM,CHEMBL1065707,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1159064,KI,CN1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3
CHEMBL27559,CHEMBL217,Dopamine D2 receptor,Ki,=,114.0,nM,CHEMBL1065707,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1159064,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3
CHEMBL62,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL596622,CHEMBL217,Dopamine D2 receptor,Ki,=,2000.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CNC3CCC3)cc2)C1
CHEMBL596824,CHEMBL217,Dopamine D2 receptor,Ki,=,159.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CC(=O)N(Cc1ccc([C@H]2CN(C)CCc3cc(Cl)c(O)cc32)cc1)C1CCC1
CHEMBL599282,CHEMBL217,Dopamine D2 receptor,Ki,=,2000.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CN(C3CCC3)S(C)(=O)=O)cc2)C1
CHEMBL603901,CHEMBL217,Dopamine D2 receptor,Ki,=,6000.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CN(C)S(C)(=O)=O)cc2)C1
CHEMBL599487,CHEMBL217,Dopamine D2 receptor,Ki,=,331.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CN(C)S(=O)(=O)c3ccccc3)cc2)C1
CHEMBL604108,CHEMBL217,Dopamine D2 receptor,Ki,=,2000.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CNc3ccccc3)cc2)C1
CHEMBL597702,CHEMBL217,Dopamine D2 receptor,Ki,=,552.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CN(Cc3ccccc3)c3ccc(F)cc3F)cc2)C1
CHEMBL298406,CHEMBL217,Dopamine D2 receptor,Ki,=,980.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21
CHEMBL598515,CHEMBL217,Dopamine D2 receptor,Ki,=,5400.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccc(N)cc3CC[C@@H]21
CHEMBL597909,CHEMBL217,Dopamine D2 receptor,Ki,=,3000.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccc(NS(C)(=O)=O)cc3CC[C@@H]21
CHEMBL600986,CHEMBL217,Dopamine D2 receptor,Ki,=,3300.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CCS(=O)(=O)Nc1ccc2c(c1)CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL600987,CHEMBL217,Dopamine D2 receptor,Ki,=,6000.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CCNC(=O)Nc1ccc2c(c1)CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL599977,CHEMBL217,Dopamine D2 receptor,Ki,=,1093.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccc(NC(=O)Nc4c(Cl)cccc4Cl)cc3CC[C@@H]21
CHEMBL603485,CHEMBL217,Dopamine D2 receptor,Ki,=,3900.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CCOC(=O)Nc1ccc2c(c1)CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL591685,CHEMBL217,Dopamine D2 receptor,Ki,=,2100.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(N)c3CC[C@@H]21
CHEMBL602659,CHEMBL217,Dopamine D2 receptor,Ki,=,2137.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(NC(=O)C4CC4)c3CC[C@@H]21
CHEMBL604135,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(NS(C)(=O)=O)c3CC[C@@H]21
CHEMBL602052,CHEMBL217,Dopamine D2 receptor,Ki,=,618.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CCS(=O)(=O)Nc1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL604132,CHEMBL217,Dopamine D2 receptor,Ki,=,900.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CCNC(=O)Nc1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL604129,CHEMBL217,Dopamine D2 receptor,Ki,=,566.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(NC(=O)Nc4c(Cl)cccc4Cl)c3CC[C@@H]21
CHEMBL601634,CHEMBL217,Dopamine D2 receptor,Ki,=,500.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CCC(=O)Nc1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL601635,CHEMBL217,Dopamine D2 receptor,Ki,=,1.3,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cc(CN4CCN(c5ccccn5)CC4)ccc3CC[C@@H]21
CHEMBL600998,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL1073809,B,Binding affinity to dopamine D2 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cc(CN4CCCCC4)ccc3CC[C@@H]21
CHEMBL298406,CHEMBL217,Dopamine D2 receptor,Ki,=,980.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21
CHEMBL600083,CHEMBL217,Dopamine D2 receptor,Ki,=,1693.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(Br)c3CC[C@@H]21
CHEMBL604316,CHEMBL217,Dopamine D2 receptor,Ki,=,1371.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(C=O)c3CC[C@@H]21
CHEMBL599116,CHEMBL217,Dopamine D2 receptor,Ki,=,1647.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(CO)c3CC[C@@H]21
CHEMBL604127,CHEMBL217,Dopamine D2 receptor,Ki,=,1328.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(C#N)c3CC[C@@H]21
CHEMBL598730,CHEMBL217,Dopamine D2 receptor,Ki,=,923.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,COC(=O)c1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL598915,CHEMBL217,Dopamine D2 receptor,Ki,=,420.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(C(=O)O)c3CC[C@@H]21
CHEMBL604314,CHEMBL217,Dopamine D2 receptor,Ki,=,440.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(O)c3CC[C@@H]21
CHEMBL598949,CHEMBL217,Dopamine D2 receptor,Ki,=,1370.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(N4CCCC4=O)c3CC[C@@H]21
CHEMBL604732,CHEMBL217,Dopamine D2 receptor,Ki,=,882.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(/C=N/O)c3CC[C@@H]21
CHEMBL599134,CHEMBL217,Dopamine D2 receptor,Ki,=,483.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CO/N=C/c1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL604525,CHEMBL217,Dopamine D2 receptor,Ki,=,217.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CCO/N=C/c1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL599135,CHEMBL217,Dopamine D2 receptor,Ki,=,69.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(/C=N/OCc4ccccc4)c3CC[C@@H]21
CHEMBL605354,CHEMBL217,Dopamine D2 receptor,Ki,=,124.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(/C=N/Oc4ccccc4)c3CC[C@@H]21
CHEMBL599528,CHEMBL217,Dopamine D2 receptor,Ki,=,79.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4ccccc4)c3CC[C@@H]21
CHEMBL598104,CHEMBL217,Dopamine D2 receptor,Ki,=,223.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cccc(F)c4)c3CC[C@@H]21
CHEMBL598105,CHEMBL217,Dopamine D2 receptor,Ki,=,584.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cccc(C#N)c4)c3CC[C@@H]21
CHEMBL605339,CHEMBL217,Dopamine D2 receptor,Ki,=,618.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cccc([N+](=O)[O-])c4)c3CC[C@@H]21
CHEMBL604383,CHEMBL217,Dopamine D2 receptor,Ki,=,1612.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cccc(OC(F)(F)F)c4)c3CC[C@H]21
CHEMBL597100,CHEMBL217,Dopamine D2 receptor,Ki,=,312.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cc(F)cc(F)c4)c3CC[C@@H]21
CHEMBL603872,CHEMBL217,Dopamine D2 receptor,Ki,=,550.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,COc1ccc(-c2cccc3c2CC[C@H]2[C@H]3c3cc(O)c(Cl)cc3CCN2C)cc1
CHEMBL597310,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN(C)c1ccc(-c2cccc3c2CC[C@H]2[C@H]3c3cc(O)c(Cl)cc3CCN2C)cc1
CHEMBL604176,CHEMBL217,Dopamine D2 receptor,Ki,=,89.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4ccc(CO)cc4)c3CC[C@@H]21
CHEMBL597900,CHEMBL217,Dopamine D2 receptor,Ki,=,93.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cccs4)c3CC[C@@H]21
CHEMBL605127,CHEMBL217,Dopamine D2 receptor,Ki,=,756.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4ccncc4)c3CC[C@@H]21
CHEMBL597503,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL1074771,B,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4ccc5[nH]ccc5c4)c3CC[C@@H]21
CHEMBL88365,CHEMBL217,Dopamine D2 receptor,Ki,=,115.0,nM,CHEMBL1066831,B,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,CHEMBL1157594,KI,Oc1cccc(N2CCN(Cc3ccccc3)CC2)c1
CHEMBL592377,CHEMBL217,Dopamine D2 receptor,Ki,=,285.0,nM,CHEMBL1066831,B,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,CHEMBL1157594,KI,Oc1cccc(C2CCN(Cc3ccccc3)CC2)c1
CHEMBL447809,CHEMBL217,Dopamine D2 receptor,Ki,=,721.0,nM,CHEMBL1066831,B,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CCCN1CCN(c2cccc(O)c2)CC1
CHEMBL592618,CHEMBL217,Dopamine D2 receptor,Ki,=,2570.0,nM,CHEMBL1066831,B,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CCCN1CCC(c2cccc(O)c2)CC1
CHEMBL597413,CHEMBL217,Dopamine D2 receptor,Ki,=,1923.0,nM,CHEMBL1066831,B,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CS(=O)(=O)c1cccc(N2CCN(Cc3ccccc3)CC2)c1
CHEMBL596800,CHEMBL217,Dopamine D2 receptor,Ki,=,841.0,nM,CHEMBL1066831,B,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CS(=O)(=O)c1cccc(C2CCN(Cc3ccccc3)CC2)c1
CHEMBL596801,CHEMBL217,Dopamine D2 receptor,Ki,=,1211.0,nM,CHEMBL1066831,B,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CCCN1CCN(c2cccc(S(C)(=O)=O)c2)CC1
CHEMBL596802,CHEMBL217,Dopamine D2 receptor,Ki,=,17550.0,nM,CHEMBL1066831,B,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CCCN1CCC(c2cccc(S(C)(=O)=O)c2)CC1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,2100.0,nM,CHEMBL1066831,B,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,CHEMBL1157594,KI,NCCc1ccc(O)c(O)c1
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,244.0,nM,CHEMBL1066831,B,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.9,nM,CHEMBL1066831,B,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,CHEMBL1157594,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL1066831,B,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,CHEMBL1157594,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL7549,CHEMBL217,Dopamine D2 receptor,Ki,=,2268.0,nM,CHEMBL1066831,B,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CCCN1CCC[C@@H](c2cccc(O)c2)C1
CHEMBL218166,CHEMBL217,Dopamine D2 receptor,Ki,=,0.1,nM,CHEMBL1066831,B,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,CHEMBL1157594,KI,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,2.6,nM,CHEMBL1066831,B,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,CHEMBL1157594,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL311730,CHEMBL217,Dopamine D2 receptor,Ki,=,3884.0,nM,CHEMBL1066831,B,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CCCN1CCC[C@@H](c2cccc(S(C)(=O)=O)c2)C1
CHEMBL88365,CHEMBL217,Dopamine D2 receptor,Ki,=,4.6,nM,CHEMBL1066832,B,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,CHEMBL1157594,KI,Oc1cccc(N2CCN(Cc3ccccc3)CC2)c1
CHEMBL592377,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL1066832,B,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,CHEMBL1157594,KI,Oc1cccc(C2CCN(Cc3ccccc3)CC2)c1
CHEMBL447809,CHEMBL217,Dopamine D2 receptor,Ki,=,69.0,nM,CHEMBL1066832,B,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CCCN1CCN(c2cccc(O)c2)CC1
CHEMBL592618,CHEMBL217,Dopamine D2 receptor,Ki,=,349.0,nM,CHEMBL1066832,B,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CCCN1CCC(c2cccc(O)c2)CC1
CHEMBL597413,CHEMBL217,Dopamine D2 receptor,Ki,=,431.0,nM,CHEMBL1066832,B,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CS(=O)(=O)c1cccc(N2CCN(Cc3ccccc3)CC2)c1
CHEMBL596800,CHEMBL217,Dopamine D2 receptor,Ki,=,392.0,nM,CHEMBL1066832,B,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CS(=O)(=O)c1cccc(C2CCN(Cc3ccccc3)CC2)c1
CHEMBL596801,CHEMBL217,Dopamine D2 receptor,Ki,=,664.0,nM,CHEMBL1066832,B,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CCCN1CCN(c2cccc(S(C)(=O)=O)c2)CC1
CHEMBL596802,CHEMBL217,Dopamine D2 receptor,Ki,=,7521.0,nM,CHEMBL1066832,B,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CCCN1CCC(c2cccc(S(C)(=O)=O)c2)CC1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,2.9,nM,CHEMBL1066832,B,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,CHEMBL1157594,KI,NCCc1ccc(O)c(O)c1
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,0.62,nM,CHEMBL1066832,B,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL1066832,B,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,CHEMBL1157594,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,6.1,nM,CHEMBL1066832,B,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,CHEMBL1157594,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL7549,CHEMBL217,Dopamine D2 receptor,Ki,=,17.4,nM,CHEMBL1066832,B,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CCCN1CCC[C@@H](c2cccc(O)c2)C1
CHEMBL218166,CHEMBL217,Dopamine D2 receptor,Ki,=,0.04,nM,CHEMBL1066832,B,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,CHEMBL1157594,KI,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,2.8,nM,CHEMBL1066832,B,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,CHEMBL1157594,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL311730,CHEMBL217,Dopamine D2 receptor,Ki,=,755.0,nM,CHEMBL1066832,B,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,CHEMBL1157594,KI,CCCN1CCC[C@@H](c2cccc(S(C)(=O)=O)c2)C1
CHEMBL285755,CHEMBL217,Dopamine D2 receptor,Ki,=,202.0,nM,CHEMBL1065654,B,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,CHEMBL1157569,KI,CCCN(CCC)C1CCc2ccc(O)cc2C1
CHEMBL273273,CHEMBL217,Dopamine D2 receptor,Ki,=,58.8,nM,CHEMBL1065654,B,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,CHEMBL1157569,KI,CCCN(CCC)C1CCc2c(O)cccc2C1
CHEMBL457024,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL1065654,B,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,CHEMBL1157569,KI,CCCN(CCN1CCN(c2ccccc2)CC1)[C@H]1CCc2c(O)cccc2C1
CHEMBL602065,CHEMBL217,Dopamine D2 receptor,Ki,=,3.74,nM,CHEMBL1065654,B,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,CHEMBL1157569,KI,CCCN(CCN1CCN(c2ccnc3ccccc23)CC1)[C@H]1CCc2c(O)cccc2C1
CHEMBL602264,CHEMBL217,Dopamine D2 receptor,Ki,=,86.0,nM,CHEMBL1065654,B,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,CHEMBL1157569,KI,CCCN(CCN1CCN(c2ccc(O)c3ncccc23)CC1)C1CCc2ccc(O)cc2C1
CHEMBL599636,CHEMBL217,Dopamine D2 receptor,Ki,=,20.7,nM,CHEMBL1065654,B,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,CHEMBL1157569,KI,CCCN(CCN1CCN(c2ccnc3c(O)cccc23)CC1)C1CCc2c(O)cccc2C1
CHEMBL599636,CHEMBL217,Dopamine D2 receptor,Ki,=,3.75,nM,CHEMBL1065654,B,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,CHEMBL1157569,KI,CCCN(CCN1CCN(c2ccnc3c(O)cccc23)CC1)C1CCc2c(O)cccc2C1
CHEMBL599635,CHEMBL217,Dopamine D2 receptor,Ki,=,15.9,nM,CHEMBL1065654,B,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,CHEMBL1157569,KI,CCCN(CCN1CCN(c2ccnc3c(O)cccc23)CC1)C1CCc2ccc(O)cc2C1
CHEMBL599636,CHEMBL217,Dopamine D2 receptor,Ki,=,13.8,nM,CHEMBL1065654,B,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,CHEMBL1157569,KI,CCCN(CCN1CCN(c2ccnc3c(O)cccc23)CC1)C1CCc2c(O)cccc2C1
CHEMBL599635,CHEMBL217,Dopamine D2 receptor,Ki,=,4.55,nM,CHEMBL1065654,B,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,CHEMBL1157569,KI,CCCN(CCN1CCN(c2ccnc3c(O)cccc23)CC1)C1CCc2ccc(O)cc2C1
CHEMBL599841,CHEMBL217,Dopamine D2 receptor,Ki,=,41.4,nM,CHEMBL1065654,B,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,CHEMBL1157569,KI,CCCN(CCN1CCN(c2ccc(O)c3ncccc23)CC1)C1CCc2c(O)cccc2C1
CHEMBL604102,CHEMBL217,Dopamine D2 receptor,Ki,=,2910.0,nM,CHEMBL1073463,B,Binding affinity to dopamine D2 receptor,CHEMBL1157614,KI,N[C@@H]1CCN(c2ccc3[nH]nc(S(=O)(=O)c4cccc5ccccc45)c3c2)C1
CHEMBL1086789,CHEMBL217,Dopamine D2 receptor,Ki,=,1476.0,nM,CHEMBL1105125,B,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in HEK293 cells by microplate scintillation counting,CHEMBL1155427,KI,c1ccc2c(c1)CCN1CCc3[nH]c4ccccc4c3C21
CHEMBL1086790,CHEMBL217,Dopamine D2 receptor,Ki,=,4458.0,nM,CHEMBL1105125,B,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in HEK293 cells by microplate scintillation counting,CHEMBL1155427,KI,c1ccc2c(c1)CCN1CCc3cccc4[nH]cc(c34)C21
CHEMBL1087301,CHEMBL217,Dopamine D2 receptor,Ki,=,55.1,nM,CHEMBL1105125,B,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in HEK293 cells by microplate scintillation counting,CHEMBL1155427,KI,CN1CCc2ccccc2Cc2c([nH]c3ccccc23)CC1
CHEMBL1087300,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL1105125,B,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in HEK293 cells by microplate scintillation counting,CHEMBL1155427,KI,CN1CCc2ccccc2Cc2c[nH]c3cccc(c23)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL1110025,B,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,CHEMBL1157886,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1087585,CHEMBL217,Dopamine D2 receptor,Ki,=,7.0,nM,CHEMBL1110025,B,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,CHEMBL1157886,KI,CS(=O)(=O)Nc1cc(OCCN2CC3CCC(C2)C3Cc2ccc3c(c2)NC(=O)CC3)ccc1F
CHEMBL1087818,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL1110025,B,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,CHEMBL1157886,KI,CS(=O)(=O)Nc1cccc(OCCN2CC3CCC(C2)C3Cc2ccc3c(c2)NC(=O)CC3)c1
CHEMBL1087817,CHEMBL217,Dopamine D2 receptor,Ki,=,6.3,nM,CHEMBL1110025,B,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,CHEMBL1157886,KI,O=C1CCc2ccc(CC3C4CCC3CN(C[C@@H]3COc5c(ccc6c5CC(=O)N6)O3)C4)cc2N1
CHEMBL1088000,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL1110025,B,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,CHEMBL1157886,KI,O=C1CCc2ccc(CC3CC4CCC(C3)N4C[C@@H]3COc4c(ccc5c4CC(=O)N5)O3)cc2N1
CHEMBL1087872,CHEMBL217,Dopamine D2 receptor,Ki,=,9.0,nM,CHEMBL1110025,B,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,CHEMBL1157886,KI,CS(=O)(=O)Nc1cc(OCCN2CCC(Oc3ccc4c(c3)NC(=O)CC4)CC2)ccc1F
CHEMBL1087745,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL1110025,B,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,CHEMBL1157886,KI,CS(=O)(=O)Nc1cccc(OCCN2CCC(Oc3ccc4c(c3)NC(=O)CC4)CC2)c1
CHEMBL1087744,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL1110025,B,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,CHEMBL1157886,KI,O=C1CCc2ccc(OC3CCN(C[C@@H]4COc5c(ccc6c5CC(=O)N6)O4)CC3)cc2N1
CHEMBL1087743,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL1110025,B,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,CHEMBL1157886,KI,CS(=O)(=O)Nc1cc(OCCN2CCC(Cc3ccc4c(c3)NC(=O)CC4)CC2)ccc1F
CHEMBL1088560,CHEMBL217,Dopamine D2 receptor,Ki,=,9.0,nM,CHEMBL1110025,B,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,CHEMBL1157886,KI,CS(=O)(=O)Nc1cccc(OCCN2CCC(Cc3ccc4c(c3)NC(=O)CC4)CC2)c1
CHEMBL1087455,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL1110025,B,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,CHEMBL1157886,KI,O=C1CCc2ccc(CC3CCN(C[C@@H]4COc5c(ccc6c5CC(=O)N6)O4)CC3)cc2N1
CHEMBL1087454,CHEMBL217,Dopamine D2 receptor,Ki,=,8.3,nM,CHEMBL1110025,B,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,CHEMBL1157886,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5[nH]c(=O)oc45)CC3)cc2N1
CHEMBL1087453,CHEMBL217,Dopamine D2 receptor,Ki,=,8.6,nM,CHEMBL1110025,B,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,CHEMBL1157886,KI,O=C1CCc2ccc(OCCCN3CCN(c4cccc5[nH]c(=O)oc45)CC3)cc2N1
CHEMBL1087452,CHEMBL217,Dopamine D2 receptor,Ki,=,8.6,nM,CHEMBL1110025,B,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,CHEMBL1157886,KI,O=C1CCc2ccc(OCCN3CCN(c4cccc5[nH]c(=O)oc45)CC3)cc2N1
CHEMBL1170096,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,COc1ccc2[nH]cc(CN3CCC(O)(c4ccc(Br)cc4)CC3)c2c1
CHEMBL1170095,CHEMBL217,Dopamine D2 receptor,Ki,=,2.3,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,COc1cccc2[nH]cc(CN3CCC(O)(c4ccc(Br)cc4)CC3)c12
CHEMBL1170683,CHEMBL217,Dopamine D2 receptor,Ki,=,4.8,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,OC1(c2ccc(Br)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL1170094,CHEMBL217,Dopamine D2 receptor,Ki,=,4.2,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,COc1ccc2[nH]cc(CN3CCC(O)(c4ccc(Cl)cc4)CC3)c2c1
CHEMBL1169904,CHEMBL217,Dopamine D2 receptor,Ki,=,4.2,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,COc1cccc2[nH]cc(CN3CCC(O)(c4ccc(Cl)cc4)CC3)c12
CHEMBL445102,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.1,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1171630,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,O=C(O)C(=O)O.O=C1N(Cc2cn(CCF)nn2)CN(c2ccccc2)C12CCN(Cc1coc3ccccc13)CC2
CHEMBL1169728,CHEMBL217,Dopamine D2 receptor,Ki,=,71.4,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,CN1CN(c2ccccc2)C2(CCN(Cc3csc4ccccc34)CC2)C1=O.O=C(O)C(=O)O
CHEMBL1170085,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,O=C(O)C(=O)O.O=C1N(CCF)CN(c2ccccc2)C12CCN(Cc1coc3ccccc13)CC2
CHEMBL1169896,CHEMBL217,Dopamine D2 receptor,Ki,=,7.1,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,CN1CN(c2ccccc2)C2(CCN(Cc3coc4ccccc34)CC2)C1=O.O=C(O)C(=O)O
CHEMBL1169895,CHEMBL217,Dopamine D2 receptor,Ki,=,37.8,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,O=C(O)C(=O)O.O=c1[nH]c2ccccc2n1C1CCN(Cc2csc3ccccc23)CC1
CHEMBL1172214,CHEMBL217,Dopamine D2 receptor,Ki,=,13.6,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,O=C(O)C(=O)O.O=c1[nH]c2ccccc2n1C1CCN(Cc2coc3ccccc23)CC1
CHEMBL1171249,CHEMBL217,Dopamine D2 receptor,Ki,=,2.4,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,O=C(O)C(=O)O.OC1(c2ccc(I)cc2)CCN(Cc2coc3ccccc23)CC1
CHEMBL1172213,CHEMBL217,Dopamine D2 receptor,Ki,=,6.6,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,O=C(O)C(=O)O.OC1(c2ccc(Br)cc2)CCN(Cc2coc3ccccc23)CC1
CHEMBL1172212,CHEMBL217,Dopamine D2 receptor,Ki,=,46.8,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,O=C(O)C(=O)O.OC1(c2ccccc2)CCN(Cc2cc3ccccc3s2)CC1
CHEMBL1170456,CHEMBL217,Dopamine D2 receptor,Ki,=,14.3,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,O=C(O)C(=O)O.OC1(c2ccc(I)cc2)CCN(Cc2cc3ccccc3o2)CC1
CHEMBL1172210,CHEMBL217,Dopamine D2 receptor,Ki,=,17.3,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,O=C(O)C(=O)O.OC1(c2ccc(Br)cc2)CCN(Cc2cc3ccccc3o2)CC1
CHEMBL1172209,CHEMBL217,Dopamine D2 receptor,Ki,=,254.0,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,CSc1ccc(C2(O)CCN(Cc3c[nH]c4ncccc34)CC2)cc1.O=C(O)C(=O)O
CHEMBL1172208,CHEMBL217,Dopamine D2 receptor,Ki,=,61.0,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,O=C(O)C(=O)O.OC1(c2ccc(I)cc2)CCN(Cc2c[nH]c3ncccc23)CC1
CHEMBL1170879,CHEMBL217,Dopamine D2 receptor,Ki,=,212.0,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,O=C(O)C(=O)O.OC1(c2ccc(Br)cc2)CCN(Cc2c[nH]c3ncccc23)CC1
CHEMBL1173778,CHEMBL217,Dopamine D2 receptor,Ki,=,12.5,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,COc1ccc2[nH]cc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)c2c1.O=C(O)C(=O)O
CHEMBL1173436,CHEMBL217,Dopamine D2 receptor,Ki,=,23.3,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,COc1cccc2[nH]cc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)c12.O=C(O)C(=O)O
CHEMBL1173366,CHEMBL217,Dopamine D2 receptor,Ki,=,13.8,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,O=C(O)C(=O)O.OC1(c2ccc(Br)cc2)CCN(Cc2c[nH]c3ccc(OCCF)cc23)CC1
CHEMBL1173711,CHEMBL217,Dopamine D2 receptor,Ki,=,27.7,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,O=C(O)C(=O)O.OC1(c2ccc(Br)cc2)CCN(Cc2c[nH]c3cccc(OCCF)c23)CC1
CHEMBL1173363,CHEMBL217,Dopamine D2 receptor,Ki,=,1396.0,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,COc1ccc2[nH]cc(CN3CCC(O)(c4ccccc4)CC3)c2c1.O=C(O)C(=O)O
CHEMBL1173288,CHEMBL217,Dopamine D2 receptor,Ki,=,0.9,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,COc1ccc2[nH]cc(CN3CCC(O)(c4ccc(I)cc4)CC3)c2c1.O=C(O)C(=O)O
CHEMBL1173287,CHEMBL217,Dopamine D2 receptor,Ki,=,0.9,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,COc1cccc2[nH]cc(CN3CCC(O)(c4ccc(I)cc4)CC3)c12.O=C(O)C(=O)O
CHEMBL1173285,CHEMBL217,Dopamine D2 receptor,Ki,=,3.8,nM,CHEMBL1176478,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1177670,KI,O=C(O)C(=O)O.OC1(c2ccc(I)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL1214830,CHEMBL217,Dopamine D2 receptor,Ki,=,2700.0,nM,CHEMBL1219344,B,Binding affinity to dopamine D2,CHEMBL1212881,KI,COc1ccc(CN2CCN(Cc3cc4ccccc4o3)CC2)cc1
CHEMBL1214831,CHEMBL217,Dopamine D2 receptor,Ki,=,4868.0,nM,CHEMBL1219344,B,Binding affinity to dopamine D2,CHEMBL1212881,KI,CCOc1ccc(CN2CCN(Cc3cc4ccccc4o3)CC2)cc1
CHEMBL1214894,CHEMBL217,Dopamine D2 receptor,Ki,=,5728.0,nM,CHEMBL1219344,B,Binding affinity to dopamine D2,CHEMBL1212881,KI,COc1cccc(CN2CCN(Cc3cc4ccccc4o3)CC2)c1
CHEMBL1214895,CHEMBL217,Dopamine D2 receptor,Ki,=,4542.0,nM,CHEMBL1219344,B,Binding affinity to dopamine D2,CHEMBL1212881,KI,CCOc1cccc(CN2CCN(Cc3cc4ccccc4o3)CC2)c1
CHEMBL1214958,CHEMBL217,Dopamine D2 receptor,Ki,=,2281.0,nM,CHEMBL1219344,B,Binding affinity to dopamine D2,CHEMBL1212881,KI,FCCOc1cccc(CN2CCN(Cc3cc4ccccc4o3)CC2)c1
CHEMBL1214959,CHEMBL217,Dopamine D2 receptor,Ki,=,2977.0,nM,CHEMBL1219344,B,Binding affinity to dopamine D2,CHEMBL1212881,KI,CCCOc1cccc(CN2CCN(Cc3cc4ccccc4o3)CC2)c1
CHEMBL1214960,CHEMBL217,Dopamine D2 receptor,Ki,=,2920.0,nM,CHEMBL1219344,B,Binding affinity to dopamine D2,CHEMBL1212881,KI,FCCCOc1cccc(CN2CCN(Cc3cc4ccccc4o3)CC2)c1
CHEMBL1214961,CHEMBL217,Dopamine D2 receptor,Ki,=,5122.0,nM,CHEMBL1219344,B,Binding affinity to dopamine D2,CHEMBL1212881,KI,COc1ccccc1CN1CCN(Cc2cc3ccccc3o2)CC1
CHEMBL1214962,CHEMBL217,Dopamine D2 receptor,Ki,=,6005.0,nM,CHEMBL1219344,B,Binding affinity to dopamine D2,CHEMBL1212881,KI,CCOc1ccccc1CN1CCN(Cc2cc3ccccc3o2)CC1
CHEMBL1224527,CHEMBL217,Dopamine D2 receptor,Ki,=,750000.0,nM,CHEMBL1225589,B,Binding affinity to dopamine D2 receptor,CHEMBL1221364,KI,Oc1ccc2c(c1O)C[C@@H](c1ccccc1)[C@@H]1CCNC[C@@H]21
CHEMBL1223615,CHEMBL217,Dopamine D2 receptor,Ki,=,0.8,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,COc1ccccc1N1CCN(CCCCNc2ccccn2)CC1
CHEMBL1223616,CHEMBL217,Dopamine D2 receptor,Ki,=,0.4,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,Clc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1Cl
CHEMBL1223617,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,FC(F)(F)c1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1
CHEMBL1223680,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,Fc1ccccc1N1CCN(CCCCNc2ccccn2)CC1
CHEMBL1223681,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,Cc1ccccc1N1CCN(CCCCNc2ccccn2)CC1
CHEMBL1223682,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,Cc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1C
CHEMBL271989,CHEMBL217,Dopamine D2 receptor,Ki,=,5.6,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,COc1ccccc1N1CCN(CCCCNc2ccc3ccccc3n2)CC1
CHEMBL1223683,CHEMBL217,Dopamine D2 receptor,Ki,=,0.6,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,Clc1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1Cl
CHEMBL1223747,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,FC(F)(F)c1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1
CHEMBL1223748,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,COc1ccccc1N1CCN(CCCCNc2nccc3ccccc23)CC1
CHEMBL1223749,CHEMBL217,Dopamine D2 receptor,Ki,=,3.1,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,Clc1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1Cl
CHEMBL1223750,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,FC(F)(F)c1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1
CHEMBL1223799,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,Fc1ccccc1N1CCN(CCCCNc2ccc(-c3ccccc3)cn2)CC1
CHEMBL1223800,CHEMBL217,Dopamine D2 receptor,Ki,=,0.59,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,Clc1cccc(N2CCN(CCCCNc3ccc(-c4ccccc4)cn3)CC2)c1Cl
CHEMBL1223801,CHEMBL217,Dopamine D2 receptor,Ki,=,1.1,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,FC(F)(F)c1cccc(N2CCN(CCCCNc3ccc(-c4ccccc4)cn3)CC2)c1
CHEMBL1223802,CHEMBL217,Dopamine D2 receptor,Ki,=,1.5,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,Fc1ccccc1N1CCN(CCCCNc2cc(-c3ccccc3)ccn2)CC1
CHEMBL1223856,CHEMBL217,Dopamine D2 receptor,Ki,=,0.55,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,Clc1cccc(N2CCN(CCCCNc3cc(-c4ccccc4)ccn3)CC2)c1Cl
CHEMBL1223857,CHEMBL217,Dopamine D2 receptor,Ki,=,0.76,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,FC(F)(F)c1cccc(N2CCN(CCCCNc3cc(-c4ccccc4)ccn3)CC2)c1
CHEMBL1223858,CHEMBL217,Dopamine D2 receptor,Ki,=,9.6,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,FC(F)(F)c1cccc(N2CCN(CCCCNc3ncc(-c4ccccc4)o3)CC2)c1
CHEMBL1223859,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL1225816,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,CHEMBL1221353,KI,FC(F)(F)c1cccc(N2CCN(CCCCNc3nc(-c4ccccc4)cs3)CC2)c1
CHEMBL1221498,CHEMBL217,Dopamine D2 receptor,Ki,=,890.0,nM,CHEMBL1227764,B,Displacement of [3H]spiperone from human D2L receptor after 60 mins,CHEMBL1221249,KI,COc1ccccc1N1CCN(CCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL497749,CHEMBL217,Dopamine D2 receptor,Ki,=,132.0,nM,CHEMBL1227764,B,Displacement of [3H]spiperone from human D2L receptor after 60 mins,CHEMBL1221249,KI,COc1ccccc1N1CCN(CCCNS(=O)(=O)c2ccc3ccccc3c2)CC1
CHEMBL1221545,CHEMBL217,Dopamine D2 receptor,Ki,=,46.5,nM,CHEMBL1227764,B,Displacement of [3H]spiperone from human D2L receptor after 60 mins,CHEMBL1221249,KI,COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1
CHEMBL1221591,CHEMBL217,Dopamine D2 receptor,Ki,=,254.0,nM,CHEMBL1227764,B,Displacement of [3H]spiperone from human D2L receptor after 60 mins,CHEMBL1221249,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL1221592,CHEMBL217,Dopamine D2 receptor,Ki,=,438.0,nM,CHEMBL1227764,B,Displacement of [3H]spiperone from human D2L receptor after 60 mins,CHEMBL1221249,KI,COc1ccccc1N1CCN(CCCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1
CHEMBL1221593,CHEMBL217,Dopamine D2 receptor,Ki,=,121.0,nM,CHEMBL1227764,B,Displacement of [3H]spiperone from human D2L receptor after 60 mins,CHEMBL1221249,KI,COc1ccccc1N1CCN(CCCCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL1221594,CHEMBL217,Dopamine D2 receptor,Ki,=,99.0,nM,CHEMBL1227764,B,Displacement of [3H]spiperone from human D2L receptor after 60 mins,CHEMBL1221249,KI,COc1ccccc1N1CCN(CCCCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1
CHEMBL1242950,CHEMBL217,Dopamine D2 receptor,Ki,=,77.0,nM,CHEMBL1248543,B,Binding affinity to human dopamine D2S receptor by radioligand displacement assay,CHEMBL1240489,KI,CCCCC1CCN(CCCC(=O)c2ccccc2C)CC1
CHEMBL1257382,CHEMBL217,Dopamine D2 receptor,Ki,=,0.0575,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCC5)CC3)cc21
CHEMBL1257262,CHEMBL217,Dopamine D2 receptor,Ki,=,0.302,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCN3CCN(c4cccc5c4CCC5)CC3)cc21
CHEMBL1257493,CHEMBL217,Dopamine D2 receptor,Ki,=,0.575,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4COC5)CC3)cc21
CHEMBL1257735,CHEMBL217,Dopamine D2 receptor,Ki,=,0.576,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4OCCC5)CC3)cc21
CHEMBL1258087,CHEMBL217,Dopamine D2 receptor,Ki,=,0.812,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,Cc1cc2c(cc1OCCCCN1CCN(c3cccc4cc(F)ccc34)CC1)C(=O)NC2
CHEMBL1258534,CHEMBL217,Dopamine D2 receptor,Ki,=,0.877,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2cc(F)c(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21
CHEMBL1258881,CHEMBL217,Dopamine D2 receptor,Ki,=,0.891,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2cc(F)c(OCCCCN3CCN(c4cccc5cc(F)ccc45)CC3)cc21
CHEMBL1258649,CHEMBL217,Dopamine D2 receptor,Ki,=,1.41,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2cc(F)c(OCCCCN3CCN(c4cccc5cccc(F)c45)CC3)cc21
CHEMBL1257614,CHEMBL217,Dopamine D2 receptor,Ki,=,1.54,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCCC5)CC3)cc21
CHEMBL1257736,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,Cc1c(OCCCN2CCN(c3cccc4cc(F)ccc34)CC2)ccc2c1C(=O)NC2
CHEMBL1258763,CHEMBL217,Dopamine D2 receptor,Ki,=,1.86,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2cc(F)c(OCCCN3CCN(c4cccc5cc(F)ccc45)CC3)cc21
CHEMBL1257492,CHEMBL217,Dopamine D2 receptor,Ki,=,2.08,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCO5)CC3)cc21
CHEMBL1257971,CHEMBL217,Dopamine D2 receptor,Ki,=,2.34,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,Cc1cc2c(cc1OCCCCN1CCN(c3cccc4cccc(F)c34)CC1)C(=O)NC2
CHEMBL1257859,CHEMBL217,Dopamine D2 receptor,Ki,=,2.46,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,Cc1cc2c(cc1OCCCCN1CCN(c3cccc4ccccc34)CC1)C(=O)NC2
CHEMBL1257613,CHEMBL217,Dopamine D2 receptor,Ki,=,2.63,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCN3CCN(c4cccc5c4CCCC5)CC3)cc21
CHEMBL1257616,CHEMBL217,Dopamine D2 receptor,Ki,=,3.03,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,Cc1c(OCCCCN2CCN(c3cccc4cccc(F)c34)CC2)ccc2c1C(=O)NC2
CHEMBL1258879,CHEMBL217,Dopamine D2 receptor,Ki,=,3.18,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cccc(F)c45)CC3)cc21
CHEMBL1258086,CHEMBL217,Dopamine D2 receptor,Ki,=,3.81,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,Cc1cc2c(cc1OCCCN1CCN(c3cccc4cc(F)ccc34)CC1)C(=O)NC2
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL1257734,CHEMBL217,Dopamine D2 receptor,Ki,=,4.47,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCN3CCN(c4cccc5c4OCCC5)CC3)cc21
CHEMBL1258085,CHEMBL217,Dopamine D2 receptor,Ki,=,5.49,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCN3CCN(c4cccc5cccc(F)c45)CC3)c(F)c21
CHEMBL1258313,CHEMBL217,Dopamine D2 receptor,Ki,=,5.75,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccc(F)cc45)CC3)c(F)c21
CHEMBL1258650,CHEMBL217,Dopamine D2 receptor,Ki,=,5.81,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2cc(F)c(OCCCN3CCN(c4cccc5ccc(F)cc45)CC3)cc21
CHEMBL1257385,CHEMBL217,Dopamine D2 receptor,Ki,=,5.91,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2cc(Cl)c(OCCCCN3CCN(c4cccc5cccc(F)c45)CC3)cc21
CHEMBL1257494,CHEMBL217,Dopamine D2 receptor,Ki,=,6.81,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,Cc1c(OCCCN2CCN(c3cccc4ccccc34)CC2)ccc2c1C(=O)NC2
CHEMBL1258647,CHEMBL217,Dopamine D2 receptor,Ki,=,7.39,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21
CHEMBL1257261,CHEMBL217,Dopamine D2 receptor,Ki,=,8.23,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cc(F)c(F)cc45)CC3)cc21
CHEMBL1258314,CHEMBL217,Dopamine D2 receptor,Ki,=,8.59,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCN3CCN(c4cccc5cc(F)ccc45)CC3)c(F)c21
CHEMBL1258428,CHEMBL217,Dopamine D2 receptor,Ki,=,8.92,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2cc(F)c(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21
CHEMBL1257146,CHEMBL217,Dopamine D2 receptor,Ki,=,9.01,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCN3CCN(c4cccc5cccc(F)c45)CC3)c(Cl)c21
CHEMBL1257264,CHEMBL217,Dopamine D2 receptor,Ki,=,9.31,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2cc(Cl)c(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21
CHEMBL1257737,CHEMBL217,Dopamine D2 receptor,Ki,=,9.44,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,Cc1c(OCCCCN2CCN(c3cccc4cc(F)ccc34)CC2)ccc2c1C(=O)NC2
CHEMBL1258535,CHEMBL217,Dopamine D2 receptor,Ki,=,9.54,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2cc(F)c(OCCCN3CCN(c4cccc5cccc(F)c45)CC3)cc21
CHEMBL1257147,CHEMBL217,Dopamine D2 receptor,Ki,=,9.86,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cccc(F)c45)CC3)c(Cl)c21
CHEMBL1257145,CHEMBL217,Dopamine D2 receptor,Ki,=,10.2,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCN3CCN(c4cccc5cc(F)c(F)cc45)CC3)cc21
CHEMBL1258200,CHEMBL217,Dopamine D2 receptor,Ki,=,10.3,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccc(F)cc45)CC3)c(F)c21
CHEMBL1258882,CHEMBL217,Dopamine D2 receptor,Ki,=,10.6,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)c(Cl)c21
CHEMBL1258762,CHEMBL217,Dopamine D2 receptor,Ki,=,11.2,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2cc(F)c(OCCCCN3CCN(c4cccc5ccc(F)cc45)CC3)cc21
CHEMBL1257968,CHEMBL217,Dopamine D2 receptor,Ki,=,11.5,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCOC5)CC3)cc21
CHEMBL1257383,CHEMBL217,Dopamine D2 receptor,Ki,=,12.1,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCN3CCN(c4cccc5c4CCO5)CC3)cc21
CHEMBL1257495,CHEMBL217,Dopamine D2 receptor,Ki,=,13.1,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,Cc1c(OCCCCN2CCN(c3cccc4ccccc34)CC2)ccc2c1C(=O)NC2
CHEMBL1258761,CHEMBL217,Dopamine D2 receptor,Ki,=,13.6,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCN3CCN(c4cccc5cccc(F)c45)CC3)cc21
CHEMBL1257615,CHEMBL217,Dopamine D2 receptor,Ki,=,13.6,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,Cc1c(OCCCN2CCN(c3cccc4cccc(F)c34)CC2)ccc2c1C(=O)NC2
CHEMBL1257969,CHEMBL217,Dopamine D2 receptor,Ki,=,13.8,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)c(F)c21
CHEMBL1258427,CHEMBL217,Dopamine D2 receptor,Ki,=,15.8,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cc(F)ccc45)CC3)c(F)c21
CHEMBL1258533,CHEMBL217,Dopamine D2 receptor,Ki,=,16.3,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21
CHEMBL1257970,CHEMBL217,Dopamine D2 receptor,Ki,=,16.6,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,Cc1cc2c(cc1OCCCN1CCN(c3cccc4cccc(F)c34)CC1)C(=O)NC2
CHEMBL1257858,CHEMBL217,Dopamine D2 receptor,Ki,=,21.8,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,Cc1cc2c(cc1OCCCN1CCN(c3cccc4ccccc34)CC1)C(=O)NC2
CHEMBL1257857,CHEMBL217,Dopamine D2 receptor,Ki,=,22.3,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4COCC5)CC3)cc21
CHEMBL1258084,CHEMBL217,Dopamine D2 receptor,Ki,=,22.3,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)c(F)c21
CHEMBL1257384,CHEMBL217,Dopamine D2 receptor,Ki,=,24.5,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2cc(Cl)c(OCCCN3CCN(c4cccc5cccc(F)c45)CC3)cc21
CHEMBL1258426,CHEMBL217,Dopamine D2 receptor,Ki,=,24.7,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,Fc1ccc2cccc(N3CCN(CCCOc4ccc5c(c4)CNC5)CC3)c2c1
CHEMBL1258648,CHEMBL217,Dopamine D2 receptor,Ki,=,27.8,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccc(F)cc45)CC3)cc21
CHEMBL1258760,CHEMBL217,Dopamine D2 receptor,Ki,=,33.8,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccc(F)cc45)CC3)cc21
CHEMBL1258312,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,c1ccc2c(N3CCN(CCCOc4ccc5c(c4)CNC5)CC3)cccc2c1
CHEMBL1258199,CHEMBL217,Dopamine D2 receptor,Ki,=,35.2,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cccc(F)c45)CC3)c(F)c21
CHEMBL1258425,CHEMBL217,Dopamine D2 receptor,Ki,=,40.7,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,c1ccc2c(N3CCN(CCCCOc4ccc5c(c4)CNC5)CC3)cccc2c1
CHEMBL1257263,CHEMBL217,Dopamine D2 receptor,Ki,=,51.6,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2cc(Cl)c(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21
CHEMBL1257144,CHEMBL217,Dopamine D2 receptor,Ki,=,58.0,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cc(F)ccc45)CC3)cc21
CHEMBL1258532,CHEMBL217,Dopamine D2 receptor,Ki,=,80.7,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,Fc1ccc2cccc(N3CCN(CCCCOc4ccc5c(c4)CNC5)CC3)c2c1
CHEMBL1257856,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCN3CCN(c4cccc5c4COCC5)CC3)cc21
CHEMBL1258880,CHEMBL217,Dopamine D2 receptor,Ki,=,44.5,nM,CHEMBL1260558,B,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1255556,KI,O=C1NCc2ccc(OCCCN3CCN(c4cccc5cc(F)ccc45)CC3)cc21
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.1,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1257688,CHEMBL217,Dopamine D2 receptor,Ki,=,4.8,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(CCCN1CCC(O)(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1ccc(F)cc1
CHEMBL1257689,CHEMBL217,Dopamine D2 receptor,Ki,=,3.4,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,Cc1ccc(C)c(C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2)c1
CHEMBL1257810,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2
CHEMBL1256169,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(CCCN1CCC(O)(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2
CHEMBL1257811,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,Cc1ccc(C)c(C(=O)CCCN2CCC(O)(c3ccc(Cl)cc3)CC2)c1
CHEMBL1257927,CHEMBL217,Dopamine D2 receptor,Ki,=,55.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,Cc1ccc(C)c(C(=O)CCCN2CCC(O)(c3cc(C)ccc3C)CC2)c1
CHEMBL476935,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1258036,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(CCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1ccc(F)cc1
CHEMBL1258037,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,Cc1ccc(C)c(N2CCN(CCCC(=O)c3ccc(F)cc3)CC2)c1
CHEMBL1258154,CHEMBL217,Dopamine D2 receptor,Ki,=,620.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2
CHEMBL1258155,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,Cc1ccc(C)c(C(=O)CCCN2CCC(c3ccc(Cl)cc3)CC2)c1
CHEMBL1256170,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(CCCN1CCC(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2
CHEMBL1258270,CHEMBL217,Dopamine D2 receptor,Ki,=,400.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,Cc1ccc(C)c(C(=O)CCCN2CCC(c3cc(C)ccc3C)CC2)c1
CHEMBL424294,CHEMBL217,Dopamine D2 receptor,Ki,=,95.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL1258382,CHEMBL217,Dopamine D2 receptor,Ki,=,83.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(NCCCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccccc2s1
CHEMBL1258383,CHEMBL217,Dopamine D2 receptor,Ki,=,84.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,Cc1ccc(C)c(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)c1
CHEMBL1258494,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc(C)ccc2C)CC1
CHEMBL1256171,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(NCCCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2
CHEMBL1258495,CHEMBL217,Dopamine D2 receptor,Ki,=,99.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,Cc1ccc(C)c(C(=O)NCCCCN2CCN(c3cc(C)ccc3C)CC2)c1
CHEMBL210567,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL1261459,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1255217,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.87,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1257688,CHEMBL217,Dopamine D2 receptor,Ki,=,3.6,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(CCCN1CCC(O)(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1ccc(F)cc1
CHEMBL1257689,CHEMBL217,Dopamine D2 receptor,Ki,=,6.5,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,Cc1ccc(C)c(C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2)c1
CHEMBL1257810,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2
CHEMBL1256169,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(CCCN1CCC(O)(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2
CHEMBL1257811,CHEMBL217,Dopamine D2 receptor,Ki,=,43.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,Cc1ccc(C)c(C(=O)CCCN2CCC(O)(c3ccc(Cl)cc3)CC2)c1
CHEMBL1257927,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,Cc1ccc(C)c(C(=O)CCCN2CCC(O)(c3cc(C)ccc3C)CC2)c1
CHEMBL476935,CHEMBL217,Dopamine D2 receptor,Ki,=,61.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1258036,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(CCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1ccc(F)cc1
CHEMBL1258037,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,Cc1ccc(C)c(N2CCN(CCCC(=O)c3ccc(F)cc3)CC2)c1
CHEMBL1258154,CHEMBL217,Dopamine D2 receptor,Ki,=,440.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2
CHEMBL1258155,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,Cc1ccc(C)c(C(=O)CCCN2CCC(c3ccc(Cl)cc3)CC2)c1
CHEMBL1256170,CHEMBL217,Dopamine D2 receptor,Ki,=,30.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(CCCN1CCC(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2
CHEMBL1258270,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,Cc1ccc(C)c(C(=O)CCCN2CCC(c3cc(C)ccc3C)CC2)c1
CHEMBL424294,CHEMBL217,Dopamine D2 receptor,Ki,=,72.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL1258382,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(NCCCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccccc2s1
CHEMBL1258383,CHEMBL217,Dopamine D2 receptor,Ki,=,65.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,Cc1ccc(C)c(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)c1
CHEMBL1258494,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc(C)ccc2C)CC1
CHEMBL1256171,CHEMBL217,Dopamine D2 receptor,Ki,=,48.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,O=C(NCCCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2
CHEMBL1258495,CHEMBL217,Dopamine D2 receptor,Ki,=,86.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,Cc1ccc(C)c(C(=O)NCCCCN2CCN(c3cc(C)ccc3C)CC2)c1
CHEMBL210567,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL1261460,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1255217,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1
CHEMBL12713,CHEMBL217,Dopamine D2 receptor,Ki,=,0.45,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1
CHEMBL319352,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1
CHEMBL328187,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,Cn1cc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)nn1
CHEMBL1259172,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,NCc1ccc2c(c1)c(C1CCN(CCN3CCNC3=O)CC1)cn2-c1ccc(F)cc1
CHEMBL1259187,CHEMBL217,Dopamine D2 receptor,Ki,=,3.1,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CC(=O)NCc1ccc2c(c1)c(C1CCN(CCN3CCNC3=O)CC1)cn2-c1ccc(F)cc1
CHEMBL1259188,CHEMBL217,Dopamine D2 receptor,Ki,=,2.7,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,Cn1nnc(Cc2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1
CHEMBL1259203,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cncnc4)cc23)CC1
CHEMBL64249,CHEMBL217,Dopamine D2 receptor,Ki,=,0.67,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL1259216,CHEMBL217,Dopamine D2 receptor,Ki,=,2.3,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnn(C)n4)cc32)CC1
CHEMBL1259231,CHEMBL217,Dopamine D2 receptor,Ki,=,0.86,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccnn4C)cc32)CC1
CHEMBL1259232,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccn(C)n4)cc32)CC1
CHEMBL1258987,CHEMBL217,Dopamine D2 receptor,Ki,=,2.3,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cnn(C)c4)cc32)CC1
CHEMBL1258988,CHEMBL217,Dopamine D2 receptor,Ki,=,5.9,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ncn(C)n4)cc32)CC1
CHEMBL1259005,CHEMBL217,Dopamine D2 receptor,Ki,=,2.9,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,Cc1ccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)s1
CHEMBL1259006,CHEMBL217,Dopamine D2 receptor,Ki,=,1.9,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccccn4)cc32)CC1
CHEMBL1259023,CHEMBL217,Dopamine D2 receptor,Ki,=,0.62,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cccnc4)cc32)CC1
CHEMBL1259024,CHEMBL217,Dopamine D2 receptor,Ki,=,1.1,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccncc4)cc32)CC1
CHEMBL1259042,CHEMBL217,Dopamine D2 receptor,Ki,=,0.73,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cncnc4)cc32)CC1
CHEMBL1259043,CHEMBL217,Dopamine D2 receptor,Ki,=,1.8,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccccc4)cc32)CC1
CHEMBL1259062,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,Cc1ccccc1-c1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2
CHEMBL1259063,CHEMBL217,Dopamine D2 receptor,Ki,=,3.4,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,Cc1cccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c1
CHEMBL1259079,CHEMBL217,Dopamine D2 receptor,Ki,=,6.3,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,Cc1ccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)cc1
CHEMBL1259080,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,Cc1cccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c1C
CHEMBL1259097,CHEMBL217,Dopamine D2 receptor,Ki,=,4.6,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,Cc1cccc(C)c1-c1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2
CHEMBL1259098,CHEMBL217,Dopamine D2 receptor,Ki,=,4.9,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,Cc1cc(C)c(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c(C)c1
CHEMBL1259112,CHEMBL217,Dopamine D2 receptor,Ki,=,1.4,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CN1CCN(C2Cc3ccccc3Sc3ccc(C#N)cc32)CC1
CHEMBL1259113,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CN1CCN(C2Cc3ccccc3Sc3ccc(CN)cc32)CC1
CHEMBL1259128,CHEMBL217,Dopamine D2 receptor,Ki,=,0.35,nM,CHEMBL1261596,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in HEK293 cells,CHEMBL1255222,KI,CN1CCN(C2Cc3ccccc3Sc3ccc(Cc4nnn(C)n4)cc32)CC1
CHEMBL1259144,CHEMBL217,Dopamine D2 receptor,Ki,=,7.1,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CC(=O)NCc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2
CHEMBL1259145,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CC(C)C(=O)NCc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2
CHEMBL1259158,CHEMBL217,Dopamine D2 receptor,Ki,=,6.1,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CN1CCN(C2Cc3ccccc3Sc3ccc(CNC(=O)C(C)(C)C)cc32)CC1
CHEMBL64875,CHEMBL217,Dopamine D2 receptor,Ki,=,7.3,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CN1CCN([C@@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL303313,CHEMBL217,Dopamine D2 receptor,Ki,=,1.1,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CN1CCN([C@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL1259173,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CC(=O)NCc1ccc2c(c1)[C@H](N1CCN(C)CC1)Cc1ccccc1S2
CHEMBL1259174,CHEMBL217,Dopamine D2 receptor,Ki,=,3.3,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CC(=O)NCc1ccc2c(c1)[C@@H](N1CCN(C)CC1)Cc1ccccc1S2
CHEMBL1259189,CHEMBL217,Dopamine D2 receptor,Ki,=,31.0,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CC(C)C(=O)NCc1ccc2c(c1)[C@H](N1CCN(C)CC1)Cc1ccccc1S2
CHEMBL1259190,CHEMBL217,Dopamine D2 receptor,Ki,=,4.5,nM,CHEMBL1261591,B,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL1255222,KI,CC(C)C(=O)NCc1ccc2c(c1)[C@@H](N1CCN(C)CC1)Cc1ccccc1S2
CHEMBL1259129,CHEMBL217,Dopamine D2 receptor,Ki,=,1.9,nM,CHEMBL1261596,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in HEK293 cells,CHEMBL1255222,KI,CN1CCN(C2Cc3ccccc3Sc3ccc(Cc4nnnn4C)cc32)CC1
CHEMBL1259216,CHEMBL217,Dopamine D2 receptor,Ki,=,0.44,nM,CHEMBL1261596,B,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in HEK293 cells,CHEMBL1255222,KI,CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnn(C)n4)cc32)CC1
CHEMBL1259071,CHEMBL217,Dopamine D2 receptor,Ki,=,73000.0,nM,CHEMBL1259261,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor,CHEMBL1255227,KI,Cc1ccc(CNCC2(F)CCN(C(=O)c3cc(Br)cs3)CC2)nc1
CHEMBL1259241,CHEMBL217,Dopamine D2 receptor,Ki,=,20000.0,nM,CHEMBL1259261,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor,CHEMBL1255227,KI,Cc1ccc(CNCC2(F)CCN(C(=O)c3csc4ccccc34)CC2)nc1
CHEMBL1258999,CHEMBL217,Dopamine D2 receptor,Ki,=,27000.0,nM,CHEMBL1259261,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor,CHEMBL1255227,KI,Cc1ccc(CNCC2(F)CCN(C(=O)c3coc4ccccc34)CC2)nc1
CHEMBL45305,CHEMBL217,Dopamine D2 receptor,Ki,=,15000.0,nM,CHEMBL1259261,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor,CHEMBL1255227,KI,Cc1ccc(CNCC2(F)CCN(C(=O)c3ccc(F)c(Cl)c3)CC2)nc1
CHEMBL1259071,CHEMBL217,Dopamine D2 receptor,Ki,=,100000.0,nM,CHEMBL1259262,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor,CHEMBL1255227,KI,Cc1ccc(CNCC2(F)CCN(C(=O)c3cc(Br)cs3)CC2)nc1
CHEMBL1259241,CHEMBL217,Dopamine D2 receptor,Ki,=,54000.0,nM,CHEMBL1259262,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor,CHEMBL1255227,KI,Cc1ccc(CNCC2(F)CCN(C(=O)c3csc4ccccc34)CC2)nc1
CHEMBL1258999,CHEMBL217,Dopamine D2 receptor,Ki,=,28000.0,nM,CHEMBL1259262,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor,CHEMBL1255227,KI,Cc1ccc(CNCC2(F)CCN(C(=O)c3coc4ccccc34)CC2)nc1
CHEMBL45305,CHEMBL217,Dopamine D2 receptor,Ki,=,46000.0,nM,CHEMBL1259262,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor,CHEMBL1255227,KI,Cc1ccc(CNCC2(F)CCN(C(=O)c3ccc(F)c(Cl)c3)CC2)nc1
CHEMBL1277917,CHEMBL217,Dopamine D2 receptor,Ki,=,355.0,nM,CHEMBL1286377,B,Displacement of [3H]LSD from human cloned dopamine D2 receptor expressed in human HeLa cells,CHEMBL1275334,KI,CN1CCN(c2ccc3[nH]nc(S(=O)(=O)c4ccccc4)c3c2)CC1
CHEMBL1277104,CHEMBL217,Dopamine D2 receptor,Ki,=,334.0,nM,CHEMBL1286377,B,Displacement of [3H]LSD from human cloned dopamine D2 receptor expressed in human HeLa cells,CHEMBL1275334,KI,CN1CCN(c2ccc3[nH]nc(S(=O)(=O)c4cccc5ccccc45)c3c2)CC1
CHEMBL1277565,CHEMBL217,Dopamine D2 receptor,Ki,=,2243.0,nM,CHEMBL1286377,B,Displacement of [3H]LSD from human cloned dopamine D2 receptor expressed in human HeLa cells,CHEMBL1275334,KI,Cn1nc(S(=O)(=O)c2cccc3ccccc23)c2cc(N3CCNCC3)ccc21
CHEMBL1277837,CHEMBL217,Dopamine D2 receptor,Ki,=,2036.0,nM,CHEMBL1286377,B,Displacement of [3H]LSD from human cloned dopamine D2 receptor expressed in human HeLa cells,CHEMBL1275334,KI,CC(C)n1nc(S(=O)(=O)c2cccc3ccccc23)c2cc(N3CCNCC3)ccc21
CHEMBL1275630,CHEMBL217,Dopamine D2 receptor,Ki,=,1903.0,nM,CHEMBL1286377,B,Displacement of [3H]LSD from human cloned dopamine D2 receptor expressed in human HeLa cells,CHEMBL1275334,KI,CC(C)Cn1nc(S(=O)(=O)c2cccc3ccccc23)c2cc(N3CCNCC3)ccc21
CHEMBL1278001,CHEMBL217,Dopamine D2 receptor,Ki,=,605.0,nM,CHEMBL1286377,B,Displacement of [3H]LSD from human cloned dopamine D2 receptor expressed in human HeLa cells,CHEMBL1275334,KI,O=S(=O)(c1cccc2ccccc12)c1nn(Cc2ccccc2)c2ccc(N3CCNCC3)cc12
CHEMBL338606,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL1291990,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,CHEMBL1287708,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(F)cc2)CC1
CHEMBL1180455,CHEMBL217,Dopamine D2 receptor,Ki,=,22.6,nM,CHEMBL1291990,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,CHEMBL1287708,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(Cl)cc2)CC1
CHEMBL1180430,CHEMBL217,Dopamine D2 receptor,Ki,=,13.54,nM,CHEMBL1291990,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,CHEMBL1287708,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccccc2)CC1
CHEMBL567286,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL1291990,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,CHEMBL1287708,KI,N#[11C]c1cccc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)c1
CHEMBL338606,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL1291989,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,CHEMBL1287708,KI,COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(F)cc2)CC1
CHEMBL567286,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL1291989,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,CHEMBL1287708,KI,N#[11C]c1cccc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)c1
CHEMBL1288585,CHEMBL217,Dopamine D2 receptor,Ki,=,8.5,nM,CHEMBL1291980,B,Binding affinity to human dopamine D2 receptor expressed in CHO cells,CHEMBL1287708,KI,CC[11CH2]N1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21
CHEMBL1632223,CHEMBL217,Dopamine D2 receptor,Ki,=,79.43,nM,CHEMBL1635455,B,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,CHEMBL1629528,KI,Cc1ccc2c(N3CCN(CCc4cccc(NC(=O)Nc5ccccc5)c4)CC3)cccc2n1
CHEMBL1631532,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL1635455,B,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,CHEMBL1629528,KI,COC(=O)Nc1cccc(CCN2CCN(c3cccc4nc(C)ccc34)CC2)c1
CHEMBL1632217,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL1635455,B,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,CHEMBL1629528,KI,Cc1ccc2c(N3CCN(CCc4cccc(NC(=O)c5cnccn5)c4)CC3)cccc2n1
CHEMBL1632220,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL1635455,B,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,CHEMBL1629528,KI,CCNC(=O)Nc1cccc(CCN2CCN(c3cccc4nc(C)ccc34)CC2)c1
CHEMBL1631545,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL1635455,B,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,CHEMBL1629528,KI,Cc1ccc2c(N3CCN(CCc4cccc(-n5cccn5)c4)CC3)cccc2n1
CHEMBL1632210,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL1635455,B,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,CHEMBL1629528,KI,Cc1ccc2c(N3CCN(CCc4cccc(NC(=O)c5ccccc5)c4)CC3)cccc2n1
CHEMBL1632206,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL1635455,B,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,CHEMBL1629528,KI,CC(=O)Nc1cccc(CCN2CCN(c3cccc4nc(C)ccc34)CC2)c1
CHEMBL1631535,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL1635455,B,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,CHEMBL1629528,KI,Cc1ccc2c(N3CCN(CCc4cccc(NS(C)(=O)=O)c4)CC3)cccc2n1
CHEMBL1631540,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL1635455,B,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,CHEMBL1629528,KI,Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1
CHEMBL1631542,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL1635455,B,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,CHEMBL1629528,KI,Cc1ccc2c(N3CCN(CCc4cccc(N5CCOC5=O)c4)CC3)cccc2n1
CHEMBL1684128,CHEMBL217,Dopamine D2 receptor,Ki,=,88.0,nM,CHEMBL1686531,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2C1Cc1cccc(OCCCCN2CCN(c4ccccc4OC)CC2)c1-3
CHEMBL1684135,CHEMBL217,Dopamine D2 receptor,Ki,=,141.0,nM,CHEMBL1686531,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OCCCCN2CCN(c4ccccc4OC)CC2)c1-3
CHEMBL1684134,CHEMBL217,Dopamine D2 receptor,Ki,=,174.0,nM,CHEMBL1686531,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2[C@@H]1Cc1cccc(OCCCCN2CCN(c4ccccc4OC)CC2)c1-3
CHEMBL1684029,CHEMBL217,Dopamine D2 receptor,Ki,=,206.0,nM,CHEMBL1686531,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2C1Cc1cccc(OCCCn2cc(CCCCN4CCN(c5ccccc5OC)CC4)nn2)c1-3
CHEMBL1684130,CHEMBL217,Dopamine D2 receptor,Ki,=,293.0,nM,CHEMBL1686531,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2[C@@H]1Cc1cccc(OCc2cn(CCCCN4CCN(c5ccccc5OC)CC4)nn2)c1-3
CHEMBL1684129,CHEMBL217,Dopamine D2 receptor,Ki,=,399.0,nM,CHEMBL1686531,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2C1Cc1cccc(OCCCN(CCCN2CCN(c4ccccc4OC)CC2)S(C)(=O)=O)c1-3
CHEMBL1684132,CHEMBL217,Dopamine D2 receptor,Ki,=,600.0,nM,CHEMBL1686531,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2[C@@H]1Cc1cccc(OCCCn2cc(CCN4CCN(c5ccccc5OC)CC4)nn2)c1-3
CHEMBL1684131,CHEMBL217,Dopamine D2 receptor,Ki,=,616.0,nM,CHEMBL1686531,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OCc2cn(CCCCN4CCN(c5ccccc5OC)CC4)nn2)c1-3
CHEMBL1684028,CHEMBL217,Dopamine D2 receptor,Ki,=,661.0,nM,CHEMBL1686531,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2C1Cc1cccc(OCc2cn(CCCCN4CCN(c5ccccc5OC)CC4)nn2)c1-3
CHEMBL1684133,CHEMBL217,Dopamine D2 receptor,Ki,=,770.0,nM,CHEMBL1686531,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OCCCn2cc(CCN4CCN(c5ccccc5OC)CC4)nn2)c1-3
CHEMBL1684023,CHEMBL217,Dopamine D2 receptor,Ki,=,1203.0,nM,CHEMBL1686531,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2C1Cc1cccc(OCc2cn(CCCN4CCN(c5ccccc5OC)CC4)nn2)c1-3
CHEMBL1684125,CHEMBL217,Dopamine D2 receptor,Ki,=,7384.0,nM,CHEMBL1686531,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2C1Cc1cccc(OCCCn2cc(CCN4CCN(c5ccccc5OC)CC4)nn2)c1-3
CHEMBL1689012,CHEMBL217,Dopamine D2 receptor,Ki,=,70.5,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,O=C(NC/C=C/CN1CCN(c2ccccc2OCCF)CC1)c1ccc(-c2ccsc2)cc1.O=C(O)C(=O)O
CHEMBL1689011,CHEMBL217,Dopamine D2 receptor,Ki,=,64.8,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,O=C(NC/C=C/CN1CCN(c2ccccc2OCCF)CC1)c1ccc(OCCOCCF)cc1.O=C(O)C(=O)O
CHEMBL1689010,CHEMBL217,Dopamine D2 receptor,Ki,=,37.9,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,O=C(NC/C=C/CN1CCN(c2ccccc2OCCF)CC1)c1ccc(OCCF)cc1.O=C(O)C(=O)O
CHEMBL1689009,CHEMBL217,Dopamine D2 receptor,Ki,=,17.7,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,O=C(NC/C=C/CN1CCN(c2ccccc2OCCF)CC1)c1ccc(CCF)cc1.O=C(O)C(=O)O
CHEMBL1689008,CHEMBL217,Dopamine D2 receptor,Ki,=,35.2,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,CN(C)c1ccc(C(=O)NC/C=C/CN2CCN(c3ccccc3OCCF)CC2)cc1.O=C(O)C(=O)O
CHEMBL1689007,CHEMBL217,Dopamine D2 receptor,Ki,=,31.7,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1ccc(OCCOCCOCCF)cc1.O=C(O)C(=O)O
CHEMBL1689006,CHEMBL217,Dopamine D2 receptor,Ki,=,27.7,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1ccc(-c2ccsc2)cc1.O=C(O)C(=O)O
CHEMBL1689005,CHEMBL217,Dopamine D2 receptor,Ki,=,14.2,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1ccc(OCCOCCF)cc1.O=C(O)C(=O)O
CHEMBL1689004,CHEMBL217,Dopamine D2 receptor,Ki,=,15.1,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1ccc(OCCF)cc1.O=C(O)C(=O)O
CHEMBL1689003,CHEMBL217,Dopamine D2 receptor,Ki,=,21.4,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1ccc(CCF)cc1.O=C(O)C(=O)O
CHEMBL1689002,CHEMBL217,Dopamine D2 receptor,Ki,=,15.1,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,CN(C)c1ccc(C(=O)NCCCCN2CCN(c3ccccc3OCCF)CC2)cc1.O=C(O)C(=O)O
CHEMBL1689001,CHEMBL217,Dopamine D2 receptor,Ki,=,57.6,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2cc(Br)cc(OC)c2OCCF)CC1.O=C(O)C(=O)O
CHEMBL1689000,CHEMBL217,Dopamine D2 receptor,Ki,=,13.2,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2cc(I)ccc2OCCF)CC1.O=C(O)C(=O)O
CHEMBL1688999,CHEMBL217,Dopamine D2 receptor,Ki,=,13.4,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2cc(Br)ccc2OCCF)CC1.O=C(O)C(=O)O
CHEMBL1688998,CHEMBL217,Dopamine D2 receptor,Ki,=,17.8,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2cc(C)ccc2OCCF)CC1.O=C(O)C(=O)O
CHEMBL1688997,CHEMBL217,Dopamine D2 receptor,Ki,=,59.2,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc(OCCOCCF)cc2)CC1.O=C(O)C(=O)O
CHEMBL1688996,CHEMBL217,Dopamine D2 receptor,Ki,=,55.3,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc(OCCF)cc2)CC1.O=C(O)C(=O)O
CHEMBL1688995,CHEMBL217,Dopamine D2 receptor,Ki,=,131.0,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc(CCF)cc2)CC1.O=C(O)C(=O)O
CHEMBL1688994,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(OCCOCCOCCF)cc2)CC1.O=C(O)C(=O)O
CHEMBL1688993,CHEMBL217,Dopamine D2 receptor,Ki,=,20.9,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(OCCOCCF)cc2)CC1.O=C(O)C(=O)O
CHEMBL1688992,CHEMBL217,Dopamine D2 receptor,Ki,=,27.1,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(OCCF)cc2)CC1.O=C(O)C(=O)O
CHEMBL1688991,CHEMBL217,Dopamine D2 receptor,Ki,=,54.5,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(CCF)cc2)CC1
CHEMBL1688990,CHEMBL217,Dopamine D2 receptor,Ki,=,34.4,nM,CHEMBL1694505,B,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,CHEMBL1687933,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(N(C)C)cc2)CC1
CHEMBL112065,CHEMBL217,Dopamine D2 receptor,Ki,=,48.0,nM,CHEMBL1769067,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL193337,CHEMBL217,Dopamine D2 receptor,Ki,=,410.0,nM,CHEMBL1769067,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCC)[C@H]1CCn2nccc2C1
CHEMBL197159,CHEMBL217,Dopamine D2 receptor,Ki,=,55000.0,nM,CHEMBL1769067,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCC)[C@@H]1CCn2nccc2C1
CHEMBL1765629,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL1769067,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCn2nccc2C1
CHEMBL1765630,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL1769067,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCn2ncc(Cl)c2C1
CHEMBL1765631,CHEMBL217,Dopamine D2 receptor,Ki,=,8400.0,nM,CHEMBL1769067,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCn2ncc(C=O)c2C1
CHEMBL1765632,CHEMBL217,Dopamine D2 receptor,Ki,=,270.0,nM,CHEMBL1769067,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1Cc2cccn3ncc(c23)C1
CHEMBL112065,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL1769068,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL193337,CHEMBL217,Dopamine D2 receptor,Ki,=,270.0,nM,CHEMBL1769068,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCC)[C@H]1CCn2nccc2C1
CHEMBL197159,CHEMBL217,Dopamine D2 receptor,Ki,=,53000.0,nM,CHEMBL1769068,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCC)[C@@H]1CCn2nccc2C1
CHEMBL1765629,CHEMBL217,Dopamine D2 receptor,Ki,=,77.0,nM,CHEMBL1769068,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCn2nccc2C1
CHEMBL1765630,CHEMBL217,Dopamine D2 receptor,Ki,=,43.0,nM,CHEMBL1769068,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCn2ncc(Cl)c2C1
CHEMBL1765631,CHEMBL217,Dopamine D2 receptor,Ki,=,4700.0,nM,CHEMBL1769068,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCn2ncc(C=O)c2C1
CHEMBL1765632,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL1769068,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1Cc2cccn3ncc(c23)C1
CHEMBL193337,CHEMBL217,Dopamine D2 receptor,Ki,=,4.6,nM,CHEMBL1769072,B,Displacement of [3H]7-OH-DPAT from human dopamine D2long receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCC)[C@H]1CCn2nccc2C1
CHEMBL197159,CHEMBL217,Dopamine D2 receptor,Ki,=,57000.0,nM,CHEMBL1769072,B,Displacement of [3H]7-OH-DPAT from human dopamine D2long receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCC)[C@@H]1CCn2nccc2C1
CHEMBL1765633,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL1769072,B,Displacement of [3H]7-OH-DPAT from human dopamine D2long receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)[C@H]1CCn2nccc2C1
CHEMBL1765634,CHEMBL217,Dopamine D2 receptor,Ki,=,49.0,nM,CHEMBL1769072,B,Displacement of [3H]7-OH-DPAT from human dopamine D2long receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)[C@@H]1CCn2nccc2C1
CHEMBL1765633,CHEMBL217,Dopamine D2 receptor,Ki,=,5.3,nM,CHEMBL1769067,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)[C@H]1CCn2nccc2C1
CHEMBL1765634,CHEMBL217,Dopamine D2 receptor,Ki,=,300.0,nM,CHEMBL1769067,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,CHEMBL1765048,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)[C@@H]1CCn2nccc2C1
CHEMBL477250,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL1771855,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCc3ccccc3C2=O)CC1
CHEMBL477206,CHEMBL217,Dopamine D2 receptor,Ki,=,3.9,nM,CHEMBL1771855,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCCc3ccccc3C2=O)CC1
CHEMBL1771105,CHEMBL217,Dopamine D2 receptor,Ki,=,3.2,nM,CHEMBL1771855,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccc2c(c1)CCCN(CCCCN1CCN(c3ccccc3OC)CC1)C2=O
CHEMBL1771106,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL1771855,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCc3cc(F)ccc3C2=O)CC1
CHEMBL1771107,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL1771855,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCc3cc(-c4ccccc4)ccc3C2=O)CC1
CHEMBL1771108,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL1771855,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCc3c(cccc3-c3ccccc3)C2=O)CC1
CHEMBL1771109,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL1771855,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCc3cc(-c4ccco4)ccc3C2=O)CC1
CHEMBL1771110,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL1771855,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCc3cc(-c4cccs4)ccc3C2=O)CC1
CHEMBL1771111,CHEMBL217,Dopamine D2 receptor,Ki,=,5.1,nM,CHEMBL1771855,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCCc3cc(-c4cccs4)ccc3C2=O)CC1
CHEMBL1771112,CHEMBL217,Dopamine D2 receptor,Ki,=,7.1,nM,CHEMBL1771855,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCc3cc(-c4ccncc4)ccc3C2=O)CC1
CHEMBL1771113,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL1771855,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCc3cc(C#N)ccc3C2=O)CC1
CHEMBL1771114,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL1771855,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,CHEMBL1770099,KI,C#Cc1ccc2c(c1)CCN(CCCCN1CCN(c3ccccc3OC)CC1)C2=O
CHEMBL477250,CHEMBL217,Dopamine D2 receptor,Ki,=,7.0,nM,CHEMBL1771856,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCc3ccccc3C2=O)CC1
CHEMBL477206,CHEMBL217,Dopamine D2 receptor,Ki,=,1.5,nM,CHEMBL1771856,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCCc3ccccc3C2=O)CC1
CHEMBL1771105,CHEMBL217,Dopamine D2 receptor,Ki,=,0.93,nM,CHEMBL1771856,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccc2c(c1)CCCN(CCCCN1CCN(c3ccccc3OC)CC1)C2=O
CHEMBL1771106,CHEMBL217,Dopamine D2 receptor,Ki,=,9.2,nM,CHEMBL1771856,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCc3cc(F)ccc3C2=O)CC1
CHEMBL1771107,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL1771856,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCc3cc(-c4ccccc4)ccc3C2=O)CC1
CHEMBL1771108,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL1771856,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCc3c(cccc3-c3ccccc3)C2=O)CC1
CHEMBL1771109,CHEMBL217,Dopamine D2 receptor,Ki,=,4.8,nM,CHEMBL1771856,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCc3cc(-c4ccco4)ccc3C2=O)CC1
CHEMBL1771110,CHEMBL217,Dopamine D2 receptor,Ki,=,6.9,nM,CHEMBL1771856,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCc3cc(-c4cccs4)ccc3C2=O)CC1
CHEMBL1771111,CHEMBL217,Dopamine D2 receptor,Ki,=,2.1,nM,CHEMBL1771856,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCCc3cc(-c4cccs4)ccc3C2=O)CC1
CHEMBL1771112,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL1771856,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCc3cc(-c4ccncc4)ccc3C2=O)CC1
CHEMBL1771113,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL1771856,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1770099,KI,COc1ccccc1N1CCN(CCCCN2CCc3cc(C#N)ccc3C2=O)CC1
CHEMBL1771114,CHEMBL217,Dopamine D2 receptor,Ki,=,8.8,nM,CHEMBL1771856,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,CHEMBL1770099,KI,C#Cc1ccc2c(c1)CCN(CCCCN1CCN(c3ccccc3OC)CC1)C2=O
CHEMBL1774386,CHEMBL217,Dopamine D2 receptor,Ki,=,9163.0,nM,CHEMBL1777239,B,Displacement of [125I]-IABN from wild type human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1772985,KI,O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,1.8,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL1774062,CHEMBL217,Dopamine D2 receptor,Ki,=,2.6,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(CCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nc2N1
CHEMBL1774063,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nc2N1
CHEMBL1774064,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=c1ccc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nc2[nH]1
CHEMBL1774065,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=c1ccc2cnc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1
CHEMBL1774066,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=c1ccc2cnc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nc2[nH]1
CHEMBL1774067,CHEMBL217,Dopamine D2 receptor,Ki,=,5.7,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4Cl)CC3)nc2N1
CHEMBL1774068,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(F)c4Cl)CC3)nc2N1
CHEMBL1774069,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,Cc1cccc(N2CCN(CCCCOc3ccc4c(n3)NC(=O)CC4)CC2)c1Cl
CHEMBL1774070,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,Cc1ccccc1N1CCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1
CHEMBL1774071,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,Cc1cccc(N2CCN(CCCCOc3ccc4c(n3)NC(=O)CC4)CC2)c1C
CHEMBL1774072,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,Cc1c(Cl)cccc1N1CCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1
CHEMBL1774073,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4F)CC3)nc2N1
CHEMBL1774074,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(C(F)(F)F)c4Cl)CC3)nc2N1
CHEMBL1774075,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4C(F)(F)F)CC3)nc2N1
CHEMBL1774076,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4CCC5)CC3)nc2N1
CHEMBL1774077,CHEMBL217,Dopamine D2 receptor,Ki,=,1.4,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4CCCC5)CC3)nc2N1
CHEMBL1774078,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4CCCO5)CC3)nc2N1
CHEMBL1774079,CHEMBL217,Dopamine D2 receptor,Ki,=,0.71,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCCC5)CC3)nc2N1
CHEMBL1774080,CHEMBL217,Dopamine D2 receptor,Ki,=,0.81,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)nc2N1
CHEMBL1774081,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4c(F)ccc5ccccc45)CC3)nc2N1
CHEMBL1774082,CHEMBL217,Dopamine D2 receptor,Ki,=,1.1,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cc(F)cc5ccccc45)CC3)nc2N1
CHEMBL1774083,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccc(F)c5ccccc45)CC3)nc2N1
CHEMBL1774084,CHEMBL217,Dopamine D2 receptor,Ki,=,6.0,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c(F)cccc45)CC3)nc2N1
CHEMBL1774085,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5cc(F)ccc45)CC3)nc2N1
CHEMBL1774086,CHEMBL217,Dopamine D2 receptor,Ki,=,1.2,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5ccc(F)cc45)CC3)nc2N1
CHEMBL1774087,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL1776016,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL1773056,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5cccc(F)c45)CC3)nc2N1
CHEMBL1774383,CHEMBL217,Dopamine D2 receptor,Ki,=,390.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc(-c3ccccn3)cc2)CC1
CHEMBL1774384,CHEMBL217,Dopamine D2 receptor,Ki,=,378.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL1774385,CHEMBL217,Dopamine D2 receptor,Ki,=,329.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1
CHEMBL1774386,CHEMBL217,Dopamine D2 receptor,Ki,=,14600.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL1774532,CHEMBL217,Dopamine D2 receptor,Ki,=,274.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,COc1ccc2oc(C(=O)NCCC(F)CN3CCN(c4ccccc4OC)CC3)cc2c1
CHEMBL1774533,CHEMBL217,Dopamine D2 receptor,Ki,=,279.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,COc1ccc2oc(C(=O)NCCC(F)CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2c1
CHEMBL1774534,CHEMBL217,Dopamine D2 receptor,Ki,=,421.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1
CHEMBL1774535,CHEMBL217,Dopamine D2 receptor,Ki,=,526.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL1774536,CHEMBL217,Dopamine D2 receptor,Ki,=,2890.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1
CHEMBL1774537,CHEMBL217,Dopamine D2 receptor,Ki,=,4260.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL1774538,CHEMBL217,Dopamine D2 receptor,Ki,=,241.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL1774539,CHEMBL217,Dopamine D2 receptor,Ki,=,472.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL1774540,CHEMBL217,Dopamine D2 receptor,Ki,=,302.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,COc1ccc2[nH]c(C(=O)NCCC(F)CN3CCN(c4ccccc4OC)CC3)cc2c1
CHEMBL1774541,CHEMBL217,Dopamine D2 receptor,Ki,=,230.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,COc1ccc2[nH]c(C(=O)NCCC(F)CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2c1
CHEMBL1774542,CHEMBL217,Dopamine D2 receptor,Ki,=,195.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2ccccc2c1
CHEMBL180010,CHEMBL217,Dopamine D2 receptor,Ki,=,93.3,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL1774543,CHEMBL217,Dopamine D2 receptor,Ki,=,69.9,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,CCCN(CCCCN1CCN(c2ccccc2OC)CC1)Cc1csc2ccccc12
CHEMBL1774544,CHEMBL217,Dopamine D2 receptor,Ki,=,162.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,CCCN(CCCCN1CCN(c2cccc(Cl)c2Cl)CC1)Cc1csc2ccccc12
CHEMBL1774545,CHEMBL217,Dopamine D2 receptor,Ki,=,196.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,CCCN(CCCCN1CCN(c2ccccc2OC)CC1)Cc1ccc2c(c1)Cc1ccccc1-2
CHEMBL1774546,CHEMBL217,Dopamine D2 receptor,Ki,=,269.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,CCCN(CCCCN1CCN(c2cccc(Cl)c2Cl)CC1)Cc1ccc2c(c1)Cc1ccccc1-2
CHEMBL1774547,CHEMBL217,Dopamine D2 receptor,Ki,=,119.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,CCCN(CCCCN1CCN(c2ccccc2OC)CC1)Cc1ccc2ccccc2c1
CHEMBL1774548,CHEMBL217,Dopamine D2 receptor,Ki,=,313.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,CCCN(CCCCN1CCN(c2cccc(Cl)c2Cl)CC1)Cc1ccc2ccccc2c1
CHEMBL1774549,CHEMBL217,Dopamine D2 receptor,Ki,=,2090.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,OC(CCNCc1ccc2c(c1)Cc1ccccc1-2)CN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL1774550,CHEMBL217,Dopamine D2 receptor,Ki,=,5270.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,FC(CCNCc1ccc2c(c1)Cc1ccccc1-2)CN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL1774551,CHEMBL217,Dopamine D2 receptor,Ki,=,869.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,CN(CCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)Cc1ccc2c(c1)Cc1ccccc1-2
CHEMBL1773087,CHEMBL217,Dopamine D2 receptor,Ki,=,2060.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,CN(CCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)Cc1ccc2c(c1)Cc1ccccc1-2
CHEMBL25236,CHEMBL217,Dopamine D2 receptor,Ki,=,33.6,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL300780,CHEMBL217,Dopamine D2 receptor,Ki,=,112.0,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL1774552,CHEMBL217,Dopamine D2 receptor,Ki,=,64.7,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1csc2ccccc12
CHEMBL139926,CHEMBL217,Dopamine D2 receptor,Ki,=,44.8,nM,CHEMBL1777183,B,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1772985,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL1779058,CHEMBL217,Dopamine D2 receptor,Ki,=,1724.0,nM,CHEMBL1781414,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEK cells,CHEMBL1777734,KI,O=C(CCCN1C2C3C4CC5C6C4C2C6C1(O)C53)c1ccc(F)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL1781414,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEK cells,CHEMBL1777734,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL64260,CHEMBL217,Dopamine D2 receptor,Ki,=,2850.0,nM,CHEMBL1781414,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEK cells,CHEMBL1777734,KI,COc1cc2c(cc1OC)CN(CCNC(=O)c1cc(C)ccc1OC)CC2
CHEMBL1803023,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL1803210,B,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCn2cc(COc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803024,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL1803210,B,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803025,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL1803210,B,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803026,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL1803210,B,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCCc1cn(CCCCCCCCCCn2cc(CCCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803027,CHEMBL217,Dopamine D2 receptor,Ki,=,3.3,nM,CHEMBL1803210,B,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCOCCOCCn2cc(COc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803028,CHEMBL217,Dopamine D2 receptor,Ki,=,2.8,nM,CHEMBL1803210,B,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCOCCOCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803029,CHEMBL217,Dopamine D2 receptor,Ki,=,4.8,nM,CHEMBL1803210,B,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCOCCOCCOCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803030,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL1803210,B,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,CHEMBL1799971,KI,CCCCn1cc(COc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1
CHEMBL1803049,CHEMBL217,Dopamine D2 receptor,Ki,=,67.0,nM,CHEMBL1803210,B,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,CHEMBL1799971,KI,CCCCn1cc(CCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1
CHEMBL1803050,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL1803210,B,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,CHEMBL1799971,KI,CCCCn1cc(CCCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1
CHEMBL1803051,CHEMBL217,Dopamine D2 receptor,Ki,=,68.0,nM,CHEMBL1803210,B,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,CHEMBL1799971,KI,CCOCCn1cc(COc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1
CHEMBL1803052,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL1803210,B,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,CHEMBL1799971,KI,CCOCCn1cc(CCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1
CHEMBL1803053,CHEMBL217,Dopamine D2 receptor,Ki,=,36.0,nM,CHEMBL1803210,B,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,CHEMBL1799971,KI,CCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803054,CHEMBL217,Dopamine D2 receptor,Ki,=,9.8,nM,CHEMBL1803210,B,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(C)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803055,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL1803210,B,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(C5CCCCC5)CC4)cc3OC)nn2)nn1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.5,nM,CHEMBL1803210,B,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,CHEMBL1799971,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1803023,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL1803211,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCn2cc(COc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803024,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL1803211,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803025,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL1803211,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803026,CHEMBL217,Dopamine D2 receptor,Ki,=,8.2,nM,CHEMBL1803211,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCCc1cn(CCCCCCCCCCn2cc(CCCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803027,CHEMBL217,Dopamine D2 receptor,Ki,=,3.4,nM,CHEMBL1803211,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCOCCOCCn2cc(COc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803028,CHEMBL217,Dopamine D2 receptor,Ki,=,3.7,nM,CHEMBL1803211,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCOCCOCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803029,CHEMBL217,Dopamine D2 receptor,Ki,=,6.2,nM,CHEMBL1803211,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCOCCOCCOCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803030,CHEMBL217,Dopamine D2 receptor,Ki,=,70.0,nM,CHEMBL1803211,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1799971,KI,CCCCn1cc(COc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1
CHEMBL1803049,CHEMBL217,Dopamine D2 receptor,Ki,=,53.0,nM,CHEMBL1803211,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1799971,KI,CCCCn1cc(CCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1
CHEMBL1803050,CHEMBL217,Dopamine D2 receptor,Ki,=,67.0,nM,CHEMBL1803211,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1799971,KI,CCCCn1cc(CCCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1
CHEMBL1803051,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL1803211,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1799971,KI,CCOCCn1cc(COc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1
CHEMBL1803052,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL1803211,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1799971,KI,CCOCCn1cc(CCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1
CHEMBL1803053,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL1803211,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1799971,KI,CCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803054,CHEMBL217,Dopamine D2 receptor,Ki,=,7.3,nM,CHEMBL1803211,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(C)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803055,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL1803211,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1799971,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(C5CCCCC5)CC4)cc3OC)nn2)nn1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.1,nM,CHEMBL1803211,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL1799971,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1803024,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL1803214,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells in presence of 100 mM sodium chloride,CHEMBL1799971,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1803049,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL1803214,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells in presence of 100 mM sodium chloride,CHEMBL1799971,KI,CCCCn1cc(CCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1
CHEMBL478671,CHEMBL217,Dopamine D2 receptor,Ki,=,55.5,nM,CHEMBL1811739,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,CHEMBL1806354,KI,CCCC(=O)Oc1cccc2c1-c1cccc3c1[C@@H](C2)N(CCC)CC3
CHEMBL329904,CHEMBL217,Dopamine D2 receptor,Ki,=,854.0,nM,CHEMBL1811739,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,CHEMBL1806354,KI,CCCN1CCc2cccc3c2C1Cc1cccc(O)c1-3
CHEMBL1806867,CHEMBL217,Dopamine D2 receptor,Ki,=,2800.0,nM,CHEMBL1811739,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,CHEMBL1806354,KI,CCCN1CCc2cccc3c2C1Cc1cccc(OC(=O)NC(C)(C)C)c1-3
CHEMBL1806868,CHEMBL217,Dopamine D2 receptor,Ki,=,871.0,nM,CHEMBL1811739,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,CHEMBL1806354,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC(=O)NC(C)(C)C)c1-3
CHEMBL1806869,CHEMBL217,Dopamine D2 receptor,Ki,=,2005.0,nM,CHEMBL1811739,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,CHEMBL1806354,KI,CCCN1CCc2cccc3c2C1Cc1cccc(OC(=O)Nc2cccc4ccccc24)c1-3
CHEMBL1806870,CHEMBL217,Dopamine D2 receptor,Ki,=,4300.0,nM,CHEMBL1811739,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,CHEMBL1806354,KI,CCCN1CCc2cccc3c2C1Cc1cccc(OC(=O)NCc2ccccc2)c1-3
CHEMBL1806871,CHEMBL217,Dopamine D2 receptor,Ki,=,2200.0,nM,CHEMBL1811739,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,CHEMBL1806354,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC(=O)NCc2ccccc2)c1-3
CHEMBL1806872,CHEMBL217,Dopamine D2 receptor,Ki,=,851.0,nM,CHEMBL1811739,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,CHEMBL1806354,KI,CCCN1CCc2cccc3c2C1Cc1cccc(OC(=O)CSc2ccccc2)c1-3
CHEMBL1806874,CHEMBL217,Dopamine D2 receptor,Ki,=,174.0,nM,CHEMBL1811739,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,CHEMBL1806354,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC(=O)CCCCC2CCSS2)c1-3
CHEMBL1806875,CHEMBL217,Dopamine D2 receptor,Ki,=,296.0,nM,CHEMBL1811739,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,CHEMBL1806354,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC(=O)CCCC[C@@H]2CCSS2)c1-3
CHEMBL1806876,CHEMBL217,Dopamine D2 receptor,Ki,=,342.0,nM,CHEMBL1811739,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,CHEMBL1806354,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC(=O)CCCC[C@H]2CCSS2)c1-3
CHEMBL1806877,CHEMBL217,Dopamine D2 receptor,Ki,=,352.0,nM,CHEMBL1811739,B,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,CHEMBL1806354,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(N)c1-3
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,3.1,nM,CHEMBL1815674,B,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,CHEMBL1811837,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL1813586,CHEMBL217,Dopamine D2 receptor,Ki,=,2604.0,nM,CHEMBL1815674,B,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,CHEMBL1811837,KI,O=C(O)C(=O)O.O=C1CCc2ccc(OCCCCN3CCC(O)(c4ccc(Cl)cc4)CC3)cc2N1
CHEMBL1813587,CHEMBL217,Dopamine D2 receptor,Ki,=,145.0,nM,CHEMBL1815674,B,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,CHEMBL1811837,KI,O=C(O)C(=O)O.O=C1CCc2ccc(OCCCCN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2N1
CHEMBL1813588,CHEMBL217,Dopamine D2 receptor,Ki,=,309.0,nM,CHEMBL1815674,B,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,CHEMBL1811837,KI,O=C(O)C(=O)O.O=C1CCc2ccc(OCCCCN3CCC(n4c(=O)[nH]c5cc(Cl)ccc54)CC3)cc2N1
CHEMBL1813589,CHEMBL217,Dopamine D2 receptor,Ki,=,611.0,nM,CHEMBL1815674,B,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,CHEMBL1811837,KI,CN1CN(c2ccccc2)C2(CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)C1=O.O=C(O)C(=O)O
CHEMBL1813590,CHEMBL217,Dopamine D2 receptor,Ki,=,0.22,nM,CHEMBL1815674,B,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,CHEMBL1811837,KI,COc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1.O=C(O)C(=O)O
CHEMBL1813591,CHEMBL217,Dopamine D2 receptor,Ki,=,0.26,nM,CHEMBL1815674,B,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,CHEMBL1811837,KI,O=C(O)C(=O)O.O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4OCCF)CC3)cc2N1
CHEMBL1813585,CHEMBL217,Dopamine D2 receptor,Ki,=,102.0,nM,CHEMBL1815674,B,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,CHEMBL1811837,KI,COc1ccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)cc1.O=C(O)C(=O)O
CHEMBL1813592,CHEMBL217,Dopamine D2 receptor,Ki,=,25.3,nM,CHEMBL1815674,B,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,CHEMBL1811837,KI,COc1ccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)c(OC)c1.O=C(O)C(=O)O
CHEMBL1813593,CHEMBL217,Dopamine D2 receptor,Ki,=,4.6,nM,CHEMBL1815674,B,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,CHEMBL1811837,KI,COc1cc(C)ccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1.O=C(O)C(=O)O
CHEMBL1813594,CHEMBL217,Dopamine D2 receptor,Ki,=,0.14,nM,CHEMBL1815674,B,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,CHEMBL1811837,KI,COc1ccccc1N1CCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1.O=C(O)C(=O)O
CHEMBL1813595,CHEMBL217,Dopamine D2 receptor,Ki,=,0.07,nM,CHEMBL1815674,B,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,CHEMBL1811837,KI,O=C(O)C(=O)O.O=c1ccc2ccc(OCCCCN3CCN(c4ccccc4OCCF)CC3)cc2[nH]1
CHEMBL1813596,CHEMBL217,Dopamine D2 receptor,Ki,=,4.8,nM,CHEMBL1815674,B,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,CHEMBL1811837,KI,COc1ccccc1N1CCN(CCCOc2ccc3c(c2)NC(=O)CC3)CC1.O=C(O)C(=O)O
CHEMBL1813597,CHEMBL217,Dopamine D2 receptor,Ki,=,2.6,nM,CHEMBL1815674,B,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,CHEMBL1811837,KI,COc1ccccc1N1CCN(CCCOc2ccc3ccc(=O)[nH]c3c2)CC1.O=C(O)C(=O)O
CHEMBL1813598,CHEMBL217,Dopamine D2 receptor,Ki,=,7.3,nM,CHEMBL1815674,B,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,CHEMBL1811837,KI,COc1ccccc1N1CCN(CCCCCOc2ccc3c(c2)NC(=O)CC3)CC1.O=C(O)C(=O)O
CHEMBL1813599,CHEMBL217,Dopamine D2 receptor,Ki,=,7.4,nM,CHEMBL1815674,B,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,CHEMBL1811837,KI,COc1ccccc1N1CCN(CCCCCOc2ccc3ccc(=O)[nH]c3c2)CC1.O=C(O)C(=O)O
CHEMBL1255588,CHEMBL217,Dopamine D2 receptor,Ki,=,0.5,nM,CHEMBL1817460,B,Displacement of [3H]methyl-spiperone from human dopamine D2s receptor,CHEMBL1811872,KI,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1
CHEMBL1822386,CHEMBL217,Dopamine D2 receptor,Ki,=,1350.0,nM,CHEMBL1827958,B,Displacement of [125I]IABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1821670,KI,O=C(c1ccc(F)cc1)C1CCN([C@H]2CCN(Cc3ccc(F)cc3)C[C@@H]2O)CC1
CHEMBL1822390,CHEMBL217,Dopamine D2 receptor,Ki,=,1489.0,nM,CHEMBL1827958,B,Displacement of [125I]IABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,CHEMBL1821670,KI,COc1ccc(C(=O)C2CCN([C@H]3CCN(Cc4ccc(F)cc4)C[C@@H]3O)CC2)cc1
CHEMBL1831166,CHEMBL217,Dopamine D2 receptor,Ki,=,870.0,nM,CHEMBL1833373,B,Displacement of [3H]YM-09151-2 from human D2 receptor expressed in CHO cells,CHEMBL1828538,KI,COc1cc2c(cc1OC)CN(CCCCn1cc(-c3ccc(F)cc3)c3ccccc31)CC2
CHEMBL1834252,CHEMBL217,Dopamine D2 receptor,Ki,=,1648.0,nM,CHEMBL1839313,B,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,CHEMBL1833923,KI,COc1ccccc1CCN1CCN(Cc2cc3ccccc3o2)CC1
CHEMBL1834255,CHEMBL217,Dopamine D2 receptor,Ki,=,1025.0,nM,CHEMBL1839313,B,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,CHEMBL1833923,KI,c1ccc(CCCN2CCN(Cc3cc4ccccc4o3)CC2)cc1
CHEMBL1834256,CHEMBL217,Dopamine D2 receptor,Ki,=,5866.0,nM,CHEMBL1839313,B,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,CHEMBL1833923,KI,COc1ccccc1CCCN1CCN(Cc2cc3ccccc3o2)CC1
CHEMBL1834257,CHEMBL217,Dopamine D2 receptor,Ki,=,556.0,nM,CHEMBL1839313,B,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,CHEMBL1833923,KI,COc1cccc(CCCN2CCN(Cc3cc4ccccc4o3)CC2)c1
CHEMBL1834258,CHEMBL217,Dopamine D2 receptor,Ki,=,89.0,nM,CHEMBL1839313,B,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,CHEMBL1833923,KI,c1ccc(CCCCN2CCN(Cc3cc4ccccc4o3)CC2)cc1
CHEMBL1834259,CHEMBL217,Dopamine D2 receptor,Ki,=,432.0,nM,CHEMBL1839313,B,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,CHEMBL1833923,KI,COc1ccccc1CCCCN1CCN(Cc2cc3ccccc3o2)CC1
CHEMBL1834260,CHEMBL217,Dopamine D2 receptor,Ki,=,484.0,nM,CHEMBL1839313,B,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,CHEMBL1833923,KI,COc1cccc(CCCCN2CCN(Cc3cc4ccccc4o3)CC2)c1
CHEMBL1834261,CHEMBL217,Dopamine D2 receptor,Ki,=,5791.0,nM,CHEMBL1839313,B,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,CHEMBL1833923,KI,COc1ccc(CCCCN2CCN(Cc3cc4ccccc4o3)CC2)cc1
CHEMBL49,CHEMBL217,Dopamine D2 receptor,Ki,=,108.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
CHEMBL493,CHEMBL217,Dopamine D2 receptor,Ki,=,0.527,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL508112,CHEMBL217,Dopamine D2 receptor,Ki,=,1955.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,c1ccc2sc(SSc3nc4ccccc4s3)nc2c1
CHEMBL296419,CHEMBL217,Dopamine D2 receptor,Ki,=,1507.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1
CHEMBL1113,CHEMBL217,Dopamine D2 receptor,Ki,=,67.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
CHEMBL633,CHEMBL217,Dopamine D2 receptor,Ki,=,6651.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1
CHEMBL1403281,CHEMBL217,Dopamine D2 receptor,Ki,=,0.65,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL629,CHEMBL217,Dopamine D2 receptor,Ki,=,336.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CN(C)CCC=C1c2ccccc2CCc2ccccc21
CHEMBL305660,CHEMBL217,Dopamine D2 receptor,Ki,=,383.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1
CHEMBL64894,CHEMBL217,Dopamine D2 receptor,Ki,=,1059.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]
CHEMBL808,CHEMBL217,Dopamine D2 receptor,Ki,=,4269.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1
CHEMBL1385840,CHEMBL217,Dopamine D2 receptor,Ki,=,1.677,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL30008,CHEMBL217,Dopamine D2 receptor,Ki,=,117.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1
CHEMBL119443,CHEMBL217,Dopamine D2 receptor,Ki,=,184.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL726,CHEMBL217,Dopamine D2 receptor,Ki,=,0.539,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
CHEMBL442,CHEMBL217,Dopamine D2 receptor,Ki,=,1.433,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL1108,CHEMBL217,Dopamine D2 receptor,Ki,=,0.802,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,2.197,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1626,CHEMBL217,Dopamine D2 receptor,Ki,=,45.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1
CHEMBL936,CHEMBL217,Dopamine D2 receptor,Ki,=,1097.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1
CHEMBL1729,CHEMBL217,Dopamine D2 receptor,Ki,=,158.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC
CHEMBL1255837,CHEMBL217,Dopamine D2 receptor,Ki,=,0.491,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O
CHEMBL964,CHEMBL217,Dopamine D2 receptor,Ki,=,7673.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CCN(CC)C(=S)SSC(=S)N(CC)CC
CHEMBL104,CHEMBL217,Dopamine D2 receptor,Ki,=,4062.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1
CHEMBL1732,CHEMBL217,Dopamine D2 receptor,Ki,=,2.96,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL411,CHEMBL217,Dopamine D2 receptor,Ki,=,4440.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1
CHEMBL43064,CHEMBL217,Dopamine D2 receptor,Ki,=,259.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,129.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL71,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL415,CHEMBL217,Dopamine D2 receptor,Ki,=,138.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21
CHEMBL516,CHEMBL217,Dopamine D2 receptor,Ki,=,55.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1
CHEMBL219916,CHEMBL217,Dopamine D2 receptor,Ki,=,0.882,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
CHEMBL723,CHEMBL217,Dopamine D2 receptor,Ki,=,49.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12
CHEMBL564,CHEMBL217,Dopamine D2 receptor,Ki,=,168.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CN(C)CCCN1c2ccccc2Sc2ccccc21
CHEMBL643,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CC(CN1c2ccccc2Sc2ccccc21)N(C)C
CHEMBL531,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL1909072,CHEMBL217,Dopamine D2 receptor,Ki,=,1.35,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL716,CHEMBL217,Dopamine D2 receptor,Ki,=,443.3,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL728,CHEMBL217,Dopamine D2 receptor,Ki,=,3.608,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL1065,CHEMBL217,Dopamine D2 receptor,Ki,=,269.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1
CHEMBL21731,CHEMBL217,Dopamine D2 receptor,Ki,=,1154.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CNCCCC12CCC(c3ccccc31)c1ccccc12
CHEMBL86,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC
CHEMBL91,CHEMBL217,Dopamine D2 receptor,Ki,=,4168.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
CHEMBL19215,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21
CHEMBL1221512,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS
CHEMBL157138,CHEMBL217,Dopamine D2 receptor,Ki,=,0.953,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL1909065,CHEMBL217,Dopamine D2 receptor,Ki,=,234.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C
CHEMBL1201356,CHEMBL217,Dopamine D2 receptor,Ki,=,276.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL267044,CHEMBL217,Dopamine D2 receptor,Ki,=,43.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC
CHEMBL141343,CHEMBL217,Dopamine D2 receptor,Ki,=,5587.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,Cc1c(C)c2c(c(C)c1O)CCC(C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2
CHEMBL15245,CHEMBL217,Dopamine D2 receptor,Ki,=,687.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL479,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2
CHEMBL83,CHEMBL217,Dopamine D2 receptor,Ki,=,4628.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
CHEMBL84158,CHEMBL217,Dopamine D2 receptor,Ki,=,411.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,6.545,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL26,CHEMBL217,Dopamine D2 receptor,Ki,=,68.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC
CHEMBL17157,CHEMBL217,Dopamine D2 receptor,Ki,=,2056.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1
CHEMBL81,CHEMBL217,Dopamine D2 receptor,Ki,=,391.0,nM,CHEMBL1909140,B,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),CHEMBL1909046,KI,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.1,nM,CHEMBL1920024,B,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1916548,CHEMBL217,Dopamine D2 receptor,Ki,=,8.8,nM,CHEMBL1920024,B,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(CN5CCN(c6ccccc6OC)CC5)cc4OC)nn3)nn2)c(OC)c1)C1Cc2ccccc2C1
CHEMBL1916720,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL1920024,B,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(C(=O)NCCCCN5CCN(c6ccccc6OC)CC5)cc4OC)nn3)nn2)c(OC)c1)C1Cc2ccccc2C1
CHEMBL1803049,CHEMBL217,Dopamine D2 receptor,Ki,=,53.0,nM,CHEMBL1920024,B,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,CCCCn1cc(CCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1
CHEMBL1916552,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL1920024,B,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)cc2OC)nn1
CHEMBL1916551,CHEMBL217,Dopamine D2 receptor,Ki,=,4.1,nM,CHEMBL1920024,B,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)C3Cc4ccccc4C3)cc2OC)nn1
CHEMBL1803024,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL1920024,B,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1916550,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL1920024,B,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,COc1cc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1916549,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL1920024,B,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(C(=O)NCCCCN(CCC)C5Cc6ccccc6C5)cc4OC)nn3)nn2)c(OC)c1)C1Cc2ccccc2C1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.5,nM,CHEMBL1920023,B,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1916548,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL1920023,B,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(CN5CCN(c6ccccc6OC)CC5)cc4OC)nn3)nn2)c(OC)c1)C1Cc2ccccc2C1
CHEMBL1916720,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL1920023,B,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(C(=O)NCCCCN5CCN(c6ccccc6OC)CC5)cc4OC)nn3)nn2)c(OC)c1)C1Cc2ccccc2C1
CHEMBL1803049,CHEMBL217,Dopamine D2 receptor,Ki,=,67.0,nM,CHEMBL1920023,B,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,CCCCn1cc(CCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1
CHEMBL1916552,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL1920023,B,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)cc2OC)nn1
CHEMBL1916551,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL1920023,B,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)C3Cc4ccccc4C3)cc2OC)nn1
CHEMBL1803024,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL1920023,B,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1916550,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL1920023,B,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,COc1cc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1
CHEMBL1916549,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL1920023,B,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,CHEMBL1914371,KI,CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(C(=O)NCCCCN(CCC)C5Cc6ccccc6C5)cc4OC)nn3)nn2)c(OC)c1)C1Cc2ccccc2C1
CHEMBL1923292,CHEMBL217,Dopamine D2 receptor,Ki,=,7600.0,nM,CHEMBL1926041,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,CHEMBL1921774,KI,Fc1ccc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)cc1
CHEMBL1923293,CHEMBL217,Dopamine D2 receptor,Ki,=,17000.0,nM,CHEMBL1926041,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,CHEMBL1921774,KI,COc1cc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)ccc1F
CHEMBL1923415,CHEMBL217,Dopamine D2 receptor,Ki,=,9000.0,nM,CHEMBL1926041,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,CHEMBL1921774,KI,Oc1cc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)ccc1F
CHEMBL1923416,CHEMBL217,Dopamine D2 receptor,Ki,=,29000.0,nM,CHEMBL1926041,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,CHEMBL1921774,KI,Fc1ccc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)cn1
CHEMBL1923292,CHEMBL217,Dopamine D2 receptor,Ki,=,5700.0,nM,CHEMBL1926042,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,CHEMBL1921774,KI,Fc1ccc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)cc1
CHEMBL1923293,CHEMBL217,Dopamine D2 receptor,Ki,=,16000.0,nM,CHEMBL1926042,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,CHEMBL1921774,KI,COc1cc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)ccc1F
CHEMBL1923415,CHEMBL217,Dopamine D2 receptor,Ki,=,6100.0,nM,CHEMBL1926042,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,CHEMBL1921774,KI,Oc1cc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)ccc1F
CHEMBL1923416,CHEMBL217,Dopamine D2 receptor,Ki,=,45000.0,nM,CHEMBL1926042,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,CHEMBL1921774,KI,Fc1ccc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)cn1
CHEMBL1928126,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1
CHEMBL1928125,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1
CHEMBL1928124,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOCc1ccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL1928123,CHEMBL217,Dopamine D2 receptor,Ki,=,780.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOCc1ccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL1928121,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1
CHEMBL1928122,CHEMBL217,Dopamine D2 receptor,Ki,=,6.6,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1
CHEMBL1928120,CHEMBL217,Dopamine D2 receptor,Ki,=,95.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOc1cccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL1928119,CHEMBL217,Dopamine D2 receptor,Ki,=,270.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOc1cccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL1928127,CHEMBL217,Dopamine D2 receptor,Ki,=,47.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1
CHEMBL1928128,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1
CHEMBL1928129,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1
CHEMBL1928130,CHEMBL217,Dopamine D2 receptor,Ki,=,40.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1
CHEMBL1928131,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1
CHEMBL1928132,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1
CHEMBL1928133,CHEMBL217,Dopamine D2 receptor,Ki,=,29.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1
CHEMBL1928134,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1
CHEMBL1928135,CHEMBL217,Dopamine D2 receptor,Ki,=,67.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOCc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1
CHEMBL1928136,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOCc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1
CHEMBL1926700,CHEMBL217,Dopamine D2 receptor,Ki,=,8.4,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1
CHEMBL1928137,CHEMBL217,Dopamine D2 receptor,Ki,=,1.8,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1
CHEMBL1928138,CHEMBL217,Dopamine D2 receptor,Ki,=,4.7,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1
CHEMBL1928139,CHEMBL217,Dopamine D2 receptor,Ki,=,8.3,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1
CHEMBL1928247,CHEMBL217,Dopamine D2 receptor,Ki,=,19000.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOCc1ccc(N2CCN(CCCCNC(=O)c3ccccc3)CC2)c(OC)c1
CHEMBL1928248,CHEMBL217,Dopamine D2 receptor,Ki,=,270.0,nM,CHEMBL1930838,B,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,CHEMBL1926639,KI,COc1cc(COCCOCCOCCOCCOCc2ccc(N3CCN(CCCCNC(=O)c4ccccc4)CC3)c(OC)c2)ccc1N1CCN(CCCCNC(=O)c2ccccc2)CC1
CHEMBL1928119,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOc1cccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL1928120,CHEMBL217,Dopamine D2 receptor,Ki,=,44.0,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOc1cccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL1928121,CHEMBL217,Dopamine D2 receptor,Ki,=,6.4,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1
CHEMBL1928122,CHEMBL217,Dopamine D2 receptor,Ki,=,1.8,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1
CHEMBL1928123,CHEMBL217,Dopamine D2 receptor,Ki,=,320.0,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOCc1ccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL1928124,CHEMBL217,Dopamine D2 receptor,Ki,=,83.0,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOCc1ccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL1928125,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1
CHEMBL1928126,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1
CHEMBL1928127,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1
CHEMBL1928128,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1
CHEMBL1928129,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1
CHEMBL1928130,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1
CHEMBL1928131,CHEMBL217,Dopamine D2 receptor,Ki,=,66.0,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1
CHEMBL1928132,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1
CHEMBL1928133,CHEMBL217,Dopamine D2 receptor,Ki,=,6.4,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1
CHEMBL1928134,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1
CHEMBL1928135,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOCc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1
CHEMBL1928136,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOCc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1
CHEMBL1926700,CHEMBL217,Dopamine D2 receptor,Ki,=,2.7,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1
CHEMBL1928137,CHEMBL217,Dopamine D2 receptor,Ki,=,0.59,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1
CHEMBL1928138,CHEMBL217,Dopamine D2 receptor,Ki,=,3.9,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1
CHEMBL1928139,CHEMBL217,Dopamine D2 receptor,Ki,=,4.6,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1
CHEMBL1928247,CHEMBL217,Dopamine D2 receptor,Ki,=,9700.0,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,CCOCCOCc1ccc(N2CCN(CCCCNC(=O)c3ccccc3)CC2)c(OC)c1
CHEMBL1928248,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL1930837,B,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,CHEMBL1926639,KI,COc1cc(COCCOCCOCCOCCOCc2ccc(N3CCN(CCCCNC(=O)c4ccccc4)CC3)c(OC)c2)ccc1N1CCN(CCCCNC(=O)c2ccccc2)CC1
CHEMBL26188,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL1930845,B,Binding affinity to D2 long receptor,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccccc2)CC1
CHEMBL26188,CHEMBL217,Dopamine D2 receptor,Ki,=,90.0,nM,CHEMBL1930846,B,Binding affinity to D2 short receptor,CHEMBL1926639,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccccc2)CC1
CHEMBL25856,CHEMBL217,Dopamine D2 receptor,Ki,=,58.0,nM,CHEMBL1936228,B,Binding affinity to dopamine D2 receptor,CHEMBL1932931,KI,Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2
CHEMBL319707,CHEMBL217,Dopamine D2 receptor,Ki,=,302.0,nM,CHEMBL1936228,B,Binding affinity to dopamine D2 receptor,CHEMBL1932931,KI,Cc1ccc2c(c1)[C@@H]1c3cc(O)c(O)cc3CC[C@H]1NC2
CHEMBL104571,CHEMBL217,Dopamine D2 receptor,Ki,=,420.0,nM,CHEMBL1936228,B,Binding affinity to dopamine D2 receptor,CHEMBL1932931,KI,CCc1ccc2c(c1)[C@@H]1c3cc(O)c(O)cc3CC[C@H]1NC2
CHEMBL1940402,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,OC1(c2ccc(Cl)cc2)CCN(CCCCc2ccc(F)cc2)CC1
CHEMBL1940403,CHEMBL217,Dopamine D2 receptor,Ki,=,8.8,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,OC1(c2ccc(Cl)cc2)CCN(CCCSc2ccc(F)cc2)CC1
CHEMBL1940404,CHEMBL217,Dopamine D2 receptor,Ki,=,5.3,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,OC1(c2ccc(Cl)cc2)CCN(CCCOc2ccc(F)cc2)CC1
CHEMBL1940405,CHEMBL217,Dopamine D2 receptor,Ki,=,185.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,Fc1ccc(SCCCN2CCC(c3ccc(Cl)cc3)CC2)cc1
CHEMBL1940406,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,Fc1ccc(OCCCN2CCC(c3ccc(Cl)cc3)CC2)cc1
CHEMBL1940407,CHEMBL217,Dopamine D2 receptor,Ki,=,998.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,[O-][S+](CCCN1CCC(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1940408,CHEMBL217,Dopamine D2 receptor,Ki,=,284.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,Fc1ccc(CCCCN2CCN(c3ccc(Cl)cc3)CC2)cc1
CHEMBL1940409,CHEMBL217,Dopamine D2 receptor,Ki,=,211.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,Fc1ccc(SCCCN2CCN(c3ccc(Cl)cc3)CC2)cc1
CHEMBL1940410,CHEMBL217,Dopamine D2 receptor,Ki,=,4753.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,Fc1ccc(SCCCN2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1
CHEMBL1940411,CHEMBL217,Dopamine D2 receptor,Ki,=,390.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,Fc1ccc(OCCCN2CCN(c3ccc(Cl)cc3)CC2)cc1
CHEMBL1940412,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,Fc1ccc(OCCCN2CCN(c3ccccc3)CC2)cc1
CHEMBL1940413,CHEMBL217,Dopamine D2 receptor,Ki,=,447.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,Clc1ccc(N2CCN(CCCOc3ccccc3)CC2)cc1
CHEMBL1940414,CHEMBL217,Dopamine D2 receptor,Ki,=,119.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,c1ccc(OCCCN2CCN(c3ccccc3)CC2)cc1
CHEMBL140872,CHEMBL217,Dopamine D2 receptor,Ki,=,98.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,O=C(CCCN1CCN(c2ncccn2)CC1)c1ccc(F)cc1
CHEMBL1940415,CHEMBL217,Dopamine D2 receptor,Ki,=,269.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,Fc1ccc(CCCCN2CCN(c3ncccn3)CC2)cc1
CHEMBL1940416,CHEMBL217,Dopamine D2 receptor,Ki,=,424.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,Fc1ccc(SCCCN2CCN(c3ncccn3)CC2)cc1
CHEMBL1940417,CHEMBL217,Dopamine D2 receptor,Ki,=,636.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,Fc1ccc(OCCCN2CCN(c3ncccn3)CC2)cc1
CHEMBL1940418,CHEMBL217,Dopamine D2 receptor,Ki,=,124.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,Fc1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL1940419,CHEMBL217,Dopamine D2 receptor,Ki,=,183.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,Fc1ccc(SCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL1940420,CHEMBL217,Dopamine D2 receptor,Ki,=,186.0,nM,CHEMBL1944110,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL1938349,KI,Fc1ccc(OCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL1946122,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL1949469,B,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,CHEMBL1944557,KI,OC1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2CCCOc1ccc(F)cc1
CHEMBL1946123,CHEMBL217,Dopamine D2 receptor,Ki,=,33.0,nM,CHEMBL1949469,B,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,CHEMBL1944557,KI,OC1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2CCCCc1ccc(F)cc1
CHEMBL1946124,CHEMBL217,Dopamine D2 receptor,Ki,=,1021.0,nM,CHEMBL1949469,B,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,CHEMBL1944557,KI,O=C1c2ccc(F)cc2CC1CCN1CCCN(c2ccc(Cl)cc2)CC1
CHEMBL1946125,CHEMBL217,Dopamine D2 receptor,Ki,=,751.1,nM,CHEMBL1949469,B,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,CHEMBL1944557,KI,Fc1ccc(SCCCN2CCCN(c3ccc(Cl)cc3)CC2)cc1
CHEMBL1946126,CHEMBL217,Dopamine D2 receptor,Ki,=,172.0,nM,CHEMBL1949469,B,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,CHEMBL1944557,KI,Fc1ccc(OCCCN2CCCN(c3ccc(Cl)cc3)CC2)cc1
CHEMBL1946253,CHEMBL217,Dopamine D2 receptor,Ki,=,139.0,nM,CHEMBL1949469,B,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,CHEMBL1944557,KI,Fc1ccc(CCCCN2CCCN(c3ccc(Cl)cc3)CC2)cc1
CHEMBL1946254,CHEMBL217,Dopamine D2 receptor,Ki,=,258.7,nM,CHEMBL1949469,B,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,CHEMBL1944557,KI,Clc1ccc(N2CCCN(CCCCc3nc4ccccc4s3)CC2)cc1
CHEMBL1946257,CHEMBL217,Dopamine D2 receptor,Ki,=,1983.0,nM,CHEMBL1949469,B,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,CHEMBL1944557,KI,O=C(CCCCN1CCCN(c2ccc(Cl)cc2)CC1)c1nc2ccccc2s1
CHEMBL1946744,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL1949469,B,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,CHEMBL1944557,KI,O=C(CCCCN1[C@@H]2CC[C@H]1CC(O)(c1ccc(Cl)cc1)C2)c1nc2ccccc2s1
CHEMBL1946745,CHEMBL217,Dopamine D2 receptor,Ki,=,44.0,nM,CHEMBL1949469,B,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,CHEMBL1944557,KI,OC1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2CCCCc1nc2ccccc2s1
CHEMBL1949725,CHEMBL217,Dopamine D2 receptor,Ki,=,85.3,nM,CHEMBL1954777,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in human HEK293 cells,CHEMBL1949524,KI,C[C@H]1Cc2c([nH]c3ccccc23)Cc2ccccc2CCN1C
CHEMBL1949728,CHEMBL217,Dopamine D2 receptor,Ki,=,268.0,nM,CHEMBL1954777,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in human HEK293 cells,CHEMBL1949524,KI,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2C[C@@H]1CO
CHEMBL1949729,CHEMBL217,Dopamine D2 receptor,Ki,=,2923.0,nM,CHEMBL1954777,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in human HEK293 cells,CHEMBL1949524,KI,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2C[C@H]1CO
CHEMBL2016631,CHEMBL217,Dopamine D2 receptor,Ki,=,245.47,nM,CHEMBL2020817,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,CHEMBL2016514,KI,O=C(CCCCCCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016628,CHEMBL217,Dopamine D2 receptor,Ki,=,1.23,nM,CHEMBL2020817,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,CHEMBL2016514,KI,O=C(CCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016627,CHEMBL217,Dopamine D2 receptor,Ki,=,1.349,nM,CHEMBL2020817,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,CHEMBL2016514,KI,O=C(CCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016626,CHEMBL217,Dopamine D2 receptor,Ki,=,3.162,nM,CHEMBL2020817,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,CHEMBL2016514,KI,O=C(CCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016625,CHEMBL217,Dopamine D2 receptor,Ki,=,8.913,nM,CHEMBL2020817,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,CHEMBL2016514,KI,CCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,102.33,nM,CHEMBL2020817,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,CHEMBL2016514,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,106.0,nM,CHEMBL2020817,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,CHEMBL2016514,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016625,CHEMBL217,Dopamine D2 receptor,Ki,=,9.1,nM,CHEMBL2020817,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,CHEMBL2016514,KI,CCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016626,CHEMBL217,Dopamine D2 receptor,Ki,=,3.6,nM,CHEMBL2020817,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,CHEMBL2016514,KI,O=C(CCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016627,CHEMBL217,Dopamine D2 receptor,Ki,=,1.41,nM,CHEMBL2020817,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,CHEMBL2016514,KI,O=C(CCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016628,CHEMBL217,Dopamine D2 receptor,Ki,=,1.35,nM,CHEMBL2020817,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,CHEMBL2016514,KI,O=C(CCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2016631,CHEMBL217,Dopamine D2 receptor,Ki,=,269.0,nM,CHEMBL2020817,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,CHEMBL2016514,KI,O=C(CCCCCCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2024517,CHEMBL217,Dopamine D2 receptor,Ki,=,5.7,nM,CHEMBL2026141,B,Binding affinity to human dopamine D2L receptor,CHEMBL2021900,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1.Cl
CHEMBL2024517,CHEMBL217,Dopamine D2 receptor,Ki,=,0.81,nM,CHEMBL2026142,B,Binding affinity to human dopamine D2S receptor,CHEMBL2021900,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1.Cl
CHEMBL2032049,CHEMBL217,Dopamine D2 receptor,Ki,=,3160.0,nM,CHEMBL2032870,B,Binding affinity to dopamine D2 receptor,CHEMBL2029200,KI,C[C@H]1c2c([nH]c3ccc(C(F)(F)F)cc23)C[C@H]2CCN(CCC3(C(=O)O)CCCCC3)C[C@@H]21
CHEMBL2029915,CHEMBL217,Dopamine D2 receptor,Ki,=,4189.0,nM,CHEMBL2032826,B,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,CHEMBL2029251,KI,O=C(Cc1ccccc1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1
CHEMBL2029916,CHEMBL217,Dopamine D2 receptor,Ki,=,70.7,nM,CHEMBL2032826,B,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,CHEMBL2029251,KI,O=C(Cc1ccccn1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1
CHEMBL2029917,CHEMBL217,Dopamine D2 receptor,Ki,=,69.6,nM,CHEMBL2032826,B,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,CHEMBL2029251,KI,O=C(Cc1cccnc1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1
CHEMBL2029918,CHEMBL217,Dopamine D2 receptor,Ki,=,48.6,nM,CHEMBL2032826,B,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,CHEMBL2029251,KI,O=C(Cc1ccncc1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1
CHEMBL2029919,CHEMBL217,Dopamine D2 receptor,Ki,=,482.5,nM,CHEMBL2032826,B,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,CHEMBL2029251,KI,O=C(Nc1ccccc1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1
CHEMBL2029920,CHEMBL217,Dopamine D2 receptor,Ki,=,14.2,nM,CHEMBL2032826,B,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,CHEMBL2029251,KI,O=C(Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1)Nc1ccccn1
CHEMBL2029921,CHEMBL217,Dopamine D2 receptor,Ki,=,8.2,nM,CHEMBL2032826,B,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,CHEMBL2029251,KI,O=C(Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1)Nc1cccnc1
CHEMBL2029922,CHEMBL217,Dopamine D2 receptor,Ki,=,3.6,nM,CHEMBL2032826,B,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,CHEMBL2029251,KI,O=C(Nc1ccncc1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1
CHEMBL2029923,CHEMBL217,Dopamine D2 receptor,Ki,=,3575.0,nM,CHEMBL2032826,B,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,CHEMBL2029251,KI,O=C(Cc1ccccc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1
CHEMBL2029924,CHEMBL217,Dopamine D2 receptor,Ki,=,277.8,nM,CHEMBL2032826,B,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,CHEMBL2029251,KI,O=C(Cc1ccccn1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1
CHEMBL2029925,CHEMBL217,Dopamine D2 receptor,Ki,=,82.4,nM,CHEMBL2032826,B,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,CHEMBL2029251,KI,O=C(Cc1cccnc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1
CHEMBL2029926,CHEMBL217,Dopamine D2 receptor,Ki,=,201.6,nM,CHEMBL2032826,B,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,CHEMBL2029251,KI,O=C(Cc1ccncc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1
CHEMBL2029927,CHEMBL217,Dopamine D2 receptor,Ki,=,3250.0,nM,CHEMBL2032826,B,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,CHEMBL2029251,KI,O=C(Nc1ccccc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1
CHEMBL2029928,CHEMBL217,Dopamine D2 receptor,Ki,=,364.0,nM,CHEMBL2032826,B,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,CHEMBL2029251,KI,O=C(Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1)Nc1ccccn1
CHEMBL2029929,CHEMBL217,Dopamine D2 receptor,Ki,=,29.7,nM,CHEMBL2032826,B,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,CHEMBL2029251,KI,O=C(Nc1cccnc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1
CHEMBL2029930,CHEMBL217,Dopamine D2 receptor,Ki,=,48.7,nM,CHEMBL2032826,B,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,CHEMBL2029251,KI,O=C(Nc1ccncc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1
CHEMBL2029931,CHEMBL217,Dopamine D2 receptor,Ki,=,478.0,nM,CHEMBL2032826,B,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,CHEMBL2029251,KI,c1ccc(CCN2CCN(c3ccccc3)CC2)cc1
CHEMBL2030637,CHEMBL217,Dopamine D2 receptor,Ki,=,9914.0,nM,CHEMBL2033368,B,Inhibition of D2 dopamine receptor,CHEMBL2029272,KI,Fc1cccc(CCCN2CCCC2)c1
CHEMBL439849,CHEMBL217,Dopamine D2 receptor,Ki,=,666.0,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1
CHEMBL1946254,CHEMBL217,Dopamine D2 receptor,Ki,=,259.0,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,Clc1ccc(N2CCCN(CCCCc3nc4ccccc4s3)CC2)cc1
CHEMBL1946257,CHEMBL217,Dopamine D2 receptor,Ki,=,1983.0,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,O=C(CCCCN1CCCN(c2ccc(Cl)cc2)CC1)c1nc2ccccc2s1
CHEMBL2037430,CHEMBL217,Dopamine D2 receptor,Ki,=,2321.0,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,Clc1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)cc1
CHEMBL2037431,CHEMBL217,Dopamine D2 receptor,Ki,=,219.0,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,Clc1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)cc1
CHEMBL2037432,CHEMBL217,Dopamine D2 receptor,Ki,=,201.0,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,OC1(c2ccc(Cl)cc2)CCN(CCCCc2nc3ccccc3s2)CC1
CHEMBL2037521,CHEMBL217,Dopamine D2 receptor,Ki,=,26.5,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,c1cnc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1
CHEMBL2037522,CHEMBL217,Dopamine D2 receptor,Ki,=,30.8,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,c1ccc2c(c1)CCN(CCCCc1nc3ccccc3s1)C2
CHEMBL2037523,CHEMBL217,Dopamine D2 receptor,Ki,=,990.0,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,c1ccc2c(c1)CN(CCCCc1nc3ccccc3s1)C2
CHEMBL2037524,CHEMBL217,Dopamine D2 receptor,Ki,=,8355.0,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1nc2ccccc2s1
CHEMBL2037518,CHEMBL217,Dopamine D2 receptor,Ki,=,530.0,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,O=C(CCCN1CCC(c2ccccc2)CC1)c1nc2ccccc2s1
CHEMBL2037519,CHEMBL217,Dopamine D2 receptor,Ki,=,1522.0,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,O=C(CCCN1CCN(c2ncccn2)CC1)c1nc2ccccc2s1
CHEMBL2037520,CHEMBL217,Dopamine D2 receptor,Ki,=,217.0,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,O=C(CCCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)c1nc2ccccc2s1
CHEMBL2037526,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,O=C(CCCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1nc2ccccc2s1
CHEMBL2037527,CHEMBL217,Dopamine D2 receptor,Ki,=,2931.0,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,O=C(CCCCN1Cc2ccccc2C1)c1nc2ccccc2s1
CHEMBL2037528,CHEMBL217,Dopamine D2 receptor,Ki,=,4793.0,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,O=C(CCCCN1CCN(c2ccc(Cl)cc2)CC1)c1nc2ccccc2s1
CHEMBL2037529,CHEMBL217,Dopamine D2 receptor,Ki,=,505.0,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,O=C(CCCCN1CCN(c2ncccn2)CC1)c1nc2ccccc2s1
CHEMBL2037530,CHEMBL217,Dopamine D2 receptor,Ki,=,198.0,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,O=C(CCCCN1CCN(c2ccccc2)CC1)c1nc2ccccc2s1
CHEMBL2037531,CHEMBL217,Dopamine D2 receptor,Ki,=,642.0,nM,CHEMBL2037965,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL2034919,KI,O=C(CCCCN1CCC(c2ccccc2)CC1)c1nc2ccccc2s1
CHEMBL2059323,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3cc(F)ccc32)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL2059304,CHEMBL217,Dopamine D2 receptor,Ki,=,5.5,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=c1[nH]c2ccccc2n1C1CCN(CCOc2ccccc2)CC1
CHEMBL2059318,CHEMBL217,Dopamine D2 receptor,Ki,=,6.5,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1CCc2cc(F)ccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1
CHEMBL2059306,CHEMBL217,Dopamine D2 receptor,Ki,=,9.5,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1CCc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1
CHEMBL2059322,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccc(F)cc32)CC1
CHEMBL2059324,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3c(F)cccc32)CC1
CHEMBL2059311,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1
CHEMBL2059321,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3cccc(F)c32)CC1
CHEMBL2059305,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1CCc2ccccc2N1CCCN1CCC(c2ccc3[nH]ccc3c2)CC1
CHEMBL2059312,CHEMBL217,Dopamine D2 receptor,Ki,=,55.0,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1CCc2ccccc2N1OCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1
CHEMBL2059317,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1CCc2c(F)cccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1
CHEMBL2059319,CHEMBL217,Dopamine D2 receptor,Ki,=,90.0,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1CCc2ccc(F)cc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1
CHEMBL2059320,CHEMBL217,Dopamine D2 receptor,Ki,=,95.0,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1CCc2cccc(F)c2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1
CHEMBL2059310,CHEMBL217,Dopamine D2 receptor,Ki,=,600.0,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1CCc2cccnc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1
CHEMBL2059316,CHEMBL217,Dopamine D2 receptor,Ki,=,650.0,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ncccc32)CC1
CHEMBL2059308,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1CCc2cnccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1
CHEMBL2059313,CHEMBL217,Dopamine D2 receptor,Ki,=,1250.0,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3cccnc32)CC1
CHEMBL2059315,CHEMBL217,Dopamine D2 receptor,Ki,=,1350.0,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3cnccc32)CC1
CHEMBL2059307,CHEMBL217,Dopamine D2 receptor,Ki,=,2200.0,nM,CHEMBL2060138,B,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,CHEMBL2057071,KI,O=C1CCc2ncccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1
CHEMBL267930,CHEMBL217,Dopamine D2 receptor,Ki,=,0.28,nM,CHEMBL2060922,B,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL2057072,KI,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
CHEMBL487387,CHEMBL217,Dopamine D2 receptor,Ki,=,56.17,nM,CHEMBL2060922,B,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL2057457,CHEMBL217,Dopamine D2 receptor,Ki,=,160.99,nM,CHEMBL2060922,B,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL2057456,CHEMBL217,Dopamine D2 receptor,Ki,=,146.99,nM,CHEMBL2060922,B,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1cc2c(cc1O)[C@@H]1Cc3c(CO)c(OC)cc(OC)c3CN1CC2
CHEMBL2057453,CHEMBL217,Dopamine D2 receptor,Ki,=,346.76,nM,CHEMBL2060922,B,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1ccc2c(c1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2
CHEMBL2057451,CHEMBL217,Dopamine D2 receptor,Ki,=,223.61,nM,CHEMBL2060922,B,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1cc2c(cc1OC)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL2062848,CHEMBL217,Dopamine D2 receptor,Ki,=,12000.0,nM,CHEMBL2066740,B,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,CHEMBL2062374,KI,CCN(CC)[C@@H]1[C@@H](CO)[C@H]2CN(Cc3ccccc3)[C@H](c3ccccc3)[C@H]21
CHEMBL2062849,CHEMBL217,Dopamine D2 receptor,Ki,=,1700.0,nM,CHEMBL2066740,B,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,CHEMBL2062374,KI,CCN(CC)[C@H]1[C@H](CO)[C@@H]2CN(Cc3ccccc3)[C@@H](c3ccccc3)[C@@H]21
CHEMBL2062850,CHEMBL217,Dopamine D2 receptor,Ki,=,7400.0,nM,CHEMBL2066740,B,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,CHEMBL2062374,KI,OC[C@H]1[C@H]2CN(Cc3ccccc3)[C@H](c3ccccc3)[C@H]2[C@@H]1N1CCCC1
CHEMBL2062851,CHEMBL217,Dopamine D2 receptor,Ki,=,250.0,nM,CHEMBL2066740,B,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,CHEMBL2062374,KI,OC[C@@H]1[C@@H]2CN(Cc3ccccc3)[C@@H](c3ccccc3)[C@@H]2[C@H]1N1CCCC1
CHEMBL2062852,CHEMBL217,Dopamine D2 receptor,Ki,=,38000.0,nM,CHEMBL2066740,B,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,CHEMBL2062374,KI,CCN(CC)[C@@H]1[C@@H](CO)[C@H]2CN(Cc3ccccc3)[C@H](C)[C@H]21
CHEMBL2062853,CHEMBL217,Dopamine D2 receptor,Ki,=,3900.0,nM,CHEMBL2066740,B,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,CHEMBL2062374,KI,CCN(CC)[C@H]1[C@H](CO)[C@@H]2CN(Cc3ccccc3)[C@@H](C)[C@@H]21
CHEMBL2062854,CHEMBL217,Dopamine D2 receptor,Ki,=,66000.0,nM,CHEMBL2066740,B,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,CHEMBL2062374,KI,C[C@@H]1[C@@H]2[C@H](CN1Cc1ccccc1)[C@H](CO)[C@H]2N1CCCC1
CHEMBL2062855,CHEMBL217,Dopamine D2 receptor,Ki,=,16000.0,nM,CHEMBL2066740,B,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,CHEMBL2062374,KI,C[C@H]1[C@H]2[C@@H](CN1Cc1ccccc1)[C@@H](CO)[C@@H]2N1CCCC1
CHEMBL2062856,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL2066740,B,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,CHEMBL2062374,KI,CCN(CC)[C@@H]1[C@@H](CO)[C@H]2CN(Cc3ccccc3)[C@H](c3ccc(Br)cc3)[C@H]21
CHEMBL2062857,CHEMBL217,Dopamine D2 receptor,Ki,=,2000.0,nM,CHEMBL2066740,B,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,CHEMBL2062374,KI,CCN(CC)[C@H]1[C@H](CO)[C@@H]2CN(Cc3ccccc3)[C@@H](c3ccc(Br)cc3)[C@@H]21
CHEMBL2062858,CHEMBL217,Dopamine D2 receptor,Ki,=,42000.0,nM,CHEMBL2066740,B,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,CHEMBL2062374,KI,CCN(CC)[C@@H]1[C@@H](CO)[C@H]2CN(Cc3ccccc3)[C@H](c3ccccn3)[C@H]21
CHEMBL2062859,CHEMBL217,Dopamine D2 receptor,Ki,=,12000.0,nM,CHEMBL2066740,B,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,CHEMBL2062374,KI,CCN(CC)[C@H]1[C@H](CO)[C@@H]2CN(Cc3ccccc3)[C@@H](c3ccccn3)[C@@H]21
CHEMBL2062860,CHEMBL217,Dopamine D2 receptor,Ki,=,7000.0,nM,CHEMBL2066740,B,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,CHEMBL2062374,KI,OC[C@H]1[C@H]2CN(Cc3ccccc3)[C@H](c3ccccc3)[C@H]2[C@@H]1N1CCCCC1
CHEMBL2062861,CHEMBL217,Dopamine D2 receptor,Ki,=,2000.0,nM,CHEMBL2066740,B,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,CHEMBL2062374,KI,OC[C@@H]1[C@@H]2CN(Cc3ccccc3)[C@@H](c3ccccc3)[C@@H]2[C@H]1N1CCCCC1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,2100.0,nM,CHEMBL2066740,B,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,CHEMBL2062374,KI,NCCc1ccc(O)c(O)c1
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,50.0,nM,CHEMBL2066740,B,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,CHEMBL2062374,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL1802360,CHEMBL217,Dopamine D2 receptor,Ki,=,0.5012,nM,CHEMBL2149602,B,Binding affinity to dopamine D2 receptor,CHEMBL2146410,KI,O=c1[nH]c2ccccc2n1C1CCN(CCCOc2ccc(F)cc2)CC1
CHEMBL2159455,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NCC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1ccc(Cl)s1
CHEMBL2159456,CHEMBL217,Dopamine D2 receptor,Ki,=,1059.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NCC1CCN(CCOc2cccc(F)c2)CC1)c1cccs1
CHEMBL2159457,CHEMBL217,Dopamine D2 receptor,Ki,=,50.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,CC(C)c1ccccc1OCCN1CCC(CNS(=O)(=O)c2ccc(F)cc2)CC1
CHEMBL2159458,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NCC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1ccc(F)cc1
CHEMBL2159459,CHEMBL217,Dopamine D2 receptor,Ki,=,839.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NCC1CCN(CCOc2cccc(F)c2)CC1)c1ccc(F)cc1
CHEMBL2159460,CHEMBL217,Dopamine D2 receptor,Ki,=,66.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,CC(C)c1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2)CC1
CHEMBL2159461,CHEMBL217,Dopamine D2 receptor,Ki,=,50.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,CSc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2)CC1
CHEMBL2159462,CHEMBL217,Dopamine D2 receptor,Ki,=,560.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NCC1CCN(CCOc2cccc(F)c2)CC1)c1cccc(Cl)c1
CHEMBL2159463,CHEMBL217,Dopamine D2 receptor,Ki,=,76.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,CCOc1ccccc1C(=O)NC1CCN(CCOc2cccc(F)c2)CC1
CHEMBL2159464,CHEMBL217,Dopamine D2 receptor,Ki,=,84.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1cccs1
CHEMBL2159465,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2ccc(F)cc2)CC1
CHEMBL2159466,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1ccc(F)c(F)c1
CHEMBL2159467,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=C(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1cccc(F)c1F
CHEMBL2159468,CHEMBL217,Dopamine D2 receptor,Ki,=,79.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,CC(C)c1ccccc1OCCN1CCC(NC(=O)c2ccc3ccccc3n2)C1
CHEMBL2159469,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=C(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccc2ccccc2n1
CHEMBL2159470,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2cccs2)C1
CHEMBL2159471,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1cccs1
CHEMBL2159472,CHEMBL217,Dopamine D2 receptor,Ki,=,72.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NC1CCN(CCOc2cccc3c2CCCC3)C1)c1cccs1
CHEMBL2159473,CHEMBL217,Dopamine D2 receptor,Ki,=,729.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NC1CCN(CCOc2cccc(F)c2)C1)c1cccs1
CHEMBL2159474,CHEMBL217,Dopamine D2 receptor,Ki,=,67.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NC1CCN(CCOc2cccc(Cl)c2Cl)C1)c1ccc(Cl)s1
CHEMBL2159475,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NC1CCN(CCOc2cc(Cl)ccc2Cl)C1)c1ccc(Cl)s1
CHEMBL2159476,CHEMBL217,Dopamine D2 receptor,Ki,=,318.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NC1CCN(CCOc2ccccc2)C1)c1ccc(Cl)s1
CHEMBL2159477,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2cccc3cccnc23)C1
CHEMBL2159478,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,CSc1ccccc1OCCN1CCC(NS(=O)(=O)c2ccc(F)cc2)C1
CHEMBL2159479,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NC1CCN(CCOc2ccccc2)C1)c1ccc(F)cc1
CHEMBL2159480,CHEMBL217,Dopamine D2 receptor,Ki,=,72.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NC1CCN(CCOc2cccc3c2CCCC3)C1)c1ccc(F)cc1
CHEMBL2159481,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccc(F)c(F)c1
CHEMBL2159482,CHEMBL217,Dopamine D2 receptor,Ki,=,523.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NC1CCN(CCOc2cccc(F)c2)C1)c1ccc(F)c(F)c1
CHEMBL2159483,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1cc(F)ccc1F
CHEMBL2159484,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(NC1CCN(CCOc2cccc3c2CCCC3)C1)c1cc(F)ccc1F
CHEMBL2159485,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2cccc(Cl)c2)C1
CHEMBL2159486,CHEMBL217,Dopamine D2 receptor,Ki,=,36.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,CSc1ccccc1OCCN1CCC(NS(=O)(=O)c2cccc(Cl)c2)C1
CHEMBL2159487,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,CC(C)c1ccccc1OCCN1CC[C@@H](NS(=O)(=O)c2ccc(Cl)s2)C1
CHEMBL2159488,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(N[C@@H]1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccc(Cl)s1
CHEMBL2159489,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(N[C@@H]1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccc(F)cc1
CHEMBL2159490,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,CC(C)c1ccccc1OCCN1CC[C@H](NS(=O)(=O)c2ccc(Cl)s2)C1
CHEMBL2159491,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(N[C@H]1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccc(Cl)s1
CHEMBL2159492,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,O=S(=O)(N[C@H]1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccc(F)cc1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,72.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,7.0,nM,CHEMBL2162846,B,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2157986,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL1255966,CHEMBL217,Dopamine D2 receptor,Ki,=,1430.0,nM,CHEMBL2162509,B,Displacement of [3H]-N-methylspiperone from human dopamine D2long receptor expressed in HEK293 cells after 30 mins by scintillation counting,CHEMBL2157876,KI,Br.CCCN(CCC)C1CCc2ccc(O)cc2C1
CHEMBL71,CHEMBL217,Dopamine D2 receptor,Ki,=,1.2,nM,CHEMBL2162509,B,Displacement of [3H]-N-methylspiperone from human dopamine D2long receptor expressed in HEK293 cells after 30 mins by scintillation counting,CHEMBL2157876,KI,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL2158640,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL2162509,B,Displacement of [3H]-N-methylspiperone from human dopamine D2long receptor expressed in HEK293 cells after 30 mins by scintillation counting,CHEMBL2157876,KI,Br.CCCN1C[C@H](c2ccc(O)cc2)C[C@@H]2c3cc(O)c(O)cc3CC[C@H]21
CHEMBL2158636,CHEMBL217,Dopamine D2 receptor,Ki,=,490.0,nM,CHEMBL2162509,B,Displacement of [3H]-N-methylspiperone from human dopamine D2long receptor expressed in HEK293 cells after 30 mins by scintillation counting,CHEMBL2157876,KI,Br.Oc1ccc([C@H]2CN[C@@H]3CCc4cc(O)c(O)cc4[C@H]3C2)cc1
CHEMBL1224527,CHEMBL217,Dopamine D2 receptor,Ki,=,230.0,nM,CHEMBL2162509,B,Displacement of [3H]-N-methylspiperone from human dopamine D2long receptor expressed in HEK293 cells after 30 mins by scintillation counting,CHEMBL2157876,KI,Oc1ccc2c(c1O)C[C@@H](c1ccccc1)[C@@H]1CCNC[C@@H]21
CHEMBL125916,CHEMBL217,Dopamine D2 receptor,Ki,=,37.4,nM,CHEMBL2167045,B,Displacement of [125I]-IABN from D2 receptor,CHEMBL2163217,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1
CHEMBL346692,CHEMBL217,Dopamine D2 receptor,Ki,=,103.0,nM,CHEMBL2167045,B,Displacement of [125I]-IABN from D2 receptor,CHEMBL2163217,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL2165120,CHEMBL217,Dopamine D2 receptor,Ki,=,3.4,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=c1ccc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1
CHEMBL2165119,CHEMBL217,Dopamine D2 receptor,Ki,=,1.2,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)nc2N1
CHEMBL2165118,CHEMBL217,Dopamine D2 receptor,Ki,=,5.7,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1NCCc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc21
CHEMBL2165117,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1NCCc2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21
CHEMBL2165116,CHEMBL217,Dopamine D2 receptor,Ki,=,104.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,Clc1cccc(N2CCN(CCCOc3ccc4cn[nH]c4c3)CC2)c1Cl
CHEMBL2165115,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=c1[nH]c2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc2[nH]1
CHEMBL2165114,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,Clc1cccc(N2CCCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl
CHEMBL2165140,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,Clc1cccc(N2CCCN(CCCOc3ccc4scnc4c3)CC2)c1Cl
CHEMBL2165139,CHEMBL217,Dopamine D2 receptor,Ki,=,30.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,Clc1cccc(N2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl
CHEMBL2165138,CHEMBL217,Dopamine D2 receptor,Ki,=,75.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,Clc1cccc(C2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl
CHEMBL2165137,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,Clc1cccc(C2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl
CHEMBL2165136,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,Clc1cccc(N2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl
CHEMBL2165135,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=c1[nH]c2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1
CHEMBL2165134,CHEMBL217,Dopamine D2 receptor,Ki,=,66.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,Clc1cccc(N2CCN(CCCCOc3ccc4cn[nH]c4c3)CC2)c1Cl
CHEMBL2165133,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1NCCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21
CHEMBL1774063,CHEMBL217,Dopamine D2 receptor,Ki,=,3.4,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nc2N1
CHEMBL161792,CHEMBL217,Dopamine D2 receptor,Ki,=,7.3,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,Oc1ccc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2n1
CHEMBL2165132,CHEMBL217,Dopamine D2 receptor,Ki,=,108.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1CCc2ccc(Oc3ccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)cc2N1
CHEMBL2165131,CHEMBL217,Dopamine D2 receptor,Ki,=,113.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1CCc2ccc(Oc3cccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)c3)cc2N1
CHEMBL2165130,CHEMBL217,Dopamine D2 receptor,Ki,=,235.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1CCc2ccc(CO[C@@H]3C[C@H]3CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2165129,CHEMBL217,Dopamine D2 receptor,Ki,=,1004.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1CCc2ccc(OCC#CCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2165128,CHEMBL217,Dopamine D2 receptor,Ki,=,145.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1CCc2ccc(OC[C@H]3CC[C@H](CN4CCN(c5cccc(Cl)c5Cl)CC4)CC3)cc2N1
CHEMBL2165127,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1CCc2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2165126,CHEMBL217,Dopamine D2 receptor,Ki,=,3.6,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2165125,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1CCc2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL160744,CHEMBL217,Dopamine D2 receptor,Ki,=,8.1,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,Cc1cccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)c1C
CHEMBL2165124,CHEMBL217,Dopamine D2 receptor,Ki,=,53.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,CCOc1ccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)cc1
CHEMBL2165123,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,CCOc1cccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)c1
CHEMBL2165122,CHEMBL217,Dopamine D2 receptor,Ki,=,4.2,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4C(F)(F)F)CC3)cc2N1
CHEMBL346129,CHEMBL217,Dopamine D2 receptor,Ki,=,5.9,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,Cc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1
CHEMBL160921,CHEMBL217,Dopamine D2 receptor,Ki,=,2.9,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,N#Cc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1
CHEMBL157923,CHEMBL217,Dopamine D2 receptor,Ki,=,3.7,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4Cl)CC3)cc2N1
CHEMBL160630,CHEMBL217,Dopamine D2 receptor,Ki,=,5.5,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4F)CC3)cc2N1
CHEMBL160357,CHEMBL217,Dopamine D2 receptor,Ki,=,4.3,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1
CHEMBL2165121,CHEMBL217,Dopamine D2 receptor,Ki,=,3.1,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,CC(C)Oc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1
CHEMBL443034,CHEMBL217,Dopamine D2 receptor,Ki,=,2.8,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,CCOc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1
CHEMBL160296,CHEMBL217,Dopamine D2 receptor,Ki,=,0.3,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,COc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,3.9,nM,CHEMBL2169117,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,CHEMBL2163335,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2164434,CHEMBL217,Dopamine D2 receptor,Ki,=,13570.0,nM,CHEMBL2168000,B,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2163237,KI,CCCCNC(=O)c1cc2ccccc2[nH]1
CHEMBL2165679,CHEMBL217,Dopamine D2 receptor,Ki,=,84.0,nM,CHEMBL2168000,B,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2163237,KI,CCC(=O)NCCCCN1CCN(c2ccccc2OC)CC1
CHEMBL2165678,CHEMBL217,Dopamine D2 receptor,Ki,=,15.6,nM,CHEMBL2168000,B,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2163237,KI,CCC(=O)NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL26789,CHEMBL217,Dopamine D2 receptor,Ki,=,20.6,nM,CHEMBL2168000,B,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2163237,KI,CCCCN1CCN(c2ccccc2OC)CC1
CHEMBL2165677,CHEMBL217,Dopamine D2 receptor,Ki,=,3.4,nM,CHEMBL2168000,B,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2163237,KI,CCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL2165676,CHEMBL217,Dopamine D2 receptor,Ki,=,5.2,nM,CHEMBL2168000,B,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2163237,KI,CCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL2165675,CHEMBL217,Dopamine D2 receptor,Ki,=,63.7,nM,CHEMBL2168000,B,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2163237,KI,OCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL2165674,CHEMBL217,Dopamine D2 receptor,Ki,=,265.0,nM,CHEMBL2168000,B,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2163237,KI,COc1ccccc1N1CCN(C)CC1
CHEMBL2165673,CHEMBL217,Dopamine D2 receptor,Ki,=,45.9,nM,CHEMBL2168000,B,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2163237,KI,CN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL9666,CHEMBL217,Dopamine D2 receptor,Ki,=,679.6,nM,CHEMBL2168000,B,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2163237,KI,COc1ccccc1N1CCNCC1
CHEMBL1424807,CHEMBL217,Dopamine D2 receptor,Ki,=,137.3,nM,CHEMBL2168000,B,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2163237,KI,Clc1cccc(N2CCNCC2)c1Cl
CHEMBL125916,CHEMBL217,Dopamine D2 receptor,Ki,=,37.4,nM,CHEMBL2168000,B,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2163237,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1
CHEMBL346692,CHEMBL217,Dopamine D2 receptor,Ki,=,103.0,nM,CHEMBL2168000,B,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2163237,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL2179222,CHEMBL217,Dopamine D2 receptor,Ki,=,1812.0,nM,CHEMBL2185773,B,Binding affinity to dopamine D2 receptor,CHEMBL2176989,KI,COc1ccc(S(=O)(=O)n2cc(C)c3cc(Cl)cnc32)cc1NC1CCN(C)CC1
CHEMBL2179217,CHEMBL217,Dopamine D2 receptor,Ki,=,302.6,nM,CHEMBL2185773,B,Binding affinity to dopamine D2 receptor,CHEMBL2176989,KI,COc1ccc(S(=O)(=O)n2cc(C)c3cc(Cl)ccc32)cc1NC1CCN(C)CC1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,1185.0,nM,CHEMBL2182832,B,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,CHEMBL2177058,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,422.0,nM,CHEMBL2182832,B,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,CHEMBL2177058,KI,NCCc1ccc(O)c(O)c1
CHEMBL2180641,CHEMBL217,Dopamine D2 receptor,Ki,=,831.0,nM,CHEMBL2182832,B,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,CHEMBL2177058,KI,CCCCCCN(CCc1ccccc1)CCc1cccc(O)c1
CHEMBL2180640,CHEMBL217,Dopamine D2 receptor,Ki,=,1233.0,nM,CHEMBL2182832,B,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,CHEMBL2177058,KI,CCCCN(CCc1ccccc1)CCc1cccc(O)c1
CHEMBL2180639,CHEMBL217,Dopamine D2 receptor,Ki,=,450.0,nM,CHEMBL2182832,B,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,CHEMBL2177058,KI,Oc1cccc(CCN(CCc2ccccc2)CC2CCC2)c1
CHEMBL2180638,CHEMBL217,Dopamine D2 receptor,Ki,=,118.0,nM,CHEMBL2182832,B,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,CHEMBL2177058,KI,Oc1cccc(CCN(CCc2ccccc2)CC2CC2)c1
CHEMBL2180637,CHEMBL217,Dopamine D2 receptor,Ki,=,1420.0,nM,CHEMBL2182832,B,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,CHEMBL2177058,KI,CCCCCN(CCc1ccccc1)CCc1cccc(O)c1
CHEMBL1188090,CHEMBL217,Dopamine D2 receptor,Ki,=,64.4,nM,CHEMBL2182832,B,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,CHEMBL2177058,KI,CCCN(CCc1ccccc1)CCc1cccc(O)c1
CHEMBL2204343,CHEMBL217,Dopamine D2 receptor,Ki,=,0.55,nM,CHEMBL2208721,B,Inhibition of human dopamine D2 receptor,CHEMBL2203023,KI,O=C(CCCN1CC[Si](O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,2.84,nM,CHEMBL2208721,B,Inhibition of human dopamine D2 receptor,CHEMBL2203023,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL2207498,CHEMBL217,Dopamine D2 receptor,Ki,=,574.0,nM,CHEMBL2211560,B,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2cc3ccccc3s2)CC1
CHEMBL2207497,CHEMBL217,Dopamine D2 receptor,Ki,=,1535.0,nM,CHEMBL2211560,B,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2ccc3ccccc3c2)CC1
CHEMBL2207496,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL2211560,B,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2cccc3ccccc23)CC1
CHEMBL2207495,CHEMBL217,Dopamine D2 receptor,Ki,=,12830.0,nM,CHEMBL2211560,B,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(N2C(=O)C(=O)c3ccccc32)CC1
CHEMBL2207494,CHEMBL217,Dopamine D2 receptor,Ki,=,5182.0,nM,CHEMBL2211560,B,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(n2c(=O)n(C)c3cc(Cl)ccc32)CC1
CHEMBL2207493,CHEMBL217,Dopamine D2 receptor,Ki,=,456.0,nM,CHEMBL2211560,B,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
CHEMBL2207492,CHEMBL217,Dopamine D2 receptor,Ki,=,10820.0,nM,CHEMBL2211560,B,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(n2cnc3ccccc32)CC1
CHEMBL2207491,CHEMBL217,Dopamine D2 receptor,Ki,=,109.0,nM,CHEMBL2211560,B,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(n2ccc3ccccc32)CC1
CHEMBL2207490,CHEMBL217,Dopamine D2 receptor,Ki,=,187.0,nM,CHEMBL2211560,B,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2n[nH]c3ccccc23)CC1
CHEMBL2207489,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL2211560,B,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2noc3cc(F)ccc23)CC1
CHEMBL2207488,CHEMBL217,Dopamine D2 receptor,Ki,=,803.0,nM,CHEMBL2211560,B,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2coc3ccccc23)CC1
CHEMBL2207487,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL2211560,B,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2csc3ccccc23)CC1
CHEMBL2207486,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL2211560,B,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2cn(C)c3ccc(F)cc23)CC1
CHEMBL2207485,CHEMBL217,Dopamine D2 receptor,Ki,=,157.0,nM,CHEMBL2211560,B,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2cn(C)c3cc(F)ccc23)CC1
CHEMBL2207484,CHEMBL217,Dopamine D2 receptor,Ki,=,43.0,nM,CHEMBL2211560,B,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2c[nH]c3cc(F)ccc23)CC1
CHEMBL1423,CHEMBL217,Dopamine D2 receptor,Ki,=,11.7,nM,CHEMBL2211561,B,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL708,CHEMBL217,Dopamine D2 receptor,Ki,=,8.5,nM,CHEMBL2211561,B,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,2.7,nM,CHEMBL2211561,B,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL2207498,CHEMBL217,Dopamine D2 receptor,Ki,=,2325.0,nM,CHEMBL2211561,B,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2cc3ccccc3s2)CC1
CHEMBL2207497,CHEMBL217,Dopamine D2 receptor,Ki,=,2870.0,nM,CHEMBL2211561,B,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2ccc3ccccc3c2)CC1
CHEMBL2207496,CHEMBL217,Dopamine D2 receptor,Ki,=,112.0,nM,CHEMBL2211561,B,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2cccc3ccccc23)CC1
CHEMBL2207495,CHEMBL217,Dopamine D2 receptor,Ki,=,12160.0,nM,CHEMBL2211561,B,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(N2C(=O)C(=O)c3ccccc32)CC1
CHEMBL2207494,CHEMBL217,Dopamine D2 receptor,Ki,=,2002.0,nM,CHEMBL2211561,B,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(n2c(=O)n(C)c3cc(Cl)ccc32)CC1
CHEMBL2207493,CHEMBL217,Dopamine D2 receptor,Ki,=,371.0,nM,CHEMBL2211561,B,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
CHEMBL2207491,CHEMBL217,Dopamine D2 receptor,Ki,=,1136.0,nM,CHEMBL2211561,B,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(n2ccc3ccccc32)CC1
CHEMBL2207490,CHEMBL217,Dopamine D2 receptor,Ki,=,1066.0,nM,CHEMBL2211561,B,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2n[nH]c3ccccc23)CC1
CHEMBL2207489,CHEMBL217,Dopamine D2 receptor,Ki,=,194.0,nM,CHEMBL2211561,B,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2noc3cc(F)ccc23)CC1
CHEMBL2207488,CHEMBL217,Dopamine D2 receptor,Ki,=,2717.0,nM,CHEMBL2211561,B,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2coc3ccccc23)CC1
CHEMBL2207487,CHEMBL217,Dopamine D2 receptor,Ki,=,121.0,nM,CHEMBL2211561,B,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2csc3ccccc23)CC1
CHEMBL2207486,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL2211561,B,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2cn(C)c3ccc(F)cc23)CC1
CHEMBL2207485,CHEMBL217,Dopamine D2 receptor,Ki,=,275.0,nM,CHEMBL2211561,B,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2cn(C)c3cc(F)ccc23)CC1
CHEMBL2207484,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL2211561,B,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,CHEMBL2203152,KI,CCCN1CCC(c2c[nH]c3cc(F)ccc23)CC1
CHEMBL2205831,CHEMBL217,Dopamine D2 receptor,Ki,=,2830.0,nM,CHEMBL2210352,B,Binding affinity to D2 dopamine receptor,CHEMBL2203059,KI,OC12C3C4CC5C6C4C1C6C(C53)N2CC1CCCCC1
CHEMBL2207643,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL2214282,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2ccc3cccccc2-3)CC1
CHEMBL2207642,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL2214282,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)c3cccccc2-3)CC1
CHEMBL2207641,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL2214282,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(CN3CCN(c4ccccc4OC)CC3)c3cccccc2-3)CC1
CHEMBL2207640,CHEMBL217,Dopamine D2 receptor,Ki,=,57.0,nM,CHEMBL2214282,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(CN3CCN(C)CC3)c3cccccc2-3)CC1
CHEMBL2207639,CHEMBL217,Dopamine D2 receptor,Ki,=,92.0,nM,CHEMBL2214282,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(CN3CCOCC3)c3cccccc2-3)CC1
CHEMBL2207638,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL2214282,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(CN3CCCCC3)c3cccccc2-3)CC1
CHEMBL2207637,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL2214282,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(CN(C)C)c3cccccc2-3)CC1
CHEMBL2207636,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL2214282,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(C#N)c3cccccc2-3)CC1
CHEMBL2207635,CHEMBL217,Dopamine D2 receptor,Ki,=,68.0,nM,CHEMBL2214282,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(CO)c3cccccc2-3)CC1
CHEMBL2207634,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL2214282,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,CCCC#Cc1cc(CN2CCN(c3ccccc3OC)CC2)c2cccccc1-2
CHEMBL2207633,CHEMBL217,Dopamine D2 receptor,Ki,=,67.0,nM,CHEMBL2214282,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(C#Cc3ccccc3)c3cccccc2-3)CC1
CHEMBL2207632,CHEMBL217,Dopamine D2 receptor,Ki,=,76.0,nM,CHEMBL2214282,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,C#Cc1cc(CN2CCN(c3ccccc3OC)CC2)c2cccccc1-2
CHEMBL2207643,CHEMBL217,Dopamine D2 receptor,Ki,=,33.0,nM,CHEMBL2214283,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2ccc3cccccc2-3)CC1
CHEMBL2207642,CHEMBL217,Dopamine D2 receptor,Ki,=,95.0,nM,CHEMBL2214283,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)c3cccccc2-3)CC1
CHEMBL2207641,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL2214283,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(CN3CCN(c4ccccc4OC)CC3)c3cccccc2-3)CC1
CHEMBL2207640,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL2214283,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(CN3CCN(C)CC3)c3cccccc2-3)CC1
CHEMBL2207639,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL2214283,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(CN3CCOCC3)c3cccccc2-3)CC1
CHEMBL2207638,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL2214283,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(CN3CCCCC3)c3cccccc2-3)CC1
CHEMBL2207637,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL2214283,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(CN(C)C)c3cccccc2-3)CC1
CHEMBL2207636,CHEMBL217,Dopamine D2 receptor,Ki,=,8.3,nM,CHEMBL2214283,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(C#N)c3cccccc2-3)CC1
CHEMBL2207635,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL2214283,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(CO)c3cccccc2-3)CC1
CHEMBL2207634,CHEMBL217,Dopamine D2 receptor,Ki,=,76.0,nM,CHEMBL2214283,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,CCCC#Cc1cc(CN2CCN(c3ccccc3OC)CC2)c2cccccc1-2
CHEMBL2207633,CHEMBL217,Dopamine D2 receptor,Ki,=,65.0,nM,CHEMBL2214283,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,COc1ccccc1N1CCN(Cc2cc(C#Cc3ccccc3)c3cccccc2-3)CC1
CHEMBL2207632,CHEMBL217,Dopamine D2 receptor,Ki,=,95.0,nM,CHEMBL2214283,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,CHEMBL2203106,KI,C#Cc1cc(CN2CCN(c3ccccc3OC)CC2)c2cccccc1-2
CHEMBL84819,CHEMBL217,Dopamine D2 receptor,Ki,=,1403.0,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,Clc1cccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)c1
CHEMBL87260,CHEMBL217,Dopamine D2 receptor,Ki,=,865.0,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,Clc1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1
CHEMBL85441,CHEMBL217,Dopamine D2 receptor,Ki,=,406.0,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1
CHEMBL312877,CHEMBL217,Dopamine D2 receptor,Ki,=,293.0,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,COc1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1
CHEMBL85972,CHEMBL217,Dopamine D2 receptor,Ki,=,269.0,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,c1cnc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)nc1
CHEMBL2298813,CHEMBL217,Dopamine D2 receptor,Ki,=,129.0,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,c1ccc(N2CCN(CCCc3ccc4nc[nH]c4c3)CC2)cc1
CHEMBL88058,CHEMBL217,Dopamine D2 receptor,Ki,=,126.0,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,Clc1ccccc1N1CCN(CCCOc2ccc(-c3nc4ccccc4[nH]3)cc2)CC1
CHEMBL2298831,CHEMBL217,Dopamine D2 receptor,Ki,=,105.0,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,COc1ccc(N2CCN(CCOc3ccc4[nH]c(=S)[nH]c4c3)CC2)cc1
CHEMBL2298817,CHEMBL217,Dopamine D2 receptor,Ki,=,97.0,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,COc1ccccc1N1CCN(CCCc2ccc3nc[nH]c3c2)CC1
CHEMBL314983,CHEMBL217,Dopamine D2 receptor,Ki,=,70.0,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)nc1
CHEMBL2298799,CHEMBL217,Dopamine D2 receptor,Ki,=,51.3,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,O=[N+]([O-])c1ccc(CCN2CCN(c3ccccc3)CC2)cc1[N+](=O)[O-]
CHEMBL2298801,CHEMBL217,Dopamine D2 receptor,Ki,=,45.5,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,O=c1[nH]c2ccc(OCCN3CCN(c4cccc(Cl)c4)CC3)cc2[nH]1
CHEMBL2299003,CHEMBL217,Dopamine D2 receptor,Ki,=,44.8,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,COc1cccc(N2CCN(CCOc3ccc4[nH]c(=O)[nH]c4c3)CC2)c1
CHEMBL2298821,CHEMBL217,Dopamine D2 receptor,Ki,=,33.0,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,COc1ccc(N2CCN(CCCc3ccc4[nH]c(=S)[nH]c4c3)CC2)cc1
CHEMBL2299001,CHEMBL217,Dopamine D2 receptor,Ki,=,26.1,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,O=c1[nH]c2ccc(OCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)cc2[nH]1
CHEMBL2298820,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,S=c1[nH]c2ccc(CCCN3CCN(c4ccc(Cl)cc4)CC3)cc2[nH]1
CHEMBL2298830,CHEMBL217,Dopamine D2 receptor,Ki,=,13.2,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,COc1cccc(N2CCN(CCOc3ccc4[nH]c(=S)[nH]c4c3)CC2)c1
CHEMBL2298824,CHEMBL217,Dopamine D2 receptor,Ki,=,12.6,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,COc1ccccc1N1CCN(CCOc2ccc3nc[nH]c3c2)CC1
CHEMBL313620,CHEMBL217,Dopamine D2 receptor,Ki,=,8.8,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,COc1ccccc1N1CCN(CCCOc2ccc(-c3nc4ccccc4[nH]3)cc2)CC1
CHEMBL2298806,CHEMBL217,Dopamine D2 receptor,Ki,=,1.66,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,c1ccc2c(N3CCN(CCc4ccc5[nH]cnc5c4)CC3)cccc2c1
CHEMBL183776,CHEMBL217,Dopamine D2 receptor,Ki,=,5.37,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,COc1ccccc1N1CCN(CCc2ccc3[nH]nnc3c2)CC1
CHEMBL87478,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,CCCSc1ccccc1N1CCN(CCCOc2ccc(-c3nc4ccccc4[nH]3)cc2)CC1
CHEMBL363124,CHEMBL217,Dopamine D2 receptor,Ki,=,23.99,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,c1ccc2c(N3CCN(CCc4ccc5[nH]nnc5c4)CC3)cccc2c1
CHEMBL2298807,CHEMBL217,Dopamine D2 receptor,Ki,=,28.18,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,O=c1[nH]c2ccc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)cc2[nH]c1=O
CHEMBL2299000,CHEMBL217,Dopamine D2 receptor,Ki,=,7.53,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,O=c1[nH]c2ccc(OCCN3CCN(c4ccccc4)CC3)cc2[nH]1
CHEMBL185436,CHEMBL217,Dopamine D2 receptor,Ki,=,31.62,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,c1ccc(-c2nc3cc(CCN4CCN(c5ccccc5)CC4)ccc3[nH]2)cc1
CHEMBL184770,CHEMBL217,Dopamine D2 receptor,Ki,=,51.29,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,Cc1cccc(N2CCN(CCc3ccc4[nH]nnc4c3)CC2)c1C
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,7.11,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL2298833,CHEMBL217,Dopamine D2 receptor,Ki,=,7.06,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,S=c1[nH]c2ccc(OCCN3CCN(c4cccc(Cl)c4)CC3)cc2[nH]1
CHEMBL2298828,CHEMBL217,Dopamine D2 receptor,Ki,=,5.94,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,FC(F)(F)c1cccc(N2CCN(CCOc3ccc4[nH]c(=S)[nH]c4c3)CC2)c1
CHEMBL2298819,CHEMBL217,Dopamine D2 receptor,Ki,=,5.8,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,FC(F)(F)c1cccc(N2CCN(CCCc3ccc4[nH]c(=S)[nH]c4c3)CC2)c1
CHEMBL2298818,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,S=c1[nH]c2ccc(CCCN3CCN(c4ccccc4)CC3)cc2[nH]1
CHEMBL2298832,CHEMBL217,Dopamine D2 receptor,Ki,=,2.75,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,S=c1[nH]c2ccc(OCCN3CCN(c4ccccc4Cl)CC3)cc2[nH]1
CHEMBL2298805,CHEMBL217,Dopamine D2 receptor,Ki,=,1.51,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,COc1ccccc1N1CCN(CCOc2ccc3nn[nH]c3c2)CC1
CHEMBL2299002,CHEMBL217,Dopamine D2 receptor,Ki,=,1.3,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,COc1ccccc1N1CCN(CCOc2ccc3[nH]c(=O)[nH]c3c2)CC1
CHEMBL2298827,CHEMBL217,Dopamine D2 receptor,Ki,=,0.67,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,S=c1[nH]c2ccc(OCCN3CCN(c4ccccc4)CC3)cc2[nH]1
CHEMBL2298822,CHEMBL217,Dopamine D2 receptor,Ki,=,0.4,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,COc1ccccc1N1CCN(CCCc2ccc3[nH]c(=S)[nH]c3c2)CC1
CHEMBL2298829,CHEMBL217,Dopamine D2 receptor,Ki,=,0.19,nM,CHEMBL3073105,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3046886,KI,COc1ccccc1N1CCN(CCOc2ccc3[nH]c(=S)[nH]c3c2)CC1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.8,nM,CHEMBL2321509,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,CHEMBL2311489,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2312640,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL2321509,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,CHEMBL2311489,KI,O=S(=O)(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cncc2ccccc12
CHEMBL2312639,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL2321509,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,CHEMBL2311489,KI,O=S(=O)(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2cn1
CHEMBL2312637,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL2321509,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,CHEMBL2311489,KI,O=S(=O)(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2cccnc2c1
CHEMBL2312935,CHEMBL217,Dopamine D2 receptor,Ki,=,9.0,nM,CHEMBL2321509,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,CHEMBL2311489,KI,O=S(=O)(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2c1
CHEMBL2312934,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL2321509,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,CHEMBL2311489,KI,O=S(=O)(NCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2cccnc2c1
CHEMBL2326176,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL2327488,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,CHEMBL2321719,KI,CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccn(C)n4)cc23)CC1
CHEMBL2326175,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL2327488,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,CHEMBL2321719,KI,CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncn(C)n4)cc23)CC1
CHEMBL2325935,CHEMBL217,Dopamine D2 receptor,Ki,=,69.0,nM,CHEMBL2327488,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,CHEMBL2321719,KI,CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4nnn(C)n4)cc23)CC1
CHEMBL2325934,CHEMBL217,Dopamine D2 receptor,Ki,=,830.0,nM,CHEMBL2327488,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,CHEMBL2321719,KI,CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cncnc4)cc23)CC1
CHEMBL1259203,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL2327488,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,CHEMBL2321719,KI,CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cncnc4)cc23)CC1
CHEMBL2325933,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL2327488,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,CHEMBL2321719,KI,CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cccnc4)cc23)CC1
CHEMBL2325932,CHEMBL217,Dopamine D2 receptor,Ki,=,76.0,nM,CHEMBL2327488,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,CHEMBL2321719,KI,CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cccnc4)cc23)CC1
CHEMBL2325931,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL2327488,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,CHEMBL2321719,KI,CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4ccncc4)cc23)CC1
CHEMBL2325930,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL2327488,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,CHEMBL2321719,KI,CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccncc4)cc23)CC1
CHEMBL2325929,CHEMBL217,Dopamine D2 receptor,Ki,=,6400.0,nM,CHEMBL2327488,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,CHEMBL2321719,KI,CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cnn(C)c4)cc23)CC1
CHEMBL2325928,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL2327488,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,CHEMBL2321719,KI,CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cnn(C)c4)cc23)CC1
CHEMBL2325927,CHEMBL217,Dopamine D2 receptor,Ki,=,880.0,nM,CHEMBL2327488,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,CHEMBL2321719,KI,CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4ccnn4C)cc23)CC1
CHEMBL2325926,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL2327488,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,CHEMBL2321719,KI,CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccnn4C)cc23)CC1
CHEMBL328187,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL2327488,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,CHEMBL2321719,KI,Cn1cc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)nn1
CHEMBL319352,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL2327488,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,CHEMBL2321719,KI,Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1
CHEMBL12713,CHEMBL217,Dopamine D2 receptor,Ki,=,0.45,nM,CHEMBL2327488,B,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,CHEMBL2321719,KI,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1
CHEMBL2326473,CHEMBL217,Dopamine D2 receptor,Ki,=,350.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,Cn1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)n1
CHEMBL2326472,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,Cn1cc(CN2CCc3cc4nc(N)sc4cc3CC2)cn1
CHEMBL2326471,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,Nc1nc2cc3c(cc2s1)CCN(Cc1ncon1)CC3
CHEMBL2326470,CHEMBL217,Dopamine D2 receptor,Ki,=,580.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,Nc1nc2cc3c(cc2s1)CCN(Cc1cnc[nH]1)CC3
CHEMBL2326469,CHEMBL217,Dopamine D2 receptor,Ki,=,490.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,Nc1nc2cc3c(cc2s1)CCN(Cc1cscn1)CC3
CHEMBL2326468,CHEMBL217,Dopamine D2 receptor,Ki,=,320.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,Nc1nc2cc3c(cc2s1)CCN(Cc1cnco1)CC3
CHEMBL2326485,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,Nc1nc2cc3c(cc2s1)CCN(Cc1ccncc1)CC3
CHEMBL2326484,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,Nc1nc2cc3c(cc2s1)CCN(Cc1cccnc1)CC3
CHEMBL2326483,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,Nc1nc2cc3c(cc2s1)CCN(Cc1ccccn1)CC3
CHEMBL2326482,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,CN(C)C(=O)c1cccc(CN2CCc3cc4nc(N)sc4cc3CC2)c1
CHEMBL2326481,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,CN(C)C(=O)c1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)cc1
CHEMBL2326480,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,COc1cccc(CN2CCc3cc4nc(N)sc4cc3CC2)c1
CHEMBL2326479,CHEMBL217,Dopamine D2 receptor,Ki,=,92.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,COc1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)cc1
CHEMBL2326478,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,Nc1nc2cc3c(cc2s1)CCN(Cc1cccc(F)c1)CC3
CHEMBL2326477,CHEMBL217,Dopamine D2 receptor,Ki,=,75.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,Nc1nc2cc3c(cc2s1)CCN(Cc1ccc(F)cc1)CC3
CHEMBL2326476,CHEMBL217,Dopamine D2 receptor,Ki,=,80.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,Nc1nc2cc3c(cc2s1)CCN(Cc1ccccc1)CC3
CHEMBL2326475,CHEMBL217,Dopamine D2 receptor,Ki,=,4300.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,Nc1nc2cc3c(cc2s1)CCN(C(=O)c1ccccc1)CC3
CHEMBL2326474,CHEMBL217,Dopamine D2 receptor,Ki,=,800.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,Nc1nc2cc3c(cc2s1)CCN(CCO)CC3
CHEMBL2326492,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,CN(C)C(=O)CN1CCc2cc3nc(N)sc3cc2CC1
CHEMBL2326491,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,Nc1nc2cc3c(cc2s1)CCN(CC(F)(F)F)CC3
CHEMBL2326490,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,Nc1nc2cc3c(cc2s1)CCN(C1CC1)CC3
CHEMBL2326489,CHEMBL217,Dopamine D2 receptor,Ki,=,2500.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,CCN1CCc2cc3nc(N)sc3cc2CC1
CHEMBL2326488,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,CN1CCc2cc3nc(N)sc3cc2CC1
CHEMBL2326487,CHEMBL217,Dopamine D2 receptor,Ki,=,3900.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,Nc1nc2cc3c(cc2s1)CCNCC3
CHEMBL2326486,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,CCN[C@@H]1Cc2cc3nc(N)sc3cc2C1
CHEMBL218166,CHEMBL217,Dopamine D2 receptor,Ki,=,0.6,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.2,nM,CHEMBL2328745,B,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,CHEMBL2321835,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2323582,CHEMBL217,Dopamine D2 receptor,Ki,=,1971.0,nM,CHEMBL2328677,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO-K1 cells,CHEMBL2321700,KI,CC1=CC(C)=[N+]2C1=C(c1ccc(OCCCN3CCCCC3)cc1)c1c(C)cc(C)n1[B-]2(F)F
CHEMBL210405,CHEMBL217,Dopamine D2 receptor,Ki,=,75.0,nM,CHEMBL2346426,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,CHEMBL2331212,KI,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL2346426,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,CHEMBL2331212,KI,NCCc1ccc(O)c(O)c1
CHEMBL2336893,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL2346426,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,CHEMBL2331212,KI,c1ccc(-n2cc(CN3CCN(c4cc5ccc4CCc4ccc(cc4)CC5)CC3)cn2)cc1
CHEMBL2336892,CHEMBL217,Dopamine D2 receptor,Ki,=,33.0,nM,CHEMBL2346426,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,CHEMBL2331212,KI,c1ccc(N2CCN(Cc3cnn(-c4cc5ccc4CCc4ccc(cc4)CC5)c3)CC2)cc1
CHEMBL2336892,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL2346426,B,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,CHEMBL2331212,KI,c1ccc(N2CCN(Cc3cnn(-c4cc5ccc4CCc4ccc(cc4)CC5)c3)CC2)cc1
CHEMBL210405,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL2346428,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,CHEMBL2331212,KI,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL2346428,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,CHEMBL2331212,KI,NCCc1ccc(O)c(O)c1
CHEMBL2336893,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL2346428,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,CHEMBL2331212,KI,c1ccc(-n2cc(CN3CCN(c4cc5ccc4CCc4ccc(cc4)CC5)CC3)cn2)cc1
CHEMBL2336892,CHEMBL217,Dopamine D2 receptor,Ki,=,55.0,nM,CHEMBL2346428,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,CHEMBL2331212,KI,c1ccc(N2CCN(Cc3cnn(-c4cc5ccc4CCc4ccc(cc4)CC5)c3)CC2)cc1
CHEMBL2336892,CHEMBL217,Dopamine D2 receptor,Ki,=,350.0,nM,CHEMBL2346428,B,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,CHEMBL2331212,KI,c1ccc(N2CCN(Cc3cnn(-c4cc5ccc4CCc4ccc(cc4)CC5)c3)CC2)cc1
CHEMBL2334891,CHEMBL217,Dopamine D2 receptor,Ki,=,91.0,nM,CHEMBL2343279,B,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2
CHEMBL1457510,CHEMBL217,Dopamine D2 receptor,Ki,=,145.0,nM,CHEMBL2343279,B,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1c(O)ccc2c1CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL448891,CHEMBL217,Dopamine D2 receptor,Ki,=,305.0,nM,CHEMBL2343279,B,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL2057453,CHEMBL217,Dopamine D2 receptor,Ki,=,347.0,nM,CHEMBL2343279,B,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1ccc2c(c1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2
CHEMBL2334892,CHEMBL217,Dopamine D2 receptor,Ki,=,105.0,nM,CHEMBL2343279,B,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)[C@H]1Cc3ccc(OC)c(OC)c3CN1CC2
CHEMBL2334893,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL2343279,B,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)[C@@H]1Cc3cc4c(cc3CN1CC2)OCO4
CHEMBL1235966,CHEMBL217,Dopamine D2 receptor,Ki,=,214.0,nM,CHEMBL2343279,B,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)[C@@H]1Cc3ccc(OC)c(O)c3CN1CC2
CHEMBL2057457,CHEMBL217,Dopamine D2 receptor,Ki,=,161.0,nM,CHEMBL2343279,B,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL490533,CHEMBL217,Dopamine D2 receptor,Ki,=,119.0,nM,CHEMBL2343279,B,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1ccc2c(c1OC)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL320397,CHEMBL217,Dopamine D2 receptor,Ki,=,113.0,nM,CHEMBL2343279,B,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)CCN1Cc3c(ccc(O)c3OC)C[C@@H]21
CHEMBL2057456,CHEMBL217,Dopamine D2 receptor,Ki,=,147.0,nM,CHEMBL2343279,B,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)[C@@H]1Cc3c(CO)c(OC)cc(OC)c3CN1CC2
CHEMBL487387,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL2343279,B,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL267930,CHEMBL217,Dopamine D2 receptor,Ki,=,1.2,nM,CHEMBL2343279,B,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
CHEMBL449920,CHEMBL217,Dopamine D2 receptor,Ki,=,6400.0,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCN(c2ccc(OC)cc2)CC1
CHEMBL2048230,CHEMBL217,Dopamine D2 receptor,Ki,=,23000.0,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCC(c2ccc(OC)cc2)CC1
CHEMBL2048227,CHEMBL217,Dopamine D2 receptor,Ki,=,900.0,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCC(c2ccc(Cl)cc2)CC1
CHEMBL2336282,CHEMBL217,Dopamine D2 receptor,Ki,=,580.0,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCN(c2ccccc2S(C)(=O)=O)CC1
CHEMBL2336280,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCC(c2ccccc2OC)CC1
CHEMBL92887,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCN(c2ccccc2OC)CC1
CHEMBL2336289,CHEMBL217,Dopamine D2 receptor,Ki,=,3800.0,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCC(c2cccc(S(=O)(=O)C3CCCC3)c2)CC1
CHEMBL480434,CHEMBL217,Dopamine D2 receptor,Ki,=,270.0,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCN(c2cccc(C#N)c2)CC1
CHEMBL2336285,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCC(c2cccc(C(F)(F)F)c2)CC1
CHEMBL2336284,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCC(c2cccc(OC)c2)CC1
CHEMBL451149,CHEMBL217,Dopamine D2 receptor,Ki,=,300.0,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCN(c2cccc(OC)c2)CC1
CHEMBL2048226,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCC(c2ccccc2)CC1
CHEMBL114510,CHEMBL217,Dopamine D2 receptor,Ki,=,470.0,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCN(c2ccccc2)CC1
CHEMBL449920,CHEMBL217,Dopamine D2 receptor,Ki,=,6309.57,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCN(c2ccc(OC)cc2)CC1
CHEMBL2048230,CHEMBL217,Dopamine D2 receptor,Ki,=,25118.86,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCC(c2ccc(OC)cc2)CC1
CHEMBL2048227,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCC(c2ccc(Cl)cc2)CC1
CHEMBL2336282,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCN(c2ccccc2S(C)(=O)=O)CC1
CHEMBL2336280,CHEMBL217,Dopamine D2 receptor,Ki,=,12.59,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCC(c2ccccc2OC)CC1
CHEMBL92887,CHEMBL217,Dopamine D2 receptor,Ki,=,19.95,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCN(c2ccccc2OC)CC1
CHEMBL2336284,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCC(c2cccc(OC)c2)CC1
CHEMBL114510,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCN(c2ccccc2)CC1
CHEMBL2048226,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCC(c2ccccc2)CC1
CHEMBL451149,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCN(c2cccc(OC)c2)CC1
CHEMBL2336289,CHEMBL217,Dopamine D2 receptor,Ki,=,3981.07,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCC(c2cccc(S(=O)(=O)C3CCCC3)c2)CC1
CHEMBL2336285,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCC(c2cccc(C(F)(F)F)c2)CC1
CHEMBL480434,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL2344228,B,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,CHEMBL2331278,KI,CCCN1CCN(c2cccc(C#N)c2)CC1
CHEMBL2335738,CHEMBL217,Dopamine D2 receptor,Ki,=,195.0,nM,CHEMBL2346210,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,CHEMBL2331372,KI,COc1ccc2c(c1)CCN1CC[C@](O)(c3ccc(Cl)cc3)C[C@H]21
CHEMBL2331599,CHEMBL217,Dopamine D2 receptor,Ki,=,132.0,nM,CHEMBL2346210,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,CHEMBL2331372,KI,Cc1cc2c(cc1O)[C@H]1C[C@](O)(c3ccc(Cl)cc3)CCN1CC2
CHEMBL2335741,CHEMBL217,Dopamine D2 receptor,Ki,=,101.0,nM,CHEMBL2346210,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,CHEMBL2331372,KI,COc1cc2c(cc1O)[C@H]1C[C@](O)(c3ccc(Cl)cc3)CCN1CC2
CHEMBL2335740,CHEMBL217,Dopamine D2 receptor,Ki,=,14.8,nM,CHEMBL2346210,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,CHEMBL2331372,KI,COc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(Cl)cc3)CCN1CC2
CHEMBL2335737,CHEMBL217,Dopamine D2 receptor,Ki,=,12.3,nM,CHEMBL2346210,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,CHEMBL2331372,KI,Cc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(Cl)cc3)CCN1CC2
CHEMBL2335736,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL2346210,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,CHEMBL2331372,KI,COc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(OC(F)(F)F)cc3)CCN1CC2
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL2352923,B,Displacement of [3H]raclopride from D2 receptor in human corpus striatum after 30 mins by scintillation counting,CHEMBL2346662,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL2377445,CHEMBL217,Dopamine D2 receptor,Ki,=,80.0,nM,CHEMBL2379237,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2375249,KI,O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCN1CCC(c2c[nH]c3ccc(F)cc23)CC1
CHEMBL2377443,CHEMBL217,Dopamine D2 receptor,Ki,=,343.0,nM,CHEMBL2379237,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2375249,KI,COc1ccc2[nH]cc(C3CCN(CCCN4C(=O)CC(c5c[nH]c6ccccc56)C4=O)CC3)c2c1
CHEMBL2377591,CHEMBL217,Dopamine D2 receptor,Ki,=,161.0,nM,CHEMBL2379237,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2375249,KI,COc1ccc2[nH]cc(C3CCN(CCCCN4C(=O)CC(c5c[nH]c6ccccc56)C4=O)CC3)c2c1
CHEMBL2377590,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL2379237,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL2375249,KI,O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccc(F)cc23)CC1
CHEMBL52096,CHEMBL217,Dopamine D2 receptor,Ki,=,10.8,nM,CHEMBL2390029,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL2385071,KI,Cc1cc(=O)oc2cc(OCCCN3CCN(c4ccccc4)CC3)ccc12
CHEMBL51767,CHEMBL217,Dopamine D2 receptor,Ki,=,11.75,nM,CHEMBL2390029,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL2385071,KI,COc1ccccc1N1CCN(CCCOc2ccc3c(C)cc(=O)oc3c2)CC1
CHEMBL300780,CHEMBL217,Dopamine D2 receptor,Ki,=,112.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL2386623,CHEMBL217,Dopamine D2 receptor,Ki,=,169.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,CNc1ccc(C(=O)NCCCCN2CCCN(c3ccccc3OC)CC2)cc1
CHEMBL2386622,CHEMBL217,Dopamine D2 receptor,Ki,=,152.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2cccc(OC)c2OC)CC1
CHEMBL2386621,CHEMBL217,Dopamine D2 receptor,Ki,=,145.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(Br)nc2)CC1
CHEMBL2386620,CHEMBL217,Dopamine D2 receptor,Ki,=,119.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(Cl)nc2)CC1
CHEMBL2386619,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(-c3ccc(F)cc3)s2)CC1
CHEMBL2386618,CHEMBL217,Dopamine D2 receptor,Ki,=,43.7,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(Br)s2)CC1
CHEMBL2386617,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2cccc3c2-c2ccccc2C3=O)CC1
CHEMBL2386616,CHEMBL217,Dopamine D2 receptor,Ki,=,151.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(CCO)cc2)CC1
CHEMBL2386615,CHEMBL217,Dopamine D2 receptor,Ki,=,107.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(-c3ccccc3)s2)CC1
CHEMBL2386614,CHEMBL217,Dopamine D2 receptor,Ki,=,125.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL2386613,CHEMBL217,Dopamine D2 receptor,Ki,=,138.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1
CHEMBL2386612,CHEMBL217,Dopamine D2 receptor,Ki,=,56.5,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(C)s2)CC1
CHEMBL2386611,CHEMBL217,Dopamine D2 receptor,Ki,=,95.2,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(F)cc2)CC1
CHEMBL2386610,CHEMBL217,Dopamine D2 receptor,Ki,=,111.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(Cl)cc2)CC1
CHEMBL2386609,CHEMBL217,Dopamine D2 receptor,Ki,=,128.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,C=Cc1ccc(C(=O)NCCCCN2CCCN(c3ccccc3OC)CC2)cc1
CHEMBL2386608,CHEMBL217,Dopamine D2 receptor,Ki,=,108.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(CCF)cc2)CC1
CHEMBL2386607,CHEMBL217,Dopamine D2 receptor,Ki,=,125.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2cc3ccccc3o2)CC1
CHEMBL2386606,CHEMBL217,Dopamine D2 receptor,Ki,=,101.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(SC)cc2)CC1
CHEMBL2386605,CHEMBL217,Dopamine D2 receptor,Ki,=,119.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(N(C)C)cc2)CC1
CHEMBL2386604,CHEMBL217,Dopamine D2 receptor,Ki,=,128.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(-c3ccsc3)cc2)CC1
CHEMBL59713,CHEMBL217,Dopamine D2 receptor,Ki,=,58.8,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1cc(Br)cc(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1OC
CHEMBL59725,CHEMBL217,Dopamine D2 receptor,Ki,=,3600.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL304605,CHEMBL217,Dopamine D2 receptor,Ki,=,198.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL2386603,CHEMBL217,Dopamine D2 receptor,Ki,=,89.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)C(=O)c1ccccc1-2
CHEMBL540612,CHEMBL217,Dopamine D2 receptor,Ki,=,61.0,nM,CHEMBL2388819,B,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,CHEMBL2385020,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1.Cl
CHEMBL267930,CHEMBL217,Dopamine D2 receptor,Ki,=,0.089,nM,CHEMBL2395274,B,Displacement of [3H]Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells after 2 hrs,CHEMBL2390918,KI,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
CHEMBL1255588,CHEMBL217,Dopamine D2 receptor,Ki,=,0.74,nM,CHEMBL2395699,B,Binding affinity to human dopamine D2S receptor by radioligand displacement assay,CHEMBL2390830,KI,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1
CHEMBL2397385,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL2399862,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,CHEMBL2396540,KI,CN1CCc2ccc(Cc3ccc(O)c4ccccc34)c3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL3216146,CHEMBL217,Dopamine D2 receptor,Ki,=,79.0,nM,CHEMBL2399862,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,CHEMBL2396540,KI,CN(C)c1ccc(Cc2ccc3c4c2-c2c(ccc(O)c2O)C[C@H]4N(C)CC3)cc1.Cl.Cl
CHEMBL2397383,CHEMBL217,Dopamine D2 receptor,Ki,=,47.0,nM,CHEMBL2399862,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,CHEMBL2396540,KI,CN1CCc2ccc(Cc3ccc(O)cc3)c3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL2397382,CHEMBL217,Dopamine D2 receptor,Ki,=,43.0,nM,CHEMBL2399862,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,CHEMBL2396540,KI,CN1CCc2ccc(CO)c3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL2397381,CHEMBL217,Dopamine D2 receptor,Ki,=,77.0,nM,CHEMBL2399862,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,CHEMBL2396540,KI,CN1CCc2ccc(Cc3ccccc3)c3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL2397380,CHEMBL217,Dopamine D2 receptor,Ki,=,54.0,nM,CHEMBL2399862,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,CHEMBL2396540,KI,Cc1ccc2c3c1-c1c(ccc(O)c1O)C[C@H]3N(C)CC2.Cl
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,53.0,nM,CHEMBL2399862,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,CHEMBL2396540,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,2100.0,nM,CHEMBL2399862,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,CHEMBL2396540,KI,NCCc1ccc(O)c(O)c1
CHEMBL2397480,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL2400820,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL2397479,CHEMBL217,Dopamine D2 receptor,Ki,=,33.0,nM,CHEMBL2400820,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL2397478,CHEMBL217,Dopamine D2 receptor,Ki,=,3.9,nM,CHEMBL2400820,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cnn(CCCC)n3)c(OC)c2)CC1
CHEMBL2397477,CHEMBL217,Dopamine D2 receptor,Ki,=,8.8,nM,CHEMBL2400820,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cnn(CCCC)n3)c(OC)c2)CC1
CHEMBL2397476,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL2400820,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL2397392,CHEMBL217,Dopamine D2 receptor,Ki,=,9.3,nM,CHEMBL2400820,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL2397391,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL2400820,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL2397390,CHEMBL217,Dopamine D2 receptor,Ki,=,230.0,nM,CHEMBL2400820,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL2396663,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL2400820,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL2397389,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL2400820,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,70.0,nM,CHEMBL2400820,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,CHEMBL2396548,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL2397480,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL2400822,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL2397479,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL2400822,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL2397478,CHEMBL217,Dopamine D2 receptor,Ki,=,6.0,nM,CHEMBL2400822,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cnn(CCCC)n3)c(OC)c2)CC1
CHEMBL2397477,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL2400822,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cnn(CCCC)n3)c(OC)c2)CC1
CHEMBL2397476,CHEMBL217,Dopamine D2 receptor,Ki,=,7.8,nM,CHEMBL2400822,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL2397392,CHEMBL217,Dopamine D2 receptor,Ki,=,7.1,nM,CHEMBL2400822,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL2397391,CHEMBL217,Dopamine D2 receptor,Ki,=,66.0,nM,CHEMBL2400822,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL2397390,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL2400822,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL2396663,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL2400822,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL2397389,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL2400822,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL2400822,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL2397480,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL2400821,B,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL2397479,CHEMBL217,Dopamine D2 receptor,Ki,=,3.1,nM,CHEMBL2400821,B,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL2397478,CHEMBL217,Dopamine D2 receptor,Ki,=,0.53,nM,CHEMBL2400821,B,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cnn(CCCC)n3)c(OC)c2)CC1
CHEMBL2397477,CHEMBL217,Dopamine D2 receptor,Ki,=,4.2,nM,CHEMBL2400821,B,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cnn(CCCC)n3)c(OC)c2)CC1
CHEMBL2397476,CHEMBL217,Dopamine D2 receptor,Ki,=,1.1,nM,CHEMBL2400821,B,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL2397392,CHEMBL217,Dopamine D2 receptor,Ki,=,0.55,nM,CHEMBL2400821,B,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL2397391,CHEMBL217,Dopamine D2 receptor,Ki,=,3.9,nM,CHEMBL2400821,B,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL2397390,CHEMBL217,Dopamine D2 receptor,Ki,=,5.5,nM,CHEMBL2400821,B,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL2396663,CHEMBL217,Dopamine D2 receptor,Ki,=,1.2,nM,CHEMBL2400821,B,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL2397389,CHEMBL217,Dopamine D2 receptor,Ki,=,0.6,nM,CHEMBL2400821,B,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL2400821,B,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,CHEMBL2396548,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL2413153,CHEMBL217,Dopamine D2 receptor,Ki,=,37.1,nM,CHEMBL2416736,B,Binding affinity to dopamine 2 receptor (unknown origin),CHEMBL2413016,KI,Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O
CHEMBL310843,CHEMBL217,Dopamine D2 receptor,Ki,=,3200.0,nM,CHEMBL2423805,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL2417399,KI,Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1
CHEMBL2420895,CHEMBL217,Dopamine D2 receptor,Ki,=,502.0,nM,CHEMBL2423805,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL2417399,KI,Clc1cccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)c1Cl
CHEMBL2420894,CHEMBL217,Dopamine D2 receptor,Ki,=,473.0,nM,CHEMBL2423805,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL2417399,KI,CCOc1ccccc1N1CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL2420893,CHEMBL217,Dopamine D2 receptor,Ki,=,242.0,nM,CHEMBL2423805,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL2417399,KI,Clc1cccc(N2CCN(Cc3ccccc3)CC2)c1Cl
CHEMBL2420892,CHEMBL217,Dopamine D2 receptor,Ki,=,217.0,nM,CHEMBL2423805,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL2417399,KI,CCOc1ccccc1N1CCN(Cc2ccccc2)CC1
CHEMBL2420891,CHEMBL217,Dopamine D2 receptor,Ki,=,383.0,nM,CHEMBL2423805,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL2417399,KI,Clc1cccc(N2CCN(Cc3csc4ccccc34)CC2)c1Cl
CHEMBL2420890,CHEMBL217,Dopamine D2 receptor,Ki,=,219.0,nM,CHEMBL2423805,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL2417399,KI,CCOc1ccccc1N1CCN(Cc2csc3ccccc23)CC1
CHEMBL2420782,CHEMBL217,Dopamine D2 receptor,Ki,=,351.0,nM,CHEMBL2423805,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL2417399,KI,Clc1cccc(N2CCN(Cc3cccc4ccccc34)CC2)c1Cl
CHEMBL2420781,CHEMBL217,Dopamine D2 receptor,Ki,=,264.0,nM,CHEMBL2423805,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL2417399,KI,CCOc1ccccc1N1CCN(Cc2cccc3ccccc23)CC1
CHEMBL2420780,CHEMBL217,Dopamine D2 receptor,Ki,=,327.0,nM,CHEMBL2423805,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL2417399,KI,Clc1cccc(N2CCN(Cc3cccnc3)CC2)c1Cl
CHEMBL2420779,CHEMBL217,Dopamine D2 receptor,Ki,=,255.0,nM,CHEMBL2423805,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL2417399,KI,CCOc1ccccc1N1CCN(Cc2cccnc2)CC1
CHEMBL2420778,CHEMBL217,Dopamine D2 receptor,Ki,=,2167.0,nM,CHEMBL2423805,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL2417399,KI,Oc1ccc(N2CCN(Cc3cccs3)CC2)cc1
CHEMBL2420777,CHEMBL217,Dopamine D2 receptor,Ki,=,1593.0,nM,CHEMBL2423805,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL2417399,KI,Clc1ccc(N2CCN(Cc3cccs3)CC2)cc1Cl
CHEMBL2420773,CHEMBL217,Dopamine D2 receptor,Ki,=,162.0,nM,CHEMBL2423805,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL2417399,KI,CCOc1ccccc1N1CCN(Cc2cccs2)CC1
CHEMBL2420772,CHEMBL217,Dopamine D2 receptor,Ki,=,1545.0,nM,CHEMBL2423805,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL2417399,KI,Clc1cccc(N2CCN(Cc3cccs3)CC2)c1Cl
CHEMBL2420771,CHEMBL217,Dopamine D2 receptor,Ki,=,2179.0,nM,CHEMBL2423805,B,Displacement of [3H]spiperone from human dopamine D2 receptor,CHEMBL2417399,KI,Clc1ccccc1N1CCN(Cc2cccs2)CC1
CHEMBL2430438,CHEMBL217,Dopamine D2 receptor,Ki,=,136.6,nM,CHEMBL2434803,B,Displacement of [3H]-spiperone from cloned human dopamine D2 receptor,CHEMBL2429816,KI,COc1ccccc1N1CCN(CCCCn2cc(-c3ccc(-c4cnco4)cc3)nn2)CC1
CHEMBL2430439,CHEMBL217,Dopamine D2 receptor,Ki,=,181.5,nM,CHEMBL2434803,B,Displacement of [3H]-spiperone from cloned human dopamine D2 receptor,CHEMBL2429816,KI,COc1ccccc1N1CCN(CCCCn2cc(-c3cccnc3)nn2)CC1
CHEMBL2430440,CHEMBL217,Dopamine D2 receptor,Ki,=,198.8,nM,CHEMBL2434803,B,Displacement of [3H]-spiperone from cloned human dopamine D2 receptor,CHEMBL2429816,KI,COc1ccccc1N1CCN(CCCCn2cc(-c3ccc(N)cc3)nn2)CC1
CHEMBL2430441,CHEMBL217,Dopamine D2 receptor,Ki,=,211.7,nM,CHEMBL2434803,B,Displacement of [3H]-spiperone from cloned human dopamine D2 receptor,CHEMBL2429816,KI,COc1ccc(-c2cn(CCCCN3CCN(c4ccccc4OC)CC3)nn2)cc1
CHEMBL2430442,CHEMBL217,Dopamine D2 receptor,Ki,=,226.6,nM,CHEMBL2434803,B,Displacement of [3H]-spiperone from cloned human dopamine D2 receptor,CHEMBL2429816,KI,COc1ccccc1N1CCN(CCCCn2cc(-c3ccc(Br)cc3)nn2)CC1
CHEMBL2430443,CHEMBL217,Dopamine D2 receptor,Ki,=,228.3,nM,CHEMBL2434803,B,Displacement of [3H]-spiperone from cloned human dopamine D2 receptor,CHEMBL2429816,KI,COc1ccccc1N1CCN(CCCCn2cc(-c3ccccc3)nn2)CC1
CHEMBL2432039,CHEMBL217,Dopamine D2 receptor,Ki,=,5675.0,nM,CHEMBL2432454,B,Inhibition of dopamine D2 receptor (unknown origin) by PDSP assay,CHEMBL2429832,KI,C1C2C3CC4C2C2C1C3[C@H](NCC13C5C6C7C5C1C7C63)C42
CHEMBL2432049,CHEMBL217,Dopamine D2 receptor,Ki,=,9906.0,nM,CHEMBL2432454,B,Inhibition of dopamine D2 receptor (unknown origin) by PDSP assay,CHEMBL2429832,KI,c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)nc1
CHEMBL2205831,CHEMBL217,Dopamine D2 receptor,Ki,=,2830.0,nM,CHEMBL2432454,B,Inhibition of dopamine D2 receptor (unknown origin) by PDSP assay,CHEMBL2429832,KI,OC12C3C4CC5C6C4C1C6C(C53)N2CC1CCCCC1
CHEMBL2432058,CHEMBL217,Dopamine D2 receptor,Ki,=,5096.0,nM,CHEMBL2432454,B,Inhibition of dopamine D2 receptor (unknown origin) by PDSP assay,CHEMBL2429832,KI,CN(CCc1ccccc1)[C@H]1C2C3CC4C5C3CC2C5C41
CHEMBL210232,CHEMBL217,Dopamine D2 receptor,Ki,=,65.0,nM,CHEMBL2443403,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(-c3ccccc3)nn2)CC1
CHEMBL2443008,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL2443403,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCOC4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4F)cc3)nn2)CC1
CHEMBL2443007,CHEMBL217,Dopamine D2 receptor,Ki,=,770.0,nM,CHEMBL2443403,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCOCCF)cc3)nn2)CC1
CHEMBL2443006,CHEMBL217,Dopamine D2 receptor,Ki,=,2900.0,nM,CHEMBL2443403,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCOCCOCCF)cc3)nn2)CC1
CHEMBL2443005,CHEMBL217,Dopamine D2 receptor,Ki,=,520.0,nM,CHEMBL2443403,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCF)cc3)nn2)CC1
CHEMBL2443004,CHEMBL217,Dopamine D2 receptor,Ki,=,18000.0,nM,CHEMBL2443403,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCF)cc3)nn2)CC1
CHEMBL2443003,CHEMBL217,Dopamine D2 receptor,Ki,=,51000.0,nM,CHEMBL2443403,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn([C@@H]3O[C@H](CF)[C@@H](O)[C@H](O)[C@H]3O)nn2)CC1
CHEMBL2443002,CHEMBL217,Dopamine D2 receptor,Ki,=,42000.0,nM,CHEMBL2443403,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3F)nn2)CC1
CHEMBL2443001,CHEMBL217,Dopamine D2 receptor,Ki,=,4700.0,nM,CHEMBL2443403,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(CCOCCOCCOCCF)nn2)CC1
CHEMBL2443000,CHEMBL217,Dopamine D2 receptor,Ki,=,3400.0,nM,CHEMBL2443403,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(CCOCCOCCF)nn2)CC1
CHEMBL2443010,CHEMBL217,Dopamine D2 receptor,Ki,=,750.0,nM,CHEMBL2443403,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(CCOCCF)nn2)CC1
CHEMBL2443009,CHEMBL217,Dopamine D2 receptor,Ki,=,560.0,nM,CHEMBL2443403,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(CCCCCCF)nn2)CC1
CHEMBL210232,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL2443402,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(-c3ccccc3)nn2)CC1
CHEMBL2443008,CHEMBL217,Dopamine D2 receptor,Ki,=,4100.0,nM,CHEMBL2443402,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCOC4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4F)cc3)nn2)CC1
CHEMBL2443007,CHEMBL217,Dopamine D2 receptor,Ki,=,440.0,nM,CHEMBL2443402,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCOCCF)cc3)nn2)CC1
CHEMBL2443006,CHEMBL217,Dopamine D2 receptor,Ki,=,2700.0,nM,CHEMBL2443402,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCOCCOCCF)cc3)nn2)CC1
CHEMBL2443005,CHEMBL217,Dopamine D2 receptor,Ki,=,340.0,nM,CHEMBL2443402,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCF)cc3)nn2)CC1
CHEMBL2443004,CHEMBL217,Dopamine D2 receptor,Ki,=,1600.0,nM,CHEMBL2443402,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCF)cc3)nn2)CC1
CHEMBL2443003,CHEMBL217,Dopamine D2 receptor,Ki,=,24000.0,nM,CHEMBL2443402,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn([C@@H]3O[C@H](CF)[C@@H](O)[C@H](O)[C@H]3O)nn2)CC1
CHEMBL2443002,CHEMBL217,Dopamine D2 receptor,Ki,=,23000.0,nM,CHEMBL2443402,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3F)nn2)CC1
CHEMBL2443001,CHEMBL217,Dopamine D2 receptor,Ki,=,8300.0,nM,CHEMBL2443402,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(CCOCCOCCOCCF)nn2)CC1
CHEMBL2443000,CHEMBL217,Dopamine D2 receptor,Ki,=,7700.0,nM,CHEMBL2443402,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(CCOCCOCCF)nn2)CC1
CHEMBL2443010,CHEMBL217,Dopamine D2 receptor,Ki,=,1600.0,nM,CHEMBL2443402,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(CCOCCF)nn2)CC1
CHEMBL2443009,CHEMBL217,Dopamine D2 receptor,Ki,=,460.0,nM,CHEMBL2443402,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,CHEMBL2440010,KI,COc1ccccc1N1CCN(Cc2cn(CCCCCCF)nn2)CC1
CHEMBL708,CHEMBL217,Dopamine D2 receptor,Ki,=,4.8,nM,CHEMBL3090831,B,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,CHEMBL3085767,KI,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL3089791,B,Displacement of [3H]-NPA from dopamine D2L receptor (unknown origin) expressed in CHO cell membranes,CHEMBL3085627,KI,NCCc1ccc(O)c(O)c1
CHEMBL3085826,CHEMBL217,Dopamine D2 receptor,Ki,=,102.33,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CN(C)C(=O)N[C@H]1CC[C@@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL3085825,CHEMBL217,Dopamine D2 receptor,Ki,=,42.66,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CN(C)C(=O)NC[C@H]1CC[C@H](CN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL3085824,CHEMBL217,Dopamine D2 receptor,Ki,=,33.11,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CC(C)(C)OC(=O)N[C@H]1CC[C@@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL3085823,CHEMBL217,Dopamine D2 receptor,Ki,=,147.91,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CC(C)(C)OC(=O)NC[C@H]1CC[C@H](CN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL3085822,CHEMBL217,Dopamine D2 receptor,Ki,=,309.03,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CC(C)(C)OC(=O)N[C@H]1CC[C@H](CN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL3085821,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL3085820,CHEMBL217,Dopamine D2 receptor,Ki,=,10.47,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,Ki,=,17.78,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL3085819,CHEMBL217,Dopamine D2 receptor,Ki,=,23.44,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CC(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(C#N)cc3C2)CC1
CHEMBL3085818,CHEMBL217,Dopamine D2 receptor,Ki,=,2238.72,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(C#N)cc3C2)CC1
CHEMBL3085817,CHEMBL217,Dopamine D2 receptor,Ki,=,380.19,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCc3ccc([N+](=O)[O-])cc3C2)CC1
CHEMBL3085816,CHEMBL217,Dopamine D2 receptor,Ki,=,13489.63,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CN(C)C(=O)N[C@H]1CC[C@@H](CCN2CCc3ccccc3C2)CC1
CHEMBL3085815,CHEMBL217,Dopamine D2 receptor,Ki,=,549.54,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CC(C)(C)OC(=O)Nc1ccc(CCN2CCc3ccccc3C2)cc1
CHEMBL3085814,CHEMBL217,Dopamine D2 receptor,Ki,=,1071.52,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CC(C)(C)OC(=O)N[C@H]1CC[C@@H](CCN2CCc3ccccc3C2)CC1
CHEMBL3085813,CHEMBL217,Dopamine D2 receptor,Ki,=,1148.15,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CC(C)(C)OC(=O)NC[C@H]1CC[C@H](CN2CCc3ccccc3C2)CC1
CHEMBL3085812,CHEMBL217,Dopamine D2 receptor,Ki,=,354.81,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CC(C)(C)OC(=O)N[C@H]1CC[C@H](CN2CCc3ccccc3C2)CC1
CHEMBL3088215,CHEMBL217,Dopamine D2 receptor,Ki,=,245.47,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CC(C)(C)NC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1
CHEMBL3085802,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1
CHEMBL3088214,CHEMBL217,Dopamine D2 receptor,Ki,=,912.01,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,O=C(N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1)Oc1ccccc1
CHEMBL3088213,CHEMBL217,Dopamine D2 receptor,Ki,=,5248.07,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CC(C)COC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1
CHEMBL3088212,CHEMBL217,Dopamine D2 receptor,Ki,=,1479.11,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CC(C)OC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1
CHEMBL3088209,CHEMBL217,Dopamine D2 receptor,Ki,=,741.31,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1
CHEMBL3088211,CHEMBL217,Dopamine D2 receptor,Ki,=,2691.53,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CCOC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1
CHEMBL3088210,CHEMBL217,Dopamine D2 receptor,Ki,=,6025.6,nM,CHEMBL3089794,B,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,CHEMBL3085627,KI,CC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1
CHEMBL3092753,CHEMBL217,Dopamine D2 receptor,Ki,=,1400.0,nM,CHEMBL3095674,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3091369,KI,NC(N)=NC(=O)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL294951,CHEMBL217,Dopamine D2 receptor,Ki,=,2.4,nM,CHEMBL3095674,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3091369,KI,CN1CCC(=C2c3ccccc3CCc3sccc32)CC1
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,6.166,nM,CHEMBL3106891,B,Displacement of [3H]spiperone from human D2 receptor,CHEMBL3102756,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,223.87,nM,CHEMBL3106891,B,Displacement of [3H]spiperone from human D2 receptor,CHEMBL3102756,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.6026,nM,CHEMBL3106891,B,Displacement of [3H]spiperone from human D2 receptor,CHEMBL3102756,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL3104515,CHEMBL217,Dopamine D2 receptor,Ki,=,112.2,nM,CHEMBL3106891,B,Displacement of [3H]spiperone from human D2 receptor,CHEMBL3102756,KI,Nc1ccc2c(c1)C(=O)C(CCN1CCC(C(=O)c3ccc(F)cc3O)CC1)CC2
CHEMBL3104648,CHEMBL217,Dopamine D2 receptor,Ki,=,50.12,nM,CHEMBL3106891,B,Displacement of [3H]spiperone from human D2 receptor,CHEMBL3102756,KI,COc1ccccc1N1CCN(CCC2CCc3ccc(N)cc3C2=O)CC1
CHEMBL3104647,CHEMBL217,Dopamine D2 receptor,Ki,=,46.77,nM,CHEMBL3106891,B,Displacement of [3H]spiperone from human D2 receptor,CHEMBL3102756,KI,Nc1ccc2c(c1)C(=O)C(CCN1CCC(c3noc4cc(F)ccc34)CC1)CC2
CHEMBL3104646,CHEMBL217,Dopamine D2 receptor,Ki,=,41.69,nM,CHEMBL3106891,B,Displacement of [3H]spiperone from human D2 receptor,CHEMBL3102756,KI,COc1ccccc1N1CCN(CCC2CCc3ccc([N+](=O)[O-])cc3C2=O)CC1
CHEMBL3104524,CHEMBL217,Dopamine D2 receptor,Ki,=,37.15,nM,CHEMBL3106891,B,Displacement of [3H]spiperone from human D2 receptor,CHEMBL3102756,KI,O=C1c2cc([N+](=O)[O-])ccc2CCC1CCN1CCC(c2noc3cc(F)ccc23)CC1
CHEMBL3104523,CHEMBL217,Dopamine D2 receptor,Ki,=,645.65,nM,CHEMBL3106891,B,Displacement of [3H]spiperone from human D2 receptor,CHEMBL3102756,KI,Nc1ccc2c(c1)C(O)C(CCN1CCC(C(=O)c3ccc(F)cc3O)CC1)CC2
CHEMBL3104522,CHEMBL217,Dopamine D2 receptor,Ki,=,87.1,nM,CHEMBL3106891,B,Displacement of [3H]spiperone from human D2 receptor,CHEMBL3102756,KI,Nc1ccc2c(c1)C(O)C(CCN1CCC(c3noc4cc(F)ccc34)CC1)CC2
CHEMBL3104521,CHEMBL217,Dopamine D2 receptor,Ki,=,177.83,nM,CHEMBL3106891,B,Displacement of [3H]spiperone from human D2 receptor,CHEMBL3102756,KI,COc1ccccc1N1CCN(CCC2CCc3ccc(N)cc3C2O)CC1
CHEMBL3104520,CHEMBL217,Dopamine D2 receptor,Ki,=,19.05,nM,CHEMBL3106891,B,Displacement of [3H]spiperone from human D2 receptor,CHEMBL3102756,KI,COc1ccccc1N1CCN(CCC2CCc3ccc([N+](=O)[O-])cc3C2O)CC1
CHEMBL3104519,CHEMBL217,Dopamine D2 receptor,Ki,=,120.23,nM,CHEMBL3106891,B,Displacement of [3H]spiperone from human D2 receptor,CHEMBL3102756,KI,O=[N+]([O-])c1ccc2c(c1)C(O)C(CCN1CCC(c3noc4cc(F)ccc34)CC1)CC2
CHEMBL3102875,CHEMBL217,Dopamine D2 receptor,Ki,=,32.36,nM,CHEMBL3106891,B,Displacement of [3H]spiperone from human D2 receptor,CHEMBL3102756,KI,CC(=O)c1ccc2c(c1)CC(CN1CCC(C(=O)c3ccc(F)cc3)CC1)CC2=O
CHEMBL3104517,CHEMBL217,Dopamine D2 receptor,Ki,=,17.38,nM,CHEMBL3106891,B,Displacement of [3H]spiperone from human D2 receptor,CHEMBL3102756,KI,O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2cc(-c3ccccc3)ccc21
CHEMBL3104516,CHEMBL217,Dopamine D2 receptor,Ki,=,50.12,nM,CHEMBL3106891,B,Displacement of [3H]spiperone from human D2 receptor,CHEMBL3102756,KI,CC(=O)c1ccc2c(c1)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)CC2=O
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,3.548,nM,CHEMBL3106129,B,Displacement of [3H]N-Methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL3102773,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,3.5,nM,CHEMBL3106129,B,Displacement of [3H]N-Methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL3102773,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL3104091,CHEMBL217,Dopamine D2 receptor,Ki,=,835.0,nM,CHEMBL3106129,B,Displacement of [3H]N-Methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL3102773,KI,CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1
CHEMBL3104091,CHEMBL217,Dopamine D2 receptor,Ki,=,831.76,nM,CHEMBL3106129,B,Displacement of [3H]N-Methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL3102773,KI,CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1
CHEMBL538542,CHEMBL217,Dopamine D2 receptor,Ki,=,0.11,nM,CHEMBL3119982,B,Binding affinity to high-affinity state of D2L receptor (unknown origin) expressed in CHO cell membranes,CHEMBL3112461,KI,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL538542,CHEMBL217,Dopamine D2 receptor,Ki,=,0.38,nM,CHEMBL3119983,B,Displacement of [3H]-spiperone from high-affinity state of recombinant human dopamine D2L receptor expressed in CHO cells after 45 mins by scintillation counting analysis,CHEMBL3112461,KI,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL2106804,CHEMBL217,Dopamine D2 receptor,Ki,=,1.5,nM,CHEMBL3119984,B,Binding affinity to high-affinity state of D2L receptor (unknown origin),CHEMBL3112461,KI,CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21.Cl
CHEMBL1557,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL3119986,B,Displacement of [3H]-iodosulpiride from cloned human dopamine D2S receptor expressed in CHO cells,CHEMBL3112461,KI,Cl.NCCc1ccc(O)c(O)c1
CHEMBL1557,CHEMBL217,Dopamine D2 receptor,Ki,=,56.0,nM,CHEMBL3119988,B,Displacement of [3H]-iodosulpiride from recombinant high-affinity state of human dopamine D2L receptor,CHEMBL3112461,KI,Cl.NCCc1ccc(O)c(O)c1
CHEMBL1557,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL3119990,B,Displacement of [3H]-raclopride from high-affinity state of human dopamine D2L receptor (443 amino acids) expressed in LTK deficient mouse fibroblasts after 60 mins by liquid scintillation counting analysis,CHEMBL3112461,KI,Cl.NCCc1ccc(O)c(O)c1
CHEMBL3115582,CHEMBL217,Dopamine D2 receptor,Ki,=,252.0,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(OCCF)cc3)CC1)CC2
CHEMBL3115582,CHEMBL217,Dopamine D2 receptor,Ki,=,235.0,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(OCCF)cc3)CC1)CC2
CHEMBL3115582,CHEMBL217,Dopamine D2 receptor,Ki,=,6.67,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(OCCF)cc3)CC1)CC2
CHEMBL3115582,CHEMBL217,Dopamine D2 receptor,Ki,=,234.42,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(OCCF)cc3)CC1)CC2
CHEMBL3115582,CHEMBL217,Dopamine D2 receptor,Ki,=,218.78,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(OCCF)cc3)CC1)CC2
CHEMBL3115582,CHEMBL217,Dopamine D2 receptor,Ki,=,5.012,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(OCCF)cc3)CC1)CC2
CHEMBL3115580,CHEMBL217,Dopamine D2 receptor,Ki,=,452.0,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1OCCCCF)CC2
CHEMBL3115580,CHEMBL217,Dopamine D2 receptor,Ki,=,156.0,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1OCCCCF)CC2
CHEMBL3115580,CHEMBL217,Dopamine D2 receptor,Ki,=,354.81,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1OCCCCF)CC2
CHEMBL3115580,CHEMBL217,Dopamine D2 receptor,Ki,=,144.54,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1OCCCCF)CC2
CHEMBL3115579,CHEMBL217,Dopamine D2 receptor,Ki,=,92.7,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccc(OCCCCF)cc1)CC2
CHEMBL3115579,CHEMBL217,Dopamine D2 receptor,Ki,=,80.5,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccc(OCCCCF)cc1)CC2
CHEMBL3115579,CHEMBL217,Dopamine D2 receptor,Ki,=,5.6,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccc(OCCCCF)cc1)CC2
CHEMBL3115579,CHEMBL217,Dopamine D2 receptor,Ki,=,91.2,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccc(OCCCCF)cc1)CC2
CHEMBL3115579,CHEMBL217,Dopamine D2 receptor,Ki,=,61.66,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccc(OCCCCF)cc1)CC2
CHEMBL3115579,CHEMBL217,Dopamine D2 receptor,Ki,=,5.495,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccc(OCCCCF)cc1)CC2
CHEMBL3115578,CHEMBL217,Dopamine D2 receptor,Ki,=,131.0,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(I)cc3)CC1)CC2
CHEMBL3115578,CHEMBL217,Dopamine D2 receptor,Ki,=,80.5,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(I)cc3)CC1)CC2
CHEMBL3115578,CHEMBL217,Dopamine D2 receptor,Ki,=,95.5,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(I)cc3)CC1)CC2
CHEMBL3115578,CHEMBL217,Dopamine D2 receptor,Ki,=,66.07,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(I)cc3)CC1)CC2
CHEMBL3115576,CHEMBL217,Dopamine D2 receptor,Ki,=,166.0,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1I)CC2
CHEMBL3115576,CHEMBL217,Dopamine D2 receptor,Ki,=,51.2,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1I)CC2
CHEMBL3115576,CHEMBL217,Dopamine D2 receptor,Ki,=,0.68,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1I)CC2
CHEMBL3115576,CHEMBL217,Dopamine D2 receptor,Ki,=,83.18,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1I)CC2
CHEMBL3115576,CHEMBL217,Dopamine D2 receptor,Ki,=,29.51,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1I)CC2
CHEMBL3115576,CHEMBL217,Dopamine D2 receptor,Ki,=,0.1622,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1I)CC2
CHEMBL3115575,CHEMBL217,Dopamine D2 receptor,Ki,=,30.8,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1cccc(I)c1)CC2
CHEMBL3115575,CHEMBL217,Dopamine D2 receptor,Ki,=,72.9,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1cccc(I)c1)CC2
CHEMBL3115575,CHEMBL217,Dopamine D2 receptor,Ki,=,2.06,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1cccc(I)c1)CC2
CHEMBL3115575,CHEMBL217,Dopamine D2 receptor,Ki,=,28.84,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1cccc(I)c1)CC2
CHEMBL3115575,CHEMBL217,Dopamine D2 receptor,Ki,=,33.88,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1cccc(I)c1)CC2
CHEMBL3115575,CHEMBL217,Dopamine D2 receptor,Ki,=,1.023,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1cccc(I)c1)CC2
CHEMBL3115574,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccc(I)cc1)CC2
CHEMBL3115574,CHEMBL217,Dopamine D2 receptor,Ki,=,51.8,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccc(I)cc1)CC2
CHEMBL3115574,CHEMBL217,Dopamine D2 receptor,Ki,=,3.79,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccc(I)cc1)CC2
CHEMBL3115574,CHEMBL217,Dopamine D2 receptor,Ki,=,81.28,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccc(I)cc1)CC2
CHEMBL3115574,CHEMBL217,Dopamine D2 receptor,Ki,=,35.48,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccc(I)cc1)CC2
CHEMBL3115574,CHEMBL217,Dopamine D2 receptor,Ki,=,2.042,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccc(I)cc1)CC2
CHEMBL3115585,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCCCCNC[C@H]1CCc2ccc(O)cc2O1.O=C(O)C(=O)O
CHEMBL3115585,CHEMBL217,Dopamine D2 receptor,Ki,=,168.0,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCCCCNC[C@H]1CCc2ccc(O)cc2O1.O=C(O)C(=O)O
CHEMBL3115585,CHEMBL217,Dopamine D2 receptor,Ki,=,8.19,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCCCCNC[C@H]1CCc2ccc(O)cc2O1.O=C(O)C(=O)O
CHEMBL3115585,CHEMBL217,Dopamine D2 receptor,Ki,=,257.04,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCCCCNC[C@H]1CCc2ccc(O)cc2O1.O=C(O)C(=O)O
CHEMBL3115585,CHEMBL217,Dopamine D2 receptor,Ki,=,151.36,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCCCCNC[C@H]1CCc2ccc(O)cc2O1.O=C(O)C(=O)O
CHEMBL3115585,CHEMBL217,Dopamine D2 receptor,Ki,=,6.31,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCCCCNC[C@H]1CCc2ccc(O)cc2O1.O=C(O)C(=O)O
CHEMBL134807,CHEMBL217,Dopamine D2 receptor,Ki,=,736.0,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2
CHEMBL134807,CHEMBL217,Dopamine D2 receptor,Ki,=,70.2,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2
CHEMBL134807,CHEMBL217,Dopamine D2 receptor,Ki,=,2.98,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2
CHEMBL134807,CHEMBL217,Dopamine D2 receptor,Ki,=,186.21,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2
CHEMBL134807,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2
CHEMBL134807,CHEMBL217,Dopamine D2 receptor,Ki,=,1.23,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2
CHEMBL538542,CHEMBL217,Dopamine D2 receptor,Ki,=,10.6,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL538542,CHEMBL217,Dopamine D2 receptor,Ki,=,1.73,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL538542,CHEMBL217,Dopamine D2 receptor,Ki,=,0.075,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL538542,CHEMBL217,Dopamine D2 receptor,Ki,=,4.898,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL538542,CHEMBL217,Dopamine D2 receptor,Ki,=,1.622,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL538542,CHEMBL217,Dopamine D2 receptor,Ki,=,0.07413,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL2106804,CHEMBL217,Dopamine D2 receptor,Ki,=,18.7,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21.Cl
CHEMBL2106804,CHEMBL217,Dopamine D2 receptor,Ki,=,21.4,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21.Cl
CHEMBL2106804,CHEMBL217,Dopamine D2 receptor,Ki,=,0.45,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21.Cl
CHEMBL2106804,CHEMBL217,Dopamine D2 receptor,Ki,=,16.98,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21.Cl
CHEMBL2106804,CHEMBL217,Dopamine D2 receptor,Ki,=,20.89,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21.Cl
CHEMBL2106804,CHEMBL217,Dopamine D2 receptor,Ki,=,0.3388,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21.Cl
CHEMBL1557,CHEMBL217,Dopamine D2 receptor,Ki,=,920.0,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,Cl.NCCc1ccc(O)c(O)c1
CHEMBL1557,CHEMBL217,Dopamine D2 receptor,Ki,=,11600.0,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,Cl.NCCc1ccc(O)c(O)c1
CHEMBL1557,CHEMBL217,Dopamine D2 receptor,Ki,=,231.0,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,Cl.NCCc1ccc(O)c(O)c1
CHEMBL1557,CHEMBL217,Dopamine D2 receptor,Ki,=,870.96,nM,CHEMBL3117737,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,Cl.NCCc1ccc(O)c(O)c1
CHEMBL1557,CHEMBL217,Dopamine D2 receptor,Ki,=,5623.41,nM,CHEMBL3117738,B,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,Cl.NCCc1ccc(O)c(O)c1
CHEMBL1557,CHEMBL217,Dopamine D2 receptor,Ki,=,107.15,nM,CHEMBL3117739,B,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,Cl.NCCc1ccc(O)c(O)c1
CHEMBL1195032,CHEMBL217,Dopamine D2 receptor,Ki,=,5000.0,nM,CHEMBL3131489,B,Agonist activity at dopamine D2 receptor (unknown origin),CHEMBL3124851,KI,C[C@@H]1NCCc2cc(O)c(O)cc21
CHEMBL3133874,CHEMBL217,Dopamine D2 receptor,Ki,=,5.9,nM,CHEMBL3136930,B,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,CHEMBL3132749,KI,COc1ccc2c(C(=O)NC/C=C/CN3CCN(c4ccccc4OCCF)CC3)c[nH]c2c1.O=C(O)C(=O)O
CHEMBL3133873,CHEMBL217,Dopamine D2 receptor,Ki,=,7.5,nM,CHEMBL3136930,B,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,CHEMBL3132749,KI,COc1ccc2[nH]cc(C(=O)NC/C=C/CN3CCN(c4ccccc4OCCF)CC3)c2c1.O=C(O)C(=O)O
CHEMBL3133872,CHEMBL217,Dopamine D2 receptor,Ki,=,11.7,nM,CHEMBL3136930,B,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,CHEMBL3132749,KI,COc1ccc2[nH]cc(C(=O)NC/C=C/CN3CCN(c4ccccc4OC)CC3)c2c1.O=C(O)C(=O)O
CHEMBL3133871,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL3136930,B,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,CHEMBL3132749,KI,COc1ccc2[nH]cc(C(=O)NCCCCN3CCN(c4ccccc4OCCF)CC3)c2c1.O=C(O)C(=O)O
CHEMBL3133870,CHEMBL217,Dopamine D2 receptor,Ki,=,5.1,nM,CHEMBL3136930,B,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,CHEMBL3132749,KI,O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1c[nH]c2ccccc12.O=C(O)C(=O)O
CHEMBL3133869,CHEMBL217,Dopamine D2 receptor,Ki,=,155.0,nM,CHEMBL3136930,B,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,CHEMBL3132749,KI,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2cc3cc(OCCOCCOCCF)ccc3[nH]2)CC1.O=C(O)C(=O)O
CHEMBL3133868,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL3136930,B,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,CHEMBL3132749,KI,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2cc3cc(OCCOCCF)ccc3[nH]2)CC1.O=C(O)C(=O)O
CHEMBL3133867,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL3136930,B,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,CHEMBL3132749,KI,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2cc3cc(OCCF)ccc3[nH]2)CC1.O=C(O)C(=O)O
CHEMBL3133866,CHEMBL217,Dopamine D2 receptor,Ki,=,119.0,nM,CHEMBL3136930,B,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,CHEMBL3132749,KI,COc1ccc2[nH]c(C(=O)NC/C=C/CN3CCN(c4ccccc4OC)CC3)cc2c1.O=C(O)C(=O)O
CHEMBL3133865,CHEMBL217,Dopamine D2 receptor,Ki,=,66.3,nM,CHEMBL3136930,B,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,CHEMBL3132749,KI,COc1ccc2[nH]c(C(=O)NC/C=C/CN3CCN(c4ccccc4OCCF)CC3)cc2c1.O=C(O)C(=O)O
CHEMBL3133864,CHEMBL217,Dopamine D2 receptor,Ki,=,33.6,nM,CHEMBL3136930,B,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,CHEMBL3132749,KI,O=C(NC/C=C/CN1CCN(c2ccccc2OCCF)CC1)c1cc2cc(O)ccc2[nH]1.O=C(O)C(=O)O
CHEMBL3133863,CHEMBL217,Dopamine D2 receptor,Ki,=,40.4,nM,CHEMBL3136930,B,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,CHEMBL3132749,KI,O=C(NC/C=C/CN1CCN(c2ccccc2OCCF)CC1)c1cc2ccccc2[nH]1.O=C(O)C(=O)O
CHEMBL3133862,CHEMBL217,Dopamine D2 receptor,Ki,=,42.4,nM,CHEMBL3136930,B,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,CHEMBL3132749,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(OCCOCCOCCF)ccc3[nH]2)CC1.O=C(O)C(=O)O
CHEMBL3133780,CHEMBL217,Dopamine D2 receptor,Ki,=,21.8,nM,CHEMBL3136930,B,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,CHEMBL3132749,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(OCCOCCF)ccc3[nH]2)CC1.O=C(O)C(=O)O
CHEMBL3133779,CHEMBL217,Dopamine D2 receptor,Ki,=,23.9,nM,CHEMBL3136930,B,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,CHEMBL3132749,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(OCCF)ccc3[nH]2)CC1.O=C(O)C(=O)O
CHEMBL3133875,CHEMBL217,Dopamine D2 receptor,Ki,=,15.7,nM,CHEMBL3136930,B,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,CHEMBL3132749,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(O)ccc3[nH]2)CC1.O=C(O)C(=O)O
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL3226695,B,Binding affinity to dopamine D2 receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL3226695,B,Binding affinity to dopamine D2 receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL716,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL3226695,B,Binding affinity to dopamine D2 receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL3226695,B,Binding affinity to dopamine D2 receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL3217984,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL3226695,B,Binding affinity to dopamine D2 receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3
CHEMBL26,CHEMBL217,Dopamine D2 receptor,Ki,=,7.6,nM,CHEMBL3224961,B,Antagonist activity at dopamine D2 receptor (unknown origin),CHEMBL3217715,KI,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC
CHEMBL3221299,CHEMBL217,Dopamine D2 receptor,Ki,=,3.9,nM,CHEMBL3224961,B,Antagonist activity at dopamine D2 receptor (unknown origin),CHEMBL3217715,KI,CCN1CCCC1CNc1nncc2ccc(OC)c(OC)c12
CHEMBL397543,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL3222870,B,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,CHEMBL3217716,KI,O=C1CC(CN2CCC(C(=O)c3ccc(F)cc3)CC2)Cc2[nH]ncc21
CHEMBL246484,CHEMBL217,Dopamine D2 receptor,Ki,=,112.2,nM,CHEMBL3222870,B,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,CHEMBL3217716,KI,O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2[nH]ncc21
CHEMBL391985,CHEMBL217,Dopamine D2 receptor,Ki,=,120.23,nM,CHEMBL3222870,B,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,CHEMBL3217716,KI,Cc1noc2c1C(=O)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)C2
CHEMBL3220212,CHEMBL217,Dopamine D2 receptor,Ki,=,63.1,nM,CHEMBL3222870,B,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,CHEMBL3217716,KI,Cc1noc2c1C(=O)CC(CN1CCC(c3c[nH]c4cc(F)ccc34)CC1)C2
CHEMBL3220214,CHEMBL217,Dopamine D2 receptor,Ki,=,32.36,nM,CHEMBL3222870,B,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,CHEMBL3217716,KI,Cc1nc2c(o1)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)CC2=O
CHEMBL3220215,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL3222870,B,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,CHEMBL3217716,KI,Cc1nc2c(o1)CC(CN1CCC(c3c[nH]c4cc(F)ccc34)CC1)CC2=O
CHEMBL3220216,CHEMBL217,Dopamine D2 receptor,Ki,=,173.78,nM,CHEMBL3222870,B,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,CHEMBL3217716,KI,Cc1nc2c(o1)CC(CN1CC=C(c3c[nH]c4cc(F)ccc34)CC1)CC2=O
CHEMBL3220218,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL3222870,B,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,CHEMBL3217716,KI,O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2nc(N3CCCC3)sc21
CHEMBL3220219,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL3222870,B,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,CHEMBL3217716,KI,O=C1CC(CN2CCC(c3c[nH]c4cc(F)ccc34)CC2)Cc2nc(N3CCCC3)sc21
CHEMBL3220220,CHEMBL217,Dopamine D2 receptor,Ki,=,54.95,nM,CHEMBL3222870,B,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,CHEMBL3217716,KI,O=C1CC(CN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)Cc2nc(N3CCCC3)sc21
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.6026,nM,CHEMBL3222870,B,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,CHEMBL3217716,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,223.87,nM,CHEMBL3222870,B,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,CHEMBL3217716,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,6.166,nM,CHEMBL3222870,B,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,CHEMBL3217716,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL59713,CHEMBL217,Dopamine D2 receptor,Ki,=,58.8,nM,CHEMBL3238580,B,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,CHEMBL3232965,KI,COc1cc(Br)cc(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1OC
CHEMBL291439,CHEMBL217,Dopamine D2 receptor,Ki,=,2200.0,nM,CHEMBL3238580,B,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,CHEMBL3232965,KI,COc1cc2c(cc1OC)CN(CCCCNC(=O)c1cc(Br)cc(OC)c1OC)CC2
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,88.65,nM,CHEMBL3240292,B,Displacement of [3H]spiperone from wild-type human dopamine D2S receptor expressed in CHO-K1 cell membrane after 2 hrs by beta counting,CHEMBL3232770,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,89.13,nM,CHEMBL3240292,B,Displacement of [3H]spiperone from wild-type human dopamine D2S receptor expressed in CHO-K1 cell membrane after 2 hrs by beta counting,CHEMBL3232770,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,57.54,nM,CHEMBL3240293,B,Displacement of [3H]spiperone from human dopamine D2S receptor S5.43T/S5.46A mutant expressed in CHO-K1 cell membrane after 2 hrs by beta counting,CHEMBL3232770,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,58.04,nM,CHEMBL3240293,B,Displacement of [3H]spiperone from human dopamine D2S receptor S5.43T/S5.46A mutant expressed in CHO-K1 cell membrane after 2 hrs by beta counting,CHEMBL3232770,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,23.45,nM,CHEMBL3240292,B,Displacement of [3H]spiperone from wild-type human dopamine D2S receptor expressed in CHO-K1 cell membrane after 2 hrs by beta counting,CHEMBL3232770,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,23.44,nM,CHEMBL3240292,B,Displacement of [3H]spiperone from wild-type human dopamine D2S receptor expressed in CHO-K1 cell membrane after 2 hrs by beta counting,CHEMBL3232770,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,173.78,nM,CHEMBL3240293,B,Displacement of [3H]spiperone from human dopamine D2S receptor S5.43T/S5.46A mutant expressed in CHO-K1 cell membrane after 2 hrs by beta counting,CHEMBL3232770,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,173.9,nM,CHEMBL3240293,B,Displacement of [3H]spiperone from human dopamine D2S receptor S5.43T/S5.46A mutant expressed in CHO-K1 cell membrane after 2 hrs by beta counting,CHEMBL3232770,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.4,nM,CHEMBL3239709,B,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,CHEMBL3232915,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL445102,CHEMBL217,Dopamine D2 receptor,Ki,=,7.5,nM,CHEMBL3239709,B,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,CHEMBL3232915,KI,OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL1200270,CHEMBL217,Dopamine D2 receptor,Ki,=,0.9,nM,CHEMBL3239709,B,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,CHEMBL3232915,KI,COc1cccc2[nH]cc(CN3CCC(O)(c4ccc(I)cc4)CC3)c12
CHEMBL3234237,CHEMBL217,Dopamine D2 receptor,Ki,=,158.0,nM,CHEMBL3239709,B,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,CHEMBL3232915,KI,Fc1ccc(CN2CCC(Nc3ccc(C(F)(F)F)nn3)CC2)cc1F
CHEMBL1503220,CHEMBL217,Dopamine D2 receptor,Ki,=,300.0,nM,CHEMBL3239709,B,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,CHEMBL3232915,KI,CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(OC)cc3)cc21
CHEMBL3234522,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL3239709,B,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,CHEMBL3232915,KI,CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCCc3cccs3)cc21
CHEMBL3234536,CHEMBL217,Dopamine D2 receptor,Ki,=,90.0,nM,CHEMBL3239709,B,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,CHEMBL3232915,KI,CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3ccc(F)cc3)cc21
CHEMBL3234537,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL3239709,B,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,CHEMBL3232915,KI,CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3ccc(C#N)cc3)cc21
CHEMBL3234538,CHEMBL217,Dopamine D2 receptor,Ki,=,530.0,nM,CHEMBL3239709,B,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,CHEMBL3232915,KI,CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)N[C@H](C)c3ccc(Br)cc3)cc21
CHEMBL3234539,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL3239709,B,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,CHEMBL3232915,KI,CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)N[C@H](C)c3ccc4ccccc4c3)cc21
CHEMBL3234541,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL3239709,B,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,CHEMBL3232915,KI,CN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3ccc(Br)cc3)cc21
CHEMBL3234542,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL3239709,B,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,CHEMBL3232915,KI,CN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3cccnc3)cc21
CHEMBL3234543,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL3239709,B,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,CHEMBL3232915,KI,CN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCCN3CCCC3)cc21
CHEMBL3234544,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL3239709,B,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,CHEMBL3232915,KI,CN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCCc3cccs3)cc21
CHEMBL3265065,CHEMBL217,Dopamine D2 receptor,Ki,=,1220.0,nM,CHEMBL3270692,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,CHEMBL3259695,KI,CCCN(CC[C@]1(O)C[C@@H](NC(=O)c2ccc3ccccc3c2)C1)[C@H]1C[C@@H]1c1cccc(Cl)c1
CHEMBL3265064,CHEMBL217,Dopamine D2 receptor,Ki,=,923.0,nM,CHEMBL3270692,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,CHEMBL3259695,KI,CCCN(CC[C@]1(O)C[C@@H](NC(=O)c2ccc3ccccc3c2)C1)[C@H]1C[C@@H]1c1ccccc1Cl
CHEMBL3265063,CHEMBL217,Dopamine D2 receptor,Ki,=,667.0,nM,CHEMBL3270692,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,CHEMBL3259695,KI,CCCN(CC[C@]1(O)C[C@@H](NC(=O)c2ccc3ccccc3c2)C1)C1CC1c1ccc(Cl)cc1
CHEMBL3265067,CHEMBL217,Dopamine D2 receptor,Ki,=,623.0,nM,CHEMBL3270692,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,CHEMBL3259695,KI,CCCN(CC[C@]1(O)C[C@@H](NC(=O)c2ccc3ccccc3c2)C1)[C@@H]1C[C@H]1c1ccc(Cl)cc1
CHEMBL267932,CHEMBL217,Dopamine D2 receptor,Ki,=,0.133,nM,CHEMBL3270692,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,CHEMBL3259695,KI,CN1CN(c2ccccc2)C2(CCN(CCCC(=O)c3ccc(F)cc3)CC2)C1=O
CHEMBL8946,CHEMBL217,Dopamine D2 receptor,Ki,=,0.086,nM,CHEMBL3270692,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,CHEMBL3259695,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1O
CHEMBL8809,CHEMBL217,Dopamine D2 receptor,Ki,=,12.7,nM,CHEMBL3270692,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,CHEMBL3259695,KI,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC
CHEMBL1255588,CHEMBL217,Dopamine D2 receptor,Ki,=,2.58,nM,CHEMBL3270692,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,CHEMBL3259695,KI,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1
CHEMBL242644,CHEMBL217,Dopamine D2 receptor,Ki,=,1090.0,nM,CHEMBL3270692,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,CHEMBL3259695,KI,COc1ccccc1N1CCN(CC(O)CCNC(=O)c2ccc(-c3ccccn3)cc2)CC1
CHEMBL1627305,CHEMBL217,Dopamine D2 receptor,Ki,=,746.0,nM,CHEMBL3270692,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,CHEMBL3259695,KI,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL3265038,CHEMBL217,Dopamine D2 receptor,Ki,=,21.47,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N3CCC[C@H]3C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCC(N)=O)C(=O)O)C2=O)cc(OC)c1OC
CHEMBL3265039,CHEMBL217,Dopamine D2 receptor,Ki,=,9.69,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C2=O)cc(OC)c1OC
CHEMBL3265040,CHEMBL217,Dopamine D2 receptor,Ki,=,10.32,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC
CHEMBL3265041,CHEMBL217,Dopamine D2 receptor,Ki,=,27.32,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@H](C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N3CCC[C@H]3C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](CO)C(=O)N3CCC[C@H]3C(=O)N[C@H](C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N3CCC[C@H]3C(=O)O)C(C)C)[C@@H](C)O)C2=O)cc(OC)c1OC
CHEMBL3265042,CHEMBL217,Dopamine D2 receptor,Ki,=,12.27,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C2=O)cc(OC)c1OC
CHEMBL3265043,CHEMBL217,Dopamine D2 receptor,Ki,=,8.14,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C2=O)cc(OC)c1OC
CHEMBL3265044,CHEMBL217,Dopamine D2 receptor,Ki,=,12.96,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N3CCC[C@H]3C(=O)O)C(C)C)C2=O)cc(OC)c1OC
CHEMBL3265045,CHEMBL217,Dopamine D2 receptor,Ki,=,8.01,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@H](C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)[C@@H](C)O)[C@@H](C)O)C2=O)cc(OC)c1OC
CHEMBL3265046,CHEMBL217,Dopamine D2 receptor,Ki,=,28.43,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCCC(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC
CHEMBL3265047,CHEMBL217,Dopamine D2 receptor,Ki,=,30.33,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCC(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC
CHEMBL3265048,CHEMBL217,Dopamine D2 receptor,Ki,=,23.78,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCCOCCOCCOCCC(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC
CHEMBL3265049,CHEMBL217,Dopamine D2 receptor,Ki,=,1.47,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCC(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC
CHEMBL3265314,CHEMBL217,Dopamine D2 receptor,Ki,=,27.39,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCOCCOCCC(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC
CHEMBL3265315,CHEMBL217,Dopamine D2 receptor,Ki,=,53.92,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC
CHEMBL3265316,CHEMBL217,Dopamine D2 receptor,Ki,=,25.27,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC
CHEMBL3265317,CHEMBL217,Dopamine D2 receptor,Ki,=,26.13,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCC(=O)N[C@H](C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)[C@@H](C)O)[C@@H](C)O)C2=O)cc(OC)c1OC
CHEMBL3265318,CHEMBL217,Dopamine D2 receptor,Ki,=,35.77,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCOCCOCCC(=O)N[C@H](C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)[C@@H](C)O)[C@@H](C)O)C2=O)cc(OC)c1OC
CHEMBL3265319,CHEMBL217,Dopamine D2 receptor,Ki,=,42.8,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)N[C@H](C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)[C@@H](C)O)[C@@H](C)O)C2=O)cc(OC)c1OC
CHEMBL3265320,CHEMBL217,Dopamine D2 receptor,Ki,=,44.67,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)N[C@H](C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)[C@@H](C)O)[C@@H](C)O)C2=O)cc(OC)c1OC
CHEMBL3265321,CHEMBL217,Dopamine D2 receptor,Ki,=,5.98,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCC(=O)N[C@@H](CCCCNC(=O)O/N=C/c3ccc([Si](F)(C(C)(C)C)C(C)(C)C)cc3)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC
CHEMBL3265322,CHEMBL217,Dopamine D2 receptor,Ki,=,52.03,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCC(=O)N[C@@H](CCCCNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC
CHEMBL3265323,CHEMBL217,Dopamine D2 receptor,Ki,=,64.16,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@H](C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCC[n+]3c(C)cc(/C=C/C=C/c4ccc(N(C)C)cc4)cc3C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)[C@@H](C)O)[C@@H](C)O)C2=O)cc(OC)c1OC
CHEMBL3265324,CHEMBL217,Dopamine D2 receptor,Ki,=,7.31,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCC(N)=O)C2=O)cc(OC)c1OC
CHEMBL392158,CHEMBL217,Dopamine D2 receptor,Ki,=,0.097,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCF)cc(OC)c1OC
CHEMBL1255588,CHEMBL217,Dopamine D2 receptor,Ki,=,0.37,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1
CHEMBL3265329,CHEMBL217,Dopamine D2 receptor,Ki,=,0.63,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,C=CCN1CCC[C@H]1CNC(=O)c1cccc(CCCF)c1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.85,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL8809,CHEMBL217,Dopamine D2 receptor,Ki,=,1.21,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC
CHEMBL71,CHEMBL217,Dopamine D2 receptor,Ki,=,6.1,nM,CHEMBL3265956,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,CHEMBL3259715,KI,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL3286567,CHEMBL217,Dopamine D2 receptor,Ki,=,2100.0,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,c1cc2c3c(c[nH]c3c1)CC1CNCCN21
CHEMBL3286568,CHEMBL217,Dopamine D2 receptor,Ki,=,660.0,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,CN1CCN2c3cccc4[nH]cc(c34)CC2C1
CHEMBL3286569,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,CCN1CCN2c3cccc4[nH]cc(c34)CC2C1
CHEMBL3286570,CHEMBL217,Dopamine D2 receptor,Ki,=,570.0,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,CCCN1CCN2c3cccc4[nH]cc(c34)CC2C1
CHEMBL3286571,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,CCCCN1CCN2c3cccc4[nH]cc(c34)CC2C1
CHEMBL3286572,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,CC(C)CN1CCN2c3cccc4[nH]cc(c34)CC2C1
CHEMBL3286573,CHEMBL217,Dopamine D2 receptor,Ki,=,98.0,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,CCCCCN1CCN2c3cccc4[nH]cc(c34)CC2C1
CHEMBL3286574,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,CC(C)CCN1CCN2c3cccc4[nH]cc(c34)CC2C1
CHEMBL3286575,CHEMBL217,Dopamine D2 receptor,Ki,=,54.0,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,c1cc2c3c(c[nH]c3c1)CC1CN(CC3CCCCC3)CCN21
CHEMBL3286576,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,c1ccc(CN2CCN3c4cccc5[nH]cc(c45)CC3C2)cc1
CHEMBL3286577,CHEMBL217,Dopamine D2 receptor,Ki,=,450.0,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,c1ccc(-c2ccccc2CN2CCN3c4cccc5[nH]cc(c45)CC3C2)cc1
CHEMBL3286578,CHEMBL217,Dopamine D2 receptor,Ki,=,0.65,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,c1ccc(-c2cccc(CN3CCN4c5cccc6[nH]cc(c56)CC4C3)c2)cc1
CHEMBL3286579,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,c1ccc(-c2ccc(CN3CCN4c5cccc6[nH]cc(c56)CC4C3)cc2)cc1
CHEMBL531,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL3294602,B,Displacement of [125]iodosulpride from human recombinant dopamine D2L receptor expressed in CHO cells after 30 mins,CHEMBL3286112,KI,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL493,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL3294602,B,Displacement of [125]iodosulpride from human recombinant dopamine D2L receptor expressed in CHO cells after 30 mins,CHEMBL3286112,KI,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL157138,CHEMBL217,Dopamine D2 receptor,Ki,=,0.66,nM,CHEMBL3294602,B,Displacement of [125]iodosulpride from human recombinant dopamine D2L receptor expressed in CHO cells after 30 mins,CHEMBL3286112,KI,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL218166,CHEMBL217,Dopamine D2 receptor,Ki,=,2.3,nM,CHEMBL3294603,B,Displacement of [3H]nemonapride from dopamine D2L receptor (unknown origin) expressed in African green monkey COS7 cells,CHEMBL3286112,KI,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1
CHEMBL3286567,CHEMBL217,Dopamine D2 receptor,Ki,=,2089.3,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,c1cc2c3c(c[nH]c3c1)CC1CNCCN21
CHEMBL3286568,CHEMBL217,Dopamine D2 receptor,Ki,=,660.69,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,CN1CCN2c3cccc4[nH]cc(c34)CC2C1
CHEMBL3286569,CHEMBL217,Dopamine D2 receptor,Ki,=,141.25,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,CCN1CCN2c3cccc4[nH]cc(c34)CC2C1
CHEMBL3286570,CHEMBL217,Dopamine D2 receptor,Ki,=,575.44,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,CCCN1CCN2c3cccc4[nH]cc(c34)CC2C1
CHEMBL3286571,CHEMBL217,Dopamine D2 receptor,Ki,=,109.65,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,CCCCN1CCN2c3cccc4[nH]cc(c34)CC2C1
CHEMBL3286572,CHEMBL217,Dopamine D2 receptor,Ki,=,309.03,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,CC(C)CN1CCN2c3cccc4[nH]cc(c34)CC2C1
CHEMBL3286573,CHEMBL217,Dopamine D2 receptor,Ki,=,97.72,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,CCCCCN1CCN2c3cccc4[nH]cc(c34)CC2C1
CHEMBL3286574,CHEMBL217,Dopamine D2 receptor,Ki,=,23.99,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,CC(C)CCN1CCN2c3cccc4[nH]cc(c34)CC2C1
CHEMBL3286575,CHEMBL217,Dopamine D2 receptor,Ki,=,53.7,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,c1cc2c3c(c[nH]c3c1)CC1CN(CC3CCCCC3)CCN21
CHEMBL3286576,CHEMBL217,Dopamine D2 receptor,Ki,=,128.82,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,c1ccc(CN2CCN3c4cccc5[nH]cc(c45)CC3C2)cc1
CHEMBL3286577,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,c1ccc(-c2ccccc2CN2CCN3c4cccc5[nH]cc(c45)CC3C2)cc1
CHEMBL3286578,CHEMBL217,Dopamine D2 receptor,Ki,=,0.2291,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,c1ccc(-c2cccc(CN3CCN4c5cccc6[nH]cc(c56)CC4C3)c2)cc1
CHEMBL3286579,CHEMBL217,Dopamine D2 receptor,Ki,=,120.23,nM,CHEMBL3294601,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,CHEMBL3286112,KI,c1ccc(-c2ccc(CN3CCN4c5cccc6[nH]cc(c56)CC4C3)cc2)cc1
CHEMBL531,CHEMBL217,Dopamine D2 receptor,Ki,=,25.7,nM,CHEMBL3294602,B,Displacement of [125]iodosulpride from human recombinant dopamine D2L receptor expressed in CHO cells after 30 mins,CHEMBL3286112,KI,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL493,CHEMBL217,Dopamine D2 receptor,Ki,=,14.79,nM,CHEMBL3294602,B,Displacement of [125]iodosulpride from human recombinant dopamine D2L receptor expressed in CHO cells after 30 mins,CHEMBL3286112,KI,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL157138,CHEMBL217,Dopamine D2 receptor,Ki,=,0.6607,nM,CHEMBL3294602,B,Displacement of [125]iodosulpride from human recombinant dopamine D2L receptor expressed in CHO cells after 30 mins,CHEMBL3286112,KI,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL218166,CHEMBL217,Dopamine D2 receptor,Ki,=,2.291,nM,CHEMBL3294603,B,Displacement of [3H]nemonapride from dopamine D2L receptor (unknown origin) expressed in African green monkey COS7 cells,CHEMBL3286112,KI,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1
CHEMBL476935,CHEMBL217,Dopamine D2 receptor,Ki,=,253.3,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL3289383,CHEMBL217,Dopamine D2 receptor,Ki,=,635.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,[O-][S+](CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL3289383,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,[O-][S+](CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1940408,CHEMBL217,Dopamine D2 receptor,Ki,=,284.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(CCCCN2CCN(c3ccc(Cl)cc3)CC2)cc1
CHEMBL1940409,CHEMBL217,Dopamine D2 receptor,Ki,=,211.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(SCCCN2CCN(c3ccc(Cl)cc3)CC2)cc1
CHEMBL1940411,CHEMBL217,Dopamine D2 receptor,Ki,=,390.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(OCCCN2CCN(c3ccc(Cl)cc3)CC2)cc1
CHEMBL1940413,CHEMBL217,Dopamine D2 receptor,Ki,=,447.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Clc1ccc(N2CCN(CCCOc3ccccc3)CC2)cc1
CHEMBL1940413,CHEMBL217,Dopamine D2 receptor,Ki,=,446.68,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Clc1ccc(N2CCN(CCCOc3ccccc3)CC2)cc1
CHEMBL1940406,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(OCCCN2CCC(c3ccc(Cl)cc3)CC2)cc1
CHEMBL3289642,CHEMBL217,Dopamine D2 receptor,Ki,=,1543.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,O=C1c2ccc(F)cc2CC1CCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL3289642,CHEMBL217,Dopamine D2 receptor,Ki,=,1548.82,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,O=C1c2ccc(F)cc2CC1CCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL3289644,CHEMBL217,Dopamine D2 receptor,Ki,=,1417.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc2c(c1)CC(CCN1CCN(c3ccc(Cl)cc3)CC1)C2
CHEMBL1940418,CHEMBL217,Dopamine D2 receptor,Ki,=,124.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL1940419,CHEMBL217,Dopamine D2 receptor,Ki,=,183.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(SCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL1940420,CHEMBL217,Dopamine D2 receptor,Ki,=,186.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(OCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL3289645,CHEMBL217,Dopamine D2 receptor,Ki,=,1092.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,FC(F)(F)c1ccc(OCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL3289645,CHEMBL217,Dopamine D2 receptor,Ki,=,1096.48,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,FC(F)(F)c1ccc(OCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL3289646,CHEMBL217,Dopamine D2 receptor,Ki,=,1046.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Cc1ccc(N2CCN(CCCOc3ccc(F)cc3)CC2)nc1
CHEMBL3289646,CHEMBL217,Dopamine D2 receptor,Ki,=,1047.13,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Cc1ccc(N2CCN(CCCOc3ccc(F)cc3)CC2)nc1
CHEMBL3289647,CHEMBL217,Dopamine D2 receptor,Ki,=,1106.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Cc1ccc(N2CCN(CCCSc3ccc(F)cc3)CC2)nc1
CHEMBL3289647,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Cc1ccc(N2CCN(CCCSc3ccc(F)cc3)CC2)nc1
CHEMBL3289648,CHEMBL217,Dopamine D2 receptor,Ki,=,1861.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Cc1ccc(N2CCN(CCCCc3ccc(F)cc3)CC2)nc1
CHEMBL3289648,CHEMBL217,Dopamine D2 receptor,Ki,=,1995.26,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Cc1ccc(N2CCN(CCCCc3ccc(F)cc3)CC2)nc1
CHEMBL1940417,CHEMBL217,Dopamine D2 receptor,Ki,=,636.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(OCCCN2CCN(c3ncccn3)CC2)cc1
CHEMBL1940416,CHEMBL217,Dopamine D2 receptor,Ki,=,424.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(SCCCN2CCN(c3ncccn3)CC2)cc1
CHEMBL1940415,CHEMBL217,Dopamine D2 receptor,Ki,=,269.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(CCCCN2CCN(c3ncccn3)CC2)cc1
CHEMBL2037431,CHEMBL217,Dopamine D2 receptor,Ki,=,219.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Clc1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)cc1
CHEMBL2037430,CHEMBL217,Dopamine D2 receptor,Ki,=,2321.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Clc1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)cc1
CHEMBL3289649,CHEMBL217,Dopamine D2 receptor,Ki,=,3108.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Clc1ccc(N2CCN(CCCCCc3nc4ccccc4o3)CC2)cc1
CHEMBL3286429,CHEMBL217,Dopamine D2 receptor,Ki,=,3962.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Clc1ccc(N2CCN(CCCc3nc4ccccc4o3)CC2)cc1
CHEMBL3289653,CHEMBL217,Dopamine D2 receptor,Ki,=,1979.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Clc1ccc(N2CCN(CCCc3cc4ccccc4o3)CC2)cc1
CHEMBL3289655,CHEMBL217,Dopamine D2 receptor,Ki,=,2507.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Clc1ccc(N2CCCN(CCCc3cc4ccccc4o3)CC2)cc1
CHEMBL2037521,CHEMBL217,Dopamine D2 receptor,Ki,=,26.5,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,c1cnc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1
CHEMBL7927,CHEMBL217,Dopamine D2 receptor,Ki,=,3200.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,960.0,nM,CHEMBL3292986,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3286287,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.54,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,Ki,=,0.47,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL3287390,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,Clc1cccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c1Cl
CHEMBL3287391,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,Clc1cccc(N2CCN(CCCCOc3cccn4nccc34)CC2)c1Cl
CHEMBL3287392,CHEMBL217,Dopamine D2 receptor,Ki,=,4.2,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,Clc1cccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)c1Cl
CHEMBL3287393,CHEMBL217,Dopamine D2 receptor,Ki,=,64.0,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,Clc1cccc(N2CCN(CCCCOc3cccc4ccnn34)CC2)c1Cl
CHEMBL3287394,CHEMBL217,Dopamine D2 receptor,Ki,=,9.4,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,Clc1cccc(N2CCN(CCCCOc3cc4ccccn4n3)CC2)c1Cl
CHEMBL3287395,CHEMBL217,Dopamine D2 receptor,Ki,=,7.4,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1
CHEMBL3287396,CHEMBL217,Dopamine D2 receptor,Ki,=,3.1,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,OCc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1
CHEMBL3287397,CHEMBL217,Dopamine D2 receptor,Ki,=,4.6,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O=Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL3287398,CHEMBL217,Dopamine D2 receptor,Ki,=,29.0,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O=Cc1cnn2cccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)c12
CHEMBL3287399,CHEMBL217,Dopamine D2 receptor,Ki,=,6.2,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O=Cc1cnn2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccc12
CHEMBL3287400,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O=Cc1cnn2c(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cccc12
CHEMBL3287401,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O=Cc1c(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nn2ccccc12
CHEMBL3287402,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O=Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1
CHEMBL3287403,CHEMBL217,Dopamine D2 receptor,Ki,=,1.8,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL3287403,CHEMBL217,Dopamine D2 receptor,Ki,=,0.17,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL3287404,CHEMBL217,Dopamine D2 receptor,Ki,=,3.3,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O/N=C/c1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1
CHEMBL3287405,CHEMBL217,Dopamine D2 receptor,Ki,=,0.58,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,N#Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL3287406,CHEMBL217,Dopamine D2 receptor,Ki,=,8.9,nM,CHEMBL3295080,B,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,N#Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,70.0,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.45,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,Ki,=,0.41,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL3287390,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,Clc1cccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c1Cl
CHEMBL3287391,CHEMBL217,Dopamine D2 receptor,Ki,=,30.0,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,Clc1cccc(N2CCN(CCCCOc3cccn4nccc34)CC2)c1Cl
CHEMBL3287392,CHEMBL217,Dopamine D2 receptor,Ki,=,2.1,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,Clc1cccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)c1Cl
CHEMBL3287393,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,Clc1cccc(N2CCN(CCCCOc3cccc4ccnn34)CC2)c1Cl
CHEMBL3287394,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,Clc1cccc(N2CCN(CCCCOc3cc4ccccn4n3)CC2)c1Cl
CHEMBL3287395,CHEMBL217,Dopamine D2 receptor,Ki,=,6.7,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1
CHEMBL3287396,CHEMBL217,Dopamine D2 receptor,Ki,=,2.3,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,OCc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1
CHEMBL3287397,CHEMBL217,Dopamine D2 receptor,Ki,=,3.2,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O=Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL3287398,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O=Cc1cnn2cccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)c12
CHEMBL3287399,CHEMBL217,Dopamine D2 receptor,Ki,=,8.1,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O=Cc1cnn2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccc12
CHEMBL3287400,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O=Cc1cnn2c(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cccc12
CHEMBL3287401,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O=Cc1c(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nn2ccccc12
CHEMBL3287402,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O=Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1
CHEMBL3287403,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL3287403,CHEMBL217,Dopamine D2 receptor,Ki,=,0.25,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL3287404,CHEMBL217,Dopamine D2 receptor,Ki,=,2.3,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,O/N=C/c1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1
CHEMBL3287405,CHEMBL217,Dopamine D2 receptor,Ki,=,0.32,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,N#Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL3287406,CHEMBL217,Dopamine D2 receptor,Ki,=,6.7,nM,CHEMBL3295081,B,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,CHEMBL3286313,KI,N#Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1
CHEMBL1627305,CHEMBL217,Dopamine D2 receptor,Ki,=,750.0,nM,CHEMBL3291797,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in human HEK293 cell membrane for 1 hr by liquid scintillation counting analysis,CHEMBL3286326,KI,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL1627306,CHEMBL217,Dopamine D2 receptor,Ki,=,300.0,nM,CHEMBL3291797,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in human HEK293 cell membrane for 1 hr by liquid scintillation counting analysis,CHEMBL3286326,KI,O=C(NCC[C@@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL1627307,CHEMBL217,Dopamine D2 receptor,Ki,=,790.0,nM,CHEMBL3291797,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in human HEK293 cell membrane for 1 hr by liquid scintillation counting analysis,CHEMBL3286326,KI,O=C(NCC[C@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL1774386,CHEMBL217,Dopamine D2 receptor,Ki,=,960.0,nM,CHEMBL3291797,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in human HEK293 cell membrane for 1 hr by liquid scintillation counting analysis,CHEMBL3286326,KI,O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL3287279,CHEMBL217,Dopamine D2 receptor,Ki,=,800.0,nM,CHEMBL3291797,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in human HEK293 cell membrane for 1 hr by liquid scintillation counting analysis,CHEMBL3286326,KI,O=C(NCC[C@@H](F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL3287280,CHEMBL217,Dopamine D2 receptor,Ki,=,2500.0,nM,CHEMBL3291797,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in human HEK293 cell membrane for 1 hr by liquid scintillation counting analysis,CHEMBL3286326,KI,O=C(NCC[C@H](F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL3287281,CHEMBL217,Dopamine D2 receptor,Ki,=,7400.0,nM,CHEMBL3291797,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in human HEK293 cell membrane for 1 hr by liquid scintillation counting analysis,CHEMBL3286326,KI,O=C(NCCC(CF)N1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL3290012,CHEMBL217,Dopamine D2 receptor,Ki,=,1.8,nM,CHEMBL3297335,B,Displacement of [3H]methylspiperone from human recombinant D2S receptor expressed in HEK293 cells,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccccc2s1
CHEMBL8514,CHEMBL217,Dopamine D2 receptor,Ki,=,0.04,nM,CHEMBL3297335,B,Displacement of [3H]methylspiperone from human recombinant D2S receptor expressed in HEK293 cells,CHEMBL3286108,KI,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL3289708,CHEMBL217,Dopamine D2 receptor,Ki,=,43.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,Cc1cccc(S(=O)(=O)NCCN2CCN(c3nsc4ccccc34)CC2)c1
CHEMBL3289709,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,Cc1cccc(S(=O)(=O)NCCCN2CCN(c3nsc4ccccc34)CC2)c1
CHEMBL3289944,CHEMBL217,Dopamine D2 receptor,Ki,=,8.7,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,Cc1cccc(S(=O)(=O)NCCCCN2CCN(c3nsc4ccccc34)CC2)c1
CHEMBL3289945,CHEMBL217,Dopamine D2 receptor,Ki,=,7.8,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc(Cl)c(Cl)c1
CHEMBL3289946,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc(Cl)c(Cl)c1
CHEMBL3289947,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc(F)c(Cl)c1
CHEMBL3286432,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc(F)c(Cl)c1
CHEMBL3289948,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc(OC(F)(F)F)cc1
CHEMBL3289949,CHEMBL217,Dopamine D2 receptor,Ki,=,48.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc(OC(F)(F)F)cc1
CHEMBL3289950,CHEMBL217,Dopamine D2 receptor,Ki,=,56.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1cccs1
CHEMBL3289951,CHEMBL217,Dopamine D2 receptor,Ki,=,3.2,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1cccs1
CHEMBL3289952,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2ccccc2c1
CHEMBL3289953,CHEMBL217,Dopamine D2 receptor,Ki,=,2.2,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2ccccc2c1
CHEMBL3289954,CHEMBL217,Dopamine D2 receptor,Ki,=,0.9,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2ccccc2c1
CHEMBL3289955,CHEMBL217,Dopamine D2 receptor,Ki,=,6.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2cc(Cl)ccc2c1
CHEMBL3289956,CHEMBL217,Dopamine D2 receptor,Ki,=,49.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2cc(Cl)ccc2c1
CHEMBL3289957,CHEMBL217,Dopamine D2 receptor,Ki,=,48.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1cc2ccccc2s1
CHEMBL3289958,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1cc2ccccc2s1
CHEMBL3289960,CHEMBL217,Dopamine D2 receptor,Ki,=,45.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1cc2ccc(Cl)cc2s1
CHEMBL3289961,CHEMBL217,Dopamine D2 receptor,Ki,=,8.3,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,Cc1c(S(=O)(=O)NCCCN2CCN(c3nsc4ccccc34)CC2)sc2ccc(F)cc12
CHEMBL3289962,CHEMBL217,Dopamine D2 receptor,Ki,=,44.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,Cc1c(S(=O)(=O)NCCCCN2CCN(c3nsc4ccccc34)CC2)sc2ccc(F)cc12
CHEMBL3289963,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1cnc2ccccn12
CHEMBL3289964,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1cnc2ccccn12
CHEMBL3289965,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1cccc2scnc12
CHEMBL3289966,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1cccc2scnc12
CHEMBL3289967,CHEMBL217,Dopamine D2 receptor,Ki,=,2000.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,Cc1cccc(S(=O)(=O)NCCCN2CCN(c3noc4ccccc34)CC2)c1
CHEMBL3289968,CHEMBL217,Dopamine D2 receptor,Ki,=,44.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,Cc1cccc(S(=O)(=O)NCCCCN2CCN(c3noc4ccccc34)CC2)c1
CHEMBL3289970,CHEMBL217,Dopamine D2 receptor,Ki,=,57.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1ccc(Cl)c(Cl)c1
CHEMBL3289972,CHEMBL217,Dopamine D2 receptor,Ki,=,77.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1ccc(F)c(Cl)c1
CHEMBL3289973,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCN(c2noc3ccccc23)CC1)c1ccc(OC(F)(F)F)cc1
CHEMBL3289974,CHEMBL217,Dopamine D2 receptor,Ki,=,400.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1ccc(OC(F)(F)F)cc1
CHEMBL3289975,CHEMBL217,Dopamine D2 receptor,Ki,=,55.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCN(c2noc3ccccc23)CC1)c1cccs1
CHEMBL3289976,CHEMBL217,Dopamine D2 receptor,Ki,=,5.3,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1cccs1
CHEMBL3289977,CHEMBL217,Dopamine D2 receptor,Ki,=,7200.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCN(c2noc3ccccc23)CC1)c1ccc2ccccc2c1
CHEMBL3289978,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1ccc2ccccc2c1
CHEMBL3289980,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1ccc2cc(Cl)ccc2c1
CHEMBL3289981,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCN(c2noc3ccccc23)CC1)c1cc2ccccc2s1
CHEMBL3289982,CHEMBL217,Dopamine D2 receptor,Ki,=,1300.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1cc2ccccc2s1
CHEMBL3289983,CHEMBL217,Dopamine D2 receptor,Ki,=,30.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCN(c2noc3ccccc23)CC1)c1cc2ccc(Cl)cc2s1
CHEMBL3289984,CHEMBL217,Dopamine D2 receptor,Ki,=,54.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1cc2ccc(Cl)cc2s1
CHEMBL3289986,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,Cc1c(S(=O)(=O)NCCCCN2CCN(c3noc4ccccc34)CC2)sc2ccc(F)cc12
CHEMBL3289987,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1cnc2ccccn12
CHEMBL3289989,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1cccc2scnc12
CHEMBL3289990,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,Cc1cccc(S(=O)(=O)NCCN2CCC(c3noc4cc(F)ccc34)CC2)c1
CHEMBL3289991,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,Cc1cccc(S(=O)(=O)NCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1
CHEMBL3289992,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,Cc1cccc(S(=O)(=O)NCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1
CHEMBL3289993,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc(Cl)c(Cl)c1
CHEMBL3289994,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc(Cl)c(Cl)c1
CHEMBL3289995,CHEMBL217,Dopamine D2 receptor,Ki,=,3.7,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc(F)c(Cl)c1
CHEMBL3289996,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc(F)c(Cl)c1
CHEMBL3289997,CHEMBL217,Dopamine D2 receptor,Ki,=,33.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc(OC(F)(F)F)cc1
CHEMBL3289998,CHEMBL217,Dopamine D2 receptor,Ki,=,64.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc(OC(F)(F)F)cc1
CHEMBL3289999,CHEMBL217,Dopamine D2 receptor,Ki,=,8.7,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cccs1
CHEMBL3290001,CHEMBL217,Dopamine D2 receptor,Ki,=,9.1,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cccc2ccccc12
CHEMBL3290002,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cccc2ccccc12
CHEMBL3290003,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cccc2ccccc12
CHEMBL3290004,CHEMBL217,Dopamine D2 receptor,Ki,=,5.2,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc2ccccc2c1
CHEMBL3290005,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc2ccccc2c1
CHEMBL3290006,CHEMBL217,Dopamine D2 receptor,Ki,=,1.1,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc2ccccc2c1
CHEMBL3290007,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc2cc(Cl)ccc2c1
CHEMBL3290008,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc2cc(Cl)ccc2c1
CHEMBL3290009,CHEMBL217,Dopamine D2 receptor,Ki,=,36.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1csc2ccccc12
CHEMBL3290010,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1csc2ccccc12
CHEMBL3290011,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccccc2s1
CHEMBL3290012,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccccc2s1
CHEMBL3290013,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccc(Cl)cc2s1
CHEMBL3290014,CHEMBL217,Dopamine D2 receptor,Ki,=,1.2,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccc(Cl)cc2s1
CHEMBL3290015,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,Cc1c(S(=O)(=O)NCCCN2CCC(c3noc4cc(F)ccc34)CC2)sc2ccc(F)cc12
CHEMBL3290016,CHEMBL217,Dopamine D2 receptor,Ki,=,1.9,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,Cc1c(S(=O)(=O)NCCCCN2CCC(c3noc4cc(F)ccc34)CC2)sc2ccc(F)cc12
CHEMBL3290017,CHEMBL217,Dopamine D2 receptor,Ki,=,1.5,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,Cc1c(S(=O)(=O)NCCCCN2CCC(c3noc4cc(F)ccc34)CC2)sc2ccc(Cl)cc12
CHEMBL3290018,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cnc2ccccn12
CHEMBL3290021,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL3297244,B,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cccc2scnc12
CHEMBL3298755,CHEMBL217,Dopamine D2 receptor,Ki,=,9090.0,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,OC1(c2ccc(Cl)cc2)CCNCC1
CHEMBL3298756,CHEMBL217,Dopamine D2 receptor,Ki,=,2750.0,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,CC(C)(C)OC(=O)NCCN1CCC(O)(c2ccc(Cl)cc2)CC1
CHEMBL3298757,CHEMBL217,Dopamine D2 receptor,Ki,=,1350.0,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,CC(C)(C)OC(=O)NCCCN1CCC(O)(c2ccc(Cl)cc2)CC1
CHEMBL3298825,CHEMBL217,Dopamine D2 receptor,Ki,=,2110.0,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,CC(C)(C)OC(=O)NCCCCN1CCC(O)(c2ccc(Cl)cc2)CC1
CHEMBL3299091,CHEMBL217,Dopamine D2 receptor,Ki,=,2050.0,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,CC(C)(C)OC(=O)NCCCCCN1CCC(O)(c2ccc(Cl)cc2)CC1
CHEMBL3299092,CHEMBL217,Dopamine D2 receptor,Ki,=,902.0,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,CC(C)(C)OC(=O)NCCCCCCN1CCC(O)(c2ccc(Cl)cc2)CC1
CHEMBL9666,CHEMBL217,Dopamine D2 receptor,Ki,=,4110.0,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCNCC1
CHEMBL3299093,CHEMBL217,Dopamine D2 receptor,Ki,=,171.0,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCNC(=O)OC(C)(C)C)CC1
CHEMBL3299094,CHEMBL217,Dopamine D2 receptor,Ki,=,16.1,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCCNC(=O)OC(C)(C)C)CC1
CHEMBL3299095,CHEMBL217,Dopamine D2 receptor,Ki,=,18.9,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCCCNC(=O)OC(C)(C)C)CC1
CHEMBL3299096,CHEMBL217,Dopamine D2 receptor,Ki,=,12.1,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCCCCNC(=O)OC(C)(C)C)CC1
CHEMBL3299097,CHEMBL217,Dopamine D2 receptor,Ki,=,74.8,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCCCCCNC(=O)OC(C)(C)C)CC1
CHEMBL3299098,CHEMBL217,Dopamine D2 receptor,Ki,=,910.0,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,Cc1cc(C)c2c(N)c(C(=O)NCCN3CCC(O)(c4ccc(Cl)cc4)CC3)sc2n1
CHEMBL3299099,CHEMBL217,Dopamine D2 receptor,Ki,=,1700.0,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,Cc1cc(C)c2c(N)c(C(=O)NCCCN3CCC(O)(c4ccc(Cl)cc4)CC3)sc2n1
CHEMBL3298200,CHEMBL217,Dopamine D2 receptor,Ki,=,2250.0,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,Cc1cc(C)c2c(N)c(C(=O)NCCCCN3CCC(O)(c4ccc(Cl)cc4)CC3)sc2n1
CHEMBL3298685,CHEMBL217,Dopamine D2 receptor,Ki,=,1980.0,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,Cc1cc(C)c2c(N)c(C(=O)NCCCCCN3CCC(O)(c4ccc(Cl)cc4)CC3)sc2n1
CHEMBL3298686,CHEMBL217,Dopamine D2 receptor,Ki,=,975.0,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,Cc1cc(C)c2c(N)c(C(=O)NCCCCCCN3CCC(O)(c4ccc(Cl)cc4)CC3)sc2n1
CHEMBL3298758,CHEMBL217,Dopamine D2 receptor,Ki,=,48.3,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCNC(=O)c2sc3nc(OC)c(Cl)c(C)c3c2N)CC1
CHEMBL3298759,CHEMBL217,Dopamine D2 receptor,Ki,=,19.5,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCCNC(=O)c2sc3nc(OC)c(Cl)c(C)c3c2N)CC1
CHEMBL3298826,CHEMBL217,Dopamine D2 receptor,Ki,=,6.3,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2sc3nc(OC)c(Cl)c(C)c3c2N)CC1
CHEMBL3298827,CHEMBL217,Dopamine D2 receptor,Ki,=,3.5,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2sc3nc(OC)c(Cl)c(C)c3c2N)CC1
CHEMBL3298828,CHEMBL217,Dopamine D2 receptor,Ki,=,0.6,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1nc2sc(C(=O)NCCCCCCN3CCC(c4ccc(Cl)cc4)CC3)c(N)c2c(C)c1Cl
CHEMBL3298755,CHEMBL217,Dopamine D2 receptor,Ki,=,9120.11,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,OC1(c2ccc(Cl)cc2)CCNCC1
CHEMBL3298756,CHEMBL217,Dopamine D2 receptor,Ki,=,2754.23,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,CC(C)(C)OC(=O)NCCN1CCC(O)(c2ccc(Cl)cc2)CC1
CHEMBL3298757,CHEMBL217,Dopamine D2 receptor,Ki,=,1348.96,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,CC(C)(C)OC(=O)NCCCN1CCC(O)(c2ccc(Cl)cc2)CC1
CHEMBL3298825,CHEMBL217,Dopamine D2 receptor,Ki,=,2089.3,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,CC(C)(C)OC(=O)NCCCCN1CCC(O)(c2ccc(Cl)cc2)CC1
CHEMBL3299091,CHEMBL217,Dopamine D2 receptor,Ki,=,2041.74,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,CC(C)(C)OC(=O)NCCCCCN1CCC(O)(c2ccc(Cl)cc2)CC1
CHEMBL3299092,CHEMBL217,Dopamine D2 receptor,Ki,=,891.25,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,CC(C)(C)OC(=O)NCCCCCCN1CCC(O)(c2ccc(Cl)cc2)CC1
CHEMBL9666,CHEMBL217,Dopamine D2 receptor,Ki,=,4073.8,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCNCC1
CHEMBL3299093,CHEMBL217,Dopamine D2 receptor,Ki,=,169.82,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCNC(=O)OC(C)(C)C)CC1
CHEMBL3299094,CHEMBL217,Dopamine D2 receptor,Ki,=,15.85,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCCNC(=O)OC(C)(C)C)CC1
CHEMBL3299095,CHEMBL217,Dopamine D2 receptor,Ki,=,19.05,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCCCNC(=O)OC(C)(C)C)CC1
CHEMBL3299096,CHEMBL217,Dopamine D2 receptor,Ki,=,12.02,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCCCCNC(=O)OC(C)(C)C)CC1
CHEMBL3299097,CHEMBL217,Dopamine D2 receptor,Ki,=,74.13,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCCCCCNC(=O)OC(C)(C)C)CC1
CHEMBL3299098,CHEMBL217,Dopamine D2 receptor,Ki,=,912.01,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,Cc1cc(C)c2c(N)c(C(=O)NCCN3CCC(O)(c4ccc(Cl)cc4)CC3)sc2n1
CHEMBL3299099,CHEMBL217,Dopamine D2 receptor,Ki,=,1698.24,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,Cc1cc(C)c2c(N)c(C(=O)NCCCN3CCC(O)(c4ccc(Cl)cc4)CC3)sc2n1
CHEMBL3298200,CHEMBL217,Dopamine D2 receptor,Ki,=,2238.72,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,Cc1cc(C)c2c(N)c(C(=O)NCCCCN3CCC(O)(c4ccc(Cl)cc4)CC3)sc2n1
CHEMBL3298685,CHEMBL217,Dopamine D2 receptor,Ki,=,1995.26,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,Cc1cc(C)c2c(N)c(C(=O)NCCCCCN3CCC(O)(c4ccc(Cl)cc4)CC3)sc2n1
CHEMBL3298686,CHEMBL217,Dopamine D2 receptor,Ki,=,977.24,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,Cc1cc(C)c2c(N)c(C(=O)NCCCCCCN3CCC(O)(c4ccc(Cl)cc4)CC3)sc2n1
CHEMBL3298758,CHEMBL217,Dopamine D2 receptor,Ki,=,47.86,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCNC(=O)c2sc3nc(OC)c(Cl)c(C)c3c2N)CC1
CHEMBL3298759,CHEMBL217,Dopamine D2 receptor,Ki,=,19.5,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCCNC(=O)c2sc3nc(OC)c(Cl)c(C)c3c2N)CC1
CHEMBL3298826,CHEMBL217,Dopamine D2 receptor,Ki,=,6.31,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2sc3nc(OC)c(Cl)c(C)c3c2N)CC1
CHEMBL3298827,CHEMBL217,Dopamine D2 receptor,Ki,=,3.548,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2sc3nc(OC)c(Cl)c(C)c3c2N)CC1
CHEMBL3298828,CHEMBL217,Dopamine D2 receptor,Ki,=,0.6166,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1nc2sc(C(=O)NCCCCCCN3CCC(c4ccc(Cl)cc4)CC3)c(N)c2c(C)c1Cl
CHEMBL1424807,CHEMBL217,Dopamine D2 receptor,Ki,=,1160.0,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,Clc1cccc(N2CCNCC2)c1Cl
CHEMBL3298829,CHEMBL217,Dopamine D2 receptor,Ki,=,42.6,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,CC(C)(C)OC(=O)NCCCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL3298830,CHEMBL217,Dopamine D2 receptor,Ki,=,15.5,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1nc2sc(C(=O)NCCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)c(N)c2c(C)c1Cl
CHEMBL3298895,CHEMBL217,Dopamine D2 receptor,Ki,=,11.2,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,Cc1cc(C)c2c(N)c(C(=O)NCCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)sc2n1
CHEMBL3298896,CHEMBL217,Dopamine D2 receptor,Ki,=,9.1,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2sc3nc(C)cc(C)c3c2N)CC1
CHEMBL1424807,CHEMBL217,Dopamine D2 receptor,Ki,=,1148.15,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,Clc1cccc(N2CCNCC2)c1Cl
CHEMBL3298829,CHEMBL217,Dopamine D2 receptor,Ki,=,42.66,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,CC(C)(C)OC(=O)NCCCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL3298830,CHEMBL217,Dopamine D2 receptor,Ki,=,15.49,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1nc2sc(C(=O)NCCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)c(N)c2c(C)c1Cl
CHEMBL3298895,CHEMBL217,Dopamine D2 receptor,Ki,=,11.22,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,Cc1cc(C)c2c(N)c(C(=O)NCCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)sc2n1
CHEMBL3298896,CHEMBL217,Dopamine D2 receptor,Ki,=,9.12,nM,CHEMBL3300162,B,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,CHEMBL3297649,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2sc3nc(C)cc(C)c3c2N)CC1
CHEMBL3353916,CHEMBL217,Dopamine D2 receptor,Ki,=,9.4,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCCc2cn(-c3ccccc3O)nn2)CC1
CHEMBL3353915,CHEMBL217,Dopamine D2 receptor,Ki,=,12.8,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCc2cn(-c3ccccc3O)nn2)CC1
CHEMBL3353914,CHEMBL217,Dopamine D2 receptor,Ki,=,26.6,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCCCc2cn(-c3ccc(SC)cc3)nn2)CC1
CHEMBL3353913,CHEMBL217,Dopamine D2 receptor,Ki,=,37.7,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCCc2cn(-c3ccc(SC)cc3)nn2)CC1
CHEMBL3353912,CHEMBL217,Dopamine D2 receptor,Ki,=,44.1,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCc2cn(-c3ccc(SC)cc3)nn2)CC1
CHEMBL3353911,CHEMBL217,Dopamine D2 receptor,Ki,=,62.6,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCCCc2cn(-c3ccc(N(C)C)cc3)nn2)CC1
CHEMBL3353910,CHEMBL217,Dopamine D2 receptor,Ki,=,171.0,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCCc2cn(-c3ccc(N(C)C)cc3)nn2)CC1
CHEMBL3353909,CHEMBL217,Dopamine D2 receptor,Ki,=,162.0,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCc2cn(-c3ccc(N(C)C)cc3)nn2)CC1
CHEMBL3353908,CHEMBL217,Dopamine D2 receptor,Ki,=,62.7,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCCCc2cn(-c3ccccc3OC)nn2)CC1
CHEMBL3353907,CHEMBL217,Dopamine D2 receptor,Ki,=,139.0,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCCc2cn(-c3ccccc3OC)nn2)CC1
CHEMBL3353906,CHEMBL217,Dopamine D2 receptor,Ki,=,272.0,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCc2cn(-c3ccccc3OC)nn2)CC1
CHEMBL3353905,CHEMBL217,Dopamine D2 receptor,Ki,=,23.7,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCCCc2cn(-c3ccc(F)cc3)nn2)CC1
CHEMBL3353904,CHEMBL217,Dopamine D2 receptor,Ki,=,46.7,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCCc2cn(-c3ccc(F)cc3)nn2)CC1
CHEMBL3353903,CHEMBL217,Dopamine D2 receptor,Ki,=,73.5,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCc2cn(-c3ccc(F)cc3)nn2)CC1
CHEMBL3353902,CHEMBL217,Dopamine D2 receptor,Ki,=,109.0,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCCCc2cn(-c3ccc(-c4ccsc4)cc3)nn2)CC1
CHEMBL3353901,CHEMBL217,Dopamine D2 receptor,Ki,=,94.3,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCCc2cn(-c3ccc(-c4ccsc4)cc3)nn2)CC1
CHEMBL3353900,CHEMBL217,Dopamine D2 receptor,Ki,=,158.0,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCc2cn(-c3ccc(-c4ccsc4)cc3)nn2)CC1
CHEMBL3353899,CHEMBL217,Dopamine D2 receptor,Ki,=,17.7,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCCCc2cn(-c3cccc4cnccc34)nn2)CC1
CHEMBL3353898,CHEMBL217,Dopamine D2 receptor,Ki,=,42.3,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCCc2cn(-c3cccc4cnccc34)nn2)CC1
CHEMBL3353897,CHEMBL217,Dopamine D2 receptor,Ki,=,79.3,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCc2cn(-c3cccc4cnccc34)nn2)CC1
CHEMBL3353896,CHEMBL217,Dopamine D2 receptor,Ki,=,19.4,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCCCc2cn(-c3ccccc3)nn2)CC1
CHEMBL3353895,CHEMBL217,Dopamine D2 receptor,Ki,=,30.9,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCCc2cn(-c3ccccc3)nn2)CC1
CHEMBL3353894,CHEMBL217,Dopamine D2 receptor,Ki,=,64.0,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCc2cn(-c3ccccc3)nn2)CC1
CHEMBL1688991,CHEMBL217,Dopamine D2 receptor,Ki,=,54.5,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(CCF)cc2)CC1
CHEMBL1688990,CHEMBL217,Dopamine D2 receptor,Ki,=,34.4,nM,CHEMBL3374187,B,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,CHEMBL3352598,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(N(C)C)cc2)CC1
CHEMBL3323010,CHEMBL217,Dopamine D2 receptor,Ki,=,191.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1nc(C2CC2)cc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)n1
CHEMBL3323009,CHEMBL217,Dopamine D2 receptor,Ki,=,361.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1cc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)nc(C(C)(C)C)n1
CHEMBL3323008,CHEMBL217,Dopamine D2 receptor,Ki,=,366.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,Cc1cc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)nc(C(C)(C)C)n1
CHEMBL3323007,CHEMBL217,Dopamine D2 receptor,Ki,=,4604.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,Cc1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(C)(C)C)n1
CHEMBL3323006,CHEMBL217,Dopamine D2 receptor,Ki,=,3646.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,Cc1cc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)nc(C(F)(F)F)n1
CHEMBL3323005,CHEMBL217,Dopamine D2 receptor,Ki,=,24938.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,Cc1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1
CHEMBL3323004,CHEMBL217,Dopamine D2 receptor,Ki,=,1452.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)c2ccccc2n1
CHEMBL3323003,CHEMBL217,Dopamine D2 receptor,Ki,=,1133.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,O=C(NCCCCN1CCN(c2ncnc3ccccc23)CC1)c1cn2ccccc2n1
CHEMBL3323002,CHEMBL217,Dopamine D2 receptor,Ki,=,1563.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,O=C(NCCCCN1CCN(c2ccc3ccccc3n2)CC1)c1cn2ccccc2n1
CHEMBL3323001,CHEMBL217,Dopamine D2 receptor,Ki,=,1883.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,O=C(NCCCCN1CCN(c2ccnc3cc(Cl)ccc23)CC1)c1cn2ccccc2n1
CHEMBL3323000,CHEMBL217,Dopamine D2 receptor,Ki,=,4983.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,O=C(NCCCCN1CCN(c2ccnc3cc(C(F)(F)F)ccc23)CC1)c1cn2ccccc2n1
CHEMBL3322999,CHEMBL217,Dopamine D2 receptor,Ki,=,13567.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,O=C(NCCCCN1CCN(c2cc(C(F)(F)F)nc3ccccc23)CC1)c1cn2ccccc2n1
CHEMBL3322998,CHEMBL217,Dopamine D2 receptor,Ki,=,572.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,O=C(NCCCCN1CCN(c2ccnc3ccccc23)CC1)c1cn2ccccc2n1
CHEMBL3322997,CHEMBL217,Dopamine D2 receptor,Ki,=,1303.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1cc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(C)(C)C)c1
CHEMBL3322996,CHEMBL217,Dopamine D2 receptor,Ki,=,191.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,N#Cc1cc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)c1
CHEMBL3322995,CHEMBL217,Dopamine D2 receptor,Ki,=,162.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cn2ccccc2n1
CHEMBL3322994,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cn2ccccc2n1
CHEMBL3322993,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1
CHEMBL3322992,CHEMBL217,Dopamine D2 receptor,Ki,=,178.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn2ccccc2n1
CHEMBL3323116,CHEMBL217,Dopamine D2 receptor,Ki,=,337.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)C3CCN(Cc4ccccc4)CC3)CC2)cc(C(F)(F)F)n1
CHEMBL3323117,CHEMBL217,Dopamine D2 receptor,Ki,=,1510.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)[C@H]3CC[C@H](c4ccccc4)CC3)CC2)cc(C(F)(F)F)n1
CHEMBL3323011,CHEMBL217,Dopamine D2 receptor,Ki,=,702.0,nM,CHEMBL3379354,B,Displacement of [125I]IABN from wild type human D2R expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1
CHEMBL3323112,CHEMBL217,Dopamine D2 receptor,Ki,=,191.0,nM,CHEMBL3379354,B,Displacement of [125I]IABN from wild type human D2R expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CN(C)Cc1c(C(=O)NCCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)nc2ccccn12
CHEMBL3323114,CHEMBL217,Dopamine D2 receptor,Ki,=,245.0,nM,CHEMBL3379354,B,Displacement of [125I]IABN from wild type human D2R expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CN(C)Cc1cccc2nc(C(=O)NCCCCN3CCN(c4cc(C(F)(F)F)nc(C(C)(C)C)n4)CC3)cn12
CHEMBL3323011,CHEMBL217,Dopamine D2 receptor,Ki,=,148.0,nM,CHEMBL3379897,B,Displacement of [125I]IABN from chimeric human D2 receptor possessing extracellular loop II of D3 receptor expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1
CHEMBL3323112,CHEMBL217,Dopamine D2 receptor,Ki,=,72.0,nM,CHEMBL3379897,B,Displacement of [125I]IABN from chimeric human D2 receptor possessing extracellular loop II of D3 receptor expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CN(C)Cc1c(C(=O)NCCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)nc2ccccn12
CHEMBL3323114,CHEMBL217,Dopamine D2 receptor,Ki,=,176.0,nM,CHEMBL3379897,B,Displacement of [125I]IABN from chimeric human D2 receptor possessing extracellular loop II of D3 receptor expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CN(C)Cc1cccc2nc(C(=O)NCCCCN3CCN(c4cc(C(F)(F)F)nc(C(C)(C)C)n4)CC3)cn12
CHEMBL3318831,CHEMBL217,Dopamine D2 receptor,Ki,=,6.7,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318832,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318833,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318834,CHEMBL217,Dopamine D2 receptor,Ki,=,3.3,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318835,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318836,CHEMBL217,Dopamine D2 receptor,Ki,=,5.6,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318837,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318838,CHEMBL217,Dopamine D2 receptor,Ki,=,66.0,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318839,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318840,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318841,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318842,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCCCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318843,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCCCCCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318844,CHEMBL217,Dopamine D2 receptor,Ki,=,56.0,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,Cc1ccc(C(=O)OC2(c3ccc(Cl)cc3)CCN(CCCC(=O)c3ccc(F)cc3)CC2)cc1
CHEMBL3318845,CHEMBL217,Dopamine D2 receptor,Ki,=,4.5,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,CC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318824,CHEMBL217,Dopamine D2 receptor,Ki,=,3.9,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL1200986,CHEMBL217,Dopamine D2 receptor,Ki,=,1.8,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,CCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318846,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCN1CCN(CCC(=O)OC2(c3ccc(Cl)cc3)CCN(CCCC(=O)c3ccc(F)cc3)CC2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318847,CHEMBL217,Dopamine D2 receptor,Ki,=,3.2,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,CN(CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)CCN(C)CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318848,CHEMBL217,Dopamine D2 receptor,Ki,=,1.9,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,CN(C)CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318849,CHEMBL217,Dopamine D2 receptor,Ki,=,1.3,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCc1cn(CCCCCCCCn2cc(CCC(=O)OC3(c4ccc(Cl)cc4)CCN(CCCC(=O)c4ccc(F)cc4)CC3)nn2)nn1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318850,CHEMBL217,Dopamine D2 receptor,Ki,=,4.9,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCc1cn(CCCCCCCCCCn2cc(CCC(=O)OC3(c4ccc(Cl)cc4)CCN(CCCC(=O)c4ccc(F)cc4)CC3)nn2)nn1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3317465,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCc1cn(CCOCCOCCOCCn2cc(CCC(=O)OC3(c4ccc(Cl)cc4)CCN(CCCC(=O)c4ccc(F)cc4)CC3)nn2)nn1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318851,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCc1cn(CCOCCOCCOCCOCCn2cc(CCC(=O)OC3(c4ccc(Cl)cc4)CCN(CCCC(=O)c4ccc(F)cc4)CC3)nn2)nn1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318852,CHEMBL217,Dopamine D2 receptor,Ki,=,860.0,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCC(=O)N1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.81,nM,CHEMBL3369121,B,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL3318831,CHEMBL217,Dopamine D2 receptor,Ki,=,5.4,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318832,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318833,CHEMBL217,Dopamine D2 receptor,Ki,=,2.3,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318834,CHEMBL217,Dopamine D2 receptor,Ki,=,2.6,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318835,CHEMBL217,Dopamine D2 receptor,Ki,=,2.9,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318836,CHEMBL217,Dopamine D2 receptor,Ki,=,6.5,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318837,CHEMBL217,Dopamine D2 receptor,Ki,=,31.0,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318838,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318839,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318840,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318841,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318842,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCCCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318843,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCCCCCCCCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318844,CHEMBL217,Dopamine D2 receptor,Ki,=,47.0,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,Cc1ccc(C(=O)OC2(c3ccc(Cl)cc3)CCN(CCCC(=O)c3ccc(F)cc3)CC2)cc1
CHEMBL3318845,CHEMBL217,Dopamine D2 receptor,Ki,=,4.5,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,CC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318824,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL1200986,CHEMBL217,Dopamine D2 receptor,Ki,=,0.46,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,CCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318846,CHEMBL217,Dopamine D2 receptor,Ki,=,1.1,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCN1CCN(CCC(=O)OC2(c3ccc(Cl)cc3)CCN(CCCC(=O)c3ccc(F)cc3)CC2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318847,CHEMBL217,Dopamine D2 receptor,Ki,=,2.2,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,CN(CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)CCN(C)CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318848,CHEMBL217,Dopamine D2 receptor,Ki,=,1.8,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,CN(C)CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318849,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCc1cn(CCCCCCCCn2cc(CCC(=O)OC3(c4ccc(Cl)cc4)CCN(CCCC(=O)c4ccc(F)cc4)CC3)nn2)nn1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318850,CHEMBL217,Dopamine D2 receptor,Ki,=,5.4,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCc1cn(CCCCCCCCCCn2cc(CCC(=O)OC3(c4ccc(Cl)cc4)CCN(CCCC(=O)c4ccc(F)cc4)CC3)nn2)nn1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3317465,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCc1cn(CCOCCOCCOCCn2cc(CCC(=O)OC3(c4ccc(Cl)cc4)CCN(CCCC(=O)c4ccc(F)cc4)CC3)nn2)nn1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318851,CHEMBL217,Dopamine D2 receptor,Ki,=,3.8,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCc1cn(CCOCCOCCOCCOCCn2cc(CCC(=O)OC3(c4ccc(Cl)cc4)CCN(CCCC(=O)c4ccc(F)cc4)CC3)nn2)nn1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL3318852,CHEMBL217,Dopamine D2 receptor,Ki,=,470.0,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCC(=O)N1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.85,nM,CHEMBL3369122,B,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL3352709,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL3323115,CHEMBL217,Dopamine D2 receptor,Ki,=,809.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)C3CCN(c4ccccc4)CC3)CC2)cc(C(F)(F)F)n1
CHEMBL3323114,CHEMBL217,Dopamine D2 receptor,Ki,=,298.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CN(C)Cc1cccc2nc(C(=O)NCCCCN3CCN(c4cc(C(F)(F)F)nc(C(C)(C)C)n4)CC3)cn12
CHEMBL3323113,CHEMBL217,Dopamine D2 receptor,Ki,=,934.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4c(CO)cccc4n3)CC2)cc(C(F)(F)F)n1
CHEMBL3323112,CHEMBL217,Dopamine D2 receptor,Ki,=,301.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CN(C)Cc1c(C(=O)NCCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)nc2ccccn12
CHEMBL3323019,CHEMBL217,Dopamine D2 receptor,Ki,=,527.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CN(C)Cc1c(C(=O)NCCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)[nH]c2ccccc12
CHEMBL3323018,CHEMBL217,Dopamine D2 receptor,Ki,=,481.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3sc4ncccc4c3N)CC2)cc(C(F)(F)F)n1
CHEMBL3323017,CHEMBL217,Dopamine D2 receptor,Ki,=,655.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4nc(Cl)ccc4n3)CC2)cc(C(F)(F)F)n1
CHEMBL3323016,CHEMBL217,Dopamine D2 receptor,Ki,=,450.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccncc4n3)CC2)cc(C(F)(F)F)n1
CHEMBL3323015,CHEMBL217,Dopamine D2 receptor,Ki,=,436.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4cccnc4n3)CC2)cc(C(F)(F)F)n1
CHEMBL3323014,CHEMBL217,Dopamine D2 receptor,Ki,=,683.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cc4cccnc4s3)CC2)cc(C(F)(F)F)n1
CHEMBL3323013,CHEMBL217,Dopamine D2 receptor,Ki,=,336.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3nc4ccccc4[nH]3)CC2)cc(C(F)(F)F)n1
CHEMBL3323012,CHEMBL217,Dopamine D2 receptor,Ki,=,913.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cc4ccccc4[nH]3)CC2)cc(C(F)(F)F)n1
CHEMBL3323011,CHEMBL217,Dopamine D2 receptor,Ki,=,511.0,nM,CHEMBL3379351,B,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,CHEMBL3351252,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.89,nM,CHEMBL3366156,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL3352364,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1940402,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL3366156,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL3352364,KI,OC1(c2ccc(Cl)cc2)CCN(CCCCc2ccc(F)cc2)CC1
CHEMBL1940404,CHEMBL217,Dopamine D2 receptor,Ki,=,8.8,nM,CHEMBL3366156,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL3352364,KI,OC1(c2ccc(Cl)cc2)CCN(CCCOc2ccc(F)cc2)CC1
CHEMBL1940403,CHEMBL217,Dopamine D2 receptor,Ki,=,5.3,nM,CHEMBL3366156,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL3352364,KI,OC1(c2ccc(Cl)cc2)CCN(CCCSc2ccc(F)cc2)CC1
CHEMBL210578,CHEMBL217,Dopamine D2 receptor,Ki,=,0.31,nM,CHEMBL3366156,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL3352364,KI,O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1
CHEMBL3321788,CHEMBL217,Dopamine D2 receptor,Ki,=,33.0,nM,CHEMBL3366156,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL3352364,KI,OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2CCCCc1ccc(F)cc1
CHEMBL3321789,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL3366156,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL3352364,KI,OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2CCCOc1ccc(F)cc1
CHEMBL3321790,CHEMBL217,Dopamine D2 receptor,Ki,=,2.9,nM,CHEMBL3366156,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL3352364,KI,OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2CCCSc1ccc(F)cc1
CHEMBL3321791,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL3366156,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL3352364,KI,OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2CCCSc1cccc(F)c1
CHEMBL3321792,CHEMBL217,Dopamine D2 receptor,Ki,=,4.8,nM,CHEMBL3366156,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL3352364,KI,OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2CCCSc1ccccc1F
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL3366156,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL3352364,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL3344356,CHEMBL217,Dopamine D2 receptor,Ki,=,88.02,nM,CHEMBL3387736,B,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sccc3CN1CC2
CHEMBL3344456,CHEMBL217,Dopamine D2 receptor,Ki,=,40.83,nM,CHEMBL3387736,B,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,CCc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2
CHEMBL3344457,CHEMBL217,Dopamine D2 receptor,Ki,=,38.63,nM,CHEMBL3387736,B,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,CCCc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2
CHEMBL3344458,CHEMBL217,Dopamine D2 receptor,Ki,=,17.61,nM,CHEMBL3387736,B,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,CCCCc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2
CHEMBL3344459,CHEMBL217,Dopamine D2 receptor,Ki,=,7.54,nM,CHEMBL3387736,B,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sc(CC(C)C)cc3CN1CC2
CHEMBL3344460,CHEMBL217,Dopamine D2 receptor,Ki,=,46.7,nM,CHEMBL3387736,B,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,CCCCCc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2
CHEMBL3344461,CHEMBL217,Dopamine D2 receptor,Ki,=,79.54,nM,CHEMBL3387736,B,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sc(CCC(C)C)cc3CN1CC2
CHEMBL3344462,CHEMBL217,Dopamine D2 receptor,Ki,=,29.1,nM,CHEMBL3387736,B,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,CCC(C)Cc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2
CHEMBL3344463,CHEMBL217,Dopamine D2 receptor,Ki,=,189.99,nM,CHEMBL3387736,B,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sc(CC(C)(C)C)cc3CN1CC2
CHEMBL3344465,CHEMBL217,Dopamine D2 receptor,Ki,=,34.23,nM,CHEMBL3387736,B,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sc(CC4CCC4)cc3CN1CC2
CHEMBL3344466,CHEMBL217,Dopamine D2 receptor,Ki,=,11.51,nM,CHEMBL3387736,B,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sc(CC4CC4)cc3CN1CC2
CHEMBL3344467,CHEMBL217,Dopamine D2 receptor,Ki,=,34.36,nM,CHEMBL3387736,B,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sc(CCCl)cc3CN1CC2
CHEMBL3344468,CHEMBL217,Dopamine D2 receptor,Ki,=,18.38,nM,CHEMBL3387736,B,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sc(CCCCl)cc3CN1CC2
CHEMBL3344469,CHEMBL217,Dopamine D2 receptor,Ki,=,16.49,nM,CHEMBL3387736,B,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sc(CC(C)Cl)cc3CN1CC2
CHEMBL3344470,CHEMBL217,Dopamine D2 receptor,Ki,=,12.02,nM,CHEMBL3387736,B,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sc(CCCCCl)cc3CN1CC2
CHEMBL487387,CHEMBL217,Dopamine D2 receptor,Ki,=,105.41,nM,CHEMBL3387736,B,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL3358513,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL3381713,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3351528,KI,O=C(NCCCCN1CCN(c2cnc3ccccc3c2)CC1)c1ccccc1
CHEMBL3358512,CHEMBL217,Dopamine D2 receptor,Ki,=,58.0,nM,CHEMBL3381713,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3351528,KI,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1ccccc1
CHEMBL3358506,CHEMBL217,Dopamine D2 receptor,Ki,=,3412.0,nM,CHEMBL3381713,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3351528,KI,Cc1cccc(N2CCN(CCCCNC(=O)[C@H]3CCc4ccccc4N3)CC2)c1
CHEMBL3358498,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL3381713,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3351528,KI,O=C(NCCCCN1CCN(c2cccc(F)c2)CC1)c1cc2ccccc2cn1
CHEMBL3358098,CHEMBL217,Dopamine D2 receptor,Ki,=,5596.0,nM,CHEMBL3381713,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3351528,KI,O=C(NCCCCN1CCN(c2ccccn2)CC1)c1cc2ccccc2cn1
CHEMBL3358100,CHEMBL217,Dopamine D2 receptor,Ki,=,286.0,nM,CHEMBL3381713,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3351528,KI,Cc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4cn3)CC2)c1
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,3.8,nM,CHEMBL3381713,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3351528,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.8,nM,CHEMBL3381713,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3351528,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL3381713,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3351528,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL3381713,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3351528,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL496739,CHEMBL217,Dopamine D2 receptor,Ki,=,263.0,nM,CHEMBL3381713,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3351528,KI,Cc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1
CHEMBL3358102,CHEMBL217,Dopamine D2 receptor,Ki,=,219.0,nM,CHEMBL3381713,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3351528,KI,COc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4n3C)CC2)c1
CHEMBL3358104,CHEMBL217,Dopamine D2 receptor,Ki,=,53.0,nM,CHEMBL3381713,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3351528,KI,O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc2ccccc2[nH]1
CHEMBL3358105,CHEMBL217,Dopamine D2 receptor,Ki,=,76.0,nM,CHEMBL3381713,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3351528,KI,O=C(NCCCCN1CCN(c2ccccc2F)CC1)c1cc2ccccc2o1
CHEMBL3358493,CHEMBL217,Dopamine D2 receptor,Ki,=,85.0,nM,CHEMBL3381713,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3351528,KI,Cc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1C
CHEMBL3335470,CHEMBL217,Dopamine D2 receptor,Ki,=,30.0,nM,CHEMBL3387258,B,Displacement of [3H]-raclopride from human D2long receptor expressed in HEK293Galpha15 cells after 120 mins by scintillation counting analysis,CHEMBL3352435,KI,N#Cc1cc(N2CCN(CC[C@H]3CC[C@H](NC(N)=O)CC3)CC2)cc(C(F)(F)F)c1
CHEMBL3335471,CHEMBL217,Dopamine D2 receptor,Ki,=,5.4,nM,CHEMBL3387258,B,Displacement of [3H]-raclopride from human D2long receptor expressed in HEK293Galpha15 cells after 120 mins by scintillation counting analysis,CHEMBL3352435,KI,N#Cc1cc(N2CCN(CC[C@H]3CC[C@H](NC(=O)CN)CC3)CC2)cc(C(F)(F)F)c1
CHEMBL3335472,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL3387258,B,Displacement of [3H]-raclopride from human D2long receptor expressed in HEK293Galpha15 cells after 120 mins by scintillation counting analysis,CHEMBL3352435,KI,N#Cc1cc(N2CCN(CC[C@H]3CC[C@H](NS(N)(=O)=O)CC3)CC2)cc(C(F)(F)F)c1
CHEMBL3335538,CHEMBL217,Dopamine D2 receptor,Ki,=,5500.0,nM,CHEMBL3383656,B,Inhibition of human dopamine D2L receptor,CHEMBL3352711,KI,FC(F)(F)Oc1ccc(CN2CCOC(CCc3ccccc3)C2)cc1
CHEMBL3335554,CHEMBL217,Dopamine D2 receptor,Ki,=,5500.0,nM,CHEMBL3383656,B,Inhibition of human dopamine D2L receptor,CHEMBL3352711,KI,FC(F)(F)Oc1ccc(CN2CCO[C@H](CCc3ccccc3)C2)cc1
CHEMBL3409257,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,NC(=O)c1ccccc1OCCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1
CHEMBL3409256,CHEMBL217,Dopamine D2 receptor,Ki,=,6.3,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1
CHEMBL3409255,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCOc4ccc5ccoc5c4)CC3)cccc21
CHEMBL3409254,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=C1CCc2ccc(OCCCN3CCN(c4cccc5c4ccn5S(=O)(=O)c4ccccc4)CC3)cc2N1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL3409253,CHEMBL217,Dopamine D2 receptor,Ki,=,76.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3Cc2cccc(Cl)c2)CC1
CHEMBL3409252,CHEMBL217,Dopamine D2 receptor,Ki,=,44.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3Cc2ccc(F)cc2)CC1
CHEMBL3409251,CHEMBL217,Dopamine D2 receptor,Ki,=,45.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3Cc2cccc(F)c2)CC1
CHEMBL3409250,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3Cc2ccccc2F)CC1
CHEMBL3409249,CHEMBL217,Dopamine D2 receptor,Ki,=,95.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3Cc2ccccc2)CC1
CHEMBL3409248,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,NC(=O)c1ccccc1OCCCNCCc1cn(S(=O)(=O)c2ccccc2)c2ccccc12
CHEMBL3409247,CHEMBL217,Dopamine D2 receptor,Ki,=,270.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,NC(=O)c1ccccc1OCCCNCCc1cn(Cc2ccccc2)c2ccccc12
CHEMBL3409246,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,NC(=O)c1ccccc1OCCCN1CCC(c2cn(S(=O)(=O)c3ccccc3)c3ccccc23)CC1
CHEMBL3409245,CHEMBL217,Dopamine D2 receptor,Ki,=,29.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,NC(=O)c1ccccc1OCCCN1CCC(c2cn(Cc3ccccc3)c3ccccc23)CC1
CHEMBL3409244,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,NC(=O)c1ccccc1OCCCN1CC=C(c2cn(S(=O)(=O)c3ccccc3)c3ccccc23)CC1
CHEMBL3409243,CHEMBL217,Dopamine D2 receptor,Ki,=,31.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,NC(=O)c1ccccc1OCCCN1CC=C(c2cn(Cc3ccccc3)c3ccccc23)CC1
CHEMBL3409242,CHEMBL217,Dopamine D2 receptor,Ki,=,1.3,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5Cc4cccc(Cl)c4)CC3)cc2N1
CHEMBL3409241,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5Cc4ccc(F)cc4)CC3)cc2N1
CHEMBL3409240,CHEMBL217,Dopamine D2 receptor,Ki,=,6.1,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5Cc4cccc(F)c4)CC3)cc2N1
CHEMBL3409239,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5Cc4ccccc4F)CC3)cc2N1
CHEMBL3409238,CHEMBL217,Dopamine D2 receptor,Ki,=,1.3,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5S(=O)(=O)c4ccccc4)CC3)cc2N1
CHEMBL3409237,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5Cc4ccccc4)CC3)cc2N1
CHEMBL3409236,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=C1CCc2ccc(OCCCCNCCc3cn(S(=O)(=O)c4ccccc4)c4ccccc34)cc2N1
CHEMBL3409235,CHEMBL217,Dopamine D2 receptor,Ki,=,70.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=C1CCc2ccc(OCCCCNCCc3cn(Cc4ccccc4)c4ccccc34)cc2N1
CHEMBL3407518,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=C1CCc2ccc(OCCCCN3CCC(c4cn(S(=O)(=O)c5ccccc5)c5ccccc45)CC3)cc2N1
CHEMBL3409234,CHEMBL217,Dopamine D2 receptor,Ki,=,4.8,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=C1CCc2ccc(OCCCCN3CCC(c4cn(Cc5ccccc5)c5ccccc45)CC3)cc2N1
CHEMBL3409233,CHEMBL217,Dopamine D2 receptor,Ki,=,40.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=C1CCc2ccc(OCCCCN3CC=C(c4cn(S(=O)(=O)c5ccccc5)c5ccccc45)CC3)cc2N1
CHEMBL3409232,CHEMBL217,Dopamine D2 receptor,Ki,=,73.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=C1CCc2ccc(OCCCCN3CC=C(c4cn(Cc5ccccc5)c5ccccc45)CC3)cc2N1
CHEMBL8514,CHEMBL217,Dopamine D2 receptor,Ki,=,0.04,nM,CHEMBL3413553,B,Displacement of [3H]methylspiperone from human D2S receptor expressed in HEK293 cells,CHEMBL3407464,KI,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1
CHEMBL3409256,CHEMBL217,Dopamine D2 receptor,Ki,=,6.3,nM,CHEMBL3413553,B,Displacement of [3H]methylspiperone from human D2S receptor expressed in HEK293 cells,CHEMBL3407464,KI,NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1
CHEMBL3409263,CHEMBL217,Dopamine D2 receptor,Ki,=,47.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCOc4ccc(F)cc4)CC3)cccc21
CHEMBL3409262,CHEMBL217,Dopamine D2 receptor,Ki,=,67.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCOc4ccc(F)cc4)CC3)cccc21
CHEMBL3409261,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCOc4ccccc4)CC3)cccc21
CHEMBL3409260,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCOc4ccccc4)CC3)cccc21
CHEMBL3409259,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,CC(C)Oc1ccccc1OCCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1
CHEMBL3409258,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL3413541,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,CHEMBL3407464,KI,CC(C)Oc1ccccc1OCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1
CHEMBL3423328,CHEMBL217,Dopamine D2 receptor,Ki,=,700.0,nM,CHEMBL3423552,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,CHEMBL3421538,KI,Cn1c(=O)c2c(nc3n(CCCCN4CCN(c5ccccc5O)CC4)ccn23)n(C)c1=O
CHEMBL3423329,CHEMBL217,Dopamine D2 receptor,Ki,=,265.0,nM,CHEMBL3423552,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,CHEMBL3421538,KI,Cn1c(=O)c2c(nc3n(CCCCCN4CCN(c5ccccc5O)CC4)ccn23)n(C)c1=O
CHEMBL3423330,CHEMBL217,Dopamine D2 receptor,Ki,=,430.0,nM,CHEMBL3423552,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,CHEMBL3421538,KI,Cc1cn2c3c(=O)n(C)c(=O)n(C)c3nc2n1CCCCN1CCN(c2ccccc2O)CC1
CHEMBL3423331,CHEMBL217,Dopamine D2 receptor,Ki,=,468.0,nM,CHEMBL3423552,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,CHEMBL3421538,KI,Cc1cn2c3c(=O)n(C)c(=O)n(C)c3nc2n1CCCCCN1CCN(c2ccccc2O)CC1
CHEMBL3423332,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL3423552,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,CHEMBL3421538,KI,Cn1c(=O)c2c(nc3n(CCCCN4CCN(c5ccccc5O)CC4)c(-c4ccccc4)cn23)n(C)c1=O
CHEMBL3423333,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL3423552,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,CHEMBL3421538,KI,Cn1c(=O)c2c(nc3n(CCCCCN4CCN(c5ccccc5O)CC4)c(-c4ccccc4)cn23)n(C)c1=O
CHEMBL3423334,CHEMBL217,Dopamine D2 receptor,Ki,=,259.0,nM,CHEMBL3423552,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,CHEMBL3421538,KI,Cn1c(=O)c2c(nc3n(CCCCCN4CCN(c5ccc(Cl)cc5)CC4)ccn23)n(C)c1=O
CHEMBL3423335,CHEMBL217,Dopamine D2 receptor,Ki,=,123.0,nM,CHEMBL3423552,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,CHEMBL3421538,KI,Cc1cn2c3c(=O)n(C)c(=O)n(C)c3nc2n1CCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL3423336,CHEMBL217,Dopamine D2 receptor,Ki,=,106.0,nM,CHEMBL3423552,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,CHEMBL3421538,KI,Cc1cn2c3c(=O)n(C)c(=O)n(C)c3nc2n1CCCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL3423337,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL3423552,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,CHEMBL3421538,KI,Cn1c(=O)c2c(nc3n(CCCCN4CCN(c5ccc(Cl)cc5)CC4)c(-c4ccccc4)cn23)n(C)c1=O
CHEMBL3423338,CHEMBL217,Dopamine D2 receptor,Ki,=,9.0,nM,CHEMBL3423552,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,CHEMBL3421538,KI,Cn1c(=O)c2c(nc3n(CCCCCN4CCN(c5ccc(Cl)cc5)CC4)c(-c4ccccc4)cn23)n(C)c1=O
CHEMBL3423339,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL3423552,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,CHEMBL3421538,KI,Cc1cccc(N2CCN(CCCCn3c(C)cn4c5c(=O)n(C)c(=O)n(C)c5nc34)CC2)c1C
CHEMBL3423340,CHEMBL217,Dopamine D2 receptor,Ki,=,59.0,nM,CHEMBL3423552,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,CHEMBL3421538,KI,Cc1cn2c3c(=O)n(C)c(=O)n(C)c3nc2n1CCCCCN1CCN(c2ccc(Cl)c(Cl)c2)CC1
CHEMBL3423377,CHEMBL217,Dopamine D2 receptor,Ki,=,340.0,nM,CHEMBL3423552,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,CHEMBL3421538,KI,Cn1c(=O)c2c(nc3n(CCCCCN4CCN(c5ccccc5O)CC4)c(=O)ccn23)n(C)c1=O
CHEMBL3423378,CHEMBL217,Dopamine D2 receptor,Ki,=,68.0,nM,CHEMBL3423552,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,CHEMBL3421538,KI,Cn1c(=O)c2c(nc3n(CCCCN4CCN(c5ccc(Cl)cc5)CC4)c(=O)ccn23)n(C)c1=O
CHEMBL3423379,CHEMBL217,Dopamine D2 receptor,Ki,=,215.0,nM,CHEMBL3423552,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,CHEMBL3421538,KI,Cn1c(=O)c2c(nc3n(CCCCCN4CCN(c5ccc(Cl)cc5)CC4)c(=O)ccn23)n(C)c1=O
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL3578854,B,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL2397389,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL3578854,B,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL2396663,CHEMBL217,Dopamine D2 receptor,Ki,=,9.4,nM,CHEMBL3578854,B,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL3577342,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL3578854,B,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1
CHEMBL3577343,CHEMBL217,Dopamine D2 receptor,Ki,=,4.9,nM,CHEMBL3578854,B,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1
CHEMBL3577344,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL3578854,B,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)CCc3ccc(O)c4[nH]c(=O)ccc34)cc2OC)nn1
CHEMBL3577345,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL3578854,B,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@@H]3CCc4c(O)cccc4C3)cc2OC)nn1
CHEMBL3577346,CHEMBL217,Dopamine D2 receptor,Ki,=,0.47,nM,CHEMBL3578854,B,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)cc2OC)nn1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,70.0,nM,CHEMBL3578855,B,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL2397389,CHEMBL217,Dopamine D2 receptor,Ki,=,8.8,nM,CHEMBL3578855,B,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL2396663,CHEMBL217,Dopamine D2 receptor,Ki,=,3.9,nM,CHEMBL3578855,B,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL3577342,CHEMBL217,Dopamine D2 receptor,Ki,=,2.9,nM,CHEMBL3578855,B,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1
CHEMBL3577343,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL3578855,B,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1
CHEMBL3577344,CHEMBL217,Dopamine D2 receptor,Ki,=,53.0,nM,CHEMBL3578855,B,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)CCc3ccc(O)c4[nH]c(=O)ccc34)cc2OC)nn1
CHEMBL3577345,CHEMBL217,Dopamine D2 receptor,Ki,=,30.0,nM,CHEMBL3578855,B,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@@H]3CCc4c(O)cccc4C3)cc2OC)nn1
CHEMBL3577346,CHEMBL217,Dopamine D2 receptor,Ki,=,0.54,nM,CHEMBL3578855,B,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)cc2OC)nn1
CHEMBL589,CHEMBL217,Dopamine D2 receptor,Ki,=,3.7,nM,CHEMBL3587541,B,Binding affinity to human dopamine D2 receptor,CHEMBL3585327,KI,CCCN(CCC)CCc1cccc2c1CC(=O)N2
CHEMBL3590077,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL3592693,B,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,CHEMBL3588764,KI,COc1ccccc1N1CCN(CCCCNC(=O)/N=N/c2ccc(F)cc2)CC1
CHEMBL3590078,CHEMBL217,Dopamine D2 receptor,Ki,=,7.5,nM,CHEMBL3592693,B,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,CHEMBL3588764,KI,COc1ccccc1N1CCN(CCCCNC(=O)/N=N/c2ccc(F)c(F)c2)CC1
CHEMBL3590079,CHEMBL217,Dopamine D2 receptor,Ki,=,6.6,nM,CHEMBL3592693,B,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,CHEMBL3588764,KI,COc1ccccc1N1CCN(CCCCNC(=O)/N=N/c2cc(F)c(F)c(F)c2)CC1
CHEMBL3590080,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL3592693,B,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,CHEMBL3588764,KI,CCCN(CCCCNC(=O)/C=C/c1ccc(F)cc1)C1Cc2ccccc2C1
CHEMBL3590081,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL3592693,B,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,CHEMBL3588764,KI,CCCN(CCCCNC(=O)/N=N/c1ccc(F)cc1)C1Cc2ccccc2C1
CHEMBL3590082,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL3592693,B,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,CHEMBL3588764,KI,CCCN(CCCCNC(=O)/N=N/c1ccc(F)c(F)c1)C1Cc2ccccc2C1
CHEMBL3590083,CHEMBL217,Dopamine D2 receptor,Ki,=,40.0,nM,CHEMBL3592693,B,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,CHEMBL3588764,KI,CCCN(CCCCNC(=O)/N=N/c1cc(F)c(F)c(F)c1)C1Cc2ccccc2C1
CHEMBL3590084,CHEMBL217,Dopamine D2 receptor,Ki,=,43.0,nM,CHEMBL3592693,B,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,CHEMBL3588764,KI,CCCN(CCNC(=O)/C=C/c1ccc(F)cc1)C1Cc2ccccc2C1
CHEMBL3589575,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL3592693,B,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,CHEMBL3588764,KI,CCCN(CCNC(=O)/N=N/c1ccc(F)cc1)C1Cc2ccccc2C1
CHEMBL3589576,CHEMBL217,Dopamine D2 receptor,Ki,=,3.9,nM,CHEMBL3592693,B,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,CHEMBL3588764,KI,CCCN(CCNC(=O)/N=N/c1ccc(F)c(F)c1)C1Cc2ccccc2C1
CHEMBL3589577,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL3592693,B,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,CHEMBL3588764,KI,CCCN(CCNC(=O)/N=N/c1cc(F)c(F)c(F)c1)C1Cc2ccccc2C1
CHEMBL3590077,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL3592694,B,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,CHEMBL3588764,KI,COc1ccccc1N1CCN(CCCCNC(=O)/N=N/c2ccc(F)cc2)CC1
CHEMBL3590078,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL3592694,B,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,CHEMBL3588764,KI,COc1ccccc1N1CCN(CCCCNC(=O)/N=N/c2ccc(F)c(F)c2)CC1
CHEMBL3590079,CHEMBL217,Dopamine D2 receptor,Ki,=,9.5,nM,CHEMBL3592694,B,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,CHEMBL3588764,KI,COc1ccccc1N1CCN(CCCCNC(=O)/N=N/c2cc(F)c(F)c(F)c2)CC1
CHEMBL3590080,CHEMBL217,Dopamine D2 receptor,Ki,=,2.9,nM,CHEMBL3592694,B,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,CHEMBL3588764,KI,CCCN(CCCCNC(=O)/C=C/c1ccc(F)cc1)C1Cc2ccccc2C1
CHEMBL3590081,CHEMBL217,Dopamine D2 receptor,Ki,=,36.0,nM,CHEMBL3592694,B,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,CHEMBL3588764,KI,CCCN(CCCCNC(=O)/N=N/c1ccc(F)cc1)C1Cc2ccccc2C1
CHEMBL3590082,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL3592694,B,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,CHEMBL3588764,KI,CCCN(CCCCNC(=O)/N=N/c1ccc(F)c(F)c1)C1Cc2ccccc2C1
CHEMBL3590083,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL3592694,B,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,CHEMBL3588764,KI,CCCN(CCCCNC(=O)/N=N/c1cc(F)c(F)c(F)c1)C1Cc2ccccc2C1
CHEMBL3590084,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL3592694,B,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,CHEMBL3588764,KI,CCCN(CCNC(=O)/C=C/c1ccc(F)cc1)C1Cc2ccccc2C1
CHEMBL3589575,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL3592694,B,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,CHEMBL3588764,KI,CCCN(CCNC(=O)/N=N/c1ccc(F)cc1)C1Cc2ccccc2C1
CHEMBL3589576,CHEMBL217,Dopamine D2 receptor,Ki,=,8.5,nM,CHEMBL3592694,B,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,CHEMBL3588764,KI,CCCN(CCNC(=O)/N=N/c1ccc(F)c(F)c1)C1Cc2ccccc2C1
CHEMBL3589577,CHEMBL217,Dopamine D2 receptor,Ki,=,73.0,nM,CHEMBL3592694,B,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,CHEMBL3588764,KI,CCCN(CCNC(=O)/N=N/c1cc(F)c(F)c(F)c1)C1Cc2ccccc2C1
CHEMBL3588913,CHEMBL217,Dopamine D2 receptor,Ki,=,31.5,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1N1CCN(CCCCc2cn(-c3ccc4ccccc4c3)nn2)CC1
CHEMBL3588914,CHEMBL217,Dopamine D2 receptor,Ki,=,57.2,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1N1CCN(CCCCc2cn(-c3ccc4c(c3)Cc3ccccc3-4)nn2)CC1
CHEMBL3588915,CHEMBL217,Dopamine D2 receptor,Ki,=,51.8,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1N1CCN(CCCCc2cn(-c3ccc4[nH]ccc4c3)nn2)CC1
CHEMBL3588916,CHEMBL217,Dopamine D2 receptor,Ki,=,83.4,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1N1CCN(CCCCc2cn(-c3ccc4cnccc4c3)nn2)CC1
CHEMBL3353895,CHEMBL217,Dopamine D2 receptor,Ki,=,53.6,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1N1CCN(CCCCc2cn(-c3ccccc3)nn2)CC1
CHEMBL3588917,CHEMBL217,Dopamine D2 receptor,Ki,=,80.8,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,Clc1cccc(N2CCN(CCCCc3cn(-c4ccc5ccccc5c4)nn3)CC2)c1Cl
CHEMBL3588918,CHEMBL217,Dopamine D2 receptor,Ki,=,424.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,Clc1cccc(N2CCN(CCCCc3cn(-c4ccc5c(c4)Cc4ccccc4-5)nn3)CC2)c1Cl
CHEMBL3588919,CHEMBL217,Dopamine D2 receptor,Ki,=,46.6,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,Clc1cccc(N2CCN(CCCCc3cn(-c4ccc5[nH]ccc5c4)nn3)CC2)c1Cl
CHEMBL3588920,CHEMBL217,Dopamine D2 receptor,Ki,=,23.3,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1N1CCN(CCCCn2cc(-c3ccc4ccccc4c3)nn2)CC1
CHEMBL3588921,CHEMBL217,Dopamine D2 receptor,Ki,=,50.1,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1N1CCN(CCCCn2cc(-c3ccc4c(c3)Cc3ccccc3-4)nn2)CC1
CHEMBL3588981,CHEMBL217,Dopamine D2 receptor,Ki,=,43.7,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1N1CCN(CCCCn2cc(-c3ccc4[nH]ccc4c3)nn2)CC1
CHEMBL3588982,CHEMBL217,Dopamine D2 receptor,Ki,=,42.5,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1N1CCN(CCCCn2cc(-c3ccc4ncccc4c3)nn2)CC1
CHEMBL3588983,CHEMBL217,Dopamine D2 receptor,Ki,=,69.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1N1CCN(CCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)CC1
CHEMBL2430443,CHEMBL217,Dopamine D2 receptor,Ki,=,137.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1N1CCN(CCCCn2cc(-c3ccccc3)nn2)CC1
CHEMBL3588984,CHEMBL217,Dopamine D2 receptor,Ki,=,103.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,Clc1cccc(N2CCN(CCCCn3cc(-c4ccc5ccccc5c4)nn3)CC2)c1Cl
CHEMBL3588985,CHEMBL217,Dopamine D2 receptor,Ki,=,885.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,Clc1cccc(N2CCN(CCCCn3cc(-c4ccc5c(c4)Cc4ccccc4-5)nn3)CC2)c1Cl
CHEMBL3588986,CHEMBL217,Dopamine D2 receptor,Ki,=,56.1,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,Clc1cccc(N2CCN(CCCCn3cc(-c4ccc5[nH]ccc5c4)nn3)CC2)c1Cl
CHEMBL3588987,CHEMBL217,Dopamine D2 receptor,Ki,=,53.9,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,Clc1cccc(N2CCN(CCCCn3cc(-c4ccc5ncccc5c4)nn3)CC2)c1Cl
CHEMBL3588988,CHEMBL217,Dopamine D2 receptor,Ki,=,2590.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,Clc1cccc(N2CCN(CCCCn3cc(-c4ccc(-c5ccccc5)cc4)nn3)CC2)c1Cl
CHEMBL3588989,CHEMBL217,Dopamine D2 receptor,Ki,=,189.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1N1CCN(CC(O)CCn2cc(-c3ccc4ccccc4c3)nn2)CC1
CHEMBL3588990,CHEMBL217,Dopamine D2 receptor,Ki,=,819.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1N1CCN(CC(O)CCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)CC1
CHEMBL3588991,CHEMBL217,Dopamine D2 receptor,Ki,=,1210.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1N1CCN(CC(O)CCn2cc(-c3ccccc3)nn2)CC1
CHEMBL3588992,CHEMBL217,Dopamine D2 receptor,Ki,=,1020.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1-c1cn(CCC(O)CN2CCN(c3ccccc3OC)CC2)nn1
CHEMBL3588993,CHEMBL217,Dopamine D2 receptor,Ki,=,607.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1N1CCN(CC(O)CCn2cc(-c3ccc4c(c3)Cc3ccccc3-4)nn2)CC1
CHEMBL3588994,CHEMBL217,Dopamine D2 receptor,Ki,=,424.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1N1CCN(CC(O)CCn2cc(-c3ccc4ncccc4c3)nn2)CC1
CHEMBL3588995,CHEMBL217,Dopamine D2 receptor,Ki,=,18800.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,OC(CCn1cc(-c2ccc3ccccc3c2)nn1)CN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL3588996,CHEMBL217,Dopamine D2 receptor,Ki,=,15100.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,OC(CCn1cc(-c2ccc(-c3ccccc3)cc2)nn1)CN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL3588997,CHEMBL217,Dopamine D2 receptor,Ki,=,789.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,COc1ccccc1N1CCN(CC(O)CCn2cc(-c3ccc4[nH]ccc4c3)nn2)CC1
CHEMBL3588998,CHEMBL217,Dopamine D2 receptor,Ki,=,963.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,OC(CCn1cc(-c2ccc3[nH]ccc3c2)nn1)CN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL3589650,CHEMBL217,Dopamine D2 receptor,Ki,=,244.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,OC(CCn1cc(-c2ccc3ncccc3c2)nn1)CN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL1627305,CHEMBL217,Dopamine D2 receptor,Ki,=,746.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL3589651,CHEMBL217,Dopamine D2 receptor,Ki,=,321.0,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2c1
CHEMBL3589652,CHEMBL217,Dopamine D2 receptor,Ki,=,54.7,nM,CHEMBL3591124,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL3588746,KI,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)-c1ccccc1C2
CHEMBL1627314,CHEMBL217,Dopamine D2 receptor,Ki,=,217.0,nM,CHEMBL3591366,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL3588810,KI,COc1ccc2[nH]c(C(=O)NCCC(O)CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2c1
CHEMBL300780,CHEMBL217,Dopamine D2 receptor,Ki,=,54.7,nM,CHEMBL3591366,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL3588810,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2
CHEMBL3590086,CHEMBL217,Dopamine D2 receptor,Ki,=,46.9,nM,CHEMBL3591366,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL3588810,KI,Cc1ccc(Cl)c(N2CCN(CCCCNC(=O)c3ccc4oc(=O)[nH]c4c3)CC2)c1
CHEMBL180010,CHEMBL217,Dopamine D2 receptor,Ki,=,74.0,nM,CHEMBL3591366,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL3588810,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1
CHEMBL3590085,CHEMBL217,Dopamine D2 receptor,Ki,=,2110.0,nM,CHEMBL3591366,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL3588810,KI,Cc1ncoc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3F)C2)n1C
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.343,nM,CHEMBL3591366,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,CHEMBL3588810,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL3590086,CHEMBL217,Dopamine D2 receptor,Ki,=,335.0,nM,CHEMBL3591527,B,Binding affinity to human dopamine D2 receptor,CHEMBL3588810,KI,Cc1ccc(Cl)c(N2CCN(CCCCNC(=O)c3ccc4oc(=O)[nH]c4c3)CC2)c1
CHEMBL1627306,CHEMBL217,Dopamine D2 receptor,Ki,=,295.0,nM,CHEMBL3599871,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3596172,KI,O=C(NCC[C@@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL1627305,CHEMBL217,Dopamine D2 receptor,Ki,=,746.0,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL3597641,CHEMBL217,Dopamine D2 receptor,Ki,=,53.0,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,COc1c(Cl)cccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1
CHEMBL3597642,CHEMBL217,Dopamine D2 receptor,Ki,=,72.3,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,COc1c(Cl)cccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1
CHEMBL3597643,CHEMBL217,Dopamine D2 receptor,Ki,=,12.9,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cc2ccccc2[nH]1
CHEMBL3597644,CHEMBL217,Dopamine D2 receptor,Ki,=,13.8,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,COc1ccc2[nH]c(C(=O)NCCCCN3CCN(c4cccc5ccccc45)CC3)cc2c1
CHEMBL3596212,CHEMBL217,Dopamine D2 receptor,Ki,=,14.8,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cc2ccccc2o1
CHEMBL3597645,CHEMBL217,Dopamine D2 receptor,Ki,=,8.37,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cc2ccccc2s1
CHEMBL68740,CHEMBL217,Dopamine D2 receptor,Ki,=,36.8,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(F)ccc2[nH]1
CHEMBL1627310,CHEMBL217,Dopamine D2 receptor,Ki,=,328.0,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(F)ccc2[nH]1
CHEMBL127317,CHEMBL217,Dopamine D2 receptor,Ki,=,66.8,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3n2)CC1
CHEMBL3597646,CHEMBL217,Dopamine D2 receptor,Ki,=,929.0,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,COc1ccccc1N1CCN(CC(O)CCNC(=O)c2ccc3ccccc3n2)CC1
CHEMBL3597647,CHEMBL217,Dopamine D2 receptor,Ki,=,68.2,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3cc(F)ccc3n2)CC1
CHEMBL3597648,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,COc1ccccc1N1CCN(CC(O)CCNC(=O)c2ccc3cc(F)ccc3n2)CC1
CHEMBL3597649,CHEMBL217,Dopamine D2 receptor,Ki,=,915.0,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,COc1ccccc1N1CCN(CC(O)CCNC(=O)c2cnc3ccccc3c2)CC1
CHEMBL3597650,CHEMBL217,Dopamine D2 receptor,Ki,=,34.1,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cnc3ccc(F)cc3c2)CC1
CHEMBL3597651,CHEMBL217,Dopamine D2 receptor,Ki,=,682.0,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,COc1ccccc1N1CCN(CC(O)CCNC(=O)c2cnc3ccc(F)cc3c2)CC1
CHEMBL3597652,CHEMBL217,Dopamine D2 receptor,Ki,=,707.0,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,COc1ccccc1N1CCN(CC(O)CCNC(=O)c2cnc3ccc(C)cc3c2)CC1
CHEMBL3597653,CHEMBL217,Dopamine D2 receptor,Ki,=,774.0,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,COc1ccc2ncc(C(=O)NCCC(O)CN3CCN(c4ccccc4OC)CC3)cc2c1
CHEMBL3597654,CHEMBL217,Dopamine D2 receptor,Ki,=,1030.0,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,COc1ccccc1N1CCN(CC(O)CCNC(=O)c2ccc3cccnc3c2)CC1
CHEMBL3597635,CHEMBL217,Dopamine D2 receptor,Ki,=,15.8,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cnc2ccccc2c1
CHEMBL3597636,CHEMBL217,Dopamine D2 receptor,Ki,=,258.0,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,O=C(NCCC(O)CN1CCN(c2cccc3ccccc23)CC1)c1cnc2ccccc2c1
CHEMBL3597637,CHEMBL217,Dopamine D2 receptor,Ki,=,43.1,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,COc1c(Cl)cccc1N1CCN(CCCCNC(=O)c2cnc3ccccc3c2)CC1
CHEMBL3597638,CHEMBL217,Dopamine D2 receptor,Ki,=,885.0,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,COc1c(Cl)cccc1N1CCN(CC(O)CCNC(=O)c2cnc3ccccc3c2)CC1
CHEMBL3597639,CHEMBL217,Dopamine D2 receptor,Ki,=,39.2,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccc(F)cc2c1
CHEMBL3597640,CHEMBL217,Dopamine D2 receptor,Ki,=,827.0,nM,CHEMBL3599873,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,CHEMBL3596172,KI,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccc(F)cc2c1
CHEMBL3605327,CHEMBL217,Dopamine D2 receptor,Ki,=,5586.0,nM,CHEMBL3608115,B,Displacement of [3H]-sulpiride from human dopamine D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting,CHEMBL3603825,KI,Cl.O=C(CCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)Nc1nc2ccccc2s1
CHEMBL3605331,CHEMBL217,Dopamine D2 receptor,Ki,=,175.0,nM,CHEMBL3608115,B,Displacement of [3H]-sulpiride from human dopamine D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting,CHEMBL3603825,KI,O=C(CCCCN1CCN(c2ccccc2F)CC1)Nc1nc2ccccc2s1
CHEMBL3605344,CHEMBL217,Dopamine D2 receptor,Ki,=,197.0,nM,CHEMBL3608115,B,Displacement of [3H]-sulpiride from human dopamine D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting,CHEMBL3603825,KI,COc1ccc2nc(NC(=O)CCCCN3CCN(c4ccc(Cl)cc4)CC3)sc2c1
CHEMBL267930,CHEMBL217,Dopamine D2 receptor,Ki,=,1.08,nM,CHEMBL3610650,B,Displacement of [3H]-spiperone from dopamine D2 receptor (unknown origin) expressed in HEK293 cell membranes incubated for 15 mins by liquid scintillation spectrometry,CHEMBL3608303,KI,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
CHEMBL221843,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2nnn(Cc3ccccc3)c2C)CC1
CHEMBL373873,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,Cc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nnn1Cc1ccccc1
CHEMBL344677,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccc3ccnn23)CC1
CHEMBL342060,CHEMBL217,Dopamine D2 receptor,Ki,=,58.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccn3nccc3c2)CC1
CHEMBL143352,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccn3nccc23)CC1
CHEMBL139600,CHEMBL217,Dopamine D2 receptor,Ki,=,7.1,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL140968,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL357684,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL221587,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2nnn(Cc3ccccc3)c2C)CC1
CHEMBL218607,CHEMBL217,Dopamine D2 receptor,Ki,=,6.4,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,CCCc1c(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)nnn1Cc1ccccc1
CHEMBL437525,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccc(Cn2nnc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2C)cc1
CHEMBL220754,CHEMBL217,Dopamine D2 receptor,Ki,=,2.7,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccc(Cn2nnc(C(=O)NCCCCCN3CCN(c4ccccc4OC)CC3)c2C)cc1
CHEMBL218351,CHEMBL217,Dopamine D2 receptor,Ki,=,7.1,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,CCCc1c(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)nnn1Cc1ccc(OC)cc1
CHEMBL385289,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2nnn(Cc3ccccc3Br)c2C)CC1
CHEMBL217981,CHEMBL217,Dopamine D2 receptor,Ki,=,0.58,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2nnn(Cc3ccccc3Br)c2C)CC1
CHEMBL386986,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,CCCc1c(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)nnn1Cc1ccccc1Br
CHEMBL221129,CHEMBL217,Dopamine D2 receptor,Ki,=,0.91,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,CCCc1c(C(=O)NCCCCCN2CCN(c3ccccc3OC)CC2)nnn1Cc1ccccc1Br
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.48,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL424294,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL59725,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL124444,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1
CHEMBL139926,CHEMBL217,Dopamine D2 receptor,Ki,=,82.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL346692,CHEMBL217,Dopamine D2 receptor,Ki,=,760.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL3613873,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCCc2cn(-c3ccn4nccc4c3)nn2)CC1
CHEMBL3613874,CHEMBL217,Dopamine D2 receptor,Ki,=,6.7,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,O=Cc1cnn2ccc(-n3cc(CCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12
CHEMBL3613875,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,O=Cc1cnn2ccc(-n3cc(CCCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12
CHEMBL142020,CHEMBL217,Dopamine D2 receptor,Ki,=,99.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL141845,CHEMBL217,Dopamine D2 receptor,Ki,=,85.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCNC(=O)c2cnn3ccccc23)CC1
CHEMBL425285,CHEMBL217,Dopamine D2 receptor,Ki,=,6.4,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,CCCc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nnn1Cc1ccccc1
CHEMBL221866,CHEMBL217,Dopamine D2 receptor,Ki,=,1.5,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccc(Cn2nnc(C(=O)NCCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)c2C)cc1
CHEMBL3613876,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,O=Cc1cnn2ccc(-n3cc(CCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12
CHEMBL3613877,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCc2cn(-c3ccn4ncc(C=O)c4c3)nn2)CC1
CHEMBL3613878,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,Clc1cccc(N2CCN(CCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl
CHEMBL3613879,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,Clc1cccc(N2CCN(CCCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl
CHEMBL3613880,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL3614290,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,Clc1cccc(N2CCN(CCCCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl
CHEMBL3613873,CHEMBL217,Dopamine D2 receptor,Ki,=,81.0,nM,CHEMBL3614291,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCCc2cn(-c3ccn4nccc4c3)nn2)CC1
CHEMBL3613874,CHEMBL217,Dopamine D2 receptor,Ki,=,3.8,nM,CHEMBL3614291,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,O=Cc1cnn2ccc(-n3cc(CCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12
CHEMBL3613875,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL3614291,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,O=Cc1cnn2ccc(-n3cc(CCCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12
CHEMBL3613876,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL3614291,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,O=Cc1cnn2ccc(-n3cc(CCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12
CHEMBL3613877,CHEMBL217,Dopamine D2 receptor,Ki,=,9.4,nM,CHEMBL3614291,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCc2cn(-c3ccn4ncc(C=O)c4c3)nn2)CC1
CHEMBL3613878,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL3614291,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,Clc1cccc(N2CCN(CCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl
CHEMBL3613879,CHEMBL217,Dopamine D2 receptor,Ki,=,54.0,nM,CHEMBL3614291,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,Clc1cccc(N2CCN(CCCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl
CHEMBL3613880,CHEMBL217,Dopamine D2 receptor,Ki,=,7.3,nM,CHEMBL3614291,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,Clc1cccc(N2CCN(CCCCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.96,nM,CHEMBL3626473,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL3621057,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL3622103,CHEMBL217,Dopamine D2 receptor,Ki,=,920.0,nM,CHEMBL3626473,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL3621057,KI,CCCN(CCN1CCN(Cc2cc3ccccc3[nH]2)CC1)Cc1ccc(Br)cc1
CHEMBL3622102,CHEMBL217,Dopamine D2 receptor,Ki,=,4100.0,nM,CHEMBL3626473,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL3621057,KI,CCCN(CCN1CCN(Cc2cc3ccccc3[nH]2)CC1)Cc1ccc(OC)cc1
CHEMBL3622101,CHEMBL217,Dopamine D2 receptor,Ki,=,5200.0,nM,CHEMBL3626473,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL3621057,KI,Brc1ccc(CNCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1
CHEMBL3622100,CHEMBL217,Dopamine D2 receptor,Ki,=,4000.0,nM,CHEMBL3626473,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL3621057,KI,COc1ccc(CNCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1
CHEMBL3622099,CHEMBL217,Dopamine D2 receptor,Ki,=,58.0,nM,CHEMBL3626473,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL3621057,KI,CCCN(CCN1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccc(Br)cc1
CHEMBL3622098,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL3626473,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL3621057,KI,CCCN(CCN1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccc(OC)cc1
CHEMBL3622097,CHEMBL217,Dopamine D2 receptor,Ki,=,53.0,nM,CHEMBL3626473,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL3621057,KI,Brc1ccc(NCCN2CCN(CCc3c[nH]c4ccccc34)CC2)cc1
CHEMBL3622096,CHEMBL217,Dopamine D2 receptor,Ki,=,430.0,nM,CHEMBL3626473,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL3621057,KI,COc1ccc(NCCN2CCN(CCc3c[nH]c4ccccc34)CC2)cc1
CHEMBL3622095,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL3626473,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL3621057,KI,CCCN(CCN1CCN(Cc2cc3ccccc3[nH]2)CC1)c1ccc(Br)cc1
CHEMBL3622094,CHEMBL217,Dopamine D2 receptor,Ki,=,520.0,nM,CHEMBL3626473,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL3621057,KI,CCCN(CCN1CCN(Cc2cc3ccccc3[nH]2)CC1)c1ccc(OC)cc1
CHEMBL3622093,CHEMBL217,Dopamine D2 receptor,Ki,=,920.0,nM,CHEMBL3626473,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL3621057,KI,Brc1ccc(NCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1
CHEMBL3622092,CHEMBL217,Dopamine D2 receptor,Ki,=,7500.0,nM,CHEMBL3626473,B,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL3621057,KI,COc1ccc(NCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1
CHEMBL3622099,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL3626475,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,CHEMBL3621057,KI,CCCN(CCN1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccc(Br)cc1
CHEMBL3622097,CHEMBL217,Dopamine D2 receptor,Ki,=,48.0,nM,CHEMBL3626475,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,CHEMBL3621057,KI,Brc1ccc(NCCN2CCN(CCc3c[nH]c4ccccc34)CC2)cc1
CHEMBL313620,CHEMBL217,Dopamine D2 receptor,Ki,=,8.8,nM,CHEMBL3636470,B,Binding affinity to dopaminergic D2 receptor (unknown origin),CHEMBL3632483,KI,COc1ccccc1N1CCN(CCCOc2ccc(-c3nc4ccccc4[nH]3)cc2)CC1
CHEMBL3664838,CHEMBL217,Dopamine D2 receptor,Ki,=,277.39,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3676915,CHEMBL217,Dopamine D2 receptor,Ki,=,15.19,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,N#Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1
CHEMBL3695369,CHEMBL217,Dopamine D2 receptor,Ki,=,729.0,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(CC1COCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3695446,CHEMBL217,Dopamine D2 receptor,Ki,=,243.6,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(Cc1noc2ccccc12)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3664873,CHEMBL217,Dopamine D2 receptor,Ki,=,149.51,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CN1CCC(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)CC1
CHEMBL3664833,CHEMBL217,Dopamine D2 receptor,Ki,=,202.82,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,N#CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3697976,CHEMBL217,Dopamine D2 receptor,Ki,=,150.42,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CO[C@@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3697974,CHEMBL217,Dopamine D2 receptor,Ki,=,181.01,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CC(C)(O)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3697998,CHEMBL217,Dopamine D2 receptor,Ki,=,88.19,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1cccnc1
CHEMBL3642735,CHEMBL217,Dopamine D2 receptor,Ki,=,592.9,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1(O)CC1
CHEMBL3664860,CHEMBL217,Dopamine D2 receptor,Ki,=,183.74,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCOCC1
CHEMBL3697975,CHEMBL217,Dopamine D2 receptor,Ki,=,250.3,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CO[C@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3695435,CHEMBL217,Dopamine D2 receptor,Ki,=,366.1,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,COC(CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)OC
CHEMBL3664859,CHEMBL217,Dopamine D2 receptor,Ki,=,165.4,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCOC1
CHEMBL3676919,CHEMBL217,Dopamine D2 receptor,Ki,=,92.47,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(Cc1ccc2c(c1)OCO2)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3642749,CHEMBL217,Dopamine D2 receptor,Ki,=,444.2,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC(C)(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642703,CHEMBL217,Dopamine D2 receptor,Ki,=,246.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5sccc45)CC3)CC2)C1
CHEMBL3695361,CHEMBL217,Dopamine D2 receptor,Ki,=,650.0,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3642719,CHEMBL217,Dopamine D2 receptor,Ki,=,609.5,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCOC1
CHEMBL3676870,CHEMBL217,Dopamine D2 receptor,Ki,=,33.71,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(CC1CC1)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3676920,CHEMBL217,Dopamine D2 receptor,Ki,=,60.84,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CS(=O)(=O)c1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)s1
CHEMBL3664845,CHEMBL217,Dopamine D2 receptor,Ki,=,406.7,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CC(C)(O)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3676904,CHEMBL217,Dopamine D2 receptor,Ki,=,46.9,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(-n2cccn2)cc1
CHEMBL3642695,CHEMBL217,Dopamine D2 receptor,Ki,=,539.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1
CHEMBL3676877,CHEMBL217,Dopamine D2 receptor,Ki,=,46.39,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C(O)C(F)(F)F
CHEMBL3642765,CHEMBL217,Dopamine D2 receptor,Ki,=,731.8,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(C[C@@H](O)C(F)(F)F)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3664867,CHEMBL217,Dopamine D2 receptor,Ki,=,164.9,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CS(=O)(=O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3676878,CHEMBL217,Dopamine D2 receptor,Ki,=,45.27,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,5.9,nM,CHEMBL3707630,B,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.",CHEMBL3638417,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL3676846,CHEMBL217,Dopamine D2 receptor,Ki,=,50.4,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3976966,CHEMBL217,Dopamine D2 receptor,Ki,=,3248.0,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc2ncccc2c1
CHEMBL3642812,CHEMBL217,Dopamine D2 receptor,Ki,=,3161.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC(C)(C)Oc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)cc1
CHEMBL3642781,CHEMBL217,Dopamine D2 receptor,Ki,=,1126.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,Cc1cnc(N2CCN(CC[C@H]3CC[C@H](NC(=O)C4CCOCC4)CC3)CC2)c2ccoc12
CHEMBL3642743,CHEMBL217,Dopamine D2 receptor,Ki,=,781.5,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3698017,CHEMBL217,Dopamine D2 receptor,Ki,=,72.43,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=S(=O)(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccccc1
CHEMBL3676906,CHEMBL217,Dopamine D2 receptor,Ki,=,226.91,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,Cc1nc(-c2ccc(C(=O)N[C@H]3CC[C@H](CCN4CCC(c5coc6ccccc56)CC4)CC3)cc2)no1
CHEMBL3695413,CHEMBL217,Dopamine D2 receptor,Ki,=,301.2,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(CC1CCC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3697961,CHEMBL217,Dopamine D2 receptor,Ki,=,269.17,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccccc1
CHEMBL3695432,CHEMBL217,Dopamine D2 receptor,Ki,=,808.8,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc2c(c1)OCO2
CHEMBL3664834,CHEMBL217,Dopamine D2 receptor,Ki,=,361.06,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(CC1(O)CCCCC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3695444,CHEMBL217,Dopamine D2 receptor,Ki,=,501.4,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(-c2ccccc2)cc1
CHEMBL3695367,CHEMBL217,Dopamine D2 receptor,Ki,=,671.2,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,COCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3642705,CHEMBL217,Dopamine D2 receptor,Ki,=,392.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(C[C@H]1CC[C@H](O)CC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1
CHEMBL3642801,CHEMBL217,Dopamine D2 receptor,Ki,=,116.6,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(N2CCS(=O)(=O)CC2)cc1
CHEMBL3695406,CHEMBL217,Dopamine D2 receptor,Ki,=,372.6,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CCCO1
CHEMBL3676869,CHEMBL217,Dopamine D2 receptor,Ki,=,68.89,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(F)cc1
CHEMBL3642718,CHEMBL217,Dopamine D2 receptor,Ki,=,733.5,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(CCO)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642792,CHEMBL217,Dopamine D2 receptor,Ki,=,312.6,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)cn1
CHEMBL3695389,CHEMBL217,Dopamine D2 receptor,Ki,=,239.4,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(C[C@@H](O)C(F)(F)F)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3676931,CHEMBL217,Dopamine D2 receptor,Ki,=,79.51,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CS(=O)(=O)c1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1
CHEMBL3697999,CHEMBL217,Dopamine D2 receptor,Ki,=,4818.65,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccc2c(c1)OCCO2
CHEMBL3664875,CHEMBL217,Dopamine D2 receptor,Ki,=,360.81,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)CC1
CHEMBL3698004,CHEMBL217,Dopamine D2 receptor,Ki,=,91.14,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCC1
CHEMBL3676903,CHEMBL217,Dopamine D2 receptor,Ki,=,28.63,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc2c(c1)OCO2
CHEMBL3695384,CHEMBL217,Dopamine D2 receptor,Ki,=,514.1,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(C[C@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3676898,CHEMBL217,Dopamine D2 receptor,Ki,=,18.01,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC(C)=CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3642699,CHEMBL217,Dopamine D2 receptor,Ki,=,234.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5sccc45)CC3)CC2)C1
CHEMBL3676855,CHEMBL217,Dopamine D2 receptor,Ki,=,83.59,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,Cc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)on1
CHEMBL3642682,CHEMBL217,Dopamine D2 receptor,Ki,=,780.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1
CHEMBL3642704,CHEMBL217,Dopamine D2 receptor,Ki,=,218.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(CO)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1
CHEMBL3697987,CHEMBL217,Dopamine D2 receptor,Ki,=,175.4,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1(O)CCCCC1
CHEMBL3664839,CHEMBL217,Dopamine D2 receptor,Ki,=,194.24,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CC1(F)F
CHEMBL3642815,CHEMBL217,Dopamine D2 receptor,Ki,=,801.3,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,COC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3697954,CHEMBL217,Dopamine D2 receptor,Ki,=,301.03,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(C[C@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3676908,CHEMBL217,Dopamine D2 receptor,Ki,=,22.11,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(-c2ccccc2)cc1
CHEMBL3664854,CHEMBL217,Dopamine D2 receptor,Ki,=,491.09,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(C[C@H]1CCCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3664850,CHEMBL217,Dopamine D2 receptor,Ki,=,233.95,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccc(F)cc1
CHEMBL3695398,CHEMBL217,Dopamine D2 receptor,Ki,=,191.8,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,N#Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4CCO5)CC3)CC2)cc1
CHEMBL3642726,CHEMBL217,Dopamine D2 receptor,Ki,=,1093.5,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3664821,CHEMBL217,Dopamine D2 receptor,Ki,=,302.84,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(CC1CC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3676847,CHEMBL217,Dopamine D2 receptor,Ki,=,71.18,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3676863,CHEMBL217,Dopamine D2 receptor,Ki,=,81.48,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCCO1
CHEMBL3664866,CHEMBL217,Dopamine D2 receptor,Ki,=,100.3,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCC1
CHEMBL3695405,CHEMBL217,Dopamine D2 receptor,Ki,=,135.0,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CCOC1
CHEMBL3642693,CHEMBL217,Dopamine D2 receptor,Ki,=,119.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1
CHEMBL3676854,CHEMBL217,Dopamine D2 receptor,Ki,=,32.32,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccccc1
CHEMBL716,CHEMBL217,Dopamine D2 receptor,Ki,=,400.0,nM,CHEMBL3707630,B,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.",CHEMBL3638417,KI,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL3642683,CHEMBL217,Dopamine D2 receptor,Ki,=,1347.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1
CHEMBL3664855,CHEMBL217,Dopamine D2 receptor,Ki,=,321.69,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(C[C@@H]1CCCOC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3697953,CHEMBL217,Dopamine D2 receptor,Ki,=,197.58,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(CC1COCCO1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3664884,CHEMBL217,Dopamine D2 receptor,Ki,=,114.29,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,Cn1cnc(S(=O)(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)c1
CHEMBL3697969,CHEMBL217,Dopamine D2 receptor,Ki,=,143.65,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3676907,CHEMBL217,Dopamine D2 receptor,Ki,=,50.09,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CN1CCN(c2ccc(C(=O)N[C@H]3CC[C@H](CCN4CCC(c5coc6ccccc56)CC4)CC3)cc2)CC1
CHEMBL3642740,CHEMBL217,Dopamine D2 receptor,Ki,=,485.6,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CC1
CHEMBL3676885,CHEMBL217,Dopamine D2 receptor,Ki,=,53.03,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC(C)(C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3698000,CHEMBL217,Dopamine D2 receptor,Ki,=,572.43,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1COc2ccccc2C1
CHEMBL3695443,CHEMBL217,Dopamine D2 receptor,Ki,=,85.1,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(-n2cccc2)cc1
CHEMBL3697986,CHEMBL217,Dopamine D2 receptor,Ki,=,123.97,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1(O)CCCC1
CHEMBL3695366,CHEMBL217,Dopamine D2 receptor,Ki,=,345.7,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3642717,CHEMBL217,Dopamine D2 receptor,Ki,=,1568.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(CO)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642694,CHEMBL217,Dopamine D2 receptor,Ki,=,780.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1
CHEMBL3642813,CHEMBL217,Dopamine D2 receptor,Ki,=,788.5,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CO[C@@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642742,CHEMBL217,Dopamine D2 receptor,Ki,=,2451.9,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)CC1
CHEMBL3676892,CHEMBL217,Dopamine D2 receptor,Ki,=,33.75,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC[C@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3697970,CHEMBL217,Dopamine D2 receptor,Ki,=,143.98,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CC1(F)F
CHEMBL3639943,CHEMBL217,Dopamine D2 receptor,Ki,=,721.3,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(Cc1ccc2c(c1)OCO2)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3639637,CHEMBL217,Dopamine D2 receptor,Ki,=,408.24,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(C[C@H]1CCCOC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3695419,CHEMBL217,Dopamine D2 receptor,Ki,=,615.9,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCC(c3ccc(F)c4occc34)CC2)CC1
CHEMBL3642681,CHEMBL217,Dopamine D2 receptor,Ki,=,1538.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(C[C@H]1CC[C@H](O)CC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1
CHEMBL3642800,CHEMBL217,Dopamine D2 receptor,Ki,=,1265.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC(C)(O)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3676932,CHEMBL217,Dopamine D2 receptor,Ki,=,38.17,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(Cl)cc1Cl
CHEMBL3953892,CHEMBL217,Dopamine D2 receptor,Ki,=,102.85,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc2ncccc2c1
CHEMBL3698005,CHEMBL217,Dopamine D2 receptor,Ki,=,95.38,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CS(=O)(=O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3664822,CHEMBL217,Dopamine D2 receptor,Ki,=,120.38,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccccc1
CHEMBL3695420,CHEMBL217,Dopamine D2 receptor,Ki,=,612.9,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3ccc(F)c4occc34)CC2)CC1
CHEMBL3676897,CHEMBL217,Dopamine D2 receptor,Ki,=,48.85,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,COC(CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)OC
CHEMBL3642734,CHEMBL217,Dopamine D2 receptor,Ki,=,867.1,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(N2CCOCC2)cc1
CHEMBL3676871,CHEMBL217,Dopamine D2 receptor,Ki,=,37.09,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCCOC1
CHEMBL3642711,CHEMBL217,Dopamine D2 receptor,Ki,=,869.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3664868,CHEMBL217,Dopamine D2 receptor,Ki,=,593.34,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccc(N2CCOCC2)cc1
CHEMBL3642816,CHEMBL217,Dopamine D2 receptor,Ki,=,842.7,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC[C@@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642757,CHEMBL217,Dopamine D2 receptor,Ki,=,198.4,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC(C)=CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3664885,CHEMBL217,Dopamine D2 receptor,Ki,=,346.12,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C(F)(F)F
CHEMBL3695365,CHEMBL217,Dopamine D2 receptor,Ki,=,219.0,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(CC1COCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4occc34)CC2)CC1
CHEMBL3676933,CHEMBL217,Dopamine D2 receptor,Ki,=,70.03,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC(C)(C)c1ccc(S(=O)(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1
CHEMBL3664883,CHEMBL217,Dopamine D2 receptor,Ki,=,104.22,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=S(=O)(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccc(F)cc1
CHEMBL3642758,CHEMBL217,Dopamine D2 receptor,Ki,=,945.4,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,C/C=C/CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3676891,CHEMBL217,Dopamine D2 receptor,Ki,=,55.43,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC[C@@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3664891,CHEMBL217,Dopamine D2 receptor,Ki,=,229.43,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=S(=O)(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)N1CCOCC1
CHEMBL3698010,CHEMBL217,Dopamine D2 receptor,Ki,=,81.06,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CC(Cl)C1
CHEMBL3664846,CHEMBL217,Dopamine D2 receptor,Ki,=,463.94,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CO[C@@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3698016,CHEMBL217,Dopamine D2 receptor,Ki,=,73.84,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=S(=O)(CC(F)(F)F)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642750,CHEMBL217,Dopamine D2 receptor,Ki,=,602.7,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(CC1CCC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3676862,CHEMBL217,Dopamine D2 receptor,Ki,=,52.97,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCOC1
CHEMBL3642780,CHEMBL217,Dopamine D2 receptor,Ki,=,1461.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3ncc(C)c4occc34)CC2)CC1
CHEMBL3664890,CHEMBL217,Dopamine D2 receptor,Ki,=,229.21,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3695359,CHEMBL217,Dopamine D2 receptor,Ki,=,509.4,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3698002,CHEMBL217,Dopamine D2 receptor,Ki,=,58.95,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCS(=O)(=O)C1
CHEMBL3697988,CHEMBL217,Dopamine D2 receptor,Ki,=,122.13,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CCC(O)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3695414,CHEMBL217,Dopamine D2 receptor,Ki,=,235.8,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CC1(F)F
CHEMBL3664851,CHEMBL217,Dopamine D2 receptor,Ki,=,208.99,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)[C@H](O)C(F)(F)F
CHEMBL3695390,CHEMBL217,Dopamine D2 receptor,Ki,=,240.5,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C(O)C(F)(F)F
CHEMBL3642793,CHEMBL217,Dopamine D2 receptor,Ki,=,381.2,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,N#Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)cc1
CHEMBL3642775,CHEMBL217,Dopamine D2 receptor,Ki,=,640.6,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,Cc1cc2occc2c(N2CCN(CC[C@H]3CC[C@H](NC(=O)CC4CCOCC4)CC3)CC2)n1
CHEMBL3642741,CHEMBL217,Dopamine D2 receptor,Ki,=,1262.8,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(CC1CCCO1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642710,CHEMBL217,Dopamine D2 receptor,Ki,=,503.5,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCOCC1
CHEMBL3695397,CHEMBL217,Dopamine D2 receptor,Ki,=,147.1,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CN1CCN(c2ccc(C(=O)N[C@H]3CC[C@H](CCN4CCC(c5cccc6c5CCO6)CC4)CC3)cc2)CC1
CHEMBL3695360,CHEMBL217,Dopamine D2 receptor,Ki,=,716.3,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CCOCC1
CHEMBL3695368,CHEMBL217,Dopamine D2 receptor,Ki,=,418.7,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CS(=O)(=O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3664831,CHEMBL217,Dopamine D2 receptor,Ki,=,133.11,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,COC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3676926,CHEMBL217,Dopamine D2 receptor,Ki,=,204.42,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CCc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1
CHEMBL3642779,CHEMBL217,Dopamine D2 receptor,Ki,=,1486.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nc(C)cc4c3CCO4)CC2)CC1
CHEMBL3695433,CHEMBL217,Dopamine D2 receptor,Ki,=,196.5,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(CC1COC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3676861,CHEMBL217,Dopamine D2 receptor,Ki,=,53.71,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC(C)(O)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3695382,CHEMBL217,Dopamine D2 receptor,Ki,=,151.4,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CC1
CHEMBL3697968,CHEMBL217,Dopamine D2 receptor,Ki,=,132.77,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL708,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL3707630,B,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.",CHEMBL3638417,KI,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL3642685,CHEMBL217,Dopamine D2 receptor,Ki,=,1360.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(CO)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1
CHEMBL3695358,CHEMBL217,Dopamine D2 receptor,Ki,=,297.7,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3695399,CHEMBL217,Dopamine D2 receptor,Ki,=,919.5,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(N2CCOCC2)nc1
CHEMBL3642702,CHEMBL217,Dopamine D2 receptor,Ki,=,992.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1)C1CCOCC1
CHEMBL3695370,CHEMBL217,Dopamine D2 receptor,Ki,=,318.7,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccccc1
CHEMBL3695376,CHEMBL217,Dopamine D2 receptor,Ki,=,285.0,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CC(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3695417,CHEMBL217,Dopamine D2 receptor,Ki,=,403.7,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3ccc(F)c4occc34)CC2)CC1
CHEMBL3664823,CHEMBL217,Dopamine D2 receptor,Ki,=,209.41,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(CC(F)(F)F)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642713,CHEMBL217,Dopamine D2 receptor,Ki,=,812.7,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3698020,CHEMBL217,Dopamine D2 receptor,Ki,=,113.43,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C(F)(F)F
CHEMBL3676876,CHEMBL217,Dopamine D2 receptor,Ki,=,46.02,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CCC(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3695447,CHEMBL217,Dopamine D2 receptor,Ki,=,161.5,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CS(=O)(=O)c1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4CCO5)CC3)CC2)cc1
CHEMBL3664874,CHEMBL217,Dopamine D2 receptor,Ki,=,225.02,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CC1(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)COC1
CHEMBL3695354,CHEMBL217,Dopamine D2 receptor,Ki,=,186.6,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4occc34)CC2)CC1
CHEMBL3697996,CHEMBL217,Dopamine D2 receptor,Ki,=,82.51,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccc(F)cc1
CHEMBL3698018,CHEMBL217,Dopamine D2 receptor,Ki,=,46.18,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=S(=O)(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccc(F)cc1
CHEMBL3642684,CHEMBL217,Dopamine D2 receptor,Ki,=,959.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(CCO)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1
CHEMBL3697997,CHEMBL217,Dopamine D2 receptor,Ki,=,509.13,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccnc2ccccc12
CHEMBL3695416,CHEMBL217,Dopamine D2 receptor,Ki,=,1063.3,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CN(C)C(=O)CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3697956,CHEMBL217,Dopamine D2 receptor,Ki,=,188.71,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(CC1CCCO1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3676849,CHEMBL217,Dopamine D2 receptor,Ki,=,77.56,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3642725,CHEMBL217,Dopamine D2 receptor,Ki,=,1269.5,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3676922,CHEMBL217,Dopamine D2 receptor,Ki,=,344.55,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC(C)(C)C1CCC(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)CC1
CHEMBL3676914,CHEMBL217,Dopamine D2 receptor,Ki,=,28.13,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cn1
CHEMBL3676930,CHEMBL217,Dopamine D2 receptor,Ki,=,244.83,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(Cc1noc2ccccc12)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3676896,CHEMBL217,Dopamine D2 receptor,Ki,=,345.18,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(N2CCCCC2)cc1
CHEMBL3695388,CHEMBL217,Dopamine D2 receptor,Ki,=,73.7,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(F)cc1
CHEMBL3664877,CHEMBL217,Dopamine D2 receptor,Ki,=,297.86,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(CO)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3695387,CHEMBL217,Dopamine D2 receptor,Ki,=,71.9,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(Cl)cc1
CHEMBL3698003,CHEMBL217,Dopamine D2 receptor,Ki,=,138.86,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3697981,CHEMBL217,Dopamine D2 receptor,Ki,=,310.25,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(C[C@H]1CCCCO1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642807,CHEMBL217,Dopamine D2 receptor,Ki,=,1663.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC(C)(C)c1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)cc1
CHEMBL3676873,CHEMBL217,Dopamine D2 receptor,Ki,=,37.96,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC(C)(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3642728,CHEMBL217,Dopamine D2 receptor,Ki,=,586.8,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(CC1CC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642716,CHEMBL217,Dopamine D2 receptor,Ki,=,1018.3,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CS(=O)(=O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3695412,CHEMBL217,Dopamine D2 receptor,Ki,=,394.4,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CC(C)(C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3642752,CHEMBL217,Dopamine D2 receptor,Ki,=,705.1,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642806,CHEMBL217,Dopamine D2 receptor,Ki,=,506.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1cnc(N2CCOCC2)cn1
CHEMBL3664816,CHEMBL217,Dopamine D2 receptor,Ki,=,529.67,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(CC1COCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642798,CHEMBL217,Dopamine D2 receptor,Ki,=,3042.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(Cc1ccc2c(c1)OCO2)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642786,CHEMBL217,Dopamine D2 receptor,Ki,=,2951.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,Cc1cnc(N2CCN(CC[C@H]3CC[C@H](NC(=O)CC4CCOCC4)CC3)CC2)c2c1OCC2
CHEMBL3664889,CHEMBL217,Dopamine D2 receptor,Ki,=,2707.02,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(Nc1ccc(Cl)cc1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3676905,CHEMBL217,Dopamine D2 receptor,Ki,=,1111.22,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC(C)(C)c1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1
CHEMBL3642739,CHEMBL217,Dopamine D2 receptor,Ki,=,547.5,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccnc2ccccc12
CHEMBL3676884,CHEMBL217,Dopamine D2 receptor,Ki,=,37.47,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C(F)(F)F
CHEMBL3676889,CHEMBL217,Dopamine D2 receptor,Ki,=,61.16,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(CCC(F)(F)F)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3642691,CHEMBL217,Dopamine D2 receptor,Ki,=,261.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1)C1CC1
CHEMBL3664837,CHEMBL217,Dopamine D2 receptor,Ki,=,238.8,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3664861,CHEMBL217,Dopamine D2 receptor,Ki,=,245.32,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1(O)CC1
CHEMBL3642814,CHEMBL217,Dopamine D2 receptor,Ki,=,242.6,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=S(=O)(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccccc1
CHEMBL3695442,CHEMBL217,Dopamine D2 receptor,Ki,=,233.5,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(Cl)cc1Cl
CHEMBL3664830,CHEMBL217,Dopamine D2 receptor,Ki,=,531.19,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(C[C@@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3697973,CHEMBL217,Dopamine D2 receptor,Ki,=,182.55,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)C1
CHEMBL3664853,CHEMBL217,Dopamine D2 receptor,Ki,=,422.11,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(C[C@@H]1CCCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3697990,CHEMBL217,Dopamine D2 receptor,Ki,=,73.41,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CC(C)[C@H](O)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642756,CHEMBL217,Dopamine D2 receptor,Ki,=,773.3,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C(F)(F)F
CHEMBL3642773,CHEMBL217,Dopamine D2 receptor,Ki,=,248.8,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nc(C)cc4occc34)CC2)CC1
CHEMBL3695400,CHEMBL217,Dopamine D2 receptor,Ki,=,328.2,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3642764,CHEMBL217,Dopamine D2 receptor,Ki,=,999.7,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC(C)(O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3698026,CHEMBL217,Dopamine D2 receptor,Ki,=,62.99,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=S(=O)(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)N1CCOCC1
CHEMBL3695355,CHEMBL217,Dopamine D2 receptor,Ki,=,287.6,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4occc34)CC2)CC1
CHEMBL3698009,CHEMBL217,Dopamine D2 receptor,Ki,=,101.02,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,N#Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)cc1
CHEMBL3676852,CHEMBL217,Dopamine D2 receptor,Ki,=,50.8,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CS(=O)(=O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3642769,CHEMBL217,Dopamine D2 receptor,Ki,=,828.3,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642744,CHEMBL217,Dopamine D2 receptor,Ki,=,1461.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(C[C@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3695374,CHEMBL217,Dopamine D2 receptor,Ki,=,420.3,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(C[C@@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3642698,CHEMBL217,Dopamine D2 receptor,Ki,=,302.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5sccc45)CC3)CC2)CC1
CHEMBL3664836,CHEMBL217,Dopamine D2 receptor,Ki,=,397.43,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CC(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642733,CHEMBL217,Dopamine D2 receptor,Ki,=,5340.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(N2CCCCC2)cc1
CHEMBL3695445,CHEMBL217,Dopamine D2 receptor,Ki,=,99.8,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(-c2cccnc2)cc1
CHEMBL3664827,CHEMBL217,Dopamine D2 receptor,Ki,=,152.76,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,N#Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)cc1
CHEMBL3695430,CHEMBL217,Dopamine D2 receptor,Ki,=,329.1,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(N2CCS(=O)(=O)CC2)cc1
CHEMBL3642790,CHEMBL217,Dopamine D2 receptor,Ki,=,2365.4,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,COC(CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)OC
CHEMBL3642778,CHEMBL217,Dopamine D2 receptor,Ki,=,1950.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,Cc1cc2c(c(N3CCN(CC[C@H]4CC[C@H](NC(=O)C5CCOCC5)CC4)CC3)n1)CCO2
CHEMBL3698019,CHEMBL217,Dopamine D2 receptor,Ki,=,55.32,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,Cn1cnc(S(=O)(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)c1
CHEMBL3676850,CHEMBL217,Dopamine D2 receptor,Ki,=,48.1,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3698024,CHEMBL217,Dopamine D2 receptor,Ki,=,157.94,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(Nc1ccc(Cl)cc1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642782,CHEMBL217,Dopamine D2 receptor,Ki,=,2718.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,Cc1cnc(N2CCN(CC[C@H]3CC[C@H](NC(=O)CC4CCOCC4)CC3)CC2)c2ccoc12
CHEMBL3642730,CHEMBL217,Dopamine D2 receptor,Ki,=,766.8,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCCOC1
CHEMBL3695378,CHEMBL217,Dopamine D2 receptor,Ki,=,379.2,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(CC1CCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3664887,CHEMBL217,Dopamine D2 receptor,Ki,=,52.74,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642746,CHEMBL217,Dopamine D2 receptor,Ki,=,857.9,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(C[C@@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3676924,CHEMBL217,Dopamine D2 receptor,Ki,=,72.97,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCC(C(F)(F)F)CC1
CHEMBL3698011,CHEMBL217,Dopamine D2 receptor,Ki,=,38.06,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CN1CCN(CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)CC1
CHEMBL3676888,CHEMBL217,Dopamine D2 receptor,Ki,=,47.02,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3664864,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCS(=O)(=O)C1
CHEMBL3676911,CHEMBL217,Dopamine D2 receptor,Ki,=,19.22,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(N2CCS(=O)(=O)CC2)cc1
CHEMBL3642699,CHEMBL217,Dopamine D2 receptor,Ki,=,271.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5sccc45)CC3)CC2)C1
CHEMBL3642753,CHEMBL217,Dopamine D2 receptor,Ki,=,709.4,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CCC(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3676917,CHEMBL217,Dopamine D2 receptor,Ki,=,67.41,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)CC1
CHEMBL3695363,CHEMBL217,Dopamine D2 receptor,Ki,=,256.3,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,COCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4occc34)CC2)CC1
CHEMBL3695429,CHEMBL217,Dopamine D2 receptor,Ki,=,411.0,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CCCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3642687,CHEMBL217,Dopamine D2 receptor,Ki,=,1463.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5occc45)CC3)CC2)CC1
CHEMBL3695436,CHEMBL217,Dopamine D2 receptor,Ki,=,69.9,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3664848,CHEMBL217,Dopamine D2 receptor,Ki,=,281.84,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CC(C)(O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3697964,CHEMBL217,Dopamine D2 receptor,Ki,=,75.98,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,N#CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642724,CHEMBL217,Dopamine D2 receptor,Ki,=,871.2,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(C(F)(F)F)cc1
CHEMBL3695371,CHEMBL217,Dopamine D2 receptor,Ki,=,344.6,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(CC(F)(F)F)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3642794,CHEMBL217,Dopamine D2 receptor,Ki,=,179.5,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CN1CCN(c2ccc(C(=O)N[C@H]3CC[C@H](CCN4CCN(c5nccc6c5CCO6)CC4)CC3)cc2)CC1
CHEMBL3698007,CHEMBL217,Dopamine D2 receptor,Ki,=,62.94,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CN1CCC(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)CC1
CHEMBL3697965,CHEMBL217,Dopamine D2 receptor,Ki,=,159.74,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(CC1(O)CCCCC1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642797,CHEMBL217,Dopamine D2 receptor,Ki,=,3372.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc2c(c1)OCO2
CHEMBL3695415,CHEMBL217,Dopamine D2 receptor,Ki,=,1201.3,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CCC(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3698012,CHEMBL217,Dopamine D2 receptor,Ki,=,86.54,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,COC1(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)CC1
CHEMBL3695385,CHEMBL217,Dopamine D2 receptor,Ki,=,557.4,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(C[C@@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3664886,CHEMBL217,Dopamine D2 receptor,Ki,=,229.19,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)N1CCc2ccccc21
CHEMBL3676856,CHEMBL217,Dopamine D2 receptor,Ki,=,46.52,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(CO)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3698014,CHEMBL217,Dopamine D2 receptor,Ki,=,89.5,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CO[C@@H](C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C(C)C
CHEMBL3676880,CHEMBL217,Dopamine D2 receptor,Ki,=,50.42,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(C[C@@H](O)C(F)(F)F)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3642709,CHEMBL217,Dopamine D2 receptor,Ki,=,770.1,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642770,CHEMBL217,Dopamine D2 receptor,Ki,=,1277.1,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC(C)CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL3707630,B,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.",CHEMBL3638417,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL3695407,CHEMBL217,Dopamine D2 receptor,Ki,=,633.0,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CCCOC1
CHEMBL3664852,CHEMBL217,Dopamine D2 receptor,Ki,=,283.73,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)[C@@H](O)C(F)(F)F
CHEMBL3676890,CHEMBL217,Dopamine D2 receptor,Ki,=,65.98,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC(C)CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3642777,CHEMBL217,Dopamine D2 receptor,Ki,=,915.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nc(C)cc4c3CCO4)CC2)CC1
CHEMBL3695439,CHEMBL217,Dopamine D2 receptor,Ki,=,118.4,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CC#CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3642767,CHEMBL217,Dopamine D2 receptor,Ki,=,1291.7,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)C1
CHEMBL3698023,CHEMBL217,Dopamine D2 receptor,Ki,=,116.67,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(C[C@H]1C[C@H](CO)C1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642689,CHEMBL217,Dopamine D2 receptor,Ki,=,515.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1)C1CCOCC1
CHEMBL3664829,CHEMBL217,Dopamine D2 receptor,Ki,=,227.84,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(C[C@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642772,CHEMBL217,Dopamine D2 receptor,Ki,=,1253.7,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(CCC(F)(F)F)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642688,CHEMBL217,Dopamine D2 receptor,Ki,=,683.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1
CHEMBL3697960,CHEMBL217,Dopamine D2 receptor,Ki,=,183.57,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(CO)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3695437,CHEMBL217,Dopamine D2 receptor,Ki,=,73.9,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CC(C)=CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3664869,CHEMBL217,Dopamine D2 receptor,Ki,=,370.18,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccnc2ccccc12
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,31.0,nM,CHEMBL3707630,B,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.",CHEMBL3638417,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL3697967,CHEMBL217,Dopamine D2 receptor,Ki,=,136.57,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CC(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3664878,CHEMBL217,Dopamine D2 receptor,Ki,=,218.85,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1(O)CCCCC1
CHEMBL3676882,CHEMBL217,Dopamine D2 receptor,Ki,=,47.99,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3695426,CHEMBL217,Dopamine D2 receptor,Ki,=,196.8,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3697982,CHEMBL217,Dopamine D2 receptor,Ki,=,136.98,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(C[C@@H]1CCCOC1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642808,CHEMBL217,Dopamine D2 receptor,Ki,=,518.3,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(Cl)cc1Cl
CHEMBL3664881,CHEMBL217,Dopamine D2 receptor,Ki,=,413.56,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3664870,CHEMBL217,Dopamine D2 receptor,Ki,=,345.34,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccc2c(c1)OCCO2
CHEMBL3698015,CHEMBL217,Dopamine D2 receptor,Ki,=,111.52,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CO[C@H](C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C(C)C
CHEMBL3642692,CHEMBL217,Dopamine D2 receptor,Ki,=,866.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1
CHEMBL3695440,CHEMBL217,Dopamine D2 receptor,Ki,=,167.2,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=CN[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3642804,CHEMBL217,Dopamine D2 receptor,Ki,=,500.6,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc2ncccc2c1
CHEMBL3676887,CHEMBL217,Dopamine D2 receptor,Ki,=,92.3,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CN(C)C(=O)CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3676866,CHEMBL217,Dopamine D2 receptor,Ki,=,62.94,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(CCO)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3642700,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,COCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1
CHEMBL3695402,CHEMBL217,Dopamine D2 receptor,Ki,=,137.7,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=S(=O)(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccccc1
CHEMBL3642762,CHEMBL217,Dopamine D2 receptor,Ki,=,396.8,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,Cc1cc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)on1
CHEMBL3697995,CHEMBL217,Dopamine D2 receptor,Ki,=,1510.24,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccc(N2CCOCC2)cc1
CHEMBL3695386,CHEMBL217,Dopamine D2 receptor,Ki,=,128.1,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(N2CCOCC2)cc1
CHEMBL3642748,CHEMBL217,Dopamine D2 receptor,Ki,=,654.8,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3676867,CHEMBL217,Dopamine D2 receptor,Ki,=,47.49,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1(O)CC1
CHEMBL3697977,CHEMBL217,Dopamine D2 receptor,Ki,=,76.78,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CC(C)(O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642774,CHEMBL217,Dopamine D2 receptor,Ki,=,274.6,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,Cc1cc2occc2c(N2CCN(CC[C@H]3CC[C@H](NC(=O)C4CCOCC4)CC3)CC2)n1
CHEMBL3676928,CHEMBL217,Dopamine D2 receptor,Ki,=,401.84,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC(C)c1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1
CHEMBL3642805,CHEMBL217,Dopamine D2 receptor,Ki,=,1308.9,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(Cc1noc2ccccc12)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642751,CHEMBL217,Dopamine D2 receptor,Ki,=,438.3,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CC1(F)F
CHEMBL3639416,CHEMBL217,Dopamine D2 receptor,Ki,=,1935.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,Cc1cc2c(c(N3CCN(CC[C@H]4CC[C@H](NC(=O)CC5CCOCC5)CC4)CC3)n1)CCO2
CHEMBL3676929,CHEMBL217,Dopamine D2 receptor,Ki,=,355.25,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(C2CC2)cc1
CHEMBL3664871,CHEMBL217,Dopamine D2 receptor,Ki,=,324.88,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(Cc1ccc2c(c1)OCO2)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3695357,CHEMBL217,Dopamine D2 receptor,Ki,=,218.8,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4occc34)CC2)CC1
CHEMBL3664863,CHEMBL217,Dopamine D2 receptor,Ki,=,351.61,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CCC(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3664847,CHEMBL217,Dopamine D2 receptor,Ki,=,503.95,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CO[C@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642707,CHEMBL217,Dopamine D2 receptor,Ki,=,265.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1
CHEMBL3695394,CHEMBL217,Dopamine D2 receptor,Ki,=,124.1,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,Cc1cc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4CCO5)CC3)CC2)on1
CHEMBL3642787,CHEMBL217,Dopamine D2 receptor,Ki,=,3564.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3ncc(C)c4c3CCO4)CC2)CC1
CHEMBL3698001,CHEMBL217,Dopamine D2 receptor,Ki,=,680.96,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(Cc1ccc2c(c1)OCO2)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3695377,CHEMBL217,Dopamine D2 receptor,Ki,=,212.6,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3664849,CHEMBL217,Dopamine D2 receptor,Ki,=,146.9,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccc(Cl)cc1
CHEMBL3664865,CHEMBL217,Dopamine D2 receptor,Ki,=,351.77,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3695380,CHEMBL217,Dopamine D2 receptor,Ki,=,344.3,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(CCO)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3676900,CHEMBL217,Dopamine D2 receptor,Ki,=,25.62,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC#CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3664820,CHEMBL217,Dopamine D2 receptor,Ki,=,203.61,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642720,CHEMBL217,Dopamine D2 receptor,Ki,=,1044.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCCO1
CHEMBL3695379,CHEMBL217,Dopamine D2 receptor,Ki,=,144.8,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CCC1
CHEMBL3695411,CHEMBL217,Dopamine D2 receptor,Ki,=,377.7,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CC(C)(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3676848,CHEMBL217,Dopamine D2 receptor,Ki,=,37.32,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCOCC1
CHEMBL3695418,CHEMBL217,Dopamine D2 receptor,Ki,=,361.3,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3ccc(F)c4occc34)CC2)CC1)C1CCOCC1
CHEMBL3698025,CHEMBL217,Dopamine D2 receptor,Ki,=,127.71,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3695383,CHEMBL217,Dopamine D2 receptor,Ki,=,267.5,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(CC1CC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3642723,CHEMBL217,Dopamine D2 receptor,Ki,=,289.2,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(Cl)cc1
CHEMBL3697971,CHEMBL217,Dopamine D2 receptor,Ki,=,181.28,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,COC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642729,CHEMBL217,Dopamine D2 receptor,Ki,=,555.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.7,nM,CHEMBL3707630,B,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.",CHEMBL3638417,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL3642768,CHEMBL217,Dopamine D2 receptor,Ki,=,926.5,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(CC1C[C@H](O)CO1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3664817,CHEMBL217,Dopamine D2 receptor,Ki,=,467.56,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(C[C@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3697994,CHEMBL217,Dopamine D2 receptor,Ki,=,116.64,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCCO1
CHEMBL3695396,CHEMBL217,Dopamine D2 receptor,Ki,=,288.7,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C(F)(F)F
CHEMBL3676864,CHEMBL217,Dopamine D2 receptor,Ki,=,96.68,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccnc2ccccc12
CHEMBL3664843,CHEMBL217,Dopamine D2 receptor,Ki,=,330.53,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)C1
CHEMBL3642745,CHEMBL217,Dopamine D2 receptor,Ki,=,914.7,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(C[C@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3695403,CHEMBL217,Dopamine D2 receptor,Ki,=,104.8,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=S(=O)(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(F)cc1
CHEMBL3676865,CHEMBL217,Dopamine D2 receptor,Ki,=,38.05,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCC1
CHEMBL3639968,CHEMBL217,Dopamine D2 receptor,Ki,=,241.28,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)N1CCc2ccccc21
CHEMBL3697992,CHEMBL217,Dopamine D2 receptor,Ki,=,89.81,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,C[C@@H](O)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642727,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=S(=O)(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(F)cc1
CHEMBL3676872,CHEMBL217,Dopamine D2 receptor,Ki,=,22.68,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CC1
CHEMBL3664832,CHEMBL217,Dopamine D2 receptor,Ki,=,515.7,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,Cc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)on1
CHEMBL3642712,CHEMBL217,Dopamine D2 receptor,Ki,=,1488.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3676913,CHEMBL217,Dopamine D2 receptor,Ki,=,34.26,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(-n2cccc2)cc1
CHEMBL3642738,CHEMBL217,Dopamine D2 receptor,Ki,=,1124.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(C[C@@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3695410,CHEMBL217,Dopamine D2 receptor,Ki,=,1461.2,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(C(F)(F)F)cc1
CHEMBL3676858,CHEMBL217,Dopamine D2 receptor,Ki,=,406.32,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(N2CCOCC2)cc1
CHEMBL3676881,CHEMBL217,Dopamine D2 receptor,Ki,=,47.35,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3642737,CHEMBL217,Dopamine D2 receptor,Ki,=,687.5,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(CC(F)(F)F)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3695409,CHEMBL217,Dopamine D2 receptor,Ki,=,2272.3,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(N2CCCCC2)cc1
CHEMBL3695427,CHEMBL217,Dopamine D2 receptor,Ki,=,253.0,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(CCC(F)(F)F)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3676857,CHEMBL217,Dopamine D2 receptor,Ki,=,42.66,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(CC(F)(F)F)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3642706,CHEMBL217,Dopamine D2 receptor,Ki,=,461.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1)c1ccnc2ccccc12
CHEMBL3698022,CHEMBL217,Dopamine D2 receptor,Ki,=,123.11,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(CF)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642714,CHEMBL217,Dopamine D2 receptor,Ki,=,1471.4,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(CC1COCCO1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642736,CHEMBL217,Dopamine D2 receptor,Ki,=,702.5,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,N#CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642732,CHEMBL217,Dopamine D2 receptor,Ki,=,475.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,C[C@]1(O)CC[C@@H](C(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)CC1
CHEMBL3664835,CHEMBL217,Dopamine D2 receptor,Ki,=,523.08,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(CC1CCCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642802,CHEMBL217,Dopamine D2 receptor,Ki,=,478.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(-n2cccn2)cc1
CHEMBL3642817,CHEMBL217,Dopamine D2 receptor,Ki,=,408.6,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(CC1(O)CCC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3676910,CHEMBL217,Dopamine D2 receptor,Ki,=,51.8,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(N2CCOCC2)nc1
CHEMBL3697962,CHEMBL217,Dopamine D2 receptor,Ki,=,68.55,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,COC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3676916,CHEMBL217,Dopamine D2 receptor,Ki,=,168.26,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC(C)(C)Oc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1
CHEMBL3664844,CHEMBL217,Dopamine D2 receptor,Ki,=,305.62,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(CC1(O)CCOCC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642759,CHEMBL217,Dopamine D2 receptor,Ki,=,425.6,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC#CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3697963,CHEMBL217,Dopamine D2 receptor,Ki,=,314.12,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,Cc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)on1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL3707630,B,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.",CHEMBL3638417,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL3695434,CHEMBL217,Dopamine D2 receptor,Ki,=,355.8,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CC[C@@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3642799,CHEMBL217,Dopamine D2 receptor,Ki,=,958.6,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1(O)CCC1
CHEMBL3642785,CHEMBL217,Dopamine D2 receptor,Ki,=,4510.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,Cc1cnc(N2CCN(CC[C@H]3CC[C@H](NC(=O)C4CCOCC4)CC3)CC2)c2c1OCC2
CHEMBL3664828,CHEMBL217,Dopamine D2 receptor,Ki,=,133.46,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)cn1
CHEMBL3642788,CHEMBL217,Dopamine D2 receptor,Ki,=,842.6,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C(O)C(F)(F)F
CHEMBL3676883,CHEMBL217,Dopamine D2 receptor,Ki,=,58.62,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,Cc1ccc(S(=O)(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1
CHEMBL3642761,CHEMBL217,Dopamine D2 receptor,Ki,=,1304.6,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,Cc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)on1
CHEMBL3642722,CHEMBL217,Dopamine D2 receptor,Ki,=,341.9,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(F)cc1
CHEMBL3695393,CHEMBL217,Dopamine D2 receptor,Ki,=,563.0,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccnc2ccccc12
CHEMBL3642811,CHEMBL217,Dopamine D2 receptor,Ki,=,680.5,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CO[C@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642795,CHEMBL217,Dopamine D2 receptor,Ki,=,998.4,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(N2CCOCC2)nc1
CHEMBL3664819,CHEMBL217,Dopamine D2 receptor,Ki,=,389.06,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(CC1CCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3697978,CHEMBL217,Dopamine D2 receptor,Ki,=,94.57,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(CC1(O)CCC1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3698008,CHEMBL217,Dopamine D2 receptor,Ki,=,81.08,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CC1(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)COC1
CHEMBL3642810,CHEMBL217,Dopamine D2 receptor,Ki,=,1132.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(-c2ccccc2)cc1
CHEMBL3697989,CHEMBL217,Dopamine D2 receptor,Ki,=,90.15,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CC(C)[C@@H](O)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3664888,CHEMBL217,Dopamine D2 receptor,Ki,=,229.7,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(CF)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3664876,CHEMBL217,Dopamine D2 receptor,Ki,=,268.44,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,C[C@@H](O)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642771,CHEMBL217,Dopamine D2 receptor,Ki,=,1143.6,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CCCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3695372,CHEMBL217,Dopamine D2 receptor,Ki,=,540.0,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,Cc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4CCO5)CC3)CC2)on1
CHEMBL3695356,CHEMBL217,Dopamine D2 receptor,Ki,=,305.0,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4occc34)CC2)CC1)C1CCOCC1
CHEMBL3642690,CHEMBL217,Dopamine D2 receptor,Ki,=,996.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CCOCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1
CHEMBL3695401,CHEMBL217,Dopamine D2 receptor,Ki,=,333.0,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3695438,CHEMBL217,Dopamine D2 receptor,Ki,=,437.7,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,C/C=C/CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3642796,CHEMBL217,Dopamine D2 receptor,Ki,=,222.9,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(-c2cccnc2)cc1
CHEMBL3676901,CHEMBL217,Dopamine D2 receptor,Ki,=,38.76,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=CN[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3664880,CHEMBL217,Dopamine D2 receptor,Ki,=,103.73,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CN1CCN(CC(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)CC1
CHEMBL3697957,CHEMBL217,Dopamine D2 receptor,Ki,=,74.48,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3676868,CHEMBL217,Dopamine D2 receptor,Ki,=,41.51,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,N#CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3642760,CHEMBL217,Dopamine D2 receptor,Ki,=,837.2,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=CN[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3695428,CHEMBL217,Dopamine D2 receptor,Ki,=,1067.6,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CC(C)CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3642789,CHEMBL217,Dopamine D2 receptor,Ki,=,1384.9,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,COC(CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)OC
CHEMBL3664858,CHEMBL217,Dopamine D2 receptor,Ki,=,463.7,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCCO1
CHEMBL3664862,CHEMBL217,Dopamine D2 receptor,Ki,=,245.54,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1(C(F)(F)F)CC1
CHEMBL3695425,CHEMBL217,Dopamine D2 receptor,Ki,=,175.51,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CC(C)(O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3642763,CHEMBL217,Dopamine D2 receptor,Ki,=,2562.7,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CN(C)C(=O)CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642766,CHEMBL217,Dopamine D2 receptor,Ki,=,887.4,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC[C@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3642686,CHEMBL217,Dopamine D2 receptor,Ki,=,1158.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,COCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1
CHEMBL3695422,CHEMBL217,Dopamine D2 receptor,Ki,=,3728.0,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,Cc1nc(-c2ccc(C(=O)N[C@H]3CC[C@H](CCN4CCC(c5cccc6c5CCO6)CC4)CC3)cc2)no1
CHEMBL3697980,CHEMBL217,Dopamine D2 receptor,Ki,=,219.64,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(C[C@@H]1CCCCO1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3664814,CHEMBL217,Dopamine D2 receptor,Ki,=,253.68,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3695364,CHEMBL217,Dopamine D2 receptor,Ki,=,153.9,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CS(=O)(=O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4occc34)CC2)CC1
CHEMBL3664841,CHEMBL217,Dopamine D2 receptor,Ki,=,305.12,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CC(Cl)C1
CHEMBL3695404,CHEMBL217,Dopamine D2 receptor,Ki,=,250.9,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3642721,CHEMBL217,Dopamine D2 receptor,Ki,=,481.2,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccccc1
CHEMBL3642803,CHEMBL217,Dopamine D2 receptor,Ki,=,2147.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,Cc1nc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCN(c5nccc6c5CCO6)CC4)CC3)c2)no1
CHEMBL3676909,CHEMBL217,Dopamine D2 receptor,Ki,=,16.72,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(-c2cccnc2)cc1
CHEMBL3697952,CHEMBL217,Dopamine D2 receptor,Ki,=,173.34,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3664882,CHEMBL217,Dopamine D2 receptor,Ki,=,63.45,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=S(=O)(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccccc1
CHEMBL3676921,CHEMBL217,Dopamine D2 receptor,Ki,=,34.19,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(CC1COC1)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3697955,CHEMBL217,Dopamine D2 receptor,Ki,=,172.17,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(C[C@@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3676860,CHEMBL217,Dopamine D2 receptor,Ki,=,43.49,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3676912,CHEMBL217,Dopamine D2 receptor,Ki,=,105.59,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1cnc(N2CCOCC2)cn1
CHEMBL3664856,CHEMBL217,Dopamine D2 receptor,Ki,=,393.12,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,CCOCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642783,CHEMBL217,Dopamine D2 receptor,Ki,=,2471.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3ncc(C)c4occc34)CC2)CC1
CHEMBL3698006,CHEMBL217,Dopamine D2 receptor,Ki,=,752.51,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)CC1
CHEMBL3697979,CHEMBL217,Dopamine D2 receptor,Ki,=,61.45,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1(O)CC1
CHEMBL3664857,CHEMBL217,Dopamine D2 receptor,Ki,=,262.23,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(CC1(O)CCC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642784,CHEMBL217,Dopamine D2 receptor,Ki,=,2308.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3ncc(C)c4c3CCO4)CC2)CC1
CHEMBL3697985,CHEMBL217,Dopamine D2 receptor,Ki,=,84.94,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1(O)CCC1
CHEMBL3676879,CHEMBL217,Dopamine D2 receptor,Ki,=,41.33,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC(C)(O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3695362,CHEMBL217,Dopamine D2 receptor,Ki,=,91.9,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4occc34)CC2)CC1
CHEMBL3695375,CHEMBL217,Dopamine D2 receptor,Ki,=,687.4,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(C[C@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3664815,CHEMBL217,Dopamine D2 receptor,Ki,=,426.6,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3697983,CHEMBL217,Dopamine D2 receptor,Ki,=,183.73,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(C[C@H]1CCCOC1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3676923,CHEMBL217,Dopamine D2 receptor,Ki,=,129.19,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C12CC3CC(CC(C3)C1)C2
CHEMBL3698013,CHEMBL217,Dopamine D2 receptor,Ki,=,116.62,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,COC(C)(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642776,CHEMBL217,Dopamine D2 receptor,Ki,=,429.7,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nc(C)cc4occc34)CC2)CC1
CHEMBL3664872,CHEMBL217,Dopamine D2 receptor,Ki,=,1047.58,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1COc2ccccc2C1
CHEMBL3697966,CHEMBL217,Dopamine D2 receptor,Ki,=,91.22,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(CC(F)(F)F)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3664842,CHEMBL217,Dopamine D2 receptor,Ki,=,258.19,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(CC1COC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3698021,CHEMBL217,Dopamine D2 receptor,Ki,=,30.42,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3697993,CHEMBL217,Dopamine D2 receptor,Ki,=,218.89,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCOCC1
CHEMBL3642696,CHEMBL217,Dopamine D2 receptor,Ki,=,163.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1
CHEMBL3676893,CHEMBL217,Dopamine D2 receptor,Ki,=,58.22,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(CC1CCC1)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3642680,CHEMBL217,Dopamine D2 receptor,Ki,=,802.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5occc45)CC3)CC2)C1
CHEMBL3695423,CHEMBL217,Dopamine D2 receptor,Ki,=,194.8,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CS(=O)(=O)c1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4CCO5)CC3)CC2)s1
CHEMBL3642701,CHEMBL217,Dopamine D2 receptor,Ki,=,144.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1
CHEMBL3642809,CHEMBL217,Dopamine D2 receptor,Ki,=,163.3,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(-n2cccc2)cc1
CHEMBL3697958,CHEMBL217,Dopamine D2 receptor,Ki,=,141.87,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(CC1CC1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642754,CHEMBL217,Dopamine D2 receptor,Ki,=,754.6,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,O=C(CC1COC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3676874,CHEMBL217,Dopamine D2 receptor,Ki,=,52.86,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(CC1CCCO1)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3695421,CHEMBL217,Dopamine D2 receptor,Ki,=,1700.0,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(-n2cccn2)cc1
CHEMBL3695408,CHEMBL217,Dopamine D2 receptor,Ki,=,139.6,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,N#CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3664818,CHEMBL217,Dopamine D2 receptor,Ki,=,332.35,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(C[C@@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3697959,CHEMBL217,Dopamine D2 receptor,Ki,=,238.22,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,COCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3695395,CHEMBL217,Dopamine D2 receptor,Ki,=,151.0,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4CCO5)CC3)CC2)cn1
CHEMBL3676886,CHEMBL217,Dopamine D2 receptor,Ki,=,36.41,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,Cc1cc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)on1
CHEMBL3664824,CHEMBL217,Dopamine D2 receptor,Ki,=,410.4,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(CCC(F)(F)F)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3664840,CHEMBL217,Dopamine D2 receptor,Ki,=,402.37,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,COC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3676859,CHEMBL217,Dopamine D2 receptor,Ki,=,39.54,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3642715,CHEMBL217,Dopamine D2 receptor,Ki,=,1545.4,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,COCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3676851,CHEMBL217,Dopamine D2 receptor,Ki,=,80.1,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,COCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3664826,CHEMBL217,Dopamine D2 receptor,Ki,=,507.18,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,COCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642731,CHEMBL217,Dopamine D2 receptor,Ki,=,506.5,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,C[C@]1(O)CC[C@H](C(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)CC1
CHEMBL3695373,CHEMBL217,Dopamine D2 receptor,Ki,=,570.9,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(CO)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3695381,CHEMBL217,Dopamine D2 receptor,Ki,=,298.6,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1(O)CC1
CHEMBL3642791,CHEMBL217,Dopamine D2 receptor,Ki,=,516.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CS(=O)(=O)c1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)s1
CHEMBL3695392,CHEMBL217,Dopamine D2 receptor,Ki,=,305.5,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1(O)CCC1
CHEMBL3639415,CHEMBL217,Dopamine D2 receptor,Ki,=,486.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1
CHEMBL3676895,CHEMBL217,Dopamine D2 receptor,Ki,=,151.81,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(C(F)(F)F)cc1
CHEMBL3697972,CHEMBL217,Dopamine D2 receptor,Ki,=,105.93,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,O=C(CC1COC1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3642755,CHEMBL217,Dopamine D2 receptor,Ki,=,322.5,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3676902,CHEMBL217,Dopamine D2 receptor,Ki,=,65.71,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CCCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3676875,CHEMBL217,Dopamine D2 receptor,Ki,=,28.11,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CC1(F)F
CHEMBL3664825,CHEMBL217,Dopamine D2 receptor,Ki,=,235.5,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C(O)C(F)(F)F
CHEMBL3664879,CHEMBL217,Dopamine D2 receptor,Ki,=,196.5,nM,CHEMBL3707825,B,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3638396,KI,COC1(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)CCCCC1
CHEMBL3676899,CHEMBL217,Dopamine D2 receptor,Ki,=,57.95,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,C/C=C/CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3697984,CHEMBL217,Dopamine D2 receptor,Ki,=,145.23,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3676925,CHEMBL217,Dopamine D2 receptor,Ki,=,291.61,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,CC(C)Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1
CHEMBL3642697,CHEMBL217,Dopamine D2 receptor,Ki,=,305.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1
CHEMBL3642747,CHEMBL217,Dopamine D2 receptor,Ki,=,523.9,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CC(C)(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1
CHEMBL3676853,CHEMBL217,Dopamine D2 receptor,Ki,=,85.9,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(CC1COCCO1)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1
CHEMBL3642708,CHEMBL217,Dopamine D2 receptor,Ki,=,217.0,nM,CHEMBL3705135,B,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",CHEMBL3639183,KI,CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1
CHEMBL3695391,CHEMBL217,Dopamine D2 receptor,Ki,=,495.1,nM,CHEMBL3705383,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3638568,KI,CC(C)(O)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1
CHEMBL3697951,CHEMBL217,Dopamine D2 receptor,Ki,=,67.35,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1
CHEMBL3676894,CHEMBL217,Dopamine D2 receptor,Ki,=,25.8,nM,CHEMBL3706129,B,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",CHEMBL3639297,KI,O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(Cl)cc1
CHEMBL3697991,CHEMBL217,Dopamine D2 receptor,Ki,=,250.97,nM,CHEMBL3707837,B,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",CHEMBL3639169,KI,COC1(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)CCCCC1
CHEMBL3735756,CHEMBL217,Dopamine D2 receptor,Ki,=,1729.0,nM,CHEMBL3736706,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in stable fibroblast after 90 mins by scintillation counting method,CHEMBL3734659,KI,COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC
CHEMBL3740360,CHEMBL217,Dopamine D2 receptor,Ki,=,6230.0,nM,CHEMBL3742610,B,Displacement of [3H]-sulpiride from human dopamine D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting,CHEMBL3739355,KI,Clc1ccc(N2CCN(CCCCNc3noc(-c4ccccc4)n3)CC2)c(Cl)c1
CHEMBL3740498,CHEMBL217,Dopamine D2 receptor,Ki,=,1290.0,nM,CHEMBL3742610,B,Displacement of [3H]-sulpiride from human dopamine D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting,CHEMBL3739355,KI,Cl.Clc1ccc(N2CCN(CCCCNc3noc(-c4ccccc4)n3)CC2)c(Cl)c1
CHEMBL3739820,CHEMBL217,Dopamine D2 receptor,Ki,=,79630.0,nM,CHEMBL3742610,B,Displacement of [3H]-sulpiride from human dopamine D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting,CHEMBL3739355,KI,Cl.Clc1ccc(N2CCN(CCCCNc3noc(-c4ccccc4)n3)CC2)cc1
CHEMBL3742076,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL3744663,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,CHEMBL3739404,KI,CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2ccccc2F)CC1
CHEMBL3740054,CHEMBL217,Dopamine D2 receptor,Ki,=,102.0,nM,CHEMBL3744663,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,CHEMBL3739404,KI,CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2cccc(F)c2)CC1
CHEMBL3740235,CHEMBL217,Dopamine D2 receptor,Ki,=,147.0,nM,CHEMBL3744663,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,CHEMBL3739404,KI,CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2cc(F)ccc2F)CC1
CHEMBL3739745,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL3744663,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,CHEMBL3739404,KI,CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2cnn(C)c2)CC1
CHEMBL3739680,CHEMBL217,Dopamine D2 receptor,Ki,=,104.0,nM,CHEMBL3744663,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,CHEMBL3739404,KI,CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2cccc3ncccc23)CC1
CHEMBL3740055,CHEMBL217,Dopamine D2 receptor,Ki,=,85.0,nM,CHEMBL3744663,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,CHEMBL3739404,KI,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1cccc(Cl)c1
CHEMBL2159466,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL3744663,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,CHEMBL3739404,KI,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1ccc(F)c(F)c1
CHEMBL3747052,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,CC(C)c1ccccc1OCCN1CCC(N(C)S(=O)(=O)c2ccccc2)CC1
CHEMBL3747114,CHEMBL217,Dopamine D2 receptor,Ki,=,45.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,CC(C)c1ccccc1OCCN1CCC(N(C)S(=O)(=O)c2cccc(F)c2)CC1
CHEMBL3747071,CHEMBL217,Dopamine D2 receptor,Ki,=,50.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,CC(C)c1ccccc1OCCN1CCC(N(C)S(=O)(=O)c2ccc(F)cc2)CC1
CHEMBL3747459,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,CC(C)c1ccccc1OCCN1CCC(N(C)S(=O)(=O)c2cnn(C)c2)CC1
CHEMBL3746806,CHEMBL217,Dopamine D2 receptor,Ki,=,360.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,CN(C1CCN(CCOc2ccccc2C(C)(C)C)CC1)S(=O)(=O)c1ccccc1
CHEMBL3745975,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,CN(C1CCN(CCOc2ccccc2C(C)(C)C)CC1)S(=O)(=O)c1cccc(F)c1
CHEMBL3746079,CHEMBL217,Dopamine D2 receptor,Ki,=,324.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,CN(C1CCN(CCOc2ccccc2C(C)(C)C)CC1)S(=O)(=O)c1ccc(F)cc1
CHEMBL3746771,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,CN(C1CCN(CCOc2ccccc2C(C)(C)C)CC1)S(=O)(=O)c1cnn(C)c1
CHEMBL3746713,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,CN(C1CCN(CCOc2ccccc2-c2ccccc2)CC1)S(=O)(=O)c1ccccc1
CHEMBL3745815,CHEMBL217,Dopamine D2 receptor,Ki,=,54.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,CN(C1CCN(CCOc2ccccc2-c2ccccc2)CC1)S(=O)(=O)c1ccc(F)cc1
CHEMBL3747003,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,CN(C1CCN(CCOc2ccccc2-c2ccccc2)CC1)S(=O)(=O)c1cnn(C)c1
CHEMBL3747148,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,CC(C)c1ccccc1OCCN1CCC(N(CC2CC2)S(=O)(=O)c2cccc(F)c2)CC1
CHEMBL3747744,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,CC(C)c1ccccc1OCCN1CCC(N(CC2CC2)S(=O)(=O)c2ccc(F)cc2)CC1
CHEMBL3745882,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,CC(C)c1ccccc1OCCN1CCC(N(CC2CC2)S(=O)(=O)c2cnn(C)c2)CC1
CHEMBL3746083,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,CC(C)(C)c1ccccc1OCCN1CCC(N(CC2CC2)S(=O)(=O)c2ccc(F)cc2)CC1
CHEMBL3746493,CHEMBL217,Dopamine D2 receptor,Ki,=,230.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,Cn1cc(S(=O)(=O)N(CC2CC2)C2CCN(CCOc3ccccc3C(C)(C)C)CC2)cn1
CHEMBL3745853,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,O=S(=O)(c1ccc(F)cc1)N(CC1CC1)C1CCN(CCOc2ccccc2-c2ccccc2)CC1
CHEMBL3747240,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL3750144,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,CHEMBL3745654,KI,Cn1cc(S(=O)(=O)N(CC2CC2)C2CCN(CCOc3ccccc3-c3ccccc3)CC2)cn1
CHEMBL3753318,CHEMBL217,Dopamine D2 receptor,Ki,=,5128.61,nM,CHEMBL3756490,B,Binding affinity to D2 dopamine receptor (unknown origin) by competition binding assay,CHEMBL3751848,KI,C=CCN(CC=C)CCc1c[nH]c2ccc(C)cc12
CHEMBL3752900,CHEMBL217,Dopamine D2 receptor,Ki,=,1862.09,nM,CHEMBL3756490,B,Binding affinity to D2 dopamine receptor (unknown origin) by competition binding assay,CHEMBL3751848,KI,C=CCN(CC=C)CCc1c[nH]c2ccc(Cl)cc12
CHEMBL3754166,CHEMBL217,Dopamine D2 receptor,Ki,=,4365.16,nM,CHEMBL3756490,B,Binding affinity to D2 dopamine receptor (unknown origin) by competition binding assay,CHEMBL3751848,KI,C=CCN(CC=C)CCc1c[nH]c2ccc(Br)cc12
CHEMBL3754496,CHEMBL217,Dopamine D2 receptor,Ki,=,2454.71,nM,CHEMBL3756490,B,Binding affinity to D2 dopamine receptor (unknown origin) by competition binding assay,CHEMBL3751848,KI,C=CCN(CC=C)CCc1c[nH]c2ccc(F)cc12
CHEMBL3752512,CHEMBL217,Dopamine D2 receptor,Ki,=,45.0,nM,CHEMBL3757879,B,Displacement of [3H]spiperone from human cloned D2 dopamine receptor incubated for 90 mins by radioligand binding assay,CHEMBL3751719,KI,CN1CCc2ccccc2Cc2sccc2CC1
CHEMBL201093,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL3757879,B,Displacement of [3H]spiperone from human cloned D2 dopamine receptor incubated for 90 mins by radioligand binding assay,CHEMBL3751719,KI,CN1CCc2ccccc2Cc2ccsc2CC1
CHEMBL3753266,CHEMBL217,Dopamine D2 receptor,Ki,=,1.5,nM,CHEMBL3757879,B,Displacement of [3H]spiperone from human cloned D2 dopamine receptor incubated for 90 mins by radioligand binding assay,CHEMBL3751719,KI,CN1CCc2ccccc2Cc2sc3ccccc3c2CC1
CHEMBL441618,CHEMBL217,Dopamine D2 receptor,Ki,=,44.5,nM,CHEMBL3757879,B,Displacement of [3H]spiperone from human cloned D2 dopamine receptor incubated for 90 mins by radioligand binding assay,CHEMBL3751719,KI,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL201525,CHEMBL217,Dopamine D2 receptor,Ki,=,56.5,nM,CHEMBL3757879,B,Displacement of [3H]spiperone from human cloned D2 dopamine receptor incubated for 90 mins by radioligand binding assay,CHEMBL3751719,KI,CN1CCc2ccccc2Cc2ccccc2CC1
CHEMBL201170,CHEMBL217,Dopamine D2 receptor,Ki,=,44.5,nM,CHEMBL3757879,B,Displacement of [3H]spiperone from human cloned D2 dopamine receptor incubated for 90 mins by radioligand binding assay,CHEMBL3751719,KI,CN1CCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,431.0,nM,CHEMBL3757886,B,Displacement of [3H]N-methylspiperone from human cloned D2 dopamine receptor expressed in human fibroblasts incubated for 90 mins by scintillation counting based radioligand binding assay,CHEMBL3751719,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,53.0,nM,CHEMBL3757886,B,Displacement of [3H]N-methylspiperone from human cloned D2 dopamine receptor expressed in human fibroblasts incubated for 90 mins by scintillation counting based radioligand binding assay,CHEMBL3751719,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL3187365,CHEMBL217,Dopamine D2 receptor,Ki,=,8.9,nM,CHEMBL3757886,B,Displacement of [3H]N-methylspiperone from human cloned D2 dopamine receptor expressed in human fibroblasts incubated for 90 mins by scintillation counting based radioligand binding assay,CHEMBL3751719,KI,CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1
CHEMBL3758368,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,COc1ccccc1N1CCN(CCCCCOc2ccc3ccccc3c2)CC1
CHEMBL3758913,CHEMBL217,Dopamine D2 receptor,Ki,=,322.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,COc1ccccc1N1CCN(CCCCNC(=O)CC2CCCCC2)CC1
CHEMBL26962,CHEMBL217,Dopamine D2 receptor,Ki,=,168.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,COc1ccccc1N1CCN(CCCCNC(=O)C2CCCCC2)CC1
CHEMBL3760063,CHEMBL217,Dopamine D2 receptor,Ki,=,482.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,COc1ccccc1N1CCN(CCCCNC(=O)N2CCOCC2)CC1
CHEMBL3759312,CHEMBL217,Dopamine D2 receptor,Ki,=,1549.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,COc1ccccc1N1CCN(CCCCNC(=O)N(C)c2ccccc2)CC1
CHEMBL3758991,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,COc1ccccc1N1CCN(CCCCNC(=O)Nc2cccc(Cl)c2)CC1
CHEMBL3758665,CHEMBL217,Dopamine D2 receptor,Ki,=,911.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,CCOC(=O)Nc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1
CHEMBL3758610,CHEMBL217,Dopamine D2 receptor,Ki,=,55.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,CS(=O)(=O)Nc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1
CHEMBL3760110,CHEMBL217,Dopamine D2 receptor,Ki,=,131.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,O=C(NCCCCN1CCN(c2cccc3[nH]c(=O)[nH]c23)CC1)c1ccc2ccccc2c1
CHEMBL3759441,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,O=C1Cc2c(cccc2N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)N1
CHEMBL3759865,CHEMBL217,Dopamine D2 receptor,Ki,=,95.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,O=C(NCCCCN1CCN(c2cccc3[nH]ccc23)CC1)c1ccc2ccccc2c1
CHEMBL3759491,CHEMBL217,Dopamine D2 receptor,Ki,=,373.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,O=C(NCCCCN1CCN(c2cccc(O)c2)CC1)c1ccc2ccccc2c1
CHEMBL3758711,CHEMBL217,Dopamine D2 receptor,Ki,=,1553.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1ccc2ccccc2c1
CHEMBL3758741,CHEMBL217,Dopamine D2 receptor,Ki,=,302.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,Cc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1C
CHEMBL154508,CHEMBL217,Dopamine D2 receptor,Ki,=,1149.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2ccccc2c1
CHEMBL3758920,CHEMBL217,Dopamine D2 receptor,Ki,=,12143.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,O=C(NCCCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc2ccccc2c1
CHEMBL3759513,CHEMBL217,Dopamine D2 receptor,Ki,=,3323.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2)CC1)c1ccc2ccccc2c1
CHEMBL218203,CHEMBL217,Dopamine D2 receptor,Ki,=,238.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1ccc2ccccc2c1
CHEMBL3759607,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,O=C(NCCCCN1CCN(c2ccccc2F)CC1)c1ccc2ccccc2c1
CHEMBL3758330,CHEMBL217,Dopamine D2 receptor,Ki,=,5031.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,O=C(NCCCCN1CCN(c2ccccc2O)CC1)c1ccc2ccccc2c1
CHEMBL3758881,CHEMBL217,Dopamine D2 receptor,Ki,=,404.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,Cc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL25236,CHEMBL217,Dopamine D2 receptor,Ki,=,186.0,nM,CHEMBL3762401,B,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,CHEMBL3758127,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL3758591,CHEMBL217,Dopamine D2 receptor,Ki,=,322.0,nM,CHEMBL3762073,B,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL3758131,KI,O=S(=O)(NC1CCN(CCOc2ccccc2C2CCCC2)CC1)c1cccc(F)c1
CHEMBL3759617,CHEMBL217,Dopamine D2 receptor,Ki,=,199.0,nM,CHEMBL3762073,B,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL3758131,KI,CC(C)c1cccc(OCCN2C3CCC2CC(NS(=O)(=O)c2cccc(F)c2)C3)c1
CHEMBL3759205,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL3762073,B,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL3758131,KI,CC(C)c1cccc(OCCN2C3CCC2CC(NS(=O)(=O)c2ccc(F)cc2)C3)c1
CHEMBL3759819,CHEMBL217,Dopamine D2 receptor,Ki,=,94.0,nM,CHEMBL3762073,B,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL3758131,KI,O=S(=O)(NC1CC2CCC(C1)N2CCOc1cccc(-c2ccccc2)c1)c1cccc(Cl)c1
CHEMBL3740054,CHEMBL217,Dopamine D2 receptor,Ki,=,102.0,nM,CHEMBL3762073,B,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells after 1 hr,CHEMBL3758131,KI,CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2cccc(F)c2)CC1
CHEMBL85606,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2
CHEMBL3764557,CHEMBL217,Dopamine D2 receptor,Ki,=,12589.25,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cc1ncoc1-c1nnc(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3764586,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cc1ncoc1-c1nnc(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3F)C2)n1C
CHEMBL3764833,CHEMBL217,Dopamine D2 receptor,Ki,=,15848.93,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cc1ncoc1-c1nnc(SCCCN2CCOC(c3ccc(Br)cc3)C2)n1C
CHEMBL3764191,CHEMBL217,Dopamine D2 receptor,Ki,=,7943.28,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccsc1
CHEMBL3764884,CHEMBL217,Dopamine D2 receptor,Ki,=,7943.28,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1nccs1
CHEMBL3764739,CHEMBL217,Dopamine D2 receptor,Ki,=,6309.57,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1cccc1-c1nnc(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3764245,CHEMBL217,Dopamine D2 receptor,Ki,=,7943.28,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCCCC1
CHEMBL3763200,CHEMBL217,Dopamine D2 receptor,Ki,=,12589.25,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccncc1
CHEMBL3764612,CHEMBL217,Dopamine D2 receptor,Ki,=,15848.93,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccnc1
CHEMBL3765169,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cnccn1
CHEMBL3764306,CHEMBL217,Dopamine D2 receptor,Ki,=,25118.86,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)nc1
CHEMBL3765422,CHEMBL217,Dopamine D2 receptor,Ki,=,15848.93,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cncc(C(N)=O)c1
CHEMBL3765426,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)cc1
CHEMBL3765426,CHEMBL217,Dopamine D2 receptor,Ki,=,12589.25,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)cc1
CHEMBL3764212,CHEMBL217,Dopamine D2 receptor,Ki,=,15848.93,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccc(C(N)=O)c1
CHEMBL3765267,CHEMBL217,Dopamine D2 receptor,Ki,=,19952.62,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,CC(=O)c1ccc(-c2nnc(SCCCN3CCOC(c4ccc(C(F)(F)F)cc4)C3)n2C)cc1
CHEMBL3764639,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C#N)cc1
CHEMBL3764597,CHEMBL217,Dopamine D2 receptor,Ki,=,15848.93,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3F)C2)nnc1-c1ccc(C(N)=O)cc1
CHEMBL3764143,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(-c2ncco2)cc1
CHEMBL3764143,CHEMBL217,Dopamine D2 receptor,Ki,=,15848.93,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(-c2ncco2)cc1
CHEMBL3764143,CHEMBL217,Dopamine D2 receptor,Ki,=,5011.87,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(-c2ncco2)cc1
CHEMBL3765072,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(-n2cnnc2)cc1
CHEMBL3765285,CHEMBL217,Dopamine D2 receptor,Ki,=,12589.25,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(-c2nnco2)cc1
CHEMBL3764246,CHEMBL217,Dopamine D2 receptor,Ki,=,25118.86,nM,CHEMBL3768209,B,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,CHEMBL3763143,KI,Cc1ccc(C2CN(CCCSc3nnc(-c4ccc(-c5noc(C)n5)cc4)n3C)CCO2)cc1
CHEMBL3769968,CHEMBL217,Dopamine D2 receptor,Ki,=,4897.79,nM,CHEMBL3774018,B,Binding affinity to human dopamine D2 receptor by radioligand binding assay,CHEMBL3769385,KI,C=CCOc1cc(F)c(F)cc1C1CC1CN.Cl
CHEMBL3769968,CHEMBL217,Dopamine D2 receptor,Ki,=,4898.0,nM,CHEMBL3774018,B,Binding affinity to human dopamine D2 receptor by radioligand binding assay,CHEMBL3769385,KI,C=CCOc1cc(F)c(F)cc1C1CC1CN.Cl
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,9.0,nM,CHEMBL3771916,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL3769356,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL3771222,CHEMBL217,Dopamine D2 receptor,Ki,=,261.0,nM,CHEMBL3771916,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL3769356,KI,CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1=O
CHEMBL3770110,CHEMBL217,Dopamine D2 receptor,Ki,=,2261.0,nM,CHEMBL3771916,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL3769356,KI,Cc1ccc(N2CCN(CC(O)CN3C(=O)NC(C)(c4ccc(F)cc4)C3=O)CC2)cc1C
CHEMBL3770581,CHEMBL217,Dopamine D2 receptor,Ki,=,1976.0,nM,CHEMBL3771916,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL3769356,KI,CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3ccc(Cl)c(Cl)c3)CC2)C1=O
CHEMBL3769536,CHEMBL217,Dopamine D2 receptor,Ki,=,6790.0,nM,CHEMBL3771916,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL3769356,KI,CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3ccc(F)cc3F)CC2)C1=O
CHEMBL3770522,CHEMBL217,Dopamine D2 receptor,Ki,=,4255.0,nM,CHEMBL3771916,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL3769356,KI,CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3ccc(Cl)cc3)CC2)C1=O
CHEMBL3770293,CHEMBL217,Dopamine D2 receptor,Ki,=,5641.0,nM,CHEMBL3771916,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL3769356,KI,CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3ccc(F)cc3)CC2)C1=O
CHEMBL3769612,CHEMBL217,Dopamine D2 receptor,Ki,=,1814.0,nM,CHEMBL3771916,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL3769356,KI,Cc1ccc(C)c(N2CCN(CC(O)CN3C(=O)NC(C)(c4ccc(F)cc4)C3=O)CC2)c1
CHEMBL3771309,CHEMBL217,Dopamine D2 receptor,Ki,=,302.0,nM,CHEMBL3771916,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL3769356,KI,CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3cccc(Cl)c3Cl)CC2)C1=O
CHEMBL3770639,CHEMBL217,Dopamine D2 receptor,Ki,=,931.0,nM,CHEMBL3771916,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL3769356,KI,CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3ccccc3C#N)CC2)C1=O
CHEMBL3769534,CHEMBL217,Dopamine D2 receptor,Ki,=,127.0,nM,CHEMBL3771916,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL3769356,KI,CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3ccc(F)cc3)C2=O)CC1
CHEMBL3769606,CHEMBL217,Dopamine D2 receptor,Ki,=,839.0,nM,CHEMBL3771916,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL3769356,KI,CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3ccccc3Cl)CC2)C1=O
CHEMBL3770473,CHEMBL217,Dopamine D2 receptor,Ki,=,1709.0,nM,CHEMBL3771916,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL3769356,KI,CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3ccccc3F)CC2)C1=O
CHEMBL3769441,CHEMBL217,Dopamine D2 receptor,Ki,=,5187.0,nM,CHEMBL3771916,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL3769356,KI,COc1cccc(N2CCN(CC(O)CN3C(=O)NC(C)(c4ccc(F)cc4)C3=O)CC2)c1
CHEMBL3769836,CHEMBL217,Dopamine D2 receptor,Ki,=,2906.0,nM,CHEMBL3771916,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL3769356,KI,CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3ccccc3)CC2)C1=O
CHEMBL3302600,CHEMBL217,Dopamine D2 receptor,Ki,=,715.0,nM,CHEMBL3771916,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,CHEMBL3769356,KI,COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3ccc(F)cc3)C2=O)CC1
CHEMBL3775589,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL3776848,B,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of dopamine-mediated Ca+2 stimulation pretreated for 10 mins followed by addition of dopamine by fluo-4 AM dye-based FLIPR assay,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccccc4)C3C2)n1C
CHEMBL3775226,CHEMBL217,Dopamine D2 receptor,Ki,=,50.12,nM,CHEMBL3776848,B,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of dopamine-mediated Ca+2 stimulation pretreated for 10 mins followed by addition of dopamine by fluo-4 AM dye-based FLIPR assay,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4F)C3C2)n1C
CHEMBL3774431,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1C1CCCCC1
CHEMBL3774431,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1C1CCCCC1
CHEMBL3774431,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1C1CCCCC1
CHEMBL3774463,CHEMBL217,Dopamine D2 receptor,Ki,=,6309.57,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1C1CCCCC1
CHEMBL3774462,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1C1CCCC1
CHEMBL3774462,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1C1CCCC1
CHEMBL3774462,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1C1CCCC1
CHEMBL3775737,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1C1CCOCC1
CHEMBL3775737,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1C1CCOCC1
CHEMBL3775737,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1C1CCOCC1
CHEMBL3774649,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccccc4)C3C2)nnc1C1CCOCC1
CHEMBL3774649,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccccc4)C3C2)nnc1C1CCOCC1
CHEMBL3774649,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccccc4)C3C2)nnc1C1CCOCC1
CHEMBL3775243,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1N1CCOCC1
CHEMBL3775243,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1N1CCOCC1
CHEMBL3775243,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1N1CCOCC1
CHEMBL3775350,CHEMBL217,Dopamine D2 receptor,Ki,=,3981.07,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4c(F)cc(F)cc4F)C3C2)nnc1-c1ccn(C)c(=O)c1
CHEMBL3775350,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4c(F)cc(F)cc4F)C3C2)nnc1-c1ccn(C)c(=O)c1
CHEMBL3775350,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4c(F)cc(F)cc4F)C3C2)nnc1-c1ccn(C)c(=O)c1
CHEMBL3774569,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1-c1ccn(C)c(=O)c1
CHEMBL3775033,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1-c1cc[nH]c(=O)c1
CHEMBL3774769,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccc(=O)n(C)c1
CHEMBL3774769,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccc(=O)n(C)c1
CHEMBL3774769,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccc(=O)n(C)c1
CHEMBL3775718,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccc(=O)[nH]c1
CHEMBL3774411,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cc[nH]c(=O)c1
CHEMBL3774411,CHEMBL217,Dopamine D2 receptor,Ki,=,1995.26,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cc[nH]c(=O)c1
CHEMBL3774411,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cc[nH]c(=O)c1
CHEMBL3775408,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1ccccn1
CHEMBL3775214,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1ccncc1
CHEMBL3775197,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1cccnc1
CHEMBL3775197,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1cccnc1
CHEMBL3775197,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1cccnc1
CHEMBL3775554,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccccn1
CHEMBL3774490,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccncc1
CHEMBL3775604,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cccnc1
CHEMBL3775482,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1cc(-c2nnc(SCCCN3CC4CCN(c5ccc(C(F)(F)F)cc5)C4C3)n2C)on1
CHEMBL3775256,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1nccs1
CHEMBL3775036,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1cc(-c2nnc(SCCCN3CC4CCN(c5ccc(C(F)(F)F)cc5)C4C3)n2C)cn1
CHEMBL3775583,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cccnn1
CHEMBL3774534,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccnnc1
CHEMBL3775810,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccncn1
CHEMBL3775572,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cncnc1
CHEMBL3774519,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4c(F)cc(F)cc4F)C3C2)nnc1-c1cnccn1
CHEMBL3775771,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4c(F)cccc4F)C3C2)nnc1-c1cnccn1
CHEMBL3775946,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4c(F)cccc4C(F)(F)F)C3C2)nnc1-c1cnccn1
CHEMBL3774911,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4C(F)(F)F)C3C2)nnc1-c1cnccn1
CHEMBL3775753,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,COc1cc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)n4C)CC32)ccc1F
CHEMBL3774591,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4F)C3C2)nnc1-c1cnccn1
CHEMBL3774591,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4F)C3C2)nnc1-c1cnccn1
CHEMBL3774591,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4F)C3C2)nnc1-c1cnccn1
CHEMBL3775598,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,CC(C)Oc1ccccc1N1CCC2CN(CCCSc3nnc(-c4cnccn4)n3C)CC21
CHEMBL3775598,CHEMBL217,Dopamine D2 receptor,Ki,=,5011.87,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,CC(C)Oc1ccccc1N1CCC2CN(CCCSc3nnc(-c4cnccn4)n3C)CC21
CHEMBL3775598,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,CC(C)Oc1ccccc1N1CCC2CN(CCCSc3nnc(-c4cnccn4)n3C)CC21
CHEMBL3775631,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccccc4C#N)C3C2)nnc1-c1cnccn1
CHEMBL3775667,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4cccc(C#N)c4)C3C2)nnc1-c1cnccn1
CHEMBL3775097,CHEMBL217,Dopamine D2 receptor,Ki,=,6309.57,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C#N)cc4)C3C2)nnc1-c1cnccn1
CHEMBL3774621,CHEMBL217,Dopamine D2 receptor,Ki,=,31.62,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccccc4OC(F)(F)F)C3C2)nnc1-c1cnccn1
CHEMBL3774895,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4cccc(OC(F)(F)F)c4)C3C2)nnc1-c1cnccn1
CHEMBL3775386,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(OC(F)(F)F)cc4)C3C2)nnc1-c1cnccn1
CHEMBL3775618,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,COc1ccccc1N1CCC2CN(CCCSc3nnc(-c4cnccn4)n3C)CC21
CHEMBL3774412,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,COc1cccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)n4C)CC32)c1
CHEMBL3775023,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,COc1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)n4C)CC32)cc1
CHEMBL3774927,CHEMBL217,Dopamine D2 receptor,Ki,=,3162.28,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ccccc1N1CCC2CN(CCCSc3nnc(-c4cnccn4)n3C)CC21
CHEMBL3775836,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1cccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)n4C)CC32)c1
CHEMBL3775071,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)n4C)CC32)cc1
CHEMBL3775294,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccccc4F)C3C2)nnc1-c1cnccn1
CHEMBL3774869,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4cccc(F)c4)C3C2)nnc1-c1cnccn1
CHEMBL3774996,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1-c1cnccn1
CHEMBL3774783,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1cnccn1
CHEMBL3774783,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1cnccn1
CHEMBL3774783,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1cnccn1
CHEMBL3774425,CHEMBL217,Dopamine D2 receptor,Ki,=,31.62,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4cccc(C(F)(F)F)c4)C3C2)nnc1-c1cnccn1
CHEMBL3774683,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cnccn1
CHEMBL3774683,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cnccn1
CHEMBL3774683,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cnccn1
CHEMBL3775872,CHEMBL217,Dopamine D2 receptor,Ki,=,19.95,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccccc4OC(F)(F)F)C3C2)n1C
CHEMBL3775967,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4c(F)cccc4F)C3C2)n1C
CHEMBL3775301,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(Cl)cc4Cl)C3C2)n1C
CHEMBL3775338,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4cc(Cl)cc(Cl)c4)C3C2)n1C
CHEMBL3775534,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4cccc(C#N)c4)C3C2)n1C
CHEMBL3775534,CHEMBL217,Dopamine D2 receptor,Ki,=,31.62,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4cccc(C#N)c4)C3C2)n1C
CHEMBL3775534,CHEMBL217,Dopamine D2 receptor,Ki,=,50.12,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4cccc(C#N)c4)C3C2)n1C
CHEMBL3775005,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4cccc(F)c4)C3C2)n1C
CHEMBL3775395,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(OC(F)(F)F)cc4)C3C2)n1C
CHEMBL3774588,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)n1C
CHEMBL3774588,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)n1C
CHEMBL3774588,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)n1C
CHEMBL3775226,CHEMBL217,Dopamine D2 receptor,Ki,=,63.1,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4F)C3C2)n1C
CHEMBL3775226,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4F)C3C2)n1C
CHEMBL3775226,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4F)C3C2)n1C
CHEMBL3774540,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)n1C
CHEMBL3774540,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)n1C
CHEMBL3774540,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)n1C
CHEMBL3775589,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccccc4)C3C2)n1C
CHEMBL3775589,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccccc4)C3C2)n1C
CHEMBL3775589,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccccc4)C3C2)n1C
CHEMBL85606,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL3776608,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,CHEMBL3774368,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,9.6,nM,CHEMBL3783165,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3779868,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL3780975,CHEMBL217,Dopamine D2 receptor,Ki,=,1095.0,nM,CHEMBL3783165,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3779868,KI,COc1cc2c(cc1O)C(C)N(Cc1cccc(O)c1OC)CC2
CHEMBL3780184,CHEMBL217,Dopamine D2 receptor,Ki,=,54.0,nM,CHEMBL3783165,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3779868,KI,COc1cc2c(cc1O)C1Cc3ccc(OCC4CC4)c(OC)c3CN1CC2
CHEMBL3780268,CHEMBL217,Dopamine D2 receptor,Ki,=,211.0,nM,CHEMBL3783165,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3779868,KI,COc1cc2c(cc1O)C1Cc3ccc(OCCCO)c(OC)c3CN1CC2
CHEMBL3780140,CHEMBL217,Dopamine D2 receptor,Ki,=,283.0,nM,CHEMBL3783165,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3779868,KI,CCCCCOc1ccc2c(c1OC)CN1CCc3cc(OC)c(O)cc3C1C2
CHEMBL3781840,CHEMBL217,Dopamine D2 receptor,Ki,=,121.0,nM,CHEMBL3783165,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3779868,KI,CCCCOc1ccc2c(c1OC)CN1CCc3cc(OC)c(O)cc3C1C2
CHEMBL3780506,CHEMBL217,Dopamine D2 receptor,Ki,=,99.0,nM,CHEMBL3783165,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3779868,KI,CCCOc1ccc2c(c1OC)CN1CCc3cc(OC)c(O)cc3C1C2
CHEMBL3779928,CHEMBL217,Dopamine D2 receptor,Ki,=,159.0,nM,CHEMBL3783165,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3779868,KI,CCOc1ccc2c(c1OC)CN1CCc3cc(OC)c(O)cc3C1C2
CHEMBL3780481,CHEMBL217,Dopamine D2 receptor,Ki,=,102.0,nM,CHEMBL3783165,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3779868,KI,COc1cc2c(cc1O)C1Cc3ccc(OC)c(OC)c3CN1CC2
CHEMBL595489,CHEMBL217,Dopamine D2 receptor,Ki,=,115.5,nM,CHEMBL3783165,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,CHEMBL3779868,KI,COc1cc2c(cc1O)C1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL1258313,CHEMBL217,Dopamine D2 receptor,Ki,=,5.754,nM,CHEMBL3790456,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL3784936,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccc(F)cc45)CC3)c(F)c21
CHEMBL1258427,CHEMBL217,Dopamine D2 receptor,Ki,=,15.85,nM,CHEMBL3790456,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL3784936,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cc(F)ccc45)CC3)c(F)c21
CHEMBL1258084,CHEMBL217,Dopamine D2 receptor,Ki,=,22.39,nM,CHEMBL3790456,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL3784936,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)c(F)c21
CHEMBL1258199,CHEMBL217,Dopamine D2 receptor,Ki,=,35.48,nM,CHEMBL3790456,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL3784936,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cccc(F)c45)CC3)c(F)c21
CHEMBL1257382,CHEMBL217,Dopamine D2 receptor,Ki,=,0.05754,nM,CHEMBL3790456,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL3784936,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCC5)CC3)cc21
CHEMBL1257493,CHEMBL217,Dopamine D2 receptor,Ki,=,0.5754,nM,CHEMBL3790456,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL3784936,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4COC5)CC3)cc21
CHEMBL1257735,CHEMBL217,Dopamine D2 receptor,Ki,=,0.5754,nM,CHEMBL3790456,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL3784936,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4OCCC5)CC3)cc21
CHEMBL1257614,CHEMBL217,Dopamine D2 receptor,Ki,=,1.549,nM,CHEMBL3790456,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL3784936,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCCC5)CC3)cc21
CHEMBL1257492,CHEMBL217,Dopamine D2 receptor,Ki,=,2.089,nM,CHEMBL3790456,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL3784936,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCO5)CC3)cc21
CHEMBL1258647,CHEMBL217,Dopamine D2 receptor,Ki,=,7.413,nM,CHEMBL3790456,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL3784936,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21
CHEMBL1257968,CHEMBL217,Dopamine D2 receptor,Ki,=,11.48,nM,CHEMBL3790456,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL3784936,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCOC5)CC3)cc21
CHEMBL1257857,CHEMBL217,Dopamine D2 receptor,Ki,=,22.39,nM,CHEMBL3790456,B,Inhibition of dopamine D2 receptor (unknown origin),CHEMBL3784936,KI,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4COCC5)CC3)cc21
CHEMBL3799626,CHEMBL217,Dopamine D2 receptor,Ki,=,5.47,nM,CHEMBL3801665,B,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CN(CCCCNC(=O)c1ccc2c(c1)Cc1ccccc1-2)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3798179,CHEMBL217,Dopamine D2 receptor,Ki,=,5.78,nM,CHEMBL3801665,B,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3800633,CHEMBL217,Dopamine D2 receptor,Ki,=,15.5,nM,CHEMBL3801665,B,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CN(CCCCNC(=O)c1cc2ccccc2o1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3798803,CHEMBL217,Dopamine D2 receptor,Ki,=,12.8,nM,CHEMBL3801665,B,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CCCCn1c(=O)n2c3c(cccc31)C[C@@H](NC)C2
CHEMBL3799157,CHEMBL217,Dopamine D2 receptor,Ki,=,13.2,nM,CHEMBL3801665,B,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CCCn1c(=O)n2c3c(cccc31)C[C@@H](NC)C2
CHEMBL3797209,CHEMBL217,Dopamine D2 receptor,Ki,=,2.59,nM,CHEMBL3801665,B,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL3797740,CHEMBL217,Dopamine D2 receptor,Ki,=,12.5,nM,CHEMBL3801665,B,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CCCN(C)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3800165,CHEMBL217,Dopamine D2 receptor,Ki,=,8.08,nM,CHEMBL3801665,B,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CCCN[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL26181,CHEMBL217,Dopamine D2 receptor,Ki,=,11.4,nM,CHEMBL3801665,B,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CCCN(CCC)[C@@H]1Cc2cccc3nc(O)n(c23)C1
CHEMBL434665,CHEMBL217,Dopamine D2 receptor,Ki,=,2.78,nM,CHEMBL3801665,B,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CCCN[C@@H]1Cc2cccc3nc(O)n(c23)C1
CHEMBL3798018,CHEMBL217,Dopamine D2 receptor,Ki,=,5120.0,nM,CHEMBL3801665,B,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CN[C@@H]1Cc2cc(C#N)cc3[nH]c(=O)n(c23)C1
CHEMBL3799271,CHEMBL217,Dopamine D2 receptor,Ki,=,114.0,nM,CHEMBL3801665,B,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,N[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL419792,CHEMBL217,Dopamine D2 receptor,Ki,=,17.1,nM,CHEMBL3801665,B,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,5.56,nM,CHEMBL3801665,B,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL285755,CHEMBL217,Dopamine D2 receptor,Ki,=,2.27,nM,CHEMBL3801665,B,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CCCN(CCC)C1CCc2ccc(O)cc2C1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,8.73,nM,CHEMBL3801665,B,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,NCCc1ccc(O)c(O)c1
CHEMBL3799626,CHEMBL217,Dopamine D2 receptor,Ki,=,3700.0,nM,CHEMBL3801662,B,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CN(CCCCNC(=O)c1ccc2c(c1)Cc1ccccc1-2)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3798179,CHEMBL217,Dopamine D2 receptor,Ki,=,4230.0,nM,CHEMBL3801662,B,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3800633,CHEMBL217,Dopamine D2 receptor,Ki,=,14700.0,nM,CHEMBL3801662,B,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CN(CCCCNC(=O)c1cc2ccccc2o1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3798803,CHEMBL217,Dopamine D2 receptor,Ki,=,361.0,nM,CHEMBL3801662,B,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CCCCn1c(=O)n2c3c(cccc31)C[C@@H](NC)C2
CHEMBL3799157,CHEMBL217,Dopamine D2 receptor,Ki,=,751.0,nM,CHEMBL3801662,B,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CCCn1c(=O)n2c3c(cccc31)C[C@@H](NC)C2
CHEMBL3797209,CHEMBL217,Dopamine D2 receptor,Ki,=,146.0,nM,CHEMBL3801662,B,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL3797740,CHEMBL217,Dopamine D2 receptor,Ki,=,1180.0,nM,CHEMBL3801662,B,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CCCN(C)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3800165,CHEMBL217,Dopamine D2 receptor,Ki,=,868.0,nM,CHEMBL3801662,B,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CCCN[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL434665,CHEMBL217,Dopamine D2 receptor,Ki,=,2430.0,nM,CHEMBL3801662,B,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CCCN[C@@H]1Cc2cccc3nc(O)n(c23)C1
CHEMBL3799271,CHEMBL217,Dopamine D2 receptor,Ki,=,12100.0,nM,CHEMBL3801662,B,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,N[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL419792,CHEMBL217,Dopamine D2 receptor,Ki,=,16300.0,nM,CHEMBL3801662,B,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,2950.0,nM,CHEMBL3801662,B,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL285755,CHEMBL217,Dopamine D2 receptor,Ki,=,143.0,nM,CHEMBL3801662,B,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,CCCN(CCC)C1CCc2ccc(O)cc2C1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,3690.0,nM,CHEMBL3801662,B,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,CHEMBL3797097,KI,NCCc1ccc(O)c(O)c1
CHEMBL3799638,CHEMBL217,Dopamine D2 receptor,Ki,=,547.0,nM,CHEMBL3800738,B,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,CHEMBL3797149,KI,CC(C)CS(=O)(=O)n1ccc2c(-c3ccccc3)cc(N3CCN(C)CC3)nc21
CHEMBL3798953,CHEMBL217,Dopamine D2 receptor,Ki,=,614.0,nM,CHEMBL3800738,B,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,CHEMBL3797149,KI,CCc1ccc(-c2cc(N3CCN(C)CC3)nc3c2ccn3S(=O)(=O)CC(C)C)cc1
CHEMBL3797717,CHEMBL217,Dopamine D2 receptor,Ki,=,367.0,nM,CHEMBL3800738,B,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,CHEMBL3797149,KI,CC(C)CS(=O)(=O)n1ccc2c(-c3ccc(C(F)(F)F)cc3)cc(N3CCN(C)CC3)nc21
CHEMBL3798840,CHEMBL217,Dopamine D2 receptor,Ki,=,630.0,nM,CHEMBL3800738,B,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,CHEMBL3797149,KI,CC(C)CS(=O)(=O)n1ccc2c(-c3cccc(C(F)(F)F)c3)cc(N3CCN(C)CC3)nc21
CHEMBL3799547,CHEMBL217,Dopamine D2 receptor,Ki,=,113.0,nM,CHEMBL3800738,B,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,CHEMBL3797149,KI,CC(C)CS(=O)(=O)n1ccc2c(-c3ccccc3C(F)(F)F)cc(N3CCN(C)CC3)nc21
CHEMBL3797651,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL3800738,B,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,CHEMBL3797149,KI,COc1ccc(-c2cc(N3CCN(C)CC3)nc3c2ccn3S(=O)(=O)CC(C)C)cc1
CHEMBL3800150,CHEMBL217,Dopamine D2 receptor,Ki,=,86.0,nM,CHEMBL3800738,B,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,CHEMBL3797149,KI,CC(C)CS(=O)(=O)n1ccc2c(-c3ccc(OCc4ccccc4)cc3)cc(N3CCN(C)CC3)nc21
CHEMBL3800539,CHEMBL217,Dopamine D2 receptor,Ki,=,108.0,nM,CHEMBL3800738,B,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,CHEMBL3797149,KI,CC(C)CS(=O)(=O)n1ccc2c(-c3ccc(O)cc3)cc(N3CCN(C)CC3)nc21
CHEMBL3797435,CHEMBL217,Dopamine D2 receptor,Ki,=,205.0,nM,CHEMBL3800738,B,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,CHEMBL3797149,KI,CC(C)CS(=O)(=O)n1ccc2c(-c3ccc(C#N)cc3)cc(N3CCN(C)CC3)nc21
CHEMBL3798478,CHEMBL217,Dopamine D2 receptor,Ki,=,382.0,nM,CHEMBL3800738,B,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,CHEMBL3797149,KI,CC(C)CS(=O)(=O)n1ccc2c(-c3ccc4[nH]ccc4c3)cc(N3CCN(C)CC3)nc21
CHEMBL3800251,CHEMBL217,Dopamine D2 receptor,Ki,=,640.0,nM,CHEMBL3800738,B,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,CHEMBL3797149,KI,Cc1cc(-c2cc(N3CCN(C)CC3)nc3c2ccn3S(=O)(=O)CC(C)C)c(C)s1
CHEMBL3800153,CHEMBL217,Dopamine D2 receptor,Ki,=,1231.0,nM,CHEMBL3800738,B,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,CHEMBL3797149,KI,CN1CCN(c2cc(-c3ccc(C(F)(F)F)cc3)c3ccn(S(C)(=O)=O)c3n2)CC1
CHEMBL3799120,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL3800738,B,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,CHEMBL3797149,KI,CC(C)S(=O)(=O)n1ccc2c(-c3ccc(C(F)(F)F)cc3)cc(N3CCN(C)CC3)nc21
CHEMBL3798490,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL3800738,B,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,CHEMBL3797149,KI,COCCS(=O)(=O)n1ccc2c(-c3ccc(C(F)(F)F)cc3)cc(N3CCN(C)CC3)nc21
CHEMBL3799529,CHEMBL217,Dopamine D2 receptor,Ki,=,1700.0,nM,CHEMBL3800738,B,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,CHEMBL3797149,KI,CC(C)CS(=O)(=O)n1ccc2c(-c3ccc(C(F)(F)F)cc3)cc(N3CCNCC3)nc21
CHEMBL3800400,CHEMBL217,Dopamine D2 receptor,Ki,=,5700.0,nM,CHEMBL3801476,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1
CHEMBL3800468,CHEMBL217,Dopamine D2 receptor,Ki,=,2900.0,nM,CHEMBL3801476,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1
CHEMBL3799455,CHEMBL217,Dopamine D2 receptor,Ki,=,64.0,nM,CHEMBL3801476,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNCCc2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1
CHEMBL3800303,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL3801476,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1
CHEMBL3799427,CHEMBL217,Dopamine D2 receptor,Ki,=,1900.0,nM,CHEMBL3801476,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNC[C@@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1
CHEMBL3800636,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL3801476,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNCCc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1
CHEMBL3798748,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL3801476,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNC[C@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1
CHEMBL3797205,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL3801476,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNC[C@@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1
CHEMBL3800341,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL3801476,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNCCc2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1
CHEMBL3797876,CHEMBL217,Dopamine D2 receptor,Ki,=,640.0,nM,CHEMBL3801476,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL3797035,KI,COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1
CHEMBL3799593,CHEMBL217,Dopamine D2 receptor,Ki,=,350.0,nM,CHEMBL3801476,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL3797035,KI,COc1ccccc1OCCNC[C@@H](O)c1ccc(O)c(O)c1
CHEMBL3797758,CHEMBL217,Dopamine D2 receptor,Ki,=,85.0,nM,CHEMBL3801476,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL3797035,KI,COc1ccccc1OCCNCCc1ccc(O)c(O)c1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL3801476,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL3797035,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL434,CHEMBL217,Dopamine D2 receptor,Ki,=,48000.0,nM,CHEMBL3801476,B,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,CHEMBL3797035,KI,CC(C)NCC(O)c1ccc(O)c(O)c1
CHEMBL3800400,CHEMBL217,Dopamine D2 receptor,Ki,=,3200.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1
CHEMBL3800468,CHEMBL217,Dopamine D2 receptor,Ki,=,2300.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1
CHEMBL3799455,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNCCc2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1
CHEMBL3800303,CHEMBL217,Dopamine D2 receptor,Ki,=,67.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1
CHEMBL3799427,CHEMBL217,Dopamine D2 receptor,Ki,=,1700.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNC[C@@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1
CHEMBL3800636,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNCCc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1
CHEMBL3798748,CHEMBL217,Dopamine D2 receptor,Ki,=,65.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNC[C@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1
CHEMBL3797205,CHEMBL217,Dopamine D2 receptor,Ki,=,96.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNC[C@@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1
CHEMBL3800341,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,COc1cc(CCNCCc2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1
CHEMBL3797876,CHEMBL217,Dopamine D2 receptor,Ki,=,430.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1
CHEMBL3799593,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,COc1ccccc1OCCNC[C@@H](O)c1ccc(O)c(O)c1
CHEMBL3797758,CHEMBL217,Dopamine D2 receptor,Ki,=,48.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,COc1ccccc1OCCNCCc1ccc(O)c(O)c1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,70.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL434,CHEMBL217,Dopamine D2 receptor,Ki,=,12000.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,CC(C)NCC(O)c1ccc(O)c(O)c1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,48.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,NCCc1ccc(O)c(O)c1
CHEMBL269004,CHEMBL217,Dopamine D2 receptor,Ki,=,7.1,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,CCCN(CCC)[C@H]1CCc2c(O)cccc2C1
CHEMBL301559,CHEMBL217,Dopamine D2 receptor,Ki,=,40.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL1256786,CHEMBL217,Dopamine D2 receptor,Ki,=,13000.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1
CHEMBL160519,CHEMBL217,Dopamine D2 receptor,Ki,=,86000.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,CCC(NC(C)C)C(O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL1263,CHEMBL217,Dopamine D2 receptor,Ki,=,32000.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O
CHEMBL679,CHEMBL217,Dopamine D2 receptor,Ki,=,910.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,CNC[C@H](O)c1ccc(O)c(O)c1
CHEMBL1437,CHEMBL217,Dopamine D2 receptor,Ki,=,1300.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,NC[C@H](O)c1ccc(O)c(O)c1
CHEMBL3799125,CHEMBL217,Dopamine D2 receptor,Ki,=,49.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,COc1ccccc1OCCNC[C@H](O)COc1cccc2[nH]c3ccccc3c12
CHEMBL3798017,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL3801477,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,CHEMBL3797035,KI,COc1ccccc1OCCNC[C@@H](O)COc1cccc2[nH]c3ccccc3c12
CHEMBL3819494,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,c1ccc2c(c1)CCN(CCCCc1c[nH]c3ccccc13)C2
CHEMBL3819082,CHEMBL217,Dopamine D2 receptor,Ki,=,1150.0,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,Cl.Fc1ccc2c(c1)CC(CCN1CCc3ccccc3C1)C2
CHEMBL3818128,CHEMBL217,Dopamine D2 receptor,Ki,=,319.0,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,Cl.Fc1ccc(CCCCN2CCc3ccccc3C2)cc1
CHEMBL3819366,CHEMBL217,Dopamine D2 receptor,Ki,=,166.0,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,Cl.Fc1ccc(OCCCN2CCc3ccccc3C2)cc1
CHEMBL3819556,CHEMBL217,Dopamine D2 receptor,Ki,=,123.0,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,Cl.Fc1ccc(SCCCN2CCc3ccccc3C2)cc1
CHEMBL3818710,CHEMBL217,Dopamine D2 receptor,Ki,=,422.0,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,Cl.[O-][S+](CCCN1CCc2ccccc2C1)c1ccc(F)cc1
CHEMBL3818994,CHEMBL217,Dopamine D2 receptor,Ki,=,49.0,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,O=C(CCCN1CCc2ccccc2C1)c1ccc(F)cc1
CHEMBL3818989,CHEMBL217,Dopamine D2 receptor,Ki,=,646.0,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,O=C(CCCN1CCc2ccccc2C1)c1ccccc1
CHEMBL3818200,CHEMBL217,Dopamine D2 receptor,Ki,=,1456.0,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,N#Cc1ccc(C(=O)CCCN2CCc3ccccc3C2)cc1
CHEMBL3819427,CHEMBL217,Dopamine D2 receptor,Ki,=,218.0,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,NC(=O)c1ccc(C(=O)CCCN2CCc3ccccc3C2)cc1
CHEMBL3817898,CHEMBL217,Dopamine D2 receptor,Ki,=,249.0,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,COc1ccc(C(=O)CCCN2CCc3ccccc3C2)cc1
CHEMBL3818056,CHEMBL217,Dopamine D2 receptor,Ki,=,366.0,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,O=C(CCCN1CCc2ccccc2C1)c1ccc(O)cc1
CHEMBL3818047,CHEMBL217,Dopamine D2 receptor,Ki,=,126.0,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,O=C(CCCN1CCc2ccccc2C1)c1ccc(Cl)cc1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,3.3,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL3821459,B,Inhibition of D2 receptor (unknown origin),CHEMBL3817758,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL3819494,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,c1ccc2c(c1)CCN(CCCCc1c[nH]c3ccccc13)C2
CHEMBL3818128,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,Cl.Fc1ccc(CCCCN2CCc3ccccc3C2)cc1
CHEMBL3819366,CHEMBL217,Dopamine D2 receptor,Ki,=,165.96,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,Cl.Fc1ccc(OCCCN2CCc3ccccc3C2)cc1
CHEMBL3819556,CHEMBL217,Dopamine D2 receptor,Ki,=,123.03,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,Cl.Fc1ccc(SCCCN2CCc3ccccc3C2)cc1
CHEMBL3818710,CHEMBL217,Dopamine D2 receptor,Ki,=,426.58,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,Cl.[O-][S+](CCCN1CCc2ccccc2C1)c1ccc(F)cc1
CHEMBL3818989,CHEMBL217,Dopamine D2 receptor,Ki,=,645.65,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,O=C(CCCN1CCc2ccccc2C1)c1ccccc1
CHEMBL3818200,CHEMBL217,Dopamine D2 receptor,Ki,=,1445.44,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,N#Cc1ccc(C(=O)CCCN2CCc3ccccc3C2)cc1
CHEMBL3819427,CHEMBL217,Dopamine D2 receptor,Ki,=,218.78,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,NC(=O)c1ccc(C(=O)CCCN2CCc3ccccc3C2)cc1
CHEMBL3817898,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,COc1ccc(C(=O)CCCN2CCc3ccccc3C2)cc1
CHEMBL3818056,CHEMBL217,Dopamine D2 receptor,Ki,=,363.08,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,O=C(CCCN1CCc2ccccc2C1)c1ccc(O)cc1
CHEMBL3818047,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL3821452,B,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,CHEMBL3817758,KI,O=C(CCCN1CCc2ccccc2C1)c1ccc(Cl)cc1
CHEMBL3818881,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,Cl.O=C(CCCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1nc2ccccc2s1
CHEMBL3819434,CHEMBL217,Dopamine D2 receptor,Ki,=,44.0,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,Cl.OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2CCCCc1nc2ccccc2s1
CHEMBL3818940,CHEMBL217,Dopamine D2 receptor,Ki,=,438.0,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,OC1(c2ccc(Cl)cc2)CCN(CCCCc2nc3ccccc3o2)CC1
CHEMBL2037432,CHEMBL217,Dopamine D2 receptor,Ki,=,201.0,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,OC1(c2ccc(Cl)cc2)CCN(CCCCc2nc3ccccc3s2)CC1
CHEMBL3819642,CHEMBL217,Dopamine D2 receptor,Ki,=,763.0,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,Cl.OC1(c2ccc(Cl)cc2)CCN(CCCc2nc3ccccc3s2)CC1
CHEMBL3819403,CHEMBL217,Dopamine D2 receptor,Ki,=,159.0,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=C(CCCCN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)c1nc2ccccc2s1
CHEMBL3818799,CHEMBL217,Dopamine D2 receptor,Ki,=,195.0,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,Fc1ccc(C(c2ccc(F)cc2)N2CCN(CCCCc3nc4ccccc4s3)CC2)cc1
CHEMBL3818805,CHEMBL217,Dopamine D2 receptor,Ki,=,134.0,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=c1[nH]c2cc(Cl)ccc2n1C1CCN(CCCCc2c[nH]c3ccccc23)CC1
CHEMBL3819153,CHEMBL217,Dopamine D2 receptor,Ki,=,95.0,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=c1[nH]c2cc(Cl)ccc2n1C1CCN(CCCCc2nc3ccccc3o2)CC1
CHEMBL2037520,CHEMBL217,Dopamine D2 receptor,Ki,=,217.0,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=C(CCCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)c1nc2ccccc2s1
CHEMBL3818398,CHEMBL217,Dopamine D2 receptor,Ki,=,215.0,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=c1[nH]c2cc(Cl)ccc2n1C1CCN(CCCCc2nc3ccccc3s2)CC1
CHEMBL3818478,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=C1NCN(c2ccccc2)C12CCN(CCCCc1c[nH]c3ccccc13)CC2
CHEMBL3818935,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=C1NCN(c2ccccc2)C12CCN(CCCCc1nc3ccccc3o1)CC2
CHEMBL2037526,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=C(CCCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1nc2ccccc2s1
CHEMBL3818124,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=C1NCN(c2ccccc2)C12CCN(CCCCc1nc3cc(Cl)ccc3s1)CC2
CHEMBL3819567,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=C1NCN(c2ccccc2)C12CCN(CCCCc1nc3ccccc3s1)CC2
CHEMBL297302,CHEMBL217,Dopamine D2 receptor,Ki,=,0.027,nM,CHEMBL3820059,B,Binding affinity to human dopamine D2 receptor by radioligand displacement assay,CHEMBL3817845,KI,O=C(CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
CHEMBL3819567,CHEMBL217,Dopamine D2 receptor,Ki,=,23.99,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=C1NCN(c2ccccc2)C12CCN(CCCCc1nc3ccccc3s1)CC2
CHEMBL3818124,CHEMBL217,Dopamine D2 receptor,Ki,=,18.2,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=C1NCN(c2ccccc2)C12CCN(CCCCc1nc3cc(Cl)ccc3s1)CC2
CHEMBL2037526,CHEMBL217,Dopamine D2 receptor,Ki,=,25.7,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=C(CCCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1nc2ccccc2s1
CHEMBL3818935,CHEMBL217,Dopamine D2 receptor,Ki,=,10.23,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=C1NCN(c2ccccc2)C12CCN(CCCCc1nc3ccccc3o1)CC2
CHEMBL3818478,CHEMBL217,Dopamine D2 receptor,Ki,=,22.39,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=C1NCN(c2ccccc2)C12CCN(CCCCc1c[nH]c3ccccc13)CC2
CHEMBL3818398,CHEMBL217,Dopamine D2 receptor,Ki,=,213.8,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=c1[nH]c2cc(Cl)ccc2n1C1CCN(CCCCc2nc3ccccc3s2)CC1
CHEMBL2037520,CHEMBL217,Dopamine D2 receptor,Ki,=,218.78,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=C(CCCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)c1nc2ccccc2s1
CHEMBL3819153,CHEMBL217,Dopamine D2 receptor,Ki,=,95.5,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=c1[nH]c2cc(Cl)ccc2n1C1CCN(CCCCc2nc3ccccc3o2)CC1
CHEMBL3818805,CHEMBL217,Dopamine D2 receptor,Ki,=,134.9,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=c1[nH]c2cc(Cl)ccc2n1C1CCN(CCCCc2c[nH]c3ccccc23)CC1
CHEMBL3818799,CHEMBL217,Dopamine D2 receptor,Ki,=,194.98,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,Fc1ccc(C(c2ccc(F)cc2)N2CCN(CCCCc3nc4ccccc4s3)CC2)cc1
CHEMBL3819403,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,O=C(CCCCN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)c1nc2ccccc2s1
CHEMBL3819642,CHEMBL217,Dopamine D2 receptor,Ki,=,758.58,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,Cl.OC1(c2ccc(Cl)cc2)CCN(CCCc2nc3ccccc3s2)CC1
CHEMBL2037432,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,OC1(c2ccc(Cl)cc2)CCN(CCCCc2nc3ccccc3s2)CC1
CHEMBL3819434,CHEMBL217,Dopamine D2 receptor,Ki,=,44.67,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,Cl.OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2CCCCc1nc2ccccc2s1
CHEMBL3818881,CHEMBL217,Dopamine D2 receptor,Ki,=,181.97,nM,CHEMBL3820048,B,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,CHEMBL3817845,KI,Cl.O=C(CCCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1nc2ccccc2s1
CHEMBL85606,CHEMBL217,Dopamine D2 receptor,Ki,=,489.78,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2
CHEMBL3958494,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccccc3)C2)n1C
CHEMBL3958494,CHEMBL217,Dopamine D2 receptor,Ki,=,512.86,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccccc3)C2)n1C
CHEMBL3901211,CHEMBL217,Dopamine D2 receptor,Ki,=,707.95,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccccc3)C2)n1C
CHEMBL3913062,CHEMBL217,Dopamine D2 receptor,Ki,=,933.25,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccccc3)C2)n1C
CHEMBL3913062,CHEMBL217,Dopamine D2 receptor,Ki,=,16982.44,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccccc3)C2)n1C
CHEMBL3983937,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccccc3)C2)n1C
CHEMBL3913607,CHEMBL217,Dopamine D2 receptor,Ki,=,660.69,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3913607,CHEMBL217,Dopamine D2 receptor,Ki,=,891.25,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3944642,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3935692,CHEMBL217,Dopamine D2 receptor,Ki,=,295.12,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3935692,CHEMBL217,Dopamine D2 receptor,Ki,=,213.8,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3954568,CHEMBL217,Dopamine D2 receptor,Ki,=,512.86,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3954568,CHEMBL217,Dopamine D2 receptor,Ki,=,977.24,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3953365,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCN2CC[C@@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3936812,CHEMBL217,Dopamine D2 receptor,Ki,=,524.81,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3908862,CHEMBL217,Dopamine D2 receptor,Ki,=,977.24,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3914195,CHEMBL217,Dopamine D2 receptor,Ki,=,123.03,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccccc3C(F)(F)F)C2)n1C
CHEMBL3914195,CHEMBL217,Dopamine D2 receptor,Ki,=,724.44,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccccc3C(F)(F)F)C2)n1C
CHEMBL3975989,CHEMBL217,Dopamine D2 receptor,Ki,=,63.1,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccccc3C(F)(F)F)C2)n1C
CHEMBL3905196,CHEMBL217,Dopamine D2 receptor,Ki,=,1584.89,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccccc3C(F)(F)F)C2)n1C
CHEMBL3950264,CHEMBL217,Dopamine D2 receptor,Ki,=,977.24,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(F)cc3)C2)n1C
CHEMBL3950264,CHEMBL217,Dopamine D2 receptor,Ki,=,1096.48,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(F)cc3)C2)n1C
CHEMBL3912029,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccc(F)cc3)C2)n1C
CHEMBL3922143,CHEMBL217,Dopamine D2 receptor,Ki,=,426.58,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(F)cc3)C2)n1C
CHEMBL3922143,CHEMBL217,Dopamine D2 receptor,Ki,=,8128.31,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(F)cc3)C2)n1C
CHEMBL3963783,CHEMBL217,Dopamine D2 receptor,Ki,=,239.88,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(F)cc3)C2)n1C
CHEMBL3908548,CHEMBL217,Dopamine D2 receptor,Ki,=,537.03,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(F)cc3F)C2)n1C
CHEMBL3908548,CHEMBL217,Dopamine D2 receptor,Ki,=,676.08,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(F)cc3F)C2)n1C
CHEMBL3945775,CHEMBL217,Dopamine D2 receptor,Ki,=,954.99,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccc(F)cc3F)C2)n1C
CHEMBL3917887,CHEMBL217,Dopamine D2 receptor,Ki,=,295.12,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(F)cc3F)C2)n1C
CHEMBL3926847,CHEMBL217,Dopamine D2 receptor,Ki,=,257.04,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(F)cc3F)C2)n1C
CHEMBL3935776,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C
CHEMBL3935776,CHEMBL217,Dopamine D2 receptor,Ki,=,309.03,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C
CHEMBL3901587,CHEMBL217,Dopamine D2 receptor,Ki,=,977.24,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C
CHEMBL3927895,CHEMBL217,Dopamine D2 receptor,Ki,=,331.13,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C
CHEMBL3927895,CHEMBL217,Dopamine D2 receptor,Ki,=,4365.16,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C
CHEMBL3955505,CHEMBL217,Dopamine D2 receptor,Ki,=,223.87,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C
CHEMBL3985877,CHEMBL217,Dopamine D2 receptor,Ki,=,165.96,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(F)cc3C(F)(F)F)C2)n1C
CHEMBL3966647,CHEMBL217,Dopamine D2 receptor,Ki,=,2187.76,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccc(F)cc3C(F)(F)F)C2)n1C
CHEMBL3945776,CHEMBL217,Dopamine D2 receptor,Ki,=,3801.89,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(F)cc3C(F)(F)F)C2)n1C
CHEMBL3975147,CHEMBL217,Dopamine D2 receptor,Ki,=,1288.25,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(F)cc3C(F)(F)F)C2)n1C
CHEMBL3954490,CHEMBL217,Dopamine D2 receptor,Ki,=,1737.8,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCC(O)CN2CC[C@@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3983121,CHEMBL217,Dopamine D2 receptor,Ki,=,66.07,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3cc(Cl)cc(Cl)c3)C2)n1C
CHEMBL3899336,CHEMBL217,Dopamine D2 receptor,Ki,=,61.66,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3cc(Cl)cc(Cl)c3)C2)n1C
CHEMBL3894257,CHEMBL217,Dopamine D2 receptor,Ki,=,1230.27,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncsc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3923578,CHEMBL217,Dopamine D2 receptor,Ki,=,1621.81,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncsc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3895585,CHEMBL217,Dopamine D2 receptor,Ki,=,467.74,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1nccs1
CHEMBL3914556,CHEMBL217,Dopamine D2 receptor,Ki,=,426.58,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1nccs1
CHEMBL3984387,CHEMBL217,Dopamine D2 receptor,Ki,=,117.49,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1csnn1
CHEMBL3905582,CHEMBL217,Dopamine D2 receptor,Ki,=,128.82,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1csnn1
CHEMBL3976319,CHEMBL217,Dopamine D2 receptor,Ki,=,346.74,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccs1
CHEMBL3896638,CHEMBL217,Dopamine D2 receptor,Ki,=,331.13,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccsc1
CHEMBL3967806,CHEMBL217,Dopamine D2 receptor,Ki,=,478.63,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccco1
CHEMBL3985419,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccoc1
CHEMBL3956758,CHEMBL217,Dopamine D2 receptor,Ki,=,537.03,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1cc(-c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)cn1
CHEMBL3908174,CHEMBL217,Dopamine D2 receptor,Ki,=,851.14,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1nccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3978613,CHEMBL217,Dopamine D2 receptor,Ki,=,524.81,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1cc(-c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)on1
CHEMBL3899125,CHEMBL217,Dopamine D2 receptor,Ki,=,354.81,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)cc1
CHEMBL3970323,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccc(C(N)=O)c1
CHEMBL3890178,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccccc1C(N)=O
CHEMBL3959240,CHEMBL217,Dopamine D2 receptor,Ki,=,218.78,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(S(N)(=O)=O)cc1
CHEMBL3979523,CHEMBL217,Dopamine D2 receptor,Ki,=,446.68,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,CC(=O)c1ccc(-c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)cc1
CHEMBL3950540,CHEMBL217,Dopamine D2 receptor,Ki,=,346.74,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C#N)cc1
CHEMBL3981856,CHEMBL217,Dopamine D2 receptor,Ki,=,467.74,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(CC(N)=O)cc1
CHEMBL3941818,CHEMBL217,Dopamine D2 receptor,Ki,=,363.08,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(-c2ncco2)cc1
CHEMBL3920167,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccc(-c2ncco2)c1
CHEMBL3947961,CHEMBL217,Dopamine D2 receptor,Ki,=,870.96,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccncc1
CHEMBL3929083,CHEMBL217,Dopamine D2 receptor,Ki,=,616.6,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccncc1
CHEMBL3956612,CHEMBL217,Dopamine D2 receptor,Ki,=,1348.96,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccnc1
CHEMBL3938107,CHEMBL217,Dopamine D2 receptor,Ki,=,891.25,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccnc1
CHEMBL3967683,CHEMBL217,Dopamine D2 receptor,Ki,=,630.96,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccccn1
CHEMBL3946901,CHEMBL217,Dopamine D2 receptor,Ki,=,524.81,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccccn1
CHEMBL3976192,CHEMBL217,Dopamine D2 receptor,Ki,=,1445.44,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cnccn1
CHEMBL3955608,CHEMBL217,Dopamine D2 receptor,Ki,=,467.74,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cnccn1
CHEMBL3984236,CHEMBL217,Dopamine D2 receptor,Ki,=,436.52,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccncn1
CHEMBL3958309,CHEMBL217,Dopamine D2 receptor,Ki,=,295.12,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccncn1
CHEMBL3930825,CHEMBL217,Dopamine D2 receptor,Ki,=,1778.28,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccnn1
CHEMBL3969386,CHEMBL217,Dopamine D2 receptor,Ki,=,1380.38,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccnn1
CHEMBL3939830,CHEMBL217,Dopamine D2 receptor,Ki,=,2570.4,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccnnc1
CHEMBL3940897,CHEMBL217,Dopamine D2 receptor,Ki,=,1548.82,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccnnc1
CHEMBL3912897,CHEMBL217,Dopamine D2 receptor,Ki,=,3311.31,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccccc3)C2)nnc1-c1cccnc1
CHEMBL3949662,CHEMBL217,Dopamine D2 receptor,Ki,=,724.44,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3F)C2)nnc1-c1cccnc1
CHEMBL3921885,CHEMBL217,Dopamine D2 receptor,Ki,=,524.81,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(F)cc3F)C2)nnc1-c1cccnc1
CHEMBL3897134,CHEMBL217,Dopamine D2 receptor,Ki,=,660.69,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(F)cc3)C2)nnc1-c1cccnc1
CHEMBL3968272,CHEMBL217,Dopamine D2 receptor,Ki,=,1479.11,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ncccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3946313,CHEMBL217,Dopamine D2 receptor,Ki,=,954.99,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccnc1C(F)(F)F
CHEMBL3958949,CHEMBL217,Dopamine D2 receptor,Ki,=,1148.15,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,COc1ncccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3922535,CHEMBL217,Dopamine D2 receptor,Ki,=,691.83,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C#N)nc1
CHEMBL3950254,CHEMBL217,Dopamine D2 receptor,Ki,=,549.54,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)nc1
CHEMBL3913542,CHEMBL217,Dopamine D2 receptor,Ki,=,1230.27,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1ccc(-c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)c(C)n1
CHEMBL3941520,CHEMBL217,Dopamine D2 receptor,Ki,=,1148.15,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1nc(C(N)=O)ccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3964649,CHEMBL217,Dopamine D2 receptor,Ki,=,7585.78,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cc1nc(C(=O)O)ccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3894853,CHEMBL217,Dopamine D2 receptor,Ki,=,2238.72,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccn(C)c(=O)c1
CHEMBL3963243,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCN(C(N)=O)CC1
CHEMBL3948167,CHEMBL217,Dopamine D2 receptor,Ki,=,812.83,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCOCC1
CHEMBL3903779,CHEMBL217,Dopamine D2 receptor,Ki,=,741.31,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CC2CCC(C1)O2
CHEMBL3958201,CHEMBL217,Dopamine D2 receptor,Ki,=,588.84,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCCCC1
CHEMBL3964512,CHEMBL217,Dopamine D2 receptor,Ki,=,338.84,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1=CCC(=O)N=C1
CHEMBL3897772,CHEMBL217,Dopamine D2 receptor,Ki,=,1445.44,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1=CC=NC(=O)C1
CHEMBL3912801,CHEMBL217,Dopamine D2 receptor,Ki,=,457.09,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,CC(=O)NC1CCC(c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)CC1
CHEMBL3964512,CHEMBL217,Dopamine D2 receptor,Ki,=,758.58,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1=CCC(=O)N=C1
CHEMBL3922838,CHEMBL217,Dopamine D2 receptor,Ki,=,870.96,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(=O)n(C)c1
CHEMBL3913849,CHEMBL217,Dopamine D2 receptor,Ki,=,1348.96,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCNC(=O)C1
CHEMBL3983684,CHEMBL217,Dopamine D2 receptor,Ki,=,1698.24,nM,CHEMBL3855278,B,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,CHEMBL3853329,KI,CN1CCC(c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)CC1=O
CHEMBL3914155,CHEMBL217,Dopamine D2 receptor,Ki,=,631.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,N#Cc1ccc(CNC(=O)CCOCCN2CCN(c3ccccc3-c3ccccc3)CC2)cc1
CHEMBL3895172,CHEMBL217,Dopamine D2 receptor,Ki,=,345.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,O=C(CCOCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccc(C(F)(F)F)cc1
CHEMBL3923145,CHEMBL217,Dopamine D2 receptor,Ki,=,2450.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,O=C(CCOCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccncc1
CHEMBL3904094,CHEMBL217,Dopamine D2 receptor,Ki,=,537.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,N#Cc1ccc(CNC(=O)CCOCCN2CCN(c3ncccc3-c3ccccc3)CC2)cc1
CHEMBL3950020,CHEMBL217,Dopamine D2 receptor,Ki,=,268.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,O=C(CCOCCN1CCN(c2ncccc2-c2ccccc2)CC1)NCc1ccc(C(F)(F)F)cc1
CHEMBL3913100,CHEMBL217,Dopamine D2 receptor,Ki,=,4346.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,N#Cc1ccc(CNC(=O)CCOCCN2CCN(c3cccnc3-c3ccccc3)CC2)cc1
CHEMBL3941102,CHEMBL217,Dopamine D2 receptor,Ki,=,2766.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,O=C(CCOCCN1CCN(c2cccnc2-c2ccccc2)CC1)NCc1ccc(C(F)(F)F)cc1
CHEMBL3947670,CHEMBL217,Dopamine D2 receptor,Ki,=,1959.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,N#Cc1ccc(CNC(=O)CCOCCN2CCN(c3cccnc3-c3ccc(F)cc3)CC2)cc1
CHEMBL3976948,CHEMBL217,Dopamine D2 receptor,Ki,=,3460.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,O=C(CCOCCN1CCN(c2cccnc2-c2ccc(F)cc2)CC1)NCc1ccc(C(F)(F)F)cc1
CHEMBL3922670,CHEMBL217,Dopamine D2 receptor,Ki,=,685.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,N#Cc1ccc(CNC(=O)CCOCCN2CCN(c3ncccc3-c3ccc(F)cc3)CC2)cc1
CHEMBL3894679,CHEMBL217,Dopamine D2 receptor,Ki,=,393.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,O=C(CCOCCN1CCN(c2ncccc2-c2ccc(F)cc2)CC1)NCc1ccc(C(F)(F)F)cc1
CHEMBL3983496,CHEMBL217,Dopamine D2 receptor,Ki,=,321.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,COCOc1ccc(CNC(=O)CCCCCN2CCN(c3ccccc3-c3ccc(OC)cc3)CC2)cc1
CHEMBL3984541,CHEMBL217,Dopamine D2 receptor,Ki,=,419.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,COc1ccc(-c2ccccc2N2CCN(CCCCCC(=O)NCc3ccc(OCCO)cc3)CC2)cc1
CHEMBL3955917,CHEMBL217,Dopamine D2 receptor,Ki,=,375.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,COc1ccc(-c2ccccc2N2CCN(CCCCCC(=O)NCc3ccc(OCCN4CCOCC4)cc3)CC2)cc1
CHEMBL3896355,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,COc1ccc(-c2ccccc2N2CCN(CCCCCC(=O)NCc3ccc(OCCCN4CCOCC4)cc3)CC2)cc1
CHEMBL3924375,CHEMBL217,Dopamine D2 receptor,Ki,=,293.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,COc1ccc(-c2ccccc2N2CCN(CCCCCC(=O)NCc3ccc(C#N)cc3)CC2)cc1
CHEMBL3985152,CHEMBL217,Dopamine D2 receptor,Ki,=,36.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,COCOc1ccc(CNC(=O)CCCCCN2CCN(c3ccccc3-c3ccccc3)CC2)cc1
CHEMBL3977072,CHEMBL217,Dopamine D2 receptor,Ki,=,136.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccc(OCCN2CCOCC2)cc1
CHEMBL3906408,CHEMBL217,Dopamine D2 receptor,Ki,=,64.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccc(OCCCN2CCOCC2)cc1
CHEMBL3968569,CHEMBL217,Dopamine D2 receptor,Ki,=,75.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,CN(C)Cc1ccc(CNC(=O)CCCCCN2CCN(c3ccccc3-c3ccccc3)CC2)cc1
CHEMBL3897426,CHEMBL217,Dopamine D2 receptor,Ki,=,522.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,COc1ccc(-c2cc(F)ccc2N2CCN(CCCCCC(=O)NCc3ccc(C#N)cc3)CC2)cc1
CHEMBL3910730,CHEMBL217,Dopamine D2 receptor,Ki,=,1385.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,N#Cc1ccc(CNC(=O)CCCCCN2CCN(c3ccc(F)cc3-c3ccc(C#N)cc3)CC2)cc1
CHEMBL3986254,CHEMBL217,Dopamine D2 receptor,Ki,=,308.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,COc1ccc(-c2ccccc2N2CCN(CCCCCC(=O)N[C@@H](C)c3ccc(C#N)cc3)CC2)cc1
CHEMBL3971125,CHEMBL217,Dopamine D2 receptor,Ki,=,243.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,COc1ccc(-c2ccccc2N2CCN(CCCCCC(=O)N[C@H](C)c3ccc(C#N)cc3)CC2)cc1
CHEMBL3941529,CHEMBL217,Dopamine D2 receptor,Ki,=,53.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,C[C@H](NC(=O)CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)c1ccccc1
CHEMBL3960056,CHEMBL217,Dopamine D2 receptor,Ki,=,116.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,C[C@@H](NC(=O)CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)c1ccccc1
CHEMBL3932551,CHEMBL217,Dopamine D2 receptor,Ki,=,295.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,COc1ccc(-c2ccccc2N2CCN(CCCCCC(=O)N[C@H](C)c3ccccc3)CC2)cc1
CHEMBL3892201,CHEMBL217,Dopamine D2 receptor,Ki,=,177.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,COc1ccc(-c2ccccc2N2CCN(CCCCCC(=O)N[C@@H](C)c3ccccc3)CC2)cc1
CHEMBL3958956,CHEMBL217,Dopamine D2 receptor,Ki,=,178.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,C[C@@H]1CN(c2ccccc2-c2ccccc2)CCN1CCCCCC(=O)NCc1ccccc1
CHEMBL3979307,CHEMBL217,Dopamine D2 receptor,Ki,=,243.0,nM,CHEMBL3857974,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,CHEMBL3856221,KI,C[C@H]1CN(c2ccccc2-c2ccccc2)CCN1CCCCCC(=O)NCc1ccccc1
CHEMBL522691,CHEMBL217,Dopamine D2 receptor,Ki,=,242.0,nM,CHEMBL3857980,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL3856221,KI,N#Cc1ccc(CNC(=O)CCCCCN2CCN(c3ccccc3-c3ccccc3)CC2)cc1
CHEMBL3959209,CHEMBL217,Dopamine D2 receptor,Ki,=,915.0,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,Cl.Cl.c1ccc2c(c1)CCN(CCCc1nc3ccccc3[nH]1)C2
CHEMBL3899099,CHEMBL217,Dopamine D2 receptor,Ki,=,272.0,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,Cl.Clc1cccc2c1CN(CCCCc1nc3ccccc3s1)CC2
CHEMBL3970299,CHEMBL217,Dopamine D2 receptor,Ki,=,138.0,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,Cl.Clc1ccc2sc(CCCCN3CCc4ccccc4C3)nc2c1
CHEMBL3971383,CHEMBL217,Dopamine D2 receptor,Ki,=,853.0,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,Cl.Clc1ccc2sc(CCCCN3CCc4c(Cl)cccc4C3)nc2c1
CHEMBL3941795,CHEMBL217,Dopamine D2 receptor,Ki,=,1087.0,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,Cl.Clc1ccc2sc(CCCCN3CCC4CCCCC4C3)nc2c1
CHEMBL3959919,CHEMBL217,Dopamine D2 receptor,Ki,=,418.0,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,COc1cc2c(cc1OC)CN(CCCCc1nc3cc(Cl)ccc3s1)CC2.Cl
CHEMBL3970994,CHEMBL217,Dopamine D2 receptor,Ki,=,5647.0,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,C1=C(CCN2CCc3ccccc3C2)CCc2ccccc21
CHEMBL3908870,CHEMBL217,Dopamine D2 receptor,Ki,=,2933.0,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,CC1(C)CC(=O)N(CCCCN2Cc3ccccc3C2)C(=O)C1
CHEMBL3924565,CHEMBL217,Dopamine D2 receptor,Ki,=,3578.0,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,Cl.O=C(CCCN1CCCc2ccccc2C1)c1ccc(Cl)cc1
CHEMBL3952251,CHEMBL217,Dopamine D2 receptor,Ki,=,1170.0,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,Cl.O=C(CCCN1CCc2ccccc2CC1)c1ccc(Cl)cc1
CHEMBL3986927,CHEMBL217,Dopamine D2 receptor,Ki,=,5399.0,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,O=C1Cc2cc(C(=O)CCCN3CCc4ccccc4C3)ccc2N1
CHEMBL3958215,CHEMBL217,Dopamine D2 receptor,Ki,=,750.0,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,O=C1c2ccc(F)cc2CC1CCN1CCc2ccccc2C1
CHEMBL3978642,CHEMBL217,Dopamine D2 receptor,Ki,=,2583.5,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,Cl.O=C1c2ccccc2CC1CCN1CCc2ccccc2C1
CHEMBL3898250,CHEMBL217,Dopamine D2 receptor,Ki,=,946.0,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,Cl.O=C1c2ccc(Cl)cc2CC1CCN1CCc2ccccc2C1
CHEMBL3959209,CHEMBL217,Dopamine D2 receptor,Ki,=,812.83,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,Cl.Cl.c1ccc2c(c1)CCN(CCCc1nc3ccccc3[nH]1)C2
CHEMBL3899099,CHEMBL217,Dopamine D2 receptor,Ki,=,269.15,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,Cl.Clc1cccc2c1CN(CCCCc1nc3ccccc3s1)CC2
CHEMBL3970299,CHEMBL217,Dopamine D2 receptor,Ki,=,138.04,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,Cl.Clc1ccc2sc(CCCCN3CCc4ccccc4C3)nc2c1
CHEMBL3971383,CHEMBL217,Dopamine D2 receptor,Ki,=,851.14,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,Cl.Clc1ccc2sc(CCCCN3CCc4c(Cl)cccc4C3)nc2c1
CHEMBL3941795,CHEMBL217,Dopamine D2 receptor,Ki,=,1096.48,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,Cl.Clc1ccc2sc(CCCCN3CCC4CCCCC4C3)nc2c1
CHEMBL3959919,CHEMBL217,Dopamine D2 receptor,Ki,=,416.87,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,COc1cc2c(cc1OC)CN(CCCCc1nc3cc(Cl)ccc3s1)CC2.Cl
CHEMBL3970994,CHEMBL217,Dopamine D2 receptor,Ki,=,5623.41,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,C1=C(CCN2CCc3ccccc3C2)CCc2ccccc21
CHEMBL3908870,CHEMBL217,Dopamine D2 receptor,Ki,=,2951.21,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,CC1(C)CC(=O)N(CCCCN2Cc3ccccc3C2)C(=O)C1
CHEMBL3924565,CHEMBL217,Dopamine D2 receptor,Ki,=,3548.13,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,Cl.O=C(CCCN1CCCc2ccccc2C1)c1ccc(Cl)cc1
CHEMBL3952251,CHEMBL217,Dopamine D2 receptor,Ki,=,1174.9,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,Cl.O=C(CCCN1CCc2ccccc2CC1)c1ccc(Cl)cc1
CHEMBL3986927,CHEMBL217,Dopamine D2 receptor,Ki,=,5370.32,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,O=C1Cc2cc(C(=O)CCCN3CCc4ccccc4C3)ccc2N1
CHEMBL3958215,CHEMBL217,Dopamine D2 receptor,Ki,=,758.58,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,O=C1c2ccc(F)cc2CC1CCN1CCc2ccccc2C1
CHEMBL3898250,CHEMBL217,Dopamine D2 receptor,Ki,=,954.99,nM,CHEMBL3863657,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,CHEMBL3862017,KI,Cl.O=C1c2ccc(Cl)cc2CC1CCN1CCc2ccccc2C1
CHEMBL11493,CHEMBL217,Dopamine D2 receptor,Ki,=,68.1,nM,CHEMBL3863990,B,Displacement of [3H]N-methylspiperone from human D2R expressed in HEK293 cell membranes incubated for 1 hr by radioligand binding assay,CHEMBL3862037,KI,CCCCN1C2CCC1CC(OC(c1ccc(F)cc1)c1ccc(F)cc1)C2
CHEMBL3126735,CHEMBL217,Dopamine D2 receptor,Ki,=,228.0,nM,CHEMBL3863990,B,Displacement of [3H]N-methylspiperone from human D2R expressed in HEK293 cell membranes incubated for 1 hr by radioligand binding assay,CHEMBL3862037,KI,Fc1ccc(C(SCCNCCCc2ccccc2)c2ccc(F)cc2)cc1
CHEMBL3916231,CHEMBL217,Dopamine D2 receptor,Ki,=,693.0,nM,CHEMBL3863990,B,Displacement of [3H]N-methylspiperone from human D2R expressed in HEK293 cell membranes incubated for 1 hr by radioligand binding assay,CHEMBL3862037,KI,CC(O)CN1CCN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL3931765,CHEMBL217,Dopamine D2 receptor,Ki,=,298.0,nM,CHEMBL3863990,B,Displacement of [3H]N-methylspiperone from human D2R expressed in HEK293 cell membranes incubated for 1 hr by radioligand binding assay,CHEMBL3862037,KI,CC(O)CN1CCN(CC[S+]([O-])C(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL3918282,CHEMBL217,Dopamine D2 receptor,Ki,=,78.6,nM,CHEMBL3863990,B,Displacement of [3H]N-methylspiperone from human D2R expressed in HEK293 cell membranes incubated for 1 hr by radioligand binding assay,CHEMBL3862037,KI,[O-][S+](CCN1CCN(CC(O)Cc2ccccc2)CC1)C(c1ccc(F)cc1)c1ccc(F)cc1
CHEMBL8946,CHEMBL217,Dopamine D2 receptor,Ki,=,0.26,nM,CHEMBL3863990,B,Displacement of [3H]N-methylspiperone from human D2R expressed in HEK293 cell membranes incubated for 1 hr by radioligand binding assay,CHEMBL3862037,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1O
CHEMBL3966484,CHEMBL217,Dopamine D2 receptor,Ki,=,15848.93,nM,CHEMBL3872136,B,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,CHEMBL3871306,KI,CN[C@H]1c2c(ccc3c2ccn3S(=O)(=O)c2ccccc2)[C@@H]1CCO
CHEMBL3910287,CHEMBL217,Dopamine D2 receptor,Ki,=,251.19,nM,CHEMBL3872136,B,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,CHEMBL3871306,KI,CC(=O)Nc1ccc(CCN(C)CC2Cc3ccc4c(ccn4S(=O)(=O)c4ccccc4)c32)cc1
CHEMBL3929918,CHEMBL217,Dopamine D2 receptor,Ki,=,1995.26,nM,CHEMBL3872136,B,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,CHEMBL3871306,KI,CNCC1Cc2ccc3c(ccn3S(=O)(=O)c3ccccc3)c21
CHEMBL3948819,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL3872136,B,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,CHEMBL3871306,KI,CNCC1Cc2ccc3c(ccn3S(=O)(=O)c3cccc4ccccc34)c21
CHEMBL3889852,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL3872136,B,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,CHEMBL3871306,KI,O=S(=O)(c1ccccc1)n1ccc2c3c(ccc21)[C@H]1CCNCC[C@@H]31
CHEMBL3961596,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL3872136,B,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,CHEMBL3871306,KI,CNCC1Cc2cc3ccn(S(=O)(=O)c4cccc5ccccc45)c3cc21
CHEMBL3890882,CHEMBL217,Dopamine D2 receptor,Ki,=,15848.93,nM,CHEMBL3872136,B,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,CHEMBL3871306,KI,CN[C@@H]1c2cc3ccn(S(=O)(=O)c4ccccc4)c3cc2[C@H]1CCO
CHEMBL3963688,CHEMBL217,Dopamine D2 receptor,Ki,=,6309.57,nM,CHEMBL3872136,B,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,CHEMBL3871306,KI,CN[C@H]1c2cc3c(ccn3S(=O)(=O)c3ccccc3)cc2[C@@H]1CCO
CHEMBL3941190,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,Nc1ccc2c(N3CCN(CC[C@H]4CC[C@H](NC(=O)c5ccco5)CC4)CC3)nsc2c1
CHEMBL3970746,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4cc([N+](=O)[O-])ccc34)CC2)CC1)c1ccco1
CHEMBL3932186,CHEMBL217,Dopamine D2 receptor,Ki,=,2.1,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(NC[C@H]1CC[C@H](CN2CCN(c3nsc4cc(Cl)ccc34)CC2)CC1)c1ccco1
CHEMBL3959698,CHEMBL217,Dopamine D2 receptor,Ki,=,8.9,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(NC[C@H]1CC[C@H](CN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccco1
CHEMBL3923240,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,CCOC(=O)N[C@H]1CC[C@@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1
CHEMBL3950977,CHEMBL217,Dopamine D2 receptor,Ki,=,6.3,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(N[C@H]1CC[C@@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccco1
CHEMBL3914241,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,CCOC(=O)N1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1
CHEMBL3942236,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(c1ccco1)N1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1
CHEMBL3905247,CHEMBL217,Dopamine D2 receptor,Ki,=,0.43,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1cc2ccccc2[nH]1
CHEMBL3933256,CHEMBL217,Dopamine D2 receptor,Ki,=,0.35,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=S(=O)(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1cccnc1
CHEMBL3895540,CHEMBL217,Dopamine D2 receptor,Ki,=,0.3,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,CN([C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)S(=O)(=O)c1cccs1
CHEMBL3966842,CHEMBL217,Dopamine D2 receptor,Ki,=,0.43,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=S(=O)(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1cccs1
CHEMBL3967779,CHEMBL217,Dopamine D2 receptor,Ki,=,0.85,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1cccnc1
CHEMBL3938210,CHEMBL217,Dopamine D2 receptor,Ki,=,0.21,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccc[nH]1
CHEMBL3976282,CHEMBL217,Dopamine D2 receptor,Ki,=,0.19,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1cccs1
CHEMBL3946995,CHEMBL217,Dopamine D2 receptor,Ki,=,2.9,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccco1
CHEMBL3948056,CHEMBL217,Dopamine D2 receptor,Ki,=,0.42,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,Cc1ccc(S(=O)(=O)N[C@H]2CC[C@H](CCN3CCN(c4nsc5ccccc45)CC3)CC2)cc1
CHEMBL3920252,CHEMBL217,Dopamine D2 receptor,Ki,=,0.33,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccccc1
CHEMBL3956720,CHEMBL217,Dopamine D2 receptor,Ki,=,0.85,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)C1CC1
CHEMBL3929168,CHEMBL217,Dopamine D2 receptor,Ki,=,0.94,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)C1CCCCC1
CHEMBL3920432,CHEMBL217,Dopamine D2 receptor,Ki,=,1.9,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,CCCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1
CHEMBL3892440,CHEMBL217,Dopamine D2 receptor,Ki,=,8.9,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1
CHEMBL3913691,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)C(F)(F)F
CHEMBL3962525,CHEMBL217,Dopamine D2 receptor,Ki,=,2.8,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,CCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1
CHEMBL3902496,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1
CHEMBL3973487,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1
CHEMBL3903560,CHEMBL217,Dopamine D2 receptor,Ki,=,9.6,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,COCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,Ki,=,1.3,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL3982486,CHEMBL217,Dopamine D2 receptor,Ki,=,0.71,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,CCOC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1
CHEMBL3953773,CHEMBL217,Dopamine D2 receptor,Ki,=,2.4,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,CN(C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccccc1
CHEMBL3896937,CHEMBL217,Dopamine D2 receptor,Ki,=,0.51,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(Nc1cccnc1)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1
CHEMBL3918755,CHEMBL217,Dopamine D2 receptor,Ki,=,0.63,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(Nc1ccccc1)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1
CHEMBL3940712,CHEMBL217,Dopamine D2 receptor,Ki,=,1.4,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(NCc1ccccc1)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1
CHEMBL3909821,CHEMBL217,Dopamine D2 receptor,Ki,=,2.2,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)N1CCOCC1
CHEMBL3971907,CHEMBL217,Dopamine D2 receptor,Ki,=,0.51,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,CCN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1
CHEMBL3900752,CHEMBL217,Dopamine D2 receptor,Ki,=,0.72,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,CC(C)N(C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)C(C)C
CHEMBL3960785,CHEMBL217,Dopamine D2 receptor,Ki,=,0.53,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1
CHEMBL3891773,CHEMBL217,Dopamine D2 receptor,Ki,=,4.6,nM,CHEMBL3872755,B,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,CHEMBL3872208,KI,N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,72.0,nM,CHEMBL3880782,B,Competitive antagonist activity against human dopamine D2 receptor short isoform by R-SAT assay,CHEMBL3880399,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL3646149,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL3705566,B,"Binding Assay: The ability of test compounds to displace 3H-raclopride at the D2s receptor can be determined on membranes from D2s-transfected CHO cells (Bmax 13 pmol/mg protein). An assay can use a standard 96-well glass-fiber filter plate to retain radioligand bound by the receptor. Retained 3H can be determined in a TopCount scintillation plate counter following the addition of a liquid scintillant to each well. Compounds can be evaluated for their potency using competition curve analysis, resulting in calculated Ki values.",CHEMBL3639279,KI,Fc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1S2
CHEMBL3526391,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL3705566,B,"Binding Assay: The ability of test compounds to displace 3H-raclopride at the D2s receptor can be determined on membranes from D2s-transfected CHO cells (Bmax 13 pmol/mg protein). An assay can use a standard 96-well glass-fiber filter plate to retain radioligand bound by the receptor. Retained 3H can be determined in a TopCount scintillation plate counter following the addition of a liquid scintillant to each well. Compounds can be evaluated for their potency using competition curve analysis, resulting in calculated Ki values.",CHEMBL3639279,KI,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1S2
CHEMBL3646150,CHEMBL217,Dopamine D2 receptor,Ki,=,0.7,nM,CHEMBL3705566,B,"Binding Assay: The ability of test compounds to displace 3H-raclopride at the D2s receptor can be determined on membranes from D2s-transfected CHO cells (Bmax 13 pmol/mg protein). An assay can use a standard 96-well glass-fiber filter plate to retain radioligand bound by the receptor. Retained 3H can be determined in a TopCount scintillation plate counter following the addition of a liquid scintillant to each well. Compounds can be evaluated for their potency using competition curve analysis, resulting in calculated Ki values.",CHEMBL3639279,KI,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1S2
CHEMBL304902,CHEMBL217,Dopamine D2 receptor,Ki,=,0.49,nM,CHEMBL3705566,B,"Binding Assay: The ability of test compounds to displace 3H-raclopride at the D2s receptor can be determined on membranes from D2s-transfected CHO cells (Bmax 13 pmol/mg protein). An assay can use a standard 96-well glass-fiber filter plate to retain radioligand bound by the receptor. Retained 3H can be determined in a TopCount scintillation plate counter following the addition of a liquid scintillant to each well. Compounds can be evaluated for their potency using competition curve analysis, resulting in calculated Ki values.",CHEMBL3639279,KI,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL3646151,CHEMBL217,Dopamine D2 receptor,Ki,=,1.1,nM,CHEMBL3705566,B,"Binding Assay: The ability of test compounds to displace 3H-raclopride at the D2s receptor can be determined on membranes from D2s-transfected CHO cells (Bmax 13 pmol/mg protein). An assay can use a standard 96-well glass-fiber filter plate to retain radioligand bound by the receptor. Retained 3H can be determined in a TopCount scintillation plate counter following the addition of a liquid scintillant to each well. Compounds can be evaluated for their potency using competition curve analysis, resulting in calculated Ki values.",CHEMBL3639279,KI,CN1CCN(C2=Nc3ccccc3Sc3ccc(F)cc32)CC1
CHEMBL3647673,CHEMBL217,Dopamine D2 receptor,Ki,=,10.8,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O
CHEMBL3647674,CHEMBL217,Dopamine D2 receptor,Ki,=,6.9,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCCC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O
CHEMBL3647675,CHEMBL217,Dopamine D2 receptor,Ki,=,45.2,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCCCC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O
CHEMBL3647676,CHEMBL217,Dopamine D2 receptor,Ki,=,182.5,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
CHEMBL3647677,CHEMBL217,Dopamine D2 receptor,Ki,=,28.5,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O
CHEMBL3647678,CHEMBL217,Dopamine D2 receptor,Ki,=,100.9,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O
CHEMBL3647679,CHEMBL217,Dopamine D2 receptor,Ki,=,16.9,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)c(F)c2)NC1=O
CHEMBL3647680,CHEMBL217,Dopamine D2 receptor,Ki,=,25.4,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2cc(F)cc(F)c2)NC1=O
CHEMBL3647681,CHEMBL217,Dopamine D2 receptor,Ki,=,30.3,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2cccc(F)c2)NC1=O
CHEMBL3647682,CHEMBL217,Dopamine D2 receptor,Ki,=,31.8,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2F)NC1=O
CHEMBL3647683,CHEMBL217,Dopamine D2 receptor,Ki,=,40.4,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2c(F)c(F)c(F)c(F)c2F)NC1=O
CHEMBL3647684,CHEMBL217,Dopamine D2 receptor,Ki,=,34.3,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
CHEMBL3647685,CHEMBL217,Dopamine D2 receptor,Ki,=,112.8,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](CCCCNC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
CHEMBL3647686,CHEMBL217,Dopamine D2 receptor,Ki,=,39.2,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](CCCCNC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
CHEMBL3647687,CHEMBL217,Dopamine D2 receptor,Ki,=,56.4,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCS(=O)(=O)C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O
CHEMBL4110066,CHEMBL217,Dopamine D2 receptor,Ki,=,79.7,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCC[S@+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
CHEMBL3647688,CHEMBL217,Dopamine D2 receptor,Ki,=,255.1,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCC[S@@+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
CHEMBL3647689,CHEMBL217,Dopamine D2 receptor,Ki,=,32.5,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)C[S+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O
CHEMBL3647690,CHEMBL217,Dopamine D2 receptor,Ki,=,76.5,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCC[S+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O
CHEMBL3647691,CHEMBL217,Dopamine D2 receptor,Ki,=,149.3,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)C[S+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
CHEMBL3647692,CHEMBL217,Dopamine D2 receptor,Ki,=,22.5,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](CCCCNC(=O)C[S+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)NC(=O)C[S+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
CHEMBL3647693,CHEMBL217,Dopamine D2 receptor,Ki,=,67.6,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](CCCCNC(=O)C[S+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)NC(=O)C[S+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
CHEMBL3647695,CHEMBL217,Dopamine D2 receptor,Ki,=,114.6,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCS(=O)(=O)C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
CHEMBL3647697,CHEMBL217,Dopamine D2 receptor,Ki,=,199.5,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,CC(=O)N(CCCNC[C@@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1)[C@@H]1CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O
CHEMBL3647698,CHEMBL217,Dopamine D2 receptor,Ki,=,328.3,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
CHEMBL3647699,CHEMBL217,Dopamine D2 receptor,Ki,=,175.3,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
CHEMBL3647700,CHEMBL217,Dopamine D2 receptor,Ki,=,272.4,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
CHEMBL3647701,CHEMBL217,Dopamine D2 receptor,Ki,=,309.0,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
CHEMBL3647702,CHEMBL217,Dopamine D2 receptor,Ki,=,276.8,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,CC(=O)N(CCC(=O)N[C@@H](CN[C@@H]1CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O)Cc1ccc(O)cc1)C[C@@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL3647703,CHEMBL217,Dopamine D2 receptor,Ki,=,39.9,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,CC(=O)N(CCCN(C(C)=O)[C@@H]1CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O)C[C@@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL3647704,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,CC(=O)N(CCCN[C@@H](CN[C@@H]1CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O)Cc1ccc(O)cc1)C[C@@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL3647705,CHEMBL217,Dopamine D2 receptor,Ki,=,135.2,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N(CCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
CHEMBL3647706,CHEMBL217,Dopamine D2 receptor,Ki,=,46.8,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,CC(=O)N(CCCN[C@@H]1CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O)C[C@@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL3647707,CHEMBL217,Dopamine D2 receptor,Ki,=,24.2,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
CHEMBL3647708,CHEMBL217,Dopamine D2 receptor,Ki,=,38.6,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
CHEMBL3647707,CHEMBL217,Dopamine D2 receptor,Ki,=,44.0,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
CHEMBL3647709,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
CHEMBL3647710,CHEMBL217,Dopamine D2 receptor,Ki,=,298.9,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O
CHEMBL3647711,CHEMBL217,Dopamine D2 receptor,Ki,=,345.2,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N(CCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
CHEMBL3647712,CHEMBL217,Dopamine D2 receptor,Ki,=,25.3,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
CHEMBL3647713,CHEMBL217,Dopamine D2 receptor,Ki,=,179.4,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2cccnc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
CHEMBL3647714,CHEMBL217,Dopamine D2 receptor,Ki,=,329.7,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N(CCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O
CHEMBL3650452,CHEMBL217,Dopamine D2 receptor,Ki,=,444.9,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N(CCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
CHEMBL3650453,CHEMBL217,Dopamine D2 receptor,Ki,=,8.5,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
CHEMBL3650454,CHEMBL217,Dopamine D2 receptor,Ki,=,285.3,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)CCN(C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)S(C)(=O)=O)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O
CHEMBL3650455,CHEMBL217,Dopamine D2 receptor,Ki,=,199.6,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)C1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
CHEMBL3647688,CHEMBL217,Dopamine D2 receptor,Ki,=,31.6,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCC[S@@+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
CHEMBL3650456,CHEMBL217,Dopamine D2 receptor,Ki,=,84.2,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](CCCCNC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O
CHEMBL3650457,CHEMBL217,Dopamine D2 receptor,Ki,=,19.4,nM,CHEMBL3705539,B,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",CHEMBL3638685,KI,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCCS(=O)(=O)C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O
CHEMBL398615,CHEMBL217,Dopamine D2 receptor,Ki,=,0.07,nM,CHEMBL3887246,B,"Radioligand Binding Assay: The pharmacological profile of metopimazine, metopimazine acid (MPZA), domperidone, and metoclopramide were assessed by radioligand binding and by a functional antagonist assay. For the radioligand binding assay, cell membranes of dopamine D2 receptor expressing cells were incubated with [3H]spiperone and competing drugs in buffer. The assay was terminated by rapid filtration, and the bound radioactive signal was determined by liquid scintillation counting.",CHEMBL3886237,KI,CS(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(C(N)=O)CC1)c1ccccc1S2
CHEMBL3954123,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL3887246,B,"Radioligand Binding Assay: The pharmacological profile of metopimazine, metopimazine acid (MPZA), domperidone, and metoclopramide were assessed by radioligand binding and by a functional antagonist assay. For the radioligand binding assay, cell membranes of dopamine D2 receptor expressing cells were incubated with [3H]spiperone and competing drugs in buffer. The assay was terminated by rapid filtration, and the bound radioactive signal was determined by liquid scintillation counting.",CHEMBL3886237,KI,CS(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(C(=O)O)CC1)c1ccccc1S2
CHEMBL219916,CHEMBL217,Dopamine D2 receptor,Ki,=,1.3,nM,CHEMBL3887246,B,"Radioligand Binding Assay: The pharmacological profile of metopimazine, metopimazine acid (MPZA), domperidone, and metoclopramide were assessed by radioligand binding and by a functional antagonist assay. For the radioligand binding assay, cell membranes of dopamine D2 receptor expressing cells were incubated with [3H]spiperone and competing drugs in buffer. The assay was terminated by rapid filtration, and the bound radioactive signal was determined by liquid scintillation counting.",CHEMBL3886237,KI,O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
CHEMBL86,CHEMBL217,Dopamine D2 receptor,Ki,=,64.0,nM,CHEMBL3887246,B,"Radioligand Binding Assay: The pharmacological profile of metopimazine, metopimazine acid (MPZA), domperidone, and metoclopramide were assessed by radioligand binding and by a functional antagonist assay. For the radioligand binding assay, cell membranes of dopamine D2 receptor expressing cells were incubated with [3H]spiperone and competing drugs in buffer. The assay was terminated by rapid filtration, and the bound radioactive signal was determined by liquid scintillation counting.",CHEMBL3886237,KI,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC
CHEMBL3918805,CHEMBL217,Dopamine D2 receptor,Ki,=,8.3,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1CCc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2165126,CHEMBL217,Dopamine D2 receptor,Ki,=,3.6,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2165119,CHEMBL217,Dopamine D2 receptor,Ki,=,1.2,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)nc2N1
CHEMBL2165120,CHEMBL217,Dopamine D2 receptor,Ki,=,3.4,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=c1ccc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1
CHEMBL2165118,CHEMBL217,Dopamine D2 receptor,Ki,=,5.7,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1NCCc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc21
CHEMBL3943838,CHEMBL217,Dopamine D2 receptor,Ki,=,4.6,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1NCCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc21
CHEMBL2165114,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,Clc1cccc(N2CCCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl
CHEMBL2165140,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,Clc1cccc(N2CCCN(CCCOc3ccc4scnc4c3)CC2)c1Cl
CHEMBL3973357,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,COc1ccccc1N1CCCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1
CHEMBL3957278,CHEMBL217,Dopamine D2 receptor,Ki,=,2.1,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,COc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1
CHEMBL3929710,CHEMBL217,Dopamine D2 receptor,Ki,=,5.7,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,COc1ccccc1N1CCCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1
CHEMBL3891542,CHEMBL217,Dopamine D2 receptor,Ki,=,4.1,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,CCOc1ccccc1N1CCCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1
CHEMBL3935170,CHEMBL217,Dopamine D2 receptor,Ki,=,4.4,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,CCOc1ccccc1N1CCCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1
CHEMBL3944009,CHEMBL217,Dopamine D2 receptor,Ki,=,3.6,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,CCOc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1
CHEMBL3916047,CHEMBL217,Dopamine D2 receptor,Ki,=,3.4,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=c1ccc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1
CHEMBL3952761,CHEMBL217,Dopamine D2 receptor,Ki,=,0.87,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,CC(C)Oc1ccccc1N1CCCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1
CHEMBL3978288,CHEMBL217,Dopamine D2 receptor,Ki,=,1.29,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,CC(C)Oc1ccccc1N1CCCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1
CHEMBL3921903,CHEMBL217,Dopamine D2 receptor,Ki,=,0.93,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,CC(C)Oc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1
CHEMBL3915863,CHEMBL217,Dopamine D2 receptor,Ki,=,4.5,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=c1[nH]c2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1
CHEMBL2165116,CHEMBL217,Dopamine D2 receptor,Ki,=,104.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,Clc1cccc(N2CCN(CCCOc3ccc4cn[nH]c4c3)CC2)c1Cl
CHEMBL2165137,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,Clc1cccc(C2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl
CHEMBL2165138,CHEMBL217,Dopamine D2 receptor,Ki,=,75.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,Clc1cccc(C2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl
CHEMBL2165139,CHEMBL217,Dopamine D2 receptor,Ki,=,30.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,Clc1cccc(N2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl
CHEMBL2165115,CHEMBL217,Dopamine D2 receptor,Ki,=,10.9,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=c1[nH]c2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc2[nH]1
CHEMBL2165133,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1NCCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21
CHEMBL3903542,CHEMBL217,Dopamine D2 receptor,Ki,=,145.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1CCc2ccc(OCC3CCC(CN4CCN(c5cccc(Cl)c5Cl)CC4)CC3)cc2N1
CHEMBL2165129,CHEMBL217,Dopamine D2 receptor,Ki,=,1004.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1CCc2ccc(OCC#CCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2165134,CHEMBL217,Dopamine D2 receptor,Ki,=,66.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,Clc1cccc(N2CCN(CCCCOc3ccc4cn[nH]c4c3)CC2)c1Cl
CHEMBL3896746,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1CCc2ccc(OC/C=C/CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2165131,CHEMBL217,Dopamine D2 receptor,Ki,=,113.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1CCc2ccc(Oc3cccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)c3)cc2N1
CHEMBL2165132,CHEMBL217,Dopamine D2 receptor,Ki,=,108.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1CCc2ccc(Oc3ccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)cc2N1
CHEMBL2165117,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1NCCc2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21
CHEMBL3898054,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1NCCc2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc21
CHEMBL3934712,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=c1[nH]c2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1
CHEMBL2165135,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=c1[nH]c2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1
CHEMBL2165136,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,Clc1cccc(N2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl
CHEMBL3937643,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,COc1ccccc1N1CCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1
CHEMBL3983588,CHEMBL217,Dopamine D2 receptor,Ki,=,0.47,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCC(=O)N5)CC3)cc2N1
CHEMBL160296,CHEMBL217,Dopamine D2 receptor,Ki,=,0.32,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,COc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1
CHEMBL3982360,CHEMBL217,Dopamine D2 receptor,Ki,=,0.3,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)cc2N1
CHEMBL3912435,CHEMBL217,Dopamine D2 receptor,Ki,=,0.45,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)nc2N1
CHEMBL3966956,CHEMBL217,Dopamine D2 receptor,Ki,=,0.4,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)cc2[nH]1
CHEMBL3899117,CHEMBL217,Dopamine D2 receptor,Ki,=,72.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,CC(=O)Nc1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc1C
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2165119,CHEMBL217,Dopamine D2 receptor,Ki,=,2.6,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)nc2N1
CHEMBL2165126,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL3887359,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL3982119,CHEMBL217,Dopamine D2 receptor,Ki,=,334.38,nM,CHEMBL3888598,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(cc1OC)[C@@H]1Cc3c(OC)ccc(OC)c3CN1CC2
CHEMBL3903297,CHEMBL217,Dopamine D2 receptor,Ki,=,239.9,nM,CHEMBL3888598,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,c1c2c(cc3c1OCO3)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL3897805,CHEMBL217,Dopamine D2 receptor,Ki,=,485.43,nM,CHEMBL3888598,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1ccc(OC)c2c1C[C@H]1c3cc4c(cc3CCN1C2)OCO4
CHEMBL2057451,CHEMBL217,Dopamine D2 receptor,Ki,=,223.61,nM,CHEMBL3888598,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(cc1OC)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL2334893,CHEMBL217,Dopamine D2 receptor,Ki,=,32.16,nM,CHEMBL3888598,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(cc1O)[C@@H]1Cc3cc4c(cc3CN1CC2)OCO4
CHEMBL2057457,CHEMBL217,Dopamine D2 receptor,Ki,=,160.99,nM,CHEMBL3888598,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL267930,CHEMBL217,Dopamine D2 receptor,Ki,=,0.5,nM,CHEMBL3888598,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
CHEMBL2334882,CHEMBL217,Dopamine D2 receptor,Ki,=,146.9,nM,CHEMBL3888603,B,"Radioligand Binding Assay: The affinity of compounds to D1 and D2 dopamine receptors were determined by competition binding assays. Membrane homogenates of HEK293T cells were stably transfected with D1, or D2 receptors. Duplicated tubes were incubated at 30° C. for 50 mins (for D1, and D2) with increasing concentrations of respective compound and with [3H]SCH23390 (for D1 dopamine receptors), or [3H]Spiperone (for dopamine D2 receptor) in a final volume of 200 μL binding buffer containing 50 mM Tris, 4 mM MgCl2, pH 7.4. Nonspecific binding was determined by parallel incubations with either 10 μM SCH23390 for D1, or Spiperone for D2 receptors respectively. The reaction was started by addition of membranes (15 ng/tube) and stopped by rapid filtration through Whatman GF/B glassfiber filter and subsequently washed with cold buffer (50 mM Tris, 5 mM EDTA, pH 7.4) using a Brandel 24-well cell harvester. Scintillation cocktail was added and the radioactivity was determined in a MicroBeta liquid scintillation counter.",CHEMBL3886775,KI,COc1c(O)ccc2c1CN1CCc3cc4c(cc3[C@@H]1C2)OCC4
CHEMBL2057457,CHEMBL217,Dopamine D2 receptor,Ki,=,160.9,nM,CHEMBL3888603,B,"Radioligand Binding Assay: The affinity of compounds to D1 and D2 dopamine receptors were determined by competition binding assays. Membrane homogenates of HEK293T cells were stably transfected with D1, or D2 receptors. Duplicated tubes were incubated at 30° C. for 50 mins (for D1, and D2) with increasing concentrations of respective compound and with [3H]SCH23390 (for D1 dopamine receptors), or [3H]Spiperone (for dopamine D2 receptor) in a final volume of 200 μL binding buffer containing 50 mM Tris, 4 mM MgCl2, pH 7.4. Nonspecific binding was determined by parallel incubations with either 10 μM SCH23390 for D1, or Spiperone for D2 receptors respectively. The reaction was started by addition of membranes (15 ng/tube) and stopped by rapid filtration through Whatman GF/B glassfiber filter and subsequently washed with cold buffer (50 mM Tris, 5 mM EDTA, pH 7.4) using a Brandel 24-well cell harvester. Scintillation cocktail was added and the radioactivity was determined in a MicroBeta liquid scintillation counter.",CHEMBL3886775,KI,COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL3899169,CHEMBL217,Dopamine D2 receptor,Ki,=,2780.0,nM,CHEMBL3889270,B,"Binding Assay or Functional Activity Assay: Further, the compounds of the invention may be tested in binding assays and functional activity assays by well known methods for other physiologically important receptors such as, but not limited to, the hERG channel, other serotonin receptors (specifically 5-HT1B, 5-HT1D, receptors, lack of agonist activity at 5-HT2B receptors, 5-HT2C, 5-HT5, 5-HT6, and 5-HT7 receptors), dopaminergic receptors (specifically D1, D2, and D3), GABAA receptors, adrenergic receptors and monoamine transporters.",CHEMBL3887018,KI,Cc1ccc2c(c1)Oc1sc(Cl)cc1C(N1CCN(CC(C)(C)C(=O)O)CC1)=N2
CHEMBL708,CHEMBL217,Dopamine D2 receptor,Ki,=,2.1,nM,CHEMBL3997508,B,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),CHEMBL3994665,KI,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL4068850,CHEMBL217,Dopamine D2 receptor,Ki,=,4287.0,nM,CHEMBL3997508,B,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),CHEMBL3994665,KI,O=S(=O)(c1cccc2ccccc12)n1cc2c3c(cccc31)OC(CO)=C2
CHEMBL4060194,CHEMBL217,Dopamine D2 receptor,Ki,=,4351.0,nM,CHEMBL3997508,B,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),CHEMBL3994665,KI,CCN(CC)CC1=Cc2cn(S(=O)(=O)c3ccccc3)c3cccc(c23)O1
CHEMBL4083059,CHEMBL217,Dopamine D2 receptor,Ki,=,1489.0,nM,CHEMBL3997508,B,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),CHEMBL3994665,KI,CN(C)CC1=Cc2cn(S(=O)(=O)c3cccc4ccccc34)c3cccc(c23)O1
CHEMBL4061189,CHEMBL217,Dopamine D2 receptor,Ki,=,6698.0,nM,CHEMBL3997508,B,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),CHEMBL3994665,KI,CN(C)CC1=CC2=CN(S(=O)(=O)c3ccccc3)C3=CC=CC(O1)C23
CHEMBL4079631,CHEMBL217,Dopamine D2 receptor,Ki,=,5162.0,nM,CHEMBL3997508,B,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),CHEMBL3994665,KI,O=CC1=Cc2cn(S(=O)(=O)c3cccc4ccccc34)c3cccc(c23)O1
CHEMBL1457510,CHEMBL217,Dopamine D2 receptor,Ki,=,49.2,nM,CHEMBL3999639,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor after 1 hr,CHEMBL3997822,KI,COc1c(O)ccc2c1CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL490533,CHEMBL217,Dopamine D2 receptor,Ki,=,80.2,nM,CHEMBL3999639,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor after 1 hr,CHEMBL3997822,KI,COc1ccc2c(c1OC)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL448891,CHEMBL217,Dopamine D2 receptor,Ki,=,533.0,nM,CHEMBL3999639,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor after 1 hr,CHEMBL3997822,KI,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL2334885,CHEMBL217,Dopamine D2 receptor,Ki,=,42.4,nM,CHEMBL3999639,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor after 1 hr,CHEMBL3997822,KI,COc1cc2c(cc1O)CCN1Cc3c(ccc(OC)c3OC)C[C@@H]21
CHEMBL487182,CHEMBL217,Dopamine D2 receptor,Ki,=,1125.0,nM,CHEMBL3999644,B,Displacement of [3H]SCH23390 from human FLAG-tagged dopamine D2 receptor expressed in HEK293 cells after 1 hr,CHEMBL3997822,KI,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2
CHEMBL2334891,CHEMBL217,Dopamine D2 receptor,Ki,=,41.8,nM,CHEMBL3999644,B,Displacement of [3H]SCH23390 from human FLAG-tagged dopamine D2 receptor expressed in HEK293 cells after 1 hr,CHEMBL3997822,KI,COc1cc2c(cc1O)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2
CHEMBL4093980,CHEMBL217,Dopamine D2 receptor,Ki,=,275.42,nM,CHEMBL4000277,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,CHEMBL4000143,KI,O=C1COc2ccccc2N1CCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL4066435,CHEMBL217,Dopamine D2 receptor,Ki,=,42.66,nM,CHEMBL4000277,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,CHEMBL4000143,KI,COc1ccccc1N1CCN(CCCN2C(=O)COc3ccccc32)CC1
CHEMBL4090568,CHEMBL217,Dopamine D2 receptor,Ki,=,17.78,nM,CHEMBL4000277,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,CHEMBL4000143,KI,O=C1COc2ccccc2N1CCCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4062602,CHEMBL217,Dopamine D2 receptor,Ki,=,3.236,nM,CHEMBL4000277,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,CHEMBL4000143,KI,O=C1COc2ccccc2N1CCCN1CCC(c2noc3cc(F)ccc23)CC1
CHEMBL4104013,CHEMBL217,Dopamine D2 receptor,Ki,=,1.738,nM,CHEMBL4000277,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,CHEMBL4000143,KI,O=C1COc2ccccc2N1CCCN1CCN(c2cccc3[nH]c(=O)oc23)CC1
CHEMBL1242923,CHEMBL217,Dopamine D2 receptor,Ki,=,831.76,nM,CHEMBL4000277,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,CHEMBL4000143,KI,O=C(Cc1ccccc1)NC1CCN(CCCN2C(=O)COc3ccccc32)CC1
CHEMBL4093980,CHEMBL217,Dopamine D2 receptor,Ki,=,273.0,nM,CHEMBL4000277,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,CHEMBL4000143,KI,O=C1COc2ccccc2N1CCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL4066435,CHEMBL217,Dopamine D2 receptor,Ki,=,42.7,nM,CHEMBL4000277,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,CHEMBL4000143,KI,COc1ccccc1N1CCN(CCCN2C(=O)COc3ccccc32)CC1
CHEMBL4090568,CHEMBL217,Dopamine D2 receptor,Ki,=,17.7,nM,CHEMBL4000277,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,CHEMBL4000143,KI,O=C1COc2ccccc2N1CCCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4062602,CHEMBL217,Dopamine D2 receptor,Ki,=,3.2,nM,CHEMBL4000277,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,CHEMBL4000143,KI,O=C1COc2ccccc2N1CCCN1CCC(c2noc3cc(F)ccc23)CC1
CHEMBL4104013,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL4000277,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,CHEMBL4000143,KI,O=C1COc2ccccc2N1CCCN1CCN(c2cccc3[nH]c(=O)oc23)CC1
CHEMBL1242923,CHEMBL217,Dopamine D2 receptor,Ki,=,834.0,nM,CHEMBL4000277,B,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,CHEMBL4000143,KI,O=C(Cc1ccccc1)NC1CCN(CCCN2C(=O)COc3ccccc32)CC1
CHEMBL8514,CHEMBL217,Dopamine D2 receptor,Ki,=,0.27,nM,CHEMBL4001156,B,Displacement of [3H]methyl-spiperone from human recombinant D2S receptor in HEK293 cells after 60 mins by scintillation counting,CHEMBL4000185,KI,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1
CHEMBL4088639,CHEMBL217,Dopamine D2 receptor,Ki,=,1.4,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(C=O)c3c2)CC1
CHEMBL4060403,CHEMBL217,Dopamine D2 receptor,Ki,=,0.3,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,O=Cc1cnn2ccc(NC(=O)CCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL4063282,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3nccc3c2)CC1
CHEMBL4091155,CHEMBL217,Dopamine D2 receptor,Ki,=,8.1,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)Nc1ccn2nccc2c1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.53,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4069091,CHEMBL217,Dopamine D2 receptor,Ki,=,0.57,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)Nc1ccn2ncc(/C=N\O)c2c1
CHEMBL4096353,CHEMBL217,Dopamine D2 receptor,Ki,=,0.97,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(/C=N\O)c3c2)CC1
CHEMBL4091064,CHEMBL217,Dopamine D2 receptor,Ki,=,0.91,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,N#Cc1cnn2ccc(NC(=O)CCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL4070091,CHEMBL217,Dopamine D2 receptor,Ki,=,1.1,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(C#N)c3c2)CC1
CHEMBL4098803,CHEMBL217,Dopamine D2 receptor,Ki,=,1.8,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1
CHEMBL4080762,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3nccc3c2)CC1
CHEMBL4072821,CHEMBL217,Dopamine D2 receptor,Ki,=,8.1,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4ccccc4OC)CC3)ccn2n1
CHEMBL4099711,CHEMBL217,Dopamine D2 receptor,Ki,=,6.0,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3nc(CO)cc3c2)CC1
CHEMBL4087187,CHEMBL217,Dopamine D2 receptor,Ki,=,5.1,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C=O)cc3c2)CC1
CHEMBL4105030,CHEMBL217,Dopamine D2 receptor,Ki,=,3.3,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3nc(/C=N/O)cc3c2)CC1
CHEMBL4079301,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C#N)cc3c2)CC1
CHEMBL4097330,CHEMBL217,Dopamine D2 receptor,Ki,=,0.63,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4102616,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4078348,CHEMBL217,Dopamine D2 receptor,Ki,=,2.1,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4094869,CHEMBL217,Dopamine D2 receptor,Ki,=,96.0,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4067439,CHEMBL217,Dopamine D2 receptor,Ki,=,7.8,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1
CHEMBL4098236,CHEMBL217,Dopamine D2 receptor,Ki,=,1.8,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C=O)c3c2)CC1
CHEMBL4071185,CHEMBL217,Dopamine D2 receptor,Ki,=,2.4,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4090208,CHEMBL217,Dopamine D2 receptor,Ki,=,2.3,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4069145,CHEMBL217,Dopamine D2 receptor,Ki,=,4.2,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1
CHEMBL4060461,CHEMBL217,Dopamine D2 receptor,Ki,=,1.2,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1
CHEMBL4060461,CHEMBL217,Dopamine D2 receptor,Ki,=,0.16,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1
CHEMBL4071868,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccc2c(/C=N/O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4098859,CHEMBL217,Dopamine D2 receptor,Ki,=,2.2,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccn2ncc(/C=N\O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4063235,CHEMBL217,Dopamine D2 receptor,Ki,=,0.25,nM,CHEMBL4010156,B,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C#N)c3c2)CC1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.45,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4091155,CHEMBL217,Dopamine D2 receptor,Ki,=,7.8,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)Nc1ccn2nccc2c1
CHEMBL4063282,CHEMBL217,Dopamine D2 receptor,Ki,=,36.0,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3nccc3c2)CC1
CHEMBL4060403,CHEMBL217,Dopamine D2 receptor,Ki,=,0.41,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,O=Cc1cnn2ccc(NC(=O)CCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL4088639,CHEMBL217,Dopamine D2 receptor,Ki,=,1.5,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(C=O)c3c2)CC1
CHEMBL4069091,CHEMBL217,Dopamine D2 receptor,Ki,=,0.5,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)Nc1ccn2ncc(/C=N\O)c2c1
CHEMBL4096353,CHEMBL217,Dopamine D2 receptor,Ki,=,0.52,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(/C=N\O)c3c2)CC1
CHEMBL4091064,CHEMBL217,Dopamine D2 receptor,Ki,=,0.52,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,N#Cc1cnn2ccc(NC(=O)CCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL4070091,CHEMBL217,Dopamine D2 receptor,Ki,=,0.55,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(C#N)c3c2)CC1
CHEMBL4098803,CHEMBL217,Dopamine D2 receptor,Ki,=,0.74,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1
CHEMBL4080762,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3nccc3c2)CC1
CHEMBL4072821,CHEMBL217,Dopamine D2 receptor,Ki,=,7.4,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4ccccc4OC)CC3)ccn2n1
CHEMBL4099711,CHEMBL217,Dopamine D2 receptor,Ki,=,5.8,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3nc(CO)cc3c2)CC1
CHEMBL4087187,CHEMBL217,Dopamine D2 receptor,Ki,=,5.5,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C=O)cc3c2)CC1
CHEMBL4105030,CHEMBL217,Dopamine D2 receptor,Ki,=,1.9,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3nc(/C=N/O)cc3c2)CC1
CHEMBL4079301,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C#N)cc3c2)CC1
CHEMBL4097330,CHEMBL217,Dopamine D2 receptor,Ki,=,0.75,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4102616,CHEMBL217,Dopamine D2 receptor,Ki,=,48.0,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4078348,CHEMBL217,Dopamine D2 receptor,Ki,=,0.7,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4094869,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4067439,CHEMBL217,Dopamine D2 receptor,Ki,=,7.7,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1
CHEMBL4098236,CHEMBL217,Dopamine D2 receptor,Ki,=,2.3,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C=O)c3c2)CC1
CHEMBL4071185,CHEMBL217,Dopamine D2 receptor,Ki,=,0.94,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4090208,CHEMBL217,Dopamine D2 receptor,Ki,=,0.9,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4069145,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1
CHEMBL4060461,CHEMBL217,Dopamine D2 receptor,Ki,=,0.72,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1
CHEMBL4060461,CHEMBL217,Dopamine D2 receptor,Ki,=,0.094,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1
CHEMBL4071868,CHEMBL217,Dopamine D2 receptor,Ki,=,0.84,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccc2c(/C=N/O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4098859,CHEMBL217,Dopamine D2 receptor,Ki,=,0.87,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccn2ncc(/C=N\O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4063235,CHEMBL217,Dopamine D2 receptor,Ki,=,0.16,nM,CHEMBL4010153,B,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C#N)c3c2)CC1
CHEMBL4096422,CHEMBL217,Dopamine D2 receptor,Ki,=,40.1,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CN(CCCCOc1ccc2c(c1)NC(=O)CC2)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL4078379,CHEMBL217,Dopamine D2 receptor,Ki,=,21.8,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CCCn1c(=O)n2c3c(cccc31)C[C@@H](N(C)CCCCNC(=O)c1cc3ccccc3[nH]1)C2
CHEMBL4093477,CHEMBL217,Dopamine D2 receptor,Ki,=,8.43,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL4095452,CHEMBL217,Dopamine D2 receptor,Ki,=,306.0,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCOc2ccc3c(c2)NC(=O)CC3)C1
CHEMBL4085282,CHEMBL217,Dopamine D2 receptor,Ki,=,34.7,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCCCc2ccccc2)C1
CHEMBL4100322,CHEMBL217,Dopamine D2 receptor,Ki,=,111.0,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCCCc2ccccc2)C1
CHEMBL4068455,CHEMBL217,Dopamine D2 receptor,Ki,=,86.8,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL4065353,CHEMBL217,Dopamine D2 receptor,Ki,=,18.5,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CCCN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL4100734,CHEMBL217,Dopamine D2 receptor,Ki,=,284.0,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCCCOc2ccc3c(c2)NC(=O)CC3)C1
CHEMBL4077430,CHEMBL217,Dopamine D2 receptor,Ki,=,338.0,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOc2ccc3c(c2)NC(=O)CC3)C1
CHEMBL4086953,CHEMBL217,Dopamine D2 receptor,Ki,=,124.0,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCCCOCCCCc2ccccc2)C1
CHEMBL4076129,CHEMBL217,Dopamine D2 receptor,Ki,=,23.8,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCOCCCCc2ccccc2)C1
CHEMBL4097572,CHEMBL217,Dopamine D2 receptor,Ki,=,38.7,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCOCCCCc2ccccc2)C1
CHEMBL4071243,CHEMBL217,Dopamine D2 receptor,Ki,=,60.6,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCOCCCCc2ccccc2)C1
CHEMBL4093223,CHEMBL217,Dopamine D2 receptor,Ki,=,54.8,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CCCN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCOCCCCc2ccccc2)C1
CHEMBL4060603,CHEMBL217,Dopamine D2 receptor,Ki,=,121.0,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOCCCCc2ccccc2)C1
CHEMBL4059581,CHEMBL217,Dopamine D2 receptor,Ki,=,37.2,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CCCN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOCCCCc2ccccc2)C1
CHEMBL419792,CHEMBL217,Dopamine D2 receptor,Ki,=,46.3,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.48,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,NCCc1ccc(O)c(O)c1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,Ki,=,13.1,nM,CHEMBL4011211,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,CHEMBL4007493,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,Ki,=,0.49,nM,CHEMBL4012540,B,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,CHEMBL4011616,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,Ki,=,0.69,nM,CHEMBL4012541,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHO cells,CHEMBL4011616,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL4083239,CHEMBL217,Dopamine D2 receptor,Ki,=,0.89,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2N1
CHEMBL4099666,CHEMBL217,Dopamine D2 receptor,Ki,=,4.8,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5oc(=O)ccc45)CC3)cc2N1
CHEMBL4072780,CHEMBL217,Dopamine D2 receptor,Ki,=,0.87,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc2N1
CHEMBL4091933,CHEMBL217,Dopamine D2 receptor,Ki,=,2.9,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCCO5)CC3)cc2N1
CHEMBL4064186,CHEMBL217,Dopamine D2 receptor,Ki,=,3.4,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5ncccc45)CC3)cc2N1
CHEMBL4102628,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2N1
CHEMBL4084690,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5oc(=O)ccc45)CC3)cc2N1
CHEMBL4064742,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc2N1
CHEMBL4092441,CHEMBL217,Dopamine D2 receptor,Ki,=,8.3,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2[nH]1
CHEMBL4073330,CHEMBL217,Dopamine D2 receptor,Ki,=,40.0,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2o1
CHEMBL4100183,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1COc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2N1
CHEMBL4083727,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c2c1OCCO2
CHEMBL4061986,CHEMBL217,Dopamine D2 receptor,Ki,=,33.0,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c2cccnc12
CHEMBL4091507,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=c1ccc2c(N3CCCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2[nH]1
CHEMBL4070604,CHEMBL217,Dopamine D2 receptor,Ki,=,350.0,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2OC)nn1
CHEMBL4068702,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2OC)nn1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.52,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2165126,CHEMBL217,Dopamine D2 receptor,Ki,=,0.53,nM,CHEMBL4015806,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4083239,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2N1
CHEMBL4099666,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5oc(=O)ccc45)CC3)cc2N1
CHEMBL4072780,CHEMBL217,Dopamine D2 receptor,Ki,=,0.67,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc2N1
CHEMBL4091933,CHEMBL217,Dopamine D2 receptor,Ki,=,2.2,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCCO5)CC3)cc2N1
CHEMBL4064186,CHEMBL217,Dopamine D2 receptor,Ki,=,1.5,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5ncccc45)CC3)cc2N1
CHEMBL4102628,CHEMBL217,Dopamine D2 receptor,Ki,=,0.81,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2N1
CHEMBL4084690,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5oc(=O)ccc45)CC3)cc2N1
CHEMBL4064742,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc2N1
CHEMBL4092441,CHEMBL217,Dopamine D2 receptor,Ki,=,3.7,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2[nH]1
CHEMBL4073330,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2o1
CHEMBL4100183,CHEMBL217,Dopamine D2 receptor,Ki,=,0.86,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1COc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2N1
CHEMBL4083727,CHEMBL217,Dopamine D2 receptor,Ki,=,68.0,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c2c1OCCO2
CHEMBL4061986,CHEMBL217,Dopamine D2 receptor,Ki,=,25.0,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c2cccnc12
CHEMBL4091507,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=c1ccc2c(N3CCCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2[nH]1
CHEMBL4070604,CHEMBL217,Dopamine D2 receptor,Ki,=,440.0,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2OC)nn1
CHEMBL4068702,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2OC)nn1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.38,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2165126,CHEMBL217,Dopamine D2 receptor,Ki,=,0.2,nM,CHEMBL4015807,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4084262,CHEMBL217,Dopamine D2 receptor,Ki,=,10895.0,nM,CHEMBL4032441,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,CHEMBL4028897,KI,COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccccc4)n3C)CC2)CC1
CHEMBL4062553,CHEMBL217,Dopamine D2 receptor,Ki,=,6168.0,nM,CHEMBL4032441,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,CHEMBL4028897,KI,COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccccc4)n3C)CC2)C1
CHEMBL4092015,CHEMBL217,Dopamine D2 receptor,Ki,=,29300.0,nM,CHEMBL4032441,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,CHEMBL4028897,KI,COc1ccccc1N1CCC12CCN(CCCSc1nnc(-c3ccccc3)n1C)CC2
CHEMBL4071189,CHEMBL217,Dopamine D2 receptor,Ki,=,37579.0,nM,CHEMBL4032441,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,CHEMBL4028897,KI,COc1ccccc1N1CC2(CCN(CCCSc3nnc(-c4ccccc4)n3C)CC2)C1
CHEMBL4076516,CHEMBL217,Dopamine D2 receptor,Ki,=,6370.0,nM,CHEMBL4032441,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,CHEMBL4028897,KI,COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccccc4)n3C)C2)C1
CHEMBL4089290,CHEMBL217,Dopamine D2 receptor,Ki,=,60152.0,nM,CHEMBL4032441,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,CHEMBL4028897,KI,COc1ccccc1N1CCC2(CN(CCCSc3nnc(-c4ccccc4)n3C)C2)C1
CHEMBL4079642,CHEMBL217,Dopamine D2 receptor,Ki,=,114945.0,nM,CHEMBL4032441,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,CHEMBL4028897,KI,COc1ccccc1N1CCC12CN(CCCSc1nnc(-c3ccccc3)n1C)C2
CHEMBL4077251,CHEMBL217,Dopamine D2 receptor,Ki,=,21216.0,nM,CHEMBL4032441,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,CHEMBL4028897,KI,COc1ccccc1N1CC2(CN(CCCSc3nnc(-c4ccccc4)n3C)C2)C1
CHEMBL4100699,CHEMBL217,Dopamine D2 receptor,Ki,=,104847.0,nM,CHEMBL4032441,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,CHEMBL4028897,KI,COc1ccc(N2CCC3(CCN(CCCSc4nnc(-c5ccccc5)n4C)CC3)CC2)cc1
CHEMBL4073927,CHEMBL217,Dopamine D2 receptor,Ki,=,9792.0,nM,CHEMBL4032441,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,CHEMBL4028897,KI,Cn1c(SCCCN2CCC3(CC2)CCN(c2ccc(F)cc2)CC3)nnc1-c1ccccc1
CHEMBL4076527,CHEMBL217,Dopamine D2 receptor,Ki,=,83671.0,nM,CHEMBL4032441,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,CHEMBL4028897,KI,Cn1c(SCCCN2CCC3(CC2)CCN(c2ccccn2)CC3)nnc1-c1ccccc1
CHEMBL4076086,CHEMBL217,Dopamine D2 receptor,Ki,=,57101.0,nM,CHEMBL4032441,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,CHEMBL4028897,KI,Cn1c(SCCCN2CCC3(CC2)CCN(c2cccc(C#N)c2)CC3)nnc1-c1ccccc1
CHEMBL4101993,CHEMBL217,Dopamine D2 receptor,Ki,=,7501.0,nM,CHEMBL4032441,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,CHEMBL4028897,KI,Cn1c(SCCCN2CCC3(CC2)CCN(c2cccc(Cl)c2Cl)CC3)nnc1-c1ccccc1
CHEMBL4083252,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL4032441,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,CHEMBL4028897,KI,COc1ccccc1N1CCN(CCCSc2nnc(-c3ccccc3)n2C)CC1
CHEMBL267930,CHEMBL217,Dopamine D2 receptor,Ki,=,0.06,nM,CHEMBL4032441,B,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,CHEMBL4028897,KI,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
CHEMBL4076903,CHEMBL217,Dopamine D2 receptor,Ki,=,1237.0,nM,CHEMBL4036228,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,CHEMBL4033716,KI,O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1
CHEMBL4075422,CHEMBL217,Dopamine D2 receptor,Ki,=,1218.0,nM,CHEMBL4036228,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,CHEMBL4033716,KI,O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1
CHEMBL4080398,CHEMBL217,Dopamine D2 receptor,Ki,=,141.0,nM,CHEMBL4036228,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,CHEMBL4033716,KI,O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3ccc(Cl)cc3)CC2)CC1
CHEMBL4076525,CHEMBL217,Dopamine D2 receptor,Ki,=,223.0,nM,CHEMBL4036228,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,CHEMBL4033716,KI,O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3ccc(F)cc3)CC2)CC1
CHEMBL4089427,CHEMBL217,Dopamine D2 receptor,Ki,=,418.0,nM,CHEMBL4036228,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,CHEMBL4033716,KI,O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3ccc(F)cc3)CC2)CC1
CHEMBL4076408,CHEMBL217,Dopamine D2 receptor,Ki,=,76.0,nM,CHEMBL4036228,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,CHEMBL4033716,KI,O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3cccc(Cl)c3)CC2)CC1
CHEMBL4096866,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL4036228,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,CHEMBL4033716,KI,O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3cccc(Cl)c3)CC2)CC1
CHEMBL4077538,CHEMBL217,Dopamine D2 receptor,Ki,=,1821.0,nM,CHEMBL4036228,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,CHEMBL4033716,KI,O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3cccc(F)c3)CC2)CC1
CHEMBL4061131,CHEMBL217,Dopamine D2 receptor,Ki,=,1011.0,nM,CHEMBL4036228,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,CHEMBL4033716,KI,O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3cccc(F)c3)CC2)CC1
CHEMBL4081383,CHEMBL217,Dopamine D2 receptor,Ki,=,149.0,nM,CHEMBL4036228,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,CHEMBL4033716,KI,O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3cccc(C(F)(F)F)c3)CC2)CC1
CHEMBL4100470,CHEMBL217,Dopamine D2 receptor,Ki,=,148.0,nM,CHEMBL4036228,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,CHEMBL4033716,KI,O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3cccc(C(F)(F)F)c3)CC2)CC1
CHEMBL4082456,CHEMBL217,Dopamine D2 receptor,Ki,=,36.0,nM,CHEMBL4036228,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,CHEMBL4033716,KI,O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL4093971,CHEMBL217,Dopamine D2 receptor,Ki,=,30.0,nM,CHEMBL4036228,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,CHEMBL4033716,KI,O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL4066426,CHEMBL217,Dopamine D2 receptor,Ki,=,121.0,nM,CHEMBL4036228,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,CHEMBL4033716,KI,O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3ccc(Cl)c(Cl)c3)CC2)CC1
CHEMBL4086211,CHEMBL217,Dopamine D2 receptor,Ki,=,145.0,nM,CHEMBL4036228,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,CHEMBL4033716,KI,O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3ccc(Cl)c(Cl)c3)CC2)CC1
CHEMBL49,CHEMBL217,Dopamine D2 receptor,Ki,=,484.0,nM,CHEMBL4037101,B,Displacement of [3H]methylspiperone from human D2 receptor expressed in HEK cells,CHEMBL4033775,KI,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
CHEMBL284092,CHEMBL217,Dopamine D2 receptor,Ki,=,4320.0,nM,CHEMBL4037101,B,Displacement of [3H]methylspiperone from human D2 receptor expressed in HEK cells,CHEMBL4033775,KI,CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,960.0,nM,CHEMBL4039163,B,Inhibition of human dopamine D2 receptor,CHEMBL4038300,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL346389,CHEMBL217,Dopamine D2 receptor,Ki,=,413.0,nM,CHEMBL4039163,B,Inhibition of human dopamine D2 receptor,CHEMBL4038300,KI,O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1
CHEMBL103772,CHEMBL217,Dopamine D2 receptor,Ki,=,2230.0,nM,CHEMBL4039163,B,Inhibition of human dopamine D2 receptor,CHEMBL4038300,KI,c1ccc(-c2nc(CN3CCN(c4ncccn4)CC3)c[nH]2)cc1
CHEMBL146556,CHEMBL217,Dopamine D2 receptor,Ki,=,738.0,nM,CHEMBL4039163,B,Inhibition of human dopamine D2 receptor,CHEMBL4038300,KI,c1ccc2c(c1)CC(CN1CCN(c3ccc4c(c3)OCCO4)CC1)C2
CHEMBL81330,CHEMBL217,Dopamine D2 receptor,Ki,=,199.0,nM,CHEMBL4039163,B,Inhibition of human dopamine D2 receptor,CHEMBL4038300,KI,Fc1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1
CHEMBL4095082,CHEMBL217,Dopamine D2 receptor,Ki,=,1842.0,nM,CHEMBL4039163,B,Inhibition of human dopamine D2 receptor,CHEMBL4038300,KI,Cc1ccc(N2CCN(CCC3C(=O)Nc4ccccc43)CC2)cc1C
CHEMBL69759,CHEMBL217,Dopamine D2 receptor,Ki,=,5147.0,nM,CHEMBL4039163,B,Inhibition of human dopamine D2 receptor,CHEMBL4038300,KI,NS(=O)(=O)c1ccc(N2CCN(CC[C@@H]3OCCc4ccccc43)CC2)cc1
CHEMBL126429,CHEMBL217,Dopamine D2 receptor,Ki,=,93.0,nM,CHEMBL4039163,B,Inhibition of human dopamine D2 receptor,CHEMBL4038300,KI,Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)cc1Cl
CHEMBL305276,CHEMBL217,Dopamine D2 receptor,Ki,=,133.0,nM,CHEMBL4039163,B,Inhibition of human dopamine D2 receptor,CHEMBL4038300,KI,CN1C(=O)C(N2CCN(Cc3ccc(Cl)cc3)CC2)Cc2ccccc21
CHEMBL320597,CHEMBL217,Dopamine D2 receptor,Ki,=,113.0,nM,CHEMBL4039163,B,Inhibition of human dopamine D2 receptor,CHEMBL4038300,KI,Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4C[C@H]3C)CC2)cc1
CHEMBL4069306,CHEMBL217,Dopamine D2 receptor,Ki,=,1300.0,nM,CHEMBL4039163,B,Inhibition of human dopamine D2 receptor,CHEMBL4038300,KI,c1ccc(CCC2CN(Cc3c[nH]c4ccccc34)CCO2)cc1
CHEMBL4104272,CHEMBL217,Dopamine D2 receptor,Ki,=,400.0,nM,CHEMBL4039163,B,Inhibition of human dopamine D2 receptor,CHEMBL4038300,KI,c1ccc(OCC2CN(Cc3c[nH]c4ccccc34)CCO2)cc1
CHEMBL4080034,CHEMBL217,Dopamine D2 receptor,Ki,=,133.0,nM,CHEMBL4039163,B,Inhibition of human dopamine D2 receptor,CHEMBL4038300,KI,COc1ccc(Cl)cc1OC[C@@H]1CN(Cc2ccc(Cl)cc2)CCO1
CHEMBL7927,CHEMBL217,Dopamine D2 receptor,Ki,=,4300.0,nM,CHEMBL4039193,B,Inhibition of human dopamine D2 (short) receptor,CHEMBL4038300,KI,Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL310843,CHEMBL217,Dopamine D2 receptor,Ki,=,6300.0,nM,CHEMBL4039193,B,Inhibition of human dopamine D2 (short) receptor,CHEMBL4038300,KI,Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1
CHEMBL7927,CHEMBL217,Dopamine D2 receptor,Ki,=,3200.0,nM,CHEMBL4039194,B,Inhibition of human dopamine D2 (long) receptor (unknown origin),CHEMBL4038300,KI,Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL4078873,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,Cc1cccc(S(=O)(=O)NCCN2CC=C(c3c[nH]c4ccc(F)cc34)CC2)c1
CHEMBL4060649,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,Cc1cccc(S(=O)(=O)NCCCN2CC=C(c3c[nH]c4ccc(F)cc34)CC2)c1
CHEMBL4075673,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,Cc1cccc(S(=O)(=O)NCCCCN2CC=C(c3c[nH]c4ccc(F)cc34)CC2)c1
CHEMBL4065568,CHEMBL217,Dopamine D2 receptor,Ki,=,3.3,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,Cc1cccc(S(=O)(=O)NCCN2CC=C(c3c[nH]c4ccc(Cl)cc34)CC2)c1
CHEMBL4077040,CHEMBL217,Dopamine D2 receptor,Ki,=,5.5,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,Cc1cccc(S(=O)(=O)NCCCN2CC=C(c3c[nH]c4ccc(Cl)cc34)CC2)c1
CHEMBL4080369,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,Cc1cccc(S(=O)(=O)NCCCCN2CC=C(c3c[nH]c4ccc(Cl)cc34)CC2)c1
CHEMBL4104596,CHEMBL217,Dopamine D2 receptor,Ki,=,350.0,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,Cc1cccc(S(=O)(=O)NCCN2CC=C(c3c(C)[nH]c4ccc(Cl)cc34)CC2)c1
CHEMBL4081987,CHEMBL217,Dopamine D2 receptor,Ki,=,67.0,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,Cc1cccc(S(=O)(=O)NCCCN2CC=C(c3c(C)[nH]c4ccc(Cl)cc34)CC2)c1
CHEMBL4099997,CHEMBL217,Dopamine D2 receptor,Ki,=,56.0,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,Cc1cccc(S(=O)(=O)NCCCCN2CC=C(c3c(C)[nH]c4ccc(Cl)cc34)CC2)c1
CHEMBL4071451,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1)c1ccc2ccccc2c1
CHEMBL4092243,CHEMBL217,Dopamine D2 receptor,Ki,=,0.7,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1)c1ccc2ccccc2c1
CHEMBL4062817,CHEMBL217,Dopamine D2 receptor,Ki,=,0.3,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1)c1ccc2ccccc2c1
CHEMBL4084492,CHEMBL217,Dopamine D2 receptor,Ki,=,44.0,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc2ccccc2c1
CHEMBL4100951,CHEMBL217,Dopamine D2 receptor,Ki,=,3.7,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc2ccccc2c1
CHEMBL4074195,CHEMBL217,Dopamine D2 receptor,Ki,=,2.6,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc2ccccc2c1
CHEMBL4067700,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,Cc1[nH]c2ccc(Cl)cc2c1C1=CCN(CCNS(=O)(=O)c2ccc3ccccc3c2)CC1
CHEMBL4088925,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,Cc1[nH]c2ccc(Cl)cc2c1C1=CCN(CCCNS(=O)(=O)c2ccc3ccccc3c2)CC1
CHEMBL4079972,CHEMBL217,Dopamine D2 receptor,Ki,=,99.0,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,Cc1[nH]c2ccc(Cl)cc2c1C1=CCN(CCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1
CHEMBL4104216,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc2ccccc12
CHEMBL4069237,CHEMBL217,Dopamine D2 receptor,Ki,=,2.8,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc2ccccc12
CHEMBL4096479,CHEMBL217,Dopamine D2 receptor,Ki,=,2.3,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc2ccccc12
CHEMBL4095555,CHEMBL217,Dopamine D2 receptor,Ki,=,2.4,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(F)c1
CHEMBL4075144,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(F)c1
CHEMBL4087852,CHEMBL217,Dopamine D2 receptor,Ki,=,1.8,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(F)c1
CHEMBL4066532,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(Cl)c1
CHEMBL4091193,CHEMBL217,Dopamine D2 receptor,Ki,=,5.6,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(Cl)c1
CHEMBL4070254,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(Cl)c1
CHEMBL4104622,CHEMBL217,Dopamine D2 receptor,Ki,=,1.5,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(O)c1
CHEMBL4080399,CHEMBL217,Dopamine D2 receptor,Ki,=,2.6,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(O)c1
CHEMBL4066971,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(O)c1
CHEMBL4088249,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc(F)cc1
CHEMBL4077937,CHEMBL217,Dopamine D2 receptor,Ki,=,3.5,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc(F)cc1
CHEMBL4095979,CHEMBL217,Dopamine D2 receptor,Ki,=,4.4,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc(F)cc1
CHEMBL4085802,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc(Cl)cc1
CHEMBL4103725,CHEMBL217,Dopamine D2 receptor,Ki,=,2.7,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc(Cl)cc1
CHEMBL4070715,CHEMBL217,Dopamine D2 receptor,Ki,=,4.5,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc(Cl)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.4,nM,CHEMBL4041093,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,CHEMBL4038339,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4086894,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL4044352,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cell membranes by radioligand binding assay,CHEMBL4043101,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(OCCSSCCO)cc1.O=CO
CHEMBL4065455,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL4044352,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cell membranes by radioligand binding assay,CHEMBL4043101,KI,COc1cc(CCN2CCC(O)(c3ccc(Cl)cc3)CC2)ccc1OCCSSCCN.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4082245,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL4044352,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cell membranes by radioligand binding assay,CHEMBL4043101,KI,COc1cc(CCN2CCC(O)(c3ccc(Cl)cc3)CC2)ccc1OCCCSSCCN.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4100263,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL4044352,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cell membranes by radioligand binding assay,CHEMBL4043101,KI,O=C(O)C(F)(F)F.[N-]=[N+]=NCCSSCCn1cc(C(=O)CCCN2CCC(O)(c3ccc(Cl)cc3)CC2)nn1
CHEMBL4071729,CHEMBL217,Dopamine D2 receptor,Ki,=,2200.0,nM,CHEMBL4044352,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cell membranes by radioligand binding assay,CHEMBL4043101,KI,O=C(NCCN1CCC(O)(c2ccc(Cl)cc2)CC1)NCCN1C(=O)C=CC1=O.O=C(O)C(F)(F)F
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.42,nM,CHEMBL4044352,B,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cell membranes by radioligand binding assay,CHEMBL4043101,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4086894,CHEMBL217,Dopamine D2 receptor,Ki,=,73.0,nM,CHEMBL4044353,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cell membranes by radioligand binding assay,CHEMBL4043101,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(OCCSSCCO)cc1.O=CO
CHEMBL4065455,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL4044353,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cell membranes by radioligand binding assay,CHEMBL4043101,KI,COc1cc(CCN2CCC(O)(c3ccc(Cl)cc3)CC2)ccc1OCCSSCCN.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4082245,CHEMBL217,Dopamine D2 receptor,Ki,=,940.0,nM,CHEMBL4044353,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cell membranes by radioligand binding assay,CHEMBL4043101,KI,COc1cc(CCN2CCC(O)(c3ccc(Cl)cc3)CC2)ccc1OCCCSSCCN.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4100263,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL4044353,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cell membranes by radioligand binding assay,CHEMBL4043101,KI,O=C(O)C(F)(F)F.[N-]=[N+]=NCCSSCCn1cc(C(=O)CCCN2CCC(O)(c3ccc(Cl)cc3)CC2)nn1
CHEMBL4071729,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL4044353,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cell membranes by radioligand binding assay,CHEMBL4043101,KI,O=C(NCCN1CCC(O)(c2ccc(Cl)cc2)CC1)NCCN1C(=O)C=CC1=O.O=C(O)C(F)(F)F
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.25,nM,CHEMBL4044353,B,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cell membranes by radioligand binding assay,CHEMBL4043101,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4079375,CHEMBL217,Dopamine D2 receptor,Ki,=,1.1,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,O=Cc1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc12
CHEMBL4103639,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,O=Cc1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc12
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.52,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4095881,CHEMBL217,Dopamine D2 receptor,Ki,=,5.7,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,O=Cc1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCCO5)CC3)cc12
CHEMBL4068561,CHEMBL217,Dopamine D2 receptor,Ki,=,3.4,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,O=c1ccc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2[nH]1
CHEMBL4068561,CHEMBL217,Dopamine D2 receptor,Ki,=,1.6,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,O=c1ccc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2[nH]1
CHEMBL4063145,CHEMBL217,Dopamine D2 receptor,Ki,=,0.91,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,O=C1COc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2N1
CHEMBL4063145,CHEMBL217,Dopamine D2 receptor,Ki,=,0.98,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,O=C1COc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2N1
CHEMBL4085752,CHEMBL217,Dopamine D2 receptor,Ki,=,29.0,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCCO5)CC3)cc12
CHEMBL4085752,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCCO5)CC3)cc12
CHEMBL4064191,CHEMBL217,Dopamine D2 receptor,Ki,=,5300.0,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,O=c1ccc2c(N3CCNCC3)ccc(O)c2[nH]1
CHEMBL4093493,CHEMBL217,Dopamine D2 receptor,Ki,=,8300.0,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,O=C1COc2c(N3CCNCC3)ccc(O)c2N1
CHEMBL4072785,CHEMBL217,Dopamine D2 receptor,Ki,=,14000.0,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,O=C1COc2c(N3CCCNCC3)ccc(O)c2N1
CHEMBL4066916,CHEMBL217,Dopamine D2 receptor,Ki,=,6900.0,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,Oc1ccc(N2CCNCC2)c2c1OCCO2
CHEMBL4094407,CHEMBL217,Dopamine D2 receptor,Ki,=,780.0,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,CN1CCN(c2ccc(O)c3[nH]c(=O)ccc23)CC1
CHEMBL4102646,CHEMBL217,Dopamine D2 receptor,Ki,=,630.0,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,CN1CCN(c2ccc(O)c3c2OCC(=O)N3)CC1
CHEMBL4084712,CHEMBL217,Dopamine D2 receptor,Ki,=,6400.0,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,CN1CCCN(c2ccc(O)c3c2OCC(=O)N3)CC1
CHEMBL4064759,CHEMBL217,Dopamine D2 receptor,Ki,=,3200.0,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,CN1CCN(c2ccc(O)c3c2OCCO3)CC1
CHEMBL4092462,CHEMBL217,Dopamine D2 receptor,Ki,=,1900.0,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,CCCN1CCN(c2ccc(O)c3[nH]c(=O)ccc23)CC1
CHEMBL4087217,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,CCCN1CCN(c2ccc(O)c3c2OCC(=O)N3)CC1
CHEMBL4065797,CHEMBL217,Dopamine D2 receptor,Ki,=,360.0,nM,CHEMBL4046973,B,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,CHEMBL4043213,KI,CCCN1CCCN(c2ccc(O)c3c2OCC(=O)N3)CC1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.38,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4103639,CHEMBL217,Dopamine D2 receptor,Ki,=,0.58,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,O=Cc1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc12
CHEMBL4079375,CHEMBL217,Dopamine D2 receptor,Ki,=,0.73,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,O=Cc1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc12
CHEMBL4095881,CHEMBL217,Dopamine D2 receptor,Ki,=,2.9,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,O=Cc1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCCO5)CC3)cc12
CHEMBL4068561,CHEMBL217,Dopamine D2 receptor,Ki,=,1.3,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,O=c1ccc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2[nH]1
CHEMBL4068561,CHEMBL217,Dopamine D2 receptor,Ki,=,0.54,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,O=c1ccc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2[nH]1
CHEMBL4063145,CHEMBL217,Dopamine D2 receptor,Ki,=,0.67,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,O=C1COc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2N1
CHEMBL4063145,CHEMBL217,Dopamine D2 receptor,Ki,=,0.95,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,O=C1COc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2N1
CHEMBL4085752,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCCO5)CC3)cc12
CHEMBL4085752,CHEMBL217,Dopamine D2 receptor,Ki,=,1.1,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCCO5)CC3)cc12
CHEMBL4064191,CHEMBL217,Dopamine D2 receptor,Ki,=,1200.0,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,O=c1ccc2c(N3CCNCC3)ccc(O)c2[nH]1
CHEMBL4093493,CHEMBL217,Dopamine D2 receptor,Ki,=,1800.0,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,O=C1COc2c(N3CCNCC3)ccc(O)c2N1
CHEMBL4072785,CHEMBL217,Dopamine D2 receptor,Ki,=,8900.0,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,O=C1COc2c(N3CCCNCC3)ccc(O)c2N1
CHEMBL4066916,CHEMBL217,Dopamine D2 receptor,Ki,=,6000.0,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,Oc1ccc(N2CCNCC2)c2c1OCCO2
CHEMBL4094407,CHEMBL217,Dopamine D2 receptor,Ki,=,250.0,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,CN1CCN(c2ccc(O)c3[nH]c(=O)ccc23)CC1
CHEMBL4102646,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,CN1CCN(c2ccc(O)c3c2OCC(=O)N3)CC1
CHEMBL4084712,CHEMBL217,Dopamine D2 receptor,Ki,=,3400.0,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,CN1CCCN(c2ccc(O)c3c2OCC(=O)N3)CC1
CHEMBL4064759,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,CN1CCN(c2ccc(O)c3c2OCCO3)CC1
CHEMBL4092462,CHEMBL217,Dopamine D2 receptor,Ki,=,480.0,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,CCCN1CCN(c2ccc(O)c3[nH]c(=O)ccc23)CC1
CHEMBL4087217,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,CCCN1CCN(c2ccc(O)c3c2OCC(=O)N3)CC1
CHEMBL4065797,CHEMBL217,Dopamine D2 receptor,Ki,=,56.0,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,CCCN1CCCN(c2ccc(O)c3c2OCC(=O)N3)CC1
CHEMBL4094900,CHEMBL217,Dopamine D2 receptor,Ki,=,5700.0,nM,CHEMBL4046974,B,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,CHEMBL4043213,KI,CCCN1CCN(c2ccc(O)c3c2OCCO3)CC1
CHEMBL4093656,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL4052936,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,CHEMBL4052584,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2c1
CHEMBL3589651,CHEMBL217,Dopamine D2 receptor,Ki,=,268.0,nM,CHEMBL4052936,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,CHEMBL4052584,KI,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2c1
CHEMBL4081424,CHEMBL217,Dopamine D2 receptor,Ki,=,202.0,nM,CHEMBL4052936,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,CHEMBL4052584,KI,O=C(NCC[C@@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2c1
CHEMBL4105681,CHEMBL217,Dopamine D2 receptor,Ki,=,316.0,nM,CHEMBL4052936,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,CHEMBL4052584,KI,O=C(NCC[C@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2c1
CHEMBL4072171,CHEMBL217,Dopamine D2 receptor,Ki,=,588.0,nM,CHEMBL4052936,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,CHEMBL4052584,KI,CC[C@@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL4092928,CHEMBL217,Dopamine D2 receptor,Ki,=,93.1,nM,CHEMBL4052936,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,CHEMBL4052584,KI,CC[C@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL4063564,CHEMBL217,Dopamine D2 receptor,Ki,=,1400.0,nM,CHEMBL4052936,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,CHEMBL4052584,KI,C[C@@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL4085184,CHEMBL217,Dopamine D2 receptor,Ki,=,317.0,nM,CHEMBL4052936,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,CHEMBL4052584,KI,C[C@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL1627306,CHEMBL217,Dopamine D2 receptor,Ki,=,433.0,nM,CHEMBL4052936,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,CHEMBL4052584,KI,O=C(NCC[C@@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL1627307,CHEMBL217,Dopamine D2 receptor,Ki,=,715.0,nM,CHEMBL4052936,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,CHEMBL4052584,KI,O=C(NCC[C@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL346692,CHEMBL217,Dopamine D2 receptor,Ki,=,103.0,nM,CHEMBL4052936,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,CHEMBL4052584,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL2165677,CHEMBL217,Dopamine D2 receptor,Ki,=,3.4,nM,CHEMBL4052936,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,CHEMBL4052584,KI,CCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL4099491,CHEMBL217,Dopamine D2 receptor,Ki,=,4890.0,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,N#Cc1cccc(N2CCNCC2)c1
CHEMBL4076796,CHEMBL217,Dopamine D2 receptor,Ki,=,53800.0,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,N#Cc1ccc2c(c1)CCNC2
CHEMBL27162,CHEMBL217,Dopamine D2 receptor,Ki,=,11400.0,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,N#Cc1ccc2c(c1)CNCC2
CHEMBL4086613,CHEMBL217,Dopamine D2 receptor,Ki,=,493.0,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,CCCCN1CCN(c2cccc(C#N)c2)CC1
CHEMBL4062165,CHEMBL217,Dopamine D2 receptor,Ki,=,8300.0,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,CCCCN1CCc2cc(C#N)ccc2C1
CHEMBL4083890,CHEMBL217,Dopamine D2 receptor,Ki,=,832.0,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,CCCCN1CCc2ccc(C#N)cc2C1
CHEMBL4064919,CHEMBL217,Dopamine D2 receptor,Ki,=,13400.0,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,CCCC(CCC)NC(=O)c1cc2ccccc2[nH]1
CHEMBL2219578,CHEMBL217,Dopamine D2 receptor,Ki,=,485.0,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,N#Cc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)c3cc4ccccc4[nH]3)CC1)CC2
CHEMBL85606,CHEMBL217,Dopamine D2 receptor,Ki,=,5160.0,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2
CHEMBL4077536,CHEMBL217,Dopamine D2 receptor,Ki,=,8.41,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,O=C(NC[C@@H]1C[C@H]1CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL4083903,CHEMBL217,Dopamine D2 receptor,Ki,=,19.9,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,O=C(NC[C@@H]1C[C@H]1CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccnc2ccccc12
CHEMBL4105375,CHEMBL217,Dopamine D2 receptor,Ki,=,2290.0,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,N#Cc1cccc(N2CCN(C[C@@H]3C[C@H]3CNC(=O)c3ccnc4ccccc34)CC2)c1
CHEMBL4087513,CHEMBL217,Dopamine D2 receptor,Ki,=,9500.0,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,N#Cc1ccc2c(c1)CCN(C[C@@H]1C[C@H]1CNC(=O)c1ccnc3ccccc13)C2
CHEMBL4067792,CHEMBL217,Dopamine D2 receptor,Ki,=,1440.0,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,N#Cc1ccc2c(c1)CN(C[C@@H]1C[C@H]1CNC(=O)c1ccnc3ccccc13)CC2
CHEMBL4095216,CHEMBL217,Dopamine D2 receptor,Ki,=,695.0,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,N#Cc1ccc2c(c1)CN(C[C@@H]1C[C@H]1CNC(=O)c1cc3ccccc3[nH]1)CC2
CHEMBL4089939,CHEMBL217,Dopamine D2 receptor,Ki,=,182.0,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,N#Cc1ccc2c(c1)CN(C[C@@H]1C[C@H]1CCNC(=O)c1cc3ccccc3[nH]1)CC2
CHEMBL4068843,CHEMBL217,Dopamine D2 receptor,Ki,=,14.4,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,N#Cc1ccc2c(c1)CN(C[C@@H]1C[C@H]1CCNC(=O)c1cc3cccnc3[nH]1)CC2
CHEMBL4097669,CHEMBL217,Dopamine D2 receptor,Ki,=,476.0,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,N#Cc1ccc2c(c1)CN(CC[C@@H]1C[C@H]1CNC(=O)c1cc3ccccc3[nH]1)CC2
CHEMBL4079637,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL4053560,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,CHEMBL4052607,KI,N#Cc1ccc2c(c1)CN(CC[C@@H]1C[C@H]1CNC(=O)c1cc3cccnc3[nH]1)CC2
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,Ki,=,0.47,nM,CHEMBL4054777,B,Displacement of [3H]spiperone from human D2-long receptor expressed in CHO cell membranes,CHEMBL4052643,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL142020,CHEMBL217,Dopamine D2 receptor,Ki,=,270.0,nM,CHEMBL4054777,B,Displacement of [3H]spiperone from human D2-long receptor expressed in CHO cell membranes,CHEMBL4052643,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL4064974,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL4054777,B,Displacement of [3H]spiperone from human D2-long receptor expressed in CHO cell membranes,CHEMBL4052643,KI,O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1cc2ccccn2n1
CHEMBL4085920,CHEMBL217,Dopamine D2 receptor,Ki,=,430.0,nM,CHEMBL4054777,B,Displacement of [3H]spiperone from human D2-long receptor expressed in CHO cell membranes,CHEMBL4052643,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cc4ccccn4n3)CC2)cc(C(F)(F)F)n1
CHEMBL4060837,CHEMBL217,Dopamine D2 receptor,Ki,=,6300.0,nM,CHEMBL4054777,B,Displacement of [3H]spiperone from human D2-long receptor expressed in CHO cell membranes,CHEMBL4052643,KI,Cc1ccc(S(=O)(=O)[O-])cc1.O=C(NCCCCN1CC[N+]2(CCOc3ccccc32)CC1)c1cc2ccccn2n1
CHEMBL4096858,CHEMBL217,Dopamine D2 receptor,Ki,=,4000.0,nM,CHEMBL4054777,B,Displacement of [3H]spiperone from human D2-long receptor expressed in CHO cell membranes,CHEMBL4052643,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)cc(C(F)(F)F)n1
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,Ki,=,0.41,nM,CHEMBL4054778,B,Displacement of [3H]spiperone from human D2-short receptor expressed in CHO cell membranes,CHEMBL4052643,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL142020,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL4054778,B,Displacement of [3H]spiperone from human D2-short receptor expressed in CHO cell membranes,CHEMBL4052643,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL4064974,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL4054778,B,Displacement of [3H]spiperone from human D2-short receptor expressed in CHO cell membranes,CHEMBL4052643,KI,O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1cc2ccccn2n1
CHEMBL4085920,CHEMBL217,Dopamine D2 receptor,Ki,=,200.0,nM,CHEMBL4054778,B,Displacement of [3H]spiperone from human D2-short receptor expressed in CHO cell membranes,CHEMBL4052643,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cc4ccccn4n3)CC2)cc(C(F)(F)F)n1
CHEMBL4060837,CHEMBL217,Dopamine D2 receptor,Ki,=,4500.0,nM,CHEMBL4054778,B,Displacement of [3H]spiperone from human D2-short receptor expressed in CHO cell membranes,CHEMBL4052643,KI,Cc1ccc(S(=O)(=O)[O-])cc1.O=C(NCCCCN1CC[N+]2(CCOc3ccccc32)CC1)c1cc2ccccn2n1
CHEMBL4096858,CHEMBL217,Dopamine D2 receptor,Ki,=,2700.0,nM,CHEMBL4054778,B,Displacement of [3H]spiperone from human D2-short receptor expressed in CHO cell membranes,CHEMBL4052643,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)cc(C(F)(F)F)n1
CHEMBL4166411,CHEMBL217,Dopamine D2 receptor,Ki,=,3683.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,CN1CCN(CCCNC(=O)c2cc(=O)c3ccccc3[nH]2)CC1
CHEMBL4174330,CHEMBL217,Dopamine D2 receptor,Ki,=,3420.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,Fc1ccc(N2CCN(CCNc3cncc(Cl)n3)CC2)cc1
CHEMBL4176490,CHEMBL217,Dopamine D2 receptor,Ki,=,2187.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,Clc1cncc(NCCCN2CCN(c3ccccc3)CC2)n1
CHEMBL4171171,CHEMBL217,Dopamine D2 receptor,Ki,=,53.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,Clc1cncc(NCCCCN2CCN(c3ccccc3)CC2)n1
CHEMBL4164849,CHEMBL217,Dopamine D2 receptor,Ki,=,5698.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,Cc1oc(-c2ccco2)nc1CN(C)C[C@@H]1Cc2ccccc2O1
CHEMBL4161436,CHEMBL217,Dopamine D2 receptor,Ki,=,3231.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,c1ccc(-c2nc(CN3CCCN(c4nccs4)CC3)co2)cc1
CHEMBL4168691,CHEMBL217,Dopamine D2 receptor,Ki,=,1821.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,N#Cc1c(CN2CCN(CCc3ccccc3)CC2)cn2ccccc12
CHEMBL4176546,CHEMBL217,Dopamine D2 receptor,Ki,=,7881.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,CN(C)Cc1cccc(CN/C=C2/C(=O)NC(=O)c3ccccc32)c1
CHEMBL4165273,CHEMBL217,Dopamine D2 receptor,Ki,=,5947.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,CCN(CCc1ccccn1)Cc1csc(C2CCCC2)n1
CHEMBL4173176,CHEMBL217,Dopamine D2 receptor,Ki,=,334.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,C[C@H](CNc1cncc(Cl)n1)N1CCN(c2ccccc2)CC1
CHEMBL4161837,CHEMBL217,Dopamine D2 receptor,Ki,=,2233.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,Cc1ccn(CCN2CCC(Cc3ccccc3F)CC2)n1
CHEMBL4169755,CHEMBL217,Dopamine D2 receptor,Ki,=,3195.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,C[C@@H]1CN(CCCNC(=O)CN2CCc3ccccc3C2)C[C@H](C)O1
CHEMBL4169603,CHEMBL217,Dopamine D2 receptor,Ki,=,5596.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,Cc1cc(C)n(C2CN(CCCc3nc(-c4ccccc4)no3)C2)n1
CHEMBL4161676,CHEMBL217,Dopamine D2 receptor,Ki,=,1996.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,CCOc1ccc([C@H](O)CN2CCN(c3ccccc3F)CC2)cc1
CHEMBL4166178,CHEMBL217,Dopamine D2 receptor,Ki,=,4918.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,O=C(CO)NC[C@H]1CCN(Cc2csc(-c3ccccc3)n2)C1
CHEMBL4176800,CHEMBL217,Dopamine D2 receptor,Ki,=,7745.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,O[C@@H](COC[C@@H]1CCCO1)CN1CCN(c2ccccc2F)CC1
CHEMBL3461530,CHEMBL217,Dopamine D2 receptor,Ki,=,1606.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,Cc1cccc(N2CCN(CCCNC(=O)c3cn[nH]c3C)CC2)c1
CHEMBL4173442,CHEMBL217,Dopamine D2 receptor,Ki,=,6912.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,COC[C@@H](C)N1CCN(c2cccc(F)c2C#N)CC1
CHEMBL4164695,CHEMBL217,Dopamine D2 receptor,Ki,=,6787.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,COc1ccc(-c2nc(CN(C)C[C@@H]3Cc4ccccc4O3)c(C)o2)cc1C
CHEMBL4160967,CHEMBL217,Dopamine D2 receptor,Ki,=,1522.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,Cc1oc(-c2ccc3ccccc3c2)nc1CN1CCO[C@H](CCN)C1
CHEMBL4175018,CHEMBL217,Dopamine D2 receptor,Ki,=,1245.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,Cc1oc(-c2ccco2)nc1CN1CCN([C@@H]2CCc3ccccc3C2)CC1
CHEMBL4159893,CHEMBL217,Dopamine D2 receptor,Ki,=,3129.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,CC(C)c1nc(CN2CC[C@H](c3ccccc3)C2)cs1
CHEMBL4167807,CHEMBL217,Dopamine D2 receptor,Ki,=,5044.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,CCCc1nc(CN2CC[C@H](c3ccccc3)C2)cs1
CHEMBL4163265,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL4137914,B,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,CHEMBL4130639,KI,Fc1ccccc1N1CCN(CCCNc2cncc(Cl)n2)CC1
CHEMBL4175829,CHEMBL217,Dopamine D2 receptor,Ki,=,3482.0,nM,CHEMBL4146376,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,CHEMBL4145461,KI,CCc1nc2c(N3CCNCC3)ccnc2n1Cc1cccc(F)c1
CHEMBL4164541,CHEMBL217,Dopamine D2 receptor,Ki,=,6100.0,nM,CHEMBL4146376,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,CHEMBL4145461,KI,CCc1nc2c(N3CCNCC3)ccnc2n1Cc1cccc(Cl)c1
CHEMBL4169236,CHEMBL217,Dopamine D2 receptor,Ki,=,3436.0,nM,CHEMBL4146376,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,CHEMBL4145461,KI,CC(C)c1nc2c(N3CCNCC3)ccnc2n1Cc1cccc(F)c1
CHEMBL4161308,CHEMBL217,Dopamine D2 receptor,Ki,=,2941.0,nM,CHEMBL4146376,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,CHEMBL4145461,KI,CC(C)c1nc2c(N3CCNCC3)ccnc2n1Cc1cccc(Cl)c1
CHEMBL1083390,CHEMBL217,Dopamine D2 receptor,Ki,=,997.0,nM,CHEMBL4146376,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,CHEMBL4145461,KI,O=S(=O)(c1ccccc1)c1cnc2c(N3CCNCC3)cccc2c1
CHEMBL4163778,CHEMBL217,Dopamine D2 receptor,Ki,=,1165.0,nM,CHEMBL4148417,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,CHEMBL4145534,KI,COc1ccc(C2(C)NC(=O)N(CC(O)CN3CCN(c4ccccc4OC)CC3)C2=O)cc1.Cl
CHEMBL4171652,CHEMBL217,Dopamine D2 receptor,Ki,=,782.0,nM,CHEMBL4148417,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,CHEMBL4145534,KI,COc1ccc(C2(C)NC(=O)N(CC(O)CN3CCN(c4ccccc4C#N)CC3)C2=O)cc1.Cl
CHEMBL4163626,CHEMBL217,Dopamine D2 receptor,Ki,=,931.0,nM,CHEMBL4148417,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,CHEMBL4145534,KI,COc1ccc(C2(C)NC(=O)N(CC(O)CN3CCN(C(c4ccccc4)c4ccccc4)CC3)C2=O)cc1.Cl
CHEMBL4176588,CHEMBL217,Dopamine D2 receptor,Ki,=,876.0,nM,CHEMBL4148417,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,CHEMBL4145534,KI,COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3ccc(C)cc3)C2=O)CC1.Cl
CHEMBL4160262,CHEMBL217,Dopamine D2 receptor,Ki,=,301.0,nM,CHEMBL4148417,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,CHEMBL4145534,KI,COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3ccccc3F)C2=O)CC1.Cl
CHEMBL4174681,CHEMBL217,Dopamine D2 receptor,Ki,=,269.0,nM,CHEMBL4148417,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,CHEMBL4145534,KI,COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3cccc(F)c3)C2=O)CC1.Cl
CHEMBL4170484,CHEMBL217,Dopamine D2 receptor,Ki,=,497.0,nM,CHEMBL4148417,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,CHEMBL4145534,KI,COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(c3ccccc3)(c3ccccc3)C2=O)CC1.Cl
CHEMBL4162548,CHEMBL217,Dopamine D2 receptor,Ki,=,534.0,nM,CHEMBL4148417,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,CHEMBL4145534,KI,Cl.N#Cc1ccccc1N1CCN(CC(O)CN2C(=O)NC(c3ccccc3)(c3ccccc3)C2=O)CC1
CHEMBL4170657,CHEMBL217,Dopamine D2 receptor,Ki,=,267.0,nM,CHEMBL4148417,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,CHEMBL4145534,KI,COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3ccc(Br)cc3)C2=O)CC1.Cl
CHEMBL4162279,CHEMBL217,Dopamine D2 receptor,Ki,=,1690.0,nM,CHEMBL4148417,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,CHEMBL4145534,KI,CC1(c2ccccc2)NC(=O)N(CC(O)CN2CCN(c3ccccc3C#N)CC2)C1=O.Cl
CHEMBL4168743,CHEMBL217,Dopamine D2 receptor,Ki,=,1033.0,nM,CHEMBL4148417,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,CHEMBL4145534,KI,COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3ccccc3)C2=O)CC1.Cl
CHEMBL4176950,CHEMBL217,Dopamine D2 receptor,Ki,=,303.0,nM,CHEMBL4148417,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,CHEMBL4145534,KI,CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3ccccc3)C2=O)CC1.Cl
CHEMBL4166804,CHEMBL217,Dopamine D2 receptor,Ki,=,601.0,nM,CHEMBL4148417,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,CHEMBL4145534,KI,CC1(c2ccc(Cl)cc2)NC(=O)N(CC(O)CN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1=O.Cl
CHEMBL4174055,CHEMBL217,Dopamine D2 receptor,Ki,=,1285.0,nM,CHEMBL4148417,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,CHEMBL4145534,KI,CC1(c2ccc(Cl)cc2)NC(=O)N(CC(O)CN2CCN(c3ccccc3C#N)CC2)C1=O.Cl
CHEMBL4159967,CHEMBL217,Dopamine D2 receptor,Ki,=,366.0,nM,CHEMBL4148417,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,CHEMBL4145534,KI,COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3ccc(Cl)cc3)C2=O)CC1.Cl
CHEMBL4170613,CHEMBL217,Dopamine D2 receptor,Ki,=,506.0,nM,CHEMBL4148417,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,CHEMBL4145534,KI,CC1(c2ccc(Br)cc2)NC(=O)N(CC(O)CN2CCN(c3ccccc3C#N)CC2)C1=O.Cl
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,9.0,nM,CHEMBL4148417,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,CHEMBL4145534,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL4216126,CHEMBL217,Dopamine D2 receptor,Ki,=,328.0,nM,CHEMBL4178665,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 or CHO-K1 cells after 1 hr by microbeta counting analysis,CHEMBL4177556,KI,CC(C)c1ccccc1OCCCN1CCC(NS(=O)(=O)c2ccc(F)cc2)CC1
CHEMBL4212199,CHEMBL217,Dopamine D2 receptor,Ki,=,343.0,nM,CHEMBL4178665,B,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 or CHO-K1 cells after 1 hr by microbeta counting analysis,CHEMBL4177556,KI,O=S(=O)(NC1CCN(CC(O)COc2ccccc2-c2ccccc2)CC1)c1cccc(Cl)c1
CHEMBL3763633,CHEMBL217,Dopamine D2 receptor,Ki,=,2300.0,nM,CHEMBL4179172,B,Displacement of [3H]methyl-spiperone from human recombinant dopamine D2 receptor expressed in HEK293 cells,CHEMBL4177580,KI,O=C(NCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccncc1
CHEMBL4208744,CHEMBL217,Dopamine D2 receptor,Ki,=,250.0,nM,CHEMBL4179172,B,Displacement of [3H]methyl-spiperone from human recombinant dopamine D2 receptor expressed in HEK293 cells,CHEMBL4177580,KI,O=C(NCCN1CCN(c2ccc(Cl)c(Cl)c2)CC1)c1ccccn1
CHEMBL4216870,CHEMBL217,Dopamine D2 receptor,Ki,=,8210.0,nM,CHEMBL4189962,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293T cell membranes after 90 mins by scintillation counting method,CHEMBL4184336,KI,NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,5.9,nM,CHEMBL4195136,B,Displacement of [3H]methylspiperonee from recombinant human D2 receptor expressed in HEK293 cells cell membranes after 60 mins by liquid scintillation counting method,CHEMBL4190389,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4207653,CHEMBL217,Dopamine D2 receptor,Ki,=,189.0,nM,CHEMBL4195136,B,Displacement of [3H]methylspiperonee from recombinant human D2 receptor expressed in HEK293 cells cell membranes after 60 mins by liquid scintillation counting method,CHEMBL4190389,KI,COc1ccccc1N1CCN(CCOCCOc2c(C)cc(C)cc2C)CC1.Cl.Cl
CHEMBL4213352,CHEMBL217,Dopamine D2 receptor,Ki,=,162.0,nM,CHEMBL4195136,B,Displacement of [3H]methylspiperonee from recombinant human D2 receptor expressed in HEK293 cells cell membranes after 60 mins by liquid scintillation counting method,CHEMBL4190389,KI,COc1ccccc1N1CCN(CCOCCOc2cc(C)cc(C)c2C)CC1.Cl.Cl
CHEMBL4217761,CHEMBL217,Dopamine D2 receptor,Ki,=,1206.0,nM,CHEMBL4195136,B,Displacement of [3H]methylspiperonee from recombinant human D2 receptor expressed in HEK293 cells cell membranes after 60 mins by liquid scintillation counting method,CHEMBL4190389,KI,Cc1cccc(OCCOCCN2CCN(CCc3ccccc3)CC2)c1C.Cl.Cl
CHEMBL4212812,CHEMBL217,Dopamine D2 receptor,Ki,=,299.0,nM,CHEMBL4195136,B,Displacement of [3H]methylspiperonee from recombinant human D2 receptor expressed in HEK293 cells cell membranes after 60 mins by liquid scintillation counting method,CHEMBL4190389,KI,Cc1cc(OCCCN2CCN(c3ccccc3)CC2)ccc1Cl.Cl.Cl
CHEMBL4205526,CHEMBL217,Dopamine D2 receptor,Ki,=,4963.0,nM,CHEMBL4195136,B,Displacement of [3H]methylspiperonee from recombinant human D2 receptor expressed in HEK293 cells cell membranes after 60 mins by liquid scintillation counting method,CHEMBL4190389,KI,COc1ccc(N2CCN(CCCOc3c(C)cc(C)cc3C)CC2)cc1.Cl.Cl
CHEMBL4209888,CHEMBL217,Dopamine D2 receptor,Ki,=,97.0,nM,CHEMBL4195136,B,Displacement of [3H]methylspiperonee from recombinant human D2 receptor expressed in HEK293 cells cell membranes after 60 mins by liquid scintillation counting method,CHEMBL4190389,KI,COc1ccccc1N1CCN(CCCOc2ccc(C)cc2C)CC1.Cl
CHEMBL4213647,CHEMBL217,Dopamine D2 receptor,Ki,=,219.0,nM,CHEMBL4195129,B,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHOK1 cell membranes after 60 mins by liquid scintillation counting method,CHEMBL4190389,KI,COc1ccccc1N1CCN(CCOCCOc2c(C)cccc2C)CC1.Cl
CHEMBL896,CHEMBL217,Dopamine D2 receptor,Ki,=,378.0,nM,CHEMBL4195122,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4190389,KI,OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1
CHEMBL4204059,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL4199279,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hR,CHEMBL4196098,KI,CCCCc1cc(-c2ccoc2)nc(N2CCN(C)CC2)n1
CHEMBL4208934,CHEMBL217,Dopamine D2 receptor,Ki,=,466.0,nM,CHEMBL4199279,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hR,CHEMBL4196098,KI,CCc1cc(-c2ccoc2)nc(N2CCN(C)CC2)n1
CHEMBL1201343,CHEMBL217,Dopamine D2 receptor,Ki,=,3.9,nM,CHEMBL4223409,B,Binding affinity to human dopamine D2 receptor,CHEMBL4219212,KI,CCCN[C@H]1CCC2N=C(N)SC2C1
CHEMBL7549,CHEMBL217,Dopamine D2 receptor,Ki,=,137.0,nM,CHEMBL4223409,B,Binding affinity to human dopamine D2 receptor,CHEMBL4219212,KI,CCCN1CCC[C@@H](c2cccc(O)c2)C1
CHEMBL81675,CHEMBL217,Dopamine D2 receptor,Ki,=,68.0,nM,CHEMBL4223409,B,Binding affinity to human dopamine D2 receptor,CHEMBL4219212,KI,CCCN1CCC(c2cccc(O)c2)C1
CHEMBL4225830,CHEMBL217,Dopamine D2 receptor,Ki,=,2877.0,nM,CHEMBL4223412,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,CHEMBL4219212,KI,CCCCN1CCC(c2cccc(O)c2)C1
CHEMBL4227192,CHEMBL217,Dopamine D2 receptor,Ki,=,3555.0,nM,CHEMBL4223412,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,CHEMBL4219212,KI,CCCCCCN1CCC(c2cccc(O)c2)C1
CHEMBL4226336,CHEMBL217,Dopamine D2 receptor,Ki,=,369.0,nM,CHEMBL4223412,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,CHEMBL4219212,KI,CCCCCCCN1CCC(c2cccc(O)c2)C1
CHEMBL4224763,CHEMBL217,Dopamine D2 receptor,Ki,=,368.0,nM,CHEMBL4223412,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,CHEMBL4219212,KI,CCCCCCCCN1CCC(c2cccc(O)c2)C1
CHEMBL4225278,CHEMBL217,Dopamine D2 receptor,Ki,=,98.0,nM,CHEMBL4223412,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,CHEMBL4219212,KI,CCCCCCCCCN1CCC(c2cccc(O)c2)C1
CHEMBL4229178,CHEMBL217,Dopamine D2 receptor,Ki,=,464.0,nM,CHEMBL4223412,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,CHEMBL4219212,KI,CCCCCCCCCCN1CCC(c2cccc(O)c2)C1
CHEMBL4225278,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL4223412,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,CHEMBL4219212,KI,CCCCCCCCCN1CCC(c2cccc(O)c2)C1
CHEMBL4225278,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL4223412,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,CHEMBL4219212,KI,CCCCCCCCCN1CCC(c2cccc(O)c2)C1
CHEMBL4226226,CHEMBL217,Dopamine D2 receptor,Ki,=,343.0,nM,CHEMBL4223412,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,CHEMBL4219212,KI,CN(C)c1ccc(C(=O)NCCCCN2CCC(c3cccc(O)c3)C2)cc1
CHEMBL4226226,CHEMBL217,Dopamine D2 receptor,Ki,=,360.0,nM,CHEMBL4223412,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,CHEMBL4219212,KI,CN(C)c1ccc(C(=O)NCCCCN2CCC(c3cccc(O)c3)C2)cc1
CHEMBL4226226,CHEMBL217,Dopamine D2 receptor,Ki,=,345.0,nM,CHEMBL4223412,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,CHEMBL4219212,KI,CN(C)c1ccc(C(=O)NCCCCN2CCC(c3cccc(O)c3)C2)cc1
CHEMBL4239823,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL4229953,B,Displacement of [3H]methyl-spiperone from recombinant human dopamine D2 receptor after 60 mins by scintillation counting method,CHEMBL4229332,KI,O=S(=O)(c1cncc2ccccc12)N1CCC[C@H]1CCN1CCN(c2cccc3sccc23)CC1
CHEMBL708,CHEMBL217,Dopamine D2 receptor,Ki,=,0.8,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,0.6,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,71.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.8,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4245607,CHEMBL217,Dopamine D2 receptor,Ki,=,6.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cncc2ccccc12)N1CCCCC[C@H]1CCN1CCN(c2cccc3sccc23)CC1
CHEMBL4241497,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CCCCC[C@H]1CCN1CCN(c2cccc3sccc23)CC1
CHEMBL4244280,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cncc2ccccc12)N1CCCC[C@@H]1CCN1CCN(c2cccc3sccc23)CC1
CHEMBL4248544,CHEMBL217,Dopamine D2 receptor,Ki,=,21.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CCCC[C@@H]1CCN1CCN(c2cccc3sccc23)CC1
CHEMBL4239705,CHEMBL217,Dopamine D2 receptor,Ki,=,29.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cncc2ccccc12)N1CC[C@@H]1CCN1CCN(c2cccc3sccc23)CC1
CHEMBL4243932,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CC[C@@H]1CCN1CCN(c2cccc3sccc23)CC1
CHEMBL4250274,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1ccnc2ccccc12)N1CCCCC[C@H]1CCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4240162,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CCCCC[C@H]1CCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4240642,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1ccnc2ccccc12)N1CCCC[C@@H]1CCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4241081,CHEMBL217,Dopamine D2 receptor,Ki,=,7.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CCCC[C@@H]1CCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4243497,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cncc2ccccc12)N1CC[C@@H]1CCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4238897,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CC[C@@H]1CCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4245997,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cncc2ccccc12)N1CCC[C@@H]1CCN1CCN(c2cccc3[nH]ccc23)CC1
CHEMBL4248597,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CCC[C@@H]1CCN1CCN(c2cccc3[nH]ccc23)CC1
CHEMBL4242170,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cncc2ccccc12)N1CCC[C@H]1CCN1CCN(c2cccc3[nH]ccc23)CC1
CHEMBL4238029,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CCC[C@H]1CCN1CCN(c2cccc3[nH]ccc23)CC1
CHEMBL4238479,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2cnccc12)N1CCC[C@@H]1CCN1CCN(c2cccc3sccc23)CC1
CHEMBL4248491,CHEMBL217,Dopamine D2 receptor,Ki,=,6.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cncc2ccccc12)N1CCC[C@@H]1CCN1CCN(c2cccc3sccc23)CC1
CHEMBL4243848,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CCC[C@@H]1CCN1CCN(c2cccc3sccc23)CC1
CHEMBL4244691,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2cnccc12)N1CCC[C@H]1CCN1CCN(c2cccc3sccc23)CC1
CHEMBL4239823,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cncc2ccccc12)N1CCC[C@H]1CCN1CCN(c2cccc3sccc23)CC1
CHEMBL4240954,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CCC[C@H]1CCN1CCN(c2cccc3sccc23)CC1
CHEMBL4243579,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2cnccc12)N1CCC[C@H]1CCN1CCN(c2noc3ccccc23)CC1
CHEMBL4249640,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cncc2ccccc12)N1CCC[C@H]1CCN1CCN(c2noc3ccccc23)CC1
CHEMBL4249179,CHEMBL217,Dopamine D2 receptor,Ki,=,4.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CCC[C@H]1CCN1CCN(c2noc3ccccc23)CC1
CHEMBL4239091,CHEMBL217,Dopamine D2 receptor,Ki,=,0.3,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2cnccc12)N1CCC[C@@H]1CCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4238679,CHEMBL217,Dopamine D2 receptor,Ki,=,0.9,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cncc2ccccc12)N1CCC[C@@H]1CCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4242858,CHEMBL217,Dopamine D2 receptor,Ki,=,0.7,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CCC[C@@H]1CCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4242392,CHEMBL217,Dopamine D2 receptor,Ki,=,0.5,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2cnccc12)N1CCC[C@H]1CCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4246655,CHEMBL217,Dopamine D2 receptor,Ki,=,0.14,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cncc2ccccc12)N1CCC[C@H]1CCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4246202,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CCC[C@H]1CCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4250475,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CCC[C@@H]1CCN1CCC(c2noc3cc(F)ccc23)CC1
CHEMBL4245263,CHEMBL217,Dopamine D2 receptor,Ki,=,0.1,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cncc2ccccc12)N1CCC[C@H]1CCN1CCC(c2noc3cc(F)ccc23)CC1
CHEMBL4241050,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CCC[C@H]1CCN1CCC(c2noc3cc(F)ccc23)CC1
CHEMBL4246630,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cncc2ccccc12)N1CCC[C@@H]1CCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1
CHEMBL4245622,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CCC[C@@H]1CCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1
CHEMBL4250244,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cncc2ccccc12)N1CCC[C@H]1CCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1
CHEMBL4249426,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CCC[C@H]1CCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1
CHEMBL4242268,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cncc2ccccc12)N1CCC[C@@H]1CCN1CCN(c2cccc3c2OCCO3)CC1
CHEMBL4238124,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CCC[C@@H]1CCN1CCN(c2cccc3c2OCCO3)CC1
CHEMBL4247770,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cncc2ccccc12)N1CCC[C@H]1CCN1CCN(c2cccc3c2OCCO3)CC1
CHEMBL4241830,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=S(=O)(c1cccc2ncccc12)N1CCC[C@H]1CCN1CCN(c2cccc3c2OCCO3)CC1
CHEMBL4243036,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=c1[nH]c2c(N3CCN(CC[C@H]4CCCN4S(=O)(=O)c4cncc5ccccc45)CC3)cccc2o1
CHEMBL4247275,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=c1[nH]c2c(N3CCN(CC[C@@H]4CCCN4S(=O)(=O)c4cncc5ccccc45)CC3)cccc2o1
CHEMBL4240910,CHEMBL217,Dopamine D2 receptor,Ki,=,9.0,nM,CHEMBL4229838,B,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,CHEMBL4229332,KI,O=c1[nH]c2c(N3CCN(CC[C@@H]4CCCN4S(=O)(=O)c4cccc5ncccc45)CC3)cccc2o1
CHEMBL4241776,CHEMBL217,Dopamine D2 receptor,Ki,=,252.0,nM,CHEMBL4236718,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCCCN(C)CCCCCNC(=O)COc2cccc(C#Cc3csc(C)n3)c2)nn1
CHEMBL4241180,CHEMBL217,Dopamine D2 receptor,Ki,=,94.0,nM,CHEMBL4236718,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCN(C)CCCCCNC(=O)COc2cccc(C#Cc3csc(C)n3)c2)nn1
CHEMBL4242453,CHEMBL217,Dopamine D2 receptor,Ki,=,115.0,nM,CHEMBL4236718,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCCCN(C)CCCCCNC(=O)COc2cncc(C#Cc3csc(C)n3)c2)nn1
CHEMBL4246881,CHEMBL217,Dopamine D2 receptor,Ki,=,45.0,nM,CHEMBL4236718,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCN(C)CCCCCNC(=O)COc2cncc(C#Cc3csc(C)n3)c2)nn1
CHEMBL4246185,CHEMBL217,Dopamine D2 receptor,Ki,=,171.0,nM,CHEMBL4236718,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCCCCCN(C)CCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1
CHEMBL4241844,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL4236718,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCCCN(C)CCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1
CHEMBL4239987,CHEMBL217,Dopamine D2 receptor,Ki,=,142.0,nM,CHEMBL4236718,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1
CHEMBL4250062,CHEMBL217,Dopamine D2 receptor,Ki,=,69.0,nM,CHEMBL4236718,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,C#CCOc1ccc(CN2CCN(c3ccccc3OC)CC2)cc1OC
CHEMBL4242192,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL4236718,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,C#CCCC(=O)Nc1ccc(CCN(CCC)C2CCc3c(O)cccc3C2)cc1
CHEMBL4239573,CHEMBL217,Dopamine D2 receptor,Ki,=,352.0,nM,CHEMBL4236717,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCOCCOCCOCCOCCOCCNC(=O)COc2cncc(C#Cc3csc(C)n3)c2)nn1
CHEMBL4249547,CHEMBL217,Dopamine D2 receptor,Ki,=,438.0,nM,CHEMBL4236717,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCOCCOCCOCCNC(=O)COc2cncc(C#Cc3csc(C)n3)c2)nn1
CHEMBL4241776,CHEMBL217,Dopamine D2 receptor,Ki,=,398.0,nM,CHEMBL4236717,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCCCN(C)CCCCCNC(=O)COc2cccc(C#Cc3csc(C)n3)c2)nn1
CHEMBL4241180,CHEMBL217,Dopamine D2 receptor,Ki,=,147.0,nM,CHEMBL4236717,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCN(C)CCCCCNC(=O)COc2cccc(C#Cc3csc(C)n3)c2)nn1
CHEMBL4242453,CHEMBL217,Dopamine D2 receptor,Ki,=,303.0,nM,CHEMBL4236717,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCCCN(C)CCCCCNC(=O)COc2cncc(C#Cc3csc(C)n3)c2)nn1
CHEMBL4246881,CHEMBL217,Dopamine D2 receptor,Ki,=,132.0,nM,CHEMBL4236717,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCN(C)CCCCCNC(=O)COc2cncc(C#Cc3csc(C)n3)c2)nn1
CHEMBL4246185,CHEMBL217,Dopamine D2 receptor,Ki,=,79.0,nM,CHEMBL4236717,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCCCCCN(C)CCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1
CHEMBL4241844,CHEMBL217,Dopamine D2 receptor,Ki,=,50.0,nM,CHEMBL4236717,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCCCN(C)CCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1
CHEMBL4239987,CHEMBL217,Dopamine D2 receptor,Ki,=,295.0,nM,CHEMBL4236717,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1
CHEMBL4250062,CHEMBL217,Dopamine D2 receptor,Ki,=,77.0,nM,CHEMBL4236717,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,C#CCOc1ccc(CN2CCN(c3ccccc3OC)CC2)cc1OC
CHEMBL4242192,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL4236717,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,C#CCCC(=O)Nc1ccc(CCN(CCC)C2CCc3c(O)cccc3C2)cc1
CHEMBL4249547,CHEMBL217,Dopamine D2 receptor,Ki,=,251.0,nM,CHEMBL4236718,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCOCCOCCOCCNC(=O)COc2cncc(C#Cc3csc(C)n3)c2)nn1
CHEMBL4239573,CHEMBL217,Dopamine D2 receptor,Ki,=,186.0,nM,CHEMBL4236718,B,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,CHEMBL4229559,KI,COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCOCCOCCOCCOCCOCCNC(=O)COc2cncc(C#Cc3csc(C)n3)c2)nn1
CHEMBL3771222,CHEMBL217,Dopamine D2 receptor,Ki,=,261.0,nM,CHEMBL4259654,B,Displacement of [3H]-raclopride from D2 receptor (unknown origin),CHEMBL4257531,KI,CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1=O
CHEMBL4285942,CHEMBL217,Dopamine D2 receptor,Ki,=,202.3,nM,CHEMBL4259825,B,Displacement of [3H]-sulpiride from human D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting method,CHEMBL4257542,KI,Cl.O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL3605327,CHEMBL217,Dopamine D2 receptor,Ki,=,5586.0,nM,CHEMBL4259825,B,Displacement of [3H]-sulpiride from human D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting method,CHEMBL4257542,KI,Cl.O=C(CCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)Nc1nc2ccccc2s1
CHEMBL3605331,CHEMBL217,Dopamine D2 receptor,Ki,=,175.0,nM,CHEMBL4259825,B,Displacement of [3H]-sulpiride from human D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting method,CHEMBL4257542,KI,O=C(CCCCN1CCN(c2ccccc2F)CC1)Nc1nc2ccccc2s1
CHEMBL4294744,CHEMBL217,Dopamine D2 receptor,Ki,=,2163.1,nM,CHEMBL4259825,B,Displacement of [3H]-sulpiride from human D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting method,CHEMBL4257542,KI,O=C1c2ccccc2C(=O)N1CCCCN1CCN(c2cccc(F)c2F)CC1
CHEMBL4287623,CHEMBL217,Dopamine D2 receptor,Ki,=,317.0,nM,CHEMBL4260833,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells by radioligand binding assay,CHEMBL4257579,KI,OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCC=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL4282702,CHEMBL217,Dopamine D2 receptor,Ki,=,460.0,nM,CHEMBL4260833,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells by radioligand binding assay,CHEMBL4257579,KI,OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCCCc2ccc(F)cc2)CC1
CHEMBL4291048,CHEMBL217,Dopamine D2 receptor,Ki,=,148.0,nM,CHEMBL4260833,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells by radioligand binding assay,CHEMBL4257579,KI,OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCN(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL4278465,CHEMBL217,Dopamine D2 receptor,Ki,=,550.0,nM,CHEMBL4260833,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells by radioligand binding assay,CHEMBL4257579,KI,OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCCN(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL1644978,CHEMBL217,Dopamine D2 receptor,Ki,=,194.0,nM,CHEMBL4260833,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells by radioligand binding assay,CHEMBL4257579,KI,OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL1644980,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL4260833,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells by radioligand binding assay,CHEMBL4257579,KI,OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCC(c2ccccc2)c2ccccc2)CC1
CHEMBL4293307,CHEMBL217,Dopamine D2 receptor,Ki,=,417.0,nM,CHEMBL4260833,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells by radioligand binding assay,CHEMBL4257579,KI,COc1ccc(N(CCCCN2CCC(O)(c3ccc(Cl)c(C(F)(F)F)c3)CC2)c2ccc(OC)cc2)cc1
CHEMBL47050,CHEMBL217,Dopamine D2 receptor,Ki,=,159.0,nM,CHEMBL4260833,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells by radioligand binding assay,CHEMBL4257579,KI,OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL4282887,CHEMBL217,Dopamine D2 receptor,Ki,=,860.0,nM,CHEMBL4269466,B,Displacement of [3H]N-Methylspiperone from human dopamine D2 receptor expressed in fibroblasts,CHEMBL4266003,KI,COc1cc2c(cc1O)CN(CCCCNC(=O)c1ccc(C(N)=O)cc1)CC2
CHEMBL4283982,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL4269466,B,Displacement of [3H]N-Methylspiperone from human dopamine D2 receptor expressed in fibroblasts,CHEMBL4266003,KI,COc1cc2c(cc1O)CN(CCCCNC(=O)c1ccc(Cl)cc1)CC2
CHEMBL4287062,CHEMBL217,Dopamine D2 receptor,Ki,=,700.0,nM,CHEMBL4269466,B,Displacement of [3H]N-Methylspiperone from human dopamine D2 receptor expressed in fibroblasts,CHEMBL4266003,KI,COc1cc2c(cc1O)CN(CCCCNC(=O)c1ccc3ccccc3c1)CC2
CHEMBL4287471,CHEMBL217,Dopamine D2 receptor,Ki,=,800.0,nM,CHEMBL4269466,B,Displacement of [3H]N-Methylspiperone from human dopamine D2 receptor expressed in fibroblasts,CHEMBL4266003,KI,COc1cc2c(cc1O)CN(CCCCNC(=O)c1ccc(-c3ccccc3)cc1)CC2
CHEMBL4440695,CHEMBL217,Dopamine D2 receptor,Ki,=,9.0,nM,CHEMBL4308346,B,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,CHEMBL4304820,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4470487,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL4308346,B,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,CHEMBL4304820,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ncccn2)CC1
CHEMBL4592941,CHEMBL217,Dopamine D2 receptor,Ki,=,239.0,nM,CHEMBL4308346,B,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,CHEMBL4304820,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccn2)CC1
CHEMBL4434735,CHEMBL217,Dopamine D2 receptor,Ki,=,15.0,nM,CHEMBL4308346,B,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,CHEMBL4304820,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2cccc3cccnc23)CC1
CHEMBL4454105,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL4308346,B,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,CHEMBL4304820,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2cccc3ccccc23)CC1
CHEMBL4540404,CHEMBL217,Dopamine D2 receptor,Ki,=,48.0,nM,CHEMBL4308346,B,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,CHEMBL4304820,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2)CC1
CHEMBL4463030,CHEMBL217,Dopamine D2 receptor,Ki,=,7.0,nM,CHEMBL4308346,B,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,CHEMBL4304820,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1
CHEMBL4462839,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL4308346,B,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,CHEMBL4304820,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2C(F)(F)F)CC1
CHEMBL4439144,CHEMBL217,Dopamine D2 receptor,Ki,=,950.0,nM,CHEMBL4308346,B,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,CHEMBL4304820,KI,COc1ccc(N2CCN(CCCCCCN3C(=O)c4ccccc4S3(=O)=O)CC2)cc1
CHEMBL4456046,CHEMBL217,Dopamine D2 receptor,Ki,=,113.0,nM,CHEMBL4308346,B,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,CHEMBL4304820,KI,COc1cccc(N2CCN(CCCCCCN3C(=O)c4ccccc4S3(=O)=O)CC2)c1
CHEMBL4565558,CHEMBL217,Dopamine D2 receptor,Ki,=,61.0,nM,CHEMBL4308346,B,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,CHEMBL4304820,KI,COc1ccccc1N1CCN(CCCCCCN2C(=O)c3ccccc3S2(=O)=O)CC1
CHEMBL4465181,CHEMBL217,Dopamine D2 receptor,Ki,=,105.0,nM,CHEMBL4308346,B,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,CHEMBL4304820,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccc(Cl)c(Cl)c2)CC1
CHEMBL4569757,CHEMBL217,Dopamine D2 receptor,Ki,=,132.0,nM,CHEMBL4308346,B,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,CHEMBL4304820,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL4439795,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL4308346,B,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,CHEMBL4304820,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL4464512,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL4308346,B,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,CHEMBL4304820,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2cccc(Cl)c2)CC1
CHEMBL4473026,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL4308346,B,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,CHEMBL4304820,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2F)CC1
CHEMBL4457109,CHEMBL217,Dopamine D2 receptor,Ki,=,45.0,nM,CHEMBL4308346,B,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,CHEMBL4304820,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2Cl)CC1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,3.3,nM,CHEMBL4308344,B,Displacement of [3H]methylspiperone from human D2 receptor by radio ligand binding assay,CHEMBL4304820,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL49,CHEMBL217,Dopamine D2 receptor,Ki,=,484.0,nM,CHEMBL4308339,B,Displacement of [3H]methylspiperone from human D2 receptor expressed in HEK-GIRK-M4 cell membrane by radioligand binding assay,CHEMBL4304820,KI,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
CHEMBL8412,CHEMBL217,Dopamine D2 receptor,Ki,=,1224.0,nM,CHEMBL4308338,B,Displacement of [3H]raclopride from human cloned D2 receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL4304820,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ncccn2)CC1
CHEMBL2105760,CHEMBL217,Dopamine D2 receptor,Ki,=,0.3,nM,CHEMBL4314365,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,CHEMBL4311986,KI,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.34,nM,CHEMBL4314365,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,CHEMBL4311986,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2377591,CHEMBL217,Dopamine D2 receptor,Ki,=,161.0,nM,CHEMBL4314365,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,CHEMBL4311986,KI,COc1ccc2[nH]cc(C3CCN(CCCCN4C(=O)CC(c5c[nH]c6ccccc56)C4=O)CC3)c2c1
CHEMBL2377590,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL4314365,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,CHEMBL4311986,KI,O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccc(F)cc23)CC1
CHEMBL1237021,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL4314365,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,CHEMBL4311986,KI,O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,Ki,=,0.49,nM,CHEMBL4314365,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,CHEMBL4311986,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL4454176,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL4314365,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,CHEMBL4311986,KI,COc1ccc2[nH]cc(C3CCN(CCCCN4C(=O)CC(c5c[nH]c6ccc(F)cc56)C4=O)CC3)c2c1
CHEMBL4515160,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL4314365,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,CHEMBL4311986,KI,O=C1CC(c2c[nH]c3ccc(F)cc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccc(F)cc23)CC1
CHEMBL4571862,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL4314365,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,CHEMBL4311986,KI,O=C1CC(c2c[nH]c3ccc(F)cc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccccc23)CC1
CHEMBL4591440,CHEMBL217,Dopamine D2 receptor,Ki,=,217.0,nM,CHEMBL4314365,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,CHEMBL4311986,KI,COc1ccc2[nH]cc(C3CCN(CCCCN4C(=O)CC(c5c[nH]c6ccc(OC)cc56)C4=O)CC3)c2c1
CHEMBL4571321,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL4314365,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,CHEMBL4311986,KI,COc1ccc2[nH]cc(C3CC(=O)N(CCCCN4CCC(c5c[nH]c6ccc(F)cc56)CC4)C3=O)c2c1
CHEMBL4483554,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL4314365,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,CHEMBL4311986,KI,COc1ccc2[nH]cc(C3CC(=O)N(CCCCN4CCC(c5c[nH]c6ccccc56)CC4)C3=O)c2c1
CHEMBL4462814,CHEMBL217,Dopamine D2 receptor,Ki,=,676.0,nM,CHEMBL4316415,B,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,CHEMBL4312034,KI,c1ccc(-c2ccc(CNCCc3c[nH]c4ccccc34)o2)cc1
CHEMBL4435528,CHEMBL217,Dopamine D2 receptor,Ki,=,391.0,nM,CHEMBL4316415,B,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,CHEMBL4312034,KI,COc1ccc2[nH]cc(CCNCc3ccc(-c4cccc(O)c4)o3)c2c1
CHEMBL4591410,CHEMBL217,Dopamine D2 receptor,Ki,=,1730.0,nM,CHEMBL4316415,B,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,CHEMBL4312034,KI,COc1ccc2[nH]cc(CCNCc3ccc(-c4cn[nH]c4)o3)c2c1
CHEMBL4448285,CHEMBL217,Dopamine D2 receptor,Ki,=,1025.0,nM,CHEMBL4316415,B,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,CHEMBL4312034,KI,COc1ccc2[nH]cc(CCNCc3ccc(-c4cnc5ccccc5c4)o3)c2c1
CHEMBL4593671,CHEMBL217,Dopamine D2 receptor,Ki,=,571.0,nM,CHEMBL4316415,B,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,CHEMBL4312034,KI,COc1ccc2[nH]cc(CCNCc3ccc(-c4ccc(Cl)cc4)o3)c2c1
CHEMBL4519266,CHEMBL217,Dopamine D2 receptor,Ki,=,1365.0,nM,CHEMBL4316415,B,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,CHEMBL4312034,KI,COc1ccc(-c2ccc(CNCCc3c[nH]c4ccc(OC)cc34)o2)cc1
CHEMBL4465414,CHEMBL217,Dopamine D2 receptor,Ki,=,757.0,nM,CHEMBL4316415,B,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,CHEMBL4312034,KI,Oc1ccc(-c2ccc(CNCCc3c[nH]c4ccccc34)o2)cc1
CHEMBL4474618,CHEMBL217,Dopamine D2 receptor,Ki,=,178.0,nM,CHEMBL4316415,B,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,CHEMBL4312034,KI,COc1cccc2[nH]cc(CCNCc3ccc(-c4ccc(O)cc4)o3)c12
CHEMBL4583082,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL4316415,B,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,CHEMBL4312034,KI,COc1ccc2[nH]cc(CCNCc3ccc(-c4ccc(O)cc4)o3)c2c1
CHEMBL4552041,CHEMBL217,Dopamine D2 receptor,Ki,=,368.0,nM,CHEMBL4316415,B,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,CHEMBL4312034,KI,CN(CCc1c[nH]c2ccccc12)Cc1ccc(-c2ccccc2)o1
CHEMBL4437523,CHEMBL217,Dopamine D2 receptor,Ki,=,376.0,nM,CHEMBL4316415,B,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,CHEMBL4312034,KI,Oc1ccc(-c2ccc(CNCCc3c[nH]c4ccc(F)cc34)o2)cc1
CHEMBL4584504,CHEMBL217,Dopamine D2 receptor,Ki,=,446.0,nM,CHEMBL4316415,B,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,CHEMBL4312034,KI,Oc1ccc(-c2ccc(CNCCc3c[nH]c4cc(F)ccc34)o2)cc1
CHEMBL4536315,CHEMBL217,Dopamine D2 receptor,Ki,=,167.0,nM,CHEMBL4316415,B,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,CHEMBL4312034,KI,COc1ccc2[nH]c(C)c(CCNCc3ccc(-c4ccc(O)cc4)o3)c2c1
CHEMBL4442855,CHEMBL217,Dopamine D2 receptor,Ki,=,505.0,nM,CHEMBL4316415,B,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,CHEMBL4312034,KI,Oc1ccc(-c2ccc(CNCCc3c[nH]c4ncc(F)cc34)o2)cc1
CHEMBL3286580,CHEMBL217,Dopamine D2 receptor,Ki,=,1215.0,nM,CHEMBL4316415,B,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,CHEMBL4312034,KI,Fc1ccc2c(CCNCc3cccc(OCC(F)(F)C(F)F)c3)c[nH]c2c1
CHEMBL708,CHEMBL217,Dopamine D2 receptor,Ki,=,2.1,nM,CHEMBL4316415,B,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,CHEMBL4312034,KI,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,47000.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL45244,CHEMBL217,Dopamine D2 receptor,Ki,=,2300.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,Cc1cccc(C(=O)NCN2CCN(c3ccccc3C#N)CC2)c1
CHEMBL4463276,CHEMBL217,Dopamine D2 receptor,Ki,=,270.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCNC(=O)/N=N/c2ccc(F)cc2)CC1
CHEMBL4534703,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)/N=N/c2ccc(F)cc2)CC1
CHEMBL3590077,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCCNC(=O)/N=N/c2ccc(F)cc2)CC1
CHEMBL4465002,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCNC(=O)NN(Cc2ccccc2)c2ccc(F)cc2)CC1
CHEMBL4563944,CHEMBL217,Dopamine D2 receptor,Ki,=,6.6,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccc(F)cc2)CC1
CHEMBL4448166,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCCNC(=O)NN(Cc2ccccc2)c2ccc(F)cc2)CC1
CHEMBL4442460,CHEMBL217,Dopamine D2 receptor,Ki,=,77.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1
CHEMBL4544086,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1
CHEMBL4442470,CHEMBL217,Dopamine D2 receptor,Ki,=,92.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2F)c2ccc(F)cc2)CC1
CHEMBL4437233,CHEMBL217,Dopamine D2 receptor,Ki,=,73.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2cccc(F)c2)c2ccc(F)cc2)CC1
CHEMBL4463200,CHEMBL217,Dopamine D2 receptor,Ki,=,77.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL4550633,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1cccc(CN(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c2ccc(F)cc2)c1
CHEMBL4520460,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(C#N)cc2)c2ccc(F)cc2)CC1
CHEMBL4454096,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(-c3ccccc3)cc2)c2ccc(F)cc2)CC1
CHEMBL4470231,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccc(Cl)cc2)CC1
CHEMBL4570073,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2F)c2ccc(Cl)cc2)CC1
CHEMBL4475042,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccc(Cl)cc2Cl)CC1
CHEMBL4583596,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(C#N)cc2)c2ccc(Cl)cc2Cl)CC1
CHEMBL4439644,CHEMBL217,Dopamine D2 receptor,Ki,=,55.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccc(Br)cc2)CC1
CHEMBL4467437,CHEMBL217,Dopamine D2 receptor,Ki,=,45.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2F)c2ccc(Br)cc2)CC1
CHEMBL4460743,CHEMBL217,Dopamine D2 receptor,Ki,=,45.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccc(N(Cc2ccccc2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL4434714,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccc(N(Cc2ccccc2F)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL4585384,CHEMBL217,Dopamine D2 receptor,Ki,=,59.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccc(N(Cc2cccc(F)c2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL4582096,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccc(N(Cc2ccc(F)cc2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL4442419,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccc(N(Cc2cccc(OC)c2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL4445706,CHEMBL217,Dopamine D2 receptor,Ki,=,250.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccc(N(Cc2ccc(C#N)cc2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL4475978,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,C=CCN(NC(=O)NCCCN1CCN(c2ccccc2OC)CC1)c1ccc(OC)cc1
CHEMBL4472580,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,C=C(C)CN(NC(=O)NCCCN1CCN(c2ccccc2OC)CC1)c1ccc(OC)cc1
CHEMBL4587645,CHEMBL217,Dopamine D2 receptor,Ki,=,640.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCCN1CCN(c2ccc(Cl)cc2)CC1)NN(Cc1ccccc1)c1ccccc1
CHEMBL4476278,CHEMBL217,Dopamine D2 receptor,Ki,=,730.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCCN1CCN(c2ccc(Br)cc2)CC1)NN(Cc1ccccc1)c1ccccc1
CHEMBL4443944,CHEMBL217,Dopamine D2 receptor,Ki,=,580.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCCN1CCN(c2ncccn2)CC1)NN(Cc1ccccc1)c1ccccc1
CHEMBL4589982,CHEMBL217,Dopamine D2 receptor,Ki,=,500.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCCN1CCN(c2ccc(Cl)cc2)CC1)NN(Cc1ccc(F)cc1)c1ccccc1
CHEMBL4439728,CHEMBL217,Dopamine D2 receptor,Ki,=,790.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCCN1CCN(c2ccc(Br)cc2)CC1)NN(Cc1ccc(F)cc1)c1ccccc1
CHEMBL4567758,CHEMBL217,Dopamine D2 receptor,Ki,=,430.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCCN1CCN(c2ncccn2)CC1)NN(Cc1ccc(F)cc1)c1ccccc1
CHEMBL4536530,CHEMBL217,Dopamine D2 receptor,Ki,=,390.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCN1CCN(c2ccc(Br)cc2)CC1)NN(Cc1ccccc1)c1ccccc1
CHEMBL4572646,CHEMBL217,Dopamine D2 receptor,Ki,=,690.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCCN1CCN(c2ccc(I)cc2)CC1)NN(Cc1ccccc1)c1ccccc1
CHEMBL4466114,CHEMBL217,Dopamine D2 receptor,Ki,=,490.0,nM,CHEMBL4323478,B,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCN1CCN(c2ccc(I)cc2)CC1)NN(Cc1ccccc1)c1ccccc1
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,33000.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL45244,CHEMBL217,Dopamine D2 receptor,Ki,=,1100.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,Cc1cccc(C(=O)NCN2CCN(c3ccccc3C#N)CC2)c1
CHEMBL4463276,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCNC(=O)/N=N/c2ccc(F)cc2)CC1
CHEMBL4534703,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)/N=N/c2ccc(F)cc2)CC1
CHEMBL3590077,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCCNC(=O)/N=N/c2ccc(F)cc2)CC1
CHEMBL4465002,CHEMBL217,Dopamine D2 receptor,Ki,=,71.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCNC(=O)NN(Cc2ccccc2)c2ccc(F)cc2)CC1
CHEMBL4563944,CHEMBL217,Dopamine D2 receptor,Ki,=,4.3,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccc(F)cc2)CC1
CHEMBL4448166,CHEMBL217,Dopamine D2 receptor,Ki,=,94.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCCNC(=O)NN(Cc2ccccc2)c2ccc(F)cc2)CC1
CHEMBL4442460,CHEMBL217,Dopamine D2 receptor,Ki,=,73.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1
CHEMBL4544086,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1
CHEMBL4442470,CHEMBL217,Dopamine D2 receptor,Ki,=,47.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2F)c2ccc(F)cc2)CC1
CHEMBL4437233,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2cccc(F)c2)c2ccc(F)cc2)CC1
CHEMBL4463200,CHEMBL217,Dopamine D2 receptor,Ki,=,30.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL4550633,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1cccc(CN(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c2ccc(F)cc2)c1
CHEMBL4520460,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(C#N)cc2)c2ccc(F)cc2)CC1
CHEMBL4454096,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(-c3ccccc3)cc2)c2ccc(F)cc2)CC1
CHEMBL4470231,CHEMBL217,Dopamine D2 receptor,Ki,=,23.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccc(Cl)cc2)CC1
CHEMBL4570073,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2F)c2ccc(Cl)cc2)CC1
CHEMBL4475042,CHEMBL217,Dopamine D2 receptor,Ki,=,24.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccc(Cl)cc2Cl)CC1
CHEMBL4583596,CHEMBL217,Dopamine D2 receptor,Ki,=,94.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(C#N)cc2)c2ccc(Cl)cc2Cl)CC1
CHEMBL4439644,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccc(Br)cc2)CC1
CHEMBL4467437,CHEMBL217,Dopamine D2 receptor,Ki,=,22.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2F)c2ccc(Br)cc2)CC1
CHEMBL4460743,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccc(N(Cc2ccccc2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL4434714,CHEMBL217,Dopamine D2 receptor,Ki,=,19.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccc(N(Cc2ccccc2F)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL4585384,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccc(N(Cc2cccc(F)c2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL4582096,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccc(N(Cc2ccc(F)cc2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL4442419,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccc(N(Cc2cccc(OC)c2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL4445706,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,COc1ccc(N(Cc2ccc(C#N)cc2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1
CHEMBL4475978,CHEMBL217,Dopamine D2 receptor,Ki,=,340.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,C=CCN(NC(=O)NCCCN1CCN(c2ccccc2OC)CC1)c1ccc(OC)cc1
CHEMBL4472580,CHEMBL217,Dopamine D2 receptor,Ki,=,300.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,C=C(C)CN(NC(=O)NCCCN1CCN(c2ccccc2OC)CC1)c1ccc(OC)cc1
CHEMBL4587645,CHEMBL217,Dopamine D2 receptor,Ki,=,410.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCCN1CCN(c2ccc(Cl)cc2)CC1)NN(Cc1ccccc1)c1ccccc1
CHEMBL4476278,CHEMBL217,Dopamine D2 receptor,Ki,=,520.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCCN1CCN(c2ccc(Br)cc2)CC1)NN(Cc1ccccc1)c1ccccc1
CHEMBL4443944,CHEMBL217,Dopamine D2 receptor,Ki,=,440.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCCN1CCN(c2ncccn2)CC1)NN(Cc1ccccc1)c1ccccc1
CHEMBL4589982,CHEMBL217,Dopamine D2 receptor,Ki,=,380.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCCN1CCN(c2ccc(Cl)cc2)CC1)NN(Cc1ccc(F)cc1)c1ccccc1
CHEMBL4439728,CHEMBL217,Dopamine D2 receptor,Ki,=,620.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCCN1CCN(c2ccc(Br)cc2)CC1)NN(Cc1ccc(F)cc1)c1ccccc1
CHEMBL4567758,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCCN1CCN(c2ncccn2)CC1)NN(Cc1ccc(F)cc1)c1ccccc1
CHEMBL4536530,CHEMBL217,Dopamine D2 receptor,Ki,=,430.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCN1CCN(c2ccc(Br)cc2)CC1)NN(Cc1ccccc1)c1ccccc1
CHEMBL4572646,CHEMBL217,Dopamine D2 receptor,Ki,=,670.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCCN1CCN(c2ccc(I)cc2)CC1)NN(Cc1ccccc1)c1ccccc1
CHEMBL4466114,CHEMBL217,Dopamine D2 receptor,Ki,=,510.0,nM,CHEMBL4323479,B,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,CHEMBL4321823,KI,O=C(NCCN1CCN(c2ccc(I)cc2)CC1)NN(Cc1ccccc1)c1ccccc1
CHEMBL279085,CHEMBL217,Dopamine D2 receptor,Ki,=,616.6,nM,CHEMBL4334861,B,Displacement of [125I]iodosupride from human recombinant dopamine D2S receptor expressed in CHO cells incubated for 30 mins by competitive radioligand binding analysis,CHEMBL4334436,KI,C=CCN1CCc2nc(N)sc2CC1
CHEMBL4448120,CHEMBL217,Dopamine D2 receptor,Ki,=,3.236,nM,CHEMBL4334858,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,CHEMBL4334436,KI,COc1ccccc1N1CCN(CCCCOc2ccc3scnc3c2)CC1
CHEMBL4462915,CHEMBL217,Dopamine D2 receptor,Ki,=,2.818,nM,CHEMBL4334858,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,CHEMBL4334436,KI,COc1ccccc1N1CCN(CCCCOc2ccc3sc(N)nc3c2)CC1
CHEMBL4572887,CHEMBL217,Dopamine D2 receptor,Ki,=,22.39,nM,CHEMBL4334858,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,CHEMBL4334436,KI,Nc1nc2c(s1)CCN(CCCCN1CCN(c3cccc(Cl)c3Cl)CC1)CC2
CHEMBL4435367,CHEMBL217,Dopamine D2 receptor,Ki,=,2754.23,nM,CHEMBL4334858,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,CHEMBL4334436,KI,Nc1nc2c(s1)CCN(CCCCN1CCN(c3ncccn3)CC1)CC2
CHEMBL4439577,CHEMBL217,Dopamine D2 receptor,Ki,=,18.2,nM,CHEMBL4334858,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,CHEMBL4334436,KI,Clc1cccc(N2CCN(CCCCN3CCc4ncsc4CC3)CC2)c1Cl
CHEMBL4438968,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL4334858,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,CHEMBL4334436,KI,c1cnc(N2CCN(CCCCN3CCc4ncsc4CC3)CC2)nc1
CHEMBL4437202,CHEMBL217,Dopamine D2 receptor,Ki,=,41686.94,nM,CHEMBL4334858,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,CHEMBL4334436,KI,O=C(c1ccccc1)N1CCN(CCN2CCc3ncsc3CC2)CC1
CHEMBL4451351,CHEMBL217,Dopamine D2 receptor,Ki,=,151.36,nM,CHEMBL4334858,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,CHEMBL4334436,KI,COc1ccccc1N1CCN(CCN2CCc3ncsc3CC2)CC1
CHEMBL4570930,CHEMBL217,Dopamine D2 receptor,Ki,=,64.57,nM,CHEMBL4334858,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,CHEMBL4334436,KI,COc1ccccc1N1CCN(CCCN2CCc3ncsc3CC2)CC1
CHEMBL4582714,CHEMBL217,Dopamine D2 receptor,Ki,=,85.11,nM,CHEMBL4334858,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,CHEMBL4334436,KI,COc1ccccc1N1CCN(CCCCN2CCc3ncsc3CC2)CC1
CHEMBL4472043,CHEMBL217,Dopamine D2 receptor,Ki,=,6309.57,nM,CHEMBL4334858,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,CHEMBL4334436,KI,c1nc2c(s1)CCN(CCCCN1CCc3ncsc3CC1)CC2
CHEMBL4460592,CHEMBL217,Dopamine D2 receptor,Ki,=,5495.41,nM,CHEMBL4334858,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,CHEMBL4334436,KI,O=C(NCCCCN1CCc2ncsc2CC1)C12CC3CC(CC(C3)C1)C2
CHEMBL4475262,CHEMBL217,Dopamine D2 receptor,Ki,=,177.83,nM,CHEMBL4334858,B,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,CHEMBL4334436,KI,COc1ccccc1N1CCN(CCCN2CCCc3ncsc3C2)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,6.22,nM,CHEMBL4344297,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO-K1 cells by radioligand competitive binding analysis,CHEMBL4342460,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL2414991,CHEMBL217,Dopamine D2 receptor,Ki,=,340.0,nM,CHEMBL4344297,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO-K1 cells by radioligand competitive binding analysis,CHEMBL4342460,KI,CN1CCc2cc(O)c(O)c3c2C1Cc1ccccc1-3
CHEMBL4591554,CHEMBL217,Dopamine D2 receptor,Ki,=,286.0,nM,CHEMBL4344297,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO-K1 cells by radioligand competitive binding analysis,CHEMBL4342460,KI,CN1CCc2cc(O)c(O)cc2C1Cc1ccccc1Br
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,6.166,nM,CHEMBL4344297,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO-K1 cells by radioligand competitive binding analysis,CHEMBL4342460,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL2414991,CHEMBL217,Dopamine D2 receptor,Ki,=,338.84,nM,CHEMBL4344297,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO-K1 cells by radioligand competitive binding analysis,CHEMBL4342460,KI,CN1CCc2cc(O)c(O)c3c2C1Cc1ccccc1-3
CHEMBL4591554,CHEMBL217,Dopamine D2 receptor,Ki,=,288.4,nM,CHEMBL4344297,B,Displacement of [3H]spiperone from human D2S receptor expressed in CHO-K1 cells by radioligand competitive binding analysis,CHEMBL4342460,KI,CN1CCc2cc(O)c(O)cc2C1Cc1ccccc1Br
CHEMBL1739963,CHEMBL217,Dopamine D2 receptor,Ki,=,0.17,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1ccc(-c2ccsc2)cc1
CHEMBL4438361,CHEMBL217,Dopamine D2 receptor,Ki,=,14.7,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,CCCCN1CCN(c2ccccc2OCCF)CC1
CHEMBL4586531,CHEMBL217,Dopamine D2 receptor,Ki,=,8434.0,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1
CHEMBL4450777,CHEMBL217,Dopamine D2 receptor,Ki,=,169.0,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1ccc(-c2ccsc2)cc1
CHEMBL4446350,CHEMBL217,Dopamine D2 receptor,Ki,=,12046.0,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2)CC1)c1ccc(-c2ccsc2)cc1
CHEMBL4442321,CHEMBL217,Dopamine D2 receptor,Ki,=,27359.0,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,O=C(NCCCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(-c2ccsc2)cc1
CHEMBL4535174,CHEMBL217,Dopamine D2 receptor,Ki,=,63.1,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccsc2)cc1
CHEMBL4438037,CHEMBL217,Dopamine D2 receptor,Ki,=,757.0,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1ccc(-c2ccsc2)cc1
CHEMBL4583609,CHEMBL217,Dopamine D2 receptor,Ki,=,2049.0,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,O=C(NCCCCN1CCN(c2cc(Cl)cc(Cl)c2)CC1)c1ccc(-c2ccsc2)cc1
CHEMBL4567895,CHEMBL217,Dopamine D2 receptor,Ki,=,38.6,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccsc3)cc2)CC1
CHEMBL4570430,CHEMBL217,Dopamine D2 receptor,Ki,=,1832.0,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,COc1cccc(N2CCN(CCCCNC(=O)c3ccc(-c4ccsc4)cc3)CC2)c1
CHEMBL4459381,CHEMBL217,Dopamine D2 receptor,Ki,=,3449.0,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,O=C(NCCCCN1CCN(c2ccccc2O)CC1)c1ccc(-c2ccsc2)cc1
CHEMBL4579251,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,O=C(NCCCCN1CCN(c2cccc(O)c2)CC1)c1ccc(-c2ccsc2)cc1
CHEMBL4565997,CHEMBL217,Dopamine D2 receptor,Ki,=,4753.0,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,O=C(NCCCCN1CCN(c2ccc(O)cc2)CC1)c1ccc(-c2ccsc2)cc1
CHEMBL4587635,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,Cc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccsc3)cc2)CC1
CHEMBL4438630,CHEMBL217,Dopamine D2 receptor,Ki,=,16318.0,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,Cc1cccc(N2CCN(CCCCNC(=O)c3ccc(-c4ccsc4)cc3)CC2)c1
CHEMBL4545775,CHEMBL217,Dopamine D2 receptor,Ki,=,24994.0,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,Cc1ccc(N2CCN(CCCCNC(=O)c3ccc(-c4ccsc4)cc3)CC2)cc1
CHEMBL4571568,CHEMBL217,Dopamine D2 receptor,Ki,=,92.9,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,N#Cc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccsc3)cc2)CC1
CHEMBL4437341,CHEMBL217,Dopamine D2 receptor,Ki,=,743.0,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,N#Cc1cccc(N2CCN(CCCCNC(=O)c3ccc(-c4ccsc4)cc3)CC2)c1
CHEMBL4476605,CHEMBL217,Dopamine D2 receptor,Ki,=,261.0,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,O=C(NCCCCN1CCN(c2ccccc2C(F)(F)F)CC1)c1ccc(-c2ccsc2)cc1
CHEMBL4590192,CHEMBL217,Dopamine D2 receptor,Ki,=,99.7,nM,CHEMBL4350893,B,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",CHEMBL4346764,KI,O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1ccc(-c2ccsc2)cc1
CHEMBL4441060,CHEMBL217,Dopamine D2 receptor,Ki,=,87.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,Cl.Nc1ncc(-c2cn(S(=O)(=O)c3ccccc3)c3ccccc23)[nH]1
CHEMBL4586353,CHEMBL217,Dopamine D2 receptor,Ki,=,794.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,Cc1nc(N)[nH]c1-c1cn(S(=O)(=O)c2ccccc2)c2ccccc12.Cl
CHEMBL4469860,CHEMBL217,Dopamine D2 receptor,Ki,=,1585.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,CCc1nc(N)[nH]c1-c1cn(S(=O)(=O)c2ccccc2)c2ccccc12.Cl
CHEMBL4435010,CHEMBL217,Dopamine D2 receptor,Ki,=,1202.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,COc1ccc2c(c1)c(-c1cnc(N)[nH]1)cn2S(=O)(=O)c1ccccc1.Cl
CHEMBL4516784,CHEMBL217,Dopamine D2 receptor,Ki,=,1622.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,CCc1nc(N)[nH]c1-c1cn(S(=O)(=O)c2ccccc2)c2ccc(OC)cc12.Cl
CHEMBL4590882,CHEMBL217,Dopamine D2 receptor,Ki,=,7079.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,COc1ccc2c(c1)c(-c1cnc(N)[nH]1)cn2S(=O)(=O)c1cccc(F)c1.Cl
CHEMBL4471055,CHEMBL217,Dopamine D2 receptor,Ki,=,1175.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,Cc1nc(N)[nH]c1-c1cn(S(=O)(=O)c2cccc3ccccc23)c2ccccc12.Cl
CHEMBL4442332,CHEMBL217,Dopamine D2 receptor,Ki,=,1318.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,COc1ccc2c(c1)c(-c1[nH]c(N)nc1C)cn2S(=O)(=O)c1cccc2ccccc12.Cl
CHEMBL4451939,CHEMBL217,Dopamine D2 receptor,Ki,=,2344.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,COc1ccc2c(c1)c(-c1[nH]c(N)nc1C)cn2S(=O)(=O)c1ccc2ccccc2c1.Cl
CHEMBL4450907,CHEMBL217,Dopamine D2 receptor,Ki,=,3981.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,Cl.Nc1ncc(-c2cccc3c2ccn3S(=O)(=O)c2ccccc2)[nH]1
CHEMBL4472629,CHEMBL217,Dopamine D2 receptor,Ki,=,708.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,Cc1nc(N)[nH]c1-c1ccc2ccn(S(=O)(=O)c3ccccc3)c2c1.Cl
CHEMBL4483304,CHEMBL217,Dopamine D2 receptor,Ki,=,3631.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,CCC(=O)Nc1nc(C)c(-c2ccc3ccn(S(=O)(=O)c4ccccc4)c3c2)[nH]1
CHEMBL4572629,CHEMBL217,Dopamine D2 receptor,Ki,=,1230.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,COc1ccc2c(c1)c(-c1nc3n(c1C)CCCN3)cn2S(=O)(=O)c1ccccc1.Cl
CHEMBL4455699,CHEMBL217,Dopamine D2 receptor,Ki,=,3162.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,COc1ccc2c(c1)c(-c1[nH]c3cccc[n+]3c1C)cn2S(=O)(=O)c1ccccc1.[Br-]
CHEMBL4463737,CHEMBL217,Dopamine D2 receptor,Ki,=,3802.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,COc1ccc2c(c1)c(-c1c(C)nc(N)n1CC(F)F)cn2S(=O)(=O)c1ccccc1
CHEMBL4453733,CHEMBL217,Dopamine D2 receptor,Ki,=,3981.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,COc1ccc2c(c1)c(-c1[nH]c(NCC(F)F)nc1C)cn2S(=O)(=O)c1ccccc1
CHEMBL4519004,CHEMBL217,Dopamine D2 receptor,Ki,=,2138.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,COc1ccc2c(c1)c(-c1[nH]c(NCCc3ccccc3)nc1C)cn2S(=O)(=O)c1ccccc1
CHEMBL4520003,CHEMBL217,Dopamine D2 receptor,Ki,=,1175.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,COc1ccc2c(c1)c(-c1[nH]c(NCc3ccccc3)nc1C)cn2S(=O)(=O)c1ccccc1
CHEMBL4468396,CHEMBL217,Dopamine D2 receptor,Ki,=,5129.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,Cc1sc(N)nc1-c1cn(S(=O)(=O)c2ccccc2)c2ccccc12
CHEMBL708,CHEMBL217,Dopamine D2 receptor,Ki,=,0.8511,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL708,CHEMBL217,Dopamine D2 receptor,Ki,=,0.9,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL4469147,CHEMBL217,Dopamine D2 receptor,Ki,=,5248.0,nM,CHEMBL4354013,B,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,CHEMBL4351001,KI,CC(=O)Nc1nc(C)c(-c2ccc3ccn(S(=O)(=O)c4ccccc4)c3c2)[nH]1
CHEMBL4465929,CHEMBL217,Dopamine D2 receptor,Ki,=,1348.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,CN1CCN(c2nc(N)nc(COc3ccccc3)n2)CC1
CHEMBL4548041,CHEMBL217,Dopamine D2 receptor,Ki,=,2362.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,CN1CCN(c2nc(N)nc(COc3ccccc3Cl)n2)CC1
CHEMBL4524981,CHEMBL217,Dopamine D2 receptor,Ki,=,674.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,CN1CCN(c2nc(N)nc(COc3cccc(Cl)c3)n2)CC1
CHEMBL4520796,CHEMBL217,Dopamine D2 receptor,Ki,=,1094.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,Cc1ccc(C(C)C)c(OCc2nc(N)nc(N3CCN(C)CC3)n2)c1
CHEMBL4570584,CHEMBL217,Dopamine D2 receptor,Ki,=,4247.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,Cc1ccccc1OCc1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4532712,CHEMBL217,Dopamine D2 receptor,Ki,=,740.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,Cc1cccc(OCc2nc(N)nc(N3CCN(C)CC3)n2)c1
CHEMBL4584325,CHEMBL217,Dopamine D2 receptor,Ki,=,2916.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,Cc1ccc(OCc2nc(N)nc(N3CCN(C)CC3)n2)cc1
CHEMBL4560883,CHEMBL217,Dopamine D2 receptor,Ki,=,4369.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,Cc1cc(Cl)ccc1OCc1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4473083,CHEMBL217,Dopamine D2 receptor,Ki,=,1234.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,CN1CCN(c2nc(N)nc(COc3ccc(Cl)cc3Cl)n2)CC1
CHEMBL4527124,CHEMBL217,Dopamine D2 receptor,Ki,=,1224.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,Cc1cc(OCc2nc(N)nc(N3CCN(C)CC3)n2)ccc1Cl
CHEMBL4522568,CHEMBL217,Dopamine D2 receptor,Ki,=,566.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,CC(Oc1cccc(Cl)c1)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4447416,CHEMBL217,Dopamine D2 receptor,Ki,=,1001.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,CC(Oc1ccccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4557247,CHEMBL217,Dopamine D2 receptor,Ki,=,734.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,CN1CCN(c2nc(N)nc(CSc3ccccc3)n2)CC1
CHEMBL4591878,CHEMBL217,Dopamine D2 receptor,Ki,=,329.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,CN1CCN(c2nc(N)nc(CSc3ccccc3Cl)n2)CC1
CHEMBL4515075,CHEMBL217,Dopamine D2 receptor,Ki,=,520.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,CC(Sc1ccccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4580959,CHEMBL217,Dopamine D2 receptor,Ki,=,506.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,CN1CCN(c2nc(N)nc(C[Se]c3ccccc3)n2)CC1
CHEMBL4462404,CHEMBL217,Dopamine D2 receptor,Ki,=,656.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,CC([Se]c1ccccc1)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4441655,CHEMBL217,Dopamine D2 receptor,Ki,=,50140.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,CN1CCN(c2nc(N)nc(CS(=O)(=O)c3ccccc3Cl)n2)CC1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,9.0,nM,CHEMBL4366763,B,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,CHEMBL4364280,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL4476164,CHEMBL217,Dopamine D2 receptor,Ki,=,2349.0,nM,CHEMBL4368000,B,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,CHEMBL4364313,KI,O=c1c(-c2ccccc2)c2n(c(=O)n1CCCCN1CCCC(c3c[nH]c4ccccc34)C1)CCCC2
CHEMBL4455658,CHEMBL217,Dopamine D2 receptor,Ki,=,896.0,nM,CHEMBL4368000,B,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,CHEMBL4364313,KI,O=c1c(-c2ccccc2Cl)c2n(c(=O)n1CCCCN1CCCC(c3c[nH]c4ccccc34)C1)CCCC2
CHEMBL4469633,CHEMBL217,Dopamine D2 receptor,Ki,=,1651.0,nM,CHEMBL4368000,B,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,CHEMBL4364313,KI,O=c1c(-c2ccc(Cl)cc2)c2n(c(=O)n1CCCCN1CCCC(c3c[nH]c4ccccc34)C1)CCCC2
CHEMBL4469537,CHEMBL217,Dopamine D2 receptor,Ki,=,1977.0,nM,CHEMBL4368000,B,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,CHEMBL4364313,KI,O=c1c(-c2ccc(F)cc2)c2n(c(=O)n1CCCCN1CCCC(c3c[nH]c4ccccc34)C1)CCCC2
CHEMBL4582567,CHEMBL217,Dopamine D2 receptor,Ki,=,1047.0,nM,CHEMBL4368000,B,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,CHEMBL4364313,KI,O=c1c(-c2ccc(F)cc2)c2n(c(=O)n1CCCCN1CCCC(c3c[nH]c4ccc(F)cc34)C1)CCCC2
CHEMBL4471755,CHEMBL217,Dopamine D2 receptor,Ki,=,1802.0,nM,CHEMBL4368000,B,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,CHEMBL4364313,KI,COc1ccc(-c2c3n(c(=O)n(CCCCN4CCCC(c5c[nH]c6ccc(OC)cc56)C4)c2=O)CCCC3)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,4.5,nM,CHEMBL4368000,B,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,CHEMBL4364313,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL4368000,B,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,CHEMBL4364313,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL71,CHEMBL217,Dopamine D2 receptor,Ki,=,1.8,nM,CHEMBL4368000,B,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,CHEMBL4364313,KI,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL4463034,CHEMBL217,Dopamine D2 receptor,Ki,=,58.0,nM,CHEMBL4368218,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHO cell membranes,CHEMBL4364325,KI,COc1ccc2[nH]cc(C3=CCN(Cc4cc(=O)[nH]c5ccccc45)CC3)c2c1
CHEMBL4521477,CHEMBL217,Dopamine D2 receptor,Ki,=,257.0,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccco2)C1
CHEMBL4543263,CHEMBL217,Dopamine D2 receptor,Ki,=,142.0,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,COc1ccc2[nH]cc(C3=CCN(Cc4ccco4)CC3)c2c1
CHEMBL4554558,CHEMBL217,Dopamine D2 receptor,Ki,=,71.9,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,C1=C(c2c[nH]c3ccccc23)CCN(Cc2cccs2)C1
CHEMBL4444351,CHEMBL217,Dopamine D2 receptor,Ki,=,141.0,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,COc1ccc2[nH]cc(C3=CCN(Cc4cccs4)CC3)c2c1
CHEMBL4527257,CHEMBL217,Dopamine D2 receptor,Ki,=,166.0,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,CCOc1ccc2[nH]cc(C3=CCN(Cc4cccs4)CC3)c2c1
CHEMBL4558444,CHEMBL217,Dopamine D2 receptor,Ki,=,465.0,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,CC(C)Oc1ccc2[nH]cc(C3=CCN(Cc4cccs4)CC3)c2c1
CHEMBL285157,CHEMBL217,Dopamine D2 receptor,Ki,=,25.8,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccccc2)C1
CHEMBL366081,CHEMBL217,Dopamine D2 receptor,Ki,=,62.7,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,COc1ccc2[nH]cc(C3=CCN(Cc4ccccc4)CC3)c2c1
CHEMBL4454000,CHEMBL217,Dopamine D2 receptor,Ki,=,151.0,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,CCOc1ccc2[nH]cc(C3=CCN(Cc4ccccc4)CC3)c2c1
CHEMBL4457881,CHEMBL217,Dopamine D2 receptor,Ki,=,321.0,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,CC(C)Oc1ccc2[nH]cc(C3=CCN(Cc4ccccc4)CC3)c2c1
CHEMBL4565126,CHEMBL217,Dopamine D2 receptor,Ki,=,87.3,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,COc1ccc(CN2CC=C(c3c[nH]c4ccccc34)CC2)cc1
CHEMBL4449936,CHEMBL217,Dopamine D2 receptor,Ki,=,148.0,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,COc1ccc(CN2CC=C(c3c[nH]c4ccc(OC)cc34)CC2)cc1
CHEMBL4466356,CHEMBL217,Dopamine D2 receptor,Ki,=,132.0,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,CCOc1ccc2[nH]cc(C3=CCN(Cc4ccc(OC)cc4)CC3)c2c1
CHEMBL4548632,CHEMBL217,Dopamine D2 receptor,Ki,=,165.0,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,COc1ccc(CN2CC=C(c3c[nH]c4ccc(OC(C)C)cc34)CC2)cc1
CHEMBL4552542,CHEMBL217,Dopamine D2 receptor,Ki,=,26.9,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,COc1cccc(CN2CC=C(c3c[nH]c4ccccc34)CC2)c1
CHEMBL4460564,CHEMBL217,Dopamine D2 receptor,Ki,=,112.0,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,COc1cccc(CN2CC=C(c3c[nH]c4ccc(OC)cc34)CC2)c1
CHEMBL4578143,CHEMBL217,Dopamine D2 receptor,Ki,=,108.0,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,CCOc1ccc2[nH]cc(C3=CCN(Cc4cccc(OC)c4)CC3)c2c1
CHEMBL4460839,CHEMBL217,Dopamine D2 receptor,Ki,=,299.0,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,COc1cccc(CN2CC=C(c3c[nH]c4ccc(OC(C)C)cc34)CC2)c1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,3.25,nM,CHEMBL4368222,B,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,CHEMBL4364325,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4467984,CHEMBL217,Dopamine D2 receptor,Ki,=,0.84,nM,CHEMBL4368754,B,Binding affinity to human D2R,CHEMBL4364348,KI,CCCN(CCc1ccc(NC(=O)CCC(=O)NCCCC[C@H](NC(C)=O)C(=O)NCCCC[C@H](NC(C)=O)C(=O)NCCCCCCNC(=O)c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2C)cc1)C1CCc2c(O)cccc2C1
CHEMBL4541515,CHEMBL217,Dopamine D2 receptor,Ki,=,2.2,nM,CHEMBL4368754,B,Binding affinity to human D2R,CHEMBL4364348,KI,CCCN(CCc1ccc(NC(=O)CCC(=O)NCCCCCC(=O)NCc2ccc(C(=O)NCCCCCC(=O)NCCCCCCNC(=O)c3nn(-c4ccc(Cl)cc4Cl)c(-c4ccc(Cl)cc4)c3C)cc2)cc1)C1CCc2c(O)cccc2C1
CHEMBL4465127,CHEMBL217,Dopamine D2 receptor,Ki,=,2.4,nM,CHEMBL4368754,B,Binding affinity to human D2R,CHEMBL4364348,KI,CCCN(CCc1ccc(NC(=O)CCC(=O)NCCOCCOCC(=O)NCCCC[C@H](NC(C)=O)C(=O)NCCCC[C@H](NC(C)=O)C(=O)NCCCCCCNC(=O)c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2C)cc1)C1CCc2c(O)cccc2C1
CHEMBL4546839,CHEMBL217,Dopamine D2 receptor,Ki,=,1.1,nM,CHEMBL4368754,B,Binding affinity to human D2R,CHEMBL4364348,KI,CCCN(CCc1ccc(NC(=O)CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCCC[C@H](NC(C)=O)C(=O)NCCCC[C@H](NC(C)=O)C(=O)NCCCCCCNC(=O)c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2C)cc1)C1CCc2c(O)cccc2C1
CHEMBL4579585,CHEMBL217,Dopamine D2 receptor,Ki,=,4.2,nM,CHEMBL4368754,B,Binding affinity to human D2R,CHEMBL4364348,KI,CCCN(CCc1ccc(NC(=O)CCC(=O)NCCCCCC(=O)NCc2ccc(C(=O)NCCCCCC(=O)NCCCCCC(=O)NCc3ccc(C(=O)NCCCCCC(=O)NCCCCCCNC(=O)c4nn(-c5ccc(Cl)cc5Cl)c(-c5ccc(Cl)cc5)c4C)cc3)cc2)cc1)C1CCc2c(O)cccc2C1
CHEMBL109684,CHEMBL217,Dopamine D2 receptor,Ki,=,13.3,nM,CHEMBL4368751,B,Displacement of [3H] spiperone from human D2 dopamine receptor expressed in monkey caudate-putamen membranes,CHEMBL4364348,KI,CCCN(CCc1ccccc1)C1CCc2c(O)cccc2C1
CHEMBL4474827,CHEMBL217,Dopamine D2 receptor,Ki,=,5561.0,nM,CHEMBL4369114,B,Displacement of [3H]-raclopride from recombinant human D2LR receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4368858,KI,Cn1cncc1-c1c[nH]c2ccc(C(N)=O)cc12
CHEMBL4216263,CHEMBL217,Dopamine D2 receptor,Ki,=,4847.0,nM,CHEMBL4369114,B,Displacement of [3H]-raclopride from recombinant human D2LR receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4368858,KI,CCn1cncc1-c1c[nH]c2ccc(I)cc12
CHEMBL522691,CHEMBL217,Dopamine D2 receptor,Ki,=,142.0,nM,CHEMBL4369149,B,Displacement of [3H]-raclopride from recombinant human D2 receptor expressed in cell membrane measured after 1.5 hrs by scintillation counting method,CHEMBL4368858,KI,N#Cc1ccc(CNC(=O)CCCCCN2CCN(c3ccccc3-c3ccccc3)CC2)cc1
CHEMBL4542754,CHEMBL217,Dopamine D2 receptor,Ki,=,114.0,nM,CHEMBL4390409,B,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4387768,KI,COc1cccc(N2CCN(CCCCCCN3C(=O)c4cccc5cccc3c45)CC2)c1
CHEMBL4443185,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL4390409,B,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4387768,KI,COc1ccc(N2CCN(CCCCCCN3C(=O)c4cccc5cccc3c45)CC2)cc1
CHEMBL4587772,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL4390409,B,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4387768,KI,CCOc1ccccc1N1CCN(CCCCCCN2C(=O)c3cccc4cccc2c34)CC1
CHEMBL4442385,CHEMBL217,Dopamine D2 receptor,Ki,=,867.0,nM,CHEMBL4390409,B,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4387768,KI,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccn2)CC1
CHEMBL4470304,CHEMBL217,Dopamine D2 receptor,Ki,=,188.0,nM,CHEMBL4390409,B,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4387768,KI,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ncccn2)CC1
CHEMBL4468036,CHEMBL217,Dopamine D2 receptor,Ki,=,431.0,nM,CHEMBL4390409,B,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4387768,KI,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2[N+](=O)[O-])CC1
CHEMBL4458938,CHEMBL217,Dopamine D2 receptor,Ki,=,82.0,nM,CHEMBL4390409,B,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4387768,KI,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2cccc3cccnc23)CC1
CHEMBL4555890,CHEMBL217,Dopamine D2 receptor,Ki,=,30.0,nM,CHEMBL4390409,B,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4387768,KI,CCOc1ccccc1N1CCN(CCCCCCN2c3cccc4cccc(c34)S2(=O)=O)CC1
CHEMBL4571077,CHEMBL217,Dopamine D2 receptor,Ki,=,118.0,nM,CHEMBL4390409,B,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4387768,KI,O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccn2)CC1
CHEMBL4449148,CHEMBL217,Dopamine D2 receptor,Ki,=,264.0,nM,CHEMBL4390409,B,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4387768,KI,O=[N+]([O-])c1ccccc1N1CCN(CCCCCCN2c3cccc4cccc(c34)S2(=O)=O)CC1
CHEMBL4584719,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL4390409,B,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4387768,KI,COc1ccccc1N1CCN(CCCCCCN2C(=O)c3cccc4cccc(c34)C2=O)CC1
CHEMBL4532741,CHEMBL217,Dopamine D2 receptor,Ki,=,271.0,nM,CHEMBL4390409,B,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4387768,KI,COc1cccc(N2CCN(CCCCCCN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c1
CHEMBL4447330,CHEMBL217,Dopamine D2 receptor,Ki,=,40040.0,nM,CHEMBL4390409,B,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4387768,KI,COc1ccc(N2CCN(CCCCCCN3C(=O)c4cccc5cccc(c45)C3=O)CC2)cc1
CHEMBL4476432,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL4390409,B,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4387768,KI,CCOc1ccccc1N1CCN(CCCCCCN2C(=O)c3cccc4cccc(c34)C2=O)CC1
CHEMBL4564093,CHEMBL217,Dopamine D2 receptor,Ki,=,1302.0,nM,CHEMBL4390409,B,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4387768,KI,O=C1c2cccc3cccc(c23)C(=O)N1CCCCCCN1CCN(c2ccccn2)CC1
CHEMBL4469539,CHEMBL217,Dopamine D2 receptor,Ki,=,141.0,nM,CHEMBL4390409,B,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4387768,KI,O=C1c2cccc3cccc(c23)C(=O)N1CCCCCCN1CCN(c2ccccc2[N+](=O)[O-])CC1
CHEMBL4538667,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL4390409,B,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4387768,KI,COc1ccccc1N1CCN(CCCCCCn2c(=O)n3c4c(cccc42)CCC3)CC1
CHEMBL4530770,CHEMBL217,Dopamine D2 receptor,Ki,=,90.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2F)CC1
CHEMBL4455845,CHEMBL217,Dopamine D2 receptor,Ki,=,142.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2Cl)CC1
CHEMBL4453687,CHEMBL217,Dopamine D2 receptor,Ki,=,121.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2cccc(Cl)c2)CC1
CHEMBL4436319,CHEMBL217,Dopamine D2 receptor,Ki,=,336.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL4449590,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL4528793,CHEMBL217,Dopamine D2 receptor,Ki,=,254.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccc(Cl)c(Cl)c2)CC1
CHEMBL4447659,CHEMBL217,Dopamine D2 receptor,Ki,=,304.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1
CHEMBL4464370,CHEMBL217,Dopamine D2 receptor,Ki,=,927.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccc(C(F)(F)F)cc2)CC1
CHEMBL4541606,CHEMBL217,Dopamine D2 receptor,Ki,=,320.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2F)CC1
CHEMBL4567345,CHEMBL217,Dopamine D2 receptor,Ki,=,58.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2Cl)CC1
CHEMBL4519312,CHEMBL217,Dopamine D2 receptor,Ki,=,75.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2cccc(Cl)c2)CC1
CHEMBL4548353,CHEMBL217,Dopamine D2 receptor,Ki,=,197.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL4546775,CHEMBL217,Dopamine D2 receptor,Ki,=,94.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL4592962,CHEMBL217,Dopamine D2 receptor,Ki,=,246.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccc(Cl)c(Cl)c2)CC1
CHEMBL4442062,CHEMBL217,Dopamine D2 receptor,Ki,=,204.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccc(Br)cc2)CC1
CHEMBL4585051,CHEMBL217,Dopamine D2 receptor,Ki,=,161.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2C(F)(F)F)CC1
CHEMBL4447594,CHEMBL217,Dopamine D2 receptor,Ki,=,496.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1
CHEMBL4545270,CHEMBL217,Dopamine D2 receptor,Ki,=,945.0,nM,CHEMBL4390419,B,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,CHEMBL4387769,KI,Cl.O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccc(C(F)(F)F)cc2)CC1
CHEMBL4559278,CHEMBL217,Dopamine D2 receptor,Ki,=,323.59,nM,CHEMBL4391918,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting,CHEMBL4390666,KI,COc1ccccc1OCCNCC1OCCOC1(c1ccccc1)c1ccccc1
CHEMBL4466677,CHEMBL217,Dopamine D2 receptor,Ki,=,112.2,nM,CHEMBL4391918,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting,CHEMBL4390666,KI,COc1ccccc1N1CCN(CC2COCC(c3ccccc3)(c3ccccc3)O2)CC1
CHEMBL4441888,CHEMBL217,Dopamine D2 receptor,Ki,=,2187.76,nM,CHEMBL4391918,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting,CHEMBL4390666,KI,COc1ccccc1N1CCN(C[C@H]2OCCOC2(c2ccccc2)c2ccccc2)CC1
CHEMBL4277264,CHEMBL217,Dopamine D2 receptor,Ki,=,8300.0,nM,CHEMBL4392130,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cells measured after 90 mins by microbeta scintillation counting method,CHEMBL4390674,KI,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12
CHEMBL4572614,CHEMBL217,Dopamine D2 receptor,Ki,=,9600.0,nM,CHEMBL4392130,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cells measured after 90 mins by microbeta scintillation counting method,CHEMBL4390674,KI,Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F
CHEMBL4469848,CHEMBL217,Dopamine D2 receptor,Ki,=,7600.0,nM,CHEMBL4392130,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cells measured after 90 mins by microbeta scintillation counting method,CHEMBL4390674,KI,FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12
CHEMBL4466483,CHEMBL217,Dopamine D2 receptor,Ki,=,8700.0,nM,CHEMBL4392130,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cells measured after 90 mins by microbeta scintillation counting method,CHEMBL4390674,KI,FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12
CHEMBL4555349,CHEMBL217,Dopamine D2 receptor,Ki,=,3020.0,nM,CHEMBL4394035,B,Displacement of [3H] raclopride from human recombinant D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting method,CHEMBL4393658,KI,CCn1cncc1-c1c[nH]c2c(F)cc(I)cc12
CHEMBL4216263,CHEMBL217,Dopamine D2 receptor,Ki,=,4898.0,nM,CHEMBL4394035,B,Displacement of [3H] raclopride from human recombinant D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting method,CHEMBL4393658,KI,CCn1cncc1-c1c[nH]c2ccc(I)cc12
CHEMBL4592256,CHEMBL217,Dopamine D2 receptor,Ki,=,8710.0,nM,CHEMBL4394035,B,Displacement of [3H] raclopride from human recombinant D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting method,CHEMBL4393658,KI,CCn1cncc1-c1c[nH]c2ccc(C(F)(F)F)cc12
CHEMBL4476372,CHEMBL217,Dopamine D2 receptor,Ki,=,9333.0,nM,CHEMBL4394035,B,Displacement of [3H] raclopride from human recombinant D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting method,CHEMBL4393658,KI,CCn1cncc1-c1c[nH]c2ccc(Cl)c(F)c12
CHEMBL4526012,CHEMBL217,Dopamine D2 receptor,Ki,=,1862.0,nM,CHEMBL4394035,B,Displacement of [3H] raclopride from human recombinant D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting method,CHEMBL4393658,KI,Cn1cncc1-c1c[nH]c2ccc(Br)cc12
CHEMBL4452569,CHEMBL217,Dopamine D2 receptor,Ki,=,7080.0,nM,CHEMBL4394035,B,Displacement of [3H] raclopride from human recombinant D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting method,CHEMBL4393658,KI,CCn1cncc1-c1c[nH]c2ccc(I)c(F)c12
CHEMBL708,CHEMBL217,Dopamine D2 receptor,Ki,=,0.9,nM,CHEMBL4394035,B,Displacement of [3H] raclopride from human recombinant D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting method,CHEMBL4393658,KI,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL71,CHEMBL217,Dopamine D2 receptor,Ki,=,1.8,nM,CHEMBL4401065,B,Displacement of [3H]-raclopride from recombinant human D2 receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting analysis,CHEMBL4400523,KI,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL4401065,B,Displacement of [3H]-raclopride from recombinant human D2 receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting analysis,CHEMBL4400523,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,4.5,nM,CHEMBL4401065,B,Displacement of [3H]-raclopride from recombinant human D2 receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting analysis,CHEMBL4400523,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4570209,CHEMBL217,Dopamine D2 receptor,Ki,=,11160.0,nM,CHEMBL4401065,B,Displacement of [3H]-raclopride from recombinant human D2 receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting analysis,CHEMBL4400523,KI,COc1ccc(-c2c(=O)n(CCCCN3CCCC(c4c[nH]c5ccc(OC)cc45)C3)c(=O)n3ccccc23)cc1
CHEMBL4469813,CHEMBL217,Dopamine D2 receptor,Ki,=,1129.0,nM,CHEMBL4401065,B,Displacement of [3H]-raclopride from recombinant human D2 receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting analysis,CHEMBL4400523,KI,COc1ccc(-c2c(=O)n(CCCCN3CCCC(c4c[nH]c5ccccc45)C3)c(=O)n3ccccc23)cc1
CHEMBL4462139,CHEMBL217,Dopamine D2 receptor,Ki,=,963.0,nM,CHEMBL4401065,B,Displacement of [3H]-raclopride from recombinant human D2 receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting analysis,CHEMBL4400523,KI,O=c1c(-c2ccc(F)cc2)c2ccccn2c(=O)n1CCCCN1CCCC(c2c[nH]c3ccccc23)C1
CHEMBL4451231,CHEMBL217,Dopamine D2 receptor,Ki,=,17670.0,nM,CHEMBL4401065,B,Displacement of [3H]-raclopride from recombinant human D2 receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting analysis,CHEMBL4400523,KI,O=c1c(-c2ccccc2)c2ccccn2c(=O)n1CCCCN1CCCC(c2c[nH]c3ccccc23)C1
CHEMBL4442936,CHEMBL217,Dopamine D2 receptor,Ki,=,1161.4,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(F)ccc1OC.Cl
CHEMBL4590966,CHEMBL217,Dopamine D2 receptor,Ki,=,275.4,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(F)ccc1OC.Cl
CHEMBL4514800,CHEMBL217,Dopamine D2 receptor,Ki,=,323.6,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,COc1ccc(F)cc1C1CC1CN(C)CCCSc1nnc(-c2ccccc2)n1C.Cl
CHEMBL4514586,CHEMBL217,Dopamine D2 receptor,Ki,=,253.1,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,COc1ccc(F)cc1C1CC1CNCCCSc1nnc(-c2ccccc2)n1C.Cl
CHEMBL4450429,CHEMBL217,Dopamine D2 receptor,Ki,=,380.2,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCOc1ccc(F)cc1C1CC1CN(CC)CCCSc1nnc(-c2ccccc2)n1C.Cl
CHEMBL4590356,CHEMBL217,Dopamine D2 receptor,Ki,=,660.7,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCOc1ccc(F)cc1C1CC1CNCCCSc1nnc(-c2ccccc2)n1C.Cl
CHEMBL4448853,CHEMBL217,Dopamine D2 receptor,Ki,=,844.6,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(F)ccc1OCCF.Cl
CHEMBL4585289,CHEMBL217,Dopamine D2 receptor,Ki,=,2435.9,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(F)ccc1OCCF.Cl
CHEMBL4546749,CHEMBL217,Dopamine D2 receptor,Ki,=,1502.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,Cl.Cn1c(SCCCNCC2CC2c2cc(F)ccc2OCCF)nnc1-c1ccccc1
CHEMBL4453405,CHEMBL217,Dopamine D2 receptor,Ki,=,512.9,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,COc1ccc(F)cc1C1CC1CN(CCCSc1nnc(-c2ccccc2)n1C)C(C)C.Cl
CHEMBL4578364,CHEMBL217,Dopamine D2 receptor,Ki,=,238.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(Cl)ccc1OC.Cl
CHEMBL4584372,CHEMBL217,Dopamine D2 receptor,Ki,=,233.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(Cl)ccc1OC.Cl
CHEMBL4475699,CHEMBL217,Dopamine D2 receptor,Ki,=,216.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,COc1ccc(Cl)cc1C1CC1CN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1.Cl
CHEMBL540612,CHEMBL217,Dopamine D2 receptor,Ki,=,247.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1.Cl
CHEMBL4452683,CHEMBL217,Dopamine D2 receptor,Ki,=,407.4,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cc(F)ccc1OC.Cl
CHEMBL4454872,CHEMBL217,Dopamine D2 receptor,Ki,=,1083.9,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cc(F)ccc1OC.Cl
CHEMBL4561808,CHEMBL217,Dopamine D2 receptor,Ki,=,380.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cc(F)ccc1OC.Cl
CHEMBL4531363,CHEMBL217,Dopamine D2 receptor,Ki,=,507.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cc(F)ccc1OC.Cl
CHEMBL4442408,CHEMBL217,Dopamine D2 receptor,Ki,=,3144.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)CC1CC1c1cc(F)ccc1OC.Cl
CHEMBL4541924,CHEMBL217,Dopamine D2 receptor,Ki,=,408.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cc(Cl)ccc1OC.Cl
CHEMBL4456964,CHEMBL217,Dopamine D2 receptor,Ki,=,1116.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cc(Cl)ccc1OC.Cl
CHEMBL4577162,CHEMBL217,Dopamine D2 receptor,Ki,=,1421.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cc(Cl)ccc1OC.Cl
CHEMBL4455719,CHEMBL217,Dopamine D2 receptor,Ki,=,2105.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)CC1CC1c1cc(Cl)ccc1OC.Cl
CHEMBL4439535,CHEMBL217,Dopamine D2 receptor,Ki,=,4823.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cccc(F)c1.Cl
CHEMBL4590839,CHEMBL217,Dopamine D2 receptor,Ki,=,3494.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cccc(F)c1.Cl
CHEMBL4525624,CHEMBL217,Dopamine D2 receptor,Ki,=,4012.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cccc(Cl)c1.Cl
CHEMBL4453478,CHEMBL217,Dopamine D2 receptor,Ki,=,3494.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cccc(Cl)c1.Cl
CHEMBL4550187,CHEMBL217,Dopamine D2 receptor,Ki,=,5623.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1ccc(F)cc1.Cl
CHEMBL4569006,CHEMBL217,Dopamine D2 receptor,Ki,=,5934.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1ccc(F)cc1.Cl
CHEMBL4469584,CHEMBL217,Dopamine D2 receptor,Ki,=,4606.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1ccc(Cl)cc1.Cl
CHEMBL4472900,CHEMBL217,Dopamine D2 receptor,Ki,=,3162.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1ccc(Cl)cc1.Cl
CHEMBL4590211,CHEMBL217,Dopamine D2 receptor,Ki,=,2105.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cccc(Cl)c1Cl.Cl
CHEMBL4456007,CHEMBL217,Dopamine D2 receptor,Ki,=,1502.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cccc(Cl)c1Cl.Cl
CHEMBL4527244,CHEMBL217,Dopamine D2 receptor,Ki,=,2362.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)CC1CC1c1cccc(Cl)c1Cl.Cl
CHEMBL4475406,CHEMBL217,Dopamine D2 receptor,Ki,=,1349.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)C[C@@H]1C[C@H]1c1cc(F)ccc1OC.Cl
CHEMBL4593394,CHEMBL217,Dopamine D2 receptor,Ki,=,1230.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)C[C@H]1C[C@@H]1c1cc(F)ccc1OC.Cl
CHEMBL4454380,CHEMBL217,Dopamine D2 receptor,Ki,=,676.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)C[C@@H]1C[C@H]1c1cccc(Cl)c1Cl.Cl
CHEMBL4580817,CHEMBL217,Dopamine D2 receptor,Ki,=,1148.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)C[C@H]1C[C@@H]1c1cccc(Cl)c1Cl.Cl
CHEMBL4439544,CHEMBL217,Dopamine D2 receptor,Ki,=,537.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)C[C@@H]1C[C@H]1c1cccc(Cl)c1Cl.Cl
CHEMBL4586582,CHEMBL217,Dopamine D2 receptor,Ki,=,992.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)C[C@H]1C[C@@H]1c1cccc(Cl)c1Cl.Cl
CHEMBL4443039,CHEMBL217,Dopamine D2 receptor,Ki,=,550.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)C[C@@H]1C[C@H]1c1cccc(Cl)c1Cl.Cl
CHEMBL4522558,CHEMBL217,Dopamine D2 receptor,Ki,=,1023.0,nM,CHEMBL4406061,B,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)C[C@H]1C[C@@H]1c1cccc(Cl)c1Cl.Cl
CHEMBL4473519,CHEMBL217,Dopamine D2 receptor,Ki,=,186.0,nM,CHEMBL4409079,B,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,CHEMBL4406846,KI,NC(=O)c1ccn(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)c1
CHEMBL4471658,CHEMBL217,Dopamine D2 receptor,Ki,=,138.0,nM,CHEMBL4409079,B,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,CHEMBL4406846,KI,Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)o1
CHEMBL4565200,CHEMBL217,Dopamine D2 receptor,Ki,=,214.0,nM,CHEMBL4409079,B,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,CHEMBL4406846,KI,Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)s1
CHEMBL4517296,CHEMBL217,Dopamine D2 receptor,Ki,=,56.0,nM,CHEMBL4409079,B,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,CHEMBL4406846,KI,Cn1c(C(N)=O)ccc1-c1cccc(OC(=O)NCCN2CCN(c3ccccc3)CC2)c1
CHEMBL4554053,CHEMBL217,Dopamine D2 receptor,Ki,=,66.0,nM,CHEMBL4409079,B,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,CHEMBL4406846,KI,NC(=O)c1ccn(-c2cccc(OC(=O)NCCCN3CCN(c4ccccc4)CC3)c2)c1
CHEMBL4540218,CHEMBL217,Dopamine D2 receptor,Ki,=,29.0,nM,CHEMBL4409079,B,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,CHEMBL4406846,KI,Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCCN3CCN(c4ccccc4)CC3)c2)o1
CHEMBL4473519,CHEMBL217,Dopamine D2 receptor,Ki,=,186.21,nM,CHEMBL4409079,B,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,CHEMBL4406846,KI,NC(=O)c1ccn(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)c1
CHEMBL4471658,CHEMBL217,Dopamine D2 receptor,Ki,=,138.04,nM,CHEMBL4409079,B,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,CHEMBL4406846,KI,Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)o1
CHEMBL4565200,CHEMBL217,Dopamine D2 receptor,Ki,=,213.8,nM,CHEMBL4409079,B,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,CHEMBL4406846,KI,Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)s1
CHEMBL4517296,CHEMBL217,Dopamine D2 receptor,Ki,=,56.23,nM,CHEMBL4409079,B,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,CHEMBL4406846,KI,Cn1c(C(N)=O)ccc1-c1cccc(OC(=O)NCCN2CCN(c3ccccc3)CC2)c1
CHEMBL4554053,CHEMBL217,Dopamine D2 receptor,Ki,=,66.07,nM,CHEMBL4409079,B,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,CHEMBL4406846,KI,NC(=O)c1ccn(-c2cccc(OC(=O)NCCCN3CCN(c4ccccc4)CC3)c2)c1
CHEMBL4540218,CHEMBL217,Dopamine D2 receptor,Ki,=,29.51,nM,CHEMBL4409079,B,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,CHEMBL4406846,KI,Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCCN3CCN(c4ccccc4)CC3)c2)o1
CHEMBL4534566,CHEMBL217,Dopamine D2 receptor,Ki,=,20800.0,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cc(Cl)c(OC)c(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1
CHEMBL4436317,CHEMBL217,Dopamine D2 receptor,Ki,=,21400.0,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cc(Cl)c(OC)c(N2CCN(C[C@H](F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1
CHEMBL4527078,CHEMBL217,Dopamine D2 receptor,Ki,=,18900.0,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cc(Cl)c(OC)c(N2CCN(C[C@@H](F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1
CHEMBL4515234,CHEMBL217,Dopamine D2 receptor,Ki,=,247.0,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl
CHEMBL4584497,CHEMBL217,Dopamine D2 receptor,Ki,=,80.2,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cccc(N2CCN(C[C@H](F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl
CHEMBL4446609,CHEMBL217,Dopamine D2 receptor,Ki,=,891.0,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cccc(N2CCN(C[C@@H](F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl
CHEMBL4546210,CHEMBL217,Dopamine D2 receptor,Ki,=,10800.0,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cc(Cl)c(OC)c(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1
CHEMBL4553059,CHEMBL217,Dopamine D2 receptor,Ki,=,328.0,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl
CHEMBL4464971,CHEMBL217,Dopamine D2 receptor,Ki,=,364.0,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cc(Cl)c(OC)c(N2CCN(CC(O)CCNC(=O)c3ccc4c(c3)OCO4)CC2)c1
CHEMBL4518618,CHEMBL217,Dopamine D2 receptor,Ki,=,424.0,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cccc(N2CCN(CC(O)CCNC(=O)c3ccc4c(c3)OCO4)CC2)c1Cl
CHEMBL4463620,CHEMBL217,Dopamine D2 receptor,Ki,=,537.0,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cc2c(cc1N1CCN(CC(O)CCNC(=O)c3cc4ccccc4[nH]3)CC1)OCO2
CHEMBL4465596,CHEMBL217,Dopamine D2 receptor,Ki,=,1440.0,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cc2c(cc1N1CCN(CC(O)CCNC(=O)c3cc4ccccc4o3)CC1)OCO2
CHEMBL4476394,CHEMBL217,Dopamine D2 receptor,Ki,=,13200.0,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cc(Cl)c(OC)c(N2CCN(CC(O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1
CHEMBL4555827,CHEMBL217,Dopamine D2 receptor,Ki,=,10800.0,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cc(Cl)c(OC)c(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1
CHEMBL4570554,CHEMBL217,Dopamine D2 receptor,Ki,=,13500.0,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cc(Cl)c(OC)c(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1
CHEMBL4451683,CHEMBL217,Dopamine D2 receptor,Ki,=,132.0,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cccc(N2CCN(CC(O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl
CHEMBL4519938,CHEMBL217,Dopamine D2 receptor,Ki,=,75.8,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl
CHEMBL4483569,CHEMBL217,Dopamine D2 receptor,Ki,=,219.0,nM,CHEMBL4415924,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL4414587,KI,CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.4677,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4455788,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2cccc(Cl)c2)CC1)c1ccc(F)cc1
CHEMBL4540679,CHEMBL217,Dopamine D2 receptor,Ki,=,2.138,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccccc2Cl)CC1)c1ccc(F)cc1
CHEMBL4570273,CHEMBL217,Dopamine D2 receptor,Ki,=,0.1202,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2cccc(Cl)c2Cl)CC1)c1ccc(F)cc1
CHEMBL4444768,CHEMBL217,Dopamine D2 receptor,Ki,=,2.63,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2Cl)CC1)c1ccc(F)cc1
CHEMBL4529368,CHEMBL217,Dopamine D2 receptor,Ki,=,1.023,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2cc(Cl)ccc2Cl)CC1)c1ccc(F)cc1
CHEMBL4453290,CHEMBL217,Dopamine D2 receptor,Ki,=,1.479,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2c(Cl)cccc2Cl)CC1)c1ccc(F)cc1
CHEMBL4544491,CHEMBL217,Dopamine D2 receptor,Ki,=,0.1549,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)c(Cl)c2)CC1)c1ccc(F)cc1
CHEMBL4436241,CHEMBL217,Dopamine D2 receptor,Ki,=,0.4467,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2cc(Cl)cc(Cl)c2)CC1)c1ccc(F)cc1
CHEMBL54206,CHEMBL217,Dopamine D2 receptor,Ki,=,7.586,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccccc2)CC1)c1ccc(F)cc1
CHEMBL2104700,CHEMBL217,Dopamine D2 receptor,Ki,=,0.7244,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,Cc1ccc(C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2)cc1
CHEMBL4436610,CHEMBL217,Dopamine D2 receptor,Ki,=,0.3236,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccc(C(F)(F)F)cc2)CC1)c1ccc(F)cc1
CHEMBL4568709,CHEMBL217,Dopamine D2 receptor,Ki,=,5.248,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,CN(C)c1ccc(C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2)cc1
CHEMBL4461948,CHEMBL217,Dopamine D2 receptor,Ki,=,3.311,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccc(F)cc2)CC1)c1ccc(F)cc1
CHEMBL4472206,CHEMBL217,Dopamine D2 receptor,Ki,=,2.455,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccccc2-c2ccccc2Cl)CC1)c1ccc(F)cc1
CHEMBL4514517,CHEMBL217,Dopamine D2 receptor,Ki,=,7.943,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccccc1F
CHEMBL611991,CHEMBL217,Dopamine D2 receptor,Ki,=,38.02,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1cccc(F)c1
CHEMBL4590085,CHEMBL217,Dopamine D2 receptor,Ki,=,46.77,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1cccc(F)c1F
CHEMBL4468416,CHEMBL217,Dopamine D2 receptor,Ki,=,83.18,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1F
CHEMBL4482896,CHEMBL217,Dopamine D2 receptor,Ki,=,112.2,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1cc(F)ccc1F
CHEMBL4576998,CHEMBL217,Dopamine D2 receptor,Ki,=,63.1,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1c(F)cccc1F
CHEMBL4463187,CHEMBL217,Dopamine D2 receptor,Ki,=,7.762,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)c(F)c1
CHEMBL4465318,CHEMBL217,Dopamine D2 receptor,Ki,=,169.82,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1cc(F)cc(F)c1
CHEMBL4472585,CHEMBL217,Dopamine D2 receptor,Ki,=,3.548,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccccc1Cl
CHEMBL4475608,CHEMBL217,Dopamine D2 receptor,Ki,=,3.548,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,Cc1ccccc1C(=O)CCCN1CCC(O)(c2ccc(Cl)cc2)CC1
CHEMBL363548,CHEMBL217,Dopamine D2 receptor,Ki,=,5.012,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(Cl)cc1
CHEMBL199226,CHEMBL217,Dopamine D2 receptor,Ki,=,1.778,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccccc1
CHEMBL1940403,CHEMBL217,Dopamine D2 receptor,Ki,=,2.089,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,OC1(c2ccc(Cl)cc2)CCN(CCCSc2ccc(F)cc2)CC1
CHEMBL1940404,CHEMBL217,Dopamine D2 receptor,Ki,=,1.072,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,OC1(c2ccc(Cl)cc2)CCN(CCCOc2ccc(F)cc2)CC1
CHEMBL1036,CHEMBL217,Dopamine D2 receptor,Ki,=,91.2,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,OC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4474020,CHEMBL217,Dopamine D2 receptor,Ki,=,11.22,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,OC1(c2ccc(Cl)cc2)CCN(CC/C=C/c2ccc(F)cc2)CC1
CHEMBL4440708,CHEMBL217,Dopamine D2 receptor,Ki,=,29.51,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,OC1(c2ccc(Cl)cc2)CCN(CC/C=C\c2ccc(F)cc2)CC1
CHEMBL4472382,CHEMBL217,Dopamine D2 receptor,Ki,=,1.514,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,OC1(c2ccc(Cl)cc2)CCN(CC[C@H]2C[C@@H]2c2ccc(F)cc2)CC1
CHEMBL4537230,CHEMBL217,Dopamine D2 receptor,Ki,=,29.51,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,OC1(c2ccc(Cl)cc2)CCN(CC[C@H]2C[C@H]2c2ccc(F)cc2)CC1
CHEMBL94371,CHEMBL217,Dopamine D2 receptor,Ki,=,131.83,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4450047,CHEMBL217,Dopamine D2 receptor,Ki,=,12.02,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4579971,CHEMBL217,Dopamine D2 receptor,Ki,=,61.66,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,OC1(c2ccc(Cl)cc2)CCN(CCCc2ccc(F)cc2)CC1
CHEMBL1940402,CHEMBL217,Dopamine D2 receptor,Ki,=,5.37,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,OC1(c2ccc(Cl)cc2)CCN(CCCCc2ccc(F)cc2)CC1
CHEMBL4519420,CHEMBL217,Dopamine D2 receptor,Ki,=,21.88,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,OC1(c2ccc(Cl)cc2)CCN(CCCCCc2ccc(F)cc2)CC1
CHEMBL4584060,CHEMBL217,Dopamine D2 receptor,Ki,=,281.84,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,OC1(c2ccc(Cl)cc2)CCN(CC#Cc2ccc(F)cc2)CC1
CHEMBL4475451,CHEMBL217,Dopamine D2 receptor,Ki,=,74.13,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,OC1(c2ccc(Cl)cc2)CCN(CCC#Cc2ccc(F)cc2)CC1
CHEMBL4470321,CHEMBL217,Dopamine D2 receptor,Ki,=,19.05,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,OC1(c2ccc(Cl)cc2)CCN(CCCC#Cc2ccc(F)cc2)CC1
CHEMBL4451384,CHEMBL217,Dopamine D2 receptor,Ki,=,0.05248,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1[C@@H]2CC[C@H]1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1
CHEMBL476935,CHEMBL217,Dopamine D2 receptor,Ki,=,29.51,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL3544895,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CC=C(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4528835,CHEMBL217,Dopamine D2 receptor,Ki,=,0.1585,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC2(c3ccc(Cl)cc3)CC2C1)c1ccc(F)cc1
CHEMBL56843,CHEMBL217,Dopamine D2 receptor,Ki,=,7.762,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccc(F)cc1
CHEMBL147830,CHEMBL217,Dopamine D2 receptor,Ki,=,1.738,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL422334,CHEMBL217,Dopamine D2 receptor,Ki,=,1.905,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,COC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL4556173,CHEMBL217,Dopamine D2 receptor,Ki,=,17.78,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccc(F)cc2)CC1)c1ccc(Cl)cc1
CHEMBL4446597,CHEMBL217,Dopamine D2 receptor,Ki,=,32.36,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KI,O=C(CCCN1CCC(O)(c2ccccc2)CC1)c1ccccc1
CHEMBL4469309,CHEMBL217,Dopamine D2 receptor,Ki,=,3319.0,nM,CHEMBL4426355,B,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells by microbeta liquid scintillation counting,CHEMBL4425120,KI,COc1ccc2c(c1)c(C1=CCNCC1)cn2S(=O)(=O)c1cncc2ccccc12
CHEMBL4447846,CHEMBL217,Dopamine D2 receptor,Ki,=,240.0,nM,CHEMBL4426355,B,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells by microbeta liquid scintillation counting,CHEMBL4425120,KI,COc1ccc2c(c1)c(C1=CCNCC1)cn2S(=O)(=O)c1ccc2cccnc2c1
CHEMBL4440130,CHEMBL217,Dopamine D2 receptor,Ki,=,302.0,nM,CHEMBL4426355,B,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells by microbeta liquid scintillation counting,CHEMBL4425120,KI,COc1ccc2c(c1)c(C1=CCNCC1)cn2S(=O)(=O)c1cccc2ncccc12
CHEMBL4572158,CHEMBL217,Dopamine D2 receptor,Ki,=,1168.0,nM,CHEMBL4426355,B,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells by microbeta liquid scintillation counting,CHEMBL4425120,KI,O=S(=O)(c1ccc2cccnc2c1)n1cc(C2=CCNCC2)c2cc(Cl)ccc21
CHEMBL4442456,CHEMBL217,Dopamine D2 receptor,Ki,=,1410.0,nM,CHEMBL4426355,B,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells by microbeta liquid scintillation counting,CHEMBL4425120,KI,O=S(=O)(c1ccc2ncccc2c1)n1cc(C2=CCNCC2)c2ccccc21
CHEMBL4586327,CHEMBL217,Dopamine D2 receptor,Ki,=,619.0,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cc(Cl)c(OC)c(N2CCNCC2)c1
CHEMBL4441358,CHEMBL217,Dopamine D2 receptor,Ki,=,139.0,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cccc(N2CCNCC2)c1Cl
CHEMBL4543685,CHEMBL217,Dopamine D2 receptor,Ki,=,233.0,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cc(Cl)c(OC)c(N2CCN(C)CC2)c1
CHEMBL4469777,CHEMBL217,Dopamine D2 receptor,Ki,=,58.1,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cccc(N2CCN(C)CC2)c1Cl
CHEMBL4440301,CHEMBL217,Dopamine D2 receptor,Ki,=,29.8,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCCCN1CCN(c2cc(CC)cc(Cl)c2OC)CC1
CHEMBL4471669,CHEMBL217,Dopamine D2 receptor,Ki,=,2.93,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCCCN1CCN(c2cccc(CC)c2Cl)CC1
CHEMBL4521947,CHEMBL217,Dopamine D2 receptor,Ki,=,27.8,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cc(Cl)c(OC)c(N2CCN(CCCCNC(=O)c3cc4ccccc4[nH]3)CC2)c1
CHEMBL4476394,CHEMBL217,Dopamine D2 receptor,Ki,=,11400.0,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cc(Cl)c(OC)c(N2CCN(CC(O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1
CHEMBL4459533,CHEMBL217,Dopamine D2 receptor,Ki,=,137.0,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cc(Cl)c(OC)c(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1
CHEMBL4436025,CHEMBL217,Dopamine D2 receptor,Ki,=,1620.0,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cc(Cl)c(OC)c(N2CCN(CC(O)CCNC(=O)c3cc4ccccc4o3)CC2)c1
CHEMBL4544583,CHEMBL217,Dopamine D2 receptor,Ki,=,5.5,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl
CHEMBL4451683,CHEMBL217,Dopamine D2 receptor,Ki,=,151.0,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cccc(N2CCN(CC(O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl
CHEMBL4476699,CHEMBL217,Dopamine D2 receptor,Ki,=,6.34,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1Cl
CHEMBL4517102,CHEMBL217,Dopamine D2 receptor,Ki,=,164.0,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cccc(N2CCN(CC(O)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl
CHEMBL4555307,CHEMBL217,Dopamine D2 receptor,Ki,=,5.64,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cccc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)c1Cl
CHEMBL4517898,CHEMBL217,Dopamine D2 receptor,Ki,=,193.0,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cccc(N2CCN(CC(O)CCNC(=O)c3cn4ccccc4n3)CC2)c1Cl
CHEMBL4577414,CHEMBL217,Dopamine D2 receptor,Ki,=,4.65,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cccc(N2CCN(CCCCNC(=O)c3nc4sccn4c3C)CC2)c1Cl
CHEMBL4543524,CHEMBL217,Dopamine D2 receptor,Ki,=,12.5,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1c[nH]c(C(=O)NCCCCN2CCN(c3cccc(CC)c3Cl)CC2)n1
CHEMBL4461461,CHEMBL217,Dopamine D2 receptor,Ki,=,12.2,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cccc(N2CCN(CCCCNC(=O)c3nc(C)c[nH]3)CC2)c1Cl
CHEMBL4516799,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cccc(N2CCN(CC(O)CCNC(=O)c3nc(C)c[nH]3)CC2)c1Cl
CHEMBL4564507,CHEMBL217,Dopamine D2 receptor,Ki,=,16.1,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cccc(N2CCN(C/C=C/CNC(=O)c3nc(C)c[nH]3)CC2)c1Cl
CHEMBL4552939,CHEMBL217,Dopamine D2 receptor,Ki,=,6.83,nM,CHEMBL4429153,B,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,CHEMBL4428060,KI,CCc1cccc(N2CCN(CCC(O)CNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl
CHEMBL8809,CHEMBL217,Dopamine D2 receptor,Ki,=,12.7,nM,CHEMBL4429179,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4428060,KI,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC
CHEMBL4586276,CHEMBL217,Dopamine D2 receptor,Ki,=,458.0,nM,CHEMBL4479923,B,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,CHEMBL4477255,KI,CN1CCN(c2ccc3c(c2)N(S(=O)(=O)c2ccccc2)CC3)CC1
CHEMBL4551220,CHEMBL217,Dopamine D2 receptor,Ki,=,136.0,nM,CHEMBL4479923,B,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,CHEMBL4477255,KI,CCN1CCN(c2ccc3c(c2)N(S(=O)(=O)c2ccccc2)CC3)CC1
CHEMBL4591250,CHEMBL217,Dopamine D2 receptor,Ki,=,95.0,nM,CHEMBL4479923,B,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,CHEMBL4477255,KI,CCCN1CCN(c2ccc3c(c2)N(S(=O)(=O)c2ccccc2)CC3)CC1
CHEMBL4483496,CHEMBL217,Dopamine D2 receptor,Ki,=,411.0,nM,CHEMBL4479923,B,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,CHEMBL4477255,KI,O=S(=O)(c1ccccc1)N1CCc2ccc(N3CCN(C4CCC4)CC3)cc21
CHEMBL4550561,CHEMBL217,Dopamine D2 receptor,Ki,=,1826.0,nM,CHEMBL4479923,B,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,CHEMBL4477255,KI,O=S(=O)(c1ccccc1)N1Cc2cccc(C3CCN(C4CCC4)CC3)c2C1
CHEMBL4549734,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL4479923,B,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,CHEMBL4477255,KI,CCN1CCN(c2cccc3c2CN(S(=O)(=O)c2ccccc2)C3)CC1
CHEMBL4537294,CHEMBL217,Dopamine D2 receptor,Ki,=,180.0,nM,CHEMBL4479923,B,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,CHEMBL4477255,KI,CCCN1CCN(c2cccc3c2CN(S(=O)(=O)c2ccccc2)C3)CC1
CHEMBL4520580,CHEMBL217,Dopamine D2 receptor,Ki,=,1592.0,nM,CHEMBL4479923,B,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,CHEMBL4477255,KI,O=S(=O)(c1ccccc1)N1Cc2cccc(N3CCN(C4CCC4)CC3)c2C1
CHEMBL4566363,CHEMBL217,Dopamine D2 receptor,Ki,=,1042.0,nM,CHEMBL4479923,B,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,CHEMBL4477255,KI,O=S(=O)(c1ccccc1)N1CCc2c(C3CCN(C4CCC4)CC3)cccc21
CHEMBL4534733,CHEMBL217,Dopamine D2 receptor,Ki,=,211.0,nM,CHEMBL4479923,B,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,CHEMBL4477255,KI,CN1CCN(c2cccc3c2CCN3S(=O)(=O)c2ccccc2)CC1
CHEMBL4566992,CHEMBL217,Dopamine D2 receptor,Ki,=,84.0,nM,CHEMBL4479923,B,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,CHEMBL4477255,KI,CCN1CCN(c2cccc3c2CCN3S(=O)(=O)c2ccccc2)CC1
CHEMBL4579883,CHEMBL217,Dopamine D2 receptor,Ki,=,42.0,nM,CHEMBL4479923,B,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,CHEMBL4477255,KI,CCCN1CCN(c2cccc3c2CCN3S(=O)(=O)c2ccccc2)CC1
CHEMBL4525992,CHEMBL217,Dopamine D2 receptor,Ki,=,355.0,nM,CHEMBL4479923,B,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,CHEMBL4477255,KI,O=S(=O)(c1ccccc1)N1CCc2c(N3CCN(C4CCC4)CC3)cccc21
CHEMBL4562787,CHEMBL217,Dopamine D2 receptor,Ki,=,438.0,nM,CHEMBL4479923,B,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,CHEMBL4477255,KI,CCN1CCN(c2ccc3c(c2)CCN3S(=O)(=O)c2ccccc2)CC1
CHEMBL4519916,CHEMBL217,Dopamine D2 receptor,Ki,=,245.0,nM,CHEMBL4479923,B,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,CHEMBL4477255,KI,CCCN1CCN(c2ccc3c(c2)CCN3S(=O)(=O)c2ccccc2)CC1
CHEMBL4536834,CHEMBL217,Dopamine D2 receptor,Ki,=,324.0,nM,CHEMBL4479923,B,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,CHEMBL4477255,KI,CCCN1CCC(c2ccc3c(c2)N(S(=O)(=O)c2ccccc2)CC3)CC1
CHEMBL4645139,CHEMBL217,Dopamine D2 receptor,Ki,=,1507.8,nM,CHEMBL4625240,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4622940,KI,C=CCN1CCc2cc(OC)c(O)cc2C(c2c(Cl)cccc2Cl)C1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,5.58,nM,CHEMBL4625240,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4622940,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4641502,CHEMBL217,Dopamine D2 receptor,Ki,=,1740.0,nM,CHEMBL4625526,B,Displacement of [3H]-N-Methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells incubated for 90 mins by microbeta counting method,CHEMBL4622954,KI,CN1CCc2cccc3c2C1Cc1ccc2nc(N)sc2c1-3
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,5.58,nM,CHEMBL4625526,B,Displacement of [3H]-N-Methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells incubated for 90 mins by microbeta counting method,CHEMBL4622954,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.97,nM,CHEMBL4628381,B,Binding affinity to human D2 receptor,CHEMBL4627308,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4633772,CHEMBL217,Dopamine D2 receptor,Ki,=,854.0,nM,CHEMBL4628381,B,Binding affinity to human D2 receptor,CHEMBL4627308,KI,C#CCOc1c(OC)cc2c3c1-c1cc(NC(C)=O)ccc1CC3N(C)CC2
CHEMBL4637673,CHEMBL217,Dopamine D2 receptor,Ki,=,978.0,nM,CHEMBL4628381,B,Binding affinity to human D2 receptor,CHEMBL4627308,KI,COc1cc2c3c(c1OC)-c1cc(NC(C)=O)ccc1CC3N(C)CC2
CHEMBL4636589,CHEMBL217,Dopamine D2 receptor,Ki,=,431.0,nM,CHEMBL4628381,B,Binding affinity to human D2 receptor,CHEMBL4627308,KI,C#CCOc1c(OC)cc2c3c1-c1cc(N)ccc1CC3N(C)CC2
CHEMBL4649785,CHEMBL217,Dopamine D2 receptor,Ki,=,759.0,nM,CHEMBL4628381,B,Binding affinity to human D2 receptor,CHEMBL4627308,KI,C=CCOc1c(OC)cc2c3c1-c1cc(N)ccc1CC3N(C)CC2
CHEMBL4636318,CHEMBL217,Dopamine D2 receptor,Ki,=,963.0,nM,CHEMBL4628381,B,Binding affinity to human D2 receptor,CHEMBL4627308,KI,COc1cc2c3c(c1OC1CC1)-c1cc(N)ccc1CC3N(C)CC2
CHEMBL4639398,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL4628381,B,Binding affinity to human D2 receptor,CHEMBL4627308,KI,COc1cc2c3c(c1OC)-c1cc(N)ccc1CC3N(C)CC2
CHEMBL4637246,CHEMBL217,Dopamine D2 receptor,Ki,=,231.0,nM,CHEMBL4628381,B,Binding affinity to human D2 receptor,CHEMBL4627308,KI,COc1cc2c3c(c1O)-c1cc(N)ccc1CC3N(C)CC2
CHEMBL4638749,CHEMBL217,Dopamine D2 receptor,Ki,=,2048.0,nM,CHEMBL4628381,B,Binding affinity to human D2 receptor,CHEMBL4627308,KI,C#CCOc1c(OC)cc2c3c1-c1cc([N+](=O)[O-])ccc1CC3N(C)CC2
CHEMBL4646927,CHEMBL217,Dopamine D2 receptor,Ki,=,478.0,nM,CHEMBL4628381,B,Binding affinity to human D2 receptor,CHEMBL4627308,KI,COc1cc2c3c(c1OC)-c1cc([N+](=O)[O-])ccc1CC3N(C)CC2
CHEMBL4636948,CHEMBL217,Dopamine D2 receptor,Ki,=,320.0,nM,CHEMBL4628381,B,Binding affinity to human D2 receptor,CHEMBL4627308,KI,COc1cc2c3c(c1O)-c1cc([N+](=O)[O-])ccc1CC3N(C)CC2
CHEMBL4634039,CHEMBL217,Dopamine D2 receptor,Ki,=,679.0,nM,CHEMBL4628381,B,Binding affinity to human D2 receptor,CHEMBL4627308,KI,CN1CCc2cccc3c2C1Cc1ccc(N)cc1-3
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Ki,=,82.0,nM,CHEMBL4628391,B,Displacement of [125I]iodosulpride from human D2 receptor expressed in CHO cells incubated for 40 mins by radio ligand binding assay,CHEMBL4627308,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL4641609,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4645308,CHEMBL217,Dopamine D2 receptor,Ki,=,35.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCCCN1CCN(c2ccccc2Cl)CC1
CHEMBL4635363,CHEMBL217,Dopamine D2 receptor,Ki,=,225.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCCCN1CCN(c2cccc(Cl)c2)CC1
CHEMBL4632519,CHEMBL217,Dopamine D2 receptor,Ki,=,370.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL4639203,CHEMBL217,Dopamine D2 receptor,Ki,=,55.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL4636435,CHEMBL217,Dopamine D2 receptor,Ki,=,168.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1
CHEMBL4645292,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,COc1ccccc1N1CCN(CCCCCCN2C(=O)[C@@H]3[C@H]4CC[C@H](C4)[C@@H]3C2=O)CC1
CHEMBL38409,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=C1c2ccccc2C(=O)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4648581,CHEMBL217,Dopamine D2 receptor,Ki,=,9.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=c1n(CCCCCCN2CCN(c3nsc4ccccc34)CC2)nc2ccccn12
CHEMBL4643450,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=c1oc2ccccc2n1CCCCCCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4635603,CHEMBL217,Dopamine D2 receptor,Ki,=,33.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,c1ccc2oc(SCCCCCCN3CCN(c4nsc5ccccc45)CC3)nc2c1
CHEMBL4644906,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=C1CCc2cc(OCCCCCCN3CCN(c4nsc5ccccc45)CC3)ccc2N1
CHEMBL4637294,CHEMBL217,Dopamine D2 receptor,Ki,=,56.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4642594,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4646868,CHEMBL217,Dopamine D2 receptor,Ki,=,59.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=C1c2cccc3cccc(c23)C(=O)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4642981,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=c1n(CCCCCCN2CCN(c3nsc4ccccc34)CC2)c2cccc3c2n1CCC3
CHEMBL4648390,CHEMBL217,Dopamine D2 receptor,Ki,=,164.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=S(=O)(c1ccccc1)N(CCCCCCN1CCN(c2nsc3ccccc23)CC1)c1cccc(C(F)(F)F)c1
CHEMBL4638388,CHEMBL217,Dopamine D2 receptor,Ki,=,106.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,Cc1ccc(S(=O)(=O)N(CCCCCCN2CCN(c3nsc4ccccc34)CC2)c2ccccc2)cc1
CHEMBL4638308,CHEMBL217,Dopamine D2 receptor,Ki,=,16.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=c1[nH]c2ccccc2n1CCCCCCN1CCN(c2nsc3ccccc23)CC1
CHEMBL4645793,CHEMBL217,Dopamine D2 receptor,Ki,=,14.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=C(NCCCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccccc1
CHEMBL4641296,CHEMBL217,Dopamine D2 receptor,Ki,=,31.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=S(=O)(NCCCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccccc1
CHEMBL4636031,CHEMBL217,Dopamine D2 receptor,Ki,=,31.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=S(=O)(NCCCCCCN1CCN(c2nsc3ccccc23)CC1)c1cccc2ccccc12
CHEMBL4645525,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL4629186,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4627360,KI,O=S(=O)(NCCCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2ccccc2c1
CHEMBL1442422,CHEMBL217,Dopamine D2 receptor,Ki,=,30200.0,nM,CHEMBL4669829,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4665756,KI,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21
CHEMBL4746800,CHEMBL217,Dopamine D2 receptor,Ki,=,11600.0,nM,CHEMBL4669829,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4665756,KI,CN(C)CCN1C(=O)c2ccccc2/C=C\c2ccccc21
CHEMBL4756446,CHEMBL217,Dopamine D2 receptor,Ki,=,9000.0,nM,CHEMBL4669829,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4665756,KI,CN(C)CCCN1C(=O)c2ccccc2/C=C\c2ccccc21
CHEMBL4742201,CHEMBL217,Dopamine D2 receptor,Ki,=,65300.0,nM,CHEMBL4669829,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4665756,KI,CN(C)CCN1C(=O)c2ccccc2N(C)C(=O)c2ccccc21
CHEMBL4778076,CHEMBL217,Dopamine D2 receptor,Ki,=,19100.0,nM,CHEMBL4669829,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4665756,KI,O=C1c2ccccc2/C=C\c2ccccc2N1CCCN1CCOCC1
CHEMBL4796968,CHEMBL217,Dopamine D2 receptor,Ki,=,7500.0,nM,CHEMBL4669829,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4665756,KI,CN1CCN(CCCN2C(=O)c3ccccc3/C=C\c3ccccc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,389.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,58.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL3039528,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C
CHEMBL298406,CHEMBL217,Dopamine D2 receptor,Ki,=,1240.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21
CHEMBL4748915,CHEMBL217,Dopamine D2 receptor,Ki,=,1380.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,CN1CC=C(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL4782694,CHEMBL217,Dopamine D2 receptor,Ki,=,1180.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,CN1CCC(C2=Nc3cc(Cl)ccc3Nc3ccccc32)=CC1(C)C
CHEMBL4779001,CHEMBL217,Dopamine D2 receptor,Ki,=,479.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,C[C@H]1C=C(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CCN1C
CHEMBL4745124,CHEMBL217,Dopamine D2 receptor,Ki,=,63.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,Cc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1cc(Cl)ccc1N2
CHEMBL4760903,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,CCc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1cc(Cl)ccc1N2
CHEMBL4757297,CHEMBL217,Dopamine D2 receptor,Ki,=,69.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,COc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1cc(Cl)ccc1N2
CHEMBL4758966,CHEMBL217,Dopamine D2 receptor,Ki,=,47.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,CCOc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1cc(Cl)ccc1N2
CHEMBL4745489,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,C[C@H]1C=C(C2=Nc3cc(Cl)ccc3Nc3ccc(OC(F)(F)F)cc32)CCN1C
CHEMBL4758723,CHEMBL217,Dopamine D2 receptor,Ki,=,127.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,C[C@H]1C=C(C2=Nc3cc(Cl)ccc3Nc3ccc(F)cc32)CCN1C
CHEMBL4795230,CHEMBL217,Dopamine D2 receptor,Ki,=,106.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,C[C@H]1C=C(C2=Nc3cc(Cl)ccc3Nc3ccc(Cl)cc32)CCN1C
CHEMBL4742056,CHEMBL217,Dopamine D2 receptor,Ki,=,135.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,C[C@H]1C=C(C2=Nc3cc(Cl)ccc3Nc3ccc(C#N)cc32)CCN1C
CHEMBL4797375,CHEMBL217,Dopamine D2 receptor,Ki,=,1218.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,Cc1ccc2c(c1)N=C(C1=C[C@H](C)N(C)CC1)c1cc(OC(F)(F)F)ccc1N2
CHEMBL4776090,CHEMBL217,Dopamine D2 receptor,Ki,=,453.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,Cc1ccc2c(c1)N=C(C1=C[C@H](C)N(C)CC1)c1cc(F)ccc1N2
CHEMBL4756254,CHEMBL217,Dopamine D2 receptor,Ki,=,98.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,Cc1ccc2c(c1)N=C(C1=C[C@H](C)N(C)CC1)c1cc(Cl)ccc1N2
CHEMBL4793813,CHEMBL217,Dopamine D2 receptor,Ki,=,819.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,Cc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1ccccc1N2
CHEMBL4756987,CHEMBL217,Dopamine D2 receptor,Ki,=,167.5,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,CCc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1ccccc1N2
CHEMBL4740880,CHEMBL217,Dopamine D2 receptor,Ki,=,124.0,nM,CHEMBL4671577,B,Binding affinity to human dopamine D2 receptor,CHEMBL4665835,KI,C[C@H]1C=C(C2=Nc3ccccc3Nc3ccc(Cl)cc32)CCN1C
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,Ki,=,0.49,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL4779912,CHEMBL217,Dopamine D2 receptor,Ki,=,290.5,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,C[C@@H]1CN(CC[C@H]2CC[C@H](NC(=O)N(C)C)CC2)CCc2ccc(Cl)cc21
CHEMBL4755563,CHEMBL217,Dopamine D2 receptor,Ki,=,188.7,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)N(C)c3ccccc3)CC2)CCc2ccc(Cl)cc21
CHEMBL4759975,CHEMBL217,Dopamine D2 receptor,Ki,=,2.8,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)Nc3ccccc3)CC2)CCc2ccc(Cl)cc21
CHEMBL4797996,CHEMBL217,Dopamine D2 receptor,Ki,=,6.3,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)N3CCCC3)CC2)CCc2ccc(Cl)cc21
CHEMBL4741702,CHEMBL217,Dopamine D2 receptor,Ki,=,2.9,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)N3CCOCC3)CC2)CCc2ccc(Cl)cc21
CHEMBL4743651,CHEMBL217,Dopamine D2 receptor,Ki,=,91.1,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,CCN(CC)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(Cl)cc3[C@@H](C)C2)CC1
CHEMBL4750939,CHEMBL217,Dopamine D2 receptor,Ki,=,23.9,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,CCN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(Cl)cc3[C@@H](C)C2)CC1
CHEMBL4799863,CHEMBL217,Dopamine D2 receptor,Ki,=,5.9,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)N(C)C)CC2)CCc2ccc(Cl)cc21
CHEMBL4753808,CHEMBL217,Dopamine D2 receptor,Ki,=,12.1,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,C[C@H]1CN(CC[C@H]2CC[C@H](N3C(=O)CC4(CCCC4)CC3=O)CC2)CCc2ccc(Cl)cc21
CHEMBL4788140,CHEMBL217,Dopamine D2 receptor,Ki,=,43.7,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,C[C@H]1CN(CC[C@H]2CC[C@H](N3C(=O)[C@@H]4[C@H](C3=O)[C@@H]3C=C[C@H]4C3)CC2)CCc2ccc(Cl)cc21
CHEMBL4784751,CHEMBL217,Dopamine D2 receptor,Ki,=,31.6,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,C[C@H]1CN(CC[C@H]2CC[C@H](N3C(=O)[C@@H]4[C@@H]5CC[C@@H](C5)[C@@H]4C3=O)CC2)CCc2ccc(Cl)cc21
CHEMBL4752414,CHEMBL217,Dopamine D2 receptor,Ki,=,5.8,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,C[C@H]1CN(CC[C@H]2CC[C@H](N3C(=O)c4ccccc4C3=O)CC2)CCc2ccc(Cl)cc21
CHEMBL4762024,CHEMBL217,Dopamine D2 receptor,Ki,=,14.1,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,C[C@H]1CN(CC[C@H]2CC[C@H](N3C(=O)[C@H]4CCCC[C@H]4C3=O)CC2)CCc2ccc(Cl)cc21
CHEMBL4741673,CHEMBL217,Dopamine D2 receptor,Ki,=,25.3,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)[C@@H]3CCCN3)CC2)CCc2ccc(Cl)cc21
CHEMBL4745809,CHEMBL217,Dopamine D2 receptor,Ki,=,20.6,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)[C@@H]3CCCO3)CC2)CCc2ccc(Cl)cc21
CHEMBL4762918,CHEMBL217,Dopamine D2 receptor,Ki,=,99.3,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)C3CCCCC3)CC2)CCc2ccc(Cl)cc21
CHEMBL4756826,CHEMBL217,Dopamine D2 receptor,Ki,=,9.8,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)C3CC3)CC2)CCc2ccc(Cl)cc21
CHEMBL4761274,CHEMBL217,Dopamine D2 receptor,Ki,=,84.0,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,CCCC(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(Cl)cc3[C@@H](C)C2)CC1
CHEMBL4780335,CHEMBL217,Dopamine D2 receptor,Ki,=,93.9,nM,CHEMBL4677471,B,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,CHEMBL4673287,KI,C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)c3ccco3)CC2)CCc2ccc(Cl)cc21
CHEMBL4785434,CHEMBL217,Dopamine D2 receptor,Ki,=,12.3,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,Cn1ccc2cc(S(=O)(=O)N[C@H]3CCN(CCCc4noc5ccccc45)C3)ccc21
CHEMBL4759492,CHEMBL217,Dopamine D2 receptor,Ki,=,0.9333,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,Cn1ccc2cc(S(=O)(=O)N[C@@H]3CCN(CCCc4noc5ccccc45)C3)ccc21
CHEMBL4749824,CHEMBL217,Dopamine D2 receptor,Ki,=,38.02,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,Cn1ccc2c(S(=O)(=O)N[C@H]3CCN(CCCc4noc5ccccc45)C3)cccc21
CHEMBL4748107,CHEMBL217,Dopamine D2 receptor,Ki,=,102.33,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1ccc2cc(Cl)ccc2c1
CHEMBL4764557,CHEMBL217,Dopamine D2 receptor,Ki,=,56.23,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,COc1ccc2cc(S(=O)(=O)N[C@H]3CCN(CCCc4noc5ccccc45)C3)ccc2c1
CHEMBL4784228,CHEMBL217,Dopamine D2 receptor,Ki,=,56.23,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1cccc(Cl)c1
CHEMBL4747225,CHEMBL217,Dopamine D2 receptor,Ki,=,0.1995,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1ccc2ccccc2c1
CHEMBL4750587,CHEMBL217,Dopamine D2 receptor,Ki,=,169.82,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1ccc(F)c(Cl)c1
CHEMBL4758402,CHEMBL217,Dopamine D2 receptor,Ki,=,95.5,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1ccc(F)cc1
CHEMBL4744007,CHEMBL217,Dopamine D2 receptor,Ki,=,3.09,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,COc1ccc2cc(S(=O)(=O)N[C@@H]3CCN(CCCc4noc5ccccc45)C3)ccc2c1
CHEMBL4776225,CHEMBL217,Dopamine D2 receptor,Ki,=,32.36,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1cccc2ccccc12
CHEMBL4775997,CHEMBL217,Dopamine D2 receptor,Ki,=,56.23,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1ccc(F)c(Cl)c1
CHEMBL4779739,CHEMBL217,Dopamine D2 receptor,Ki,=,104.71,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,Cc1cccc(S(=O)(=O)N[C@H]2CCN(CCCc3noc4ccccc34)C2)c1
CHEMBL4742856,CHEMBL217,Dopamine D2 receptor,Ki,=,9.12,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,Cn1ccc2c(S(=O)(=O)N[C@@H]3CCN(CCCc4noc5ccccc45)C3)cccc21
CHEMBL4760655,CHEMBL217,Dopamine D2 receptor,Ki,=,2.57,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1ccc2cc(Cl)ccc2c1
CHEMBL4750664,CHEMBL217,Dopamine D2 receptor,Ki,=,31.62,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,Cc1cccc(S(=O)(=O)N[C@@H]2CCN(CCCc3noc4ccccc34)C2)c1
CHEMBL4763085,CHEMBL217,Dopamine D2 receptor,Ki,=,14.13,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1ccc2ccccc2c1
CHEMBL4754138,CHEMBL217,Dopamine D2 receptor,Ki,=,20.42,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1cccc2ccccc12
CHEMBL4796647,CHEMBL217,Dopamine D2 receptor,Ki,=,323.59,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1ccc(F)cc1
CHEMBL4741142,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1cccc(Cl)c1
CHEMBL4764006,CHEMBL217,Dopamine D2 receptor,Ki,=,1.23,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2o1
CHEMBL4753094,CHEMBL217,Dopamine D2 receptor,Ki,=,5.623,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2o1
CHEMBL4793608,CHEMBL217,Dopamine D2 receptor,Ki,=,19.95,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1csc2ccccc12
CHEMBL4782149,CHEMBL217,Dopamine D2 receptor,Ki,=,43.65,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1csc2ccccc12
CHEMBL4795995,CHEMBL217,Dopamine D2 receptor,Ki,=,0.4467,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1
CHEMBL4764468,CHEMBL217,Dopamine D2 receptor,Ki,=,16.22,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1
CHEMBL4751063,CHEMBL217,Dopamine D2 receptor,Ki,=,8.318,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1cc2ccc(Cl)cc2s1
CHEMBL4763106,CHEMBL217,Dopamine D2 receptor,Ki,=,34.67,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1cc2ccc(Cl)cc2s1
CHEMBL4754193,CHEMBL217,Dopamine D2 receptor,Ki,=,1.413,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1cc2ccc(F)cc2s1
CHEMBL4762226,CHEMBL217,Dopamine D2 receptor,Ki,=,17.78,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1cc2ccc(F)cc2s1
CHEMBL4748379,CHEMBL217,Dopamine D2 receptor,Ki,=,1.738,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,Cc1ccc2sc(S(=O)(=O)N[C@@H]3CCN(CCCc4noc5ccccc45)C3)cc2c1
CHEMBL4784414,CHEMBL217,Dopamine D2 receptor,Ki,=,23.99,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,Cc1ccc2sc(S(=O)(=O)N[C@H]3CCN(CCCc4noc5ccccc45)C3)cc2c1
CHEMBL4780470,CHEMBL217,Dopamine D2 receptor,Ki,=,8.913,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,Cc1c(S(=O)(=O)N[C@@H]2CCN(CCCc3noc4ccccc34)C2)sc2ccc(Cl)cc12
CHEMBL4790020,CHEMBL217,Dopamine D2 receptor,Ki,=,38.9,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,Cc1c(S(=O)(=O)N[C@H]2CCN(CCCc3noc4ccccc34)C2)sc2ccc(Cl)cc12
CHEMBL4747978,CHEMBL217,Dopamine D2 receptor,Ki,=,0.631,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,Cc1c(S(=O)(=O)N[C@@H]2CCN(CCCc3noc4ccccc34)C2)sc2ccc(F)cc12
CHEMBL4778418,CHEMBL217,Dopamine D2 receptor,Ki,=,15.14,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,Cc1c(S(=O)(=O)N[C@H]2CCN(CCCc3noc4ccccc34)C2)sc2ccc(F)cc12
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.862,nM,CHEMBL4685403,B,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,CHEMBL4680205,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4751170,CHEMBL217,Dopamine D2 receptor,Ki,=,3.981,nM,CHEMBL4686239,B,Displacement of [3H]spiperone from recombinant human D2S receptor expressed in CHO cell membrane measured after 60 mins by scintillation counting method,CHEMBL4680230,KI,Cl.Fc1ccc(-c2cncc(CN3CCN(c4cccc5c4OCCO5)CC3)c2)cc1
CHEMBL1940418,CHEMBL217,Dopamine D2 receptor,Ki,=,124.0,nM,CHEMBL4688544,B,Displacement of [3H]-methylspiperone from dopamine D2 receptor (unknown origin) expressed in HEK293T cells measured after 15 mins by GloSensor cAMP assay,CHEMBL4680313,KI,Fc1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,3.3,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL340211,CHEMBL217,Dopamine D2 receptor,Ki,=,229.0,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1
CHEMBL4462108,CHEMBL217,Dopamine D2 receptor,Ki,=,193.0,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,Fc1ccc(CCCCN2CCN(c3ccc(Cl)cn3)CC2)cc1
CHEMBL4573441,CHEMBL217,Dopamine D2 receptor,Ki,=,287.0,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C(CCCN1CCN(c2ccc(Cl)cn2)CC1)c1ccc(F)cc1
CHEMBL3289648,CHEMBL217,Dopamine D2 receptor,Ki,=,1861.0,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,Cc1ccc(N2CCN(CCCCc3ccc(F)cc3)CC2)nc1
CHEMBL4743284,CHEMBL217,Dopamine D2 receptor,Ki,=,641.0,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,Cl.Fc1ccc(CCCCN2CCN(c3cccc(-c4ccccc4)n3)CC2)cc1
CHEMBL4533305,CHEMBL217,Dopamine D2 receptor,Ki,=,181.0,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C(CCCN1CCCN(c2ccccn2)CC1)c1ccc(F)cc1
CHEMBL4574793,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C(CCCN1CCCN(c2ccc(Cl)cn2)CC1)c1ccc(F)cc1
CHEMBL4570411,CHEMBL217,Dopamine D2 receptor,Ki,=,649.0,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C1c2ccc(F)cc2CC1CCN1CCCN(c2ccccn2)CC1
CHEMBL4474014,CHEMBL217,Dopamine D2 receptor,Ki,=,599.0,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,Fc1ccc2c(c1)CC(CCN1CCCN(c3ccccn3)CC1)C2
CHEMBL4558031,CHEMBL217,Dopamine D2 receptor,Ki,=,364.0,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C1c2ccc(F)cc2CC1CCN1CCCN(c2ccc(Cl)cn2)CC1
CHEMBL1946124,CHEMBL217,Dopamine D2 receptor,Ki,=,1021.0,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C1c2ccc(F)cc2CC1CCN1CCCN(c2ccc(Cl)cc2)CC1
CHEMBL4789472,CHEMBL217,Dopamine D2 receptor,Ki,=,1249.0,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C(CCCN1C2CCC1CN(c1ccc(Cl)cn1)C2)c1ccc(F)cc1
CHEMBL4793296,CHEMBL217,Dopamine D2 receptor,Ki,=,1168.0,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C(CCCN1CCN(c2cccnc2)CC1)c1ccc(F)cc1.O=C(O)C(=O)O
CHEMBL340211,CHEMBL217,Dopamine D2 receptor,Ki,=,229.09,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1
CHEMBL4462108,CHEMBL217,Dopamine D2 receptor,Ki,=,194.98,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,Fc1ccc(CCCCN2CCN(c3ccc(Cl)cn3)CC2)cc1
CHEMBL4573441,CHEMBL217,Dopamine D2 receptor,Ki,=,288.4,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C(CCCN1CCN(c2ccc(Cl)cn2)CC1)c1ccc(F)cc1
CHEMBL3289648,CHEMBL217,Dopamine D2 receptor,Ki,=,1995.26,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,Cc1ccc(N2CCN(CCCCc3ccc(F)cc3)CC2)nc1
CHEMBL4743284,CHEMBL217,Dopamine D2 receptor,Ki,=,645.65,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,Cl.Fc1ccc(CCCCN2CCN(c3cccc(-c4ccccc4)n3)CC2)cc1
CHEMBL4533305,CHEMBL217,Dopamine D2 receptor,Ki,=,199.53,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C(CCCN1CCCN(c2ccccn2)CC1)c1ccc(F)cc1
CHEMBL4574793,CHEMBL217,Dopamine D2 receptor,Ki,=,40.74,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C(CCCN1CCCN(c2ccc(Cl)cn2)CC1)c1ccc(F)cc1
CHEMBL4570411,CHEMBL217,Dopamine D2 receptor,Ki,=,645.65,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C1c2ccc(F)cc2CC1CCN1CCCN(c2ccccn2)CC1
CHEMBL4474014,CHEMBL217,Dopamine D2 receptor,Ki,=,602.56,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,Fc1ccc2c(c1)CC(CCN1CCCN(c3ccccn3)CC1)C2
CHEMBL4558031,CHEMBL217,Dopamine D2 receptor,Ki,=,363.08,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C1c2ccc(F)cc2CC1CCN1CCCN(c2ccc(Cl)cn2)CC1
CHEMBL1946124,CHEMBL217,Dopamine D2 receptor,Ki,=,1023.29,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C1c2ccc(F)cc2CC1CCN1CCCN(c2ccc(Cl)cc2)CC1
CHEMBL4789472,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C(CCCN1C2CCC1CN(c1ccc(Cl)cn1)C2)c1ccc(F)cc1
CHEMBL4793296,CHEMBL217,Dopamine D2 receptor,Ki,=,1174.9,nM,CHEMBL4688549,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,CHEMBL4680313,KI,O=C(CCCN1CCN(c2cccnc2)CC1)c1ccc(F)cc1.O=C(O)C(=O)O
CHEMBL4293999,CHEMBL217,Dopamine D2 receptor,Ki,=,2.9,nM,CHEMBL4709830,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4706549,KI,O=C(CCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2c3c(c1)CCN3C(=O)CC2
CHEMBL2105760,CHEMBL217,Dopamine D2 receptor,Ki,=,0.3,nM,CHEMBL4709838,B,Displacement of [3H]raclopride from human D2 long receptor expressed in CHO cells measured after 60 mins,CHEMBL4706549,KI,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1
CHEMBL3931765,CHEMBL217,Dopamine D2 receptor,Ki,=,298.0,nM,CHEMBL4711026,B,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,CHEMBL4706586,KI,CC(O)CN1CCN(CC[S+]([O-])C(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL3918282,CHEMBL217,Dopamine D2 receptor,Ki,=,78.6,nM,CHEMBL4711026,B,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,CHEMBL4706586,KI,[O-][S+](CCN1CCN(CC(O)Cc2ccccc2)CC1)C(c1ccc(F)cc1)c1ccc(F)cc1
CHEMBL3916231,CHEMBL217,Dopamine D2 receptor,Ki,=,693.0,nM,CHEMBL4711026,B,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,CHEMBL4706586,KI,CC(O)CN1CCN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL4636778,CHEMBL217,Dopamine D2 receptor,Ki,=,11900.0,nM,CHEMBL4711026,B,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,CHEMBL4706586,KI,CC(O)CN1[C@H](C)CN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)C[C@@H]1C
CHEMBL4794406,CHEMBL217,Dopamine D2 receptor,Ki,=,2920.0,nM,CHEMBL4711026,B,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,CHEMBL4706586,KI,Fc1ccc(CN2CCC(NCCSC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1
CHEMBL4750660,CHEMBL217,Dopamine D2 receptor,Ki,=,12400.0,nM,CHEMBL4711026,B,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,CHEMBL4706586,KI,[O-][S+](CCNC1CCN(Cc2ccc(F)cc2)CC1)C(c1ccc(F)cc1)c1ccc(F)cc1
CHEMBL4750607,CHEMBL217,Dopamine D2 receptor,Ki,=,4020.0,nM,CHEMBL4711026,B,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,CHEMBL4706586,KI,OC(Cc1ccccc1)CN1CCC(NCCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL4758774,CHEMBL217,Dopamine D2 receptor,Ki,=,6610.0,nM,CHEMBL4711026,B,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,CHEMBL4706586,KI,[O-][S+](CCNC1CCN(CC(O)Cc2ccccc2)CC1)C(c1ccc(F)cc1)c1ccc(F)cc1
CHEMBL4798638,CHEMBL217,Dopamine D2 receptor,Ki,=,2270.0,nM,CHEMBL4711026,B,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,CHEMBL4706586,KI,OC(CNC1CCN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1)Cc1ccccc1
CHEMBL4744824,CHEMBL217,Dopamine D2 receptor,Ki,=,2900.0,nM,CHEMBL4711026,B,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,CHEMBL4706586,KI,O=C(c1ccccc1)N1CCC(NCCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL4741279,CHEMBL217,Dopamine D2 receptor,Ki,=,8830.0,nM,CHEMBL4711026,B,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,CHEMBL4706586,KI,O=C(c1ccc(F)cc1)N1CCC(NCCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL4777080,CHEMBL217,Dopamine D2 receptor,Ki,=,156000.0,nM,CHEMBL4711026,B,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,CHEMBL4706586,KI,O=C(c1ccc(F)cc1)N1CCC(NCC[S+]([O-])C(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL4765081,CHEMBL217,Dopamine D2 receptor,Ki,=,6070.0,nM,CHEMBL4711026,B,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,CHEMBL4706586,KI,CC(C)(C)C(=O)N1CCC(NCCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL4791063,CHEMBL217,Dopamine D2 receptor,Ki,=,7440.0,nM,CHEMBL4711026,B,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,CHEMBL4706586,KI,O=C(c1ccc(F)cc1F)N1CCC(NCCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL4741978,CHEMBL217,Dopamine D2 receptor,Ki,=,813.0,nM,CHEMBL4711041,B,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK293 cells measured after 1 hr by microbeta plate reader analysis,CHEMBL4706587,KI,C#CCN(C)Cc1ccc(OCCCCCN2CCN(c3cccc4c3ccn4S(=O)(=O)c3ccccc3)CC2)cc1
CHEMBL716,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL4718597,B,Binding affinity to human dopamine D2 receptor,CHEMBL4715748,KI,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL4718597,B,Binding affinity to human dopamine D2 receptor,CHEMBL4715748,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.12,nM,CHEMBL4723517,B,Antagonist activity at dopamine D2 receptor (unknown origin),CHEMBL4715859,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL596802,CHEMBL217,Dopamine D2 receptor,Ki,=,17500.0,nM,CHEMBL4723553,B,Binding affinity to dopamine D2 (low) receptor (unknown origin),CHEMBL4715859,KI,CCCN1CCC(c2cccc(S(C)(=O)=O)c2)CC1
CHEMBL596802,CHEMBL217,Dopamine D2 receptor,Ki,=,7500.0,nM,CHEMBL4723554,B,Binding affinity to dopamine D2 (high) receptor (unknown origin),CHEMBL4715859,KI,CCCN1CCC(c2cccc(S(C)(=O)=O)c2)CC1
CHEMBL4779364,CHEMBL217,Dopamine D2 receptor,Ki,=,167.2,nM,CHEMBL4729778,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4725387,KI,CC(=O)Nc1ccc(OCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1
CHEMBL4789422,CHEMBL217,Dopamine D2 receptor,Ki,=,467.3,nM,CHEMBL4729778,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4725387,KI,COc1ccccc1N1CCN(CCCOc2ccc(NC(C)=O)cc2)CC1
CHEMBL4798631,CHEMBL217,Dopamine D2 receptor,Ki,=,498.2,nM,CHEMBL4729778,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4725387,KI,CC(=O)Nc1ccc(OCCCN2CCN(c3ncccn3)CC2)cc1
CHEMBL4784373,CHEMBL217,Dopamine D2 receptor,Ki,=,2.1,nM,CHEMBL4729778,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4725387,KI,CC(=O)Nc1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1
CHEMBL4777055,CHEMBL217,Dopamine D2 receptor,Ki,=,79.1,nM,CHEMBL4729778,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4725387,KI,CC(=O)Nc1ccc(OCCCN2CCN(c3nsc4ccccc34)CC2)cc1
CHEMBL4764692,CHEMBL217,Dopamine D2 receptor,Ki,=,16.3,nM,CHEMBL4729778,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4725387,KI,CC(=O)Nc1ccc(OCCCN2CCN(c3cccc4ccsc34)CC2)cc1
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,3.8,nM,CHEMBL4729778,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4725387,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL4790699,CHEMBL217,Dopamine D2 receptor,Ki,=,148.3,nM,CHEMBL4729778,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4725387,KI,CC(=O)Nc1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1F
CHEMBL4760689,CHEMBL217,Dopamine D2 receptor,Ki,=,150.3,nM,CHEMBL4729778,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4725387,KI,CC(=O)Nc1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1C
CHEMBL4764639,CHEMBL217,Dopamine D2 receptor,Ki,=,1589.0,nM,CHEMBL4729778,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4725387,KI,CC(=O)NCc1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1
CHEMBL4792709,CHEMBL217,Dopamine D2 receptor,Ki,=,20.6,nM,CHEMBL4729778,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4725387,KI,CC(=O)N(C)c1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1
CHEMBL4794963,CHEMBL217,Dopamine D2 receptor,Ki,=,1143.0,nM,CHEMBL4729778,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4725387,KI,CC(=O)Nc1ccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1
CHEMBL4799934,CHEMBL217,Dopamine D2 receptor,Ki,=,119.2,nM,CHEMBL4729778,B,Binding affinity to D2 receptor (unknown origin),CHEMBL4725387,KI,CC(=O)Nc1ccc(OCC(O)CN2CCC(c3noc4cc(F)ccc34)CC2)cc1
CHEMBL4764883,CHEMBL217,Dopamine D2 receptor,Ki,=,1010.0,nM,CHEMBL4731081,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cells after 90 mins by microbeta counting based assay,CHEMBL4725442,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC(O)CCNC(=O)c1cc2ccccc2[nH]1
CHEMBL4744811,CHEMBL217,Dopamine D2 receptor,Ki,=,104.0,nM,CHEMBL4731081,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cells after 90 mins by microbeta counting based assay,CHEMBL4725442,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC[C@H]1CC[C@H](NC(=O)c2cc3ccccc3[nH]2)CC1
CHEMBL4791884,CHEMBL217,Dopamine D2 receptor,Ki,=,9420.0,nM,CHEMBL4731081,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cells after 90 mins by microbeta counting based assay,CHEMBL4725442,KI,O=C(NCCCCN1CCO[C@@H]2c3cc(O)ccc3OC[C@@H]21)c1cc2ccccc2[nH]1
CHEMBL4778398,CHEMBL217,Dopamine D2 receptor,Ki,=,5880.0,nM,CHEMBL4731081,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cells after 90 mins by microbeta counting based assay,CHEMBL4725442,KI,O=C(NCCCCN1CCO[C@H]2c3cc(O)ccc3OC[C@@H]21)c1cc2ccccc2[nH]1
CHEMBL97424,CHEMBL217,Dopamine D2 receptor,Ki,=,7580.0,nM,CHEMBL4731081,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cells after 90 mins by microbeta counting based assay,CHEMBL4725442,KI,CCCN1CCO[C@H]2c3cc(O)ccc3OC[C@@H]21
CHEMBL70565,CHEMBL217,Dopamine D2 receptor,Ki,=,28.0,nM,CHEMBL4731081,B,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cells after 90 mins by microbeta counting based assay,CHEMBL4725442,KI,CCCN1CCO[C@@H]2c3cc(O)ccc3OC[C@H]21
CHEMBL4759730,CHEMBL217,Dopamine D2 receptor,Ki,=,31.0,nM,CHEMBL4735854,B,Displacement of [3H]-Raclopride from dopamine D2 receptor (unknown origin) incubated for 1 hr by microbeta counting method,CHEMBL4732129,KI,CN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1
CHEMBL4759208,CHEMBL217,Dopamine D2 receptor,Ki,=,241.0,nM,CHEMBL4735854,B,Displacement of [3H]-Raclopride from dopamine D2 receptor (unknown origin) incubated for 1 hr by microbeta counting method,CHEMBL4732129,KI,CN1CCN(c2ccc3ccn(S(=O)(=O)c4ccccc4)c3c2)CC1
CHEMBL4781480,CHEMBL217,Dopamine D2 receptor,Ki,=,189.0,nM,CHEMBL4736183,B,Displacement of [3H]raclopride from human D2R isoform 2 stably expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method,CHEMBL4732144,KI,C#CCCCCN(CCC)C1Cc2ccccc2C1
CHEMBL4790018,CHEMBL217,Dopamine D2 receptor,Ki,=,73.0,nM,CHEMBL4736183,B,Displacement of [3H]raclopride from human D2R isoform 2 stably expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method,CHEMBL4732144,KI,CCCN(CCCCc1cn(CCOCCOCCOCCn2cc(CCCCN(CCC)C3Cc4ccccc4C3)nn2)nn1)C1Cc2ccccc2C1
CHEMBL4786420,CHEMBL217,Dopamine D2 receptor,Ki,=,66.0,nM,CHEMBL4736183,B,Displacement of [3H]raclopride from human D2R isoform 2 stably expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method,CHEMBL4732144,KI,CCCN(CCCCc1cn(CCOCCOCCOCCOCCn2cc(CCCCN(CCC)C3Cc4ccccc4C3)nn2)nn1)C1Cc2ccccc2C1
CHEMBL4755336,CHEMBL217,Dopamine D2 receptor,Ki,=,48.0,nM,CHEMBL4736183,B,Displacement of [3H]raclopride from human D2R isoform 2 stably expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method,CHEMBL4732144,KI,CCCN(CCCCc1cn(CCOCCOCCOCCOCCOCCn2cc(CCCCN(CCC)C3Cc4ccccc4C3)nn2)nn1)C1Cc2ccccc2C1
CHEMBL4794870,CHEMBL217,Dopamine D2 receptor,Ki,=,970.0,nM,CHEMBL4736183,B,Displacement of [3H]raclopride from human D2R isoform 2 stably expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method,CHEMBL4732144,KI,C#CCOc1ccc(-c2ccc(C(=O)NCCCCN(CCC)C3Cc4ccccc4C3)cc2)cc1
CHEMBL4748201,CHEMBL217,Dopamine D2 receptor,Ki,=,270.0,nM,CHEMBL4736183,B,Displacement of [3H]raclopride from human D2R isoform 2 stably expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method,CHEMBL4732144,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccc(OCc3cn(CCOCCOCCOCCn4cc(COc5ccc(-c6ccc(C(=O)NCCCCN(CCC)C7Cc8ccccc8C7)cc6)cc5)nn4)nn3)cc2)cc1)C1Cc2ccccc2C1
CHEMBL4792999,CHEMBL217,Dopamine D2 receptor,Ki,=,250.0,nM,CHEMBL4736183,B,Displacement of [3H]raclopride from human D2R isoform 2 stably expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method,CHEMBL4732144,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccc(OCc3cn(CCOCCOCCOCCOCCn4cc(COc5ccc(-c6ccc(C(=O)NCCCCN(CCC)C7Cc8ccccc8C7)cc6)cc5)nn4)nn3)cc2)cc1)C1Cc2ccccc2C1
CHEMBL4740785,CHEMBL217,Dopamine D2 receptor,Ki,=,59.0,nM,CHEMBL4736183,B,Displacement of [3H]raclopride from human D2R isoform 2 stably expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method,CHEMBL4732144,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccc(OCc3cn(CCOCCOCCOCCOCCOCCn4cc(COc5ccc(-c6ccc(C(=O)NCCCCN(CCC)C7Cc8ccccc8C7)cc6)cc5)nn4)nn3)cc2)cc1)C1Cc2ccccc2C1
CHEMBL4856059,CHEMBL217,Dopamine D2 receptor,Ki,=,154.88,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)N[C@H](C)c1ccccc1
CHEMBL4860528,CHEMBL217,Dopamine D2 receptor,Ki,=,446.68,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C
CHEMBL4875600,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NC(C)c1cccc(F)c1
CHEMBL4846638,CHEMBL217,Dopamine D2 receptor,Ki,=,263.03,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NCC(C)C1CCCCC1
CHEMBL249420,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,CCCN[C@@H]1CCc2nc(N)sc2C1
CHEMBL4853668,CHEMBL217,Dopamine D2 receptor,Ki,=,562.34,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,CCCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C
CHEMBL4856005,CHEMBL217,Dopamine D2 receptor,Ki,=,602.56,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NCc1ccccc1
CHEMBL4867962,CHEMBL217,Dopamine D2 receptor,Ki,=,794.33,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)N[C@@H](C)c1ccccc1
CHEMBL4846380,CHEMBL217,Dopamine D2 receptor,Ki,=,1698.24,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NC(C)c1ccco1
CHEMBL4848815,CHEMBL217,Dopamine D2 receptor,Ki,=,524.81,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,CCC(CNC(=O)/N=C(\N)NCCCc1sc(N)nc1C)c1ccccc1
CHEMBL4857560,CHEMBL217,Dopamine D2 receptor,Ki,=,478.63,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NCC(C)CC1CCCCC1
CHEMBL4853107,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,Cc1ccc(CC(C)CNC(=O)/N=C(\N)NCCCc2sc(N)nc2C)cc1
CHEMBL4865765,CHEMBL217,Dopamine D2 receptor,Ki,=,354.81,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NCC(C)CCc1ccccc1
CHEMBL4846201,CHEMBL217,Dopamine D2 receptor,Ki,=,588.84,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NCC(C)CCCc1ccccc1
CHEMBL4853772,CHEMBL217,Dopamine D2 receptor,Ki,=,1174.9,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,Cc1nc(N)sc1CCCN/C(N)=N/C(=S)N[C@H](C)c1ccccc1
CHEMBL4872375,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,CCCCCCNC(=O)/N=C(\N)Nc1cccc(-c2csc(N)n2)c1
CHEMBL4876799,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,CCCCCCNC(=O)/N=C(\N)NC1CCc2nc(N)sc2C1
CHEMBL4878215,CHEMBL217,Dopamine D2 receptor,Ki,=,549.54,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,N/C(=N\C(=O)NCc1ccccc1)NC1CCc2nc(N)sc2C1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,0.263,nM,CHEMBL4815484,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,CHEMBL4813951,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL340211,CHEMBL217,Dopamine D2 receptor,Ki,=,228.0,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1
CHEMBL1940418,CHEMBL217,Dopamine D2 receptor,Ki,=,124.0,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,Fc1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL4875079,CHEMBL217,Dopamine D2 receptor,Ki,=,1092.0,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,CC(=O)Nc1ccc(C(=O)CCCN2CCN(c3ccccn3)CC2)cc1.O=C(O)C(=O)O
CHEMBL4859988,CHEMBL217,Dopamine D2 receptor,Ki,=,1930.0,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,CC(=O)Nc1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL4861794,CHEMBL217,Dopamine D2 receptor,Ki,=,1095.0,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,Nc1ccc(C(=O)CCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL4845741,CHEMBL217,Dopamine D2 receptor,Ki,=,674.0,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,Nc1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL4857597,CHEMBL217,Dopamine D2 receptor,Ki,=,526.5,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,O=C1CCc2cc(CCCCN3CCN(c4ccccn4)CC3)ccc2N1
CHEMBL4865591,CHEMBL217,Dopamine D2 receptor,Ki,=,2667.0,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,O=C1CCc2cc(OCCCN3CCN(c4ccccn4)CC3)ccc2N1
CHEMBL4859722,CHEMBL217,Dopamine D2 receptor,Ki,=,2798.0,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,O=C(O)C(=O)O.O=C1CCc2cc(OCCCN3CCCN(c4ccccn4)CC3)ccc2N1
CHEMBL4874069,CHEMBL217,Dopamine D2 receptor,Ki,=,699.0,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc2c(c1)CCC2
CHEMBL4866053,CHEMBL217,Dopamine D2 receptor,Ki,=,510.0,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,OC1c2ccc(F)cc2CC1CCN1CCN(c2ccccn2)CC1
CHEMBL4866058,CHEMBL217,Dopamine D2 receptor,Ki,=,1234.0,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,Clc1ccc2c(c1)CC(CCN1CCN(c3ccccn3)CC1)C2
CHEMBL4876297,CHEMBL217,Dopamine D2 receptor,Ki,=,4513.0,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,O=C1c2cc(Cl)ccc2CC1CCN1CCN(c2ccccn2)CC1
CHEMBL4854456,CHEMBL217,Dopamine D2 receptor,Ki,=,3071.0,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,O=C1c2cc(Cl)c(Cl)cc2CC1CCN1CCN(c2ccccn2)CC1
CHEMBL4857665,CHEMBL217,Dopamine D2 receptor,Ki,=,1056.0,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,O=C1c2ccc(Cl)cc2CC1CCCCN1CCN(c2ccccn2)CC1
CHEMBL4846823,CHEMBL217,Dopamine D2 receptor,Ki,=,1096.0,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,CC1(CCCN2CCN(c3ccccn3)CC2)Cc2cc(Cl)ccc2C1=O
CHEMBL4871868,CHEMBL217,Dopamine D2 receptor,Ki,=,3260.0,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,CC1(CCCCN2CCN(c3ccccn3)CC2)Cc2cc(Cl)ccc2C1=O
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,3.3,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL340211,CHEMBL217,Dopamine D2 receptor,Ki,=,229.09,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1
CHEMBL4875079,CHEMBL217,Dopamine D2 receptor,Ki,=,1096.48,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,CC(=O)Nc1ccc(C(=O)CCCN2CCN(c3ccccn3)CC2)cc1.O=C(O)C(=O)O
CHEMBL4859988,CHEMBL217,Dopamine D2 receptor,Ki,=,1949.84,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,CC(=O)Nc1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL4861794,CHEMBL217,Dopamine D2 receptor,Ki,=,1096.48,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,Nc1ccc(C(=O)CCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL4845741,CHEMBL217,Dopamine D2 receptor,Ki,=,676.08,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,Nc1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL4857597,CHEMBL217,Dopamine D2 receptor,Ki,=,501.19,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,O=C1CCc2cc(CCCCN3CCN(c4ccccn4)CC3)ccc2N1
CHEMBL4865591,CHEMBL217,Dopamine D2 receptor,Ki,=,2691.53,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,O=C1CCc2cc(OCCCN3CCN(c4ccccn4)CC3)ccc2N1
CHEMBL4859722,CHEMBL217,Dopamine D2 receptor,Ki,=,2818.38,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,O=C(O)C(=O)O.O=C1CCc2cc(OCCCN3CCCN(c4ccccn4)CC3)ccc2N1
CHEMBL4874069,CHEMBL217,Dopamine D2 receptor,Ki,=,691.83,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc2c(c1)CCC2
CHEMBL4866058,CHEMBL217,Dopamine D2 receptor,Ki,=,1230.27,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,Clc1ccc2c(c1)CC(CCN1CCN(c3ccccn3)CC1)C2
CHEMBL4876297,CHEMBL217,Dopamine D2 receptor,Ki,=,4466.84,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,O=C1c2cc(Cl)ccc2CC1CCN1CCN(c2ccccn2)CC1
CHEMBL4854456,CHEMBL217,Dopamine D2 receptor,Ki,=,3090.3,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,O=C1c2cc(Cl)c(Cl)cc2CC1CCN1CCN(c2ccccn2)CC1
CHEMBL4857665,CHEMBL217,Dopamine D2 receptor,Ki,=,1047.13,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,O=C1c2ccc(Cl)cc2CC1CCCCN1CCN(c2ccccn2)CC1
CHEMBL4846823,CHEMBL217,Dopamine D2 receptor,Ki,=,1096.48,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,CC1(CCCN2CCN(c3ccccn3)CC2)Cc2cc(Cl)ccc2C1=O
CHEMBL4871868,CHEMBL217,Dopamine D2 receptor,Ki,=,3235.94,nM,CHEMBL4815619,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL4813955,KI,CC1(CCCCN2CCN(c3ccccn3)CC2)Cc2cc(Cl)ccc2C1=O
CHEMBL4447416,CHEMBL217,Dopamine D2 receptor,Ki,=,1001.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CC(Oc1ccccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4847379,CHEMBL217,Dopamine D2 receptor,Ki,=,1506.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CCC(Oc1ccccc1)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4855393,CHEMBL217,Dopamine D2 receptor,Ki,=,432.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CC(Oc1cccc(Cl)c1Cl)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4873623,CHEMBL217,Dopamine D2 receptor,Ki,=,421.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CCC(Oc1cccc(Cl)c1Cl)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4869411,CHEMBL217,Dopamine D2 receptor,Ki,=,495.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CCCC(Oc1cccc(Cl)c1Cl)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4873127,CHEMBL217,Dopamine D2 receptor,Ki,=,506.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CCCCC(Oc1cccc(Cl)c1Cl)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4860719,CHEMBL217,Dopamine D2 receptor,Ki,=,206.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CN1CCN(c2nc(N)nc(CCCOc3cccc(Cl)c3Cl)n2)CC1
CHEMBL4846146,CHEMBL217,Dopamine D2 receptor,Ki,=,375.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CC(Oc1cc(Cl)ccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4860275,CHEMBL217,Dopamine D2 receptor,Ki,=,320.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CCC(Oc1cc(Cl)ccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4858771,CHEMBL217,Dopamine D2 receptor,Ki,=,229.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CCCC(Oc1cc(Cl)ccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4864863,CHEMBL217,Dopamine D2 receptor,Ki,=,103.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CCCCC(Oc1cc(Cl)ccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4849230,CHEMBL217,Dopamine D2 receptor,Ki,=,413.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CN1CCN(c2nc(N)nc(CCCOc3cc(Cl)ccc3Cl)n2)CC1
CHEMBL4861431,CHEMBL217,Dopamine D2 receptor,Ki,=,754.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CC(Oc1ccc(Cl)c(Cl)c1)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4857676,CHEMBL217,Dopamine D2 receptor,Ki,=,580.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CCC(Oc1ccc(Cl)c(Cl)c1)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4868911,CHEMBL217,Dopamine D2 receptor,Ki,=,356.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CN1CCN(c2nc(N)nc(CCCOc3ccc(Cl)c(Cl)c3)n2)CC1
CHEMBL4860006,CHEMBL217,Dopamine D2 receptor,Ki,=,157.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CC(Oc1cc(Cl)cc(Cl)c1)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4876727,CHEMBL217,Dopamine D2 receptor,Ki,=,368.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CCC(Oc1cc(Cl)cc(Cl)c1)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4864448,CHEMBL217,Dopamine D2 receptor,Ki,=,377.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CCCC(Oc1cc(Cl)cc(Cl)c1)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4849077,CHEMBL217,Dopamine D2 receptor,Ki,=,270.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,CCCCC(Oc1cc(Cl)cc(Cl)c1)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,9.0,nM,CHEMBL4819277,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,CHEMBL4818985,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL2387229,CHEMBL217,Dopamine D2 receptor,Ki,=,2.6,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,Cc1cc(=O)oc2c(Cl)c(OCCCCN3CCC(c4noc5cc(F)ccc45)CC3)ccc12
CHEMBL3883955,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,O=c1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)nn1-c1c(F)cccc1F
CHEMBL4289498,CHEMBL217,Dopamine D2 receptor,Ki,=,2.9,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,O=C(CCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2c3c(c1)CCN3C(=O)CC2
CHEMBL4852663,CHEMBL217,Dopamine D2 receptor,Ki,=,12.2,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCCC5)cc4)CC3)noc2c1
CHEMBL4879054,CHEMBL217,Dopamine D2 receptor,Ki,=,14.1,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCCC5)cc4Cl)CC3)noc2c1
CHEMBL4857350,CHEMBL217,Dopamine D2 receptor,Ki,=,12.6,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,Cc1cc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccc1CN1CCCC1
CHEMBL4877940,CHEMBL217,Dopamine D2 receptor,Ki,=,6.2,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,COc1cc(CN2CCCC2)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1
CHEMBL4865735,CHEMBL217,Dopamine D2 receptor,Ki,=,10.8,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCCCC5)cc4)CC3)noc2c1
CHEMBL4861311,CHEMBL217,Dopamine D2 receptor,Ki,=,9.7,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,Fc1ccc2c(C3CCN(CCCOc4ccc(CCN5CCCCC5)cc4)CC3)noc2c1
CHEMBL4859348,CHEMBL217,Dopamine D2 receptor,Ki,=,10.3,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCCCC5)cc4F)CC3)noc2c1
CHEMBL4876719,CHEMBL217,Dopamine D2 receptor,Ki,=,11.6,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCCCC5)c(F)c4)CC3)noc2c1
CHEMBL4870307,CHEMBL217,Dopamine D2 receptor,Ki,=,9.5,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,COc1cc(CN2CCCCC2)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1
CHEMBL4870716,CHEMBL217,Dopamine D2 receptor,Ki,=,1.5,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCOCC5)cc4)CC3)noc2c1
CHEMBL4856753,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,Fc1ccc2c(C3CCN(CCCCOc4ccc(CN5CCOCC5)cc4)CC3)noc2c1
CHEMBL4860828,CHEMBL217,Dopamine D2 receptor,Ki,=,1.9,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCOCC5)cc4F)CC3)noc2c1
CHEMBL4878271,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCOCC5)c(F)c4)CC3)noc2c1
CHEMBL4853342,CHEMBL217,Dopamine D2 receptor,Ki,=,2.5,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCOCC5)cc4Cl)CC3)noc2c1
CHEMBL4863980,CHEMBL217,Dopamine D2 receptor,Ki,=,5.4,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCOCC5)c(Cl)c4)CC3)noc2c1
CHEMBL4877973,CHEMBL217,Dopamine D2 receptor,Ki,=,3.1,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,Cc1cc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccc1CN1CCOCC1
CHEMBL4873319,CHEMBL217,Dopamine D2 receptor,Ki,=,2.6,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,COc1cc(CN2CCOCC2)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1
CHEMBL4861193,CHEMBL217,Dopamine D2 receptor,Ki,=,7.4,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,CC1CCN(CCc2ccc(OCCCN3CCC(c4noc5cc(F)ccc45)CC3)cc2)CC1
CHEMBL4861643,CHEMBL217,Dopamine D2 receptor,Ki,=,2.7,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,CC1CCN(CCc2ccc(OCCCCN3CCC(c4noc5cc(F)ccc45)CC3)cc2)CC1
CHEMBL4865907,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,CN1CCN(Cc2ccc(OCCCN3CCC(c4noc5cc(F)ccc45)CC3)cc2)CC1
CHEMBL4846866,CHEMBL217,Dopamine D2 receptor,Ki,=,1.9,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,CN1CCN(Cc2ccc(OCCCCN3CCC(c4noc5cc(F)ccc45)CC3)cc2)CC1
CHEMBL4857918,CHEMBL217,Dopamine D2 receptor,Ki,=,13.4,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,CN1CCN(CCc2ccc(OCCCN3CCC(c4noc5cc(F)ccc45)CC3)cc2)CC1
CHEMBL4867978,CHEMBL217,Dopamine D2 receptor,Ki,=,10.5,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,Fc1ccc2c(C3CCN(CCCOc4ccc(CCN5CCOCC5)cc4)CC3)noc2c1
CHEMBL85,CHEMBL217,Dopamine D2 receptor,Ki,=,3.9,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,9.7,nM,CHEMBL4821052,B,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL4819047,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL394110,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL4821476,B,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,CHEMBL4819072,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1
CHEMBL238915,CHEMBL217,Dopamine D2 receptor,Ki,=,177.0,nM,CHEMBL4821476,B,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,CHEMBL4819072,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL238916,CHEMBL217,Dopamine D2 receptor,Ki,=,113.0,nM,CHEMBL4821476,B,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,CHEMBL4819072,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1
CHEMBL238917,CHEMBL217,Dopamine D2 receptor,Ki,=,360.0,nM,CHEMBL4821476,B,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,CHEMBL4819072,KI,COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1
CHEMBL8412,CHEMBL217,Dopamine D2 receptor,Ki,=,1224.0,nM,CHEMBL4821476,B,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,CHEMBL4819072,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ncccn2)CC1
CHEMBL4565558,CHEMBL217,Dopamine D2 receptor,Ki,=,1.0,nM,CHEMBL4821476,B,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,CHEMBL4819072,KI,COc1ccccc1N1CCN(CCCCCCN2C(=O)c3ccccc3S2(=O)=O)CC1
CHEMBL4470487,CHEMBL217,Dopamine D2 receptor,Ki,=,51.0,nM,CHEMBL4821476,B,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,CHEMBL4819072,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ncccn2)CC1
CHEMBL4860626,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL4821476,B,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,CHEMBL4819072,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL4872713,CHEMBL217,Dopamine D2 receptor,Ki,=,165.0,nM,CHEMBL4821476,B,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,CHEMBL4819072,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2ccccc2)CC1
CHEMBL4860754,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL4821476,B,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,CHEMBL4819072,KI,COc1ccccc1N1CCN(CCCCCN2C(=O)c3ccccc3S2(=O)=O)CC1
CHEMBL4869198,CHEMBL217,Dopamine D2 receptor,Ki,=,17.0,nM,CHEMBL4821476,B,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,CHEMBL4819072,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL4867109,CHEMBL217,Dopamine D2 receptor,Ki,=,254.0,nM,CHEMBL4821476,B,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,CHEMBL4819072,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL4874914,CHEMBL217,Dopamine D2 receptor,Ki,=,34.0,nM,CHEMBL4821476,B,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,CHEMBL4819072,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1
CHEMBL4873100,CHEMBL217,Dopamine D2 receptor,Ki,=,954.0,nM,CHEMBL4821476,B,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,CHEMBL4819072,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2ncccn2)CC1
CHEMBL4853700,CHEMBL217,Dopamine D2 receptor,Ki,=,92.0,nM,CHEMBL4821476,B,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,CHEMBL4819072,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2ccccn2)CC1
CHEMBL4866981,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL4821476,B,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,CHEMBL4819072,KI,O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2cccc3ccccc23)CC1
CHEMBL4876545,CHEMBL217,Dopamine D2 receptor,Ki,=,2.0,nM,CHEMBL4821476,B,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,CHEMBL4819072,KI,COc1ccccc1N1CCN(Cc2ccc(CN3C(=O)c4ccccc4S3(=O)=O)cc2)CC1
CHEMBL4855019,CHEMBL217,Dopamine D2 receptor,Ki,=,310.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccc3ccccc3c1)CC2
CHEMBL4863748,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccccc1Cl)CC2
CHEMBL4856161,CHEMBL217,Dopamine D2 receptor,Ki,=,420.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccccc1Br)CC2
CHEMBL4878121,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccccc1OC)CC2
CHEMBL4854512,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1cccc(Cl)c1)CC2
CHEMBL4876926,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1cccc(Br)c1)CC2
CHEMBL4867331,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1cccc(C(=O)NCc2ccccc2CN2CCc3cc(OC)c(O)cc3C2)c1
CHEMBL4877460,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1cccc(C#N)c1)CC2
CHEMBL4876207,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccc(F)cc1)CC2
CHEMBL4854935,CHEMBL217,Dopamine D2 receptor,Ki,=,47.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccc(Cl)cc1)CC2
CHEMBL4848910,CHEMBL217,Dopamine D2 receptor,Ki,=,76.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccc(Br)cc1)CC2
CHEMBL4855361,CHEMBL217,Dopamine D2 receptor,Ki,=,84.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccc(I)cc1)CC2
CHEMBL4857166,CHEMBL217,Dopamine D2 receptor,Ki,=,74.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1ccc(C(=O)NCc2ccccc2CN2CCc3cc(OC)c(O)cc3C2)cc1
CHEMBL4876546,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccc(C#N)cc1)CC2
CHEMBL4862839,CHEMBL217,Dopamine D2 receptor,Ki,=,280.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1cccc(Cl)c1Cl)CC2
CHEMBL4855891,CHEMBL217,Dopamine D2 receptor,Ki,=,27.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccc(I)c(OC)c1)CC2
CHEMBL4846574,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1OC)CN(Cc1ccccc1CNC(=O)c1cccc(C#N)c1)CC2
CHEMBL4878587,CHEMBL217,Dopamine D2 receptor,Ki,=,50.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1OC)CN(Cc1ccccc1CNC(=O)c1ccc(C#N)cc1)CC2
CHEMBL4876260,CHEMBL217,Dopamine D2 receptor,Ki,=,56.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,O=C(NCc1ccccc1CN1CCc2cc(O)c(O)cc2C1)c1cccc(Br)c1
CHEMBL4849499,CHEMBL217,Dopamine D2 receptor,Ki,=,900.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,N#Cc1cccc(C(=O)NCc2ccccc2CN2CCc3cc(O)c(O)cc3C2)c1
CHEMBL4860225,CHEMBL217,Dopamine D2 receptor,Ki,=,83.0,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,N#Cc1ccc(C(=O)NCc2ccccc2CN2CCc3cc(O)c(O)cc3C2)cc1
CHEMBL20734,CHEMBL217,Dopamine D2 receptor,Ki,=,2.61,nM,CHEMBL4822008,B,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),CHEMBL4819092,KI,CNc1cc(OC)c(C(=O)NC2CCN(Cc3ccccc3)C2C)cc1Cl
CHEMBL4878826,CHEMBL217,Dopamine D2 receptor,Ki,=,473.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1ccc(Cl)cc1
CHEMBL4878501,CHEMBL217,Dopamine D2 receptor,Ki,=,723.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1ccc2ccccc2c1
CHEMBL4845838,CHEMBL217,Dopamine D2 receptor,Ki,=,897.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1ccc(Br)cc1
CHEMBL4862399,CHEMBL217,Dopamine D2 receptor,Ki,=,563.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1cccc2ccccc12
CHEMBL4854126,CHEMBL217,Dopamine D2 receptor,Ki,=,1025.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1ccc(-c2ccccc2)cc1
CHEMBL4863032,CHEMBL217,Dopamine D2 receptor,Ki,=,708.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1cc(C(=O)NCCCCN2CCO[C@@H]3c4ccccc4OC[C@H]32)cc(OC)c1OC
CHEMBL4875008,CHEMBL217,Dopamine D2 receptor,Ki,=,785.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1cc2ccccc2[nH]1
CHEMBL4878577,CHEMBL217,Dopamine D2 receptor,Ki,=,663.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1cccc(Cl)c1
CHEMBL4862320,CHEMBL217,Dopamine D2 receptor,Ki,=,568.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccc(C(=O)NCCCCN2CCO[C@@H]3c4ccccc4OC[C@H]32)cc1
CHEMBL4848907,CHEMBL217,Dopamine D2 receptor,Ki,=,853.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1ccco1
CHEMBL4869122,CHEMBL217,Dopamine D2 receptor,Ki,=,962.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1ccc([N+](=O)[O-])cc1
CHEMBL4849734,CHEMBL217,Dopamine D2 receptor,Ki,=,863.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccccc1C(=O)NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21
CHEMBL4848199,CHEMBL217,Dopamine D2 receptor,Ki,=,776.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1ccccc1
CHEMBL4855711,CHEMBL217,Dopamine D2 receptor,Ki,=,417.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1cccs1
CHEMBL4869668,CHEMBL217,Dopamine D2 receptor,Ki,=,728.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)C1CCCCC1
CHEMBL4853503,CHEMBL217,Dopamine D2 receptor,Ki,=,958.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3ccc(Br)cc3)[C@@H]1CO2
CHEMBL4864074,CHEMBL217,Dopamine D2 receptor,Ki,=,1065.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3ccc(-c4ccccc4)cc3)[C@@H]1CO2
CHEMBL4860687,CHEMBL217,Dopamine D2 receptor,Ki,=,967.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3ccc(Cl)cc3)[C@@H]1CO2
CHEMBL4877715,CHEMBL217,Dopamine D2 receptor,Ki,=,861.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3cccc4ccccc34)[C@@H]1CO2
CHEMBL4854351,CHEMBL217,Dopamine D2 receptor,Ki,=,732.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3cc4ccccc4[nH]3)[C@@H]1CO2
CHEMBL4855879,CHEMBL217,Dopamine D2 receptor,Ki,=,962.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3cc(OC)c(OC)c(OC)c3)[C@@H]1CO2
CHEMBL4864813,CHEMBL217,Dopamine D2 receptor,Ki,=,589.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3ccc([N+](=O)[O-])cc3)[C@@H]1CO2
CHEMBL4864112,CHEMBL217,Dopamine D2 receptor,Ki,=,697.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccc(C(=O)NCCCCN2CCO[C@@H]3c4cc(OC)ccc4OC[C@H]32)cc1
CHEMBL4875181,CHEMBL217,Dopamine D2 receptor,Ki,=,923.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3ccco3)[C@@H]1CO2
CHEMBL4862275,CHEMBL217,Dopamine D2 receptor,Ki,=,688.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)C3CCCCC3)[C@@H]1CO2
CHEMBL4862790,CHEMBL217,Dopamine D2 receptor,Ki,=,744.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3cccnc3)[C@@H]1CO2
CHEMBL4852472,CHEMBL217,Dopamine D2 receptor,Ki,=,803.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3cccs3)[C@@H]1CO2
CHEMBL4853993,CHEMBL217,Dopamine D2 receptor,Ki,=,785.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3cccc(Cl)c3)[C@@H]1CO2
CHEMBL4848710,CHEMBL217,Dopamine D2 receptor,Ki,=,568.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3ccccc3)[C@@H]1CO2
CHEMBL4864969,CHEMBL217,Dopamine D2 receptor,Ki,=,642.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3ccc4ccccc4c3)[C@@H]1CO2
CHEMBL25236,CHEMBL217,Dopamine D2 receptor,Ki,=,69.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL70565,CHEMBL217,Dopamine D2 receptor,Ki,=,43.0,nM,CHEMBL4825013,B,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,CHEMBL4823295,KI,CCCN1CCO[C@@H]2c3cc(O)ccc3OC[C@H]21
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.687,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL8946,CHEMBL217,Dopamine D2 receptor,Ki,=,0.117,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1O
CHEMBL4861573,CHEMBL217,Dopamine D2 receptor,Ki,=,2.26,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2)c1O.Cl
CHEMBL4865434,CHEMBL217,Dopamine D2 receptor,Ki,=,0.688,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCCN1CCC[C@H]1CNC(=O)c1c(O)c(CC)cc(Cl)c1OC
CHEMBL4858824,CHEMBL217,Dopamine D2 receptor,Ki,=,205.0,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2Cc2ccccc2)c1O
CHEMBL4868275,CHEMBL217,Dopamine D2 receptor,Ki,=,2590.0,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2Cc2ccccc2)c1OCc1ccccc1
CHEMBL4864366,CHEMBL217,Dopamine D2 receptor,Ki,=,162.0,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CCCc2ccccc2)c1O
CHEMBL4876353,CHEMBL217,Dopamine D2 receptor,Ki,=,74.4,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CCc2c(C)nc3n(c2=O)CCCC3)c1O
CHEMBL4849107,CHEMBL217,Dopamine D2 receptor,Ki,=,25.3,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CCCCOc2ccc3c(c2)NC(=O)CC3)c1O
CHEMBL4853938,CHEMBL217,Dopamine D2 receptor,Ki,=,27.6,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CCCCNC(=O)c2cc3ccccc3o2)c1O
CHEMBL4871811,CHEMBL217,Dopamine D2 receptor,Ki,=,173.0,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CCCCNC(=O)c2cc3ccccc3[nH]2)c1O
CHEMBL4875195,CHEMBL217,Dopamine D2 receptor,Ki,=,217.0,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NCC2CCN(C)C2)c1O
CHEMBL4871669,CHEMBL217,Dopamine D2 receptor,Ki,=,38.2,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NCC2CCN(CC)C2)c1O
CHEMBL4858961,CHEMBL217,Dopamine D2 receptor,Ki,=,66.4,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCCN1CCC(CNC(=O)c2c(O)c(CC)cc(Cl)c2OC)C1
CHEMBL4862405,CHEMBL217,Dopamine D2 receptor,Ki,=,1310.0,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NCC2CCCN(CCCCNC(=O)c3cc4ccccc4[nH]3)C2)c1O
CHEMBL4869151,CHEMBL217,Dopamine D2 receptor,Ki,=,1760.0,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NCC2CCCN(CCCCNC(=O)c3cc4ccccc4o3)C2)c1O
CHEMBL4873313,CHEMBL217,Dopamine D2 receptor,Ki,=,1.77,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCCOc3ccc4c(c3)NC(=O)CC4)CN2)c1O
CHEMBL4864320,CHEMBL217,Dopamine D2 receptor,Ki,=,2.57,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCCN1C[C@H](OCCCCOc2ccc3c(c2)NC(=O)CC3)C[C@H]1CNC(=O)c1c(O)c(CC)cc(Cl)c1OC
CHEMBL4860478,CHEMBL217,Dopamine D2 receptor,Ki,=,2.54,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCCNC(=O)c3cc4ccccc4[nH]3)CN2)c1O
CHEMBL4850300,CHEMBL217,Dopamine D2 receptor,Ki,=,2.29,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCCNC(=O)c3cc4ccccc4o3)CN2)c1O
CHEMBL4853568,CHEMBL217,Dopamine D2 receptor,Ki,=,1.86,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCCNC(=O)c3cc4ccccc4[nH]3)CN2CC)c1O
CHEMBL4846561,CHEMBL217,Dopamine D2 receptor,Ki,=,0.947,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCCNC(=O)c3cc4ccccc4o3)CN2CC)c1O
CHEMBL4868595,CHEMBL217,Dopamine D2 receptor,Ki,=,7.42,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCc3ccccc3)CN2)c1O
CHEMBL4856983,CHEMBL217,Dopamine D2 receptor,Ki,=,7.24,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCCOCc3ccccc3)CN2)c1O
CHEMBL4847432,CHEMBL217,Dopamine D2 receptor,Ki,=,1.9,nM,CHEMBL4828545,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,CHEMBL4825766,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCCO)CN2)c1O
CHEMBL4862301,CHEMBL217,Dopamine D2 receptor,Ki,=,61.9,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4862301,CHEMBL217,Dopamine D2 receptor,Ki,=,61.66,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4872548,CHEMBL217,Dopamine D2 receptor,Ki,=,59.9,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4872548,CHEMBL217,Dopamine D2 receptor,Ki,=,60.26,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4863992,CHEMBL217,Dopamine D2 receptor,Ki,=,125.7,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4863992,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4850635,CHEMBL217,Dopamine D2 receptor,Ki,=,155.7,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4850635,CHEMBL217,Dopamine D2 receptor,Ki,=,154.88,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4859394,CHEMBL217,Dopamine D2 receptor,Ki,=,259.2,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCCCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4859394,CHEMBL217,Dopamine D2 receptor,Ki,=,257.04,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCCCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4871774,CHEMBL217,Dopamine D2 receptor,Ki,=,217.8,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCCCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4871774,CHEMBL217,Dopamine D2 receptor,Ki,=,218.78,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCCCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4855775,CHEMBL217,Dopamine D2 receptor,Ki,=,453.9,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNC/C=C/COc1ccc2c(c1)NC(=O)CC2
CHEMBL4855775,CHEMBL217,Dopamine D2 receptor,Ki,=,457.09,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNC/C=C/COc1ccc2c(c1)NC(=O)CC2
CHEMBL4871762,CHEMBL217,Dopamine D2 receptor,Ki,=,126.7,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNC/C=C/COc1ccc2ccc(=O)[nH]c2c1
CHEMBL4871762,CHEMBL217,Dopamine D2 receptor,Ki,=,125.89,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNC/C=C/COc1ccc2ccc(=O)[nH]c2c1
CHEMBL4845711,CHEMBL217,Dopamine D2 receptor,Ki,=,1825.0,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCC[C@H]1CC[C@H](NC(=O)N(C)C)CC1
CHEMBL4845711,CHEMBL217,Dopamine D2 receptor,Ki,=,1819.7,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCC[C@H]1CC[C@H](NC(=O)N(C)C)CC1
CHEMBL4874131,CHEMBL217,Dopamine D2 receptor,Ki,=,2188.0,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCC[C@H]1CC[C@H](NC(=O)N2CCCC2)CC1
CHEMBL4874131,CHEMBL217,Dopamine D2 receptor,Ki,=,2187.76,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCC[C@H]1CC[C@H](NC(=O)N2CCCC2)CC1
CHEMBL4876611,CHEMBL217,Dopamine D2 receptor,Ki,=,1040.0,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCC[C@H]1CC[C@H](NC(=O)c2ccccc2)CC1
CHEMBL4876611,CHEMBL217,Dopamine D2 receptor,Ki,=,1047.13,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCC[C@H]1CC[C@H](NC(=O)c2ccccc2)CC1
CHEMBL4864369,CHEMBL217,Dopamine D2 receptor,Ki,=,977.2,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCC[C@H]1CC[C@H](NS(=O)(=O)c2ccccc2)CC1
CHEMBL4864369,CHEMBL217,Dopamine D2 receptor,Ki,=,977.24,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccccc1C1CC1CNCC[C@H]1CC[C@H](NS(=O)(=O)c2ccccc2)CC1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,2.13,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,2.138,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2105760,CHEMBL217,Dopamine D2 receptor,Ki,=,0.51,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1
CHEMBL2105760,CHEMBL217,Dopamine D2 receptor,Ki,=,0.5129,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,Ki,=,1.45,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,Ki,=,1.445,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,6.33,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,6.31,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4871833,CHEMBL217,Dopamine D2 receptor,Ki,=,244.3,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc(Cl)c3Cl)cc2N1
CHEMBL4871833,CHEMBL217,Dopamine D2 receptor,Ki,=,245.47,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc(Cl)c3Cl)cc2N1
CHEMBL4859080,CHEMBL217,Dopamine D2 receptor,Ki,=,128.1,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc(Cl)c3Cl)cc2[nH]1
CHEMBL4859080,CHEMBL217,Dopamine D2 receptor,Ki,=,128.82,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc(Cl)c3Cl)cc2[nH]1
CHEMBL4870140,CHEMBL217,Dopamine D2 receptor,Ki,=,321.6,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cccc(Cl)c1Cl
CHEMBL4870140,CHEMBL217,Dopamine D2 receptor,Ki,=,323.59,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cccc(Cl)c1Cl
CHEMBL4846101,CHEMBL217,Dopamine D2 receptor,Ki,=,426.6,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CCCN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC1CC1c1cccc(Cl)c1Cl
CHEMBL4846101,CHEMBL217,Dopamine D2 receptor,Ki,=,426.58,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CCCN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC1CC1c1cccc(Cl)c1Cl
CHEMBL4851121,CHEMBL217,Dopamine D2 receptor,Ki,=,1330.0,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCNCC2CC2c2cccc(Cl)c2Cl)CC1
CHEMBL4851121,CHEMBL217,Dopamine D2 receptor,Ki,=,1122.02,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCNCC2CC2c2cccc(Cl)c2Cl)CC1
CHEMBL4861553,CHEMBL217,Dopamine D2 receptor,Ki,=,365.6,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CSc1ccccc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4861553,CHEMBL217,Dopamine D2 receptor,Ki,=,363.08,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CSc1ccccc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4877827,CHEMBL217,Dopamine D2 receptor,Ki,=,95.2,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CSc1ccccc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4877827,CHEMBL217,Dopamine D2 receptor,Ki,=,95.5,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CSc1ccccc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4854391,CHEMBL217,Dopamine D2 receptor,Ki,=,384.3,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc4c3OCCO4)cc2N1
CHEMBL4854391,CHEMBL217,Dopamine D2 receptor,Ki,=,380.19,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc4c3OCCO4)cc2N1
CHEMBL4859567,CHEMBL217,Dopamine D2 receptor,Ki,=,178.0,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc4c3OCCO4)cc2[nH]1
CHEMBL4859567,CHEMBL217,Dopamine D2 receptor,Ki,=,177.83,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc4c3OCCO4)cc2[nH]1
CHEMBL4870901,CHEMBL217,Dopamine D2 receptor,Ki,=,2309.0,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCNCC2CC2c2cccc3c2OCCO3)CC1
CHEMBL4870901,CHEMBL217,Dopamine D2 receptor,Ki,=,2290.87,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCNCC2CC2c2cccc3c2OCCO3)CC1
CHEMBL4863636,CHEMBL217,Dopamine D2 receptor,Ki,=,299.9,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc4ccccc34)cc2N1
CHEMBL4863636,CHEMBL217,Dopamine D2 receptor,Ki,=,302.0,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc4ccccc34)cc2N1
CHEMBL4848451,CHEMBL217,Dopamine D2 receptor,Ki,=,98.3,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc4ccccc34)cc2[nH]1
CHEMBL4848451,CHEMBL217,Dopamine D2 receptor,Ki,=,97.72,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc4ccccc34)cc2[nH]1
CHEMBL4863920,CHEMBL217,Dopamine D2 receptor,Ki,=,832.4,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCNCC2CC2c2cccc3ccccc23)CC1
CHEMBL4863920,CHEMBL217,Dopamine D2 receptor,Ki,=,831.76,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCNCC2CC2c2cccc3ccccc23)CC1
CHEMBL4862439,CHEMBL217,Dopamine D2 receptor,Ki,=,49.3,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(F)cc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4862439,CHEMBL217,Dopamine D2 receptor,Ki,=,48.98,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(F)cc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4872467,CHEMBL217,Dopamine D2 receptor,Ki,=,42.7,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(F)cc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4872467,CHEMBL217,Dopamine D2 receptor,Ki,=,42.66,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(F)cc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4864436,CHEMBL217,Dopamine D2 receptor,Ki,=,27.4,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(F)cc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4864436,CHEMBL217,Dopamine D2 receptor,Ki,=,27.54,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(F)cc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4874021,CHEMBL217,Dopamine D2 receptor,Ki,=,25.8,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(F)cc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4874021,CHEMBL217,Dopamine D2 receptor,Ki,=,25.7,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(F)cc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4859410,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(Cl)cc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4859410,CHEMBL217,Dopamine D2 receptor,Ki,=,38.02,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(Cl)cc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4857759,CHEMBL217,Dopamine D2 receptor,Ki,=,15.6,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(Cl)cc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4857759,CHEMBL217,Dopamine D2 receptor,Ki,=,15.49,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(Cl)cc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4852808,CHEMBL217,Dopamine D2 receptor,Ki,=,32.2,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(Cl)cc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4852808,CHEMBL217,Dopamine D2 receptor,Ki,=,32.36,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(Cl)cc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4846472,CHEMBL217,Dopamine D2 receptor,Ki,=,32.9,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(Cl)cc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4846472,CHEMBL217,Dopamine D2 receptor,Ki,=,33.11,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(Cl)cc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4865389,CHEMBL217,Dopamine D2 receptor,Ki,=,322.5,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CCN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(F)ccc1OC
CHEMBL4865389,CHEMBL217,Dopamine D2 receptor,Ki,=,323.59,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CCN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(F)ccc1OC
CHEMBL4865118,CHEMBL217,Dopamine D2 receptor,Ki,=,159.0,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CCN(CCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(F)ccc1OC
CHEMBL4865118,CHEMBL217,Dopamine D2 receptor,Ki,=,158.49,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CCN(CCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(F)ccc1OC
CHEMBL4849780,CHEMBL217,Dopamine D2 receptor,Ki,=,263.3,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CCN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(Cl)ccc1OC
CHEMBL4849780,CHEMBL217,Dopamine D2 receptor,Ki,=,263.03,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CCN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(Cl)ccc1OC
CHEMBL4855583,CHEMBL217,Dopamine D2 receptor,Ki,=,214.0,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CCN(CCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(Cl)ccc1OC
CHEMBL4855583,CHEMBL217,Dopamine D2 receptor,Ki,=,213.8,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CCN(CCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(Cl)ccc1OC
CHEMBL4862890,CHEMBL217,Dopamine D2 receptor,Ki,=,20.8,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4862890,CHEMBL217,Dopamine D2 receptor,Ki,=,20.89,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4852524,CHEMBL217,Dopamine D2 receptor,Ki,=,43.8,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(F)cc1[C@@H]1C[C@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4852524,CHEMBL217,Dopamine D2 receptor,Ki,=,43.65,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(F)cc1[C@@H]1C[C@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4863832,CHEMBL217,Dopamine D2 receptor,Ki,=,6.58,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4863832,CHEMBL217,Dopamine D2 receptor,Ki,=,6.607,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4852835,CHEMBL217,Dopamine D2 receptor,Ki,=,362.5,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(F)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4852835,CHEMBL217,Dopamine D2 receptor,Ki,=,363.08,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(F)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4862770,CHEMBL217,Dopamine D2 receptor,Ki,=,11.5,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4862770,CHEMBL217,Dopamine D2 receptor,Ki,=,11.48,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2c(c1)NC(=O)CC2
CHEMBL4876116,CHEMBL217,Dopamine D2 receptor,Ki,=,30.1,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(Cl)cc1[C@@H]1C[C@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4876116,CHEMBL217,Dopamine D2 receptor,Ki,=,30.2,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(Cl)cc1[C@@H]1C[C@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4875081,CHEMBL217,Dopamine D2 receptor,Ki,=,12.8,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4875081,CHEMBL217,Dopamine D2 receptor,Ki,=,12.88,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4867794,CHEMBL217,Dopamine D2 receptor,Ki,=,317.0,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(Cl)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4867794,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL4842092,B,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,COc1ccc(Cl)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4867565,CHEMBL217,Dopamine D2 receptor,Ki,=,4392.0,nM,CHEMBL4844536,B,Displacement of [3H]-haloperidol from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4842371,KI,O=S(=O)(c1cccc(F)c1)n1ccc2c(N3CCNCC3)nc3ccccc3c21
CHEMBL4846153,CHEMBL217,Dopamine D2 receptor,Ki,=,1345.0,nM,CHEMBL4844536,B,Displacement of [3H]-haloperidol from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4842371,KI,O=S(=O)(c1cccc(Cl)c1)n1ccc2c(N3CCNCC3)nc3ccccc3c21
CHEMBL4870374,CHEMBL217,Dopamine D2 receptor,Ki,=,2156.0,nM,CHEMBL4844536,B,Displacement of [3H]-haloperidol from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,CHEMBL4842371,KI,Cc1cccc(S(=O)(=O)n2ccc3c(N4CCNCC4)nc4ccccc4c32)c1
CHEMBL4526351,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4507270,KI,Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
CHEMBL4526351,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4507270,KI,Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
CHEMBL4520788,CHEMBL217,Dopamine D2 receptor,Ki,=,2333.64,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4507273,KI,CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
CHEMBL4520788,CHEMBL217,Dopamine D2 receptor,Ki,=,1995.26,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4507273,KI,CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
CHEMBL4558518,CHEMBL217,Dopamine D2 receptor,Ki,=,1219.0,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4507288,KI,CC(C)(C)OC(=O)N1CCCC1CNC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1
CHEMBL4558518,CHEMBL217,Dopamine D2 receptor,Ki,=,1258.93,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4507288,KI,CC(C)(C)OC(=O)N1CCCC1CNC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1
CHEMBL561132,CHEMBL217,Dopamine D2 receptor,Ki,=,3746.0,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4507290,KI,CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1
CHEMBL561132,CHEMBL217,Dopamine D2 receptor,Ki,=,3981.07,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4507290,KI,CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1
CHEMBL3480577,CHEMBL217,Dopamine D2 receptor,Ki,=,4328.0,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4507309,KI,Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1
CHEMBL3480577,CHEMBL217,Dopamine D2 receptor,Ki,=,3981.07,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4507309,KI,Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1
CHEMBL4456585,CHEMBL217,Dopamine D2 receptor,Ki,=,397.52,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4507321,KI,O=C(NNS(=O)(=O)c1ccccc1F)c1cc(F)cc(-c2ccccn2)c1
CHEMBL4456585,CHEMBL217,Dopamine D2 receptor,Ki,=,389.05,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4507321,KI,O=C(NNS(=O)(=O)c1ccccc1F)c1cc(F)cc(-c2ccccn2)c1
CHEMBL4520293,CHEMBL217,Dopamine D2 receptor,Ki,=,369.37,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4507322,KI,CN(C)[C@@H]1CCN(c2cc(-c3ccccc3)nc3ccnn23)C1
CHEMBL4520293,CHEMBL217,Dopamine D2 receptor,Ki,=,354.81,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4507322,KI,CN(C)[C@@H]1CCN(c2cc(-c3ccccc3)nc3ccnn23)C1
CHEMBL4637208,CHEMBL217,Dopamine D2 receptor,Ki,=,967.0,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4630902,KI,CNC(=O)c1cc(C(=O)N[C@H]2[C@@H]3COC[C@@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1
CHEMBL4637208,CHEMBL217,Dopamine D2 receptor,Ki,=,812.83,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4630902,KI,CNC(=O)c1cc(C(=O)N[C@H]2[C@@H]3COC[C@@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1
CHEMBL5088622,CHEMBL217,Dopamine D2 receptor,Ki,=,1246.0,nM,CHEMBL5032915,B,Displacement of [3H]spiperone from human recombinant dopamine D2S receptor expressed in CHO cells by liquid scintillation counting analysis,CHEMBL5032500,KI,Nc1nc(-c2ccccc2)c2c(n1)-c1cc(OCCCN3CCCC3)ccc1C2
CHEMBL5082650,CHEMBL217,Dopamine D2 receptor,Ki,=,1586.0,nM,CHEMBL5032915,B,Displacement of [3H]spiperone from human recombinant dopamine D2S receptor expressed in CHO cells by liquid scintillation counting analysis,CHEMBL5032500,KI,Nc1nc(-c2ccccc2)c2c(n1)-c1cc(OCCCN3CCCCC3)ccc1C2=O
CHEMBL596,CHEMBL217,Dopamine D2 receptor,Ki,=,21000.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1
CHEMBL841,CHEMBL217,Dopamine D2 receptor,Ki,=,5790.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,3.55,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL5090346,CHEMBL217,Dopamine D2 receptor,Ki,=,17600.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,N#CC(CCNCCc1ccccc1)(c1ccccc1)c1ccccc1
CHEMBL5079903,CHEMBL217,Dopamine D2 receptor,Ki,=,2630.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,N#CC(CCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1
CHEMBL5089655,CHEMBL217,Dopamine D2 receptor,Ki,=,149.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,N#CC(CCNCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1
CHEMBL5073904,CHEMBL217,Dopamine D2 receptor,Ki,=,903.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,N#CC(CCNCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1
CHEMBL346898,CHEMBL217,Dopamine D2 receptor,Ki,=,17900.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CN(C)CCC(C#N)(c1ccccc1)c1ccccc1
CHEMBL5093200,CHEMBL217,Dopamine D2 receptor,Ki,=,42.7,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CN(C)CCC(C(=O)NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1
CHEMBL346331,CHEMBL217,Dopamine D2 receptor,Ki,=,34900.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1
CHEMBL5077104,CHEMBL217,Dopamine D2 receptor,Ki,=,1940.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,N#CC(CCNCCCCC(=O)N1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1
CHEMBL5085974,CHEMBL217,Dopamine D2 receptor,Ki,=,74.7,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CN(C)C(=O)C(CCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1
CHEMBL5084145,CHEMBL217,Dopamine D2 receptor,Ki,=,2270.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CN(C)C(=O)C(CCN1CCc2ccc(C#N)cc2C1)(c1ccccc1)c1ccccc1
CHEMBL5070377,CHEMBL217,Dopamine D2 receptor,Ki,=,3650.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CN(C)C(=O)C(CCNCCc1ccccc1)(c1ccccc1)c1ccccc1
CHEMBL5073754,CHEMBL217,Dopamine D2 receptor,Ki,=,43.9,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CN(C)C(=O)C(CCNCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1
CHEMBL5087543,CHEMBL217,Dopamine D2 receptor,Ki,=,700.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CN(C)C(=O)C(CCNCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1
CHEMBL5088070,CHEMBL217,Dopamine D2 receptor,Ki,=,43.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCc1cccc(N2CCN(CCC(C(=O)N(C)C)(c3ccccc3)c3ccccc3)CC2)c1Cl
CHEMBL5074399,CHEMBL217,Dopamine D2 receptor,Ki,=,62.1,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCc1cccc(N2CCN(CCCCNCCC(C(=O)N(C)C)(c3ccccc3)c3ccccc3)CC2)c1Cl
CHEMBL5071238,CHEMBL217,Dopamine D2 receptor,Ki,=,457.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCc1cccc(N2CCN(CC(O)CCNCCC(C(=O)N(C)C)(c3ccccc3)c3ccccc3)CC2)c1Cl
CHEMBL5090215,CHEMBL217,Dopamine D2 receptor,Ki,=,1240.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CN(C)C(=O)C(CCNCCCCN1CCc2ccc(C#N)cc2C1)(c1ccccc1)c1ccccc1
CHEMBL5091656,CHEMBL217,Dopamine D2 receptor,Ki,=,12400.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CCC(C#N)(c2ccccc2)c2ccccc2)c1O
CHEMBL5089932,CHEMBL217,Dopamine D2 receptor,Ki,=,1730.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CCCCNCCC(C(=O)N(C)C)(c2ccccc2)c2ccccc2)c1O
CHEMBL5075990,CHEMBL217,Dopamine D2 receptor,Ki,=,502.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCc1cc(Cl)c(OC)c(C(=O)NCC2CCCN2CCCCNCCC(C(=O)N(C)C)(c2ccccc2)c2ccccc2)c1O
CHEMBL5079053,CHEMBL217,Dopamine D2 receptor,Ki,=,2380.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCc1cc(Cl)c(OC)c(C(=O)NCC2CCCN2CC(=O)N2CCC(c3ccccc3)(c3ccccc3)C2)c1O
CHEMBL5081136,CHEMBL217,Dopamine D2 receptor,Ki,=,9.41,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCCNCCC(C(=O)N(C)C)(c3ccccc3)c3ccccc3)CN2)c1O
CHEMBL5076359,CHEMBL217,Dopamine D2 receptor,Ki,=,5240.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,COc1cccc(C(=CCNCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c2cccc(OC)c2)c1
CHEMBL5087504,CHEMBL217,Dopamine D2 receptor,Ki,=,987.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,Oc1cccc(C(CCNCCCCN2CCN(c3ccccc3)CC2)c2cccc(O)c2)c1
CHEMBL5092243,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCc1cccc(N2CCN(CCC(c3cccc(OC)c3)c3cccc(OC)c3)CC2)c1Cl
CHEMBL5083473,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCc1cccc(N2CCN(CCC(c3cccc(O)c3)c3cccc(OC)c3)CC2)c1Cl
CHEMBL5083441,CHEMBL217,Dopamine D2 receptor,Ki,=,187.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCc1cccc(N2CCN(CCC(c3cccc(O)c3)c3cccc(O)c3)CC2)c1Cl
CHEMBL5080654,CHEMBL217,Dopamine D2 receptor,Ki,=,636.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCOC(=O)/C=C1\[C@@H]2CCC[C@@]1(c1cccc(O)c1)CCN2CCc1ccccc1
CHEMBL5077645,CHEMBL217,Dopamine D2 receptor,Ki,=,7380.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,Oc1cccc([C@@]23CCC[C@@H]([C@H]2O)N(C/C=C/c2ccccc2)CC3)c1
CHEMBL5082465,CHEMBL217,Dopamine D2 receptor,Ki,=,2950.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCOC(=O)/C=C1\[C@@H]2CCC[C@@]1(c1cccc(O)c1)CCN2CCCCNC(=O)c1cc2ccccc2[nH]1
CHEMBL5083186,CHEMBL217,Dopamine D2 receptor,Ki,=,3890.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCOC(=O)/C=C1\[C@@H]2CCC[C@@]1(c1cccc(O)c1)CCN2CC1CC1CCNC(=O)c1cc2ccccc2[nH]1
CHEMBL5077114,CHEMBL217,Dopamine D2 receptor,Ki,=,2860.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCOC(=O)/C=C1\[C@@H]2CCC[C@@]1(c1cccc(O)c1)CCN2C[C@H]1C[C@@H]1CCNC(=O)c1cc2ccccc2[nH]1
CHEMBL5086564,CHEMBL217,Dopamine D2 receptor,Ki,=,4860.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCOC(=O)/C=C1\[C@@H]2CCC[C@@]1(c1cccc(O)c1)CCN2C[C@@H]1C[C@H]1CCNC(=O)c1cc2ccccc2[nH]1
CHEMBL5075014,CHEMBL217,Dopamine D2 receptor,Ki,=,4530.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,O=C(NCCCCN1CC[C@]2(c3cccc(O)c3)CCC[C@H]1[C@@H]2O)c1cc2ccccc2[nH]1
CHEMBL5072449,CHEMBL217,Dopamine D2 receptor,Ki,=,1310.0,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,O=C(NCCCCN1CC[C@]2(c3cccc(O)c3)CCC[C@H]1[C@H]2O)c1cc2ccccc2[nH]1
CHEMBL5075726,CHEMBL217,Dopamine D2 receptor,Ki,=,51.6,nM,CHEMBL5046486,B,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCOC(=O)/C=C1\[C@@H]2CCC[C@@]1(c1cccc(O)c1)CCN2CCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL5089655,CHEMBL217,Dopamine D2 receptor,Ki,=,36.3,nM,CHEMBL5046490,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,N#CC(CCNCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1
CHEMBL5085974,CHEMBL217,Dopamine D2 receptor,Ki,=,31.3,nM,CHEMBL5046490,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CN(C)C(=O)C(CCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1
CHEMBL5073754,CHEMBL217,Dopamine D2 receptor,Ki,=,23.1,nM,CHEMBL5046490,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CN(C)C(=O)C(CCNCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1
CHEMBL5087543,CHEMBL217,Dopamine D2 receptor,Ki,=,167.0,nM,CHEMBL5046490,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CN(C)C(=O)C(CCNCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1
CHEMBL5088070,CHEMBL217,Dopamine D2 receptor,Ki,=,20.3,nM,CHEMBL5046490,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCc1cccc(N2CCN(CCC(C(=O)N(C)C)(c3ccccc3)c3ccccc3)CC2)c1Cl
CHEMBL5074399,CHEMBL217,Dopamine D2 receptor,Ki,=,44.2,nM,CHEMBL5046490,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCc1cccc(N2CCN(CCCCNCCC(C(=O)N(C)C)(c3ccccc3)c3ccccc3)CC2)c1Cl
CHEMBL5071238,CHEMBL217,Dopamine D2 receptor,Ki,=,114.0,nM,CHEMBL5046490,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCc1cccc(N2CCN(CC(O)CCNCCC(C(=O)N(C)C)(c3ccccc3)c3ccccc3)CC2)c1Cl
CHEMBL5075990,CHEMBL217,Dopamine D2 receptor,Ki,=,93.7,nM,CHEMBL5046490,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCc1cc(Cl)c(OC)c(C(=O)NCC2CCCN2CCCCNCCC(C(=O)N(C)C)(c2ccccc2)c2ccccc2)c1O
CHEMBL5080654,CHEMBL217,Dopamine D2 receptor,Ki,=,186.0,nM,CHEMBL5046490,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,CCOC(=O)/C=C1\[C@@H]2CCC[C@@]1(c1cccc(O)c1)CCN2CCc1ccccc1
CHEMBL5077645,CHEMBL217,Dopamine D2 receptor,Ki,=,2790.0,nM,CHEMBL5046490,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5046218,KI,Oc1cccc([C@@]23CCC[C@@H]([C@H]2O)N(C/C=C/c2ccccc2)CC3)c1
CHEMBL5084167,CHEMBL217,Dopamine D2 receptor,Ki,=,5.248,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1ccc2ccccc2c1
CHEMBL5092755,CHEMBL217,Dopamine D2 receptor,Ki,=,19.95,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,Cc1ccc(S(=O)(=O)CC2CCN(CCCc3noc4cc(F)ccc34)C2)cc1C
CHEMBL5093250,CHEMBL217,Dopamine D2 receptor,Ki,=,426.58,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1ccc(F)c(F)c1
CHEMBL5077755,CHEMBL217,Dopamine D2 receptor,Ki,=,50.12,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1ccc(Cl)c(Cl)c1
CHEMBL5080955,CHEMBL217,Dopamine D2 receptor,Ki,=,134.9,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1ccc(F)c(Cl)c1
CHEMBL5089348,CHEMBL217,Dopamine D2 receptor,Ki,=,95.5,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1ccc(C(F)(F)F)cc1
CHEMBL5082267,CHEMBL217,Dopamine D2 receptor,Ki,=,302.0,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1cccc(C(F)(F)F)c1
CHEMBL5077178,CHEMBL217,Dopamine D2 receptor,Ki,=,257.04,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1ccc(F)cc1
CHEMBL5083505,CHEMBL217,Dopamine D2 receptor,Ki,=,645.65,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1cccc(F)c1
CHEMBL5082182,CHEMBL217,Dopamine D2 receptor,Ki,=,162.18,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1cccc(Cl)c1
CHEMBL5080305,CHEMBL217,Dopamine D2 receptor,Ki,=,93.33,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,Cc1cccc(S(=O)(=O)CC2CCN(CCCc3noc4cc(F)ccc34)C2)c1
CHEMBL5076882,CHEMBL217,Dopamine D2 receptor,Ki,=,154.88,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,C[C@H]1C[C@H](NS(=O)(=O)c2cccc(Cl)c2)CN1CCCc1noc2cc(F)ccc12
CHEMBL5093017,CHEMBL217,Dopamine D2 receptor,Ki,=,128.82,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,C[C@H]1C[C@H](NS(=O)(=O)c2ccc(F)c(Cl)c2)CN1CCCc1noc2cc(F)ccc12
CHEMBL5087742,CHEMBL217,Dopamine D2 receptor,Ki,=,53.7,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,C[C@H]1C[C@H](NS(=O)(=O)c2csc3ccccc23)CN1CCCc1noc2cc(F)ccc12
CHEMBL5090557,CHEMBL217,Dopamine D2 receptor,Ki,=,54.95,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,C[C@H]1C[C@H](NS(=O)(=O)c2cc3ccccc3s2)CN1CCCc1noc2cc(F)ccc12
CHEMBL5080719,CHEMBL217,Dopamine D2 receptor,Ki,=,30.2,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,C[C@H]1C[C@H](NS(=O)(=O)c2cc3ccccc3o2)CN1CCCc1noc2cc(F)ccc12
CHEMBL5076846,CHEMBL217,Dopamine D2 receptor,Ki,=,53.7,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,C[C@H]1C[C@H](NS(=O)(=O)c2cc3ccc(F)cc3s2)CN1CCCc1noc2cc(F)ccc12
CHEMBL5073337,CHEMBL217,Dopamine D2 receptor,Ki,=,112.2,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,C[C@H]1C[C@H](NS(=O)(=O)c2cc3ccc(Cl)cc3s2)CN1CCCc1noc2cc(F)ccc12
CHEMBL5079536,CHEMBL217,Dopamine D2 receptor,Ki,=,53.7,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,Cc1c(S(=O)(=O)N[C@H]2C[C@H](C)N(CCCc3noc4cc(F)ccc34)C2)sc2ccc(Cl)cc12
CHEMBL5088232,CHEMBL217,Dopamine D2 receptor,Ki,=,46.77,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,C[C@H]1C[C@H](NS(=O)(=O)c2ccc3ccccc3c2)CN1CCCc1noc2cc(F)ccc12
CHEMBL5085390,CHEMBL217,Dopamine D2 receptor,Ki,=,154.88,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,C[C@H]1C[C@H](NS(=O)(=O)c2ccc3cc(Cl)ccc3c2)CN1CCCc1noc2cc(F)ccc12
CHEMBL71,CHEMBL217,Dopamine D2 receptor,Ki,=,2.344,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL715,CHEMBL217,Dopamine D2 receptor,Ki,=,16.98,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL716,CHEMBL217,Dopamine D2 receptor,Ki,=,309.03,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,1.862,nM,CHEMBL5046640,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,CHEMBL5046222,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL3623630,CHEMBL217,Dopamine D2 receptor,Ki,=,1000000000.0,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL5058648,KI,COc1ccc(CC[C@@H](OC(=O)[C@@H]2CCCCN2C(=O)[C@H](c2cc(OC)c(OC)c(OC)c2)C2CCCCC2)c2cccc(OCCN3CCOCC3)c2)cc1OC
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,1621.81,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL3354065,CHEMBL217,Dopamine D2 receptor,Ki,=,676.08,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,CCCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1
CHEMBL4085780,CHEMBL217,Dopamine D2 receptor,Ki,=,1096.48,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1
CHEMBL5205590,CHEMBL217,Dopamine D2 receptor,Ki,=,724.44,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.c1ccc(N2CCN(CCCn3ccc4ccccc43)CC2)cc1
CHEMBL5207313,CHEMBL217,Dopamine D2 receptor,Ki,=,12022.64,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.c1ccc(N2CCN(CCCn3cnc4ccccc43)CC2)cc1
CHEMBL5203856,CHEMBL217,Dopamine D2 receptor,Ki,=,6165.95,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.c1ccc(N2CCN(CCCc3nc4ccccc4[nH]3)CC2)cc1
CHEMBL5179879,CHEMBL217,Dopamine D2 receptor,Ki,=,1698.24,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.c1ccc(N2CCN(CCCc3nc4ccccc4o3)CC2)cc1
CHEMBL5200816,CHEMBL217,Dopamine D2 receptor,Ki,=,1778.28,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)cc1
CHEMBL5169993,CHEMBL217,Dopamine D2 receptor,Ki,=,707.95,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.c1ccc(N2CCN(CCCN3CCCc4ccccc43)CC2)cc1
CHEMBL5171721,CHEMBL217,Dopamine D2 receptor,Ki,=,12882.5,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.O=C1CCc2ccccc2N1CCN1CCN(c2ccccc2)CC1
CHEMBL5199358,CHEMBL217,Dopamine D2 receptor,Ki,=,1122.02,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.O=C1CCc2ccccc2N1CCCCN1CCN(c2ccccc2)CC1
CHEMBL5188796,CHEMBL217,Dopamine D2 receptor,Ki,=,281.84,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.O=C1CCc2ccccc2N1CCCCCN1CCN(c2ccccc2)CC1
CHEMBL5209074,CHEMBL217,Dopamine D2 receptor,Ki,=,398.11,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,Cc1ccccc1N1CCN(CCCN2C(=O)CCc3ccccc32)CC1.O=C(O)C(=O)O
CHEMBL5170580,CHEMBL217,Dopamine D2 receptor,Ki,=,1445.44,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,Cc1cccc(N2CCN(CCCN3C(=O)CCc4ccccc43)CC2)c1.O=C(O)C(=O)O
CHEMBL5171439,CHEMBL217,Dopamine D2 receptor,Ki,=,5128.61,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,Cc1ccc(N2CCN(CCCN3C(=O)CCc4ccccc43)CC2)cc1.O=C(O)C(=O)O
CHEMBL5189614,CHEMBL217,Dopamine D2 receptor,Ki,=,81.28,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,COc1ccccc1N1CCN(CCCN2C(=O)CCc3ccccc32)CC1.O=C(O)C(=O)O
CHEMBL5191408,CHEMBL217,Dopamine D2 receptor,Ki,=,3090.3,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,COc1cccc(N2CCN(CCCN3C(=O)CCc4ccccc43)CC2)c1.O=C(O)C(=O)O
CHEMBL5178868,CHEMBL217,Dopamine D2 receptor,Ki,=,20892.96,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,COc1ccc(N2CCN(CCCN3C(=O)CCc4ccccc43)CC2)cc1.O=C(O)C(=O)O
CHEMBL5172201,CHEMBL217,Dopamine D2 receptor,Ki,=,138.04,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2Cl)CC1
CHEMBL5204418,CHEMBL217,Dopamine D2 receptor,Ki,=,758.58,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.O=C1CCc2ccccc2N1CCCN1CCN(c2cccc(Cl)c2)CC1
CHEMBL5196870,CHEMBL217,Dopamine D2 receptor,Ki,=,5495.41,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.O=C1CCc2ccccc2N1CCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL5198170,CHEMBL217,Dopamine D2 receptor,Ki,=,131.83,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2[N+](=O)[O-])CC1
CHEMBL5176100,CHEMBL217,Dopamine D2 receptor,Ki,=,2511.89,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.O=C1CCc2ccccc2N1CCCN1CCN(c2cccc([N+](=O)[O-])c2)CC1
CHEMBL5175009,CHEMBL217,Dopamine D2 receptor,Ki,=,23988.33,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.O=C1CCc2ccccc2N1CCCN1CCN(c2ccc([N+](=O)[O-])cc2)CC1
CHEMBL5191299,CHEMBL217,Dopamine D2 receptor,Ki,=,354.81,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,N#Cc1ccccc1N1CCN(CCCN2C(=O)CCc3ccccc32)CC1.O=C(O)C(=O)O
CHEMBL5196873,CHEMBL217,Dopamine D2 receptor,Ki,=,2754.23,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.O=C1CCc2ccccc2N1CCCN1CCN(c2ccccn2)CC1
CHEMBL5172871,CHEMBL217,Dopamine D2 receptor,Ki,=,3981.07,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.O=C1CCc2ccccc2N1CCCN1CCN(c2ncccn2)CC1
CHEMBL5177462,CHEMBL217,Dopamine D2 receptor,Ki,=,54.95,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.O=C1CCc2ccccc2N1CCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL5179930,CHEMBL217,Dopamine D2 receptor,Ki,=,549.54,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.O=C1CCc2ccccc2N1CCCN1CCN(c2ccc(Cl)cc2Cl)CC1
CHEMBL5175054,CHEMBL217,Dopamine D2 receptor,Ki,=,954.99,nM,CHEMBL5106582,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5104176,KI,O=C(O)C(=O)O.O=C1CCc2ccccc2N1CCCN1CCN(c2ccc(Cl)c(Cl)c2)CC1
CHEMBL71838,CHEMBL217,Dopamine D2 receptor,Ki,=,241.0,nM,CHEMBL5113786,B,Displacement of PNU-86170 from human dopamine D2 receptor expressed in CHO cell membrane incubated for 1 hr by competitive radioligand binding assay based,CHEMBL5113374,KI,CNC(=O)c1ccc2c(c1)CCO[C@H]2CCN1CCN(c2ccc(OC)cc2)CC1
CHEMBL4434865,CHEMBL217,Dopamine D2 receptor,Ki,=,6300.0,nM,CHEMBL5116835,B,Displacement of [3H]methyl-spiperone from recombinant human D2S receptor measured after 60 mins by scintillation counting analysis,CHEMBL5113450,KI,c1ccc(Cc2cn(C3CCN(Cc4ccccc4)CC3)nn2)cc1
CHEMBL5191141,CHEMBL217,Dopamine D2 receptor,Ki,=,4.1,nM,CHEMBL5117893,B,Displacement of [3H]7-OH-DPAT from recombinant human D2S receptor measured after 60 mins by scintillation counting analysis,CHEMBL5113485,KI,[2H]c1c([2H])c([2H])c([C@@H]2C[C@@H](N3CCN(C([2H])([2H])[2H])C(C)(C)C3)c3cc(Cl)ccc32)c([2H])c1[2H]
CHEMBL5201983,CHEMBL217,Dopamine D2 receptor,Ki,=,11.0,nM,CHEMBL5117893,B,Displacement of [3H]7-OH-DPAT from recombinant human D2S receptor measured after 60 mins by scintillation counting analysis,CHEMBL5113485,KI,[2H]c1c([2H])c([2H])c([C@@H]2C[C@@H](N3CCNC(C)(C)C3)c3cc(Cl)ccc32)c([2H])c1[2H]
CHEMBL5187578,CHEMBL217,Dopamine D2 receptor,Ki,=,5.5,nM,CHEMBL5119252,B,Competitive binding affinity to human D2R in transfected cells,CHEMBL5113516,KI,O=Cc1ccc(-c2ccccc2OCF)cc1
CHEMBL5186821,CHEMBL217,Dopamine D2 receptor,Ki,=,366.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,Nc1nc(N)nc(NCCCCN2CCN(c3ccccc3)CC2)n1
CHEMBL5197737,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,COc1ccccc1N1CCN(CCCCNc2nc(N)nc(N)n2)CC1
CHEMBL5170808,CHEMBL217,Dopamine D2 receptor,Ki,=,7.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,Nc1nc(N)nc(NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)n1
CHEMBL5202120,CHEMBL217,Dopamine D2 receptor,Ki,=,1039.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,Nc1nc(N)nc(NCCCCCN2CCN(c3ccccc3)CC2)n1
CHEMBL5187317,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,COc1ccccc1N1CCN(CCCCCNc2nc(N)nc(N)n2)CC1
CHEMBL5191557,CHEMBL217,Dopamine D2 receptor,Ki,=,8.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,Nc1nc(N)nc(NCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)n1
CHEMBL5205324,CHEMBL217,Dopamine D2 receptor,Ki,=,1009.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,Nc1nc(N)nc(NCCCCCCN2CCN(c3ccccc3)CC2)n1
CHEMBL5197911,CHEMBL217,Dopamine D2 receptor,Ki,=,20.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,COc1ccccc1N1CCN(CCCCCCNc2nc(N)nc(N)n2)CC1
CHEMBL5194270,CHEMBL217,Dopamine D2 receptor,Ki,=,5.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,Nc1nc(N)nc(NCCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)n1
CHEMBL5199820,CHEMBL217,Dopamine D2 receptor,Ki,=,418.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,Nc1nc(NCCc2c[nH]c3ccccc23)nc(NCCN2CCN(c3ccccc3)CC2)n1
CHEMBL5189648,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,Nc1nc(NCCCCN2CCN(c3ccccc3)CC2)nc(NCCc2c[nH]c3ccccc23)n1
CHEMBL5184538,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,COc1ccccc1N1CCN(CCCCNc2nc(N)nc(NCCc3c[nH]c4ccccc34)n2)CC1
CHEMBL5194614,CHEMBL217,Dopamine D2 receptor,Ki,=,39.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,Nc1nc(NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc(NCCc2c[nH]c3ccccc23)n1
CHEMBL5194826,CHEMBL217,Dopamine D2 receptor,Ki,=,8333.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,Nc1nc(NCCc2c[nH]c3ccccc23)nc(N2CCN(c3ccccc3)CC2)n1
CHEMBL5171456,CHEMBL217,Dopamine D2 receptor,Ki,=,13460.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,COc1ccccc1N1CCN(c2nc(N)nc(NCCc3c[nH]c4ccccc34)n2)CC1
CHEMBL5201719,CHEMBL217,Dopamine D2 receptor,Ki,=,3207.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,Nc1nc(NCCc2c[nH]c3ccccc23)nc(N2CCN(c3cccc(Cl)c3Cl)CC2)n1
CHEMBL5178499,CHEMBL217,Dopamine D2 receptor,Ki,=,8749.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,Nc1nc(NCCNc2ccccc2)nc(NCCc2c[nH]c3ccccc23)n1
CHEMBL5190020,CHEMBL217,Dopamine D2 receptor,Ki,=,3907.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,COc1ccccc1NCCNc1nc(N)nc(NCCc2c[nH]c3ccccc23)n1
CHEMBL5171734,CHEMBL217,Dopamine D2 receptor,Ki,=,5003.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,Nc1nc(NCCNc2cccc(Cl)c2Cl)nc(NCCc2c[nH]c3ccccc23)n1
CHEMBL5189520,CHEMBL217,Dopamine D2 receptor,Ki,=,4402.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,COc1ccccc1OCCNc1nc(N)nc(NCCc2c[nH]c3ccccc23)n1
CHEMBL5197266,CHEMBL217,Dopamine D2 receptor,Ki,=,4402.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,Nc1nc(NCCOc2cccc(Cl)c2Cl)nc(NCCc2c[nH]c3ccccc23)n1
CHEMBL5174637,CHEMBL217,Dopamine D2 receptor,Ki,=,13300.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,COc1ccccc1CCNc1nc(N)nc(NCCc2c[nH]c3ccccc23)n1
CHEMBL5177186,CHEMBL217,Dopamine D2 receptor,Ki,=,3077.0,nM,CHEMBL5121178,B,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,CHEMBL5120748,KI,Nc1nc(NCCc2cccc(Cl)c2Cl)nc(NCCc2c[nH]c3ccccc23)n1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,3.3,nM,CHEMBL5121188,B,Displacement of [3H]-N-methylspiperone from human D2 receptor incubated for 1 hr by liquid scintillation counting method,CHEMBL5120748,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,2.61,nM,CHEMBL5133886,B,Binding affinity to dopamine D2S receptor (unknown origin) by radioligand displacement assay,CHEMBL5131451,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL5171776,CHEMBL217,Dopamine D2 receptor,Ki,=,328.0,nM,CHEMBL5133886,B,Binding affinity to dopamine D2S receptor (unknown origin) by radioligand displacement assay,CHEMBL5131451,KI,Cc1cc(C)n2c1C=[N+]1[N+](=C3C=CC=C(NCCCCN4CCN(c5cccc(Cl)c5Cl)CC4)N3[B-]1(F)F)[B-]2(F)F
CHEMBL5202417,CHEMBL217,Dopamine D2 receptor,Ki,=,81.1,nM,CHEMBL5133886,B,Binding affinity to dopamine D2S receptor (unknown origin) by radioligand displacement assay,CHEMBL5131451,KI,COc1ccccc1N1CCN(CCCCNC2=CC=CC3=[N+]4[N+](=Cc5c(C)cc(C)n5[B-]4(F)F)[B-](F)(F)N23)CC1
CHEMBL5197956,CHEMBL217,Dopamine D2 receptor,Ki,=,309.0,nM,CHEMBL5133886,B,Binding affinity to dopamine D2S receptor (unknown origin) by radioligand displacement assay,CHEMBL5131451,KI,CCc1c(C)c2n(c1C)[B-](F)(F)[N+]1=C3C=CC=C(NCCCCN4CCN(c5ccccc5OC)CC4)N3[B-](F)(F)[N+]1=C2
CHEMBL5207676,CHEMBL217,Dopamine D2 receptor,Ki,=,497.3,nM,CHEMBL5133886,B,Binding affinity to dopamine D2S receptor (unknown origin) by radioligand displacement assay,CHEMBL5131451,KI,CCc1c(C)c2n(c1C)[B-](F)(F)[N+]1=C3C=CC=C(NCCCCN4CCN(c5cccc(Cl)c5Cl)CC4)N3[B-](F)(F)[N+]1=C2
CHEMBL5204696,CHEMBL217,Dopamine D2 receptor,Ki,=,182.0,nM,CHEMBL5133886,B,Binding affinity to dopamine D2S receptor (unknown origin) by radioligand displacement assay,CHEMBL5131451,KI,COc1ccccc1N1CCN(CCCCNC2=CC=CC3=[N+]4[N+](=Cc5cc6ccccc6n5[B-]4(F)F)[B-](F)(F)N23)CC1
CHEMBL5190788,CHEMBL217,Dopamine D2 receptor,Ki,=,10.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,N#Cc1cccnc1N1CCN(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5176374,CHEMBL217,Dopamine D2 receptor,Ki,=,770.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,N#Cc1cccnc1N1CCN(CCCN2CCN(c3ccccc3)CC2)CC1
CHEMBL5193798,CHEMBL217,Dopamine D2 receptor,Ki,=,1500.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,COc1ccc(N2CCN(CCCN3CCN(c4ncccc4C#N)CC3)CC2)cc1
CHEMBL5182877,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,COc1ccccc1N1CCN(CCCN2CCN(c3ncccc3C#N)CC2)CC1
CHEMBL5178994,CHEMBL217,Dopamine D2 receptor,Ki,=,260.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,COc1ccccc1N1CCN(CCCN2CCN(C(=O)c3ccccc3)CC2)CC1
CHEMBL5173564,CHEMBL217,Dopamine D2 receptor,Ki,=,2100.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,O=C(c1ccccc1)N1CCN(CCCN2CCN(c3ccccc3)CC2)CC1
CHEMBL5173624,CHEMBL217,Dopamine D2 receptor,Ki,=,5500.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,COc1ccc(N2CCN(CCCN3CCN(C(=O)c4ccccc4)CC3)CC2)cc1
CHEMBL5195091,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,O=C(c1ccccc1)N1CCN(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5178688,CHEMBL217,Dopamine D2 receptor,Ki,=,590.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,COc1ccccc1N1CCN(CCCN2CCN(C(=O)c3ccccn3)CC2)CC1
CHEMBL5188923,CHEMBL217,Dopamine D2 receptor,Ki,=,82.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,O=C(c1ccccn1)N1CCN(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5196828,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,COc1ccccc1N1CCN(CCN2CCN(c3ncccc3C#N)CC2)CC1
CHEMBL5205697,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,N#Cc1cccnc1N1CCN(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5209381,CHEMBL217,Dopamine D2 receptor,Ki,=,630.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,COc1ccccc1N1CCN(CCN2CCN(C(=O)c3nn(C)c4ccccc34)CC2)CC1
CHEMBL5200023,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,Cn1nc(C(=O)N2CCN(CCN3CCN(c4cccc(Cl)c4Cl)CC3)CC2)c2ccccc21
CHEMBL5202003,CHEMBL217,Dopamine D2 receptor,Ki,=,860.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cnccn2)CC1
CHEMBL5170927,CHEMBL217,Dopamine D2 receptor,Ki,=,81.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,N#Cc1cccnc1N1CCN(CCCOc2ccc3c(c2)NC(=O)CC3)CC1
CHEMBL5201798,CHEMBL217,Dopamine D2 receptor,Ki,=,2100.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,N#Cc1cccnc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1
CHEMBL5172819,CHEMBL217,Dopamine D2 receptor,Ki,=,9.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,O=C1CCc2ccc(OCCCCN3CCN(C(=O)c4ccccn4)CC3)cc2N1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,4.5,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL5145822,B,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,CHEMBL5143593,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.3,nM,CHEMBL5145883,B,Modulation of human D2L receptor,CHEMBL5143593,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,Ki,=,0.5012,nM,CHEMBL5145883,B,Modulation of human D2L receptor,CHEMBL5143593,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5207281,CHEMBL217,Dopamine D2 receptor,Ki,=,9549.93,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KI,CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5183205,CHEMBL217,Dopamine D2 receptor,Ki,=,3467.37,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KI,CCCCCNC(=O)/N=C(\N)NCCCc1cnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5204599,CHEMBL217,Dopamine D2 receptor,Ki,=,1621.81,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KI,CC(CNC(=O)/N=C(\N)NCCCc1nnc(N)s1)C1CCCCC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5206565,CHEMBL217,Dopamine D2 receptor,Ki,=,6309.57,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KI,N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5178472,CHEMBL217,Dopamine D2 receptor,Ki,=,4570.88,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KI,N/C(=N\C(=O)NCc1ccccc1)NCCCc1cnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5180504,CHEMBL217,Dopamine D2 receptor,Ki,=,1071.52,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KI,Cc1ccc(CC(C)CNC(=O)/N=C(\N)NCCCc2nnc(N)s2)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5202592,CHEMBL217,Dopamine D2 receptor,Ki,=,489.78,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KI,Cc1ccc(CC(C)CNC(=O)/N=C(\N)NCCCc2cnc(N)s2)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5198795,CHEMBL217,Dopamine D2 receptor,Ki,=,446.68,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KI,CC(CCCc1ccccc1)CNC(=O)/N=C(\N)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5176229,CHEMBL217,Dopamine D2 receptor,Ki,=,954.99,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KI,N/C(=N\C(=O)NCCCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,Ki,=,25.7,nM,CHEMBL5151465,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at high concentration incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KI,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL5151467,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at low concentration incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KI,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL5193103,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL5163611,B,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5154833,KI,O=c1n(CCCCCCN2CCN(c3cccc(C(F)(F)F)c3)CC2)nc2ccccn12
CHEMBL5199228,CHEMBL217,Dopamine D2 receptor,Ki,=,9.0,nM,CHEMBL5163611,B,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5154833,KI,O=c1n(CCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc2ccccn12
CHEMBL5185787,CHEMBL217,Dopamine D2 receptor,Ki,=,32.0,nM,CHEMBL5163611,B,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5154833,KI,O=c1n(CCCCCCN2CCN(c3cccc4ccccc34)CC2)nc2ccccn12
CHEMBL5172673,CHEMBL217,Dopamine D2 receptor,Ki,=,143.0,nM,CHEMBL5163611,B,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5154833,KI,O=c1n(CCCCCCN2CCN(c3cccc4cccnc34)CC2)nc2ccccn12
CHEMBL5189101,CHEMBL217,Dopamine D2 receptor,Ki,=,60.0,nM,CHEMBL5163611,B,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5154833,KI,O=c1n(CCCCCCN2CCN(c3cccc4c3OCCO4)CC2)nc2ccccn12
CHEMBL5204274,CHEMBL217,Dopamine D2 receptor,Ki,=,1940.0,nM,CHEMBL5163611,B,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5154833,KI,O=C(NCCCCCCn1nc2ccccn2c1=O)N1CCN(c2cccc(Cl)c2)CC1
CHEMBL5190996,CHEMBL217,Dopamine D2 receptor,Ki,=,559.0,nM,CHEMBL5163611,B,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5154833,KI,O=c1n(CC2CCC(CN3CCN(c4cccc(Cl)c4)CC3)CC2)nc2ccccn12
CHEMBL5186688,CHEMBL217,Dopamine D2 receptor,Ki,=,148.0,nM,CHEMBL5163611,B,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5154833,KI,O=c1n(Cc2ccc(CN3CCN(c4cccc(Cl)c4)CC3)cc2)nc2ccccn12
CHEMBL5177716,CHEMBL217,Dopamine D2 receptor,Ki,=,1390.0,nM,CHEMBL5163611,B,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5154833,KI,O=c1n(Cc2ccc(CN3CCN(c4ccc(Cl)cc4)CC3)cc2)nc2ccccn12
CHEMBL5201984,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL5163611,B,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5154833,KI,O=c1n(CCCCCCN2CCN(c3cccc(Cl)c3)CC2)c2cccc3c2n1CCC3
CHEMBL5182383,CHEMBL217,Dopamine D2 receptor,Ki,=,85.0,nM,CHEMBL5163611,B,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5154833,KI,S=c1n(CCCCCCN2CCN(c3cccc(Cl)c3)CC2)c2cccc3c2n1CCC3
CHEMBL5204088,CHEMBL217,Dopamine D2 receptor,Ki,=,253.0,nM,CHEMBL5163611,B,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5154833,KI,O=S1(=O)N(CCCCCCN2CCN(c3cccc(Cl)c3)CC2)c2cccc3c2N1CCC3
CHEMBL5201464,CHEMBL217,Dopamine D2 receptor,Ki,=,235.0,nM,CHEMBL5163611,B,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5154833,KI,NC(=O)NCCCCCCN1CCN(c2cccc(Cl)c2)CC1
CHEMBL5181868,CHEMBL217,Dopamine D2 receptor,Ki,=,229.0,nM,CHEMBL5163611,B,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5154833,KI,NS(=O)(=O)NCCCCCCN1CCN(c2cccc(Cl)c2)CC1
CHEMBL5191370,CHEMBL217,Dopamine D2 receptor,Ki,=,115900.0,nM,CHEMBL5163611,B,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5154833,KI,NC(=O)N1CCN(c2cccc(Cl)c2)CC1
CHEMBL5202054,CHEMBL217,Dopamine D2 receptor,Ki,=,137.0,nM,CHEMBL5163622,B,Binding affinity to D2L receptor (unknown origin) assessed as inhibition constant,CHEMBL5154833,KI,O=c1n(CCCCCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12
CHEMBL4520293,CHEMBL217,Dopamine D2 receptor,Ki,=,369.37,nM,CHEMBL5214422,B,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000353a DRD2,CHEMBL5212743,KI,CN(C)[C@@H]1CCN(c2cc(-c3ccccc3)nc3ccnn23)C1
CHEMBL4520293,CHEMBL217,Dopamine D2 receptor,Ki,=,369.37,nM,CHEMBL5214423,B,Selectivity interaction (PRESTO-Tango GPCR-ome screening) EUB0000353a DRD2,CHEMBL5212743,KI,CN(C)[C@@H]1CCN(c2cc(-c3ccccc3)nc3ccnn23)C1
CHEMBL4520788,CHEMBL217,Dopamine D2 receptor,Ki,=,2333.64,nM,CHEMBL5213955,B,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000743a DRD2,CHEMBL5212743,KI,CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
CHEMBL561132,CHEMBL217,Dopamine D2 receptor,Ki,=,3746.0,nM,CHEMBL5214284,B,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000297b DRD2,CHEMBL5212743,KI,CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1
CHEMBL4558518,CHEMBL217,Dopamine D2 receptor,Ki,=,1219.0,nM,CHEMBL5213926,B,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000741a DRD2,CHEMBL5212743,KI,CC(C)(C)OC(=O)N1CCCC1CNC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1
CHEMBL4576555,CHEMBL217,Dopamine D2 receptor,Ki,=,2752.0,nM,CHEMBL5213382,B,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000705a DRD2,CHEMBL5212743,KI,CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1
CHEMBL4456585,CHEMBL217,Dopamine D2 receptor,Ki,=,397.52,nM,CHEMBL5214067,B,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000329a DRD2,CHEMBL5212743,KI,O=C(NNS(=O)(=O)c1ccccc1F)c1cc(F)cc(-c2ccccn2)c1
CHEMBL26,CHEMBL217,Dopamine D2 receptor,Ki,=,9.8,nM,CHEMBL5215982,B,Binding affinity to D2R (unknown origin) assessed as inhibition constant,CHEMBL5214911,KI,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC
CHEMBL5219924,CHEMBL217,Dopamine D2 receptor,Ki,=,1.7,nM,CHEMBL5215982,B,Binding affinity to D2R (unknown origin) assessed as inhibition constant,CHEMBL5214911,KI,O=C1C2C3CCC(C3)C2C(=O)N1CC1CCCCC1CN1CCN(c2nsc3ccccc23)CC1
CHEMBL243712,CHEMBL217,Dopamine D2 receptor,Ki,=,3.0,nM,CHEMBL5215986,B,Displacement of [3H]N-methyl-spiperone from D2R (unknown origin) assessed as inhibition constant by competition binding assay,CHEMBL5214911,KI,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC
CHEMBL4086515,CHEMBL217,Dopamine D2 receptor,Ki,=,1950.0,nM,CHEMBL5216600,B,Displacement of [3H]-Raclopride from human dopamine D2 receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5214932,KI,CN1CCN(c2nc(N)nc(Cc3c[nH]c4ccccc34)n2)CC1
CHEMBL4520796,CHEMBL217,Dopamine D2 receptor,Ki,=,1090.0,nM,CHEMBL5216600,B,Displacement of [3H]-Raclopride from human dopamine D2 receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5214932,KI,Cc1ccc(C(C)C)c(OCc2nc(N)nc(N3CCN(C)CC3)n2)c1
CHEMBL4447416,CHEMBL217,Dopamine D2 receptor,Ki,=,1000.0,nM,CHEMBL5216600,B,Displacement of [3H]-Raclopride from human dopamine D2 receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5214932,KI,CC(Oc1ccccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4873623,CHEMBL217,Dopamine D2 receptor,Ki,=,420.0,nM,CHEMBL5216600,B,Displacement of [3H]-Raclopride from human dopamine D2 receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5214932,KI,CCC(Oc1cccc(Cl)c1Cl)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL4860275,CHEMBL217,Dopamine D2 receptor,Ki,=,320.0,nM,CHEMBL5216600,B,Displacement of [3H]-Raclopride from human dopamine D2 receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5214932,KI,CCC(Oc1cc(Cl)ccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1
CHEMBL5219240,CHEMBL217,Dopamine D2 receptor,Ki,=,300.0,nM,CHEMBL5216600,B,Displacement of [3H]-Raclopride from human dopamine D2 receptor expressed in HEK293 cells by radioligand binding assay,CHEMBL5214932,KI,CN1CCN(c2nc(N)nc(C(C)(C)Sc3ccc4ccccc4c3)n2)CC1
CHEMBL596802,CHEMBL217,Dopamine D2 receptor,Ki,=,10000.0,nM,CHEMBL5225126,B,Binding affinity to D2R receptor (unknown origin),CHEMBL5223132,KI,CCCN1CCC(c2cccc(S(C)(=O)=O)c2)CC1
CHEMBL4464060,CHEMBL217,Dopamine D2 receptor,Ki,=,1740.0,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,CCCN1CC(c2ccc(N)nc2)OC[C@@H]1C
CHEMBL5277640,CHEMBL217,Dopamine D2 receptor,Ki,=,1320.0,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,CCCN1C[C@H](c2ccc(N)nc2)OC[C@@H]1C
CHEMBL419792,CHEMBL217,Dopamine D2 receptor,Ki,=,80.6,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL4551160,CHEMBL217,Dopamine D2 receptor,Ki,=,87.8,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C[C@H]1C[C@@H]1CCNC(=O)c1cc2ccccc2[nH]1
CHEMBL4437740,CHEMBL217,Dopamine D2 receptor,Ki,=,831.0,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C[C@@H]1C[C@H]1CCNC(=O)c1cc2ccccc2[nH]1
CHEMBL5291065,CHEMBL217,Dopamine D2 receptor,Ki,=,86.7,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CCC1CCC(CNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL5267958,CHEMBL217,Dopamine D2 receptor,Ki,=,80.8,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC[C@@H]1CC[C@H](CNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL5280481,CHEMBL217,Dopamine D2 receptor,Ki,=,115.0,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC[C@@H]1CC[C@@H](CNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL5288831,CHEMBL217,Dopamine D2 receptor,Ki,=,55.9,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C/C=C1\CCC(CNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL5273118,CHEMBL217,Dopamine D2 receptor,Ki,=,2.03,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,CN(CC[C@@H]1CC[C@H](CNC(=O)c2cc3ccccc3[nH]2)C1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL5273776,CHEMBL217,Dopamine D2 receptor,Ki,=,4.58,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,CN(CC[C@@H]1CC[C@@H](CNC(=O)c2cc3ccccc3[nH]2)C1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL5280797,CHEMBL217,Dopamine D2 receptor,Ki,=,1870.0,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC(=O)N1CCC(CNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL5266180,CHEMBL217,Dopamine D2 receptor,Ki,=,13500.0,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CCn1cc(CNC(=O)c2cc3ccccc3[nH]2)nn1
CHEMBL5274609,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC[C@H]1CC[C@@H](NC(=O)c2cc3ccccc3[nH]2)CC1
CHEMBL4744811,CHEMBL217,Dopamine D2 receptor,Ki,=,86.2,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC[C@H]1CC[C@H](NC(=O)c2cc3ccccc3[nH]2)CC1
CHEMBL5286603,CHEMBL217,Dopamine D2 receptor,Ki,=,371.0,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C[C@H]1C[C@H]1CCNC(=O)c1cc2ccccc2[nH]1
CHEMBL5287555,CHEMBL217,Dopamine D2 receptor,Ki,=,9.56,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,CN(C[C@@H]1C[C@H]1CCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL5286161,CHEMBL217,Dopamine D2 receptor,Ki,=,49.1,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,CN(C[C@H]1C[C@@H]1CCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL4764883,CHEMBL217,Dopamine D2 receptor,Ki,=,1010.0,nM,CHEMBL5228992,B,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC(O)CCNC(=O)c1cc2ccccc2[nH]1
CHEMBL419792,CHEMBL217,Dopamine D2 receptor,Ki,=,16300.0,nM,CHEMBL5228996,B,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL4551160,CHEMBL217,Dopamine D2 receptor,Ki,=,1610.0,nM,CHEMBL5228996,B,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C[C@H]1C[C@@H]1CCNC(=O)c1cc2ccccc2[nH]1
CHEMBL4437740,CHEMBL217,Dopamine D2 receptor,Ki,=,70600.0,nM,CHEMBL5228996,B,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C[C@@H]1C[C@H]1CCNC(=O)c1cc2ccccc2[nH]1
CHEMBL5291065,CHEMBL217,Dopamine D2 receptor,Ki,=,15000.0,nM,CHEMBL5228996,B,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CCC1CCC(CNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL5267958,CHEMBL217,Dopamine D2 receptor,Ki,=,22600.0,nM,CHEMBL5228996,B,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC[C@@H]1CC[C@H](CNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL5280481,CHEMBL217,Dopamine D2 receptor,Ki,=,25400.0,nM,CHEMBL5228996,B,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC[C@@H]1CC[C@@H](CNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL5288831,CHEMBL217,Dopamine D2 receptor,Ki,=,7920.0,nM,CHEMBL5228996,B,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C/C=C1\CCC(CNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL5273118,CHEMBL217,Dopamine D2 receptor,Ki,=,853.0,nM,CHEMBL5228996,B,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,CN(CC[C@@H]1CC[C@H](CNC(=O)c2cc3ccccc3[nH]2)C1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL5273776,CHEMBL217,Dopamine D2 receptor,Ki,=,1320.0,nM,CHEMBL5228996,B,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,CN(CC[C@@H]1CC[C@@H](CNC(=O)c2cc3ccccc3[nH]2)C1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL5280797,CHEMBL217,Dopamine D2 receptor,Ki,=,7930.0,nM,CHEMBL5228996,B,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC(=O)N1CCC(CNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL5266180,CHEMBL217,Dopamine D2 receptor,Ki,=,32300.0,nM,CHEMBL5228996,B,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,CHEMBL5226346,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CCn1cc(CNC(=O)c2cc3ccccc3[nH]2)nn1
CHEMBL5279818,CHEMBL217,Dopamine D2 receptor,Ki,=,316.23,nM,CHEMBL5231713,B,Displacement of [3H] raclopride from D2DR (unknown origin),CHEMBL5230125,KI,COc1cc(CCN(C)C)c2c(c1OC)-c1ccccc1CC2
CHEMBL5283457,CHEMBL217,Dopamine D2 receptor,Ki,=,38.9,nM,CHEMBL5231713,B,Displacement of [3H] raclopride from D2DR (unknown origin),CHEMBL5230125,KI,CN(C)CCc1cc(O)c(O)c2c1CCc1ccccc1-2
CHEMBL2414990,CHEMBL217,Dopamine D2 receptor,Ki,=,173.78,nM,CHEMBL5231713,B,Displacement of [3H] raclopride from D2DR (unknown origin),CHEMBL5230125,KI,COc1cc2c3c(c1OC)-c1ccccc1CC3N(C)CC2
CHEMBL2414991,CHEMBL217,Dopamine D2 receptor,Ki,=,38.9,nM,CHEMBL5231713,B,Displacement of [3H] raclopride from D2DR (unknown origin),CHEMBL5230125,KI,CN1CCc2cc(O)c(O)c3c2C1Cc1ccccc1-3
CHEMBL5286231,CHEMBL217,Dopamine D2 receptor,Ki,=,3801.89,nM,CHEMBL5231713,B,Displacement of [3H] raclopride from D2DR (unknown origin),CHEMBL5230125,KI,COC1=CC2CCN(C)C3CC(c4ccccc4)C(=C1OC)C23
CHEMBL5273758,CHEMBL217,Dopamine D2 receptor,Ki,=,12.88,nM,CHEMBL5231713,B,Displacement of [3H] raclopride from D2DR (unknown origin),CHEMBL5230125,KI,CN1CCC2C=C(O)C(O)=C3C(c4ccccc4)CC1C32
CHEMBL5285185,CHEMBL217,Dopamine D2 receptor,Ki,=,15.85,nM,CHEMBL5231713,B,Displacement of [3H] raclopride from D2DR (unknown origin),CHEMBL5230125,KI,C=CCN1CCC2C=C(O)C(O)=C3C(c4ccccc4)CC1C32
CHEMBL328054,CHEMBL217,Dopamine D2 receptor,Ki,=,436.0,nM,CHEMBL5232011,B,Binding affinity to human D2 receptor assessed as inhibition constant,CHEMBL5230136,KI,COc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccccc1)CC3
CHEMBL92489,CHEMBL217,Dopamine D2 receptor,Ki,=,774.0,nM,CHEMBL5232011,B,Binding affinity to human D2 receptor assessed as inhibition constant,CHEMBL5230136,KI,Cc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccccc1)CC3
CHEMBL89921,CHEMBL217,Dopamine D2 receptor,Ki,=,1170.0,nM,CHEMBL5232011,B,Binding affinity to human D2 receptor assessed as inhibition constant,CHEMBL5230136,KI,Cc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccc(Cl)cc1)CC3
CHEMBL314095,CHEMBL217,Dopamine D2 receptor,Ki,=,2780.0,nM,CHEMBL5232011,B,Binding affinity to human D2 receptor assessed as inhibition constant,CHEMBL5230136,KI,O=c1oc2cc(O)ccc2c2c1CN(Cc1ccc(Cl)cc1)CC2
CHEMBL90569,CHEMBL217,Dopamine D2 receptor,Ki,=,5500.0,nM,CHEMBL5232011,B,Binding affinity to human D2 receptor assessed as inhibition constant,CHEMBL5230136,KI,COc1ccc2c3c(c(=O)oc2c1)CN(Cc1cccc(Cl)c1)CC3
CHEMBL329126,CHEMBL217,Dopamine D2 receptor,Ki,=,1170.0,nM,CHEMBL5232011,B,Binding affinity to human D2 receptor assessed as inhibition constant,CHEMBL5230136,KI,COc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccc(C)cc1)CC3
CHEMBL91938,CHEMBL217,Dopamine D2 receptor,Ki,=,3700.0,nM,CHEMBL5232011,B,Binding affinity to human D2 receptor assessed as inhibition constant,CHEMBL5230136,KI,COc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccc(C(F)(F)F)cc1)CC3
CHEMBL91524,CHEMBL217,Dopamine D2 receptor,Ki,=,0.0,nM,CHEMBL5232011,B,Binding affinity to human D2 receptor assessed as inhibition constant,CHEMBL5230136,KI,COc1ccc2c3c(c(=O)oc2c1)CN(c1ccccc1)CC3
CHEMBL42,CHEMBL217,Dopamine D2 receptor,Ki,=,41.0,nM,CHEMBL5235409,B,Binding affinity to human D2R assessed as inhibition constant,CHEMBL5233263,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL7927,CHEMBL217,Dopamine D2 receptor,Ki,=,3200.0,nM,CHEMBL5235409,B,Binding affinity to human D2R assessed as inhibition constant,CHEMBL5233263,KI,Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL160626,CHEMBL217,Dopamine D2 receptor,Ki,=,44000.0,nM,CHEMBL5235409,B,Binding affinity to human D2R assessed as inhibition constant,CHEMBL5233263,KI,N#Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12
CHEMBL310843,CHEMBL217,Dopamine D2 receptor,Ki,=,3400.0,nM,CHEMBL5235409,B,Binding affinity to human D2R assessed as inhibition constant,CHEMBL5233263,KI,Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1
CHEMBL346389,CHEMBL217,Dopamine D2 receptor,Ki,=,413.0,nM,CHEMBL5235409,B,Binding affinity to human D2R assessed as inhibition constant,CHEMBL5233263,KI,O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1
CHEMBL5272162,CHEMBL217,Dopamine D2 receptor,Ki,=,2100.0,nM,CHEMBL5235409,B,Binding affinity to human D2R assessed as inhibition constant,CHEMBL5233263,KI,OCc1[nH]c2ccccc2c1CN1CCN(c2ccccc2)CC1
CHEMBL5278853,CHEMBL217,Dopamine D2 receptor,Ki,=,4900.0,nM,CHEMBL5235409,B,Binding affinity to human D2R assessed as inhibition constant,CHEMBL5233263,KI,N#Cc1[nH]c2ccccc2c1CN1CCN(c2ccccc2)CC1
CHEMBL5280364,CHEMBL217,Dopamine D2 receptor,Ki,=,22000.0,nM,CHEMBL5235409,B,Binding affinity to human D2R assessed as inhibition constant,CHEMBL5233263,KI,CCOC(=O)c1[nH]c2ccc(F)cc2c1CN1CCN(c2ccccc2)CC1
CHEMBL140099,CHEMBL217,Dopamine D2 receptor,Ki,=,3100.0,nM,CHEMBL5235409,B,Binding affinity to human D2R assessed as inhibition constant,CHEMBL5233263,KI,N#Cc1ccc2[nH]c(CN3CCN(c4ccccc4)CC3)cc2c1
CHEMBL143761,CHEMBL217,Dopamine D2 receptor,Ki,=,28000.0,nM,CHEMBL5235409,B,Binding affinity to human D2R assessed as inhibition constant,CHEMBL5233263,KI,N#Cc1ccc2[nH]c(CN3CCN(c4ccc(F)cc4)CC3)cc2c1
CHEMBL5285358,CHEMBL217,Dopamine D2 receptor,Ki,=,8800.0,nM,CHEMBL5235409,B,Binding affinity to human D2R assessed as inhibition constant,CHEMBL5233263,KI,O/N=C/c1c(CN2CCN(c3ccccc3)CC2)[nH]c2ccccc12
CHEMBL81330,CHEMBL217,Dopamine D2 receptor,Ki,=,199.0,nM,CHEMBL5235409,B,Binding affinity to human D2R assessed as inhibition constant,CHEMBL5233263,KI,Fc1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1
CHEMBL436274,CHEMBL217,Dopamine D2 receptor,Ki,=,892.0,nM,CHEMBL5235410,B,Displacement of [3H]-methylspiperone from human D2 receptor transfected in Sf9 cells assessed as inhibition constant measured after 60 mins,CHEMBL5233263,KI,Clc1ccc2c(c1)C(N1CCN(CCc3ccccc3)CC1)=Nc1cccnc1N2
CHEMBL5286175,CHEMBL217,Dopamine D2 receptor,Ki,=,4700.0,nM,CHEMBL5235411,B,Displacement of [3H]-spiperone from human D2 receptor assessed as inhibition constant,CHEMBL5233263,KI,Clc1ccc2c(c1)N=C(N1CCN(c3ccccc3)CC1)CCN2
CHEMBL267014,CHEMBL217,Dopamine D2 receptor,Ki,=,960.0,nM,CHEMBL5235417,B,Binding affinity to D2R (unknown origin) assessed as inhibition constant,CHEMBL5233263,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL5277859,CHEMBL217,Dopamine D2 receptor,Ki,=,10200.0,nM,CHEMBL5235417,B,Binding affinity to D2R (unknown origin) assessed as inhibition constant,CHEMBL5233263,KI,CCOC(=O)N1CCN(Cc2cnn(-c3ccc(Cl)cc3)c2)CC1
CHEMBL146246,CHEMBL217,Dopamine D2 receptor,Ki,=,5147.0,nM,CHEMBL5235417,B,Binding affinity to D2R (unknown origin) assessed as inhibition constant,CHEMBL5233263,KI,NS(=O)(=O)c1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1
CHEMBL320597,CHEMBL217,Dopamine D2 receptor,Ki,=,113.0,nM,CHEMBL5235417,B,Binding affinity to D2R (unknown origin) assessed as inhibition constant,CHEMBL5233263,KI,Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4C[C@H]3C)CC2)cc1
CHEMBL351963,CHEMBL217,Dopamine D2 receptor,Ki,=,209.0,nM,CHEMBL5235417,B,Binding affinity to D2R (unknown origin) assessed as inhibition constant,CHEMBL5233263,KI,Cc1ccc(CN2CCN(C3CCc4cccc5c4N(CC5)C3=O)CC2)cc1
CHEMBL305276,CHEMBL217,Dopamine D2 receptor,Ki,=,133.0,nM,CHEMBL5235417,B,Binding affinity to D2R (unknown origin) assessed as inhibition constant,CHEMBL5233263,KI,CN1C(=O)C(N2CCN(Cc3ccc(Cl)cc3)CC2)Cc2ccccc21
CHEMBL38262,CHEMBL217,Dopamine D2 receptor,Ki,=,1842.0,nM,CHEMBL5235417,B,Binding affinity to D2R (unknown origin) assessed as inhibition constant,CHEMBL5233263,KI,Cc1ccc(N2CCN(CCC3NC(=O)c4ccccc43)CC2)cc1C
CHEMBL2207643,CHEMBL217,Dopamine D2 receptor,Ki,=,33.0,nM,CHEMBL5235427,B,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells assessed as inhibition constant,CHEMBL5233263,KI,COc1ccccc1N1CCN(Cc2ccc3cccccc2-3)CC1
CHEMBL4096543,CHEMBL217,Dopamine D2 receptor,Ki,=,568.0,nM,CHEMBL5235437,B,Displacement of [3H]-spiperone from human D2 receptor expressed in Sf9 cells assessed as inhibition constant,CHEMBL5233263,KI,CC(C)Oc1cccnc1N(C)C1CCN(Cc2ccc(I)cc2)CC1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,0.34,nM,CHEMBL5236912,B,Partial agonist activity at human D2 receptor assessed as inhibition constant,CHEMBL5236546,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4445841,CHEMBL217,Dopamine D2 receptor,Ki,=,12.0,nM,CHEMBL5236912,B,Partial agonist activity at human D2 receptor assessed as inhibition constant,CHEMBL5236546,KI,Cn1ccc2c(N3CCN(CCCCOc4ccc5c(c4)NC(=O)CC5)CC3)cccc21
CHEMBL5272965,CHEMBL217,Dopamine D2 receptor,Ki,=,26.9,nM,CHEMBL5236912,B,Partial agonist activity at human D2 receptor assessed as inhibition constant,CHEMBL5236546,KI,CC1Cc2ccccc2N1C(=O)NCCCCN(C)[C@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL5279691,CHEMBL217,Dopamine D2 receptor,Ki,=,7300.0,nM,CHEMBL5251269,B,Displacement of [3H]methylspiperone from human D2S receptor stably expressed in CHO cells by Cheng-Prusoff equation analysis,CHEMBL5247646,KI,Cc1cc(C(F)(F)F)nc(Nc2ccccc2-c2nnn[nH]2)n1
CHEMBL5279691,CHEMBL217,Dopamine D2 receptor,Ki,=,16000.0,nM,CHEMBL5251271,B,Displacement of [3H]methylspiperone from human D2L receptor stably expressed in CHO cells by Cheng-Prusoff equation analysis,CHEMBL5247646,KI,Cc1cc(C(F)(F)F)nc(Nc2ccccc2-c2nnn[nH]2)n1
CHEMBL4576555,CHEMBL217,Dopamine D2 receptor,Ki,=,2752.36,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4507307,KI,CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1
CHEMBL4576555,CHEMBL217,Dopamine D2 receptor,Ki,=,2344.23,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4507307,KI,CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1
CHEMBL4522930,CHEMBL217,Dopamine D2 receptor,Ki,=,341.44,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4800722,KI,CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12
CHEMBL4522930,CHEMBL217,Dopamine D2 receptor,Ki,=,331.13,nM,CHEMBL4880035,B,GPCRScan assay: inhibition of D2,CHEMBL4800722,KI,CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12
CHEMBL5425920,CHEMBL217,Dopamine D2 receptor,Ki,=,1050.0,nM,CHEMBL5324908,B,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5321291,KI,Cc1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1
CHEMBL5436702,CHEMBL217,Dopamine D2 receptor,Ki,=,408.0,nM,CHEMBL5324908,B,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5321291,KI,c1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1
CHEMBL2037521,CHEMBL217,Dopamine D2 receptor,Ki,=,127.0,nM,CHEMBL5324908,B,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5321291,KI,c1cnc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1
CHEMBL5426481,CHEMBL217,Dopamine D2 receptor,Ki,=,830.0,nM,CHEMBL5324908,B,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5321291,KI,Clc1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1
CHEMBL3289656,CHEMBL217,Dopamine D2 receptor,Ki,=,6370.0,nM,CHEMBL5324908,B,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5321291,KI,c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1
CHEMBL5400876,CHEMBL217,Dopamine D2 receptor,Ki,=,2930.0,nM,CHEMBL5324908,B,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5321291,KI,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1
CHEMBL5437265,CHEMBL217,Dopamine D2 receptor,Ki,=,1580.0,nM,CHEMBL5324908,B,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5321291,KI,Cc1ccnc(N2CCN(CCCc3nc4ccccc4s3)CC2)c1
CHEMBL5403504,CHEMBL217,Dopamine D2 receptor,Ki,=,519.0,nM,CHEMBL5324908,B,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5321291,KI,COc1cccnc1N1CCN(CCCc2nc3ccccc3s2)CC1
CHEMBL5403610,CHEMBL217,Dopamine D2 receptor,Ki,=,49800.0,nM,CHEMBL5324908,B,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5321291,KI,Cc1ccc2nc(CCCN3CCN(c4ccccn4)CC3)sc2c1
CHEMBL5403986,CHEMBL217,Dopamine D2 receptor,Ki,=,2420.0,nM,CHEMBL5324908,B,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5321291,KI,Clc1ccc2nc(CCCN3CCN(c4ccccn4)CC3)sc2c1
CHEMBL5400983,CHEMBL217,Dopamine D2 receptor,Ki,=,14000.0,nM,CHEMBL5324908,B,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5321291,KI,Clc1ccc2sc(CCCN3CCN(c4ccccn4)CC3)nc2c1
CHEMBL5422150,CHEMBL217,Dopamine D2 receptor,Ki,=,6500.0,nM,CHEMBL5324908,B,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5321291,KI,Clc1cccc2sc(CCCN3CCN(c4ccccn4)CC3)nc12
CHEMBL5394387,CHEMBL217,Dopamine D2 receptor,Ki,=,13300.0,nM,CHEMBL5324908,B,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5321291,KI,Cc1cccnc1C1CCN(CCCc2nc3ccccc3s2)CC1
CHEMBL5434856,CHEMBL217,Dopamine D2 receptor,Ki,=,17400.0,nM,CHEMBL5324908,B,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5321291,KI,COc1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1
CHEMBL5399689,CHEMBL217,Dopamine D2 receptor,Ki,=,6890.0,nM,CHEMBL5324908,B,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5321291,KI,Cc1ccc2nc(CCCN3CCC(c4ccccn4)CC3)sc2c1
CHEMBL5406300,CHEMBL217,Dopamine D2 receptor,Ki,=,669.0,nM,CHEMBL5324908,B,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5321291,KI,COc1cccc2nc(CCCN3CCC(c4ccccn4)CC3)sc12
CHEMBL5399720,CHEMBL217,Dopamine D2 receptor,Ki,=,427.0,nM,CHEMBL5324908,B,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,CHEMBL5321291,KI,COc1ccc2nc(CCCN3CCC(c4ccccn4)CC3)sc2c1
CHEMBL5433001,CHEMBL217,Dopamine D2 receptor,Ki,=,2089.0,nM,CHEMBL5335368,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL5410387,CHEMBL217,Dopamine D2 receptor,Ki,=,2682.0,nM,CHEMBL5335368,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL5399166,CHEMBL217,Dopamine D2 receptor,Ki,=,2739.0,nM,CHEMBL5335368,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL5399568,CHEMBL217,Dopamine D2 receptor,Ki,=,1433.0,nM,CHEMBL5335368,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL5410716,CHEMBL217,Dopamine D2 receptor,Ki,=,1491.0,nM,CHEMBL5335368,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL5428803,CHEMBL217,Dopamine D2 receptor,Ki,=,5045.0,nM,CHEMBL5335368,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,CHEMBL5331137,KI,COc1c(O)ccc2c1CN1CCc3cc(OCCF)c(O)cc3[C@@H]1C2
CHEMBL487387,CHEMBL217,Dopamine D2 receptor,Ki,=,974.0,nM,CHEMBL5335368,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,CHEMBL5331137,KI,COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL5438487,CHEMBL217,Dopamine D2 receptor,Ki,=,811.0,nM,CHEMBL5335368,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OCCC)c3CN1CC2
CHEMBL5425375,CHEMBL217,Dopamine D2 receptor,Ki,=,591.0,nM,CHEMBL5335368,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCOc1c(O)ccc2c1CN1CCc3cc(OCCC)c(O)cc3[C@@H]1C2
CHEMBL5396616,CHEMBL217,Dopamine D2 receptor,Ki,=,616.0,nM,CHEMBL5335368,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OCCOCC)c3CN1CC2
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,9.6,nM,CHEMBL5335368,B,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,CHEMBL5331137,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4852835,CHEMBL217,Dopamine D2 receptor,Ki,=,6.58,nM,CHEMBL5337412,B,Binding affinity to human D2R assessed as inhibition constant,CHEMBL5335811,KI,COc1ccc(F)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL4867794,CHEMBL217,Dopamine D2 receptor,Ki,=,12.8,nM,CHEMBL5337412,B,Binding affinity to human D2R assessed as inhibition constant,CHEMBL5335811,KI,COc1ccc(Cl)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1
CHEMBL157138,CHEMBL217,Dopamine D2 receptor,Ki,=,0.34,nM,CHEMBL5346625,B,Binding affinity to dopamine D2 receptor (unknown origin) assessed as inhibition constant,CHEMBL5344475,KI,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL531,CHEMBL217,Dopamine D2 receptor,Ki,=,0.62,nM,CHEMBL5346625,B,Binding affinity to dopamine D2 receptor (unknown origin) assessed as inhibition constant,CHEMBL5344475,KI,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL493,CHEMBL217,Dopamine D2 receptor,Ki,=,0.62,nM,CHEMBL5346625,B,Binding affinity to dopamine D2 receptor (unknown origin) assessed as inhibition constant,CHEMBL5344475,KI,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL12713,CHEMBL217,Dopamine D2 receptor,Ki,=,0.38,nM,CHEMBL5346625,B,Binding affinity to dopamine D2 receptor (unknown origin) assessed as inhibition constant,CHEMBL5344475,KI,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1
CHEMBL5400232,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL5431474,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2cccc(-c3ccccc3)c2)CC1
CHEMBL5407341,CHEMBL217,Dopamine D2 receptor,Ki,=,89.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccc(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1-c1ccc(F)cc1
CHEMBL5415335,CHEMBL217,Dopamine D2 receptor,Ki,=,340.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccc(-c3ccccc3)cc2)CC1
CHEMBL5394431,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccc(F)cc2-c2ccccc2)CC1
CHEMBL5399833,CHEMBL217,Dopamine D2 receptor,Ki,=,86.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,C#CCOc1ccc(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c(-c2ccccc2)c1
CHEMBL5422870,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COCCOCCOc1ccc(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c(-c2ccccc2)c1
CHEMBL5436809,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2cccc(F)c2)CC1
CHEMBL5411404,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1cccc(-c2ccccc2NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL5410179,CHEMBL217,Dopamine D2 receptor,Ki,=,150.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccc(C(C)C)cc2)CC1
CHEMBL5416728,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccc(C(C)(C)C)cc2)CC1
CHEMBL5394229,CHEMBL217,Dopamine D2 receptor,Ki,=,52.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccc(-c3ccccc3)cc2)CC1
CHEMBL5425252,CHEMBL217,Dopamine D2 receptor,Ki,=,190.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccccc2)CC1
CHEMBL5421272,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2c(F)cccc2-c2ccccc2)CC1
CHEMBL5433509,CHEMBL217,Dopamine D2 receptor,Ki,=,88.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2cc(F)ccc2-c2ccccc2)CC1
CHEMBL5438205,CHEMBL217,Dopamine D2 receptor,Ki,=,73.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2ccc(F)cc2-c2ccccc2)CC1
CHEMBL5412718,CHEMBL217,Dopamine D2 receptor,Ki,=,26.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2cccc(F)c2-c2ccccc2)CC1
CHEMBL5403204,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccc(-c2ccccc2)c(CNC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL5439853,CHEMBL217,Dopamine D2 receptor,Ki,=,160.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccc(CNC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c(-c2ccccc2)c1
CHEMBL5405086,CHEMBL217,Dopamine D2 receptor,Ki,=,86.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2cccc(F)c2)CC1
CHEMBL5395187,CHEMBL217,Dopamine D2 receptor,Ki,=,210.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccc(F)cc2)CC1
CHEMBL5416644,CHEMBL217,Dopamine D2 receptor,Ki,=,220.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1cccc(-c2ccccc2CNC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL5427937,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccc(C)cc2)CC1
CHEMBL5396317,CHEMBL217,Dopamine D2 receptor,Ki,=,400.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccc(C(C)C)cc2)CC1
CHEMBL5405333,CHEMBL217,Dopamine D2 receptor,Ki,=,460.0,nM,CHEMBL5351445,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccc(-c3ccccc3)cc2)CC1
CHEMBL5400232,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL5431474,CHEMBL217,Dopamine D2 receptor,Ki,=,18.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2cccc(-c3ccccc3)c2)CC1
CHEMBL5407341,CHEMBL217,Dopamine D2 receptor,Ki,=,53.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccc(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1-c1ccc(F)cc1
CHEMBL5415335,CHEMBL217,Dopamine D2 receptor,Ki,=,130.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccc(-c3ccccc3)cc2)CC1
CHEMBL5394431,CHEMBL217,Dopamine D2 receptor,Ki,=,31.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccc(F)cc2-c2ccccc2)CC1
CHEMBL5399833,CHEMBL217,Dopamine D2 receptor,Ki,=,46.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,C#CCOc1ccc(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c(-c2ccccc2)c1
CHEMBL5422870,CHEMBL217,Dopamine D2 receptor,Ki,=,74.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COCCOCCOc1ccc(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c(-c2ccccc2)c1
CHEMBL5436809,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2cccc(F)c2)CC1
CHEMBL5411404,CHEMBL217,Dopamine D2 receptor,Ki,=,110.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1cccc(-c2ccccc2NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL5410179,CHEMBL217,Dopamine D2 receptor,Ki,=,90.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccc(C(C)C)cc2)CC1
CHEMBL5416728,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccc(C(C)(C)C)cc2)CC1
CHEMBL5394229,CHEMBL217,Dopamine D2 receptor,Ki,=,36.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccc(-c3ccccc3)cc2)CC1
CHEMBL5425252,CHEMBL217,Dopamine D2 receptor,Ki,=,120.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccccc2)CC1
CHEMBL5421272,CHEMBL217,Dopamine D2 receptor,Ki,=,140.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2c(F)cccc2-c2ccccc2)CC1
CHEMBL5433509,CHEMBL217,Dopamine D2 receptor,Ki,=,38.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2cc(F)ccc2-c2ccccc2)CC1
CHEMBL5438205,CHEMBL217,Dopamine D2 receptor,Ki,=,40.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2ccc(F)cc2-c2ccccc2)CC1
CHEMBL5412718,CHEMBL217,Dopamine D2 receptor,Ki,=,13.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2cccc(F)c2-c2ccccc2)CC1
CHEMBL5403204,CHEMBL217,Dopamine D2 receptor,Ki,=,78.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccc(-c2ccccc2)c(CNC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL5439853,CHEMBL217,Dopamine D2 receptor,Ki,=,37.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccc(CNC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c(-c2ccccc2)c1
CHEMBL5405086,CHEMBL217,Dopamine D2 receptor,Ki,=,67.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2cccc(F)c2)CC1
CHEMBL5395187,CHEMBL217,Dopamine D2 receptor,Ki,=,75.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccc(F)cc2)CC1
CHEMBL5416644,CHEMBL217,Dopamine D2 receptor,Ki,=,88.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1cccc(-c2ccccc2CNC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL5427937,CHEMBL217,Dopamine D2 receptor,Ki,=,62.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccc(C)cc2)CC1
CHEMBL5396317,CHEMBL217,Dopamine D2 receptor,Ki,=,170.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccc(C(C)C)cc2)CC1
CHEMBL5405333,CHEMBL217,Dopamine D2 receptor,Ki,=,290.0,nM,CHEMBL5351446,B,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccc(-c3ccccc3)cc2)CC1
CHEMBL1423,CHEMBL217,Dopamine D2 receptor,Ki,=,1.4,nM,CHEMBL5353627,B,Binding affinity to dopamine D2 receptor (unknown origin) assessed as inhibition constant,CHEMBL5352414,KI,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL5398291,CHEMBL217,Dopamine D2 receptor,Ki,=,69.7,nM,CHEMBL5362774,B,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,CHEMBL5360565,KI,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1n[nH]c2ccccc12
CHEMBL5415412,CHEMBL217,Dopamine D2 receptor,Ki,=,8.71,nM,CHEMBL5362774,B,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,CHEMBL5360565,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2n[nH]c3ccccc23)CC1
CHEMBL5409227,CHEMBL217,Dopamine D2 receptor,Ki,=,108.0,nM,CHEMBL5362774,B,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,CHEMBL5360565,KI,COc1cccc(N2CCN(CCCCNC(=O)c3n[nH]c4ccccc34)CC2)c1
CHEMBL5395668,CHEMBL217,Dopamine D2 receptor,Ki,=,239.0,nM,CHEMBL5362774,B,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,CHEMBL5360565,KI,O=C(NCCCCN1CCN(c2ccccn2)CC1)c1n[nH]c2ccccc12
CHEMBL5420627,CHEMBL217,Dopamine D2 receptor,Ki,=,557.0,nM,CHEMBL5362774,B,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,CHEMBL5360565,KI,O=C(NCCCCN1CCN(c2cccnc2)CC1)c1n[nH]c2ccccc12
CHEMBL5439203,CHEMBL217,Dopamine D2 receptor,Ki,=,264.0,nM,CHEMBL5362774,B,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,CHEMBL5360565,KI,O=C(NCCCCN1CCN(c2ncccn2)CC1)c1n[nH]c2ccccc12
CHEMBL5429491,CHEMBL217,Dopamine D2 receptor,Ki,=,26.4,nM,CHEMBL5362774,B,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,CHEMBL5360565,KI,O=C(NCCCCN1CCN(c2ccccc2F)CC1)c1n[nH]c2ccccc12
CHEMBL5411002,CHEMBL217,Dopamine D2 receptor,Ki,=,76.4,nM,CHEMBL5362774,B,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,CHEMBL5360565,KI,O=C(NCCCCN1CCN(c2cccc(F)c2)CC1)c1n[nH]c2ccccc12
CHEMBL5431642,CHEMBL217,Dopamine D2 receptor,Ki,=,596.0,nM,CHEMBL5362774,B,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,CHEMBL5360565,KI,O=C(NCCCCN1CCN(c2ccc(F)cc2)CC1)c1n[nH]c2ccccc12
CHEMBL5424052,CHEMBL217,Dopamine D2 receptor,Ki,=,8.57,nM,CHEMBL5362774,B,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,CHEMBL5360565,KI,O=C(NCCCCN1CCN(c2ccccc2C(F)(F)F)CC1)c1n[nH]c2ccccc12
CHEMBL5435580,CHEMBL217,Dopamine D2 receptor,Ki,=,109.0,nM,CHEMBL5362774,B,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,CHEMBL5360565,KI,O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1n[nH]c2ccccc12
CHEMBL5422196,CHEMBL217,Dopamine D2 receptor,Ki,=,11.8,nM,CHEMBL5362774,B,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,CHEMBL5360565,KI,O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1n[nH]c2ccccc12
CHEMBL5404031,CHEMBL217,Dopamine D2 receptor,Ki,=,9.93,nM,CHEMBL5362774,B,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,CHEMBL5360565,KI,CSc1ccccc1N1CCN(CCCCNC(=O)c2n[nH]c3ccccc23)CC1
CHEMBL5412886,CHEMBL217,Dopamine D2 receptor,Ki,=,9.86,nM,CHEMBL5362774,B,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,CHEMBL5360565,KI,CCOc1ccccc1N1CCN(CCCCNC(=O)c2n[nH]c3ccccc23)CC1
CHEMBL5432478,CHEMBL217,Dopamine D2 receptor,Ki,=,115.0,nM,CHEMBL5362774,B,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,CHEMBL5360565,KI,O=C(NCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1n[nH]c2ccccc12
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Ki,=,7.41,nM,CHEMBL5362774,B,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,CHEMBL5360565,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL5406129,CHEMBL217,Dopamine D2 receptor,Ki,=,1400.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CN(C)C(=O)C(CCN1C[C@H](O)C/C1=C\N1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1
CHEMBL5432993,CHEMBL217,Dopamine D2 receptor,Ki,=,1180.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CN(C)C(=O)C(CCN1C[C@H](O)C[C@H]1CN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1
CHEMBL5434650,CHEMBL217,Dopamine D2 receptor,Ki,=,870.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CCc1cc(Cl)c(OC)c(N2CCN(C[C@@H]3C[C@@H](O)CN3CCC(C(=O)N(C)C)(c3ccccc3)c3ccccc3)CC2)c1
CHEMBL5398747,CHEMBL217,Dopamine D2 receptor,Ki,=,4660.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CN(C)C(=O)C(CCN1C[C@H](O)C[C@H]1CN1CCN(c2cccc(C(F)(F)F)n2)CC1)(c1ccccc1)c1ccccc1
CHEMBL5414796,CHEMBL217,Dopamine D2 receptor,Ki,=,141.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CN(C)C(=O)C(CCN1C[C@H](O)C[C@H]1C(=O)NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1
CHEMBL5404724,CHEMBL217,Dopamine D2 receptor,Ki,=,2220.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CN(C)C(=O)C(CCN1C[C@H](O)C[C@H]1C(=O)NCCCCN1CCN(c2cccc(C(F)(F)F)n2)CC1)(c1ccccc1)c1ccccc1
CHEMBL5412606,CHEMBL217,Dopamine D2 receptor,Ki,=,2010.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CN(C)C(=O)C(CCN1C[C@H](F)C[C@H]1C(=O)NCCCCN1CCN(c2cccc(C(F)(F)F)n2)CC1)(c1ccccc1)c1ccccc1
CHEMBL5421714,CHEMBL217,Dopamine D2 receptor,Ki,=,272.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CN(C)C(=O)C(CCN1C[C@H](F)C[C@H]1C(=O)NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1
CHEMBL5395539,CHEMBL217,Dopamine D2 receptor,Ki,=,322.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CN(C)C(=O)C(CCN1C[C@H](F)C[C@H]1C(=O)NCCCCN1CCN(c2nsc3ccccc23)CC1)(c1ccccc1)c1ccccc1
CHEMBL5435235,CHEMBL217,Dopamine D2 receptor,Ki,=,146.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CC1CCC(CN2CCN(c3cccc(Cl)c3Cl)CC2)CN1CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1
CHEMBL5418819,CHEMBL217,Dopamine D2 receptor,Ki,=,117.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CN(C)C(=O)C(CCN1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)C1)(c1ccccc1)c1ccccc1
CHEMBL5407131,CHEMBL217,Dopamine D2 receptor,Ki,=,1440.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CCc1cc(Cl)c(OC)c(N2CCN(Cc3cn(CCC(C(=O)N(C)C)(c4ccccc4)c4ccccc4)nn3)CC2)c1
CHEMBL5415451,CHEMBL217,Dopamine D2 receptor,Ki,=,286.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CCc1cc(Cl)c(OC)c(N2CCN(CCCCc3cn(CCC(C(=O)N(C)C)(c4ccccc4)c4ccccc4)nn3)CC2)c1
CHEMBL5417253,CHEMBL217,Dopamine D2 receptor,Ki,=,1480.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CN(C)C(=O)C(CCN1CCN(c2cccc(C(F)(F)F)n2)CC1)(c1ccccc1)c1ccccc1
CHEMBL5409322,CHEMBL217,Dopamine D2 receptor,Ki,=,465.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CN(C)C(=O)C(CCN1CCN(c2nsc3ccccc23)CC1)(c1ccccc1)c1ccccc1
CHEMBL5398913,CHEMBL217,Dopamine D2 receptor,Ki,=,851.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CN(C)C(=O)C(CCN[C@@H]1C[C@H]1c1ccc(Cl)cc1)(c1ccccc1)c1ccccc1
CHEMBL5397609,CHEMBL217,Dopamine D2 receptor,Ki,=,978.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CCCN(CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1)[C@@H]1C[C@H]1c1ccc(Cl)cc1
CHEMBL5410159,CHEMBL217,Dopamine D2 receptor,Ki,=,7330.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CN(C)C(=O)C(CCN(CCO)[C@@H]1C[C@H]1c1ccc(Cl)cc1)(c1ccccc1)c1ccccc1
CHEMBL5417643,CHEMBL217,Dopamine D2 receptor,Ki,=,8640.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,COc1ccc([C@@H]2C[C@H]2NCCC(C(=O)N(C)C)(c2ccccc2)c2ccccc2)cc1
CHEMBL5436551,CHEMBL217,Dopamine D2 receptor,Ki,=,8010.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CN(C)C(=O)C(CCN[C@@H]1C[C@H]1c1ccc(F)cc1)(c1ccccc1)c1ccccc1
CHEMBL5412995,CHEMBL217,Dopamine D2 receptor,Ki,=,1550.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,COc1ccccc1[C@@H]1C[C@H]1NCCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1
CHEMBL2443262,CHEMBL217,Dopamine D2 receptor,Ki,=,83200.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,COc1ccsc1CNCC[C@@]1(c2ccccn2)CCOC2(CCCC2)C1
CHEMBL5425944,CHEMBL217,Dopamine D2 receptor,Ki,=,58.8,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,Clc1cccc(N2CCN(CCCOC3(c4ccccn4)CCOCC3)CC2)c1Cl
CHEMBL5400356,CHEMBL217,Dopamine D2 receptor,Ki,=,1690.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,FC(F)(F)c1cccc(N2CCN(CCCOC3(c4ccccn4)CCOCC3)CC2)n1
CHEMBL5415691,CHEMBL217,Dopamine D2 receptor,Ki,=,122.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CCC1(CC)CC(OCCCN2CCN(c3cccc(Cl)c3Cl)CC2)(c2ccccn2)CCO1
CHEMBL5415842,CHEMBL217,Dopamine D2 receptor,Ki,=,1240.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CCC1(CC)CC(OCCCN2CCN(c3cccc(C(F)(F)F)n3)CC2)(c2ccccn2)CCO1
CHEMBL5423250,CHEMBL217,Dopamine D2 receptor,Ki,=,1310.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,FC(F)(F)c1cccc(N2CCN(CCCOC3(c4ccccn4)CCOC4(CCCC4)C3)CC2)n1
CHEMBL5407845,CHEMBL217,Dopamine D2 receptor,Ki,=,13400.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,CCC1(CC)CC(OCCCNCc2cccc(Cl)c2Cl)(c2ccccn2)CCO1
CHEMBL5418730,CHEMBL217,Dopamine D2 receptor,Ki,=,4070.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,Clc1ccc([C@@H]2C[C@H]2NCCC2(c3ccccn3)CCOCC2)cc1
CHEMBL5407747,CHEMBL217,Dopamine D2 receptor,Ki,=,963.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,Clc1cccc(N2CCN(CCCCNCCC3(c4ccccn4)CCOCC3)CC2)c1Cl
CHEMBL5399270,CHEMBL217,Dopamine D2 receptor,Ki,=,121.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,Clc1cccc(N2CCN(CCC3(c4ccccn4)CCOCC3)CC2)c1Cl
CHEMBL5429207,CHEMBL217,Dopamine D2 receptor,Ki,=,7460.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,FC(F)(F)c1cccc(N2CCN(CCC3(c4ccccn4)CCOCC3)CC2)n1
CHEMBL5433458,CHEMBL217,Dopamine D2 receptor,Ki,=,5520.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,Clc1ccc([C@@H]2C[C@H]2NCCC2(c3ccccn3)CCOC3(CCCC3)C2)cc1
CHEMBL5413807,CHEMBL217,Dopamine D2 receptor,Ki,=,5430.0,nM,CHEMBL5363864,B,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,CHEMBL5360615,KI,FC(F)(F)c1cccc(N2CCN(CCC3(c4ccccn4)CCOC4(CCCC4)C3)CC2)n1
CHEMBL3085821,CHEMBL217,Dopamine D2 receptor,Ki,=,8.2,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,Ki,=,0.78,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5433284,CHEMBL217,Dopamine D2 receptor,Ki,=,1.21,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CNC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5417351,CHEMBL217,Dopamine D2 receptor,Ki,=,1.49,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,NC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5398100,CHEMBL217,Dopamine D2 receptor,Ki,=,1.86,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)N1CCc2ncccc2C1
CHEMBL5395965,CHEMBL217,Dopamine D2 receptor,Ki,=,6.5,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)C1=CC2C=CC=CC2N1
CHEMBL5429826,CHEMBL217,Dopamine D2 receptor,Ki,=,29.0,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)c1ccnc2ccccc12
CHEMBL5429048,CHEMBL217,Dopamine D2 receptor,Ki,=,3.75,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)c1ccc(-c2cccnc2)cc1
CHEMBL5431103,CHEMBL217,Dopamine D2 receptor,Ki,=,2.85,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5415846,CHEMBL217,Dopamine D2 receptor,Ki,=,0.75,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CCc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)N(C)C)CC3)CC2)c1Cl
CHEMBL5425134,CHEMBL217,Dopamine D2 receptor,Ki,=,0.48,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CCc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)NC)CC3)CC2)c1Cl
CHEMBL5404807,CHEMBL217,Dopamine D2 receptor,Ki,=,0.87,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CCc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)N4CCc5ncccc5C4)CC3)CC2)c1Cl
CHEMBL5421925,CHEMBL217,Dopamine D2 receptor,Ki,=,5.76,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CCc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)C4=CC5C=CC=CC5N4)CC3)CC2)c1Cl
CHEMBL5404054,CHEMBL217,Dopamine D2 receptor,Ki,=,7.8,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CCc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)c4ccnc5ccccc45)CC3)CC2)c1Cl
CHEMBL5440422,CHEMBL217,Dopamine D2 receptor,Ki,=,1.8,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CCc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)c4ccc(-c5cccnc5)cc4)CC3)CC2)c1Cl
CHEMBL5408223,CHEMBL217,Dopamine D2 receptor,Ki,=,1.78,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CCc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)COC)CC3)CC2)c1Cl
CHEMBL5427695,CHEMBL217,Dopamine D2 receptor,Ki,=,134.0,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,COc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)N(C)C)CC3)CC2)c1F
CHEMBL5403268,CHEMBL217,Dopamine D2 receptor,Ki,=,479.0,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(OC)c3F)CC2)CC1
CHEMBL5402212,CHEMBL217,Dopamine D2 receptor,Ki,=,26.7,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(C(F)(F)F)n3)CC2)CC1
CHEMBL5436641,CHEMBL217,Dopamine D2 receptor,Ki,=,162.0,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(C(F)(F)F)n3)CC2)CC1)c1ccnc2ccccc12
CHEMBL5434229,CHEMBL217,Dopamine D2 receptor,Ki,=,127.0,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(C(F)(F)F)n3)CC2)CC1
CHEMBL5424241,CHEMBL217,Dopamine D2 receptor,Ki,=,68.1,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CCc1cc(Cl)c(OC)c(N2CCN(CC[C@H]3CC[C@H](NC(=O)OC(C)(C)C)CC3)CC2)c1
CHEMBL5409134,CHEMBL217,Dopamine D2 receptor,Ki,=,4.12,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CCc1cc(Cl)c(OC)c(N2CCN(CC[C@H]3CC[C@H](NC(=O)N(C)C)CC3)CC2)c1
CHEMBL5437660,CHEMBL217,Dopamine D2 receptor,Ki,=,5.8,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CCc1cc(Cl)c(OC)c(N2CCN(CC[C@H]3CC[C@H](NC(=O)NC)CC3)CC2)c1
CHEMBL5409755,CHEMBL217,Dopamine D2 receptor,Ki,=,5.3,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CCc1cc(Cl)c(OC)c(N2CCN(CC[C@H]3CC[C@H](NC(N)=O)CC3)CC2)c1
CHEMBL5427065,CHEMBL217,Dopamine D2 receptor,Ki,=,114.0,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CCc1cc(Cl)c(OC)c(N2CCN(CC[C@H]3CC[C@H](NC(=O)C4=CC5C=CC=CC5N4)CC3)CC2)c1
CHEMBL5424897,CHEMBL217,Dopamine D2 receptor,Ki,=,15.2,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CCc1cc(Cl)c(OC)c(N2CCN(CC[C@H]3CC[C@H](NC(=O)CCOC)CC3)CC2)c1
CHEMBL5400528,CHEMBL217,Dopamine D2 receptor,Ki,=,20.5,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CN(C)C(=O)N1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5435745,CHEMBL217,Dopamine D2 receptor,Ki,=,86.0,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,COCCC(=O)N1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5436957,CHEMBL217,Dopamine D2 receptor,Ki,=,7.2,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CN(C)C(=O)N1CCC(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5438081,CHEMBL217,Dopamine D2 receptor,Ki,=,19.4,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,COCCC(=O)N1CCC(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5420316,CHEMBL217,Dopamine D2 receptor,Ki,=,89.8,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CN(C)C(=O)N1CCC(O)(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)C1
CHEMBL5399129,CHEMBL217,Dopamine D2 receptor,Ki,=,175.0,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,COCCC(=O)N1CCC(O)(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)C1
CHEMBL5426620,CHEMBL217,Dopamine D2 receptor,Ki,=,38.4,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,CN(C)C(=O)N1CCC(O)(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5421827,CHEMBL217,Dopamine D2 receptor,Ki,=,125.0,nM,CHEMBL5381008,B,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,CHEMBL5380776,KI,COCCC(=O)N1CCC(O)(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5424038,CHEMBL217,Dopamine D2 receptor,Ki,=,7.04,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCOc3ccc4c(c3)NC(=O)CC4)oc12
CHEMBL5441140,CHEMBL217,Dopamine D2 receptor,Ki,=,0.12,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCOc3ccc4ccc(=O)[nH]c4c3)oc12
CHEMBL5425434,CHEMBL217,Dopamine D2 receptor,Ki,=,33.3,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2cc(CNCCCCOc3ccc4c(c3)NC(=O)CC4)oc12
CHEMBL5417857,CHEMBL217,Dopamine D2 receptor,Ki,=,4.01,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2cc(CNCCCCOc3ccc4ccc(=O)[nH]c4c3)oc12
CHEMBL5414943,CHEMBL217,Dopamine D2 receptor,Ki,=,582.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,O=C1CCc2ccc(OCCCCNCc3cc4ccccc4o3)cc2N1
CHEMBL5438499,CHEMBL217,Dopamine D2 receptor,Ki,=,239.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,O=c1ccc2ccc(OCCCCNCc3cc4ccccc4o3)cc2[nH]1
CHEMBL5401818,CHEMBL217,Dopamine D2 receptor,Ki,=,109.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCOc3ccc4c(c3)NC(=O)CC4)oc12
CHEMBL5426286,CHEMBL217,Dopamine D2 receptor,Ki,=,423.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCOc3ccc4ccc(=O)[nH]c4c3)oc12
CHEMBL5406355,CHEMBL217,Dopamine D2 receptor,Ki,=,439.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCCOc3ccc4c(c3)NC(=O)CC4)oc12
CHEMBL5414152,CHEMBL217,Dopamine D2 receptor,Ki,=,745.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCCOc3ccc4ccc(=O)[nH]c4c3)oc12
CHEMBL5417227,CHEMBL217,Dopamine D2 receptor,Ki,=,30.2,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCOc3ccc4scnc4c3)oc12
CHEMBL5421574,CHEMBL217,Dopamine D2 receptor,Ki,=,438.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCOc3ccc4c(c3)OCO4)oc12
CHEMBL5418748,CHEMBL217,Dopamine D2 receptor,Ki,=,6.48,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCOc3ccc4ccc(=O)oc4c3)oc12
CHEMBL5414422,CHEMBL217,Dopamine D2 receptor,Ki,=,935.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCOc3ccc4oc(C)nc4c3)oc12
CHEMBL5418890,CHEMBL217,Dopamine D2 receptor,Ki,=,2077.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCOc3ccc4c(C)noc4c3)oc12
CHEMBL5440936,CHEMBL217,Dopamine D2 receptor,Ki,=,539.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CN(C)CCCCOc3ccc4c(c3)NC(=O)CC4)oc12
CHEMBL5411545,CHEMBL217,Dopamine D2 receptor,Ki,=,1274.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCCN(CCCCOc1ccc2c(c1)NC(=O)CC2)Cc1cc2cccc(OCC)c2o1
CHEMBL5435054,CHEMBL217,Dopamine D2 receptor,Ki,=,99.3,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCC[C@H]3CC[C@H](NC(=O)N(C)C)CC3)oc12
CHEMBL5438433,CHEMBL217,Dopamine D2 receptor,Ki,=,67.9,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCC[C@H]3CC[C@H](NC(=O)N4CCCC4)CC3)oc12
CHEMBL5412359,CHEMBL217,Dopamine D2 receptor,Ki,=,62.8,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCC[C@H]3CC[C@H](NC(=O)C4CC4)CC3)oc12
CHEMBL5396612,CHEMBL217,Dopamine D2 receptor,Ki,=,707.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2cc(CNCCCCOc3ccc4ccc(=O)[nH]c4c3)sc12
CHEMBL5405133,CHEMBL217,Dopamine D2 receptor,Ki,=,181.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2cc(CNCCCOc3ccc4ccc(=O)[nH]c4c3)sc12
CHEMBL5430494,CHEMBL217,Dopamine D2 receptor,Ki,=,16.5,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2c3c(oc12)CN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC3
CHEMBL5435325,CHEMBL217,Dopamine D2 receptor,Ki,=,88.8,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CC(C)Oc1cccc2c3c(oc12)CN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC3
CHEMBL5426242,CHEMBL217,Dopamine D2 receptor,Ki,=,84.3,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC3
CHEMBL5409419,CHEMBL217,Dopamine D2 receptor,Ki,=,39.3,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC3
CHEMBL5415178,CHEMBL217,Dopamine D2 receptor,Ki,=,3189.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2c(c1)NC(=O)C2)CC3
CHEMBL5395417,CHEMBL217,Dopamine D2 receptor,Ki,=,2277.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2ccc(=O)n(C)c2c1)CC3
CHEMBL5393856,CHEMBL217,Dopamine D2 receptor,Ki,=,292.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2ccc(=O)oc2c1)CC3
CHEMBL5402456,CHEMBL217,Dopamine D2 receptor,Ki,=,1344.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2cccnc2c1)CC3
CHEMBL5410217,CHEMBL217,Dopamine D2 receptor,Ki,=,25852.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2scnc2c1)CC3
CHEMBL5433201,CHEMBL217,Dopamine D2 receptor,Ki,=,204.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCOc1ccc2c(c1)NC(=O)CC2)CC3
CHEMBL5427288,CHEMBL217,Dopamine D2 receptor,Ki,=,149.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCOc1ccc2ccc(=O)[nH]c2c1)CC3
CHEMBL5414097,CHEMBL217,Dopamine D2 receptor,Ki,=,139.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(C/C=C/COc1ccc2ccc(=O)[nH]c2c1)CC3
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,Ki,=,2180.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL5406501,CHEMBL217,Dopamine D2 receptor,Ki,=,2130.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(C(C)NCC3(O)CCCCC3)oc12
CHEMBL5424038,CHEMBL217,Dopamine D2 receptor,Ki,=,7.079,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCOc3ccc4c(c3)NC(=O)CC4)oc12
CHEMBL5441140,CHEMBL217,Dopamine D2 receptor,Ki,=,0.1288,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCOc3ccc4ccc(=O)[nH]c4c3)oc12
CHEMBL5425434,CHEMBL217,Dopamine D2 receptor,Ki,=,33.88,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2cc(CNCCCCOc3ccc4c(c3)NC(=O)CC4)oc12
CHEMBL5417857,CHEMBL217,Dopamine D2 receptor,Ki,=,4.074,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2cc(CNCCCCOc3ccc4ccc(=O)[nH]c4c3)oc12
CHEMBL5414943,CHEMBL217,Dopamine D2 receptor,Ki,=,588.84,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,O=C1CCc2ccc(OCCCCNCc3cc4ccccc4o3)cc2N1
CHEMBL5438499,CHEMBL217,Dopamine D2 receptor,Ki,=,239.88,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,O=c1ccc2ccc(OCCCCNCc3cc4ccccc4o3)cc2[nH]1
CHEMBL5401818,CHEMBL217,Dopamine D2 receptor,Ki,=,109.65,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCOc3ccc4c(c3)NC(=O)CC4)oc12
CHEMBL5426286,CHEMBL217,Dopamine D2 receptor,Ki,=,426.58,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCOc3ccc4ccc(=O)[nH]c4c3)oc12
CHEMBL5406355,CHEMBL217,Dopamine D2 receptor,Ki,=,446.68,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCCOc3ccc4c(c3)NC(=O)CC4)oc12
CHEMBL5414152,CHEMBL217,Dopamine D2 receptor,Ki,=,758.58,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCCOc3ccc4ccc(=O)[nH]c4c3)oc12
CHEMBL5417227,CHEMBL217,Dopamine D2 receptor,Ki,=,30.9,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCOc3ccc4scnc4c3)oc12
CHEMBL5421574,CHEMBL217,Dopamine D2 receptor,Ki,=,446.68,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCOc3ccc4c(c3)OCO4)oc12
CHEMBL5418748,CHEMBL217,Dopamine D2 receptor,Ki,=,6.607,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCOc3ccc4ccc(=O)oc4c3)oc12
CHEMBL5414422,CHEMBL217,Dopamine D2 receptor,Ki,=,954.99,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCOc3ccc4oc(C)nc4c3)oc12
CHEMBL5418890,CHEMBL217,Dopamine D2 receptor,Ki,=,2089.3,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCCCCOc3ccc4c(C)noc4c3)oc12
CHEMBL5440936,CHEMBL217,Dopamine D2 receptor,Ki,=,549.54,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CN(C)CCCCOc3ccc4c(c3)NC(=O)CC4)oc12
CHEMBL5411545,CHEMBL217,Dopamine D2 receptor,Ki,=,1288.25,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCCN(CCCCOc1ccc2c(c1)NC(=O)CC2)Cc1cc2cccc(OCC)c2o1
CHEMBL5435054,CHEMBL217,Dopamine D2 receptor,Ki,=,100.0,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCC[C@H]3CC[C@H](NC(=O)N(C)C)CC3)oc12
CHEMBL5438433,CHEMBL217,Dopamine D2 receptor,Ki,=,69.18,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCC[C@H]3CC[C@H](NC(=O)N4CCCC4)CC3)oc12
CHEMBL5412359,CHEMBL217,Dopamine D2 receptor,Ki,=,63.1,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2cc(CNCC[C@H]3CC[C@H](NC(=O)C4CC4)CC3)oc12
CHEMBL5396612,CHEMBL217,Dopamine D2 receptor,Ki,=,707.95,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2cc(CNCCCCOc3ccc4ccc(=O)[nH]c4c3)sc12
CHEMBL5405133,CHEMBL217,Dopamine D2 receptor,Ki,=,181.97,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2cc(CNCCCOc3ccc4ccc(=O)[nH]c4c3)sc12
CHEMBL5430494,CHEMBL217,Dopamine D2 receptor,Ki,=,16.6,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CCOc1cccc2c3c(oc12)CN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC3
CHEMBL5435325,CHEMBL217,Dopamine D2 receptor,Ki,=,89.13,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,CC(C)Oc1cccc2c3c(oc12)CN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC3
CHEMBL5426242,CHEMBL217,Dopamine D2 receptor,Ki,=,85.11,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC3
CHEMBL5409419,CHEMBL217,Dopamine D2 receptor,Ki,=,39.81,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC3
CHEMBL5415178,CHEMBL217,Dopamine D2 receptor,Ki,=,3235.94,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2c(c1)NC(=O)C2)CC3
CHEMBL5395417,CHEMBL217,Dopamine D2 receptor,Ki,=,2290.87,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2ccc(=O)n(C)c2c1)CC3
CHEMBL5393856,CHEMBL217,Dopamine D2 receptor,Ki,=,295.12,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2ccc(=O)oc2c1)CC3
CHEMBL5402456,CHEMBL217,Dopamine D2 receptor,Ki,=,1348.96,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2cccnc2c1)CC3
CHEMBL5410217,CHEMBL217,Dopamine D2 receptor,Ki,=,26302.68,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2scnc2c1)CC3
CHEMBL5433201,CHEMBL217,Dopamine D2 receptor,Ki,=,204.17,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCOc1ccc2c(c1)NC(=O)CC2)CC3
CHEMBL5427288,CHEMBL217,Dopamine D2 receptor,Ki,=,151.36,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCOc1ccc2ccc(=O)[nH]c2c1)CC3
CHEMBL5414097,CHEMBL217,Dopamine D2 receptor,Ki,=,141.25,nM,CHEMBL5385535,B,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(C/C=C/COc1ccc2ccc(=O)[nH]c2c1)CC3
CHEMBL3182733,CHEMBL217,Dopamine D2 receptor,Ki,=,3.9,nM,CHEMBL5387511,B,Binding affinity to human D2 receptor assessed as inhibition constant,CHEMBL5385871,KI,CCCN[C@H]1CCc2nc(N)sc2C1.Cl.Cl.O
CHEMBL5408427,CHEMBL217,Dopamine D2 receptor,Ki,=,1.32,nM,CHEMBL5391038,B,Displacement of [3H]-NMSP from D2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay,CHEMBL5390222,KI,CC(C)c1cc(-c2ccsc2)cc(N2CCN(C)CC2)n1
CHEMBL5394961,CHEMBL217,Dopamine D2 receptor,Ki,=,0.2,nM,CHEMBL5391038,B,Displacement of [3H]-NMSP from D2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay,CHEMBL5390222,KI,CCCCc1cc(-c2ccsc2)cc(N2CCN(C)CC2)n1
CHEMBL5420183,CHEMBL217,Dopamine D2 receptor,Ki,=,7.34,nM,CHEMBL5391038,B,Displacement of [3H]-NMSP from D2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay,CHEMBL5390222,KI,Cc1cc(-c2ccsc2)cc(N2CCN(C)CC2)n1
CHEMBL5396600,CHEMBL217,Dopamine D2 receptor,Ki,=,83.4,nM,CHEMBL5391038,B,Displacement of [3H]-NMSP from D2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay,CHEMBL5390222,KI,CN1CCN(c2cc(-c3ccsc3)cc(CC3CCCCC3)n2)CC1
CHEMBL1516474,CHEMBL217,Dopamine D2 receptor,Ki,=,296.96,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12.O=C(O)/C=C\C(=O)O
CHEMBL405355,CHEMBL217,Dopamine D2 receptor,Ki,=,279.64,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1cccc([N+](=O)[O-])c1
CHEMBL24778,CHEMBL217,Dopamine D2 receptor,Ki,=,989.13,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F
CHEMBL300555,CHEMBL217,Dopamine D2 receptor,Ki,=,6.711,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccccc3O1)CC2
CHEMBL445102,CHEMBL217,Dopamine D2 receptor,Ki,=,87.45,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL267777,CHEMBL217,Dopamine D2 receptor,Ki,=,184.04,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL1334465,CHEMBL217,Dopamine D2 receptor,Ki,=,9765.62,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1
CHEMBL543113,CHEMBL217,Dopamine D2 receptor,Ki,=,767.36,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CN1C2CCC1CC(OC(c1ccc(F)cc1)c1ccc(F)cc1)C2.Cl
CHEMBL79834,CHEMBL217,Dopamine D2 receptor,Ki,=,9.619,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,O=C1NCN(c2ccccc2)C12CCN(CCCOc1ccc(F)cc1)CC2
CHEMBL1615374,CHEMBL217,Dopamine D2 receptor,Ki,=,552.71,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cl.N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1
CHEMBL1200618,CHEMBL217,Dopamine D2 receptor,Ki,=,8806.43,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1.Cl
CHEMBL589390,CHEMBL217,Dopamine D2 receptor,Ki,=,1547.75,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1
CHEMBL1200809,CHEMBL217,Dopamine D2 receptor,Ki,=,1176.52,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1.Cl
CHEMBL1633,CHEMBL217,Dopamine D2 receptor,Ki,=,1726.64,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1.O=C(O)/C=C/C(=O)O
CHEMBL1200492,CHEMBL217,Dopamine D2 receptor,Ki,=,735.53,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1.Cl
CHEMBL2024517,CHEMBL217,Dopamine D2 receptor,Ki,=,6.378,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1.Cl
CHEMBL2105760,CHEMBL217,Dopamine D2 receptor,Ki,=,5.985,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1
CHEMBL1200517,CHEMBL217,Dopamine D2 receptor,Ki,=,60.92,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21.CS(=O)(=O)O
CHEMBL5077459,CHEMBL217,Dopamine D2 receptor,Ki,=,3845.92,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,O=c1ccn([C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)[C@@H](O)[C@H]2O)c(=O)[nH]1.[Na+].[Na+].[Na+]
CHEMBL2138684,CHEMBL217,Dopamine D2 receptor,Ki,=,694.23,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1.O.O=C(O)CCC(=O)O
CHEMBL540612,CHEMBL217,Dopamine D2 receptor,Ki,=,144.06,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1.Cl
CHEMBL567303,CHEMBL217,Dopamine D2 receptor,Ki,=,595.52,nM,CHEMBL5442215,B,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1
CHEMBL4522930,CHEMBL217,Dopamine D2 receptor,Ki,=,341.44,nM,CHEMBL5479826,B,Selectivity interaction (GPCR panel (PDSP screen)) EUB0001492b DRD2,CHEMBL5465560,KI,CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12
CHEMBL108531,CHEMBL217,Dopamine D2 receptor,EC50,=,0.5,nM,CHEMBL673022,B,Compound was evaluated for effective concentration in vivo for Dopamine receptor D2 mitogenesis. (95% confidence intervals),CHEMBL1129267,EC50,Nc1ccc(C#CCCN2CC=C(c3ccccc3)CC2)cc1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,3.7,nM,CHEMBL675193,B,Effective dose was measured by the stimulation of mitogenesis at Dopamine receptor D4.2,CHEMBL1133533,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL108532,CHEMBL217,Dopamine D2 receptor,EC50,=,9.8,nM,CHEMBL673022,B,Compound was evaluated for effective concentration in vivo for Dopamine receptor D2 mitogenesis. (95% confidence intervals),CHEMBL1129267,EC50,Nc1cccc(C#CCCN2CC=C(c3ccccc3)CC2)c1
CHEMBL109063,CHEMBL217,Dopamine D2 receptor,EC50,=,0.5,nM,CHEMBL671810,B,In vivo Dopamine receptor D2 mitogenesis measured as [3H]thymidine incorporation in CHO p-5 cells expressing human D2 receptors,CHEMBL1129267,EC50,Nc1ccc(C#CCCN2CC=C(c3ccccc3)CC2)cn1
CHEMBL108463,CHEMBL217,Dopamine D2 receptor,EC50,=,1.7,nM,CHEMBL671810,B,In vivo Dopamine receptor D2 mitogenesis measured as [3H]thymidine incorporation in CHO p-5 cells expressing human D2 receptors,CHEMBL1129267,EC50,C(#Cc1cccnc1)CCN1CC=C(c2ccccc2)CC1
CHEMBL110489,CHEMBL217,Dopamine D2 receptor,EC50,=,1.0,nM,CHEMBL671810,B,In vivo Dopamine receptor D2 mitogenesis measured as [3H]thymidine incorporation in CHO p-5 cells expressing human D2 receptors,CHEMBL1129267,EC50,C(#Cc1ccncc1)CCN1CC=C(c2ccccc2)CC1
CHEMBL109101,CHEMBL217,Dopamine D2 receptor,EC50,=,1.3,nM,CHEMBL671810,B,In vivo Dopamine receptor D2 mitogenesis measured as [3H]thymidine incorporation in CHO p-5 cells expressing human D2 receptors,CHEMBL1129267,EC50,Nc1ccc(C#CCCN2CC=C(c3ccccc3)CC2)nc1
CHEMBL355371,CHEMBL217,Dopamine D2 receptor,EC50,=,28.0,nM,CHEMBL671067,B,The in vitro intrinsic activity was measured at DA D2 receptor by measuring its ability to increase [3H]thymidine uptake in CHO-K1 cells transfected with the Dopamine receptor D2,CHEMBL1131565,EC50,c1ccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)nc1
CHEMBL165679,CHEMBL217,Dopamine D2 receptor,EC50,=,29.0,nM,CHEMBL671067,B,The in vitro intrinsic activity was measured at DA D2 receptor by measuring its ability to increase [3H]thymidine uptake in CHO-K1 cells transfected with the Dopamine receptor D2,CHEMBL1131565,EC50,c1ccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)cc1
CHEMBL25856,CHEMBL217,Dopamine D2 receptor,EC50,=,1610.0,nM,CHEMBL673021,B,Adenylate cyclase assay carried out in LTK cells transfected with human Dopamine receptor D2,CHEMBL1128531,EC50,Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2
CHEMBL28338,CHEMBL217,Dopamine D2 receptor,EC50,=,3900.0,nM,CHEMBL673021,B,Adenylate cyclase assay carried out in LTK cells transfected with human Dopamine receptor D2,CHEMBL1128531,EC50,CCCc1cc2c(s1)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,170.0,nM,CHEMBL673021,B,Adenylate cyclase assay carried out in LTK cells transfected with human Dopamine receptor D2,CHEMBL1128531,EC50,NCCc1ccc(O)c(O)c1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,18.0,nM,CHEMBL673025,B,In vitro effective concentration tested on HEK293 cells co-transfected with human Dopamine receptor D2 using FLIPR assay,CHEMBL1148372,EC50,NCCc1ccc(O)c(O)c1
CHEMBL53,CHEMBL217,Dopamine D2 receptor,EC50,=,5.8,nM,CHEMBL884215,B,In vitro effective concentration tested on HEK293 cells co-transfected with human Dopamine receptor D2 using FLIPR assay,CHEMBL1148372,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL132575,CHEMBL217,Dopamine D2 receptor,EC50,=,170.0,nM,CHEMBL671065,B,Tested for intrinsic activity towards Dopamine receptor D2 in CHO cells,CHEMBL1144936,EC50,CCCN(CCC)C1CCC2=C(CCC/C2=N\O)C1
CHEMBL11845,CHEMBL217,Dopamine D2 receptor,EC50,=,0.7,nM,CHEMBL671065,B,Tested for intrinsic activity towards Dopamine receptor D2 in CHO cells,CHEMBL1144936,EC50,CCCN(CCC)C1CCc2c(ccc(O)c2O)C1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,2.2,nM,CHEMBL672520,B,Effective concentration was determined as thymidine uptake in CHO-L6 cells transfected with the rat Dopamine receptor D2L by mitogenesis assay (intrinsic activity),CHEMBL1133651,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL1945039,CHEMBL217,Dopamine D2 receptor,EC50,=,251.19,nM,CHEMBL1947810,B,Binding affinity to dopamine D2 receptor expressed in HEK cells by GTPgammaS binding assay,CHEMBL1944599,EC50,COc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1
CHEMBL2323579,CHEMBL217,Dopamine D2 receptor,EC50,=,1.4,nM,CHEMBL2328665,B,Partial agonist activity at human D2 receptor transfected in HTLA cells measured after overnight incubation by luminescence counter analysis,CHEMBL2321823,EC50,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@@H]2c3cccc4c3c(cn4C)C[C@H]2N(C)C1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,6.7,nM,CHEMBL2390219,B,Agonist activity at dopamine D2 receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 by FLIPR assay,CHEMBL2385071,EC50,NCCc1ccc(O)c(O)c1
CHEMBL3134071,CHEMBL217,Dopamine D2 receptor,EC50,=,248.0,nM,CHEMBL3136960,B,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,CHEMBL3132795,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCCCCCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3
CHEMBL3134070,CHEMBL217,Dopamine D2 receptor,EC50,=,385.0,nM,CHEMBL3136960,B,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,CHEMBL3132795,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCCCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3
CHEMBL3134069,CHEMBL217,Dopamine D2 receptor,EC50,=,224.0,nM,CHEMBL3136960,B,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,CHEMBL3132795,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3
CHEMBL3134068,CHEMBL217,Dopamine D2 receptor,EC50,=,110.0,nM,CHEMBL3136960,B,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,CHEMBL3132795,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3
CHEMBL3134067,CHEMBL217,Dopamine D2 receptor,EC50,=,79.0,nM,CHEMBL3136960,B,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,CHEMBL3132795,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3
CHEMBL3134066,CHEMBL217,Dopamine D2 receptor,EC50,=,419.0,nM,CHEMBL3136960,B,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,CHEMBL3132795,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3
CHEMBL3134065,CHEMBL217,Dopamine D2 receptor,EC50,=,149.0,nM,CHEMBL3136960,B,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,CHEMBL3132795,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3
CHEMBL3134064,CHEMBL217,Dopamine D2 receptor,EC50,=,396.0,nM,CHEMBL3136960,B,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,CHEMBL3132795,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3
CHEMBL3134063,CHEMBL217,Dopamine D2 receptor,EC50,=,266.0,nM,CHEMBL3136960,B,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,CHEMBL3132795,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCNC(=O)OC(C)(C)C)c(O)c1-3
CHEMBL3134062,CHEMBL217,Dopamine D2 receptor,EC50,=,132.0,nM,CHEMBL3136960,B,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,CHEMBL3132795,EC50,CC(=O)NCCCOc1ccc2c(c1O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL3134061,CHEMBL217,Dopamine D2 receptor,EC50,=,10.0,nM,CHEMBL3136960,B,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,CHEMBL3132795,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCN)c(O)c1-3
CHEMBL53,CHEMBL217,Dopamine D2 receptor,EC50,=,1.7,nM,CHEMBL3136960,B,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,CHEMBL3132795,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,EC50,=,3.467,nM,CHEMBL3293233,B,Partial agonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,CHEMBL3286313,EC50,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL3299094,CHEMBL217,Dopamine D2 receptor,EC50,=,0.39,nM,CHEMBL3300166,B,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,CHEMBL3297649,EC50,COc1ccccc1N1CCN(CCCNC(=O)OC(C)(C)C)CC1
CHEMBL3299095,CHEMBL217,Dopamine D2 receptor,EC50,=,0.6,nM,CHEMBL3300166,B,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,CHEMBL3297649,EC50,COc1ccccc1N1CCN(CCCCNC(=O)OC(C)(C)C)CC1
CHEMBL3299096,CHEMBL217,Dopamine D2 receptor,EC50,=,1.43,nM,CHEMBL3300166,B,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,CHEMBL3297649,EC50,COc1ccccc1N1CCN(CCCCCNC(=O)OC(C)(C)C)CC1
CHEMBL3298827,CHEMBL217,Dopamine D2 receptor,EC50,=,2.69,nM,CHEMBL3300166,B,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,CHEMBL3297649,EC50,COc1ccccc1N1CCN(CCCCCNC(=O)c2sc3nc(OC)c(Cl)c(C)c3c2N)CC1
CHEMBL3298828,CHEMBL217,Dopamine D2 receptor,EC50,=,5.49,nM,CHEMBL3300166,B,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,CHEMBL3297649,EC50,COc1nc2sc(C(=O)NCCCCCCN3CCC(c4ccc(Cl)cc4)CC3)c(N)c2c(C)c1Cl
CHEMBL3299094,CHEMBL217,Dopamine D2 receptor,EC50,=,0.389,nM,CHEMBL3300166,B,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,CHEMBL3297649,EC50,COc1ccccc1N1CCN(CCCNC(=O)OC(C)(C)C)CC1
CHEMBL3299095,CHEMBL217,Dopamine D2 receptor,EC50,=,0.6026,nM,CHEMBL3300166,B,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,CHEMBL3297649,EC50,COc1ccccc1N1CCN(CCCCNC(=O)OC(C)(C)C)CC1
CHEMBL3299096,CHEMBL217,Dopamine D2 receptor,EC50,=,1.445,nM,CHEMBL3300166,B,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,CHEMBL3297649,EC50,COc1ccccc1N1CCN(CCCCCNC(=O)OC(C)(C)C)CC1
CHEMBL3298827,CHEMBL217,Dopamine D2 receptor,EC50,=,2.692,nM,CHEMBL3300166,B,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,CHEMBL3297649,EC50,COc1ccccc1N1CCN(CCCCCNC(=O)c2sc3nc(OC)c(Cl)c(C)c3c2N)CC1
CHEMBL3298828,CHEMBL217,Dopamine D2 receptor,EC50,=,5.495,nM,CHEMBL3300166,B,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,CHEMBL3297649,EC50,COc1nc2sc(C(=O)NCCCCCCN3CCC(c4ccc(Cl)cc4)CC3)c(N)c2c(C)c1Cl
CHEMBL3298830,CHEMBL217,Dopamine D2 receptor,EC50,=,87.6,nM,CHEMBL3300170,B,Agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,CHEMBL3297649,EC50,COc1nc2sc(C(=O)NCCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)c(N)c2c(C)c1Cl
CHEMBL3298895,CHEMBL217,Dopamine D2 receptor,EC50,=,13.2,nM,CHEMBL3300170,B,Agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,CHEMBL3297649,EC50,Cc1cc(C)c2c(N)c(C(=O)NCCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)sc2n1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,83.0,nM,CHEMBL3578969,B,Agonist activity at ARMS2-PK2-tagged human dopamine D2S receptor expressed in HEK293 cells co-expressing (EA)-tagged beta arrestin fusion protein assessed as recruitment of beta-arrestin-2 after 5 hrs by chemiluminescence assay,CHEMBL3576771,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL2397389,CHEMBL217,Dopamine D2 receptor,EC50,=,140.0,nM,CHEMBL3578969,B,Agonist activity at ARMS2-PK2-tagged human dopamine D2S receptor expressed in HEK293 cells co-expressing (EA)-tagged beta arrestin fusion protein assessed as recruitment of beta-arrestin-2 after 5 hrs by chemiluminescence assay,CHEMBL3576771,EC50,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL2396663,CHEMBL217,Dopamine D2 receptor,EC50,=,16.0,nM,CHEMBL3578969,B,Agonist activity at ARMS2-PK2-tagged human dopamine D2S receptor expressed in HEK293 cells co-expressing (EA)-tagged beta arrestin fusion protein assessed as recruitment of beta-arrestin-2 after 5 hrs by chemiluminescence assay,CHEMBL3576771,EC50,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL3577342,CHEMBL217,Dopamine D2 receptor,EC50,=,380.0,nM,CHEMBL3578969,B,Agonist activity at ARMS2-PK2-tagged human dopamine D2S receptor expressed in HEK293 cells co-expressing (EA)-tagged beta arrestin fusion protein assessed as recruitment of beta-arrestin-2 after 5 hrs by chemiluminescence assay,CHEMBL3576771,EC50,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1
CHEMBL3577343,CHEMBL217,Dopamine D2 receptor,EC50,=,480.0,nM,CHEMBL3578969,B,Agonist activity at ARMS2-PK2-tagged human dopamine D2S receptor expressed in HEK293 cells co-expressing (EA)-tagged beta arrestin fusion protein assessed as recruitment of beta-arrestin-2 after 5 hrs by chemiluminescence assay,CHEMBL3576771,EC50,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1
CHEMBL3577344,CHEMBL217,Dopamine D2 receptor,EC50,=,140.0,nM,CHEMBL3578969,B,Agonist activity at ARMS2-PK2-tagged human dopamine D2S receptor expressed in HEK293 cells co-expressing (EA)-tagged beta arrestin fusion protein assessed as recruitment of beta-arrestin-2 after 5 hrs by chemiluminescence assay,CHEMBL3576771,EC50,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)CCc3ccc(O)c4[nH]c(=O)ccc34)cc2OC)nn1
CHEMBL3577345,CHEMBL217,Dopamine D2 receptor,EC50,=,30.0,nM,CHEMBL3578969,B,Agonist activity at ARMS2-PK2-tagged human dopamine D2S receptor expressed in HEK293 cells co-expressing (EA)-tagged beta arrestin fusion protein assessed as recruitment of beta-arrestin-2 after 5 hrs by chemiluminescence assay,CHEMBL3576771,EC50,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@@H]3CCc4c(O)cccc4C3)cc2OC)nn1
CHEMBL3577346,CHEMBL217,Dopamine D2 receptor,EC50,=,1.4,nM,CHEMBL3578969,B,Agonist activity at ARMS2-PK2-tagged human dopamine D2S receptor expressed in HEK293 cells co-expressing (EA)-tagged beta arrestin fusion protein assessed as recruitment of beta-arrestin-2 after 5 hrs by chemiluminescence assay,CHEMBL3576771,EC50,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)cc2OC)nn1
CHEMBL1627305,CHEMBL217,Dopamine D2 receptor,EC50,=,170.0,nM,CHEMBL3599876,B,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as stimulation of quinpirole-stimulated mitogenesis,CHEMBL3596172,EC50,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL3597643,CHEMBL217,Dopamine D2 receptor,EC50,=,76.0,nM,CHEMBL3599876,B,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as stimulation of quinpirole-stimulated mitogenesis,CHEMBL3596172,EC50,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cc2ccccc2[nH]1
CHEMBL3597635,CHEMBL217,Dopamine D2 receptor,EC50,=,170.0,nM,CHEMBL3599876,B,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as stimulation of quinpirole-stimulated mitogenesis,CHEMBL3596172,EC50,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cnc2ccccc2c1
CHEMBL3597636,CHEMBL217,Dopamine D2 receptor,EC50,=,200.0,nM,CHEMBL3599876,B,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as stimulation of quinpirole-stimulated mitogenesis,CHEMBL3596172,EC50,O=C(NCCC(O)CN1CCN(c2cccc3ccccc23)CC1)c1cnc2ccccc2c1
CHEMBL3597637,CHEMBL217,Dopamine D2 receptor,EC50,=,10000.0,nM,CHEMBL3599876,B,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as stimulation of quinpirole-stimulated mitogenesis,CHEMBL3596172,EC50,COc1c(Cl)cccc1N1CCN(CCCCNC(=O)c2cnc3ccccc3c2)CC1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,51.0,nM,CHEMBL3614301,B,Activity at pro-link-tagged D2S-ARMS2PK2 (unknown origin) expressed in HEK293 cells by beta-arrestin-2 recruitment assay,CHEMBL3612016,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,5.0,nM,CHEMBL3801668,B,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,CHEMBL3797097,EC50,NCCc1ccc(O)c(O)c1
CHEMBL419792,CHEMBL217,Dopamine D2 receptor,EC50,=,60.1,nM,CHEMBL3801668,B,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,CHEMBL3797097,EC50,CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3799271,CHEMBL217,Dopamine D2 receptor,EC50,=,697.0,nM,CHEMBL3801668,B,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,CHEMBL3797097,EC50,N[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL434665,CHEMBL217,Dopamine D2 receptor,EC50,=,16.0,nM,CHEMBL3801668,B,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,CHEMBL3797097,EC50,CCCN[C@@H]1Cc2cccc3nc(O)n(c23)C1
CHEMBL26181,CHEMBL217,Dopamine D2 receptor,EC50,=,2.53,nM,CHEMBL3801668,B,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,CHEMBL3797097,EC50,CCCN(CCC)[C@@H]1Cc2cccc3nc(O)n(c23)C1
CHEMBL3800165,CHEMBL217,Dopamine D2 receptor,EC50,=,68.0,nM,CHEMBL3801668,B,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,CHEMBL3797097,EC50,CCCN[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL3797740,CHEMBL217,Dopamine D2 receptor,EC50,=,29.0,nM,CHEMBL3801668,B,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,CHEMBL3797097,EC50,CCCN(C)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3797209,CHEMBL217,Dopamine D2 receptor,EC50,=,33.9,nM,CHEMBL3801668,B,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,CHEMBL3797097,EC50,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL3799157,CHEMBL217,Dopamine D2 receptor,EC50,=,38.7,nM,CHEMBL3801668,B,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,CHEMBL3797097,EC50,CCCn1c(=O)n2c3c(cccc31)C[C@@H](NC)C2
CHEMBL3798803,CHEMBL217,Dopamine D2 receptor,EC50,=,30.5,nM,CHEMBL3801668,B,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,CHEMBL3797097,EC50,CCCCn1c(=O)n2c3c(cccc31)C[C@@H](NC)C2
CHEMBL3800633,CHEMBL217,Dopamine D2 receptor,EC50,=,43.3,nM,CHEMBL3801668,B,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,CHEMBL3797097,EC50,CN(CCCCNC(=O)c1cc2ccccc2o1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3798179,CHEMBL217,Dopamine D2 receptor,EC50,=,22.7,nM,CHEMBL3801668,B,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,CHEMBL3797097,EC50,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3799626,CHEMBL217,Dopamine D2 receptor,EC50,=,109.0,nM,CHEMBL3801668,B,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,CHEMBL3797097,EC50,CN(CCCCNC(=O)c1ccc2c(c1)Cc1ccccc1-2)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,7.7,nM,CHEMBL3801672,B,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,CHEMBL3797097,EC50,NCCc1ccc(O)c(O)c1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,8.2,nM,CHEMBL3801672,B,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,CHEMBL3797097,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL419792,CHEMBL217,Dopamine D2 receptor,EC50,=,64.7,nM,CHEMBL3801672,B,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,CHEMBL3797097,EC50,CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3799271,CHEMBL217,Dopamine D2 receptor,EC50,=,684.0,nM,CHEMBL3801672,B,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,CHEMBL3797097,EC50,N[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL434665,CHEMBL217,Dopamine D2 receptor,EC50,=,1.0,nM,CHEMBL3801672,B,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,CHEMBL3797097,EC50,CCCN[C@@H]1Cc2cccc3nc(O)n(c23)C1
CHEMBL3800165,CHEMBL217,Dopamine D2 receptor,EC50,=,13.0,nM,CHEMBL3801672,B,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,CHEMBL3797097,EC50,CCCN[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL3797740,CHEMBL217,Dopamine D2 receptor,EC50,=,18.1,nM,CHEMBL3801672,B,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,CHEMBL3797097,EC50,CCCN(C)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3797209,CHEMBL217,Dopamine D2 receptor,EC50,=,13.7,nM,CHEMBL3801672,B,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,CHEMBL3797097,EC50,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL3799157,CHEMBL217,Dopamine D2 receptor,EC50,=,549.0,nM,CHEMBL3801672,B,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,CHEMBL3797097,EC50,CCCn1c(=O)n2c3c(cccc31)C[C@@H](NC)C2
CHEMBL3798803,CHEMBL217,Dopamine D2 receptor,EC50,=,83.0,nM,CHEMBL3801672,B,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,CHEMBL3797097,EC50,CCCCn1c(=O)n2c3c(cccc31)C[C@@H](NC)C2
CHEMBL3800633,CHEMBL217,Dopamine D2 receptor,EC50,=,19.5,nM,CHEMBL3801672,B,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,CHEMBL3797097,EC50,CN(CCCCNC(=O)c1cc2ccccc2o1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3798179,CHEMBL217,Dopamine D2 receptor,EC50,=,27.7,nM,CHEMBL3801672,B,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,CHEMBL3797097,EC50,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3799626,CHEMBL217,Dopamine D2 receptor,EC50,=,102.0,nM,CHEMBL3801672,B,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,CHEMBL3797097,EC50,CN(CCCCNC(=O)c1ccc2c(c1)Cc1ccccc1-2)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL419792,CHEMBL217,Dopamine D2 receptor,EC50,=,4.6,nM,CHEMBL3803417,B,Agonist activity at recombinant human D2 receptor expressing in CHO cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation by beta plate counter,CHEMBL3797097,EC50,CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3799147,CHEMBL217,Dopamine D2 receptor,EC50,=,5300.0,nM,CHEMBL3803346,B,Agonist activity at human dopamine D2 receptor short isoform transfected in HEK293 cells measured for 10 mins by spectroscopic analysis,CHEMBL3797101,EC50,Cc1ccccc1N1CCN(CCCCNC(=O)Oc2cccc3ccccc23)CC1.Cl
CHEMBL3798334,CHEMBL217,Dopamine D2 receptor,EC50,=,4100.0,nM,CHEMBL3803346,B,Agonist activity at human dopamine D2 receptor short isoform transfected in HEK293 cells measured for 10 mins by spectroscopic analysis,CHEMBL3797101,EC50,COc1ccccc1N1CCN(CCCNC(=O)Oc2cccc3ccccc23)CC1
CHEMBL3798943,CHEMBL217,Dopamine D2 receptor,EC50,=,14000.0,nM,CHEMBL3803346,B,Agonist activity at human dopamine D2 receptor short isoform transfected in HEK293 cells measured for 10 mins by spectroscopic analysis,CHEMBL3797101,EC50,Cc1ccccc1N1CCN(CCCNC(=O)Oc2cccc3ccccc23)CC1.Cl
CHEMBL3798211,CHEMBL217,Dopamine D2 receptor,EC50,=,2600.0,nM,CHEMBL3803346,B,Agonist activity at human dopamine D2 receptor short isoform transfected in HEK293 cells measured for 10 mins by spectroscopic analysis,CHEMBL3797101,EC50,Cl.NC(=O)c1ccc(OC(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c2ccccc12
CHEMBL3799603,CHEMBL217,Dopamine D2 receptor,EC50,=,37.6,nM,CHEMBL3803346,B,Agonist activity at human dopamine D2 receptor short isoform transfected in HEK293 cells measured for 10 mins by spectroscopic analysis,CHEMBL3797101,EC50,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)Oc1ccccc1
CHEMBL3798372,CHEMBL217,Dopamine D2 receptor,EC50,=,3500.0,nM,CHEMBL3803346,B,Agonist activity at human dopamine D2 receptor short isoform transfected in HEK293 cells measured for 10 mins by spectroscopic analysis,CHEMBL3797101,EC50,Cl.O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)Oc1cccc2c1OCCO2
CHEMBL3798331,CHEMBL217,Dopamine D2 receptor,EC50,=,9900.0,nM,CHEMBL3803346,B,Agonist activity at human dopamine D2 receptor short isoform transfected in HEK293 cells measured for 10 mins by spectroscopic analysis,CHEMBL3797101,EC50,Cl.O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)Oc1cccc2[nH]cnc12
CHEMBL3799455,CHEMBL217,Dopamine D2 receptor,EC50,=,240.0,nM,CHEMBL3801490,B,Agonist activity at ARMS2-PK-tagged D2S receptor (unknown origin) transfected in HEK293 cells after 5 hrs by beta-arrestin assay,CHEMBL3797035,EC50,COc1cc(CCNCCc2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1
CHEMBL3800636,CHEMBL217,Dopamine D2 receptor,EC50,=,2600.0,nM,CHEMBL3801490,B,Agonist activity at ARMS2-PK-tagged D2S receptor (unknown origin) transfected in HEK293 cells after 5 hrs by beta-arrestin assay,CHEMBL3797035,EC50,COc1cc(CCNCCc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1
CHEMBL3798748,CHEMBL217,Dopamine D2 receptor,EC50,=,13000.0,nM,CHEMBL3801490,B,Agonist activity at ARMS2-PK-tagged D2S receptor (unknown origin) transfected in HEK293 cells after 5 hrs by beta-arrestin assay,CHEMBL3797035,EC50,COc1cc(CCNC[C@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1
CHEMBL3797205,CHEMBL217,Dopamine D2 receptor,EC50,=,8800.0,nM,CHEMBL3801490,B,Agonist activity at ARMS2-PK-tagged D2S receptor (unknown origin) transfected in HEK293 cells after 5 hrs by beta-arrestin assay,CHEMBL3797035,EC50,COc1cc(CCNC[C@@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1
CHEMBL3800341,CHEMBL217,Dopamine D2 receptor,EC50,=,1100.0,nM,CHEMBL3801490,B,Agonist activity at ARMS2-PK-tagged D2S receptor (unknown origin) transfected in HEK293 cells after 5 hrs by beta-arrestin assay,CHEMBL3797035,EC50,COc1cc(CCNCCc2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,86.0,nM,CHEMBL3801490,B,Agonist activity at ARMS2-PK-tagged D2S receptor (unknown origin) transfected in HEK293 cells after 5 hrs by beta-arrestin assay,CHEMBL3797035,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,0.69,nM,CHEMBL3872769,B,Agonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 by fluo-4 dye based FLIPR assay,CHEMBL3872208,EC50,NCCc1ccc(O)c(O)c1
CHEMBL53,CHEMBL217,Dopamine D2 receptor,EC50,=,575.44,nM,CHEMBL3880775,B,Agonist activity at dopamine D2 receptor short isoform (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay,CHEMBL3880399,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,EC50,=,7.079,nM,CHEMBL3880775,B,Agonist activity at dopamine D2 receptor short isoform (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay,CHEMBL3880399,EC50,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL589,CHEMBL217,Dopamine D2 receptor,EC50,=,6.457,nM,CHEMBL3880775,B,Agonist activity at dopamine D2 receptor short isoform (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay,CHEMBL3880399,EC50,CCCN(CCC)CCc1cccc2c1CC(=O)N2
CHEMBL493,CHEMBL217,Dopamine D2 receptor,EC50,=,0.5012,nM,CHEMBL3880775,B,Agonist activity at dopamine D2 receptor short isoform (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay,CHEMBL3880399,EC50,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL531,CHEMBL217,Dopamine D2 receptor,EC50,=,0.3548,nM,CHEMBL3880775,B,Agonist activity at dopamine D2 receptor short isoform (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay,CHEMBL3880399,EC50,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL157138,CHEMBL217,Dopamine D2 receptor,EC50,=,0.01,nM,CHEMBL3880775,B,Agonist activity at dopamine D2 receptor short isoform (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay,CHEMBL3880399,EC50,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,3.981,nM,CHEMBL3880775,B,Agonist activity at dopamine D2 receptor short isoform (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay,CHEMBL3880399,EC50,NCCc1ccc(O)c(O)c1
CHEMBL3918805,CHEMBL217,Dopamine D2 receptor,EC50,=,6.0,nM,CHEMBL3887362,B,"pERK High-Content Assay: Cell Culture: Chinese Hamster Ovary (CHO) cells stably expressing the hD2L dopamine receptor (Urban et al., Neuropsychopharmacology 32:67 (2007)) were maintained in Ham's F12 medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, 100 ug/mL streptomycin, and 0.5 ug/ml G418. On day 1 of the assay, cells were seeded onto black clear-bottom tissue culture-treated 96-well plates (Greiner, BioOne). On day 2 of the assay, cells were washed with serum-free medium (Ham's F-12, penicillin and streptomycin) and incubated in 100 uL serum-free medium overnight.Immunofluorescence: Automatic multichannel pipetters were used for liquid handling and multichannel vacuum manifolds for aspirations. Each tested concentration was typically measured in triplicate or quadruplicate. For concentration curves, half-log-dilutions were used. Drug dilutions were prepared in stimulation medium (serum-free medium, 100 mg/L ascorbic acid).",CHEMBL3886292,EC50,O=C1CCc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2165120,CHEMBL217,Dopamine D2 receptor,EC50,=,1.0,nM,CHEMBL3887362,B,"pERK High-Content Assay: Cell Culture: Chinese Hamster Ovary (CHO) cells stably expressing the hD2L dopamine receptor (Urban et al., Neuropsychopharmacology 32:67 (2007)) were maintained in Ham's F12 medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, 100 ug/mL streptomycin, and 0.5 ug/ml G418. On day 1 of the assay, cells were seeded onto black clear-bottom tissue culture-treated 96-well plates (Greiner, BioOne). On day 2 of the assay, cells were washed with serum-free medium (Ham's F-12, penicillin and streptomycin) and incubated in 100 uL serum-free medium overnight.Immunofluorescence: Automatic multichannel pipetters were used for liquid handling and multichannel vacuum manifolds for aspirations. Each tested concentration was typically measured in triplicate or quadruplicate. For concentration curves, half-log-dilutions were used. Drug dilutions were prepared in stimulation medium (serum-free medium, 100 mg/L ascorbic acid).",CHEMBL3886292,EC50,O=c1ccc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1
CHEMBL2165138,CHEMBL217,Dopamine D2 receptor,EC50,=,50.0,nM,CHEMBL3887362,B,"pERK High-Content Assay: Cell Culture: Chinese Hamster Ovary (CHO) cells stably expressing the hD2L dopamine receptor (Urban et al., Neuropsychopharmacology 32:67 (2007)) were maintained in Ham's F12 medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, 100 ug/mL streptomycin, and 0.5 ug/ml G418. On day 1 of the assay, cells were seeded onto black clear-bottom tissue culture-treated 96-well plates (Greiner, BioOne). On day 2 of the assay, cells were washed with serum-free medium (Ham's F-12, penicillin and streptomycin) and incubated in 100 uL serum-free medium overnight.Immunofluorescence: Automatic multichannel pipetters were used for liquid handling and multichannel vacuum manifolds for aspirations. Each tested concentration was typically measured in triplicate or quadruplicate. For concentration curves, half-log-dilutions were used. Drug dilutions were prepared in stimulation medium (serum-free medium, 100 mg/L ascorbic acid).",CHEMBL3886292,EC50,Clc1cccc(C2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl
CHEMBL4104013,CHEMBL217,Dopamine D2 receptor,EC50,=,0.631,nM,CHEMBL4000290,B,Agonist activity at human dopamine D2L receptor expressed in F1pIn CHO cells assessed as induction of ERK1/2 phosphorylation incubated for 5 mins by AlphaScreen assay,CHEMBL4000143,EC50,O=C1COc2ccccc2N1CCCN1CCN(c2cccc3[nH]c(=O)oc23)CC1
CHEMBL4104013,CHEMBL217,Dopamine D2 receptor,EC50,=,0.64,nM,CHEMBL4000290,B,Agonist activity at human dopamine D2L receptor expressed in F1pIn CHO cells assessed as induction of ERK1/2 phosphorylation incubated for 5 mins by AlphaScreen assay,CHEMBL4000143,EC50,O=C1COc2ccccc2N1CCCN1CCN(c2cccc3[nH]c(=O)oc23)CC1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,EC50,=,14.9,nM,CHEMBL4010168,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,CHEMBL4007455,EC50,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4098803,CHEMBL217,Dopamine D2 receptor,EC50,=,2.1,nM,CHEMBL4010168,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1
CHEMBL4097330,CHEMBL217,Dopamine D2 receptor,EC50,=,0.3,nM,CHEMBL4010168,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4102616,CHEMBL217,Dopamine D2 receptor,EC50,=,5.5,nM,CHEMBL4010168,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4078348,CHEMBL217,Dopamine D2 receptor,EC50,=,0.3,nM,CHEMBL4010168,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4094869,CHEMBL217,Dopamine D2 receptor,EC50,=,5.2,nM,CHEMBL4010168,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4067439,CHEMBL217,Dopamine D2 receptor,EC50,=,4.2,nM,CHEMBL4010168,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1
CHEMBL4071185,CHEMBL217,Dopamine D2 receptor,EC50,=,0.31,nM,CHEMBL4010168,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4090208,CHEMBL217,Dopamine D2 receptor,EC50,=,0.39,nM,CHEMBL4010168,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4069145,CHEMBL217,Dopamine D2 receptor,EC50,=,6.8,nM,CHEMBL4010168,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1
CHEMBL4060461,CHEMBL217,Dopamine D2 receptor,EC50,=,3.7,nM,CHEMBL4010168,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1
CHEMBL4060461,CHEMBL217,Dopamine D2 receptor,EC50,=,5.0,nM,CHEMBL4010168,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1
CHEMBL4071868,CHEMBL217,Dopamine D2 receptor,EC50,=,0.39,nM,CHEMBL4010168,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2c(/C=N/O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4098859,CHEMBL217,Dopamine D2 receptor,EC50,=,0.49,nM,CHEMBL4010168,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2ncc(/C=N\O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,3.0,nM,CHEMBL4010168,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,2.8,nM,CHEMBL4010168,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,CHEMBL4007455,EC50,NCCc1ccc(O)c(O)c1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,EC50,=,19.4,nM,CHEMBL4010167,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,CHEMBL4007455,EC50,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4098803,CHEMBL217,Dopamine D2 receptor,EC50,=,4.4,nM,CHEMBL4010167,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1
CHEMBL4097330,CHEMBL217,Dopamine D2 receptor,EC50,=,0.61,nM,CHEMBL4010167,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4102616,CHEMBL217,Dopamine D2 receptor,EC50,=,8.7,nM,CHEMBL4010167,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4078348,CHEMBL217,Dopamine D2 receptor,EC50,=,0.65,nM,CHEMBL4010167,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4094869,CHEMBL217,Dopamine D2 receptor,EC50,=,8.4,nM,CHEMBL4010167,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4067439,CHEMBL217,Dopamine D2 receptor,EC50,=,7.7,nM,CHEMBL4010167,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1
CHEMBL4071185,CHEMBL217,Dopamine D2 receptor,EC50,=,0.54,nM,CHEMBL4010167,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4090208,CHEMBL217,Dopamine D2 receptor,EC50,=,0.71,nM,CHEMBL4010167,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4069145,CHEMBL217,Dopamine D2 receptor,EC50,=,10.7,nM,CHEMBL4010167,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1
CHEMBL4060461,CHEMBL217,Dopamine D2 receptor,EC50,=,5.7,nM,CHEMBL4010167,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1
CHEMBL4060461,CHEMBL217,Dopamine D2 receptor,EC50,=,5.8,nM,CHEMBL4010167,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1
CHEMBL4071868,CHEMBL217,Dopamine D2 receptor,EC50,=,0.6,nM,CHEMBL4010167,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2c(/C=N/O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4098859,CHEMBL217,Dopamine D2 receptor,EC50,=,0.67,nM,CHEMBL4010167,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2ncc(/C=N\O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,5.1,nM,CHEMBL4010167,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,3.9,nM,CHEMBL4010167,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,CHEMBL4007455,EC50,NCCc1ccc(O)c(O)c1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,EC50,=,17.5,nM,CHEMBL4010171,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,CHEMBL4007455,EC50,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4098803,CHEMBL217,Dopamine D2 receptor,EC50,=,5.0,nM,CHEMBL4010171,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1
CHEMBL4097330,CHEMBL217,Dopamine D2 receptor,EC50,=,0.81,nM,CHEMBL4010171,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4102616,CHEMBL217,Dopamine D2 receptor,EC50,=,9.6,nM,CHEMBL4010171,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4078348,CHEMBL217,Dopamine D2 receptor,EC50,=,0.8,nM,CHEMBL4010171,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4094869,CHEMBL217,Dopamine D2 receptor,EC50,=,9.8,nM,CHEMBL4010171,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4067439,CHEMBL217,Dopamine D2 receptor,EC50,=,10.1,nM,CHEMBL4010171,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1
CHEMBL4071185,CHEMBL217,Dopamine D2 receptor,EC50,=,0.72,nM,CHEMBL4010171,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4090208,CHEMBL217,Dopamine D2 receptor,EC50,=,0.74,nM,CHEMBL4010171,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4069145,CHEMBL217,Dopamine D2 receptor,EC50,=,13.1,nM,CHEMBL4010171,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1
CHEMBL4060461,CHEMBL217,Dopamine D2 receptor,EC50,=,5.7,nM,CHEMBL4010171,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1
CHEMBL4060461,CHEMBL217,Dopamine D2 receptor,EC50,=,6.2,nM,CHEMBL4010171,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1
CHEMBL4071868,CHEMBL217,Dopamine D2 receptor,EC50,=,0.94,nM,CHEMBL4010171,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2c(/C=N/O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4098859,CHEMBL217,Dopamine D2 receptor,EC50,=,0.96,nM,CHEMBL4010171,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2ncc(/C=N\O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,5.9,nM,CHEMBL4010171,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,4.5,nM,CHEMBL4010171,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,CHEMBL4007455,EC50,NCCc1ccc(O)c(O)c1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,EC50,=,8.7,nM,CHEMBL4010173,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,CHEMBL4007455,EC50,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4098803,CHEMBL217,Dopamine D2 receptor,EC50,=,1.5,nM,CHEMBL4010173,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1
CHEMBL4097330,CHEMBL217,Dopamine D2 receptor,EC50,=,0.13,nM,CHEMBL4010173,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4102616,CHEMBL217,Dopamine D2 receptor,EC50,=,1.7,nM,CHEMBL4010173,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4078348,CHEMBL217,Dopamine D2 receptor,EC50,=,0.12,nM,CHEMBL4010173,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4094869,CHEMBL217,Dopamine D2 receptor,EC50,=,1.5,nM,CHEMBL4010173,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4067439,CHEMBL217,Dopamine D2 receptor,EC50,=,2.6,nM,CHEMBL4010173,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1
CHEMBL4071185,CHEMBL217,Dopamine D2 receptor,EC50,=,0.13,nM,CHEMBL4010173,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4090208,CHEMBL217,Dopamine D2 receptor,EC50,=,0.11,nM,CHEMBL4010173,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4069145,CHEMBL217,Dopamine D2 receptor,EC50,=,2.9,nM,CHEMBL4010173,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1
CHEMBL4060461,CHEMBL217,Dopamine D2 receptor,EC50,=,1.8,nM,CHEMBL4010173,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1
CHEMBL4060461,CHEMBL217,Dopamine D2 receptor,EC50,=,2.5,nM,CHEMBL4010173,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1
CHEMBL4071868,CHEMBL217,Dopamine D2 receptor,EC50,=,0.19,nM,CHEMBL4010173,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2c(/C=N/O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4098859,CHEMBL217,Dopamine D2 receptor,EC50,=,0.21,nM,CHEMBL4010173,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2ncc(/C=N\O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,1.2,nM,CHEMBL4010173,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,0.67,nM,CHEMBL4010173,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,CHEMBL4007455,EC50,NCCc1ccc(O)c(O)c1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,EC50,=,4.8,nM,CHEMBL4010175,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,CHEMBL4007455,EC50,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4098803,CHEMBL217,Dopamine D2 receptor,EC50,=,1.9,nM,CHEMBL4010175,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1
CHEMBL4097330,CHEMBL217,Dopamine D2 receptor,EC50,=,0.11,nM,CHEMBL4010175,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4102616,CHEMBL217,Dopamine D2 receptor,EC50,=,2.2,nM,CHEMBL4010175,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4078348,CHEMBL217,Dopamine D2 receptor,EC50,=,0.12,nM,CHEMBL4010175,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4094869,CHEMBL217,Dopamine D2 receptor,EC50,=,1.7,nM,CHEMBL4010175,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4067439,CHEMBL217,Dopamine D2 receptor,EC50,=,2.6,nM,CHEMBL4010175,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1
CHEMBL4071185,CHEMBL217,Dopamine D2 receptor,EC50,=,0.12,nM,CHEMBL4010175,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4090208,CHEMBL217,Dopamine D2 receptor,EC50,=,0.11,nM,CHEMBL4010175,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4069145,CHEMBL217,Dopamine D2 receptor,EC50,=,4.3,nM,CHEMBL4010175,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1
CHEMBL4060461,CHEMBL217,Dopamine D2 receptor,EC50,=,2.1,nM,CHEMBL4010175,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1
CHEMBL4060461,CHEMBL217,Dopamine D2 receptor,EC50,=,2.0,nM,CHEMBL4010175,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,CHEMBL4007455,EC50,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1
CHEMBL4071868,CHEMBL217,Dopamine D2 receptor,EC50,=,0.16,nM,CHEMBL4010175,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2c(/C=N/O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4098859,CHEMBL217,Dopamine D2 receptor,EC50,=,0.17,nM,CHEMBL4010175,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2ncc(/C=N\O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,1.2,nM,CHEMBL4010175,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,CHEMBL4007455,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,0.78,nM,CHEMBL4010175,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,CHEMBL4007455,EC50,NCCc1ccc(O)c(O)c1
CHEMBL4097330,CHEMBL217,Dopamine D2 receptor,EC50,=,13.7,nM,CHEMBL4010177,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4102616,CHEMBL217,Dopamine D2 receptor,EC50,=,98.0,nM,CHEMBL4010177,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4078348,CHEMBL217,Dopamine D2 receptor,EC50,=,14.5,nM,CHEMBL4010177,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4094869,CHEMBL217,Dopamine D2 receptor,EC50,=,48.0,nM,CHEMBL4010177,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4071185,CHEMBL217,Dopamine D2 receptor,EC50,=,17.7,nM,CHEMBL4010177,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4090208,CHEMBL217,Dopamine D2 receptor,EC50,=,12.5,nM,CHEMBL4010177,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4071868,CHEMBL217,Dopamine D2 receptor,EC50,=,13.1,nM,CHEMBL4010177,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2c(/C=N/O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4098859,CHEMBL217,Dopamine D2 receptor,EC50,=,11.9,nM,CHEMBL4010177,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2ncc(/C=N\O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,295.0,nM,CHEMBL4010177,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,226.0,nM,CHEMBL4010177,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,NCCc1ccc(O)c(O)c1
CHEMBL4097330,CHEMBL217,Dopamine D2 receptor,EC50,=,15.9,nM,CHEMBL4010179,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4102616,CHEMBL217,Dopamine D2 receptor,EC50,=,61.0,nM,CHEMBL4010179,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4078348,CHEMBL217,Dopamine D2 receptor,EC50,=,10.5,nM,CHEMBL4010179,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4094869,CHEMBL217,Dopamine D2 receptor,EC50,=,54.0,nM,CHEMBL4010179,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4071185,CHEMBL217,Dopamine D2 receptor,EC50,=,13.4,nM,CHEMBL4010179,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4090208,CHEMBL217,Dopamine D2 receptor,EC50,=,12.4,nM,CHEMBL4010179,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4071868,CHEMBL217,Dopamine D2 receptor,EC50,=,12.1,nM,CHEMBL4010179,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2c(/C=N/O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4098859,CHEMBL217,Dopamine D2 receptor,EC50,=,13.2,nM,CHEMBL4010179,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2ncc(/C=N\O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,151.0,nM,CHEMBL4010179,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,163.0,nM,CHEMBL4010179,B,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,CHEMBL4007455,EC50,NCCc1ccc(O)c(O)c1
CHEMBL4097330,CHEMBL217,Dopamine D2 receptor,EC50,=,3.0,nM,CHEMBL4010181,B,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4102616,CHEMBL217,Dopamine D2 receptor,EC50,=,218.0,nM,CHEMBL4010181,B,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4078348,CHEMBL217,Dopamine D2 receptor,EC50,=,1.3,nM,CHEMBL4010181,B,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4094869,CHEMBL217,Dopamine D2 receptor,EC50,=,161.0,nM,CHEMBL4010181,B,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4071185,CHEMBL217,Dopamine D2 receptor,EC50,=,3.0,nM,CHEMBL4010181,B,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4090208,CHEMBL217,Dopamine D2 receptor,EC50,=,2.9,nM,CHEMBL4010181,B,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4071868,CHEMBL217,Dopamine D2 receptor,EC50,=,1.5,nM,CHEMBL4010181,B,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccc2c(/C=N/O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4098859,CHEMBL217,Dopamine D2 receptor,EC50,=,1.7,nM,CHEMBL4010181,B,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,CHEMBL4007455,EC50,CCCN(CCCCOc1ccn2ncc(/C=N\O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,64.0,nM,CHEMBL4010181,B,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,CHEMBL4007455,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,156.0,nM,CHEMBL4010181,B,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,CHEMBL4007455,EC50,NCCc1ccc(O)c(O)c1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,147.6,nM,CHEMBL4011218,B,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,CHEMBL4007493,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL419792,CHEMBL217,Dopamine D2 receptor,EC50,=,501.2,nM,CHEMBL4011218,B,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL434665,CHEMBL217,Dopamine D2 receptor,EC50,=,121.9,nM,CHEMBL4011218,B,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,CHEMBL4007493,EC50,CCCN[C@@H]1Cc2cccc3nc(O)n(c23)C1
CHEMBL3797209,CHEMBL217,Dopamine D2 receptor,EC50,=,20.5,nM,CHEMBL4011218,B,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,CHEMBL4007493,EC50,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL4059581,CHEMBL217,Dopamine D2 receptor,EC50,=,196.8,nM,CHEMBL4011218,B,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,CHEMBL4007493,EC50,CCCN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOCCCCc2ccccc2)C1
CHEMBL4076129,CHEMBL217,Dopamine D2 receptor,EC50,=,2529.3,nM,CHEMBL4011218,B,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCOCCCCc2ccccc2)C1
CHEMBL4077430,CHEMBL217,Dopamine D2 receptor,EC50,=,1499.7,nM,CHEMBL4011218,B,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOc2ccc3c(c2)NC(=O)CC3)C1
CHEMBL4068455,CHEMBL217,Dopamine D2 receptor,EC50,=,269.8,nM,CHEMBL4011218,B,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,CHEMBL4007493,EC50,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL4100322,CHEMBL217,Dopamine D2 receptor,EC50,=,2471.7,nM,CHEMBL4011218,B,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCCCc2ccccc2)C1
CHEMBL4085282,CHEMBL217,Dopamine D2 receptor,EC50,=,139.0,nM,CHEMBL4011218,B,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCCCc2ccccc2)C1
CHEMBL4095452,CHEMBL217,Dopamine D2 receptor,EC50,=,1870.7,nM,CHEMBL4011218,B,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCOc2ccc3c(c2)NC(=O)CC3)C1
CHEMBL3800633,CHEMBL217,Dopamine D2 receptor,EC50,=,209.9,nM,CHEMBL4011218,B,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,CHEMBL4007493,EC50,CN(CCCCNC(=O)c1cc2ccccc2o1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3798179,CHEMBL217,Dopamine D2 receptor,EC50,=,154.5,nM,CHEMBL4011218,B,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,CHEMBL4007493,EC50,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL4093477,CHEMBL217,Dopamine D2 receptor,EC50,=,944.0,nM,CHEMBL4011218,B,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,CHEMBL4007493,EC50,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL4096422,CHEMBL217,Dopamine D2 receptor,EC50,=,74.0,nM,CHEMBL4011218,B,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,CHEMBL4007493,EC50,CN(CCCCOc1ccc2c(c1)NC(=O)CC2)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,353.2,nM,CHEMBL4011222,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL419792,CHEMBL217,Dopamine D2 receptor,EC50,=,543.3,nM,CHEMBL4011222,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL434665,CHEMBL217,Dopamine D2 receptor,EC50,=,111.2,nM,CHEMBL4011222,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CCCN[C@@H]1Cc2cccc3nc(O)n(c23)C1
CHEMBL3797209,CHEMBL217,Dopamine D2 receptor,EC50,=,16.8,nM,CHEMBL4011222,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL4059581,CHEMBL217,Dopamine D2 receptor,EC50,=,194.5,nM,CHEMBL4011222,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CCCN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOCCCCc2ccccc2)C1
CHEMBL4077430,CHEMBL217,Dopamine D2 receptor,EC50,=,712.9,nM,CHEMBL4011222,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOc2ccc3c(c2)NC(=O)CC3)C1
CHEMBL4100734,CHEMBL217,Dopamine D2 receptor,EC50,=,570.2,nM,CHEMBL4011222,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCCCOc2ccc3c(c2)NC(=O)CC3)C1
CHEMBL4068455,CHEMBL217,Dopamine D2 receptor,EC50,=,184.9,nM,CHEMBL4011222,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL4100322,CHEMBL217,Dopamine D2 receptor,EC50,=,1853.5,nM,CHEMBL4011222,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCCCc2ccccc2)C1
CHEMBL4085282,CHEMBL217,Dopamine D2 receptor,EC50,=,677.6,nM,CHEMBL4011222,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCCCc2ccccc2)C1
CHEMBL4095452,CHEMBL217,Dopamine D2 receptor,EC50,=,3981.1,nM,CHEMBL4011222,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCOc2ccc3c(c2)NC(=O)CC3)C1
CHEMBL3800633,CHEMBL217,Dopamine D2 receptor,EC50,=,163.3,nM,CHEMBL4011222,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN(CCCCNC(=O)c1cc2ccccc2o1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3798179,CHEMBL217,Dopamine D2 receptor,EC50,=,124.7,nM,CHEMBL4011222,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL4093477,CHEMBL217,Dopamine D2 receptor,EC50,=,1153.5,nM,CHEMBL4011222,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL4096422,CHEMBL217,Dopamine D2 receptor,EC50,=,188.8,nM,CHEMBL4011222,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN(CCCCOc1ccc2c(c1)NC(=O)CC2)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,38.7,nM,CHEMBL4011226,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL419792,CHEMBL217,Dopamine D2 receptor,EC50,=,74.8,nM,CHEMBL4011226,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL434665,CHEMBL217,Dopamine D2 receptor,EC50,=,17.1,nM,CHEMBL4011226,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CCCN[C@@H]1Cc2cccc3nc(O)n(c23)C1
CHEMBL3797209,CHEMBL217,Dopamine D2 receptor,EC50,=,0.9,nM,CHEMBL4011226,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL4059581,CHEMBL217,Dopamine D2 receptor,EC50,=,24.6,nM,CHEMBL4011226,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CCCN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOCCCCc2ccccc2)C1
CHEMBL4077430,CHEMBL217,Dopamine D2 receptor,EC50,=,104.5,nM,CHEMBL4011226,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOc2ccc3c(c2)NC(=O)CC3)C1
CHEMBL4100734,CHEMBL217,Dopamine D2 receptor,EC50,=,666.8,nM,CHEMBL4011226,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCCCOc2ccc3c(c2)NC(=O)CC3)C1
CHEMBL4068455,CHEMBL217,Dopamine D2 receptor,EC50,=,56.9,nM,CHEMBL4011226,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1
CHEMBL4100322,CHEMBL217,Dopamine D2 receptor,EC50,=,350.8,nM,CHEMBL4011226,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCCCc2ccccc2)C1
CHEMBL4085282,CHEMBL217,Dopamine D2 receptor,EC50,=,88.7,nM,CHEMBL4011226,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCCCc2ccccc2)C1
CHEMBL4095452,CHEMBL217,Dopamine D2 receptor,EC50,=,1064.1,nM,CHEMBL4011226,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCOc2ccc3c(c2)NC(=O)CC3)C1
CHEMBL3800633,CHEMBL217,Dopamine D2 receptor,EC50,=,78.2,nM,CHEMBL4011226,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN(CCCCNC(=O)c1cc2ccccc2o1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL3798179,CHEMBL217,Dopamine D2 receptor,EC50,=,1.1,nM,CHEMBL4011226,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL4093477,CHEMBL217,Dopamine D2 receptor,EC50,=,458.1,nM,CHEMBL4011226,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1
CHEMBL4096422,CHEMBL217,Dopamine D2 receptor,EC50,=,157.8,nM,CHEMBL4011226,B,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,CHEMBL4007493,EC50,CN(CCCCOc1ccc2c(c1)NC(=O)CC2)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL4083239,CHEMBL217,Dopamine D2 receptor,EC50,=,93.0,nM,CHEMBL4015816,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2N1
CHEMBL4072780,CHEMBL217,Dopamine D2 receptor,EC50,=,92.0,nM,CHEMBL4015816,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc2N1
CHEMBL4102628,CHEMBL217,Dopamine D2 receptor,EC50,=,190.0,nM,CHEMBL4015816,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2N1
CHEMBL4084690,CHEMBL217,Dopamine D2 receptor,EC50,=,220.0,nM,CHEMBL4015816,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5oc(=O)ccc45)CC3)cc2N1
CHEMBL4064742,CHEMBL217,Dopamine D2 receptor,EC50,=,470.0,nM,CHEMBL4015816,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc2N1
CHEMBL4092441,CHEMBL217,Dopamine D2 receptor,EC50,=,240.0,nM,CHEMBL4015816,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2[nH]1
CHEMBL4100183,CHEMBL217,Dopamine D2 receptor,EC50,=,62.0,nM,CHEMBL4015816,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,O=C1COc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2N1
CHEMBL4091507,CHEMBL217,Dopamine D2 receptor,EC50,=,370.0,nM,CHEMBL4015816,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,O=c1ccc2c(N3CCCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2[nH]1
CHEMBL4070604,CHEMBL217,Dopamine D2 receptor,EC50,=,680.0,nM,CHEMBL4015816,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,CCCCn1cc(CCCOc2ccc(C(=O)NCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2OC)nn1
CHEMBL4068702,CHEMBL217,Dopamine D2 receptor,EC50,=,1600.0,nM,CHEMBL4015816,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2OC)nn1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,52.0,nM,CHEMBL4015816,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,390.0,nM,CHEMBL4015816,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,NCCc1ccc(O)c(O)c1
CHEMBL1303,CHEMBL217,Dopamine D2 receptor,EC50,=,4.1,nM,CHEMBL4015816,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1
CHEMBL589,CHEMBL217,Dopamine D2 receptor,EC50,=,89.0,nM,CHEMBL4015816,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,CCCN(CCC)CCc1cccc2c1CC(=O)N2
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,EC50,=,27.0,nM,CHEMBL4015816,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,EC50,=,1100.0,nM,CHEMBL4015816,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4102628,CHEMBL217,Dopamine D2 receptor,EC50,=,200.0,nM,CHEMBL4015821,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 and GRK2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2N1
CHEMBL4084690,CHEMBL217,Dopamine D2 receptor,EC50,=,130.0,nM,CHEMBL4015821,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 and GRK2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5oc(=O)ccc45)CC3)cc2N1
CHEMBL4064742,CHEMBL217,Dopamine D2 receptor,EC50,=,630.0,nM,CHEMBL4015821,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 and GRK2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc2N1
CHEMBL4091507,CHEMBL217,Dopamine D2 receptor,EC50,=,250.0,nM,CHEMBL4015821,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 and GRK2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,O=c1ccc2c(N3CCCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2[nH]1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,16.0,nM,CHEMBL4015821,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 and GRK2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,160.0,nM,CHEMBL4015821,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 and GRK2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,NCCc1ccc(O)c(O)c1
CHEMBL1303,CHEMBL217,Dopamine D2 receptor,EC50,=,4.4,nM,CHEMBL4015821,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 and GRK2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1
CHEMBL589,CHEMBL217,Dopamine D2 receptor,EC50,=,30.0,nM,CHEMBL4015821,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 and GRK2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,CCCN(CCC)CCc1cccc2c1CC(=O)N2
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,EC50,=,9.6,nM,CHEMBL4015821,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 and GRK2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,EC50,=,740.0,nM,CHEMBL4015821,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 and GRK2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2165126,CHEMBL217,Dopamine D2 receptor,EC50,=,270.0,nM,CHEMBL4015821,B,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 and GRK2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,CHEMBL4014323,EC50,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4065568,CHEMBL217,Dopamine D2 receptor,EC50,=,56.0,nM,CHEMBL4041112,B,Agonist activity at human recombinant D2S receptor expressed in HEK-293 cells by cellular dielectric spectroscopy,CHEMBL4038339,EC50,Cc1cccc(S(=O)(=O)NCCN2CC=C(c3c[nH]c4ccc(Cl)cc34)CC2)c1
CHEMBL4103639,CHEMBL217,Dopamine D2 receptor,EC50,=,51.0,nM,CHEMBL4046981,B,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,CHEMBL4043213,EC50,O=Cc1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc12
CHEMBL4079375,CHEMBL217,Dopamine D2 receptor,EC50,=,68.0,nM,CHEMBL4046981,B,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,CHEMBL4043213,EC50,O=Cc1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc12
CHEMBL4068561,CHEMBL217,Dopamine D2 receptor,EC50,=,70.0,nM,CHEMBL4046981,B,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,CHEMBL4043213,EC50,O=c1ccc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2[nH]1
CHEMBL4068561,CHEMBL217,Dopamine D2 receptor,EC50,=,46.0,nM,CHEMBL4046981,B,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,CHEMBL4043213,EC50,O=c1ccc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2[nH]1
CHEMBL4063145,CHEMBL217,Dopamine D2 receptor,EC50,=,110.0,nM,CHEMBL4046981,B,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,CHEMBL4043213,EC50,O=C1COc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2N1
CHEMBL4063145,CHEMBL217,Dopamine D2 receptor,EC50,=,110.0,nM,CHEMBL4046981,B,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,CHEMBL4043213,EC50,O=C1COc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2N1
CHEMBL4085752,CHEMBL217,Dopamine D2 receptor,EC50,=,170.0,nM,CHEMBL4046981,B,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,CHEMBL4043213,EC50,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCCO5)CC3)cc12
CHEMBL4102646,CHEMBL217,Dopamine D2 receptor,EC50,=,300.0,nM,CHEMBL4046981,B,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,CHEMBL4043213,EC50,CN1CCN(c2ccc(O)c3c2OCC(=O)N3)CC1
CHEMBL4087217,CHEMBL217,Dopamine D2 receptor,EC50,=,130.0,nM,CHEMBL4046981,B,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,CHEMBL4043213,EC50,CCCN1CCN(c2ccc(O)c3c2OCC(=O)N3)CC1
CHEMBL4065797,CHEMBL217,Dopamine D2 receptor,EC50,=,1100.0,nM,CHEMBL4046981,B,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,CHEMBL4043213,EC50,CCCN1CCCN(c2ccc(O)c3c2OCC(=O)N3)CC1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,73.0,nM,CHEMBL4046981,B,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,CHEMBL4043213,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL589,CHEMBL217,Dopamine D2 receptor,EC50,=,89.0,nM,CHEMBL4046981,B,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,CHEMBL4043213,EC50,CCCN(CCC)CCc1cccc2c1CC(=O)N2
CHEMBL53,CHEMBL217,Dopamine D2 receptor,EC50,=,10.0,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL4467483,CHEMBL217,Dopamine D2 receptor,EC50,=,54.95,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@@H](C2)N(C)CC3
CHEMBL4442011,CHEMBL217,Dopamine D2 receptor,EC50,=,616.6,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCc1ccc2c3c1CCN(C)[C@H]3Cc1ccc(OC)c(OC)c1-2
CHEMBL4589737,CHEMBL217,Dopamine D2 receptor,EC50,=,2570.4,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,COc1ccc2c(c1OC)-c1ccc(C)c3c1[C@@H](C2)N(C)CC3
CHEMBL4438800,CHEMBL217,Dopamine D2 receptor,EC50,=,1258.93,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CC(=O)Oc1c(Br)cc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL4581262,CHEMBL217,Dopamine D2 receptor,EC50,=,602.56,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CC(=O)Oc1c(Cl)cc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL4523054,CHEMBL217,Dopamine D2 receptor,EC50,=,1819.7,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CC(=O)Oc1c(C)cc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL4437552,CHEMBL217,Dopamine D2 receptor,EC50,=,1621.81,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCc1cc2c(c(OC(C)=O)c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL3276140,CHEMBL217,Dopamine D2 receptor,EC50,=,100.0,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CC(=O)Oc1ccc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL35426,CHEMBL217,Dopamine D2 receptor,EC50,=,100.0,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc2c(c1-3)OCO2
CHEMBL4591021,CHEMBL217,Dopamine D2 receptor,EC50,=,0.3162,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,COCOc1ccc2c(c1OCOC)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL225230,CHEMBL217,Dopamine D2 receptor,EC50,=,1.175,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL4555547,CHEMBL217,Dopamine D2 receptor,EC50,=,6.31,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(OC(C)=O)c(OC(C)=O)c1-3
CHEMBL4470553,CHEMBL217,Dopamine D2 receptor,EC50,=,501.19,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCCN1CCc2cccc3c2[C@H]1Cc1ccc2c(c1-3)OCO2
CHEMBL53,CHEMBL217,Dopamine D2 receptor,EC50,=,10.1,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL4467483,CHEMBL217,Dopamine D2 receptor,EC50,=,55.37,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@@H](C2)N(C)CC3
CHEMBL4442011,CHEMBL217,Dopamine D2 receptor,EC50,=,613.5,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCc1ccc2c3c1CCN(C)[C@H]3Cc1ccc(OC)c(OC)c1-2
CHEMBL4589737,CHEMBL217,Dopamine D2 receptor,EC50,=,2561.0,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,COc1ccc2c(c1OC)-c1ccc(C)c3c1[C@@H](C2)N(C)CC3
CHEMBL4438800,CHEMBL217,Dopamine D2 receptor,EC50,=,1412.0,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CC(=O)Oc1c(Br)cc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL4581262,CHEMBL217,Dopamine D2 receptor,EC50,=,604.0,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CC(=O)Oc1c(Cl)cc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL4523054,CHEMBL217,Dopamine D2 receptor,EC50,=,1812.0,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CC(=O)Oc1c(C)cc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL4437552,CHEMBL217,Dopamine D2 receptor,EC50,=,1636.0,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCc1cc2c(c(OC(C)=O)c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL3276140,CHEMBL217,Dopamine D2 receptor,EC50,=,111.2,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CC(=O)Oc1ccc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL35426,CHEMBL217,Dopamine D2 receptor,EC50,=,102.0,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc2c(c1-3)OCO2
CHEMBL4591021,CHEMBL217,Dopamine D2 receptor,EC50,=,0.3,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,COCOc1ccc2c(c1OCOC)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL225230,CHEMBL217,Dopamine D2 receptor,EC50,=,1.18,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL4555547,CHEMBL217,Dopamine D2 receptor,EC50,=,6.34,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(OC(C)=O)c(OC(C)=O)c1-3
CHEMBL4470553,CHEMBL217,Dopamine D2 receptor,EC50,=,520.0,nM,CHEMBL4345328,B,Agonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCCN1CCc2cccc3c2[C@H]1Cc1ccc2c(c1-3)OCO2
CHEMBL3798179,CHEMBL217,Dopamine D2 receptor,EC50,=,154.0,nM,CHEMBL4371575,B,Agonist activity at dopamine D2 receptor (unknown origin) assessed as increase in beta-arrestin-2 recruitment,CHEMBL4371007,EC50,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL4442260,CHEMBL217,Dopamine D2 receptor,EC50,=,0.71,nM,CHEMBL4371571,B,Agonist activity at dopamine D2 receptor (unknown origin) assessed as increase in beta-arrestin-2 recruitment after 20 mins measured for 1 sec by BRET-based luciferase reporter gene assay,CHEMBL4371007,EC50,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5[nH]ccc45)CC3)cc2N1
CHEMBL4467404,CHEMBL217,Dopamine D2 receptor,EC50,=,2.9,nM,CHEMBL4371567,B,Agonist activity at human dopamine D2long receptor (unknown origin) expressed in HEK293T cells co-expressing TEV fused-beta-Arrestin2 and GRK2 assessed as increase in beta-arrestin-2 recruitment after overnight incubation by Tango assay,CHEMBL4371007,EC50,Cc1cc2c(N3CCN(CCCCOc4ccc5c(c4)NC(=O)CC5)CC3)cccc2n1C
CHEMBL4445841,CHEMBL217,Dopamine D2 receptor,EC50,=,6.3,nM,CHEMBL4371567,B,Agonist activity at human dopamine D2long receptor (unknown origin) expressed in HEK293T cells co-expressing TEV fused-beta-Arrestin2 and GRK2 assessed as increase in beta-arrestin-2 recruitment after overnight incubation by Tango assay,CHEMBL4371007,EC50,Cn1ccc2c(N3CCN(CCCCOc4ccc5c(c4)NC(=O)CC5)CC3)cccc21
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,EC50,=,4.0,nM,CHEMBL4371563,B,Inverse agonist activity at dopamine D2 receptor (unknown origin) assessed as increase in beta-arrestin-2 recruitment,CHEMBL4371007,EC50,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4465147,CHEMBL217,Dopamine D2 receptor,EC50,=,120.0,nM,CHEMBL4371583,B,Agonist activity at dopamine D2long receptor (unknown origin) assessed as increase in beta-arrestin recruitment,CHEMBL4371007,EC50,CC1(Oc2ccc(Cl)cc2)CCN(CCOc2ccccc2)CC1
CHEMBL4467883,CHEMBL217,Dopamine D2 receptor,EC50,=,600.0,nM,CHEMBL4371583,B,Agonist activity at dopamine D2long receptor (unknown origin) assessed as increase in beta-arrestin recruitment,CHEMBL4371007,EC50,CC1(Oc2ccc(Cl)cc2)CCN(CCOc2ccccc2C(F)(F)F)CC1
CHEMBL4550815,CHEMBL217,Dopamine D2 receptor,EC50,=,2140.0,nM,CHEMBL4371586,B,Antagonist activity at dopamine D2long receptor (unknown origin) assessed as inhibition of agonist-induced beta-arrestin recruitment,CHEMBL4371007,EC50,CC1(Oc2ccc(Cl)cc2)CCN(CCOc2ccccc2)C1
CHEMBL4467883,CHEMBL217,Dopamine D2 receptor,EC50,=,540.0,nM,CHEMBL4371586,B,Antagonist activity at dopamine D2long receptor (unknown origin) assessed as inhibition of agonist-induced beta-arrestin recruitment,CHEMBL4371007,EC50,CC1(Oc2ccc(Cl)cc2)CCN(CCOc2ccccc2C(F)(F)F)CC1
CHEMBL4519136,CHEMBL217,Dopamine D2 receptor,EC50,=,330.0,nM,CHEMBL4372473,B,Agonist activity at D2 receptor (unknown origin),CHEMBL4371045,EC50,Clc1ccc(Br)c(CN2CCN([C@@H]3CC[C@@]4(c5ccc6c(c5)OCO6)C[C@H]4C3)CC2)c1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,2.4,nM,CHEMBL4394482,B,Partial agonist activity at human D2L receptor expressed in HEK293T cells co-expressing Galpahi1/Gbeta1/GFP2-Ggamma2 assessed as Galphai1 dissociation after 15 mins in presence of coelenterazine 400a by luciferase reporter gene assay,CHEMBL4393669,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL4451797,CHEMBL217,Dopamine D2 receptor,EC50,=,0.4,nM,CHEMBL4394482,B,Partial agonist activity at human D2L receptor expressed in HEK293T cells co-expressing Galpahi1/Gbeta1/GFP2-Ggamma2 assessed as Galphai1 dissociation after 15 mins in presence of coelenterazine 400a by luciferase reporter gene assay,CHEMBL4393669,EC50,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3cccc(Cl)c3C2)CC1
CHEMBL4638599,CHEMBL217,Dopamine D2 receptor,EC50,=,13.6,nM,CHEMBL4619931,B,Agonist activity at D2 receptor (unknown origin),CHEMBL4619707,EC50,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12
CHEMBL4644391,CHEMBL217,Dopamine D2 receptor,EC50,=,27.3,nM,CHEMBL4619931,B,Agonist activity at D2 receptor (unknown origin),CHEMBL4619707,EC50,N#Cc1ccc2nn(CCCCN3CCN(c4cccc5sccc45)CC3)c(=O)n2c1
CHEMBL2105760,CHEMBL217,Dopamine D2 receptor,EC50,=,6.3,nM,CHEMBL4619931,B,Agonist activity at D2 receptor (unknown origin),CHEMBL4619707,EC50,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1
CHEMBL4645677,CHEMBL217,Dopamine D2 receptor,EC50,=,16.0,nM,CHEMBL4628564,B,Agonist activity at D2S (unknown origin),CHEMBL4627320,EC50,O=C1CCC(N2Cc3c(OCc4ccc(CN5CCN(c6ccc(F)cc6F)CC5)cc4)cccc3C2=O)C(=O)N1
CHEMBL4650337,CHEMBL217,Dopamine D2 receptor,EC50,=,10000.0,nM,CHEMBL5233302,B,Agonist activity at D2 (unknown origin) by HTRF assay,CHEMBL5233201,EC50,CNC[C@@H]1OCCc2ccsc21
CHEMBL77563,CHEMBL217,Dopamine D2 receptor,EC50,=,7.2,nM,CHEMBL5235425,B,Agonist activity at human D2R expressed in HEK293 cells incubated for 3 mins by FLIPR analysis,CHEMBL5233263,EC50,Clc1ccccc1N1CCN(Cc2nc3ccccc3[nH]2)CC1
CHEMBL309372,CHEMBL217,Dopamine D2 receptor,EC50,=,12.0,nM,CHEMBL5235425,B,Agonist activity at human D2R expressed in HEK293 cells incubated for 3 mins by FLIPR analysis,CHEMBL5233263,EC50,COc1ccccc1N1CCN(Cc2nc3ccccc3[nH]2)CC1
CHEMBL440687,CHEMBL217,Dopamine D2 receptor,EC50,=,12.0,nM,CHEMBL5235425,B,Agonist activity at human D2R expressed in HEK293 cells incubated for 3 mins by FLIPR analysis,CHEMBL5233263,EC50,c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,EC50,=,38.0,nM,CHEMBL5236915,B,Partial agonist activity at human D2 receptor assessed as increase in cAMP accumulation,CHEMBL5236546,EC50,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2028019,CHEMBL217,Dopamine D2 receptor,EC50,=,0.18,nM,CHEMBL5236915,B,Partial agonist activity at human D2 receptor assessed as increase in cAMP accumulation,CHEMBL5236546,EC50,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5272965,CHEMBL217,Dopamine D2 receptor,EC50,=,61.7,nM,CHEMBL5236915,B,Partial agonist activity at human D2 receptor assessed as increase in cAMP accumulation,CHEMBL5236546,EC50,CC1Cc2ccccc2N1C(=O)NCCCCN(C)[C@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL5289063,CHEMBL217,Dopamine D2 receptor,EC50,=,90.0,nM,CHEMBL5236915,B,Partial agonist activity at human D2 receptor assessed as increase in cAMP accumulation,CHEMBL5236546,EC50,O=c1ccc2c(N3CCCN(CCCCOc4ccc5ccnn5c4)CC3)ccc(O)c2[nH]1
CHEMBL1112,CHEMBL217,Dopamine D2 receptor,EC50,=,2.4,nM,CHEMBL5236916,B,Partial agonist activity at human D2 receptor assessed as beta arrestin-2 recruitment,CHEMBL5236546,EC50,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL5272965,CHEMBL217,Dopamine D2 receptor,EC50,=,839.5,nM,CHEMBL5236916,B,Partial agonist activity at human D2 receptor assessed as beta arrestin-2 recruitment,CHEMBL5236546,EC50,CC1Cc2ccccc2N1C(=O)NCCCCN(C)[C@H]1Cc2cccc3[nH]c(=O)n(c23)C1
CHEMBL5289063,CHEMBL217,Dopamine D2 receptor,EC50,=,250.0,nM,CHEMBL5236916,B,Partial agonist activity at human D2 receptor assessed as beta arrestin-2 recruitment,CHEMBL5236546,EC50,O=c1ccc2c(N3CCCN(CCCCOc4ccc5ccnn5c4)CC3)ccc(O)c2[nH]1
CHEMBL4445841,CHEMBL217,Dopamine D2 receptor,EC50,=,6.3,nM,CHEMBL5236922,B,Partial agonist activity at D2 receptor (unknown origin) assessed as beta arrestin-2 recruitment,CHEMBL5236546,EC50,Cn1ccc2c(N3CCN(CCCCOc4ccc5c(c4)NC(=O)CC5)CC3)cccc21
CHEMBL5266559,CHEMBL217,Dopamine D2 receptor,EC50,=,260.0,nM,CHEMBL5236924,B,Partial agonist activity at human D2 receptor expressed in CHO-K1 cells assessed as forskolin-stimulated cAMP production incubated for 60 mins,CHEMBL5236546,EC50,Oc1cc(CN2CCN(c3ccccn3)CC2)c(Cl)c2cccnc12
CHEMBL5278239,CHEMBL217,Dopamine D2 receptor,EC50,=,3.236,nM,CHEMBL5236933,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as beta-arrestin recruitment preincubated for 10 mins with coelenterazine followed by compound addition and measured after 10 mins by BRET assay,CHEMBL5236546,EC50,CN(CC(=O)NCc1ccccc1)C(=O)CCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL5268231,CHEMBL217,Dopamine D2 receptor,EC50,=,2.344,nM,CHEMBL5236933,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as beta-arrestin recruitment preincubated for 10 mins with coelenterazine followed by compound addition and measured after 10 mins by BRET assay,CHEMBL5236546,EC50,CN(CC(=O)NC1CCCCC1)C(=O)CCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL5281830,CHEMBL217,Dopamine D2 receptor,EC50,=,5011.87,nM,CHEMBL5236933,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as beta-arrestin recruitment preincubated for 10 mins with coelenterazine followed by compound addition and measured after 10 mins by BRET assay,CHEMBL5236546,EC50,Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc(-c2ccccc2)c1C(=O)NCc1ccccc1
CHEMBL5278601,CHEMBL217,Dopamine D2 receptor,EC50,=,3162.28,nM,CHEMBL5236933,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as beta-arrestin recruitment preincubated for 10 mins with coelenterazine followed by compound addition and measured after 10 mins by BRET assay,CHEMBL5236546,EC50,O=C(Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc2cc(Br)c(Br)cc21)NCc1ccccc1
CHEMBL5273430,CHEMBL217,Dopamine D2 receptor,EC50,=,0.2138,nM,CHEMBL5236933,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as beta-arrestin recruitment preincubated for 10 mins with coelenterazine followed by compound addition and measured after 10 mins by BRET assay,CHEMBL5236546,EC50,CN1CCN(C(=O)CCCN2CCN(c3cccc(Cl)c3Cl)CC2)C(C(=O)NCc2ccccc2)C1
CHEMBL5270832,CHEMBL217,Dopamine D2 receptor,EC50,=,3.631,nM,CHEMBL5236933,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as beta-arrestin recruitment preincubated for 10 mins with coelenterazine followed by compound addition and measured after 10 mins by BRET assay,CHEMBL5236546,EC50,CN1CCN(C(=O)CCCN2CCN(c3cccc(Cl)c3Cl)CC2)C(C(=O)NC2CCCCC2)C1
CHEMBL5283891,CHEMBL217,Dopamine D2 receptor,EC50,=,7.586,nM,CHEMBL5236933,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as beta-arrestin recruitment preincubated for 10 mins with coelenterazine followed by compound addition and measured after 10 mins by BRET assay,CHEMBL5236546,EC50,O=C1NCCN(C(=O)CCCN2CCN(c3cccc(Cl)c3Cl)CC2)C1C(=O)NCc1ccccc1
CHEMBL5266508,CHEMBL217,Dopamine D2 receptor,EC50,=,0.3715,nM,CHEMBL5236933,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as beta-arrestin recruitment preincubated for 10 mins with coelenterazine followed by compound addition and measured after 10 mins by BRET assay,CHEMBL5236546,EC50,CC(C)(C)NC(=O)C1C(=O)NCCN1C(=O)CCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL240773,CHEMBL217,Dopamine D2 receptor,EC50,=,2.455,nM,CHEMBL5236933,B,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as beta-arrestin recruitment preincubated for 10 mins with coelenterazine followed by compound addition and measured after 10 mins by BRET assay,CHEMBL5236546,EC50,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL269004,CHEMBL217,Dopamine D2 receptor,EC50,=,41.0,nM,CHEMBL5240625,B,Agonist activity at human D2 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding by Perkin elmer analysis,CHEMBL5236649,EC50,CCCN(CCC)[C@H]1CCc2c(O)cccc2C1
CHEMBL5275212,CHEMBL217,Dopamine D2 receptor,EC50,=,1.7,nM,CHEMBL5240625,B,Agonist activity at human D2 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding by Perkin elmer analysis,CHEMBL5236649,EC50,CCCN(CCCCCCCCCN(CCC)[C@H]1CCc2c(O)cccc2C1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL5276671,CHEMBL217,Dopamine D2 receptor,EC50,=,0.44,nM,CHEMBL5240625,B,Agonist activity at human D2 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding by Perkin elmer analysis,CHEMBL5236649,EC50,CCCN(CCCCCCCCCCN(CCC)[C@H]1CCc2c(O)cccc2C1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL5267221,CHEMBL217,Dopamine D2 receptor,EC50,=,13.4,nM,CHEMBL5240625,B,Agonist activity at human D2 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding by Perkin elmer analysis,CHEMBL5236649,EC50,CCCN(CCc1ccc(CCN(CCC)[C@H]2CCc3nc(N)sc3C2)cc1)[C@H]1CCc2c(O)cccc2C1
CHEMBL5272529,CHEMBL217,Dopamine D2 receptor,EC50,=,7.69,nM,CHEMBL5240625,B,Agonist activity at human D2 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding by Perkin elmer analysis,CHEMBL5236649,EC50,Br.Br.CCCN(CCc1cc(O)c(CCN(CCC)[C@H]2CCc3c(O)cccc3C2)cc1O)[C@H]1CCc2c(O)cccc2C1
CHEMBL5266134,CHEMBL217,Dopamine D2 receptor,EC50,=,34.37,nM,CHEMBL5240625,B,Agonist activity at human D2 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding by Perkin elmer analysis,CHEMBL5236649,EC50,CCCN(CCc1cc(O)c(CCN(CCC)[C@H]2CCc3nc(N)sc3C2)cc1O)[C@H]1CCc2nc(N)sc2C1
CHEMBL5283620,CHEMBL217,Dopamine D2 receptor,EC50,=,5.29,nM,CHEMBL5240625,B,Agonist activity at human D2 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding by Perkin elmer analysis,CHEMBL5236649,EC50,CCCN(CCc1ccc(CCN(CCC)[C@H]2CCc3c(O)cccc3C2)cc1)[C@@H]1CCc2cc(O)c(O)cc2C1
CHEMBL59,CHEMBL217,Dopamine D2 receptor,EC50,=,200.41,nM,CHEMBL5240625,B,Agonist activity at human D2 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding by Perkin elmer analysis,CHEMBL5236649,EC50,NCCc1ccc(O)c(O)c1
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,EC50,=,251.0,nM,CHEMBL5240625,B,Agonist activity at human D2 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding by Perkin elmer analysis,CHEMBL5236649,EC50,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL24077,CHEMBL217,Dopamine D2 receptor,Kd,=,9500.0,nM,CHEMBL671443,B,Equilibrium dissociation constant against recombinant Dopamine receptor D2A expressed in COS7 cells,CHEMBL1129489,KD,Oc1cc2c(cc1O)[C@@H](c1ccccc1)CNCC2
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Kd,=,24.0,nM,CHEMBL671443,B,Equilibrium dissociation constant against recombinant Dopamine receptor D2A expressed in COS7 cells,CHEMBL1129489,KD,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL225230,CHEMBL217,Dopamine D2 receptor,Kd,=,20.0,nM,CHEMBL671443,B,Equilibrium dissociation constant against recombinant Dopamine receptor D2A expressed in COS7 cells,CHEMBL1129489,KD,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL276326,CHEMBL217,Dopamine D2 receptor,Kd,=,6.75,nM,CHEMBL672779,B,Compound was evaluated for the ability to displace [3H]spiperone at Dopamine receptor D2 in porcine anterior pituitary gland as high affinity state,CHEMBL1124481,KD,CN1CCc2cc(Br)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL276326,CHEMBL217,Dopamine D2 receptor,Kd,=,728.0,nM,CHEMBL669939,B,Compound was evaluated for the ability to displace [3H]spiperone at Dopamine receptor D2 in porcine anterior pituitary gland as low affinity state,CHEMBL1124481,KD,CN1CCc2cc(Br)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL18598,CHEMBL217,Dopamine D2 receptor,Kd,=,0.43,nM,CHEMBL669940,B,Compound was evaluated for the ability to displace [3H]spiperone at dopamine receptor in porcine anterior pituitary gland as high affinity state,CHEMBL1124481,KD,CN1CCc2cc(F)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL18598,CHEMBL217,Dopamine D2 receptor,Kd,=,94.3,nM,CHEMBL672779,B,Compound was evaluated for the ability to displace [3H]spiperone at Dopamine receptor D2 in porcine anterior pituitary gland as high affinity state,CHEMBL1124481,KD,CN1CCc2cc(F)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL276042,CHEMBL217,Dopamine D2 receptor,Kd,=,19.9,nM,CHEMBL672779,B,Compound was evaluated for the ability to displace [3H]spiperone at Dopamine receptor D2 in porcine anterior pituitary gland as high affinity state,CHEMBL1124481,KD,CN1CCc2cc(N)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL276042,CHEMBL217,Dopamine D2 receptor,Kd,=,3300.0,nM,CHEMBL669939,B,Compound was evaluated for the ability to displace [3H]spiperone at Dopamine receptor D2 in porcine anterior pituitary gland as low affinity state,CHEMBL1124481,KD,CN1CCc2cc(N)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Kd,=,0.66,nM,CHEMBL672779,B,Compound was evaluated for the ability to displace [3H]spiperone at Dopamine receptor D2 in porcine anterior pituitary gland as high affinity state,CHEMBL1124481,KD,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL53,CHEMBL217,Dopamine D2 receptor,Kd,=,127.0,nM,CHEMBL669939,B,Compound was evaluated for the ability to displace [3H]spiperone at Dopamine receptor D2 in porcine anterior pituitary gland as low affinity state,CHEMBL1124481,KD,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL19130,CHEMBL217,Dopamine D2 receptor,Kd,=,1.1,nM,CHEMBL672776,B,Compound was evaluated for the ability to displace [3H]spiperone at Dopamine receptor D2 in porcine anterior pituitary gland as high affinity state,CHEMBL1124481,KD,CN1CCc2cc(O)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL267932,CHEMBL217,Dopamine D2 receptor,Kd,=,0.097,nM,CHEMBL670664,B,Affinity constant of compound was evaluated in human brain,CHEMBL1124222,KD,CN1CN(c2ccccc2)C2(CCN(CCCC(=O)c3ccc(F)cc3)CC2)C1=O
CHEMBL388509,CHEMBL217,Dopamine D2 receptor,Kd,=,16000.0,nM,CHEMBL889374,B,Displacement of [3H]YM 09151-2 from dopamine D2 receptor in lamb striatum membrane after 2 hrs,CHEMBL1145382,KD,CC(C)[C@H](NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N1CCC[C@H]1C(N)=O
CHEMBL390297,CHEMBL217,Dopamine D2 receptor,Kd,=,300.0,nM,CHEMBL889374,B,Displacement of [3H]YM 09151-2 from dopamine D2 receptor in lamb striatum membrane after 2 hrs,CHEMBL1145382,KD,CN1C[C@H](C(=O)N[C@@H](Cc2ccc([N+](=O)[O-])cc2)C(=O)N[C@@H](CCC2CCCCC2)C(=O)N2CCCC(C(N)=O)C2)C=C2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL390299,CHEMBL217,Dopamine D2 receptor,Kd,=,20.0,nM,CHEMBL889374,B,Displacement of [3H]YM 09151-2 from dopamine D2 receptor in lamb striatum membrane after 2 hrs,CHEMBL1145382,KD,CN1C[C@H](C(=O)N[C@@H](Cc2ccc([N+](=O)[O-])cc2)C(=O)N[C@@H](Cc2ccc(F)cc2)C(=O)N2CCCC(C(N)=O)C2)C=C2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL225368,CHEMBL217,Dopamine D2 receptor,Kd,=,2000.0,nM,CHEMBL889374,B,Displacement of [3H]YM 09151-2 from dopamine D2 receptor in lamb striatum membrane after 2 hrs,CHEMBL1145382,KD,CC(C)[C@H](NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1)C(=O)N1c2ccccc2C[C@H]1C(N)=O
CHEMBL254500,CHEMBL217,Dopamine D2 receptor,Kd,=,56.23,nM,CHEMBL944839,B,Binding affinity to human dopamine D2 receptor,CHEMBL1140830,KD,CN1C[C@H](C(=O)N2CCN(c3cccc(=O)n3C)CC2)C[C@@H]2c3cccc4[nH]c(Br)c(c34)C[C@H]21
CHEMBL251835,CHEMBL217,Dopamine D2 receptor,Kd,=,125.89,nM,CHEMBL944839,B,Binding affinity to human dopamine D2 receptor,CHEMBL1140830,KD,CN1C[C@H](C(=O)N2CCN(c3ccc4nonc4c3)CC2)C[C@@H]2c3cccc4[nH]c(Br)c(c34)C[C@H]21
CHEMBL254500,CHEMBL217,Dopamine D2 receptor,Kd,=,56.23,nM,CHEMBL964156,B,Binding affinity to dopamine D2 receptor,CHEMBL1153278,KD,CN1C[C@H](C(=O)N2CCN(c3cccc(=O)n3C)CC2)C[C@@H]2c3cccc4[nH]c(Br)c(c34)C[C@H]21
CHEMBL473763,CHEMBL217,Dopamine D2 receptor,Kd,=,776.25,nM,CHEMBL964156,B,Binding affinity to dopamine D2 receptor,CHEMBL1153278,KD,CN(CCC(=O)N1CCN(c2ccc(F)c(F)c2)CC1)CCC1c2ccccc2-c2ccccc21.Cl
CHEMBL460542,CHEMBL217,Dopamine D2 receptor,Kd,=,489.78,nM,CHEMBL964156,B,Binding affinity to dopamine D2 receptor,CHEMBL1153278,KD,CN(CCC(=O)N1CCN(c2ccc(F)c(F)c2)CC1)CCC1c2ccccc2Oc2ccccc21
CHEMBL1076624,CHEMBL217,Dopamine D2 receptor,Kd,=,741.31,nM,CHEMBL1102025,B,Binding affinity to dopamine D2 receptor,CHEMBL1154945,KD,COc1ccc(C[C@H](C)CN2C[C@@H]3CCCC[C@@H]3[C@H](C(=O)N3CCN(c4ccc(F)c(F)c4)CC3)C2)cn1.O=C(O)/C=C/C(=O)O
CHEMBL1423,CHEMBL217,Dopamine D2 receptor,Kd,=,29.0,nM,CHEMBL1219201,B,Inhibition of dopamine D2 receptor,CHEMBL1212879,KD,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL1774386,CHEMBL217,Dopamine D2 receptor,Kd,=,0.03,nM,CHEMBL1777192,B,Binding affinity to wild type human dopamine D2 receptor expressed in HEK293 cells,CHEMBL1772985,KD,O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL3423402,CHEMBL217,Dopamine D2 receptor,Kd,=,7000.0,nM,CHEMBL3423747,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O
CHEMBL3423411,CHEMBL217,Dopamine D2 receptor,Kd,=,400.0,nM,CHEMBL3423746,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,NCCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)[C@H]1CCCN1C(=O)CCCCCNC(=O)[C@@H]1CC[C@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O
CHEMBL3423410,CHEMBL217,Dopamine D2 receptor,Kd,=,200.0,nM,CHEMBL3423746,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,NCCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)[C@H]1CCCN1C(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O
CHEMBL3423409,CHEMBL217,Dopamine D2 receptor,Kd,=,2000.0,nM,CHEMBL3423746,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N[C@@H](CCCCN)C(N)=O
CHEMBL3423408,CHEMBL217,Dopamine D2 receptor,Kd,=,500.0,nM,CHEMBL3423746,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N1C[C@@H](N)C[C@H]1C(N)=O
CHEMBL3423407,CHEMBL217,Dopamine D2 receptor,Kd,=,190.0,nM,CHEMBL3423746,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(F)c(F)c1)C(=O)N[C@@H](CCCCN)C(N)=O
CHEMBL3423406,CHEMBL217,Dopamine D2 receptor,Kd,=,900.0,nM,CHEMBL3423746,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
CHEMBL3423405,CHEMBL217,Dopamine D2 receptor,Kd,=,600.0,nM,CHEMBL3423746,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1C[C@@H](N)C[C@H]1C(N)=O
CHEMBL3423404,CHEMBL217,Dopamine D2 receptor,Kd,=,4700.0,nM,CHEMBL3423746,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(N)=O
CHEMBL3423403,CHEMBL217,Dopamine D2 receptor,Kd,=,280.0,nM,CHEMBL3423746,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,NCCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)[C@@H]1CCCN1C(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O
CHEMBL3423402,CHEMBL217,Dopamine D2 receptor,Kd,=,240.0,nM,CHEMBL3423746,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O
CHEMBL3423401,CHEMBL217,Dopamine D2 receptor,Kd,=,6300.0,nM,CHEMBL3423746,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(N)=O
CHEMBL3423400,CHEMBL217,Dopamine D2 receptor,Kd,=,5000.0,nM,CHEMBL3423746,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)[C@H]1CC[C@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N1C[C@@H](N)C[C@H]1C(N)=O
CHEMBL3423403,CHEMBL217,Dopamine D2 receptor,Kd,=,9000.0,nM,CHEMBL3423747,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,NCCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)[C@@H]1CCCN1C(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O
CHEMBL3423405,CHEMBL217,Dopamine D2 receptor,Kd,=,20000.0,nM,CHEMBL3423747,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1C[C@@H](N)C[C@H]1C(N)=O
CHEMBL3423406,CHEMBL217,Dopamine D2 receptor,Kd,=,16000.0,nM,CHEMBL3423747,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
CHEMBL3423407,CHEMBL217,Dopamine D2 receptor,Kd,=,8000.0,nM,CHEMBL3423747,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(F)c(F)c1)C(=O)N[C@@H](CCCCN)C(N)=O
CHEMBL3423408,CHEMBL217,Dopamine D2 receptor,Kd,=,13000.0,nM,CHEMBL3423747,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N1C[C@@H](N)C[C@H]1C(N)=O
CHEMBL3423410,CHEMBL217,Dopamine D2 receptor,Kd,=,4000.0,nM,CHEMBL3423747,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,NCCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)[C@H]1CCCN1C(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O
CHEMBL3423411,CHEMBL217,Dopamine D2 receptor,Kd,=,14000.0,nM,CHEMBL3423747,B,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 2 hrs by scintillation counting analysis,CHEMBL3421581,KD,NCCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)[C@H]1CCCN1C(=O)CCCCCNC(=O)[C@@H]1CC[C@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O
CHEMBL267930,CHEMBL217,Dopamine D2 receptor,Kd,=,0.16,nM,CHEMBL3820047,B,Binding affinity to dopamine D2 receptor in human brain caudate nucleus,CHEMBL3817845,KD,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
CHEMBL26,CHEMBL217,Dopamine D2 receptor,Kd,=,2.818,nM,CHEMBL4053573,B,Competitive antagonist activity at D2 long receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine induced beta-arrestin recruitment after 90 mins by DiscoveRx PathHunter assay,CHEMBL4052607,KD,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC
CHEMBL54,CHEMBL217,Dopamine D2 receptor,Kd,=,0.4898,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4455788,CHEMBL217,Dopamine D2 receptor,Kd,=,1.0,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2cccc(Cl)c2)CC1)c1ccc(F)cc1
CHEMBL4540679,CHEMBL217,Dopamine D2 receptor,Kd,=,3.236,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccccc2Cl)CC1)c1ccc(F)cc1
CHEMBL4570273,CHEMBL217,Dopamine D2 receptor,Kd,=,0.1445,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2cccc(Cl)c2Cl)CC1)c1ccc(F)cc1
CHEMBL4444768,CHEMBL217,Dopamine D2 receptor,Kd,=,2.399,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2Cl)CC1)c1ccc(F)cc1
CHEMBL4529368,CHEMBL217,Dopamine D2 receptor,Kd,=,1.047,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2cc(Cl)ccc2Cl)CC1)c1ccc(F)cc1
CHEMBL4453290,CHEMBL217,Dopamine D2 receptor,Kd,=,2.089,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2c(Cl)cccc2Cl)CC1)c1ccc(F)cc1
CHEMBL4544491,CHEMBL217,Dopamine D2 receptor,Kd,=,0.1445,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccc(Cl)c(Cl)c2)CC1)c1ccc(F)cc1
CHEMBL4436241,CHEMBL217,Dopamine D2 receptor,Kd,=,0.537,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2cc(Cl)cc(Cl)c2)CC1)c1ccc(F)cc1
CHEMBL54206,CHEMBL217,Dopamine D2 receptor,Kd,=,8.511,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccccc2)CC1)c1ccc(F)cc1
CHEMBL2104700,CHEMBL217,Dopamine D2 receptor,Kd,=,0.955,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,Cc1ccc(C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2)cc1
CHEMBL4436610,CHEMBL217,Dopamine D2 receptor,Kd,=,0.4571,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccc(C(F)(F)F)cc2)CC1)c1ccc(F)cc1
CHEMBL4568709,CHEMBL217,Dopamine D2 receptor,Kd,=,7.586,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,CN(C)c1ccc(C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2)cc1
CHEMBL4461948,CHEMBL217,Dopamine D2 receptor,Kd,=,3.02,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccc(F)cc2)CC1)c1ccc(F)cc1
CHEMBL4472206,CHEMBL217,Dopamine D2 receptor,Kd,=,2.692,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccccc2-c2ccccc2Cl)CC1)c1ccc(F)cc1
CHEMBL4514517,CHEMBL217,Dopamine D2 receptor,Kd,=,10.23,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccccc1F
CHEMBL611991,CHEMBL217,Dopamine D2 receptor,Kd,=,40.74,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1cccc(F)c1
CHEMBL4590085,CHEMBL217,Dopamine D2 receptor,Kd,=,52.48,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1cccc(F)c1F
CHEMBL4468416,CHEMBL217,Dopamine D2 receptor,Kd,=,120.23,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1F
CHEMBL4482896,CHEMBL217,Dopamine D2 receptor,Kd,=,141.25,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1cc(F)ccc1F
CHEMBL4576998,CHEMBL217,Dopamine D2 receptor,Kd,=,60.26,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1c(F)cccc1F
CHEMBL4463187,CHEMBL217,Dopamine D2 receptor,Kd,=,7.413,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)c(F)c1
CHEMBL4465318,CHEMBL217,Dopamine D2 receptor,Kd,=,213.8,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1cc(F)cc(F)c1
CHEMBL4472585,CHEMBL217,Dopamine D2 receptor,Kd,=,3.388,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccccc1Cl
CHEMBL4475608,CHEMBL217,Dopamine D2 receptor,Kd,=,1.95,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,Cc1ccccc1C(=O)CCCN1CCC(O)(c2ccc(Cl)cc2)CC1
CHEMBL363548,CHEMBL217,Dopamine D2 receptor,Kd,=,5.012,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(Cl)cc1
CHEMBL199226,CHEMBL217,Dopamine D2 receptor,Kd,=,1.778,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccccc1
CHEMBL1940403,CHEMBL217,Dopamine D2 receptor,Kd,=,1.95,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,OC1(c2ccc(Cl)cc2)CCN(CCCSc2ccc(F)cc2)CC1
CHEMBL1940404,CHEMBL217,Dopamine D2 receptor,Kd,=,0.7943,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,OC1(c2ccc(Cl)cc2)CCN(CCCOc2ccc(F)cc2)CC1
CHEMBL1036,CHEMBL217,Dopamine D2 receptor,Kd,=,91.2,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,OC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4474020,CHEMBL217,Dopamine D2 receptor,Kd,=,11.48,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,OC1(c2ccc(Cl)cc2)CCN(CC/C=C/c2ccc(F)cc2)CC1
CHEMBL4440708,CHEMBL217,Dopamine D2 receptor,Kd,=,32.36,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,OC1(c2ccc(Cl)cc2)CCN(CC/C=C\c2ccc(F)cc2)CC1
CHEMBL4472382,CHEMBL217,Dopamine D2 receptor,Kd,=,1.514,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,OC1(c2ccc(Cl)cc2)CCN(CC[C@H]2C[C@@H]2c2ccc(F)cc2)CC1
CHEMBL4537230,CHEMBL217,Dopamine D2 receptor,Kd,=,30.9,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,OC1(c2ccc(Cl)cc2)CCN(CC[C@H]2C[C@H]2c2ccc(F)cc2)CC1
CHEMBL94371,CHEMBL217,Dopamine D2 receptor,Kd,=,144.54,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4450047,CHEMBL217,Dopamine D2 receptor,Kd,=,12.88,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4579971,CHEMBL217,Dopamine D2 receptor,Kd,=,66.07,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,OC1(c2ccc(Cl)cc2)CCN(CCCc2ccc(F)cc2)CC1
CHEMBL1940402,CHEMBL217,Dopamine D2 receptor,Kd,=,6.761,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,OC1(c2ccc(Cl)cc2)CCN(CCCCc2ccc(F)cc2)CC1
CHEMBL4519420,CHEMBL217,Dopamine D2 receptor,Kd,=,21.88,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,OC1(c2ccc(Cl)cc2)CCN(CCCCCc2ccc(F)cc2)CC1
CHEMBL4584060,CHEMBL217,Dopamine D2 receptor,Kd,=,288.4,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,OC1(c2ccc(Cl)cc2)CCN(CC#Cc2ccc(F)cc2)CC1
CHEMBL4475451,CHEMBL217,Dopamine D2 receptor,Kd,=,70.79,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,OC1(c2ccc(Cl)cc2)CCN(CCC#Cc2ccc(F)cc2)CC1
CHEMBL4470321,CHEMBL217,Dopamine D2 receptor,Kd,=,17.78,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,OC1(c2ccc(Cl)cc2)CCN(CCCC#Cc2ccc(F)cc2)CC1
CHEMBL4451384,CHEMBL217,Dopamine D2 receptor,Kd,=,0.05495,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1[C@@H]2CC[C@H]1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1
CHEMBL476935,CHEMBL217,Dopamine D2 receptor,Kd,=,28.18,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL3544895,CHEMBL217,Dopamine D2 receptor,Kd,=,10.0,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CC=C(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL4528835,CHEMBL217,Dopamine D2 receptor,Kd,=,0.1445,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC2(c3ccc(Cl)cc3)CC2C1)c1ccc(F)cc1
CHEMBL56843,CHEMBL217,Dopamine D2 receptor,Kd,=,7.943,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccc(F)cc1
CHEMBL147830,CHEMBL217,Dopamine D2 receptor,Kd,=,1.905,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL422334,CHEMBL217,Dopamine D2 receptor,Kd,=,1.862,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,COC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
CHEMBL4556173,CHEMBL217,Dopamine D2 receptor,Kd,=,18.62,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccc(F)cc2)CC1)c1ccc(Cl)cc1
CHEMBL4446597,CHEMBL217,Dopamine D2 receptor,Kd,=,30.9,nM,CHEMBL4416273,B,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,O=C(CCCN1CCC(O)(c2ccccc2)CC1)c1ccccc1
CHEMBL1256754,CHEMBL217,Dopamine D2 receptor,Kd,=,4.32,nM,CHEMBL4416276,B,Binding affinity to SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,CHEMBL4414605,KD,CCCN(CCc1ccccc1)C1CCc2c(O)cccc2C1.Cl
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL5207281,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5183205,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,CCCCCNC(=O)/N=C(\N)NCCCc1cnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5200771,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,CCCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5204599,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,CC(CNC(=O)/N=C(\N)NCCCc1nnc(N)s1)C1CCCCC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5206565,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5178472,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,N/C(=N\C(=O)NCc1ccccc1)NCCCc1cnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5208845,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,C[C@@H](NC(=O)/N=C(\N)NCCCc1nnc(N)s1)c1ccccc1.Cl.Cl
CHEMBL5201074,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1.Cl.Cl
CHEMBL5184911,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,CC(NC(=O)/N=C(\N)NCCCc1nnc(N)s1)c1cccc(F)c1.Cl.Cl
CHEMBL5180504,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,Cc1ccc(CC(C)CNC(=O)/N=C(\N)NCCCc2nnc(N)s2)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5202592,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,Cc1ccc(CC(C)CNC(=O)/N=C(\N)NCCCc2cnc(N)s2)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5198795,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,CC(CCCc1ccccc1)CNC(=O)/N=C(\N)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5176229,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151464,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,N/C(=N\C(=O)NCCCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL301265,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151465,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at high concentration incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,CCCN[C@H]1CCc2nc(N)sc2C1
CHEMBL5207281,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151465,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at high concentration incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5183205,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151465,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at high concentration incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,CCCCCNC(=O)/N=C(\N)NCCCc1cnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5200771,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151465,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at high concentration incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,CCCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5204599,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151465,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at high concentration incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,CC(CNC(=O)/N=C(\N)NCCCc1nnc(N)s1)C1CCCCC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5206565,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151465,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at high concentration incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5178472,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151465,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at high concentration incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,N/C(=N\C(=O)NCc1ccccc1)NCCCc1cnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5208845,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151465,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at high concentration incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,C[C@@H](NC(=O)/N=C(\N)NCCCc1nnc(N)s1)c1ccccc1.Cl.Cl
CHEMBL5201074,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151465,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at high concentration incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1.Cl.Cl
CHEMBL5184911,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151465,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at high concentration incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,CC(NC(=O)/N=C(\N)NCCCc1nnc(N)s1)c1cccc(F)c1.Cl.Cl
CHEMBL5180504,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151465,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at high concentration incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,Cc1ccc(CC(C)CNC(=O)/N=C(\N)NCCCc2nnc(N)s2)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5202592,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151465,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at high concentration incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,Cc1ccc(CC(C)CNC(=O)/N=C(\N)NCCCc2cnc(N)s2)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5198795,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151465,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at high concentration incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,CC(CCCc1ccccc1)CNC(=O)/N=C(\N)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5176229,CHEMBL217,Dopamine D2 receptor,Kd,=,0.0149,nM,CHEMBL5151465,B,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at high concentration incubated for 140 mins by radioligand competition binding based assay,CHEMBL5149991,KD,N/C(=N\C(=O)NCCCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
